Citrus Sinensis ID: 022956

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------29
Protein Sequence
MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPSP
Secondary Structure (PSIPRED)
ccccccccccccccccccEEcccEEcccccccEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHccccccccccccccccEEEEccccEEEEEEcHHHHHHcccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccccccHHHHHHHHHHHccccccccHHHHHccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccEEEEEEEccccHcHEEEEEEcccccEEEEEEEcHHHHHccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccccEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccEEEccccHHHEEEccccccEEEEcccccccccccccccccccccccccHHHHHccccccEEHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHcccHHccccHHHHHccHHHcccccccccccc
Coil and Loop (DISEMBL)
msdrdgepfvevdpsgrfgrysdllgsgAVKKVYRAFDQEEGIEVAWNQVrlshfsedpvlvnRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCtsgnlrtyrkKHRHVSIKALKKWSKQVLEGLEylhthepciihrdlncsnifingnigqvkigdlGFAAIVGrshaahsiigtpeymapelyeedyTEMVDIYSFGLCLLEMVtmeipysecdSVAKIYKKVtggvkpqalnkvkdpEVKAFIEKCIaqprarpsasellkdpffselndddsepsp
Flexible Loop (DISEMBL)
msdrdgepfvevdpsgrfgrysdllgsGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVctsgnlrtyrkkhRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVtggvkpqalnkvkdpeVKAFIEKCiaqprarpsasellkdpffselndddsepsp
Low Complexity Region (SEG)
MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPSP
Disordered region (IsUnstruct)
*****************FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA*****************************
Disordered Region (DISOPRED)
******E*****DP**RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRL**************SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH**HSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL*KVKDPEVKAFIEKCIAQPRARPSASELLKDPFF************
Disordered Region (DISEMBL)
*********VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSE**********
Disordered Region (DISPRO)
************DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSEL*********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPSP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	289	2.2.26 [Sep-21-2011]
Q6ICW6	314	Probable serine/threonine	yes	no	0.951	0.875	0.785	1e-134
Q0D541	327	Probable serine/threonine	yes	no	0.948	0.837	0.690	1e-118
Q9STK6	516	Probable serine/threonine	no	no	0.927	0.519	0.664	1e-106
Q65X23	621	Probable serine/threonine	no	no	0.951	0.442	0.608	1e-101
Q9CAV6	700	Serine/threonine-protein	no	no	0.961	0.397	0.609	1e-98
Q0D598	704	Probable serine/threonine	no	no	0.927	0.380	0.605	2e-96
A2YMV6	704	Probable serine/threonine	N/A	no	0.927	0.380	0.605	2e-96
Q2V338	492	Probable serine/threonine	no	no	0.941	0.552	0.586	4e-95
Q8S8Y9	568	Serine/threonine-protein	no	no	0.961	0.489	0.573	5e-95
Q8S8Y8	567	Probable serine/threonine	no	no	0.923	0.470	0.589	1e-93

>sp|Q6ICW6|WNK11_ARATH Probable serine/threonine-protein kinase WNK11 OS=Arabidopsis thaliana GN=WNK11 PE=2 SV=1

 Score =  478 bits (1229), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 216/275 (78%), Positives = 253/275 (92%)

Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
           D+D E FVEVDP+GR+GRY +LLGSGAVKKVYRAFDQEEGIEVAWNQV+L  FS+DP + 
Sbjct: 15  DKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSDDPAMT 74

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
            RL+SEV+LL+ LKN  II  Y VW D+++NTLNFITE+CTSGNLR YRKKHRHVS++AL
Sbjct: 75  ERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSMRAL 134

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           KKWSKQ+L+GL+YLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIVG++H AHSI
Sbjct: 135 KKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSI 194

Query: 183 IGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           +GTPE+MAPELYEE+YTEMVDIYS+G+C+LE+V++EIPYSECDSVAKIYK+V+ G+KP+A
Sbjct: 195 LGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLKPEA 254

Query: 243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 277
           LNKV DPE KAFIEKCIAQPRARPSA+ELL DPFF
Sbjct: 255 LNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFF 289

May regulate flowering time by modulating the photoperiod pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q0D541|WNK5_ORYSJ Probable serine/threonine-protein kinase WNK5 OS=Oryza sativa subsp. japonica GN=WNK5 PE=2 SV=1

 Score =  424 bits (1091), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 190/275 (69%), Positives = 237/275 (86%), Gaps = 1/275 (0%)

Query: 12  VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQ 70
           VDP+GRFGRY+D+LG G+VKKVYR FDQEEGIEVAWN+VRL   ++ DP +V RLH+EV+
Sbjct: 48  VDPTGRFGRYADVLGLGSVKKVYRGFDQEEGIEVAWNRVRLRALADRDPAMVERLHAEVR 107

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
           LLR+L +++II  + VWLD     LNFITEVCTSG+LR YR +HRHVS+KALKKW++Q+L
Sbjct: 108 LLRSLHHEHIIGFHKVWLDRDAGVLNFITEVCTSGSLREYRDRHRHVSVKALKKWARQIL 167

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
            GL++LHTH+PCIIHRDLNCSN+FINGN GQVKIGDLG AAIV ++H AH+I+GTPE+MA
Sbjct: 168 LGLDHLHTHDPCIIHRDLNCSNVFINGNTGQVKIGDLGLAAIVDKTHVAHTILGTPEFMA 227

Query: 191 PELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           PELY E YTE VDIYS+G+C+LEMVT E+PY+ECDSV +IY  VT GV P AL +++DPE
Sbjct: 228 PELYTETYTESVDIYSYGMCVLEMVTREMPYAECDSVVQIYHSVTRGVPPAALKRIRDPE 287

Query: 251 VKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 285
           ++AFIE+CI QPR RPSA+ELL+DPFF+ ++DDDS
Sbjct: 288 LRAFIERCIGQPRNRPSAAELLRDPFFAGIDDDDS 322

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1

 Score =  383 bits (984), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 182/274 (66%), Positives = 222/274 (81%), Gaps = 6/274 (2%)

Query: 7   EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH---FSEDPVLVN 63
           E FVE+DP+GR+GRY ++LG GA K+VYRAFDQ EGIEVAWNQV+L      SED   ++
Sbjct: 10  EEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSED---LD 66

Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           RL+SEV LL+TLK+K II  Y+ W+D QH T+N ITEV TSGNLR YRKKH+ V ++ALK
Sbjct: 67  RLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALK 126

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
           KWS+Q+LEGL YLH+H+P +IHRDL C NIFINGN G+VKIGDLG AAI+ R+ +AHS+I
Sbjct: 127 KWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVI 186

Query: 184 GTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           GTPE+MAPELYEEDY  +VDIY+FG+CLLE+VT E PYSEC + A+IY+KVT G+KP AL
Sbjct: 187 GTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAAL 246

Query: 244 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 277
             V DP+V+AFIEKCIA+   R SA ELL DPF 
Sbjct: 247 LNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFL 280

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1

 Score =  367 bits (942), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 168/276 (60%), Positives = 216/276 (78%), Gaps = 1/276 (0%)

Query: 5   DGEP-FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           D EP F EVDP+ R+GRY+++LG GA K VY+AFDQ EG+EVAWNQ+++     +   + 
Sbjct: 13  DTEPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLE 72

Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           RL SEV+LL+TLK+K II  Y+ WLD ++N +NFITEV TSG LR YR KH+ V ++ALK
Sbjct: 73  RLRSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALK 132

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
           KWS+Q+L GL YLH+H+P +IHRDL C NIF+NGN G+VKIGDLG A I+  + +AHSII
Sbjct: 133 KWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSII 192

Query: 184 GTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           GTPE+MAPELY+E+Y E+VDIY+FG+CLLE+VT E PY EC + A+IYKKV+ G KP +L
Sbjct: 193 GTPEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSL 252

Query: 244 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSE 279
            K++DPEV+ FIEKCIA+   R SA ELL DPF  +
Sbjct: 253 AKIEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRD 288

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1

 Score =  359 bits (921), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 172/282 (60%), Positives = 215/282 (76%), Gaps = 4/282 (1%)

Query: 5   DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR 64
           D   FVEVDP+GR+GRY+++LG GA K VYRAFD+ EGIEVAWNQV+L  F + P  + R
Sbjct: 10  DYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER 69

Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
           L+ E+ LL+TLK+K I+  Y+ W+D  +  +NF+TE+ TSG LR YR +H+ V+I+A+K 
Sbjct: 70  LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKH 129

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           W +Q+L GL YLH+H+P +IHRDL C NIF+NGN G+VKIGDLG AAI+ +SHAAH  +G
Sbjct: 130 WCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH-CVG 188

Query: 185 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 244
           TPE+MAPE+YEE Y E+VDIYSFG+C+LEMVT + PYSEC   A+IYKKV  G KP AL 
Sbjct: 189 TPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALY 248

Query: 245 KVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSE 286
           KVKDPEVK FIEKC+A    R SA ELL DPF   L  DD E
Sbjct: 249 KVKDPEVKCFIEKCLATVSLRVSARELLDDPF---LRIDDGE 287

Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1

 Score =  352 bits (902), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 163/269 (60%), Positives = 207/269 (76%), Gaps = 1/269 (0%)

Query: 9   FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 68
           + EVDP+GR+GRY+D+LG GA K VYRAFD+ +G+EVAWNQV+L  F + P  + RL+ E
Sbjct: 17  YAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCE 76

Query: 69  VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 128
           + LL+TLK++ I+  Y+ W+D     +NFITE+ TSG LR YR+KH  V+I A+K W +Q
Sbjct: 77  IHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQ 136

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 188
           +L GL YLH+H+P IIHRDL C NIF+NGN G+VKIGDLG AAI+ +SHA H  +GTPE+
Sbjct: 137 ILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVH-CVGTPEF 195

Query: 189 MAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
           MAPE+YEE+Y E+VDIYSFG+C+LEMVT E PYSEC    +IYKKV  G KP+AL KVKD
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255

Query: 249 PEVKAFIEKCIAQPRARPSASELLKDPFF 277
           P V+ F+EKC+A    R SA ELLKDPF 
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFL 284

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2

 Score =  352 bits (902), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 163/269 (60%), Positives = 207/269 (76%), Gaps = 1/269 (0%)

Query: 9   FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 68
           + EVDP+GR+GRY+D+LG GA K VYRAFD+ +G+EVAWNQV+L  F + P  + RL+ E
Sbjct: 17  YAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCE 76

Query: 69  VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 128
           + LL+TLK++ I+  Y+ W+D     +NFITE+ TSG LR YR+KH  V+I A+K W +Q
Sbjct: 77  IHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQ 136

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 188
           +L GL YLH+H+P IIHRDL C NIF+NGN G+VKIGDLG AAI+ +SHA H  +GTPE+
Sbjct: 137 ILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVH-CVGTPEF 195

Query: 189 MAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
           MAPE+YEE+Y E+VDIYSFG+C+LEMVT E PYSEC    +IYKKV  G KP+AL KVKD
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255

Query: 249 PEVKAFIEKCIAQPRARPSASELLKDPFF 277
           P V+ F+EKC+A    R SA ELLKDPF 
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFL 284

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1

 Score =  347 bits (891), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 160/273 (58%), Positives = 208/273 (76%), Gaps = 1/273 (0%)

Query: 5   DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR 64
           D   +VEVDP+GR+GRY+++LG G+ K VYR FD+ +GIEVAWNQV+L  F + P  + R
Sbjct: 11  DYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQELER 70

Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
           L+ E+ LL+TLK+K I+  Y+ W+D  +  +NF+TE+ TSG LR YR KH+ V+I+A+K 
Sbjct: 71  LYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKN 130

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           W +Q+L GL YLHTH+P +IHRDL C NIFINGN G+VKIGDLG AA +  SHAAH  +G
Sbjct: 131 WCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHC-VG 189

Query: 185 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 244
           TPE+MAPE+Y+E+Y ++VDIYSFG+C+LEMVT + PYSEC   A+IYK+V  G KP  L+
Sbjct: 190 TPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLD 249

Query: 245 KVKDPEVKAFIEKCIAQPRARPSASELLKDPFF 277
           KVKDPEV+ FIEKC+A    R SA ELL D F 
Sbjct: 250 KVKDPEVRGFIEKCLATVSLRLSACELLDDHFL 282

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1

 Score =  347 bits (891), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 160/279 (57%), Positives = 213/279 (76%), Gaps = 1/279 (0%)

Query: 5   DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR 64
           D   FVE+DPSGR+GRY ++LG GA K VYRAFD+ EGIEVAWNQV+L +F+ +P  + +
Sbjct: 10  DCSVFVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNFTRNPEELEK 69

Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
              E+ LL+TL ++ I+  Y+ W+D  + ++NF+TE+ TSG LR YR +HR V+I+A+K+
Sbjct: 70  FFREIHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVKQ 129

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           W KQ+L+GL YLH+  P IIHRDL C NIFINGN G+VKIGDLG AAI+ +SHA    +G
Sbjct: 130 WCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHAVRC-VG 188

Query: 185 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 244
           TPE+MAPE+Y+E+Y E+VD+Y+FG+C+LEMVT + PYSEC   A+IYKKVT G KP+A  
Sbjct: 189 TPEFMAPEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKKPEAFY 248

Query: 245 KVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDD 283
            VKDPEV+ F+EKC+A    R +A ELL+DPF  + N D
Sbjct: 249 LVKDPEVREFVEKCLANVTCRLTALELLQDPFLQDDNMD 287

Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1

 Score =  343 bits (879), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 158/268 (58%), Positives = 210/268 (78%), Gaps = 1/268 (0%)

Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
           +EVDP+ R+ RY +++G GA K VY+AFD+ +GIEVAWNQVR+    + P  + RL+SEV
Sbjct: 19  LEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEV 78

Query: 70  QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
           +LL++LK+  II  Y+ W+DD++ T+N ITE+ TSG+LR YRKKHR V++KA+K W++Q+
Sbjct: 79  RLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQI 138

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 189
           L GL YLH  EP IIHRDL C NIFINGN G+VKIGDLG A ++ +++A  S+IGTPE+M
Sbjct: 139 LMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAK-SVIGTPEFM 197

Query: 190 APELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
           APELY+E+Y E+ DIYSFG+C+LEMVT + PY EC + A+IYKKV+ G+KP +L++VKDP
Sbjct: 198 APELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDP 257

Query: 250 EVKAFIEKCIAQPRARPSASELLKDPFF 277
           EVK FIEKC+     R SA ELL DPF 
Sbjct: 258 EVKQFIEKCLLPASERLSAKELLLDPFL 285

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	289
449444502	296	PREDICTED: probable serine/threonine-pro	0.989	0.966	0.891	1e-152
224131782	297	predicted protein [Populus trichocarpa]	0.993	0.966	0.860	1e-149
356501717	297	PREDICTED: probable serine/threonine-pro	0.989	0.962	0.857	1e-145
357495365	294	MAP kinase-like protein [Medicago trunca	0.975	0.959	0.851	1e-144
356551711	297	PREDICTED: probable serine/threonine-pro	0.989	0.962	0.850	1e-144
359485884	301	PREDICTED: probable serine/threonine-pro	0.982	0.943	0.848	1e-144
296084996	831	unnamed protein product [Vitis vinifera]	0.982	0.341	0.848	1e-144
356569661	298	PREDICTED: probable serine/threonine-pro	0.986	0.956	0.796	1e-139
356524330	298	PREDICTED: probable serine/threonine-pro	0.993	0.963	0.780	1e-136
356552725	299	PREDICTED: probable serine/threonine-pro	0.975	0.943	0.787	1e-136

>gi|449444502|ref|XP_004140013.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Cucumis sativus] gi|449505109|ref|XP_004162379.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Cucumis sativus]

 Score =  542 bits (1397), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 255/286 (89%), Positives = 268/286 (93%)

Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
           DRD EPFVEVDP+GRFGRY DLLGSGAVKKVYRAFDQEEGIEVAWNQVRL +FS DPV +
Sbjct: 10  DRDAEPFVEVDPTGRFGRYDDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLRNFSGDPVFI 69

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
           NRL SEVQLL TL NKYIIVCYSVW DD+HNTLNFITEVCTSGNLR YRKKHRHVSIKAL
Sbjct: 70  NRLRSEVQLLSTLNNKYIIVCYSVWNDDEHNTLNFITEVCTSGNLRDYRKKHRHVSIKAL 129

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           KKWSKQVLEGL+YLHTHEPCIIHRDLNCSNIF+NGNIGQVKIGDLGFAAIVGRSHAAHSI
Sbjct: 130 KKWSKQVLEGLDYLHTHEPCIIHRDLNCSNIFVNGNIGQVKIGDLGFAAIVGRSHAAHSI 189

Query: 183 IGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           IGTPEYMAPELYEEDYTEMVDIYSF +CLLEMVTMEIPYSECDSVAKIYKKVT G+KPQA
Sbjct: 190 IGTPEYMAPELYEEDYTEMVDIYSFAMCLLEMVTMEIPYSECDSVAKIYKKVTTGIKPQA 249

Query: 243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPS 288
           + KV D EV+AFIEKCIAQPRARPSASELLKDPFF E+ D+DSE +
Sbjct: 250 ITKVTDAEVRAFIEKCIAQPRARPSASELLKDPFFDEVRDEDSEQT 295

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224131782|ref|XP_002321177.1| predicted protein [Populus trichocarpa] gi|222861950|gb|EEE99492.1| predicted protein [Populus trichocarpa]

 Score =  535 bits (1377), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 247/287 (86%), Positives = 272/287 (94%)

Query: 2   SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 61
           SDRD EPFVEVDP+GRFGRY+DLLG+GAVKKVYRAFDQ EGIEVAWNQVRL +F EDPVL
Sbjct: 9   SDRDDEPFVEVDPTGRFGRYNDLLGAGAVKKVYRAFDQHEGIEVAWNQVRLRNFIEDPVL 68

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           +NRLHSEVQLLRTLKNKYIIVCYSVWLD++  +LNFITEVCTSGNLR YRKKHRHVS+KA
Sbjct: 69  INRLHSEVQLLRTLKNKYIIVCYSVWLDEEDTSLNFITEVCTSGNLRDYRKKHRHVSLKA 128

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           LK+WSKQVLEGLE+LHTH+PC+IHRDLNCSNIF+NGN GQVKIGDLGFA IVG+SH AHS
Sbjct: 129 LKRWSKQVLEGLEFLHTHDPCVIHRDLNCSNIFVNGNSGQVKIGDLGFATIVGKSHTAHS 188

Query: 182 IIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           I+GTPE+MAPELYEEDYTEMVDIYSFG+CLLEMVTMEIPYSECD+VAKIYKKVT GVKPQ
Sbjct: 189 ILGTPEFMAPELYEEDYTEMVDIYSFGMCLLEMVTMEIPYSECDNVAKIYKKVTSGVKPQ 248

Query: 242 ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPS 288
           ALNKV DPEVKAFI KCIA+PRARPSAS+LLKD FFSE+NDD++ P+
Sbjct: 249 ALNKVADPEVKAFILKCIAEPRARPSASDLLKDTFFSEVNDDETVPA 295

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356501717|ref|XP_003519670.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  520 bits (1340), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 246/287 (85%), Positives = 267/287 (93%), Gaps = 1/287 (0%)

Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
           D + E FVEVDP+GRFGRYSDLLG GAVKKVYRAFDQEEGIEVAWNQVRL +FSEDPVL+
Sbjct: 10  DNEVEAFVEVDPTGRFGRYSDLLGCGAVKKVYRAFDQEEGIEVAWNQVRLRNFSEDPVLI 69

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
           NRLHSEV LLRTL NKYIIVCYSVW D++ + +NFITEVCTSGNLR YRKKHRHVSIKA 
Sbjct: 70  NRLHSEVDLLRTLSNKYIIVCYSVWKDEERHNINFITEVCTSGNLRDYRKKHRHVSIKAF 129

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           KKWSKQVLEGLEYLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIVGR+HAAHSI
Sbjct: 130 KKWSKQVLEGLEYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGRNHAAHSI 189

Query: 183 IGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           +GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVT EIPYSECDSVAKIYKKVT G+KP+A
Sbjct: 190 LGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTTEIPYSECDSVAKIYKKVTMGIKPEA 249

Query: 243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPSP 289
           L+KV DPEVK FIEKCIAQPRARPSA++LLKDPFF ELN+D+ E +P
Sbjct: 250 LSKVTDPEVKEFIEKCIAQPRARPSATDLLKDPFFYELNNDE-ESTP 295

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357495365|ref|XP_003617971.1| MAP kinase-like protein [Medicago truncatula] gi|355519306|gb|AET00930.1| MAP kinase-like protein [Medicago truncatula]

 Score =  518 bits (1333), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 240/282 (85%), Positives = 263/282 (93%)

Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
           D + EPF EVDP+GR+GRY+DLLGSGAVK+VYR FDQEEGIEVAWNQV+L +FS DPVL+
Sbjct: 7   DGEVEPFAEVDPTGRYGRYNDLLGSGAVKRVYRGFDQEEGIEVAWNQVKLRNFSNDPVLI 66

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
           NRLHSEV+LLR L NKYIIVCYSVW DD+   +NFITEVCTSGNLR YRKKHRHVSIKA 
Sbjct: 67  NRLHSEVELLRNLSNKYIIVCYSVWKDDERGNINFITEVCTSGNLRDYRKKHRHVSIKAF 126

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           KKWSKQVLEGLEYLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIVGR+HAAHSI
Sbjct: 127 KKWSKQVLEGLEYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGRTHAAHSI 186

Query: 183 IGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           +GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVTMEIPYSECDSVAKIYKKVT G+KPQA
Sbjct: 187 LGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTMEIPYSECDSVAKIYKKVTMGIKPQA 246

Query: 243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
           L+ V++PEVKAFIEKCIAQPRARPSA++LLKDPFF ELN D+
Sbjct: 247 LSNVREPEVKAFIEKCIAQPRARPSATDLLKDPFFFELNSDE 288

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551711|ref|XP_003544217.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  517 bits (1332), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 244/287 (85%), Positives = 266/287 (92%), Gaps = 1/287 (0%)

Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
           D + E FVEVDP+GRFGRYSDLLG GAVKKVY AFDQEEGIEVAWNQVRL +FSEDPVL+
Sbjct: 10  DSEVEAFVEVDPTGRFGRYSDLLGCGAVKKVYSAFDQEEGIEVAWNQVRLRNFSEDPVLI 69

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
           NRLHSEV+LLRTL NKYIIVCYSVW D++ + +NFITEVCTSGNLR YRKKHRHVSIK  
Sbjct: 70  NRLHSEVELLRTLSNKYIIVCYSVWKDEERHNINFITEVCTSGNLRDYRKKHRHVSIKVF 129

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           KKWSKQVLEGLEYLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIVGR+HAAHSI
Sbjct: 130 KKWSKQVLEGLEYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGRNHAAHSI 189

Query: 183 IGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           +GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVT EIPYSECDSVAKIYKKVT G+KP+A
Sbjct: 190 LGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTTEIPYSECDSVAKIYKKVTMGIKPEA 249

Query: 243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPSP 289
           L+KV DPEVK FIEKCIAQPRARPSA++LLKDPFF ELN+D+ E +P
Sbjct: 250 LSKVTDPEVKEFIEKCIAQPRARPSATDLLKDPFFYELNNDE-ESTP 295

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485884|ref|XP_002270768.2| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Vitis vinifera]

 Score =  515 bits (1327), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 241/284 (84%), Positives = 264/284 (92%)

Query: 2   SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 61
           SD D EPFVEVDP+GR+GRYSDLLG GAVKKVYRAFDQEEGIEVAWNQV+L +FSED  +
Sbjct: 9   SDHDTEPFVEVDPTGRYGRYSDLLGHGAVKKVYRAFDQEEGIEVAWNQVQLRNFSEDKSM 68

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V+RLHSEV+LL TLKN+ IIV YSVW D++HNTLNFITEVCTSGNLR YRK+HRHVSIKA
Sbjct: 69  VDRLHSEVKLLSTLKNESIIVLYSVWKDNEHNTLNFITEVCTSGNLRDYRKRHRHVSIKA 128

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           LKKWS+QVL+GLEYLHTH+PCIIHRDLNCSNIFINGNIGQVKIGDLG AAIVG++H AHS
Sbjct: 129 LKKWSRQVLKGLEYLHTHDPCIIHRDLNCSNIFINGNIGQVKIGDLGLAAIVGKNHLAHS 188

Query: 182 IIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           ++GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVTMEIPYSECD++AKIYKKVT GV P 
Sbjct: 189 VLGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTMEIPYSECDNIAKIYKKVTSGVGPL 248

Query: 242 ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 285
           A+NKV DPEVK FIEKCIAQPRARPSASELL DPFFSELND D+
Sbjct: 249 AMNKVSDPEVKFFIEKCIAQPRARPSASELLNDPFFSELNDGDA 292

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296084996|emb|CBI28411.3| unnamed protein product [Vitis vinifera]

 Score =  515 bits (1326), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 241/284 (84%), Positives = 264/284 (92%)

Query: 2   SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 61
           SD D EPFVEVDP+GR+GRYSDLLG GAVKKVYRAFDQEEGIEVAWNQV+L +FSED  +
Sbjct: 539 SDHDTEPFVEVDPTGRYGRYSDLLGHGAVKKVYRAFDQEEGIEVAWNQVQLRNFSEDKSM 598

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V+RLHSEV+LL TLKN+ IIV YSVW D++HNTLNFITEVCTSGNLR YRK+HRHVSIKA
Sbjct: 599 VDRLHSEVKLLSTLKNESIIVLYSVWKDNEHNTLNFITEVCTSGNLRDYRKRHRHVSIKA 658

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           LKKWS+QVL+GLEYLHTH+PCIIHRDLNCSNIFINGNIGQVKIGDLG AAIVG++H AHS
Sbjct: 659 LKKWSRQVLKGLEYLHTHDPCIIHRDLNCSNIFINGNIGQVKIGDLGLAAIVGKNHLAHS 718

Query: 182 IIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           ++GTPEYMAPELYEEDYTEMVDIYSFG+CLLEMVTMEIPYSECD++AKIYKKVT GV P 
Sbjct: 719 VLGTPEYMAPELYEEDYTEMVDIYSFGMCLLEMVTMEIPYSECDNIAKIYKKVTSGVGPL 778

Query: 242 ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 285
           A+NKV DPEVK FIEKCIAQPRARPSASELL DPFFSELND D+
Sbjct: 779 AMNKVSDPEVKFFIEKCIAQPRARPSASELLNDPFFSELNDGDA 822

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356569661|ref|XP_003553016.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  501 bits (1289), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 227/285 (79%), Positives = 266/285 (93%)

Query: 2   SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 61
           SD+D EPFVEVDP+ R+GRYS+LLGSGAVKKVYRAFDQEEGIEVAWNQV+L +FS+DP +
Sbjct: 9   SDKDSEPFVEVDPTRRYGRYSELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRNFSDDPAM 68

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           ++RL+SEV+LLR+L NK II  YSVW D++HNTLNFITEVCTSGNLR YRKKHRHVS++A
Sbjct: 69  LDRLYSEVRLLRSLTNKNIISLYSVWRDEKHNTLNFITEVCTSGNLRKYRKKHRHVSMRA 128

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           LKKWSKQ+LEGL YLH H+PCIIHRDLNCSN+F+NGN GQVKIGDLG AAIVG+SH+AHS
Sbjct: 129 LKKWSKQILEGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAIVGKSHSAHS 188

Query: 182 IIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           I+GTPE+MAPELY+EDYTEMVDIYSFG+C+LEMVT+EIPYSECDSVAKIYKKV+ GV+PQ
Sbjct: 189 ILGTPEFMAPELYDEDYTEMVDIYSFGMCVLEMVTLEIPYSECDSVAKIYKKVSSGVRPQ 248

Query: 242 ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSE 286
           ALNK+KD EVKAFIE+C+AQPRARPSA+ELLKDPFF  L+ D+++
Sbjct: 249 ALNKIKDAEVKAFIERCLAQPRARPSAAELLKDPFFDVLDGDEND 293

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356524330|ref|XP_003530782.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  491 bits (1265), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 224/287 (78%), Positives = 265/287 (92%)

Query: 2   SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 61
           SD+D EPFVEVDP+ R+GRYS+LLG GAVKKVYRAFDQEEGIEVAWNQV+L +FS DP +
Sbjct: 9   SDKDSEPFVEVDPTRRYGRYSELLGYGAVKKVYRAFDQEEGIEVAWNQVKLRNFSYDPSM 68

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V+RL+SEV+LLR+L NK II  YSVW +++HNTLNFITEVCTSGNLR YRKKH+HVS++A
Sbjct: 69  VDRLYSEVRLLRSLTNKNIISLYSVWREEKHNTLNFITEVCTSGNLREYRKKHKHVSMRA 128

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           LKKWSKQ+LEGL YLH H+PCIIHRDLNCSN+F+NGN GQVKIGDLG AAIVG++H+AHS
Sbjct: 129 LKKWSKQILEGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAIVGKNHSAHS 188

Query: 182 IIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           I+GTPE+MAPELYEEDYTEMVDIYSFG+C+LEMVT+EIPY+ECDSVAKIYKKV+ GV+PQ
Sbjct: 189 ILGTPEFMAPELYEEDYTEMVDIYSFGMCVLEMVTLEIPYNECDSVAKIYKKVSSGVRPQ 248

Query: 242 ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEPS 288
           ALNK+KD EVKAF+E+C+AQPRARPSA+ELLKDPFF  L+ D+++ S
Sbjct: 249 ALNKIKDAEVKAFVERCLAQPRARPSAAELLKDPFFDVLDCDENDDS 295

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552725|ref|XP_003544713.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  490 bits (1262), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 222/282 (78%), Positives = 259/282 (91%)

Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
           D+D EPFVE DP+GR+GRYS+LLG GAVKKVYRAFDQEEGIEVAWNQV+L +F +DP ++
Sbjct: 8   DKDSEPFVETDPTGRYGRYSELLGCGAVKKVYRAFDQEEGIEVAWNQVKLRNFCDDPAML 67

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
           +RL+SEV+LLR+L NK II  Y+VW D+Q NTLNFITEVCTSGNLR YRKKHRHVSIKAL
Sbjct: 68  DRLYSEVRLLRSLSNKNIIALYNVWRDEQRNTLNFITEVCTSGNLREYRKKHRHVSIKAL 127

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           KKWSKQ+L+GL YLH H+PCIIHRDLNCSN+F+NGN GQVKIGDLG A IVG++H AH+I
Sbjct: 128 KKWSKQILKGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLATIVGKNHCAHTI 187

Query: 183 IGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           +GTPE+MAPELY+EDYTE+VDIYSFG+C+LEMVT+EIPYSECD+VAKIYKKV+ GV+P A
Sbjct: 188 LGTPEFMAPELYDEDYTELVDIYSFGMCVLEMVTVEIPYSECDNVAKIYKKVSSGVRPAA 247

Query: 243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
           LNKVKDPEVKAFIEKC+AQPRARPSA+ELL+DPFF E+ DDD
Sbjct: 248 LNKVKDPEVKAFIEKCLAQPRARPSAAELLRDPFFDEIVDDD 289

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	289
TAIR|locus:2176135	314	AT5G55560 [Arabidopsis thalian	0.982	0.904	0.774	2.4e-124
TAIR|locus:504955638	516	WNK3 "with no lysine (K) kinas	0.923	0.517	0.670	6.6e-97
TAIR|locus:2114845	700	WNK1 "with no lysine (K) kinas	0.961	0.397	0.609	5e-92
TAIR|locus:2182039	492	WNK9 [Arabidopsis thaliana (ta	0.968	0.569	0.570	1.6e-88
TAIR|locus:2165790	563	WNK8 "with no lysine (K) kinas	0.982	0.504	0.561	7.7e-87
TAIR|locus:2093994	567	WNK6 "with no lysine (K) kinas	0.934	0.476	0.588	2.6e-86
TAIR|locus:2028521	557	WNK7 [Arabidopsis thaliana (ta	0.927	0.481	0.572	1.7e-84
TAIR|locus:2019404	524	WNK10 "with no lysine (K) kina	0.955	0.526	0.570	1.7e-84
TAIR|locus:2161278	571	WNK4 "with no lysine (K) kinas	0.934	0.472	0.566	1.7e-84
TAIR|locus:2098242	549	WNK5 "with no lysine (K) kinas	0.986	0.519	0.548	9.1e-84

TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)]

 Score = 1222 (435.2 bits), Expect = 2.4e-124, P = 2.4e-124
 Identities = 220/284 (77%), Positives = 258/284 (90%)

Query:     3 DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
             D+D E FVEVDP+GR+GRY +LLGSGAVKKVYRAFDQEEGIEVAWNQV+L  FS+DP + 
Sbjct:    15 DKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSDDPAMT 74

Query:    63 NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
              RL+SEV+LL+ LKN  II  Y VW D+++NTLNFITE+CTSGNLR YRKKHRHVS++AL
Sbjct:    75 ERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSMRAL 134

Query:   123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
             KKWSKQ+L+GL+YLHTH+PCIIHRDLNCSNIF+NGNIGQVKIGDLG AAIVG++H AHSI
Sbjct:   135 KKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSI 194

Query:   183 IGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
             +GTPE+MAPELYEE+YTEMVDIYS+G+C+LE+V++EIPYSECDSVAKIYK+V+ G+KP+A
Sbjct:   195 LGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLKPEA 254

Query:   243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSE 286
             LNKV DPE KAFIEKCIAQPRARPSA+ELL DPFF  + DDD E
Sbjct:   255 LNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFFDGILDDDDE 298

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010260 "organ senescence" evidence=RCA

TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 963 (344.1 bits), Expect = 6.6e-97, P = 6.6e-97
 Identities = 183/273 (67%), Positives = 223/273 (81%)

Query:     7 EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH-F--SEDPVLVN 63
             E FVE+DP+GR+GRY ++LG GA K+VYRAFDQ EGIEVAWNQV+L   F  SED   ++
Sbjct:    10 EEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSED---LD 66

Query:    64 RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
             RL+SEV LL+TLK+K II  Y+ W+D QH T+N ITEV TSGNLR YRKKH+ V ++ALK
Sbjct:    67 RLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALK 126

Query:   124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
             KWS+Q+LEGL YLH+H+P +IHRDL C NIFINGN G+VKIGDLG AAI+ R+ +AHS+I
Sbjct:   127 KWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVI 186

Query:   184 GTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
             GTPE+MAPELYEEDY  +VDIY+FG+CLLE+VT E PYSEC + A+IY+KVT G+KP AL
Sbjct:   187 GTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAAL 246

Query:   244 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPF 276
               V DP+V+AFIEKCIA+   R SA ELL DPF
Sbjct:   247 LNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPF 279

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 917 (327.9 bits), Expect = 5.0e-92, P = 5.0e-92
 Identities = 172/282 (60%), Positives = 215/282 (76%)

Query:     5 DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR 64
             D   FVEVDP+GR+GRY+++LG GA K VYRAFD+ EGIEVAWNQV+L  F + P  + R
Sbjct:    10 DYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLER 69

Query:    65 LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
             L+ E+ LL+TLK+K I+  Y+ W+D  +  +NF+TE+ TSG LR YR +H+ V+I+A+K 
Sbjct:    70 LYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKH 129

Query:   125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
             W +Q+L GL YLH+H+P +IHRDL C NIF+NGN G+VKIGDLG AAI+ +SHAAH + G
Sbjct:   130 WCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV-G 188

Query:   185 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 244
             TPE+MAPE+YEE Y E+VDIYSFG+C+LEMVT + PYSEC   A+IYKKV  G KP AL 
Sbjct:   189 TPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALY 248

Query:   245 KVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSE 286
             KVKDPEVK FIEKC+A    R SA ELL DPF   L  DD E
Sbjct:   249 KVKDPEVKCFIEKCLATVSLRVSARELLDDPF---LRIDDGE 287

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IEP

GO:0016020 "membrane" evidence=IDA

TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)]

 Score = 884 (316.2 bits), Expect = 1.6e-88, P = 1.6e-88
 Identities = 161/282 (57%), Positives = 213/282 (75%)

Query:     3 DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
             + D   +VEVDP+GR+GRY+++LG G+ K VYR FD+ +GIEVAWNQV+L  F + P  +
Sbjct:     9 ESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQEL 68

Query:    63 NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
              RL+ E+ LL+TLK+K I+  Y+ W+D  +  +NF+TE+ TSG LR YR KH+ V+I+A+
Sbjct:    69 ERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 128

Query:   123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
             K W +Q+L GL YLHTH+P +IHRDL C NIFINGN G+VKIGDLG AA +  SHAAH +
Sbjct:   129 KNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCV 188

Query:   183 IGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
              GTPE+MAPE+Y+E+Y ++VDIYSFG+C+LEMVT + PYSEC   A+IYK+V  G KP  
Sbjct:   189 -GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDG 247

Query:   243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
             L+KVKDPEV+ FIEKC+A    R SA ELL D F   +++ D
Sbjct:   248 LDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLC-IDESD 288

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 868 (310.6 bits), Expect = 7.7e-87, P = 7.7e-87
 Identities = 160/285 (56%), Positives = 211/285 (74%)

Query:     1 MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV 60
             +S  +   F E DPSGR+ RY D+LG GA K VY+AFD+ +GIEVAWN V +    + P 
Sbjct:    11 ISSMEEADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPG 70

Query:    61 LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 120
              + RL+SEV LL+ LK++ II  +  W+D+++ T+N ITE+ TSG+LR YRKKHR V  K
Sbjct:    71 QLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPK 130

Query:   121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
             A+K W++Q+L+GL YLH+  P +IHRDL C NIF+NGN G+VKIGDLG A ++ +   A 
Sbjct:   131 AIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVL-QQPTAR 189

Query:   181 SIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 240
             S+IGTPE+MAPELYEE+Y E+VDIYSFG+C+LEMVT E PY+EC + A+IYKKVT  +KP
Sbjct:   190 SVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKP 249

Query:   241 QALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 285
             Q+L KV DP+V+ FIEKC+    +RP+A EL KDPF +     DS
Sbjct:   250 QSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDS 294

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0006468 "protein phosphorylation" evidence=IDA;TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0048573 "photoperiodism, flowering" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0009911 "positive regulation of flower development" evidence=IMP

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA;IMP

GO:0009909 "regulation of flower development" evidence=IMP

GO:0006865 "amino acid transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0016926 "protein desumoylation" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0050665 "hydrogen peroxide biosynthetic process" evidence=RCA

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
 Identities = 160/272 (58%), Positives = 213/272 (78%)

Query:    10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
             +EVDP+ R+ RY +++G GA K VY+AFD+ +GIEVAWNQVR+    + P  + RL+SEV
Sbjct:    19 LEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEV 78

Query:    70 QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
             +LL++LK+  II  Y+ W+DD++ T+N ITE+ TSG+LR YRKKHR V++KA+K W++Q+
Sbjct:    79 RLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQI 138

Query:   130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 189
             L GL YLH  EP IIHRDL C NIFINGN G+VKIGDLG A ++ +++A  S+IGTPE+M
Sbjct:   139 LMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAK-SVIGTPEFM 197

Query:   190 APELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
             APELY+E+Y E+ DIYSFG+C+LEMVT + PY EC + A+IYKKV+ G+KP +L++VKDP
Sbjct:   198 APELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDP 257

Query:   250 EVKAFIEKCIAQPRARPSASELLKDPFFSELN 281
             EVK FIEKC+     R SA ELL DPF  +LN
Sbjct:   258 EVKQFIEKCLLPASERLSAKELLLDPFL-QLN 288

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)]

 Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
 Identities = 154/269 (57%), Positives = 211/269 (78%)

Query:    10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
             +E+DP+ R+ RY +++G GA K V++ FD+ +GIEVAWNQVR+    + P  + RL+SEV
Sbjct:    19 LEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEV 78

Query:    70 QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
             +LL++LK+K II  Y+ W+DD++ T+N ITE+ TSG+LR YRKKHR V++KA+K W++Q+
Sbjct:    79 RLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQI 138

Query:   130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 189
             L GL+YLH+ +P IIHRD+ C NIFINGN G+VKIGDLG A ++ +++A  S+IGTPE+M
Sbjct:   139 LTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAK-SVIGTPEFM 197

Query:   190 APELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
             APELY+E+Y E+ DIYSFG+C+LEMVT E PY EC + A+IYKKV+ G+KP +L+KVKDP
Sbjct:   198 APELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDP 257

Query:   250 EVKAFIEKCIAQPRARPSASELLKDPFFS 278
             EV  FIEKC+     R SA ELL D F +
Sbjct:   258 EVMKFIEKCLLPASERLSAEELLLDSFLN 286

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
 Identities = 158/277 (57%), Positives = 208/277 (75%)

Query:     9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 68
             FV+ DP+GR+ RY+D+LG GA K VY+AFD+ EGIEVAWN + +    + P  ++RL+SE
Sbjct:     6 FVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSE 65

Query:    69 VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 128
             V LL +LK+  II  +  W+DD + ++N ITE+ TSG+L  YRKKHR V  KA+  W++Q
Sbjct:    66 VHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQ 125

Query:   129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 188
             +L+GL YLH+  P +IHRDL C NIF+NGN G+VKIGDLG AA++ +   A S+IGTPE+
Sbjct:   126 ILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVM-QQPTARSVIGTPEF 184

Query:   189 MAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
             MAPELYEE+Y E+VDIYSFG+C+LEMVT E PY EC + A+IYKKVT G+KPQ+L+KV D
Sbjct:   185 MAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDD 244

Query:   249 PEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS 285
             P+VK FIEKC+    +RP+A ELLKD   +     DS
Sbjct:   245 PQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDS 281

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=ISS

TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
 Identities = 153/270 (56%), Positives = 204/270 (75%)

Query:     9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 68
             +VE DP+GR+GR++++LG GA+K VY+A D++ GIEVAW+QV+L       V + RL+SE
Sbjct:     9 YVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSE 68

Query:    69 VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 128
             V LL TL +K II  Y+ W+D  ++TLNFITE+ TSG LR Y+ K+  + I+A+K W++Q
Sbjct:    69 VHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQ 128

Query:   129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 188
             +LEGL YLH H+P +IHRDL C NIF+NG++GQVKIGDLG A ++   H+AHSIIGTPE+
Sbjct:   129 ILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEF 188

Query:   189 MAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
             MAPELYEE+Y E++D+YSFG+C LEM+T E PYSEC+  A+IYKKV GG  P A  +V D
Sbjct:   189 MAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGD 248

Query:   249 PEVKAFIEKCIAQPRARPSASELLKDPFFS 278
              E + FI KC+     R SA ELL+DPF +
Sbjct:   249 IEAQRFIGKCLVSASKRVSAKELLQDPFLA 278

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010260 "organ senescence" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
 Identities = 157/286 (54%), Positives = 207/286 (72%)

Query:     2 SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 61
             SD D   +VE DPSGR+GR+ ++LG GA+K VY+AFDQ  G+EVAWNQV+L+     P  
Sbjct:     9 SD-DSIAYVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEP 67

Query:    62 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
             + RL+SEV LL+ L ++ II   + W+D    T NFITE+ TSG LR YR+K++ V I+A
Sbjct:    68 LQRLYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRA 127

Query:   122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
             +K W++Q+L GL YLH H+P +IHRDL C NIF+NG++GQVKIGDLG AAI+  S  AHS
Sbjct:   128 IKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHS 187

Query:   182 IIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
             +IGTPE+MAPELYEEDY E+VDIYSFG+C+LEM+T E PYSEC + A+IYKKVT G  P 
Sbjct:   188 VIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPD 247

Query:   242 ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDDSEP 287
             + + ++  E + F+ KC+     R  A ELL DPF +  ++ D  P
Sbjct:   248 SFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLAP 293

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0043424 "protein histidine kinase binding" evidence=IPI

GO:0048573 "photoperiodism, flowering" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6ICW6	WNK11_ARATH	2, ., 7, ., 1, 1, ., 1	0.7854	0.9515	0.8757	yes	no
Q0D541	WNK5_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.6909	0.9480	0.8379	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	289
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-66
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-65
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-55
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-48
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-48
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-44
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-44
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-43
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-41
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-40
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-40
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-37
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-37
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-36
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-35
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-35
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-33
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-32
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-32
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-32
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-31
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-30
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-30
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-30
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-30
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-30
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-29
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-28
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-28
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-26
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-26
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-25
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-25
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-25
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-25
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-24
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-24
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-23
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-22
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-22
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-21
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-21
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-20
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-19
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-18
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-18
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-17
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-17
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-16
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-06
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-05
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.001
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  208 bits (531), Expect = 1e-66
 Identities = 85/258 (32%), Positives = 134/258 (51%), Gaps = 11/258 (4%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + LG G+  KVY A D++ G  VA   ++     +D     R+  E+++L+ LK+  I+ 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR---ERILREIKILKKLKHPNIVR 61

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            Y V+ D+    L  + E C  G+L    KK   +S    + + +Q+L  LEYLH+    
Sbjct: 62  LYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK--G 117

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           I+HRDL   NI ++ + G VK+ D G A  +       + +GTPEYMAPE L  + Y + 
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-TGGVKPQALNKVKDPEVKAFIEKCIA 260
           VDI+S G+ L E++T + P+   D + +++KK+               PE K  I K + 
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236

Query: 261 Q-PRARPSASELLKDPFF 277
           + P  R +A E L+ PFF
Sbjct: 237 KDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  204 bits (522), Expect = 3e-65
 Identities = 89/259 (34%), Positives = 142/259 (54%), Gaps = 10/259 (3%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           LLG G+   VY A D++ G  +A   V LS  SE+   +  L  E+++L +L++  I+  
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE--ELEALEREIRILSSLQHPNIVRY 64

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           Y    D++ NTLN   E  + G+L +  KK   +    ++K+++Q+LEGL YLH++   I
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN--GI 122

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA---HSIIGTPEYMAPELYE-EDYT 199
           +HRD+  +NI ++ + G VK+ D G A  +G         S+ GTP +MAPE+   E+Y 
Sbjct: 123 VHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC- 258
              DI+S G  ++EM T + P+SE  +      K+    +P  + +    E K F+ KC 
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCL 241

Query: 259 IAQPRARPSASELLKDPFF 277
              P+ RP+A ELL+ PF 
Sbjct: 242 RRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  183 bits (467), Expect = 5e-57
 Identities = 85/261 (32%), Positives = 131/261 (50%), Gaps = 15/261 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG+   VY+A  +  G  VA   ++     E          E+++LR L +  I+   
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             + D  H  L  + E C  G+L  Y  +   +S    KK + Q+L GLEYLH++   II
Sbjct: 65  DAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--II 120

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPE--LYEEDYTEM 201
           HRDL   NI ++ N G VKI D G A  ++  S +  + +GTP YMAPE  L    Y   
Sbjct: 121 HRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVKPQALNKV-KDPEVKAFIEK 257
           VD++S G+ L E++T + P+S  + +     I + +   ++           E K  I+K
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 258 CIAQ-PRARPSASELLKDPFF 277
           C+ + P  RP+A E+L+ P+F
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (451), Expect = 3e-55
 Identities = 78/256 (30%), Positives = 124/256 (48%), Gaps = 46/256 (17%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G    VY A D++ G +VA   ++    S    L+  L  E+++L+ L +  I+  Y
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLY 57

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V+ D+ H  L  + E C  G+L+   ++    +S   + +   Q+LEGLEYLH++   I
Sbjct: 58  GVFEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--I 113

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYEE--DYTE 200
           IHRDL   NI ++ + G+VK+ D G + ++    +   +I+GTP YMAPE+      Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
             DI+S G+ L E+                                  PE+K  I K + 
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199

Query: 261 Q-PRARPSASELLKDP 275
           + P  RPSA E+L+  
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  161 bits (411), Expect = 1e-48
 Identities = 82/261 (31%), Positives = 139/261 (53%), Gaps = 14/261 (5%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
              + +G G   +VY+A  +  G EVA   ++L    +      ++ +E+Q+L+  K+  
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK----EKIINEIQILKKCKHPN 58

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHT 138
           I+  Y  +L    + L  + E C+ G+L+   K      +   +    K++L+GLEYLH+
Sbjct: 59  IVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 197
           +   IIHRD+  +NI +  + G+VK+ D G +A +  + A ++++GTP +MAPE +  + 
Sbjct: 117 NG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           Y    DI+S G+  +E+   + PYSE   +  ++K  T G  P   N  K   E K F++
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLK 232

Query: 257 KC-IAQPRARPSASELLKDPF 276
           KC    P  RP+A +LLK PF
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  159 bits (405), Expect = 9e-48
 Identities = 70/262 (26%), Positives = 131/262 (50%), Gaps = 16/262 (6%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             +G G+  KVY    + +G      ++ LS+ SE         +EV++L+ L +  II 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER--EDALNEVKILKKLNHPNIIK 63

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            Y  + +     L  + E    G+L    +  +K+ +    + +  W  Q+   L+YLH+
Sbjct: 64  YYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEED 197
            +  I+HRD+   NIF+  N G VK+GD G + ++  +   A +++GTP Y++PEL +  
Sbjct: 122 RK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178

Query: 198 -YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
            Y    DI+S G  L E+ T++ P+ E +++ ++  K+  G +   +      E++  + 
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSELRNLVS 236

Query: 257 KCI-AQPRARPSASELLKDPFF 277
             +   P  RPS +++L+ PF 
Sbjct: 237 SLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  151 bits (383), Expect = 2e-44
 Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 18/266 (6%)

Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
            + +G G   KVY A + + G  +A  ++R+     DP  +  +  E+++L  LK+  ++
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ--DNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
             Y V +      +    E C+ G L    +  R +    ++ ++ Q+LEGL YLH+H  
Sbjct: 63  KYYGVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG- 119

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-----HSIIGTPEYMAPELYEE 196
            I+HRD+  +NIF++ N G +K+GD G A  +  +         S+ GTP YMAPE+   
Sbjct: 120 -IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 197 D----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV-KDPEV 251
                +    DI+S G  +LEM T + P+SE D+  +I   V  G KP   + +   PE 
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237

Query: 252 KAFIEKCIAQ-PRARPSASELLKDPF 276
           K F+++C+   P+ RP+ASELL+ PF
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 3e-44
 Identities = 87/265 (32%), Positives = 144/265 (54%), Gaps = 13/265 (4%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL-VNRLHSEVQLLRTLKNK 78
           R   LLG GA  +VY  +D + G E+A  QV     S +    VN L  E+QLL+ L+++
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            I+  Y    DD+   L+   E    G+++   K +  ++    +K+++Q+LEG+EYLH+
Sbjct: 65  RIVQYYGCLRDDET--LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA----AIVGRSHAAHSIIGTPEYMAPELY 194
           +   I+HRD+  +NI  +   G VK+GD G +     I        S+ GTP +M+PE+ 
Sbjct: 123 NM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 195 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
             E Y    D++S G  ++EM+T + P++E +++A I+K  T    PQ  + V  P+ + 
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARN 238

Query: 254 FIEKCIAQP-RARPSASELLKDPFF 277
           F+ +   +  + RPSA ELL+  F 
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  148 bits (376), Expect = 2e-43
 Identities = 84/259 (32%), Positives = 131/259 (50%), Gaps = 12/259 (4%)

Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
            DL+G GA   VY+  + E G  VA  Q+ L    E+   +  +  E+ LL+ LK+  I+
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA--LKSIMQEIDLLKNLKHPNIV 62

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
                      ++L  I E   +G+LR   KK        +  +  QVL+GL YL  HE 
Sbjct: 63  KYIGSIET--SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL--HEQ 118

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAPELYE-EDYT 199
            +IHRD+  +NI    + G VK+ D G A  +   S    S++GTP +MAPE+ E    +
Sbjct: 119 GVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 259
              DI+S G  ++E++T   PY + + +A +++ V     P  L +   PE+K F+ +C 
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCF 235

Query: 260 A-QPRARPSASELLKDPFF 277
              P  RP+A +LLK P+ 
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  147 bits (373), Expect = 5e-43
 Identities = 84/261 (32%), Positives = 130/261 (49%), Gaps = 10/261 (3%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRL-SHFSEDPVLVNRLHSEVQLLRTLKNK 78
           R  +LLGSG+   VY   + ++G   A  +V L          V +L  E+ LL  L++ 
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            I+       ++  + L    E+   G+L    KK+       ++ +++Q+L GLEYLH 
Sbjct: 63  NIVQYLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY--EE 196
                +HRD+  +NI ++ N G VK+ D G A  V     A S  G+P +MAPE+   + 
Sbjct: 121 RN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
            Y    DI+S G  +LEM T + P+S+ + VA ++K       P  +      E K FI 
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP-PIPDHLSDEAKDFIL 236

Query: 257 KCI-AQPRARPSASELLKDPF 276
           KC+   P  RP+A+ELL+ PF
Sbjct: 237 KCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  143 bits (364), Expect = 1e-41
 Identities = 81/259 (31%), Positives = 133/259 (51%), Gaps = 16/259 (6%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+   VY+   +  G   A   ++  H   D     +L  E++ LR+ ++ Y++ CY
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT--HEPC 142
             +  +    ++ + E    G+L    KK   +    L   ++Q+L+GL+YLHT  H   
Sbjct: 66  GAFYKE--GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--- 120

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYEEDYTE 200
           IIHRD+  SN+ IN   G+VKI D G + ++  +    ++ +GT  YM+PE +  E Y+ 
Sbjct: 121 IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179

Query: 201 MVDIYSFGLCLLEMVTMEIPYS--ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 258
             DI+S GL LLE    + P+      S  ++ + +  G  P    +   PE + FI  C
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239

Query: 259 IAQ-PRARPSASELLKDPF 276
           + + P+ RPSA+ELL+ PF
Sbjct: 240 LQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  144 bits (363), Expect = 1e-41
 Identities = 87/263 (33%), Positives = 141/263 (53%), Gaps = 10/263 (3%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNK 78
           R   LLG GA  +VY  +D + G E+A  QV+    S E    VN L  E+QLL+ L ++
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            I+  Y    D    TL+   E    G+++   K +  ++    +K+++Q+LEG+ YLH+
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLG----FAAIVGRSHAAHSIIGTPEYMAPELY 194
           +   I+HRD+  +NI +  ++G VK+GD G       I        S+ GTP +M+PE+ 
Sbjct: 125 N--MIVHRDIKGANI-LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 195 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
             E Y    DI+S G  ++EM+T + P++E +++A I+K  T    P     V D   + 
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRD 240

Query: 254 FIEKCIAQPRARPSASELLKDPF 276
           F+++   + + RPSA ELL+  F
Sbjct: 241 FLKRIFVEAKLRPSADELLRHTF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  141 bits (357), Expect = 3e-40
 Identities = 87/268 (32%), Positives = 143/268 (53%), Gaps = 24/268 (8%)

Query: 21  YSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y +L  +G GA  +VY+A D+  G EVA  ++RL   +++ +++N    E+ +++  K+ 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE-LIIN----EILIMKDCKHP 75

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLE 134
            I+  Y  +L    + L  + E    G+L         +     I  +    ++VL+GLE
Sbjct: 76  NIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLE 130

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAPEL 193
           YLH+    +IHRD+   NI ++ + G VK+ D GFAA + +  +  +S++GTP +MAPE+
Sbjct: 131 YLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 194 YE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-KPQALNKVKDPEV 251
            + +DY   VDI+S G+  +EM   E PY     +  ++   T G+   +   K   PE 
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW-SPEF 246

Query: 252 KAFIEKCIA-QPRARPSASELLKDPFFS 278
           K F+ KC+   P  RPSA ELL+ PF  
Sbjct: 247 KDFLNKCLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  139 bits (352), Expect = 6e-40
 Identities = 86/263 (32%), Positives = 141/263 (53%), Gaps = 10/263 (3%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNK 78
           R   LLG GA  +VY  +D + G E+A  QV+    S E    V+ L  E+QLL+ L+++
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            I+  Y    D    TL    E    G+++   K +  ++    +K+++Q+LEG+ YLH+
Sbjct: 65  RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLG----FAAIVGRSHAAHSIIGTPEYMAPELY 194
           +   I+HRD+  +NI +  + G VK+GD G       I        S+ GTP +M+PE+ 
Sbjct: 125 N--MIVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 195 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
             E Y    D++S G  ++EM+T + P++E +++A I+K  T    PQ  + + +   + 
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240

Query: 254 FIEKCIAQPRARPSASELLKDPF 276
           F+     + R RPSA ELL+ PF
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 1e-37
 Identities = 82/263 (31%), Positives = 140/263 (53%), Gaps = 10/263 (3%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNK 78
           R   LLG GA  +VY  +D + G E+A  QV     S E    VN L  E+QLL+ L++ 
Sbjct: 5   RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            I+  Y    D +   L+   E    G+++   K +  ++    +++++Q+L+G+ YLH+
Sbjct: 65  RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLG----FAAIVGRSHAAHSIIGTPEYMAPELY 194
           +   I+HRD+  +NI +  + G VK+GD G       I        S+ GTP +M+PE+ 
Sbjct: 125 N--MIVHRDIKGANI-LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 195 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
             E Y    D++S    ++EM+T + P++E +++A I+K  T   KP   + V D   + 
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240

Query: 254 FIEKCIAQPRARPSASELLKDPF 276
           F+++   + + RP+A  LL+ PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  132 bits (333), Expect = 5e-37
 Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 25/264 (9%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + LG G+   VY+A  +E G  VA   V +    ++      +  E+ +L+   + YI+ 
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDSPYIVK 62

Query: 83  CYSVWLDDQHNTLNFITEVCTSGN----LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            Y  +   ++  L  + E C +G+    ++   K      I A+     Q L+GLEYLH+
Sbjct: 63  YYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI---LYQTLKGLEYLHS 117

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYEE 196
           ++   IHRD+   NI +N   GQ K+ D G +  +  + A  +++IGTP +MAPE + E 
Sbjct: 118 NK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAF 254
            Y    DI+S G+  +EM   + PYS+   +  I+        P  L+  +   PE   F
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--PPPTLSDPEKWSPEFNDF 232

Query: 255 IEKC-IAQPRARPSASELLKDPFF 277
           ++KC +  P  RPSA +LL+ PF 
Sbjct: 233 VKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 3e-36
 Identities = 92/288 (31%), Positives = 133/288 (46%), Gaps = 43/288 (14%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + LG G    VY+A D++ G  VA  ++RL +  E+ +    L  E+ LL+ LK+  I+ 
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTAL-REISLLKELKHPNIVK 62

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEP 141
              V   ++   L F  E C   +L+ Y  K    +S   +K    Q+L GL Y H+H  
Sbjct: 63  LLDVIHTERKLYLVF--EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH-- 117

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELY--EE 196
            I+HRDL   NI IN + G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 118 RILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEILLGSK 174

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI--------------------YKK 233
            Y+  VDI+S G    EM+T +  +   SE D + KI                    YK 
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234

Query: 234 VTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                 P+ L KV    DPE    + K +   P  R SA E LK P+F
Sbjct: 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  127 bits (320), Expect = 3e-35
 Identities = 75/256 (29%), Positives = 132/256 (51%), Gaps = 14/256 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V++   + +    A  Q+ LS    +         E ++L  L + YII  Y
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS--KQVLEGLEYLHTHEPC 142
             +LD     LN + E   +G+L    K  R   +   + W    Q+L GL +LH+ +  
Sbjct: 66  ESFLDKG--KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK-- 121

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPELYEED-YTE 200
           I+HRD+   N+F++     VKIGDLG A ++   ++ A++I+GTP Y++PEL E+  Y E
Sbjct: 122 ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
             D+++ G+ L E  T + P+   +  A I K + G   P  ++++   ++   I++C+ 
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP--VSQMYSQQLAQLIDQCLT 238

Query: 261 Q-PRARPSASELLKDP 275
           +  R RP   +LL++P
Sbjct: 239 KDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 4e-35
 Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 23/266 (8%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            ++ L  +G G+  +VY+A D+     VA   + L    ++   + +   E+Q L   ++
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFLSQCRS 58

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGN----LRTYRKKHRHVSIKALKKWSKQVLEGL 133
            YI   Y  +L    + L  I E C  G+    L+  +    +++        ++VL GL
Sbjct: 59  PYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL-----REVLLGL 111

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE 192
           EYLH      IHRD+  +NI ++   G VK+ D G +  +  + +  ++ +GTP +MAPE
Sbjct: 112 EYLHEEGK--IHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168

Query: 193 LY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 251
           +  +  Y E  DI+S G+  +E+   E P S+   + ++   +     P           
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVLFLIPKNNPPSLEGNKFSKPF 227

Query: 252 KAFIEKCIAQ-PRARPSASELLKDPF 276
           K F+  C+ + P+ RPSA ELLK  F
Sbjct: 228 KDFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 3e-34
 Identities = 82/273 (30%), Positives = 131/273 (47%), Gaps = 30/273 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWN--QVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LG GA  KVY+A  +E G+  A    Q+      ED ++      E+ +L   K+  I+ 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV------EIDILSECKHPNIVG 66

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV----SIKALKKWSKQVLEGLEYLHT 138
            Y  +  +  N L  + E C  G L +   +         I+ +    +Q+LE L +LH+
Sbjct: 67  LYEAYFYE--NKLWILIEFCDGGALDSIMLELERGLTEPQIRYV---CRQMLEALNFLHS 121

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELY--- 194
           H+  +IHRDL   NI +  + G VK+ D G +A    +     + IGTP +MAPE+    
Sbjct: 122 HK--VIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 195 ---EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPE 250
              +  Y    DI+S G+ L+E+  ME P+ E  +  ++  K+     P      K    
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSS 237

Query: 251 VKAFIEKCIAQ-PRARPSASELLKDPFFSELND 282
              F++ C+ + P  RP+A+ELLK PF S+ +D
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  123 bits (312), Expect = 6e-34
 Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 15/265 (5%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
            Y   LG+G    V +   +  G  +A   +RL     +  +  ++  E+ +L    + Y
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKCNSPY 60

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHT 138
           I+  Y  + ++    ++   E    G+L    K+ +  +  + L K +  VL+GL YLH 
Sbjct: 61  IVGFYGAFYNN--GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH- 117

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 197
            +  IIHRD+  SNI +N   GQ+K+ D G +  +  S  A + +GT  YMAPE +   D
Sbjct: 118 EKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNS-LAKTFVGTSSYMAPERIQGND 175

Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK----IYKKVTGGVKPQALNKVKDPEVKA 253
           Y+   DI+S GL L+E+ T   PY   +        + + +     P+  +    P+ + 
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235

Query: 254 FIEKC-IAQPRARPSASELLKDPFF 277
           F+  C I  PR RPS  ELL+ PF 
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  123 bits (311), Expect = 9e-34
 Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 24/264 (9%)

Query: 22  SDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
              LG GA  +VY+        ++ +EVA   V+          +     E +++R L +
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYL 136
             ++    V  +++   L  + E    G+L +Y +K+R  +S+  L  ++ Q+  G+EYL
Sbjct: 61  PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE---YMAPEL 193
            +     IHRDL   N  +  N   VKI D G  +        +   G      +MAPE 
Sbjct: 119 ESK--NFIHRDLAARNCLVGEN-LVVKISDFGL-SRDLYDDDYYRKRGGKLPIRWMAPES 174

Query: 194 YEED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV-TGGVKPQALNKVKDPE 250
            +E  +T   D++SFG+ L E+ T+ E PY    S  ++ + +  G   PQ  N    PE
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLEYLKNGYRLPQPPNCP--PE 231

Query: 251 VKAFIEKC-IAQPRARPSASELLK 273
           +   + +C    P  RP+ SEL++
Sbjct: 232 LYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  122 bits (309), Expect = 2e-33
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 31/265 (11%)

Query: 25  LGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LG GA  +VY+         + +EVA   V+          +     E +++R L +  I
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHT 138
           +    V  +++   L  + E    G+L  Y +K+R   +S+  L  ++ Q+  G+EYL +
Sbjct: 64  VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE------YMAPE 192
                IHRDL   N  +  N   VKI D G +    R                  +MAPE
Sbjct: 122 K--NFIHRDLAARNCLVGEN-LVVKISDFGLS----RDLYDDDYYKVKGGKLPIRWMAPE 174

Query: 193 LYEED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV-TGGVKPQALNKVKDP 249
             +E  +T   D++SFG+ L E+ T+ E PY    S A++ + +  G   P+  N    P
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM-SNAEVLEYLKKGYRLPKPPNCP--P 231

Query: 250 EVKAFIEKC-IAQPRARPSASELLK 273
           E+   + +C    P  RP+ SEL++
Sbjct: 232 ELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  120 bits (304), Expect = 8e-33
 Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 14/268 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G   +V     + +    A   V+  H  E       + SE ++L    + +I+  Y
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG-QQEHIFSEKEILEECNHPFIVKLY 59

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             + D ++  +  + E C  G L T  +          + +   V+   EYLH     II
Sbjct: 60  RTFKDKKY--IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--II 115

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVD 203
           +RDL   N+ ++ N G VK+ D GFA  +       +  GTPEY+APE+   + Y   VD
Sbjct: 116 YRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174

Query: 204 IYSFGLCLLEMVTMEIPYSECDSVA-KIYKKVTGGVKPQALNKVKDPEVKAFIEK-CIAQ 261
            +S G+ L E++T   P+ E D    +IY  +  G          D   K  I++     
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234

Query: 262 PRAR-----PSASELLKDPFFSELNDDD 284
           P  R         ++ K  +F+  + + 
Sbjct: 235 PEERLGNLKGGIKDIKKHKWFNGFDWEG 262

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  123 bits (308), Expect = 1e-32
 Identities = 72/296 (24%), Positives = 118/296 (39%), Gaps = 34/296 (11%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NK 78
           R    LG G+  +VY A D++        +V           V R   E+Q+L +L    
Sbjct: 3   RILRKLGEGSFGEVYLARDRKLVA----LKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEY 135
            I+  Y  + D+    L  + E    G+L    KK      +S         Q+L  LEY
Sbjct: 59  NIVKLYDFFQDEGSLYL--VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-------HAAHSIIGTPEY 188
           LH+    IIHRD+   NI ++ +   VK+ D G A ++              + +GTP Y
Sbjct: 117 LHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 189 MAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQ 241
           MAPE+         +   DI+S G+ L E++T   P+       + ++  K +     P 
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 242 ALNKVK-------DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
             + +               ++K +A  P+ R S+S  L     + L   +S+ S 
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Length = 384

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  119 bits (301), Expect = 3e-32
 Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 21/267 (7%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP-----VLVNRLHSEVQLLRTLKNK 78
           L+GSG+   VY   +   G  +A  QV L   S         +++ L  E+ LL+ L+++
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            I+      LD  H  LN   E    G++      +       ++ + +Q+L+GL YLH 
Sbjct: 67  NIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-------IVGRSHAAHSIIGTPEYMAP 191
               IIHRD+  +NI ++ N G +KI D G +            + A  S+ G+  +MAP
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 192 ELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+ ++  YT   DI+S G  ++EM+T + P+ +C  +  I+ K+     P+  + +   E
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-E 239

Query: 251 VKAFIEKCIA-QPRARPSASELLKDPF 276
              F+EK        RP+A+ELLK PF
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  119 bits (300), Expect = 3e-32
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 17/266 (6%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRL--SHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
            LG+GA    Y+A D + G  +A  QV    +  SE   +V  L  E++L+  L + +II
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
                  +D H   N   E    G++     K+       +  +++Q+L GL YLH ++ 
Sbjct: 67  RMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ- 123

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAA-----IVGRSHAAHSIIGTPEYMAPE-LYE 195
            IIHRD+  +N+ I+    +++I D G AA       G       ++GT  +MAPE L  
Sbjct: 124 -IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSE---CDSVAKIYKKVTGGVKPQALNKVKDPEVK 252
           E Y    D++S G  ++EM T + P++     + +A I+ K+       ++ +   P ++
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIASATTAPSIPEHLSPGLR 241

Query: 253 AFIEKCI-AQPRARPSASELLKDPFF 277
               +C+  QP  RP + ELLK P F
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 4e-32
 Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 36/273 (13%)

Query: 23  DLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
             LG GA  +VY+        +  EVA   ++     E+         E ++++ L +  
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE---RKDFLKEARVMKKLGHPN 57

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---------VSIKALKKWSKQVL 130
           ++    V  +++   L  + E    G+L  Y +K R          +S+K L  ++ Q+ 
Sbjct: 58  VVRLLGVCTEEEPLYL--VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE--- 187
           +G+EYL       +HRDL   N  +  +   VKI D G +    R               
Sbjct: 116 KGMEYLA--SKKFVHRDLAARNCLVGED-LVVKISDFGLS----RDVYDDDYYRKKTGGK 168

Query: 188 ----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQ 241
               +MAPE L +  +T   D++SFG+ L E+ T+   PY    S  ++ + +  G +  
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRLP 227

Query: 242 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
                 D E+   +  C    P  RP+ SEL++
Sbjct: 228 KPEYCPD-ELYELMLSCWQLDPEDRPTFSELVE 259

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  119 bits (299), Expect = 5e-32
 Identities = 75/256 (29%), Positives = 131/256 (51%), Gaps = 14/256 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    VY+A    +G  VA  +V++     D         E+ LL+ L +  +I   
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 85  SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           + ++++  N LN + E+  +G+L    + ++K+ R +  + + K+  Q+   LE++H+  
Sbjct: 69  ASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-LYEEDY 198
             I+HRD+  +N+FI    G VK+GDLG       ++ AAHS++GTP YM+PE ++E  Y
Sbjct: 127 --IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 199 TEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
               DI+S G  L EM  ++ P Y +  ++  + KK+     P         E++  + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 258 CI-AQPRARPSASELL 272
           CI   P  RP  S +L
Sbjct: 244 CINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  117 bits (296), Expect = 2e-31
 Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 25/265 (9%)

Query: 26  GS-GAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           GS G V+KV R  D +    + W ++   + +E      +L SEV +LR LK+  I+  Y
Sbjct: 11  GSFGTVRKVRRKSDGKI---LVWKEIDYGNMTEKEK--QQLVSEVNILRELKHPNIVRYY 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
              +D  + TL  + E C  G+L    +  +K+ +++  + + +   Q+L  L   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 141 PC---IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYE 195
                ++HRDL  +NIF++ N   VK+GD G A I+G   + A + +GTP YM+PE L  
Sbjct: 126 DPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH 184

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---PEVK 252
             Y E  DI+S G  + E+  +  P++     A+   ++   +K     ++      E+ 
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFT-----ARNQLQLASKIKEGKFRRIPYRYSSELN 239

Query: 253 AFIEKCIA-QPRARPSASELLKDPF 276
             I+  +   P  RPS  ELL+ P 
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 2e-31
 Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 15/259 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  KV     ++ G   A   ++     +    V    +E  +L  + + +I+  +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK-EVEHTLTERNILSRINHPFIVKLH 59

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  ++   L  + E    G L ++  K    S +  + ++ +++  LEYLH+    II
Sbjct: 60  YAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-LYEEDYTEMV 202
           +RDL   NI ++ + G +K+ D G A  +       ++  GTPEY+APE L  + Y + V
Sbjct: 116 YRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174

Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ- 261
           D +S G+ L EM+T + P+   +   +IY+K+     P    +   PE +  I   + + 
Sbjct: 175 DWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKD 231

Query: 262 PRAR---PSASELLKDPFF 277
           P  R     A E+   PFF
Sbjct: 232 PTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  116 bits (292), Expect = 5e-31
 Identities = 78/271 (28%), Positives = 124/271 (45%), Gaps = 30/271 (11%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G GA   VY A       +VA  ++ L         V+ L  EVQ +    +  ++  Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS---VDELRKEVQAMSQCNHPNVVKYY 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNL-----RTYRKKHRHVSIKA--LKKWSKQVLEGLEYLH 137
           + ++      L  +    + G+L      +Y +     +I A  LK    +VL+GLEYLH
Sbjct: 66  TSFVVGD--ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK----EVLKGLEYLH 119

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI----VGRSHAA-HSIIGTPEYMAPE 192
           ++    IHRD+   NI +  + G VKI D G +A       R+     + +GTP +MAPE
Sbjct: 120 SNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 193 LYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GVKPQALNKVK 247
           + E+   Y    DI+SFG+  +E+ T   PYS+   +  +   +      ++  A  K  
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236

Query: 248 DPEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
               +  I  C+ + P  RP+A ELLK  FF
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  114 bits (289), Expect = 1e-30
 Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 21/261 (8%)

Query: 25  LGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LG GA  +VY+       +    +VA   ++                E  +++ L +  I
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKKLSHPNI 63

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
           +    V    +   +  +TE    G+L  + RK    +++K L + + Q+ +G+EYL + 
Sbjct: 64  VRLLGVCTQGEPLYI--VTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE---YMAPELYEE 196
               +HRDL   N  +  N   VKI D G +  +          G      +MAPE  ++
Sbjct: 122 --NFVHRDLAARNCLVTEN-LVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 197 D-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             +T   D++SFG+ L E+ T+ E PY    S  ++ + +  G +     +    E+   
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLELLEDGYRLPR-PENCPDELYEL 236

Query: 255 IEKCIA-QPRARPSASELLKD 274
           + +C A  P  RP+ SEL++D
Sbjct: 237 MLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 1e-30
 Identities = 82/266 (30%), Positives = 127/266 (47%), Gaps = 27/266 (10%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN---KY 79
           +L+G GA   VYR      G  VA   + L    +D   V+ +  EV LL  L+      
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD---VSDIQREVALLSQLRQSQPPN 63

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEY 135
           I   Y  +L      L  I E    G++RT  K      +++S+       ++VL  L+Y
Sbjct: 64  ITKYYGSYLKGP--RLWIIMEYAEGGSVRTLMKAGPIAEKYISVII-----REVLVALKY 116

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELY 194
           +H     +IHRD+  +NI +  N G VK+ D G AA++ ++ +  S  +GTP +MAPE+ 
Sbjct: 117 IH-KVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173

Query: 195 EE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVKDPEV 251
            E   Y    DI+S G+ + EM T   PYS+ D+   +   +    KP  L        +
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--LIPKSKPPRLEDNGYSKLL 231

Query: 252 KAFIEKCI-AQPRARPSASELLKDPF 276
           + F+  C+  +P+ R SA ELLK  +
Sbjct: 232 REFVAACLDEEPKERLSAEELLKSKW 257

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  113 bits (285), Expect = 4e-30
 Identities = 79/266 (29%), Positives = 125/266 (46%), Gaps = 30/266 (11%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS--EVQLLRTLKNKYI 80
             LG G+   VY+     +    A  +V L   S+      R  +  E+++L ++ +  I
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK----EREDAVNEIRILASVNHPNI 61

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK-------WSK--QVLE 131
           I     +LD   N L  + E    G+L     K      K  +K       W    Q+L 
Sbjct: 62  ISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKR-----KKKRKLIPEQEIWRIFIQLLR 114

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           GL+ LH  +  I+HRDL  +NI +  N   VKIGDLG + ++ + + A + IGTP YMAP
Sbjct: 115 GLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVL-KKNMAKTQIGTPHYMAP 170

Query: 192 ELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+++   Y+   DI+S G  L EM T   P+ E  S+  +  KV  G  P  +  +   +
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYP-PIPPIYSQD 228

Query: 251 VKAFIEKCIAQ-PRARPSASELLKDP 275
           ++ FI   +   P+ RP+  ++L  P
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 6e-30
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 18/261 (6%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG    VY+A D   G  VA   ++L    +  ++      E+ +L+  ++  I+  +
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ----EISMLKECRHPNIVAYF 66

Query: 85  SVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +L    + L  + E C  G+L+  Y+     +S   +    ++ L+GL YLH      
Sbjct: 67  GSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--K 122

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAPELYEE----DY 198
           IHRD+  +NI +  + G VK+ D G +A +  + A   S IGTP +MAPE+        Y
Sbjct: 123 IHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181

Query: 199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVK-DPEVKAFIE 256
               DI++ G+  +E+  ++ P  +   +  ++        P  L +K K  P    FI+
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIK 241

Query: 257 KC-IAQPRARPSASELLKDPF 276
           KC    P+ RP+A++LL+ PF
Sbjct: 242 KCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  113 bits (283), Expect = 9e-30
 Identities = 81/267 (30%), Positives = 131/267 (49%), Gaps = 21/267 (7%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV--LVNRLHSEVQLLRTLKNKYI 80
           ++LG GA   VY      +G  +A  QV L   +         +L  EV LL++LK+  I
Sbjct: 6   EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +      LDD  NT++   E    G++ +   +   +      K++KQ+L+G+ YL  H 
Sbjct: 65  VQYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL--HN 120

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSII-----GTPEYMAPE 192
            C++HRD+  +N+ +  N G +K+ D G A   A VG  H  HS +     GTP +MAPE
Sbjct: 121 NCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVG-LHGTHSNMLKSMHGTPYWMAPE 178

Query: 193 LYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG-GVKPQALNKVKDPE 250
           +  E  Y    DI+S G  + EM T + P +  D +A ++      G+ P+  +      
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238

Query: 251 VKAFIEKCIAQPR-ARPSASELLKDPF 276
           +  F+  C+ + +  RPSA +LL+  F
Sbjct: 239 ID-FVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  111 bits (280), Expect = 4e-29
 Identities = 83/276 (30%), Positives = 136/276 (49%), Gaps = 30/276 (10%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+ + +G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 16  DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN----EILVM 70

Query: 73  RTLKNKYII-------VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 125
           R  K+  I+       V   +W+  ++     +T+V T   +           I A+   
Sbjct: 71  RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQIAAV--- 120

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIG 184
            ++ L+ LE+LH+++  +IHRD+   NI + G  G VK+ D GF A +    +  S ++G
Sbjct: 121 CRECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 185 TPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           TP +MAPE+   + Y   VDI+S G+  +EMV  E PY   + +  +Y   T G  P+  
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQ 236

Query: 244 NKVK-DPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
           N  K     + F+ +C+      R SA ELL+ PF 
Sbjct: 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 2e-28
 Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 40/285 (14%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    VY+A D+  G  VA  +++L    E   +      E++LL+ L +  II   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            V+       L  + E   +   +  + + R +    +K +  Q+L+GL + H+H   I+
Sbjct: 65  DVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEED--YTEM 201
           HRDL   N+ IN   G +K+ D G A   G     ++  + T  Y APEL   D  Y+  
Sbjct: 121 HRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 202 VDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVK----------- 247
           VDI+S G    E+++    +   SE D + KI+ +  G   P+   K             
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF-RTLGTPDPEVWPKFTSLARNYKFSFP 238

Query: 248 --------------DPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                          P+    + + +   P  R +A + L  P+F
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  107 bits (269), Expect = 9e-28
 Identities = 75/253 (29%), Positives = 134/253 (52%), Gaps = 14/253 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G   +VYRA    +G+ VA  +V++    +     + +  E+ LL+ L +  +I  Y
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPNVIKYY 68

Query: 85  SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           + +++D  N LN + E+  +G+L    + ++K+ R +  K + K+  Q+   LE++H+  
Sbjct: 69  ASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-LYEEDY 198
             ++HRD+  +N+FI    G VK+GDLG       ++ AAHS++GTP YM+PE ++E  Y
Sbjct: 127 --VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 199 TEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
               DI+S G  L EM  ++ P Y +  ++  + KK+     P   +     E++  +  
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243

Query: 258 CI-AQPRARPSAS 269
           CI   P  RP  +
Sbjct: 244 CINPDPEKRPDIT 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  107 bits (268), Expect = 1e-27
 Identities = 87/270 (32%), Positives = 129/270 (47%), Gaps = 34/270 (12%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR----LHSEVQLLRTLKNKY 79
           +LG G    VY A D          QVR++   E P   +R    LH E+ L   LK++ 
Sbjct: 15  VLGKGTYGIVYAARDLS-------TQVRIA-IKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIK--ALKKWSKQVLEGLEYL 136
           I V Y +  D ++       E    G+L    R K   +      +  ++KQ+LEGL+YL
Sbjct: 67  I-VQY-LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELYE 195
           H ++  I+HRD+   N+ +N   G VKI D G +  + G +    +  GT +YMAPE+ +
Sbjct: 125 HDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182

Query: 196 E---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-----PQALNKVK 247
           +    Y    DI+S G  ++EM T + P+ E         KV G  K     P++L+   
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIHPEIPESLSA-- 239

Query: 248 DPEVKAFIEKCIA-QPRARPSASELLKDPF 276
             E K FI +C    P  R SA +LL+DPF
Sbjct: 240 --EAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (268), Expect = 2e-27
 Identities = 76/268 (28%), Positives = 131/268 (48%), Gaps = 24/268 (8%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V +   +  G+  A   +       +P L  ++  E+++ ++ K+ YI+  Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNL-RTY---RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
             +LD+  +++    E C  G+L   Y   +K+   +  K L K ++ VL+GL YLH+ +
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYT 199
             IIHRD+  SNI +    GQVK+ D G +  +  S A  +  GT  YMAPE +  + Y+
Sbjct: 126 --IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNSLAG-TFTGTSFYMAPERIQGKPYS 181

Query: 200 EMVDIYSFGLCLLEMVTMEIPY--SECDSVAKIYKKVTGGVKPQALNKVKDPEV------ 251
              D++S GL LLE+     P+       +  I + ++  V         +P        
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNPELKDEPGNGIKWSE 240

Query: 252 --KAFIEKCIAQ-PRARPSASELLKDPF 276
             K FI++C+ + P  RP+  ++L+ P+
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  104 bits (262), Expect = 1e-26
 Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 27/273 (9%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRL------SHFSEDPVLVNRLHSEVQLLRTLK 76
           +L+G G   +VY A +   G  +A  QV L       H S    +V  L SE++ L+ L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
           +  I+       +     L+   E    G++ +  + +     + ++ +++QVLEGL YL
Sbjct: 67  HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH------AAHSIIGTPEYMA 190
           H+    I+HRDL   N+ ++ + G  KI D G   I  +S          S+ G+  +MA
Sbjct: 125 HSKG--ILHRDLKADNLLVDAD-GICKISDFG---ISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 191 PE---LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK----KVTGGVKPQAL 243
           PE    Y + Y+  VDI+S G  +LEM     P+S+ +++A ++K    +    + P   
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238

Query: 244 NKVKDPEVKAFIEKCIAQPRARPSASELLKDPF 276
             +    +          P  RP+A ELL+ PF
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 1e-26
 Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 48/291 (16%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G   +VY+A +++ G  VA  ++R+ +  E  P+   R   E++LL+ L++  I+  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKLRHPNIVRL 63

Query: 84  YSVWLDDQHNTLNFITEVCT---SGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
             +       ++  + E      +G L +   K    +   +K + KQ+LEGL+YLH++ 
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYLHSNG 120

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHS--IIGTPEYMAPELY--E 195
             I+HRD+  SNI IN N G +K+ D G A     R+ A ++  +I T  Y  PEL    
Sbjct: 121 --ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGA 176

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK---VTGGVKPQALN----- 244
             Y   VD++S G  L E+   +  +   +E + + KI++     T    P         
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236

Query: 245 -----------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                             + DP     ++K +   P+ R SA + L+  +F
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  104 bits (262), Expect = 2e-26
 Identities = 80/279 (28%), Positives = 130/279 (46%), Gaps = 28/279 (10%)

Query: 9   FVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 66
           F + DP   F   +DL  +G G+   VY A D      VA  ++  S    +      + 
Sbjct: 8   FSKDDPEKLF---TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW-QDII 63

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRHVSIKALK 123
            EV+ L+ L++   I     +L +  +T   + E C    S  L  ++K  + V I A+ 
Sbjct: 64  KEVRFLQQLRHPNTIEYKGCYLRE--HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI- 120

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
                 L+GL YLH+H    IHRD+   NI +    G VK+ D G A++V     A+S +
Sbjct: 121 --CHGALQGLAYLHSH--ERIHRDIKAGNILLTEP-GTVKLADFGSASLVS---PANSFV 172

Query: 184 GTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 239
           GTP +MAPE+     E  Y   VD++S G+  +E+   + P    ++++ +Y        
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D 230

Query: 240 PQALNKVK-DPEVKAFIEKCIAQ-PRARPSASELLKDPF 276
              L+        + F++ C+ + P+ RPS+ ELLK  F
Sbjct: 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  104 bits (260), Expect = 3e-26
 Identities = 83/269 (30%), Positives = 133/269 (49%), Gaps = 16/269 (5%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ RY  + G GA   V+ A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 16  DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN----EILVM 70

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           + LKN  I+     +L    + L  + E    G+L T       +    +    ++ L+ 
Sbjct: 71  KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQA 127

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           LE+LH ++  +IHRD+   N+ + G  G VK+ D GF A +    +  S ++GTP +MAP
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 192 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DP 249
           E+   + Y   VDI+S G+  +EMV  E PY   + +  +Y   T G  P+  N  K  P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSP 243

Query: 250 EVKAFIEKCIAQP-RARPSASELLKDPFF 277
             + F+ +C+      R SA ELL+ PF 
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  102 bits (256), Expect = 1e-25
 Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  KVY+A ++E G   A   +      E    +     E+++L T  + YI+   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYMVEIEILATCNHPYIVKLL 75

Query: 85  SVWLDDQHNTLNFITEVCTSGNL-RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +  D    L  + E C  G +     +  R ++   ++   +Q+LE L+YLH+ +  I
Sbjct: 76  GAFYWD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--I 131

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE------LYEE 196
           IHRDL   N+ +  + G +K+ D G +A  V       S IGTP +MAPE      + + 
Sbjct: 132 IHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFI 255
            Y    DI+S G+ L+EM  +E P+ E + + ++  K+     P      K   E + F+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLSQPSKWSMEFRDFL 249

Query: 256 EKCIAQ-PRARPSASELLKDPFFSELN 281
           +  + + P  RPSA++LL+ PF S + 
Sbjct: 250 KTALDKHPETRPSAAQLLEHPFVSSVT 276

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  101 bits (253), Expect = 2e-25
 Identities = 77/263 (29%), Positives = 131/263 (49%), Gaps = 26/263 (9%)

Query: 25  LGSGAVKK--VYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL-HSEVQLLRTLKNKYII 81
           LG GA  +  +YR    E+   V W +V L+  SE      R   +E+ +L  L++  II
Sbjct: 8   LGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNII 62

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             Y+ ++DD  NTL    E    G L  +  R+K +    + +  +  Q++  + Y+H  
Sbjct: 63  AYYNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH-- 118

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYE-ED 197
           +  I+HRD+   NIF+    G +K+GD G + I+G  ++ A +++GTP YM+PEL +   
Sbjct: 119 KAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177

Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP---EVKAF 254
           Y    DI++ G  L E++T++  +   + +  + K V G   P     V      E+ + 
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-----VVSVYSSELISL 232

Query: 255 IEKCIAQ-PRARPSASELLKDPF 276
           +   + Q P  RP+A E+L  P 
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  101 bits (253), Expect = 2e-25
 Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 13/215 (6%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKW 125
           E QLL  LK+  I+     W + +   L  +   C  G+L  +   +K + +    + +W
Sbjct: 49  EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDLGFAAIV-GRSHAAHSII 183
             Q+   L+YLH  E  I+HRDL   N+F+   NI  +K+GDLG A ++  +   A ++I
Sbjct: 108 FVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLI 163

Query: 184 GTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           GTP YM+PEL+  + Y    D+++ G C+ EM T++  ++  D  + +Y+ + G + P  
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP-- 221

Query: 243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF 276
           + K   PE+   I   ++ +P  RPS   +L+ P+
Sbjct: 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  102 bits (257), Expect = 2e-25
 Identities = 86/310 (27%), Positives = 137/310 (44%), Gaps = 46/310 (14%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY  L  +GSGA   V  A D+  G +VA    ++S+  +D +   R+  E++LLR L++
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRH 58

Query: 78  KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
           + II    +         N    +TE+  + +L    K  + ++   ++ +  Q+L GL+
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMA 190
           YLH+    +IHRDL  SNI +N N   +KI D G A  V             + T  Y A
Sbjct: 118 YLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174

Query: 191 PE--LYEEDYTEMVDIYSFGLCLLEMVTMEI--------------------PYSE----- 223
           PE  L    YT+ +DI+S G    E++T +                     P  E     
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234

Query: 224 CDSVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 279
               A+ Y K       + L+K+     PE    +EK +   P+ R +A E L  P+ ++
Sbjct: 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294

Query: 280 LNDDDSEPSP 289
           L+D + EP  
Sbjct: 295 LHDPEDEPVA 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  101 bits (254), Expect = 2e-25
 Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 18/270 (6%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP      +  + G G+   V  A D+  G +VA  ++ L       +L N    EV ++
Sbjct: 16  DPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN----EVVIM 70

Query: 73  RTLKNKYIIVCYSVWL-DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLE 131
           R  ++  I+  YS +L  D+   L  + E    G L T    H  ++ + +      VL+
Sbjct: 71  RDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLK 126

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMA 190
            L +LH     +IHRD+   +I +  + G+VK+ D GF A V +      S++GTP +MA
Sbjct: 127 ALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 191 PELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-D 248
           PE+     Y   VDI+S G+ ++EMV  E PY   +   +  K++   + P+  N  K  
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVS 242

Query: 249 PEVKAFIEKCIA-QPRARPSASELLKDPFF 277
           P +++F+++ +   P  R +A+ELL  PF 
Sbjct: 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  100 bits (250), Expect = 4e-25
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 28/266 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV------LVNRLHSEVQLLRTLKNK 78
           LG G+   VY   D++     A  + RL    E PV         + + E QLL  L + 
Sbjct: 8   LGKGSFGTVYLVKDKK-----AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLE 134
            I+  ++ +L  + +    ITE C   +L       +   + +S   + +W  Q+L G+ 
Sbjct: 63  AIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPE- 192
           Y+H     I+HRDL   NIF+  N+  +KIGD G +  ++G    A +  GTP YM+PE 
Sbjct: 121 YMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPE 250
           L  + Y    DI+S G  L EM  +   +   + ++ + + V G     P+  ++  +  
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236

Query: 251 VKAFIEKCIAQPRARPSASELLKDPF 276
           +++ + K    P  RPSA+E+L++PF
Sbjct: 237 MQSMLNK---DPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  100 bits (250), Expect = 5e-25
 Identities = 67/256 (26%), Positives = 125/256 (48%), Gaps = 12/256 (4%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           ++G GA   V+    + +   V   Q+ +   ++D        +E Q+L+ L +  II  
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER--LAAQNECQVLKLLSHPNIIEY 64

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI--KALKKWSKQVLEGLEYLHTHEP 141
           Y  +L+D    L  + E    G L  Y +K  +  +    +  +  Q+L  L ++HT   
Sbjct: 65  YENFLED--KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTE 200
            I+HRDL   NI ++ +   VKIGD G + I+     A++++GTP Y++PEL E + Y +
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
             DI++ G  L E+ +++  +   +  A + K ++G   P  ++    P+++  I   + 
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP--ISDRYSPDLRQLILSMLN 238

Query: 261 -QPRARPSASELLKDP 275
             P  RP  S+++  P
Sbjct: 239 LDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 7e-25
 Identities = 81/292 (27%), Positives = 127/292 (43%), Gaps = 44/292 (15%)

Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN---- 77
              +G GA   VY+A D   G  VA  +VR+   SE+ + ++ L  E+ LL+ L++    
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRV-PLSEEGIPLSTLR-EIALLKQLESFEHP 61

Query: 78  ---KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEG 132
              + + VC+     D+   L  + E     +L TY  K     +  + +K   +Q+L G
Sbjct: 62  NIVRLLDVCH-GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 192
           +++LH+H   I+HRDL   NI +  + GQVKI D G A I     A  S++ T  Y APE
Sbjct: 120 VDFLHSH--RIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176

Query: 193 -LYEEDYTEMVDIYSFGLCLLEMVTMEIP----YSECDSVAKIYKKV------------- 234
            L +  Y   VD++S G    E+     P     SE D + KI+  +             
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFRRR-PLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235

Query: 235 --------TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                         ++       E    ++K +   P  R SA E L+ P+F
Sbjct: 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 70/290 (24%), Positives = 119/290 (41%), Gaps = 51/290 (17%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNK 78
            ++G G+   V  A ++E   E A   +             V + +      L R   + 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE----VLTRLNGHP 62

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            II  Y  +  D+ N L F+ E   +G L  Y +K+  +  K  + ++ ++L  LEYLH+
Sbjct: 63  GIIKLYYTF-QDEEN-LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH------------------ 180
               IIHRDL   NI ++ +   +KI D G A ++  + +                    
Sbjct: 121 KG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 181 ---SIIGTPEYMAPELYEEDYTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
              S +GT EY++PEL  E       D+++ G  + +M+T + P+    +    ++K+  
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR-GSNEYLTFQKI-- 234

Query: 237 GVKPQALN----KVKDPEVKAFIEK-CIAQPRARPSAS----ELLKDPFF 277
                 L         P+ K  IEK  +  P+ R   +    EL   PFF
Sbjct: 235 ----LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 99.8 bits (248), Expect = 1e-24
 Identities = 82/272 (30%), Positives = 133/272 (48%), Gaps = 22/272 (8%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+  + G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 16  DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN----EILVM 70

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  KN  I+     +L    + L  + E    G+L T       +    +    ++ L+ 
Sbjct: 71  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 127

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           L++LH+++  +IHRD+   NI + G  G VK+ D GF A +    +  S ++GTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 192 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV----KPQALNKV 246
           E+   + Y   VDI+S G+  +EMV  E PY   + +  +Y   T G      P+ L+ V
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244

Query: 247 KDPEVKAFIEKCIAQP-RARPSASELLKDPFF 277
                + F+ +C+      R SA ELL+ PF 
Sbjct: 245 ----FRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 98.5 bits (246), Expect = 2e-24
 Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 20/234 (8%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V+++ +E  +L   ++ Y++  Y  +       L  + E    G+L +  +    +    
Sbjct: 37  VDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPGGDLASLLENVGSLDEDV 94

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF--AAIVGR---- 175
            + +  +++  LEYLH++   IIHRDL   NI I+ N G +K+ D G     +V R    
Sbjct: 95  ARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINL 151

Query: 176 ---SHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY 231
                    I+GTP+Y+APE +  + +++ VD +S G  L E +    P+   ++  +I+
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIF 210

Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARP---SASELLKDPFFSELN 281
           + +  G      +     E    I K +   P  R    S  E+   PFF  ++
Sbjct: 211 QNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 98.0 bits (245), Expect = 7e-24
 Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 43/292 (14%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR-LHSEVQLLRTLKNKYII 81
             LG G    VY+A D+E G  VA  +++L    E    +N     E++LL+ LK+  II
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA-LKKWSKQVLEGLEYLHTHE 140
               V+    +  +N + E     +L    K    V   A +K +    L GLEYLH++ 
Sbjct: 66  GLLDVFGHKSN--INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG--RSHAAHSIIGTPEYMAPELY--EE 196
             I+HRDL  +N+ I  + G +K+ D G A   G       H ++ T  Y APEL     
Sbjct: 123 --ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGAR 178

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GVK----P 240
            Y   VD++S G    E++ + +P+    S+ D + KI+ +  G        GV      
Sbjct: 179 HYGVGVDMWSVGCIFAELL-LRVPFLPGDSDIDQLGKIF-EALGTPTEENWPGVTSLPDY 236

Query: 241 QALNKVKDPEVKA-----------FIEKCIA-QPRARPSASELLKDPFFSEL 280
                     +K             +++ +   P  R +A + L+ P+FS  
Sbjct: 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.4 bits (242), Expect = 7e-24
 Identities = 69/257 (26%), Positives = 131/257 (50%), Gaps = 14/257 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G   +VYRA    +   VA  +V++    +     + +  E+ LL+ L +  +I   
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-KEIDLLKQLNHPNVIKYL 68

Query: 85  SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
             +++D  N LN + E+  +G+L    + ++K+ R +  + + K+  Q+   +E++H+  
Sbjct: 69  DSFIED--NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-LYEEDY 198
             ++HRD+  +N+FI    G VK+GDLG       ++ AAHS++GTP YM+PE ++E  Y
Sbjct: 127 --VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 199 TEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
               DI+S G  L EM  ++ P Y +  ++  + +K+     P    +    +++  +  
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243

Query: 258 CI-AQPRARPSASELLK 273
           CI   P  RP    + +
Sbjct: 244 CIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 97.9 bits (243), Expect = 7e-24
 Identities = 81/269 (30%), Positives = 132/269 (49%), Gaps = 16/269 (5%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+  + G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 17  DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 71

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  KN  I+     +L    + L  + E    G+L T       +    +    ++ L+ 
Sbjct: 72  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 128

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           LE+LH+++  +IHRD+   NI + G  G VK+ D GF A +    +  S ++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 192 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+   + Y   VDI+S G+  +EM+  E PY   + +  +Y   T G  P+  N  K   
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA 244

Query: 251 V-KAFIEKCI-AQPRARPSASELLKDPFF 277
           + + F+ +C+      R SA ELL+  F 
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 97.3 bits (242), Expect = 1e-23
 Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 35/282 (12%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +Y ++LG G    VY+A+       +A   V++        L  ++ SE+++L    + Y
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
           II  Y  +  +  N ++  TE    G+L  YRK   HV    L + +  V++GL YL + 
Sbjct: 61  IIGFYGAFFVE--NRISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWSL 114

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 198
           +  I+HRD+  SN+ +N   GQVK+ D G +  +  S  A + +GT  YMAPE +  E Y
Sbjct: 115 K--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQY 170

Query: 199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKD--------- 248
               D++S G+  +E+     PY +        +K  G + P Q L  + D         
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQ-------IQKNQGSLMPLQLLQCIVDEDPPVLPVG 223

Query: 249 ---PEVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSE 286
               +   FI +C+  QP+ RP+   L+  PF  + ND ++E
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAE 265

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 96.1 bits (240), Expect = 3e-23
 Identities = 61/233 (26%), Positives = 119/233 (51%), Gaps = 29/233 (12%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V  + +E ++L+++++ +++  Y  + DD +  L  + E    G L ++ +K        
Sbjct: 45  VEHVLNEKRILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPV 102

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAH 180
            + ++ QV+  LEYLH+ +  I++RDL   N+ ++ + G +KI D GFA  V GR    +
Sbjct: 103 ARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR---TY 156

Query: 181 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 239
           ++ GTPEY+APE +  + Y + VD ++ G+ + EM+    P+ + D+  +IY+K+  G  
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEG-- 213

Query: 240 PQALNKVK-----DPEVKAFIEK-CIAQPRAR-----PSASELLKDPFFSELN 281
                KV+      P+ K  I          R        +++   P+F+ ++
Sbjct: 214 -----KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 94.6 bits (235), Expect = 5e-23
 Identities = 72/259 (27%), Positives = 130/259 (50%), Gaps = 15/259 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+  K+Y A  + +       ++ L+         ++   EV LL  +K+  I+  +
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKHPNIVTFF 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
           + +   ++  L  + E C  G+L  R  R++    S   +  W  Q+  GL+  H H+  
Sbjct: 66  ASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK--HIHDRK 121

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYE-EDYTE 200
           I+HRD+   NIF++ N    K+GD G A  +  S   A++ +GTP Y++PE+ +   Y  
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG-VKPQALNKVKDPEVKAFIEKCI 259
             DI+S G  L E+ T++ P+ E +++ ++  K+  G   P + N  +D  +++ I +  
Sbjct: 182 KTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYFAPISPNFSRD--LRSLISQLF 238

Query: 260 -AQPRARPSASELLKDPFF 277
              PR RPS + +LK PF 
Sbjct: 239 KVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 93.9 bits (233), Expect = 2e-22
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 20/217 (9%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRHVSIKALKK 124
           EV+ L+ LK+   I     +L +  +T   + E C    S  L  ++K  + V I A+  
Sbjct: 71  EVKFLQQLKHPNTIEYKGCYLKE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI-- 126

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
            +   L+GL YLH+H   +IHRD+   NI +    GQVK+ D G A+       A+S +G
Sbjct: 127 -THGALQGLAYLHSH--NMIHRDIKAGNILLT-EPGQVKLADFGSASKSS---PANSFVG 179

Query: 185 TPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 240
           TP +MAPE+     E  Y   VD++S G+  +E+   + P    ++++ +Y         
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 239

Query: 241 QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 276
              N+  D   + F++ C+ + P+ RP+++ELL+  F
Sbjct: 240 LQSNEWTD-SFRGFVDYCLQKIPQERPASAELLRHDF 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 92.8 bits (230), Expect = 4e-22
 Identities = 76/264 (28%), Positives = 127/264 (48%), Gaps = 20/264 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  KVY+A ++E G+  A   +     SE+ +       E+ +L +  +  I+   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEEL--EDYMVEIDILASCDHPNIVKLL 68

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +     N L  + E C  G +     +  R ++   ++   KQ LE L YLH ++  I
Sbjct: 69  DAFY--YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--I 124

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELY------EE 196
           IHRDL   NI    + G +K+ D G +A   R+     S IGTP +MAPE+       + 
Sbjct: 125 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFI 255
            Y    D++S G+ L+EM  +E P+ E + + ++  K+     P      +   E K F+
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLAQPSRWSSEFKDFL 242

Query: 256 EKCIAQP-RARPSASELLKDPFFS 278
           +KC+ +   AR + ++LL+ PF +
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFVT 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 91.7 bits (228), Expect = 9e-22
 Identities = 57/179 (31%), Positives = 89/179 (49%), Gaps = 11/179 (6%)

Query: 110 YRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 166
           Y+K +     +    L K +  +++ LEYLH+    +IHRD+  SN+ IN N GQVK+ D
Sbjct: 90  YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRN-GQVKLCD 147

Query: 167 LGFAAIVGRSHAAHSIIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPY 221
            G +  +  S A     G   YMAPE    +     Y    D++S G+ ++E+ T   PY
Sbjct: 148 FGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207

Query: 222 SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
               +  +  K+V     PQ   +   PE + F+ KC+ +  + RP+  ELL+ PFF  
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 2e-21
 Identities = 79/289 (27%), Positives = 132/289 (45%), Gaps = 42/289 (14%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP+G F    +++G G   KVY+A  ++ G  VA   +++    ED      +  E  +L
Sbjct: 3   DPTGIFELV-EVIGEGTYGKVYKARHKKTGQLVA---IKIMDIIED--EEEEIKEEYNIL 56

Query: 73  RTLKN-KYIIVCYSVWL-------DDQHNTLNFITEVCTSGN----LRTYRKKHRHVSIK 120
           R   N   I   Y  ++       DDQ   L  + E+C  G+    ++  RKK + +  +
Sbjct: 57  RKYSNHPNIATFYGAFIKKNPPGNDDQ---LWLVMELCGGGSVTDLVKGLRKKGKRLKEE 113

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAA 179
            +    ++ L GL YLH ++  +IHRD+   NI +  N  +VK+ D G +A +  +    
Sbjct: 114 WIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRR 170

Query: 180 HSIIGTPEYMAPEL------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
           ++ IGTP +MAPE+       +  Y    D++S G+  +E+   + P  +   +  ++K 
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230

Query: 234 VTGGVKPQALNKVKDPE-----VKAFIEKC-IAQPRARPSASELLKDPF 276
                 P     +K PE        FI +C I     RP   ELL+ PF
Sbjct: 231 PRN--PPP---TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 90.9 bits (225), Expect = 3e-21
 Identities = 75/257 (29%), Positives = 129/257 (50%), Gaps = 15/257 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A ++  G +VA   + L       +L N    EV ++R  +++ ++  Y
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN----EVVIMRDYQHQNVVEMY 84

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +L  +   L  + E    G L     + R ++ + +    + VL+ L YLH+    +I
Sbjct: 85  KSYLVGEE--LWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQG--VI 139

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEED-YTEMV 202
           HRD+   +I +  + G+VK+ D GF A + +      S++GTP +MAPE+     Y   V
Sbjct: 140 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIA- 260
           DI+S G+ ++EMV  E PY   DS  +  K++     P+  N  K  P ++ F+E+ +  
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257

Query: 261 QPRARPSASELLKDPFF 277
           +P+ R +A ELL  PF 
Sbjct: 258 EPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 3e-21
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 20/265 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V +      G  +A   V   H      +  ++  E+Q++   ++ YI+  Y
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVV---HIGAKSSVRKQILRELQIMHECRSPYIVSFY 69

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +L++ +  +    E    G+L    KK   + ++ L K +  V+EGL YL+ +   I+
Sbjct: 70  GAFLNENNICM--CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY-NVHRIM 126

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   GQ+K+ D G +  +  S  A + +GT  YM+PE +    YT   D
Sbjct: 127 HRDIKPSNILVNSR-GQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 204 IYSFGLCLLEMVTMEIPYSE-------CDSVAKIYKKVTGGVK--PQALNKVKDPEV-KA 253
           ++S G+ ++E+   + P++         D    I   +   V+  P  L     PE  + 
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244

Query: 254 FIEKCIAQ-PRARPSASELLKDPFF 277
           F++ C+ + P  RP+  +L   P F
Sbjct: 245 FVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 91.0 bits (226), Expect = 5e-21
 Identities = 71/262 (27%), Positives = 118/262 (45%), Gaps = 23/262 (8%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSGA   VY+   +  G   A   +  +H  ED V   ++  E+++LR + +  ++ C+
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVR-RQICREIEILRDVNHPNVVKCH 138

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            ++  D +  +  + E    G+L              L   ++Q+L G+ YLH     I+
Sbjct: 139 DMF--DHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADVARQILSGIAYLHRRH--IV 190

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEEDYTEMV- 202
           HRD+  SN+ IN     VKI D G + I+ ++    +S +GT  YM+PE    D      
Sbjct: 191 HRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249

Query: 203 -----DIYSFGLCLLEMVTMEIPY--SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
                DI+S G+ +LE      P+        A +   +     P+A       E + FI
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS-REFRHFI 308

Query: 256 EKCIAQ-PRARPSASELLKDPF 276
             C+ + P  R SA +LL+ PF
Sbjct: 309 SCCLQREPAKRWSAMQLLQHPF 330

Length = 353

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 89.6 bits (222), Expect = 7e-21
 Identities = 86/289 (29%), Positives = 126/289 (43%), Gaps = 44/289 (15%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN------ 77
           +G GA   VY+A D   G  VA   VR+    +  P+   R   EV LL+ L+       
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR---EVALLKRLEAFDHPNI 64

Query: 78  -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLE 134
            + + VC +    D+   +  + E     +LRTY  K     +  + +K   +Q L GL+
Sbjct: 65  VRLMDVCATS-RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-L 193
           +LH +  CI+HRDL   NI +    GQVK+ D G A I     A   ++ T  Y APE L
Sbjct: 123 FLHAN--CIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179

Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIY------------KKVT--- 235
            +  Y   VD++S G    EM   +  +   SE D + KI+            + VT   
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239

Query: 236 GGVKPQALNKVKD--PEVKA-----FIEKCIAQPRARPSASELLKDPFF 277
           G   P+    V+   PE++       +E     P  R SA   L+ PFF
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.8 bits (222), Expect = 1e-20
 Identities = 81/281 (28%), Positives = 135/281 (48%), Gaps = 26/281 (9%)

Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
            E F + DP   F   +DL  +G G+   VY A D      VA  ++  S    +    +
Sbjct: 15  AELFFKEDPEKLF---TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 71

Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRHVSIK 120
            +  EV+ L+ +K+   I     +L  + +T   + E C    S  L  ++K  + V I 
Sbjct: 72  II-KEVKFLQRIKHPNSIEYKGCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 128

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
           A+   +   L+GL YLH+H   +IHRD+   NI +    GQVK+ D G A+I      A+
Sbjct: 129 AI---THGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIAS---PAN 179

Query: 181 SIIGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
           S +GTP +MAPE+     E  Y   VD++S G+  +E+   + P    ++++ +Y  +  
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQ 238

Query: 237 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 276
              P   +       + F++ C+ + P+ RP++ ELLK  F
Sbjct: 239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 89.0 bits (221), Expect = 1e-20
 Identities = 73/264 (27%), Positives = 110/264 (41%), Gaps = 42/264 (15%)

Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY 110
           +L H    P + N++  E+++L    + YI+  Y  +  D    ++   E    G+L   
Sbjct: 32  KLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQV 89

Query: 111 RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 170
            KK   +    L K S  VL GL YL   +  I+HRD+  SNI +N   G++K+ D G +
Sbjct: 90  LKKAGRIPENILGKISIAVLRGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIKLCDFGVS 147

Query: 171 AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIP--------- 220
             +  S  A+S +GT  YM+PE L    YT   DI+S GL L+EM     P         
Sbjct: 148 GQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206

Query: 221 -----YSECDSVAKIYKKVTGGV-----KPQAL----------------NKVKDPEVKAF 254
                    +  AK   +   G      +P A+                +     E + F
Sbjct: 207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDF 266

Query: 255 IEKC-IAQPRARPSASELLKDPFF 277
           ++KC    P+ R    EL K PF 
Sbjct: 267 VDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 88.2 bits (218), Expect = 2e-20
 Identities = 70/260 (26%), Positives = 130/260 (50%), Gaps = 17/260 (6%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG    VY+A +   G   A   ++L    ED  +V +   E+ +++  K+  I+  +
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQ---EIIMMKDCKHSNIVAYF 72

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +L  + + L    E C  G+L+        +S   +   S++ L+GL YLH+     +
Sbjct: 73  GSYL--RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPELYEED----YT 199
           HRD+  +NI +  N G VK+ D G +A +  + A   S IGTP +MAPE+   +    Y 
Sbjct: 129 HRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVK-DPEVKAFIEK 257
           ++ DI++ G+  +E+  ++ P  +   +  ++       +P  L +K+K       F++ 
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247

Query: 258 CIAQ-PRARPSASELLKDPF 276
            + + P+ RP+A +LL+ PF
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 88.5 bits (219), Expect = 2e-20
 Identities = 68/219 (31%), Positives = 114/219 (52%), Gaps = 11/219 (5%)

Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
           L +EV ++R  +++ ++  Y+ +L    + L  + E    G L T    H  ++ + +  
Sbjct: 64  LFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAA 120

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSII 183
               VL+ L  LH     +IHRD+   +I +  + G+VK+ D GF A V +      S++
Sbjct: 121 VCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLV 177

Query: 184 GTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           GTP +MAPEL     Y   VDI+S G+ ++EMV  E PY   +   K  K +   + P+ 
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKL 236

Query: 243 LNKVK-DPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
            N  K  P +K F+++ + + P  R +A+ELLK PF ++
Sbjct: 237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 86.6 bits (214), Expect = 1e-19
 Identities = 77/280 (27%), Positives = 133/280 (47%), Gaps = 22/280 (7%)

Query: 6   GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
            E F + DP   F    ++ G G+   VY A D      VA  ++  S    +    + +
Sbjct: 5   AELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRHVSIKAL 122
             EV+ L+ L++   I     +L  + +T   + E C    S  L  ++K  + V I A+
Sbjct: 64  -KEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
              +   L+GL YLH+H   +IHRD+   NI ++   G VK+GD G A+I+     A+  
Sbjct: 121 ---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXF 171

Query: 183 IGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
           +GTP +MAPE+     E  Y   VD++S G+  +E+   + P    ++++ +Y  +    
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNE 230

Query: 239 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
            P   +       + F++ C+ + P+ RP++  LLK  F 
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 17  RFGRYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           R  ++   LG G   KV            G +VA     L+H  E+    +    E+++L
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS--LNHSGEEQHR-SDFEREIEIL 60

Query: 73  RTLKNKYIIVCYSVWLDDQH-NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVL 130
           RTL ++  IV Y    +     +L  I E   SG+LR Y ++HR  +++K L  +S Q+ 
Sbjct: 61  RTLDHEN-IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE--- 187
           +G++YL +     IHRDL   NI +      VKI D G A ++      + +    E   
Sbjct: 120 KGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 188 -YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            + APE L    ++   D++SFG+ L E+ T
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 86.1 bits (213), Expect = 1e-19
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 22/277 (7%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D LG G    VY+   +  G+ +A  ++RL     D    N++  E+ +L    + YI+ 
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVD 63

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK---ALKKWSKQVLEGLEYLHTH 139
            Y  +       +    E   +G+L                 L++ +  V++GL++L   
Sbjct: 64  FYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KE 120

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-- 197
           E  IIHRD+  +N+ +NGN GQVK+ D G +  +  S  A + IG   YMAPE  +    
Sbjct: 121 EHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGP 178

Query: 198 -----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPE 250
                YT   D++S GL +LEM     PY   ++ A I+ +++  V   P  L      +
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDD 237

Query: 251 VKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSE 286
            + F+ KC+ + P  RP+ ++LL+ P+  +  + D +
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVD 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 85.5 bits (211), Expect = 2e-19
 Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 15/267 (5%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP   F +  + +G G+  +VY+  D      VA   + L    ++   +  +  E+ +L
Sbjct: 1   DPEELFTKL-ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE---IEDIQQEITVL 56

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
               + YI   Y  +L  +   L  I E    G+     K    +    +    +++L+G
Sbjct: 57  SQCDSPYITRYYGSYL--KGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKG 113

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAP 191
           L+YLH+     IHRD+  +N+ ++   G VK+ D G A  +  +    ++ +GTP +MAP
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 192 ELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+ ++  Y    DI+S G+  +E+   E P S+   +  ++  +     P  L       
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--LIPKNSPPTLEGQYSKP 228

Query: 251 VKAFIEKCIAQ-PRARPSASELLKDPF 276
            K F+E C+ + PR RP+A ELLK  F
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.1 bits (210), Expect = 2e-19
 Identities = 69/267 (25%), Positives = 126/267 (47%), Gaps = 15/267 (5%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP   F +   + G G+  +V++  D      VA   + L    ++   +  +  E+ +L
Sbjct: 1   DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE---IEDIQQEITVL 56

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
               + Y+   Y  +L D    L  I E    G+     +    +    +    +++L+G
Sbjct: 57  SQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKG 113

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           L+YLH+ +   IHRD+  +N+ ++ + G+VK+ D G A  +  +    +  +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 192 ELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+ ++  Y    DI+S G+  +E+   E P+SE   +  ++  +     P  L       
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--LIPKNNPPTLEGNYSKP 228

Query: 251 VKAFIEKCI-AQPRARPSASELLKDPF 276
           +K F+E C+  +P  RP+A ELLK  F
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.9 bits (211), Expect = 4e-19
 Identities = 81/294 (27%), Positives = 124/294 (42%), Gaps = 58/294 (19%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLK-NKYII 81
           LG G    VY A ++E G  VA  ++  +   + E       L  EV+ LR L  +  I+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE----CMNLR-EVKSLRKLNEHPNIV 61

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTY----RKKHRHVSIKALKKWSKQVLEGLEYLH 137
               V+ ++    L F+ E    GNL  Y     +K +  S   ++    Q+L+GL ++H
Sbjct: 62  KLKEVFRENDE--LYFVFE-YMEGNL--YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPE--LY 194
            H     HRDL   N+ ++G    VKI D G A  + RS   +   + T  Y APE  L 
Sbjct: 117 KHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREI-RSRPPYTDYVSTRWYRAPEILLR 172

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ--------- 241
              Y+  VDI++ G  + E+ T+  P     SE D + KI   V G    Q         
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKIC-SVLGTPTKQDWPEGYKLA 230

Query: 242 -ALNKVKDPEVKA----------------FIEKCIA-QPRARPSASELLKDPFF 277
             L   + P+                    I+  +   P+ RP+AS+ L+ P+F
Sbjct: 231 SKLG-FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 83.9 bits (208), Expect = 5e-19
 Identities = 46/161 (28%), Positives = 83/161 (51%), Gaps = 6/161 (3%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V  + +E ++L+ L + +++  +  + D+++  +  + ++   G+LR +  +    S + 
Sbjct: 44  VRNVLNERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQ 101

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           +K W  +++  LEYLH+    IIHRD+   NI ++   G V I D   A  V       S
Sbjct: 102 VKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTS 158

Query: 182 IIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPY 221
             GTP YMAPE+   + Y+  VD +S G+   E +  + PY
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 83.5 bits (206), Expect = 6e-19
 Identities = 70/232 (30%), Positives = 114/232 (49%), Gaps = 15/232 (6%)

Query: 46  AWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSG 105
           A  ++RL   S     V     E  LL  +K+  I+     +  D H  L  + E C  G
Sbjct: 29  AMKEIRLPKSSSA---VEDSRKEAVLLAKMKHPNIVAFKESFEADGH--LYIVMEYCDGG 83

Query: 106 NL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 163
           +L  +   ++ +      + +W  Q+  G++  H HE  ++HRD+   NIF+  N G+VK
Sbjct: 84  DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVK 140

Query: 164 IGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPY 221
           +GD G A ++    A A + +GTP Y+ PE++E   Y    DI+S G  L E+ T++ P+
Sbjct: 141 LGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200

Query: 222 SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELL 272
                   I K   G  KP  L      E+++ I++   + PR+RPSA+ +L
Sbjct: 201 QANSWKNLILKVCQGSYKP--LPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 7e-19
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 23/208 (11%)

Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
           +H+E ++L+ + + +II  +    D +   L  + E    G L +Y +     S      
Sbjct: 48  VHNEKRVLKEVSHPFIIRLFWTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNSTGLF 105

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSII 183
           ++ +++  LEYLH+ E  I++RDL   NI ++   G +K+ D GFA  +  R+    ++ 
Sbjct: 106 YASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDRTW---TLC 159

Query: 184 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           GTPEY+APE +  + + + VD ++ G+ + EM+    P+ + D+   IY+K+  G     
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAG----- 213

Query: 243 LNKVK-----DPEVKAFIEKCIAQPRAR 265
             K++     D   K  I+K +   R R
Sbjct: 214 --KLEFPRHLDLYAKDLIKKLLVVDRTR 239

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 83.9 bits (207), Expect = 7e-19
 Identities = 70/257 (27%), Positives = 125/257 (48%), Gaps = 15/257 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A ++  G +VA  ++ L       +L N    EV ++R   ++ ++  Y
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN----EVVIMRDYHHENVVDMY 85

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + +L    + L  + E    G L T    H  ++ + +      VL  L YLH     +I
Sbjct: 86  NSYL--VGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPELYEE-DYTEMV 202
           HRD+   +I +  + G++K+ D GF A V +      S++GTP +MAPE+     Y   V
Sbjct: 141 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV-KAFIE-KCIA 260
           DI+S G+ ++EM+  E PY   +   +  +++   + P+  +  K   V + F++   + 
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258

Query: 261 QPRARPSASELLKDPFF 277
           +P  R +A ELL+ PF 
Sbjct: 259 EPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 83.6 bits (206), Expect = 8e-19
 Identities = 72/284 (25%), Positives = 136/284 (47%), Gaps = 35/284 (12%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP+G F    +L+G+G   +VY+    + G   A   + ++   E+ +       E+ +L
Sbjct: 3   DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI-----KQEINML 56

Query: 73  RTLKNKYIIVCY--------SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
           +   +   I  Y           +DDQ   L  + E C +G++    K  +  ++K  ++
Sbjct: 57  KKYSHHRNIATYYGAFIKKNPPGMDDQ---LWLVMEFCGAGSVTDLIKNTKGNTLK--EE 111

Query: 125 W----SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-A 179
           W     +++L GL +LH H+  +IHRD+   N+ +  N  +VK+ D G +A + R+    
Sbjct: 112 WIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRR 168

Query: 180 HSIIGTPEYMAPELYEED------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
           ++ IGTP +MAPE+   D      Y    D++S G+  +EM     P  +   +  ++  
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-L 227

Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRA-RPSASELLKDPF 276
           +     P+  +K    + ++FIE C+ +  + RP+  +L+K PF
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 84.1 bits (208), Expect = 1e-18
 Identities = 89/306 (29%), Positives = 137/306 (44%), Gaps = 53/306 (17%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY DL  +G GA   V  A DQ  G  VA  ++ +  FS  PVL  R + E++LL+ L++
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFST-PVLAKRTYRELKLLKHLRH 68

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK-----WSKQVLEG 132
           + II    +++    + + F+TE+  +         HR ++ + L+K     +  Q+L G
Sbjct: 69  ENIISLSDIFISPLED-IYFVTELLGT-------DLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 192
           L+Y+H+    ++HRDL  SNI IN N   +KI D G A I  +       + T  Y APE
Sbjct: 121 LKYVHS--AGVVHRDLKPSNILINENC-DLKICDFGLARI--QDPQMTGYVSTRYYRAPE 175

Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY----------KKVTGGV-- 238
             L  + Y   VDI+S G    EM+  +  +   D V +              V   +  
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235

Query: 239 -------------KPQAL-NKVK--DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 281
                        +P     K K  DP     +EK +   P+ R SA+E L  P+ +  +
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295

Query: 282 DDDSEP 287
           D   EP
Sbjct: 296 DPTDEP 301

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 82.8 bits (204), Expect = 2e-18
 Identities = 70/267 (26%), Positives = 125/267 (46%), Gaps = 15/267 (5%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP   F +  + +G G+  +V++  D      VA   + L   +ED +    +  E+ +L
Sbjct: 1   DPEELFTKL-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEI--EDIQQEITVL 56

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
               + Y+   Y  +L  +   L  I E    G+     +       + +    K++L+G
Sbjct: 57  SQCDSPYVTKYYGSYL--KGTKLWIIMEYLGGGSALDLLRAGPFDEFQ-IATMLKEILKG 113

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAP 191
           L+YLH+ +   IHRD+  +N+ ++   G VK+ D G A  +  +    ++ +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 192 ELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+ ++  Y    DI+S G+  +E+   E P S+   +  ++  +     P  L       
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--LIPKNNPPTLTGEFSKP 228

Query: 251 VKAFIEKCIAQ-PRARPSASELLKDPF 276
            K FI+ C+ + P  RP+A ELLK  F
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 82/317 (25%), Positives = 137/317 (43%), Gaps = 56/317 (17%)

Query: 19  GRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY DL  LG G+   V+ A D +    VA  ++ L+    DP  V     E++++R L 
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT----DPQSVKHALREIKIIRRLD 60

Query: 77  NKYIIVCYSVWLDDQH------------NTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
           +  I+  Y V                  N++ +I +     +L    +    +S +  + 
Sbjct: 61  HDNIVKVYEVLGPSGSDLTEDVGSLTELNSV-YIVQEYMETDLANVLE-QGPLSEEHARL 118

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR--SHAAHSI 182
           +  Q+L GL+Y+H+    ++HRDL  +N+FIN     +KIGD G A IV    SH  +  
Sbjct: 119 FMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 183 IG--TPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT----------ME--------IP 220
            G  T  Y +P   L   +YT+ +D+++ G    EM+T          +E        +P
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236

Query: 221 Y------SECDSVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASE 270
                  +E  +V   + +  GG   + L  +    +PE   F+E+ +   P  R +A E
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 271 LLKDPFFSELNDDDSEP 287
            L  P+ S  +    EP
Sbjct: 297 ALMHPYMSCYSCPFDEP 313

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 77/312 (24%), Positives = 135/312 (43%), Gaps = 58/312 (18%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA  +V  AFD + G +VA    +LS   +  +   R + E++LL+ + +
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDH 73

Query: 78  KYIIVCYSVWLDDQHN----TLNFITEVCTS--GN-LRTYRKKHRHVSIKALKKWSKQVL 130
           + +I    V+           +  +T +  +   N ++  +    H+          Q+L
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY-----QIL 128

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPE 187
            GL+Y+H+    IIHRDL  SNI +N +  ++KI D G A      H    + G   T  
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA-----RHTDDEMTGYVATRW 180

Query: 188 YMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQAL 243
           Y APE  L    Y + VDI+S G  + E++T +  +   D + ++ +   + G    + L
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240

Query: 244 NKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDPF 276
            K+     + +I+     P+                            R +A+E L  P+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Query: 277 FSELNDDDSEPS 288
            +E +D + EP 
Sbjct: 301 LAEYHDPEDEPV 312

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 82.6 bits (204), Expect = 3e-18
 Identities = 79/295 (26%), Positives = 125/295 (42%), Gaps = 51/295 (17%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVC 83
           +G G   KVY+A D+  G  VA  + RL    ++  +      E+ LL+ L ++ YI+  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLE--MDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 84  YSVWLDDQHN-------TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
             V   ++ N          ++            R   R +  K +K +  Q+L+G+ + 
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA------AHSIIGTPEYMA 190
           H H   ++HRDL   N+ ++   G +KI DLG    +GR+ +       H I+ T  Y A
Sbjct: 127 HKHG--VMHRDLKPQNLLVDKQKGLLKIADLG----LGRAFSIPVKSYTHEIV-TLWYRA 179

Query: 191 PE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK-------KVTGGV 238
           PE  L    Y+  VDI+S G    EM   +  +   SE   +  I+K       +V  GV
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239

Query: 239 ------------KPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                       KPQ L++      PE    ++K +   P  R SA   L  P+F
Sbjct: 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 23/206 (11%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLK 76
           RY  L  +G GA   V++A D+E G  VA  +V L       P    R   E++ L+  +
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQ 57

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
           + Y++    V+       L    E   S      R + R +    +K + + +L+G+ Y+
Sbjct: 58  HPYVVKLLDVFPHGSGFVLVM--EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR------SHAAHSIIGTPEYMA 190
           H     I+HRDL  +N+ I    G +KI D G A +         SH     + T  Y A
Sbjct: 116 H--ANGIMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQ----VATRWYRA 168

Query: 191 PELY--EEDYTEMVDIYSFGLCLLEM 214
           PEL      Y   VD+++ G    E+
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.1 bits (203), Expect = 4e-18
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 37/216 (17%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII 81
             +G G   +VY+A D++ G  VA  +VRL +  E  P+   R   E+++LR L ++ I+
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIV 69

Query: 82  VCYSVWLDDQHNTLNFITE-----------------VCTSGNLRTYRKKHRHVSIKALKK 124
               +  D Q + L+F  +                 +  SG L  + + H       +K 
Sbjct: 70  NLKEIVTDKQ-DALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKS 120

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI--VGRSHAAHSI 182
           + KQ+LEGL Y H      +HRD+ CSNI +N N GQ+K+ D G A +     S    + 
Sbjct: 121 FMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 183 IGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVT 216
           + T  Y  PEL   EE Y   +D++S G  L E+ T
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 82.4 bits (204), Expect = 4e-18
 Identities = 79/313 (25%), Positives = 128/313 (40%), Gaps = 68/313 (21%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV-- 82
           +GSGA   V  A D   G +VA  ++   H  + P L  R   E+++LR  K+  II   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 83  ------------CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
                        Y V +D   + L+ I  + +   L        H+       +  Q+L
Sbjct: 71  DILRPPGADFKDVYVV-MDLMESDLHHI--IHSDQPLTE-----EHIRY-----FLYQLL 117

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-----IGT 185
            GL+Y+H+    +IHRDL  SN+ +N +  +++IGD G A  +  S   H       + T
Sbjct: 118 RGLKYIHS--ANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 186 PEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTME--IPYSECDSVAKIYKKVTGGVKPQ 241
             Y APEL     +YT  +D++S G    EM+      P        K+   V G    +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234

Query: 242 ALNKVKDPEVKAFIEKC----------------------IAQ-----PRARPSASELLKD 274
            LN++    V+ +I+                        ++Q     P  R +  + L+ 
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 275 PFFSELNDDDSEP 287
           PF ++ +D D EP
Sbjct: 295 PFLAQYHDPDDEP 307

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 85/310 (27%), Positives = 140/310 (45%), Gaps = 56/310 (18%)

Query: 20  RYSDLL--GSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY DL   GSGA   V  A D+  G +VA  ++     SE  +   R + E++LL+ +K+
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMKH 73

Query: 78  KYIIVCYSVW-----LDDQHNTLNFITEVCTS-GNLRTYRKKHRHVSIKALKKWSKQVLE 131
           + +I    V+     LD  H+    +  + T  G L     KH  +S   ++    Q+L+
Sbjct: 74  ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKL----MKHEKLSEDRIQFLVYQMLK 129

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEY 188
           GL+Y+H     IIHRDL   N+ +N +  ++KI D G A           + G   T  Y
Sbjct: 130 GLKYIHA--AGIIHRDLKPGNLAVNEDC-ELKILDFGLA-----RQTDSEMTGYVVTRWY 181

Query: 189 MAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALN 244
            APE  L    YT+ VDI+S G  + EM+T +  +   D + ++ +  KVTG    + + 
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241

Query: 245 KVKDPEVKAFIEK---------------------------CIAQPRARPSASELLKDPFF 277
           K++  + K +++K                            +    +R +A+E L  P+F
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301

Query: 278 SELNDDDSEP 287
            E +D + E 
Sbjct: 302 EEFHDPEDET 311

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 71/262 (27%), Positives = 125/262 (47%), Gaps = 17/262 (6%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIV 82
            +GSG   +VY+   ++ G  +A  Q+R +   E+     R+  ++  +L++    YI+ 
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE---NKRILMDLDVVLKSHDCPYIVK 78

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEP 141
           CY  ++ D   +  FI     S  L    K+ +  +    L K +  +++ L YL   + 
Sbjct: 79  CYGYFITD---SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE-KH 134

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-----E 196
            +IHRD+  SNI ++ + G VK+ D G +  +  S A     G   YMAPE  +      
Sbjct: 135 GVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKAFI 255
            Y    D++S G+ L+E+ T + PY  C +  ++  K+     P    N+   P+  +F+
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFV 253

Query: 256 EKCIAQ-PRARPSASELLKDPF 276
           + C+ +  R RP   ELL+ PF
Sbjct: 254 DLCLTKDHRKRPKYRELLQHPF 275

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    VYRA D   G  VA  +VR+ +   D + ++ L  E+ LL  L++  I+   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLR-EITLLLNLRHPNIVELK 72

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            V +    +++  + E C               S   +K    Q+L GL+YLH +   II
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN--FII 130

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY--EED 197
           HRDL  SN+ +    G +KI D G A   G    A  +  TP+     Y APEL      
Sbjct: 131 HRDLKVSNLLLTDK-GCLKIADFGLARTYG--LPAKPM--TPKVVTLWYRAPELLLGCTT 185

Query: 198 YTEMVDIYSFGLCLLEMVTME 218
           YT  +D+++ G  L E++  +
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.9 bits (197), Expect = 2e-17
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 46/288 (15%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 64

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V   +  N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 65  LDVIHTE--NKLYLVFEF-LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR- 120

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEE 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE  L  +
Sbjct: 121 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 176

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK-------KVTGGV-------- 238
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV        
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236

Query: 239 -----KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                  Q  +KV    D + +  + + +   P  R SA   L  PFF
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 3e-17
 Identities = 81/289 (28%), Positives = 124/289 (42%), Gaps = 48/289 (16%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A D+  G  VA  ++RL    E  P    R   E+ LL+ L +  I+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIVRL 63

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA--LKKWSKQVLEGLEYLHTHEP 141
             V   +  N L  + E     +L+ Y        +    +K +  Q+L+G+ Y H+H  
Sbjct: 64  LDVVHSE--NKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR- 119

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEE 196
            ++HRDL   N+ I+   G +K+ D G A   G   R++  H ++ T  Y APE  L   
Sbjct: 120 -VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEILLGSR 175

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTG--------GV------- 238
            Y+  VDI+S G    EMV     +   SE D + +I+ +  G        GV       
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF-RTLGTPDEDVWPGVTSLPDYK 234

Query: 239 ------KPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                   Q L+KV    D +    + K +   P  R SA   L+ P+F
Sbjct: 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 70  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 127 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 204 IYSFGLCLLEMVTMEIPYSECDS 226
           I+S GL L+EM     P    D+
Sbjct: 185 IWSMGLSLVEMAIGRYPIPPPDA 207

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 78.7 bits (194), Expect = 4e-17
 Identities = 67/257 (26%), Positives = 119/257 (46%), Gaps = 14/257 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+  K      +E+G +    ++ +S  S  P        EV +L  +K+  I V Y
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPNI-VQY 64

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
               ++  N L  + + C  G+L       R V      +  W  Q+   L+  H H+  
Sbjct: 65  QESFEENGN-LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--HVHDRK 121

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYE-EDYTE 200
           I+HRD+   NIF+  + G +K+GD G A ++  +   A + IGTP Y++PE+ E   Y  
Sbjct: 122 ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
             DI++ G  L EM T++  +   +    + K + G   P + +     +++  + +   
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSH--YSYDLRNLVSQLFK 238

Query: 261 Q-PRARPSASELLKDPF 276
           + PR RPS + +L+  F
Sbjct: 239 RNPRDRPSVNSILEKNF 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 79.9 bits (197), Expect = 4e-17
 Identities = 84/314 (26%), Positives = 137/314 (43%), Gaps = 61/314 (19%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY+ L  +GSGA   V  A D+  G +VA  ++     SE  +   R + E+ LL+ +++
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQH 73

Query: 78  KYIIVCYSVWLDDQ------HNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQV 129
           + +I      LD            +F         ++T  +K     +S   ++    Q+
Sbjct: 74  ENVIG----LLDVFTSAVSGDEFQDF---YLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TP 186
           L GL+Y+H+    IIHRDL   N+ +N +  ++KI D G A      HA   + G   T 
Sbjct: 127 LCGLKYIHS--AGIIHRDLKPGNLAVNEDC-ELKILDFGLA-----RHADAEMTGYVVTR 178

Query: 187 EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQA 242
            Y APE  L    Y + VDI+S G  + EM+T +  +   D + ++ +  KVTG   P+ 
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238

Query: 243 LNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDP 275
           + K++D   K++I+     PR                            R +A+E L+ P
Sbjct: 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP 298

Query: 276 FFSELNDDDSEPSP 289
           +F    D D E   
Sbjct: 299 YFDSFRDADEETEQ 312

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 80/280 (28%), Positives = 129/280 (46%), Gaps = 44/280 (15%)

Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           S +LGSGA   V  A    +G   A   V +   SE     NR  +EV  L       I+
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK--NRAQAEVCCLLNCDFFSIV 94

Query: 82  VCYSVWL-DDQHNTLN-----FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLE---G 132
            C+  +   D  N  N      + +   +G+LR          IK+  K ++   E   G
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ--------EIKSRAKTNRTFREHEAG 146

Query: 133 LEYL-------HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI--------VGRSH 177
           L ++       H H   +IHRD+  +NI +  N G VK+GD GF+ +        VGR+ 
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRT- 204

Query: 178 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
                 GTP Y+APE++    Y++  D++S G+ L E++T++ P+   +    ++K + G
Sbjct: 205 ----FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260

Query: 237 GVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDP 275
              P  L     PE++  +   + + P+ RPS+S+LL  P
Sbjct: 261 RYDP--LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 7e-17
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 14/196 (7%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L  + E    G+  +  K    +     K++  +V+ G+E LH     IIHRD+   N+ 
Sbjct: 72  LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLL 129

Query: 155 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLE 213
           I+   G +K+ D G +            +GTP+Y+APE        +M D +S G  + E
Sbjct: 130 IDQT-GHLKLTDFGLSRNG---LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185

Query: 214 MVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPEVKAFIEKCI-AQPRARPSAS- 269
            +    P+   ++   ++  +       P+ + +   PE    I + +   P  R  A+ 
Sbjct: 186 FLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG 244

Query: 270 --ELLKDPFFSELNDD 283
             E+   PFF  +N D
Sbjct: 245 YQEIKSHPFFKSINWD 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 8e-17
 Identities = 77/308 (25%), Positives = 139/308 (45%), Gaps = 52/308 (16%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 75

Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQK-LTDDHVQFLIYQILRGL 133

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEYMA 190
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A      H    + G   T  Y A
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA-----RHTDDEMTGYVATRWYRA 185

Query: 191 PELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKV 246
           PE+      Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245

Query: 247 KDPEVKAFIEKCIAQPR---------------------------ARPSASELLKDPFFSE 279
                + +I+     P+                            R +A++ L   +F++
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305

Query: 280 LNDDDSEP 287
            +D D EP
Sbjct: 306 YHDPDDEP 313

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.8 bits (191), Expect = 9e-17
 Identities = 68/260 (26%), Positives = 122/260 (46%), Gaps = 17/260 (6%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG    VY+A +   G   A   ++L    +D  L+ +   E+ +++  K+  I+  +
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQ---EIFMVKECKHCNIVAYF 72

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +L  +   L    E C  G+L+        +S   +    ++ L+GL YLH+     +
Sbjct: 73  GSYLSRE--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPELYEED----YT 199
           HRD+  +NI +  N G VK+ D G AA +  + A   S IGTP +MAPE+   +    Y 
Sbjct: 129 HRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVK-DPEVKAFIE- 256
           ++ DI++ G+  +E+  ++ P  +   +  ++       +P  L +K K       F++ 
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247

Query: 257 KCIAQPRARPSASELLKDPF 276
                P+ RP+A  LL   F
Sbjct: 248 SLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 51/177 (28%), Positives = 91/177 (51%), Gaps = 9/177 (5%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V  +  E  +L  L + +I+     + D+  N + F+ E    G L T+ +K        
Sbjct: 62  VQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDV 119

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
            K +  +++   EYLH+ +  II+RDL   N+ ++   G VK+ D GFA  V       +
Sbjct: 120 AKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKV--PDRTFT 174

Query: 182 IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           + GTPEY+APE+ + + + + VD ++ G+ L E +    P+ + D+  +IY+K+  G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230

Length = 329

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 35/284 (12%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP+G F    +++G+G   +VY+    + G   A   + ++   E+ +       E+ +L
Sbjct: 13  DPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI-----KLEINML 66

Query: 73  RTLKN-KYIIVCYSVWL-------DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
           +   + + I   Y  ++       DDQ   L  + E C +G++    K  +  ++K  + 
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQ---LWLVMEFCGAGSVTDLVKNTKGNALK--ED 121

Query: 125 W----SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA- 179
           W     +++L GL +LH H+  +IHRD+   N+ +  N  +VK+ D G +A + R+    
Sbjct: 122 WIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRR 178

Query: 180 HSIIGTPEYMAPELYEED------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
           ++ IGTP +MAPE+   D      Y    DI+S G+  +EM     P  +   +  ++  
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L 237

Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPR-ARPSASELLKDPF 276
           +     P+  +K    +   FIE C+ +   +RPS  +LLK PF
Sbjct: 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.2 bits (192), Expect = 1e-16
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 22/227 (9%)

Query: 1   MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV 60
           + D D E   E             LG+G    V +   +  G+ +A    +L H    P 
Sbjct: 2   LKDDDFERISE-------------LGAGNGGVVTKVQHKPSGLIMA---RKLIHLEIKPA 45

Query: 61  LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 120
           + N++  E+Q+L    + YI+  Y  +  D    ++   E    G+L    K+ + +  +
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKEAKRIPEE 103

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
            L K S  VL GL YL      I+HRD+  SNI +N   G++K+ D G +  +  S  A+
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MAN 160

Query: 181 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
           S +GT  YM+PE L    Y+   DI+S GL L+E+     P    D+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 61/234 (26%), Positives = 112/234 (47%), Gaps = 31/234 (13%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL-RTYRKKHR---HVSIKALK 123
           EV ++R LK+K I+     +L+  +  L  + E C +G+L R  +K ++    +   A+ 
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 124 KWSKQVLEGLEYLHTHEPC-----IIHRDLNCSNIFINGNIGQV---------------- 162
             ++Q+L  L Y H  +       ++HRDL   NIF++  I  +                
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 163 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY---EEDYTEMVDIYSFGLCLLEMVTMEI 219
           KIGD G +  +G    AHS +GTP Y +PEL     + Y +  D+++ G  + E+ + + 
Sbjct: 182 KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241

Query: 220 PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELL 272
           P+ + ++ +++  ++  G  P    K K  E+   I+  +    + RPSA + L
Sbjct: 242 PFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293

Length = 1021

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 85/291 (29%), Positives = 124/291 (42%), Gaps = 47/291 (16%)

Query: 25  LGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN----- 77
           +G GA  KV++A D + G   VA  +VR+    E  P+   R   EV +LR L+      
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---EVAVLRHLETFEHPN 65

Query: 78  --KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGL 133
             +   VC +V   D+   L  + E     +L TY  K     V  + +K    Q+L GL
Sbjct: 66  VVRLFDVC-TVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+H   ++HRDL   NI +  + GQ+K+ D G A I     A  S++ T  Y APE 
Sbjct: 124 DFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQAL-NKVKD 248
           L +  Y   VD++S G    EM   +  +   S+ D + KI   V G    +     V  
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPGEEDWPRDVAL 239

Query: 249 PEV---------------------KAFIEKCIA-QPRARPSASELLKDPFF 277
           P                       K  + KC+   P  R SA   L  P+F
Sbjct: 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 41/285 (14%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVC 83
           +G G   +V +A  ++ G   A   ++  HF      VN L  E+Q LR L  +  I+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFK-SLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
             V  D +   L  + E+    NL    + + R +  K +K +  Q+L+ L+++H +   
Sbjct: 64  IEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE--LYEEDYTE 200
           I HRD+   NI I  +I  +K+ D G    +         I T  Y APE  L +  Y  
Sbjct: 121 IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP 178

Query: 201 MVDIYSFGLCLLEMVTME--IPYS-ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF--- 254
            +DI++ G    E++++    P + E D +AKI+  V G    + L K +      +   
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD-VLGTPDAEVLKKFRKSRHMNYNFP 237

Query: 255 ------IEKCIAQ----------------PRARPSASELLKDPFF 277
                 + K +                  P  R +A + L+ P+F
Sbjct: 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 4e-16
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 18/229 (7%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V  + +E  +L T K+++++     + DD++  L    E    G+ RT       +S   
Sbjct: 45  VRHVLTERDILTTTKSEWLVKLLYAFQDDEY--LYLAMEYVPGGDFRTLLNNLGVLSEDH 102

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAH 180
            + +  ++ E ++ LH  E   IHRDL   N F+    G +K+ D G +  IV     A+
Sbjct: 103 ARFYMAEMFEAVDALH--ELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTY---AN 156

Query: 181 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYS-----ECDSVAKIYKKV 234
           S++G+P+YMAPE L  + Y   VD +S G  L E +    P+S     E     K +K+ 
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216

Query: 235 TG-GVKPQALNKVKDPEVKAFIEKCIAQPRAR-PSASELLKDPFFSELN 281
               V       + D E    I K I  P  R  S  ++   PFF E++
Sbjct: 217 LQRPVYDDPRFNLSD-EAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.9 bits (187), Expect = 5e-16
 Identities = 55/176 (31%), Positives = 78/176 (44%), Gaps = 10/176 (5%)

Query: 110 YRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 169
           Y      +  + L K +   ++ L YL   E  IIHRD+  SNI ++ N G +K+ D G 
Sbjct: 97  YEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRN-GNIKLCDFGI 154

Query: 170 AAIVGRSHAAHSIIGTPEYMAPEL----YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECD 225
           +  +  S A     G   YMAPE       + Y    D++S G+ L E+ T + PY + +
Sbjct: 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214

Query: 226 SVAKIYKKVTGGVKPQALN---KVKDPEVKAFIEKC-IAQPRARPSASELLKDPFF 277
           SV     +V  G  P   N   +   P    FI  C I     RP   ELL+ PF 
Sbjct: 215 SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 53/264 (20%), Positives = 107/264 (40%), Gaps = 50/264 (18%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK- 120
           +  L  E+   R L++  I+   + ++ D    L  ++ +   G+     K H    +  
Sbjct: 43  LKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDLLKTHFPEGLPE 100

Query: 121 -ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHA 178
            A+    K VL  L+Y+H  +  I HR +  S+I ++G+ G+V +  L ++ +++     
Sbjct: 101 LAIAFILKDVLNALDYIH-SKGFI-HRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKR 157

Query: 179 AHSIIGTPEY-------MAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSEC---- 224
              +   P+        ++PE+ +++   Y E  DIYS G+   E+    +P+ +     
Sbjct: 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217

Query: 225 -----------------------DSVAKIYKKVTGGVKPQAL----NKVKDPEVKAFIEK 257
                                  DS+++            ++     +        F+E 
Sbjct: 218 MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL 277

Query: 258 CIAQ-PRARPSASELLKDPFFSEL 280
           C+ + P +RPSAS+LL   FF + 
Sbjct: 278 CLQRDPESRPSASQLLNHSFFKQC 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 75.6 bits (186), Expect = 7e-16
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 40/233 (17%)

Query: 68  EVQLLRTLKNKYII----VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKAL 122
           E+++L++L++  I+    VCYS         L  + E    G+LR Y +KHR  +  + L
Sbjct: 55  EIEILKSLQHDNIVKYKGVCYSA----GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL 110

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
             ++ Q+ +G+EYL +     +HRDL   NI +  +  +VKIGD G   ++ +    + +
Sbjct: 111 LLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKV 167

Query: 183 IGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTG 236
               E    + APE L E  ++   D++SFG+ L E+ T    YS+   S    + ++ G
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMG 223

Query: 237 GVKPQA------LNKVKD-----------PEVKAFIEKCIA-QPRARPSASEL 271
             K         +  +K+            E+ A +++C    P  RPS SEL
Sbjct: 224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 75.2 bits (185), Expect = 8e-16
 Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 19/258 (7%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIE-VAWNQVRLSH------FSEDPVLVNRLHSEVQLLR-T 74
           + LGSGA   VY+   +  G   +A  ++ + +        E    +  + SEV +++  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR----TYRKKHRHVSIKALKKWSKQVL 130
           L++  I+  Y  +L++  + L  + ++     L     + ++K +  + + +     Q++
Sbjct: 66  LRHPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
             L YLH  E  I+HRDL  +NI + G   +V I D G A          S++GT  Y  
Sbjct: 124 LALRYLHK-EKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181

Query: 191 PELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
           PE+ + E Y E  D+++FG  L +M T++ P+   + ++   K V    +P     +   
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP-EGMYSE 240

Query: 250 EVKAFIEKCIA-QPRARP 266
           +V   I  C+     ARP
Sbjct: 241 DVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 74.3 bits (183), Expect = 1e-15
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL-RTYRKKH-RHVSIKALKKW 125
           E  ++ +L ++ +I  Y V L      L  +TE+   G+L    RK    H  I  L  +
Sbjct: 46  EAAIMHSLDHENLIRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY 102

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF--AAIVGRSH---AAH 180
           + Q+  G+ YL +     IHRDL   NI +  +  +VKIGD G   A      H     H
Sbjct: 103 AVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEH 159

Query: 181 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
             +    + APE L    ++   D++ FG+ L EM T  E P++   S ++I KK+    
Sbjct: 160 LKVPFA-WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDK-- 215

Query: 239 KPQALNKVKD--PEVKAFIEKCIA-QPRARPSASEL 271
           + + L + +    ++   + +C A  P  RP+ + L
Sbjct: 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           +Y  L  +G G+   V++  ++E G  VA  +   S   +DPV+      E+++L+ LK+
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKH 59

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
             ++    V+   +   L+ + E C    L    K  R V    +KK   Q L+ + + H
Sbjct: 60  PNLVNLIEVF--RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE 196
            H  CI HRD+   NI I    GQ+K+ D GFA I+      ++  + T  Y APEL   
Sbjct: 118 KHN-CI-HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 197 D--YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALN------- 244
           D  Y   VD+++ G    E++T +  +   S+ D +  I +K  G + P+          
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI-RKTLGDLIPRHQQIFSTNQF 233

Query: 245 ----KVKDPEVK---------------AFIEKCIA-QPRARPSASELLKDPFF 277
                + +PE +               +F++ C+   P  R S  ELL+ P+F
Sbjct: 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 74.7 bits (183), Expect = 2e-15
 Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 41/281 (14%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVR---------LSH-FSEDPVLVNRLHSEVQLLR 73
           LLG G   KV    ++  G   A   +R         ++H  +E  VL N  H     L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP---FLT 58

Query: 74  TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
            LK  +            H+ L F+ E    G L  +  + R  + +  + +  +++  L
Sbjct: 59  ALKYAF----------QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 108

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--HSIIGTPEYMAP 191
           EYLH+ +  +++RD+   N+ ++ + G +KI D G     G S  A   +  GTPEY+AP
Sbjct: 109 EYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 164

Query: 192 ELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDP 249
           E+ E+ DY   VD +  G+ + EM+   +P+   D        +   ++ P+ L+    P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS----P 220

Query: 250 EVKAFIEKCIAQ-PRAR----PS-ASELLKDPFFSELNDDD 284
           E K+ +   + + P+ R    PS A E+++  FF  +N  D
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 79/312 (25%), Positives = 134/312 (42%), Gaps = 51/312 (16%)

Query: 20  RYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVR--LSHFSEDPVLVNRLHSEVQLLRTL 75
           RY   +++G G+   V  A D   G +VA  ++     H S+      R+  E++LLR L
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD----ATRILREIKLLRLL 56

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEV--CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           ++  I+    + L         I  V      +L    K +  ++ +  + +  Q+L  L
Sbjct: 57  RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-----IGTPEY 188
           +Y+HT    + HRDL   NI  N +  ++KI D G A  V  +    +I     + T  Y
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANADC-KLKICDFGLAR-VAFNDTPTAIFWTDYVATRWY 172

Query: 189 MAPEL---YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK--IYKKVTGGVKPQAL 243
            APEL   +   YT  +DI+S G    E++T +  +   + V +  +   + G   P+ +
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 244 NKVK--------------------------DPEVKAFIEKCIA-QPRARPSASELLKDPF 276
           ++V+                          DP     +E+ +A  P+ RP+A E L DP+
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 277 FSELNDDDSEPS 288
           F  L   + EPS
Sbjct: 293 FKGLAKVEREPS 304

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 43/289 (14%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           ++G GA   V +  ++  G  VA  + + S   +D  +      EV++LR L+++ I+  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
              +       L  + E      L         +   A++ +  Q+L+ + Y H+H   I
Sbjct: 66  KEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--I 121

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYMAPELYEED--YT 199
           IHRD+   NI ++ + G +K+ D GFA  +    A+     + T  Y APEL   D  Y 
Sbjct: 122 IHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180

Query: 200 EMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---------LNKVK 247
           + VD+++ G  + E++  E  +   S+ D +  I +K  G + P              V 
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI-QKCLGPLPPSHQELFSSNPRFAGVA 239

Query: 248 DPEVK------------------AFIEKCIA-QPRARPSASELLKDPFF 277
            PE                     F++ C+   P+ R +  ELL+ P+F
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 73.6 bits (181), Expect = 3e-15
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    V++A ++E    VA  +VRL    +D  + +    E+ LL+ LK+K I+  Y
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V   D+  TL F  E C   +L+ Y       +  + +K +  Q+L+GL + H+H   +
Sbjct: 66  DVLHSDKKLTLVF--EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--V 120

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEEDY 198
           +HRDL   N+ IN N G++K+ D G A   G   R ++A  +  T  Y  P+     + Y
Sbjct: 121 LHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLY 177

Query: 199 TEMVDIYSFGLCLLEMVTMEIP----YSECDSVAKIYK 232
           +  +D++S G    E+     P        D + +I++
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 73.6 bits (181), Expect = 4e-15
 Identities = 59/192 (30%), Positives = 91/192 (47%), Gaps = 39/192 (20%)

Query: 120 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 179
             ++K+  Q+L G+E+ H+H   IIHRD+   NI ++ + G VK+ D GFA  +      
Sbjct: 100 SRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV 156

Query: 180 HS-IIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYK 232
           ++  + T  Y APEL   D  Y   VDI++ G  + EM+T E P     S+ D +  I K
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIK 215

Query: 233 KVTGGVKPQ--------------ALNKVKDPE------------VKAFIEKCIA-QPRAR 265
            + G + P+               L +VK+ E            V    ++C+   P  R
Sbjct: 216 CL-GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR 274

Query: 266 PSASELLKDPFF 277
           PS+S+LL   FF
Sbjct: 275 PSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 73.7 bits (181), Expect = 4e-15
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 46/278 (16%)

Query: 18  FGRYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLS-HFSEDPVLVNRLHSEVQL 71
           FG+    LG+GA  KV  A        +  ++VA   ++ + H SE   L+    SE+++
Sbjct: 39  FGK---TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALM----SELKI 91

Query: 72  LRTLKNKYIIV-----CYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKK 124
           +  L N   IV     C           +  ITE C  G+L  +  RK+   ++++ L  
Sbjct: 92  MSHLGNHENIVNLLGAC------TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSII 183
           +S QV +G+ +L + + C IHRDL   N+ + +G I  VKI D G A  +  + + + + 
Sbjct: 146 FSYQVAKGMAFLAS-KNC-IHRDLAARNVLLTHGKI--VKICDFGLARDI-MNDSNYVVK 200

Query: 184 GTP----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGG 237
           G      ++MAPE ++   YT   D++S+G+ L E+ ++   PY      +K YK +  G
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260

Query: 238 ---VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
               +P+        E+   ++ C    P  RP+  ++
Sbjct: 261 YRMAQPEHAPA----EIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.9 bits (179), Expect = 5e-15
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 15/167 (8%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           ++ Q++ GLE  H H+  I++RDL   N+ ++ + G V+I DLG A  +          G
Sbjct: 100 YAAQIICGLE--HLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAG 156

Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVKPQA 242
           TP YMAPE L  E Y   VD ++ G  L EM+    P+       K+ K+ +       A
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR--QRKEKVEKEELKRRTLEMA 214

Query: 243 LNKVKD--PEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELN 281
           +       PE K   E  + + P  R      SA E+ + P F +LN
Sbjct: 215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 73.3 bits (180), Expect = 6e-15
 Identities = 40/133 (30%), Positives = 70/133 (52%), Gaps = 5/133 (3%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + +          + ++ +++ GL++LH     II+RDL   N+ 
Sbjct: 71  LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVL 128

Query: 155 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLL 212
           ++ + G +KI D G     +     A +  GTP+Y+APE+ + + Y E VD +SFG+ L 
Sbjct: 129 LDKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLY 187

Query: 213 EMVTMEIPYSECD 225
           EM+  + P+   D
Sbjct: 188 EMLIGQSPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.1 bits (179), Expect = 6e-15
 Identities = 71/291 (24%), Positives = 131/291 (45%), Gaps = 47/291 (16%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV--LVNRLHSEVQ 70
           DP+  +    + +G G   KVY+  ++++G   A   +       DP+  +   + +E  
Sbjct: 19  DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-------DPISDVDEEIEAEYN 70

Query: 71  LLRTLKNKYIIV-CYSVWLDDQH---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS 126
           +L++L N   +V  Y ++          L  + E+C  G++           +K L    
Sbjct: 71  ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL--------VKGLLICG 122

Query: 127 KQVLE------------GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 174
           +++ E            GL++LH +   IIHRD+  +NI +    G VK+ D G +A + 
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKLVDFGVSAQLT 179

Query: 175 RSH-AAHSIIGTPEYMAPEL------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV 227
            +    ++ +GTP +MAPE+      Y+  Y    D++S G+  +E+   + P  +   V
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239

Query: 228 AKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQP-RARPSASELLKDPF 276
             ++ K+     P  L+  K       FI +C+ +   ARPS + LL+ PF
Sbjct: 240 KTLF-KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 8e-15
 Identities = 65/276 (23%), Positives = 112/276 (40%), Gaps = 45/276 (16%)

Query: 25  LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKN 77
           LG G+   VY          E    VA   V     +E+  +  R+   +E  +++    
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERIEFLNEASVMKEFNC 68

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-------VSIKALKK---WSK 127
            +++    V    Q   +  + E+   G+L++Y +  R        +    L+K    + 
Sbjct: 69  HHVVRLLGVVSTGQPTLV--VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT-- 185
           ++ +G+ YL       +HRDL   N  +  +   VKIGD G    +      +   G   
Sbjct: 127 EIADGMAYLA--AKKFVHRDLAARNCMVAED-LTVKIGDFGMTRDI-YETDYYRKGGKGL 182

Query: 186 -P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYS--ECDSVAKIYKKVTGGVK 239
            P  +MAPE L +  +T   D++SFG+ L EM T+ E PY     + V K      GG  
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGH- 239

Query: 240 PQALNKVKDPEVK--AFIEKCIA-QPRARPSASELL 272
              L+  ++   K    +  C    P+ RP+  E++
Sbjct: 240 ---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 37/235 (15%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY    L+G G + +VY A+D      VA  ++R    SE+P+L  R   E ++   L 
Sbjct: 2   QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLI 60

Query: 77  NKYIIVCYSVWLDDQ--HNTLNFITEVCTSGNLRTYRKK-------HRHVSIKALKKWSK 127
           +  I+  YS+  D    + T+ +I        L++  +K           S+ A      
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-------------VG 174
           ++   +EY+H+    ++HRDL   NI + G  G+V I D G AAI             V 
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWG-AAIFKKLEEEDLLDIDVD 176

Query: 175 RSHAAHS-------IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 221
             +  +S       I+GTP+YMAPE L     +E  DIY+ G+ L +M+T+  PY
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 47/171 (27%), Positives = 91/171 (53%), Gaps = 15/171 (8%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIK 120
           +  L  E+++LR L ++ I+    +  +D  N +  I E   SG+L+ Y  +++  +++K
Sbjct: 50  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK 109

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
              K++ Q+ +G++YL + +   +HRDL   N+ +  +  QVKIGD G    +      +
Sbjct: 110 QQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYY 166

Query: 181 SI---IGTPEY-MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
           ++   + +P +  APE L +  +    D++SFG+ L E++T       CDS
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY------CDS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 74/223 (33%), Positives = 97/223 (43%), Gaps = 51/223 (22%)

Query: 104 SGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 162
           S +L TY  K+ R + I       KQ+LEGL YLH     IIHRD+   NIFIN ++ QV
Sbjct: 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQV 196

Query: 163 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT----- 216
            IGDLG A     + A   + GT E  APE+   D Y    DI+S G+ L EM+      
Sbjct: 197 CIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256

Query: 217 MEIPYSECDSVAK-----IYKKVTG-GVKPQALNKVKDPE---VKAFIE--KCIAQPRA- 264
            E P S  +   K     + K ++   V P+     +DP    V+ FIE      QP   
Sbjct: 257 FEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP--RDPGSRLVRGFIEYASLERQPYTR 314

Query: 265 ---------------------------RPSASELLKDPFFSEL 280
                                      RPSA E+L  P F++L
Sbjct: 315 YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 17/202 (8%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L+ I +    G L T+  +  H +   ++ +  +++  L+  H H+  II+RD+   NI 
Sbjct: 80  LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD--HLHQLGIIYRDIKLENIL 137

Query: 155 INGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPEYMAPELY---EEDYTEMVDIYSFGL 209
           ++   G V + D G +          A+S  GT EYMAPE+       + + VD +S G+
Sbjct: 138 LDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196

Query: 210 CLLEMVTMEIPYS---ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRAR 265
              E++T   P++   E +S ++I +++     P    K    E + FI+K + + P+ R
Sbjct: 197 LTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKR 254

Query: 266 ---PSASELLKDPFFSELNDDD 284
                A E+   PFF  ++ DD
Sbjct: 255 LGANGADEIKNHPFFQGIDWDD 276

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 26/264 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G    VY+  ++  G  VA  ++ L      P    R   E+ L++ LK++ I+  +
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRLH 64

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLHTHEP 141
            V      N L  + E     +L+ Y   H     +    +K ++ Q+L+G+ + H +  
Sbjct: 65  DVI--HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR- 120

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-IGTPEYMAPE--LYEEDY 198
            ++HRDL   N+ IN   G++K+ D G A   G      S  + T  Y AP+  L    Y
Sbjct: 121 -VLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 199 TEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKD-PEVKAF 254
           +  +DI+S G  + EM+T    +   +  D + KI+ ++ G         +   PE K  
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF-RIMGTPTESTWPGISQLPEYKPT 237

Query: 255 IEKCIAQ------PRARPSASELL 272
             +   Q      P A P   +LL
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLL 261

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 25/203 (12%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L  +T+  + G L  + +K    S    K +  +++  LE+LH ++  I++RDL   NI 
Sbjct: 71  LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENIL 128

Query: 155 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCL 211
           ++   G + + D G + A +  +   ++  GT EY+APE  L E+ YT+ VD +S G+ +
Sbjct: 129 LDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187

Query: 212 LEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP------EVKAFIEKCIAQ-PRA 264
            EM     P+   D   ++Y+ +       A  KV+ P      E + F++  + + P+ 
Sbjct: 188 FEMCCGWSPFYAED-TQQMYRNI-------AFGKVRFPKNVLSDEGRQFVKGLLNRNPQH 239

Query: 265 R----PSASELLKDPFFSELNDD 283
           R      A EL + PFF++++ D
Sbjct: 240 RLGAHRDAVELKEHPFFADIDWD 262

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 79/309 (25%), Positives = 122/309 (39%), Gaps = 69/309 (22%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII-- 81
           LG G   +VY+A   + G  VA  ++ + +  +  P+   R   E+++L+ LK+  ++  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR---EIKILKKLKHPNVVPL 72

Query: 82  ----VCYSVWLDDQHNTLNFITEVCT------SGNLRTYRKKHRHVSIKALKKWSKQVLE 131
               V      D        +  V        SG L     K     IK    +  Q+LE
Sbjct: 73  IDMAVERP---DKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC---YMLQLLE 126

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------------GRSHAA 179
           G+ YLH  E  I+HRD+  +NI I+ N G +KI D G A               G +   
Sbjct: 127 GINYLH--ENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 180 HSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKK 233
            +++ T  Y  PEL   E  YT  VDI+  G    EM T   P     S+ D +  I+K 
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFKL 242

Query: 234 V---------------------TGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSA 268
                                 +    P+ L +      PE    + K ++  P  R +A
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302

Query: 269 SELLKDPFF 277
           S+ L+ P+F
Sbjct: 303 SDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 67/271 (24%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRT----YRKKHRHVSIKALK 123
           E+ LLR LK++ ++    V+L+    ++  + +       +      + K   +    +K
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAIVGRSHAA- 179
               Q+L G+ YLH++   ++HRDL  +NI + G     G VKIGDLG A +    +A  
Sbjct: 112 SLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPL 166

Query: 180 ------HSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTME------------- 218
                   ++ T  Y APEL      YT+ +DI++ G    E++T+E             
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226

Query: 219 IPYSECDSVAKI--------------------YKKVTGGVKPQA---------LNKVKDP 249
            P+   D + +I                    Y  +    K +          + K K P
Sbjct: 227 NPFQR-DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP 285

Query: 250 EVKAF--IEKCIA-QPRARPSASELLKDPFF 277
           + + F  + K +   P  R +A E L+ P+F
Sbjct: 286 DSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 15/164 (9%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E+ +L+TL ++ I+       +     L  I E    G+LR Y  KH+ +++  L  +++
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQ 114

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           Q+ EG+ YLH+     IHRDL   N+ ++ N   VKIGD G A  V   H  + +    +
Sbjct: 115 QICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 188 ----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
               + A E L E  ++   D++SFG+ L E++T       CDS
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT------HCDS 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 70.4 bits (172), Expect = 5e-14
 Identities = 71/280 (25%), Positives = 131/280 (46%), Gaps = 27/280 (9%)

Query: 24  LLGSGAVKKVY---RAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           +LG+GA  KV+   +    + G   A   ++ +   +         +E Q+L  ++    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 81  IVC--YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
           +V   Y+   D +   L+ I +    G L T+  +      + ++ +S +++  LE  H 
Sbjct: 67  LVTLHYAFQTDTK---LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE--HL 121

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPELY-- 194
           H+  II+RD+   NI ++ N G V + D G +          A+S  GT EYMAP++   
Sbjct: 122 HKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 195 -EEDYTEMVDIYSFGLCLLEMVTMEIPYS---ECDSVAKIYKKVTGGVKPQALNKVKDPE 250
            +  + + VD +S G+ + E++T   P++   E +S A+I +++     P    +     
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL 238

Query: 251 VKAFIEK-CIAQPRAR----PS-ASELLKDPFFSELNDDD 284
            K  I++  +  P+ R    PS A E+ K PFF ++N DD
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.5 bits (172), Expect = 7e-14
 Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 46/305 (15%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D     +VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKH 73

Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      +  N +  +T +    +L    K  + +S + ++    Q+L GL
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNL-MGADLNNIVKCQK-LSDEHVQFLIYQLLRGL 131

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           +Y+H+    IIHRDL  SN+ +N +  +++I D G A         +  + T  Y APE 
Sbjct: 132 KYIHS--AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADDEMTGY--VATRWYRAPEI 186

Query: 193 -LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDP 249
            L    Y + VDI+S G  + E++  +  +   D + ++ +  +V G   P+ L K+   
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246

Query: 250 EVKAFIEKCIAQPR---------------------------ARPSASELLKDPFFSELND 282
             + +I+     P+                            R SASE L  P+FS+ +D
Sbjct: 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306

Query: 283 DDSEP 287
            + EP
Sbjct: 307 PEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 69.6 bits (170), Expect = 8e-14
 Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 15/210 (7%)

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           IVC S       + L+FI ++   G+L  +  +H   S   ++ ++ +++ GLE  H H 
Sbjct: 59  IVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHN 115

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--Y 198
             +++RDL  +NI ++ + G V+I DLG A    +    H+ +GT  YMAPE+ ++   Y
Sbjct: 116 RFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAY 173

Query: 199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI-YKKVTGGVKPQALNKVKDPEVKAFIEK 257
               D +S G  L +++    P+ +  +  K    ++T  +  + L     PE+++ +E 
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSPELRSLLEG 232

Query: 258 CIAQPRAR------PSASELLKDPFFSELN 281
            + +   R        A E+ + PFF  L+
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.1 bits (171), Expect = 9e-14
 Identities = 75/280 (26%), Positives = 123/280 (43%), Gaps = 39/280 (13%)

Query: 24  LLGSGAVKKVYRAFDQEEGI---------EVAWNQVRLSH-FSEDPVLVNRLHSEVQLLR 73
           LLG G   KV    ++  G          EV   +  ++H  +E  VL N  H     L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP---FLT 58

Query: 74  TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           +LK       YS    D+   L F+ E    G L  +  + R  S    + +  +++  L
Sbjct: 59  SLK-------YSFQTKDR---LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSAL 108

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--HSIIGTPEYMAP 191
           +YLH+ +  I++RDL   N+ ++ + G +KI D G     G + AA   +  GTPEY+AP
Sbjct: 109 DYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCK-EGITDAATMKTFCGTPEYLAP 164

Query: 192 ELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDP 249
           E+ E+ DY   VD +  G+ + EM+   +P+   D        +   +K P+ L+     
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKS 224

Query: 250 EVKAFIEKCIAQPRAR-----PSASELLKDPFFSELNDDD 284
            +   +   I  P  R       A E+++  FF+ +N  D
Sbjct: 225 LLSGLL---IKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD 261

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 69.5 bits (170), Expect = 9e-14
 Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 22/171 (12%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSII 183
           ++ Q++ GLE+LH     II+RDL   N+ ++ N G V+I DLG A  +           
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158

Query: 184 GTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           GTP +MAPEL + E+Y   VD ++ G+ L EM+    P+      A+  K     +K + 
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR-----ARGEKVENKELKQRI 213

Query: 243 LNK-VKDPE-----VKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELN 281
           LN  V  P+      K+F E  +A+ P  R      +   L   P F +LN
Sbjct: 214 LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 36/275 (13%)

Query: 24  LLGSGAVKKVYRAFDQEEG---------IEVAWNQVRLSH-FSEDPVLVNRLHSEVQLLR 73
           LLG G   KV    ++  G          EV   +  ++H  +E+ VL N  H     L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP---FLT 58

Query: 74  TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
            LK  +            H+ L F+ E    G L  +  + R  S    + +  +++  L
Sbjct: 59  ALKYSF----------QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 108

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAPE 192
           +YLH+ E  +++RDL   N+ ++ + G +KI D G      +  A   +  GTPEY+APE
Sbjct: 109 DYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 193 LYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 251
           + E+ DY   VD +  G+ + EM+   +P+   D   K+++ +   ++     +   PE 
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL--MEEIRFPRTLSPEA 223

Query: 252 KAFIEKCIAQ-PRAR-----PSASELLKDPFFSEL 280
           K+ +   + + P+ R       A E+++  FF+ +
Sbjct: 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 10/155 (6%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIG 184
           Q++  L+ +H+    ++HRDL  +NIF+    G +K+GD GF+     S     A S  G
Sbjct: 177 QIVLALDEVHSR--KMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 185 TPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           TP Y+APEL+E   Y++  D++S G+ L E++T+  P+ +  S  +I ++V  G      
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVLYGKYDPFP 292

Query: 244 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
             V    +KA ++  +++ P  RP+  +LL   F 
Sbjct: 293 CPVSS-GMKALLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 53/186 (28%), Positives = 80/186 (43%), Gaps = 40/186 (21%)

Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGT 185
            Q+L G+ +LH +   I+HRDL  SN+ +N N G +KI D G A   G        ++ T
Sbjct: 113 LQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVT 169

Query: 186 PEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTG---- 236
             Y APEL    ++Y+  +D++S G    E++T +  +   SE D + KI+K +      
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229

Query: 237 ---------GVKPQALNKVKDPEV---KAFIEKCIAQ-------------PRARPSASEL 271
                    G K       K P     K F    ++              P  R SA + 
Sbjct: 230 IWPGFSELPGAKK--KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287

Query: 272 LKDPFF 277
           LK P+F
Sbjct: 288 LKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 68.2 bits (167), Expect = 2e-13
 Identities = 65/249 (26%), Positives = 120/249 (48%), Gaps = 18/249 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG   +V+     +  + VA   ++    S+D +       EVQ L+ L++K++I  +
Sbjct: 14  LGSGYFGEVWEGL-WKNRVRVAIKILK----SDDLLKQQDFQKEVQALKRLRHKHLISLF 68

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
           +V    +   +  ITE+   G+L  + +  + + + + +L   + QV EG+ YL   E  
Sbjct: 69  AVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQN 124

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPE-LYEEDYTE 200
            IHRDL   NI +  ++   K+ D G A ++    + +       ++ APE      ++ 
Sbjct: 125 SIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183

Query: 201 MVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC- 258
             D++SFG+ L EM T  ++PY    +  ++Y ++T G +     K    E+   + +C 
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCP-QEIYKIMLECW 241

Query: 259 IAQPRARPS 267
            A+P  RPS
Sbjct: 242 AAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 2e-13
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 25  LGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LGSGA   VY+     EG    I VA   +++      P     +  E  ++ ++ + ++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVA---IKVLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTH 139
           +    + L  Q      IT++   G L  Y + H+ ++  + L  W  Q+ +G+ YL   
Sbjct: 72  VRLLGICLSSQVQ---LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG--TP-EYMAPE-LYE 195
              ++HRDL   N+ +      VKI D G A ++      +   G   P ++MA E +  
Sbjct: 129 R--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 196 EDYTEMVDIYSFGLCLLEMVT 216
             YT   D++S+G+ + E++T
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 43/129 (33%), Positives = 66/129 (51%), Gaps = 8/129 (6%)

Query: 97  FITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
           F+ E    G+L  +   H  V S      ++  V+ GL+YLH ++  I++RDL   N+ +
Sbjct: 79  FVMEYAAGGDLMMH--IHTDVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLL 134

Query: 156 NGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLE 213
           +   G VKI D G     +G      +  GTPE++APE L E  YT  VD +  G+ + E
Sbjct: 135 DTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYE 193

Query: 214 MVTMEIPYS 222
           M+  E P+ 
Sbjct: 194 MLVGESPFP 202

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 3e-13
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 41/216 (18%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS----------EVQLLRT 74
           LG+G   +V+      EG+   WN       +  PV V  L            E Q+++ 
Sbjct: 14  LGAGQFGEVW------EGL---WN-------NTTPVAVKTLKPGTMDPKDFLAEAQIMKK 57

Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEG 132
           L++  +I  Y+V   ++   +  +TE+   G+L  Y      R + +  L   + QV  G
Sbjct: 58  LRHPKLIQLYAVCTLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASG 115

Query: 133 LEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTP-EYM 189
           + YL       IHRDL   N+ +   NI   K+ D G A ++    + A      P ++ 
Sbjct: 116 MAYLEAQN--YIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEAREGAKFPIKWT 171

Query: 190 APE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYS 222
           APE  LY   ++   D++SFG+ L E+VT   +PY 
Sbjct: 172 APEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYP 206

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 79/309 (25%), Positives = 130/309 (42%), Gaps = 50/309 (16%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +G GA   V  A  +  G++VA    ++S F E      R   E+++LR  K+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPF-EHQTFCQRTLREIKILRRFKH 62

Query: 78  KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
           + II    +       + N    + E+  +   +  + +H  +S   ++ +  Q+L GL+
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQILRGLK 120

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-----IGTPEYM 189
           Y+H+    ++HRDL  SN+ +N N   +KI D G A I    H  H+      + T  Y 
Sbjct: 121 YIHSAN--VLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEH-DHTGFLTEYVATRWYR 176

Query: 190 APE--LYEEDYTEMVDIYSFGLCLLEMV-------------------------TMEIPYS 222
           APE  L  + YT+ +DI+S G  L EM+                         + E    
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236

Query: 223 ECDSVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 278
                A+ Y K          NK+    DP+    ++K +   P  R +  E L  P+  
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296

Query: 279 ELNDDDSEP 287
           + +D   EP
Sbjct: 297 QYHDPSDEP 305

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 68.2 bits (167), Expect = 3e-13
 Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 7/130 (5%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++         + ++ +++ GL++LH     II+RDL   N+ 
Sbjct: 71  LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVL 128

Query: 155 INGNIGQVKIGDLGFA--AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCL 211
           ++   G +KI D G     I+G    + +  GTP+Y+APE L  + Y   VD ++ G+ L
Sbjct: 129 LDSE-GHIKIADFGMCKEGILGGVTTS-TFCGTPDYIAPEILSYQPYGPAVDWWALGVLL 186

Query: 212 LEMVTMEIPY 221
            EM+  + P+
Sbjct: 187 YEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 65/252 (25%), Positives = 111/252 (44%), Gaps = 36/252 (14%)

Query: 11  EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL----- 65
               S R+ +    LG G   KV +A+D   G  VA  +V++   S D     +L     
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 66  -H----SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 120
            H     E++++  +K++ I+    V++  + + +N + ++  S   +   +K R ++  
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYV--EGDFINLVMDIMASDLKKVVDRKIR-LTES 119

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG------ 174
            +K    Q+L GL  LH      +HRDL+ +NIFIN + G  KI D G A   G      
Sbjct: 120 QVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSD 176

Query: 175 ----RSHAAHSIIGTPE-----YMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY-- 221
                         T +     Y APEL    E Y   VD++S G    E++T +  +  
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236

Query: 222 -SECDSVAKIYK 232
            +E D + +I++
Sbjct: 237 ENEIDQLGRIFE 248

Length = 335

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 45/288 (15%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    VY+  +++ G  VA  ++RL   SE+  + +    E+ LL+ L++  I+   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYR---KKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
            V +  Q + L  I E   S +L+ Y     K +++  + +K +  Q+L+G+ + H+   
Sbjct: 66  DVLM--QESRLYLIFEF-LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEE 196
            ++HRDL   N+ I+   G +K+ D G A   G   R +  H ++ T  Y APE  L   
Sbjct: 122 -VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVY-THEVV-TLWYRAPEVLLGSP 177

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI--------------------YKK 233
            Y+  VDI+S G    EM T +  +   SE D + +I                    YK 
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237

Query: 234 VTGGVKPQAL-NKVKDPEVKAF--IEKC-IAQPRARPSASELLKDPFF 277
                K  +L + VK+ +      +EK  I  P  R SA + L  P+F
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 43/149 (28%), Positives = 80/149 (53%), Gaps = 9/149 (6%)

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
           +N ++   Y  +   +H  L F+ E    G+L  + +      +     ++ +++ GL++
Sbjct: 54  ENPFLTHLYCTFQTKEH--LFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQF 111

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPEL 193
           LH+    II+RDL   N+ ++ + G +KI D G     + G + A+ +  GTP+Y+APE+
Sbjct: 112 LHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAS-TFCGTPDYIAPEI 167

Query: 194 YE-EDYTEMVDIYSFGLCLLEMVTMEIPY 221
            +   YT  VD +SFG+ L EM+  + P+
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 7e-13
 Identities = 48/165 (29%), Positives = 86/165 (52%), Gaps = 12/165 (7%)

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHS 181
           + ++ ++L  LE LH     +I+RDL   NI ++   G + + D G   + +      ++
Sbjct: 96  RFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNT 152

Query: 182 IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 240
             GTPEY+APEL     YT+ VD ++ G+ L EM+T   P+ + ++V ++Y+K+    +P
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKIL--QEP 209

Query: 241 QALNKVKDPEVKAFIEKCIAQ-PRAR---PSASELLKDPFFSELN 281
                  D + K  +   +++ P  R     A E+   PFFS+L+
Sbjct: 210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.1 bits (164), Expect = 8e-13
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           H+ L F+ E    G L  +  + R  S    + +  +++  L YLH+ +  +++RDL   
Sbjct: 67  HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLE 124

Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAA--HSIIGTPEYMAPELYEE-DYTEMVDIYSFG 208
           N+ ++ + G +KI D G     G S  A   +  GTPEY+APE+ E+ DY   VD +  G
Sbjct: 125 NLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 209 LCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKCIAQ-PRAR- 265
           + + EM+   +P+   D        +   ++ P+ L+    PE K+ +   + + P+ R 
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS----PEAKSLLAGLLKKDPKQRL 238

Query: 266 ----PSASELLKDPFFSELNDDD 284
                 A E+++  FF+ +N  D
Sbjct: 239 GGGPEDAKEIMEHRFFASINWQD 261

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 65/287 (22%), Positives = 132/287 (45%), Gaps = 39/287 (13%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV--LVNRLHSEVQ 70
           DPS  +    + +G G   KV++  +++ G + A   V++     DP+  +   + +E  
Sbjct: 15  DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAA---VKIL----DPIHDIDEEIEAEYN 66

Query: 71  LLRTLKNKYIIV-CYSVWLDDQHNT---LNFITEVCTSGNL----RTYRKKHRHVSIKAL 122
           +L+ L +   +V  Y ++          L  + E+C  G++    + + K+   +    +
Sbjct: 67  ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHS 181
                + L GL++LH ++   IHRD+  +NI +    G VK+ D G +A +       ++
Sbjct: 127 AYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNT 183

Query: 182 IIGTPEYMAPEL------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 235
            +GTP +MAPE+       +  Y    D++S G+  +E+   + P ++   +  ++K   
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK--- 240

Query: 236 GGVKPQALNKVKDPEVKA-----FIEKCIAQP-RARPSASELLKDPF 276
             +       +  PE+ +     FI KC+ +    RP+ S+LL+  F
Sbjct: 241 --IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 17/200 (8%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D LG G+   VY+   +  G  VA  ++RL H    P    R   E  LL+ LK+  I+ 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67

Query: 83  CYSVWLDDQHN--TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTH 139
            +    D  H   TL  + E   + +L+ Y       +S+  ++ +  Q+L GL Y H  
Sbjct: 68  LH----DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE--LYEE 196
              ++HRDL   N+ I+   G++K+ D G A A    S    + + T  Y  P+  L   
Sbjct: 123 R--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 197 DYTEMVDIYSFGLCLLEMVT 216
           +Y+  +D++  G    EM T
Sbjct: 180 EYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 79/321 (24%), Positives = 138/321 (42%), Gaps = 51/321 (15%)

Query: 3   DRDGEPFVEVD---PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP 59
           D D E  ++ D      +  +  +++G+G+   VY A   +   +VA  +V      +DP
Sbjct: 49  DEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-----QDP 103

Query: 60  VLVNRLHSEVQLLRTLKNKYIIV------CYSVWLDDQHNTLNFITEV---CTSGNLRTY 110
              NR   E+ +++ L +  II             ++++  LN + E         ++ Y
Sbjct: 104 QYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY 160

Query: 111 RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 170
            + +  + +  +K +S Q+   L Y+H+   C  HRDL   N+ I+ N   +K+ D G A
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFIC--HRDLKPQNLLIDPNTHTLKLCDFGSA 218

Query: 171 AIVGRSHAAHSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA 228
             +     + S I +  Y APEL     +YT  +D++S G  + EM+     +S   SV 
Sbjct: 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278

Query: 229 KIYK--KVTG--------------------GVKPQALNKV----KDPEVKAFIEKCIA-Q 261
           ++ +  +V G                     VKP+ L KV       +   FI + +  +
Sbjct: 279 QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338

Query: 262 PRARPSASELLKDPFFSELND 282
           P  R +  E L DPFF +L D
Sbjct: 339 PLKRLNPIEALADPFFDDLRD 359

Length = 440

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 34/278 (12%)

Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R +     P     +  E  ++ ++ N +
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPH 70

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 71  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
            E  ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 127 -ERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
              YT   D++S+G+ + E++T        IP SE  S+ +      G   PQ    +  
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQP--PICT 237

Query: 249 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 285
            +V   + KC +    +RP   EL+ +  FS++  D  
Sbjct: 238 IDVYMIMVKCWMIDADSRPKFRELIIE--FSKMARDPQ 273

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 11/147 (7%)

Query: 81  IVC--YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
           IVC  Y+    D+   L FI ++   G+L  +  +H   S K ++ ++ +++ GLE  H 
Sbjct: 59  IVCMTYAFHTPDK---LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HM 113

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED- 197
           H   +++RDL  +NI ++ + G V+I DLG A    +    H+ +GT  YMAPE+ ++  
Sbjct: 114 HNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGT 171

Query: 198 -YTEMVDIYSFGLCLLEMVTMEIPYSE 223
            Y    D +S G  L +++    P+ +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 14/193 (7%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + +      +     ++ +++ GL++LH+    I++RDL   NI 
Sbjct: 71  LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNIL 128

Query: 155 INGNIGQVKIGDLGFA--AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCL 211
           ++ + G +KI D G     ++G +    +  GTP+Y+APE L  + Y   VD +SFG+ L
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTC-TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLL 186

Query: 212 LEMVTMEIPYSECDSVAKIYK-KVTGGVKPQALNK-VKDPEVKAFIEKCIAQPRARPSA- 268
            EM+  + P+   D        ++     P+ L +  KD  VK F+     +P  R    
Sbjct: 187 YEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVR----EPERRLGVK 242

Query: 269 SELLKDPFFSELN 281
            ++ + PFF E++
Sbjct: 243 GDIRQHPFFREID 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.1 bits (156), Expect = 7e-12
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 27/222 (12%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    VY+A D+     +A  ++RL    ED  + +    E+ LL+ +++  I+   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS------IKALKKWSKQVLEGLEYLHT 138
            V   ++   L F         L    KKH   S       + +K +  Q+L G+ Y H+
Sbjct: 68  DVVHSEKRLYLVF-------EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--L 193
           H   ++HRDL   N+ I+     +K+ D G A   G   R+   H ++ T  Y APE  L
Sbjct: 121 HR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF-THEVV-TLWYRAPEILL 176

Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK 232
               Y+  VDI+S G    EMV  +  +   SE D + KI++
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR 218

Length = 294

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 9e-12
 Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 53/308 (17%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR-----LHSEVQLLRTLKN 77
            ++G GA  +V+   D++ G   A   +R S       ++ R     + +E  +L    +
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS------DMIKRNQIAHVRAERDILADADS 60

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
            +I+  Y  + D++H  L  + E    G+L     +      +  + +  +++  L+ +H
Sbjct: 61  PWIVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA------------------- 178
             +   IHRD+   NI I    G +K+ D G    + ++                     
Sbjct: 119 --KLGFIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 179 -----------AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
                      A+S +GTP+Y+APE L    Y    D +S G+ L EM+    P+   D+
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS-DT 234

Query: 227 VAKIYKKVTGGVKPQALNKVKD--PEVKAFIEKCIAQPRAR-PSASELLKDPFFS--ELN 281
           + + Y K+    +           PE    I + +  P  R  S  E+   PFF   +  
Sbjct: 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE 294

Query: 282 DDDSEPSP 289
           +      P
Sbjct: 295 NLRETKPP 302

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.1 bits (156), Expect = 9e-12
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L    ++ R       + ++ +V   L +LH H   +I+RDL   NI 
Sbjct: 71  LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNIL 128

Query: 155 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G  K+ D G     +       +  GTP+Y+APE L E +Y   VD ++ G+ + 
Sbjct: 129 LDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMY 187

Query: 213 EMVTMEIPYSECDSVAKIYKKVTGG--VKPQALNKVKDPEVKAFIEK-------CIAQPR 263
           EM+  + P+ E D+   +++ +     + P  L+K     +KAF+ K       C+A   
Sbjct: 188 EMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVA--- 243

Query: 264 ARPSASELLKDPFFSELNDDDSE 286
           ++     + + PFF E++    E
Sbjct: 244 SQGGEDAIKQHPFFKEIDWVLLE 266

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 64.2 bits (156), Expect = 9e-12
 Identities = 61/274 (22%), Positives = 126/274 (45%), Gaps = 22/274 (8%)

Query: 24  LLGSGAVKKVY---RAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           +LG+GA  KV+   +    + G   A   ++ +   +    V    +E  +L  ++    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +V        +   L+ I +  + G + T+  +  + S   ++ +S +++  LE  H H+
Sbjct: 67  LVTLHYAFQTE-AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE--HLHK 123

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPELY--EE 196
             I++RD+   NI ++   G V + D G +   +       +S  GT EYMAPE+   + 
Sbjct: 124 LGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYS---ECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
            + + VD +S G+ + E++T   P++   E ++ +++ +++     P        PE + 
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP--FPSFIGPEAQD 240

Query: 254 FIEKCIAQ-PRAR-----PSASELLKDPFFSELN 281
            + K + + P+ R       ASE+ + PFF  L+
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.4 bits (154), Expect = 9e-12
 Identities = 54/185 (29%), Positives = 96/185 (51%), Gaps = 12/185 (6%)

Query: 92  HNTLNFITEVCTSGNLRTY-RKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN 149
           HN L  + E+ + GNL  + R + R  VS+  L ++S  V EG+EYL + +  ++HRDL 
Sbjct: 70  HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLA 127

Query: 150 CSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFG 208
             NI ++ + G  K+ D G A  VG     +S +   ++ APE L  + ++   D++S+G
Sbjct: 128 ARNILVSED-GVAKVSDFGLAR-VGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYG 184

Query: 209 LCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARP 266
           + L E+ +    PY +  S+ ++ + V  G + +        +V   +  C   +P+ RP
Sbjct: 185 VLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRMEPPEGCP-ADVYVLMTSCWETEPKKRP 242

Query: 267 SASEL 271
           S  +L
Sbjct: 243 SFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 9e-12
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 16/211 (7%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKA-LKKW 125
           E  ++ TL++  ++    V L      L  +TE    G+L  Y R + R V   A    +
Sbjct: 50  EASVMTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 185
           +  V EG+EYL       +HRDL   N+ ++ +    K+ D G A    +   +  +   
Sbjct: 108 ALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQDSGKL--- 161

Query: 186 P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQA 242
           P ++ APE L E+ ++   D++SFG+ L E+ +   +PY     +  +   V  G + +A
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEA 220

Query: 243 LNKVKDPEVKAFIEKCI-AQPRARPSASELL 272
                 PEV   ++ C    P  RP+  +L 
Sbjct: 221 PEGCP-PEVYKVMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 68/269 (25%), Positives = 109/269 (40%), Gaps = 45/269 (16%)

Query: 25  LGSG----AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LG G     VK VY     +E +EVA   V+                E  ++  L +  I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKE-VEVA---VKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +    V   +    L  + E+   G L  Y KK R + +  LK+ + QV  G+ YL   E
Sbjct: 59  VRLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL---E 112

Query: 141 PC-IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY----------- 188
               +HRDL   N+ +  N  Q KI D G +  +G         G+  Y           
Sbjct: 113 SKHFVHRDLAARNVLLV-NRHQAKISDFGMSRALG--------AGSDYYRATTAGRWPLK 163

Query: 189 -MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNK 245
             APE +    ++   D++S+G+ L E  +    PY E    A++   +  G   + L +
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESG---ERLPR 219

Query: 246 VKD--PEVKAFIEKC-IAQPRARPSASEL 271
            ++   E+ + +  C   +P  RP+ SEL
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 63.2 bits (154), Expect = 1e-11
 Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 72/296 (24%)

Query: 24  LLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KN 77
            LG GA  +V +A      +  E   VA   ++     +D   ++ L SE+++++ + K+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD---LSDLVSEMEMMKMIGKH 75

Query: 78  KYII----VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HV 117
           K II    VC       Q   L  + E    GNLR + +  R                 +
Sbjct: 76  KNIINLLGVC------TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 118 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 177
           + K L  ++ QV  G+E+L + +   IHRDL   N+ +  +   +KI D G A  +    
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKIADFGLARDI---- 182

Query: 178 AAHSIIGTPEY-------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTME-IPYS 222
             H I    +Y             MAPE L++  YT   D++SFG+ L E+ T+   PY 
Sbjct: 183 --HHI----DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236

Query: 223 ECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
               V +++K +  G    KPQ   +    E+   +  C    P  RP+  +L++D
Sbjct: 237 GI-PVEELFKLLKEGYRMEKPQNCTQ----ELYHLMRDCWHEVPSQRPTFKQLVED 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 67/275 (24%), Positives = 128/275 (46%), Gaps = 25/275 (9%)

Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++G G+  KV  A  + +G    ++V   ++ L+   +  ++  R      LL+ +K+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER----NVLLKNVKHPF 57

Query: 80  II-VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
           ++ + YS    ++   L F+ +    G L  + ++ R       + ++ ++   L YLH+
Sbjct: 58  LVGLHYSFQTTEK---LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEE 196
               I++RDL   NI ++ + G V + D G     + +S    +  GTPEY+APE + ++
Sbjct: 115 IN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
            Y   VD +  G  L EM+    P+  C  VA++Y  +    KP  L         + +E
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNILH--KPLVLRPGASLTAWSILE 228

Query: 257 KCIAQPR-----ARPSASELLKDPFFSELNDDDSE 286
           + + + R     A+    E+ + PFF  L+  D E
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLE 263

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 40/130 (30%), Positives = 58/130 (44%), Gaps = 17/130 (13%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRSHAA------ 179
           QVL+ L     H   I+HRDL   NI ++  G     K+ D G   ++     A      
Sbjct: 87  QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144

Query: 180 --HSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
               ++GTP Y APE L  E  T   D+Y++GL  LE +T +    +  SVA+I  +   
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAEILYQQLS 203

Query: 237 GVK---PQAL 243
            V    P  +
Sbjct: 204 PVDVSLPPWI 213

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.5 bits (149), Expect = 5e-11
 Identities = 70/299 (23%), Positives = 121/299 (40%), Gaps = 73/299 (24%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIV 82
           LG G   KV +A          +  V +    E+     +  L SE  LL+ + + ++I 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV------------------------S 118
            Y     D    L  I E    G+LR++ ++ R V                        +
Sbjct: 68  LYGACSQDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFA------- 170
           +  L  ++ Q+  G++YL   E  ++HRDL   N+ +  G    +KI D G +       
Sbjct: 126 MGDLISFAWQISRGMQYLA--EMKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEED 181

Query: 171 AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVA 228
           + V RS     +    ++MA E L++  YT   D++SFG+ L E+VT+   PY       
Sbjct: 182 SYVKRSKGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP------ 231

Query: 229 KIYKKVTGGVKPQAL-------NKVKDPE-----VKAFIEKCIAQ-PRARPSASELLKD 274
                   G+ P+ L        +++ PE     +   +  C  Q P  RP+ +++ K+
Sbjct: 232 --------GIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 51/219 (23%), Positives = 109/219 (49%), Gaps = 17/219 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL----VNRLHSEVQLLRTLKNKYI 80
           LG+G+  +V  A  + E     +  V +  F +  ++    V+ + SE ++L  + + + 
Sbjct: 38  LGTGSFGRVILATYKNED----FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +  Y  + D+ +  L  + E    G   T+ ++++         ++ Q++   EYL +  
Sbjct: 94  VNLYGSFKDESY--LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYT 199
             I++RDL   N+ ++ + G +K+ D GFA +V      +++ GTPEY+APE L    + 
Sbjct: 152 --IVYRDLKPENLLLDKD-GFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNVGHG 206

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
           +  D ++ G+ + E++    P+   + +  IY+K+  G+
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILEGI 244

Length = 340

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.6 bits (149), Expect = 6e-11
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D LG G    V++   +     VA  ++RL H    P    R   EV LL+ LK+  I+ 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVT 67

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEP 141
            + +   ++  TL F  E   S +L+ Y     ++ S+  +K +  Q+L GL Y H  + 
Sbjct: 68  LHDIIHTERCLTLVF--EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK- 123

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEE 196
            I+HRDL   N+ IN   G++K+ D G A   ++  ++++   +  T  Y  P+  L   
Sbjct: 124 -ILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGST 179

Query: 197 DYTEMVDIYSFGLCLLEMVT 216
           +Y+  +D++  G  L EM T
Sbjct: 180 EYSTPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 6e-11
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 14/157 (8%)

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA--AIVGRSHAAHSIIGTPEYMAPE-L 193
           H H+  II+RDL   NI ++   G VK+ D G    +I   +   H+  GT EYMAPE L
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172

Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
               + + VD +S G  + +M+T   P++  +    I K + G +    L     PE + 
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---NLPPYLTPEARD 229

Query: 254 FIEKCIA-QPRAR----PS-ASELLKDPFFSELNDDD 284
            ++K +   P +R    P  A+E+   PFF  +N DD
Sbjct: 230 LLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDD 266

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY---QMLCGI 132

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248

Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 249 VRNYVE 254

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.2 bits (149), Expect = 8e-11
 Identities = 77/319 (24%), Positives = 134/319 (42%), Gaps = 63/319 (19%)

Query: 8   PFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNR 64
           PF +        +Y  L  +G G   +V++A  ++    VA  +V + +  E  P+   R
Sbjct: 6   PFCDEV-----SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60

Query: 65  LHSEVQLLRTLKNKYII----VCYSVWLDDQHN----TLNFITEVCTSGNLRTYRKKHRH 116
              E+++L+ LK++ ++    +C +      +N    +   + E C          K+  
Sbjct: 61  ---EIKILQLLKHENVVNLIEICRT--KATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK 115

Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-----A 171
            ++  +KK  K +L GL Y+H ++  I+HRD+  +NI I  + G +K+ D G A     +
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLS 172

Query: 172 IVGRSHAAHSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVT----MEIPYSE-- 223
              + +   + + T  Y  PEL   E DY   +D++  G  + EM T    M+   +E  
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ-GNTEQH 231

Query: 224 --------CDSVAK----------IYKKV---TGG---VKPQALNKVKDPEVKAFIEKCI 259
                   C S+            ++KK+    G    VK +    VKDP     I+K +
Sbjct: 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291

Query: 260 A-QPRARPSASELLKDPFF 277
              P  R  A   L   FF
Sbjct: 292 VLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 20/274 (7%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY  L  +GSGA   V  AFD   GI VA    +LS   ++     R + E+ LL+ + +
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +    +  H  +  L     Q+L G+
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL---LYQMLCGI 136

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A     +      + T  Y APE 
Sbjct: 137 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + E+V   + +   D + +  K  +  G    + +N+++ P 
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252

Query: 251 VKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
           V+ ++E     P    S  EL  D  F   ++ D
Sbjct: 253 VRNYVENRPQYPGI--SFEELFPDWIFPSESERD 284

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 61.5 bits (149), Expect = 8e-11
 Identities = 42/114 (36%), Positives = 60/114 (52%), Gaps = 6/114 (5%)

Query: 106 NLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           +L  Y    R+++I  +    + VL  ++YLH +   IIHRD+   NIFIN + G V +G
Sbjct: 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLG 224

Query: 166 DLGFAA--IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT 216
           D G A   +   ++  +   GT    APEL   D Y   VDI+S G+ L EM T
Sbjct: 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 35/96 (36%), Positives = 57/96 (59%), Gaps = 6/96 (6%)

Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--HSIIG 184
           KQ+L  +EY+H  +  +IHRD+   NIF+N + G++ +GD G A    +   A  +  +G
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330

Query: 185 TPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEI 219
           T    +PE+   D Y E+ DI+S GL LL+M++ + 
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 9e-11
 Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           LLG G V +V+    +  G   A   +      +    V R+ +E ++L TL + ++   
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDHPFLPTL 66

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEP 141
           Y+ +  + +  L  + + C  G L    ++   + +S +  + ++ +VL  LEYLH    
Sbjct: 67  YASFQTETY--LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG- 123

Query: 142 CIIHRDLNCSNIFI--NGNI--------------GQVKIGDLGFAAIVGRSHA------- 178
            I++RDL   NI +  +G+I                     L   +     ++       
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 179 ------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMV 215
                 ++S +GT EY+APE+   D +   VD ++ G+ L EM+
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 255

Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 20/175 (11%)

Query: 131 EGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI--IGTPE 187
           E +  +H+ H+   +HRD+   N+ I+   G +K+ D G AA +  +   +S   +GTP+
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168

Query: 188 YMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 240
           Y+APE+           Y    D +S G+   EM+    P+ E  + AK Y  +      
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQ 225

Query: 241 QALNKVKDPEV----KAFIEKCIAQPRARPSASELLKDPFFSEL--NDDDSEPSP 289
           + L   +DP+V       I+  +   + R     L   PFFS++  N+  +   P
Sbjct: 226 RFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPP 280

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 13/197 (6%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ +    G L  + ++ R       + ++ ++   L YLH+    II+RDL   NI 
Sbjct: 71  LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENIL 128

Query: 155 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G V + D G     +  S    +  GTPEY+APE L ++ Y   VD +  G  L 
Sbjct: 129 LDSQ-GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187

Query: 213 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRA-RPSASEL 271
           EM+    P+      A++Y  +    KP  L        +  +E  + + R  R  A + 
Sbjct: 188 EMLYGLPPFY-SRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDD 244

Query: 272 LKD----PFFSELNDDD 284
             +     FFS +N DD
Sbjct: 245 FLEIKNHVFFSSINWDD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 22/195 (11%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++ R +  +  + +S ++   L YL  HE  II+RDL   N+ 
Sbjct: 71  LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--HERGIIYRDLKLDNVL 128

Query: 155 INGNIGQVKIGDLGFAAIVGRSHAAHSII-GTPEYMAPELYE-EDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G      R     S   GTP Y+APE+   EDY   VD ++ G+ + 
Sbjct: 129 LDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 187

Query: 213 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARP-SASEL 271
           EM+    P+   D V         G         +D   +  +EK I  PR+    A+ +
Sbjct: 188 EMMAGRSPF---DIV---------GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235

Query: 272 LKDPFFSELNDDDSE 286
           LK    S LN D  E
Sbjct: 236 LK----SFLNKDPKE 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 17/197 (8%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + +K R       + ++ ++   L +LH  +  II+RDL   N+ 
Sbjct: 71  LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVL 128

Query: 155 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G  K+ D G     +       +  GTP+Y+APE L E  Y   VD ++ G+ L 
Sbjct: 129 LDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLY 187

Query: 213 EMVTMEIPYSECDSVAKIYKKVTGG--VKPQALNKVKDPEVKAFIEKCIAQPRARPSA-- 268
           EM+    P+ E ++   +++ +     V P  L++     +KAF+ K    P  R  +  
Sbjct: 188 EMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK---NPTMRLGSLT 243

Query: 269 ----SELLKDPFFSELN 281
                 +L+ PFF EL+
Sbjct: 244 LGGEEAILRHPFFKELD 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 69/261 (26%), Positives = 112/261 (42%), Gaps = 29/261 (11%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG    V+  +  E+  +VA   +R    SE+  +      E Q++  L +  ++  Y
Sbjct: 12  IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSEEDFI-----EEAQVMMKLSHPKLVQLY 65

Query: 85  SVWLDDQHNTL--NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V  +     L   F+   C S  LR  R K    S + L      V EG+ YL      
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLE--SSN 120

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPELYE-EDY 198
           +IHRDL   N  +  N   VK+ D G    V       S  GT    ++ +PE++    Y
Sbjct: 121 VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKY 178

Query: 199 TEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG---VKPQALNKVKDPEVKAF 254
           +   D++SFG+ + E+ +  + PY E  S +++ + +  G    KP    ++    V   
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPY-ENRSNSEVVETINAGFRLYKP----RLASQSVYEL 233

Query: 255 IEKCIAQ-PRARPSASELLKD 274
           ++ C  + P  RPS S LL  
Sbjct: 234 MQHCWKERPEDRPSFSLLLHQ 254

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 42/281 (14%)

Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG G   +V  A     D+E+   V    V++         ++ L SE+++++ + K+K 
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 86  IINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +   H  +   
Sbjct: 144 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDI--HHIDYYKK 198

Query: 184 GTP-----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM---EIPYSECDSVAKIYKKV 234
            T      ++MAPE L++  YT   D++SFG+ L E+ T+     P    + + K+ K+ 
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258

Query: 235 TGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
               KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 HRMDKPSNCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 58/239 (24%), Positives = 111/239 (46%), Gaps = 26/239 (10%)

Query: 44  EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCT 103
           +VA   ++    SED  +      E +++  L ++ ++  Y V    +   +  +TE  +
Sbjct: 30  DVAIKMIKEGSMSEDEFI-----EEAKVMMKLSHEKLVQLYGVC--TKQRPIYIVTEYMS 82

Query: 104 SGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 162
           +G L  Y ++H +      L +  K V EG+ YL + +   IHRDL   N  ++   G V
Sbjct: 83  NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCV 139

Query: 163 KIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM- 217
           K+ D G +  V       S +G+     +  PE L    ++   D+++FG+ + E+ ++ 
Sbjct: 140 KVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198

Query: 218 EIPYSECDSVAKIYKKVTGGV---KPQ-ALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           ++PY   ++ ++  +KV+ G+   +P  A  KV       + EK       RP+  +LL
Sbjct: 199 KMPYERFNN-SETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEK----AEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D LG G    VY+   +     VA  ++RL H    P    R   EV LL+ LK+  I+ 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEP 141
            + +   ++  TL F        +L+ Y       +++  +K +  Q+L GL Y H  + 
Sbjct: 69  LHDIIHTEKSLTLVFEY---LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK- 124

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEE 196
            ++HRDL   N+ IN   G++K+ D G A   +I  ++++   +  T  Y  P+  L   
Sbjct: 125 -VLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180

Query: 197 DYTEMVDIYSFGLCLLEMVT 216
           DY+  +D++  G    EM T
Sbjct: 181 DYSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 65/226 (28%)

Query: 116 HVSIKA--LKKWSK-----QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 168
           H  I+A  L+   K     Q+L+ L+Y+H+    +IHRDL  SNI +N +  +VK+ D G
Sbjct: 96  HAVIRANILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDC-RVKLADFG 152

Query: 169 FAAIVGRSHAAHSI----------IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT 216
            A    RS +              + T  Y APE  L    YT+ VD++S G  L EM+ 
Sbjct: 153 LA----RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208

Query: 217 -------------------------------MEIPYSE--CDSVAKIYKKVTGGVKPQAL 243
                                          ++ P++    DS+    +K         L
Sbjct: 209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRK-----PLDEL 263

Query: 244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS 288
                 +    ++K +   P  R +A E L+ P+ ++ ++   EP 
Sbjct: 264 LPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPV 309

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 8/113 (7%)

Query: 106 NLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
           +L TY   + R + +  +   ++Q+L  ++Y+H     IIHRD+   N+ +NG    + +
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICL 301

Query: 165 GDLGFAAIV--GRSHAAH-SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLE 213
           GD G A       S   H  I GT +  APE+   D YT  VDI+S GL + E
Sbjct: 302 GDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 8/159 (5%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR--TYRKKHRHVSIKALKKW 125
           E ++L  + + +I+     +    H  L  +  +   G+L+   Y    R + ++ +  +
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY 100

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 185
           S Q+  G+  LH H   I++RD+   N+ ++   G  ++ DLG A  +          GT
Sbjct: 101 SAQITCGI--LHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGT 157

Query: 186 PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE 223
             YMAPE L EE Y+  VD ++ G  + EMV    P+ +
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 21/170 (12%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           ++ ++  GLE LH     I++RDL   NI ++ + G ++I DLG A  V         +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 163

Query: 185 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSE------CDSVAKIYKKVTGG 237
           T  YMAPE+ + E YT   D ++ G  L EM+  + P+ +       + V ++ K+V   
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--- 220

Query: 238 VKPQALNKVKDPEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELN 281
              +  ++   P+ ++  +  + + P+ R       A E+ + P F ++N
Sbjct: 221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 48/298 (16%)

Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG G   +V  A     D++   E + VA   ++     +D   
Sbjct: 7   DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--- 63

Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 64  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 121

Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + QV  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 178

Query: 165 GDLGFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  V    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238

Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 239 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAIPSHRPTFKQLVED 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 17/200 (8%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + LG G    V++   +     VA  ++RL H    P    R   EV LL+ LK+  I+ 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEP 141
            + +   D+  TL F        +L+ Y     ++ S+  +K +  Q+L GL Y H  + 
Sbjct: 69  LHDIVHTDKSLTLVFEY---LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEE 196
            ++HRDL   N+ IN   G++K+ D G A   ++  ++++   +  T  Y  P+  L   
Sbjct: 125 -VLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSS 180

Query: 197 DYTEMVDIYSFGLCLLEMVT 216
           +Y+  +D++  G    EM +
Sbjct: 181 EYSTQIDMWGVGCIFFEMAS 200

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.0 bits (143), Expect = 4e-10
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 18/156 (11%)

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELY- 194
           H H   II+RDL   NI ++   G +K+ D G +   +     A+S  GT EYMAPE+  
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVKDPEV 251
              +T+  D +SFG+ + EM+T  +P+   D   ++  I K   G   PQ L+    PE 
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--MPQFLS----PEA 225

Query: 252 KAFIEKCIAQ-PRARPSAS-----ELLKDPFFSELN 281
           ++ +     + P  R  A      E+ + PFFS ++
Sbjct: 226 QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.8 bits (142), Expect = 5e-10
 Identities = 59/193 (30%), Positives = 85/193 (44%), Gaps = 46/193 (23%)

Query: 65  LHSEVQLLRTL-KNKYII----VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR---- 115
           L SE++L++ + K+K II    VC       Q   L  I E    GNLR + +  R    
Sbjct: 64  LISEMELMKLIGKHKNIINLLGVC------TQEGPLYVIVEYAAKGNLREFLRARRPPGP 117

Query: 116 ------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 163
                        +S K L   + QV  G+EYL +   CI HRDL   N+ +  +   +K
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-CI-HRDLAARNVLVTED-NVMK 174

Query: 164 IGDLGFAAIVGRSHAAHSIIGTP------EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           I D G A  V   H       T       ++MAPE L++  YT   D++SFG+ + E+ T
Sbjct: 175 IADFGLARGV---HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Query: 217 ME------IPYSE 223
           +       IP  E
Sbjct: 232 LGGSPYPGIPVEE 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 6e-10
 Identities = 65/259 (25%), Positives = 116/259 (44%), Gaps = 27/259 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V+    + + I+VA   +R    SED  +      E +++  L +  ++  Y
Sbjct: 12  LGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSEDDFI-----EEAKVMMKLSHPNLVQLY 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA-LKKWSKQVLEGLEYLHTHEPCI 143
            V    +   +  +TE   +G L  Y ++ +       L      V E +EYL ++    
Sbjct: 66  GVCT--KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN--GF 121

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPELYE-EDYT 199
           IHRDL   N  +  +   VK+ D G A  V       S  GT    ++  PE+++   ++
Sbjct: 122 IHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFS 179

Query: 200 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFI 255
              D++SFG+ + E+ +  ++PY E  S +++ + V+ G    +P    K+   EV   +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPY-ERFSNSEVVESVSAGYRLYRP----KLAPTEVYTIM 234

Query: 256 EKC-IAQPRARPSASELLK 273
             C   +P  RP+  +LL 
Sbjct: 235 YSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.6 bits (141), Expect = 6e-10
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 16  GRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR 73
           G+   Y  L  LG G+   VY+   +  G  VA   +RL      P    R   E  LL+
Sbjct: 2   GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLK 58

Query: 74  TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEG 132
            LK+  I++ + +    +  TL  + E   + +L  Y  KH   +  + +K +  Q+L G
Sbjct: 59  GLKHANIVLLHDIIHTKE--TLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRG 115

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAP 191
           L Y+H  +  I+HRDL   N+ I+ + G++K+ D G A A    SH   + + T  Y  P
Sbjct: 116 LSYIH--QRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172

Query: 192 E--LYEEDYTEMVDIYSFGLCLLEMV 215
           +  L   +Y+  +D++  G   +EM+
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 28/219 (12%)

Query: 25  LGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +G G    VY+A   D ++  E A  Q+  +  S           E+ LLR LK+  +I 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC------REIALLRELKHPNVIA 62

Query: 83  CYSVWLD--DQHNTLNF------ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
              V+L   D+   L F      +  +          KK   +    +K    Q+L+G+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 135 YLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGDLGFAAIVGRSHAAHS----IIGTPE 187
           YLH +   ++HRDL  +NI + G     G+VKI D+GFA +        +    ++ T  
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 188 YMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSEC 224
           Y APEL      YT+ +DI++ G    E++T E P   C
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 7e-10
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 28/172 (16%)

Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 176
           ++++ L  +S QV  G+E+L + + CI HRDL   NI ++ N   VKI D G A      
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRK-CI-HRDLAARNILLSEN-NVVKICDFGLA------ 221

Query: 177 HAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYS 222
                I   P+Y            MAPE ++++ YT   D++SFG+ L E+ ++   PY 
Sbjct: 222 ---RDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 278

Query: 223 ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLK 273
                 +  +++  G + +A  +   PE+   +  C    P+ RP+ S L++
Sbjct: 279 GVQINEEFCQRLKDGTRMRA-PENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 46/193 (23%), Positives = 79/193 (40%), Gaps = 35/193 (18%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTP 186
           Q+L GL+Y+H+    ++HRDL  SN+ +N N   +KI D G A          +  + T 
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTR 172

Query: 187 EYMAPELY--EEDYTEMVDIYSFGLCLLEMVTME--IPYSECDSVAKIYKKVTGGVKPQA 242
            Y APEL     +YT  +D++S G    E++  +   P  +     K+  ++ G    + 
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232

Query: 243 LNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDP 275
           L  +++ + + +I      PR                            R +  E L  P
Sbjct: 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292

Query: 276 FFSELNDDDSEPS 288
           + + L+D   EP 
Sbjct: 293 YLASLHDPSDEPV 305

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 10/158 (6%)

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS 126
            E+ +L+T+ ++ II     +     +T+  +       +L TY  +   + ++      
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191

Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSII 183
           +++LE L YLH     IIHRD+   NIF++       +GD G A  +         +   
Sbjct: 192 RRLLEALAYLH--GRGIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 184 GTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIP 220
           GT E  +PEL   D Y    DI+S GL L EM    + 
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 9/97 (9%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIG 184
           Q+L GL+YLH+    I+HRD+   N+ +N N   +KI D G A +       H    ++ 
Sbjct: 111 QILRGLKYLHSAG--ILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVV- 166

Query: 185 TPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEI 219
           T  Y APE+      YT  VDI+S G    E++   I
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 35/129 (27%), Positives = 66/129 (51%), Gaps = 5/129 (3%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L  + E    G+L  + ++ R +  +  + ++ ++   L +LH  E  II+RDL   N+ 
Sbjct: 71  LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVL 128

Query: 155 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLL 212
           ++ + G +K+ D G     +G      +  GTP Y+APE+   E+Y   VD ++ G+ + 
Sbjct: 129 LDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMF 187

Query: 213 EMVTMEIPY 221
           EM+    P+
Sbjct: 188 EMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 65/300 (21%), Positives = 124/300 (41%), Gaps = 64/300 (21%)

Query: 29  AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY---- 84
           A+KK+   F ++                   +L  R   E++LLR  +    I C     
Sbjct: 31  AIKKITNVFSKK-------------------ILAKRALRELKLLRHFRGHKNITCLYDMD 71

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            V+     N L ++ E     +L    +  + ++    + +  Q+L GL+Y+H+    ++
Sbjct: 72  IVF-PGNFNEL-YLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VL 127

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-----IIGTPEYMAPE--LYEED 197
           HRDL   N+ +N +  ++KI D G A     +   ++      + T  Y APE  L  + 
Sbjct: 128 HRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS 186

Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFI 255
           YT+ +D++S G  L E++  +  +   D V ++ +  +V G    + L+++  P+ + +I
Sbjct: 187 YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYI 246

Query: 256 EKCIAQPR---------ARPSASELLKD------------------PFFSELNDDDSEPS 288
                 P+         A P A +LL+                   P+ +  +D D EP 
Sbjct: 247 RSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPV 306

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D   G  VA    +LS   ++     R + E+ L++ + +
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNH 74

Query: 78  KYIIVCYSVWLDDQHNTLNFITEV-----CTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           K II   +V+   +  +L    +V         NL   +     +  + +     Q+L G
Sbjct: 75  KNIIGLLNVFTPQK--SLEEFQDVYLVMELMDANL--CQVIQMDLDHERMSYLLYQMLCG 130

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 192
           +++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE
Sbjct: 131 IKHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 187

Query: 193 -LYEEDYTEMVDIYSFGLCLLEMV 215
            +    Y E VDI+S G  + EM+
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 20/164 (12%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSI 182
           ++ ++  GL +LH+    II+RDL   N+ ++   G +KI D G     I G      + 
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFG-GKTTRTF 161

Query: 183 IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-- 238
            GTP+Y+APE   Y+  Y + VD ++FG+ L EM+  + P+   D   ++++ +      
Sbjct: 162 CGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNVS 219

Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRAR----PSASELLKD-PFF 277
            P++L+K      K  + K    P  R    P+    +++  FF
Sbjct: 220 YPKSLSKEAVSICKGLLTK---HPAKRLGCGPTGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 38/135 (28%), Positives = 71/135 (52%), Gaps = 9/135 (6%)

Query: 94  TLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN 152
           +L  +T++   G+L  + ++HR  +  + L  W  Q+ +G+ YL  H   ++HR+L   N
Sbjct: 82  SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--RMVHRNLAARN 139

Query: 153 IFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFG 208
           I +  +   V+I D G A ++        +S   TP ++MA E +    YT   D++S+G
Sbjct: 140 ILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198

Query: 209 LCLLEMVTMEI-PYS 222
           + + EM++    PY+
Sbjct: 199 VTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 22/195 (11%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E  + G+L  + ++ R +  +  + +S ++   L +LH  E  II+RDL   N+ 
Sbjct: 71  LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVL 128

Query: 155 INGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G     +       +  GTP Y+APE L  EDY   VD ++ G+ + 
Sbjct: 129 LDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 187

Query: 213 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARP-SASEL 271
           EM+    P+   D V         G+        +D   +  +EK I  PR+    AS +
Sbjct: 188 EMMAGRSPF---DIV---------GMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV 235

Query: 272 LKDPFFSELNDDDSE 286
           LK      LN D  E
Sbjct: 236 LK----GFLNKDPKE 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 24/240 (10%)

Query: 43  IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC 102
           I+VA   +     SE+  +      E +++  L +  ++  Y V    Q   L  +TE  
Sbjct: 29  IKVAIKAINEGAMSEEDFI-----EEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEFM 81

Query: 103 TSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ 161
            +G L  Y R++   +S   L    + V EG+EYL  +    IHRDL   N  ++ + G 
Sbjct: 82  ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGV 138

Query: 162 VKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM- 217
           VK+ D G    V    + + S    P ++  PE++    Y+   D++SFG+ + E+ T  
Sbjct: 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198

Query: 218 EIPYSECDSVAKIYKKVTGG---VKPQ-ALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           ++P+ E  S  ++ + ++ G    +P+ A   V +     + EK    P  RP+ +ELL+
Sbjct: 199 KMPF-EKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEK----PEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S     V     E  L++TL++  ++  Y
Sbjct: 14  LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS-----VQAFLEEANLMKTLQHDKLVRLY 67

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
           +V   ++   +  ITE    G+L  + K      V +  L  +S Q+ EG+ Y+      
Sbjct: 68  AVVTKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPELYE- 195
            IHRDL  +N+ ++ ++   KI D G A ++       R  A   I    ++ APE    
Sbjct: 124 YIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAINF 178

Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT  +IPY
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 25/273 (9%)

Query: 24  LLGSGAVKKVYRAFDQEE----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++G G+  KV  A  + E     ++V   +  L    E  ++  R      LL+ +K+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSER----NVLLKNVKHPF 57

Query: 80  II-VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
           ++ + +S    D+   L F+ +    G L  + ++ R       + ++ ++   L YLH+
Sbjct: 58  LVGLHFSFQTADK---LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 114

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPE-LYEE 196
               I++RDL   NI ++   G + + D G     +  +    +  GTPEY+APE L+++
Sbjct: 115 LN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
            Y   VD +  G  L EM+    P+   ++ A++Y  +    KP  L        +  +E
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILN--KPLQLKPNITNSARHLLE 228

Query: 257 KCIAQPR-----ARPSASELLKDPFFSELNDDD 284
             + + R     A+    E+    FFS +N DD
Sbjct: 229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 4/98 (4%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           ++ ++  GLE LH     I++RDL   NI ++ + G ++I DLG A  +         +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163

Query: 185 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPY 221
           T  YMAPE+ + E YT   D +  G  + EM+  + P+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 40/119 (33%), Positives = 61/119 (51%), Gaps = 8/119 (6%)

Query: 179 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           AHS++GTP Y+APE L  + YT++ D +S G+ L EM+  + P+          K +   
Sbjct: 205 AHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE 264

Query: 238 VKPQALNKVK-DPEVKAFIEK--CIAQPR-ARPSASELLKDPFFSELN---DDDSEPSP 289
                  +VK  PE    I K  C A+ R  R  A ++   PFFSE++   D  ++P+P
Sbjct: 265 NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAP 323

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 50/203 (24%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA   +++ + +  P        E  ++ ++ + +
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHPH 70

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           ++    V L     T+  +T++   G L  Y  +H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 71  LVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE- 126

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
            E  ++HRDL   N+ +  +   VKI D G A ++      ++  G     ++MA E ++
Sbjct: 127 -ERRLVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 195 EEDYTEMVDIYSFGLCLLEMVTM 217
              +T   D++S+G+ + E++T 
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTF 207

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 15/162 (9%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 125
           E Q+++ L++  ++  Y+V    +   +  +TE  + G+L  + K    + + +  L   
Sbjct: 51  EAQIMKKLRHDKLVQLYAVC--SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSH-AAHSII 183
           + Q+ EG+ YL +     IHRDL   NI +    +   KI D G A ++      A    
Sbjct: 109 AAQIAEGMAYLESRN--YIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTAREGA 164

Query: 184 GTP-EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             P ++ APE   Y   +T   D++SFG+ L E+VT   +PY
Sbjct: 165 KFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.4 bits (133), Expect = 5e-09
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 14/161 (8%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 125
           E Q+++ L++  ++  Y+V  ++    +  +TE    G+L  + K+   +++ +  L   
Sbjct: 51  EAQIMKKLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIG 184
           + Q+ +G+ Y+       IHRDL  +NI +  N+   KI D G A ++    + A     
Sbjct: 108 AAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGAK 164

Query: 185 TP-EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
            P ++ APE  LY   +T   D++SFG+ L E+VT   +PY
Sbjct: 165 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.9 bits (135), Expect = 5e-09
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 16/230 (6%)

Query: 52  LSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLR 108
              F +   VL++   +E++ LR + +  I+  Y   +D  D    L+ I E CT G LR
Sbjct: 51  FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLR 110

Query: 109 TYRKKHRHVSIKALKKWSKQVLEGLEYLHTH--EPCIIHRDLNCSNIFINGNIGQVKIGD 166
               K + +S K     +    +GL  L+ +  +P   +++L   +  +  N  ++KI  
Sbjct: 111 EVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIIC 166

Query: 167 LGFAAIVGRSHAAHSIIGTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSE 223
            G   I+  S      +    Y + ++      +YT   DIYS G+ L E+ T +IP+  
Sbjct: 167 HGLEKIL--SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224

Query: 224 CDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELL 272
             +  +IY  +        L      E+K  +E C +     RP+  E+L
Sbjct: 225 LTT-KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 28/219 (12%)

Query: 25  LGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +G G    VY+A   D ++  + A  Q+  +  S           E+ LLR LK+  +I 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC------REIALLRELKHPNVIS 62

Query: 83  CYSVWLD--DQHNTLNF------ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
              V+L   D+   L F      +  +          KK   +    +K    Q+L+G+ 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 135 YLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGDLGFAAIVGRSHAAHS----IIGTPE 187
           YLH +   ++HRDL  +NI + G     G+VKI D+GFA +        +    ++ T  
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 188 YMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSEC 224
           Y APEL      YT+ +DI++ G    E++T E P   C
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.4 bits (133), Expect = 5e-09
 Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 44/244 (18%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII--- 81
           LGSG    V +   + +  E       L + + DP L + L  E  +++ L N YI+   
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 82  -VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
            +C       +  +   + E+   G L  + +K++HV+ K + +   QV  G++YL    
Sbjct: 63  GIC-------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 141 PCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTP----EYMAPE-L 193
              +HRDL   N+ +   + Q   KI D G +  +G     +          ++ APE +
Sbjct: 116 --FVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
               ++   D++SFG+ + E  +    Y +     K YK + G             EV  
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS----YGQ-----KPYKGMKGN------------EVTQ 209

Query: 254 FIEK 257
            IE 
Sbjct: 210 MIES 213

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.7 bits (134), Expect = 6e-09
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 17/222 (7%)

Query: 71  LLRTLKNKYII-VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
           LL+ LK+ +++ + YS    ++   L F+ +    G L  + ++ R       + ++ +V
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEK---LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV 105

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEY 188
              + YLH+    II+RDL   NI ++   G V + D G     V       +  GTPEY
Sbjct: 106 ASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFCGTPEY 162

Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +APE L +E Y   VD +  G  L EM+    P+   D V+++Y  +    KP  L   K
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILH--KPLQLPGGK 219

Query: 248 DPEVKAFIEKCIAQPRARPSAS-----ELLKDPFFSELNDDD 284
                  +   + + + R   +     E+    FFS +N DD
Sbjct: 220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 55.0 bits (132), Expect = 6e-09
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 34/212 (16%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKW 125
           E Q+++ L++  ++  Y+V  ++    +  +TE  + G+L  + K  + R + +  L   
Sbjct: 51  EAQIMKKLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAA 179
           + QV  G+ Y+       IHRDL  +NI +   +   KI D G A ++       R  A 
Sbjct: 108 AAQVAAGMAYIERMN--YIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQGAK 164

Query: 180 HSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY------SECDSVAKI 230
             I    ++ APE  LY   +T   D++SFG+ L E+VT   +PY         + V + 
Sbjct: 165 FPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219

Query: 231 YKKVTGGVKPQALNKV------KDPEVKAFIE 256
           Y+       P +L+++      KDPE +   E
Sbjct: 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 7e-09
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 34/235 (14%)

Query: 65  LHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------- 115
           L SE+++++ + K+K II        D    L  + E  + GNLR Y +  R        
Sbjct: 64  LVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSF 121

Query: 116 --------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 167
                    ++ K L   + QV  G+EYL + +   IHRDL   N+ +  +   +KI D 
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTED-NVMKIADF 178

Query: 168 GFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM---EIP 220
           G A  V    +   +  G    ++MAPE L++  YT   D++SFG+ L E+ T+     P
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238

Query: 221 YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
               + + K+ K+     KP         E+   + +C  A P  RP+  +L++D
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTH----ELYMIMRECWHAVPSQRPTFKQLVED 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.1 bits (133), Expect = 8e-09
 Identities = 68/304 (22%), Positives = 116/304 (38%), Gaps = 69/304 (22%)

Query: 2   SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 61
             RD     ++   G FGR            ++                +     E+ V 
Sbjct: 3   ISRDRVTLSDLLQEGTFGR------------IFYG---------ILIDEKPG--KEEEVF 39

Query: 62  VNRLH---SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS-------------- 104
           V  +    SE+Q+   L+   ++  Y +     H  +  I  VC                
Sbjct: 40  VKTVKDHASEIQVTLLLQESCLL--YGL----SHQNILPILHVCIEDGEPPFVLYPYMNW 93

Query: 105 GNLRTYRKKHRHVSIKALKKWSK--------QVLEGLEYLHTHEPCIIHRDLNCSNIFIN 156
           GNL+ + ++ R       +  S         Q+  G+ YLH     +IH+D+   N  I+
Sbjct: 94  GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID 151

Query: 157 GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY-----MAPE-LYEEDYTEMVDIYSFGLC 210
             + QVKI D   +  +      +  +G  E      MA E L  ++Y+   D++SFG+ 
Sbjct: 152 EEL-QVKITDNALSRDLFPMD--YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVL 208

Query: 211 LLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSA 268
           L E++T+ + PY E D   ++   +  G +        D E+ A +  C A  P  RPS 
Sbjct: 209 LWELMTLGQTPYVEIDPF-EMAAYLKDGYRLAQPINCPD-ELFAVMACCWALDPEERPSF 266

Query: 269 SELL 272
           S+L+
Sbjct: 267 SQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.0 bits (132), Expect = 9e-09
 Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 24/273 (8%)

Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     +G    I VA   +++   +  P     +  E  ++  + + Y
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  +T++   G L  Y ++++  +  + L  W  Q+ +G+ YL  
Sbjct: 71  VCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE- 126

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
            E  ++HRDL   N+ +  +   VKI D G A ++      +   G     ++MA E + 
Sbjct: 127 -EVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKA 253
              +T   D++S+G+ + E++T      +     +I   +  G + PQ      D  V  
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID--VYM 242

Query: 254 FIEKC-IAQPRARPSASELLKDPFFSELNDDDS 285
            + KC +     RP   EL+ +  FS +  D S
Sbjct: 243 IMVKCWMIDSECRPRFRELVDE--FSRMARDPS 273

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 56/249 (22%), Positives = 106/249 (42%), Gaps = 44/249 (17%)

Query: 57  EDPVLVNRLHS------------EVQLLRTLKNKYIIVCYSVWLD-DQHNTLNFITEVCT 103
           E  VLV  L              E+ + R L +K ++    +  + + H     I E   
Sbjct: 35  ETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY---MILEYTD 91

Query: 104 SGNLRTY---------RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
            G+L+ +         + K   +S K       Q+  G+++L       +HRDL   N  
Sbjct: 92  LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCL 149

Query: 155 INGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCL 211
           ++    +VK+  L  +  V  S  +   + +    ++APE + E+D++   D++SFG+ +
Sbjct: 150 VSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208

Query: 212 LEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE-----VKAFIEKCIA-QPRA 264
            E+ T  E+P+          ++V   ++   L ++  PE     +   + +C A  P+ 
Sbjct: 209 WEVFTQGELPFYGLSD-----EEVLNRLQAGKL-ELPVPEGCPSRLYKLMTRCWAVNPKD 262

Query: 265 RPSASELLK 273
           RPS SEL+ 
Sbjct: 263 RPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 50/224 (22%), Positives = 103/224 (45%), Gaps = 23/224 (10%)

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK-WSKQVLEGLEY 135
           N++I   +  + D+  N L  + +    G+L T   K      + + + +  +++  ++ 
Sbjct: 60  NQWITTLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPEL 193
           +H      +HRD+   NI ++ N G +++ D G    +       S   +GTP+Y++PE+
Sbjct: 118 VHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 194 YE--ED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----PQAL 243
            +  ED    Y    D +S G+C+ EM+  E P+   +S+ + Y K+    +    P  +
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQFPAQV 233

Query: 244 NKVKDPEVKAFIEKCIAQPRARPSAS---ELLKDPFFSELNDDD 284
             V + + K  I + I     R   +   +  + PFF+ ++ D+
Sbjct: 234 TDVSE-DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 17/197 (8%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+   VY+   +  G  VA   + +      P    R   E  LL+ LK+  I++ +
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVLLH 69

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCI 143
            +       TL F+ E   + +L  Y  +H   +    ++ +  Q+L GL Y+H     I
Sbjct: 70  DII--HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--I 124

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEEDY 198
           +HRDL   N+ I+  +G++K+ D G A   +I  +++++  +  T  Y  P+  L   DY
Sbjct: 125 LHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDY 181

Query: 199 TEMVDIYSFGLCLLEMV 215
           +  +DI+  G   +EM+
Sbjct: 182 SSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 23/213 (10%)

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
           +++  +  + DD++  L  + E    G+L      +  V  K  K ++ +V+  L+ +H+
Sbjct: 104 WVVQLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS 160

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYMAPELYEE 196
               +IHRD+   N+ ++ + G +K+ D G    +  +      + +GTP+Y++PE+ + 
Sbjct: 161 MG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 197 D-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 251
                 Y    D +S G+ L EM+  + P+   DS+   Y K+       +LN  +D E+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIMD--HKNSLNFPEDVEI 274

Query: 252 KAFIEKCIAQ-------PRARPSASELLKDPFF 277
               +  I            R    E+ + PFF
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 4/98 (4%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           ++ ++L GLE LH      ++RDL   NI ++ + G ++I DLG A  +    +    +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163

Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 221
           T  YMAPE L  + YT   D +  G  + EM+  + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 39/225 (17%)

Query: 9   FVEVDPSGRFGR--YSDLLGSG---AVKKVYR-AFDQEEGIEVAWNQVRLSHFSEDPVLV 62
           F+ V   G FG+   ++  G+    A+K + +    Q++ +E    + R+    + P  +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
            +LHS  Q +                    + L F+ E    G+L  + ++         
Sbjct: 64  TQLHSCFQTV--------------------DRLYFVMEYVNGGDLMYHIQQVGKFKEPQA 103

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH----- 177
             ++ ++  GL +LH     II+RDL   N+ ++   G +KI D G      + H     
Sbjct: 104 VFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSE-GHIKIADFGMC----KEHMVDGV 156

Query: 178 AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPY 221
              +  GTP+Y+APE+   + Y + VD +++G+ L EM+  + P+
Sbjct: 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 18/161 (11%)

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPELYE- 195
           H+   +HRD+   N+ ++ N G +++ D G    + +     S   +GTP+Y++PE+ + 
Sbjct: 119 HQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 196 -ED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----PQALNKV 246
            ED    Y    D +S G+C+ EM+  E P+   +S+ + Y K+    +    P  +  V
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHITDV 236

Query: 247 KDPEVKAFIEKCIAQPRARPSAS---ELLKDPFFSELNDDD 284
            + E K  I++ I     R   +   +  K  FF  ++ ++
Sbjct: 237 SE-EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 35/190 (18%)

Query: 39  QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 98
           Q++ +E    + R+   S  P  + +LHS  Q +                    + L F+
Sbjct: 40  QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--------------------DRLYFV 79

Query: 99  TEVCTSGNL-----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 153
            E    G+L     +  R K  H        ++ ++  GL +LH+    II+RDL   N+
Sbjct: 80  MEYVNGGDLMYQIQQVGRFKEPHAVF-----YAAEIAIGLFFLHSKG--IIYRDLKLDNV 132

Query: 154 FINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCL 211
            ++   G +KI D G     +       +  GTP+Y+APE+   + Y + VD ++FG+ L
Sbjct: 133 MLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191

Query: 212 LEMVTMEIPY 221
            EM+  + P+
Sbjct: 192 YEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 34/272 (12%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----------PVLVNRLHSE--VQ 70
           D++G G   +V +A  +++G+ +     R+  ++             VL    H    + 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 71  LLRTLKNK---YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH---RHVSIKALKK 124
           LL   +++   Y+ + Y+       N L+F+ +         +   +     +S + L  
Sbjct: 61  LLGACEHRGYLYLAIEYAPH----GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           ++  V  G++YL   +   IHRDL   NI +  N    KI D G +   G+       +G
Sbjct: 117 FAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA-KIADFGLSR--GQEVYVKKTMG 171

Query: 185 --TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKP 240
                +MA E L    YT   D++S+G+ L E+V++   PY    + A++Y+K+  G + 
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRL 230

Query: 241 QALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
           +      D EV   + +C   +P  RPS +++
Sbjct: 231 EKPLNCDD-EVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 68/274 (24%), Positives = 109/274 (39%), Gaps = 50/274 (18%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN----- 77
           + +G G    VY+    +   EVA    R +   +           +Q    LK      
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKF------LQEAEILKQYDHPN 53

Query: 78  --KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLE 134
             K I VC       Q   +  + E+   G+L T+ RKK   +++K L + S     G+E
Sbjct: 54  IVKLIGVCV------QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGME 107

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-----AIVGRSHAAHSIIGTP-EY 188
           YL +     IHRDL   N  +  N   +KI D G +      I   S     I   P ++
Sbjct: 108 YLESK--NCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQI---PIKW 161

Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSEC------DSVAKIYKKVTGGVKP 240
            APE L    YT   D++S+G+ L E  ++ + PY         + +   Y+     + P
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCP 221

Query: 241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 273
           + + ++        + +C A  P  RPS SE+  
Sbjct: 222 EEIYRL--------MLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 21/210 (10%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKW 125
           E  +++TL++  ++  ++V   +    +  ITE    G+L  + K        +  L  +
Sbjct: 51  EANVMKTLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI------VGRSHAA 179
           S Q+ EG+ ++       IHRDL  +NI ++ ++   KI D G A +        R  A 
Sbjct: 108 SAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAK 164

Query: 180 HSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
             I    ++ APE +    +T   D++SFG+ L+E+VT   IPY    +  ++ + +  G
Sbjct: 165 FPI----KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALERG 219

Query: 238 VKPQALNKVKDPEVKAFIEKCIAQPRARPS 267
            +        +      +     +P  RP+
Sbjct: 220 YRMPRPENCPEELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 34/275 (12%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----------EDPVLVNRLHSE- 68
           ++ D++G G   +V RA  +++G+++      L  F+          E  VL    H   
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 69  -VQLLRTLKNK---YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI---KA 121
            + LL   +N+   YI + Y+ +     N L+F+ +         + K+H   S    + 
Sbjct: 65  IINLLGACENRGYLYIAIEYAPY----GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           L +++  V  G++YL   +   IHRDL   N+ +  N+   KI D G +   G       
Sbjct: 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS-KIADFGLSR--GEEVYVKK 175

Query: 182 IIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
            +G     +MA E L    YT   D++SFG+ L E+V++   PY    + A++Y+K+  G
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYEKLPQG 234

Query: 238 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
            + +      D EV   + +C   +P  RP  +++
Sbjct: 235 YRMEKPRNCDD-EVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.9 bits (128), Expect = 4e-08
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 22/179 (12%)

Query: 49  QVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSV-WLDDQHNTLNFITEVCTSGN 106
            ++  +F+    +V   H   QL++   N   I + YSV  L      +++I +    G+
Sbjct: 48  IIKAKNFNAIEPMV---H---QLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKD----GD 95

Query: 107 LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD 166
           L    KK   +S   +KK  +Q++E L  LH H   IIH D+   N+  +    ++ + D
Sbjct: 96  LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCD 153

Query: 167 LGFAAIVGRSHAAHSII-GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE 223
            G   I+G      S   GT +Y +PE +   +Y    D ++ G+   E++T + P+ E
Sbjct: 154 YGLCKIIG----TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208

Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 12/155 (7%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSH---AAH 180
           +S QV  G+E+L +   C+ HRDL   N+ I  G +  VKI D G A  + R     +  
Sbjct: 244 FSYQVANGMEFLASKN-CV-HRDLAARNVLICEGKL--VKICDFGLARDIMRDSNYISKG 299

Query: 181 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
           S     ++MAPE ++   YT + D++SFG+ L E+ T+   PY E     + Y  +  G 
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359

Query: 239 KPQALNKVKDPEVKAFIEKCIAQP-RARPSASELL 272
           +        D E+   ++KC  +    RP  S+L+
Sbjct: 360 RMAKPAHASD-EIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 37/222 (16%)

Query: 20  RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
           R+ + LG GA  KVY+       ++     VA   ++ +    +P +      E +L+  
Sbjct: 8   RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSD 64

Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSK---- 127
           L++  I+    V   +Q   + F  E    G+L  +      H  V  ++  +  K    
Sbjct: 65  LQHPNIVCLLGVCTKEQPTCMLF--EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122

Query: 128 ---------QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 178
                    Q+  G+EYL +H    +HRDL   N  +   +  VKI D G +  +  S  
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL-TVKISDFGLSRDI-YSAD 178

Query: 179 AHSIIGTP----EYMAPE--LYEEDYTEMVDIYSFGLCLLEM 214
            + +         +M PE  LY + +T   DI+SFG+ L E+
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.2 bits (125), Expect = 6e-08
 Identities = 68/269 (25%), Positives = 113/269 (42%), Gaps = 36/269 (13%)

Query: 24  LLGSGAVKKVYRA------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            LGSGA  +VY              I VA   +R     ++         E  L+    +
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK---EFLKEAHLMSNFNH 58

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-------VSIKALKKWSKQVL 130
             I+    V L ++   +  I E+   G+L +Y +  R        +++K L      V 
Sbjct: 59  PNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 131 EGLEYLH-THEPCIIHRDLNCSNIFINGNIGQ----VKIGDLGFAAIVGRSH----AAHS 181
           +G  YL   H    IHRDL   N  ++         VKIGD G A  + +S         
Sbjct: 117 KGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 182 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK 239
           ++    +MAPE L +  +T   D++SFG+ + E++T+ + PY   ++  ++ + VT G +
Sbjct: 174 LLPV-RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQHVTAGGR 231

Query: 240 PQALNKVKDPEVKAFIEKCIAQ-PRARPS 267
            Q      D ++   +  C AQ P  RP+
Sbjct: 232 LQKPENCPD-KIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 52.1 bits (125), Expect = 8e-08
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 27/184 (14%)

Query: 105 GNLRTYRKKHR------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 158
           G+L ++    R       + ++ L K+   +  G+EYL       IHRDL   N  +  +
Sbjct: 92  GDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED 149

Query: 159 IGQVKIGDLGFAAIV--GRSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEM 214
           +  V + D G +  +  G  +    I   P +++A E L +  YT   D+++FG+ + E+
Sbjct: 150 M-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208

Query: 215 VTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE-----VKAFIEKC-IAQPRARPS 267
            T  + PY   ++  +IY  +  G      N++K PE     +   +  C  A P+ RP+
Sbjct: 209 ATRGQTPYPGVEN-HEIYDYLRHG------NRLKQPEDCLDELYDLMYSCWRADPKDRPT 261

Query: 268 ASEL 271
            ++L
Sbjct: 262 FTKL 265

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 18/161 (11%)

Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGR 175
           ++   L  ++ QV  G+E+L +     +HRDL   N+ +  G I  VKI D G A  +  
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKI--VKICDFGLARDIMH 289

Query: 176 SH---AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 230
                +  S     ++MAPE +++  YT + D++S+G+ L E+ ++   PY      +  
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349

Query: 231 YKKVTGG---VKPQ-ALNKVKDPEVKAFIEKCIAQPRARPS 267
           Y K+  G    KP  A  +V D  VK +     ++P  RPS
Sbjct: 350 YNKIKSGYRMAKPDHATQEVYDIMVKCW----NSEPEKRPS 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.5 bits (123), Expect = 9e-08
 Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 29/264 (10%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKN--- 77
           +LLG G   +V++   +++        V +    ED    L  +  SE ++L+   +   
Sbjct: 1   ELLGKGNFGEVFKGTLKDK------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 78  -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEY 135
            K I VC       Q   +  + E+   G+  ++ RKK   +  K L K++     G+ Y
Sbjct: 55  VKLIGVC------TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAY 108

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE- 192
           L +     IHRDL   N  +  N   +KI D G +       +++  +   P ++ APE 
Sbjct: 109 LESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEA 165

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 251
           L    Y+   D++S+G+ L E  ++ + PY    +  +  ++V  G +     K  D +V
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPD-DV 223

Query: 252 KAFIEKCIA-QPRARPSASELLKD 274
              +++C   +P  RP  SEL K+
Sbjct: 224 YKVMQRCWDYKPENRPKFSELQKE 247

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 51.6 bits (123), Expect = 9e-08
 Identities = 49/207 (23%), Positives = 94/207 (45%), Gaps = 26/207 (12%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWN---QVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           LG G   +V+            WN   +V +       +       E Q+++ L+++ ++
Sbjct: 14  LGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 64

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTH 139
             Y+V  ++    +  +TE  + G+L  + K    +++ +  L   + Q+  G+ Y+   
Sbjct: 65  QLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE--LYE 195
               +HRDL  +NI +  N+   K+ D G A ++    + A      P ++ APE  LY 
Sbjct: 122 N--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+ T   +PY
Sbjct: 179 R-FTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 28/164 (17%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           +S QV +G+E+L + +   IHRDL   NI ++ N   VKI D G A           I  
Sbjct: 184 YSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLA---------RDIYK 231

Query: 185 TPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 230
            P+Y            MAPE +++  YT   D++SFG+ L E+ ++   PY       + 
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291

Query: 231 YKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLK 273
            +++  G + +A +    PE+   +  C   +P  RP+ SEL++
Sbjct: 292 CRRLKEGTRMRAPD-YTTPEMYQTMLDCWHGEPSQRPTFSELVE 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 15/211 (7%)

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV-SIKALKK 124
           +E  ++  L++  ++    V ++++   L  +TE    G+L  Y R + R V     L K
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDLGFAAIVGRSHAAHSII 183
           +S  V E +EYL  +    +HRDL   N+ ++  N+   K+ D G       +     + 
Sbjct: 107 FSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVA--KVSDFGLTKEASSTQDTGKL- 161

Query: 184 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQ 241
              ++ APE L E+ ++   D++SFG+ L E+ +   +PY     +  +  +V  G K  
Sbjct: 162 -PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMD 219

Query: 242 ALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
           A +    P V   +++C       RPS  +L
Sbjct: 220 APDGCP-PVVYDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 41/232 (17%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKA----L 122
           EVQ  R L +  ++ C    ++     L    E C  G+L+ Y + +R  V+  A    L
Sbjct: 45  EVQPYRELNHPNVLQCLGQCIESIPYLLVL--EFCPLGDLKNYLRSNRGMVAQMAQKDVL 102

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           ++ + +V  GL  L  H+   IH DL   N  +  ++  VKIGD G    +         
Sbjct: 103 QRMACEVASGL--LWLHQADFIHSDLALRNCQLTADL-SVKIGDYG----LALEQYPEDY 155

Query: 183 IGTPE-------YMAPELYEE--------DYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 226
             T +       ++APEL E         D T+  +I+S G+ + E+ T  + PY +  S
Sbjct: 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-S 214

Query: 227 VAKIYKKV-----TGGVKPQALNKVKDP--EVKAFIEKCIAQPRARPSASEL 271
             ++ K+V         KPQ   K  D   EV  F   C   P  RP+A E+
Sbjct: 215 DEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQF---CWLDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 35/230 (15%)

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA----- 121
            E Q  R+L++  ++ C     +     L  + E C  G+L+ Y +  R   +       
Sbjct: 44  EEAQPYRSLQHSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTT 101

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---A 178
           L++ + ++  GL +LH +    IH DL   N  +  ++  VKIGD G +    +      
Sbjct: 102 LQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVT 158

Query: 179 AHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 229
              +     ++APEL +E        D T+  +++S G+ + E+  +   PY        
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--- 215

Query: 230 IYKKVTGGVKPQALNKVKDPEVK--------AFIEKCIAQPRARPSASEL 271
             + +T  V+ Q L K+  P +K          ++ C  QP  RPSA E+
Sbjct: 216 -EQVLTYTVREQQL-KLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 43/166 (25%), Positives = 82/166 (49%), Gaps = 21/166 (12%)

Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--G 174
           + ++ L ++   +  G+EYL +     IHRDL   N  +N N+  V + D G +  +  G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENM-TVCVADFGLSKKIYSG 166

Query: 175 RSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIY 231
             +        P +++A E L +  YT   D+++FG+ + E++T  + PY+  ++ ++IY
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIY 225

Query: 232 KKVTGGVKPQALNKVKDP-----EVKAFIEKC-IAQPRARPSASEL 271
             +  G      N++K P     +V   + +C   +P+ RPS   L
Sbjct: 226 NYLIKG------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 20/165 (12%)

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
           +E  L++ L++  ++  Y+V   +    +  ITE   +G+L  + K      ++I  L  
Sbjct: 50  AEANLMKQLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+ EG+ ++       IHRDL  +NI ++  +   KI D G A ++       R  A
Sbjct: 107 MAAQIAEGMAFIERKN--YIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREGA 163

Query: 179 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              I    ++ APE +    +T   D++SFG+ L E+VT   IPY
Sbjct: 164 KFPI----KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           GLE L      I++RDL   NI ++ + G ++I DLG A  +         +GT  YMAP
Sbjct: 114 GLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170

Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 221
           E +  E YT   D +  G  + EM+  + P+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 14/223 (6%)

Query: 59  PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV 117
           P L  +   E ++L+   +  I+    V    Q   +  + E+   G+  T+ R +   +
Sbjct: 34  PDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELVQGGDFLTFLRTEGPRL 91

Query: 118 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA--AIVGR 175
            +K L +  +    G+EYL +     IHRDL   N  +      +KI D G +     G 
Sbjct: 92  KVKELIQMVENAAAGMEYLESK--HCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGV 148

Query: 176 SHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYK 232
             +   +   P ++ APE L    Y+   D++SFG+ L E  ++  +PY+   S  +  +
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTRE 207

Query: 233 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD 274
            +  GV+        D  V   +E+C    P  RPS S + ++
Sbjct: 208 AIEQGVRLPCPELCPD-AVYRLMERCWEYDPGQRPSFSTVHQE 249

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 12/178 (6%)

Query: 105 GNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK 163
           G+LR + R +  + ++K L  +  QV +G+EYL + +   +HRDL   N  ++ +   VK
Sbjct: 82  GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESF-TVK 138

Query: 164 IGDLGFAAIVGR----SHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM 217
           + D G A  +      S   H+    P ++MA E L  + +T   D++SFG+ L E++T 
Sbjct: 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198

Query: 218 EI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKD 274
              PY + DS       + G    Q      DP  +  +     +P  RP+ SEL+  
Sbjct: 199 GAPPYPDVDSFDITVYLLQGRRLLQP-EYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 37/122 (30%), Positives = 61/122 (50%), Gaps = 14/122 (11%)

Query: 179 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK-K 233
           AHS++GTP Y+APE L    YT++ D +S G+ L EM+  + P+   +  ++  K+   +
Sbjct: 205 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ 264

Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPR---ARPSASELLKDPFFSELN---DDDSEP 287
            +  + PQA  K+  PE    I K    P     +  A E+   PFF  ++   D   + 
Sbjct: 265 TSLHIPPQA--KLS-PEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQS 321

Query: 288 SP 289
           +P
Sbjct: 322 AP 323

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 20/106 (18%)

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI----------------VGRS 176
           LEYLH +   I+HRDL   N+ I  ++G +K+ D G + I                  R 
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 177 HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 221
                + GTPEY+APE +  + Y + VD ++ G+ L E +   +P+
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 34/276 (12%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNK 78
           ++ D++G G   +V +A  +++G+ +     R+  + S+D         E+++L  L + 
Sbjct: 10  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHH 67

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKAL 122
             I+   +   +    L    E    GNL  + +K R                 +S + L
Sbjct: 68  PNII-NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
             ++  V  G++YL   +   IHRDL   NI +  N    KI D G +   G+       
Sbjct: 127 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSR--GQEVYVKKT 181

Query: 183 IG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
           +G     +MA E L    YT   D++S+G+ L E+V++   PY    + A++Y+K+  G 
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGY 240

Query: 239 K-PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELL 272
           +  + LN   D EV   + +C  + P  RPS +++L
Sbjct: 241 RLEKPLN--CDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 28/164 (17%)

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           +S QV  G+E+L + + CI HRDL   NI ++ N   VKI D G A           I  
Sbjct: 178 YSFQVARGMEFLASRK-CI-HRDLAARNILLSEN-NVVKICDFGLA---------RDIYK 225

Query: 185 TPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 230
            P+Y            MAPE ++++ YT   D++SFG+ L E+ ++   PY       + 
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285

Query: 231 YKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLK 273
            +++  G + +A      PE+ + +  C    P  RP+ SEL++
Sbjct: 286 CRRLKEGTRMRAPEYAT-PEIYSIMLDCWHNNPEDRPTFSELVE 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 13/108 (12%)

Query: 179 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--- 234
           AHS++GTP Y+APE L    YT++ D +S G+ L EM+  + P+   D+ A+   KV   
Sbjct: 201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA-DTPAETQLKVINW 259

Query: 235 --TGGVKPQALNKVKDPEVKAFIEKCIAQPRAR---PSASELLKDPFF 277
             T  +  QA       E    I +       R     A E+   PFF
Sbjct: 260 ETTLHIPSQA---KLSREASDLILRLCCGAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 53/196 (27%)

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-------------- 178
           ++ +H      IHRD+   N+ ++   G +K+ D G    + +SH               
Sbjct: 114 IDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 179 -------------------------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLL 212
                                    A+S +GTP+Y+APE++ +  Y +  D +S G+ + 
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230

Query: 213 EMVTMEIPYSECDSVAKIYKKVTGG----VKPQALNKVKDPEVKAFIEK--CIAQPR-AR 265
           EM+    P+   D+  + Y+K+         P  +     PE K  I++  C A+ R   
Sbjct: 231 EMLVGYPPFCS-DNPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKRLCCEAERRLGN 287

Query: 266 PSASELLKDPFFSELN 281
              +E+   PFF  ++
Sbjct: 288 NGVNEIKSHPFFKGVD 303

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 28/206 (13%)

Query: 22  SDLLGSGAVKKVYRAF--DQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
              +G G    VY+      E E I VA   V+       P +  +   E  ++R   + 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVA---VKTCKNCTSPSVREKFLQEAYIMRQFDHP 67

Query: 79  YII----VCYS--VWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLE 131
           +I+    V     VW+         + E+   G LR+Y + +++ + + +L  +S Q+  
Sbjct: 68  HIVKLIGVITENPVWI---------VMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYM 189
            L YL +     +HRD+   N+ +  +   VK+GD G +  +   S+   S    P ++M
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLV-SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175

Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEM 214
           APE +    +T   D++ FG+C+ E+
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 31/184 (16%)

Query: 57  EDPVLVNR--LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 114
           +DP L  R     E +LL  L++++I+  Y V  D   + L  + E    G+L  + + H
Sbjct: 44  KDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAH 101

Query: 115 R----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 158
                             + +  +   + Q+  G+ YL +     +HRDL   N  +  N
Sbjct: 102 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGAN 159

Query: 159 IGQVKIGDLGFAAIVGRSH----AAHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLL 212
           +  VKIGD G +  V  +       H+++    +M PE  +Y +  TE  D++SFG+ L 
Sbjct: 160 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPI-RWMPPESIMYRKFTTES-DVWSFGVILW 216

Query: 213 EMVT 216
           E+ T
Sbjct: 217 EIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 59/210 (28%)

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG-FAAIVGRSHAAHSIIGTPEY 188
           L GL YLH +    IHR++  S+I I+G+ G V +  L    ++V     A  +   P++
Sbjct: 111 LRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167

Query: 189 -------MAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG-- 236
                  ++PEL  +D   Y    DIYS G+   E+ T  +P+ +      + +K+ G  
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP 227

Query: 237 ------GVKPQALNKVKD-----------------------------PEVKAF------- 254
                    P   +++K+                             P  K F       
Sbjct: 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287

Query: 255 IEKCIAQ-PRARPSASELLKDPFFSELNDD 283
           +E C+ Q P  RPSAS LL   FF ++ + 
Sbjct: 288 VELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 60/217 (27%)

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL---------GFAAIVGRSHAA 179
           VL+ L+Y+H      +HR +  S+I I+ + G+V +  L         G    V      
Sbjct: 110 VLKALDYIH--HMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQRLRVVHDFPK 166

Query: 180 HSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
           +S+   P +++PE+ +++   Y    DIYS G+   E+    +P+ +  +   + +K+ G
Sbjct: 167 YSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225

Query: 237 GV----------------KP---------------------------QALNKVKDPEVKA 253
            V                KP                              N+   P    
Sbjct: 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285

Query: 254 FIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
           F+E+C+ + P ARPSAS LL   FF ++    SE  P
Sbjct: 286 FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 49.3 bits (117), Expect = 7e-07
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 21/166 (12%)

Query: 120 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSH 177
           + L K+   +  G+EYL +     IHRDL   N  +N N+  V + D G +  +  G  +
Sbjct: 112 QMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYY 168

Query: 178 AAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV 234
               I   P +++A E L +  YT   D++SFG+ + E+ T  + PY   ++ ++IY  +
Sbjct: 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYL 227

Query: 235 TGGVKPQALNKVKDPE-----VKAFIEKC-IAQPRARPSASELLKD 274
             G      N++K P      + + +  C +  P+ RPS   L  +
Sbjct: 228 RQG------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 53/192 (27%)

Query: 115 RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 174
           R++S +  +K +  + + L +LH            CS   + GN+   KI       I+ 
Sbjct: 775 RNLSWERRRKIAIGIAKALRFLHCR----------CSPAVVVGNLSPEKI-------IID 817

Query: 175 RSHAAHSIIGTPE-------------YMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIP 220
                H  +  P              Y+APE  E +D TE  DIY FGL L+E++T + P
Sbjct: 818 GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Query: 221 ------------------YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q 261
                             YS+C     I   + G V   ++N+ +  EV      C A  
Sbjct: 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV---SVNQNEIVEVMNLALHCTATD 934

Query: 262 PRARPSASELLK 273
           P ARP A+++LK
Sbjct: 935 PTARPCANDVLK 946

Length = 968

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 14/163 (8%)

Query: 119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSH 177
            + L  +S QV +G+ +L   + CI HRDL   NI + +G I   KI D G A  + R+ 
Sbjct: 213 TEDLLSFSYQVAKGMSFL-ASKNCI-HRDLAARNILLTHGRI--TKICDFGLARDI-RND 267

Query: 178 AAHSIIGTP----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIY 231
           + + + G      ++MAPE ++   YT   D++S+G+ L E+ ++   PY      +K Y
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327

Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLK 273
           K +  G +  +  +    E+   ++ C  A P  RP+  ++++
Sbjct: 328 KMIKEGYRMLS-PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.4 bits (115), Expect = 1e-06
 Identities = 66/241 (27%), Positives = 99/241 (41%), Gaps = 52/241 (21%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV--------------NRL 65
           R  + LG G   +V+    + EG+   +       F   PVLV              N  
Sbjct: 8   RLKEKLGEGQFGEVHLC--EAEGLA-EFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL------RTYRKKHRH--- 116
             E++++  LKN  II    V + D  + L  ITE   +G+L      R       H   
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANN 122

Query: 117 ---VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG----- 168
              VSI  L   + Q+  G++YL +     +HRDL   N  + GN   +KI D G     
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNL 179

Query: 169 ----FAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--EIPY 221
               +  I GR+      +    +MA E +    +T   D+++FG+ L EM T+  E PY
Sbjct: 180 YSGDYYRIQGRA------VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233

Query: 222 S 222
           S
Sbjct: 234 S 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 53/267 (19%)

Query: 25  LGSG---AVKK-VYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LGSG    VKK VY+   +++ I+VA   +++     +  + + +  E +++  L N YI
Sbjct: 3   LGSGNFGCVKKGVYKM--RKKQIDVA---IKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57

Query: 81  I----VCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEY 135
           +    VC       +   L  + E+ + G L  +   K   +++  + +   QV  G++Y
Sbjct: 58  VRMIGVC-------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTP-EYMAP 191
           L       +HRDL   N+ +  N    KI D G +  +G     + A S    P ++ AP
Sbjct: 111 LE--GKNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E +    ++   D++S+G      +TM             ++  + G KP    K+K PE
Sbjct: 168 ECINFRKFSSRSDVWSYG------ITM-------------WEAFSYGQKP--YKKMKGPE 206

Query: 251 VKAFIE--KCIAQPRARPSA-SELLKD 274
           V +FIE  K +  P   P     L+KD
Sbjct: 207 VMSFIEQGKRLDCPAECPPEMYALMKD 233

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 23/168 (13%)

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPELYE- 195
           H+   +HRD+   N+ ++ N G +++ D G    +       S   +GTP+Y++PE+ + 
Sbjct: 119 HQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177

Query: 196 -ED----YTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVK----PQALNK 245
            ED    Y    D +S G+C+ EM+  E P Y+E  S+ + Y K+    +    P  +  
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTD 235

Query: 246 VKDPEVKAFIEKCIAQPRAR---PSASELLKDPFFSELNDD---DSEP 287
           V + E K  I + I  P  R       +    PFF  ++ D   +S  
Sbjct: 236 VSE-EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTA 282

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 35/217 (16%)

Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG GA  KV+         + +   VA   V+    +           E +LL   +++ 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVA---VKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--------------RKKHRHVSIKALKKW 125
           I+  Y V  +   +    + E    G+L  +                    +++  L + 
Sbjct: 70  IVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 185
           + Q+  G+ YL +     +HRDL   N  +  ++  VKIGD G +  V  +   + + G 
Sbjct: 128 AVQIASGMVYLASQH--FVHRDLATRNCLVGYDL-VVKIGDFGMSRDV-YTTDYYRVGGH 183

Query: 186 P----EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT 216
                 +M PE  +Y +  TE  D++SFG+ L E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTES-DVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 32/123 (26%), Positives = 62/123 (50%), Gaps = 15/123 (12%)

Query: 123 KKWSK----QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 178
           +KW++    +V+  L+ +H+     IHRD+   N+ ++ + G +K+ D G    +  +  
Sbjct: 141 EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGM 197

Query: 179 AHS--IIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY 231
                 +GTP+Y++PE+ +       Y    D +S G+ L EM+  + P+   DS+   Y
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTY 256

Query: 232 KKV 234
            K+
Sbjct: 257 SKI 259

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 41/182 (22%), Positives = 80/182 (43%), Gaps = 42/182 (23%)

Query: 90  DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN 149
           D+ N L  I E    G++ T   K   +S +A + +  + +  ++ +H  +   IHRD+ 
Sbjct: 72  DKRN-LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH--QLGFIHRDIK 128

Query: 150 CSNIFINGNIGQVKIGDLGFAAIVGRSHA------------------------------- 178
             N+ ++   G VK+ D G    + ++H                                
Sbjct: 129 PDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187

Query: 179 -----AHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK 232
                A+S +GTP+Y+APE++ +  Y ++ D +S G+ + EM+    P+   ++  + Y+
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ETPQETYR 246

Query: 233 KV 234
           KV
Sbjct: 247 KV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 46.6 bits (110), Expect = 5e-06
 Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 24/170 (14%)

Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH---------- 114
            H E +LL  L++++I+  Y V ++   + L  + E    G+L  + + H          
Sbjct: 54  FHREAELLTNLQHEHIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111

Query: 115 ---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 171
                ++   +   ++Q+  G+ YL +     +HRDL   N  +  N+  VKIGD G + 
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL-LVKIGDFGMSR 168

Query: 172 IVGRSH----AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            V  +       H+++    +M PE +    +T   D++S G+ L E+ T
Sbjct: 169 DVYSTDYYRVGGHTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 9/130 (6%)

Query: 98  ITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 156
           ITE   +G+L  + +++    ++  L    + +  G++YL       +HRDL   NI +N
Sbjct: 83  ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM--NYVHRDLAARNILVN 140

Query: 157 GNIGQVKIGDLGFAAIVGRSHAAHSIIG--TP-EYMAPE-LYEEDYTEMVDIYSFGLCLL 212
            N+   K+ D G +  +  S A ++  G   P  + APE +    +T   D++SFG+ + 
Sbjct: 141 SNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 199

Query: 213 EMVTM-EIPY 221
           E+++  E PY
Sbjct: 200 EVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 42/187 (22%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------------ 115
           EV++L  LK+  II    V +D+  + L  ITE   +G+L  +   H             
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 116 -------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG 168
                   +S  +L   + Q+  G++YL +     +HRDL   N  +  N+  +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADFG 183

Query: 169 ---------FAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM- 217
                    +  I GR+      +    +MA E +    +T   D+++FG+ L E++ + 
Sbjct: 184 MSRNLYAGDYYRIQGRA------VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237

Query: 218 -EIPYSE 223
            E PY E
Sbjct: 238 KEQPYGE 244

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 6e-06
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 54/207 (26%)

Query: 100 EVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
           E C  G+L++Y  +     R+  +  L++ + ++  G+ ++H H    +H DL   N F+
Sbjct: 75  EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFL 132

Query: 156 NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-------YMAPELYEE--------DYTE 200
             ++  VK+GD G    +G S      I T +       ++APEL  E        + T+
Sbjct: 133 TSDL-TVKVGDYG----IGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTK 187

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV-KDPEVKAF----- 254
             ++++ G+ L E+          ++ A+ Y  ++     + LN V KD +VK F     
Sbjct: 188 PSNVWALGVTLWELF---------ENAAQPYSHLS---DREVLNHVIKDQQVKLFKPQLE 235

Query: 255 ----------IEKCIAQPRARPSASEL 271
                     ++ C   P  R +A E+
Sbjct: 236 LPYSERWYEVLQFCWLSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.0 bits (109), Expect = 6e-06
 Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 19/142 (13%)

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
           KYI+   SV+L  QH            G L ++  K  ++  + +K+W+ +++  L+ L 
Sbjct: 52  KYIVSEDSVFLVLQH---------AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDAL- 101

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE---LY 194
            H   I+ RDLN +NI ++ + G +++      + V  S    ++     Y APE   + 
Sbjct: 102 -HREGIVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGIS 157

Query: 195 EEDYTEMVDIYSFGLCLLEMVT 216
           EE  TE  D +S G  L E++T
Sbjct: 158 EE--TEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 39/174 (22%), Positives = 83/174 (47%), Gaps = 14/174 (8%)

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E  ++    + +++  +  + DD++  L  + E    G+L      +  V  K  + ++ 
Sbjct: 93  ERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTA 149

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGT 185
           +V+  L+ +H+     IHRD+   N+ ++ + G +K+ D G    + +       + +GT
Sbjct: 150 EVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGT 206

Query: 186 PEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           P+Y++PE+ +       Y    D +S G+ L EM+  + P+   DS+   Y K+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 38/139 (27%), Positives = 68/139 (48%), Gaps = 18/139 (12%)

Query: 98  ITEVCTSGNLRTY----RKKHRHVSIKALKKWSK------QVLEGLEYLHTHEPCIIHRD 147
           I E+ T G+L++Y    R +  +  ++A     K      ++ +G+ YL+ ++   +HRD
Sbjct: 87  IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRD 144

Query: 148 LNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           L   N  +  +   VKIGD G    +  +         +    +M+PE L +  +T   D
Sbjct: 145 LAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD 203

Query: 204 IYSFGLCLLEMVTM-EIPY 221
           ++SFG+ L E+ T+ E PY
Sbjct: 204 VWSFGVVLWEIATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 46/159 (28%), Positives = 86/159 (54%), Gaps = 16/159 (10%)

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAA-IVGRSHAA 179
           L ++S QV +G+++L +   CI HRD+   N+ + +G +   KI D G A  I+  S+  
Sbjct: 214 LLRFSSQVAQGMDFLASKN-CI-HRDVAARNVLLTDGRV--AKICDFGLARDIMNDSN-- 267

Query: 180 HSIIGTP----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKK 233
           + + G      ++MAPE +++  YT   D++S+G+ L E+ ++ + PY      +K YK 
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327

Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
           V  G +  +      PE+ + ++ C   +P  RP+ S++
Sbjct: 328 VKRGYQ-MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 50/248 (20%), Positives = 104/248 (41%), Gaps = 44/248 (17%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           ++G GA  +V     ++ G   A   +R +   E    V  + +E  +L    + +++  
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEADSLWVVKM 66

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +  + D  +  L  I E    G++ T   K   ++ +  + +  + +  ++ +H  +   
Sbjct: 67  FYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH--QLGF 122

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA------------------------- 178
           IHRD+   N+ ++   G VK+ D G    + ++H                          
Sbjct: 123 IHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 179 -----------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
                      A S +GTP+Y+APE++ +  Y ++ D +S G+ + EM+    P+   ++
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ET 240

Query: 227 VAKIYKKV 234
             + YKKV
Sbjct: 241 PQETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 45.7 bits (108), Expect = 9e-06
 Identities = 36/133 (27%), Positives = 68/133 (51%), Gaps = 10/133 (7%)

Query: 98  ITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 156
           +TE   +G+L  + +KH    ++  L    + +  G++YL   +   +HRDL   NI +N
Sbjct: 83  VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVN 140

Query: 157 GNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCL 211
            N+   K+ D G + ++     AA++  G      + APE +    +T   D++S+G+ +
Sbjct: 141 SNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 199

Query: 212 LEMVTM-EIPYSE 223
            E+++  E PY E
Sbjct: 200 WEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 34/184 (18%)

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------- 115
           N    E++++  LK+  II   +V +    + L  ITE   +G+L  +  +H        
Sbjct: 64  NDFLKEIKIMSRLKDPNIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 116 ----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG--- 168
                +S   L   + Q+  G++YL +     +HRDL   N  +  N   +KI D G   
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNY-TIKIADFGMSR 178

Query: 169 ------FAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--EI 219
                 +  I GR  A   I     +M+ E +    +T   D+++FG+ L E++T+  E 
Sbjct: 179 NLYSGDYYRIQGR--AVLPI----RWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232

Query: 220 PYSE 223
           PYS+
Sbjct: 233 PYSQ 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 27/114 (23%)

Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIG 184
           +Q+L  L+ LH+    I+HRD+   NI  +   G  KI DLG AA   VG ++     + 
Sbjct: 262 RQILFALDGLHS--TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319

Query: 185 TPEYMAPE-----------------------LYEEDYTEMVDIYSFGLCLLEMV 215
            P Y APE                       L++ +  +  DIYS GL  L+M 
Sbjct: 320 DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373

Length = 566

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 16/227 (7%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           ++G GA   V +   +E    VA  + + S  +E+  +      E+++LRTLK + I+  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE--VKETTLRELKMLRTLKQENIVEL 65

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
              +   +   L  + E      L    +    V  + ++ +  Q+++ + + H ++  I
Sbjct: 66  KEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYMAPE-LYEEDYTE 200
           +HRD+   N+ I+ N   +K+ D GFA  +     A+    + T  Y +PE L    Y +
Sbjct: 122 VHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180

Query: 201 MVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQAL 243
            VD++S G C+L  ++   P     SE D +  I +KV G +  + +
Sbjct: 181 AVDMWSVG-CILGELSDGQPLFPGESEIDQLFTI-QKVLGPLPAEQM 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 26/182 (14%)

Query: 98  ITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 156
           ITE   +G L  Y + H    S   L    + +  G++YL   +   +HRDL   NI +N
Sbjct: 84  ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVN 141

Query: 157 GNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCL 211
            N+ + K+ D G + ++       ++  G      + APE +    +T   D++SFG+ +
Sbjct: 142 SNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200

Query: 212 LEMVTM-EIPYSECDSVAKIYKKVTGGVK-------PQALNKVKDPEVKAFIEKCIAQPR 263
            E+++  E PY +  S  ++ K +  G +       P A+ ++        + +C  Q R
Sbjct: 201 WEVMSFGERPYWDM-SNHEVMKAINDGFRLPAPMDCPSAVYQL--------MLQCWQQDR 251

Query: 264 AR 265
           AR
Sbjct: 252 AR 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.4 bits (97), Expect = 2e-04
 Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 26/110 (23%)

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 185
           +KQV  G+ YL   E   +HRDL   N  +  N+  VKI D G          + +I   
Sbjct: 136 AKQVAAGMAYLS--ERKFVHRDLATRNCLVGENM-VVKIADFGL---------SRNIYSA 183

Query: 186 PEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PY 221
             Y            M PE ++   YT   D++++G+ L E+ +  + PY
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)

Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG GA  KV+ A       +++ + VA     L   SE          E +LL  L++++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQ--DFQREAELLTVLQHQH 68

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR---------------HVSIKALKK 124
           I+  Y V  + +   L  + E    G+L  + + H                 +++  +  
Sbjct: 69  IVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
            + Q+  G+ YL +     +HRDL   N  +   +  VKIGD G +  +  S   + + G
Sbjct: 127 IASQIASGMVYLASLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDI-YSTDYYRVGG 182

Query: 185 TP----EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT 216
                  +M PE  LY +  TE  DI+SFG+ L E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTES-DIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 4/69 (5%)

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSI 182
           K+  +V   L+YLH H   IIHRDL   N+ I+ N G +K+ D G + + + R      I
Sbjct: 108 KYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKVTLNRELNMMDI 164

Query: 183 IGTPEYMAP 191
           + TP    P
Sbjct: 165 LTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.5 bits (90), Expect = 0.001
 Identities = 39/158 (24%), Positives = 63/158 (39%), Gaps = 24/158 (15%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           Q L  L  LH        R     NI +  +      G + F     ++         P 
Sbjct: 25  QCLGALRELH--------RQAKSGNILLTWDGLLKLDGSVAF-----KTPEQS--RPDPY 69

Query: 188 YMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------ 240
           +MAPE+ +   YTE  DIYS G+ L E +  E+PY+E   ++ I + +  G+        
Sbjct: 70  FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129

Query: 241 QALNKVKD-PEVKAFIEKCIAQ-PRARPSASELLKDPF 276
             L  V      + F+  C ++ P+ R +A+  L    
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCR 167

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 45/192 (23%), Positives = 88/192 (45%), Gaps = 25/192 (13%)

Query: 100 EVCTSGNLRTYRKKHR-------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN 152
           E+   G+L+++ +++R        +++K L   ++ V +G +YL  +    IHRD+   N
Sbjct: 89  ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARN 146

Query: 153 IFIN--GNIGQVKIGDLGFAAIVGRS-------HAAHSIIGTPEYMAPELYEED-YTEMV 202
             +   G     KI D G A  + R+        A   I    ++M PE + +  +T   
Sbjct: 147 CLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI----KWMPPEAFLDGIFTSKT 202

Query: 203 DIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ 261
           D++SFG+ L E+ ++  +PY    +  ++ + VTGG +         P  +   +     
Sbjct: 203 DVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHT 261

Query: 262 PRARPSASELLK 273
           P  RP+ + +L+
Sbjct: 262 PEDRPNFATILE 273

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 17/43 (39%), Positives = 29/43 (67%), Gaps = 1/43 (2%)

Query: 182 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE 223
           I+GTP+Y+APE L  + +   VD ++ G+CL E +T   P+++
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFND 582

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	289
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PRK10345	210	hypothetical protein; Provisional	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
smart00090	237	RIO RIO-like kinase.	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG1243	690	consensus Protein kinase [General function predict	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
COG4248	637	Uncharacterized protein with protein kinase and he	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.04
PRK09902	216	hypothetical protein; Provisional	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.73
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.73
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.7
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.61
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.6
PF01636	239	APH: Phosphotransferase enzyme family This family	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.55
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.31
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.31
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.29
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.23
PLN02876	822	acyl-CoA dehydrogenase	98.18
KOG2270	520	consensus Serine/threonine protein kinase involved	98.16
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.06
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.99
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.98
PRK10593	297	hypothetical protein; Provisional	97.96
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.92
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.86
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.76
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.76
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.63
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.62
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.46
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.46
PRK05231	319	homoserine kinase; Provisional	97.43
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.31
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.23
PLN02236	344	choline kinase	97.16
PLN02756	418	S-methyl-5-thioribose kinase	97.11
PRK12396	409	5-methylribose kinase; Reviewed	97.1
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.96
PTZ00384	383	choline kinase; Provisional	96.78
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.6
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.54
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.44
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.09
COG2334	331	Putative homoserine kinase type II (protein kinase	95.9
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.72
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.51
PRK11768	325	serine/threonine protein kinase; Provisional	95.26
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.02
PRK06148	1013	hypothetical protein; Provisional	94.94
PTZ00296	442	choline kinase; Provisional	94.91

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-56  Score=368.00  Aligned_cols=254  Identities=31%  Similarity=0.565  Sum_probs=230.1

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ..+.||+|+.|+||+|.|+.|++.+|+|++...   .++...+.+.+|+++++..+|||||.+++.|..... .++++||
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mE  158 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICME  158 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehh
Confidence            367899999999999999999999999999543   267888999999999999999999999999987753 6999999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      ||+||||.+++...+++++..+..++.++++||.|||. ++  ++||||||+|+|++.+ |.|||||||.+...... ..
T Consensus       159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~a  234 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-IA  234 (364)
T ss_pred             hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC-CCEEeccccccHHhhhh-hc
Confidence            99999999999998999999999999999999999995 88  9999999999999999 99999999999887666 56


Q ss_pred             ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          180 HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .+..||..|||||++.+. |+.++||||||++++|+++|+.||...    ...-.....+..+.+|.......+++++.+
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F  314 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF  314 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence            778899999999988876 999999999999999999999999863    455666777777777777666789999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          255 IEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +..||+ ||.+||++.|+++|||+++...
T Consensus       315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  315 VSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            999998 9999999999999999997654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-56  Score=384.56  Aligned_cols=264  Identities=31%  Similarity=0.535  Sum_probs=231.7

Q ss_pred             CceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeE
Q 022956            8 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW   87 (289)
Q Consensus         8 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   87 (289)
                      |-++.++..++|..++.||+|+|+++|.+.+..+|+.||+|++...... .....+.+.+|+++.+.|+|||||+++++|
T Consensus         9 p~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-k~~~reKv~~EIeIHr~L~HpnIV~f~~~F   87 (592)
T KOG0575|consen    9 PEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-KPKQREKVLNEIEIHRSLKHPNIVQFYHFF   87 (592)
T ss_pred             CCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-CcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence            4445565667778899999999999999999999999999999876543 455678899999999999999999999998


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      .+  ++.+|+|.|+|..++|..+++..+.++|.+++.++.||+.||.|||+++  |+|||||..|++++.+ .+|||+||
T Consensus        88 ED--s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgDF  162 (592)
T KOG0575|consen   88 ED--SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGDF  162 (592)
T ss_pred             ec--CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEeccc
Confidence            44  4789999999999999999999999999999999999999999999999  9999999999999999 79999999


Q ss_pred             CCccccCCc-cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          168 GFAAIVGRS-HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       168 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      |+|...... ....+.||||.|.|||++.+. .+..+||||+||+||-|+.|+.||.. ......++.+..+...  ++.
T Consensus       163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~--~P~  239 (592)
T KOG0575|consen  163 GLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYS--MPS  239 (592)
T ss_pred             ceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCcc--ccc
Confidence            999998754 667788999999999977654 99999999999999999999999987 4445555555443322  445


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ..+.++++||.+||+ ||.+|||+++||.|+||+.=
T Consensus       240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            789999999999998 99999999999999999543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-57  Score=375.89  Aligned_cols=262  Identities=26%  Similarity=0.384  Sum_probs=227.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCH---HHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP---VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ..||-+.+.||+|+||.|-+|..+.||+.||||++.........   .....+.+|+++|++|+||+||+++++|..+  
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~--  248 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP--  248 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence            34446899999999999999999999999999999876543211   1234467999999999999999999998554  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCCc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFA  170 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~~  170 (289)
                      ++.|+|+||++||.|.+.+..++.+.+.....+++|++.|+.|||+.|  ++||||||+|||+..+  .-.+||+|||+|
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchh
Confidence            678999999999999999999999999999999999999999999999  9999999999999654  136999999999


Q ss_pred             cccCCccccccCCCCCCCCCCcccccC---C-CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC--CCC
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEED---Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--ALN  244 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~~---~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~  244 (289)
                      ++.+......+.||||.|.|||++.+.   + ..+.|+|||||++|-+++|..||++........+++.++....  ..+
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            999888888899999999999977643   3 3478999999999999999999998766666777777775442  345


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ..++++..+||..||. ||++|||++++|+||||+...
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            5679999999999999 999999999999999999665

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-53  Score=347.89  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=225.0

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.++||.|+||+||+|+.+.|++.||+|+++.....+. ...+...+|..+|.+++||.||.+...|.+.  ..+|+|+
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--~kLylVl  104 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTE--EKLYLVL  104 (357)
T ss_pred             eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccC--CeEEEEE
Confidence            678999999999999999999999999999998765433 4577899999999999999999999888544  6899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc-CCccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~-~~~~~  178 (289)
                      ||+.||.|...+++.+.+++..+.-++..|+.||.|||++|  ++||||||+|||+|.+ |.++|+|||++... .....
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCC-CcEEEeccccchhcccCCCc
Confidence            99999999999999999999999999999999999999999  9999999999999999 99999999999854 45556


Q ss_pred             cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      +.+.|||+.|||||++. .+++.++|.||||+++|+|++|..||.+.+..... +.+..+. ....+...+++.++++.+
T Consensus       182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~-~~I~~~k-~~~~p~~ls~~ardll~~  259 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY-DKILKGK-LPLPPGYLSEEARDLLKK  259 (357)
T ss_pred             cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH-HHHhcCc-CCCCCccCCHHHHHHHHH
Confidence            67789999999999665 55999999999999999999999999875544444 4444433 233455578999999999


Q ss_pred             HHc-CCCCCC----CHHHHhcCcccccCCCC
Q 022956          258 CIA-QPRARP----SASELLKDPFFSELNDD  283 (289)
Q Consensus       258 ~l~-dp~~Rp----s~~~il~h~~~~~~~~~  283 (289)
                      +|+ ||++|.    ++++|-+||||+.++|+
T Consensus       260 LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  260 LLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             HhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence            998 999994    89999999999999986

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-52  Score=357.06  Aligned_cols=256  Identities=26%  Similarity=0.438  Sum_probs=222.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+++.||+|+|++|++|.++.+++.||||++...... .+...+.+..|-.+|.+| .||.|++++..|.++  ..+|+|
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~sLYFv  152 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--ESLYFV  152 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-hhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--cceEEE
Confidence            6889999999999999999999999999999876543 233345577788889999 899999999998666  579999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      +||+++|.|.+++.+.+.+++.-++.++.+|+.||+|||++|  ++||||||+|||+|.| |+++|+|||.|..++....
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccCChhhc
Confidence            999999999999999999999999999999999999999999  9999999999999999 9999999999987742211


Q ss_pred             ----------c----ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          179 ----------A----HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       179 ----------~----~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                                .    .+.+||-.|.+||++.. ..++.+|+|+||||+|+|+.|..||.+..+...++.++.-..   .+
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y---~f  306 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY---EF  306 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc---cC
Confidence                      1    34679999999997765 489999999999999999999999998666655555544322   24


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +...++.+++|++++|. ||.+|+++.||-+||||.+++|++
T Consensus       307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            55668999999999998 999999999999999999999875

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-52  Score=365.60  Aligned_cols=279  Identities=60%  Similarity=1.078  Sum_probs=264.4

Q ss_pred             CCCCCCceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEE
Q 022956            3 DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV   82 (289)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   82 (289)
                      ..+.+.+...++++||.++.++||.|+|.+||+|.|..+|..||+-.++.....+.+...++|..|+.+|+.|+||||++
T Consensus        26 e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIir  105 (632)
T KOG0584|consen   26 EPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIR  105 (632)
T ss_pred             ccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceee
Confidence            45677788999999999999999999999999999999999999999988888888888999999999999999999999


Q ss_pred             eeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcE
Q 022956           83 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV  162 (289)
Q Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~  162 (289)
                      ++..+.+..++.+.+|+|.+.+|+|..|+.+.+.++.+.+..|++||+.||.|||++.||++|||||-+||||+.+.|.|
T Consensus       106 fy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V  185 (632)
T KOG0584|consen  106 FYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV  185 (632)
T ss_pred             eeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence            99999988888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEeccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC
Q 022956          163 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA  242 (289)
Q Consensus       163 ~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  242 (289)
                      ||+|+|+|+......... ..|||.|||||.+...|+...||||||..+.||+|+.-||+.-.+..+++..+.++..|..
T Consensus       186 KIGDLGLAtl~r~s~aks-vIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s  264 (632)
T KOG0584|consen  186 KIGDLGLATLLRKSHAKS-VIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA  264 (632)
T ss_pred             eecchhHHHHhhccccce-eccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence            999999999876664443 7899999999999988999999999999999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHcCCCCCCCHHHHhcCcccccCCC
Q 022956          243 LNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +....+++++++|.+||...++|+|+.++|.||||+.-..
T Consensus       265 l~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  265 LSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             hhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccc
Confidence            9999999999999999988999999999999999998644

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-51  Score=341.69  Aligned_cols=264  Identities=25%  Similarity=0.460  Sum_probs=229.8

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .+...+.| .+.+.||+|+||+||+|+++.++..||||.+.+..+  +...++.+..|+++|+.++|||||.++++....
T Consensus         5 ~~~~~~~y-~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~   81 (429)
T KOG0595|consen    5 SMRVVGDY-ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD   81 (429)
T ss_pred             cccccccc-eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence            34566777 478889999999999999999999999999998876  677788899999999999999999999988554


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--C---CcEEEe
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--I---GQVKIG  165 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~---~~~~l~  165 (289)
                        +++|+|||||.||+|.+++...+.+++..+..++.|++.||++||+++  ++||||||+|||++.+  .   -.+||+
T Consensus        82 --~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   82 --DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             --CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEec
Confidence              689999999999999999999999999999999999999999999999  9999999999999753  1   369999


Q ss_pred             ccCCccccCCccccccCCCCCCCCCCccc-ccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCC
Q 022956          166 DLGFAAIVGRSHAAHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       166 d~g~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (289)
                      |||+|+...........||+|-|||||++ ...|+-++|+||+|+|+|+|++|..||......+-..............+
T Consensus       158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~  237 (429)
T KOG0595|consen  158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP  237 (429)
T ss_pred             ccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence            99999999988888899999999999987 56699999999999999999999999987554444443333333444555


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ...++...+|+...++ ++.+|.+.++-+.|+++..-.
T Consensus       238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  238 AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            5567777788888887 999999999999999987654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-52  Score=333.95  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=214.8

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +|.+ ..++|+|+||.||+++++.||+.||||++..+.  +++...+-..+|+++|++++|+|+|.++++|..  ...++
T Consensus         3 kYE~-LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklh   77 (396)
T KOG0593|consen    3 KYEK-LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLH   77 (396)
T ss_pred             HHhh-hhccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeE
Confidence            4543 788999999999999999999999999997553  467778889999999999999999999999944  46799


Q ss_pred             EEeccccCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           97 FITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +|+|||+. ++.+.++ ....++...+.++++|++.|+.|+|+++  ++||||||+||+++.+ |.+||||||+|+....
T Consensus        78 LVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   78 LVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFARTLSA  153 (396)
T ss_pred             EEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhhHhhcC
Confidence            99999988 5544454 4456999999999999999999999999  9999999999999999 9999999999998874


Q ss_pred             ccc-cccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC--CC----------
Q 022956          176 SHA-AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KP----------  240 (289)
Q Consensus       176 ~~~-~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~----------  240 (289)
                      +.. -..+..|.+|.|||.+.++  |.++.|||++||++.||++|+..|++.++.++++.+...-.  .+          
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            433 3345678899999988775  99999999999999999999999999888888765433311  11          


Q ss_pred             -------CCC---------CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          241 -------QAL---------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       241 -------~~~---------~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                             +..         -...+..+.+|+.+||+ ||.+|++.+|+|.|++|+++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence                   000         01124577899999999 999999999999999997763

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-50  Score=347.46  Aligned_cols=258  Identities=28%  Similarity=0.539  Sum_probs=220.9

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-HHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQ   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   91 (289)
                      ..++| .+++.||+|+||+|+.|.+..+|..||+|++........ ....+.+.+|+.++++++ ||||++++.++... 
T Consensus        15 ~~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-   92 (370)
T KOG0583|consen   15 SIGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-   92 (370)
T ss_pred             ccCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence            44565 789999999999999999999999999997766422111 134566778999999999 99999999999666 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       ..+++||||+.||.|.+++.+.+++.+..+..++.|+++|++|||++|  ++||||||+|++++.+.+++||+|||++.
T Consensus        93 -~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   93 -TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             -CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence             459999999999999999999899999999999999999999999999  99999999999999886799999999999


Q ss_pred             cc-CCccccccCCCCCCCCCCcccccC--C-CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          172 IV-GRSHAAHSIIGTPEYMAPELYEED--Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       172 ~~-~~~~~~~~~~~~~~~~aPE~~~~~--~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      .. .........+|++.|+|||++.+.  | ..++||||+|+++|.|++|..||...... .....+..+...  .+...
T Consensus       170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-~l~~ki~~~~~~--~p~~~  246 (370)
T KOG0583|consen  170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-NLYRKIRKGEFK--IPSYL  246 (370)
T ss_pred             ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-HHHHHHhcCCcc--CCCCc
Confidence            88 455667788999999999987753  4 46799999999999999999999984433 444444444322  34444


Q ss_pred             -ChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          248 -DPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       248 -~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                       ++.++.|+.+||. ||.+|+++.+|+.||||+.
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence             9999999999999 9999999999999999997

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-51  Score=325.37  Aligned_cols=254  Identities=25%  Similarity=0.462  Sum_probs=224.9

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.+.||.|+||.|.+++++.+|..||+|++.....- .-...+...+|..+|+.+.||.++.+.+.+.+.  +.+++||
T Consensus        47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~lymvm  123 (355)
T KOG0616|consen   47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNLYMVM  123 (355)
T ss_pred             hheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-HHHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeEEEEE
Confidence            4578999999999999999999999999999865432 233456688999999999999999999988655  6899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      ||++||.|+.++.+.+++++..+..++.|++.||+|||+++  +++|||||+|||+|.+ |.+|++|||+|......  +
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-CcEEEEeccceEEecCc--E
Confidence            99999999999999999999999999999999999999999  9999999999999999 99999999999877654  7


Q ss_pred             ccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  258 (289)
                      .+.||||.|+|||++. ++++.++|-|+||+++|||+.|..||...........++.....   .+...++.+++|+.++
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~---fP~~fs~~~kdLl~~L  275 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK---FPSYFSSDAKDLLKKL  275 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc---CCcccCHHHHHHHHHH
Confidence            7899999999999655 55999999999999999999999999987776655555555433   5667799999999999


Q ss_pred             Hc-CCCCC-----CCHHHHhcCcccccCCCCC
Q 022956          259 IA-QPRAR-----PSASELLKDPFFSELNDDD  284 (289)
Q Consensus       259 l~-dp~~R-----ps~~~il~h~~~~~~~~~~  284 (289)
                      |+ |-.+|     ...++|..||||++++|.+
T Consensus       276 L~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  276 LQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             HhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence            98 99999     4678999999999998854

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-52  Score=331.63  Aligned_cols=246  Identities=29%  Similarity=0.519  Sum_probs=219.2

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||.|.||.||+|.+..+|+.+|.|.+.....  +....+....|+.+|++|+||||++.++.-+.+++..++||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4789999999999999999999999999999986655  67778889999999999999999999997677776779999


Q ss_pred             eccccCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           99 TEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTHEPC--IIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        99 ~e~~~~~sL~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~--~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ||+|.+|.|...++    +.+.+++..+++++.|++.||.++|+.-+.  ++||||||.||+++.+ |.+||+|||++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHhH
Confidence            99999999999886    357899999999999999999999994333  9999999999999999 9999999999998


Q ss_pred             cCCccc-cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          173 VGRSHA-AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~~-~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      +..... ..+..|||.||+||+.. .+|++++|||||||++|||+.-+.||.+. +...+...+.++..++.+....|..
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~~~~p~~~YS~~  256 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDYPPLPDEHYSTD  256 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCCCCCcHHHhhhH
Confidence            876544 45679999999999665 55999999999999999999999999884 7777777788876666666888999


Q ss_pred             HHHHHHHHHc-CCCCCCCH
Q 022956          251 VKAFIEKCIA-QPRARPSA  268 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~  268 (289)
                      ++.|+..|+. ||+.||++
T Consensus       257 l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  257 LRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHHHHccCCcccCCCc
Confidence            9999999999 99999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-51  Score=339.03  Aligned_cols=255  Identities=31%  Similarity=0.540  Sum_probs=218.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ...+.||.|+||+||++.++++|...|||.+....   .+. .+.+.+|+++|++++||+||+.++.....+...++++|
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             hhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            56899999999999999999999999999998763   222 67799999999999999999999975333324799999


Q ss_pred             ccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC-CCCcEEEeccCCccccCC--
Q 022956          100 EVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING-NIGQVKIGDLGFAAIVGR--  175 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~-~~~~~~l~d~g~~~~~~~--  175 (289)
                      ||+++|||.+++...+ .++++.+..+++|+++||.|||++|  ++|+||||+|||++. + +.+||+|||.+.....  
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~-~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSN-GDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCC-CeEEeccCcccccccccc
Confidence            9999999999999866 7999999999999999999999999  999999999999999 6 8999999999987663  


Q ss_pred             --ccccccCCCCCCCCCCcccc-cC-CCCcchHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          176 --SHAAHSIIGTPEYMAPELYE-ED-YTEMVDIYSFGLCLLEMVTMEIPYSE-CDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       176 --~~~~~~~~~~~~~~aPE~~~-~~-~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                        ........|++.|||||... +. ..+++|||||||++.||+||..||.. ................| .++...++.
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~  251 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDE  251 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHH
Confidence              22344578999999999777 43 44599999999999999999999987 44455555555555333 667778999


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +++++.+|++ ||++|||++++|.|||.++...
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999998 9999999999999999987554

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-51  Score=347.64  Aligned_cols=264  Identities=30%  Similarity=0.410  Sum_probs=224.1

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEe
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLD   89 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   89 (289)
                      ++....|| ++.++||.|.||.||+|+.+.+|+.||||.++..... -++.  .=.+|++.|++|+ ||||+++.+++.+
T Consensus         5 ~~~~m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~--~nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    5 QVIFMDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC--MNLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             ehhHHHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH--HHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            44566777 6899999999999999999999999999999865432 1221  2357999999998 9999999999977


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      ..+ .+++||||++. +|.+++..+ +.+++..+..|+.||++||+|+|++|  ++|||+||+|||+..+ ..+||+|||
T Consensus        81 ~~~-~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFG  155 (538)
T KOG0661|consen   81 NDR-ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFG  155 (538)
T ss_pred             cCc-eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccc
Confidence            653 89999999987 999999864 67999999999999999999999999  9999999999999987 699999999


Q ss_pred             CccccCCccccccCCCCCCCCCCccc-c-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CCCCC--
Q 022956          169 FAAIVGRSHAAHSIIGTPEYMAPELY-E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQA--  242 (289)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~--  242 (289)
                      +|+.......-..+..|.+|.|||++ + +.|+.+.|||++|||++|+.+-+..|++..+.++++.++.--  +....  
T Consensus       156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             cccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            99998887777788899999999954 4 449999999999999999999999999988888887655432  21111  


Q ss_pred             -----------------------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          243 -----------------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       243 -----------------------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                             .-...++++.+||.+|++ ||++|||+.|+|+||||..-...
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                                   111246788999999999 99999999999999999876554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-50  Score=351.69  Aligned_cols=264  Identities=23%  Similarity=0.432  Sum_probs=235.8

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      +..+..+-+ ++++.||.|+-|.|-+|+|-.||+..|||++..... ........+.+|+-+++.+.|||++.+++++  
T Consensus         6 ~~~~tiGpw-kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVw--   81 (786)
T KOG0588|consen    6 SHKNTIGPW-KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--   81 (786)
T ss_pred             cccccccce-eccccccCCCCceehhhhcccccceeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeee--
Confidence            344566665 789999999999999999999999999999987632 2344567789999999999999999999999  


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      +.+..+|+|.||++||-|++++-..+++++.++.++++||+.|+.|||..+  ++|+|+||+|+|+|.. +++||+|||+
T Consensus        82 e~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGM  158 (786)
T KOG0588|consen   82 ENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGM  158 (786)
T ss_pred             ccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccce
Confidence            445789999999999999999999999999999999999999999999999  9999999999999999 6799999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      |..........+.||.|.|.|||+..|.  -..++||||.|+|+|.|+||.+||++ ++...++..+.++..  .++..+
T Consensus       159 AsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f--~MPs~I  235 (786)
T KOG0588|consen  159 ASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVF--EMPSNI  235 (786)
T ss_pred             eecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcc--cCCCcC
Confidence            9988888888899999999999988876  45689999999999999999999986 777777777777653  356889


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ++++++||.+||. ||.+|+|.+||++|||+..-.-.
T Consensus       236 s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  236 SSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             CHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence            9999999999999 99999999999999999887543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.9e-49  Score=311.15  Aligned_cols=258  Identities=28%  Similarity=0.434  Sum_probs=216.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      .+|.+ .++||+|.||.||+|.+.+||+.||||+++.....  ........+|++.|+.++|+||+.++++|-.  .+.+
T Consensus         2 ~rY~~-~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k--dGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l   76 (318)
T KOG0659|consen    2 DRYEK-LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK--DGINRTALREIKLLQELKHPNIIELIDVFPH--KSNL   76 (318)
T ss_pred             chhhh-hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc--cCccHHHHHHHHHHHHccCcchhhhhhhccC--CCce
Confidence            45644 89999999999999999999999999999987653  3334567889999999999999999999944  4679


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      .+|+||++. +|+..+.. ...++..++..++.+++.|++|||++.  ++||||||.|+|++++ |.+|++|||+++.+.
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQLKIADFGLARFFG  152 (318)
T ss_pred             EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-CcEEeecccchhccC
Confidence            999999987 89999875 467899999999999999999999999  9999999999999999 999999999999887


Q ss_pred             Ccccccc-CCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CCCCC-------
Q 022956          175 RSHAAHS-IIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQA-------  242 (289)
Q Consensus       175 ~~~~~~~-~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~-------  242 (289)
                      .+..... ...|..|.|||++.|.  |....||||.|||+.||+.+..-|++..+.+++..+....  +.+..       
T Consensus       153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            6655433 4678899999977654  9999999999999999999998888877777665443332  11111       


Q ss_pred             ----------------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          243 ----------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       243 ----------------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                      .-...++.+-+|+.+||. ||.+|+++.|+|+|+||++...
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence                            112235677899999999 9999999999999999998643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-49  Score=335.84  Aligned_cols=254  Identities=27%  Similarity=0.354  Sum_probs=215.8

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      -.++||+|.||.||+|++..||+.||+|+++....  ++.....+.+|+++|++|.||||+++.+.........+|+|+|
T Consensus       121 ki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe  198 (560)
T KOG0600|consen  121 KIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE  198 (560)
T ss_pred             HHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence            36889999999999999999999999999998764  5666788899999999999999999999987765678999999


Q ss_pred             cccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc--
Q 022956          101 VCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--  177 (289)
Q Consensus       101 ~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~--  177 (289)
                      |++. .|..++.. +-.+++.++..++.|++.||+|||++|  ++|||||.+|||+|.+ |.+||+|||+|.++....  
T Consensus       199 YMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~~~  274 (560)
T KOG0600|consen  199 YMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSGSA  274 (560)
T ss_pred             cccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCC-CCEEeccccceeeccCCCCc
Confidence            9988 89998887 457999999999999999999999999  9999999999999999 999999999999876443  


Q ss_pred             ccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--CCCCCCCC---------
Q 022956          178 AAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKPQALN---------  244 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~---------  244 (289)
                      ...+.+.|..|.|||++-|.  |+.+.|+||.|||+.||++|+..|.+....+++-.+..-  .+....++         
T Consensus       275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~  354 (560)
T KOG0600|consen  275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI  354 (560)
T ss_pred             ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence            34556789999999977654  999999999999999999999999987665554332221  11111111         


Q ss_pred             ---------------CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          245 ---------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       245 ---------------~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                                     ...++...+|+..||. ||.+|.|+.++|.++||+.-
T Consensus       355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence                           1236678899999999 99999999999999999443

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-49  Score=324.07  Aligned_cols=268  Identities=27%  Similarity=0.421  Sum_probs=224.7

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe---C
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD---D   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~   90 (289)
                      ...+| ...+.||.|+||.|+.+.++.||+.||||++.....  +....++..+|++.|+.++|+||+.+.+++..   +
T Consensus        20 i~~~y-~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~--~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   20 IPRYY-VLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE--NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             cccee-cccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh--chHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            34444 447999999999999999999999999999974432  56778899999999999999999999998865   3


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      +-+.+|+|+|+++. .|...+.++..|++..+..+++|++.||.|+|+.+  ++||||||.|++++.+ -.+|+||||+|
T Consensus        97 ~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLA  172 (359)
T KOG0660|consen   97 KFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLA  172 (359)
T ss_pred             ccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccce
Confidence            34679999999965 99999999888999999999999999999999999  9999999999999999 79999999999


Q ss_pred             cccCC---ccccccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-----
Q 022956          171 AIVGR---SHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-----  240 (289)
Q Consensus       171 ~~~~~---~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----  240 (289)
                      +....   .........|..|.|||++-  ..|+.+.||||.|||+.||++|+..|.+.+...++..++.-...+     
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            88754   22334566788999999654  449999999999999999999999998866555544322221111     


Q ss_pred             -----------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCCC
Q 022956          241 -----------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS  288 (289)
Q Consensus       241 -----------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~~  288 (289)
                                             ...-...++.+.+|+++||. ||.+|+|++|+|+||||+.+..++.+|.
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~  324 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV  324 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence                                   01122457889999999999 9999999999999999999988888774

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=342.68  Aligned_cols=258  Identities=30%  Similarity=0.522  Sum_probs=232.3

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .++..+|. -.++||+|+.|.||.|....+++.||||.+.......    .+-+.+|+.+++..+|+|||..++.|+.. 
T Consensus       269 ~dP~~~y~-~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~----keLilnEi~Vm~~~~H~NiVnfl~Sylv~-  342 (550)
T KOG0578|consen  269 GDPRSKYT-DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK----KELLLNEILVMRDLHHPNIVNFLDSYLVG-  342 (550)
T ss_pred             CChhhhhc-chhhhccccccceeeeeeccCCceEEEEEEEeccCCc----hhhhHHHHHHHHhccchHHHHHHHHhccc-
Confidence            46677774 5899999999999999999999999999998865432    56788999999999999999999998765 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       +.+|.||||++||+|.+.+.... ++|.++..+.++++.||+|||.+|  ++|+|||.+|||++.+ |.+||+|||++.
T Consensus       343 -deLWVVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~-g~vKltDFGFca  417 (550)
T KOG0578|consen  343 -DELWVVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMD-GSVKLTDFGFCA  417 (550)
T ss_pred             -ceeEEEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccC-CcEEEeeeeeee
Confidence             56999999999999999998755 999999999999999999999999  9999999999999999 999999999998


Q ss_pred             ccCCcc-ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          172 IVGRSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .+.... +.....|||.|||||.... .|.++.||||||++++||+-|+.||-.......++.+-..+.+....+...++
T Consensus       418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~  497 (550)
T KOG0578|consen  418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP  497 (550)
T ss_pred             ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence            876544 5667789999999997665 59999999999999999999999999877788888777778888888899999


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+++|+.+||+ |+++|+++.++|+||||+-.
T Consensus       498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            99999999999 99999999999999999543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-48  Score=334.77  Aligned_cols=259  Identities=23%  Similarity=0.372  Sum_probs=221.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.+.||+|+||.||+|+.+.||+.||+|+++..... .....+.++.|-.+|....+|.+|+++..|.+  ..++||||
T Consensus       144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~LYLiM  220 (550)
T KOG0605|consen  144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYLYLIM  220 (550)
T ss_pred             hhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCeeEEEE
Confidence            5789999999999999999999999999999987653 34457778999999999999999999999844  47899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC----
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR----  175 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~----  175 (289)
                      ||++||.+..++...+.|++..+...+.+++.|+..+|+.|  ++|+||||+|+|+|.. |++||+|||++.....    
T Consensus       221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC-CCEeeccccccchhhhhhhh
Confidence            99999999999999999999999999999999999999999  9999999999999999 9999999999854310    


Q ss_pred             --------------------cc-----c-------------------cccCCCCCCCCCCcccccC-CCCcchHHHHHHH
Q 022956          176 --------------------SH-----A-------------------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLC  210 (289)
Q Consensus       176 --------------------~~-----~-------------------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i  210 (289)
                                          ..     .                   ..+..|||.|+|||++.+. +....|.||||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                                00     0                   0124689999999976654 9999999999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCChHHHHHHHHHHcCCCCCC---CHHHHhcCcccccCCCCC
Q 022956          211 LLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKAFIEKCIAQPRARP---SASELLKDPFFSELNDDD  284 (289)
Q Consensus       211 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~dp~~Rp---s~~~il~h~~~~~~~~~~  284 (289)
                      +|||+.|..||.+.........++....... ......++++++||.+||.||++|.   +++||-+||||++++|+.
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~  455 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDH  455 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcch
Confidence            9999999999998766666655554432221 1233457999999999999999995   699999999999999975

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-48  Score=335.99  Aligned_cols=252  Identities=23%  Similarity=0.430  Sum_probs=212.1

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      +.||+|+||.||+|.++.+|+.||+|+++..... .......+.+|+.++++++||||+++++.+...  +.+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence            4699999999999999999999999999864322 233456678899999999999999999887443  6899999999


Q ss_pred             cCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-cccccc
Q 022956          103 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS  181 (289)
Q Consensus       103 ~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~~  181 (289)
                      ++++|.+++...+.+++.++..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++..... ......
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccc
Confidence            99999999998888999999999999999999999999  9999999999999988 8999999999875422 222334


Q ss_pred             CCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc
Q 022956          182 IIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA  260 (289)
Q Consensus       182 ~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  260 (289)
                      .++++.|+|||.+.+. ++.++|||||||++|+|++|..||....... ....+....  ...+...++.+.+|+.+||+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~~~~~~--~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELILMEE--IRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-HHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence            5689999999977654 8999999999999999999999998754443 333333322  22345578999999999998


Q ss_pred             -CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          261 -QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       261 -dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                       ||++||     ++.++++||||++++|.
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence             999999     89999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-48  Score=331.16  Aligned_cols=253  Identities=23%  Similarity=0.386  Sum_probs=214.9

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+.+|++++++++||||+++++.+.+  .+.+++||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~   80 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYMLM   80 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEEEE
Confidence            6789999999999999999999999999999764321 22345678899999999999999999987744  36899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEEecCcchhccCC--c
Confidence            99999999999998888999999999999999999999999  9999999999999988 89999999998765432  2


Q ss_pred             ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  258 (289)
                      ....+++.|+|||.+.+. ++.++|||||||++|+|++|..||.+...............   ..+...++.+++|+.+|
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~  232 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---EFPRHLDLYAKDLIKKL  232 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---CCCccCCHHHHHHHHHH
Confidence            235688999999976654 88999999999999999999999987655444444333322   23444588999999999


Q ss_pred             Hc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          259 IA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       259 l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      |+ ||.+||+     ++++++||||+.+++.
T Consensus       233 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         233 LVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             cCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence            98 9999995     9999999999987765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-50  Score=313.93  Aligned_cols=261  Identities=26%  Similarity=0.452  Sum_probs=225.5

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      -.++.| .+.+.||+|.|+.|+++.+..||+.+|+|++....+...  .-+.+.+|+++.+.|+||||+.+...+  ++.
T Consensus         8 ~f~d~y-~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~   82 (355)
T KOG0033|consen    8 KFSDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSI--QEE   82 (355)
T ss_pred             ccchhh-hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhh--ccc
Confidence            345566 578999999999999999999999999999988776433  567899999999999999999999988  444


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCCc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFA  170 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~~  170 (289)
                      .+.|+|+|++.|+.|..-+-+.-..++..+...++||++||.|+|.+|  ++|+|++|.|+++...  .--+||+|||++
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvA  160 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLA  160 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceE
Confidence            789999999999999887777677899999999999999999999999  9999999999999543  246999999999


Q ss_pred             cccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC-CC-CCCCCCCC
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG-VK-PQALNKVK  247 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~-~~~~~~~~  247 (289)
                      ...+.........|+|.|+|||+++++ ++.++|||+-|+|+|-++.|.+||.+.+. ..+++.+.++ .. +...+..+
T Consensus       161 i~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~yd~~~~~w~~i  239 (355)
T KOG0033|consen  161 IEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGAYDYPSPEWDTV  239 (355)
T ss_pred             EEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhccccCCCCcccCcC
Confidence            999877777888999999999988866 89999999999999999999999988444 4445555544 32 22256678


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +++.++|+++||. ||.+|+|+.+.|.|||+++-+
T Consensus       240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             CHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            9999999999998 999999999999999998754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-48  Score=323.98  Aligned_cols=262  Identities=26%  Similarity=0.414  Sum_probs=224.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ++.+-|.+.+.||.|..++||+|..+.+++.||||++......   ...+.+.+|+..++.++||||+..+..|..+  .
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~--~   97 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD--S   97 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEec--c
Confidence            4555568999999999999999999999999999999977652   2378899999999999999999999999766  5


Q ss_pred             eeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .+|+||+|+.+||+.+++...  ..+++..+..++++++.||.|||++|  .+|||||+.|||++.+ |.|||+|||.+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d-G~VkLadFgvsa  174 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD-GTVKLADFGVSA  174 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC-CcEEEcCceeee
Confidence            799999999999999999863  45999999999999999999999999  9999999999999999 999999999986


Q ss_pred             ccCCccc-----cccCCCCCCCCCCcccc---cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC---
Q 022956          172 IVGRSHA-----AHSIIGTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---  240 (289)
Q Consensus       172 ~~~~~~~-----~~~~~~~~~~~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---  240 (289)
                      .......     +....+++.|||||.+.   .+|+.++||||||++..|+.+|..||....+...+...+...++-   
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            5433221     13457899999999754   349999999999999999999999999988888877776655431   


Q ss_pred             ----CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          241 ----QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       241 ----~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                          .......+..++.++..||. ||.+|||++++|+|+||+.....
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence                12222346689999999998 99999999999999999987543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.6e-48  Score=334.78  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=215.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+.+|++++++++||||+++++.+...  +.+++||
T Consensus        21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~   97 (329)
T PTZ00263         21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLL   97 (329)
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEEEEE
Confidence            6789999999999999999999999999999864321 223456788999999999999999999988554  6899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      ||+.+++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++......  .
T Consensus        98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC-CCEEEeeccCceEcCCC--c
Confidence            99999999999998888999999999999999999999999  9999999999999988 89999999999766433  2


Q ss_pred             ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  258 (289)
                      ....+++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+...... ...+..+..  ..+...+..+++|+.+|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~--~~p~~~~~~~~~li~~~  249 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-YEKILAGRL--KFPNWFDGRARDLVKGL  249 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-HHHHhcCCc--CCCCCCCHHHHHHHHHH
Confidence            235689999999977654 88999999999999999999999987554433 333433322  23445788999999999


Q ss_pred             Hc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          259 IA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       259 l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      |+ ||.+||+     +++++.||||++.+|+
T Consensus       250 L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        250 LQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence            98 9999986     7999999999987655

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=329.63  Aligned_cols=245  Identities=32%  Similarity=0.551  Sum_probs=212.0

Q ss_pred             eeeeecccCcceEEEEeecCCCcE-EEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      +.+.||+|+||+||++.+.  |.. +|+|++......  ....+.|.+|+.+|++++|||||++++++..... .+++||
T Consensus        45 ~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVt  119 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFD--DESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVT  119 (362)
T ss_pred             hhhhcccCCceeEEEEEeC--CceeEEEEEecchhcC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEE
Confidence            4667999999999999886  667 999999876542  2227899999999999999999999999865532 689999


Q ss_pred             ccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC-cEEEeccCCccccCCc
Q 022956          100 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGRS  176 (289)
Q Consensus       100 e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~-~~~l~d~g~~~~~~~~  176 (289)
                      ||+++|+|.+++..  ...++...++.|+.+++.||.|||++++ ++|+|||++|||++.+ + ++||+|||++......
T Consensus       120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~-~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLK-GKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCC-CCEEEECCCccceeeccc
Confidence            99999999999987  6789999999999999999999999997 8999999999999999 6 9999999999877654


Q ss_pred             -cccccCCCCCCCCCCcccccC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 -HAAHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 -~~~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                       .......||+.|||||++.+.   ++.++||||+|+++|||+||+.||.+.............+.++... ...++.+.
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p-~~~~~~l~  276 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP-KECPPHLS  276 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC-ccCCHHHH
Confidence             333446899999999988843   9999999999999999999999999988755555665566555443 33899999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .|++.||. ||++||++.+|+.
T Consensus       277 ~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  277 SLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHhCCCCCCcCCCHHHHHH
Confidence            99999998 9999999999987

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.5e-48  Score=335.83  Aligned_cols=252  Identities=25%  Similarity=0.428  Sum_probs=222.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      -+.+.||+|+||+||+|+.+.|.+.||+|.+.....  .+...+.+.+|+++++.++||||+..++.|  +....+++|+
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr--~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vVt   80 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR--NEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVVT   80 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCC--chHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEEe
Confidence            467899999999999999999999999999987654  566789999999999999999999999999  4447899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc-
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~-  178 (289)
                      ||+.| +|..+++.++.++++++..++.++++||.|||+.+  +.|+|+||.||+++.+ |.+|+||||+++....... 
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-CceeechhhhhhhcccCcee
Confidence            99988 99999999999999999999999999999999999  9999999999999999 9999999999997765433 


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      ..+..|||-|||||.+.+. ++..+|+||||||+||+++|+.||-. .......+.+....  ..++...+..+..+++.
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~--v~~p~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDP--VKPPSTASSSFVNFLQG  233 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCC--CCCcccccHHHHHHHHH
Confidence            3445799999999987755 99999999999999999999999976 44455555555532  33455678999999999


Q ss_pred             HHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          258 CIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       258 ~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +|. ||.+|.+-.+++.|||.++-..
T Consensus       234 LL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             HhhcChhhcccHHHHhcChHHhhhhh
Confidence            998 9999999999999999987643

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-47  Score=332.09  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=214.0

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .| ++.++||+|+||.||+|.+..+|+.||+|+++..... .......+.+|++++..++||||+++++.+..  ++.++
T Consensus         2 ~y-~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~   77 (333)
T cd05600           2 DF-QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLY   77 (333)
T ss_pred             Cc-EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEE
Confidence            44 6899999999999999999999999999999864321 23345678889999999999999999988754  36899


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||||++|++|.+++.....+++.++..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..... 
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEEEeCcCCccccc-
Confidence            99999999999999998888999999999999999999999999  9999999999999988 8999999999976544 


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC--C-C--CCCCCCCChH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--K-P--QALNKVKDPE  250 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~-~--~~~~~~~~~~  250 (289)
                       ......+++.|+|||.+.+. ++.++|||||||++|+|++|..||.................  . +  .......++.
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~  232 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE  232 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence             23345689999999977654 89999999999999999999999987554433332222111  1 1  1111235889


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +.+++.+||+ +|++||+++++++||||++.++
T Consensus       233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            9999999998 8999999999999999998755

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-47  Score=323.30  Aligned_cols=257  Identities=19%  Similarity=0.340  Sum_probs=212.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||+||++.++.+|+.||+|.+...... .......+.+|+++++.++|++++.+.+.+...  +.++++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv   78 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV   78 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence            36789999999999999999999999999999765432 122234577899999999999999999887443  679999


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+++++|.+++..  ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCC
Confidence            999999999888754  346899999999999999999999999  9999999999999988 89999999999876544


Q ss_pred             cccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      .......++..|+|||.+.+ .++.++|||||||++|+|++|..||......   ......+..  .....+...++.+.
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~  233 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAK  233 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHH
Confidence            33445578999999997765 4899999999999999999999999865432   222222222  12234445688999


Q ss_pred             HHHHHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          253 AFIEKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      +|+.+||+ ||++||+     ++++++||||+++++.
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence            99999998 9999997     8999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-48  Score=337.42  Aligned_cols=258  Identities=23%  Similarity=0.408  Sum_probs=214.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||+||+|.++.+|+.||+|++...... .......+.+|+++++.++||||+++++.+...  ..+++||
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~   80 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYLIM   80 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEEEE
Confidence            6789999999999999999999999999999865332 233456788899999999999999999888543  6899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc--
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~--  177 (289)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.......  
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEeecccceeccccccc
Confidence            99999999999988888999999999999999999999999  9999999999999998 899999999986542111  


Q ss_pred             -------------------------------------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCC
Q 022956          178 -------------------------------------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEI  219 (289)
Q Consensus       178 -------------------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~  219 (289)
                                                           .....+|++.|+|||.+.+. ++.++|||||||++|+|++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 01123589999999976544 8999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHhCCCCCC-CCCCCCChHHHHHHHHHHcCCCCCCC---HHHHhcCcccccCCCC
Q 022956          220 PYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKAFIEKCIAQPRARPS---ASELLKDPFFSELNDD  283 (289)
Q Consensus       220 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~dp~~Rps---~~~il~h~~~~~~~~~  283 (289)
                      ||.................... ......++.+++||.+|+.+|.+|++   +++++.||||++.+|.
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            9987655544444433221111 11224688999999999999999987   9999999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.7e-47  Score=333.59  Aligned_cols=259  Identities=20%  Similarity=0.372  Sum_probs=211.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||+||+|.++.+++.||+|++...... .......+.+|+.++..++|++|+++++.+.+.  ..+++||
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~lv~   80 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYLIM   80 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEEEE
Confidence            5789999999999999999999999999999754321 233456788899999999999999999887543  6899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc-
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~-  178 (289)
                      ||++|++|.+++.+.+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++........ 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CCEEEeeccCcccccccccc
Confidence            99999999999998888999999999999999999999999  9999999999999988 8999999999875422100 


Q ss_pred             -----------------------------------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCC
Q 022956          179 -----------------------------------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYS  222 (289)
Q Consensus       179 -----------------------------------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~  222 (289)
                                                         ....+|++.|+|||.+.+. ++.++|+|||||++|+|++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                               1234689999999976544 8999999999999999999999998


Q ss_pred             CCCcHHHHHHHHhCCCCCCCC-CCCCChHHHHHHHHHHcC---CCCCCCHHHHhcCcccccCCCCC
Q 022956          223 ECDSVAKIYKKVTGGVKPQAL-NKVKDPEVKAFIEKCIAQ---PRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~d---p~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +.................... ....++.+++++.+|+.+   +..||++++|++||||++.+|..
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence            755544444333322111111 223578999999997753   44568999999999999987754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-47  Score=334.74  Aligned_cols=260  Identities=23%  Similarity=0.392  Sum_probs=216.9

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +| ++.++||+|+||+||+|.++.+|+.||+|+++..... .......+.+|++++..++|+|++++++.+.+  ++.++
T Consensus         2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~   77 (350)
T cd05573           2 DF-EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLY   77 (350)
T ss_pred             Cc-eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEE
Confidence            44 6899999999999999999999999999999865332 12345678899999999999999999988744  36899


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKA  154 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEeecCCCCccCccc
Confidence            99999999999999998888999999999999999999999999  9999999999999998 89999999999766443


Q ss_pred             c------------------------------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 022956          177 H------------------------------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD  225 (289)
Q Consensus       177 ~------------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~  225 (289)
                      .                              ......+++.|+|||.+.+. ++.++|||||||++|+|++|..||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                              22335689999999977655 8999999999999999999999998766


Q ss_pred             cHHHHHHHHhC-CCCCCCCCCCCChHHHHHHHHHHcCCCCCCC-HHHHhcCcccccCCCC
Q 022956          226 SVAKIYKKVTG-GVKPQALNKVKDPEVKAFIEKCIAQPRARPS-ASELLKDPFFSELNDD  283 (289)
Q Consensus       226 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~dp~~Rps-~~~il~h~~~~~~~~~  283 (289)
                      ........... ...........++.+.+||.+||.||.+||+ ++++++||||++.++.
T Consensus       235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHH
Confidence            44444433331 1111111222589999999999999999999 9999999999998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-47  Score=328.35  Aligned_cols=252  Identities=23%  Similarity=0.429  Sum_probs=211.6

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      +.||+|+||.||++.++.+|..||+|+++..... .......+.+|+++++.++|||++++++.+...  ..+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCC
Confidence            4699999999999999999999999999864321 233456678899999999999999999887544  6799999999


Q ss_pred             cCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-cccccc
Q 022956          103 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS  181 (289)
Q Consensus       103 ~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~~  181 (289)
                      ++++|..++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++..... ......
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccc
Confidence            99999999988888999999999999999999999999  9999999999999988 8999999999875322 222334


Q ss_pred             CCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc
Q 022956          182 IIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA  260 (289)
Q Consensus       182 ~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  260 (289)
                      ..+++.|+|||.+.+ .++.++|+|||||++|+|++|..||.................   ..+...++.+++++.+||+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~  231 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcc
Confidence            568999999997764 489999999999999999999999987554444333333222   2344578999999999998


Q ss_pred             -CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          261 -QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       261 -dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                       ||++|+     ++.++++||||.+..|.
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence             999998     99999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.5e-47  Score=328.40  Aligned_cols=252  Identities=23%  Similarity=0.417  Sum_probs=211.2

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      +.||+|+||.||++.++.+|..||+|++...... .......+.+|+++++.++||||+++.+.+...  +.+++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCC
Confidence            4699999999999999999999999999864322 234456788899999999999999999877443  6899999999


Q ss_pred             cCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-cccccc
Q 022956          103 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS  181 (289)
Q Consensus       103 ~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~~  181 (289)
                      ++++|.+++.....+++.++..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++..... ......
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccc
Confidence            99999999988888999999999999999999999999  9999999999999988 8999999999875422 222334


Q ss_pred             CCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc
Q 022956          182 IIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA  260 (289)
Q Consensus       182 ~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  260 (289)
                      ..+++.|+|||.+.+ .++.++|||||||++|+|++|..||........ ...+....  ...+...++.+.+|+.+||+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-~~~~~~~~--~~~p~~~~~~~~~li~~~L~  231 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILMED--IKFPRTLSADAKSLLSGLLI  231 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-HHHhccCC--ccCCCCCCHHHHHHHHHHcC
Confidence            568999999997764 489999999999999999999999987544433 33333222  22345578999999999998


Q ss_pred             -CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          261 -QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       261 -dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                       ||++|+     ++.++++||||++.+|.
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence             999997     89999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4e-47  Score=329.27  Aligned_cols=254  Identities=22%  Similarity=0.395  Sum_probs=214.3

Q ss_pred             cceeeeecccCcceEEEEeecCCC-cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEG-IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      |++.+.||+|+||.||+|.++.++ ..||+|.+...... .....+.+.+|+.+++.++||||+++++.+...  +.+++
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~l  108 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYLYL  108 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEEEE
Confidence            367899999999999999876654 78999999764332 233456788999999999999999999988554  68999


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||||+.+++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++...... 
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEecCCCCeecCCC-
Confidence            9999999999999998888999999999999999999999999  9999999999999988 89999999999765432 


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                       .....+++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+......... +....  ...+...++.++++++
T Consensus       185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-i~~~~--~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK-ILEGI--IYFPKFLDNNCKHLMK  260 (340)
T ss_pred             -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH-HhcCC--CCCCCCCCHHHHHHHH
Confidence             2345689999999977654 88999999999999999999999987555443333 33332  2234557889999999


Q ss_pred             HHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          257 KCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       257 ~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      +||+ ||++|+     +++++++||||++++|.
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9998 999995     89999999999998764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-46  Score=326.50  Aligned_cols=262  Identities=26%  Similarity=0.386  Sum_probs=208.8

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC---Cee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH---NTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~   95 (289)
                      |++.++||+|+||.||+|.++.+|..||+|.+.....  .......+.+|+++++.++||||+++++++.....   ..+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            3689999999999999999999999999999874322  22334568899999999999999999988754322   358


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||+. ++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.....
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEccCcccccccc
Confidence            99999996 489999988888999999999999999999999999  9999999999999998 8999999999975432


Q ss_pred             ccc----cccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH----------------
Q 022956          176 SHA----AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK----------------  232 (289)
Q Consensus       176 ~~~----~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~----------------  232 (289)
                      ...    .....+++.|+|||.+.+   .+++++|||||||++|+|++|+.||.+.........                
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            211    233568899999997653   488999999999999999999999976443221110                


Q ss_pred             ----------HHhCCCCCC--CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          233 ----------KVTGGVKPQ--ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       233 ----------~~~~~~~~~--~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                                .+.......  ......++.+.+++.+||+ ||++||+++++++||||+++.....+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~  302 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE  302 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc
Confidence                      000000000  0011346788999999998 99999999999999999998765543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=324.71  Aligned_cols=262  Identities=25%  Similarity=0.431  Sum_probs=229.4

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCee
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   95 (289)
                      .+|.+.+.||.|.||.||+++++.||+.+|+|++........ ...+.+.+|+++|+++. |||++.+.+.|.+.  ..+
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~  111 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSV  111 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeE
Confidence            345789999999999999999999999999999987765432 24678999999999998 99999999999554  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC---CcEEEeccCCccc
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAI  172 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~---~~~~l~d~g~~~~  172 (289)
                      ++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|  ++|+|+||+|+++....   +.++++|||++..
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            9999999999999999876 4999999999999999999999999  99999999999995442   4799999999999


Q ss_pred             cCCccccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  250 (289)
                      ..........+|++.|+|||.+. ..++...||||+|+++|.|++|..||.+................ ....+...+..
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence            88766777889999999999887 56999999999999999999999999987766666666655432 33445667999


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +++++..||. ||.+|+++.++|+|||+++...+.
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~  303 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT  303 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence            9999999998 999999999999999999875544

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.8e-47  Score=322.32  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=206.5

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.++||+|+||.||+|.++.+++.||+|++......   .....+.+|+.+++.++|||++++++++...  ..
T Consensus         4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~   77 (303)
T cd07869           4 ADSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHTK--ET   77 (303)
T ss_pred             cccc-eEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEecC--Ce
Confidence            3455 6799999999999999999999999999999754321   1234567799999999999999999987544  57


Q ss_pred             eEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++...
T Consensus        78 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~  153 (303)
T cd07869          78 LTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT-GELKLADFGLARAK  153 (303)
T ss_pred             EEEEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECCCCcceec
Confidence            9999999975 77777765 356899999999999999999999999  9999999999999988 89999999998755


Q ss_pred             CCcc-ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC---CCCC-------
Q 022956          174 GRSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GVKP-------  240 (289)
Q Consensus       174 ~~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~-------  240 (289)
                      .... ......+++.|+|||.+.+  .++.++|+|||||++|+|++|..||.+..+.......+..   ....       
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            3322 2234567899999997653  3788999999999999999999999876544333322211   0000       


Q ss_pred             -------CC-------------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          241 -------QA-------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       241 -------~~-------------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                             ..             .....++.+.+|+.+||+ ||++|||++|+++||||+++....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~~  298 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPRL  298 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCChhh
Confidence                   00             001134678899999999 999999999999999999986543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-47  Score=324.43  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=209.4

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccC
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS  104 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  104 (289)
                      ||+|+||.||+|.++.+++.||+|++...... .......+.+|+.++++++||||+++++.+...  +.+++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence            79999999999999999999999999754322 233456788899999999999999999887443  689999999999


Q ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccccccCC
Q 022956          105 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSII  183 (289)
Q Consensus       105 ~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~~~~  183 (289)
                      ++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..... ........
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCcccccc
Confidence            999999988888999999999999999999999999  9999999999999988 8999999999875432 22233456


Q ss_pred             CCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-C
Q 022956          184 GTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q  261 (289)
Q Consensus       184 ~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-d  261 (289)
                      +++.|+|||.+.+. ++.++|||||||++|+|++|..||.+........ .+...  +...+...++.+++++.+||+ |
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR-KILQE--PLRFPDGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH-HHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence            89999999977654 8999999999999999999999998755444333 33332  223445678999999999998 9


Q ss_pred             CCCCC---CHHHHhcCcccccCCC
Q 022956          262 PRARP---SASELLKDPFFSELND  282 (289)
Q Consensus       262 p~~Rp---s~~~il~h~~~~~~~~  282 (289)
                      |++||   ++.+++.||||++..+
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCCCH
Confidence            99997   5799999999998644

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-47  Score=334.16  Aligned_cols=258  Identities=23%  Similarity=0.353  Sum_probs=209.7

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||+||++.++.+|+.||+|++...... .....+.+.+|+++++.++||||+++++.+.+  +..+|+||
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~   80 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYLIM   80 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEEEE
Confidence            6789999999999999999999999999999754321 23446678899999999999999999988854  36899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc--
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~--  177 (289)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.++|+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEEeeccccccccccccc
Confidence            99999999999988888999999999999999999999999  9999999999999988 899999999985321100  


Q ss_pred             ----------------------------------------------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHH
Q 022956          178 ----------------------------------------------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLC  210 (289)
Q Consensus       178 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~i  210 (289)
                                                                    ......|++.|+|||.+.+. ++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          00123588999999976544 8999999999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC-CCCCCChHHHHHHHHHHcCCCC---CCCHHHHhcCcccccCCCC
Q 022956          211 LLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDPEVKAFIEKCIAQPRA---RPSASELLKDPFFSELNDD  283 (289)
Q Consensus       211 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~dp~~---Rps~~~il~h~~~~~~~~~  283 (289)
                      +|+|++|..||..................... .....+..+++|+.+||++|.+   |+++.+++.||||++.+++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~  314 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWD  314 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999999875554443333322111111 1124678999999999986555   5699999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-47  Score=314.95  Aligned_cols=254  Identities=28%  Similarity=0.415  Sum_probs=215.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC---ee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN---TL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---~~   95 (289)
                      +.-.+++|+|+||.||+|+..++++.+|||++-.....        -.+|+++++.++|||||.+..+|.....+   +.
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            34568999999999999999999999999999765432        23489999999999999999888765444   66


Q ss_pred             EEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           96 NFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .+|+||++. +|...+..    +..++...+.-+++|++.||.|||+.|  ++||||||+|+|+|++.|.+||||||.|.
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcce
Confidence            779999987 89888874    577899999999999999999999999  99999999999999999999999999999


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC---------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---------  240 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------  240 (289)
                      ........-++..+.-|.|||.+.+-  |+.+.||||.||++.||+-|+.-|++.+..+++..++.-...|         
T Consensus       175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            98877777777888899999966543  9999999999999999999999999876666655443322111         


Q ss_pred             -----------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          241 -----------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       241 -----------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                       .......++++.+|+.++|+ +|.+|.++.|+|.||||+.+..+
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                             11334568899999999999 99999999999999999998665

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-46  Score=331.50  Aligned_cols=260  Identities=24%  Similarity=0.373  Sum_probs=212.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +.+.+.||+|+||+||+|.++.+++.||+|++...... .......+.+|+++++.++|+||+++++.+.+.  ..+++|
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv   79 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV   79 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEE
Confidence            36789999999999999999999999999999864432 234466789999999999999999999988544  679999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      |||++|++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.++|+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC-CCEEEeeCcCCcccccccc
Confidence            999999999999998888999999999999999999999999  9999999999999988 899999999875321000 


Q ss_pred             -----------------------------------------------ccccCCCCCCCCCCcccccC-CCCcchHHHHHH
Q 022956          178 -----------------------------------------------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGL  209 (289)
Q Consensus       178 -----------------------------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~  209 (289)
                                                                     ......|++.|+|||.+.+. ++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                           01234689999999976644 899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChHHHHHHHHHHc---CCCCCCCHHHHhcCcccccCCCCC
Q 022956          210 CLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKCIA---QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       210 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~---dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      ++|+|++|..||............+..... ........++++.+|+.+|+.   ++..|+++++++.||||++.+|..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~  315 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS  315 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence            999999999999876555444444332211 111223468899999999763   566699999999999999887643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.9e-46  Score=321.28  Aligned_cols=256  Identities=28%  Similarity=0.479  Sum_probs=212.8

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||++.+..+|..+|+|.+....   .......+.+|++++++++|||++++++.+...  +.+
T Consensus         5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   78 (331)
T cd06649           5 DDF-ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI   78 (331)
T ss_pred             ccc-eEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence            455 67899999999999999999999999999997542   345567899999999999999999999988654  579


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+. +  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  155 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI  155 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCC-CcEEEccCccccccc
Confidence            99999999999999999888899999999999999999999985 6  9999999999999988 899999999987654


Q ss_pred             CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-------------------
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-------------------  234 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------------------  234 (289)
                      .. ......+++.|+|||.+.+. ++.++|+|||||++|+|++|+.||....... ....+                   
T Consensus       156 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             cc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccc
Confidence            32 23345688999999977654 8999999999999999999999997543221 11111                   


Q ss_pred             ---------------------------hCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          235 ---------------------------TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       235 ---------------------------~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                                 .....+.......++.+++|+.+||+ ||++|||++++++||||+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                                       11111222233467899999999998 9999999999999999987654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.2e-48  Score=305.43  Aligned_cols=259  Identities=26%  Similarity=0.452  Sum_probs=224.1

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD   90 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   90 (289)
                      .+|+. .+.||.|..++|-++.++.+|..+|+|++......+.    .+..+.-.+|+.+|+++ .||+|+.+.++|  +
T Consensus        17 ~~y~p-keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--e   93 (411)
T KOG0599|consen   17 AKYEP-KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--E   93 (411)
T ss_pred             hhcCh-HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--c
Confidence            34543 7889999999999999999999999999988654332    34556678899999998 699999999999  4


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      ++.++++|+|.++.|.|+|++.+.-.+|+.....+++|+..|++|||.++  ++|+||||+|||++++ .+++|+|||++
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa  170 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFA  170 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEecccee
Confidence            45789999999999999999999888999999999999999999999999  9999999999999999 89999999999


Q ss_pred             cccCCccccccCCCCCCCCCCccccc-------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CC
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QA  242 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~  242 (289)
                      .......+....||||+|+|||.+..       +|+...|+|++|+|+|.++.|..||-...+...+..+..++..- ..
T Consensus       171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP  250 (411)
T ss_pred             eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence            99999989999999999999997653       37778999999999999999999998755555555555444221 12


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      -+...+...++||.+||+ ||.+|.|++++|+||||..+
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            244568889999999999 99999999999999999655

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-46  Score=318.78  Aligned_cols=253  Identities=21%  Similarity=0.324  Sum_probs=205.5

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +| ++.+.||+|+||+||++.++.+++.||+|+++....  .....+.+.+|+.+++.++||||+++++.+...  ..++
T Consensus         2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~   76 (287)
T cd07848           2 KF-EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLY   76 (287)
T ss_pred             Cc-eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEE
Confidence            44 689999999999999999999999999999986533  234456788899999999999999999887443  6899


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||||++++++..+......+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN-DVLKLCDFGFARNLSEG  153 (287)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccCccccccc
Confidence            99999999777766665667999999999999999999999999  9999999999999988 89999999999876432


Q ss_pred             c--ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--CCC------------
Q 022956          177 H--AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVK------------  239 (289)
Q Consensus       177 ~--~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~------------  239 (289)
                      .  ......+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||.+....+........  ..+            
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            2  1223467889999997654 4889999999999999999999999875543332221110  000            


Q ss_pred             ------CC---------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          240 ------PQ---------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       240 ------~~---------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                            +.         ......+..+.+|+.+||+ ||++|||++++|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                  00         0112357789999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.7e-47  Score=326.14  Aligned_cols=253  Identities=19%  Similarity=0.391  Sum_probs=210.1

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ++||+|+||.||+|.++.+++.||+|+++..... .....+.+.+|..++..+ +||||+++++.+...  +.+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~   77 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEF   77 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeC
Confidence            4699999999999999999999999999865432 334456788899999888 699999999887544  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc-CCccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~-~~~~~~~  180 (289)
                      +++++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++... .......
T Consensus        78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEECcCccccccccCCCccc
Confidence            999999999988888999999999999999999999999  9999999999999988 89999999998643 2222334


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC--------CcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC--------DSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ...+++.|+|||.+.+. ++.++|+|||||++|+|++|..||...        .......+.+....  ...+...++.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~  232 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA  232 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHH
Confidence            45789999999977654 889999999999999999999999631        11222333333332  22445678899


Q ss_pred             HHHHHHHHc-CCCCCCC------HHHHhcCcccccCCCC
Q 022956          252 KAFIEKCIA-QPRARPS------ASELLKDPFFSELNDD  283 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps------~~~il~h~~~~~~~~~  283 (289)
                      .+++.+||+ ||.+|++      ++++++||||.+.+|+
T Consensus       233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            999999998 9999987      7899999999988764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.3e-47  Score=325.09  Aligned_cols=252  Identities=23%  Similarity=0.396  Sum_probs=209.9

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.||+|+||+||+|.++.+++.||+|+++..... .....+.+..|..++..+ +|||++++++.+...  +.+++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey   77 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEF   77 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcC
Confidence            4699999999999999999999999999864322 223355667788888776 699999999887443  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Cccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~~~~~  180 (289)
                      +++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.... ......
T Consensus        78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCccc
Confidence            999999999998888999999999999999999999999  9999999999999998 899999999987542 222333


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ...+++.|+|||.+.+. +++++|+|||||++|+|++|+.||....... ....+....  ...+...++.+++++.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~~--~~~~~~~~~~~~~li~~~L  231 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDE--VVYPTWLSQDAVDILKAFM  231 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCC--CCCCCCCCHHHHHHHHHHc
Confidence            45689999999977654 8899999999999999999999998755443 344444332  2234457899999999999


Q ss_pred             c-CCCCCCCH------HHHhcCcccccCCCC
Q 022956          260 A-QPRARPSA------SELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rps~------~~il~h~~~~~~~~~  283 (289)
                      + ||++||++      ++++.||||++++|.
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence            8 99999998      999999999998763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-46  Score=332.17  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=213.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.++||+|+||+||+|.++.+++.||+|++...... .......+.+|+++++.++|+||+++++.+.+.  +.+++||
T Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv~   80 (382)
T cd05625           4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFVM   80 (382)
T ss_pred             EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEEE
Confidence            5789999999999999999999999999999754321 234466788999999999999999999988554  6899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc---
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---  176 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~---  176 (289)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.++|+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEeECCCCccccccccc
Confidence            99999999999988788999999999999999999999999  9999999999999988 89999999997432100   


Q ss_pred             ---------------------------------------------cccccCCCCCCCCCCccccc-CCCCcchHHHHHHH
Q 022956          177 ---------------------------------------------HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLC  210 (289)
Q Consensus       177 ---------------------------------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~i  210 (289)
                                                                   .......|++.|+|||.+.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         00112468899999997654 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCChHHHHHHHHHHcCCCCCCC---HHHHhcCcccccCCCCC
Q 022956          211 LLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKAFIEKCIAQPRARPS---ASELLKDPFFSELNDDD  284 (289)
Q Consensus       211 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~dp~~Rps---~~~il~h~~~~~~~~~~  284 (289)
                      +|+|++|..||............+....... ......++++.+++.+|+.+|++|++   +++++.||||+..++..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~  315 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSS  315 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence            9999999999987665554444443222211 12244688999999998789999987   99999999999987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=333.92  Aligned_cols=255  Identities=26%  Similarity=0.427  Sum_probs=220.7

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.++||.|+||+|+++..+.+++.||||+++.....+ .+..+....|.+++.... ||.++.++..|.+.  .++++|
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~l~fv  447 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EHLFFV  447 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC--CeEEEE
Confidence            67899999999999999999999999999999877543 344677788888888775 99999999999554  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc-CCcc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~-~~~~  177 (289)
                      |||+.||++..+. +.+.+++..+..++..++.||+|||++|  |++||||.+|||+|.+ |.+||+|||+++.. ....
T Consensus       448 mey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  448 MEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-CcEEecccccccccCCCCC
Confidence            9999999954433 3467999999999999999999999999  9999999999999999 99999999999765 3666


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      .+.+.||||.|+|||++.+. |+.+.|.||||++||+|+.|+.||.+.+.++..-+++...   ..++...+.+...+++
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~---~~yP~~ls~ea~~il~  600 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE---VRYPRFLSKEAIAIMR  600 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCcccHHHHHHHH
Confidence            78889999999999988766 9999999999999999999999999855555544444433   3466778999999999


Q ss_pred             HHHc-CCCCCCC-----HHHHhcCcccccCCCCC
Q 022956          257 KCIA-QPRARPS-----ASELLKDPFFSELNDDD  284 (289)
Q Consensus       257 ~~l~-dp~~Rps-----~~~il~h~~~~~~~~~~  284 (289)
                      ++|. +|++|..     +++|..||||+.++|+.
T Consensus       601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             HHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence            9998 9999963     69999999999999863

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=328.05  Aligned_cols=259  Identities=29%  Similarity=0.529  Sum_probs=227.9

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .+.+...|.+ .+.||.|+||.||+|.+..+++.||+|++....   .+..++.+.+|+.+|..++++||.+.++.|+..
T Consensus         8 ~~~~~~~~~~-~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g   83 (467)
T KOG0201|consen    8 KIDPELLYTK-LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG   83 (467)
T ss_pred             cCCccccccc-chhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence            4456667754 699999999999999999999999999998765   456688899999999999999999999999776


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ..++++||||.||++.+.++.+..+.+..+..++++++.|+.|||..+  .+|+|||+.||++..+ |.+||+|||.+
T Consensus        84 --~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa  158 (467)
T KOG0201|consen   84 --TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVA  158 (467)
T ss_pred             --ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEeccee
Confidence              579999999999999999999887899999999999999999999999  9999999999999999 99999999999


Q ss_pred             cccCCccc-cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          171 AIVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       171 ~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      .+...... .....|||-|||||+..+ .|+.++||||||++.+||++|..|+....+....+.+ .+..+| ......+
T Consensus       159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP-~L~~~~S  236 (467)
T KOG0201|consen  159 GQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPP-RLDGDFS  236 (467)
T ss_pred             eeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCC-ccccccC
Confidence            88765433 367889999999997766 5999999999999999999999999987775554443 343333 3344779


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +.+++|++.||+ ||+.||++.++|+|+|++..
T Consensus       237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  237 PPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            999999999998 99999999999999999983

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-46  Score=323.90  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             eeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++||+|+||.||++.+.   .+++.||+|+++.............+.+|+.+++.++||||+++++.+...  +.+++||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence            67999999999999863   468999999998654333334456678899999999999999999887544  6799999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~  178 (289)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++..... ...
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCc
Confidence            99999999999998888999999999999999999999999  9999999999999988 8999999999865432 222


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||............ ..+.  ...+...++.+.+++.+
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~li~~  233 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-LKGK--LNLPPYLTPEARDLLKK  233 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCC--CCCCCCCCHHHHHHHHH
Confidence            3345689999999977654 888999999999999999999999875554443333 3332  22345568899999999


Q ss_pred             HHc-CCCCCC-----CHHHHhcCcccccCCC
Q 022956          258 CIA-QPRARP-----SASELLKDPFFSELND  282 (289)
Q Consensus       258 ~l~-dp~~Rp-----s~~~il~h~~~~~~~~  282 (289)
                      ||+ ||++||     ++++++.||||+...+
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            998 999999     8999999999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-46  Score=324.34  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=205.5

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      +.||+|+||+||+|.++.+|+.||+|++..............+.++..+++.++||||+++++.+...  +.+++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcCC
Confidence            46999999999999999999999999997654322222222333334456889999999999887543  6899999999


Q ss_pred             cCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-cccccc
Q 022956          103 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS  181 (289)
Q Consensus       103 ~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~~  181 (289)
                      .+++|..++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..... ......
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCcccc
Confidence            99999999998888999999999999999999999999  9999999999999988 8999999999875422 222334


Q ss_pred             CCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc
Q 022956          182 IIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA  260 (289)
Q Consensus       182 ~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  260 (289)
                      ..+++.|+|||.+.+. ++.++|+|||||++|+|++|..||....... ....+....  .......++.+.+++.+||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~--~~~~~~~~~~~~~li~~~l~  232 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-MYDNILNKP--LRLKPNISVSARHLLEGLLQ  232 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-HHHHHHcCC--CCCCCCCCHHHHHHHHHHhh
Confidence            5689999999977654 8899999999999999999999998754443 333333322  22344568999999999998


Q ss_pred             -CCCCCCCH----HHHhcCcccccCCC
Q 022956          261 -QPRARPSA----SELLKDPFFSELND  282 (289)
Q Consensus       261 -dp~~Rps~----~~il~h~~~~~~~~  282 (289)
                       ||.+||++    .+++.||||+..+|
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence             99999987    69999999998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.5e-47  Score=332.38  Aligned_cols=258  Identities=21%  Similarity=0.342  Sum_probs=211.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||.||+|.++.+++.||+|++...... .......+.+|+++++.++|+||+++++.+..  ++.+++||
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~   80 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFVM   80 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEEE
Confidence            6899999999999999999999999999999754321 12235668889999999999999999988854  36899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc---
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---  176 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~---  176 (289)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++......   
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC-CCEEEEeCCCCccccccccc
Confidence            99999999999998888999999999999999999999999  9999999999999988 89999999997432100   


Q ss_pred             -----------------------------------------cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHH
Q 022956          177 -----------------------------------------HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEM  214 (289)
Q Consensus       177 -----------------------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l  214 (289)
                                                               .......|++.|+|||.+.+. ++.++|||||||++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                     001124689999999977654 89999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChHHHHHHHHHHcCCCCCC---CHHHHhcCcccccCCCC
Q 022956          215 VTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKCIAQPRARP---SASELLKDPFFSELNDD  283 (289)
Q Consensus       215 ~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~dp~~Rp---s~~~il~h~~~~~~~~~  283 (289)
                      ++|..||.+................ ........++.+.+++.+|+.+|.+|+   ++.+++.||||+.+++.
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~  310 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFA  310 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence            9999999876554444333322211 111223468899999999878999999   99999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=305.82  Aligned_cols=256  Identities=22%  Similarity=0.304  Sum_probs=216.3

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ....|++|+||.||+|+++.|++.||+|.++....  .+.+--.-.+|+.+|.+++|||||.+-.+.+..+-+.+|+|||
T Consensus        80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe  157 (419)
T KOG0663|consen   80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME  157 (419)
T ss_pred             HHhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence            46789999999999999999999999999998653  3334445678999999999999999999998877788999999


Q ss_pred             cccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          101 VCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      ||+. .|..++.+.+ +++..++..++.|++.|++|||.+.  ++|||||++|+|++.. |.+|++|||+|+.++.+...
T Consensus       158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccC-CcEEecccchhhhhcCCccc
Confidence            9988 8999998754 8999999999999999999999999  9999999999999988 99999999999999877554


Q ss_pred             -ccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CCCCCC-----------
Q 022956          180 -HSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQAL-----------  243 (289)
Q Consensus       180 -~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~-----------  243 (289)
                       ...+-|..|.|||++-+.  |+.+.|+||+|||+.+++++...|++....+++..+..--  +....+           
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence             345679999999966543  9999999999999999999999999877666655433221  110000           


Q ss_pred             ---------------CC-CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          244 ---------------NK-VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       244 ---------------~~-~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                     .. ..++...+|+..+|. ||.+|.|++|.|.|.||.+...
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence                           00 134677899999999 9999999999999999998543

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.2e-46  Score=333.79  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=206.9

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC----
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   90 (289)
                      ..+| ++.++||+|+||.||+|.+..+++.||+|++....        ....+|+.+++.++|||++++++++...    
T Consensus        65 ~~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         65 NKSY-KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CCeE-EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            3444 78999999999999999999999999999886431        2234699999999999999998876432    


Q ss_pred             --CCCeeEEEeccccCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           91 --QHNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        91 --~~~~~~lv~e~~~~~sL~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                        ...++++||||+++ +|.+++.    ....+++..+..++.|++.||.|||++|  ++||||||+||+++.+.+.+||
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceee
Confidence              22357899999986 7776664    3567999999999999999999999999  9999999999999977457999


Q ss_pred             eccCCccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--
Q 022956          165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--  240 (289)
Q Consensus       165 ~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--  240 (289)
                      +|||++.............+++.|+|||.+.+  .++.++|||||||++|+|++|..||.+....+.....+.....+  
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999987655444445678899999997654  48999999999999999999999998765555444433211000  


Q ss_pred             ------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          241 ------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       241 ------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                              ...+...++++.+||.+||+ ||.+|||+.|+|+||||+.+...
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence                                    01123357889999999998 99999999999999999987653

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.5e-46  Score=323.75  Aligned_cols=260  Identities=27%  Similarity=0.366  Sum_probs=207.3

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..++| ++.+.||+|+||.||++.+..+|..||+|++.....  .......+.+|+.+++.++||||+++++++....  
T Consensus        19 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          19 VLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            34666 679999999999999999999999999999975432  3344567788999999999999999999875432  


Q ss_pred             --CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 --~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ...+++||||+.+ +|.+.+.  ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~-~~~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEecCCC
Confidence              1357999999977 6666654  34889999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC---------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK---------  239 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------  239 (289)
                      +.............+++.|+|||.+.+. ++.++|||||||++|+|++|..||.+.+........+.....         
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            9765444344455788999999977654 899999999999999999999999875543322211111000         


Q ss_pred             ------------------------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          240 ------------------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       240 ------------------------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                                    ........++.+++|+.+||. ||++|||+.|+|.||||..+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence                                          000112235788999999999 9999999999999999987543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.7e-47  Score=325.69  Aligned_cols=252  Identities=23%  Similarity=0.421  Sum_probs=210.5

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      +.||+|+||.||++.+..+|..||+|+++..... .......+.+|+++++.++||||+.+.+.+...  ..+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            4699999999999999999999999999864332 233456678899999999999999999877443  6899999999


Q ss_pred             cCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Cccccc
Q 022956          103 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH  180 (289)
Q Consensus       103 ~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~~~~~  180 (289)
                      ++++|..++.....+++..+..++.|++.||.|||+ .|  ++|+||||+||+++.+ +.++|+|||++.... ......
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccc
Confidence            999999999888889999999999999999999997 78  9999999999999988 899999999987543 222233


Q ss_pred             cCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ...+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+...... ...+....  ...+...++.+.+++.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-~~~i~~~~--~~~p~~~~~~~~~li~~~L  231 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILMEE--IRFPRTLSPEAKSLLSGLL  231 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-HHHHhcCC--CCCCCCCCHHHHHHHHHHh
Confidence            4568999999997764 489999999999999999999999987554333 33333222  2234557899999999999


Q ss_pred             c-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          260 A-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      + ||++|+     ++.++++||||++..|.
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            8 999996     99999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-46  Score=311.75  Aligned_cols=258  Identities=25%  Similarity=0.413  Sum_probs=224.7

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .++.+.||+|.-|+||++....++..+|+|++....... .....+...|.++|+.++||-++.++..+  +..++.|++
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~  155 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLV  155 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEE
Confidence            467899999999999999999999999999998766542 44577889999999999999999999998  444799999


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-  175 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-  175 (289)
                      ||||+||+|..++++  ++.+++..+..++.+++-||+|||..|  ++.|||||+|||+.++ |++.|+||+++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred-GHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED-GHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC-CcEEeeeccccccCCCC
Confidence            999999999999986  468999999999999999999999999  9999999999999999 9999999999754310 


Q ss_pred             --------------------------------c-c-----------------------ccccCCCCCCCCCCcccccC-C
Q 022956          176 --------------------------------S-H-----------------------AAHSIIGTPEYMAPELYEED-Y  198 (289)
Q Consensus       176 --------------------------------~-~-----------------------~~~~~~~~~~~~aPE~~~~~-~  198 (289)
                                                      . .                       .+.+.+||-.|+|||+..+. .
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                       01124578899999988876 9


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCC----HHHHhc
Q 022956          199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPS----ASELLK  273 (289)
Q Consensus       199 ~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps----~~~il~  273 (289)
                      ..+.|.|.||+++|||+.|..||.+......+.+++.+...-...+ ..+..+++||+++|. ||++|..    +.+|-+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            9999999999999999999999999888888888887754433322 467899999999997 9999998    999999


Q ss_pred             CcccccCCCC
Q 022956          274 DPFFSELNDD  283 (289)
Q Consensus       274 h~~~~~~~~~  283 (289)
                      ||||++++|+
T Consensus       392 HpFF~gVnWa  401 (459)
T KOG0610|consen  392 HPFFEGVNWA  401 (459)
T ss_pred             CccccCCChh
Confidence            9999999997

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.9e-47  Score=326.66  Aligned_cols=259  Identities=20%  Similarity=0.301  Sum_probs=214.9

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||+||++.++.+|+.||+|+++..... .......+.+|+.+++.++|++++++++.+...  +.+++||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~lv~   80 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLVM   80 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEEEE
Confidence            6899999999999999999999999999999865321 234466788999999999999999999877443  6799999


Q ss_pred             ccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT-GHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC-CCEEeccCCCCeECCCCCc
Confidence            999999999999875 67999999999999999999999999  9999999999999988 8999999999976643322


Q ss_pred             --cccCCCCCCCCCCcccc-------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC-CCCCCC
Q 022956          179 --AHSIIGTPEYMAPELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKD  248 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  248 (289)
                        .....+++.|+|||.+.       ..++.++|||||||++|+|++|..||..................... .....+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence              22346889999999764       23778999999999999999999999875555444443332211111 122468


Q ss_pred             hHHHHHHHHHHcCCCCCCCHHHHhcCcccccCCCCC
Q 022956          249 PEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       249 ~~~~~li~~~l~dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +.+.+|+.+||++|.+||++++++.||||+.+++..
T Consensus       238 ~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         238 SDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             HHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHH
Confidence            899999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.9e-46  Score=323.42  Aligned_cols=257  Identities=23%  Similarity=0.390  Sum_probs=211.4

Q ss_pred             cceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCe
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   94 (289)
                      |++.++||+|+||.||++.+.   .++..||+|++............+.+.+|+.+++.++ |++++.+++.+..  .+.
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~   79 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EAK   79 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CCE
Confidence            367899999999999998764   4789999999986544334455677889999999994 8999999887744  367


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++....
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~  156 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-GHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence            9999999999999999988888999999999999999999999999  9999999999999998 899999999987653


Q ss_pred             Cc--cccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHhCCCCCCCCCCCC
Q 022956          175 RS--HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSEC---DSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       175 ~~--~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      ..  .......+++.|+|||.+.+.  ++.++|||||||++|+|++|..||...   .........+....  ...+...
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  234 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFI  234 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCC
Confidence            22  223345689999999977643  788999999999999999999999642   22233333333322  2234457


Q ss_pred             ChHHHHHHHHHHc-CCCCCC-----CHHHHhcCcccccCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARP-----SASELLKDPFFSELND  282 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~  282 (289)
                      ++.+++++.+||+ ||++||     +++++++||||++.++
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            8999999999998 999999     8899999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.5e-46  Score=322.31  Aligned_cols=253  Identities=22%  Similarity=0.334  Sum_probs=210.8

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ++||+|+||.||+|.++.+++.||+|+++..... .....+.+..|.+++..+ +||+|+++++.+...  +.+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~   77 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEY   77 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeC
Confidence            4699999999999999999999999999864332 233455677788888766 799999999988544  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~  180 (289)
                      +++++|.+.+...+.+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..... .....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeecccceecccCCcccc
Confidence            999999999988888999999999999999999999999  9999999999999998 8999999999875432 22233


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ...+++.|+|||.+.+. +++++|+|||||++|+|++|..||.................   ..+...++.+.+++.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~ll~~~L  231 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---LYPVWLSKEAVSILKAFM  231 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHHh
Confidence            45689999999977654 89999999999999999999999987555444444333222   234456889999999999


Q ss_pred             c-CCCCCC-------CHHHHhcCcccccCCCCC
Q 022956          260 A-QPRARP-------SASELLKDPFFSELNDDD  284 (289)
Q Consensus       260 ~-dp~~Rp-------s~~~il~h~~~~~~~~~~  284 (289)
                      + ||++||       +++++++||||.+.+|..
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~  264 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL  264 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence            8 999999       999999999999887653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-46  Score=329.41  Aligned_cols=258  Identities=21%  Similarity=0.369  Sum_probs=212.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||+||+|.++.+++.||+|+++..... .......+.+|+.++..++|++++++++.+.+.  +.+++||
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~   80 (360)
T cd05627           4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYLIM   80 (360)
T ss_pred             eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEE
Confidence            6789999999999999999999999999999754321 233466788899999999999999999887543  6899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc--
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~--  177 (289)
                      ||++|++|.+++.+.+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEeeccCCccccccccc
Confidence            99999999999998888999999999999999999999999  9999999999999988 899999999986442110  


Q ss_pred             ----------------------------------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCC
Q 022956          178 ----------------------------------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYS  222 (289)
Q Consensus       178 ----------------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~  222 (289)
                                                        .....+|++.|+|||.+.+. ++.++|+|||||++|+|++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                              01134689999999976654 8999999999999999999999998


Q ss_pred             CCCcHHHHHHHHhCCCCCCC-CCCCCChHHHHHHHHHHcCCCCCC---CHHHHhcCcccccCCCC
Q 022956          223 ECDSVAKIYKKVTGGVKPQA-LNKVKDPEVKAFIEKCIAQPRARP---SASELLKDPFFSELNDD  283 (289)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~dp~~Rp---s~~~il~h~~~~~~~~~  283 (289)
                      .................... .....++.+++|+.+|+.||.+|+   +++++++||||++.+|.
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            76554444433322111111 122368899999999877999997   58999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.3e-46  Score=314.37  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=202.9

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.++.++..||+|+++.....   .....+.+|+.+++.++||||+++++.+...  ...
T Consensus         5 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~   78 (288)
T cd07871           5 ETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCL   78 (288)
T ss_pred             ccc-eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC---CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeE
Confidence            345 6789999999999999999999999999999754321   2234567899999999999999999987543  578


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++|+||+++ +|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++....
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEECcCcceeecc
Confidence            999999986 898888654 45799999999999999999999999  9999999999999988 899999999987654


Q ss_pred             Ccc-ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC--C----------
Q 022956          175 RSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--K----------  239 (289)
Q Consensus       175 ~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~----------  239 (289)
                      ... ......+++.|+|||.+.+  .++.++|+|||||++|+|++|+.||.+....+..........  .          
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            322 2233467889999997654  378999999999999999999999987554433322211100  0          


Q ss_pred             --------C-------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          240 --------P-------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       240 --------~-------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                              +       .......++.+.+|+.+||+ ||.+|||++|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                    0       00112357789999999999 99999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=318.46  Aligned_cols=257  Identities=23%  Similarity=0.419  Sum_probs=210.5

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCH----------HHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP----------VLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      .+.+.||+|.||.|-+|.+..+++.||||++....+....          ...+..++|+.+++++.|||||+++++.-+
T Consensus       100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD  179 (576)
T KOG0585|consen  100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD  179 (576)
T ss_pred             ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence            5788999999999999999999999999999876543211          124689999999999999999999998877


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      ...+.+|+|+|||..|.+...-....-+++.+++++++.++.||+|||.+|  ++||||||+|+|++.+ |.+||+|||.
T Consensus       180 P~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g~VKIsDFGV  256 (576)
T KOG0585|consen  180 PESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-GTVKISDFGV  256 (576)
T ss_pred             cccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-CcEEeeccce
Confidence            777899999999998876554443333999999999999999999999999  9999999999999999 9999999999


Q ss_pred             ccccCCc------cccccCCCCCCCCCCcccccC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC
Q 022956          170 AAIVGRS------HAAHSIIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       170 ~~~~~~~------~~~~~~~~~~~~~aPE~~~~~-----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      +......      .......|||.|+|||...++     .+.+.||||||++||+|+.|+.||-+.... .....+....
T Consensus       257 s~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-~l~~KIvn~p  335 (576)
T KOG0585|consen  257 SNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-ELFDKIVNDP  335 (576)
T ss_pred             eeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-HHHHHHhcCc
Confidence            9876332      223346899999999965431     466899999999999999999999874433 3344333332


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .......-..+.+++||.+||. ||++|+++.+|..|||...-
T Consensus       336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            2211122257899999999998 99999999999999999875

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.1e-46  Score=319.93  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=209.7

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.||+|+||+||+|.++.++..||+|+++..... .......+..|..+++.+ +|||++++++.+...  +.+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~   77 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEY   77 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence            4699999999999999999999999999865322 233355677888888887 699999999987543  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Cccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~~~~~  180 (289)
                      ++|++|..++.....+++.++..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.... ......
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccc
Confidence            999999999988888999999999999999999999999  9999999999999998 899999999986532 222233


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ..++++.|+|||.+.+. ++.++|+|||||++|+|++|..||....... ....+.....  ..+...++.+.+|+.+||
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-~~~~i~~~~~--~~~~~~~~~~~~li~~~l  231 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-LFQSILEDEV--RYPRWLSKEAKSILKSFL  231 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence            45688999999977654 8999999999999999999999998755443 3333333221  234457899999999999


Q ss_pred             c-CCCCCCCH-----HHHhcCcccccCCC
Q 022956          260 A-QPRARPSA-----SELLKDPFFSELND  282 (289)
Q Consensus       260 ~-dp~~Rps~-----~~il~h~~~~~~~~  282 (289)
                      . ||++||++     .+++.||||++.+|
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            8 99999999     99999999999876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.7e-47  Score=313.87  Aligned_cols=256  Identities=21%  Similarity=0.437  Sum_probs=223.6

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      ..|.+.+.||.|.||+|-+|.....|..||||.++..... ++...-.+.+|+++++.|+||||++++.+|  +..+.+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIv  129 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIV  129 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEE
Confidence            3457889999999999999999889999999999887654 455577799999999999999999999999  4446899


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||||..+|.|.+++...+.|++.++..+++||++|+.|+|+++  ++|+|||.+|||+|.| +++||+|||++..+...
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhhccc
Confidence            99999999999999999999999999999999999999999999  9999999999999999 99999999999999888


Q ss_pred             cccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      +.....||+|-|.+||+..+.  -.|..|.||||+++|.|+.|.+||++.+ ...+..++..+...   ....+..+.-|
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-hk~lvrQIs~GaYr---EP~~PSdA~gL  282 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-HKRLVRQISRGAYR---EPETPSDASGL  282 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-HHHHHHHhhccccc---CCCCCchHHHH
Confidence            888899999999999988876  4677999999999999999999999854 44555555554322   12235678999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          255 IEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      |+.||- +|++|.|+++|-.|=|+ +|..+
T Consensus       283 IRwmLmVNP~RRATieDiAsHWWv-Nwgy~  311 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASHWWV-NWGYN  311 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhhhee-ecccc
Confidence            999998 99999999999988554 44433

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.5e-46  Score=324.98  Aligned_cols=258  Identities=19%  Similarity=0.289  Sum_probs=211.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||.||++.++.++..||+|++...... .......+.+|+.+++.++|||++++++.+.+.  +.+++|
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~~~lv  121 (370)
T cd05596          45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--KYLYMV  121 (370)
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEEEEE
Confidence            36789999999999999999999999999999754321 122345577899999999999999999887543  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      |||++|++|.+++... .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus       122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC-CCEEEEeccceeeccCCCc
Confidence            9999999999998764 5899999999999999999999999  9999999999999988 899999999997654332 


Q ss_pred             -ccccCCCCCCCCCCccccc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC-CCCCChH
Q 022956          178 -AAHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVKDPE  250 (289)
Q Consensus       178 -~~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  250 (289)
                       ......+++.|+|||.+.+     .++.++|+|||||++|+|++|..||...................... ....+..
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ  277 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence             2234568999999997643     27889999999999999999999998755544444433322221111 1246889


Q ss_pred             HHHHHHHHHc-CCCC--CCCHHHHhcCcccccCCCC
Q 022956          251 VKAFIEKCIA-QPRA--RPSASELLKDPFFSELNDD  283 (289)
Q Consensus       251 ~~~li~~~l~-dp~~--Rps~~~il~h~~~~~~~~~  283 (289)
                      +++|+.+||+ +|++  |+++++++.||||++.+|.
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence            9999999998 8887  9999999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-45  Score=317.98  Aligned_cols=255  Identities=21%  Similarity=0.306  Sum_probs=210.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc-eEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY-IIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.+.||+|+||.||+|.++.+++.||+|++...... .....+.+..|..++..+.|++ ++.+++.+...  +.+++|
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv   79 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFV   79 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEEE
Confidence            6789999999999999999999999999999864332 2334567788999999998754 66777666433  579999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Ccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~~  177 (289)
                      |||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.... ...
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCC
Confidence            999999999999988888999999999999999999999999  9999999999999988 899999999986432 222


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ......+++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+.......... ....  ...+...++.+.+++.
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i-~~~~--~~~~~~~~~~~~~li~  233 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI-MEHN--VSYPKSLSKEAVSICK  233 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCC--CCCCCCCCHHHHHHHH
Confidence            23345689999999977654 889999999999999999999999875544444333 3322  2234557889999999


Q ss_pred             HHHc-CCCCCCCH-----HHHhcCcccccCCCC
Q 022956          257 KCIA-QPRARPSA-----SELLKDPFFSELNDD  283 (289)
Q Consensus       257 ~~l~-dp~~Rps~-----~~il~h~~~~~~~~~  283 (289)
                      +||. ||.+|++.     +++++||||+..+|.
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9998 99999976     899999999988763

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.6e-46  Score=318.57  Aligned_cols=252  Identities=23%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh-CCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT-LKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ++||+|+||.||+|.+..+++.||+|+++..... .....+.+..|..++.. .+||||+++++.+...  ..+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~   77 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEY   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence            4699999999999999999999999999864322 12234445556666654 4899999999887443  689999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~  180 (289)
                      ++|++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..... .....
T Consensus        78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccc
Confidence            999999999988888999999999999999999999999  9999999999999988 8999999999975432 22334


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ..++++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+..... ....+....  ...+...+..+.+++.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~--~~~~~~~~~~~~~ll~~~l  231 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDSILNDR--PHFPRWISKEAKDCLSKLF  231 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence            45789999999977654 8899999999999999999999998755443 333333322  2234557889999999999


Q ss_pred             c-CCCCCCCH-HHHhcCcccccCCCC
Q 022956          260 A-QPRARPSA-SELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rps~-~~il~h~~~~~~~~~  283 (289)
                      . ||++||++ .+++.||||+..+|.
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGIDWE  257 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCCCHH
Confidence            8 99999986 588899999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.4e-46  Score=320.30  Aligned_cols=253  Identities=20%  Similarity=0.394  Sum_probs=209.0

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.||+|+||+||+|.++.+++.||+|+++..... .......+.+|..++.++ +||||+++++.+...  +.+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~   77 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEY   77 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeC
Confidence            4699999999999999999999999999865432 334456678888888776 799999999987554  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~  180 (289)
                      +++++|..++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++..... .....
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccc
Confidence            999999999988888999999999999999999999999  9999999999999998 8999999999875322 22233


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC--------CcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC--------DSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ...+++.|+|||.+.+. ++.++|+|||||++|+|++|..||...        .......+.+....  ...+...+..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~  232 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA  232 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHH
Confidence            45689999999977654 889999999999999999999999521        11222333333322  22455678899


Q ss_pred             HHHHHHHHc-CCCCCCC------HHHHhcCcccccCCCC
Q 022956          252 KAFIEKCIA-QPRARPS------ASELLKDPFFSELNDD  283 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps------~~~il~h~~~~~~~~~  283 (289)
                      .+++.+||+ ||++||+      +++++.||||++.+|.
T Consensus       233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~  271 (329)
T cd05618         233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  271 (329)
T ss_pred             HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            999999998 9999998      5899999999998763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-45  Score=317.14  Aligned_cols=257  Identities=28%  Similarity=0.476  Sum_probs=210.9

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||.||++.+..++..+|+|.+....   .......+.+|+++++.++|+||+++++++...  +.+
T Consensus         5 ~~y-~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   78 (333)
T cd06650           5 DDF-EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI   78 (333)
T ss_pred             hhh-heeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEE
Confidence            455 68999999999999999999999999999987542   344567789999999999999999999988654  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+.+++|.+++...+.+++..+..++.|++.||.|||+. +  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~  155 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCC-CCEEEeeCCcchhhh
Confidence            99999999999999999888899999999999999999999974 7  9999999999999988 899999999987553


Q ss_pred             CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH-----------------------
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI-----------------------  230 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~-----------------------  230 (289)
                      .. ......++..|+|||.+.+. ++.++|+|||||++|+|++|..||.........                       
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             hh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence            32 22334678899999977654 889999999999999999999999753321111                       


Q ss_pred             --------------------HHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          231 --------------------YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       231 --------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                          ...+.....+.......+.++++|+.+||+ ||++||++++++.||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence                                011111111122222356789999999998 9999999999999999988643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.4e-46  Score=319.12  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=208.4

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH---HhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL---RTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      |++.++||+|+||.||+|.++.+|+.||+|+++..... .....+.+.+|.+++   +.++||||+++++.+...  +.+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHV   77 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEE
Confidence            36789999999999999999999999999999864321 222345566665554   567899999999987543  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |+||||+++++|...+.. ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.+||+|||++.....
T Consensus        78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMG  153 (324)
T ss_pred             EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CcEEeCcccCCccCCC
Confidence            999999999999988865 56999999999999999999999999  9999999999999998 8999999999865422


Q ss_pred             -ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 -SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 -~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                       ........+++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+...............   ..+...++.+.+
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~  230 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSREAIS  230 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHHHH
Confidence             2223345689999999977654 88899999999999999999999987554444333333322   234456899999


Q ss_pred             HHHHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          254 FIEKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       254 li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      ++.+||+ ||++||     ++.++++||||+++++.
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence            9999998 999999     79999999999987644

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.2e-45  Score=321.77  Aligned_cols=259  Identities=26%  Similarity=0.361  Sum_probs=209.1

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC----
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   90 (289)
                      .++| ++.++||+|+||.||++.+..+++.||+|++.....  .......+.+|+.+++.++|||++++++++...    
T Consensus        23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          23 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            4566 679999999999999999999999999999975432  334456778899999999999999999877532    


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      ....+++||||+++ +|.+.+..  .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a  173 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA  173 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC-CcEEEEeCCCc
Confidence            22468999999976 77777753  4888999999999999999999999  9999999999999998 89999999999


Q ss_pred             cccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC---------
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---------  240 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------  240 (289)
                      .............+++.|+|||.+.+. ++.++|||||||++|+|++|+.||.+.+........+.....+         
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            876554444556789999999977654 8999999999999999999999998766544433332211100         


Q ss_pred             ------------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          241 ------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       241 ------------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                                    .......++.+++||.+||+ ||++|||++++|+||||..+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~  326 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  326 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence                                          00111234678999999999 9999999999999999987533

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-45  Score=312.37  Aligned_cols=257  Identities=21%  Similarity=0.337  Sum_probs=211.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||+||++.+..+++.||+|++...... .......+.+|+.+++.++||+++++++.+...  +.+++|
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv   78 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV   78 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence            36789999999999999999999999999999764332 222345577899999999999999999887443  679999


Q ss_pred             eccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC-CCEEEeeCCCceecCCC
Confidence            9999999999887643  46899999999999999999999999  9999999999999988 89999999998776444


Q ss_pred             cccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK---IYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      .......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+......   ....+...  ....+...++.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  233 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAAR  233 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHH
Confidence            33344568899999997654 488899999999999999999999987543222   22222221  2223445788999


Q ss_pred             HHHHHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          253 AFIEKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       253 ~li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      +|+.+||. ||++||     ++++++.||||++.+++
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence            99999998 999999     89999999999987665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-46  Score=322.09  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=209.7

Q ss_pred             eeecccCcceEEEEee---cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      +.||+|+||.||++.+   ..+|+.||+|+++....  .......+.+|++++++++||||+++++.+...  ..+|+||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~   77 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL   77 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence            6799999999999876   35789999999986543  222345677899999999999999999887543  6799999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-cc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-~~  178 (289)
                      ||+++++|.+++.+...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCc
Confidence            99999999999988888999999999999999999999999  9999999999999988 89999999998765433 23


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      .....+++.|+|||.+.+. ++.++|+|||||++|+|++|+.||.................   ..+...++.+.+|+.+
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~  231 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---GMPQFLSPEAQSLLRA  231 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHH
Confidence            3445789999999977654 88899999999999999999999987655444443333221   2344568999999999


Q ss_pred             HHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          258 CIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       258 ~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      ||+ ||++||+     +++++.||||+..+|.
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence            998 9999999     7889999999987653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-45  Score=317.65  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=207.2

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh-CCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT-LKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ++||+|+||.||+|.++.+|+.||+|+++...... ......+..|..++.. ++||+++++++.+...  +.+++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~   77 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEF   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECC
Confidence            46999999999999999999999999998643211 1224455667777765 4899999999888544  689999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~  180 (289)
                      +.+++|..++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..... .....
T Consensus        78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCcee
Confidence            999999999988888999999999999999999999999  9999999999999988 8999999999864322 22233


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ...+++.|+|||.+.+. ++.++|+|||||++|+|++|..||..... ....+.+....  ...+...+..+++|+.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l  231 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVDT--PHYPRWITKESKDILEKLF  231 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence            45689999999977654 89999999999999999999999986544 33444443322  2234457889999999999


Q ss_pred             c-CCCCCCCH-HHHhcCcccccCCCC
Q 022956          260 A-QPRARPSA-SELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rps~-~~il~h~~~~~~~~~  283 (289)
                      + ||++||++ ++++.||||++.++.
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCCCHH
Confidence            8 99999998 589999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.4e-45  Score=320.49  Aligned_cols=259  Identities=27%  Similarity=0.359  Sum_probs=208.4

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..++| ++.+.||+|+||.||++.+..+++.+|+|.+.....  .......+.+|+.+++.++||||+++++++....  
T Consensus        15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          15 VLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            34666 679999999999999999999999999999875432  3444567888999999999999999999875432  


Q ss_pred             --CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 --~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ...+++||||+++ +|.+.+..  .+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~-~~~kl~Dfg~  165 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL  165 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC-CCEEEeeCcc
Confidence              2457999999977 67776653  4889999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC---------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK---------  239 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------  239 (289)
                      +.............+++.|+|||.+.+. ++.++|+|||||++++|++|..||.+..........+.....         
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            9876555444556789999999977654 899999999999999999999999875543332222111000         


Q ss_pred             ------------------------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          240 ------------------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       240 ------------------------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                                                    ........+..+++|+.+||+ ||++|||+.|+|+||||..+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                                          000112235678999999999 999999999999999998664

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.7e-45  Score=311.30  Aligned_cols=252  Identities=24%  Similarity=0.406  Sum_probs=206.0

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccC
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS  104 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  104 (289)
                      ||+|+||+||++.++.+|+.||+|.+...... .....+.+..|+++++.++|++++++.+.+..  +..+++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence            79999999999999999999999999764332 22334567889999999999999999887744  3679999999999


Q ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-cc
Q 022956          105 GNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AA  179 (289)
Q Consensus       105 ~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-~~  179 (289)
                      ++|.+.+..    ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~  154 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKT  154 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccc
Confidence            999888742    456899999999999999999999999  9999999999999988 899999999987654322 22


Q ss_pred             ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---KIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      ....+++.|+|||.+.+. ++.++|+||||+++|+|++|+.||.......   .....+..  .+...+...++.+.+++
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li  232 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN--DSVTYPDKFSPASKSFC  232 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc--cCCCCcccCCHHHHHHH
Confidence            345688999999976644 8899999999999999999999997643322   22222222  12233455788999999


Q ss_pred             HHHHc-CCCCCC-----CHHHHhcCcccccCCCCC
Q 022956          256 EKCIA-QPRARP-----SASELLKDPFFSELNDDD  284 (289)
Q Consensus       256 ~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~~  284 (289)
                      .+||+ ||++||     +++++++||||++..|..
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence            99998 999999     889999999999987664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.3e-45  Score=321.72  Aligned_cols=257  Identities=19%  Similarity=0.309  Sum_probs=209.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||.||++.++.+++.+|+|++...... .......+.+|+.+++.++||||+++++.+...  ..+++|
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~lv  121 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KYLYMV  121 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEE
Confidence            47899999999999999999999999999999754321 223345678899999999999999999988544  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      |||+++++|.+++... .+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++........
T Consensus       122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEEecccceecccCCc
Confidence            9999999999999764 5899999999999999999999999  9999999999999988 8999999999987643322


Q ss_pred             --cccCCCCCCCCCCccccc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC-CCCCChH
Q 022956          179 --AHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVKDPE  250 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  250 (289)
                        .....+++.|+|||.+.+     .++.++|+|||||++|+|++|..||...................... ....+..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence              234568999999997653     26789999999999999999999998765544444444332222111 1235889


Q ss_pred             HHHHHHHHHc-CCC--CCCCHHHHhcCcccccCCC
Q 022956          251 VKAFIEKCIA-QPR--ARPSASELLKDPFFSELND  282 (289)
Q Consensus       251 ~~~li~~~l~-dp~--~Rps~~~il~h~~~~~~~~  282 (289)
                      +++++..||. ++.  .|+++.++++||||++..+
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            9999999997 443  3899999999999998544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-45  Score=317.22  Aligned_cols=253  Identities=19%  Similarity=0.380  Sum_probs=210.3

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.||+|+||+||+|.+..+++.||+|+++..... .....+.+.+|..++.++ +||+++.+++.+...  +.+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~   77 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEY   77 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeC
Confidence            4699999999999999999999999999865332 234466788899999888 689999999887544  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Cccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~~~~~  180 (289)
                      +++++|..++...+.+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.... ......
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCcee
Confidence            999999999988888999999999999999999999999  9999999999999998 899999999987532 222334


Q ss_pred             cCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCC------CcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          181 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC------DSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ..++++.|+|||.+.+ .++.++|+||||+++|+|++|..||...      .......+.+...  +...+...++.+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~  232 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH  232 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence            4678999999997654 4889999999999999999999999632      2223333433332  22345567899999


Q ss_pred             HHHHHHc-CCCCCCC------HHHHhcCcccccCCCC
Q 022956          254 FIEKCIA-QPRARPS------ASELLKDPFFSELNDD  283 (289)
Q Consensus       254 li~~~l~-dp~~Rps------~~~il~h~~~~~~~~~  283 (289)
                      ++.+||+ ||++|++      +++++.||||+.++|+
T Consensus       233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            9999998 9999987      5799999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.8e-45  Score=316.02  Aligned_cols=256  Identities=23%  Similarity=0.331  Sum_probs=211.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.+.||+|+||.||+|.++.+++.||+|+++..... .......+..|..++..+ .|++++.+++.+...  +.+++|
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv   79 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYFV   79 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEEE
Confidence            6789999999999999999999999999999864322 223345566777888777 468888888877443  679999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-cc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~  177 (289)
                      |||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..... ..
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-CcEEEccCCCceecCCCCC
Confidence            999999999999988888999999999999999999999999  9999999999999998 8999999999875432 22


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ......|++.|+|||.+.+. ++.++|+|||||++|+|++|..||.................   ..+...++.+.+++.
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~  233 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYPKSMSKEAVAICK  233 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCcCCHHHHHHHH
Confidence            23345689999999977654 89999999999999999999999987655444444433322   234457899999999


Q ss_pred             HHHc-CCCCCCCH-----HHHhcCcccccCCCCC
Q 022956          257 KCIA-QPRARPSA-----SELLKDPFFSELNDDD  284 (289)
Q Consensus       257 ~~l~-dp~~Rps~-----~~il~h~~~~~~~~~~  284 (289)
                      +||+ ||++|++.     .+++.||||+.++|..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~  267 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  267 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            9998 99999974     8999999999887643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-45  Score=318.26  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=205.5

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHH-HHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE-VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e-~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ++||+|+||.||+|.++.+|+.||+|++.......... ...+.+| ..+++.++||||+++++.+...  +.+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhH-HHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcC
Confidence            46999999999999999999999999997643322222 3334444 4567889999999999877443  689999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~  180 (289)
                      +++++|...+.....+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.++|+|||++..... .....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccc
Confidence            999999999988888999999999999999999999999  9999999999999998 8999999999875322 22233


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ...+++.|+|||.+.+. ++.++|+|||||++|+|++|..||...+.. .....+....  ...+...+..+.+++.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~--~~~~~~~~~~~~~li~~~l  231 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-QMYDNILHKP--LQLPGGKTVAACDLLVGLL  231 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-HHHHHHhcCC--CCCCCCCCHHHHHHHHHHc
Confidence            45689999999977654 889999999999999999999999875433 3444444332  2334456889999999999


Q ss_pred             c-CCCCCCCH----HHHhcCcccccCCCC
Q 022956          260 A-QPRARPSA----SELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rps~----~~il~h~~~~~~~~~  283 (289)
                      + ||.+||++    .+++.|+||..++|.
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence            8 99999875    599999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.6e-45  Score=315.16  Aligned_cols=252  Identities=23%  Similarity=0.398  Sum_probs=206.9

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh-CCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT-LKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.||+|+||.||+|.++.+++.||+|+++..... ..........|..++.. ++||||+++++.+.+.  +.+++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey   77 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEY   77 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeC
Confidence            4699999999999999999999999999864321 12223455667777765 4899999999888554  579999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~  180 (289)
                      +++++|.+++.....+++.++..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..... .....
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCcee
Confidence            999999999988778999999999999999999999999  9999999999999998 8999999999875322 22233


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ...+++.|+|||.+.+. ++.++|+|||||++|+|++|..||....... ....+.....  ..+...+..+++++.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~i~~~~~--~~~~~~~~~~~~li~~~l  231 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-LFQSIRMDNP--CYPRWLTREAKDILVKLF  231 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC--CCCccCCHHHHHHHHHHh
Confidence            45689999999977654 8999999999999999999999998755443 3333333221  234457889999999999


Q ss_pred             c-CCCCCCCHH-HHhcCcccccCCCC
Q 022956          260 A-QPRARPSAS-ELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rps~~-~il~h~~~~~~~~~  283 (289)
                      + ||++||++. +++.||||++++|.
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCCCHH
Confidence            8 999999996 99999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.8e-45  Score=310.51  Aligned_cols=254  Identities=30%  Similarity=0.447  Sum_probs=200.9

Q ss_pred             cccceeeeecccCcceEEEEeecC-CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC---CCCceEEeeeeEEe---
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLD---   89 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~---   89 (289)
                      +| ++.+.||+|+||.||+|.+.. +|..+|+|.++.....+.  ....+.+|+.+++.+   +||||+++++++..   
T Consensus         2 ~Y-~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           2 QY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             Cc-ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            44 689999999999999999854 468899999986543221  123344566665554   69999999988752   


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      .....+++|+|++.+ +|.+++...  ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+||
T Consensus        79 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~-~~~kl~Df  154 (290)
T cd07862          79 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADF  154 (290)
T ss_pred             CCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC-CCEEEccc
Confidence            233568999999975 899988753  45899999999999999999999999  9999999999999988 89999999


Q ss_pred             CCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--C---
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--Q---  241 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~---  241 (289)
                      |++.............+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+....+.....+.....+  .   
T Consensus       155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            99987655444445678999999997654 48899999999999999999999998766555544443221100  0   


Q ss_pred             -------------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          242 -------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       242 -------------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                         ......++.+++|+.+||+ ||++|||+.++|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                               0112357788999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.6e-46  Score=319.22  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=205.7

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      +.||+|+||+||+|.++.+++.||+|++..............+.++..+++.++||||+++++.+...  +.+++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCC
Confidence            46999999999999999999999999998644322222233344444567889999999999887544  6799999999


Q ss_pred             cCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-cccccc
Q 022956          103 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS  181 (289)
Q Consensus       103 ~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~~  181 (289)
                      ++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++..... ......
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCccc
Confidence            99999999998888999999999999999999999999  9999999999999988 8999999999875422 223344


Q ss_pred             CCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc
Q 022956          182 IIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA  260 (289)
Q Consensus       182 ~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  260 (289)
                      ..+++.|+|||.+.+. ++.++|||||||++|+|++|..||.+......... +....  .......++.+.+++.+||+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~--~~~~~~~~~~~~~li~~~l~  232 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN-ILNKP--LQLKPNITNSARHLLEGLLQ  232 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH-HHhCC--cCCCCCCCHHHHHHHHHHcc
Confidence            5689999999977654 88999999999999999999999987554443333 33322  22334568899999999998


Q ss_pred             -CCCCCCCHH----HHhcCcccccCCC
Q 022956          261 -QPRARPSAS----ELLKDPFFSELND  282 (289)
Q Consensus       261 -dp~~Rps~~----~il~h~~~~~~~~  282 (289)
                       ||.+|+++.    ++++|+||...+|
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence             999999876    8999999988765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-45  Score=318.83  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=204.9

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHH-HHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV-QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.||+|+||.||+|.++.+|+.+|+|++....... ......+..|. .+++.++||||+++++.+...  +.+++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcC
Confidence            46999999999999999999999999997653322 22234444444 457789999999999887543  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Cccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~~~~~  180 (289)
                      +++++|..++.....+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.++|+|||++.... ......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcc
Confidence            999999999988888999999999999999999999999  9999999999999998 899999999987532 222334


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ...+++.|+|||.+.+. ++.++|+|||||++|+|++|..||............. ...  .......+..+.+++.+||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~ll~~ll  231 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL-HKP--LVLRPGASLTAWSILEELL  231 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH-cCC--ccCCCCCCHHHHHHHHHHh
Confidence            45689999999977654 8899999999999999999999998755444333333 322  1223346889999999999


Q ss_pred             c-CCCCCCCH----HHHhcCcccccCCC
Q 022956          260 A-QPRARPSA----SELLKDPFFSELND  282 (289)
Q Consensus       260 ~-dp~~Rps~----~~il~h~~~~~~~~  282 (289)
                      + +|.+||++    .+++.||||+...|
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            8 99999876    59999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=301.75  Aligned_cols=252  Identities=33%  Similarity=0.584  Sum_probs=212.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+.+.||+|++|.||.+.+..++..+|+|.+........ ......+.+|++++++++|||++++++.+...  ..++++
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v   82 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETLSIF   82 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeEEEE
Confidence            578999999999999999999999999999986543221 23356789999999999999999999988554  589999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      +||+++++|.+++.....+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecccccc
Confidence            999999999999988888999999999999999999999999  9999999999999988 8999999999876533211


Q ss_pred             c----ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          179 A----HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       179 ~----~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .    ....++..|+|||...+. ++.++|+||||+++|+|++|+.||.................. ...+...+..+.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  238 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-PQLPSHVSPDARN  238 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-CCCCccCCHHHHH
Confidence            1    234567899999977655 889999999999999999999999876655555544433332 3345567899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ++..||. +|++||++.+++.||||
T Consensus       239 li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         239 FLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999998 99999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.3e-45  Score=307.32  Aligned_cols=253  Identities=21%  Similarity=0.346  Sum_probs=203.9

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccC
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS  104 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  104 (289)
                      ||+|+||.||++.++.+|+.||+|.+....... ......+..|+++++.++|||++++++.+..  +..+++||||++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence            799999999999999999999999997544321 1123345669999999999999999988744  3689999999999


Q ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccC
Q 022956          105 GNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI  182 (289)
Q Consensus       105 ~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~  182 (289)
                      ++|.+++...  ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++............
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~  154 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQR  154 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeecc
Confidence            9999887643  35888999999999999999999999  9999999999999988 89999999998876554444445


Q ss_pred             CCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022956          183 IGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---KIYKKVTGGVKPQALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       183 ~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  258 (289)
                      .++..|+|||.+.+. ++.++|+|||||++|+|++|..||.......   ........... .......++++++|+.+|
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  233 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-KFEHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-ccccccCCHHHHHHHHHH
Confidence            688999999976544 8899999999999999999999997643221   12222211111 112234688999999999


Q ss_pred             Hc-CCCCCCCH----HHHhcCcccccCCCCC
Q 022956          259 IA-QPRARPSA----SELLKDPFFSELNDDD  284 (289)
Q Consensus       259 l~-dp~~Rps~----~~il~h~~~~~~~~~~  284 (289)
                      |+ ||++||++    ++++.||||+.++++.
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence            98 99999999    7788999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.9e-45  Score=320.50  Aligned_cols=253  Identities=27%  Similarity=0.353  Sum_probs=201.7

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||.||+|.+..+++.||+|...          ...+.+|++++++++||||+++++.+...  ...+++
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv  161 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYN--KFTCLI  161 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEEE
Confidence            478999999999999999999999999999753          23457799999999999999999988554  578999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc--
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~--  176 (289)
                      +|++.+ +|..++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++......  
T Consensus       162 ~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        162 LPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-CCEEEEeCCcccccccccc
Confidence            999964 89998888788999999999999999999999999  9999999999999988 89999999998654322  


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhC------------
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS-------VAKIYKKVTG------------  236 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~-------~~~~~~~~~~------------  236 (289)
                      .......+++.|+|||.+.+. +++++|||||||++|+|++|..||.....       .......+..            
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            223345789999999977654 89999999999999999999987643211       1111111100            


Q ss_pred             -------------C-C-CCCCC-----CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          237 -------------G-V-KPQAL-----NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       237 -------------~-~-~~~~~-----~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                   . . .+...     ....+..+.+|+.+||+ ||++|||++|+|+||||+.+...-+.|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~  389 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNP  389 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCC
Confidence                         0 0 00000     01135678999999999 999999999999999999876554443

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=314.43  Aligned_cols=266  Identities=24%  Similarity=0.375  Sum_probs=232.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +.+.| .+.+.||+|-|+.|-+|+|.-||+.||||++....+  +......+.+|+..++.++|||||+++++.-.  ..
T Consensus        16 IAGLY-DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QT   90 (864)
T KOG4717|consen   16 IAGLY-DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QT   90 (864)
T ss_pred             eeeee-hhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cc
Confidence            45566 689999999999999999999999999999998876  55556778999999999999999999998733  36


Q ss_pred             eeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      .+|+|.|+-++|.|++++-++ ..+.++.+.+++.||+.|+.|+|+..  ++|+||||+||.+....|-|||+|||++..
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNK  168 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecccccc
Confidence            799999999999999999765 56999999999999999999999999  999999999999988889999999999998


Q ss_pred             cCCccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      +....+....||+..|-|||++-++  -.|+.||||||+|+|-|++|+.||....+.+.+.-+..=.   -..+.+.+.+
T Consensus       169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK---YtvPshvS~e  245 (864)
T KOG4717|consen  169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK---YTVPSHVSKE  245 (864)
T ss_pred             CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc---ccCchhhhHH
Confidence            8888888899999999999987665  4678999999999999999999998766655554443322   1246677899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP  289 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~~~  289 (289)
                      .++||..||. ||++|.+.++|..++|++..|...+-.+|
T Consensus       246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iP  285 (864)
T KOG4717|consen  246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIP  285 (864)
T ss_pred             HHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCc
Confidence            9999999998 99999999999999999999876554444

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=317.37  Aligned_cols=252  Identities=23%  Similarity=0.409  Sum_probs=210.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ..+..++.+.||+|-||.||.+.+. ....||+|.++.....     .+.|.+|++++++|+|++||++++++..+  ..
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~-----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~p  275 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS-----PEAFLREAQIMKKLRHEKLVKLYGVCTKQ--EP  275 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC-----hhHHHHHHHHHHhCcccCeEEEEEEEecC--Cc
Confidence            3444567899999999999999886 2348999999876432     35667899999999999999999998554  47


Q ss_pred             eEEEeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           95 LNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ++|||||++.|||.+++..  +..+...+.+.++.||++|++||++++  ++||||-..||||+.+ +.+||+|||+++.
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~-~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED-LVVKISDFGLARL  352 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC-ceEEEcccccccc
Confidence            9999999999999999987  577999999999999999999999999  9999999999999999 8999999999995


Q ss_pred             cCCc--cccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          173 VGRS--HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       173 ~~~~--~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ..+.  ...........|.|||.+. +.++.+|||||||++||||+| |+.|+++.... +..+.+.++..... +..+|
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-ev~~~le~GyRlp~-P~~CP  430 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-EVLELLERGYRLPR-PEGCP  430 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-HHHHHHhccCcCCC-CCCCC
Confidence            4432  2233344567999999665 669999999999999999999 99999885554 45556666655544 45579


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +.+.+++..||+ +|++|||++.+..  +++.+.
T Consensus       431 ~~vY~lM~~CW~~~P~~RPtF~~L~~--~l~~~~  462 (468)
T KOG0197|consen  431 DEVYELMKSCWHEDPEDRPTFETLRE--VLEDFF  462 (468)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHHH--HHHHhh
Confidence            999999999998 9999999998776  554443

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-45  Score=301.21  Aligned_cols=263  Identities=27%  Similarity=0.412  Sum_probs=214.9

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc-eEEeeeeEEeCC----
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY-IIVCYSVWLDDQ----   91 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----   91 (289)
                      .|. ..++||+|+||+||+|.++.+|+.||+|+++.....  +..-....+|+.+++.|+|+| |+.+++++...+    
T Consensus        12 ~~~-~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   12 DYE-KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHH-HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            343 367799999999999999999999999999876532  233455678999999999999 999999886653    


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHR----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      ...+++|+||++. .|..++....    .++...+..+++|++.||+|||+++  ++||||||+|++++.+ |.+||+||
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~-G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSS-GVLKLADF  164 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCC-CcEeeecc
Confidence            2378999999977 9999998754    5777899999999999999999999  9999999999999998 99999999


Q ss_pred             CCccccCCccc-cccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--CC
Q 022956          168 GFAAIVGRSHA-AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QA  242 (289)
Q Consensus       168 g~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~  242 (289)
                      |+|....-+.. ......|..|.|||++-+.  |+...||||+|||++||++++.-|++..+.++...+...-..|  ..
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            99997764443 4455678899999966544  9999999999999999999999999877766655443322111  11


Q ss_pred             CCC-------------------------CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          243 LNK-------------------------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       243 ~~~-------------------------~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                      ++.                         ..++...+++.+||+ +|.+|.|++.+|.||||.......++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~  314 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ  314 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence            111                         112477899999999 99999999999999999998665543

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.7e-46  Score=309.17  Aligned_cols=252  Identities=34%  Similarity=0.595  Sum_probs=207.3

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||+||++.++.+++.||+|++.....  .........+|+.++++++||||+++++.+...  ...+++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccc--cccccc
Confidence            4789999999999999999999999999999987643  222333445699999999999999999988664  678999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc-CCcc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~-~~~~  177 (289)
                      ||++.+++|.+++.....+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+... ....
T Consensus        77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccccccc
Confidence            999999999999997788999999999999999999999999  9999999999999987 89999999999763 3333


Q ss_pred             ccccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhCCCCCC-CCCCCCChHH
Q 022956          178 AAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQ-ALNKVKDPEV  251 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~  251 (289)
                      ......++..|+|||...  ...+.++|+||||+++++|++|..||....   ................ ......++.+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL  233 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence            445567889999999876  448999999999999999999999998762   1222222221111111 1111124899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .+++..||+ ||++||+++++++||||
T Consensus       234 ~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  234 RDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            999999998 99999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-44  Score=304.98  Aligned_cols=263  Identities=29%  Similarity=0.501  Sum_probs=216.6

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      +.+.++| ++.++||+|+||.||+|.+..++..+++|.+...    .....+.+.+|+++++.++|+|++++++.+..+ 
T Consensus         8 ~~~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   81 (292)
T cd06644           8 LDPNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-   81 (292)
T ss_pred             cCcchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-
Confidence            3456666 7899999999999999999999999999999753    455577788999999999999999999987554 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       +.+++||||+++++|..++.+ ...+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        82 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~  157 (292)
T cd06644          82 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVS  157 (292)
T ss_pred             -CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC-CCEEEccCccc
Confidence             579999999999999888754 456899999999999999999999999  9999999999999988 89999999988


Q ss_pred             cccCCc-cccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          171 AIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       171 ~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      ...... .......+++.|+|||.+.      ..++.++|+||||+++|+|++|..||..........+...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T cd06644         158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ  237 (292)
T ss_pred             eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCC
Confidence            654322 1223345778999999763      226778999999999999999999997755444444433332222233


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +...+..+.+++.+||. ||++||+++++++||||..+.++.
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            44567889999999998 999999999999999999887764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-45  Score=314.47  Aligned_cols=258  Identities=20%  Similarity=0.326  Sum_probs=208.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||.||++.++.+++.||+|++...... .....+.+.+|..++..++|+||+.+++.+...  +.+++||
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~   80 (331)
T cd05597           4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYLVM   80 (331)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEEEE
Confidence            6899999999999999999999999999999753221 233456688899999999999999999887543  6899999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||+.|++|.+++.+ ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC-CCEEEEECCceeecCCCCC
Confidence            99999999999976 567999999999999999999999999  9999999999999988 8999999999876543322


Q ss_pred             --cccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--CCCCCCCC
Q 022956          179 --AHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QALNKVKD  248 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  248 (289)
                        .....+++.|+|||.+.      +.++.++|+|||||++|+|++|+.||...................  .......+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  237 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS  237 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence              22346899999999765      236789999999999999999999998755444433333322111  11122368


Q ss_pred             hHHHHHHHHHHc-C--CCCCCCHHHHhcCcccccCCCC
Q 022956          249 PEVKAFIEKCIA-Q--PRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       249 ~~~~~li~~~l~-d--p~~Rps~~~il~h~~~~~~~~~  283 (289)
                      +.+++++++||. +  +..|+++++++.||||.+.+|.
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence            899999999986 3  3348899999999999987654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-44  Score=326.26  Aligned_cols=260  Identities=27%  Similarity=0.457  Sum_probs=215.2

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ...++| ++.++||+|+||+||++.+..+|+.||+|++.....  .+.....+.+|+..+..++|+++++++..+.....
T Consensus        29 ~~~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         29 EQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             ccCCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            445666 689999999999999999999999999999986544  45556778899999999999999998876643221


Q ss_pred             ------CeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcE
Q 022956           93 ------NTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV  162 (289)
Q Consensus        93 ------~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~  162 (289)
                            ..+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~-~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC-CCE
Confidence                  147899999999999998864    356899999999999999999999999  9999999999999998 899


Q ss_pred             EEeccCCccccCCc---cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC
Q 022956          163 KIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       163 ~l~d~g~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      ||+|||++......   .......|++.|+|||.+.+. ++.++||||||+++|+|++|..||.+..........+....
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~  262 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY  262 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            99999998765432   123345689999999987654 89999999999999999999999987554443333333322


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .  ..+...++.+.+++.+||+ ||++||++.+++.|||++..
T Consensus       263 ~--~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        263 D--PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             C--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            2  2345578999999999998 99999999999999998764

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-44  Score=315.41  Aligned_cols=251  Identities=26%  Similarity=0.453  Sum_probs=203.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.++||+|+||+||++.+..+|+.||+|++....   .......+.+|+++++.++|+||+++++++..  ++.+++|+
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  151 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLL  151 (353)
T ss_pred             hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEE
Confidence            46789999999999999999999999999996432   34556778999999999999999999998744  46799999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-c
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-A  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-~  178 (289)
                      ||+++++|.+.    ...++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus       152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEcccccceeccccccc
Confidence            99999998653    33567888999999999999999999  9999999999999998 899999999997664322 2


Q ss_pred             cccCCCCCCCCCCccccc-----C-CCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhCCCCCCCCCCCCChH
Q 022956          179 AHSIIGTPEYMAPELYEE-----D-YTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~-----~-~~~~~Di~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      .....++..|+|||.+..     . .+.++|||||||++|+|++|+.||.....  .......+.... ........+..
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  303 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASRE  303 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHH
Confidence            234568999999997642     2 45689999999999999999999974322  122222222221 22234456889


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      +++||.+||+ ||++||++.|+++||||..-...
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            9999999998 99999999999999999987433

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-44  Score=337.94  Aligned_cols=265  Identities=24%  Similarity=0.438  Sum_probs=221.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||+||+|.++.++..+|+|++.....  .......+..|+.+++.++||||+++++.+......
T Consensus        11 ~l~~Y-eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         11 RLNEY-EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             ccCCE-EEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            33455 789999999999999999999999999999986544  344567789999999999999999999998877667


Q ss_pred             eeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCceecCCCCCceEEeCC------
Q 022956           94 TLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHE-----PCIIHRDLNCSNIFINGN------  158 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~-----~~~~h~dl~~~nili~~~------  158 (289)
                      .+++||||+++++|.+++..    ...+++..++.|+.||+.||.|||+.+     .+++|+||+|+|||++.+      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            89999999999999999875    357999999999999999999999843     239999999999999642      


Q ss_pred             ----------CCcEEEeccCCccccCCccccccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 022956          159 ----------IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECD  225 (289)
Q Consensus       159 ----------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~  225 (289)
                                .+.++|+|||++.............+++.|+|||.+.+   .+++++||||||||+|+|++|..||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      24599999999987654444445578999999997642   37889999999999999999999998776


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ........+......  .....+..+.+||..||. +|.+||++.|+|.|+|++.+...
T Consensus       248 ~~~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        248 NFSQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             cHHHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            666666666554322  223457899999999998 99999999999999999977543

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-44  Score=317.71  Aligned_cols=259  Identities=19%  Similarity=0.283  Sum_probs=209.9

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .-|++.+.||+|+||.||++.++.+++.+|+|++...... .......+.+|..+++.++||||+++++.+..  +..++
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~  119 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY  119 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence            3447899999999999999999999999999999754321 22334567889999999999999999988754  36899


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||||++|++|.+++... .+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++......
T Consensus       120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcC
Confidence            999999999999998764 5899999999999999999999999  9999999999999988 89999999999766433


Q ss_pred             c--ccccCCCCCCCCCCccccc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCC
Q 022956          177 H--AAHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKD  248 (289)
Q Consensus       177 ~--~~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  248 (289)
                      .  ......+++.|+|||.+.+     .++.++|||||||++|+|++|..||.................... ......+
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence            2  2234568999999997653     267899999999999999999999987554444444333222111 1123468


Q ss_pred             hHHHHHHHHHHcC-CCC--CCCHHHHhcCcccccCCC
Q 022956          249 PEVKAFIEKCIAQ-PRA--RPSASELLKDPFFSELND  282 (289)
Q Consensus       249 ~~~~~li~~~l~d-p~~--Rps~~~il~h~~~~~~~~  282 (289)
                      +.+++++..||.+ +.+  |++++++++||||++..+
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            8999999999984 333  789999999999988654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=303.92  Aligned_cols=261  Identities=30%  Similarity=0.541  Sum_probs=216.5

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      .|.++| ++.++||+|++|.||++.+..++..+|+|.+...    .....+.+.+|++++++++|+|++++++.+...  
T Consensus         2 ~~~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   74 (280)
T cd06611           2 NPNDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--   74 (280)
T ss_pred             CchhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--
Confidence            455666 6899999999999999999889999999999754    344567788999999999999999999988544  


Q ss_pred             CeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           93 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ..+++||||+++++|.+++.+ ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~-~~~~l~d~g~~~  151 (280)
T cd06611          75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVSA  151 (280)
T ss_pred             CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC-CCEEEccCccch
Confidence            678999999999999999876 357999999999999999999999999  9999999999999988 899999999887


Q ss_pred             ccCCccc-cccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCC
Q 022956          172 IVGRSHA-AHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       172 ~~~~~~~-~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (289)
                      ....... .....+++.|+|||.+.      ..++.++|+||||+++|+|++|..||.................+....+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (280)
T cd06611         152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQP  231 (280)
T ss_pred             hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCc
Confidence            6543222 22345788999999653      2367789999999999999999999987655554444433322222334


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ...+..+.+++..||+ +|++||+++++++||||++...+
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (280)
T cd06611         232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN  271 (280)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchh
Confidence            4567899999999998 99999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-44  Score=305.78  Aligned_cols=252  Identities=28%  Similarity=0.392  Sum_probs=198.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH---hCCCCceEEeeeeEEeC---CCC
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR---TLKNKYIIVCYSVWLDD---QHN   93 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~---~~~   93 (289)
                      ++.+.||+|+||+||+|.++.+|+.||+|.++.......  ....+.+|+.+++   .++||||+++++++...   ...
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG--LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC--CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            678999999999999999999999999999976432211  1123344555554   45799999999887542   235


Q ss_pred             eeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .+++++|++.+ +|.+++...  ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccCccc
Confidence            68999999986 888888753  35899999999999999999999999  9999999999999988 899999999998


Q ss_pred             ccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC--CC--------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KP--------  240 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~--------  240 (289)
                      ............++..|+|||.+.+ .++.++|||||||++++|++|..||.+...............  ..        
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            7654444445567889999997654 489999999999999999999999976554433333221100  00        


Q ss_pred             --------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          241 --------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       241 --------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                    .......++.+++++.+||+ ||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                          00112346788999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-45  Score=314.97  Aligned_cols=256  Identities=28%  Similarity=0.504  Sum_probs=223.1

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +.| -+.+++|.|+||.+++++++.+++.|++|.+......  +..++...+|+.+++++.||||+...+.|...+ ..+
T Consensus         4 ~~Y-e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l   79 (426)
T KOG0589|consen    4 DNY-EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLL   79 (426)
T ss_pred             chh-hhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceE
Confidence            455 5799999999999999999999999999999988763  344558899999999999999999999986643 459


Q ss_pred             EEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           96 NFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      +|||+||+||+|.+.+.+.  ..++++.+..|+.|++.|+.|||+++  ++|||||+.|||++.+ +.|+|.|||+++..
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKIL  156 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-Cceeecchhhhhhc
Confidence            9999999999999999753  57899999999999999999999999  9999999999999999 78999999999999


Q ss_pred             CCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          174 GRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       174 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      +... ...+..||+.|++||++.+. |..++|||||||++|||++-+.+|...+-..-..++....  ....+...+.++
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--~~Plp~~ys~el  234 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--YSPLPSMYSSEL  234 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--CCCCCccccHHH
Confidence            8776 66778899999999988866 9999999999999999999999998755444444444443  233566678999


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +.|++.||. +|..||++.++|.+|.+...
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            999999998 99999999999999887743

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-45  Score=317.40  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=202.9

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC---CCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ||+|+||+||+|.++.+|+.||+|++....... ......+..|..++..+   +||+|+.++..+...  +.+++||||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~   77 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDY   77 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcC
Confidence            799999999999999999999999997543322 22233445566666554   699999999887544  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-ccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~~~~  180 (289)
                      +++++|..++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++..... .....
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCcc
Confidence            999999999988888999999999999999999999999  9999999999999998 8999999999875432 22334


Q ss_pred             cCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  258 (289)
                      ..++++.|+|||.+.+  .++.++|||||||++|+|++|..||........ ...+..+.. .......++.+++++.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~-~~~~~~~~~~~~~li~~~  232 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-YRNIAFGKV-RFPKNVLSDEGRQFVKGL  232 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-HHHHHcCCC-CCCCccCCHHHHHHHHHH
Confidence            5678999999997653  378999999999999999999999987544433 333333221 122334688999999999


Q ss_pred             Hc-CCCCCC----CHHHHhcCcccccCCC
Q 022956          259 IA-QPRARP----SASELLKDPFFSELND  282 (289)
Q Consensus       259 l~-dp~~Rp----s~~~il~h~~~~~~~~  282 (289)
                      |+ ||++||    +++++++||||++.++
T Consensus       233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         233 LNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             cCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            98 999998    7999999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4e-44  Score=299.80  Aligned_cols=253  Identities=26%  Similarity=0.438  Sum_probs=213.1

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccC
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS  104 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  104 (289)
                      ||.|++|.||++.+..++..+|+|++...... .....+.+.+|+++++.++|||++++++.+...  ..+++++||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence            79999999999999999999999999765432 234457799999999999999999999987543  679999999999


Q ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCCC
Q 022956          105 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG  184 (289)
Q Consensus       105 ~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  184 (289)
                      ++|.+++.+...+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+.............+
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~  154 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCG  154 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccC
Confidence            999999988778999999999999999999999999  9999999999999988 8999999999987755433444567


Q ss_pred             CCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-C
Q 022956          185 TPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q  261 (289)
Q Consensus       185 ~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-d  261 (289)
                      ++.|++||.+.+ .++.++|+||||+++|+|++|..||.... +.......+.........+...++.+++++.+||. +
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence            889999997654 48899999999999999999999998755 12333333332222333344458899999999998 9


Q ss_pred             CCCCCC-----HHHHhcCcccccCCCC
Q 022956          262 PRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       262 p~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      |++||+     ++|+++||||++.+|+
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            999999     9999999999998875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-44  Score=306.04  Aligned_cols=256  Identities=22%  Similarity=0.377  Sum_probs=209.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||+||++.+..+++.||+|.+...... .......+.+|+.+++.++|++++.+.+.+...  +.+++||
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~   79 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL   79 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEEE
Confidence            4678999999999999999999999999998765432 223345577899999999999999999887543  6899999


Q ss_pred             ccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc
Confidence            999999999988643  35899999999999999999999999  9999999999999988 899999999987654443


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ......++..|+|||.+.+. ++.++|+||||+++|+|++|..||......   ......... . ........++.+++
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~  234 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-V-QEEYSEKFSPDARS  234 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-h-hhhcCccCCHHHHH
Confidence            33445788999999976544 889999999999999999999999864321   111111111 1 11234456889999


Q ss_pred             HHHHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          254 FIEKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       254 li~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      |+.+||+ ||++|||     +++++.||||++++++
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence            9999999 9999999     8999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.1e-44  Score=299.46  Aligned_cols=254  Identities=33%  Similarity=0.581  Sum_probs=211.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.+.||+|+||.||++.+..++..|++|.+...... ........+.+|+.++++++|||++++++.+.......++++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            5789999999999999999999999999998765432 123456678999999999999999999998766555788999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      +||+++++|.+++.....+++.....++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCCCccccccccc
Confidence            999999999999988778999999999999999999999999  9999999999999988 899999999987543211 


Q ss_pred             ---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 ---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                         ......++..|+|||.+.+. ++.++|+||||+++++|++|+.||................ .....+...++.+++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  240 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHARD  240 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHHH
Confidence               11223467899999977654 8899999999999999999999998766555555443332 233345556888999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      ++. ||. +|++||++++|+.||||+
T Consensus       241 li~-~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FLG-CIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHH-HhcCChhhCcCHHHHhcCcccc
Confidence            994 665 999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.1e-44  Score=309.50  Aligned_cols=254  Identities=21%  Similarity=0.322  Sum_probs=209.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+..|..++..+.| ++++++++.+...  +.+++|
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv   79 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYFV   79 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEEE
Confidence            5789999999999999999999999999999864322 22334567778888888865 5666777766443  579999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-c
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-H  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-~  177 (289)
                      |||++|++|.+++.....+++.++..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeccccccccCCCCc
Confidence            999999999999988888999999999999999999999999  9999999999999988 89999999998754322 2


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||.+...............   ..+...++.+.+++.
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~  233 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYPKSLSKEAVSICK  233 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHHHHH
Confidence            23345689999999976654 88999999999999999999999987655444444333222   234456889999999


Q ss_pred             HHHc-CCCCCCC-----HHHHhcCcccccCCC
Q 022956          257 KCIA-QPRARPS-----ASELLKDPFFSELND  282 (289)
Q Consensus       257 ~~l~-dp~~Rps-----~~~il~h~~~~~~~~  282 (289)
                      +||+ +|.+|++     .+++++||||+.++|
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            9998 9999997     479999999999876

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.1e-44  Score=321.97  Aligned_cols=251  Identities=25%  Similarity=0.416  Sum_probs=210.5

Q ss_pred             cceeeeecccCcceEEEEeecCC-CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      |.+.+.||.|++|.||+|.+..+ +..+|+|.+...    .......+.+|+.+++.++||||+++++.+...  +.+++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~l  142 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLL  142 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEE
Confidence            57899999999999999998877 788999877543    344456788899999999999999999988554  68999


Q ss_pred             EeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           98 ITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ||||++|++|.+++..    ..++++..+..++.|++.||.|||+++  ++|+||||+||+++.+ +.++|+|||++...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~-~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC-CcEEEEeCcCceec
Confidence            9999999999988753    456899999999999999999999999  9999999999999988 89999999999876


Q ss_pred             CCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          174 GRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       174 ~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .....   ....+|++.|+|||.+.+. ++.++|||||||++++|++|..||..................  ..+...++
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~s~  297 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--PFPCPVSS  297 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCCccCCH
Confidence            43322   3345689999999977655 899999999999999999999999876554444444443332  23445688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+++++..||. ||++||++++++.|+|++..
T Consensus       298 ~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        298 GMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            99999999998 99999999999999998753

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.6e-44  Score=303.16  Aligned_cols=262  Identities=28%  Similarity=0.477  Sum_probs=216.8

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ...++..+| ++.+.||+|++|.||++.+..++..+++|.+.....    .....+.+|+.+++.++|+|++++++.+..
T Consensus        14 ~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~   88 (296)
T cd06654          14 SVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV   88 (296)
T ss_pred             ccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence            445677777 578999999999999999999999999999986543    224668889999999999999999998765


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      .  ...++|+||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        89 ~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~-~~~kl~dfg~  162 (296)
T cd06654          89 G--DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGF  162 (296)
T ss_pred             C--CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEECcccc
Confidence            4  579999999999999999875 45899999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          170 AAIVGRSHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       170 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      +........ .....+++.|+|||.+.+. +++++|+||||+++++|++|..||......................+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06654         163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL  242 (296)
T ss_pred             chhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcccc
Confidence            876543222 2234678899999977654 88999999999999999999999987655444443333332222234456


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +..+.+++.+||. ||++||++.+++.||||.....
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            7889999999998 9999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.4e-44  Score=306.24  Aligned_cols=257  Identities=23%  Similarity=0.361  Sum_probs=205.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      .+| ++.++||+|+||+||++.++.++..+|+|.++......   ....+.+|+.++++++|||++++++.+...  +..
T Consensus         6 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   79 (309)
T cd07872           6 ETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIVHTD--KSL   79 (309)
T ss_pred             Cce-EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeE
Confidence            445 67899999999999999999999999999997654321   234566799999999999999999988554  579


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++ +|.+++.. +..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECccccceecC
Confidence            999999987 78877765 345899999999999999999999999  9999999999999988 899999999987654


Q ss_pred             Cccc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CC----------
Q 022956          175 RSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VK----------  239 (289)
Q Consensus       175 ~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~----------  239 (289)
                      .... .....+++.|+|||.+.+  .++.++|+||||+++++|++|..||.+....+.........  ..          
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            3222 233457889999997653  37889999999999999999999998755433322221100  00          


Q ss_pred             --------CC-------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          240 --------PQ-------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       240 --------~~-------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                              +.       ......++++++|+.+||+ ||.+|||++|++.||||+.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence                    00       0112357789999999999 9999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.9e-43  Score=294.79  Aligned_cols=251  Identities=27%  Similarity=0.536  Sum_probs=208.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||.|++|.||.+.++.+++.+|+|.+.....  .....+.+.+|++++++++|+|++++++.+.. ....++++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv   78 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIV   78 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEE
Confidence            3689999999999999999999999999999976443  33445678899999999999999999887643 33578999


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+++++|.+++..  ...+++.++..++.+++.++.+||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecC-CcEEEecccceEEeccc
Confidence            999999999999876  346899999999999999999999999  9999999999999988 89999999999766432


Q ss_pred             c-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          177 H-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       177 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      . ......+++.|+|||...+. ++.++|+||||++++++++|..||............ ..+..+ ..+...++.+.++
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~l  233 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLP-PMPKDYSPELGEL  233 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HhcCCC-CCccccCHHHHHH
Confidence            2 22334578899999976654 888999999999999999999999865544433333 333222 2344578899999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCccc
Q 022956          255 IEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +.+||+ ||++||++.++++||||
T Consensus       234 i~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         234 IATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHhccCcccCCCHHHHhcCCCC
Confidence            999998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.8e-44  Score=315.59  Aligned_cols=256  Identities=25%  Similarity=0.384  Sum_probs=206.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC---CCeeE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---HNTLN   96 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   96 (289)
                      .+.++||+|+||.||++.+..+|+.||+|++.....  +....+++.+|+.+++.++|+||+++++++....   ...++
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ--NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEecccccc--chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            468899999999999999999999999999864321  3344567889999999999999999999875432   12689


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +|+||+.+ +|.+.+.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC-CCEEeccccceeecccC
Confidence            99999975 88888887788999999999999999999999999  9999999999999998 89999999999765432


Q ss_pred             c--ccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-----------------
Q 022956          177 H--AAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT-----------------  235 (289)
Q Consensus       177 ~--~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----------------  235 (289)
                      .  ......+++.|+|||.+.+.  ++.++|||||||++++|++|+.||.+............                 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            2  12234568899999976643  78899999999999999999999986554333221111                 


Q ss_pred             -----C-CCCCC------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          236 -----G-GVKPQ------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       236 -----~-~~~~~------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                           . ...+.      ......++.+.+|+.+||+ ||++|||++++|.||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                 1 11110      1123347889999999999 999999999999999999853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.4e-44  Score=311.41  Aligned_cols=258  Identities=20%  Similarity=0.342  Sum_probs=209.5

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||.||++.++.+++.+|+|++...... .......+.+|..++..++|++++++++.+...  ..+++||
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~   80 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYLVM   80 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEEEE
Confidence            6889999999999999999999999999999753221 223345578899999999999999999887544  6799999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||+++++|.+++.+ ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEeecchheecccCCc
Confidence            99999999999986 467899999999999999999999999  9999999999999988 8999999999875533222


Q ss_pred             --cccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC--CCCCCCC
Q 022956          179 --AHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--ALNKVKD  248 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  248 (289)
                        .....|++.|+|||.+.      +.++.++|+|||||++|+|++|+.||....................  ......+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  237 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS  237 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence              22356899999999764      2378899999999999999999999987655554444443322111  1123468


Q ss_pred             hHHHHHHHHHHc-CCC--CCCCHHHHhcCcccccCCCC
Q 022956          249 PEVKAFIEKCIA-QPR--ARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~--~Rps~~~il~h~~~~~~~~~  283 (289)
                      +.+++|+.+||. +++  .|++++++++||||.+++|+
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence            899999999996 443  37899999999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-43  Score=303.79  Aligned_cols=255  Identities=29%  Similarity=0.487  Sum_probs=209.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||.||++.+..++..+|+|.+....   .......+.+|++++++++||||+++++.+...  +.++++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv   77 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISIC   77 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEE
Confidence            368999999999999999999999999999987532   344566788999999999999999999988654  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      +||+++++|.+++.+...+++..+..++.|++.||.|||+ .+  ++|+||+|+||+++.+ +.++|+|||++...... 
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-CcEEEccCCCccccccc-
Confidence            9999999999999988889999999999999999999997 58  9999999999999988 89999999998655332 


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---------------------
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT---------------------  235 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------------  235 (289)
                      ......++..|+|||.+.+. ++.++|+||||+++++|++|..||..... ........                     
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCC
Confidence            22345678899999977654 88899999999999999999999965332 11111111                     


Q ss_pred             ---------------CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          236 ---------------GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       236 ---------------~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                     ....+.......+.++++++.+||. ||++||++.+++.||||.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                           1111111122357789999999998 99999999999999999986444

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-45  Score=286.86  Aligned_cols=264  Identities=21%  Similarity=0.372  Sum_probs=227.8

Q ss_pred             CCCceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeee
Q 022956            6 GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYS   85 (289)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   85 (289)
                      +.+.......+.+ .+++.||.|-||.||+|..++++-.||+|++...... .......+.+|+++.+.|+||||+++++
T Consensus        12 ~~~~~~~~~l~df-eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-~~~v~~qlrREiEIqs~L~hpnilrlY~   89 (281)
T KOG0580|consen   12 GSRATKTWTLDDF-EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-KTQVEHQLRREIEIQSHLRHPNILRLYG   89 (281)
T ss_pred             ccccccccchhhc-cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-HhcchhhhhheeEeecccCCccHHhhhh
Confidence            3333344445555 5799999999999999999999999999999876542 3344567899999999999999999999


Q ss_pred             eEEeCCCCeeEEEeccccCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956           86 VWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~~sL~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                      +|.++  ..+|+++||...|+|...+.  ...++++.....+..|++.|+.|+|.++  ++||||+|+|+|++.+ +.+|
T Consensus        90 ~fhd~--~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~-~~lk  164 (281)
T KOG0580|consen   90 YFHDS--KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA-GELK  164 (281)
T ss_pred             heecc--ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-CCee
Confidence            98766  57999999999999999999  5678999999999999999999999999  9999999999999999 8999


Q ss_pred             EeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC
Q 022956          164 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA  242 (289)
Q Consensus       164 l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  242 (289)
                      ++|||-+.... .+.....|||..|.|||...+. .+...|+|++|++.|+++.|..||.+.. ..+.++.+.+..  ..
T Consensus       165 iAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~--~~  240 (281)
T KOG0580|consen  165 IADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD--LK  240 (281)
T ss_pred             ccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc--cc
Confidence            99999988776 5567788999999999977765 8999999999999999999999998755 555566555532  33


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+..++.++++||..|+. +|.+|....|++.|||+...
T Consensus       241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            457789999999999998 99999999999999998754

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-43  Score=296.42  Aligned_cols=256  Identities=32%  Similarity=0.551  Sum_probs=212.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      +++.++||+|+||.||.+.+..+|..||+|.+...... ......+.+.+|+.++++++|||++++++.+.+.....+++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            36799999999999999999999999999998754322 22345678899999999999999999999876554567889


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-  176 (289)
                      ++||+++++|.+++.....+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+...... 
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV-GNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC-CCEEECcCcccccccccc
Confidence            9999999999999988778999999999999999999999999  9999999999999988 89999999998755321 


Q ss_pred             ---cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 ---HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ---~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                         .......++..|+|||.+.+. ++.++|+||||+++|+|++|+.||..........+..... .....+...+..+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  239 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-TNPVLPPHVSDHCR  239 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-CCCCCchhhCHHHH
Confidence               112234577899999976544 8899999999999999999999998765555554433322 22333445677899


Q ss_pred             HHHHHHHcCCCCCCCHHHHhcCcccc
Q 022956          253 AFIEKCIAQPRARPSASELLKDPFFS  278 (289)
Q Consensus       253 ~li~~~l~dp~~Rps~~~il~h~~~~  278 (289)
                      +++.+|+.+|++||++++++.|||+.
T Consensus       240 ~~i~~~l~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         240 DFLKRIFVEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHhcChhhCCCHHHHhcCcccC
Confidence            99999999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.3e-44  Score=302.38  Aligned_cols=254  Identities=24%  Similarity=0.453  Sum_probs=215.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|++|.||++.+..+++.+|+|++...... .....+.+.+|++++++++||||+++++.+...  +.++++
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v   79 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYLV   79 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEEE
Confidence            36799999999999999999999999999999754331 233457788999999999999999999988554  679999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      +||+++++|.+++.....+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence            999999999999998888999999999999999999999999  9999999999999988 89999999998776544  


Q ss_pred             cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      .....+++.|+|||.+.+ ..+.++|+||||+++++|++|..||....... ..+.+..+..  ..+...++.+++++.+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~~~~~~~~l~~li~~  231 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEKILEGKV--RFPSFFSPDAKDLIRN  231 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCc--cCCccCCHHHHHHHHH
Confidence            334467889999997654 47889999999999999999999998755333 3333333221  2334458899999999


Q ss_pred             HHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          258 CIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       258 ~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      ||. ||.+|+     ++++++.||||+.++|.
T Consensus       232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             HccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence            998 999999     99999999999998753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=289.12  Aligned_cols=255  Identities=22%  Similarity=0.240  Sum_probs=205.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC---
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD---   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   90 (289)
                      .+++.|++.+.||+|+|+-||++++..++..||+|++.+..    .+..+...+|++..++++|||+++++++...+   
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            45556699999999999999999999999999999999874    44578889999999999999999998766532   


Q ss_pred             CCCeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      .....|++++|+..|||.+.++.    +..+++.++++|+.+++.||.+||...++++|+||||.||++.+. +.+++.|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D  172 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMD  172 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEe
Confidence            33578999999999999999874    457999999999999999999999999999999999999999987 8999999


Q ss_pred             cCCccccCCccc----------cccCCCCCCCCCCcccccC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Q 022956          167 LGFAAIVGRSHA----------AHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKI  230 (289)
Q Consensus       167 ~g~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~--~~~  230 (289)
                      ||.+....-.-.          ......+..|.|||.+.-+    .+.++|||||||++|.|+.|..||...-..  ...
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            999986532111          1123468899999987633    788999999999999999999999531000  000


Q ss_pred             HHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          231 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ......... .......++.+.+++++||+ ||.+||++.+++.+
T Consensus       253 LAv~n~q~s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQIS-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             Eeeeccccc-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            001111111 11223378999999999999 99999999999874

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=299.36  Aligned_cols=256  Identities=29%  Similarity=0.512  Sum_probs=214.3

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +| ++.+.||+|++|.||++.+..+++.+|+|.+....   .......+.+|+++++.++|+|++++++.+...  ..++
T Consensus         2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~   75 (274)
T cd06609           2 LF-TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLW   75 (274)
T ss_pred             hh-hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEE
Confidence            45 57899999999999999999999999999997543   233356688899999999999999999987655  6899


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +|+||+++++|.+++... ++++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTST  151 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEcccccceeeccc
Confidence            999999999999999875 7999999999999999999999999  9999999999999998 89999999999877544


Q ss_pred             -cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       177 -~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                       .......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||....... ....+.....+.......++.+.++
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  230 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-VLFLIPKNNPPSLEGNKFSKPFKDF  230 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-HHHHhhhcCCCCCcccccCHHHHHH
Confidence             223344677889999976654 8999999999999999999999997655433 3333333333333222278899999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          255 IEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      +.+||. ||++||++++++.||||.+....
T Consensus       231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            999998 99999999999999999886544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-44  Score=312.14  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=207.0

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..++| ++.+.||+|+||+||+|.+..++..||+|++.....  .......+.+|++++++++||||+++++++....  
T Consensus        13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          13 VPERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            34566 678999999999999999999999999999975432  2233556778999999999999999998764321  


Q ss_pred             --CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 --~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ...++++++++ +++|.+++.. ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~  164 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGL  164 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC-CCEEEcCCcc
Confidence              13578899988 6689888764 56999999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CC------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VK------  239 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~------  239 (289)
                      +......  .....+++.|+|||.+.+  .++.++|||||||++++|++|..||.+..............  ..      
T Consensus       165 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9865432  234568899999997755  37889999999999999999999998654433322221110  00      


Q ss_pred             -------------C-------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          240 -------------P-------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       240 -------------~-------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                                   +       .......++.+.+|+.+||. ||++|||+.+++.||||.......
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence                         0       00011245678999999999 999999999999999999875543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.2e-44  Score=305.24  Aligned_cols=263  Identities=28%  Similarity=0.479  Sum_probs=216.1

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ...++.++| ++.+.||+|++|.||++.+..++..||+|.+.....    ...+.+.+|+.+++.++|+|++++++.+..
T Consensus        13 ~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   87 (297)
T cd06656          13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV   87 (297)
T ss_pred             ccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            344677777 679999999999999999999999999999975432    224567889999999999999999998854


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      .  ...++|+||+++++|.+++.+ ..+++.++..++.|++.+|.+||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        88 ~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~-~~~~l~Dfg~  161 (297)
T cd06656          88 G--DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGF  161 (297)
T ss_pred             C--CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEECcCcc
Confidence            4  679999999999999999875 45899999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          170 AAIVGRSHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       170 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      +........ .....+++.|+|||.+.+. +++++|+||||++++++++|..||...............+.+....+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (297)
T cd06656         162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL  241 (297)
T ss_pred             ceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence            876543322 2234578899999976654 88999999999999999999999976554433332222222332334556


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      +..+++++.+||. +|++||++++++.||||+.....
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            7889999999998 99999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.1e-44  Score=308.75  Aligned_cols=259  Identities=24%  Similarity=0.411  Sum_probs=205.1

Q ss_pred             eeeeeccc--CcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           21 YSDLLGSG--AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        21 ~~~~lg~g--~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +.++||+|  +|++||++.++.+|+.||+|.+.....  .....+.+.+|+.+++.++||||+++++.+...  +..++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence            56789999  678999999999999999999976533  344566788899999999999999999988655  578999


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+++++|.+++..  ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++++||+........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINH  154 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC-CcEEEcccchhhccccc
Confidence            999999999999975  345899999999999999999999999  9999999999999988 89999999865433211


Q ss_pred             cc--------cccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-----
Q 022956          177 HA--------AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-----  240 (289)
Q Consensus       177 ~~--------~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----  240 (289)
                      ..        .....++..|+|||.+.+   .++.++|||||||++++|++|..||.................+.     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence            11        112245677999997753   37899999999999999999999997644333332222211100     


Q ss_pred             --------------------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          241 --------------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       241 --------------------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                                                            .......++.+.+|+.+||+ ||++|||++++++||||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                                  00111235689999999999 999999999999999999886


Q ss_pred             CCCCC
Q 022956          282 DDDSE  286 (289)
Q Consensus       282 ~~~~~  286 (289)
                      ..+..
T Consensus       315 ~~~~~  319 (327)
T cd08227         315 RRASE  319 (327)
T ss_pred             hhhhh
Confidence            55443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.7e-44  Score=321.04  Aligned_cols=254  Identities=21%  Similarity=0.302  Sum_probs=196.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCC------ceEEeeeeEEe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK------YIIVCYSVWLD   89 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~   89 (289)
                      ++| ++.++||+|+||+||+|.+..+++.||||+++...     .....+..|+++++.++|.      +++.++.++..
T Consensus       129 ~~y-~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        129 QRF-KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CcE-EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            444 78999999999999999999999999999997421     2234455677777766554      47777776654


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCC--------
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIG--------  160 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~--------  160 (289)
                      . ...+++|++++ |++|.+++.+.+.+++..+..++.|++.||.|||+ .|  ++|+||||+||+++.+ +        
T Consensus       203 ~-~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~-~~~~~~~~~  277 (467)
T PTZ00284        203 E-TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETS-DTVVDPVTN  277 (467)
T ss_pred             C-CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecC-Ccccccccc
Confidence            3 35789999998 56899999888889999999999999999999997 59  9999999999999865 3        


Q ss_pred             --------cEEEeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 022956          161 --------QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY  231 (289)
Q Consensus       161 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~  231 (289)
                              .+||+|||.+.....  ......+++.|+|||++.+. ++.++|||||||++|+|++|+.||.+........
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                    499999998764322  22345789999999977654 8999999999999999999999998755443322


Q ss_pred             HHHhC--CCC-----------------------CC--------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHH
Q 022956          232 KKVTG--GVK-----------------------PQ--------------ALNKVKDPEVKAFIEKCIA-QPRARPSASEL  271 (289)
Q Consensus       232 ~~~~~--~~~-----------------------~~--------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~i  271 (289)
                      .....  ..+                       +.              ......++.+.+||.+||+ ||++|||++|+
T Consensus       356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~  435 (467)
T PTZ00284        356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM  435 (467)
T ss_pred             HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence            11110  000                       00              0001124567899999999 99999999999


Q ss_pred             hcCcccccCCC
Q 022956          272 LKDPFFSELND  282 (289)
Q Consensus       272 l~h~~~~~~~~  282 (289)
                      |+||||.+...
T Consensus       436 L~Hp~~~~~~~  446 (467)
T PTZ00284        436 TTHPYVLKYYP  446 (467)
T ss_pred             hcCccccccCC
Confidence            99999998644

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.5e-43  Score=299.54  Aligned_cols=254  Identities=29%  Similarity=0.474  Sum_probs=211.2

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||.||++.+..++..+++|.+...    .....+.+.+|+++++.++|+|++++++.+...  +..++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEE
Confidence            47789999999999999999999999999998643    344567788899999999999999999988554  578999


Q ss_pred             eccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-
Q 022956           99 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-  176 (289)
                      +||+++++|..++.. ..++++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-CCEEEccccccccccccc
Confidence            999999999888764 467999999999999999999999999  9999999999999988 89999999998654322 


Q ss_pred             cccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          177 HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      .......+++.|+|||.+.      ..++.++|+||||+++|+|++|..||......................+...+..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE  237 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence            1223345788999999763      2377899999999999999999999987655554444433333222334456889


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +++++.+||+ ||++||+++++++||||+...
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            9999999998 999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-43  Score=296.74  Aligned_cols=253  Identities=30%  Similarity=0.486  Sum_probs=209.7

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC--CCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      |++.+.||+|+||.||++.+ .+|..+|+|.++.....  ........+.+|+..+++++|+|++++++.+...  ..++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   78 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS   78 (265)
T ss_pred             ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence            36789999999999999986 47899999998765421  1234456789999999999999999999987544  6899


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-  175 (289)
                      +++||+++++|.+++.+...+++..+..++.|++.||++||+.+  ++|+||+|+||+++.+ +.++|+|||++..... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC-CeEEeccchhhHhhhhc
Confidence            99999999999999988778999999999999999999999999  9999999999999988 8999999999875421 


Q ss_pred             ------ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          176 ------SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       176 ------~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                            ........++..|+|||.+.+. ++.++|+||||+++++|++|..||......................+...+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence                  1112234578899999977655 788999999999999999999999876555444433333222233455678


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ..+.+++++||+ +|++||++.+++.||||
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            899999999998 99999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-43  Score=295.67  Aligned_cols=252  Identities=31%  Similarity=0.570  Sum_probs=209.9

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +++.| .+.++||+|++|.||++.+..++..+++|.+....      ..+.+.+|++++++++|+|++++++.+...  .
T Consensus         1 ~~~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~   71 (256)
T cd06612           1 PEEVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--T   71 (256)
T ss_pred             Ccccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--C
Confidence            35666 57999999999999999999889999999997432      267899999999999999999999988654  6


Q ss_pred             eeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      .+++++|++++++|.+++.. ...+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~  148 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE-GQAKLADFGVSGQ  148 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-CcEEEcccccchh
Confidence            79999999999999999975 467899999999999999999999999  9999999999999988 8999999999987


Q ss_pred             cCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          173 VGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      ..... ......++..|+|||.+.+. ++.++|+||||+++++|++|..||......................+...+..
T Consensus       149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd06612         149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE  228 (256)
T ss_pred             cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHH
Confidence            65443 22334577899999976654 88899999999999999999999987554433333222212222223345788


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +.+++..||+ ||++||++.+++.||||
T Consensus       229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         229 FNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999998 99999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.6e-43  Score=301.55  Aligned_cols=257  Identities=28%  Similarity=0.513  Sum_probs=215.0

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +..+| ++.+.||+|++|+||++.+..+|+.|++|.+.....    ...+.+.+|+..++.++|||++.+++.+...  .
T Consensus        17 ~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~   89 (296)
T cd06655          17 PKKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVG--D   89 (296)
T ss_pred             CcceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecC--c
Confidence            45555 679999999999999999999999999999975432    2246678899999999999999999988544  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+++|+||+++++|..++... .+++.++..++.|++.|+.+||+.|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~  165 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMD-GSVKLTDFGFCAQI  165 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccchhc
Confidence            799999999999999988764 5899999999999999999999999  9999999999999988 89999999998765


Q ss_pred             CCccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          174 GRSHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       174 ~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ..... .....++..|+|||.+.+. ++.++|+||||+++|++++|..||......................+...++.+
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06655         166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF  245 (296)
T ss_pred             ccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHH
Confidence            43322 2334578899999976644 889999999999999999999999876655554444333333333445568899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+++.+||. ||++||++.+++.||||+...
T Consensus       246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            999999998 999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-43  Score=293.89  Aligned_cols=249  Identities=30%  Similarity=0.555  Sum_probs=209.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.+.||+|++|.||++.++.+++.|++|.+.....  .......+.+|+++++.++|||++++++.+...  +..++|+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   78 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM   78 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence            568899999999999999999999999999976543  344567789999999999999999999987544  6899999


Q ss_pred             ccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC-CCEEEcccccceeccCcc
Confidence            999999999999764  57899999999999999999999999  9999999999999998 899999999987664432


Q ss_pred             c-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          178 A-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       178 ~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      . .....+++.|+|||...+. ++.++|+||||+++++|++|..||............ ..+..+. .....+..+.+++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i  233 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPP-VSQMYSQQLAQLI  233 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCCC-CccccCHHHHHHH
Confidence            2 2334578899999976544 889999999999999999999999876544433333 3332222 2335688999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCccc
Q 022956          256 EKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .+||+ +|++||++.++++|||+
T Consensus       234 ~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         234 DQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHccCCcccCcCHHHHhhCCCC
Confidence            99998 99999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.7e-44  Score=301.27  Aligned_cols=258  Identities=21%  Similarity=0.345  Sum_probs=210.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      +..+.||+|+||+||++.+..+++.+|+|.+...... .......+.+|+++++.++|++++.+.+.+..  ++..++++
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~   79 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL   79 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence            4678899999999999999999999999999764332 22334557789999999999999999887744  36899999


Q ss_pred             ccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+.+++|.+++..  ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence            99999999988864  346999999999999999999999999  9999999999999988 899999999987654433


Q ss_pred             ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFI  255 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li  255 (289)
                      ......++..|+|||.+.+ .++.++|+||||+++++|++|..||.................. ........++.+.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            3344568899999997654 4889999999999999999999999875443322222111111 1223445678999999


Q ss_pred             HHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          256 EKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       256 ~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      ..||+ ||++||+     +.+++.|+||++..++
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence            99998 9999999     8999999999988554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.4e-44  Score=309.07  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=200.4

Q ss_pred             CcccceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD   89 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   89 (289)
                      ++| ++.++||+|+||.||+|.+     ..++..||+|+++...   .......+.+|+.++..+ +||||+++++.+..
T Consensus         7 ~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           7 DRL-RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             hHc-eeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            455 7899999999999999974     3446789999997432   234456788999999999 89999999997754


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc-------------------------------------------------------
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH-------------------------------------------------------  114 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~-------------------------------------------------------  114 (289)
                      . +..++++|||+++++|.+++...                                                       
T Consensus        83 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 P-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             C-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            3 35689999999999999998642                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc---cccCCC
Q 022956          115 -------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIG  184 (289)
Q Consensus       115 -------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~  184 (289)
                             .++++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++........   .....+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCC
Confidence                   24778889999999999999999999  9999999999999988 8999999999976532211   122334


Q ss_pred             CCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-C
Q 022956          185 TPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q  261 (289)
Q Consensus       185 ~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-d  261 (289)
                      ++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+..........+..+..+. .+...++.+.+++.+||+ |
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATPEIYRIMLACWQGD  317 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHccCC
Confidence            678999997654 48999999999999999997 9999987554444444444443322 345678899999999998 9


Q ss_pred             CCCCCCHHHHhc
Q 022956          262 PRARPSASELLK  273 (289)
Q Consensus       262 p~~Rps~~~il~  273 (289)
                      |++|||+.++++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-43  Score=293.98  Aligned_cols=250  Identities=26%  Similarity=0.446  Sum_probs=212.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|.||++.++.++..+|+|.+.....  .......+.+|+++++.++|||++++++.+..  ++..++|+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM   78 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence            679999999999999999999999999999986544  33446789999999999999999999987744  36799999


Q ss_pred             ccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+++++|.+++...  ..+++..+..++.+++.++.+||++|  ++|+||+|+||+++.+.+.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999999999999763  45899999999999999999999999  99999999999998764678999999998776554


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ......++..|+|||.+.+. ++.++|+||||+++++|++|..||..................  ......++.+++++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~  234 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA--PISDRYSPDLRQLIL  234 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC--CCCCCcCHHHHHHHH
Confidence            44456678899999977654 788999999999999999999999876554444444333222  234456889999999


Q ss_pred             HHHc-CCCCCCCHHHHhcCccc
Q 022956          257 KCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .||. +|++|||+.++++||||
T Consensus       235 ~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         235 SMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHccCChhhCCCHHHHhhCCCC
Confidence            9998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3e-43  Score=294.42  Aligned_cols=251  Identities=28%  Similarity=0.517  Sum_probs=213.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||.|+||.||++.+..+|..+|+|.+.....  .....+.+.+|+++++.++|+|++++++.+....+...++++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            578999999999999999999999999999976544  345567788999999999999999999887766667889999


Q ss_pred             ccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956          100 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLH-----THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus       100 e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh-----~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      ||+++++|.+++..    ..++++..+..++.|++.||.+||     +.+  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~-~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN-NNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC-CCEEEeccccc
Confidence            99999999999865    467899999999999999999999     888  9999999999999988 89999999999


Q ss_pred             cccCCccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          171 AIVGRSHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       171 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ........ .....+++.|+|||.+.+. ++.++|+||||+++++|++|..||.... .....+.+..... ...+...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~  235 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIKEGKF-RRIPYRYS  235 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHHhcCCC-CCCccccC
Confidence            87754433 3345678899999976644 7889999999999999999999998755 3444444444332 23455678


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ..+.+++.+||. +|++||++.+|++|||+
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            899999999998 99999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.5e-43  Score=297.83  Aligned_cols=254  Identities=28%  Similarity=0.518  Sum_probs=207.8

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||.||++.+..++..+|+|.+....   .......+.+|++++++++|||++++++.+...  +..++|
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv   77 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISIC   77 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEE
Confidence            367899999999999999999999999999997542   334456788999999999999999999988665  578899


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      +||+++++|..+    ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~  149 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-I  149 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-c
Confidence            999999998654    34788999999999999999999999  9999999999999998 89999999999765433 2


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhCCCCCCCCCCCCChHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV------AKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      .....++..|+|||.+.+. ++.++|+||||+++|+|++|..||......      ......+.....+.......++.+
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            2335688899999976544 889999999999999999999999642211      122222222222333334467899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      ++++.+||+ +|++||++++++.||||...+....
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~  264 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA  264 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence            999999998 9999999999999999998865543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1e-43  Score=309.97  Aligned_cols=266  Identities=26%  Similarity=0.375  Sum_probs=211.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..++| ++.+.||+|+||.||+|.+..+|..||+|.+.....  +......+.+|++++++++|+|++++++.+....  
T Consensus        14 ~~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            34566 678999999999999999999999999999864322  3344566778999999999999999998875332  


Q ss_pred             --CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 --~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ....++|+||+.+ +|.+.+...  +++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~-~~~kL~Dfg~  164 (353)
T cd07850          91 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL  164 (353)
T ss_pred             cccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCcc
Confidence              2357999999976 888887654  899999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------  240 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------  240 (289)
                      +.............++..|+|||.+.+ .++.++|+|||||++++|++|+.||...+........+.....+        
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            987655444444567889999997654 48999999999999999999999998654433222221110000        


Q ss_pred             ------------------------C--------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          241 ------------------------Q--------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       241 ------------------------~--------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                              .        ......++.+++++.+||+ ||++||++.++|.||||+.+....+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~  324 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVE  324 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCC
Confidence                                    0        0011235678999999999 999999999999999999876655444


Q ss_pred             C
Q 022956          288 S  288 (289)
Q Consensus       288 ~  288 (289)
                      .
T Consensus       325 ~  325 (353)
T cd07850         325 A  325 (353)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.4e-44  Score=309.54  Aligned_cols=258  Identities=19%  Similarity=0.326  Sum_probs=209.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||.||++.++.+++.||+|++...... .......+.+|..++..++|++|+.+++.+...  +..|+||
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~lv~   80 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYLVM   80 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEE
Confidence            6899999999999999999999999999999753321 233355688899999999999999999887543  6899999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||++|++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC-CCEEEEeccceeeccCCCc
Confidence            99999999999986 467999999999999999999999999  9999999999999988 8999999999876543322


Q ss_pred             --cccCCCCCCCCCCccccc------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC--CCCCCCC
Q 022956          179 --AHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--ALNKVKD  248 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  248 (289)
                        .....+++.|+|||.+.+      .++.++|+||||+++|+|++|..||....................  ......+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~  237 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS  237 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence              223468999999997653      478899999999999999999999987554444433333221111  1122357


Q ss_pred             hHHHHHHHHHHc-CCCC--CCCHHHHhcCcccccCCCC
Q 022956          249 PEVKAFIEKCIA-QPRA--RPSASELLKDPFFSELNDD  283 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~--Rps~~~il~h~~~~~~~~~  283 (289)
                      +.+++++.+||. ++++  |++++++++||||+..+|.
T Consensus       238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence            899999999997 4443  5799999999999987653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=304.39  Aligned_cols=259  Identities=24%  Similarity=0.388  Sum_probs=214.4

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|++|+||+|.+..+++.+|+|.+...... .....+.+.+|++.++.++|+|++++++.+..  ....+++
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv   79 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCLV   79 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEEE
Confidence            36789999999999999999999999999999865432 23356778999999999999999999988744  3689999


Q ss_pred             eccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC-CCEEEeecchhhccccc
Confidence            9999999999998753  57899999999999999999999999  9999999999999988 89999999998654321


Q ss_pred             cc------------------------------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 022956          177 HA------------------------------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD  225 (289)
Q Consensus       177 ~~------------------------------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~  225 (289)
                      ..                              .....++..|+|||.+.+. ++.++||||||+++|+|++|..||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11                              1123467889999976544 8889999999999999999999998766


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCC----HHHHhcCcccccCCCCC
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPS----ASELLKDPFFSELNDDD  284 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps----~~~il~h~~~~~~~~~~  284 (289)
                      ................ .....++.+++++.+||. ||++||+    +++++.||||++.+|+.
T Consensus       237 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         237 RDETFSNILKKEVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             hHHHHHHHhcCCccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            5555544443322211 122268999999999998 9999999    99999999999987654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-43  Score=297.07  Aligned_cols=252  Identities=26%  Similarity=0.497  Sum_probs=207.8

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.++||+|+||.||+|.+..+++.||+|.++...    ......+.+|+.+++.++|||++++++.+...  +.
T Consensus         8 ~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~   80 (267)
T cd06645           8 QEDF-ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DK   80 (267)
T ss_pred             HHHH-HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CE
Confidence            3455 67899999999999999999999999999997542    22345678899999999999999999988554  67


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++++||+++++|.+++...+.+++.++..++.|++.|+.|||+.|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~  157 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-GHVKLADFGVSAQIT  157 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcceeeeEcc
Confidence            8999999999999999988888999999999999999999999999  9999999999999988 899999999987554


Q ss_pred             Ccc-ccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCC--CCC
Q 022956          175 RSH-AAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN--KVK  247 (289)
Q Consensus       175 ~~~-~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~  247 (289)
                      ... ......++..|+|||.+.    +.++.++|+|||||++|+|++|..||..................+....  ...
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW  237 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence            322 223346788999999753    3478899999999999999999999976554444333333322222221  134


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcc
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPF  276 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~  276 (289)
                      +..+.+++.+||+ +|++||++++++.|||
T Consensus       238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            6789999999998 9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-43  Score=295.37  Aligned_cols=251  Identities=30%  Similarity=0.530  Sum_probs=209.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-----HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .+.+.||+|++|.||+|.+..++..+|+|.+........     ....+.+.+|+.++++++|||++++++.+...  ..
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   80 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--DH   80 (267)
T ss_pred             cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--Cc
Confidence            578999999999999999998999999999876543222     23446788999999999999999999987554  57


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      .++++||+++++|.+++.....+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC-CCEEecccCCCcccc
Confidence            8999999999999999998888999999999999999999999999  9999999999999988 899999999987664


Q ss_pred             Cccc-------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          175 RSHA-------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       175 ~~~~-------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ....       .....++..|+|||.+.+. ++.++|+||||+++++|++|+.||.............. ... ...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~-~~~~~~  235 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NAS-PEIPSN  235 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCC-CcCCcc
Confidence            2111       1123467889999976644 88899999999999999999999987655444443322 222 223445


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .+..+.+++++||+ ||++||++.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            68899999999999 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-43  Score=297.81  Aligned_cols=255  Identities=25%  Similarity=0.518  Sum_probs=210.0

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   91 (289)
                      ++.++| ++.+.||+|+||.||+|.++.+++.+|+|.+.....     ....+.+|+.+++.+ +|+|++++++.+....
T Consensus         3 ~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           3 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             Chhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            567887 578999999999999999999999999999975432     135677899999988 6999999999886532


Q ss_pred             ----CCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           92 ----HNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        92 ----~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                          ...+++++||+.+++|.+++...  ..+++..+..++.|++.|+.|||+++  ++|+||+|+||+++.+ +.++|+
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~-~~~~l~  153 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLV  153 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC-CCEEEc
Confidence                24689999999999999998863  46899999999999999999999999  9999999999999988 899999


Q ss_pred             ccCCccccCCc-cccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC
Q 022956          166 DLGFAAIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       166 d~g~~~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      |||++...... .......++..|+|||.+.      ..++.++|+||||+++|+|++|..||............. ...
T Consensus       154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-~~~  232 (272)
T cd06637         154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNP  232 (272)
T ss_pred             cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-cCC
Confidence            99998765432 2233456788999999764      237889999999999999999999997655444443332 222


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .........+..+++|+.+||. ||.+||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            2333344567899999999998 99999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.2e-44  Score=298.99  Aligned_cols=252  Identities=31%  Similarity=0.563  Sum_probs=211.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.+.||+|++|.||++.++.+++.+++|.+....   .......+.+|++++++++|||++++++.+...  +.+++++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~   78 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM   78 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence            56889999999999999999999999999997653   234567788999999999999999999887554  6899999


Q ss_pred             ccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+++++|.+++... ..+++..+..++.|++.|+.+||+ .|  ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCC-CCEEEeecccchhhHHHH
Confidence            999999999999876 789999999999999999999999 89  9999999999999998 899999999987654332


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      .. ...++..|+|||.+.+. ++.++|+||||+++++|++|..||...    .......+.......+.......++.++
T Consensus       156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06605         156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ  234 (265)
T ss_pred             hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence            22 25678899999976554 889999999999999999999999764    2233333334443333333333688999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ++|.+||. ||++||++.+++.||||++.
T Consensus       235 ~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         235 DFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            99999998 99999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-43  Score=297.51  Aligned_cols=256  Identities=25%  Similarity=0.466  Sum_probs=208.0

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ...+.+.| ++.++||+|+||.||+|.++.+++.+|+|++.....    .....+.+|+.++++++|||++++++.+...
T Consensus         4 ~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~   78 (267)
T cd06646           4 RRNPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR   78 (267)
T ss_pred             ccCchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence            44556666 689999999999999999999999999999975432    2245678899999999999999999988554


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ..+++|+||+++++|.+++.....+++..+..++.|++.|+.|||+.|  ++|+|++|+||+++.+ +.++|+|||++
T Consensus        79 --~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~  153 (267)
T cd06646          79 --EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN-GDVKLADFGVA  153 (267)
T ss_pred             --CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEECcCccc
Confidence              578999999999999999988788999999999999999999999999  9999999999999988 89999999999


Q ss_pred             cccCCcc-ccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC--
Q 022956          171 AIVGRSH-AAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL--  243 (289)
Q Consensus       171 ~~~~~~~-~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  243 (289)
                      ....... ......++..|+|||.+.    ..++.++|+||||+++++|++|+.||..................+...  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06646         154 AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD  233 (267)
T ss_pred             eeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcc
Confidence            7654322 223345778999999653    337789999999999999999999997544333322222222121111  


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcc
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF  276 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~  276 (289)
                      ....+..+.+++..||. +|++||+++++++|+|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            22357899999999998 9999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=296.47  Aligned_cols=256  Identities=26%  Similarity=0.490  Sum_probs=209.7

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   91 (289)
                      .+.++| ++.+.||+|++|.||+|.++.++..+++|++....     ...+.+.+|+.+++++ +|+|++++++.+....
T Consensus         3 ~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           3 DPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             Cchhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            456777 68999999999999999999999999999987543     2346788999999999 7999999999886533


Q ss_pred             ----CCeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956           92 ----HNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus        92 ----~~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                          ...+++|+||+++++|.+++..    +..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~-~~~~  153 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVK  153 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC-CeEE
Confidence                4568999999999999998864    357899999999999999999999999  9999999999999988 8999


Q ss_pred             EeccCCccccCCcc-ccccCCCCCCCCCCccccc------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC
Q 022956          164 IGDLGFAAIVGRSH-AAHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG  236 (289)
Q Consensus       164 l~d~g~~~~~~~~~-~~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  236 (289)
                      |+|||++....... ......++..|+|||.+..      .++.++|+||||+++++|++|..||..........+....
T Consensus       154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  233 (275)
T cd06608         154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN  233 (275)
T ss_pred             ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence            99999987654322 2234457889999996542      2677899999999999999999999865544444443333


Q ss_pred             CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          237 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ...........+..+++++.+||. ||++|||+.++++|||+
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            222222222356789999999998 99999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-43  Score=303.37  Aligned_cols=247  Identities=25%  Similarity=0.385  Sum_probs=191.6

Q ss_pred             eeeecccCcceEEEEeec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           22 SDLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .++||+|+||+||+|.++  .++..+|+|.+.....      ...+.+|++++++++||||+++++.+....+..+++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            578999999999999865  4678999999875432      23467799999999999999999988766667899999


Q ss_pred             ccccCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe---CCCCcEEEecc
Q 022956          100 EVCTSGNLRTYRKKH---------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN---GNIGQVKIGDL  167 (289)
Q Consensus       100 e~~~~~sL~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~---~~~~~~~l~d~  167 (289)
                      ||+.+ +|.+++...         ..+++..+..++.|++.||.|||+.|  ++|+||||+||+++   ...+.+||+||
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            99966 888887532         25899999999999999999999999  99999999999994   22378999999


Q ss_pred             CCccccCCcc----ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------HHHHH
Q 022956          168 GFAAIVGRSH----AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---------AKIYK  232 (289)
Q Consensus       168 g~~~~~~~~~----~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------~~~~~  232 (289)
                      |++.......    ......+++.|+|||.+.+  .++.++|+|||||++++|++|+.||......         .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            9997664322    1234567899999997654  3788999999999999999999999643211         11110


Q ss_pred             HHhC--CCC-------------------------C--------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcc
Q 022956          233 KVTG--GVK-------------------------P--------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF  276 (289)
Q Consensus       233 ~~~~--~~~-------------------------~--------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~  276 (289)
                      ....  ...                         .        .......++.+.+|+.+||+ ||++|||++|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            0000  000                         0        00011235678899999999 9999999999999999


Q ss_pred             c
Q 022956          277 F  277 (289)
Q Consensus       277 ~  277 (289)
                      |
T Consensus       317 f  317 (317)
T cd07868         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7e-44  Score=301.78  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=199.7

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|.||+|.++.+|+.+|+|.++....  .......+.+|+.+++.++|+|++++++.+.+.  ..+++++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   78 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF   78 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence            578999999999999999999999999999976432  222335677899999999999999999988544  5799999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||+++ +|.+++.. ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-CcEEECccchhhccCCCCC
Confidence            99976 78777754 567999999999999999999999999  9999999999999988 8999999999876543322


Q ss_pred             -cccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC---------------CC
Q 022956          179 -AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---------------KP  240 (289)
Q Consensus       179 -~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---------------~~  240 (289)
                       .....+++.|+|||.+.+.  ++.++|+||||+++++|++|..|+............+.+..               ..
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence             2234567899999976543  68899999999999999999888644333332222211100               00


Q ss_pred             ------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          241 ------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       241 ------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                  .......++.+++++.+||+ ||.+|||+++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                        01112357889999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-42  Score=290.16  Aligned_cols=249  Identities=28%  Similarity=0.498  Sum_probs=211.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||.||.+.+..++..+++|.+.....  +......+.+|++++++++|+|++++++.+...  ..+++++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~   78 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEM   78 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEE
Confidence            679999999999999999999999999999976553  344566788999999999999999999988554  6799999


Q ss_pred             ccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+++++|.+++...  ..+++.++..++.|++.++.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC-CCEEECcCcceEEccccc
Confidence            999999999999764  56899999999999999999999999  9999999999999998 899999999987664433


Q ss_pred             -ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          178 -AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       178 -~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                       ......+++.|+|||...+. ++.++|+||||+++++|++|..||..................+  .....+..+.+++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i  233 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--VVSVYSSELISLV  233 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CccccCHHHHHHH
Confidence             23345678899999976654 7889999999999999999999998755555444444433332  2355688999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCccc
Q 022956          256 EKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .+||. +|++||+++++++|||+
T Consensus       234 ~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         234 HSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHcccCcccCCCHHHHhhCcCC
Confidence            99998 99999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-43  Score=298.27  Aligned_cols=252  Identities=23%  Similarity=0.380  Sum_probs=206.9

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccC
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS  104 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  104 (289)
                      ||+|+||+||+|.+..+|+.||+|.+...... .......+.+|++++++++|||++++++.+..  .+.+|+|+||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence            69999999999999999999999999754322 12234556789999999999999999988744  3679999999999


Q ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccC
Q 022956          105 GNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI  182 (289)
Q Consensus       105 ~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~  182 (289)
                      ++|.+++.+..  .+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||.+............
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~  154 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGR  154 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccc
Confidence            99999997654  7899999999999999999999999  9999999999999988 89999999998766543333445


Q ss_pred             CCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022956          183 IGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVKPQALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       183 ~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  258 (289)
                      .++..|+|||.+.+. ++.++|+||||+++++|++|+.||......   .........  .+...+...++.+.+++.+|
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~  232 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL  232 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence            577899999976544 888999999999999999999999764431   222221111  22233445689999999999


Q ss_pred             Hc-CCCCCC-----CHHHHhcCcccccCCCCC
Q 022956          259 IA-QPRARP-----SASELLKDPFFSELNDDD  284 (289)
Q Consensus       259 l~-dp~~Rp-----s~~~il~h~~~~~~~~~~  284 (289)
                      |+ ||++||     ++.+++.||||++++|+.
T Consensus       233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             ccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence            98 999999     888899999999998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.5e-43  Score=301.20  Aligned_cols=265  Identities=25%  Similarity=0.335  Sum_probs=211.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..+.| ++.+.||+|+||.||++.++.+|+.||+|.++.....  ......+.+|+.++++++|+|++++++.+.....+
T Consensus         5 ~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccce-eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            44555 6799999999999999999999999999999865432  22223456799999999999999999988766556


Q ss_pred             eeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      .+++|+||+.+ +|.+++.. ...+++.++..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~kL~dfg~~~~  157 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK-GCLKIADFGLART  157 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccceeee
Confidence            78999999976 88888875 467899999999999999999999999  9999999999999988 8999999999987


Q ss_pred             cCCccc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--C------
Q 022956          173 VGRSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--Q------  241 (289)
Q Consensus       173 ~~~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~------  241 (289)
                      ...... .....+++.|+|||.+.+  .++.++|+||||+++|+|++|..||..................+  .      
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            654322 222335778999997654  37889999999999999999999998765554443333211100  0      


Q ss_pred             ------------C-------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          242 ------------A-------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       242 ------------~-------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                  .       .....++.+.++|.+||. ||++|||+++++.||||++...+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~  301 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE  301 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence                        0       001247788999999999 9999999999999999998766543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.3e-43  Score=299.52  Aligned_cols=259  Identities=22%  Similarity=0.359  Sum_probs=211.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||.||++.+..+++.|++|.+...... .......+.+|+.+++.++|||++++++.+..  +..+++++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   80 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMVM   80 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEEE
Confidence            6789999999999999999999999999998754321 22345678899999999999999999988744  36899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc--
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~--  177 (289)
                      ||++|++|.+++...+.+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++.......  
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCC-CCEEEeeCCCccccCcCccc
Confidence            99999999999988888999999999999999999999999  9999999999999988 899999999876321000  


Q ss_pred             --------------ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC
Q 022956          178 --------------AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA  242 (289)
Q Consensus       178 --------------~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  242 (289)
                                    ......++..|+|||.+.+ .++.++|+||||++++++++|..||.+...................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                          0112346778999997654 4899999999999999999999999875544333333333322222


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCC---HHHHhcCcccccCCCCC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPS---ASELLKDPFFSELNDDD  284 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps---~~~il~h~~~~~~~~~~  284 (289)
                      .....+..+++++.+||+ ||++||+   +.++++||||...+++.
T Consensus       238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence            333568899999999998 9999997   79999999998887654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-43  Score=296.23  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=213.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||.||+|.++.+++.+|+|++...... .....+.+.+|++++++++|||++++++.+.  .+...++|
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   78 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV   78 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence            36789999999999999999999999999999865432 2345678999999999999999999998874  34689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      +||+.|++|.+++....++++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC-CCEEEeecccccccCCCcc
Confidence            999999999999988778999999999999999999999999  9999999999999998 8999999999887654433


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      .....++..|+|||.+... ++.++|+||||+++++|++|..||.....  .....+....  .....+...+..+.+++
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAI  233 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHH
Confidence            4445678899999976654 78999999999999999999999987553  3333333332  22334445678999999


Q ss_pred             HHHHc-CCCCCCCH--HHHhcCccc
Q 022956          256 EKCIA-QPRARPSA--SELLKDPFF  277 (289)
Q Consensus       256 ~~~l~-dp~~Rps~--~~il~h~~~  277 (289)
                      .+||. ||++||++  ++++.||||
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHccCChhHcCCccHHHHhcCCCC
Confidence            99998 99999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.6e-43  Score=297.52  Aligned_cols=250  Identities=25%  Similarity=0.402  Sum_probs=202.0

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|.||+|.+..++..||+|.++....  .+.....+.+|+.++++++|||++++++.+..+  ..+++|+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~   78 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIF   78 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEE
Confidence            678999999999999999999999999999976432  233346678899999999999999999988654  6789999


Q ss_pred             ccccCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956          100 EVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus       100 e~~~~~sL~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCC-CcEEECcccceeecCCC
Confidence            99985 888887642   56899999999999999999999999  9999999999999988 89999999998765433


Q ss_pred             cc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC--------------
Q 022956          177 HA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--------------  239 (289)
Q Consensus       177 ~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------------  239 (289)
                      .. .....+++.|+|||.+.+  .++.++|+||||+++++|++|+.||.+................              
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            22 223356789999997654  3688999999999999999999999865544333322111000              


Q ss_pred             ------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          240 ------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       240 ------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                  ........++++++++.+||. ||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                        001122357889999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.9e-43  Score=290.58  Aligned_cols=253  Identities=34%  Similarity=0.600  Sum_probs=217.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|.||++.+..++..+++|++.....  .....+.+.+|++.+++++|+|++++++.+.......+++++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            568999999999999999999999999999986543  245578899999999999999999999988665346799999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc-
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~-  178 (289)
                      |++++++|.+++.+...+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEcccccEEeccccccc
Confidence            99999999999998878999999999999999999999999  9999999999999998 8999999999987765543 


Q ss_pred             --cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          179 --AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                        .....++..|+|||...+. .+.++|+||||+++++|++|..||............+.........+...+..+.+++
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i  237 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL  237 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence              3445678899999977655 8899999999999999999999998765333333333332333445556689999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCccc
Q 022956          256 EKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .+||+ ||++||++.+++.||||
T Consensus       238 ~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         238 RKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHhCcCChhhCCCHHHHhhCCCC
Confidence            99998 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-43  Score=294.37  Aligned_cols=255  Identities=27%  Similarity=0.473  Sum_probs=208.9

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCC--CHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE--DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      +..+.||+|++|.||++.+..+++.+|+|++.......  .....+.+.+|++++++++|+|++++++.+..  ++.+++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~   80 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHFNL   80 (268)
T ss_pred             cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeEEE
Confidence            56899999999999999999999999999997644221  23356789999999999999999999998844  367899


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      |+||+++++|.+++.+.+++++..+..++.|++.||.+||++|  ++|+||+|+||+++.+...++|+|||.+.......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            9999999999999988888999999999999999999999999  99999999999998773469999999987664332


Q ss_pred             c-----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhCCCCCCCCCCCCCh
Q 022956          178 A-----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       178 ~-----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .     .....++..|+|||.+.+. ++.++|+||||++++++++|..||......  ................+...++
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP  238 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence            1     1223567899999976644 888999999999999999999999753321  2222222222223334455688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      .+.+++.+||. +|++||++.+++.||||+
T Consensus       239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999998 999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.1e-43  Score=292.62  Aligned_cols=254  Identities=30%  Similarity=0.574  Sum_probs=216.5

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|.||+|.+..+++.+++|.+.....   ......+.+|++.+++++|+|++++++.+...  +.+++++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~   78 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL   78 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence            578999999999999999999999999999976532   24567899999999999999999999988554  6899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||+++++|.+++.....+++..+..++.|++.|+.+||+ .+  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC-CCEEEccCccceecccCCC
Confidence            999999999999987889999999999999999999999 99  9999999999999998 8999999999987654333


Q ss_pred             cc-cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          179 AH-SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       179 ~~-~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .. ...++..|+|||.+... ++.++|+||||+++++|++|..||....  ........+.....+.......++.+.++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence            22 34577899999976654 8889999999999999999999998764  44444555444443333333278899999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          255 IEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +.+||. +|++||++.++++||||++.+
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            999998 999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.1e-43  Score=296.64  Aligned_cols=253  Identities=27%  Similarity=0.443  Sum_probs=206.2

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +| ++.+.||+|++|.||++.++.+|+.||+|.+.....  .....+.+.+|++++++++|+|++++++.+...  ..++
T Consensus         2 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~   76 (286)
T cd07847           2 KY-EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLH   76 (286)
T ss_pred             ce-eeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEE
Confidence            44 678999999999999999999999999999875432  222345678899999999999999999988554  5789


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +++||+++++|..+......+++..+..++.|++.+|.|||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTGP  153 (286)
T ss_pred             EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-CcEEECccccceecCCC
Confidence            99999999888888877777999999999999999999999999  9999999999999988 89999999999876543


Q ss_pred             c-ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC----------------
Q 022956          177 H-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG----------------  237 (289)
Q Consensus       177 ~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------------  237 (289)
                      . ......++..|+|||.+.+  .++.++|+||||+++++|++|..||.+....+.........                
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            3 2223456788999997654  37889999999999999999999998765544433222110                


Q ss_pred             ------CCCC------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          238 ------VKPQ------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       238 ------~~~~------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                            ..+.      ......+..+.+|+.+||+ ||++||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                  0000      0012346789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-43  Score=293.37  Aligned_cols=252  Identities=23%  Similarity=0.379  Sum_probs=202.4

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHH-HHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL-LRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.||+|++|.||+|.+..+|+.||+|.++........ ....+..|... ....+|+|++++++.+..  ++.+++++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~   78 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN-QVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEY   78 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHH-HHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEec
Confidence            5699999999999999999999999998754332112 22333444443 455689999999988844  3689999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS  181 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~  181 (289)
                      +++++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++.....   ...
T Consensus        79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~  152 (260)
T cd05611          79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKK  152 (260)
T ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEeecccceeccc---ccc
Confidence            999999999988888999999999999999999999999  9999999999999988 8999999998875543   223


Q ss_pred             CCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChHHHHHHHHHH
Q 022956          182 IIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       182 ~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l  259 (289)
                      ..++..|++||.+.+. ++.++|+||||+++++|++|..||.................. +.......++.+.+++.+||
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  232 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL  232 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence            4577889999976654 788999999999999999999999875544333332222211 22233356899999999999


Q ss_pred             c-CCCCCC---CHHHHhcCcccccCCCC
Q 022956          260 A-QPRARP---SASELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rp---s~~~il~h~~~~~~~~~  283 (289)
                      . +|++||   +++|++.||||+++.|+
T Consensus       233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         233 CMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             cCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence            8 999999   55899999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.1e-43  Score=299.66  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||.||++.++.++..||+|.++.....   .....+.+|+..++.++||||+++++.+...  +.+
T Consensus         6 ~~y-~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~   79 (301)
T cd07873           6 ETY-IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSL   79 (301)
T ss_pred             cce-EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeE
Confidence            345 6789999999999999999999999999999765322   1234567799999999999999999988544  679


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++|+||+.+ +|.+++.. ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKS  155 (301)
T ss_pred             EEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-CcEEECcCcchhccC
Confidence            999999976 88888765 456899999999999999999999999  9999999999999988 899999999987654


Q ss_pred             Cccc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--CCC----------
Q 022956          175 RSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVK----------  239 (289)
Q Consensus       175 ~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~----------  239 (289)
                      .... .....+++.|+|||.+.+  .++.++|+||||+++++|++|..||...............  ...          
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence            3222 223456889999997654  3788999999999999999999999875543332211110  000          


Q ss_pred             --------C-------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          240 --------P-------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       240 --------~-------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                              +       .......++.+++||.+||+ ||.+|||+++++.||||..+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                    0       00112357789999999999 9999999999999999988763

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-42  Score=295.20  Aligned_cols=257  Identities=24%  Similarity=0.441  Sum_probs=208.5

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   91 (289)
                      .+.++| .+.+.||+|+||.||++.++.+++.+|+|.+....     .....+.+|+.+++++ +|||++++++.+...+
T Consensus        19 ~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             CCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            456777 67999999999999999999999999999986432     2245677889999988 8999999999886532


Q ss_pred             ---CCeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           92 ---HNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        92 ---~~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                         ...+++|+||+++++|.+++..    +..+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~-~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEE
Confidence               2468999999999999998753    467899999999999999999999999  9999999999999988 89999


Q ss_pred             eccCCccccCCcc-ccccCCCCCCCCCCccccc------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC
Q 022956          165 GDLGFAAIVGRSH-AAHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       165 ~d~g~~~~~~~~~-~~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  237 (289)
                      +|||.+....... ......++..|+|||.+..      .++.++|+||||+++++|++|..||................
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  249 (291)
T cd06639         170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP  249 (291)
T ss_pred             eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence            9999987654322 2233457889999997643      25789999999999999999999998765544444433222


Q ss_pred             CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          238 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      ......+...+..+.+++.+||+ +|++||++.+++.||||+
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            22222233456789999999998 999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-43  Score=291.49  Aligned_cols=252  Identities=27%  Similarity=0.512  Sum_probs=209.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.+.||+|++|.||+|.+..+++.+++|++....    ....+.+.+|++++++++|||++++++.+...  ..
T Consensus         2 ~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~   74 (262)
T cd06613           2 QEDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DK   74 (262)
T ss_pred             ccce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CE
Confidence            4555 67899999999999999999999999999998653    22467888999999999999999999887554  67


Q ss_pred             eEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ++++|||+++++|.+++... ..+++.++..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~  151 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQL  151 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCC-CCEEECccccchhh
Confidence            99999999999999999875 78999999999999999999999999  9999999999999988 89999999998765


Q ss_pred             CCcc-ccccCCCCCCCCCCccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC--CCCC
Q 022956          174 GRSH-AAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA--LNKV  246 (289)
Q Consensus       174 ~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  246 (289)
                      .... ......++..|+|||...+    .++.++|+||||+++++|++|..||..................+..  ....
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd06613         152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK  231 (262)
T ss_pred             hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence            4332 2233457788999997643    4788999999999999999999999876655544433333222211  1223


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcc
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPF  276 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~  276 (289)
                      .+..+.+++.+||. +|.+||++.+++.|+|
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            46789999999998 9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.6e-43  Score=296.03  Aligned_cols=257  Identities=26%  Similarity=0.507  Sum_probs=210.0

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD   89 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   89 (289)
                      ...+.++| ++.+.||+|+||.||+|.++.+++.+|+|++...     ......+..|+.+++++ +|+|++++++.+..
T Consensus        11 ~~~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636          11 LRDPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hcChhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            34566777 6789999999999999999999999999998653     22345678899999888 69999999998754


Q ss_pred             C----CCCeeEEEeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956           90 D----QHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus        90 ~----~~~~~~lv~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                      .    ....++++|||+++++|.+++..  +..+++..+..++.|++.|+.|||+.|  ++|+||+|+||+++.+ +.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~-~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEE
Confidence            2    24678999999999999999875  345888999999999999999999999  9999999999999988 8999


Q ss_pred             EeccCCccccCCc-cccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC
Q 022956          164 IGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG  236 (289)
Q Consensus       164 l~d~g~~~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  236 (289)
                      |+|||++...... .......+++.|+|||.+.      ..++.++|+||||+++|+|++|..||........... +..
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~  240 (282)
T cd06636         162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPR  240 (282)
T ss_pred             EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-Hhh
Confidence            9999998765432 2223456788999999654      2377899999999999999999999976554444333 223


Q ss_pred             CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          237 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ...+.......+..+.+++.+||. ||.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            333333344568899999999998 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-42  Score=290.68  Aligned_cols=251  Identities=34%  Similarity=0.625  Sum_probs=209.7

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|++|.||++.+..++..+++|.++....  .....+.+.+|+.+++.++|+|++++++....  .+.+++|+
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~   78 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM   78 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence            679999999999999999998999999999987653  24567889999999999999999999997644  36799999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      ||+++++|.+++.....+++..+..++.+++.|+.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEcccccccccCCCCCc
Confidence            99999999999998878999999999999999999999999  9999999999999998 89999999999876433221


Q ss_pred             -----ccCCCCCCCCCCcccccC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC-CCCCCCh
Q 022956          180 -----HSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDP  249 (289)
Q Consensus       180 -----~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  249 (289)
                           ....++..|+|||.+.+.    ++.++|+||||++++++++|..||............+.....+.. .....++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP  235 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence                 124577899999976532    688999999999999999999999765444333333333222211 1222488


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .+.+++..||+ +|++||++.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999998 99999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.6e-43  Score=296.01  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=203.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH-HHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.+.||+|+||.||++.++.+|+.||+|.++....  ... ...+..|.. .++.++|||++++++.+...  +.++++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv   78 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC   78 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence            578999999999999999999999999999976532  122 233444544 46778999999999988544  578999


Q ss_pred             eccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           99 TEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      +||+++ +|.+++..    ...+++..+..++.|++.||.|||++ +  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN-GQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeeccccccc
Confidence            999975 78777653    35689999999999999999999997 8  9999999999999998 89999999998766


Q ss_pred             CCccccccCCCCCCCCCCccccc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          174 GRSHAAHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       174 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ..........++..|+|||.+.+     .++.++|+||||+++++|++|..||..................+.......+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS  234 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence            44333333457788999997653     2678999999999999999999999754332222223333333333344568


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      +.+.+++.+||. +|++||++.+++.||||.+....
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            899999999998 99999999999999999987644

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-42  Score=290.27  Aligned_cols=249  Identities=24%  Similarity=0.487  Sum_probs=209.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||.+|.+.+..+|..||+|.+.....  .....+.+.+|+.++++++|||++++++.+..  .+..++|+
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM   78 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence            679999999999999999999999999999986543  33445678999999999999999999988743  46899999


Q ss_pred             ccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+.+++|.+++...  ..+++.++..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++++|||.+.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEEeeccceeecCcch
Confidence            999999999998753  35799999999999999999999999  9999999999999988 899999999997664432


Q ss_pred             c-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          178 A-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       178 ~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      . .....+++.|+|||.+.+. ++.++|+||||+++++|++|..||............+.+....  .+...+..+.+++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li  233 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP--VSSHYSYDLRNLV  233 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC--CcccCCHHHHHHH
Confidence            2 1223467889999976644 8889999999999999999999998765555544444443322  2344688999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCccc
Q 022956          256 EKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .+||+ +|++||++.++++||||
T Consensus       234 ~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         234 SQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHhhCChhhCcCHHHHhhCcCC
Confidence            99998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8e-44  Score=321.52  Aligned_cols=257  Identities=21%  Similarity=0.345  Sum_probs=210.5

Q ss_pred             CceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeee-
Q 022956            8 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYS-   85 (289)
Q Consensus         8 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-   85 (289)
                      .+.....++...++.+.|.+|||+.||+|.+...|..||+|.+-..    ++...+.+.+|++++++|+ |+|||.+++ 
T Consensus        28 ~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   28 VGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             CceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            3455566777778999999999999999999988899999999765    6778899999999999996 999999999 


Q ss_pred             eEEeC-C---CCeeEEEeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC
Q 022956           86 VWLDD-Q---HNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI  159 (289)
Q Consensus        86 ~~~~~-~---~~~~~lv~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~  159 (289)
                      ..... .   ...+.|+||||.|++|-|++.+  ..+|++.++++|+.++++|+.+||...+|++|||||-+|||++.+ 
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-  182 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-  182 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-
Confidence            43322 1   1357889999999999999985  356999999999999999999999999999999999999999999 


Q ss_pred             CcEEEeccCCccccCCcccc-c---------cCCCCCCCCCCccc---ccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 022956          160 GQVKIGDLGFAAIVGRSHAA-H---------SIIGTPEYMAPELY---EED-YTEMVDIYSFGLCLLEMVTMEIPYSECD  225 (289)
Q Consensus       160 ~~~~l~d~g~~~~~~~~~~~-~---------~~~~~~~~~aPE~~---~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~  225 (289)
                      |..||||||.+...-..... .         ....|+.|++||.+   ++. .++++|||+|||+||.|+....||....
T Consensus       183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg  262 (738)
T KOG1989|consen  183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG  262 (738)
T ss_pred             CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence            89999999999765332211 1         12468999999943   343 8999999999999999999999998632


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .    ..++..+..-.. ....+..+++||..||+ ||++||++.|++.+
T Consensus       263 ~----laIlng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  263 K----LAILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             c----eeEEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            2    223333322222 24568899999999999 99999999999983

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.2e-43  Score=295.21  Aligned_cols=242  Identities=23%  Similarity=0.334  Sum_probs=203.3

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe--CCCCeeEEEec
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD--DQHNTLNFITE  100 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~~lv~e  100 (289)
                      ..||+|+++.||++..  +|+.||+|.++.... ......+.+.+|+.++++++||||+++++++.+  .....++++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999987  689999999976532 234556788999999999999999999998876  44467899999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      |+++++|.+++.+...+++.....++.+++.|+.+||+. +  ++|+||+|+||+++.+ +.+||+|||++.......  
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC-CcEEEcccchHhhhcccc--
Confidence            999999999999888899999999999999999999985 7  8899999999999998 899999999987654322  


Q ss_pred             ccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ....++..|+|||.+.+   .++.++||||||+++|+|++|..||.+..........+..+..+ ..+...++.+++++.
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~l~~li~  256 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-KLPLDCPLEIKCIVE  256 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-CCCCcCcHHHHHHHH
Confidence            23457889999997754   58999999999999999999999998765444444433333332 233356899999999


Q ss_pred             HHHc-CCCCCCCHHHHhc
Q 022956          257 KCIA-QPRARPSASELLK  273 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~  273 (289)
                      +||+ ||++|||+++++.
T Consensus       257 ~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        257 ACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHhcCCcccCcCHHHHHH
Confidence            9998 9999999999987

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.6e-43  Score=294.94  Aligned_cols=251  Identities=24%  Similarity=0.432  Sum_probs=205.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|.||+|.++.+|..+|+|++.....  .......+.+|+.++++++|||++++++.+...  ..+++|+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~   78 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLVM   78 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEEe
Confidence            688999999999999999999999999999987543  234456788999999999999999999988553  6899999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||+ +++|.+++.. ...+++.++..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC
Confidence            999 8899999865 467899999999999999999999999  9999999999999998 8999999999887654331


Q ss_pred             --cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--------------
Q 022956          179 --AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------------  240 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------  240 (289)
                        .....++..|+|||.+.+  .+++++||||||+++++|++|..||.+................+              
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence              233467889999997653  36889999999999999999988887655443333222211100              


Q ss_pred             -------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          241 -------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       241 -------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                                   .......+..+.+++.+||+ ||++||++++++.||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                         00112346889999999998 999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.6e-43  Score=295.28  Aligned_cols=252  Identities=23%  Similarity=0.395  Sum_probs=199.7

Q ss_pred             eecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHH---HHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           24 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV---QLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~---~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      .||+|+||.||++.+..+++.+|+|.+.......... .....++.   +.+...+||+++.+.+.+...  +..++|||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e   77 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILD   77 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEe
Confidence            4899999999999999999999999997654322211 12233343   334445789999998877543  57899999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccc
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH  180 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~  180 (289)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus        78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~  153 (279)
T cd05633          78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PH  153 (279)
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-cc
Confidence            9999999999988888999999999999999999999999  9999999999999988 899999999987554332 22


Q ss_pred             cCCCCCCCCCCcccc-c-CCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          181 SIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ...++..|+|||... + .++.++|+||+||++++|++|..||.....  ..........  .....+...++.+++++.
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~  231 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELPDSFSPELKSLLE  231 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc--CCcCCccccCHHHHHHHH
Confidence            346889999999764 3 378899999999999999999999975322  1222221111  222344557899999999


Q ss_pred             HHHc-CCCCCC-----CHHHHhcCcccccCCCCC
Q 022956          257 KCIA-QPRARP-----SASELLKDPFFSELNDDD  284 (289)
Q Consensus       257 ~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~~  284 (289)
                      +||+ ||.+||     +++++++||||+++++..
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence            9998 999999     699999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.9e-43  Score=297.07  Aligned_cols=260  Identities=26%  Similarity=0.377  Sum_probs=210.4

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.++||+|++|.||+|.+..+|+.||+|.++.....+. ......+.+|+++++.++|+|++++++.+..  .+..++|
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv   80 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNINLV   80 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEEEE
Confidence            568899999999999999999999999999987654311 2334567789999999999999999998865  3689999


Q ss_pred             eccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      +||+ +++|.+++.... .+++..+..++.|+++||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-CCEEEccceeeeeccCCC
Confidence            9999 789999998765 7999999999999999999999999  9999999999999988 899999999998765432


Q ss_pred             c-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--------------
Q 022956          178 A-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------------  240 (289)
Q Consensus       178 ~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------  240 (289)
                      . .....+++.|+|||.+.+  .++.++|+|||||++++|++|..||..................+              
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence            2 223345778999997643  37889999999999999999988887655444332222111000              


Q ss_pred             -----------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          241 -----------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       241 -----------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                 .......+..+.+++.+||+ ||++|||+.+++.||||++.....+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence                       00112346789999999998 9999999999999999999866554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-42  Score=291.76  Aligned_cols=251  Identities=29%  Similarity=0.493  Sum_probs=208.2

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|++|+||+|.+..++..+++|++.....   ......+.+|++.++.++|+|++++++.+...  +.++++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv   77 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLV   77 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEE
Confidence            3689999999999999999988999999999975443   22567889999999999999999999887554  679999


Q ss_pred             eccccCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           99 TEVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +|++++++|.+++...   ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccchHHHhcc
Confidence            9999999999999763   45899999999999999999999999  9999999999999998 8999999999876644


Q ss_pred             cccc-----ccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC---CC
Q 022956          176 SHAA-----HSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL---NK  245 (289)
Q Consensus       176 ~~~~-----~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  245 (289)
                      ....     ....++..|+|||.+..  .++.++|+||||+++++|++|+.||..........+...........   ..
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            3222     23357889999996654  48889999999999999999999998765554444444332211111   12


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ..++.+.+++.+||. ||++||++.+++.||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            457889999999998 99999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-42  Score=289.20  Aligned_cols=252  Identities=33%  Similarity=0.543  Sum_probs=212.4

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +..+.||+|++|.||+|.+..++..|++|.+...... ...+..+.+.+|+.+++.++|+|++++++.+...  ..++++
T Consensus         3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv   80 (258)
T cd06632           3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLYIF   80 (258)
T ss_pred             cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEEEE
Confidence            5689999999999999999989999999999865432 1244567899999999999999999999877443  678999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      +||+++++|.+++.....+++..+..++.|++.|+.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccceecccccc
Confidence            999999999999988888999999999999999999999999  9999999999999988 8999999999887654443


Q ss_pred             cccCCCCCCCCCCccccc-C-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      .....++..|++||.+.. . ++.++|+||||+++++|++|..||................ .....+...++.+.+++.
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  236 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELPPIPDHLSDEAKDFIL  236 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCCCcCCCcCHHHHHHHH
Confidence            445567889999996543 3 7889999999999999999999998766444444333212 223344556899999999


Q ss_pred             HHHc-CCCCCCCHHHHhcCccc
Q 022956          257 KCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +||. +|++||++.+++.|||+
T Consensus       237 ~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         237 KCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHhhcCcccCcCHHHHhcCCCC
Confidence            9998 99999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-42  Score=294.74  Aligned_cols=256  Identities=24%  Similarity=0.474  Sum_probs=206.5

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe--
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD--   89 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--   89 (289)
                      ++..+| ++.+.||+|+||.||++.++.+++.+|+|++....     .....+.+|+.+++.+ +|+|++++++.+..  
T Consensus        15 ~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             Ccccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            466677 67999999999999999999999999999886432     1135577899999999 69999999998753  


Q ss_pred             -CCCCeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           90 -DQHNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        90 -~~~~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                       ..+..++++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC-CCEEE
Confidence             234578999999999999988752    356889999999999999999999999  9999999999999998 89999


Q ss_pred             eccCCccccCCcc-ccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC
Q 022956          165 GDLGFAAIVGRSH-AAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       165 ~d~g~~~~~~~~~-~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  237 (289)
                      +|||++....... ......+++.|+|||.+.      ..++.++|+||||+++|+|++|..||................
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  245 (286)
T cd06638         166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP  245 (286)
T ss_pred             ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence            9999987654322 223346788999999764      237889999999999999999999998755444433322222


Q ss_pred             CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          238 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ......+...+..+.+++.+||+ ||++|||+.++++|+||
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            12222334457789999999998 99999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-42  Score=292.87  Aligned_cols=256  Identities=29%  Similarity=0.502  Sum_probs=208.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ...+.||.|++|.||++.+..+++.+|+|.+....   .......+.+|+++++.++||||+++++.+.....+.+++||
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46899999999999999999999999999997543   234467788999999999999999999988776667899999


Q ss_pred             ccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          100 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       100 e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC-CeEEEeeccccccccc
Confidence            99999999888653    356899999999999999999999999  9999999999999988 8999999999875543


Q ss_pred             ccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhCCCCCCCCC-----C
Q 022956          176 SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQALN-----K  245 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~-----~  245 (289)
                      ... ....++..|+|||...+ .++.++|+||||+++|+|++|..||...    .........+.....+....     .
T Consensus       158 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         158 SLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             ccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence            221 23456788999997654 4889999999999999999999999864    22223333333322111111     1


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ..++.+.+++.+||. +|++|||+.|++.||||++...
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            235789999999998 9999999999999999977643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-43  Score=306.45  Aligned_cols=246  Identities=30%  Similarity=0.410  Sum_probs=193.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||.||+|.+..++..||+|+....          ....|+.+++.++|+||+++++.+...  ...++|
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  135 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV  135 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence            47899999999999999999999999999985422          123588999999999999999988654  578899


Q ss_pred             eccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      +|++.+ +|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.......
T Consensus       136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEecCccccccccCc
Confidence            999966 78777754 567999999999999999999999999  9999999999999988 899999999997654443


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCC-CCCCCcH---------HHHHHHHhC-CCCCCCC--
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIP-YSECDSV---------AKIYKKVTG-GVKPQAL--  243 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p-~~~~~~~---------~~~~~~~~~-~~~~~~~--  243 (289)
                      ......+++.|+|||.+.+. ++.++|||||||++|+|+++..| |......         ......+.. +..+...  
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            44455689999999977654 89999999999999999985444 3321110         111111111 0000000  


Q ss_pred             ----------------------------CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          244 ----------------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       244 ----------------------------~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                                                  ....+..+.+||.+||+ ||++|||+.|+|+||||+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence                                        11235567789999999 99999999999999999874

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=288.37  Aligned_cols=254  Identities=30%  Similarity=0.548  Sum_probs=214.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.+.||+|++|.||++.++.++..+|+|.+...... ........+.+|+.++++++|+|++++++.+.......++++
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF   84 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence            6899999999999999999999999999998653221 134456789999999999999999999998766555678999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      +||+++++|.+++.....+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECccccccccccccc
Confidence            999999999999988777999999999999999999999999  9999999999999988 899999999997653211 


Q ss_pred             ---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 ---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                         ......++..|+|||.+.+. ++.++|+||||++++++++|..||..........+.... ......+...++.+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ-PTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC-CCCCCCCcccCHHHHH
Confidence               11234578899999977654 889999999999999999999999876666555544433 2334456667899999


Q ss_pred             HHHHHHcCCCCCCCHHHHhcCccc
Q 022956          254 FIEKCIAQPRARPSASELLKDPFF  277 (289)
Q Consensus       254 li~~~l~dp~~Rps~~~il~h~~~  277 (289)
                      ++.+||++|.+||++.+++.|||.
T Consensus       241 ~i~~~l~~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFVEEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhcCcccCccHHHHhcCCCC
Confidence            999999988999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.6e-43  Score=307.16  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=207.5

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-C-----CceEEeeeeEEeC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-N-----KYIIVCYSVWLDD   90 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~   90 (289)
                      || .+.+.||+|+||.|.+|.+.+|++.||||+++.     ..........|+++|..|+ |     -|+|+++++|...
T Consensus       187 rY-~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  187 RY-EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EE-EEEEEecccccceeEEEEecCCCcEEEEEeecc-----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            44 468999999999999999999999999999985     4556677788999999997 3     4899999998665


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe-CCCCcEEEecc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDL  167 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~-~~~~~~~l~d~  167 (289)
                        +++|||+|.++. +|.+++.++  ..++...+..++.|++.+|.+||+.|  ++|+||||+|||+. .+...||++||
T Consensus       261 --~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  261 --NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             --cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEec
Confidence              689999999966 999999875  46889999999999999999999999  99999999999994 44468999999


Q ss_pred             CCccccCCccccccCCCCCCCCCCcc-cccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-----
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPEL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-----  241 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~-~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  241 (289)
                      |++.+....--  .+.-+.-|.|||+ +...|+.+.||||||||++||++|...|++....+++..++.-...+.     
T Consensus       336 GSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  336 GSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99998765533  5566778999995 455699999999999999999999999987665555543222111000     


Q ss_pred             --------------------------------------------CCC-----------CCCChHHHHHHHHHHc-CCCCC
Q 022956          242 --------------------------------------------ALN-----------KVKDPEVKAFIEKCIA-QPRAR  265 (289)
Q Consensus       242 --------------------------------------------~~~-----------~~~~~~~~~li~~~l~-dp~~R  265 (289)
                                                                  ..+           ......+.+++.+||+ ||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                                                        000           0123467899999999 99999


Q ss_pred             CCHHHHhcCcccccCCCC
Q 022956          266 PSASELLKDPFFSELNDD  283 (289)
Q Consensus       266 ps~~~il~h~~~~~~~~~  283 (289)
                      +|..++|+||||......
T Consensus       494 ~tp~qal~Hpfl~~~~~~  511 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTSLE  511 (586)
T ss_pred             CCHHHHhcCccccccccc
Confidence            999999999999965443

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=292.21  Aligned_cols=255  Identities=30%  Similarity=0.507  Sum_probs=210.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC---CCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~   95 (289)
                      |++.++||+|+||.||+|.+..++..+|+|.+....   .......+.+|+++++.++   |||++++++.+...  ...
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~   77 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRL   77 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEE
Confidence            467899999999999999999999999999987543   2334567888999999986   99999999987543  678


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++++||+++++|.+++..+ .+++..+..++.|++.+|.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~  153 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNT-GNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCC-CCEEEccCCceeecCC
Confidence            9999999999999998764 7999999999999999999999999  9999999999999988 8999999999976654


Q ss_pred             ccc-cccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          176 SHA-AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       176 ~~~-~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ... .....++..|+|||.+.+.  ++.++|+||||+++|+|++|..||......... ..+.....+.......+.++.
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-MLIPKSKPPRLEDNGYSKLLR  232 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-hccccCCCCCCCcccCCHHHH
Confidence            322 2334578889999976532  688999999999999999999999875443332 222222223222333678999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      +++..||+ ||++||++.+++.|+||++...+
T Consensus       233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         233 EFVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence            99999998 99999999999999999887644

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-42  Score=293.96  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=205.9

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .| ++.+.||+|++|.||+|.++.+++.+++|.++.....  +.....+.+|+..+++++|||++++++.+.....+..+
T Consensus         6 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           6 EY-EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hh-hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            44 5789999999999999999999999999999865432  23344567899999999999999999988766557899


Q ss_pred             EEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           97 FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +|+||+.+ +|.+++... ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR-GILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CcEEEeecCceeeccC
Confidence            99999986 899988764 45899999999999999999999999  9999999999999998 8999999999887655


Q ss_pred             cc-ccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-------------
Q 022956          176 SH-AAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-------------  239 (289)
Q Consensus       176 ~~-~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------------  239 (289)
                      .. ......+++.|+|||.+.+.  ++.++|+||||+++++|++|..||..................             
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            42 22334567889999976543  688999999999999999999999865544333222111000             


Q ss_pred             ---------------CCCCCCC-CChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          240 ---------------PQALNKV-KDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       240 ---------------~~~~~~~-~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                     ....+.. .++.+.+++.+||+ ||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                           0011111 47889999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.5e-43  Score=300.46  Aligned_cols=247  Identities=26%  Similarity=0.396  Sum_probs=190.3

Q ss_pred             eeeecccCcceEEEEeecC--CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           22 SDLLGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .++||+|+||+||+|.++.  ++..||+|.+.....      ...+.+|+++++.++|||++++++.+....+..+++++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            5789999999999998653  568899999874322      24567899999999999999999988766667899999


Q ss_pred             ccccCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe---CCCCcEEEecc
Q 022956          100 EVCTSGNLRTYRKK---------HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN---GNIGQVKIGDL  167 (289)
Q Consensus       100 e~~~~~sL~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~---~~~~~~~l~d~  167 (289)
                      ||+.+ +|.+++..         ...+++..+..++.|++.||.|||+.+  ++|+||||+||++.   ...+.++|+||
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            99976 78777642         124889999999999999999999999  99999999999993   22278999999


Q ss_pred             CCccccCCccc----cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------HHHHH
Q 022956          168 GFAAIVGRSHA----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---------AKIYK  232 (289)
Q Consensus       168 g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------~~~~~  232 (289)
                      |++........    .....+++.|+|||.+.+  .++.++|||||||++++|+||..||......         .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            99986643321    223457889999997654  3788999999999999999999999643211         00000


Q ss_pred             HHh--------------CCCC---------------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcc
Q 022956          233 KVT--------------GGVK---------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF  276 (289)
Q Consensus       233 ~~~--------------~~~~---------------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~  276 (289)
                      ...              ....                     ........+..+.+|+.+||+ ||.+|||++|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            000              0000                     000111235678899999999 9999999999999999


Q ss_pred             c
Q 022956          277 F  277 (289)
Q Consensus       277 ~  277 (289)
                      |
T Consensus       317 f  317 (317)
T cd07867         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-42  Score=291.58  Aligned_cols=253  Identities=23%  Similarity=0.406  Sum_probs=201.3

Q ss_pred             eecccCcceEEEEeecCCCcEEEEEEeeecccCCCHH--HHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           24 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV--LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      .||+|+||.||++.+..+++.||+|.+..........  .........+.++...||+++.+.+.+...  ..+++|+||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence            4899999999999999999999999997654321111  111222234455566899999998877543  579999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS  181 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~  181 (289)
                      +.|++|..++...+.+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++...... ....
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~  154 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHA  154 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcC
Confidence            999999999988888999999999999999999999999  9999999999999988 89999999998755432 2234


Q ss_pred             CCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          182 IIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       182 ~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      ..++..|+|||.+.+  .++.++|+||+|+++++|++|..||.....  ..........  .....+...+..+.+++.+
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~  232 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG  232 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence            468899999997653  378999999999999999999999986522  1222222221  1222344468899999999


Q ss_pred             HHc-CCCCCC-----CHHHHhcCcccccCCCCC
Q 022956          258 CIA-QPRARP-----SASELLKDPFFSELNDDD  284 (289)
Q Consensus       258 ~l~-dp~~Rp-----s~~~il~h~~~~~~~~~~  284 (289)
                      ||. +|.+||     ++.++++||||+..+|+.
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence            998 999999     999999999999987754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.9e-42  Score=292.16  Aligned_cols=257  Identities=25%  Similarity=0.477  Sum_probs=212.4

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      +..| +..++||+|+||.||+|.+..++..+|+|.++...   .......+.+|+++++++.|+|++++++.+.+.  ..
T Consensus         3 ~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   76 (277)
T cd06640           3 EELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TK   76 (277)
T ss_pred             HHhh-hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CE
Confidence            3455 46788999999999999999999999999997543   234467889999999999999999999988554  68


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++|+||+++++|.+++.. .++++.++..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++++|||++....
T Consensus        77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~  152 (277)
T cd06640          77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC-CCEEEcccccceecc
Confidence            9999999999999999876 46899999999999999999999999  9999999999999988 899999999997654


Q ss_pred             Cccc-cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      .... .....++..|+|||.+.+ .++.++|+||||+++++|++|..||.......... .+..... .......+..+.
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~  230 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPKNNP-PTLTGEFSKPFK  230 (277)
T ss_pred             CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-hhhcCCC-CCCchhhhHHHH
Confidence            3321 223356778999997654 48899999999999999999999998655443332 2222222 233445678899


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      +++.+||+ +|++||++.+++.|+||.+....
T Consensus       231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         231 EFIDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            99999998 99999999999999999877543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-42  Score=293.25  Aligned_cols=255  Identities=29%  Similarity=0.520  Sum_probs=208.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.+.||+|+||.||++.+..+|..||+|.++...   .......+.+|++++++++|+|++++++.+...  +.+++|
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv   77 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMC   77 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEE
Confidence            367899999999999999999999999999987532   344467788999999999999999999987553  689999


Q ss_pred             eccccCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           99 TEVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +||+++++|..++...   ..+++..+..++.|++.||.|||+ .+  ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCC-CCEEEeecCCccccc
Confidence            9999999999988763   378999999999999999999996 58  9999999999999987 899999999987653


Q ss_pred             CccccccCCCCCCCCCCcccccC-------CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHhCCCCCCCCCC
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK--IYKKVTGGVKPQALNK  245 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  245 (289)
                      .. ......+++.|+|||.+.+.       ++.++|+|||||++++|++|..||........  ....+..+..+ ..+.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~  232 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP-TLPS  232 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-CCCc
Confidence            32 22234577899999976432       47899999999999999999999975433221  12222222222 2334


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ..++.+++++.+||. +|++||++++++.||||......
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            478999999999998 99999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.7e-42  Score=288.30  Aligned_cols=248  Identities=30%  Similarity=0.483  Sum_probs=201.7

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ..+||+|+||.||++.+..++..+++|.+...    .....+.+.+|+.+++.++|+|++++++.+...  ..+++++||
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~   86 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQ   86 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEec
Confidence            46899999999999999999999999998754    333456788999999999999999999987544  689999999


Q ss_pred             ccCCcHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          102 CTSGNLRTYRKKH-RHV--SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       102 ~~~~sL~~~~~~~-~~l--~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      +++++|.+++... ..+  ++..+..++.|++.|+.|||+.|  ++|+||+|+||+++.+.+.++|+|||.+........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9999999999764 445  88899999999999999999999  999999999999987547999999999876543222


Q ss_pred             -cccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          179 -AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       179 -~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                       .....+++.|+|||.+.+   .++.++|+||||+++++|++|..||......................+...++.++++
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence             223457889999997643   2788999999999999999999999764433222211111112223445578899999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCccc
Q 022956          255 IEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +.+||. +|++||++.+++.||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999998 99999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-42  Score=290.72  Aligned_cols=251  Identities=24%  Similarity=0.407  Sum_probs=207.9

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccC
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS  104 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  104 (289)
                      ||+|+||.||++.+..+|+.+++|.+...... .....+.+.+|++.+++++|+|++++++.+..  +...++++||+.+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhh-hhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCC
Confidence            68999999999999989999999999755331 23456788999999999999999999987743  4679999999999


Q ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-------
Q 022956          105 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-------  177 (289)
Q Consensus       105 ~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-------  177 (289)
                      ++|.+++...+.+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|+|||++.......       
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccc
Confidence            999999988778999999999999999999999999  9999999999999998 899999999987654321       


Q ss_pred             --ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          178 --AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       178 --~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                        ......++..|++||...+. .+.++|+||||++++++++|..||......... ..+..+..........++.+.++
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF-QNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcCCcCCCccccCCHHHHHH
Confidence              12234567889999966544 888999999999999999999999875544433 33333222211122248899999


Q ss_pred             HHHHHc-CCCCCCCH---HHHhcCcccccCCC
Q 022956          255 IEKCIA-QPRARPSA---SELLKDPFFSELND  282 (289)
Q Consensus       255 i~~~l~-dp~~Rps~---~~il~h~~~~~~~~  282 (289)
                      +.+||+ +|++||++   .++|.||||++++|
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            999998 99999999   99999999999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.3e-42  Score=289.75  Aligned_cols=253  Identities=29%  Similarity=0.500  Sum_probs=206.5

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCC------CHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE------DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      .+.+.||+|++|.||+|.+..+|+.+|+|.++......      .....+.+.+|+++++.++|+|++++++.+..  .+
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   81 (272)
T cd06629           4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--EE   81 (272)
T ss_pred             eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--CC
Confidence            56899999999999999999999999999987543211      12234568889999999999999999987744  36


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+++|+||+++++|.+++.....+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++++|||.+...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC-CeEEEeeccccccc
Confidence            78999999999999999988788999999999999999999999999  9999999999999988 89999999998755


Q ss_pred             CCcc---ccccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC---CCCC
Q 022956          174 GRSH---AAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---QALN  244 (289)
Q Consensus       174 ~~~~---~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~  244 (289)
                      ....   ......++..|+|||.+..   .++.++|+||||++++++++|..||...................   ....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS  238 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence            3221   1223457789999997653   27889999999999999999999997655544443332222221   1222


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ...+..+.+++.+||+ ||++||+++++++||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            2357899999999998 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-42  Score=294.91  Aligned_cols=262  Identities=28%  Similarity=0.486  Sum_probs=213.4

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      ....++.++| .+.+.||+|+||.||++.+..++..+++|.+....    ....+.+.+|+.+++.++|||++++++.+.
T Consensus        12 ~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~   86 (293)
T cd06647          12 VSVGDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYL   86 (293)
T ss_pred             eeccCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheee
Confidence            3345566777 57899999999999999998899999999986432    223466888999999999999999999886


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      ..  +..++|+||+++++|.+++.+. .+++..+..++.|++.|+.+||++|  ++|+||+|+||+++.+ +.++|+|||
T Consensus        87 ~~--~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~-~~~kL~dfg  160 (293)
T cd06647          87 VG--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFG  160 (293)
T ss_pred             eC--CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC-CCEEEccCc
Confidence            54  5789999999999999998764 5889999999999999999999999  9999999999999988 899999999


Q ss_pred             CccccCCcc-ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          169 FAAIVGRSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       169 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ++....... ......+++.|++||.+.+ .++.++|+||||+++|++++|..||......................+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd06647         161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK  240 (293)
T ss_pred             ceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence            886554322 2223457788999997654 48889999999999999999999998755443333222222222223344


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+..+++++..||. +|++||++++++.|+||+...
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            57889999999998 999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-42  Score=305.68  Aligned_cols=256  Identities=24%  Similarity=0.337  Sum_probs=203.0

Q ss_pred             cceeeeecccCcceEEEEeec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      |++.++||+|+||.||++...  .++..+|+|.+...         ....+|++++++++||||+++++.+...  ..++
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~  162 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWK--STVC  162 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeC--CEEE
Confidence            478999999999999999754  45678999988642         2345699999999999999999887544  5799


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      ++||++.+ +|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++......
T Consensus       163 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        163 MVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEccCccccccCcc
Confidence            99999965 89898877788999999999999999999999999  9999999999999988 89999999998765432


Q ss_pred             c---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhC-------------
Q 022956          177 H---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTG-------------  236 (289)
Q Consensus       177 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~-------------  236 (289)
                      .   ......+++.|+|||.+.+. ++.++|||||||++|+|++|+.||.+...   ...+...+..             
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            2   22345689999999987654 88999999999999999999999965321   1111111110             


Q ss_pred             ------------CCCCCC------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCCCC
Q 022956          237 ------------GVKPQA------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP  289 (289)
Q Consensus       237 ------------~~~~~~------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~~~  289 (289)
                                  ...+..      .....+..+.++|.+||. ||++||++.++|.||||++..++.-+.+|
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~~~~  390 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLNITP  390 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhcCcc
Confidence                        000000      012235678899999998 99999999999999999998777655443

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-42  Score=300.49  Aligned_cols=267  Identities=25%  Similarity=0.385  Sum_probs=211.0

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC---
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---   91 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   91 (289)
                      ..+| ++.+.||+|+||+||++.+..+++.||+|.+.....  .......+.+|+.+++.++|+|++++++++....   
T Consensus         4 ~~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           4 DTKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             ccce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            4455 679999999999999999999999999999875422  2223456778999999999999999998765432   


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ...+++++||+. ++|.+++...+.+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcCcccc
Confidence            135899999996 489999988888999999999999999999999999  9999999999999988 899999999997


Q ss_pred             ccCCcc-ccccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--CC---------
Q 022956          172 IVGRSH-AAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GG---------  237 (289)
Q Consensus       172 ~~~~~~-~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~---------  237 (289)
                      ...... ......++..|+|||.+.  ..++.++|+||||+++++|++|..||.+.+..........  +.         
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            664332 222345678899999664  3488999999999999999999999976432221111100  00         


Q ss_pred             ---------------CCC--CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCCC
Q 022956          238 ---------------VKP--QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS  288 (289)
Q Consensus       238 ---------------~~~--~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~~  288 (289)
                                     ...  .......++.+.+++.+||+ +|++|||++++++||||+.+.....+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~  305 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV  305 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc
Confidence                           000  01122457889999999999 9999999999999999998866665543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=292.45  Aligned_cols=253  Identities=24%  Similarity=0.419  Sum_probs=206.7

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +| ++.++||+|++|.||+|.++.+++.|++|.++....  .....+.+.+|+++++.++|+|++++++.+...  +..+
T Consensus         2 ~y-~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   76 (288)
T cd07833           2 KY-EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLY   76 (288)
T ss_pred             ce-eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEE
Confidence            44 689999999999999999999999999999876433  344467889999999999999999999988653  6799


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +++||++++.+..+..+...+++.++..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRAR  153 (288)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEEeeecccccCCC
Confidence            99999999777777776677999999999999999999999999  9999999999999988 89999999998876544


Q ss_pred             c--ccccCCCCCCCCCCcccc-c-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--CCCC-----------
Q 022956          177 H--AAHSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVK-----------  239 (289)
Q Consensus       177 ~--~~~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~~-----------  239 (289)
                      .  ......++..|+|||... . .++.++|+||||+++++|++|..||.+....+.......  ....           
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            3  223345678899999654 3 478899999999999999999999986544433322111  0000           


Q ss_pred             --------C--------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          240 --------P--------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       240 --------~--------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                              .        .......++.+.+|+.+||. +|++||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                    0        01122347889999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-42  Score=293.17  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=202.5

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||.|++|.||+|.++.+|..+|+|.+.....  .......+.+|++++++++|||++++++.+..  ++..++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~   78 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF   78 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence            678999999999999999999999999999875432  22234578889999999999999999998744  46789999


Q ss_pred             ccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+.+ +|.+++..  ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        79 e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEeeccchhhcccCc
Confidence            99965 88888865  356899999999999999999999999  9999999999999998 899999999987654332


Q ss_pred             c-cccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-------------
Q 022956          178 A-AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-------------  241 (289)
Q Consensus       178 ~-~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------  241 (289)
                      . .....+++.|+|||.+.+.  ++.++|+||||+++++|+||+.||..........+.+.....+.             
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            2 2233467889999976543  68889999999999999999999987555444433332211110             


Q ss_pred             -------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          242 -------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       242 -------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                   ......++.++++|.+||+ ||++||+++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                         0112357889999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-42  Score=290.63  Aligned_cols=255  Identities=25%  Similarity=0.464  Sum_probs=209.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|++|+||++.+..+|..+|+|++....   .+...+.+.+|+++++.++|||++++++.+...  ..+++|
T Consensus         7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   81 (284)
T cd06620           7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMC   81 (284)
T ss_pred             HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEE
Confidence            367899999999999999999999999999987542   344567889999999999999999999988654  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      +||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+  ++|+||+|+||+++.+ +.++|+|||++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCC-CcEEEccCCcccchhhh-
Confidence            9999999999999887889999999999999999999997 58  9999999999999988 89999999998654322 


Q ss_pred             ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH----------HHHHHHHhCCCCCCCCCCC
Q 022956          178 AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV----------AKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~~  246 (289)
                      ......++..|+|||.+. +.++.++|+|||||+++++++|..||......          ......+.....+......
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD  237 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence            122346788999999654 45889999999999999999999999854331          1122222222222222223


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .+..+.+|+.+||+ ||++||++.++++|+||.+...
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            67889999999998 9999999999999999966543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-42  Score=290.39  Aligned_cols=263  Identities=32%  Similarity=0.583  Sum_probs=218.8

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ..++.+.| .+.+.||+|++|.||++.+..++..+++|++.....     ..+.+.+|++.++.++|+|++++++.+...
T Consensus        14 ~~~~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   87 (286)
T cd06614          14 EGDPRELY-KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG   87 (286)
T ss_pred             CCCccccc-hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence            34566665 578999999999999999998999999999986432     356788899999999999999999988665


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ...++++||+++++|.+++.... .++...+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        88 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~-~~~~l~d~~~  162 (286)
T cd06614          88 --DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGF  162 (286)
T ss_pred             --CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC-CCEEECccch
Confidence              67999999999999999999876 8999999999999999999999999  9999999999999988 8999999998


Q ss_pred             ccccCCccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          170 AAIVGRSHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       170 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      +........ .....++..|+|||.+.+. ++.++|+||||+++++|++|..||..........................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (286)
T cd06614         163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW  242 (286)
T ss_pred             hhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence            876543321 1223467889999976544 88999999999999999999999987655544444443333332333336


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +..+++++..||+ +|.+||++.+++.|+||++..+..
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  280 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE  280 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCchH
Confidence            7899999999999 999999999999999999976554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.4e-42  Score=293.02  Aligned_cols=255  Identities=26%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ...++||+|+||.||++.+..++..+|+|.+.....   ......+.+|+..+.++. |+|++++++.+...  ...+++
T Consensus         7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~   81 (288)
T cd06616           7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC   81 (288)
T ss_pred             HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence            356889999999999999999999999999875432   244667888999999996 99999999987654  567889


Q ss_pred             eccccCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           99 TEVCTSGNLRTYRK-----KHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        99 ~e~~~~~sL~~~~~-----~~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +|++.. ++.++..     ....+++..+..++.|++.||.|||+. +  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~  157 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGISGQ  157 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC-CcEEEeecchhHH
Confidence            999865 6655432     246799999999999999999999974 8  9999999999999988 8999999999976


Q ss_pred             cCCccccccCCCCCCCCCCccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC---CC
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL---NK  245 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  245 (289)
                      ...........++..|+|||.+.+    .++.++|+||||+++++|++|+.||...............+..+...   ..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence            554433344467889999997654    37889999999999999999999998654332332332222222221   22


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ..+..+.+|+.+||+ ||++||++++|+.||||....+.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            367899999999998 99999999999999999886543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-42  Score=294.66  Aligned_cols=257  Identities=26%  Similarity=0.447  Sum_probs=210.6

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      ++....+||+|+||.||++.++.++..||+|.+.....    ...+.+.+|+..++.++|||++++++.+...  +..++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~i   95 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWV   95 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEE
Confidence            33456789999999999999999999999999875432    2245678899999999999999999987554  67899


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ++||+++++|..++.. ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC-CcEEEeechhHhhccccc
Confidence            9999999999998765 56899999999999999999999999  9999999999999988 899999999986553322


Q ss_pred             -ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          178 -AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       178 -~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                       ......++..|+|||.+.+ .++.++|+||||+++++|++|..||..........................++.+.+++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL  251 (297)
T ss_pred             ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHH
Confidence             2233567889999997765 48889999999999999999999998655444443332222222223344678999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          256 EKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      .+||+ +|++||+++++++||||.+...+.
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~  281 (297)
T cd06659         252 ERMLTREPQERATAQELLDHPFLLQTGLPE  281 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence            99998 999999999999999999886543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-42  Score=294.90  Aligned_cols=254  Identities=25%  Similarity=0.433  Sum_probs=208.3

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ....||+|+||.||++.+..++..+|+|.+...    .....+.+.+|+..++.++|+|++++++.+...  +..++++|
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e   99 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVME   99 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEe
Confidence            357799999999999999999999999998653    234456788999999999999999999887544  67899999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-cc
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AA  179 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-~~  179 (289)
                      |+++++|.+++.. ..+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus       100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658         100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccCcchhhcccccccC
Confidence            9999999998865 45899999999999999999999999  9999999999999988 899999999987553222 22


Q ss_pred             ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  258 (289)
                      ....++..|+|||.+.+. ++.++|+||||+++++|++|..||..........................++.+.+++.+|
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  255 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM  255 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence            234578899999977654 8889999999999999999999998755444333322221111122334678899999999


Q ss_pred             Hc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          259 IA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       259 l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      |. ||.+|||++++++||||+......
T Consensus       256 l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         256 LVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ccCChhHCcCHHHHhhChhhhccCCcc
Confidence            98 999999999999999999775544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.6e-42  Score=296.97  Aligned_cols=264  Identities=25%  Similarity=0.356  Sum_probs=211.0

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCH----------HHHHHHHHHHHHHHhCCCCceEE
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP----------VLVNRLHSEVQLLRTLKNKYIIV   82 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~   82 (289)
                      +..+||..+.+.||+|+||+||+|.++.+++.||+|+++........          .....+.+|++++++++|+|+++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            46788987789999999999999999999999999999765432211          01124678999999999999999


Q ss_pred             eeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcE
Q 022956           83 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV  162 (289)
Q Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~  162 (289)
                      +++.+...  ...+++|||+.+ +|.+++.....+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.+
T Consensus        85 ~~~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~-~~~  158 (335)
T PTZ00024         85 LVDVYVEG--DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GIC  158 (335)
T ss_pred             eeEEEecC--CcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC-CCE
Confidence            99987544  689999999975 89999988788999999999999999999999999  9999999999999988 899


Q ss_pred             EEeccCCccccCCc---------------cccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 022956          163 KIGDLGFAAIVGRS---------------HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECD  225 (289)
Q Consensus       163 ~l~d~g~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~  225 (289)
                      +|+|||.+......               .......+++.|+|||.+.+.  ++.++|+||||+++++|++|..||.+..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999998765411               111123457789999977543  6889999999999999999999998766


Q ss_pred             cHHHHHHHHhCC--CCCC-----------------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          226 SVAKIYKKVTGG--VKPQ-----------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       226 ~~~~~~~~~~~~--~~~~-----------------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ............  ....                       ......+..+.+++.+||+ +|++||++++++.||||++
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence            554433222211  1000                       0012346788999999999 9999999999999999997


Q ss_pred             CCC
Q 022956          280 LND  282 (289)
Q Consensus       280 ~~~  282 (289)
                      ...
T Consensus       319 ~~~  321 (335)
T PTZ00024        319 DPL  321 (335)
T ss_pred             CCC
Confidence            743

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-42  Score=299.23  Aligned_cols=264  Identities=30%  Similarity=0.434  Sum_probs=215.4

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC---CCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---HNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~   95 (289)
                      |++.++||+|++|.||+|.+..+|+.+|+|.+.....  .....+.+.+|+.+++.++|+|++++.+++....   ...+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            3689999999999999999998999999999975432  2444677889999999999999999998875542   2468


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +++++|+.+ +|.+++.....+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~  155 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVDP  155 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEeecc
Confidence            999999985 89999988778999999999999999999999999  9999999999999999 8999999999987654


Q ss_pred             cc----ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC--------
Q 022956          176 SH----AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--------  241 (289)
Q Consensus       176 ~~----~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  241 (289)
                      ..    ......++..|+|||.+.+  .++.++|+||||+++++|++|..||.+................+.        
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            43    2233456888999997654  478899999999999999999999987655443333222111100        


Q ss_pred             --------------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCCC
Q 022956          242 --------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS  288 (289)
Q Consensus       242 --------------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~~  288 (289)
                                          ......++.+.+++..||+ +|++||++++++.||||+++.....++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~  303 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV  303 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCC
Confidence                                0112247789999999998 9999999999999999999987766543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-41  Score=288.37  Aligned_cols=250  Identities=28%  Similarity=0.500  Sum_probs=207.3

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      .++||+|++|.||++.++.++..+++|.+....    ....+.+.+|+.+++.++|||++++++.+...  +..++++||
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e~   97 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVMEF   97 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEec
Confidence            578999999999999999999999999986542    23345688899999999999999999987543  678999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-cccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-~~~~  180 (289)
                      +++++|.+++.. .++++..+..++.|++.|+.+||++|  ++|+||+|+||+++.+ +.++|+|||.+...... ....
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648          98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC-CcEEEcccccchhhccCCcccc
Confidence            999999999987 66999999999999999999999999  9999999999999998 89999999988655332 2223


Q ss_pred             cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCChHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  258 (289)
                      ...+++.|+|||...+. ++.++|+||||+++++|++|..||.......... .+.....+ .......+..+.+++.+|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-RIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-HHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            34578899999976654 8889999999999999999999997755443333 33333222 222233678999999999


Q ss_pred             Hc-CCCCCCCHHHHhcCcccccCCC
Q 022956          259 IA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       259 l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      |. +|++||++.++++||||++...
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCCC
Confidence            98 9999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.2e-42  Score=298.49  Aligned_cols=265  Identities=26%  Similarity=0.376  Sum_probs=208.8

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      +.+++| ++.+.||+|+||.||+|.++.+|+.||+|.+.....    ...+.+.+|+++++.++|||++++++.+.....
T Consensus         2 ~~~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           2 DLGSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcCcce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            356777 679999999999999999999999999999976532    335668889999999999999999877644321


Q ss_pred             ------------CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           93 ------------NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        93 ------------~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                                  ...++++||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+.+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~  152 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence                        357899999975 89888865 46899999999999999999999999  999999999999986546


Q ss_pred             cEEEeccCCccccCCccc----cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 022956          161 QVKIGDLGFAAIVGRSHA----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV  234 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~  234 (289)
                      .++++|||.+........    .....++..|+|||.+.+  .++.++|+|||||++++|++|..||............+
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            899999999876533211    122346778999996543  37889999999999999999999997655444433332


Q ss_pred             hCCCCC---------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          235 TGGVKP---------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       235 ~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                      ......                           .......+.++.+|+.+||+ ||++||++.+++.||||+.+..+.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~  312 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDE  312 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccc
Confidence            211000                           00112356789999999998 99999999999999999987655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-42  Score=307.34  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=195.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      +..| .+.++||+|+||.||++.+..++..||+|....          ..+.+|++++++++|+||+++++++...  +.
T Consensus       168 ~~gy-~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~  234 (461)
T PHA03211        168 GLGF-AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GL  234 (461)
T ss_pred             cCCe-EEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CE
Confidence            3455 689999999999999999999999999996432          2346799999999999999999987554  57


Q ss_pred             eEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+++++++.+ +|.+++... ..+++.++..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++...
T Consensus       235 ~~lv~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~-~~vkL~DFGla~~~  310 (461)
T PHA03211        235 TCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFA  310 (461)
T ss_pred             EEEEEEccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-CCEEEcccCCceec
Confidence            8899999965 888887653 56999999999999999999999999  9999999999999988 89999999999765


Q ss_pred             CCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHhCCCCC--
Q 022956          174 GRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD-------SVAKIYKKVTGGVKP--  240 (289)
Q Consensus       174 ~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~-------~~~~~~~~~~~~~~~--  240 (289)
                      .....   .....|++.|+|||.+.+. ++.++|||||||++|+|++|..|+....       ......+.+......  
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~  390 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD  390 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence            43221   2234689999999977654 8999999999999999999775543211       112222222221100  


Q ss_pred             ------------------------CC----C--CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          241 ------------------------QA----L--NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       241 ------------------------~~----~--~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                                              ..    +  ....+..+.+||.+||+ ||.+|||+.|+|+||||+.
T Consensus       391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    00    0  01235678999999999 9999999999999999974

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-44  Score=307.11  Aligned_cols=236  Identities=35%  Similarity=0.520  Sum_probs=203.3

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      +-||+|+.|.||+++..  ++.||||+++.           .-+.+++-|++|+|+||+.+.+++.  +.-.+|||||||
T Consensus       130 eWlGSGaQGAVF~Grl~--netVAVKKV~e-----------lkETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiMEfC  194 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH--NETVAVKKVRE-----------LKETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIMEFC  194 (904)
T ss_pred             hhhccCcccceeeeecc--CceehhHHHhh-----------hhhhhHHHHHhccCcceeeEeeeec--CCceeEEeeecc
Confidence            44999999999999876  88999999863           2234789999999999999999984  446899999999


Q ss_pred             cCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccC
Q 022956          103 TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI  182 (289)
Q Consensus       103 ~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~  182 (289)
                      ..|.|...+..+..++......|..+|+.|+.|||.+.  ++|+|||.-||||..+ ..|||+|||-+..........+.
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhh
Confidence            99999999999999999999999999999999999999  9999999999999999 79999999999888776666778


Q ss_pred             CCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-
Q 022956          183 IGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-  260 (289)
Q Consensus       183 ~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-  260 (289)
                      +||..|||||..+.+ .+.+.||||||++||||+||..||.+.+....++ -+-.+......+..+++.++-|++.||+ 
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-GVGsNsL~LpvPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-GVGSNSLHLPVPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-eccCCcccccCcccCchHHHHHHHHHHhc
Confidence            999999999987766 8999999999999999999999998744332221 1122223334566678999999999998 


Q ss_pred             CCCCCCCHHHHhcCccc
Q 022956          261 QPRARPSASELLKDPFF  277 (289)
Q Consensus       261 dp~~Rps~~~il~h~~~  277 (289)
                      .|.+||++++||.|--+
T Consensus       351 KpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CCCCCccHHHHHHHHhh
Confidence            99999999999999543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.2e-42  Score=289.40  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=199.3

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      |++.++||+|+||.||++.+..++..+|+|.++....  ... .....+|+..++++. |+|++++++.+.+...+.+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            3678999999999999999999999999999875432  112 123346788888885 999999999987665568999


Q ss_pred             EeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           98 ITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |+||+.+ +|.+.+.. ...+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.  +.++|+|||++......
T Consensus        78 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          78 VFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence            9999976 77777765 457899999999999999999999999  999999999999998  79999999999876544


Q ss_pred             cccccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC---------------
Q 022956          177 HAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK---------------  239 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------------  239 (289)
                      .......++..|+|||.+.  +.++.++|+|||||++++|++|..||.+....+...........               
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            4434455788999999653  33788999999999999999999999875543322221110000               


Q ss_pred             CC-----------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          240 PQ-----------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       240 ~~-----------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ..           ......+..+.+++.+||. +|++||++++++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00           0012347899999999998 99999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.6e-41  Score=281.59  Aligned_cols=249  Identities=32%  Similarity=0.587  Sum_probs=209.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |.+.+.||+|++|.||++.+..+++.+++|++.....    .....+.+|+..++.++|++++++++.+...  ...+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~   75 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIV   75 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence            3578999999999999999998999999999986532    3467888999999999999999999987554  678999


Q ss_pred             eccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      +||+++++|.+++... ..+++..+..++.|++.++.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccC-CeEEEeeccccccccccc
Confidence            9999999999999876 67999999999999999999999999  9999999999999988 899999999998776543


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ......++..|+|||.+.+. ++.++|+||||+++++|++|..||..........................+..+.+++.
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  232 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK  232 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence            23445678899999976644 78899999999999999999999987544444333333222222222223788999999


Q ss_pred             HHHc-CCCCCCCHHHHhcCcc
Q 022956          257 KCIA-QPRARPSASELLKDPF  276 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~h~~  276 (289)
                      .||+ ||++|||+.++++|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            9998 9999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1e-41  Score=283.93  Aligned_cols=249  Identities=27%  Similarity=0.524  Sum_probs=211.5

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||.|++|.||++.+..++..+++|++.....  .......+.+|+++++.++|+|++++.+.+...  ...++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~   78 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM   78 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence            678999999999999999999999999999987543  345567788999999999999999999988654  6899999


Q ss_pred             ccccCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          100 EVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       100 e~~~~~sL~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |++++++|.+++...    ..+++..+..++.+++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC-CcEEECCccceeeccc
Confidence            999999999998763    77999999999999999999999999  9999999999999988 8999999999977654


Q ss_pred             cc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 SH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .. ......+++.|+|||...+. ++.++|+||+|+++++|++|..||................  ....+...+..+.+
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  233 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPPIPSQYSSELRN  233 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--CCCCCCCCCHHHHH
Confidence            43 22334678899999976544 8889999999999999999999998755444333333322  23344467889999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ++..||. +|++||++.++|.||||
T Consensus       234 ~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         234 LVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHcCCChhhCcCHHHHhcCCCC
Confidence            9999998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.4e-43  Score=293.94  Aligned_cols=255  Identities=27%  Similarity=0.497  Sum_probs=210.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ..| +..+.||+|+||.||+|.+..++..+|+|.+....   .....+.+.+|++.+++++|+|++++++.+...  +.+
T Consensus         4 ~~y-~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   77 (277)
T cd06642           4 ELF-TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKL   77 (277)
T ss_pred             HHH-HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--Cce
Confidence            344 46788999999999999999999999999987543   234467889999999999999999999988543  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++|+||+++++|.+++.. ..+++..+..++.|++.|+.|||+++  ++|+||+|+||+++.+ +.++++|||++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~  153 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCC-CCEEEccccccccccC
Confidence            999999999999998875 56899999999999999999999999  9999999999999988 8999999999876543


Q ss_pred             ccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 SHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ... .....++..|+|||.+.+. ++.++|+||||+++++|++|..||.......... .+..... .......+..+.+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~  231 (277)
T cd06642         154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSP-PTLEGQYSKPFKE  231 (277)
T ss_pred             cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-hhhcCCC-CCCCcccCHHHHH
Confidence            322 2233567889999977654 8889999999999999999999997644333322 2222222 2233456788999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ++.+||+ +|++||++.+++.||||.....
T Consensus       232 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         232 FVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             HHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence            9999998 9999999999999999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2e-41  Score=289.99  Aligned_cols=261  Identities=27%  Similarity=0.456  Sum_probs=213.0

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      +...++..+| ++.++||+|+||+||+|.+..+|+.||+|++...... .......+.+|+++++.++|||++++++.+.
T Consensus         8 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607           8 FSKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hcCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            4445677776 6789999999999999999999999999998754322 3444567889999999999999999999886


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      ..  +..++|+||+.| ++.+++.. ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+||
T Consensus        86 ~~--~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~-~~~kL~df  159 (307)
T cd06607          86 RE--HTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADF  159 (307)
T ss_pred             eC--CeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-CCEEEeec
Confidence            54  578999999976 77777653 457999999999999999999999999  9999999999999998 89999999


Q ss_pred             CCccccCCccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      |++......   ....+++.|+|||.+.    +.++.++|+||||+++|+|++|..||.+.......... .....+...
T Consensus       160 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~  235 (307)
T cd06607         160 GSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNDSPTLS  235 (307)
T ss_pred             CcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-hcCCCCCCC
Confidence            988755432   2345678899999653    34888999999999999999999999875554443333 333333333


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ....+..+.+++.+||. ||++||++.+++.||||..-.
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            33457889999999998 999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.5e-41  Score=288.60  Aligned_cols=253  Identities=24%  Similarity=0.377  Sum_probs=198.1

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .+.| ++.+.||+|+||.||++.+..+|..||+|.+.......   ....+.+|+.+++.++|+|++++++.+...  ..
T Consensus         4 ~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~   77 (291)
T cd07870           4 ATSY-LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VPFTAIREASLLKGLKHANIVLLHDIIHTK--ET   77 (291)
T ss_pred             ccee-EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---CcHHHHHHHHHHHhcCCCCEeEEEEEEecC--Ce
Confidence            4555 68999999999999999999999999999997653221   133556799999999999999999987543  67


Q ss_pred             eEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .++|+||+.+ +|.+++.. ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        78 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL-GELKLADFGLARAK  153 (291)
T ss_pred             EEEEEecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC-CcEEEecccccccc
Confidence            8999999965 67666654 456788899999999999999999999  9999999999999988 89999999998754


Q ss_pred             CCccc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--------------
Q 022956          174 GRSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--------------  236 (289)
Q Consensus       174 ~~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------------  236 (289)
                      ..... .....+++.|+|||.+.+  .++.++|+||||+++++|++|..||...............              
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            33221 223456889999997754  3788999999999999999999999765433222211110              


Q ss_pred             -CC---C-------CC-----CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          237 -GV---K-------PQ-----ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       237 -~~---~-------~~-----~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                       ..   .       +.     ......++.+.+++.+|++ ||.+|||+.|++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             00   0       00     0001125688999999998 99999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-41  Score=285.72  Aligned_cols=256  Identities=27%  Similarity=0.488  Sum_probs=209.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||.||+|.++.++..||+|.+...... .......+.+|+++++.++|||++++++.+...  +..
T Consensus         2 ~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   77 (267)
T cd08228           2 ANF-QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NEL   77 (267)
T ss_pred             cce-eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeE
Confidence            344 6899999999999999999999999999998754332 345566788999999999999999999988654  578


Q ss_pred             EEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           96 NFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ++++||+++++|.+++..    ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~d~g~~~  154 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC-CCEEECccccce
Confidence            999999999999988853    345899999999999999999999999  9999999999999988 899999999987


Q ss_pred             ccCCccc-cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhCCCCCCCCCCCCC
Q 022956          172 IVGRSHA-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       172 ~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ....... .....+++.|+|||.+.+ .++.++|+||||+++++|++|+.||.... +.......+.....+.......+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS  234 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence            6643322 223457789999997654 48889999999999999999999996533 23344444444444444444567


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ..+.+++.+||+ +|++||++.++++  .++++
T Consensus       235 ~~~~~li~~cl~~~p~~Rp~~~~vl~--~~~~~  265 (267)
T cd08228         235 EKLRELVSMCIYPDPDQRPDIGYVHQ--IAKQM  265 (267)
T ss_pred             HHHHHHHHHHCCCCcccCcCHHHHHH--HHHHh
Confidence            889999999998 9999999999998  55443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-42  Score=296.77  Aligned_cols=264  Identities=27%  Similarity=0.450  Sum_probs=206.5

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..++| ++.++||+|++|.||+|.++.+|+.||+|.+....   .......+.+|+.+++.++|+|++++++++....  
T Consensus         3 ~~~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           3 VGPRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE   78 (336)
T ss_pred             cccce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence            34666 68999999999999999999999999999986422   2334566788999999999999999998764332  


Q ss_pred             -CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 -~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       ...+++++||+.+ +|.+.+.. ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~  153 (336)
T cd07849          79 SFNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLA  153 (336)
T ss_pred             ccceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEECcccce
Confidence             2468999999976 88877754 56999999999999999999999999  9999999999999988 89999999998


Q ss_pred             cccCCccc----cccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--CC-----
Q 022956          171 AIVGRSHA----AHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GG-----  237 (289)
Q Consensus       171 ~~~~~~~~----~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~-----  237 (289)
                      ........    .....+++.|+|||...  ..++.++|+||||+++++|++|+.||.+............  ..     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            76543221    12245788999999653  3488899999999999999999999976433221111100  00     


Q ss_pred             ---------------CC-C-----CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          238 ---------------VK-P-----QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       238 ---------------~~-~-----~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                                     .. .     .......++.+.+++.+||+ ||++||++.+++.||||+....+..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~  304 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDE  304 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCc
Confidence                           00 0     00112346789999999998 99999999999999999988765443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-42  Score=299.22  Aligned_cols=266  Identities=26%  Similarity=0.443  Sum_probs=211.9

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC--CC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD--QH   92 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   92 (289)
                      +.+| .+.+.||+|++|.||++.++.+|..||+|++.....  .......+.+|+.++++++|||++++++.+...  ..
T Consensus         4 ~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           4 GSRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhce-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            3555 578999999999999999999999999999875432  223456677899999999999999998876532  23


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..+++|+||+.+ +|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~  156 (334)
T cd07855          81 KDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARG  156 (334)
T ss_pred             ceEEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEeccccccee
Confidence            578999999965 89999987778999999999999999999999999  9999999999999998 8999999999876


Q ss_pred             cCCccc-----cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----------
Q 022956          173 VGRSHA-----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT----------  235 (289)
Q Consensus       173 ~~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----------  235 (289)
                      ......     .....++..|+|||.+.+  .++.++|+||||+++++|++|..||.+............          
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            533221     123467889999997643  378899999999999999999999976443222111110          


Q ss_pred             -------------CCCCCC-----CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          236 -------------GGVKPQ-----ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       236 -------------~~~~~~-----~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                   ......     ......++.+.+++.+||+ ||++||++++++.||||++...+..++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~  307 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP  307 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc
Confidence                         000000     0112357889999999998 999999999999999999987777654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-44  Score=309.87  Aligned_cols=263  Identities=27%  Similarity=0.490  Sum_probs=227.0

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .++|.+.. .|..-||.|+||+||+|+++.++..-|-|++...    .++..+.+.-|+++|..+.||+|+++++.|+.+
T Consensus        27 dlnP~d~W-eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~e  101 (1187)
T KOG0579|consen   27 DLNPRDHW-EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE  101 (1187)
T ss_pred             cCCHHHHH-HHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence            34455554 5677899999999999999999988999999754    566688899999999999999999999988877


Q ss_pred             CCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        +.++++.|||.||-....+-. +..|++.++.-+.+|++.||.|||+++  ++|+|||..|||++-+ |.++|+|||.
T Consensus       102 --nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld-GdirLADFGV  176 (1187)
T KOG0579|consen  102 --NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD-GDIRLADFGV  176 (1187)
T ss_pred             --CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-CcEeeecccc
Confidence              569999999999988777654 678999999999999999999999999  9999999999999999 9999999999


Q ss_pred             ccccCCc-cccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC
Q 022956          170 AAIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA  242 (289)
Q Consensus       170 ~~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  242 (289)
                      +...... ....+..|||.|||||+.-      .+|+.++||||||+++.+|..+..|.........+..+-.+.++...
T Consensus       177 SAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl  256 (1187)
T KOG0579|consen  177 SAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL  256 (1187)
T ss_pred             cccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence            8654332 3355678999999999553      34899999999999999999999999988888888877766665555


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      .+..-+..+++++..||. ||..||++.++|+||||.+.+-+
T Consensus       257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            556667889999999997 99999999999999999987644

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.9e-42  Score=299.54  Aligned_cols=246  Identities=26%  Similarity=0.408  Sum_probs=198.8

Q ss_pred             cceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   92 (289)
                      +++.+.||+|+||.||+|.+..+     +..||+|.++...   .......+.+|+.+++.+ +|+||+++++.+...  
T Consensus        40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--  114 (374)
T cd05106          40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTHG--  114 (374)
T ss_pred             ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence            46889999999999999986544     3579999997543   233466788999999999 899999999987544  


Q ss_pred             CeeEEEeccccCCcHHHHHHhc----------------------------------------------------------
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH----------------------------------------------------------  114 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~----------------------------------------------------------  114 (289)
                      ..+++||||+++++|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            5799999999999999988532                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc---c
Q 022956          115 ------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---A  179 (289)
Q Consensus       115 ------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~---~  179 (289)
                                  .++++.++..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++........   .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeec
Confidence                        24788899999999999999999999  9999999999999988 8999999999876533221   1


Q ss_pred             ccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      ....++..|+|||.+. +.++.++||||||+++|+|++ |..||............+.....+ ..+...++.+.+++.+
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~  350 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIYSIMKM  350 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHHHHHHH
Confidence            1223456799999665 458999999999999999997 999998765544444554443322 2344568999999999


Q ss_pred             HHc-CCCCCCCHHHHhc
Q 022956          258 CIA-QPRARPSASELLK  273 (289)
Q Consensus       258 ~l~-dp~~Rps~~~il~  273 (289)
                      ||+ ||++|||+.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            998 9999999999987

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=274.50  Aligned_cols=252  Identities=25%  Similarity=0.471  Sum_probs=210.8

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEEEec
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ..-||.|+.|.|+++....+|...|||.+....   +.+..+++...+++..... .|+||+++++|....  .+++.||
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~IcMe  171 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVFICME  171 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHHHHHH
Confidence            356999999999999999999999999998764   5666888888888876665 799999999997764  5788899


Q ss_pred             cccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          101 VCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       101 ~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      .+.. .+..++.. .+++++.-+-++...+++||.||.. ++  ++|||+||+|||+|.. |++||||||.+.+..+...
T Consensus       172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccC-CCEEeecccccceeecccc
Confidence            9855 66666654 4679999999999999999999955 47  9999999999999999 9999999999998888777


Q ss_pred             cccCCCCCCCCCCccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCC-CCCChHHHH
Q 022956          179 AHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVKDPEVKA  253 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  253 (289)
                      .....|-+.|||||.++-    .|+.++||||||++++||.||+-||.+...+-...-.+....++.... ...++.+.+
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~  327 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQS  327 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHH
Confidence            777889999999997763    388899999999999999999999998654444444444443333222 236899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ++..||+ |+.+||...++|+|||+...+-
T Consensus       328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  328 FVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            9999998 9999999999999999876643

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-45  Score=294.05  Aligned_cols=251  Identities=27%  Similarity=0.511  Sum_probs=216.0

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .++++||+|+||.||++.|+++|+.+|||.+...      ...+++..|+.++++++.|++|+.++.|+..  ..+|+||
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIVM  107 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIVM  107 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEeeh
Confidence            4688999999999999999999999999999853      3377888999999999999999999999765  4699999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      |||..||..+.+.- +++|++.++..+++..+.||+|||...  -+|||||..|||++.+ |..||+|||.+..+.+.- 
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc-chhhhhhccccchhhhhHH
Confidence            99999999999874 578999999999999999999999998  8999999999999999 999999999998775432 


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC-CCCCChHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL-NKVKDPEVKAFI  255 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li  255 (289)
                      +.....|||-|+|||+.... |+-.+||||||++..+|..|+.||.+..+...+. .+..++++... +..-+..+.+++
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-MIPT~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-MIPTKPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-eccCCCCCCCCChHhhhhHHHHHH
Confidence            34556899999999977654 9999999999999999999999999876665443 23344333222 222366889999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          256 EKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ++||- .|++|.++.++++|||+++...
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            99996 9999999999999999998643

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=280.86  Aligned_cols=249  Identities=32%  Similarity=0.560  Sum_probs=213.7

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.+.||+|++|.||++.+..+++.+++|.+.....  .....+.+.+|++++++++|+|++++++.+...  +..++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   78 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL   78 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence            578999999999999999999999999999987643  245567899999999999999999999887554  6799999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc-
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~-  178 (289)
                      |++++++|.+++.....+++..+..++.|++.++.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCC-CCEEEeccccceecCCCccc
Confidence            99999999999988888999999999999999999999999  9999999999999987 8999999999987754433 


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      .....++..|+|||...+. ++.++|+|+||+++++|++|..||.................  ...+...++.+++++.+
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~  233 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH--PPLPEGISPELKDFLMQ  233 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC--CCCCCCCCHHHHHHHHH
Confidence            2334578899999976544 78899999999999999999999987665554444443322  23455678999999999


Q ss_pred             HHc-CCCCCCCHHHHhcCccc
Q 022956          258 CIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       258 ~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ||. +|++||++.+++.||||
T Consensus       234 ~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         234 CFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHhCChhhCcCHHHHhcCCCC
Confidence            998 99999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.7e-42  Score=290.47  Aligned_cols=259  Identities=23%  Similarity=0.384  Sum_probs=205.9

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +| ++.+.||.|++|+||++.++.+|+.||+|.+.....  .....+.+.+|++++++++|||++++++.+...  ...+
T Consensus         3 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~   77 (294)
T PLN00009          3 QY-EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLY   77 (294)
T ss_pred             ce-EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEE
Confidence            44 678999999999999999999999999999876533  223346678899999999999999999988544  6899


Q ss_pred             EEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           97 FITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|+||+++ +|.+++....  .+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+.+.++|+|||++....
T Consensus        78 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         78 LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            99999965 7888776543  3578889999999999999999999  99999999999998654689999999997654


Q ss_pred             Cccc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--CCCCC--------
Q 022956          175 RSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKPQ--------  241 (289)
Q Consensus       175 ~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~--------  241 (289)
                      .... .....+++.|+|||.+.+  .++.++|+||||+++++|++|..||..........+....  .....        
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            3222 223456789999997654  3788999999999999999999999876555444433211  00000        


Q ss_pred             ----------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          242 ----------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       242 ----------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                      ......++.+.+++.+||+ +|++||++.+++.||||++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence                            0112357789999999998 99999999999999999988653

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-42  Score=289.27  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=203.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||.|++|.||++.++.+|..||+|++.....  .......+.+|+++++.++|||++++++.+...  ...++++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~   77 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVF   77 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEE
Confidence            568999999999999999999999999999986543  223345677899999999999999999987543  6899999


Q ss_pred             ccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+. ++|.+++....  .+++..+..++.|++.||.+||+++  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPV  153 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CcEEEeecccccccCCCc
Confidence            9996 58999987755  6899999999999999999999999  9999999999999997 899999999987554322


Q ss_pred             c-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC----------------
Q 022956          178 A-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV----------------  238 (289)
Q Consensus       178 ~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----------------  238 (289)
                      . .....+++.|+|||.+.+  .++.++|+||||+++|+|++|+.||.................                
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            2 122345788999997654  368899999999999999999999987655444433222110                


Q ss_pred             ----------CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          239 ----------KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       239 ----------~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                .........++.+.+++.+||+ ||++||++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                      0011123456889999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-41  Score=285.61  Aligned_cols=247  Identities=19%  Similarity=0.286  Sum_probs=200.2

Q ss_pred             cccceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      .-+++.+.||+|+||.||++.++   ..+..+|+|.++...   .......+.+|+..+++++|||++++++.+..  ++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CC
Confidence            33478999999999999999765   456789999997542   33445678899999999999999999998754  36


Q ss_pred             eeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..++||||+++++|.+++... ..+++.++..++.|++.||+|||+.|  ++|+||+|+||+++.+ +.++++|||.+..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~-~~~~l~dfg~~~~  156 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD-LVCKISGFRRLQE  156 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-CcEEECCCccccc
Confidence            799999999999999999763 57899999999999999999999999  9999999999999988 8999999998765


Q ss_pred             cCCcccc--ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          173 VGRSHAA--HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       173 ~~~~~~~--~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      .......  ....++..|+|||.+.+ .++.++|||||||+++++++ |..||.+..... ....+..+.... .+...+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~  234 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-VIKAVEDGFRLP-APRNCP  234 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHHCCCCCC-CCCCCC
Confidence            4322111  12234568999997654 48999999999999999875 999998755443 344444443322 345578


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..+.+++.+||+ +|++||++++|++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            899999999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-41  Score=298.86  Aligned_cols=246  Identities=25%  Similarity=0.379  Sum_probs=199.5

Q ss_pred             cceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   92 (289)
                      +++.++||+|+||+||+|.+     ..++..||+|+++...   .....+.+.+|+.+++.+ +||||+++++.+...  
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            36789999999999999963     4567789999997443   233456788899999999 899999999987443  


Q ss_pred             CeeEEEeccccCCcHHHHHHhc----------------------------------------------------------
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH----------------------------------------------------------  114 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~----------------------------------------------------------  114 (289)
                      ...++||||+++|+|.+++...                                                          
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            5789999999999999988642                                                          


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          115 -----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       115 -----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                                       ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC-CcEEEecCccceeccCcc
Confidence                             14678889999999999999999999  9999999999999988 899999999997654322


Q ss_pred             c---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          178 A---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       178 ~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      .   .....++..|+|||.+.+ .++.++|+||||+++|+|++ |..||..........+.+..+.... .+...+.+++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~  347 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECAPSEMY  347 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCCCHHHH
Confidence            1   112234567999997654 48999999999999999998 8999987665555555555543322 2345678999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +|+.+||+ ||++||++.+|++
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHH
Confidence            99999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-43  Score=303.34  Aligned_cols=259  Identities=25%  Similarity=0.426  Sum_probs=225.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ..-+|.+.++||.|.|++|.++.+.-||..||||.+.....  +......+.+|+++++.++||||++++.+...+  ..
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~~  129 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--AT  129 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--ce
Confidence            33445788999999999999999999999999999998766  555556699999999999999999999998554  67


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|+||||+.++.+++++.+++++.+..+...+.|+++|++|||+++  ++|+|||++|++++.+ .++||+|||++.++.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeeccccceeec
Confidence            9999999999999999999999999999999999999999999999  9999999999999999 789999999999999


Q ss_pred             CccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ......+++|++.|.|||++.+.  -.+..|+||||+++|-|+.|.+||++..-..-.-..+.+.   -.++...+.+..
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk---~rIp~~ms~dce  283 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK---YRIPFYMSCDCE  283 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee---ecccceeechhH
Confidence            88888999999999999988865  6778999999999999999999998743222222222222   224455678999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ++|+++|- +|.+|++.+++++|.|.......
T Consensus       284 ~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  284 DLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            99999998 99999999999999998766443

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-41  Score=284.01  Aligned_cols=250  Identities=27%  Similarity=0.495  Sum_probs=206.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.+.||+|+||.||++.++.+|..+|+|.+.....  .....+.+.+|+.++++++|+|++++++.+..  +...++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~   78 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM   78 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence            578999999999999999999999999999987543  22335677889999999999999999988744  36899999


Q ss_pred             ccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+...++++|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999999987543  5799999999999999999999999  99999999999998874457999999987664432


Q ss_pred             c-cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          178 A-AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       178 ~-~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      . .....+++.|+|||.+.+ .++.++|+||||+++++|++|..||..........+.......+  .....+..+++++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i  234 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP--ISPNFSRDLRSLI  234 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC--CCCCCCHHHHHHH
Confidence            2 222357888999997654 48899999999999999999999998655444444433332221  2334578999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCccc
Q 022956          256 EKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .+||. +|++||++.++++||||
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCCCC
Confidence            99998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.9e-41  Score=289.80  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=195.0

Q ss_pred             CcccceeeeecccCcceEEEEeec----------------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQ----------------EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY   79 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~----------------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   79 (289)
                      ++| ++.++||+|+||.||+|.+.                .++..||+|.+....   .......+.+|++++.+++|||
T Consensus         5 ~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           5 GHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence            455 68999999999999999753                234579999987542   3445677899999999999999


Q ss_pred             eEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHhcCC
Q 022956           80 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-------------------RHVSIKALKKWSKQVLEGLEYLHTHE  140 (289)
Q Consensus        80 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-------------------~~l~~~~~~~~~~ql~~~l~~lh~~~  140 (289)
                      |+++++.+...  +..+++|||+++++|.+++...                   ..+++..+..++.|++.||.|||+.|
T Consensus        81 iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          81 IIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             eeEEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999988654  5689999999999999998653                   23677889999999999999999999


Q ss_pred             CCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh
Q 022956          141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT  216 (289)
Q Consensus       141 ~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t  216 (289)
                        ++|+||+|+||+++.+ +.++|+|||++........   .....++..|+|||.+. +.++.++|+||||+++|+|++
T Consensus       159 --ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         159 --FVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             --ccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence              9999999999999988 8999999999976533221   22234567899999755 458999999999999999987


Q ss_pred             --CCCCCCCCCcHHHHHHHH---hCCC--CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          217 --MEIPYSECDSVAKIYKKV---TGGV--KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       217 --g~~p~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                        +..||.............   ....  .....+...++.+.+|+.+||. ||++|||+.+|.+
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence              567887654433322111   1111  1111234467899999999998 9999999999965

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.3e-42  Score=295.83  Aligned_cols=266  Identities=23%  Similarity=0.346  Sum_probs=212.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   92 (289)
                      ..++| .+.+.||+|+||.||+|.+..+|+.+|+|.+.....  .......+.+|+.+++++ +||||+++++.+.....
T Consensus         5 ~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           5 ILRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             hhhHH-HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            34555 578999999999999999998999999999864321  233345677899999999 99999999998766555


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..+++|+||+.+ +|.+++..+ .+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~~~kl~d~g~~~~  156 (337)
T cd07852          82 KDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARS  156 (337)
T ss_pred             ceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccchhc
Confidence            678999999976 999988875 7889999999999999999999999  9999999999999998 8999999999876


Q ss_pred             cCCcc------ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-----
Q 022956          173 VGRSH------AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-----  239 (289)
Q Consensus       173 ~~~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----  239 (289)
                      .....      ......++..|+|||.+.+  ..+.++|+||||+++++|++|+.||..................     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            54322      1223457888999997643  3788999999999999999999999765544332222111100     


Q ss_pred             -----------------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          240 -----------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       240 -----------------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                             ........+..+.+++.+||+ ||++|||+.+++.||||.......+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~  308 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP  308 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence                                   001112257889999999998 999999999999999999987765554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-41  Score=285.44  Aligned_cols=251  Identities=26%  Similarity=0.492  Sum_probs=208.7

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||.||++.+..++..+|+|.+....   .......+.+|++.+++++|||++++++.+...  ..+++|+
T Consensus         7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~   81 (277)
T cd06641           7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM   81 (277)
T ss_pred             hhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence            56889999999999999999899999999986543   234456788999999999999999999988554  6799999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-c
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-A  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-~  178 (289)
                      ||+++++|.+++.. ..+++..+..++.|++.++.+||+.|  ++|+||+|+||+++.+ +.++++|||++....... .
T Consensus        82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC-CCEEEeecccceecccchhh
Confidence            99999999999875 46899999999999999999999999  9999999999999988 899999999987654322 1


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      .....++..|+|||.+.+. ++.++|+||||+++++|++|..||......... ..+..... .......+..+.+++..
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL-FLIPKNNP-PTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH-HHHhcCCC-CCCCcccCHHHHHHHHH
Confidence            2234567889999976544 888999999999999999999999865443333 33333322 22344568899999999


Q ss_pred             HHc-CCCCCCCHHHHhcCcccccCC
Q 022956          258 CIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       258 ~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ||. +|++||++.+++.||||.+..
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhhhh
Confidence            998 999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=286.96  Aligned_cols=256  Identities=23%  Similarity=0.439  Sum_probs=221.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.++||+|.||+|-+++-+.+|+.||+|+++..... ..+....-..|-++|+..+||.+..+-..|  +.+..+|+||
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drlCFVM  247 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRLCFVM  247 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceEEEEE
Confidence            4678999999999999999999999999999865443 344456677899999999999999888777  4447899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc-cCCccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~-~~~~~~  178 (289)
                      ||..||.|.-+++..+-+++.....+...|++||.|||+++  ++.+|||.+|.++|.+ |.+|++|||++.. +.....
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccC-CceEeeecccchhcccccce
Confidence            99999999999998888999999999999999999999999  9999999999999999 9999999999964 345556


Q ss_pred             cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      ....||||.|+|||.+.. +|..+.|.|++|+++|+|++|++||.+.+... +...+....  ...+...+++++.|+..
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-LFeLIl~ed--~kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-LFELILMED--LKFPRTLSPEAKTLLSG  401 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-HHHHHHhhh--ccCCccCCHHHHHHHHH
Confidence            778999999999998765 49999999999999999999999998855544 444443321  23566679999999999


Q ss_pred             HHc-CCCCCC-----CHHHHhcCcccccCCCCC
Q 022956          258 CIA-QPRARP-----SASELLKDPFFSELNDDD  284 (289)
Q Consensus       258 ~l~-dp~~Rp-----s~~~il~h~~~~~~~~~~  284 (289)
                      +|. ||.+|.     ++.+|.+|+||+.++|.+
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence            998 999994     689999999999998853

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-41  Score=281.60  Aligned_cols=245  Identities=28%  Similarity=0.485  Sum_probs=204.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||.||++.++.++..+|+|.++...   .....+.+.+|+.+++.++|+|++++.+.+...  ..+++++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   77 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVM   77 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence            67899999999999999999999999999997543   233467788899999999999999999988544  6899999


Q ss_pred             ccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+++++|.+++..  ...+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++++|||.+.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC-CcEEEcccCcceeecccc
Confidence            99999999998864  346899999999999999999999999  9999999999999988 899999999987664332


Q ss_pred             c-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          178 A-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       178 ~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      . .....+++.|+|||.+.+. +++++|+||||+++++|++|..||........... +..+... ..+...+..+++++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~li  232 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK-VCQGSYK-PLPSHYSYELRSLI  232 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH-HhcCCCC-CCCcccCHHHHHHH
Confidence            2 2234578899999987654 88899999999999999999999987544433333 3333222 23445678999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcC
Q 022956          256 EKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h  274 (289)
                      .+||+ ||++||++.+++.-
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99998 99999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.2e-42  Score=289.68  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=203.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|++|.||+|.++.+++.+|+|.+.....  .....+.+.+|+++++.++|||++++++.+..  ....++|+
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   79 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLVF   79 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEEE
Confidence            678999999999999999998999999999865432  22345678889999999999999999998843  46899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc-
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~-  178 (289)
                      ||+++++|..+......+++.++..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++........ 
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccc
Confidence            99999999888777667999999999999999999999999  9999999999999998 8999999999876543322 


Q ss_pred             cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--CCC----------------
Q 022956          179 AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGV----------------  238 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~----------------  238 (289)
                      .....++..|+|||.+.+  .++.++|+||||+++++|++|..||......+.......  ...                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            223456788999997654  367889999999999999999999976443332222111  000                


Q ss_pred             --CCC--------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          239 --KPQ--------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       239 --~~~--------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                        .+.        ......+..+.+|+.+||. +|++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              000        0112357789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.8e-41  Score=283.56  Aligned_cols=243  Identities=21%  Similarity=0.300  Sum_probs=193.6

Q ss_pred             eeee--ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEE
Q 022956           21 YSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        21 ~~~~--lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      +.+.  ||+|+||.||++.++.++..+|+|.+........         |+.....+ +|||++++++.+...  +.+++
T Consensus        18 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---------e~~~~~~~~~h~~iv~~~~~~~~~--~~~~i   86 (267)
T PHA03390         18 IVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI---------EPMVHQLMKDNPNFIKLYYSVTTL--KGHVL   86 (267)
T ss_pred             cccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh---------hHHHHHHhhcCCCEEEEEEEEecC--CeeEE
Confidence            4445  5999999999999999999999999976543211         11122222 699999999988654  57999


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||||+++++|.+++.....+++.++..++.|++.|+.+||+.|  ++|+||+|+||+++.+.+.++|+|||++...... 
T Consensus        87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence            9999999999999988778999999999999999999999999  9999999999999988239999999998765432 


Q ss_pred             ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-CCCCCCCCCCCCChHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT-GGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li  255 (289)
                        ....++..|+|||.+.+ .+++++|+||||+++++|++|..||.............. ............++.+.++|
T Consensus       164 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T PHA03390        164 --SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFV  241 (267)
T ss_pred             --ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHH
Confidence              22357889999997765 488899999999999999999999975433221111111 11122233446789999999


Q ss_pred             HHHHc-CCCCCCC-HHHHhcCccccc
Q 022956          256 EKCIA-QPRARPS-ASELLKDPFFSE  279 (289)
Q Consensus       256 ~~~l~-dp~~Rps-~~~il~h~~~~~  279 (289)
                      .+||+ +|.+||+ ++++|+||||++
T Consensus       242 ~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        242 QSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHhccChhhCCchHHHHhcCCcccC
Confidence            99999 9999996 699999999975

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-41  Score=290.41  Aligned_cols=258  Identities=24%  Similarity=0.401  Sum_probs=201.1

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC-
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ-   91 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   91 (289)
                      +..++| ++.++||+|+||.||+|.+..+++.||+|.+.....  .......+.+|++++++++|||++++++++.... 
T Consensus         9 ~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865           9 DEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             chhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            345566 579999999999999999999999999999875432  2222345567999999999999999998875432 


Q ss_pred             -----CCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           92 -----HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        92 -----~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                           ....++|+||+.+ +|.+++... ..+++.++..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~  161 (310)
T cd07865          86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLA  161 (310)
T ss_pred             cccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CcEEEC
Confidence                 2457999999976 788777654 36899999999999999999999999  9999999999999988 899999


Q ss_pred             ccCCccccCCcccc-----ccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHhC
Q 022956          166 DLGFAAIVGRSHAA-----HSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY--KKVTG  236 (289)
Q Consensus       166 d~g~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~--~~~~~  236 (289)
                      |||++.........     ....++..|+|||.+.+.  ++.++|+||||+++++|++|..||..........  ..+.+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999766432221     223467789999976543  6789999999999999999999997644332211  11111


Q ss_pred             CCCCC---------------------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          237 GVKPQ---------------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       237 ~~~~~---------------------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ..++.                           ......++.+.+++.+||. ||++|||++++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            11100                           0111235678899999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-41  Score=288.79  Aligned_cols=256  Identities=26%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCC---
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH---   92 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~---   92 (289)
                      +| ++.+.||+|+||.||++.+..+|+.||+|.++....  .......+.+|+.+++.+. |+|++++++.+...+.   
T Consensus         2 ~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           2 AY-EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             Cc-eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            44 578999999999999999999999999999876432  2223456788999999995 5999999988755432   


Q ss_pred             CeeEEEeccccCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           93 NTLNFITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      ...++++||+++ +|.+++..     +..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+.+.++|+||
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeec
Confidence            247999999987 78888754     245799999999999999999999999  9999999999999983389999999


Q ss_pred             CCccccCCccc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC----
Q 022956          168 GFAAIVGRSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP----  240 (289)
Q Consensus       168 g~~~~~~~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----  240 (289)
                      |++........ .....+++.|+|||.+.+  .++.++|+||||+++++|++|..||.+................+    
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99876543222 222346788999997643  37889999999999999999999998765555444332211000    


Q ss_pred             ---------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          241 ---------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       241 ---------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                                           .......++.+.++|.+||. ||.+||++++++.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                 00112357889999999998 999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-41  Score=281.39  Aligned_cols=248  Identities=29%  Similarity=0.492  Sum_probs=208.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|++|.||++.++.+++.+++|.+.....  .......+.+|++.++.++|+|++++.+.+...  ...++|+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   78 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM   78 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence            678999999999999999999999999999986543  334456778899999999999999999888554  6799999


Q ss_pred             ccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          100 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       100 e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ||+++++|.+++..    ...+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecC-CcEEEeeccchhhhcc
Confidence            99999999999876    456899999999999999999999999  9999999999999998 8999999999977654


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      . ......+++.|+|||.+.+. +++++|+||||+++++|++|..||........ ...+.....+ ......+..++++
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~l  232 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-RYKVQRGKYP-PIPPIYSQDLQNF  232 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCCC-CCchhhCHHHHHH
Confidence            4 33335578899999976654 88899999999999999999999987654433 3333333222 2334568899999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCccc
Q 022956          255 IEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +.+||. +|++||++.++++||++
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         233 IRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHcCCCcccCCCHHHHhcCCCC
Confidence            999998 99999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.8e-42  Score=286.45  Aligned_cols=243  Identities=30%  Similarity=0.537  Sum_probs=196.0

Q ss_pred             eeeeecccCcceEEEEeec----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           21 YSDLLGSGAVKKVYRAFDQ----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +.+.||+|.||.||+|.+.    ..+..|+||.++..   ......+.+.+|++.+++++||||+++++++...  +..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccccc--cccc
Confidence            5788999999999999887    45788999999542   2455578899999999999999999999998743  4589


Q ss_pred             EEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           97 FITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|+||+++++|.+++...  ..++..++..|+.|++.||.|||+++  ++|++|+++||+++.+ +.+||+|||++....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccc
Confidence            999999999999999886  78999999999999999999999999  9999999999999999 899999999998763


Q ss_pred             Cc---cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          175 RS---HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       175 ~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ..   ...........|+|||.+... ++.++||||||++++|+++ |+.||.+... ......+..+.... .+...+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~  232 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEKLKQGQRLP-IPDNCPK  232 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHHHHTTEETT-SBTTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccce-eccchhH
Confidence            22   112334466789999987655 8999999999999999999 7899988744 44444444444333 3455688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.+++..||. ||++||++.+|++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            99999999998 9999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=303.72  Aligned_cols=261  Identities=27%  Similarity=0.469  Sum_probs=225.5

Q ss_pred             CceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeE
Q 022956            8 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW   87 (289)
Q Consensus         8 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   87 (289)
                      .+..-||+..|.. .+-||+|+||.||.|.+..+.+.||||++...... ..+....+..|+++|++++|||.+..-++|
T Consensus        18 LF~k~DPEklf~d-LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ-s~EKWqDIlKEVrFL~~l~HPntieYkgCy   95 (948)
T KOG0577|consen   18 LFFKDDPEKLFSD-LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDILKEVRFLRQLRHPNTIEYKGCY   95 (948)
T ss_pred             HHccCCHHHHHHH-HHHhcCCccceeEEeeccCccceeeeeeccccccc-cHHHHHHHHHHHHHHHhccCCCccccccee
Confidence            3556688888865 78899999999999999999999999999876543 455678899999999999999999999999


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      +.+  .+.|+|||||-| |-.|++.= .+++.+..+..|..+.+.||+|||+++  .+|+|||..|||+++. |.|||+|
T Consensus        96 Lre--~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~-g~VKLaD  169 (948)
T KOG0577|consen   96 LRE--HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEP-GLVKLAD  169 (948)
T ss_pred             ecc--chHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCC-Ceeeecc
Confidence            876  579999999977 88888874 467999999999999999999999999  9999999999999999 9999999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCcc-cc---cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPEL-YE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA  242 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~-~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  242 (289)
                      ||.+.....   ..+..|||-|||||+ +.   |.|+-+.||||||++..++...+.|+.+......++.+- ++.+|..
T Consensus       170 FGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-QNesPtL  245 (948)
T KOG0577|consen  170 FGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTL  245 (948)
T ss_pred             ccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-hcCCCCC
Confidence            999986643   446789999999994 32   559999999999999999999999998877777766554 4444444


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ....-+..++.++..||+ -|.+|||.+++|+|+|+..-
T Consensus       246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence            444457889999999998 89999999999999998653

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=285.75  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=198.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +.| ++.+.||+|++|.||++.++.+++.||+|.+.......   ....+.+|+++++.++|+||+++++++..  ++..
T Consensus         5 ~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~   78 (291)
T cd07844           5 ETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVTLHDIIHT--KKTL   78 (291)
T ss_pred             cce-eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---CchhHHHHHHHHhhCCCcceeeEEEEEec--CCeE
Confidence            455 67899999999999999999999999999997643211   12345679999999999999999998754  3689


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++|+||+.+ +|.+++... ..+++..+..++.|+++||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER-GELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-CCEEECccccccccC
Confidence            999999986 899988753 46899999999999999999999999  9999999999999998 899999999987543


Q ss_pred             Cccc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC---CCC--------
Q 022956          175 RSHA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKP--------  240 (289)
Q Consensus       175 ~~~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~--------  240 (289)
                      .... .....++..|+|||.+.+  .++.++|+||||+++++|++|..||.+..........+...   ...        
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            2221 122345778999997653  37889999999999999999999997654222222111110   000        


Q ss_pred             --------------C---CCCCCCC--hHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          241 --------------Q---ALNKVKD--PEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       241 --------------~---~~~~~~~--~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                    .   ......+  ..+.+++.+||+ +|++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                          0   0001123  778899999998 99999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.4e-41  Score=285.20  Aligned_cols=244  Identities=22%  Similarity=0.374  Sum_probs=201.2

Q ss_pred             ceeeeecccCcceEEEEeecCCC-----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEG-----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ++.+.||+|+||.||+|.+...+     ..+++|.++...   .......+.+|++.+++++|||++++++.+...  ..
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~   82 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QP   82 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--Cc
Confidence            67899999999999999876555     679999987432   345567789999999999999999999987543  57


Q ss_pred             eEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC
Q 022956           95 LNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~  158 (289)
                      .++++||+++++|.+++...                ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~  160 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEG  160 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCC
Confidence            89999999999999998754                45788999999999999999999999  9999999999999988


Q ss_pred             CCcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 022956          159 IGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK  233 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  233 (289)
                       +.++|+|||++.......   ......+++.|+|||.+. +.+++++|+|||||++|+|++ |..||.+.... .....
T Consensus       161 -~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~~~~~  238 (283)
T cd05048         161 -LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EVIEM  238 (283)
T ss_pred             -CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Confidence             899999999987553221   122334577899999655 458999999999999999998 99999875544 34444


Q ss_pred             HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +.....+. .+...++++.+|+.+||+ ||.+||++.+|++
T Consensus       239 i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~  278 (283)
T cd05048         239 IRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHT  278 (283)
T ss_pred             HHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            44443332 345578999999999998 9999999999998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-43  Score=302.96  Aligned_cols=242  Identities=26%  Similarity=0.467  Sum_probs=204.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.+.||+|+||+||+|.+-+   .||||++.....  ..+..+.|++|+.++++-+|-||+-++|++...   .+.||+
T Consensus       395 ~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~AIiT  466 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLAIIT  466 (678)
T ss_pred             hccceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---ceeeee
Confidence            467889999999999999853   599999998765  456789999999999999999999999998555   359999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc---CC
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GR  175 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~---~~  175 (289)
                      -||+|.+|..++.- ...+.......|++|+++|+.|||.++  |+|+|||..||++..+ ++|||+|||++..-   ..
T Consensus       467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC-CcEEEecccceeeeeeecc
Confidence            99999999999863 346888999999999999999999999  9999999999999998 89999999999654   23


Q ss_pred             ccccccCCCCCCCCCCccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC---CCCCCCCCCCC
Q 022956          176 SHAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKVKD  248 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  248 (289)
                      ........+...|+|||+.+.    ++++.+||||+|+++|||++|.+||+ ....+++.=.+-++   .+........+
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~p  622 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCP  622 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCH
Confidence            333444567889999996542    38999999999999999999999999 45555555455555   22333444567


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .++++|+..||+ ++++||.+.+||.
T Consensus       623 k~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  623 KAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHhcCcccCccHHHHHH
Confidence            799999999999 9999999999988

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.6e-41  Score=285.14  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=202.1

Q ss_pred             CCcccceeeeecccCcceEEEEe----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .+||+++.+.||+|+||+||++.    ...++..+|+|.++...   .......+.+|+++++.++|||++++++.+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ   78 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            46888889999999999998764    44578899999997542   233456788899999999999999999987665


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      ....++++|||+.+++|.+++... .+++.++..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~  154 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-RLVKIGDFGLA  154 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-CcEEEeecccc
Confidence            556789999999999999999764 5999999999999999999999999  9999999999999988 89999999998


Q ss_pred             cccCCccc----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--------------HHHH
Q 022956          171 AIVGRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--------------AKIY  231 (289)
Q Consensus       171 ~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~--------------~~~~  231 (289)
                      ........    .....++..|+|||...+ ..+.++|+||||+++++|++|..||......              ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            76643222    112234567999997654 4899999999999999999999998643211              0111


Q ss_pred             HHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          232 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +.+...... ..+...+..+.+++..||+ ||++|||+++++.  ++++
T Consensus       235 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~--~l~~  280 (283)
T cd05080         235 ELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP--ILKE  280 (283)
T ss_pred             hhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH--HHHH
Confidence            111111111 1234467899999999999 9999999999997  5544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.1e-41  Score=284.73  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=201.4

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|++|.||+|.++.+|..||+|+++....   ......+.+|+.+++.++|+|++++++.+...  +..++|+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   77 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF   77 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence            678999999999999999999999999999986543   22245567799999999999999999988654  5789999


Q ss_pred             ccccCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956          100 EVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus       100 e~~~~~sL~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR-GELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CcEEEeecchhhhhcCC
Confidence            99986 888887653   35899999999999999999999999  9999999999999988 89999999999765432


Q ss_pred             cc-cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-------------
Q 022956          177 HA-AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------------  240 (289)
Q Consensus       177 ~~-~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  240 (289)
                      .. .....++..|++||.+.+  .++.++|+||||+++++|++|..||.+................+             
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            22 223456788999997654  36889999999999999999999998765444333322111000             


Q ss_pred             -------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          241 -------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       241 -------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                   .......++.+++++.+||+ ||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                         00112347789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7e-41  Score=284.15  Aligned_cols=256  Identities=21%  Similarity=0.359  Sum_probs=202.4

Q ss_pred             CcccceeeeecccCcceEEEEeecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ++| ++.++||+|+||.||+|.++.     ++..||+|.+....   .......+.+|+.+++.++|+|++++++.+.. 
T Consensus         6 ~~~-~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   80 (288)
T cd05061           6 EKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-   80 (288)
T ss_pred             HHc-eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence            344 689999999999999997542     35679999876432   23334567889999999999999999998744 


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                       +...+++|||+++++|.+++...          ..++...+..++.|++.||.|||+++  ++|+||+|+||+++.+ +
T Consensus        81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~-~  156 (288)
T cd05061          81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD-F  156 (288)
T ss_pred             -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC-C
Confidence             35789999999999999999742          23466788999999999999999999  9999999999999988 8


Q ss_pred             cEEEeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh
Q 022956          161 QVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVT  235 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~  235 (289)
                      .++|+|||++........   .....++..|+|||.+.+ .++.++|+|||||++++|++ |..||.+....+ ....+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH
Confidence            999999999875532211   112234668999997654 48999999999999999998 788998755444 333333


Q ss_pred             CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc------CcccccCCC
Q 022956          236 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK------DPFFSELND  282 (289)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~------h~~~~~~~~  282 (289)
                      ..... ..+...++.+++++.+||+ ||++|||+.++++      ||||.+++|
T Consensus       236 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         236 DGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             cCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            22222 1234457899999999998 9999999999988      999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.6e-41  Score=286.48  Aligned_cols=249  Identities=28%  Similarity=0.462  Sum_probs=208.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+.+.||+|++|.||++.+..+|+.+++|++...... .....+.+.+|+++++++. |+|++++++.+..  .+.++++
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv   80 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLYFV   80 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEEEE
Confidence            6789999999999999999999999999999764432 2334567888999999998 9999999988744  3679999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||++++++|.+++.+.+.+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++++|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEecCCccccccCCccc
Confidence            999999999999998888999999999999999999999999  9999999999999988 8999999999876643321


Q ss_pred             ---------------------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC
Q 022956          179 ---------------------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG  236 (289)
Q Consensus       179 ---------------------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  236 (289)
                                           .....++..|+|||..... ++.++|+||||++++++++|..||...............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                 1223467899999976544 888999999999999999999999876544333333321


Q ss_pred             CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCH----HHHhcCccc
Q 022956          237 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSA----SELLKDPFF  277 (289)
Q Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~----~~il~h~~~  277 (289)
                      .   ...+...++.+.+++..||+ +|++||++    ++++.||||
T Consensus       238 ~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 E---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             C---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            1   12334458899999999998 99999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=284.80  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=204.9

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.++||+|++|.||+|.+..+|+.+|+|.+....  ........+.+|+++++.++|+|++++++.+........++|+
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            57899999999999999999999999999998764  1334456678899999999999999999988655346899999


Q ss_pred             ccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956          100 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      ||+++ +|.+++... ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC-CCEEEccccceeeccCCCc
Confidence            99986 888888765 57999999999999999999999999  9999999999999998 899999999998765443 


Q ss_pred             -ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--C-----------
Q 022956          178 -AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--Q-----------  241 (289)
Q Consensus       178 -~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~-----------  241 (289)
                       ......++..|+|||.+.+  .+++++|+||||+++++|++|..||..................+  .           
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence             1223456778999996654  37889999999999999999999998755443333222211000  0           


Q ss_pred             ---------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          242 ---------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       242 ---------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                     ......++.+.+++.+||. +|++||++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                           0111137889999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-42  Score=295.54  Aligned_cols=259  Identities=26%  Similarity=0.402  Sum_probs=206.5

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDD   90 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   90 (289)
                      +...++-|.+.++||.|+.+.||+|... +...||+|++.....  ++.....+.+|+..|.+|+ |.+|++++++-..+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~--D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEA--DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhc--CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            3455666788999999999999999764 446677777765443  6777889999999999995 79999999876654


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l-~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        +++|+|||+-+. .|..++.+.... +.-.+..+..||+.|+.++|++|  ++|-||||.|+++-.  |.+||+|||.
T Consensus       433 --~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk--G~LKLIDFGI  505 (677)
T KOG0596|consen  433 --GYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK--GRLKLIDFGI  505 (677)
T ss_pred             --ceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe--eeEEeeeech
Confidence              699999999855 999999976433 33488899999999999999999  999999999999976  5899999999


Q ss_pred             ccccCCccc---cccCCCCCCCCCCcccccC------------CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 022956          170 AAIVGRSHA---AHSIIGTPEYMAPELYEED------------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV  234 (289)
Q Consensus       170 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~------------~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~  234 (289)
                      |........   ..+.+||+.||+||.+...            .++++||||||||||+|+.|+.||......-.-...+
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI  585 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI  585 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence            987754322   4567899999999966311            5679999999999999999999998654333333333


Q ss_pred             hCCCCCCCCCCCCCh-HHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          235 TGGVKPQALNKVKDP-EVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       235 ~~~~~~~~~~~~~~~-~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ..-.....++...+. ++.++++.||+ ||++||++.++|+|||+.-+
T Consensus       586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            332222233444444 49999999998 99999999999999999764

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-41  Score=293.16  Aligned_cols=251  Identities=26%  Similarity=0.406  Sum_probs=200.8

Q ss_pred             CCcccceeeeecccCcceEEEEeecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEE
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWL   88 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   88 (289)
                      .++| ++.+.||+|+||.||+|.+..     +++.||+|+++...   .....+.+.+|+.++.++ +|+||+++++.+.
T Consensus         6 ~~~~-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           6 RDRL-KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHHh-hhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            4465 789999999999999997543     45789999997543   233456678899999999 7999999999776


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhc------------------------------------------------------
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKH------------------------------------------------------  114 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~------------------------------------------------------  114 (289)
                      .. +..+++++||+++++|.+++...                                                      
T Consensus        82 ~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          82 KP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             cC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            54 35788999999999999988531                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc---cccCCC
Q 022956          115 -------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIG  184 (289)
Q Consensus       115 -------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~  184 (289)
                             .++++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++........   .....+
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~  237 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARL  237 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCC
Confidence                   25789999999999999999999999  9999999999999988 8999999999986533221   222344


Q ss_pred             CCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-C
Q 022956          185 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q  261 (289)
Q Consensus       185 ~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-d  261 (289)
                      +..|+|||.+. ..++.++|||||||++++|++ |..||.+..........+...... ..+...++.+.+++.+||+ +
T Consensus       238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~  316 (337)
T cd05054         238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNN  316 (337)
T ss_pred             CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCC
Confidence            66899999665 459999999999999999998 999998654444444444433222 2344567899999999998 9


Q ss_pred             CCCCCCHHHHhcC
Q 022956          262 PRARPSASELLKD  274 (289)
Q Consensus       262 p~~Rps~~~il~h  274 (289)
                      |++||+++++++|
T Consensus       317 p~~RPs~~ell~~  329 (337)
T cd05054         317 PEDRPTFSELVEI  329 (337)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999984

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.2e-41  Score=285.74  Aligned_cols=258  Identities=25%  Similarity=0.403  Sum_probs=210.1

Q ss_pred             cceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCe
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   94 (289)
                      |++.+.||+|+||.||.|.+.   .+|..||+|+++...........+.+.+|+++++++ +|++|+.+++.+..  +..
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~   79 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DTK   79 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CCe
Confidence            367899999999999999874   478999999998654333344456788899999999 58999999887744  367


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++|+||+++++|.+++.....+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~  156 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence            8999999999999999988888999999999999999999999999  9999999999999988 899999999987654


Q ss_pred             Ccc--ccccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhCCCCCCCCCCC
Q 022956          175 RSH--AAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       175 ~~~--~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ...  ......++..|+|||...+   .++.++|+||||+++++|++|..||....   ........+.....+  .+..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  234 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQE  234 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCcc
Confidence            322  2223457889999997653   36789999999999999999999996432   223333333332222  2445


Q ss_pred             CChHHHHHHHHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      .++.+.+++++||. ||++||     ++++++.||||.+..|.
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence            68899999999998 999997     89999999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-41  Score=291.32  Aligned_cols=263  Identities=27%  Similarity=0.425  Sum_probs=210.5

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC-
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH-   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-   92 (289)
                      ..++| ++.+.||+|++|.||++.+..+|..||+|.+.....  .......+.+|+.+++.++||||+++++.+..... 
T Consensus        13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          13 VPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             cccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            45666 679999999999999999999999999999864322  34445678899999999999999999988754321 


Q ss_pred             ---CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           93 ---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        93 ---~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                         ..+++|++++ +++|.+++.. ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~-~~~kl~dfg~  164 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGL  164 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeccc
Confidence               2468999998 6689888875 56999999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------  240 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------  240 (289)
                      +......  .....+++.|+|||.+.+  .++.++|+||||++++++++|..||.+.................       
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            8765432  223456788999997654  37889999999999999999999998755443333222211000       


Q ss_pred             ---------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          241 ---------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       241 ---------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                                           .......++.+.+++.+||+ ||++||++.+++.||||+....+..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~  310 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE  310 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccc
Confidence                                 01123457789999999998 99999999999999999998665544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.1e-41  Score=279.11  Aligned_cols=240  Identities=23%  Similarity=0.390  Sum_probs=198.2

Q ss_pred             eecccCcceEEEEee--cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           24 LLGSGAVKKVYRAFD--QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      .||+|+||.||+|.+  +.++..+|+|+++....  +....+.+.+|+.+++.++|||++++++.+.   ....++|+||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC--cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEec
Confidence            599999999999964  56789999999875432  4556778999999999999999999998763   2457899999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc--
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--  179 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~--  179 (289)
                      +++++|.+++.....+++..+..++.|++.||.+||++|  ++|+||+|.||+++.+ +.++|+|||++.........  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-CeEEECCCccccccCCCCCeee
Confidence            999999999988788999999999999999999999999  9999999999999988 89999999999766433221  


Q ss_pred             --ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          180 --HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       180 --~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                        ....++..|+|||.+.. .++.++|+||||+++|+|++ |..||..... ......+..+..+ ..+...++.+.+++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~i~~~~~~-~~~~~~~~~l~~li  231 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGERM-ECPQRCPPEMYDLM  231 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence              12233578999997664 48889999999999999998 9999986544 3444455554332 23455789999999


Q ss_pred             HHHHc-CCCCCCCHHHHhc
Q 022956          256 EKCIA-QPRARPSASELLK  273 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~  273 (289)
                      .+||+ ||++||++.+|..
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         232 KLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHhccCchhCcCHHHHHH
Confidence            99998 9999999999876

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-41  Score=294.54  Aligned_cols=263  Identities=27%  Similarity=0.428  Sum_probs=210.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..++| ++.+.||+|++|.||+|.+..++..||+|++.....  .......+.+|+.++++++|+|++++.+.+...+  
T Consensus        13 ~~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          13 VPDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             ccCce-EEEEEeccCCceEEEEEEECCCCcEEEEEecccccc--hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            45666 679999999999999999999999999999875422  2334566778999999999999999988764432  


Q ss_pred             --CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 --~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ...+++|+||+ +++|.+++.. .++++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~-~~~kL~dfg~  164 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGL  164 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEccccc
Confidence              13589999999 5599999876 46999999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ------  241 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------  241 (289)
                      +......  .....++..|+|||...+  .++.++|+||||++++++++|..||.+................+.      
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            9866433  223456788999997653  478899999999999999999999987555443333222111000      


Q ss_pred             ----------------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          242 ----------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       242 ----------------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                                            ......++.+.+++.+||+ ||++|||+.+|+.||||+++..+..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~  310 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE  310 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc
Confidence                                  0011247889999999998 99999999999999999988665443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.3e-41  Score=285.42  Aligned_cols=251  Identities=28%  Similarity=0.474  Sum_probs=207.0

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ..+||+|+||.||++.++.+|+.+|+|++...    .......+.+|+.+++.++|+|++++++.+...  +..++++||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~   98 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEF   98 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEec
Confidence            36799999999999999999999999998643    233456788999999999999999999988554  689999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-ccc
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AAH  180 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-~~~  180 (289)
                      +++++|.+++.. ..+++..+..++.|++.++.+||+.|  ++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEcccccceeccccccccc
Confidence            999999998765 45899999999999999999999999  9999999999999988 899999999886554322 223


Q ss_pred             cCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCChHHHHHHHHH
Q 022956          181 SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPEVKAFIEKC  258 (289)
Q Consensus       181 ~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  258 (289)
                      ...+++.|+|||...+ .+++++|+||+|+++++|++|..||........ ...+....+. .......++.+.+++.+|
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLPPKLKNLHKVSPSLKGFLDRL  253 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhCCcccCCcccCCHHHHHHHHHH
Confidence            3457889999997654 488899999999999999999999986444333 3333332222 112334688999999999


Q ss_pred             Hc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          259 IA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       259 l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      |. ||.+||++.+++.||||......
T Consensus       254 l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         254 LVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             HhCCcccCcCHHHHhcChHHhccCCC
Confidence            98 99999999999999999988753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.8e-41  Score=278.33  Aligned_cols=241  Identities=22%  Similarity=0.391  Sum_probs=196.2

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      +.||+|+||.||+|.++.+++.+|+|.+....   ..+....+.+|+++++.++|||++++++++...  ..+++|+||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence            46999999999999999999999999886432   345567789999999999999999999987543  5789999999


Q ss_pred             cCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc--
Q 022956          103 TSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--  179 (289)
Q Consensus       103 ~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~--  179 (289)
                      ++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.........  
T Consensus        76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC-CcEEECccccCccccccccccc
Confidence            999999998753 46899999999999999999999999  9999999999999988 89999999998754322111  


Q ss_pred             -ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          180 -HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       180 -~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                       .....+..|+|||.+.+. ++.++|+||||+++++|++ |..||....... ....+...... ..+...+..+.+++.
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~  230 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAIEQGVRL-PCPELCPDAVYRLME  230 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence             111224569999976544 8889999999999999998 889997644433 33333333222 234456889999999


Q ss_pred             HHHc-CCCCCCCHHHHhc
Q 022956          257 KCIA-QPRARPSASELLK  273 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~  273 (289)
                      +||+ +|++|||+.++++
T Consensus       231 ~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         231 RCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            9998 9999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-43  Score=306.14  Aligned_cols=249  Identities=31%  Similarity=0.518  Sum_probs=214.4

Q ss_pred             eecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecccc
Q 022956           24 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCT  103 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~  103 (289)
                      +||.|.||+||.|++..|....|||.+...    +....+-+.+|+...++|+|.|||+.++.+  ++++++-|.||-++
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCC
Confidence            499999999999999999999999999865    334467789999999999999999999987  55678999999999


Q ss_pred             CCcHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Ccccc
Q 022956          104 SGNLRTYRKKH-RHV--SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAA  179 (289)
Q Consensus       104 ~~sL~~~~~~~-~~l--~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~~~~  179 (289)
                      ||||.+++... +++  .+.....+..||++||.|||.+.  ++|||||-+||+++.-+|.+||+|||-++... -.+.+
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            99999999864 667  78889999999999999999999  99999999999998877999999999998764 45557


Q ss_pred             ccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ....||.-|||||+.+.   +|.+++|||||||++.||.||+.||-.........-.+--....+.++...+.+.+.+|.
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence            77889999999997763   399999999999999999999999987655544333322222334456667889999999


Q ss_pred             HHHc-CCCCCCCHHHHhcCcccccC
Q 022956          257 KCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +|+. ||.+||++.++|.+||++.-
T Consensus       814 rcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHcCCCcccCccHHHhccCcccccC
Confidence            9999 99999999999999999865

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-41  Score=291.83  Aligned_cols=265  Identities=26%  Similarity=0.400  Sum_probs=209.3

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..++| .+.+.||+|+||.||++.+..+|+.||+|++.....  .....+.+.+|+.++++++||||+++++++....  
T Consensus        15 ~~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          15 VPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             ccCce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            44666 679999999999999999999999999999975422  2333566788999999999999999998775321  


Q ss_pred             --CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 --~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ...++++++++ +++|.+++... .+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~dfg~  166 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGL  166 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC-CCEEEecccc
Confidence              23578888887 66998888754 5999999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC---------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---------  238 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---------  238 (289)
                      +......  .....++..|+|||.+.+  .++.++|+|||||++++|++|..||............+....         
T Consensus       167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         167 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             ccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            8765332  223456788999997654  378899999999999999999999976544333222111100         


Q ss_pred             ----------------CCC---CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCCC
Q 022956          239 ----------------KPQ---ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS  288 (289)
Q Consensus       239 ----------------~~~---~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~~  288 (289)
                                      ...   ......++.+.+++..||+ ||.+||++.+++.||||++...+...+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~  314 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV  314 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcccc
Confidence                            000   0011347789999999998 9999999999999999998877666654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-41  Score=279.21  Aligned_cols=242  Identities=25%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             eeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++||+|+||.||+|.+...   +..+++|.+.....   ....+.+.+|++.++.++|+|++++++++..  ...+++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence            4799999999999998866   89999999986543   2246788999999999999999999998855  46899999


Q ss_pred             ccccCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956          100 EVCTSGNLRTYRKKH---------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus       100 e~~~~~sL~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      ||+++++|.+++...         ..+++..+..++.|++.||.+||+++  ++|+||+|+||+++.+ +.++|+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEcccccc
Confidence            999999999999875         78999999999999999999999999  9999999999999999 89999999999


Q ss_pred             cccCCcc---ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          171 AIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       171 ~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      .......   ......++..|+|||.+.. .++.++|+||||+++++|++ |..||..... ......+..+... ..+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~  230 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRL-PKPE  230 (262)
T ss_pred             cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC-CCCc
Confidence            8765432   2334456789999997665 48899999999999999999 6999987643 3444444443322 2344


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..++.+.+++.+||+ +|++|||+.+++++
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         231 YCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            568999999999998 99999999999974

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-40  Score=278.18  Aligned_cols=251  Identities=30%  Similarity=0.542  Sum_probs=205.8

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|++|.||+|.+..+|+.+|+|.++..... .....+.+.+|++++++++|++++++++.+...  +..
T Consensus         2 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~   77 (267)
T cd08224           2 GNF-KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NEL   77 (267)
T ss_pred             Cce-eeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence            355 6899999999999999999999999999999764432 334467889999999999999999999988654  678


Q ss_pred             EEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           96 NFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ++++||+++++|.+++..    ...+++.++..++.+++.|+.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~-~~~~l~d~~~~~  154 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGR  154 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC-CcEEEeccceee
Confidence            999999999999998864    345899999999999999999999999  9999999999999988 899999999987


Q ss_pred             ccCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhCCCCCCCCCCCCC
Q 022956          172 IVGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       172 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ...... ......++..|.|||.+.+. ++.++|+||||+++++|++|..||.... +.......+..+..+.......+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS  234 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence            654322 22334578889999976544 8889999999999999999999996532 33333444444333333333567


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..+++++.+||. +|++||++.+|++
T Consensus       235 ~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         235 EELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            899999999998 9999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-41  Score=291.61  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=207.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC-
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH-   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-   92 (289)
                      ..++| .+.+.||+|+||.||+|.++.+|+.||+|++.....  .+.....+.+|+++++.++|||++++++++..... 
T Consensus        13 ~~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          13 LPERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             cccce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence            34566 578999999999999999999999999999875432  23334567889999999999999999988754321 


Q ss_pred             ---CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           93 ---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        93 ---~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                         ..+++++||+.. +|..++.  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~-~~~kL~dfg~  163 (342)
T cd07879          90 DEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGL  163 (342)
T ss_pred             CCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCCC
Confidence               346899999965 7777653  45899999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC--------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--------  239 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------  239 (289)
                      +......  .....++..|+|||.+.+  .++.++|+||||+++++|++|+.||.+..........+.....        
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            8754322  223456788999997654  3788999999999999999999999875544433322221100        


Q ss_pred             -------------CCC-------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          240 -------------PQA-------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       240 -------------~~~-------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                   +..       .....++.+.+|+.+||+ ||++||++++++.||||+.....++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~  310 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET  310 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence                         000       012346788999999998 999999999999999999997765443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-41  Score=277.88  Aligned_cols=244  Identities=27%  Similarity=0.470  Sum_probs=206.5

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccC
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS  104 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  104 (289)
                      ||+|++|.||++.++.+++.+++|.+...... .......+..|++++++++|+|++++++.+.  .+...+++||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-chHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCC
Confidence            79999999999999989999999999865432 3345678899999999999999999998874  34689999999999


Q ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-cccccCC
Q 022956          105 GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSII  183 (289)
Q Consensus       105 ~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-~~~~~~~  183 (289)
                      ++|.+++.....+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++...... .......
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCc
Confidence            999999998878999999999999999999999999  9999999999999998 89999999999776543 2233456


Q ss_pred             CCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-C
Q 022956          184 GTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-Q  261 (289)
Q Consensus       184 ~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-d  261 (289)
                      ++..|++||...+. .+.++|+||||++++++++|..||..... ......+...  ....+...+..+.+++.+||. |
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILKD--PLRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCC
Confidence            78899999976544 78899999999999999999999976554 3333333332  223455568899999999998 9


Q ss_pred             CCCCCCH---HHHhcCccc
Q 022956          262 PRARPSA---SELLKDPFF  277 (289)
Q Consensus       262 p~~Rps~---~~il~h~~~  277 (289)
                      |++||++   ++++.||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=277.12  Aligned_cols=251  Identities=21%  Similarity=0.325  Sum_probs=209.6

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeC--CCCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD--QHNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~~lv~   99 (289)
                      ++||-|-.|+|-.+.++.||+.+|+|++.-.         ...++|++..-.. .|||||.++++|.+.  ..+.+.+||
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm  138 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM  138 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence            7899999999999999999999999999732         4456688776555 699999999998643  335778899


Q ss_pred             ccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC--CcEEEeccCCccccCC
Q 022956          100 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGR  175 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~--~~~~l~d~g~~~~~~~  175 (289)
                      |+++||.|+.-+++.+  .++++++..|+.||..|+.|||+.+  ++||||||+|+|...+.  -.+||+|||+|+....
T Consensus       139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999999999865  4999999999999999999999999  99999999999996532  4699999999998887


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhCCC--CCCCCCCCCCh
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGV--KPQALNKVKDP  249 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~  249 (289)
                      .....+.+.||-|.|||.+..+ ++...|+||||+++|-|++|..||-+...   .-.....+..+.  -+..-+...|+
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe  296 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE  296 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence            7777888999999999988765 99999999999999999999999964321   122233333332  23334556799


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +.+++|+++|+ +|.+|.++++++.|||+..-....
T Consensus       297 ~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp  332 (400)
T KOG0604|consen  297 AAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP  332 (400)
T ss_pred             HHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence            99999999999 999999999999999998765443

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=279.44  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=214.5

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.||+|+|+.|--++...+|..||||++....    ...+.++.+|++++.+. .|+||++++++|.++  ..+|+|||-
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEK  157 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEK  157 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEec
Confidence            77999999999999999999999999998763    34478899999999999 599999999998554  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-C-CcEEEeccCCccccCC----
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-I-GQVKIGDLGFAAIVGR----  175 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-~-~~~~l~d~g~~~~~~~----  175 (289)
                      +.||+|...+.+...+++.++..+...|+.||.|||.+|  +.|+|+||+|||-..- . .-||||||++......    
T Consensus       158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            999999999999999999999999999999999999999  9999999999998543 1 3599999998765422    


Q ss_pred             ----ccccccCCCCCCCCCCccc---ccC---CCCcchHHHHHHHHHHHHhCCCCCCCCC--------------cHHHHH
Q 022956          176 ----SHAAHSIIGTPEYMAPELY---EED---YTEMVDIYSFGLCLLEMVTMEIPYSECD--------------SVAKIY  231 (289)
Q Consensus       176 ----~~~~~~~~~~~~~~aPE~~---~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~--------------~~~~~~  231 (289)
                          .+...+.+|+..|||||+.   .++   |+.+.|.||||+|+|-|++|..||.+.-              =...+.
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                1223345788899999954   343   8899999999999999999999997521              123345


Q ss_pred             HHHhCCC--CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCCC
Q 022956          232 KKVTGGV--KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS  288 (289)
Q Consensus       232 ~~~~~~~--~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~~  288 (289)
                      +.+..+.  -|..-+..++.+.++|++.+|. |+.+|.++.+++.|||+.......--|.
T Consensus       316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalpt  375 (463)
T KOG0607|consen  316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPT  375 (463)
T ss_pred             HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCC
Confidence            5555542  2444566789999999999997 9999999999999999998865544433

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6e-41  Score=284.47  Aligned_cols=257  Identities=24%  Similarity=0.406  Sum_probs=207.7

Q ss_pred             ceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCee
Q 022956           20 RYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++.+.||+|++|.||++.+.   .++..+|+|+++...........+.+.+|++++.++ +||+++++.+.+..  +..+
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~~~   80 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DTKL   80 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CCEE
Confidence            67899999999999999753   467899999998654333344566788999999999 58999999987743  3678


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++|+||+.+++|.+++.....+++..+..++.|++.+|.+||+.+  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEEECcccccccc
Confidence            999999999999999987778999999999999999999999999  9999999999999988 8999999999876543


Q ss_pred             ccc--cccCCCCCCCCCCcccccC---CCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhCCCCCCCCCCCC
Q 022956          176 SHA--AHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       176 ~~~--~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      ...  .....++..|++||...+.   .+.++|+||||+++++|++|..||....   ........+.....  ..+...
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  235 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTM  235 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCccc
Confidence            222  2234578899999976543   6889999999999999999999996422   12222222322222  234446


Q ss_pred             ChHHHHHHHHHHc-CCCCCCC---HHHHhcCcccccCCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPS---ASELLKDPFFSELNDD  283 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps---~~~il~h~~~~~~~~~  283 (289)
                      +..+.+++.+||+ ||++|||   +.++|.||||++++|+
T Consensus       236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence            7899999999998 9999998   5778999999999886

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8e-41  Score=280.53  Aligned_cols=248  Identities=30%  Similarity=0.539  Sum_probs=204.0

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|.||++.++.+|..+++|.+...... +......+.+|+.+++.++|+|++++++.+...  +..++++
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~   81 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNIVL   81 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEEEE
Confidence            6789999999999999999999999999998764432 344456788999999999999999999988654  5789999


Q ss_pred             ccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          100 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       100 e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEECcchhhhcccc
Confidence            99999999998863    356899999999999999999999999  9999999999999988 8999999999876643


Q ss_pred             ccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          176 SHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS-VAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       176 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ... .....++..|+|||...+. ++.++|+||||+++++|++|..||..... .......+.....+.......++.++
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR  238 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence            322 2234678899999976544 88899999999999999999999975332 22333333333333334455788999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +++.+||+ ||++|||+.+|++
T Consensus       239 ~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         239 QLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHhcCCCcccCCCHHHHHH
Confidence            99999998 9999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=281.59  Aligned_cols=252  Identities=29%  Similarity=0.402  Sum_probs=199.4

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC---CCCceEEeeeeEEeCCC---C
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLDDQH---N   93 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~---~   93 (289)
                      ++.++||+|++|.||++.++.+++.||+|.++....  .......+.+|+.+++++   +|+|++++++.+.....   .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            678999999999999999998899999999986543  222234555677766655   59999999998865432   2


Q ss_pred             eeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .+++++|++.+ +|.+++...  ..+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcce
Confidence            48999999976 898888764  35899999999999999999999999  9999999999999999 899999999997


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC----------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP----------  240 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----------  240 (289)
                      ............++..|+|||.+.+. ++.++|+||||+++++|++|..||......+...........+          
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            76544333344578889999976644 8889999999999999999999998755444333332211000          


Q ss_pred             --------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          241 --------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       241 --------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                    .......++.+.+++..||+ ||++||++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                          00011235678899999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.1e-41  Score=290.73  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=200.5

Q ss_pred             eeeeccc--CcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           22 SDLLGSG--AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        22 ~~~lg~g--~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.||.|  +||+||++.+..+|+.||+|++.....  .....+.+.+|+.+++.++||||+++++++...  ...++|+
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~   78 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVIS   78 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEE
Confidence            3567777  889999999999999999999976543  344567899999999999999999999988554  5789999


Q ss_pred             ccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+.+++|.+++.+.  ..+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.++++||+.+.......
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC-CcEEEechHHHhhhhccC
Confidence            999999999998864  35899999999999999999999999  9999999999999988 899999997653321111


Q ss_pred             c--------cccCCCCCCCCCCcccccC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC------
Q 022956          178 A--------AHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------  240 (289)
Q Consensus       178 ~--------~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------  240 (289)
                      .        .....++..|+|||.+.+.   +++++|+|||||++++|++|..||............+......      
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence            0        0111245679999977543   6889999999999999999999998765444443333221100      


Q ss_pred             --------------------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          241 --------------------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       241 --------------------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                                                            .......++.+.+|+.+||. ||++|||++++++||||+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                                  00011235678999999998 999999999999999998874


Q ss_pred             C
Q 022956          282 D  282 (289)
Q Consensus       282 ~  282 (289)
                      .
T Consensus       316 ~  316 (328)
T cd08226         316 E  316 (328)
T ss_pred             H
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.5e-41  Score=284.42  Aligned_cols=256  Identities=27%  Similarity=0.492  Sum_probs=203.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.++||+|++|.||+|.+..++..||+|.++....   ......+..|+..+..+ .|+|++++++.+...  ...+++
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v   92 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFIC   92 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEEE
Confidence            678999999999999999998899999999975432   22345556676666566 599999999988554  579999


Q ss_pred             eccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+.+ ++.+++.. ...+++..+..++.|++.|+.|||+ .|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        93 ~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCC-CCEEECccccchhccCC
Confidence            999865 77777765 4578999999999999999999997 58  9999999999999988 89999999998766543


Q ss_pred             cccccCCCCCCCCCCcccccC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCChH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPE  250 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  250 (289)
                      .......++..|+|||.+.+.     ++.++|+||||+++++|++|..||............+.....+. ......+++
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD  248 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence            333334567889999976533     68899999999999999999999976444333333333322221 122246789


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +.+|+.+||. ||++||++++++.||||.......
T Consensus       249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  283 (296)
T cd06618         249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE  283 (296)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence            9999999998 999999999999999999875543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-41  Score=287.92  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=198.9

Q ss_pred             ceeeeecccCcceEEEEeecC--CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      ++.++||+|++|.||+|.++.  ++..||+|.+..... ......+.+.+|+.+++.++|||++++++.+.......+++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            678999999999999999988  899999999986431 12233456778999999999999999999987765578999


Q ss_pred             EeccccCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC----CCCcEEEeccC
Q 022956           98 ITEVCTSGNLRTYRKKH-----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING----NIGQVKIGDLG  168 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~----~~~~~~l~d~g  168 (289)
                      |+||+++ +|.+++...     ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.    + +.++|+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPER-GVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCcc-ceEEECCCc
Confidence            9999976 677666432     36899999999999999999999999  999999999999988    6 899999999


Q ss_pred             CccccCCccc----cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---------HHHHH
Q 022956          169 FAAIVGRSHA----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---------KIYKK  233 (289)
Q Consensus       169 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~---------~~~~~  233 (289)
                      ++........    .....++..|+|||.+.+  .++.++|+||||+++++|++|..||.+.....         .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9886643322    223456788999996554  37889999999999999999999997543221         00000


Q ss_pred             Hh-----------------------CCCCCCCCC-----------CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          234 VT-----------------------GGVKPQALN-----------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       234 ~~-----------------------~~~~~~~~~-----------~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +.                       .........           ...+..+.+++.+||. ||++|||+.+++.||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00                       000000000           1456788999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.9e-41  Score=312.04  Aligned_cols=252  Identities=28%  Similarity=0.415  Sum_probs=199.5

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||.||+|.+..+|+.||+|++.... ...+...+++.+|+++++.++|||++++++.+.+.  +..
T Consensus         2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~l   77 (932)
T PRK13184          2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPV   77 (932)
T ss_pred             CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEE
Confidence            466 68999999999999999999999999999997533 23455567899999999999999999999887543  678


Q ss_pred             EEEeccccCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           96 NFITEVCTSGNLRTYRKKH-----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                      +++|||++|++|.+++...           ..++...+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d-g~vKL  154 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF-GEVVI  154 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC-CCEEE
Confidence            9999999999999988641           23566788999999999999999999  9999999999999988 89999


Q ss_pred             eccCCccccCCcc-------------------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 022956          165 GDLGFAAIVGRSH-------------------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC  224 (289)
Q Consensus       165 ~d~g~~~~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~  224 (289)
                      +|||++.......                   ......|++.|+|||...+. ++.++|||||||++++|+||..||...
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            9999997652110                   01124589999999976654 899999999999999999999999764


Q ss_pred             CcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          225 DSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .......................++.+.+++.+||. ||++|++..+.+.+
T Consensus       235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            433322221111111111223467899999999998 99999876555543

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.4e-40  Score=282.46  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=210.5

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .+++..| ...++||+|+||+||+|++..+|..+++|.+...... .......+.+|+++++.++|||++++++.+.+. 
T Consensus        17 ~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   93 (313)
T cd06633          17 DDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-   93 (313)
T ss_pred             CCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-
Confidence            3444555 3468899999999999999999999999999765332 334456788899999999999999999988654 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       ...++|+||+.+ ++.+++.. ..++++.++..++.|++.++.|||+.|  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        94 -~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~-~~~kL~dfg~~  168 (313)
T cd06633          94 -HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSA  168 (313)
T ss_pred             -CEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC-CCEEEeecCCC
Confidence             578999999976 77777754 457899999999999999999999999  9999999999999988 89999999988


Q ss_pred             cccCCccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      .....   .....++..|+|||.+.    +.++.++|+||||+++++|++|..||................ .+......
T Consensus       169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  244 (313)
T cd06633         169 SKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLQSNE  244 (313)
T ss_pred             cccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCccc
Confidence            64322   22345778899999763    347889999999999999999999998765555554443332 33333444


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+..+++++.+||+ +|.+||++.+++.||||....
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            57789999999998 999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-40  Score=282.51  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=203.4

Q ss_pred             cceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +++.+.||+|+||+||++.+     ..++..+|+|.+...    .......+.+|+.++++++|||++++++.+..  .+
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   80 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD   80 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence            46889999999999999975     335667999988643    34456778999999999999999999998754  36


Q ss_pred             eeEEEeccccCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKHR-------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~-------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      .+++++||+++++|.+++....             .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~-~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-L  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC-C
Confidence            7899999999999999987533             4899999999999999999999999  9999999999999988 8


Q ss_pred             cEEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh
Q 022956          161 QVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVT  235 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~  235 (289)
                      .++|+|||++........   .....++..|+|||.+.+. ++.++|+||||+++++|++ |..||....... ....+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH
Confidence            999999999875533221   1122346789999977644 8999999999999999998 899997755444 333344


Q ss_pred             CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          236 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      .+... ..+...++++.+++.+||+ ||.+|||+.++++  .++++...
T Consensus       237 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~~~~  282 (288)
T cd05093         237 QGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNLAKA  282 (288)
T ss_pred             cCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHHHHh
Confidence            43322 2334568899999999998 9999999999987  67666543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-40  Score=281.56  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=201.3

Q ss_pred             CCcccceeeeecccCcceEEEEee----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFD----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      +++++++.++||+|+||.||++..    +.++..||+|.++...   .......+.+|+++++.++|||++++.+.+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            578889999999999999999973    5678999999986442   344467799999999999999999999987665


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      +....++|+||++|++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~~l~dfg~  155 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGL  155 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC-CCEEECCCcc
Confidence            456789999999999999999764 46899999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccc----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCC--------------CcHHHH
Q 022956          170 AAIVGRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC--------------DSVAKI  230 (289)
Q Consensus       170 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~--------------~~~~~~  230 (289)
                      +........    .....++..|+|||.+.+ .+++++|+||||+++++|+++..|....              ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            976643322    123345667999996654 4889999999999999999976654321              111112


Q ss_pred             HHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          231 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ...+...... ......+..+.+|+.+||+ ||++||++.++++
T Consensus       236 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         236 VRVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             HHHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            2222222221 2234468899999999998 9999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-40  Score=284.46  Aligned_cols=253  Identities=26%  Similarity=0.413  Sum_probs=200.7

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC-------
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ-------   91 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------   91 (289)
                      |++.++||+|++|.||+|.++.+|+.||+|.++.....  ......+.+|++++++++|||++++++.+....       
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            36789999999999999999999999999999865432  222356778999999999999999998875432       


Q ss_pred             -CCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 -HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 -~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                       ...+++++||+++ ++.+.+... ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||.
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~  162 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK-GQIKLADFGL  162 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CcEEeCcccc
Confidence             2478999999987 677766653 46899999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccc--cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--CCCCCC--
Q 022956          170 AAIVGRSHA--AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQ--  241 (289)
Q Consensus       170 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~--  241 (289)
                      +........  .....++..|+|||.+.+  ..++++|+||||+++++|++|..||..............  +...+.  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            976643321  122345678999996653  378899999999999999999999986544333322111  111110  


Q ss_pred             -----------------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          242 -----------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       242 -----------------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                             ......+..+.+++..||+ ||++||++++++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                   0112357899999999998 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.4e-41  Score=286.71  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=199.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC---
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---   91 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   91 (289)
                      .++| ++.++||+|++|.||+|.++.+++.+|+|.+......  ......+.+|+++++.++||||+++++.+....   
T Consensus         7 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            3566 6899999999999999999999999999999765432  112345677999999999999999998775432   


Q ss_pred             ---CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           92 ---HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        92 ---~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                         ...++++++|+.+ +|...+.. ...+++.++..++.|+++||.|||+.|  ++|+||+|+||+++.+ +.++|+||
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~df  159 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADF  159 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcC
Confidence               2367999999976 67666654 457999999999999999999999999  9999999999999998 89999999


Q ss_pred             CCccccCCcccc------------ccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 022956          168 GFAAIVGRSHAA------------HSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK  233 (289)
Q Consensus       168 g~~~~~~~~~~~------------~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~  233 (289)
                      |++.........            ....+++.|+|||...+  .++.++|+||||+++++|++|..||.+..........
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999765432211            11235678999997643  3788999999999999999999999865544333322


Q ss_pred             HhCCCC--CC------------------C-------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          234 VTGGVK--PQ------------------A-------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       234 ~~~~~~--~~------------------~-------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      ......  +.                  .       .....++.+.+++.+||+ ||++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            211000  00                  0       001234678899999998 99999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.4e-40  Score=285.86  Aligned_cols=264  Identities=30%  Similarity=0.428  Sum_probs=207.8

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ...++| ++.+.||.|+||.||+|.++.+|+.+|+|.+.....  .....+.+.+|+++++.++|||++++.+++.... 
T Consensus         7 ~~~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-   82 (328)
T cd07856           7 EITNRY-VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-   82 (328)
T ss_pred             ccccce-EEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-
Confidence            345565 689999999999999999999999999999865432  2233566778999999999999999999875433 


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ...++++||+. ++|..++.. ..+++..+..++.|+++||.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+..
T Consensus        83 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~-~~~~l~dfg~~~~  157 (328)
T cd07856          83 EDIYFVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLARI  157 (328)
T ss_pred             CcEEEEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCC-CCEEeCccccccc
Confidence            56889999985 589888875 45888899999999999999999999  9999999999999988 8999999999875


Q ss_pred             cCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---------------
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT---------------  235 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------  235 (289)
                      ....  .....++..|+|||.+.+  .+++++|+||||+++++|++|..||..............               
T Consensus       158 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            4332  223456788999997654  488999999999999999999999976543221111000               


Q ss_pred             --------CCC-----CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          236 --------GGV-----KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       236 --------~~~-----~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                              ...     +........++.+++++++||+ +|++||++++++.||||..+...-.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~  301 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP  301 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence                    000     0001112357889999999998 999999999999999998887665443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-40  Score=286.79  Aligned_cols=263  Identities=25%  Similarity=0.393  Sum_probs=206.9

Q ss_pred             cceeeeecccCcceEEEEeecCC--CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe--CCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE--GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD--DQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~   93 (289)
                      |++.+.||+|+||.||++.+..+  +..||+|.+.....  .....+.+.+|+.+++++ +||||+++++....  ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            36789999999999999999888  99999999874322  233456678899999999 59999999886432  2224


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .++++++++.+ +|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        80 ~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~-~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC-CCEEeCcCCCceec
Confidence            67889999864 89999988888999999999999999999999999  9999999999999998 89999999999765


Q ss_pred             CCccc-----cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC---------
Q 022956          174 GRSHA-----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---------  237 (289)
Q Consensus       174 ~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------  237 (289)
                      .....     .....+++.|+|||...+  .++.++|+||||+++++|++|..||............+...         
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            43211     123457889999996553  37889999999999999999999997654332222111100         


Q ss_pred             ----------------CCC---CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          238 ----------------VKP---QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       238 ----------------~~~---~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                      ...   .......+..+.+++.+||+ ||++|||+.+++.||||..+......+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~  305 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEP  305 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccc
Confidence                            000   01122347789999999998 999999999999999999887665443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-40  Score=276.89  Aligned_cols=243  Identities=24%  Similarity=0.393  Sum_probs=200.8

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +.+.++||+|++|.||+|.++.+++.+|+|.+...     ......+.+|++.++.++|+|++++++.+..+  ..++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   80 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII   80 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence            35789999999999999999999999999998643     22356788899999999999999999987443  578999


Q ss_pred             eccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+++++|.+++...  ..+++..++.++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CcEEeCCCccccccccc
Confidence            9999999999998753  45899999999999999999999999  9999999999999988 89999999999766433


Q ss_pred             cccc--cCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 HAAH--SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~~~~--~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ....  ....+..|+|||...+ .++.++|+||||+++++|++ |..||.+... ......+...... ..+...++.+.
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~  235 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKGYRM-ERPEGCPPKVY  235 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCCC-CCCCCCCHHHH
Confidence            2211  1223567999997654 48889999999999999998 8999987443 4444445544333 23455689999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +++.+||+ ||++||++.++++
T Consensus       236 ~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         236 ELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHccCCcccCCCHHHHHH
Confidence            99999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-40  Score=275.71  Aligned_cols=244  Identities=24%  Similarity=0.399  Sum_probs=198.9

Q ss_pred             eeecccCcceEEEEeecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++||+|+||.||+|....++   ..+|+|.+.....   ....+.+.+|+++++.+.|+|++++++.+.   .+.+++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEE
Confidence            47999999999999866554   7899999976543   234567889999999999999999998763   24689999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      ||+.+++|.+++.....+++..+..++.|++.++.+||..+  ++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-CcEEeccccccceeecCCcc
Confidence            99999999999998778999999999999999999999999  9999999999999998 89999999998765433221


Q ss_pred             c----cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          180 H----SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       180 ~----~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .    ...++..|+|||...+. ++.++|+||||+++++|++ |..||...... .....+.+.... ..+...+..+++
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~l~~  229 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESGERL-PRPEECPQEIYS  229 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHcCCcC-CCCCCCCHHHHH
Confidence            1    11224579999976544 8899999999999999998 99999875543 344444444332 334556889999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ++.+||+ +|++||++.++++  .|.+
T Consensus       230 li~~cl~~~p~~Rp~~~~l~~--~l~~  254 (257)
T cd05060         230 IMLSCWKYRPEDRPTFSELES--TFRR  254 (257)
T ss_pred             HHHHHhcCChhhCcCHHHHHH--HHHh
Confidence            9999998 9999999999987  5544

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.9e-40  Score=278.80  Aligned_cols=246  Identities=23%  Similarity=0.369  Sum_probs=195.8

Q ss_pred             cceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +++.+.||+|+||.||++.++     .++..+|+|++....   .......+.+|+.+++.++|||++++++.+.  .+.
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~   82 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QGQ   82 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCC
Confidence            478999999999999999764     245779999986432   2334566889999999999999999998873  346


Q ss_pred             eeEEEeccccCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956           94 TLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                      ..++|+||+++++|.+++.+.          ..++...+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~-~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC-CCEE
Confidence            789999999999999998752          23567889999999999999999999  9999999999999988 8999


Q ss_pred             EeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCC
Q 022956          164 IGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       164 l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      |+|||++........   .....+++.|+|||.+.+ .+++++|+||||+++++|++ |..||.+...............
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            999999875532211   112234678999997664 48999999999999999999 7899987554433333333222


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                        ...+...++.+++++.+||+ ||++||++.+++++
T Consensus       240 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 --LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              22345568899999999998 99999999999873

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2e-40  Score=292.56  Aligned_cols=245  Identities=27%  Similarity=0.393  Sum_probs=197.7

Q ss_pred             ceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCC
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   93 (289)
                      ++.++||+|+||.||+|.+...     +..||+|+++...   .....+.+.+|+++++++. ||||+++++.+..  ..
T Consensus        40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--~~  114 (400)
T cd05105          40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--SG  114 (400)
T ss_pred             ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CC
Confidence            5679999999999999986433     4579999997542   3344567899999999996 9999999998844  36


Q ss_pred             eeEEEeccccCCcHHHHHHhc-----------------------------------------------------------
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-----------------------------------------------------------  114 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-----------------------------------------------------------  114 (289)
                      .+++||||+++++|.+++.+.                                                           
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            799999999999999887542                                                           


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC
Q 022956          115 -------------------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING  157 (289)
Q Consensus       115 -------------------------------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~  157 (289)
                                                           ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~  272 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeC
Confidence                                                 23677888999999999999999999  999999999999999


Q ss_pred             CCCcEEEeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 022956          158 NIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYK  232 (289)
Q Consensus       158 ~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~  232 (289)
                      + +.++|+|||++........   .....+++.|+|||.+.+ .+++++||||||+++|+|++ |..||...........
T Consensus       273 ~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         273 G-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             C-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            8 8999999999876533221   222345678999997654 48999999999999999997 9999987555455555


Q ss_pred             HHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          233 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.....+. .+...+..+.+++.+||+ ||++||++.++.+
T Consensus       352 ~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            555543332 334568899999999998 9999999999887

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-40  Score=276.74  Aligned_cols=245  Identities=21%  Similarity=0.330  Sum_probs=199.5

Q ss_pred             cceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +++.+.||+|+||+||+|.++.+   ...+|+|.++...   .......+.+|+..++.++|||++++++.+..  ++..
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   80 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPV   80 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCce
Confidence            36789999999999999988644   4679999887543   34446678889999999999999999998744  3678


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++++||+++++|.+++... ..+++..+..++.|++.|+.+||+++  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CCEEECccchhhccc
Confidence            9999999999999998763 57899999999999999999999999  9999999999999988 899999999998764


Q ss_pred             Cccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          175 RSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       175 ~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ....   .....++..|+|||...+ .+++++|+||||+++++|++ |..||........ ...+....... .+...++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~-~~~~~~~  235 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-IKAVEDGYRLP-PPMDCPS  235 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-HHHHHcCCCCC-CCCCCCH
Confidence            2111   112234568999997764 48999999999999999998 9999976554433 33333332221 2345688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.+++..||+ +|++||+++++++
T Consensus       236 ~l~~li~~cl~~~p~~Rp~~~ei~~  260 (266)
T cd05033         236 ALYQLMLDCWQKDRNERPTFSQIVS  260 (266)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-41  Score=282.20  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|.||++.++.+|+.+++|.+.....  .+.....+.+|+++++.++|++++++++.+...  ..+++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   77 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVF   77 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEE
Confidence            567899999999999999999999999999876543  234456788899999999999999999987544  6789999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      ||+++ +|.+++.. ...+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+....... 
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcc
Confidence            99987 78777765 467999999999999999999999999  9999999999999988 899999999987665443 


Q ss_pred             ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC---------------
Q 022956          178 AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---------------  240 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------------  240 (289)
                      ......++..|+|||.+.+  .++.++|+||||+++++|++|+.||......+...........+               
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            2223456778999996653  48889999999999999999999998766544433332221110               


Q ss_pred             ------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          241 ------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       241 ------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                  .......+..+++++.+||+ ||.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                        00112347789999999998 99999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.2e-40  Score=279.73  Aligned_cols=245  Identities=22%  Similarity=0.334  Sum_probs=200.1

Q ss_pred             cceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +.+.+.||+|+||.||+|.+.     .++..+|+|.++...   ..+..+.+.+|+++++.++|+|++++++.+...  .
T Consensus         7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~   81 (280)
T cd05049           7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--D   81 (280)
T ss_pred             hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--C
Confidence            467899999999999999864     346889999987542   233467889999999999999999999988554  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKH--------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI  159 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~--------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~  159 (289)
                      ..+++|||+++++|.+++...              ..+++.++..++.|++.|+.+||++|  ++|+||+|+||+++.+ 
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD-  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC-
Confidence            799999999999999998753              34788899999999999999999999  9999999999999998 


Q ss_pred             CcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 022956          160 GQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKV  234 (289)
Q Consensus       160 ~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~  234 (289)
                      +.++|+|||++.......   ......+++.|+|||.+.+. +++++||||||+++++|++ |..||....... ....+
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-~~~~~  237 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VIECI  237 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH
Confidence            899999999987543221   11223346789999976644 8999999999999999998 999997655443 33444


Q ss_pred             hCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          235 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..+... ......+..+.+++.+||+ ||++||++.++++
T Consensus       238 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            443332 2344578999999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.3e-40  Score=278.47  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=198.8

Q ss_pred             cceeeeecccCcceEEEEeecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +++.+.||+|++|.||+|.++.     ++..+++|.+....   .......+.+|+.+++.++|+|++++++.+...  .
T Consensus         8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~   82 (277)
T cd05036           8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--L   82 (277)
T ss_pred             cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence            4688999999999999999887     77889999886432   233345688899999999999999999977543  5


Q ss_pred             eeEEEeccccCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEE
Q 022956           94 TLNFITEVCTSGNLRTYRKKHR-------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKI  164 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l  164 (289)
                      ..++++||+.|++|.+++....       .+++..+..++.|++.|+.|||+++  ++|+||+|+||+++.+  ...++|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence            6789999999999999987643       4889999999999999999999999  9999999999999865  136999


Q ss_pred             eccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC
Q 022956          165 GDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK  239 (289)
Q Consensus       165 ~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  239 (289)
                      +|||++........   ......+..|+|||.+. +.++.++|||||||++++|++ |..||...... .....+.....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~  239 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFVTGGGR  239 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCc
Confidence            99999976532211   11222346899999765 449999999999999999997 99999875443 33444444333


Q ss_pred             CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          240 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       240 ~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      +. .+...+..+.+++.+||+ +|++||++.++++|
T Consensus       240 ~~-~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            32 344568899999999998 99999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-40  Score=282.98  Aligned_cols=245  Identities=25%  Similarity=0.392  Sum_probs=195.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEE--EEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEV--AWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      ++.+.||+|+||.||+|.++.++..+  ++|.++...   .......+.+|+.++.++ +|+|++++++.+..  ++.++
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~   84 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY   84 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCce
Confidence            68899999999999999988777654  666654321   344567788999999999 89999999998744  36799


Q ss_pred             EEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           97 FITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      +++||+++++|.+++...                ..+++..+..++.|++.|+.|||++|  ++|+||+|+||+++.+ +
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~-~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-Y  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC-C
Confidence            999999999999998643                25789999999999999999999999  9999999999999988 8


Q ss_pred             cEEEeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCC
Q 022956          161 QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      .++|+|||++..............+..|+|||...+. ++.++||||||+++++|+| |..||...... .....+....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~  240 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGY  240 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHHHHHhcCC
Confidence            9999999998643322222222345679999976654 7889999999999999998 99999764443 3333343332


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .+. .+...++.+.+|+.+||+ +|++||++++++.+
T Consensus       241 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222 233467899999999998 99999999999974

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=295.42  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=209.2

Q ss_pred             eeeeecccCcceEEEEeecCCCc---E-EEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGI---E-VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~---~-~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +.++||+|+||.||+|..+..+.   . ||+|..+... ....+.+.++.+|++++++++||||++++|+...+  ..++
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--~Pl~  237 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--EPLM  237 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CccE
Confidence            45899999999999998765422   3 8999988522 12467789999999999999999999999988665  5799


Q ss_pred             EEeccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           97 FITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +|||+|.||+|.+++.+.+ .++..+...++.+.+.||+|||+++  ++||||-.+|+|++.+ +.+|++|||++.....
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQ  314 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCccccccCCcc
Confidence            9999999999999999876 5999999999999999999999999  9999999999999998 6889999999886653


Q ss_pred             ccccc-cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          176 SHAAH-SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       176 ~~~~~-~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ..... ...-..+|+|||.+... +++++||||+|+++||+++ |..||.+.........++..+.+... +...+..+.
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~-~~~~p~~~~  393 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI-PSKTPKELA  393 (474)
T ss_pred             eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC-CCCCHHHHH
Confidence            32222 12356799999977655 9999999999999999999 88899987766555555455544433 446788999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .++.+|+. ||++||++.++.+  +++.+
T Consensus       394 ~~~~~c~~~~p~~R~tm~~i~~--~l~~~  420 (474)
T KOG0194|consen  394 KVMKQCWKKDPEDRPTMSTIKK--KLEAL  420 (474)
T ss_pred             HHHHHhccCChhhccCHHHHHH--HHHHH
Confidence            99999998 9999999999988  55544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-41  Score=305.75  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=211.2

Q ss_pred             ceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ++.+.||+|+||.||+|.-.     ++...||||.++...   +...+.+|++|++++..++|||||+++|++...  +.
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~P  563 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG--DP  563 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--Ce
Confidence            46789999999999999632     334669999998653   455788999999999999999999999999554  68


Q ss_pred             eEEEeccccCCcHHHHHHhc----------C----CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           95 LNFITEVCTSGNLRTYRKKH----------R----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~----------~----~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      +++|+||+..|+|.+++..+          .    +|+..+.+.|+.||+.|+.||-++.  ++|+||-..|.||.++ -
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~-l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGEN-L  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccc-e
Confidence            99999999999999998632          2    3889999999999999999999999  9999999999999999 7


Q ss_pred             cEEEeccCCccccCCc--cc-cccCCCCCCCCCCc-ccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh
Q 022956          161 QVKIGDLGFAAIVGRS--HA-AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVT  235 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~--~~-~~~~~~~~~~~aPE-~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~  235 (289)
                      .|||+|||+++.....  .+ .....-..+||||| ++.++++..+||||+|+++||+++ |..||.+..+.+.+.- +.
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~-i~  719 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC-IR  719 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-HH
Confidence            9999999999876432  22 22344567999999 788899999999999999999999 9999998766655544 44


Q ss_pred             CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          236 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      .+.. -..+..+|.++..|+..||+ +|++||++.||=.  -++.+..+++
T Consensus       720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~--~L~~~~~~s~  767 (774)
T KOG1026|consen  720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS--RLQAWAQASP  767 (774)
T ss_pred             cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH--HHHHHHhcCc
Confidence            4444 34567789999999999998 9999999999965  5555544443

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=277.06  Aligned_cols=247  Identities=19%  Similarity=0.355  Sum_probs=199.3

Q ss_pred             ceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC----
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH----   92 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   92 (289)
                      ++.+.||+|+||.||+|.+..+   +..+|+|.++....  .......+.+|++.++.++|||++++++.+...+.    
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            5789999999999999987654   47899999875432  34456778999999999999999999987754332    


Q ss_pred             CeeEEEeccccCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      ...++++||+++++|..++...      ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED-MTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC-CeEEECC
Confidence            3578999999999999888532      36899999999999999999999999  9999999999999988 8999999


Q ss_pred             cCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCC
Q 022956          167 LGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ  241 (289)
Q Consensus       167 ~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  241 (289)
                      ||++........   ......+..|+|||.+.+. ++.++|+|||||++++|++ |..||.+..... ....+..+....
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~  235 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-IYDYLRHGNRLK  235 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCC
Confidence            999876543221   1122345689999977644 8899999999999999999 889997755443 334444433322


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                       .+...++.+.+++.+||+ ||++||++.++++
T Consensus       236 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         236 -QPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             -CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             345578899999999999 9999999999987

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.9e-40  Score=281.56  Aligned_cols=245  Identities=24%  Similarity=0.380  Sum_probs=195.5

Q ss_pred             ceeeeecccCcceEEEEeecCCCc--EEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGI--EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      ++.+.||+|+||.||+|.++.++.  .+++|.++...   .....+.+.+|+.+++++ +|||++++++.+...  ..++
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~   79 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY   79 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence            689999999999999999887765  46888776321   233456788999999999 799999999887443  5789


Q ss_pred             EEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           97 FITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      +++||+++++|.+++...                ..+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN-L  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC-C
Confidence            999999999999998653                24788999999999999999999999  9999999999999988 8


Q ss_pred             cEEEeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCC
Q 022956          161 QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      .++|+|||++..............+..|+|||...+. ++.++||||||+++++|++ |..||........ ...+....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-~~~~~~~~  235 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQGY  235 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhcCC
Confidence            9999999998644322222222334579999976544 8899999999999999998 9999987554433 33333332


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .. ..+...++.+++|+.+||+ +|.+||+++++++.
T Consensus       236 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22 2344578899999999998 99999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.3e-40  Score=278.55  Aligned_cols=246  Identities=22%  Similarity=0.356  Sum_probs=198.6

Q ss_pred             cceeeeecccCcceEEEEee----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           19 GRYSDLLGSGAVKKVYRAFD----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      +++.+.||+|+||+||+|.+    ..++..+++|.++...   .......+.+|+.++++++|||++++++.+...  ..
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~   81 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP   81 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence            36789999999999999985    3456889999997532   344456788999999999999999999987544  57


Q ss_pred             eEEEeccccCCcHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC
Q 022956           95 LNFITEVCTSGNLRTYRKKH-----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING  157 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~  157 (289)
                      .+++|||+++++|.+++...                 ..+++.++..++.|++.||.|||++|  ++|+||+|+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~  159 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGE  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcC
Confidence            89999999999999998532                 24788899999999999999999999  999999999999998


Q ss_pred             CCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 022956          158 NIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYK  232 (289)
Q Consensus       158 ~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~  232 (289)
                      + +.++|+|||++.......   ......++..|+|||.+. +.+++++|+||||+++++|++ |..||.+... ....+
T Consensus       160 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~  237 (283)
T cd05090         160 Q-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIE  237 (283)
T ss_pred             C-CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHH
Confidence            8 899999999997653321   122233456799999765 448999999999999999998 8899976543 33344


Q ss_pred             HHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          233 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .+...... ..+...++.+++++.+||+ ||.+||++.+|+++
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            44443322 2345568999999999998 99999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.9e-40  Score=275.49  Aligned_cols=247  Identities=23%  Similarity=0.402  Sum_probs=199.7

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .+++.++||+|++|.||+|.+. ++..+|+|.+....     ...+.+.+|+.+++.++|+|++++++.+..  .+..++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l   78 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYI   78 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence            3478999999999999999864 56789999886432     225678889999999999999999987743  367899


Q ss_pred             EeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           98 ITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||+++++|.+++..  ...++...+..++.|++.||+|||+.+  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~  155 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSES-LMCKIADFGLARVIED  155 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCC-CcEEECCCccceecCC
Confidence            9999999999999865  356889999999999999999999999  9999999999999988 8999999999976643


Q ss_pred             ccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          176 SHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       176 ~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ...  .....++..|+|||...+ .+++++|+||||+++|+|++ |..||....... ....+........ ....+.++
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~  233 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-VMSALQRGYRMPR-MENCPDEL  233 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-HHHHHHcCCCCCC-CCCCCHHH
Confidence            221  112234568999997654 48889999999999999998 999998754433 3444444433322 23468899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      .+++.+||+ +|++||+++++.+  +|++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~--~l~~  260 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQS--VLDD  260 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH--HHhc
Confidence            999999998 9999999999987  5543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=279.63  Aligned_cols=249  Identities=29%  Similarity=0.454  Sum_probs=201.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++.+.||+|++|+||+|....+++.+++|.+......   .......+|+..+++++ |+|++++++.+..  +...++|
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv   76 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFV   76 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEE
Confidence            5789999999999999999889999999998754321   11233456888999998 9999999998855  4678999


Q ss_pred             eccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+ +++|.+++....  .+++.++..++.|++.+|.+||++|  ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSR  152 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CCEEEeecccceeccCC
Confidence            9999 668988887654  7899999999999999999999999  9999999999999998 89999999999876554


Q ss_pred             cccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--------------
Q 022956          177 HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------------  240 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------  240 (289)
                      .......++..|+|||.+.+  .++.++|+||||+++++|++|+.||......+...........+              
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            44444567888999997643  37889999999999999999999997765544433322110000              


Q ss_pred             -------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          241 -------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       241 -------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                                   .......+..+.+++.+||+ ||++||+++|++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                         00011225789999999998 99999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-40  Score=285.03  Aligned_cols=248  Identities=24%  Similarity=0.431  Sum_probs=195.6

Q ss_pred             CcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccCCcHH
Q 022956           29 AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR  108 (289)
Q Consensus        29 ~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~  108 (289)
                      +++.||.+.++.+++.||+|++.....  .....+.+.+|++.+++++|+||+++++.+...  +..++++||+++++|.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~   87 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCE   87 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHH
Confidence            445566666677899999999986532  344567899999999999999999999988554  5789999999999999


Q ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc--------
Q 022956          109 TYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--------  178 (289)
Q Consensus       109 ~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~--------  178 (289)
                      +++...  ..+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++++|||.+........        
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC-CceEEecCccceeeccccccccccccc
Confidence            999753  46899999999999999999999999  9999999999999988 8999999998865432111        


Q ss_pred             cccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC---------------
Q 022956          179 AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---------------  240 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------------  240 (289)
                      .....++..|+|||.+.+   .++.++|+||+|+++++|++|..||..........+.+.+....               
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS  244 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence            122345678999997754   37889999999999999999999998755444443333221110               


Q ss_pred             ----------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          241 ----------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       241 ----------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                      .......+..+.+++..||+ ||++|||++++|+||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence                            00011123578899999998 99999999999999999988643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.6e-40  Score=276.62  Aligned_cols=248  Identities=21%  Similarity=0.336  Sum_probs=198.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCc--EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC----CC
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGI--EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ----HN   93 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~   93 (289)
                      .++++||+|+||.||+|.+..++.  .+|+|.++....  .....+.+.+|+.+++.++|+|++++++.+....    ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            367899999999999999877765  699999876432  3455678889999999999999999998764321    23


Q ss_pred             eeEEEeccccCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           94 TLNFITEVCTSGNLRTYRKK------HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      ..++++||+.+++|.+++..      ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN-MNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC-CCEEECCC
Confidence            56889999999999988742      234789999999999999999999999  9999999999999988 89999999


Q ss_pred             CCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCC
Q 022956          168 GFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQA  242 (289)
Q Consensus       168 g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  242 (289)
                      |++........   ......++.|++||...+. +++++|+||||+++|+|++ |..||.+.... .....+..+.... 
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~-  234 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIYDYLRQGNRLK-  234 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCCCC-
Confidence            99986543221   1223456789999977654 8999999999999999999 88999775443 3444444433322 


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .....+..+.+++.+||+ ||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            233467889999999998 99999999999873

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-40  Score=287.79  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=199.8

Q ss_pred             CCCcccceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeE
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW   87 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   87 (289)
                      +.++| ++.+.||+|+||.||+|.+     ..+++.||+|.++...   .......+.+|+.++.++ +|||++++++.+
T Consensus         5 ~~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           5 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             chhHh-cccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            34565 7899999999999999974     3567899999997543   233456788899999999 679999999877


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhc-----------------------------------------------------
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKH-----------------------------------------------------  114 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~-----------------------------------------------------  114 (289)
                      ... +..+++++||+++++|.+++...                                                     
T Consensus        81 ~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          81 TKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             ecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            554 35788999999999999998642                                                     


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc--
Q 022956          115 --------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--  178 (289)
Q Consensus       115 --------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~--  178 (289)
                                    ..++...+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++........  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~  236 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYV  236 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEecccccccccCcchh
Confidence                          23677888999999999999999999  9999999999999988 8999999999876532211  


Q ss_pred             -cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          179 -AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       179 -~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                       .....++..|+|||.+.+ .++.++|+||||+++++|++ |..||............+..+.... .+...++.+.+++
T Consensus       237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  315 (343)
T cd05103         237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTM  315 (343)
T ss_pred             hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-CCCCCCHHHHHHH
Confidence             112234567999996654 48999999999999999997 9999987554444444444333322 2344678999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcC
Q 022956          256 EKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..||+ ||++||++.+|++|
T Consensus       316 ~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         316 LDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99998 99999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=316.33  Aligned_cols=258  Identities=20%  Similarity=0.364  Sum_probs=216.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.++||.|+||.|..++++.|++.||+|++....... .....-|..|-.++.--+.+=|+.++..|.+  .+++|+||
T Consensus        78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LYlVM  154 (1317)
T KOG0612|consen   78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLYLVM  154 (1317)
T ss_pred             HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceEEEE
Confidence            57899999999999999999999999999998643321 2224568889999988888889999888744  47899999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc-
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~-  178 (289)
                      ||++||.|..++.+..+++++.+..++..|+.||..||+.|  ++||||||+|||+|.. |+++|+|||.+......+. 
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~-GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc-CcEeeccchhHHhcCCCCcE
Confidence            99999999999999889999999999999999999999999  9999999999999999 9999999999987764433 


Q ss_pred             -cccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCC--CCCCh
Q 022956          179 -AHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN--KVKDP  249 (289)
Q Consensus       179 -~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  249 (289)
                       ....+|||.|.+||++.      +.|.+..|.||||+++|+|+.|..||-. +.....+..|..-.....++  ..+|+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSe  310 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSE  310 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCH
Confidence             44568999999999764      3489999999999999999999999976 44444444333321111111  33799


Q ss_pred             HHHHHHHHHHcCCCCCCC---HHHHhcCcccccCCCCC
Q 022956          250 EVKAFIEKCIAQPRARPS---ASELLKDPFFSELNDDD  284 (289)
Q Consensus       250 ~~~~li~~~l~dp~~Rps---~~~il~h~~~~~~~~~~  284 (289)
                      .+++||++++.+|+.|..   ++++-.||||.+++|+.
T Consensus       311 eakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  311 EAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             HHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhh
Confidence            999999999999999887   99999999999999953

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.9e-40  Score=273.70  Aligned_cols=242  Identities=24%  Similarity=0.397  Sum_probs=196.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.+.||+|+||.||++.++ ++..+|+|.+.....     ....+.+|+.+++.++|||++++++.+..  ...++++
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv   77 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV   77 (256)
T ss_pred             cEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence            367899999999999999875 556899998864322     13567889999999999999999988744  3679999


Q ss_pred             eccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++++|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-CeEEECCCCCccccCCCc
Confidence            999999999999875 346899999999999999999999999  9999999999999988 899999999987653222


Q ss_pred             cc--ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 AA--HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ~~--~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ..  ....++..|+|||...+ .++.++|+||||+++++|++ |+.||........ ...+..+... ..+...+..+.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-~~~i~~~~~~-~~~~~~~~~~~~  232 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-VEMISRGFRL-YRPKLASMTVYE  232 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCCC-CCCCCCCHHHHH
Confidence            11  12234568999997764 48889999999999999999 8999977544433 3444443322 234456789999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhc
Q 022956          254 FIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~  273 (289)
                      ++.+||+ +|++||+++++++
T Consensus       233 li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            9999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-40  Score=277.37  Aligned_cols=243  Identities=25%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||.||+|.++. +..+++|.+....    ......+.+|+.+++.++|+|++++++.+...  ..++++
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   80 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYII   80 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEE
Confidence            4678999999999999999876 8999999987543    22355688899999999999999999887443  678999


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+++++|.+++.+  +..+++.++..++.|++.|+.|||++|  ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED-LVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC-ceEEEccccchhhcCCc
Confidence            999999999999975  356899999999999999999999999  9999999999999998 89999999999766432


Q ss_pred             cc-cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          177 HA-AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       177 ~~-~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .. .....++..|+|||... +.++.++|+||||+++++|++ |..||.......... .+....... .+...++.+.+
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~  235 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD-QITAGYRMP-CPAKCPQEIYK  235 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHHhCCcCC-CCCCCCHHHHH
Confidence            21 11223456899999665 448889999999999999998 899997755443333 333333222 34566899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhc
Q 022956          254 FIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~  273 (289)
                      ++.+||+ ||++|||+.++++
T Consensus       236 ~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         236 IMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            9999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.6e-40  Score=273.87  Aligned_cols=239  Identities=22%  Similarity=0.387  Sum_probs=196.8

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.+.||+|+||.||++...  |..+|+|.++..      ...+.+.+|+.++++++|++++++++.+... +...+++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv   78 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV   78 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEE
Confidence            468899999999999999764  889999998632      2246788899999999999999999876543 3568999


Q ss_pred             eccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+++++|.+++.+..  .+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST  155 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC-CcEEecCCccceecccc
Confidence            99999999999987643  4789999999999999999999999  9999999999999988 89999999998755432


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .  .....+..|+|||...+. ++.++|+|||||++|+|++ |+.||.... .......+.+...+ ......++.+.++
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~l  231 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKM-DAPDGCPPVVYDV  231 (256)
T ss_pred             C--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcCCCC-CCCCCCCHHHHHH
Confidence            2  122345689999976654 8889999999999999998 999997643 34444444444332 3345678999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhc
Q 022956          255 IEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~  273 (289)
                      +.+||+ +|++|||+.++++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            999998 9999999999987

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3e-40  Score=283.94  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=199.8

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcE----EEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIE----VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      ..| ++.+.||+|+||.||+|.+..++..    ||+|.++...   .....+.+.+|+.+++.++||||+++++.+... 
T Consensus         7 ~~f-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           7 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhc-eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            344 6799999999999999988766654    8999986432   344567788999999999999999999987543 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ..+++++|+.+++|.+++.+. ..++...+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.++|+|||++
T Consensus        82 --~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~-~~~kl~DfG~a  156 (316)
T cd05108          82 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP-QHVKITDFGLA  156 (316)
T ss_pred             --CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-CcEEEcccccc
Confidence              467899999999999998864 46889999999999999999999999  9999999999999988 89999999999


Q ss_pred             cccCCcccc---ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          171 AIVGRSHAA---HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       171 ~~~~~~~~~---~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      .........   .....+..|+|||.+.+ .++.++||||||+++|+|++ |..||.+.... ...+.+....... .+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~  234 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGERLP-QPP  234 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhCCCCCC-CCC
Confidence            876533221   12234568999997654 48999999999999999998 99999864433 3444444433322 234


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..+..+.+++.+||. ||.+||++.+++.+
T Consensus       235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            467889999999998 99999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=288.44  Aligned_cols=263  Identities=24%  Similarity=0.366  Sum_probs=221.7

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ...+++.-++||.|+||.||-++-..||+-||+|.+...+... ........+|-.+|.+++.+.||.+-..|  ++.+.
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~  259 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDA  259 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCc
Confidence            3445566799999999999999999999999999987655421 22234467789999999999888887666  45578


Q ss_pred             eEEEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           95 LNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +|+|+..+.||.|.-++.+.+  .+++..+..++.+|+.||++||+.+  ++.||+||+|||+|+. |+++|+|+|+|..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~-GhvRISDLGLAve  336 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDH-GHVRISDLGLAVE  336 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccC-CCeEeeccceEEe
Confidence            999999999999999998754  7999999999999999999999999  9999999999999999 9999999999999


Q ss_pred             cCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC-CCCCCCCCCCCChH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG-GVKPQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  250 (289)
                      +.....-....||.+|||||++.++ |+...|.|||||++|+|+.|+.||.......+..+.-.. ...+..++...+++
T Consensus       337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e  416 (591)
T KOG0986|consen  337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE  416 (591)
T ss_pred             cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence            8887777778999999999988765 999999999999999999999999865433333211111 12445567888999


Q ss_pred             HHHHHHHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          251 VKAFIEKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      ++++.+.+|+ ||++|.     .++++-+||||+.++|.
T Consensus       417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            9999999998 999985     45799999999999885

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-39  Score=280.12  Aligned_cols=258  Identities=27%  Similarity=0.458  Sum_probs=210.2

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .++...| ...+.||+|+||.||++.+..++..+|+|.+...... ..+....+.+|+++++.++|+|++++++.+... 
T Consensus        21 ~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   97 (317)
T cd06635          21 EDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-   97 (317)
T ss_pred             CCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-
Confidence            3444554 5688999999999999999999999999998754332 344566788999999999999999999988554 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       ...++|+||+.| +|.+.+.. ..++++.++..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        98 -~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~-~~~kl~dfg~~  172 (317)
T cd06635          98 -HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSA  172 (317)
T ss_pred             -CeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCC-CCEEEecCCCc
Confidence             578999999976 77777654 566899999999999999999999999  9999999999999988 89999999988


Q ss_pred             cccCCccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ......   ....+++.|+|||.+.    +.++.++|+||||+++++|++|..||................. +......
T Consensus       173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  248 (317)
T cd06635         173 SIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PTLQSNE  248 (317)
T ss_pred             cccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC-CCCCCcc
Confidence            654322   2345778899999752    3488899999999999999999999977554444444443332 2233445


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .++.+++++.+||+ +|.+||++.++++|+|+....
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            67889999999998 999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.8e-40  Score=281.67  Aligned_cols=261  Identities=26%  Similarity=0.460  Sum_probs=211.4

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      +....+..+| ...+.||+|++|.||+|.++.++..+++|.+...... .......+.+|+++++.++|+|++++.+.+.
T Consensus         8 ~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   85 (308)
T cd06634           8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL   85 (308)
T ss_pred             hhcCCcHHHH-HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence            3344566666 4588999999999999999999999999998754322 2344567888999999999999999999886


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      ..  ...++|+||+.+ ++.+++.. ..++++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+||
T Consensus        86 ~~--~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~kl~df  159 (308)
T cd06634          86 RE--HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDF  159 (308)
T ss_pred             cC--CeeEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC-CcEEECCc
Confidence            54  578999999975 77776653 456899999999999999999999999  9999999999999988 89999999


Q ss_pred             CCccccCCccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      |++......   ....+++.|+|||.+.    +..+.++||||||+++++|++|..||.............. ...+...
T Consensus       160 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~  235 (308)
T cd06634         160 GSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQ  235 (308)
T ss_pred             ccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh-cCCCCcC
Confidence            998765432   2345678999999653    3478899999999999999999999976554444443333 3333333


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ....+..+++++.+||. +|++||++++++.|||+....
T Consensus       236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            44568899999999998 999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5e-40  Score=275.18  Aligned_cols=243  Identities=21%  Similarity=0.372  Sum_probs=196.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||.||+|.+..+ ..+|+|.++....  .   .+.+.+|++++++++|+|++++++.+.   ....
T Consensus         6 ~~~-~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~   75 (262)
T cd05071           6 ESL-RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPI   75 (262)
T ss_pred             HHe-eEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--C---HHHHHHHHHHHHhCCCCCcceEEEEEC---CCCc
Confidence            444 7899999999999999988755 4699999975332  1   356788999999999999999988762   2457


Q ss_pred             EEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           96 NFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~  152 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLI  152 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC-CcEEeccCCceeec
Confidence            8999999999999999753  45889999999999999999999999  9999999999999988 89999999999765


Q ss_pred             CCccc--cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          174 GRSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       174 ~~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .....  .....++..|+|||... +.++.++|+||||+++++|++ |..||.+..... ....+....... .....+.
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~  230 (262)
T cd05071         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMP-CPPECPE  230 (262)
T ss_pred             cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHHhcCCCCC-CccccCH
Confidence            43322  12233566899999665 458999999999999999999 888997754443 333343332222 2344688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.+++.+|++ ||++||++.++++
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=272.78  Aligned_cols=242  Identities=23%  Similarity=0.380  Sum_probs=197.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.+.||+|++|.||+|.+. ++..||+|.++....     ..+.+.+|++++++++|+|++++++.+...  +..+++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   79 (261)
T cd05068           8 IQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIV   79 (261)
T ss_pred             eeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeee
Confidence            478999999999999999875 457899999875432     145678899999999999999999876443  578999


Q ss_pred             eccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +|++++++|.+++...  ..+++..+..++.|++.|+.+||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC-CCEEECCcceEEEccCC
Confidence            9999999999999764  36899999999999999999999999  9999999999999998 89999999999876532


Q ss_pred             ccc--ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 HAA--HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~~~--~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ...  ........|+|||...+ .++.++|+||||+++++|++ |+.||.+.... .....+...... ......+..+.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~  234 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQQVDQGYRM-PCPPGCPKELY  234 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCC-CCCCcCCHHHH
Confidence            211  11222457999997664 48899999999999999999 99999875443 334444444322 22345688999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +++.+||+ +|++||+++++++
T Consensus       235 ~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         235 DIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHhhcCcccCCCHHHHHH
Confidence            99999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.5e-40  Score=272.87  Aligned_cols=243  Identities=22%  Similarity=0.389  Sum_probs=196.3

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.+.||+|++|+||.+.+. .+..+|+|.+.....     ..+.+.+|+.++++++|||++++++++..  ...++++
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIV   77 (256)
T ss_pred             eEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEE
Confidence            367899999999999999765 345699999874432     13567889999999999999999998743  3578999


Q ss_pred             eccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      |||+.+++|.+++... ..+++.++..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CCEEECCCccceecCCCc
Confidence            9999999999999763 46899999999999999999999999  9999999999999988 899999999987553322


Q ss_pred             c--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 A--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .  .....++..|+|||...+ .++.++|+||||+++|+|++ |..||........... +...... ......++.+.+
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~  232 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK-VSQGLRL-YRPHLASEKVYA  232 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HhcCCCC-CCCCCCCHHHHH
Confidence            1  112234567999997764 48889999999999999998 9999986554433333 3333222 233446889999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcC
Q 022956          254 FIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ++.+||+ ||++||++.+++.+
T Consensus       233 li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         233 IMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHHHh
Confidence            9999998 99999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.3e-40  Score=278.32  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=202.6

Q ss_pred             cceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +.+.+.||+|+||.||++.+.     .++..+++|.++..    .....+.+.+|+..+++++|+|++++++.+..  ..
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   80 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGD--GD   80 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CC
Confidence            357899999999999999753     34567888888643    33445678899999999999999999998754  36


Q ss_pred             eeEEEeccccCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC
Q 022956           94 TLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING  157 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~----------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~  157 (289)
                      ..++||||+++++|.+++....                .+++..+..++.|++.|+.+||++|  ++|+||+|+||+++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~  158 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA  158 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence            7899999999999999997532                3789999999999999999999999  999999999999998


Q ss_pred             CCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 022956          158 NIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYK  232 (289)
Q Consensus       158 ~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~  232 (289)
                      + +.++|+|||++........   .....++..|+|||.+.+. ++.++||||||+++++|++ |..||....... ..+
T Consensus       159 ~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~  236 (291)
T cd05094         159 N-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIE  236 (291)
T ss_pred             C-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence            8 8999999999976543221   2223456789999976544 8899999999999999999 999997654443 333


Q ss_pred             HHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          233 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      .+..+..+ ......+..+.+++.+||+ ||++||++.++++  .+.++....
T Consensus       237 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~--~l~~~~~~~  286 (291)
T cd05094         237 CITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK--ILHALGKAT  286 (291)
T ss_pred             HHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH--HHHHHHhhc
Confidence            33333322 2344568899999999998 9999999999998  666664433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.4e-40  Score=278.12  Aligned_cols=249  Identities=22%  Similarity=0.281  Sum_probs=199.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCC----------------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEG----------------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY   79 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----------------~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   79 (289)
                      ++| ++.+.||+|+||.||+|.+..++                ..+|+|.+....   .....+.+.+|++++++++|||
T Consensus         5 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           5 QPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence            344 78999999999999999876544                558999987543   3355678899999999999999


Q ss_pred             eEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 022956           80 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDL  148 (289)
Q Consensus        80 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-----------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl  148 (289)
                      ++++++.+...  ...++++|++.+++|.+++....           .+++..+..++.|++.||.|||++|  ++|+||
T Consensus        81 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dl  156 (296)
T cd05051          81 IARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDL  156 (296)
T ss_pred             EeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccc
Confidence            99999987554  57899999999999999997654           6899999999999999999999999  999999


Q ss_pred             CCCceEEeCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh--CCCCCC
Q 022956          149 NCSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT--MEIPYS  222 (289)
Q Consensus       149 ~~~nili~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t--g~~p~~  222 (289)
                      +|+||+++.+ +.++|+|||++.......   ......++..|+|||.+.+ .++.++||||||+++|+|++  +..||.
T Consensus       157 kp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         157 ATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             chhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999998 899999999987653322   1223345678999997654 58999999999999999998  678887


Q ss_pred             CCCcHHHHHHHHhC-----CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          223 ECDSVAKIYKKVTG-----GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       223 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..............     .......+...++++.+++.+||+ ||++||++.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            65444333322211     111111233457899999999998 9999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.4e-40  Score=277.89  Aligned_cols=245  Identities=20%  Similarity=0.314  Sum_probs=198.6

Q ss_pred             cceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +++.++||+|+||.||++.+..+     +..+|+|+++...   .....+.+.+|+.+++.++||||+++++.+...  .
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~   81 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--Q   81 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--C
Confidence            46789999999999999987543     5789999997542   344567788999999999999999999987444  5


Q ss_pred             eeEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC
Q 022956           94 TLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING  157 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~  157 (289)
                      ..++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~  159 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFD  159 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecC
Confidence            689999999999999998532                34788889999999999999999999  999999999999998


Q ss_pred             CCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 022956          158 NIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYK  232 (289)
Q Consensus       158 ~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~  232 (289)
                      + +.++|+|||++........   .....+++.|+|||... +.++.++|+||||+++++|++ |..||.+.... ...+
T Consensus       160 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~  237 (283)
T cd05091         160 K-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVIE  237 (283)
T ss_pred             C-CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Confidence            8 8999999999876533221   22334567899999664 558999999999999999998 88898775544 3444


Q ss_pred             HHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          233 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+...... ..+...+..+.+++..||+ +|++||++++|++
T Consensus       238 ~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         238 MIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            44443322 2344578899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=275.17  Aligned_cols=245  Identities=22%  Similarity=0.353  Sum_probs=198.3

Q ss_pred             cceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +++.+.||+|+||.||++.++..     +..+|+|.+....   .......+.+|+.+++.++|+|++++++.+...  .
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~   82 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--Q   82 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--C
Confidence            36889999999999999987643     4889999986442   334456788899999999999999999987443  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956           94 TLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                      ..++|+||+++++|.+++...          ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~-~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC-CCEE
Confidence            789999999999999998642          23678899999999999999999999  9999999999999998 8999


Q ss_pred             EeccCCccccCCcc---ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCC
Q 022956          164 IGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       164 l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      |+|||++.......   ......++..|+|||.+. +.+++++|+||||++++++++ |..||........ ...+..+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~  238 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-LKFVIDGG  238 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-HHHHhcCC
Confidence            99999987553321   122334567899999765 448999999999999999998 9999976554443 33333332


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .. ..+...+..+.+++.+||+ +|++|||+.++++
T Consensus       239 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22 2344468999999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-39  Score=275.91  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=196.3

Q ss_pred             cceeeeecccCcceEEEEe----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           19 GRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      +++.+.||+|+||.||++.    +..++..||+|.+...    .....+.+.+|+++++.++|||++++++.+...+...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            4788999999999999987    4567899999998743    3445678899999999999999999998876555567


Q ss_pred             eEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      +++|+||+++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC-CeEEECCCcccccc
Confidence            89999999999999999754 46899999999999999999999999  9999999999999988 89999999999866


Q ss_pred             CCcccc----ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHH
Q 022956          174 GRSHAA----HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV---------------AKIYKK  233 (289)
Q Consensus       174 ~~~~~~----~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------------~~~~~~  233 (289)
                      ......    ....++..|+|||...+. ++.++|+||||+++++|++|..++......               ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            433221    111233458999976644 889999999999999999987665432111               111122


Q ss_pred             HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +...... ......+..+.+|+.+||+ +|++|||+.++++
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         239 LKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2222111 2234467899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-39  Score=271.64  Aligned_cols=239  Identities=21%  Similarity=0.385  Sum_probs=194.2

Q ss_pred             eecccCcceEEEEeec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           24 LLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      .||+|+||.||+|.+.  .++..+|+|++....   .....+.+.+|+.++++++|+|++++++.+.   ....++|+||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEe
Confidence            3899999999999764  446679999987542   3445677999999999999999999998762   2468999999


Q ss_pred             ccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc-
Q 022956          102 CTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-  179 (289)
Q Consensus       102 ~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~-  179 (289)
                      +++++|.+++.. ...+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++......... 
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC-CcEEeccCCccccccCCccce
Confidence            999999999875 457899999999999999999999999  9999999999999988 89999999998765433221 


Q ss_pred             ---ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          180 ---HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       180 ---~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                         ....++..|+|||.+.. .++.++|+||||+++|++++ |..||....... ....+.++... ..+...++++.++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~l~~l  230 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRL-DCPAECPPEMYAL  230 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHHCCCCC-CCCCCCCHHHHHH
Confidence               11123468999997654 48889999999999999996 999998755443 33444444332 2345568999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhc
Q 022956          255 IEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~  273 (289)
                      +.+||. ||++||++.+|.+
T Consensus       231 i~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         231 MKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            999998 9999999999976

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-39  Score=275.20  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=201.0

Q ss_pred             ccceeeeecccCcceEEEEeecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      .+++.++||+|+||+||+|.+..+|.    .||+|.+....   .......+.+|+..++.++|+|++.+++.+..   .
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~   81 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---S   81 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---C
Confidence            34678999999999999999877776    47899886532   34456678899999999999999999988754   3


Q ss_pred             eeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..+++++++++++|.+++.. ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~  158 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSP-NHVKITDFGLARL  158 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEECCCCceee
Confidence            47789999999999999976 456899999999999999999999999  9999999999999888 7999999999976


Q ss_pred             cCCcccc---ccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          173 VGRSHAA---HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       173 ~~~~~~~---~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      .......   ....+++.|+|||... ..++.++|||||||++|+|++ |..||..... ......+....... .+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~  236 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPDLLEKGERLP-QPPIC  236 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCcCC-CCccC
Confidence            6433221   1123456899999765 448999999999999999998 8999976443 33334444433322 23446


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +..+.+++.+||+ ||++||++.+++.  -+..+.
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~--~l~~~~  269 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVD--EFSRMA  269 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH--HHHHhh
Confidence            8899999999998 9999999999995  344443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.7e-40  Score=276.05  Aligned_cols=244  Identities=24%  Similarity=0.364  Sum_probs=197.2

Q ss_pred             cceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +++.++||+|+||.||++..     ..++..+++|.+...    .......+.+|++.++.++|+||+++++.+...  .
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   80 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R   80 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence            46789999999999999963     345778999987643    345567899999999999999999999877443  5


Q ss_pred             eeEEEeccccCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKHR---------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~---------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~  158 (289)
                      ..++++||+++++|.+++....               .+++..+..++.|++.|++|||+.|  ++|+||+|+||+++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~  158 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG  158 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC
Confidence            7899999999999999987542               4789999999999999999999999  9999999999999988


Q ss_pred             CCcEEEeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 022956          159 IGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK  233 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  233 (289)
                       +.++|+|||++........   .....+++.|+|||...+ .++.++|+|||||++++|++ |..||............
T Consensus       159 -~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         159 -LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             -CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence             8999999999875432211   122234678999996654 48999999999999999998 89999765554444333


Q ss_pred             HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                       ..+... ..+...++.+.+++.+||+ ||++||++.++++
T Consensus       238 -~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 -TQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             -HcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             333222 2344568899999999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=271.86  Aligned_cols=242  Identities=23%  Similarity=0.397  Sum_probs=196.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.+.||+|++|.||++.++ ++..+|+|.+.....  .   ...+.+|+++++.++|+|++++++.+..  .+..++|
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--S---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV   77 (256)
T ss_pred             cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--C---HHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence            467899999999999999875 567899999864332  1   3457789999999999999999987743  3678999


Q ss_pred             eccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      +||+++++|.+++.. ...+++..+..++.|++.|+.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC-CcEEECCcccceeccccc
Confidence            999999999999875 346899999999999999999999999  9999999999999988 899999999987654322


Q ss_pred             ccc--cCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 AAH--SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ~~~--~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ...  ...++..|+|||.+.+ .++.++|+||||+++|++++ |..||....... ....+...... ..+...++.+.+
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~  232 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRL-YRPKLAPTEVYT  232 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHHHcCCcC-CCCCCCCHHHHH
Confidence            111  1123457999997664 48889999999999999999 899997654443 34444443322 233457899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhc
Q 022956          254 FIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~  273 (289)
                      ++.+||+ +|++||++.++++
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~  253 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLS  253 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHH
Confidence            9999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-39  Score=277.76  Aligned_cols=246  Identities=25%  Similarity=0.400  Sum_probs=200.4

Q ss_pred             cceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   92 (289)
                      +.+.+.||+|+||.||++.+     ..++..+|+|.++...   .....+.+.+|+++++++ +|+||+++++.+...  
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  111 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTIG--  111 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence            36789999999999999975     3456689999987543   234467789999999999 799999999987443  


Q ss_pred             CeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      +..++++||+.+++|.+++...  ..+++.++..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++++|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHG-KIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCC-CeEEECCCccc
Confidence            5789999999999999998753  34899999999999999999999999  9999999999999988 89999999998


Q ss_pred             cccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          171 AIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       171 ~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      ........   .....++..|+|||.+.+ .++.++||||||+++++|++ |..||............+...... ..+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~  267 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPE  267 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCC
Confidence            76543221   112234678999996654 48999999999999999998 999998765555555555544332 2334


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..++.+.+++.+||. +|++||++.++++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            568899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.3e-40  Score=275.08  Aligned_cols=250  Identities=28%  Similarity=0.511  Sum_probs=201.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCC-CHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+.++||+|+||.||++.+..++..+++|+++.....+ .......+..|+.+++.++|||++++++.+...  ...+++
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   80 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFCII   80 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceEEE
Confidence            67899999999999999998888888787776543321 222334567789999999999999999887544  568999


Q ss_pred             eccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           99 TEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +||+++++|.+++..    +..+++..+..++.|++.|+.+||+.|  ++|+||+|+||+++.  +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCceeecC
Confidence            999999999988853    457899999999999999999999999  999999999999975  479999999987654


Q ss_pred             Ccc-ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSH-AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ... ......+++.|+|||...+ .++.++|+||||+++++|++|..||........... +..+..+ ..+...+..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~  234 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR-IVEGPTP-SLPETYSRQLN  234 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHcCCCC-CCcchhcHHHH
Confidence            322 2233457789999997654 478899999999999999999999976544333333 3333222 23455688999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +++.+||. +|++||++.++++||||
T Consensus       235 ~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         235 SIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999998 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-39  Score=272.72  Aligned_cols=247  Identities=22%  Similarity=0.399  Sum_probs=198.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|++|.||++.+..+ ..+|+|.+.....     ..+.+.+|+++++.++|++++++++.+.   .+..
T Consensus         6 ~~~-~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~   75 (260)
T cd05069           6 ESL-RLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPI   75 (260)
T ss_pred             HHe-eeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCc
Confidence            344 6899999999999999987654 4699998764322     2356788999999999999999988762   2457


Q ss_pred             EEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           96 NFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      +++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~  152 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN-LVCKIADFGLARLI  152 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CeEEECCCccceEc
Confidence            8999999999999999753  35789999999999999999999999  9999999999999988 89999999999765


Q ss_pred             CCccc--cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          174 GRSHA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       174 ~~~~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .....  .....++..|+|||... +.++.++|+||||+++++|++ |..||.+..... ....+..+.... .+...+.
T Consensus       153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~  230 (260)
T cd05069         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VLEQVERGYRMP-CPQGCPE  230 (260)
T ss_pred             cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCC-CCcccCH
Confidence            43221  11233566899999665 448899999999999999999 899998755443 334444443322 2345688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      .+++++.+||+ ||++||+++++++  ++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~--~l~~  259 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQS--FLED  259 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH--HHhc
Confidence            99999999998 9999999999988  6553

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-39  Score=271.54  Aligned_cols=245  Identities=23%  Similarity=0.394  Sum_probs=198.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||.||+|..+ +++.+|+|.+.....     ....+.+|+.++++++|+|++++++.+.   .+.++++
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v   78 (260)
T cd05067           8 LKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYII   78 (260)
T ss_pred             ceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEE
Confidence            478999999999999999864 678899999875432     1356788999999999999999998752   2468999


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+.+++|.+++..  +..++..++..++.|++.||++||+.|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET-LCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC-CCEEEccCcceeecCCC
Confidence            999999999999865  346899999999999999999999999  9999999999999998 89999999998765422


Q ss_pred             cc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 HA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ..  .....++..|+|||.+.. .+++++|+||||++++++++ |..||.+..... ....+...... ..+...+.++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~  233 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYRM-PRPDNCPEELY  233 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHHcCCCC-CCCCCCCHHHH
Confidence            11  122334568999997654 48889999999999999999 999998755433 33333333322 23445678999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +++.+||+ +|++||+++++++  ++++
T Consensus       234 ~li~~~l~~~p~~Rp~~~~l~~--~l~~  259 (260)
T cd05067         234 ELMRLCWKEKPEERPTFEYLRS--VLED  259 (260)
T ss_pred             HHHHHHccCChhhCCCHHHHHH--Hhhc
Confidence            99999998 9999999999988  5554

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-39  Score=272.03  Aligned_cols=241  Identities=26%  Similarity=0.426  Sum_probs=197.5

Q ss_pred             eeecccCcceEEEEeecC-CC--cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQE-EG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++||+|++|.||+|.+.. ++  ..+|+|.+......   ...+.+.+|+..+++++|||++++++.+..   ...++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence            469999999999998765 33  36999999765431   567789999999999999999999988755   6789999


Q ss_pred             ccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+++++|.+++.+..  .+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEeccccccccccccc
Confidence            9999999999997754  6899999999999999999999999  9999999999999999 899999999997764422


Q ss_pred             c----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          178 A----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       178 ~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      .    .....++..|+|||...+ .++.++|+||||+++++|++ |..||......+......... .....+...+..+
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  230 (257)
T cd05040         152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ERLERPEACPQDI  230 (257)
T ss_pred             cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CcCCCCccCCHHH
Confidence            1    112345678999997664 48999999999999999999 999997655444333333222 2222334567899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhc
Q 022956          252 KAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+++..||+ +|++||++.++++
T Consensus       231 ~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         231 YNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHCCCCcccCCCHHHHHH
Confidence            999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=278.26  Aligned_cols=250  Identities=31%  Similarity=0.460  Sum_probs=202.7

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|.+|.||++++..+++.+|+|++.....  .....+.+.+|+.++++++|++++++++.+...  ...++|+
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~   77 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVF   77 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEe
Confidence            467889999999999999999999999999987542  233456677899999999999999999987544  6799999


Q ss_pred             ccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      |++++ +|.+++... ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC-CCEEEecCCcccccCCCcc
Confidence            99985 899999876 57999999999999999999999999  9999999999999998 8999999999976654332


Q ss_pred             -cccCCCCCCCCCCcccc-c-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC-----------------
Q 022956          179 -AHSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-----------------  238 (289)
Q Consensus       179 -~~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----------------  238 (289)
                       ......+..|+|||.+. . .++.++|+||||++++++++|..||.................                 
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence             22334567899999654 3 488899999999999999999999977554433322221100                 


Q ss_pred             --CCC-------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          239 --KPQ-------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       239 --~~~-------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                        .+.       ......+..+.+++.+||. ||++||++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence              000       0011236789999999998 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=269.40  Aligned_cols=241  Identities=23%  Similarity=0.395  Sum_probs=200.3

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      ..+++.+.||.|++|.||++...  |..+|+|.++....     ..+.+.+|+.+++.++|+|++++++.+..  ....+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~   76 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLY   76 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeE
Confidence            34478999999999999999765  88999999975421     46778899999999999999999998754  36789


Q ss_pred             EEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           97 FITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|+||+++++|.+++....  .+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~  153 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC-CCEEEcccccccccc
Confidence            9999999999999998654  7999999999999999999999999  9999999999999988 899999999998664


Q ss_pred             CccccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ....  ....+..|+|||... +.++.++|+||||++++++++ |..||.... .......+.....+. .+...++.+.
T Consensus       154 ~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~  229 (256)
T cd05039         154 QGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVEKGYRME-APEGCPPEVY  229 (256)
T ss_pred             cccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhcCCCCC-CccCCCHHHH
Confidence            3322  233456799999765 448889999999999999997 999997654 344444444443332 2345689999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +++.+||+ +|++||+++++++
T Consensus       230 ~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         230 KVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHhccChhhCcCHHHHHH
Confidence            99999998 9999999999987

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=273.36  Aligned_cols=241  Identities=26%  Similarity=0.386  Sum_probs=191.4

Q ss_pred             eeecccCcceEEEEeecCCCcE--EEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIE--VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      +.||+|+||.||+|.++.++..  +++|.++...   .....+.+.+|+++++++ +|||++++++.+...  +.++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence            4699999999999999888764  5777776321   234456788999999999 799999999987443  5789999


Q ss_pred             ccccCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956          100 EVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~----------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                      ||+++++|.+++....                .+++.++..++.|++.|+.|||+.|  ++|+||+|+||+++.+ +.++
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~-~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC-CeEE
Confidence            9999999999987532                4789999999999999999999999  9999999999999998 8999


Q ss_pred             EeccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCC
Q 022956          164 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ  241 (289)
Q Consensus       164 l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  241 (289)
                      |+|||++..............+..|+|||.... .++.++|+||||+++++|++ |..||...... ...+.+.......
T Consensus       153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~  231 (270)
T cd05047         153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGYRLE  231 (270)
T ss_pred             ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-HHHHHHhCCCCCC
Confidence            999999864332211222233567999997654 48889999999999999997 99999764433 3334343332222


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                       .+...+..+.+++.+||+ ||.+|||+.+++.
T Consensus       232 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         232 -KPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence             233467899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=249.53  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=207.4

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +|.+ .++||+|.||+||++++..+++.||+|.++...-  ++.......+|+-+++.++|.||++++++.-  +++.+-
T Consensus         3 ~ydk-mekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlh--sdkklt   77 (292)
T KOG0662|consen    3 KYDK-MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLT   77 (292)
T ss_pred             chHH-HHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhc--cCceeE
Confidence            4444 6899999999999999999999999999998653  4444566788999999999999999999873  336789


Q ss_pred             EEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           97 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +|+|||.. .|..+... ++.++.+.+..++.|++.||.++|+++  +.|+|+||+|.+++.| |.+|++|||+++.++-
T Consensus        78 lvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgi  153 (292)
T KOG0662|consen   78 LVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGI  153 (292)
T ss_pred             EeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCC
Confidence            99999976 88888875 578999999999999999999999999  9999999999999999 9999999999998775


Q ss_pred             ccc-cccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC-----CCCCCC-
Q 022956          176 SHA-AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK-----PQALNK-  245 (289)
Q Consensus       176 ~~~-~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~-  245 (289)
                      +-. ......|..|.+|..+.+.  ++...|+||-|||+.|+.. |...|++.+-.++...+...-..     ++.+.. 
T Consensus       154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence            542 2334568899999987765  8999999999999999988 77777776655554443322111     111000 


Q ss_pred             --------------------CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          246 --------------------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       246 --------------------~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                                          .....-++|++++|. +|.+|+++++.++||+|.+.
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                                012345799999998 99999999999999999864

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-39  Score=271.45  Aligned_cols=243  Identities=23%  Similarity=0.325  Sum_probs=190.0

Q ss_pred             eeecccCcceEEEEeec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           23 DLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      +.||+|+||.||+|...  .++..+|+|.++....   ......+.+|+.+++.++|||++++++.+...  ..+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS---VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEE
Confidence            46999999999999754  3467799998875432   23345688899999999999999999887443  56899999


Q ss_pred             cccCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          101 VCTSGNLRTYRKKH-----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       101 ~~~~~sL~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |+++++|.+++...     ...+...+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~  152 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEECCccccccccC
Confidence            99999999998752     24567788899999999999999999  9999999999999988 8999999999865432


Q ss_pred             cc---ccccCCCCCCCCCCccccc--------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC---C
Q 022956          176 SH---AAHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK---P  240 (289)
Q Consensus       176 ~~---~~~~~~~~~~~~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~---~  240 (289)
                      ..   ......++..|+|||...+        .++.++|+||||+++++|++ |..||............+.....   .
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK  232 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence            21   1122346778999997653        25779999999999999996 99999876555443333322211   1


Q ss_pred             CCCCCCCChHHHHHHHHHHcCCCCCCCHHHHhc
Q 022956          241 QALNKVKDPEVKAFIEKCIAQPRARPSASELLK  273 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~dp~~Rps~~~il~  273 (289)
                      .......++.+.++++.|+.+|++|||+++|++
T Consensus       233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~  265 (269)
T cd05087         233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL  265 (269)
T ss_pred             CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence            222334578899999999989999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-39  Score=276.95  Aligned_cols=245  Identities=26%  Similarity=0.390  Sum_probs=198.2

Q ss_pred             cceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   92 (289)
                      +++.+.||+|+||.||++.++..     ...+|+|.+....   .......+.+|+++++++ +|+|++++++.+..  +
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~   88 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--E   88 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--C
Confidence            46789999999999999987643     3789999987532   233456788999999999 89999999998744  3


Q ss_pred             CeeEEEeccccCCcHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe
Q 022956           93 NTLNFITEVCTSGNLRTYRKK----------------HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN  156 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~----------------~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~  156 (289)
                      ..++++|||+.+++|.+++..                ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~  166 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT  166 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc
Confidence            579999999999999999853                346889999999999999999999999  99999999999999


Q ss_pred             CCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 022956          157 GNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIY  231 (289)
Q Consensus       157 ~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~  231 (289)
                      .+ +.++|+|||++........   .....++..|+|||.+.+ .++.++|||||||++|++++ |..||...... ...
T Consensus       167 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~  244 (293)
T cd05053         167 ED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-ELF  244 (293)
T ss_pred             CC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-HHH
Confidence            88 8999999999986543221   112234567999997654 48899999999999999998 99999875443 344


Q ss_pred             HHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          232 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..+.....+. .+...+..+.+|+.+||. ||++|||+.++++
T Consensus       245 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~  286 (293)
T cd05053         245 KLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE  286 (293)
T ss_pred             HHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            4444443322 334567899999999998 9999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.5e-39  Score=269.69  Aligned_cols=244  Identities=27%  Similarity=0.455  Sum_probs=201.2

Q ss_pred             ceeeeecccCcceEEEEeecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++.+.||+|+||.||++.+..++    ..+|+|.++...   .....+.+.+|+..++.++|+|++++++.+...  +..
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence            46789999999999999998766    899999997543   222567889999999999999999999988554  679


Q ss_pred             EEEeccccCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           96 NFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~--l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ++++|++++++|.+++.....  +++.++..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~  153 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN-LVVKISDFGLSRDL  153 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC-CeEEEcccCCceec
Confidence            999999999999999976544  999999999999999999999999  9999999999999998 89999999999766


Q ss_pred             CCccccc--cCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          174 GRSHAAH--SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       174 ~~~~~~~--~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .......  ...+++.|+|||...+ .++.++|+||||+++++|++ |..||..... ....+.+....... .....+.
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~  231 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLEYLKKGYRLP-KPENCPP  231 (258)
T ss_pred             ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCCCCC-CCCcCCH
Confidence            5432211  2235688999997654 48999999999999999998 7888876443 33344444433332 3344789


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.+++.+||+ ||++|||+.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            99999999998 9999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-39  Score=272.07  Aligned_cols=245  Identities=19%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             cceeeeecccCcceEEEEeecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +++.+.||+|+||.||+|.++.++.   .||+|.++...   .+.....+..|+..++.++|||++++++.+..  +...
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~   80 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPV   80 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCce
Confidence            4789999999999999999887765   59999987532   35556789999999999999999999988743  3678


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++|+||+++++|.+++.. .+.+++.++..++.|++.|+.+||++|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-CcEEECCCccccccc
Confidence            999999999999999875 456899999999999999999999999  9999999999999988 899999999987654


Q ss_pred             Ccccccc---CC---CCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          175 RSHAAHS---II---GTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       175 ~~~~~~~---~~---~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      .......   ..   .+..|+|||.+.+ .++.++|+||||++++++++ |..||....... ....+........ +..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~~~~~~~~-~~~  235 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIEQDYRLPP-PMD  235 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHHcCCcCCC-ccc
Confidence            3221111   11   1347999997654 48999999999999999887 999997755443 3333433322222 234


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+..+.+++..||+ +|++||++++++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            57889999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=292.55  Aligned_cols=256  Identities=23%  Similarity=0.426  Sum_probs=231.6

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ....||-|+||.|-++..+.....+|+|+++..+.-+ ....+.+..|-.++..++.|.||+++..|.++  +++|++||
T Consensus       424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--kyvYmLmE  500 (732)
T KOG0614|consen  424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KYVYMLME  500 (732)
T ss_pred             hhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hhhhhhHH
Confidence            3567999999999999887666679999998876542 34466788899999999999999999999665  79999999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccc
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH  180 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~  180 (289)
                      -|-||.||..+...+++.+..+..++..+++|++|||++|  ++.|||||+|.+++.+ |.+||+|||+|+......+++
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccC-CceEEeehhhHHHhccCCcee
Confidence            9999999999999999999999999999999999999999  9999999999999999 999999999999999999999


Q ss_pred             cCCCCCCCCCCc-ccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          181 SIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       181 ~~~~~~~~~aPE-~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      +.||||.|.||| ++.++.+.+.|.|+||++++||++|..||++.++.. .++.+.++.....++..++....+|+.++.
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tYn~ILkGid~i~~Pr~I~k~a~~Lik~LC  656 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TYNLILKGIDKIEFPRRITKTATDLIKKLC  656 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence            999999999999 567779999999999999999999999999866654 566677787888888899999999999999


Q ss_pred             c-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          260 A-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      + +|.+|..     +.+|-+|.||.+.+|.
T Consensus       657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  657 RDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             hcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence            8 9999965     8999999999999985

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=271.43  Aligned_cols=247  Identities=23%  Similarity=0.391  Sum_probs=199.3

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .+++.++||+|++|.||++.+. ++..+|+|.+.....     ..+.+.+|++.+++++|+|++++++.+..  ....++
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~   78 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYI   78 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEE
Confidence            3478999999999999999875 557899999875432     24568889999999999999999988743  357899


Q ss_pred             EeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           98 ITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||+++++|.+++.+.  ..+++..+..++.+++.|+.+||++|  ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN-LVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC-CCEEECccccceeccc
Confidence            99999999999999764  46899999999999999999999999  9999999999999998 8999999999876543


Q ss_pred             ccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          176 SHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       176 ~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ...  ......+..|+|||...+ .+++++|+||||++++++++ |+.||.+...... ...+....... .+...+..+
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~  233 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV-LEQVERGYRMP-RPPNCPEEL  233 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCC-CCCCCCHHH
Confidence            211  112234568999997664 48899999999999999998 9999987554443 33444332222 223347899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      .+++.+||+ +|++||+++++++  +|++
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~l~~--~l~~  260 (261)
T cd05034         234 YDLMLQCWDKDPEERPTFEYLQS--FLED  260 (261)
T ss_pred             HHHHHHHcccCcccCCCHHHHHH--HHhc
Confidence            999999998 9999999999987  5543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3e-39  Score=271.19  Aligned_cols=245  Identities=21%  Similarity=0.337  Sum_probs=197.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++..+.||+|++|.||+|.++.++.   .+++|.++...   .....+.+.+|++++++++|+|++++.+.+...  +..
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   81 (268)
T cd05063           7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPA   81 (268)
T ss_pred             ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCc
Confidence            3678999999999999999876655   68899886542   234466788999999999999999999987443  578


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++++|.+++.. ...+++.++..++.|++.|+.+||+.|  ++|+||+|+||+++.+ +.++++|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSN-LECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCC-CcEEECCCccceecc
Confidence            999999999999999975 357899999999999999999999999  9999999999999988 899999999987654


Q ss_pred             Ccccc----ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          175 RSHAA----HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       175 ~~~~~----~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      .....    .....+..|+|||.+.+ .++.++|+||||+++|++++ |..||....... ....+...... ......+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-~~~~i~~~~~~-~~~~~~~  236 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-VMKAINDGFRL-PAPMDCP  236 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhcCCCC-CCCCCCC
Confidence            32211    11122457999997654 48899999999999999998 999997655433 44444433222 1233467


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +++.+++.+||+ +|++||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=276.32  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=194.5

Q ss_pred             CcccceeeeecccCcceEEEEeecCC--------------CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEE--------------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII   81 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~--------------~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   81 (289)
                      ++| ++.++||+|+||.||++.+..+              ...||+|.++...   .......+.+|++++++++|+|++
T Consensus         5 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQL-RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhC-eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            344 7899999999999999987543              2358999987532   344566789999999999999999


Q ss_pred             EeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 022956           82 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN  149 (289)
Q Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~  149 (289)
                      ++++.+...  +..++||||+.+++|.+++....            .+++..+..++.|++.||.|||+.|  ++|+||+
T Consensus        81 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlk  156 (295)
T cd05097          81 RLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLA  156 (295)
T ss_pred             eEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccC
Confidence            999988543  67899999999999999986431            3678899999999999999999999  9999999


Q ss_pred             CCceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q 022956          150 CSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT--MEIPYSE  223 (289)
Q Consensus       150 ~~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~p~~~  223 (289)
                      |+||+++.+ +.++|+|||++........   .....++..|+|||... +.++.++|+||||+++++|++  +..||..
T Consensus       157 p~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         157 TRNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999988 8999999999876533221   11223456899999655 458999999999999999988  6678876


Q ss_pred             CCcHHHHHHHHh-----CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          224 CDSVAKIYKKVT-----GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       224 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ............     ........+...++.+.+|+.+||. ||++|||+++|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            443332222111     0111122234467899999999998 9999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.1e-39  Score=302.61  Aligned_cols=149  Identities=24%  Similarity=0.388  Sum_probs=133.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.+..+++.||+|+++..... .......+.+|+.+++.++|+||++++..+...  ..+
T Consensus         4 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~   79 (669)
T cd05610           4 EEF-VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNV   79 (669)
T ss_pred             CCE-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEE
Confidence            345 6899999999999999999999999999999765432 345567889999999999999999999877544  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      |+||||+.|++|.+++...+.+++..+..++.|++.||.|||+++  ++|+||||+|||++.+ +.++|+|||++.
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~-g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNE-GHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence            999999999999999988888999999999999999999999999  9999999999999988 899999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=306.17  Aligned_cols=247  Identities=22%  Similarity=0.376  Sum_probs=210.2

Q ss_pred             cccceeeeecccCcceEEEEeecCCC-----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEG-----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .-..+.+.||+|.||.||.|....-.     ..||+|.++...   ++.....|.+|..+++.++||||++++++.++. 
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-  767 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-  767 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-
Confidence            33456789999999999999765332     348889887653   566788999999999999999999999999884 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKH-------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                       ...++++||++||+|..++++.       ..++...++.++.++++|+.||++++  ++||||..+|+|++.. ..||+
T Consensus       768 -~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKI  843 (1025)
T KOG1095|consen  768 -GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKI  843 (1025)
T ss_pred             -CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEE
Confidence             5789999999999999999875       35899999999999999999999999  9999999999999999 79999


Q ss_pred             eccCCccccCC--c-cccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC
Q 022956          165 GDLGFAAIVGR--S-HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK  239 (289)
Q Consensus       165 ~d~g~~~~~~~--~-~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  239 (289)
                      +|||+|+....  . .......-..+|||||.+. +.++.++||||||+++||++| |..||++.++.+.+.....+++.
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL  923 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence            99999985432  1 1111224467999999766 669999999999999999999 99999998888777767777733


Q ss_pred             CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          240 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       240 ~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                        ..+..+++.+.+++..||+ +|++||++..|+.
T Consensus       924 --~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 --DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             --CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence              3566789999999999999 9999999999998

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.3e-39  Score=269.77  Aligned_cols=245  Identities=23%  Similarity=0.395  Sum_probs=197.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|++|.||+|.+. ++..+|+|.+.....  .   .+.+.+|+.++++++|++++++++.+.   ....+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv   78 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIV   78 (260)
T ss_pred             hhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEE
Confidence            378999999999999999765 567799999875433  1   346788999999999999999998762   2457899


Q ss_pred             eccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG-LVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC-ceEEeCCceeeeeccCc
Confidence            9999999999998753  45899999999999999999999999  9999999999999988 89999999999765432


Q ss_pred             cc--cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 HA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ..  .....++..|+|||... ..++.++|+||||+++++|++ |..||.+.... .....+..+.... .+...+..+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~  233 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLEQVERGYRMP-CPQDCPISLH  233 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCCC-CCCcCCHHHH
Confidence            21  11223456799999665 448899999999999999999 89999775443 3444444433322 2345688999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +++.+||+ +|++|||++++.+  |+++
T Consensus       234 ~li~~~l~~~p~~Rpt~~~l~~--~l~~  259 (260)
T cd05070         234 ELMLQCWKKDPEERPTFEYLQS--FLED  259 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH--HHhc
Confidence            99999998 9999999999987  6654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-39  Score=275.08  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=199.0

Q ss_pred             ceeeeecccCcceEEEEeecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ++.+.||+|+||.||+|.+..     ....+++|.+....   .......+.+|+++++.++||||+++++.+...  +.
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~   77 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GP   77 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CC
Confidence            678999999999999998653     23568888886432   234457788999999999999999999887443  56


Q ss_pred             eEEEeccccCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 022956           95 LNFITEVCTSGNLRTYRKKH------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC  150 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~------------------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~  150 (289)
                      .++++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+.+  ++|+||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp  155 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAA  155 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhh
Confidence            88999999999999998642                        24788899999999999999999999  99999999


Q ss_pred             CceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 022956          151 SNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECD  225 (289)
Q Consensus       151 ~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~  225 (289)
                      +||+++.+ +.++|+|||++........   .....++..|+|||... ..++.++||||||+++++|++ |..||.+..
T Consensus       156 ~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         156 RNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             heEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999988 8999999999875532211   12234567899999654 448899999999999999998 999997644


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                       .....+.+....... .+...+..+.+++..||+ +|++||++.++++  .|+++
T Consensus       235 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~--~l~~~  286 (290)
T cd05045         235 -PERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK--ELEKM  286 (290)
T ss_pred             -HHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH--HHHHH
Confidence             444455555443332 344568899999999998 9999999999988  55543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.8e-39  Score=272.33  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=204.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecC----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQE----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      +...+++.+.||+|+||.||+|.+..    ++..+++|.+...   ........+.+|+..++.++|+|++++++.+...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            34445789999999999999999876    3578999987632   2455577789999999999999999999877654


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcE
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH--------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV  162 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~  162 (289)
                       +...+++++|+.+++|.+++...        ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.+
T Consensus        81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~  156 (280)
T cd05043          81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-LQV  156 (280)
T ss_pred             -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-CcE
Confidence             35788999999999999998753        45889999999999999999999999  9999999999999988 899


Q ss_pred             EEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCC
Q 022956          163 KIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       163 ~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  237 (289)
                      +++|||++........   .....++..|+|||.+.+. ++.++||||||++++++++ |..||...... .....+...
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~  235 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-EMAAYLKDG  235 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-HHHHHHHcC
Confidence            9999999975432211   1122345679999976644 8899999999999999999 99999875443 344444444


Q ss_pred             CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          238 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ..... ....++.+.+++.+||. ||++|||+.++++  .|+++
T Consensus       236 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~--~l~~~  276 (280)
T cd05043         236 YRLAQ-PINCPDELFAVMACCWALDPEERPSFSQLVQ--CLTDF  276 (280)
T ss_pred             CCCCC-CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence            33322 34468899999999998 9999999999997  54443

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.7e-39  Score=271.25  Aligned_cols=243  Identities=23%  Similarity=0.381  Sum_probs=195.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcE----EEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIE----VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++.+.||+|+||+||+|.+..++..    +++|.+...   ........+..|+..+++++||||+++++++..   ...
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~   83 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL   83 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence            6789999999999999998877764    666666432   123445678888889999999999999997632   357


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++++||+++++|.+++.. ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD-SIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence            789999999999999975 457899999999999999999999999  9999999999999988 899999999997653


Q ss_pred             Cccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          175 RSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       175 ~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ....   .....++..|+|||... +.++.++|+||||+++|++++ |..||.+... ......+..+.... .+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~  238 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGERLA-QPQICTI  238 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCcCC-CCCCCCH
Confidence            2221   12234567899999765 458999999999999999998 9999976543 33344444443322 2344678


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+..++..||. ||.+|||+.+++.
T Consensus       239 ~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         239 DVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHH
Confidence            89999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.3e-39  Score=270.20  Aligned_cols=245  Identities=21%  Similarity=0.348  Sum_probs=198.0

Q ss_pred             cceeeeecccCcceEEEEeecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +++.+.||+|+||.||+|.++.++   ..+|+|.++...   .....+.+.+|+.++++++|||++++++.+..  ++..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   80 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPV   80 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcc
Confidence            368899999999999999886554   379999886533   23446788999999999999999999998744  3678


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++|||+++++|.+++... ..+++.++..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-CeEEeCCCCcccccc
Confidence            9999999999999999764 56899999999999999999999999  9999999999999988 899999999997664


Q ss_pred             Ccccc----ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          175 RSHAA----HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       175 ~~~~~----~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      .....    .....+..|+|||.+.+ .++.++|+||||++++++++ |..||....... ....+.+..... .....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~  235 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-VIKAIEEGYRLP-APMDCP  235 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-HHHHHhCCCcCC-CCCCCC
Confidence            32211    11122457999997764 58999999999999999887 999997755443 333334332222 233467


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +.+.+++.+||+ +|++||++.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHH
Confidence            899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=289.13  Aligned_cols=261  Identities=25%  Similarity=0.419  Sum_probs=219.4

Q ss_pred             CCCCccccee-eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           13 DPSGRFGRYS-DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        13 ~~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      +...-|..+. +.||+|-||+||-+++.++|+.||||++..-++..+.+  ..+++|+.+|+.+.||.||.+...+.+. 
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe--sqlR~EVaILq~l~HPGiV~le~M~ET~-  635 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE--SQLRNEVAILQNLHHPGIVNLECMFETP-  635 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchH--HHHHHHHHHHHhcCCCCeeEEEEeecCC-
Confidence            4455553322 88999999999999999999999999999988865544  7789999999999999999998777443 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccC
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLG  168 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g  168 (289)
                       +.++.|||-+.|.-|+-.+.+ .++|++..-..++.||+.||.|||-++  ++|.||||+|||+...  +.++||||||
T Consensus       636 -ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  636 -ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             -ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeecccc
Confidence             679999999988666666654 578999999999999999999999999  9999999999999654  4689999999


Q ss_pred             CccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          169 FAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      +|+.++......+..|||.|+|||.+.. +|+...|+||.|+|+|--++|..||...++..+..+. ...-.+...+.-+
T Consensus       713 fARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN-AaFMyPp~PW~ei  791 (888)
T KOG4236|consen  713 FARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN-AAFMYPPNPWSEI  791 (888)
T ss_pred             ceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc-cccccCCCchhhc
Confidence            9999988877788899999999997764 5999999999999999999999999865544433321 1122344455567


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ++.+-+||..+|+ .-.+|-|.++.|.|||+++.
T Consensus       792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             CHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            8899999999999 99999999999999999875

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.2e-39  Score=276.46  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=198.6

Q ss_pred             CcccceeeeecccCcceEEEEeecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeE
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW   87 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   87 (289)
                      ++| .+.+.||+|+||.||++.+..       ++..+|+|.++...   .+.....+.+|+.+++.+ +|||++++++.+
T Consensus        18 ~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          18 DRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             HHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            455 689999999999999997643       23569999987542   233456788899999999 799999999987


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS  151 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~  151 (289)
                      ...  ...++|+||+++++|.+++...                ..++..++..++.|++.||.|||++|  ++|+||+|+
T Consensus        94 ~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~  169 (307)
T cd05098          94 TQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR  169 (307)
T ss_pred             ecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHH
Confidence            544  5789999999999999999753                24788999999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 022956          152 NIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDS  226 (289)
Q Consensus       152 nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~  226 (289)
                      ||+++.+ +.++|+|||.+........   .....++..|+|||.+.+. ++.++|+||||+++|+|++ |..||... +
T Consensus       170 Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~  247 (307)
T cd05098         170 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-P  247 (307)
T ss_pred             heEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-C
Confidence            9999988 8999999999876543211   1112234689999976544 8899999999999999998 88999764 4


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          227 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .......+...... ..+...+.++.+++.+||. +|++||++.++++
T Consensus       248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         248 VEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            44555555544332 2344568899999999998 9999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-39  Score=271.74  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=203.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .++| ++.+.||+|+||.||+|.++.+|.    .+|+|......   .......+.+|+..+++++|||++++++.+.. 
T Consensus         6 ~~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           6 ETEL-EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHHc-EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            3454 789999999999999999877665    58888876543   24456778899999999999999999998755 


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ...++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||.
T Consensus        81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kL~dfg~  155 (279)
T cd05057          81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVKITDFGL  155 (279)
T ss_pred             --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC-CeEEECCCcc
Confidence              4688999999999999998763 56899999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccccc---cCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCC
Q 022956          170 AAIVGRSHAAH---SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       170 ~~~~~~~~~~~---~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (289)
                      +..........   ...++..|+|||... ..++.++|+||||++++++++ |..||.+.... ...+.+..+... ..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~  233 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-EIPDLLEKGERL-PQP  233 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHhCCCCC-CCC
Confidence            97664332211   122356799999665 458899999999999999998 99999875443 344444443222 223


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ...+..+.+++.+||. ||++||++.++++  .|+++
T Consensus       234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~--~l~~~  268 (279)
T cd05057         234 PICTIDVYMVLVKCWMIDAESRPTFKELIN--EFSKM  268 (279)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence            4467889999999998 9999999999988  66655

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=281.43  Aligned_cols=245  Identities=26%  Similarity=0.435  Sum_probs=191.1

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ..+||+|+||+||+|... +|..||||.+......+    ..+|.+|+.++.+++|||++++++++.+.+. ..++|+||
T Consensus        80 ~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEy  153 (361)
T KOG1187|consen   80 SNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEY  153 (361)
T ss_pred             hcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEc
Confidence            468999999999999865 45899999776543211    3459999999999999999999999966532 58999999


Q ss_pred             ccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-cc
Q 022956          102 CTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SH  177 (289)
Q Consensus       102 ~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-~~  177 (289)
                      +++|||.+++....  .+++.+.++|+..++.||+|||.. .++++|+|||++|||+|.+ .+.||+|||++..... ..
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~~~  232 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEGDT  232 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCcccc
Confidence            99999999998654  899999999999999999999996 4479999999999999999 7999999999966554 32


Q ss_pred             ccccC-CCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----cHHHH-HHHHhCC-----CCCCCCC
Q 022956          178 AAHSI-IGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECD-----SVAKI-YKKVTGG-----VKPQALN  244 (289)
Q Consensus       178 ~~~~~-~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~-----~~~~~-~~~~~~~-----~~~~~~~  244 (289)
                      ..... .|+.+|++||+.. +..+.++||||+|+++.|++||+.+.+...     ..... ...+...     .++....
T Consensus       233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~  312 (361)
T KOG1187|consen  233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE  312 (361)
T ss_pred             ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC
Confidence            22223 7999999999765 569999999999999999999998887432     11121 2222222     1122111


Q ss_pred             CCCC--hH---HHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          245 KVKD--PE---VKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       245 ~~~~--~~---~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ...+  ..   +..+...|++ +|++||+..|+++
T Consensus       313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            2222  23   4566778998 9999999999866

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.7e-39  Score=283.69  Aligned_cols=245  Identities=28%  Similarity=0.417  Sum_probs=198.0

Q ss_pred             ceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCC
Q 022956           20 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   93 (289)
                      .+.++||+|+||.||+|.+.     .+++.||+|+++...   .....+.+.+|++++.++. ||||+++++.+...  +
T Consensus        40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--~  114 (401)
T cd05107          40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--G  114 (401)
T ss_pred             ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--C
Confidence            35689999999999999853     456789999997643   2333456889999999997 99999999987544  5


Q ss_pred             eeEEEeccccCCcHHHHHHhc-----------------------------------------------------------
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-----------------------------------------------------------  114 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-----------------------------------------------------------  114 (289)
                      .+++|+||+.+++|.+++...                                                           
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            789999999999999998542                                                           


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE
Q 022956          115 ---------------------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI  155 (289)
Q Consensus       115 ---------------------------------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili  155 (289)
                                                             ..+++..+..++.|++.||.|||+.+  ++|+||+|+||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl  272 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI  272 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence                                                   13567788899999999999999999  9999999999999


Q ss_pred             eCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 022956          156 NGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKI  230 (289)
Q Consensus       156 ~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~  230 (289)
                      +.+ +.++|+|||++.......   ......++..|+|||.+.+ .+++++|+||||+++++|++ |..||.........
T Consensus       273 ~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         273 CEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             eCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            988 899999999997653221   1122345678999997654 48899999999999999998 89999876655555


Q ss_pred             HHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          231 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ...+..+..+. .+...+..+.+++.+||. +|.+||++++|+.
T Consensus       352 ~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~  394 (401)
T cd05107         352 YNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH  394 (401)
T ss_pred             HHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            55555543332 344568899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-40  Score=297.71  Aligned_cols=259  Identities=25%  Similarity=0.364  Sum_probs=188.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCC-CcEEEEEEeee-------------cccCCCHHHHHHHHHHHHHHHhCCCCceE
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEE-GIEVAWNQVRL-------------SHFSEDPVLVNRLHSEVQLLRTLKNKYII   81 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~aiK~~~~-------------~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   81 (289)
                      ++| ++.++||+|+||+||++..+.. +...+.|.+..             ............+.+|+.++++++|+||+
T Consensus       148 ~~Y-~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        148 AHF-RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hcc-EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            455 7899999999999999865432 22222221110             11111233456788999999999999999


Q ss_pred             EeeeeEEeCCCCeeEEEeccccCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe
Q 022956           82 VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN  156 (289)
Q Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~  156 (289)
                      ++++++...  +..+++++++.+ +|.+++...     ......++..++.|++.||.|||++|  ++|+||||+||+++
T Consensus       227 ~l~~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~  301 (501)
T PHA03210        227 KIEEILRSE--ANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN  301 (501)
T ss_pred             cEeEEEEEC--CeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence            999988554  568889999965 677766432     23456778899999999999999999  99999999999999


Q ss_pred             CCCCcEEEeccCCccccCCccc--cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCC-CCCCC--CcHHHH
Q 022956          157 GNIGQVKIGDLGFAAIVGRSHA--AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEI-PYSEC--DSVAKI  230 (289)
Q Consensus       157 ~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~-p~~~~--~~~~~~  230 (289)
                      .+ +.+||+|||++........  .....|+..|+|||.+.+. ++.++|||||||++|+|++|.. |+...  ......
T Consensus       302 ~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CD-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CC-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            88 8999999999987654322  2345789999999977654 8999999999999999999875 44322  222222


Q ss_pred             HHHHhCCC------C------------------C-----CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          231 YKKVTGGV------K------------------P-----QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       231 ~~~~~~~~------~------------------~-----~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+.+....      +                  +     .......+..+.+++.+||+ ||++|||+.|+|.||||...
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            22221110      0                  0     00011245667888999999 99999999999999999875


Q ss_pred             C
Q 022956          281 N  281 (289)
Q Consensus       281 ~  281 (289)
                      .
T Consensus       461 ~  461 (501)
T PHA03210        461 E  461 (501)
T ss_pred             C
Confidence            4

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=317.98  Aligned_cols=253  Identities=31%  Similarity=0.526  Sum_probs=221.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      +.+.+||+|.||.||-|.+..||+..|+|.++.....  ....+.+.+|.+++..++|||+|..+++-+..  ..++|.|
T Consensus      1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~IFM 1313 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYIFM 1313 (1509)
T ss_pred             ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecH--HHHHHHH
Confidence            4578899999999999999999999999999987653  45567788999999999999999999987665  4588899


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc---
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---  176 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~---  176 (289)
                      |||++|+|.++++.++-.++.....+..|++.|+.|||++|  +||+||||.||+++.+ |.+|++|||.|......   
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEecCchhc
Confidence            99999999999999887888888889999999999999999  9999999999999999 89999999999766433   


Q ss_pred             --cccccCCCCCCCCCCccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          177 --HAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       177 --~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                        .......||+.|||||.+.+    +.-.++|||||||++.||+||+.||...++.-.+.-.+-.+..|..... .+++
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSE 1469 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHh
Confidence              22345689999999997653    3567899999999999999999999998888777777777766655444 8999


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      -+++|+.||. ||++|-++.|+++|.|-+.-
T Consensus      1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            9999999998 99999999999999987765

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-39  Score=266.01  Aligned_cols=240  Identities=25%  Similarity=0.421  Sum_probs=195.7

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      ++||+|++|.||++.+.. ++.|++|.+.....   ......+.+|++++++++|+|++++++.+...  ...++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence            479999999999999877 99999999876533   23466789999999999999999999887544  5789999999


Q ss_pred             cCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc--
Q 022956          103 TSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--  179 (289)
Q Consensus       103 ~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~--  179 (289)
                      .+++|.+++.. ...+++..+..++.+++.++.+||+++  ++|+||+|+||+++.+ +.++|+|||++.........  
T Consensus        75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~  151 (251)
T cd05041          75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVS  151 (251)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-CcEEEeeccccccccCCcceec
Confidence            99999999865 456899999999999999999999999  9999999999999988 89999999998765422111  


Q ss_pred             -ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          180 -HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       180 -~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                       .....+..|+|||.+.+ .++.++|+||||+++++|++ |..||....... ....+..... ...+...+..+.+++.
T Consensus       152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~  229 (251)
T cd05041         152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-TRERIESGYR-MPAPQLCPEEIYRLML  229 (251)
T ss_pred             cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-HHHHHhcCCC-CCCCccCCHHHHHHHH
Confidence             11223567999997654 48899999999999999999 889997755433 3333333322 2234456889999999


Q ss_pred             HHHc-CCCCCCCHHHHhc
Q 022956          257 KCIA-QPRARPSASELLK  273 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~  273 (289)
                      +||+ +|++||++.++++
T Consensus       230 ~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         230 QCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            9998 9999999999987

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.5e-39  Score=273.13  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=194.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeec----------------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQ----------------EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN   77 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~----------------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~   77 (289)
                      +.++| ++.++||+|+||.||++.+.                .++..+|+|.+....   .......+.+|+..++.++|
T Consensus         3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~   78 (296)
T cd05095           3 PRKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD   78 (296)
T ss_pred             Chhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence            44565 78999999999999998543                234578999987542   34446778899999999999


Q ss_pred             CceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 022956           78 KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHR  146 (289)
Q Consensus        78 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-----------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~  146 (289)
                      +|++++++.+...  ...++++||+.+++|.+++....           .+++..+..++.|++.||.|||+.|  ++|+
T Consensus        79 ~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~  154 (296)
T cd05095          79 PNIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR  154 (296)
T ss_pred             CCcceEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence            9999999987554  57899999999999999987532           3667889999999999999999999  9999


Q ss_pred             CCCCCceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh--CCCC
Q 022956          147 DLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT--MEIP  220 (289)
Q Consensus       147 dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~p  220 (289)
                      ||+|+||+++.+ +.++|+|||++........   ......+..|++||... +.++.++|+||||+++|+|++  |..|
T Consensus       155 dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p  233 (296)
T cd05095         155 DLATRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP  233 (296)
T ss_pred             cCChheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence            999999999988 8999999999876533221   11223456899999544 558999999999999999998  7788


Q ss_pred             CCCCCcHHHHHHHH---hCC--CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          221 YSECDSVAKIYKKV---TGG--VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       221 ~~~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      |.............   ...  ......+...++.+.+|+..||+ ||++||++.+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            87644333222111   010  01111233467899999999998 9999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.9e-39  Score=269.75  Aligned_cols=249  Identities=23%  Similarity=0.413  Sum_probs=199.4

Q ss_pred             cceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +.+.++||+|+||.||+|.+...   ...+++|......   .....+.+.+|+.+++.++|||++++++.+..   ...
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~   81 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPV   81 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCc
Confidence            46789999999999999987544   3568899886442   24556788999999999999999999987743   357


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-CCeEEccCceeeecc
Confidence            8999999999999999764 45899999999999999999999999  9999999999999988 899999999987654


Q ss_pred             Cccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          175 RSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       175 ~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      ....  .....++..|+|||.... .++.++|+||||++++++++ |..||.......... .+...... ..+...++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~-~~~~~~~~~  236 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-RIENGERL-PMPPNCPPT  236 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcCCcC-CCCCCCCHH
Confidence            3321  112233467999997654 48899999999999999986 999998765544433 33333222 234456889


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +.+++.+|+. +|++|||+.++++  .+.++
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~--~l~~~  265 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKA--QLSDI  265 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH--HHHHH
Confidence            9999999998 9999999999988  44443

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.8e-39  Score=270.02  Aligned_cols=245  Identities=22%  Similarity=0.371  Sum_probs=198.2

Q ss_pred             ceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ++.+.||+|+||.||+|..+.+     .+.+++|.+....   .......+.+|++++++++|+|++++++.+..  ...
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~   82 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AEP   82 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CCc
Confidence            5789999999999999986543     4678888876432   34457789999999999999999999987743  367


Q ss_pred             eEEEeccccCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           95 LNFITEVCTSGNLRTYRKKHR---------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~---------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                      .++|+||+++++|.+++....         .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ-REVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC-CcEEEc
Confidence            899999999999999998654         6899999999999999999999999  9999999999999998 899999


Q ss_pred             ccCCccccCCcc--ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCC
Q 022956          166 DLGFAAIVGRSH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ  241 (289)
Q Consensus       166 d~g~~~~~~~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  241 (289)
                      |||++.......  ......++..|+|||... +..++++|+||||++++++++ |..||....... ....+..+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-~~~~~~~~~~~~  238 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRLQAGKLEL  238 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-HHHHHHcCCcCC
Confidence            999986443211  122234566799999665 448889999999999999998 888997654443 333333333222


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ......+..+.+++.+||+ +|++||++.++++
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~  271 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS  271 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3345578899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.9e-39  Score=274.25  Aligned_cols=248  Identities=28%  Similarity=0.422  Sum_probs=197.4

Q ss_pred             CCcccceeeeecccCcceEEEEeecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeee
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSV   86 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~   86 (289)
                      .++| .+.++||+|+||.||+|.+..       ....+|+|.++...   .......+.+|+.+++++ +||||++++++
T Consensus        11 ~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099          11 RDRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             HHHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            3455 579999999999999997532       34579999887432   234466788899999999 69999999998


Q ss_pred             EEeCCCCeeEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 022956           87 WLDDQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC  150 (289)
Q Consensus        87 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~  150 (289)
                      +...  ..+++++||+.+++|.+++...                ..++...+..++.|++.||.|||++|  ++|+||+|
T Consensus        87 ~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp  162 (314)
T cd05099          87 CTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA  162 (314)
T ss_pred             EccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence            7543  5789999999999999999653                34788999999999999999999999  99999999


Q ss_pred             CceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 022956          151 SNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECD  225 (289)
Q Consensus       151 ~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~  225 (289)
                      +||+++.+ +.++|+|||.+........   .....++..|+|||.+.+ .++.++|+||||+++|+|++ |..||....
T Consensus       163 ~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         163 RNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999988 8999999999976543211   112223467999997654 48899999999999999999 889997643


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                       .......+...... ..+...+..+.+++.+||+ ||++||++.++++
T Consensus       242 -~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         242 -VEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             -HHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             34444444444322 2234567899999999998 9999999999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.8e-39  Score=268.55  Aligned_cols=243  Identities=25%  Similarity=0.380  Sum_probs=189.9

Q ss_pred             eeecccCcceEEEEeecC--CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           23 DLLGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      +.||+|+||.||+|....  ....+++|.+....   .......+.+|+..++.++|+||+++++.+...  ..+++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEE
Confidence            359999999999996432  34567777765432   344466788899999999999999999987443  57899999


Q ss_pred             cccCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          101 VCTSGNLRTYRKKHR-----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |+++++|.+++....     ..++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~  152 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYP  152 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC-CcEEEecccccccccc
Confidence            999999999997642     2467788999999999999999999  9999999999999998 8999999999865422


Q ss_pred             cc---ccccCCCCCCCCCCcccc--------cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC---C
Q 022956          176 SH---AAHSIIGTPEYMAPELYE--------EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK---P  240 (289)
Q Consensus       176 ~~---~~~~~~~~~~~~aPE~~~--------~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~---~  240 (289)
                      ..   ......++..|+|||.+.        ..++.++||||||+++|+|++ |..||....+.......+.....   .
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK  232 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence            11   112234567799999653        236789999999999999999 78899876655554444443321   2


Q ss_pred             CCCCCCCChHHHHHHHHHHcCCCCCCCHHHHhc
Q 022956          241 QALNKVKDPEVKAFIEKCIAQPRARPSASELLK  273 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~dp~~Rps~~~il~  273 (289)
                      .......++.+.+++..|+.||++||++++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 PQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE  265 (269)
T ss_pred             CcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence            223445678899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-38  Score=264.61  Aligned_cols=240  Identities=23%  Similarity=0.384  Sum_probs=194.4

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      ++||+|+||.||++.+. ++..+|+|.+....   .......+.+|+.++++++|||++++++.+...  ...++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence            46999999999999864 68899999987542   234455688999999999999999999987544  5789999999


Q ss_pred             cCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc--c
Q 022956          103 TSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--A  179 (289)
Q Consensus       103 ~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~--~  179 (289)
                      ++++|.+++.. ...+++..+..++.+++.+|.++|++|  ++|+||+|+||+++.+ +.++|+|||++........  .
T Consensus        75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~  151 (250)
T cd05085          75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSS  151 (250)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCC-CeEEECCCccceeccccccccC
Confidence            99999999875 346899999999999999999999999  9999999999999988 8999999999865432211  1


Q ss_pred             ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      .....+..|+|||.+.+ .++.++|+||||++++++++ |..||....... ....+...... ..+...+..+.+++.+
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~  229 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-AREQVEKGYRM-SCPQKCPDDVYKVMQR  229 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence            11233567999997664 48889999999999999998 999998754443 33344444332 2234568999999999


Q ss_pred             HHc-CCCCCCCHHHHhc
Q 022956          258 CIA-QPRARPSASELLK  273 (289)
Q Consensus       258 ~l~-dp~~Rps~~~il~  273 (289)
                      ||+ +|++||++.++++
T Consensus       230 ~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         230 CWDYKPENRPKFSELQK  246 (250)
T ss_pred             HcccCcccCCCHHHHHH
Confidence            998 9999999999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.6e-39  Score=272.67  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=202.9

Q ss_pred             CcccceeeeecccCcceEEEEeec----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQ----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .+++++.++||+|+||.||++...    .++..+|+|.+.....   ......+.+|++.++.+.|+|++++++++....
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            455678899999999999999854    3588999999975532   245678999999999999999999998876655


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      +...++++||+++++|.+++.... .+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~  156 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLA  156 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccccc
Confidence            568999999999999999997644 6899999999999999999999999  9999999999999998 89999999999


Q ss_pred             cccCCcccc----ccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--------------HHHHH
Q 022956          171 AIVGRSHAA----HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS--------------VAKIY  231 (289)
Q Consensus       171 ~~~~~~~~~----~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~--------------~~~~~  231 (289)
                      .........    ........|++||... ..++.++|+||||+++++|++|..|+.....              .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            876532211    1223455699999665 4488899999999999999999999865321              11222


Q ss_pred             HHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          232 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ..+...... ..+...+.++.+++.+||+ +|++||++.++++  .+++
T Consensus       237 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~--~l~~  282 (284)
T cd05038         237 ELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL--IVDR  282 (284)
T ss_pred             HHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH--HHhh
Confidence            333322222 2234457899999999998 9999999999997  4443

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-38  Score=267.77  Aligned_cols=249  Identities=24%  Similarity=0.404  Sum_probs=201.3

Q ss_pred             cceeeeecccCcceEEEEeecC-CCcEEEEEEeeecccC------CCHHHHHHHHHHHHHHHh-CCCCceEEeeeeEEeC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRT-LKNKYIIVCYSVWLDD   90 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~------~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~   90 (289)
                      |++.+.||+|+||.||++.++. +++.+|+|.+......      ........+.+|+.++.+ ++|||++++++.+.. 
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-   80 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-   80 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-
Confidence            3578999999999999999887 6889999998754321      223445667788888865 799999999998754 


Q ss_pred             CCCeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                       ++..++++||+++++|.+++..    ...+++..++.++.|++.+|.+||+ .+  ++|+||+|+||+++.+ +.++|+
T Consensus        81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~-~~~~l~  156 (269)
T cd08528          81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED-DKVTIT  156 (269)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC-CcEEEe
Confidence             3689999999999999988743    4568999999999999999999996 67  9999999999999988 899999


Q ss_pred             ccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCC
Q 022956          166 DLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       166 d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (289)
                      |||.+.............++..|+|||...+. ++.++|+||||+++|+|++|..||............. .........
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~  235 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV-EAVYEPLPE  235 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh-hccCCcCCc
Confidence            99999876554444455678899999976644 8899999999999999999999997655444333333 322222233


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ...++.+.+++.+||+ ||++||++.++.+
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~  265 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSA  265 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence            3568899999999998 9999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.4e-39  Score=271.32  Aligned_cols=244  Identities=23%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             ceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ++.+.||+|+||.||+|.+.     .++..+|+|.+....   .......+.+|+.++++++|||++++++.+..  +..
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~~~   82 (288)
T cd05050           8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAV--GKP   82 (288)
T ss_pred             eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCc
Confidence            67899999999999999875     367889999987432   34456778899999999999999999987744  357


Q ss_pred             eEEEeccccCCcHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCc
Q 022956           95 LNFITEVCTSGNLRTYRKKH----------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN  152 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~----------------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~n  152 (289)
                      .++++||+++++|.+++...                      ..+++..++.++.|++.||.+||+.+  ++|+||+|+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~n  160 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRN  160 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhh
Confidence            89999999999999998743                      24678889999999999999999999  9999999999


Q ss_pred             eEEeCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcH
Q 022956          153 IFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSV  227 (289)
Q Consensus       153 ili~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  227 (289)
                      |+++.+ +.++|+|||++.......   .......+..|+|||... ..++.++|+||||+++|+|++ |..||.+....
T Consensus       161 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999988 899999999987543221   112223456799999665 448999999999999999998 88898765544


Q ss_pred             HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          228 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .... .+..+.... .+...+..+.+++.+||+ ||++||++.|+++
T Consensus       240 ~~~~-~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIY-YVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHH-HHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            4333 333332221 233467899999999998 9999999999976

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.7e-39  Score=276.58  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=197.5

Q ss_pred             cccceeeeecccCcceEEEEeecCC-------CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEE-------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWL   88 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   88 (289)
                      ..+++.+.||+|+||.||+|.+...       +..+|+|.++...   .....+.+.+|+++++++ +||||+++++.+.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            3457899999999999999976432       2468999887432   334467788999999999 7999999999874


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCc
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN  152 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~n  152 (289)
                      ..  +.+++++||+++++|.+++...                ..++...+..++.|++.||.|||++|  ++|+||+|+|
T Consensus        89 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~N  164 (334)
T cd05100          89 QD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARN  164 (334)
T ss_pred             cC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccce
Confidence            43  5789999999999999998753                24778889999999999999999999  9999999999


Q ss_pred             eEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcH
Q 022956          153 IFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSV  227 (289)
Q Consensus       153 ili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  227 (289)
                      |+++.+ +.++|+|||++........   .....++..|+|||.+.+. ++.++||||||+++++|++ |..||.... .
T Consensus       165 ill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~  242 (334)
T cd05100         165 VLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V  242 (334)
T ss_pred             EEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-H
Confidence            999988 8999999999876543221   1112234679999976544 8899999999999999998 889997744 3


Q ss_pred             HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          228 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ......+....... .+...+..+.+++.+||+ +|++||++.+++.+
T Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 EELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            44444444433322 234567899999999998 99999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-38  Score=272.13  Aligned_cols=245  Identities=28%  Similarity=0.424  Sum_probs=197.6

Q ss_pred             cceeeeecccCcceEEEEeec-------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ-------EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD   90 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   90 (289)
                      +.+.+.||+|+||.||++.+.       .++..+|+|.+....   .......+.+|+.+++.+ +|||++++++.+...
T Consensus        17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            368899999999999999742       235579999987432   234457788999999999 899999999987544


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceE
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF  154 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nil  154 (289)
                        ..++++|||+.+++|.+++.+.                ..++...+..++.|++.||.|||++|  ++|+||+|+||+
T Consensus        94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil  169 (304)
T cd05101          94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL  169 (304)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence              5789999999999999998753                24678889999999999999999999  999999999999


Q ss_pred             EeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 022956          155 INGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAK  229 (289)
Q Consensus       155 i~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~  229 (289)
                      ++.+ +.++|+|||++........   .....++..|+|||.+.+. ++.++||||||+++|+|++ |..||... ....
T Consensus       170 i~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~  247 (304)
T cd05101         170 VTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE  247 (304)
T ss_pred             EcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHH
Confidence            9988 8999999999976643221   2223345689999976544 8899999999999999998 78888764 3445


Q ss_pred             HHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          230 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..+.+...... ..+...+..+++++.+||. +|++||++.++++
T Consensus       248 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         248 LFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             HHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            55555444332 2344568899999999998 9999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-41  Score=266.24  Aligned_cols=261  Identities=23%  Similarity=0.396  Sum_probs=208.9

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe---
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD---   89 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   89 (289)
                      +.++.|-+ ..+||+|.||.||+|..+.+|+.||+|++.....  .+..-....+|+++|..|+|+|++.+++.+..   
T Consensus        14 ~~~~~yek-~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   14 DEVSKYEK-LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             ecchHHHH-HHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            45677766 7899999999999999999999999998866432  23344567789999999999999988776532   


Q ss_pred             ---CCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           90 ---DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        90 ---~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                         .....+|+|+++|+. .|..++.+. .+++...+.+++.++.+||.|+|...  ++|||+|+.||+++.+ |.++|+
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilklA  166 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILKLA  166 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEEee
Confidence               223469999999988 899999876 67999999999999999999999999  9999999999999999 999999


Q ss_pred             ccCCccccCCccc-----cccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHhC
Q 022956          166 DLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI--YKKVTG  236 (289)
Q Consensus       166 d~g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~~  236 (289)
                      |||+++.+.....     -..+..|..|.+||.+-+  ++.++.|||+.|||+.+|+|+..-+.+......+  .+.+.+
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            9999976643322     223456899999996544  4999999999999999999999888764433332  233333


Q ss_pred             CCCCCCCC------------------------------CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          237 GVKPQALN------------------------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       237 ~~~~~~~~------------------------------~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ...+..++                              ...++...+|+++||+ ||.+|++++++|.|.||..-
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            33222211                              1225578899999999 99999999999999999754

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.2e-39  Score=266.66  Aligned_cols=233  Identities=23%  Similarity=0.365  Sum_probs=187.1

Q ss_pred             eeecccCcceEEEEeecCCC----------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           23 DLLGSGAVKKVYRAFDQEEG----------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ++||+|+||.||++.+..++          ..+++|.+....     .....+.+|+.+++.++|||++++++.+..   
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR---   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence            46999999999999998776          347777765432     115778889999999999999999998755   


Q ss_pred             CeeEEEeccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC-------cEEE
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-------QVKI  164 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~-------~~~l  164 (289)
                      ...++|+||+++++|.+++.... .++...+..++.|++.||.|||++|  ++|+||+|+||+++.+ +       .++|
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~kl  149 (259)
T cd05037          73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFIKL  149 (259)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeEEe
Confidence            34789999999999999998755 7899999999999999999999999  9999999999999877 5       7999


Q ss_pred             eccCCccccCCccccccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCC
Q 022956          165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP  240 (289)
Q Consensus       165 ~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~  240 (289)
                      +|||++.....   .....++..|+|||.+.+   .++.++|+||||+++++|++ |..||.......... .....   
T Consensus       150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~~~---  222 (259)
T cd05037         150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQ---  222 (259)
T ss_pred             CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHhcC---
Confidence            99999886543   222345678999997664   37889999999999999999 688887654322221 11111   


Q ss_pred             CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ...+......+.+++.+||. +|++||++.++++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11222234789999999998 9999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.1e-38  Score=263.22  Aligned_cols=241  Identities=23%  Similarity=0.416  Sum_probs=195.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||.||++.+. ++..+|+|.+.....  .   ...+.+|++++++++||+++++++.+...  ...++++
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   78 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--S---EEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLVF   78 (256)
T ss_pred             EEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--C---HHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEEE
Confidence            67899999999999999875 467899999875432  1   34578899999999999999999887443  5789999


Q ss_pred             ccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||+.+++|.+++... ..++++.+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC-CeEEECCCcceeecccCcc
Confidence            999999999998753 56899999999999999999999999  9999999999999988 8999999999876543211


Q ss_pred             --cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          179 --AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                        ......+..|+|||...+ .++.++|+||||+++|+|++ |..||..... ....+.+..+... ..+...+..+.+|
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~l  233 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAGFRL-YKPRLASQSVYEL  233 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHhCCCCC-CCCCCCCHHHHHH
Confidence              112234568999997664 48889999999999999998 9999976443 3444444443222 2234468899999


Q ss_pred             HHHHHc-CCCCCCCHHHHhc
Q 022956          255 IEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~  273 (289)
                      +.+||+ +|++||++.++++
T Consensus       234 ~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         234 MQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             HHHHcccChhhCCCHHHHHH
Confidence            999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-38  Score=264.23  Aligned_cols=241  Identities=23%  Similarity=0.397  Sum_probs=195.2

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||.||++.+. ++..+++|.+...     ....+.+.+|++++++++|+|++++++.+..   ...+++
T Consensus         8 ~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05073           8 LKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYII   78 (260)
T ss_pred             eeEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEE
Confidence            478999999999999999754 5567999988642     2235678889999999999999999988744   468899


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||+++++|.+++..  +..++...+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCCcceeeccCC
Confidence            999999999999975  346788899999999999999999999  9999999999999998 89999999998765432


Q ss_pred             cc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 HA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ..  .....++..|+|||.+.. .++.++|+||||++++++++ |..||....... ....+.+..... .....+.++.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~  233 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMP-RPENCPEELY  233 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHhCCCCCC-CcccCCHHHH
Confidence            21  112234567999997654 48889999999999999999 999998754433 333334433222 2345678999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +++.+||+ +|++||++.++++
T Consensus       234 ~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         234 NIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            99999998 9999999999886

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-38  Score=267.94  Aligned_cols=241  Identities=26%  Similarity=0.422  Sum_probs=192.5

Q ss_pred             eeecccCcceEEEEeecCCC------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           23 DLLGSGAVKKVYRAFDQEEG------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +.||+|+||.||++.++...      ..+|+|.+....   .......+.+|+..++.++||||+++++++...  ...+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeE
Confidence            36999999999999876443      789999986532   223456788899999999999999999987544  5789


Q ss_pred             EEeccccCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC-----cEEE
Q 022956           97 FITEVCTSGNLRTYRKKH-------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-----QVKI  164 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~-----~~~l  164 (289)
                      +++||+++++|.+++...       ..+++.++..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +     .+++
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEK-GYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecC-CCCCCcceEE
Confidence            999999999999998642       34788999999999999999999999  9999999999999987 5     8999


Q ss_pred             eccCCccccCCcc---ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC
Q 022956          165 GDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK  239 (289)
Q Consensus       165 ~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  239 (289)
                      +|||++.......   ......++..|+|||.+.+ .+++++|+||||+++|+|++ |..||....... ....+..+..
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~  231 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGR  231 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHHHhcCCc
Confidence            9999987553221   1122345678999997654 48999999999999999998 999998655443 3333333222


Q ss_pred             CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          240 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       240 ~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      . ......++.+.+++.+||+ +|++||+++++++
T Consensus       232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 L-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             c-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2 2334568899999999998 9999999999976

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.1e-38  Score=264.09  Aligned_cols=239  Identities=24%  Similarity=0.441  Sum_probs=195.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +.| ++.+.||+|+||.||++.  .+++.+|+|.++...      ....+.+|+.+++.++|||++++++.+..   +..
T Consensus         6 ~~~-~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~   73 (254)
T cd05083           6 QKL-TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGL   73 (254)
T ss_pred             HHc-eeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCc
Confidence            344 689999999999999985  468899999986432      24568889999999999999999988743   347


Q ss_pred             EEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           96 NFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ++++||+.+++|.+++...  ..+++..+..++.|++.|+.+||+.|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~  150 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED-GVAKVSDFGLARVG  150 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CcEEECCCccceec
Confidence            8999999999999999764  35789999999999999999999999  9999999999999988 89999999998754


Q ss_pred             CCccccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          174 GRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       174 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ....  .....+..|+|||.+. +.++.++|+||||+++++|++ |..||...... .....+.+...+. .....++.+
T Consensus       151 ~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~  226 (254)
T cd05083         151 SMGV--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKECVEKGYRME-PPEGCPADV  226 (254)
T ss_pred             cccC--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhCCCCCC-CCCcCCHHH
Confidence            3221  1223456899999765 458889999999999999998 99999875443 3444454443332 234568899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhc
Q 022956          252 KAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+++.+||+ +|++||++.+++.
T Consensus       227 ~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         227 YVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.8e-39  Score=264.43  Aligned_cols=227  Identities=20%  Similarity=0.297  Sum_probs=184.5

Q ss_pred             cCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccCCcH
Q 022956           28 GAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL  107 (289)
Q Consensus        28 g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL  107 (289)
                      |.+|+||+|.++.+|+.||+|.+.....         ..++...+....|||++++++.+...  ..++++|||++|++|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh---------hhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence            8899999999999999999999975421         22244444556799999999987543  679999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCCCCCC
Q 022956          108 RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE  187 (289)
Q Consensus       108 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  187 (289)
                      .+++.....+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++++|||.+.......  ....++..
T Consensus        73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~~--~~~~~~~~  147 (237)
T cd05576          73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDSC--DGEAVENM  147 (237)
T ss_pred             HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEecccchhcccccc--ccCCcCcc
Confidence            999988778999999999999999999999999  9999999999999998 899999999876554321  22345667


Q ss_pred             CCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCC
Q 022956          188 YMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRAR  265 (289)
Q Consensus       188 ~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~R  265 (289)
                      |+|||...+ .+++++|+||+|+++++|++|..|+......      .... .....+...++.+++++.+||+ ||++|
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R  220 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTH-TTLNIPEWVSEEARSLLQQLLQFNPTER  220 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccc-cccCCcccCCHHHHHHHHHHccCCHHHh
Confidence            999997654 4889999999999999999999887542211      0000 1112344568899999999998 99999


Q ss_pred             CCH-----HHHhcCccc
Q 022956          266 PSA-----SELLKDPFF  277 (289)
Q Consensus       266 ps~-----~~il~h~~~  277 (289)
                      |++     ++++.||||
T Consensus       221 ~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         221 LGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cCCCccchHHHHcCCCC
Confidence            985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-38  Score=267.21  Aligned_cols=237  Identities=20%  Similarity=0.307  Sum_probs=184.9

Q ss_pred             eeecccCcceEEEEeecCC------------------------CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCC
Q 022956           23 DLLGSGAVKKVYRAFDQEE------------------------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK   78 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~------------------------~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~   78 (289)
                      .+||+|+||.||++....+                        ...+++|++...    .......+.+|+.+++.++||
T Consensus         1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCC
Confidence            3699999999999975322                        245888888643    233456688899999999999


Q ss_pred             ceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC
Q 022956           79 YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING  157 (289)
Q Consensus        79 ~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~  157 (289)
                      ||+++++++...  ...++||||+++++|..++.. .+.+++..+..++.|++.||.|||+++  ++|+||+|+||+++.
T Consensus        77 niv~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~  152 (274)
T cd05076          77 HLAFVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLAR  152 (274)
T ss_pred             CeeeEEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEec
Confidence            999999988654  578999999999999999865 567899999999999999999999999  999999999999975


Q ss_pred             C------CCcEEEeccCCccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHH
Q 022956          158 N------IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMV-TMEIPYSECDSVA  228 (289)
Q Consensus       158 ~------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~-tg~~p~~~~~~~~  228 (289)
                      .      .+.++++|||.+......   ....++..|+|||.+.+  .+++++|+||||+++|+++ +|..||.......
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            3      124899999987544221   12346778999997654  3889999999999999995 6899997654332


Q ss_pred             HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      . ........   ..+...++.+.+++.+||+ +|++||++.+++++
T Consensus       230 ~-~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 K-ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             H-HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            2 22222111   1223345789999999998 99999999999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.8e-39  Score=267.35  Aligned_cols=235  Identities=23%  Similarity=0.371  Sum_probs=187.4

Q ss_pred             eeecccCcceEEEEeecCCCcE-------EEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIE-------VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~-------~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +.||+|+||.||+|.+..++..       +++|.+...    .....+.+.+|+.+++.++|||++++++.+...  ...
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~   74 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DES   74 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCc
Confidence            4699999999999988665443       888887643    234456788899999999999999999988654  468


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc--------EEEec
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--------VKIGD  166 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~--------~~l~d  166 (289)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.        ++++|
T Consensus        75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~~~~~~~~~~l~d  151 (258)
T cd05078          75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIRE-EDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecc-cccccCCCceEEecc
Confidence            8999999999999999764 45899999999999999999999999  9999999999999876 33        79999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      ||.+......   ....++..|+|||.+.+  .++.++|+||||+++|+|++| ..|+........ .......   ...
T Consensus       152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~---~~~  224 (258)
T cd05078         152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDR---HQL  224 (258)
T ss_pred             cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHcc---ccC
Confidence            9988654322   22456778999997764  378899999999999999998 566665443332 2222221   123


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +...+..+.+++.+||+ ||++|||++++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  255 (258)
T cd05078         225 PAPKWTELANLINQCMDYEPDFRPSFRAIIR  255 (258)
T ss_pred             CCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            33456889999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.1e-38  Score=263.86  Aligned_cols=242  Identities=20%  Similarity=0.339  Sum_probs=186.6

Q ss_pred             eecccCcceEEEEeecCC--CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           24 LLGSGAVKKVYRAFDQEE--GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      .||+|+||+||++....+  ...+++|.+....   .....+.+.+|+..++.++|||++++++.+...  ...++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEec
Confidence            599999999999975432  2345556554332   344567889999999999999999999988543  578999999


Q ss_pred             ccCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-
Q 022956          102 CTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-  176 (289)
Q Consensus       102 ~~~~sL~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-  176 (289)
                      +++++|.+++.+.    ...++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++...... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC-ccEEecccccccccCcch
Confidence            9999999999753    34567788899999999999999999  9999999999999988 89999999987643221 


Q ss_pred             --cccccCCCCCCCCCCccccc--------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC---CCC
Q 022956          177 --HAAHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK---PQA  242 (289)
Q Consensus       177 --~~~~~~~~~~~~~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~---~~~  242 (289)
                        .......++..|+|||.+..        .++.++|+||||+++|+|++ |..||............+.....   ...
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ  233 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence              11223456789999997632        25778999999999999997 57788765554444443333211   122


Q ss_pred             CCCCCChHHHHHHHHHHcCCCCCCCHHHHhc
Q 022956          243 LNKVKDPEVKAFIEKCIAQPRARPSASELLK  273 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~dp~~Rps~~~il~  273 (289)
                      .....++.+.+++..||.+|++||++++|++
T Consensus       234 ~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~  264 (268)
T cd05086         234 LELPYSERWYEVLQFCWLSPEKRATAEEVHR  264 (268)
T ss_pred             cCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence            3334678899999999999999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.5e-38  Score=262.15  Aligned_cols=242  Identities=23%  Similarity=0.372  Sum_probs=190.1

Q ss_pred             eeecccCcceEEEEeecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      +.||+|+||.||+|.+..   ++..+|+|.+....   .....+.+.+|+.+++.++|||++++++.+...+ ...++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence            468999999999998643   34679999875322   3444677888999999999999999998765433 4678999


Q ss_pred             ccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956          100 EVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      ||+.+++|.+++... ..++...+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCccccccccCCcc
Confidence            999999999999763 45677888999999999999999999  9999999999999988 899999999987543211 


Q ss_pred             ----ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          178 ----AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       178 ----~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                          ......++..|+|||.+. ..++.++||||||+++++|++| ..||...... .....+.....+. .+...++.+
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~  231 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-DITVYLLQGRRLL-QPEYCPDPL  231 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCCC-CCCcCCHHH
Confidence                111233466899999765 4488999999999999999995 5666654433 3333444433222 234467899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhc
Q 022956          252 KAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+++.+||+ +|++||++.+++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.7e-40  Score=263.98  Aligned_cols=258  Identities=27%  Similarity=0.431  Sum_probs=201.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      |....+||+|.||.||+|+.+.++.    .+|+|.++...-  ........-+|+..++.++|+|++.+..++... +..
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~  102 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK  102 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence            4667889999999999997665543    689999986532  122334566799999999999999999998875 478


Q ss_pred             eEEEeccccCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC---CCcEEEec
Q 022956           95 LNFITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGD  166 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~---~~~~~l~d  166 (289)
                      +++++||.+. .|+..+..     .+.++...+..+++||+.|+.|||++-  ++||||||.||++..+   .|+|||+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence            9999999988 89888863     357899999999999999999999999  9999999999999654   47999999


Q ss_pred             cCCccccCCcccc----ccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCC------------cHH
Q 022956          167 LGFAAIVGRSHAA----HSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECD------------SVA  228 (289)
Q Consensus       167 ~g~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~------------~~~  228 (289)
                      +|+++.+..+...    .....|..|.|||++-|.  |+++.|+|+.|||+.||+|-+..|.+..            +.+
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999988665432    234568899999966543  9999999999999999999887775411            111


Q ss_pred             HHHHHHhCCCCCCCCC--------------------------------CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCc
Q 022956          229 KIYKKVTGGVKPQALN--------------------------------KVKDPEVKAFIEKCIA-QPRARPSASELLKDP  275 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~  275 (289)
                      .+.+ +.+.+....++                                ..-++...+|+.+||+ ||.+|+|++|.|+|+
T Consensus       260 rIf~-vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFE-VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHH-HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            1111 11221111110                                1124557899999999 999999999999999


Q ss_pred             ccccCCCC
Q 022956          276 FFSELNDD  283 (289)
Q Consensus       276 ~~~~~~~~  283 (289)
                      ||..-.-+
T Consensus       339 yF~~d~lp  346 (438)
T KOG0666|consen  339 YFTEDPLP  346 (438)
T ss_pred             ccccCCCC
Confidence            99987544

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.5e-38  Score=263.40  Aligned_cols=236  Identities=22%  Similarity=0.359  Sum_probs=184.6

Q ss_pred             eeecccCcceEEEEeecC------------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           23 DLLGSGAVKKVYRAFDQE------------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~------------~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      +.||+|+||.||++....            ....+++|++...    .......+.+|+.+++.++||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            469999999999997532            2335888887543    234456788899999999999999999987544


Q ss_pred             CCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc-------E
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ-------V  162 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~-------~  162 (289)
                        ...++++||+++++|..++.. ...+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.       +
T Consensus        77 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~~~~~~~~  151 (262)
T cd05077          77 --VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLARE-GIDGECGPFI  151 (262)
T ss_pred             --CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecC-CccCCCCcee
Confidence              567899999999999988875 456899999999999999999999999  9999999999999765 43       8


Q ss_pred             EEeccCCccccCCccccccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHhCCCC
Q 022956          163 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMV-TMEIPYSECDSVAKIYKKVTGGVK  239 (289)
Q Consensus       163 ~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~-tg~~p~~~~~~~~~~~~~~~~~~~  239 (289)
                      +++|||++......   ....++..|+|||.+.  ..++.++||||||+++|+|+ +|..||........ ... .....
T Consensus       152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~-~~~~~  226 (262)
T cd05077         152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERF-YEGQC  226 (262)
T ss_pred             EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHH-HhcCc
Confidence            99999988655322   2234677899999765  34888999999999999997 58888876432222 111 11111


Q ss_pred             CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          240 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       240 ~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .  .....++.+.+|+.+||+ ||++||++.+|+.+
T Consensus       227 ~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         227 M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            1  122345789999999999 99999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-40  Score=270.65  Aligned_cols=266  Identities=23%  Similarity=0.405  Sum_probs=206.7

Q ss_pred             CCCCCCceeeC-C-CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC--C
Q 022956            3 DRDGEPFVEVD-P-SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN--K   78 (289)
Q Consensus         3 ~~~~~~~~~~~-~-~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~   78 (289)
                      +++|+-+.+++ . .+|| .+..++|+|.||.|-.+.+.+++..||+|+++..     ....+...-|+++|+++.+  |
T Consensus        74 D~dGH~v~~~gD~l~~Ry-~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP  147 (415)
T KOG0671|consen   74 DKDGHYVYQVGDILTNRY-EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDP  147 (415)
T ss_pred             CCCceEEEEeccccccce-ehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCC
Confidence            56776666664 3 5666 6899999999999999999999999999999854     3345556779999999943  3


Q ss_pred             c----eEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCc
Q 022956           79 Y----IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN  152 (289)
Q Consensus        79 ~----i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~n  152 (289)
                      +    ++++.++|  +-+++.|+|+|.+ |.|+.+++.++  .+++..++..+++|+++++++||+.+  ++|.||||+|
T Consensus       148 ~g~~rcv~m~~wF--dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPEN  222 (415)
T KOG0671|consen  148 NGKFRCVQMRDWF--DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPEN  222 (415)
T ss_pred             CCceEEEeeehhh--hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChhe
Confidence            2    34444444  3447899999999 66999999875  46788999999999999999999999  9999999999


Q ss_pred             eEEeCC-------------------CCcEEEeccCCccccCCccccccCCCCCCCCCCccc-ccCCCCcchHHHHHHHHH
Q 022956          153 IFINGN-------------------IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLL  212 (289)
Q Consensus       153 ili~~~-------------------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Di~slG~il~  212 (289)
                      |++...                   +-.++++|||.|++.....  .....|..|.|||++ .=+++.+.||||+||||+
T Consensus       223 ILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~  300 (415)
T KOG0671|consen  223 ILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV  300 (415)
T ss_pred             EEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence            998321                   1369999999998776554  445678999999955 456999999999999999


Q ss_pred             HHHhCCCCCCCCCcHH--HHHHHHhCCCCCCCCCC-----------------------------------------CCCh
Q 022956          213 EMVTMEIPYSECDSVA--KIYKKVTGGVKPQALNK-----------------------------------------VKDP  249 (289)
Q Consensus       213 ~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~-----------------------------------------~~~~  249 (289)
                      |+++|...|.+.++.+  .+.+.+.+..+...+..                                         ....
T Consensus       301 ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~  380 (415)
T KOG0671|consen  301 ELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV  380 (415)
T ss_pred             EeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence            9999999998766443  23333333221110000                                         0112


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+.+|+++||. ||.+|+|+.|+|.||||+.+.
T Consensus       381 ~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  381 QLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            57899999999 999999999999999999864

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.1e-38  Score=269.89  Aligned_cols=243  Identities=24%  Similarity=0.412  Sum_probs=195.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +..+.||+|+||.||++.+..+|.    .+|+|.+....   .......+.+|+.+++.++|||++++++.+...   ..
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~   83 (303)
T cd05110          10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TI   83 (303)
T ss_pred             eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Cc
Confidence            567899999999999999887776    46888776432   234445688899999999999999999987543   46


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++++|+++++|.+++... ..+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.+||+|||++....
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP-NHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC-CceEEcccccccccc
Confidence            7899999999999998764 46899999999999999999999999  9999999999999888 799999999998654


Q ss_pred             Cccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          175 RSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       175 ~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ....   .....++..|+|||...+ .++.++||||||+++|++++ |..||.+.. .......+..+.... .+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~  238 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDLLEKGERLP-QPPICTI  238 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHCCCCCC-CCCCCCH
Confidence            3222   122334678999997654 48899999999999999997 899997643 333344444433222 2344678


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.+++..||. +|++||+++++++
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~  263 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAA  263 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            89999999998 9999999999988

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=264.43  Aligned_cols=258  Identities=19%  Similarity=0.375  Sum_probs=221.8

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      +++.++||.|+|++|-++.+++|.+.||+|+++..-..+ .+.++....|-.+..+. +||.+|-++.+|.++  ..+++
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglhscfqte--srlff  328 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE--SRLFF  328 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehhhhhccc--ceEEE
Confidence            368999999999999999999999999999998765544 34477788888888766 689999999888555  57999


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc-CCc
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~-~~~  176 (289)
                      |.||++||.|--.++..+.++++.+..+...|+.||.|||++|  ++.+|||.+||++|.. |.+||+|+|+++.- ...
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-CceeecccchhhcCCCCC
Confidence            9999999999999998899999999999999999999999999  9999999999999999 99999999999653 455


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCC-------CCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYS-------ECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ..+...+|||.|.|||+++++ |....|.|+||+++++|+.|+.||+       ....++.+.+.+...  ...++...+
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--qiriprsls  483 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--QIRIPRSLS  483 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--cccccceee
Confidence            567788999999999999987 9999999999999999999999996       223445556666553  344566667


Q ss_pred             hHHHHHHHHHHc-CCCCCC------CHHHHhcCcccccCCCCC
Q 022956          249 PEVKAFIEKCIA-QPRARP------SASELLKDPFFSELNDDD  284 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rp------s~~~il~h~~~~~~~~~~  284 (289)
                      -.+..+++.-|+ ||.+|.      .+.++-.|+||..++|+.
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence            788899999998 999984      468999999999999974

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.6e-38  Score=263.67  Aligned_cols=247  Identities=21%  Similarity=0.346  Sum_probs=194.9

Q ss_pred             ceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC----
Q 022956           20 RYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH----   92 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   92 (289)
                      ++.+.||+|+||.||+|.+.   .++..+|+|.+.....  .....+.+.+|++++++++|||++++++.+.....    
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            57889999999999999854   3578999999975432  34456778899999999999999999998755322    


Q ss_pred             CeeEEEeccccCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      ...+++++|+.+++|.+++...      ..++...+..++.|++.|++|||+.|  ++|+||+|+||+++.+ +.++++|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~-~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN-MTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC-CCEEECc
Confidence            1347889999999998887432      24788999999999999999999999  9999999999999988 8999999


Q ss_pred             cCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCC
Q 022956          167 LGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ  241 (289)
Q Consensus       167 ~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  241 (289)
                      ||.+........   .....+++.|++||...+ .++.++|+||||+++|+|++ |..||...... .....+.......
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~  235 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-EIYNYLIKGNRLK  235 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-HHHHHHHcCCcCC
Confidence            999876543221   112234568999996654 48889999999999999999 88998765443 3333333332221


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                       .....++.+.+++.+||+ +|++||++.+++.
T Consensus       236 -~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         236 -QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             233467899999999998 9999999999987

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=262.08  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=214.4

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEec
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ...||.|+||+|++..++.+|+..|||.++...   .+..+.++..|++...+- +.||||++++..+.+  +..|+.||
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWiCME  143 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWICME  143 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--CceeeeHH
Confidence            356999999999999999999999999998765   356678888888876555 569999999998877  45899999


Q ss_pred             cccCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956          101 VCTSGNLRTYRK-----KHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus       101 ~~~~~sL~~~~~-----~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      .++- ||..+-.     +...+++.-+-.+....+.||.||-. ..  ++|||+||+|||++.. |.+||||||.+..+.
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~-G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRH-GDVKLCDFGICGQLV  219 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecC-CCEeeecccchHhHH
Confidence            9965 7766542     34679999999999999999999954 47  9999999999999999 999999999998877


Q ss_pred             CccccccCCCCCCCCCCcccc---cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCC----CC
Q 022956          175 RSHAAHSIIGTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK----VK  247 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~  247 (289)
                      ..-......|-..|+|||.+.   .+++.++|+||||++++|+.||+.|+..+++.-+...++..+.++.....    ..
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~  299 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY  299 (361)
T ss_pred             HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence            665556667888999999765   23999999999999999999999999998877777777777766554333    25


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      +..+..++..||. |.+.||...+++++||+........
T Consensus       300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~  338 (361)
T KOG1006|consen  300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP  338 (361)
T ss_pred             CHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence            7889999999997 9999999999999999987655443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=291.03  Aligned_cols=248  Identities=21%  Similarity=0.357  Sum_probs=213.8

Q ss_pred             CcccceeeeecccCcceEEEEeecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      .-|.++.++||.|.||.|+++..+..|   ..||||.++...   .+..+..|..|+.++-+.+||||+.+-++..  +.
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks  702 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KS  702 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cC
Confidence            344568999999999999999988766   559999998764   4666888999999999999999999999984  44


Q ss_pred             CeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           93 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      +.++||+||+++|+|..++.+ .++++..++..+++.|+.|+.||.+.|  ++||||-..|||++.| -.+|++|||+++
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKVsDFGLSR  779 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKVSDFGLSR  779 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEecccccee
Confidence            789999999999999999986 467999999999999999999999999  9999999999999999 799999999999


Q ss_pred             ccCCccc-cccCCC---CCCCCCCcc-cccCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          172 IVGRSHA-AHSIIG---TPEYMAPEL-YEEDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       172 ~~~~~~~-~~~~~~---~~~~~aPE~-~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      ...+... ..+..|   ..+|.|||. -.+.++.++|+||+|++|||.++ |+.||.+..+.+.+..+..+...|..+. 
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD-  858 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD-  858 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC-
Confidence            8855432 222222   479999995 45779999999999999999988 9999999887777777666665554433 


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                       +|.++.+|+..||+ |..+||.+.||+.
T Consensus       859 -CP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  859 -CPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             -CcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence             58999999999998 9999999999988

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.5e-38  Score=266.35  Aligned_cols=254  Identities=21%  Similarity=0.231  Sum_probs=187.7

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCC-HHH------HHHHHHHHHHHHhCCCCceEE
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSED-PVL------VNRLHSEVQLLRTLKNKYIIV   82 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~-~~~------~~~~~~e~~~l~~l~~~~i~~   82 (289)
                      +..++.|++.++||+|+||+||+|.+..+   +..+|+|+......... +..      ......+...+..+.|++++.
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            44444558999999999999999998877   66777776543321100 100      011223345566778999999


Q ss_pred             eeeeEEeCCC--CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           83 CYSVWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        83 ~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      +++.......  ...+++++++.. ++.+.+......++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~-~  163 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN-N  163 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-C
Confidence            9886544322  244678887754 77777776666788999999999999999999999  9999999999999988 8


Q ss_pred             cEEEeccCCccccCCcc--------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH--
Q 022956          161 QVKIGDLGFAAIVGRSH--------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK--  229 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~--  229 (289)
                      .++|+|||++.......        ......+++.|+|||...+. ++.++|||||||++++|++|..||........  
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999999997653211        11224689999999977655 89999999999999999999999986532221  


Q ss_pred             ------HHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          230 ------IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       230 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                            ....+..+   .......+..+.++++.|++ +|++||+++++++
T Consensus       244 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDFIKRLHEG---KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHHHHHhhhh---hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                  11222221   11223457889999999999 9999999999986

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.1e-39  Score=252.87  Aligned_cols=261  Identities=18%  Similarity=0.354  Sum_probs=211.9

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQ   91 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   91 (289)
                      +--+.| ++.+++|.|.++.||.|.+..+++.++||+++..       ..+.+.+|+++|..|. +|||+.++++..+..
T Consensus        35 g~~ddY-eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   35 GNQDDY-EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE  106 (338)
T ss_pred             cccchH-HHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence            344555 6899999999999999999999999999999754       3678999999999996 999999999999888


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .....+++|++.+.....+..   .++...+...+.+++.||.|||+.|  ++|+|+||.||++|...-.++|+|||+|.
T Consensus       107 SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHh
Confidence            889999999998765555444   3888899999999999999999999  99999999999999876789999999999


Q ss_pred             ccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHH---------------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYS-ECDSVAKIYKK---------------  233 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~-~~~~~~~~~~~---------------  233 (289)
                      +......-..+..+.-|.-||.+..  .++...|+|||||++..|+..+.||- +.++.+++..+               
T Consensus       182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            8876655555556667789997664  48999999999999999999888874 33333333211               


Q ss_pred             ------------HhCCCC-------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          234 ------------VTGGVK-------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       234 ------------~~~~~~-------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                                  +.+...       ........++++-+|+.++|. |..+|+|+.+++.||||.......+.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~  334 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS  334 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence                        101100       112233457899999999999 99999999999999999987655544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=280.56  Aligned_cols=240  Identities=22%  Similarity=0.384  Sum_probs=197.0

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH-HhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL-RTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+...+|.|+|+.|-.+.+..+++.+++|++.....        ...+|+.++ ..-+|||+++..+++.  .+...|+|
T Consensus       325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v  394 (612)
T KOG0603|consen  325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLV  394 (612)
T ss_pred             ccccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceec--CCceeeee
Confidence            367779999999999999999999999999986521        122355444 3447999999999984  44789999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||.+.|+-+.+.+...+... ..+..|+.+|+.|+.|||.+|  ++||||||+|||++.+.++++|+|||.+......  
T Consensus       395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            99999998888777655455 788899999999999999999  9999999999999533389999999999876554  


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      ....+-|..|.|||.+... ++++.|+||||+++|+|++|+.||.......++...+..    .......|+.+++|+++
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~----~~~s~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM----PKFSECVSDEAKDLLQQ  545 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC----CccccccCHHHHHHHHH
Confidence            2234568899999977754 999999999999999999999999876555344433332    22337789999999999


Q ss_pred             HHc-CCCCCCCHHHHhcCcccc
Q 022956          258 CIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       258 ~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      ||+ ||.+|+++.+++.||||.
T Consensus       546 LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             hccCChhhCcChhhhccCcchh
Confidence            999 999999999999999993

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-37  Score=255.79  Aligned_cols=241  Identities=34%  Similarity=0.590  Sum_probs=205.2

Q ss_pred             CcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccCCcHH
Q 022956           29 AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR  108 (289)
Q Consensus        29 ~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~  108 (289)
                      +||.||++.+..+|+.+++|++.......   ..+.+.+|++.+++++|++++++++.+...  ...++++|++++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK---KRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence            58999999999899999999998654321   157889999999999999999999988554  5789999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCCCCCCC
Q 022956          109 TYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY  188 (289)
Q Consensus       109 ~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  188 (289)
                      +++.....++...+..++.+++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||.+.............++..|
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCC
Confidence            99987666999999999999999999999999  9999999999999998 89999999999887665455556678899


Q ss_pred             CCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC-CChHHHHHHHHHHc-CCCCC
Q 022956          189 MAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV-KDPEVKAFIEKCIA-QPRAR  265 (289)
Q Consensus       189 ~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~-dp~~R  265 (289)
                      ++||... ..+++++|+|+||++++++++|..||..........+.+............ .+..+.+++.+||. +|++|
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            9999765 448889999999999999999999998755555555555544333222221 67899999999998 99999


Q ss_pred             CCHHHHhcCccc
Q 022956          266 PSASELLKDPFF  277 (289)
Q Consensus       266 ps~~~il~h~~~  277 (289)
                      |++.++++||||
T Consensus       233 p~~~~~~~~~~~  244 (244)
T smart00220      233 LTAEEALQHPFF  244 (244)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.7e-38  Score=292.57  Aligned_cols=247  Identities=31%  Similarity=0.556  Sum_probs=199.2

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC-----------
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ-----------   91 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----------   91 (289)
                      +.||+|+||.||+|+++-+|..||||++....   ......++.+|++.|.+|+|||+|..+..+.++.           
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~  561 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS  561 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence            77999999999999999999999999998764   4556788999999999999999987763221100           


Q ss_pred             --------------------------------------------------------------------------------
Q 022956           92 --------------------------------------------------------------------------------   91 (289)
Q Consensus        92 --------------------------------------------------------------------------------   91 (289)
                                                                                                      
T Consensus       562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~  641 (1351)
T KOG1035|consen  562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI  641 (1351)
T ss_pred             chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence                                                                                            


Q ss_pred             ------------------C--------CeeEEEeccccCCcHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhcCCCCce
Q 022956           92 ------------------H--------NTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPCII  144 (289)
Q Consensus        92 ------------------~--------~~~~lv~e~~~~~sL~~~~~~~~~l-~~~~~~~~~~ql~~~l~~lh~~~~~~~  144 (289)
                                        .        ..+||-||||+..+|.+++..+... ....++.++++|++||.|+|+.|  ++
T Consensus       642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iI  719 (1351)
T KOG1035|consen  642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--II  719 (1351)
T ss_pred             cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--ee
Confidence                              0        3579999999997788888776554 46789999999999999999999  99


Q ss_pred             ecCCCCCceEEeCCCCcEEEeccCCccccC-------------------CccccccCCCCCCCCCCccccc----CCCCc
Q 022956          145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVG-------------------RSHAAHSIIGTPEYMAPELYEE----DYTEM  201 (289)
Q Consensus       145 h~dl~~~nili~~~~~~~~l~d~g~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~----~~~~~  201 (289)
                      ||||||.||+++++ +.|||+|||+++...                   ......+..||.-|+|||++.+    .|+.+
T Consensus       720 HRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  720 HRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            99999999999998 899999999998721                   0011234578999999998763    38889


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC--CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA--LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       202 ~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      +||||||+|++||+.   ||+...........+.++.-|..  .....-+.-+.+|++|++ ||.+|||+.|+|.+.||-
T Consensus       799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             hhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            999999999999996   78876555555555554433332  223334567899999998 999999999999998886

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=264.21  Aligned_cols=256  Identities=23%  Similarity=0.353  Sum_probs=214.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++..+||.|+||+|-++..+.|.+.||||+++.....++. ..+--..|-++|..... |.+++++..|.+-  +.+|+|
T Consensus       352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD-Dvectm~EKrvLAL~~kppFL~qlHScFQTm--DRLyFV  428 (683)
T KOG0696|consen  352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD-DVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLYFV  428 (683)
T ss_pred             ceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC-cccceehhhhheecCCCCchHHHHHHHhhhh--hheeeE
Confidence            4678999999999999999999999999999986654322 13333446677766654 5666777776444  579999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc-CCcc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~-~~~~  177 (289)
                      |||+.||.|--.+++-+.+.+..+..++..|+-||-+||++|  ++.||||.+||+++.+ |.+||+|||++... -...
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccCCc
Confidence            999999999999999999999999999999999999999999  9999999999999999 99999999999754 3344


Q ss_pred             ccccCCCCCCCCCCccc-ccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      .+...+|||.|+|||+. ..+|....|.||+|+++|||+.|+.||.+.+..+..+.+...+.   .++...+.++.++..
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---syPKslSkEAv~ick  582 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---SYPKSLSKEAVAICK  582 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---cCcccccHHHHHHHH
Confidence            56778999999999965 46699999999999999999999999998666665566555543   356667899999999


Q ss_pred             HHHc-CCCCCCCH-----HHHhcCcccccCCCCC
Q 022956          257 KCIA-QPRARPSA-----SELLKDPFFSELNDDD  284 (289)
Q Consensus       257 ~~l~-dp~~Rps~-----~~il~h~~~~~~~~~~  284 (289)
                      ..|. .|.+|...     .+|-.||||+.+||..
T Consensus       583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             HHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence            9997 99999644     7899999999999964

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=277.58  Aligned_cols=258  Identities=25%  Similarity=0.474  Sum_probs=220.1

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeC-
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD-   90 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-   90 (289)
                      ++.+.+ .+.+.||.|.+|.||+++++++|+..|+|+.......     -++++.|+.+|+.+ .|||++..+++|... 
T Consensus        16 dp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-----deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   16 DPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-----EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-----cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            567776 5899999999999999999999999999999876432     35566789999888 579999999988642 


Q ss_pred             --CCCeeEEEeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           91 --QHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        91 --~~~~~~lv~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                        .++.+|||||||.|||..|++.+  +.++.++.+..|++.++.|+.+||.+.  ++|+|++-.|||++.+ +.|||+|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEEee
Confidence              34689999999999999999875  678999999999999999999999999  9999999999999999 9999999


Q ss_pred             cCCccccCCc-cccccCCCCCCCCCCcccccC------CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC
Q 022956          167 LGFAAIVGRS-HAAHSIIGTPEYMAPELYEED------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK  239 (289)
Q Consensus       167 ~g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~------~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  239 (289)
                      ||.+...... .......|+|.|||||+....      ++.++|+||||++..||.-|..|+.+..+...+..+ ..+++
T Consensus       167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-pRNPP  245 (953)
T KOG0587|consen  167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-PRNPP  245 (953)
T ss_pred             eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-CCCCC
Confidence            9999887654 345567899999999976532      677899999999999999999999987777666544 45555


Q ss_pred             CCCC-CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          240 PQAL-NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       240 ~~~~-~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +... +..-+..+.++|..||. |-++||+..++|+|||+++.
T Consensus       246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            4443 44456789999999997 99999999999999999854

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=278.00  Aligned_cols=224  Identities=25%  Similarity=0.392  Sum_probs=185.2

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      .++.+...-.. ..+.||+|+||.||+++++++|..||||.+....   .....++.-+|++++++++|+|||+.+++--
T Consensus         6 ~l~~~~~y~W~-~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee   81 (732)
T KOG4250|consen    6 VLTSGENYLWE-MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEE   81 (732)
T ss_pred             ccccCCCccee-ehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCC
Confidence            34444444443 4789999999999999999999999999998644   2334677888999999999999999998643


Q ss_pred             eCC----CCeeEEEeccccCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC--
Q 022956           89 DDQ----HNTLNFITEVCTSGNLRTYRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--  159 (289)
Q Consensus        89 ~~~----~~~~~lv~e~~~~~sL~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~--  159 (289)
                      +..    ...-.++||||.||+|...+++   ...|++.+++.++..++.||.|||++|  ++||||||.||++..+.  
T Consensus        82 ~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedg  159 (732)
T KOG4250|consen   82 TKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDG  159 (732)
T ss_pred             ccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCC
Confidence            322    3456889999999999999974   467999999999999999999999999  99999999999995432  


Q ss_pred             -CcEEEeccCCccccCCccccccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH----HHHHH
Q 022956          160 -GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV----AKIYK  232 (289)
Q Consensus       160 -~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~----~~~~~  232 (289)
                       ...||+|||.|+..++.....+..||+.|++||.+.  +.++...|.||+||++|+++||..||-.....    ...+.
T Consensus       160 q~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  160 QSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             ceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence             469999999999998888888899999999999877  44888999999999999999999999653332    34455


Q ss_pred             HHhCCC
Q 022956          233 KVTGGV  238 (289)
Q Consensus       233 ~~~~~~  238 (289)
                      .+.+..
T Consensus       240 ~~tkkp  245 (732)
T KOG4250|consen  240 IITKKP  245 (732)
T ss_pred             hhccCC
Confidence            554443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.4e-37  Score=280.28  Aligned_cols=253  Identities=21%  Similarity=0.241  Sum_probs=173.2

Q ss_pred             cceeeeecccCcceEEEEeecCC----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE----eC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL----DD   90 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~   90 (289)
                      |.+.++||+|+||.||+|.+..+    +..||+|.+.....  .    +....+  .++...+.++......+.    ..
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--V----EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--h----HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            36789999999999999999988    99999998763211  1    111111  112222222221111111    13


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRH--------------------VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC  150 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~--------------------l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~  150 (289)
                      .+..+++|+||+.+++|.+++.....                    .....+..++.|++.||.|||+++  ++|+||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP  283 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKP  283 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCH
Confidence            44678999999999999999875321                    123456689999999999999999  99999999


Q ss_pred             CceEEeCCCCcEEEeccCCccccCCc--cccccCCCCCCCCCCccccc-C----------------------CCCcchHH
Q 022956          151 SNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTPEYMAPELYEE-D----------------------YTEMVDIY  205 (289)
Q Consensus       151 ~nili~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~----------------------~~~~~Di~  205 (289)
                      +|||++.+.+.+||+|||++......  .......+++.|+|||.+.. .                      +..++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            99999975479999999999755322  22334578899999995421 1                      22346999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC----------CCC---------CCCCCCChHHHHHHHHHHc-CCCCC
Q 022956          206 SFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV----------KPQ---------ALNKVKDPEVKAFIEKCIA-QPRAR  265 (289)
Q Consensus       206 slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----------~~~---------~~~~~~~~~~~~li~~~l~-dp~~R  265 (289)
                      ||||++|+|+++..+++.  ........+....          ...         ......+....+|+.+||+ ||++|
T Consensus       364 SlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            999999999998766542  2222222221110          000         0011123455689999998 99999


Q ss_pred             CCHHHHhcCcccccCCCC
Q 022956          266 PSASELLKDPFFSELNDD  283 (289)
Q Consensus       266 ps~~~il~h~~~~~~~~~  283 (289)
                      ||++++|+||||++....
T Consensus       442 ~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        442 ISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CCHHHHhCCcCcCCCCcc
Confidence            999999999999987654

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=270.70  Aligned_cols=241  Identities=24%  Similarity=0.436  Sum_probs=200.9

Q ss_pred             eeeecccCcceEEEEeec----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           22 SDLLGSGAVKKVYRAFDQ----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .++||+|-||.||.|...    ...--||||.-+..-   ..+..+.|.+|..+++.++||||++++|++.+.   ..||
T Consensus       394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~Wi  467 (974)
T KOG4257|consen  394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMWI  467 (974)
T ss_pred             HHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---ceeE
Confidence            478999999999999743    223448888887643   345588999999999999999999999998554   6999


Q ss_pred             EeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           98 ITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||.++-|.|..+++.+ ..|+...+..+..|++.||.|||+.+  ++||||-..|||+... ..|||+|||+++-....
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhhcccc
Confidence            99999999999999864 57999999999999999999999999  9999999999999988 69999999999876432


Q ss_pred             --cccccCCCCCCCCCCc-ccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 --HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 --~~~~~~~~~~~~~aPE-~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                        .....-.-...||||| +-.+.++.++|||.||+.+||+++ |..||.+-.+.+.+-.+..+...|  .+..+|+.+.
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP--~P~nCPp~LY  622 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP--CPPNCPPALY  622 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC--CCCCCChHHH
Confidence              2233333467999999 455779999999999999999988 999999876666555444444433  4566799999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .|+.+||. ||.+||.+.+|..
T Consensus       623 slmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHH
Confidence            99999999 9999999988765

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=267.50  Aligned_cols=254  Identities=23%  Similarity=0.363  Sum_probs=205.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +.++- +++++||+|-||.|.++.-. .+..||+|+++...   ....+..|.+|+++|.+|+||||+.+++++..+  +
T Consensus       536 PRs~L-~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--e  608 (807)
T KOG1094|consen  536 PRSRL-RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--D  608 (807)
T ss_pred             chhhe-ehhhhhcCcccceeEEEEec-CceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--C
Confidence            44444 57899999999999999653 36899999998654   455678899999999999999999999999766  5


Q ss_pred             eeEEEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .+++++||++.|.|.+++..+.  -+.-.....++.||++|++||.+.+  ++||||.+.|+|++.+ .++|++|||+++
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR  685 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSR  685 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCccccc
Confidence            7999999999999999999873  2344667789999999999999999  9999999999999999 799999999998


Q ss_pred             ccCCcc---ccccCCCCCCCCCCc-ccccCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHH--HhCCCCC---
Q 022956          172 IVGRSH---AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT--MEIPYSECDSVAKIYKK--VTGGVKP---  240 (289)
Q Consensus       172 ~~~~~~---~~~~~~~~~~~~aPE-~~~~~~~~~~Di~slG~il~~l~t--g~~p~~~~~~~~~~~~~--~~~~~~~---  240 (289)
                      ......   .........+|+||| ++-+.++.++|+|++|+++||+++  ...||+...++....+.  .......   
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            664332   122334568999999 677889999999999999999866  78999876555443322  1121111   


Q ss_pred             CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ...+..++.++.+++-.||+ |.++||+++++-.  +|.+
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~--~lq~  803 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL--FLQE  803 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH--HHHH
Confidence            23456678899999999998 9999999999976  5544

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=273.00  Aligned_cols=247  Identities=22%  Similarity=0.396  Sum_probs=205.6

Q ss_pred             ceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      ++.++||+|.||.|+++.++..   -..||||+++.....   .....|.+|+..+.+|+|+|+++++++.++.   .++
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~q---p~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeeccc---hhh
Confidence            4678999999999999988644   255999999877642   2688999999999999999999999999774   588


Q ss_pred             EEeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           97 FITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|+|++++|||.+.+.+  ...+....+..++.||+.|+.||.+++  ++||||-..|+++..- ..|||+|||+.+.++
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp-rtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP-RTVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc-ceeeeecccceeccC
Confidence            99999999999999986  356788899999999999999999999  9999999999999876 699999999999886


Q ss_pred             Cccccc----cCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          175 RSHAAH----SIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       175 ~~~~~~----~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      .....+    ...-...|+|||.+. +.++.++|+|++|++||||+| |+.||.+......+..+ ..+.... .+..++
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i-D~~erLp-RPk~cs  341 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI-DAGERLP-RPKYCS  341 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc-cccccCC-CCCCCh
Confidence            554432    223456899999766 559999999999999999999 89999986655544444 3332222 345579


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +.+.+++..||+ +|.+||++.+|.+.-++
T Consensus       342 edIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            999999999999 99999999999754333

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=267.13  Aligned_cols=242  Identities=23%  Similarity=0.394  Sum_probs=208.0

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ....+||.|-||.||.+.+++-...||||.++..     .-..++|..|+.+++.++|||+|++++++..+  -.+|||+
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYIiT  342 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYIIT  342 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEEEE
Confidence            3568999999999999999999999999999854     33478899999999999999999999999555  5799999


Q ss_pred             ccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      ||+..|+|.+++...  ..++.-.++.++.||.+|+.||..++  ++|+||-..|.|+..+ ..||++|||++++.....
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc-ceEEeeccchhhhhcCCc
Confidence            999999999999863  34666788899999999999999999  9999999999999999 899999999998775332


Q ss_pred             c--cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 A--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      -  ....-....|.|||-+. ..++.++|||+||+++||+.| |..||++ -+..+.+..+..+..+.. +..+++.+..
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~~-PeGCPpkVYe  497 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMDG-PEGCPPKVYE  497 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhccccccC-CCCCCHHHHH
Confidence            1  22233567999999554 569999999999999999999 9999998 456667777777776554 5667999999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhc
Q 022956          254 FIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~  273 (289)
                      |+..||+ .|.+||++.++-+
T Consensus       498 LMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHHH
Confidence            9999999 9999999999854

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=260.54  Aligned_cols=263  Identities=26%  Similarity=0.439  Sum_probs=213.3

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecc-cCC--CHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH-FSE--DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~-~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ..+|| -+...||.|+|+.||+|.+...+..||+|+-.... +.+  .+...+..-+|..+.+.|.||-||++++++.-+
T Consensus       461 Ln~RY-LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  461 LNDRY-LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             hHHHH-HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            45566 57899999999999999999999999999866543 221  233455678899999999999999999988654


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC--CcEEEeccC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLG  168 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~--~~~~l~d~g  168 (289)
                      . ..+|-|.|||+|..|.-++.+++.+++.++..|+.||++||.||....+|++|.||||.|||+-.+.  |.+||+|||
T Consensus       540 t-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  540 T-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             c-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            4 5789999999999999999999999999999999999999999999999999999999999995432  789999999


Q ss_pred             CccccCCcc--------ccccCCCCCCCCCCcccc-c-C---CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--
Q 022956          169 FAAIVGRSH--------AAHSIIGTPEYMAPELYE-E-D---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK--  233 (289)
Q Consensus       169 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~-~-~---~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~--  233 (289)
                      ++.......        .+....||-+|+|||.+. + .   .+.+.||||.|+|+|+++.|+.||+......++.+.  
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            998764321        123356899999999664 2 1   577899999999999999999999864433333321  


Q ss_pred             -HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          234 -VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       234 -~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                       +.............+++++++|+.||+ .-++|.+..++-.||+|-
T Consensus       699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence             111112222355678999999999999 899999999999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=276.98  Aligned_cols=242  Identities=29%  Similarity=0.418  Sum_probs=194.3

Q ss_pred             eeeeecccCcce-EEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEE
Q 022956           21 YSDLLGSGAVKK-VYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        21 ~~~~lg~g~~g~-v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      -.+.+|.|+-|+ ||+|..  .|+.||||.+-.       +......+|++.|+.- +||||++.++.-  .+..+.||.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIa  581 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIA  581 (903)
T ss_pred             cHHHcccCCCCcEEEEEee--CCceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEE
Confidence            357799999885 699976  488999999853       3356778899999888 699999998764  444799999


Q ss_pred             eccccCCcHHHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC----CCCcEEEeccCCc
Q 022956           99 TEVCTSGNLRTYRKKH-R---HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING----NIGQVKIGDLGFA  170 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~-~---~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~----~~~~~~l~d~g~~  170 (289)
                      .|.|.. +|.++++.+ .   .........++.|+++||++||+.+  ++||||||+||||+.    ....++|+|||++
T Consensus       582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccc
Confidence            999977 999999874 1   1122456788999999999999999  999999999999976    2357999999999


Q ss_pred             cccCCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCC
Q 022956          171 AIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       171 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (289)
                      +.......    .....|+-+|+|||.+... .+.++|||||||++|+.++ |..||++  ......+++.++.....+.
T Consensus       659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L~~L~  736 (903)
T KOG1027|consen  659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTLVHLE  736 (903)
T ss_pred             cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccceeeec
Confidence            98865433    3345689999999988765 6678999999999999999 5899974  4445555666655444444


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      .....++.+||.+|++ ||..||++.+||.||||=
T Consensus       737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence            4334489999999999 999999999999999983

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.2e-35  Score=260.60  Aligned_cols=260  Identities=21%  Similarity=0.273  Sum_probs=180.1

Q ss_pred             CcccceeeeecccCcceEEEEeec----------------CCCcEEEEEEeeecccCCCHHH----------HHHHHHHH
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQ----------------EEGIEVAWNQVRLSHFSEDPVL----------VNRLHSEV   69 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~----------------~~~~~~aiK~~~~~~~~~~~~~----------~~~~~~e~   69 (289)
                      +.| ++.++||+|+||+||++.+.                ..+..||||.+.........+.          .+....|+
T Consensus       145 d~F-~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        145 DDF-QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             cCc-eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            344 67899999999999999642                2356799999875432111111          11233466


Q ss_pred             HHHHhCCCCce-----EEeeeeEEeC------CCCeeEEEeccccCCcHHHHHHhc------------------------
Q 022956           70 QLLRTLKNKYI-----IVCYSVWLDD------QHNTLNFITEVCTSGNLRTYRKKH------------------------  114 (289)
Q Consensus        70 ~~l~~l~~~~i-----~~~~~~~~~~------~~~~~~lv~e~~~~~sL~~~~~~~------------------------  114 (289)
                      .++.+++|.++     +.+++++...      .....++|+||+++++|.+++...                        
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777776654     3444444221      124579999999999999988631                        


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccccc--CCCCCCCCCCc
Q 022956          115 RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPE  192 (289)
Q Consensus       115 ~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~--~~~~~~~~aPE  192 (289)
                      ..+++..+..++.|++.+|.|||+.+  ++|+||||+||+++.+ +.++|+|||++...........  ...++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            12356678899999999999999999  9999999999999988 8999999999965533222222  23478999999


Q ss_pred             ccccC-----------------------CCCcchHHHHHHHHHHHHhCCC-CCCCCCcHHHH----------HHHHhCCC
Q 022956          193 LYEED-----------------------YTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKI----------YKKVTGGV  238 (289)
Q Consensus       193 ~~~~~-----------------------~~~~~Di~slG~il~~l~tg~~-p~~~~~~~~~~----------~~~~~~~~  238 (289)
                      .+...                       .....|+||+||++++|+++.. |+.+.......          ........
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            65421                       1124699999999999999875 76542211111          11111111


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CC---CCCCCHHHHhcCccccc
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QP---RARPSASELLKDPFFSE  279 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp---~~Rps~~~il~h~~~~~  279 (289)
                      .........++..++|+.+||. +|   .+|+|++|+|+||||..
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            1122234468899999999996 55   67999999999999964

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-36  Score=262.77  Aligned_cols=257  Identities=22%  Similarity=0.367  Sum_probs=210.2

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      .+.||=|+||.|.++....|...||+|.++..... .......++.|-++|.....+-+|+++..|.+.  +.+|+||||
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySFQDk--dnLYFVMdY  710 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFVMDY  710 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC--CceEEEEec
Confidence            46799999999999999999999999999865432 223345688899999999999999999888444  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-------
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-------  174 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-------  174 (289)
                      ++||.+-.++.+.+-+.+..+..++..+..|+++.|..|  ++||||||+|||||.+ |.+||+|||+++-+-       
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-Cceeeeeccccccceecccccc
Confidence            999999999988888999999999999999999999999  9999999999999999 999999999996530       


Q ss_pred             -Cccc-----------------------------------cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhC
Q 022956          175 -RSHA-----------------------------------AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM  217 (289)
Q Consensus       175 -~~~~-----------------------------------~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg  217 (289)
                       ..+.                                   .....||+.|+|||++. .+++...|.||.|+|||+|+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence             0000                                   01246899999999665 4599999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHH-hCCCCCCCCCCCCChHHHHHHHHHHcCCCCCC---CHHHHhcCcccccCCCCC
Q 022956          218 EIPYSECDSVAKIYKKV-TGGVKPQALNKVKDPEVKAFIEKCIAQPRARP---SASELLKDPFFSELNDDD  284 (289)
Q Consensus       218 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~dp~~Rp---s~~~il~h~~~~~~~~~~  284 (289)
                      +.||............+ .++..........+.+..+||.++..+++.|.   .++||-.||||+.+|+.+
T Consensus       868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence            99997644433322222 22333444556678999999999888777774   567899999999999865

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=243.11  Aligned_cols=257  Identities=26%  Similarity=0.354  Sum_probs=208.8

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ...||.. .+.+|.|.. .|..+.+.-++.+||+|++-....  +....++..+|.+.+..+.|+|++.++.+|.-.+  
T Consensus        15 v~~Ry~n-L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~--n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   15 VPKRYVN-LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ--NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeee-ecccCCCCc-eEEecchhhccCceehhhhcCccc--cCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            4456654 788999999 899999999999999999976632  3444677889999999999999999999885321  


Q ss_pred             --CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 --~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        -..+|+|||++.. +|...+.  -.++.+.+..+++|++.|++|||+.|  ++||||||+||++..+ ..+|++|||+
T Consensus        91 ~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~dfg~  164 (369)
T KOG0665|consen   91 EEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKILDFGL  164 (369)
T ss_pred             HHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeeccchh
Confidence              2357999999977 8988877  33788899999999999999999999  9999999999999999 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcc-cccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPEL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--------  240 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~-~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------  240 (289)
                      +......-.......+.-|.|||+ +.-.+.+..||||+||++.+|++|...|.+.+..++..+.+....-+        
T Consensus       165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            987766645566778889999994 45559999999999999999999999998876666655433332110        


Q ss_pred             -------------------------C------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          241 -------------------------Q------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       241 -------------------------~------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                                               .      .........+++|+.+||. ||++|.|++++|+||+++-|
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence                                     0      0111224568999999998 99999999999999999944

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=7.8e-37  Score=261.25  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=202.9

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC------CceEEeeeeE
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN------KYIIVCYSVW   87 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~   87 (289)
                      ..++| .+....|+|-||+|.+|.+..-|..||||++..     ++...+.=..|+++|++|..      -|++.++..|
T Consensus       430 LD~RY-~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  430 LDSRY-EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hccee-EEEeccccceeeeeeeccccCCCCeeEEEEeec-----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            34454 678899999999999999999999999999985     45556777889999999963      3778888777


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                      ...  +++|+|+|.+.- +|.+.+.+.   -.|....+..++.|+..||..|-..|  ++|.||||+|||++.+.+.+||
T Consensus       504 ~hk--nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  504 KHK--NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             hhc--ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeee
Confidence            443  789999999954 999999874   35888999999999999999999999  9999999999999998889999


Q ss_pred             eccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--HHhCCCCCC
Q 022956          165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQ  241 (289)
Q Consensus       165 ~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~--~~~~~~~~~  241 (289)
                      ||||.|.+.+....+ ++..+.-|.|||+.-| .|+.+.|+||.||+|||+.||+..|++..+...+.-  .+.+..+..
T Consensus       579 CDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  579 CDFGSASFASENEIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             ccCcccccccccccc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            999999988765433 3334557899996554 599999999999999999999999998655544321  111111100


Q ss_pred             C---------------------------------C----C------------CC------CChHHHHHHHHHHc-CCCCC
Q 022956          242 A---------------------------------L----N------------KV------KDPEVKAFIEKCIA-QPRAR  265 (289)
Q Consensus       242 ~---------------------------------~----~------------~~------~~~~~~~li~~~l~-dp~~R  265 (289)
                      .                                 +    +            ..      .-..+++|+.+||. ||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            0                                 0    0            00      01367899999999 99999


Q ss_pred             CCHHHHhcCccccc
Q 022956          266 PSASELLKDPFFSE  279 (289)
Q Consensus       266 ps~~~il~h~~~~~  279 (289)
                      .+..|+|+||||..
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999974

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=241.52  Aligned_cols=140  Identities=27%  Similarity=0.415  Sum_probs=117.8

Q ss_pred             CceeeC-CC-CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-----C---
Q 022956            8 PFVEVD-PS-GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-----N---   77 (289)
Q Consensus         8 ~~~~~~-~~-~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~---   77 (289)
                      |..+.+ .. +|| -+.+|||+|-|+|||++.|..+...||+|+++-     .+...+....|+++|++++     |   
T Consensus        68 pV~IGD~F~~gRY-~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~  141 (590)
T KOG1290|consen   68 PVRIGDVFNGGRY-HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGK  141 (590)
T ss_pred             eeeccccccCceE-EEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence            444444 33 666 689999999999999999999999999999984     3555677888999999984     2   


Q ss_pred             CceEEeeeeEEe--CCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCc
Q 022956           78 KYIIVCYSVWLD--DQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSN  152 (289)
Q Consensus        78 ~~i~~~~~~~~~--~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~n  152 (289)
                      .+||++++.|..  ..+.++|+|+|++ |.+|..++..+  +.++...+.+|++|++.||.|||.. |  ++|.||||+|
T Consensus       142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPEN  218 (590)
T KOG1290|consen  142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPEN  218 (590)
T ss_pred             ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcce
Confidence            368999998864  3457899999999 55999998764  5699999999999999999999987 7  9999999999


Q ss_pred             eEEe
Q 022956          153 IFIN  156 (289)
Q Consensus       153 ili~  156 (289)
                      ||+.
T Consensus       219 vLl~  222 (590)
T KOG1290|consen  219 VLLC  222 (590)
T ss_pred             eeee
Confidence            9983

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=263.09  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=206.3

Q ss_pred             ceeeeecccCcceEEEEeec----C---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCC
Q 022956           20 RYSDLLGSGAVKKVYRAFDQ----E---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~----~---~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   91 (289)
                      .+.+.||+|.||.|+++..+    .   ....||||..+....   ....+.+..|+++++.+ .|+|++.+++.+..  
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~---~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--  373 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS---SSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--  373 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccC---cHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence            45679999999999999633    1   146799999987653   35678899999999999 59999999998855  


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI  155 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~----------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili  155 (289)
                      +..+++|+||+..|+|.+++...+                .++...+..++.||+.|++||++..  .+||||-..||++
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLI  451 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEe
Confidence            468999999999999999998755                4889999999999999999999999  9999999999999


Q ss_pred             eCCCCcEEEeccCCccccCCcccc--ccCC--CCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 022956          156 NGNIGQVKIGDLGFAAIVGRSHAA--HSII--GTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAK  229 (289)
Q Consensus       156 ~~~~~~~~l~d~g~~~~~~~~~~~--~~~~--~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~  229 (289)
                      ..+ ..+|++|||+++........  ....  -...|||||.+.. .++.++||||+|+++||++| |..||++......
T Consensus       452 ~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  452 TKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             cCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            999 79999999999864332211  1111  3557999997665 49999999999999999999 9999998664555


Q ss_pred             HHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          230 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ..+.+..+..... +..+++++.+++..||+ +|++||++.++..  +|..
T Consensus       531 l~~~l~~G~r~~~-P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~  578 (609)
T KOG0200|consen  531 LLEFLKEGNRMEQ-PEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK  578 (609)
T ss_pred             HHHHHhcCCCCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence            5667777766554 44559999999999998 9999999999988  6554

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=221.71  Aligned_cols=213  Identities=27%  Similarity=0.424  Sum_probs=180.7

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEEEec
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      .+-||.|++|.|-+.++..+|...|+|.++.+-   +...++++..|+.+..+. ..|.+|.+++.++.+  ..+++.||
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIcME  125 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWICME  125 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEeHH
Confidence            466999999999999999999999999998664   345577788888887555 679999999988776  46999999


Q ss_pred             cccCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          101 VCTSGNLRTYR----KKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       101 ~~~~~sL~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      .+.. ||..+-    .++..+++.-+-+++..++.||.|||++ .  ++|||+||+|||++.+ |+||+||||.+..+.+
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYD-GQVKICDFGISGYLVD  201 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccC-CcEEEcccccceeehh
Confidence            9976 886664    4578899999999999999999999987 6  9999999999999999 9999999999987766


Q ss_pred             ccccccCCCCCCCCCCccccc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          176 SHAAHSIIGTPEYMAPELYEE-----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      .-......|-..|+|||+...     .|+.++||||||++++||.+++.||..+...-+...++...++|...
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence            655555678889999997653     48889999999999999999999999987777777777766655443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=243.90  Aligned_cols=258  Identities=27%  Similarity=0.455  Sum_probs=193.3

Q ss_pred             CCCCceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH--hCCCCceEE
Q 022956            5 DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR--TLKNKYIIV   82 (289)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~   82 (289)
                      +|-|+..+....|-.++.+.||+|.||.||+|.+.  |+.||||++....    |   +...+|.++.+  .|+|+||+.
T Consensus       199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd----E---~SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD----E---RSWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             CCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc----h---hhhhhHHHHHHHHHhccchhhh
Confidence            34455556666666688899999999999999886  9999999997542    2   33344555554  459999999


Q ss_pred             eeeeEEeCCC--CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCceE
Q 022956           83 CYSVWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------EPCIIHRDLNCSNIF  154 (289)
Q Consensus        83 ~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~------~~~~~h~dl~~~nil  154 (289)
                      +++.-..+.+  ..+++|++|.+.|||.|++.. ..++.+..++++..+++||+|||..      .|.++|||||..|||
T Consensus       270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL  348 (513)
T KOG2052|consen  270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL  348 (513)
T ss_pred             hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence            8876544332  378999999999999999998 6699999999999999999999953      446999999999999


Q ss_pred             EeCCCCcEEEeccCCccccCCcc-----ccccCCCCCCCCCCcccccCCC-------CcchHHHHHHHHHHHHh----C-
Q 022956          155 INGNIGQVKIGDLGFAAIVGRSH-----AAHSIIGTPEYMAPELYEEDYT-------EMVDIYSFGLCLLEMVT----M-  217 (289)
Q Consensus       155 i~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-------~~~Di~slG~il~~l~t----g-  217 (289)
                      +..+ +...|+|+|+|.......     .....+||.+|||||+++...+       ..+||||||.++||++.    | 
T Consensus       349 VKkn-~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg  427 (513)
T KOG2052|consen  349 VKKN-GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG  427 (513)
T ss_pred             EccC-CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence            9999 999999999997765432     2456789999999998875422       26999999999999865    2 


Q ss_pred             -----CCCCCCC----CcHHHHHHH-HhCCCCCCCCCCC-CCh---HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          218 -----EIPYSEC----DSVAKIYKK-VTGGVKPQALNKV-KDP---EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       218 -----~~p~~~~----~~~~~~~~~-~~~~~~~~~~~~~-~~~---~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                           +.||.+.    .+.+++... +.+...|...... ..+   .+..+++.||. +|..|.++-.|-+
T Consensus       428 i~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  428 IVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             EehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                 3677532    223333322 2223333322222 233   45677889998 9999999876655

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.4e-33  Score=273.75  Aligned_cols=238  Identities=21%  Similarity=0.331  Sum_probs=179.1

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ..+.||+|+||.||+|.++.+|..||+|.+.....        ...+|++.+++++||||+++++++...  ...++|||
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~E  763 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIHE  763 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEEe
Confidence            35689999999999999999999999999864321        112357889999999999999998554  56899999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---cCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH---THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      |+++++|.+++..   +++..+..++.|++.|++|||   +.+  ++|+|+||+||+++.+ +..++. ++.+.....  
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEECCC-CceEEE-ecccccccc--
Confidence            9999999999964   889999999999999999999   556  9999999999999987 666665 554433211  


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHhCCC------CCCCCCC-
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD----SVAKIYKKVTGGV------KPQALNK-  245 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~------~~~~~~~-  245 (289)
                       .....+++.|+|||...+. ++.++||||||+++|||+||+.||....    .............      .+..... 
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence             1123567899999977654 8999999999999999999999985321    1111111111100      0100000 


Q ss_pred             ----CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          246 ----VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       246 ----~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                          ....++.+++.+||+ ||++||+++|+++  .++++
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~~  951 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLK--TLESA  951 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH--HHHHh
Confidence                112256788999998 9999999999998  45554

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-34  Score=253.93  Aligned_cols=242  Identities=26%  Similarity=0.426  Sum_probs=200.2

Q ss_pred             eeeeecccCcceEEEEeecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      -.++||+|+||+||++.+...|+    +||+|++....   ......++.+|+-.+.+|+|||+++++++...+   .+.
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~q  773 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQ  773 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHH
Confidence            36889999999999999876654    57778776543   344467888999999999999999999998654   489


Q ss_pred             EEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           97 FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ||++|+++|+|.++++.+ ..+.....+.|..||++||.|||.++  ++||||-..|||+..- +.+|++|||+++....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhccCc
Confidence            999999999999999864 57899999999999999999999999  9999999999999877 6999999999998765


Q ss_pred             ccccccC---CCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          176 SHAAHSI---IGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       176 ~~~~~~~---~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      .......   .-.+.|+|-|... +.++.++||||+|+++||++| |..|+.+. +.+++-..+..+.+ -.-+...+-.
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi-~~~eI~dlle~geR-LsqPpiCtiD  928 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI-PAEEIPDLLEKGER-LSQPPICTID  928 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC-CHHHhhHHHhcccc-CCCCCCccHH
Confidence            4443332   2356888888555 559999999999999999999 99999874 44455555555544 3335556889


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          251 VKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +..++.+||- |++.||+++++..
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            9999999997 9999999998865

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=236.20  Aligned_cols=241  Identities=24%  Similarity=0.363  Sum_probs=183.4

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH--hCCCCceEEeeeeEEeCC--CCee
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR--TLKNKYIIVCYSVWLDDQ--HNTL   95 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~--~~~~   95 (289)
                      ++.+.||+|+||.||+|+..  ++.||||++..       ...+.+.+|-.+.+  .|+|+||+++++.-....  ...+
T Consensus       213 ~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhHHHhhcCccceeehhhcc--CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            56789999999999999765  79999999973       33556666665554  558999999987643211  2368


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCC-------CCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE-------PCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~-------~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      ++|++|.+.|||.+++..+- +++....+++..++.||+|||+.-       ++|+|||||..|||+..| ++..|+|||
T Consensus       284 wLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFG  361 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFG  361 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccc
Confidence            99999999999999999754 899999999999999999999743       369999999999999999 899999999


Q ss_pred             CccccCCcc---ccccCCCCCCCCCCcccccCC--C-----CcchHHHHHHHHHHHHhCCC------------CCC----
Q 022956          169 FAAIVGRSH---AAHSIIGTPEYMAPELYEEDY--T-----EMVDIYSFGLCLLEMVTMEI------------PYS----  222 (289)
Q Consensus       169 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~--~-----~~~Di~slG~il~~l~tg~~------------p~~----  222 (289)
                      +|..+....   ......||.+|||||.+.+..  .     .+.||||+|.++|||++...            ||.    
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            998775332   234478999999999988752  2     25899999999999998532            221    


Q ss_pred             CCCcHHHHHHHHhCC-CCCCC---C-CCCCChHHHHHHHHHHc-CCCCCCCHHHH
Q 022956          223 ECDSVAKIYKKVTGG-VKPQA---L-NKVKDPEVKAFIEKCIA-QPRARPSASEL  271 (289)
Q Consensus       223 ~~~~~~~~~~~~~~~-~~~~~---~-~~~~~~~~~~li~~~l~-dp~~Rps~~~i  271 (289)
                      .....++++..+.+. .+|..   + .......+++.++.||. |++.|.|+.=+
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            122334444443332 22221   1 22234568999999998 99999998533

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=6.1e-34  Score=238.28  Aligned_cols=254  Identities=23%  Similarity=0.390  Sum_probs=201.1

Q ss_pred             CcccceeeeecccCcceEEEEeecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   91 (289)
                      ..+++...+||+|.|++||++.+..   .+..||+|.+.....      ..++.+|+++|..+. +.||+++.+.+... 
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~------p~ri~~El~~L~~~gG~~ni~~~~~~~rnn-  107 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS------PSRILNELEMLYRLGGSDNIIKLNGCFRNN-  107 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC------chHHHHHHHHHHHhccchhhhcchhhhccC-
Confidence            3455789999999999999999887   788999999987654      467889999999994 78999999888444 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       +.+.+|+||++...-.++...   ++..++.+.++.++.||.++|.+|  ++|+|+||+|++++...+.-.|+|||++.
T Consensus       108 -d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  108 -DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             -CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence             679999999999888888776   778999999999999999999999  99999999999999998999999999997


Q ss_pred             ccCC--------c-------c------------------------------ccccCCCCCCCCCCccccc--CCCCcchH
Q 022956          172 IVGR--------S-------H------------------------------AAHSIIGTPEYMAPELYEE--DYTEMVDI  204 (289)
Q Consensus       172 ~~~~--------~-------~------------------------------~~~~~~~~~~~~aPE~~~~--~~~~~~Di  204 (289)
                      ....        .       .                              ...+..||++|.|||++.+  ..+++.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            2100        0       0                              0012468999999997653  38889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCcHHH-HH--------------------------------------------HHHhCCC-
Q 022956          205 YSFGLCLLEMVTMEIPYSECDSVAK-IY--------------------------------------------KKVTGGV-  238 (289)
Q Consensus       205 ~slG~il~~l~tg~~p~~~~~~~~~-~~--------------------------------------------~~~~~~~-  238 (289)
                      ||-|+|+..++++..||-...+... ..                                            ..+.... 
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            9999999999999999953111100 00                                            0000000 


Q ss_pred             ---CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          239 ---KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       239 ---~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                         ......+..+..+.+|+.+||. ||.+|+|+++.|+||||...+.
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence               0112233345688999999999 9999999999999999997643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.3e-31  Score=215.49  Aligned_cols=209  Identities=38%  Similarity=0.675  Sum_probs=183.0

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccC
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTS  104 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  104 (289)
                      ||+|.+|.||++.+..+|+.+++|++.......   ..+.+.+|++.++.+.|++++++++.+...  ...++++|++.|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence            689999999999998889999999998654321   357789999999999999999999988554  678999999998


Q ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC-CCCcEEEeccCCccccCCcc-cccc
Q 022956          105 GNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING-NIGQVKIGDLGFAAIVGRSH-AAHS  181 (289)
Q Consensus       105 ~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~-~~~~~~l~d~g~~~~~~~~~-~~~~  181 (289)
                      ++|.+++... ..++...+..++.+++.++.+||+.|  ++|+||+|.||+++. + +.++|+|||.+....... ....
T Consensus        76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhc
Confidence            9999999875 57899999999999999999999999  999999999999998 6 799999999998765443 2233


Q ss_pred             CCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          182 IIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       182 ~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                      ..+...|++||....  .++.++|+|+||++++++                                  ..+.+++..|+
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l  198 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKML  198 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHh
Confidence            457789999997765  578899999999999999                                  78899999999


Q ss_pred             c-CCCCCCCHHHHhcCc
Q 022956          260 A-QPRARPSASELLKDP  275 (289)
Q Consensus       260 ~-dp~~Rps~~~il~h~  275 (289)
                      . +|++||+++++++|+
T Consensus       199 ~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         199 QKDPEKRPSAKEILEHL  215 (215)
T ss_pred             hCCcccCcCHHHHhhCC
Confidence            8 999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=226.84  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=198.1

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC---CeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH---NTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~lv~   99 (289)
                      +-||-|+||.||.+.+..+|+.+|+|++.....  +-...+++.+|+++|...+|.|++..++......-   ..+|.++
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq--~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ--NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHH--HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            559999999999999999999999999975432  45557889999999999999999988776532211   1257788


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      |.+.. .|...+..-..++.+.+.-+++||+.||.|||+.+  +.|+||||.|.+++.| -.+||||||+++........
T Consensus       137 ELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  137 ELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhhhh
Confidence            88866 88888888888999999999999999999999999  9999999999999999 79999999999877543322


Q ss_pred             --ccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-----------------------
Q 022956          180 --HSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK-----------------------  232 (289)
Q Consensus       180 --~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~-----------------------  232 (289)
                        ....-|.-|.|||++-+.  |+.+.||||.|||+.|++..+..|....+..++.-                       
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence              222456789999987654  99999999999999999999888875444433221                       


Q ss_pred             HHhCCCCCCCCCC--------CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          233 KVTGGVKPQALNK--------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       233 ~~~~~~~~~~~~~--------~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+.+...+...+.        ....+...++..++. ||++|.+.++.+.|+++.+..
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            1111111111111        112355677888888 999999999999999988764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=248.96  Aligned_cols=259  Identities=27%  Similarity=0.505  Sum_probs=223.3

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .-++-+.|+ +...+|+|.||.||+++++.+++..|+|+++....    +....+.+|+-+++..+||||+..++.|...
T Consensus        10 rrnP~ddye-llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   10 RRNPQDDYE-LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             hcCCccchh-heeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHhhhhhh
Confidence            337888885 78999999999999999999999999999997643    3366778899999999999999999999665


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ..++++||||.|++|.+.-.--+++++.++..+.+..+.++.|||+.|  -+|||||-.||++++. |.+|++|||.+
T Consensus        85 --dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~-gDvklaDfgvs  159 (829)
T KOG0576|consen   85 --DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDE-GDVKLADFGVS  159 (829)
T ss_pred             --cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeeccc-CceeecccCch
Confidence              469999999999999998777788999999999999999999999999  8999999999999999 99999999999


Q ss_pred             cccCC-ccccccCCCCCCCCCCccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          171 AIVGR-SHAAHSIIGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       171 ~~~~~-~~~~~~~~~~~~~~aPE~~----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      ..+.. -.+..+..|++.|+|||.-    .+.|+...|+|++|++..++-.-+.|-....+.....-.-.+++.+....+
T Consensus       160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD  239 (829)
T KOG0576|consen  160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD  239 (829)
T ss_pred             hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC
Confidence            77653 3345677899999999942    355999999999999999998888887777777766666666665554433


Q ss_pred             --CCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          246 --VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       246 --~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                        .-++.+..|++.+|. +|++||+++.+|.|||...
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence              347789999999997 9999999999999999865

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2e-30  Score=211.38  Aligned_cols=212  Identities=33%  Similarity=0.520  Sum_probs=180.7

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|++|+||++.+..+++.+++|.+......   ...+.+.+|++.++.++|+|++++++.+...  ...++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~   76 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVM   76 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEE
Confidence            5688999999999999999988999999999865432   2467889999999999999999999887544  5789999


Q ss_pred             ccccCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956          100 EVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~-l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      |++++++|.+++..... +++..+..++.+++.++.+||+.+  ++|+|++|.||+++.+ +.++|+|||.+....... 
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCccc
Confidence            99999999999987666 899999999999999999999999  9999999999999998 899999999998775543 


Q ss_pred             -ccccCCCCCCCCCCccc-cc-CCCCcchHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhCCCC
Q 022956          178 -AAHSIIGTPEYMAPELY-EE-DYTEMVDIYSFGLCLLEMVTMEIPYSE-CDSVAKIYKKVTGGVK  239 (289)
Q Consensus       178 -~~~~~~~~~~~~aPE~~-~~-~~~~~~Di~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~  239 (289)
                       ......++..|++||.. .. .++.++|+|+||+++++|++|+.||.. ..+.....+.+..+.+
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP  219 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence             33445677889999976 33 377799999999999999999999977 4555566666666543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=235.08  Aligned_cols=197  Identities=28%  Similarity=0.390  Sum_probs=167.6

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHH----HHHHHHHHHHHHHhCC---CCceEEeeeeEEeCCCC
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV----LVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~   93 (289)
                      ..+.||+|+||.|++|.++++...|++|.+...+.-.+.=    ..-.+--|+++|.+|+   |+||++++++|.  +++
T Consensus       565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE--ddd  642 (772)
T KOG1152|consen  565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE--DDD  642 (772)
T ss_pred             eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee--cCC
Confidence            4688999999999999999999999999998644311100    0112455899999997   999999999984  447


Q ss_pred             eeEEEecccc-CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCT-SGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~-~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ++|++||-.. |..|+++++-.+.+++.++..|++|++.|+++||+.|  ++|||||-+||+++.+ |.+||+|||.+..
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsaa~  719 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSAAY  719 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccchhh
Confidence            8999999854 4589999999999999999999999999999999999  9999999999999999 9999999999875


Q ss_pred             cCCccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCC
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSE  223 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~  223 (289)
                      .... .+....||..|.|||.+.|.  ....-|||+||+++|.++....||-+
T Consensus       720 ~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            5443 56677899999999999876  56678999999999999998888753

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=211.45  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=192.5

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEE
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWL   88 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   88 (289)
                      -.++..+.| .+.+.||+|.||.+-++.|..++..+++|.+...     ...++.|.+|.-.--.| .|.||+..+++.+
T Consensus        18 ~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF   91 (378)
T KOG1345|consen   18 KKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAF   91 (378)
T ss_pred             cccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence            345667777 5789999999999999999999999999999854     33467888888776666 4789998888766


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE-eCCCCcEEEecc
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDL  167 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili-~~~~~~~~l~d~  167 (289)
                      ... +++++++||++-|+|..-+...+ +.+.....++.|+++|+.|||+++  ++|||||.+|||+ +++.-+||||||
T Consensus        92 qt~-d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   92 QTS-DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             hcC-ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeec
Confidence            654 58899999999999998887644 889999999999999999999999  9999999999998 566679999999


Q ss_pred             CCccccCCccccccCCCCCCCCCCcccc---c-C--CCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhCCC
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPELYE---E-D--YTEMVDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGV  238 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~~~---~-~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~  238 (289)
                      |.....+..-..  .--...|.+||...   . .  ..+.+|+|.||+++|.++||..||......   -..+..-.+..
T Consensus       168 G~t~k~g~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  168 GLTRKVGTTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK  245 (378)
T ss_pred             ccccccCceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence            998765433221  11245788898432   2 2  678899999999999999999999742211   11122222221


Q ss_pred             C--CCCCCCCCChHHHHHHHHHHc-CCCCC---CCHHHHhcCccccc
Q 022956          239 K--PQALNKVKDPEVKAFIEKCIA-QPRAR---PSASELLKDPFFSE  279 (289)
Q Consensus       239 ~--~~~~~~~~~~~~~~li~~~l~-dp~~R---ps~~~il~h~~~~~  279 (289)
                      .  .+......++.+..+.++-|. ++++|   -++.......|...
T Consensus       246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            1  112223346777777888887 88888   34444444455443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3e-30  Score=214.42  Aligned_cols=245  Identities=27%  Similarity=0.358  Sum_probs=194.5

Q ss_pred             ceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ++...+-+|.||.||.|.+.+.     .+.+-+|.++...   ++-....+.+|.-.+..+.|||++++.++..++. .+
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-~~  362 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-AT  362 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-Cc
Confidence            4556688999999999976544     2446677776432   4555677899999999999999999999887654 56


Q ss_pred             eEEEeccccCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           95 LNFITEVCTSGNLRTYRKKH--------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      .+.++.+..-++|..++...        +.++..+...++.|++.|+.|||++|  ++|.||-..|.++|+. -++||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~-LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ-LQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh-eeEEecc
Confidence            67788998889999999731        34667788899999999999999999  9999999999999999 7999999


Q ss_pred             cCCccccC--Cccccc-cCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCC
Q 022956          167 LGFAAIVG--RSHAAH-SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ  241 (289)
Q Consensus       167 ~g~~~~~~--~~~~~~-~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  241 (289)
                      =.+++..-  +..-.. .--....||+||.+... ++.++|+||||+++|||+| |+.|+...++.+..- -+..+.+. 
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-ylkdGyRl-  517 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-YLKDGYRL-  517 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-HHhcccee-
Confidence            98886542  222111 22246799999976654 9999999999999999999 999999877665544 34444332 


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..+-.+|+++..++..||+ +|++||+++|+..
T Consensus       518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            2345579999999999999 9999999999876

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=6e-29  Score=195.70  Aligned_cols=160  Identities=25%  Similarity=0.360  Sum_probs=126.3

Q ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCC
Q 022956          105 GNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII  183 (289)
Q Consensus       105 ~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~  183 (289)
                      |+|.+++.. +.++++.++..++.|++.||.|||+.+        ||+||+++.+ +.+++  ||.+.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeecccc----CC
Confidence            589999986 456999999999999999999999887        9999999988 88998  99987664432    25


Q ss_pred             CCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC-----CCCCCCh--HHHHHH
Q 022956          184 GTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-----LNKVKDP--EVKAFI  255 (289)
Q Consensus       184 ~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~--~~~~li  255 (289)
                      +++.|+|||.+.+. +++++|||||||++|+|++|..||............+........     .....+.  .+.+++
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            78999999977654 899999999999999999999999765443333333332222111     1111222  699999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCccccc
Q 022956          256 EKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ..||+ ||++||++.+++.|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            99998 9999999999999999764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3e-29  Score=239.54  Aligned_cols=181  Identities=19%  Similarity=0.230  Sum_probs=132.7

Q ss_pred             CeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-------------
Q 022956           93 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-------------  158 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-------------  158 (289)
                      ..+++++|++.+ +|.+++.. ...+++.++..++.||+.||.|||++|  ++|+||||+|||++..             
T Consensus        53 ~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~  129 (793)
T PLN00181         53 DSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSD  129 (793)
T ss_pred             chhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCc
Confidence            457788998844 99999975 456999999999999999999999999  9999999999999643             


Q ss_pred             -----CCcEEEeccCCccccCCcc-----------------ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHH
Q 022956          159 -----IGQVKIGDLGFAAIVGRSH-----------------AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMV  215 (289)
Q Consensus       159 -----~~~~~l~d~g~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~  215 (289)
                           .+.+|++|||++.......                 ......+++.|+|||.+.+ .++.++|||||||++|||+
T Consensus       130 ~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl  209 (793)
T PLN00181        130 SGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELF  209 (793)
T ss_pred             ccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHh
Confidence                 1456666666664321100                 0011346888999997654 4899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          216 TMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       216 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +|..|+....   .....+.....+... ....+...+++..||+ ||.+||++.++++||||.+.
T Consensus       210 ~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        210 CPVSSREEKS---RTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hCCCchhhHH---HHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            9888765321   111112111111111 1124566788999998 99999999999999999864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.9e-27  Score=191.71  Aligned_cols=200  Identities=19%  Similarity=0.268  Sum_probs=167.7

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQH   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~   92 (289)
                      ..+--|+++++||+|+||.++.+++.-++++||||.......      ...+..|....+.|.+ ++|+..+.+  .+++
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~------APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG   96 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE------APQLRDEYRTYKLLGGTEGIPQVYYF--GQEG   96 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCC------cchHHHHHHHHHHHcCCCCCCceeee--cccc
Confidence            344445899999999999999999999999999999875432      4567778888888864 888877743  4666


Q ss_pred             CeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe----CCCCcEEEecc
Q 022956           93 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN----GNIGQVKIGDL  167 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~----~~~~~~~l~d~  167 (289)
                      .+-.+|+|++ |.||+|+++- ++.++...+..++.|++.-++++|++.  ++.|||||+|+||.    .+-+.+.++||
T Consensus        97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence            7788899999 6699999984 678999999999999999999999999  99999999999993    23357999999


Q ss_pred             CCccccCCcc--------ccccCCCCCCCCCCcc-cccCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 022956          168 GFAAIVGRSH--------AAHSIIGTPEYMAPEL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSEC  224 (289)
Q Consensus       168 g~~~~~~~~~--------~~~~~~~~~~~~aPE~-~~~~~~~~~Di~slG~il~~l~tg~~p~~~~  224 (289)
                      |+|+.+-++.        ...+..||.+||+--. +.++.+.+.|+-|||.++++.+.|.+||.+.
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            9998875432        2345678999998774 4556999999999999999999999999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-27  Score=185.40  Aligned_cols=243  Identities=19%  Similarity=0.279  Sum_probs=183.8

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQH   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~   92 (289)
                      ..++| ++.++||+|+||.+|.+....+|+.||||+......      ...+.-|.++.+.|++ ..|+.+..+.  .+.
T Consensus        13 v~gky-~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~   83 (341)
T KOG1163|consen   13 VGGKY-KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYG--TEK   83 (341)
T ss_pred             eccce-EEEEeecCCchhheeeeeeccCCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhc--ccc
Confidence            45666 899999999999999999999999999999875432      3456668888888876 5666655443  344


Q ss_pred             CeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCC
Q 022956           93 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGF  169 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~  169 (289)
                      .+-.+|||.+ |.||++++.- ++.++...++.++-|++.-++|+|.++  ++|+||||+|+++.-+  .+.+.|+|||+
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence            6778899999 6699999874 577999999999999999999999999  9999999999999543  25899999999


Q ss_pred             ccccCCc--------cccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHhC--
Q 022956          170 AAIVGRS--------HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI--YKKVTG--  236 (289)
Q Consensus       170 ~~~~~~~--------~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~~--  236 (289)
                      +..+-+.        .......||.+|.+--..-+ ..+.+.|+-|+|.++.++-.|.+||.+.....+.  ++.+..  
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK  240 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK  240 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence            9876432        22344578889987664443 4788999999999999999999999875433222  222221  


Q ss_pred             -CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCH
Q 022956          237 -GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSA  268 (289)
Q Consensus       237 -~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~  268 (289)
                       ..+........|.++.-.+..|=. --++-|+.
T Consensus       241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence             223334444556777777777755 55555554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.7e-28  Score=224.07  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=203.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeec--ccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS--HFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ..+|.+-.+.+|.|++|.|+.+......+.++.|.+...  ...........+..|+-+-.+++|++++..+..+.+.. 
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-  394 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-  394 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-
Confidence            466777789999999998888887777777777766532  22223333444778888889999999988776664432 


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                       ...-.||||++ .|+.++.....++..++-.++.|++.|+.|+|+.|  +.|+|+|++|++++.+ |.+|++|||.+..
T Consensus       395 -~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  395 -GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASV  469 (601)
T ss_pred             -cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCccee
Confidence             22234999999 99999998778999999999999999999999999  9999999999999999 9999999999976


Q ss_pred             cCCcc-----ccccCCCCCCCCCCcccccC-CCCc-chHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC-C-----CC
Q 022956          173 VGRSH-----AAHSIIGTPEYMAPELYEED-YTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG-G-----VK  239 (289)
Q Consensus       173 ~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~-~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~-----~~  239 (289)
                      ...+.     .....+|+..|+|||.+.+. +.++ .||||.|+++..|.+|+.||......+..+..... .     ..
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~  549 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG  549 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence            64332     23456789999999977755 7775 89999999999999999999865444332111111 1     11


Q ss_pred             CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          240 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       240 ~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +..+....+...+.+|..||+ ||.+|.++++|++.+||+.+.
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            122333457788999999999 999999999999999999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=6.6e-26  Score=194.97  Aligned_cols=247  Identities=20%  Similarity=0.225  Sum_probs=187.1

Q ss_pred             cccceeeeecccCcceEEEEeecCCC-cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC----CceEEeeeeEEeCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEG-IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQ   91 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~----~~i~~~~~~~~~~~   91 (289)
                      +| ++.++||+|+||.||.|.+..++ ..+|+|..........    ..+..|..++..+..    ++++.++.... ..
T Consensus        19 ~~-~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~   92 (322)
T KOG1164|consen   19 RY-KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-ST   92 (322)
T ss_pred             ce-EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CC
Confidence            44 78999999999999999988775 6789998876532211    156668888888863    67888887764 33


Q ss_pred             CCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC----CcEEEe
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI----GQVKIG  165 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~----~~~~l~  165 (289)
                      ..+-++||+.+ |.+|.++....  +.++...++.++.|++.+|++||+.|  ++||||||+|+.+....    ..+++.
T Consensus        93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence            46789999999 66999998653  57999999999999999999999999  99999999999997652    469999


Q ss_pred             ccCCccccC--Ccc--------c-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---H
Q 022956          166 DLGFAAIVG--RSH--------A-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK---I  230 (289)
Q Consensus       166 d~g~~~~~~--~~~--------~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~---~  230 (289)
                      |||++....  ...        . .....||.+|+++....+. .+++.|+||++.++.++..|.+||........   .
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999998321  111        1 1234589999999976654 99999999999999999999999976543222   2


Q ss_pred             HHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          231 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+......... .....+..+.++...+-. +...+|....+..
T Consensus       250 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  250 EKDPRKLLTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             HHHhhhhcccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            22111111111 234456778887777777 9999999988765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=219.44  Aligned_cols=243  Identities=21%  Similarity=0.246  Sum_probs=181.7

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +-+++.||.+.|=+|.++++. .|. |+||++-...-.-.-....+..++++ ...+++||.+++..+-...  +..|+|
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~--kAAylv   99 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD--KAAYLV   99 (1431)
T ss_pred             eeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh--HHHHHH
Confidence            357899999999999999875 344 89999876542112222333334455 6777999999988765333  567889


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC--c
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR--S  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~--~  176 (289)
                      -+|+.. +|.|.+..++.+..-+..+++.|++.||.-+|..|  ++|||||.+|||++.- +++.|+||...+...-  .
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSW-NWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeee-chhhhhcccccCCccCCCC
Confidence            999977 99999999999999999999999999999999999  9999999999999999 8999999987754321  1


Q ss_pred             cc------cccCCCCCCCCCCccccc-----------C-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCC
Q 022956          177 HA------AHSIIGTPEYMAPELYEE-----------D-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       177 ~~------~~~~~~~~~~~aPE~~~~-----------~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  237 (289)
                      +.      +.+.....+|.|||.+..           . .+++.||||+||+++|+++ |..||.- .+...+.   ..+
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-SQL~aYr---~~~  251 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-SQLLAYR---SGN  251 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-HHHHhHh---ccC
Confidence            11      123345679999997642           1 5789999999999999988 6777741 1111111   111


Q ss_pred             C--CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          238 V--KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       238 ~--~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .  +...+....+..++.|+..|++ ||++|.++++.|+.
T Consensus       252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0  0111222345689999999999 99999999999984

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=7.3e-24  Score=181.63  Aligned_cols=256  Identities=29%  Similarity=0.403  Sum_probs=205.3

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCC-ceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK-YIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~~l   97 (289)
                      +++.+.||.|+|+.||++.+.   ..+++|.+....... ......+.+|+..+..+.|+ +++.+...+...  ...++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence            367899999999999999876   889999998765422 23567889999999999988 799999888333  45799


Q ss_pred             EeccccCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC-cEEEeccCCcccc
Q 022956           98 ITEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIV  173 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~-~~~l~d~g~~~~~  173 (289)
                      +++++.++++.+++....   .++......++.|++.++.++|+.+  ++|+|++|+||+++.. + .++++|||.+...
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~-~~~~~l~dfg~~~~~  152 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRD-GRVVKLIDFGLAKLL  152 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCC-CCeEEEeccCcceec
Confidence            999999999998777664   7999999999999999999999999  9999999999999988 5 7999999999755


Q ss_pred             CCcc-------ccccCCCCCCCCCCccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhCCCC
Q 022956          174 GRSH-------AAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVK  239 (289)
Q Consensus       174 ~~~~-------~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~  239 (289)
                      ....       ......++..|++||...+    ......|+|++|++++++++|..||.....   .......+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence            4332       2355678999999997664    588899999999999999999999876553   4455555444443


Q ss_pred             C-CCCCCCC------ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          240 P-QALNKVK------DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       240 ~-~~~~~~~------~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      + .......      ...+.+++..++. +|..|.+..+...+++.......
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence            3 1111111      2578999999998 99999999999988666655433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=4e-25  Score=190.33  Aligned_cols=172  Identities=15%  Similarity=0.144  Sum_probs=128.6

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEEeecC-CCcEEEEEEeeeccc-CCCHHHHHHHHHHHHHHHhCCCCceEEeeee
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV   86 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   86 (289)
                      ..++.+....|++.+.||+|+||+||+|.++. ++..+|||++..... .......+.+.+|++++++++|+++++.+..
T Consensus        10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~   89 (365)
T PRK09188         10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA   89 (365)
T ss_pred             ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            33443333334789999999999999998876 677789998753211 0123446779999999999999999854432


Q ss_pred             EEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCceEEeCCCCcEEEe
Q 022956           87 WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDL-NCSNIFINGNIGQVKIG  165 (289)
Q Consensus        87 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl-~~~nili~~~~~~~~l~  165 (289)
                      +     ...++||||++|++|... ..   ..   ...++.|++.+|.+||++|  ++|+|| ||+||+++.+ +.++|+
T Consensus        90 ~-----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~~ikLi  154 (365)
T PRK09188         90 T-----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-GEAAVI  154 (365)
T ss_pred             c-----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-CCEEEE
Confidence            2     247899999999999732 11   11   1467899999999999999  999999 9999999877 899999


Q ss_pred             ccCCccccCCcccc---------ccCCCCCCCCCCcccc
Q 022956          166 DLGFAAIVGRSHAA---------HSIIGTPEYMAPELYE  195 (289)
Q Consensus       166 d~g~~~~~~~~~~~---------~~~~~~~~~~aPE~~~  195 (289)
                      |||++.........         ....+++.|.+||.+.
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999876433211         1235677889999775

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=3.5e-26  Score=189.07  Aligned_cols=232  Identities=17%  Similarity=0.208  Sum_probs=151.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC----------CceEEeeeeEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN----------KYIIVCYSVWLD   89 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~----------~~i~~~~~~~~~   89 (289)
                      +.++.||.|+++.||.+.+.+||+.+|+|++..... .....++.+++|.-....+.+          -.++..++....
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccc-cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            456889999999999999999999999999988763 234457777777655544322          123333332221


Q ss_pred             ---------CC-CC-----eeEEEeccccCCcHHHHHHh---cC----CCCHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 022956           90 ---------DQ-HN-----TLNFITEVCTSGNLRTYRKK---HR----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD  147 (289)
Q Consensus        90 ---------~~-~~-----~~~lv~e~~~~~sL~~~~~~---~~----~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~d  147 (289)
                               .. ..     ..+++|+-..+ +|.+++..   ..    .+.....+.+..|++..+++||..|  ++|+|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgd  170 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGD  170 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecc
Confidence                     11 11     13567787755 88887642   21    1333455667799999999999999  99999


Q ss_pred             CCCCceEEeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCccccc---------CCCCcchHHHHHHHHHHHHhCC
Q 022956          148 LNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE---------DYTEMVDIYSFGLCLLEMVTME  218 (289)
Q Consensus       148 l~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~Di~slG~il~~l~tg~  218 (289)
                      |+|+|++++.+ |.++|+||+.....+.....  ...+..|.|||....         .++.+.|.|+||+++|.|+++.
T Consensus       171 i~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  171 IKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             -SGGGEEE-TT-S-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeEEEcCC-CCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            99999999999 99999999888766554332  334577889995432         2788999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCC
Q 022956          219 IPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRAR  265 (289)
Q Consensus       219 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~R  265 (289)
                      .||+..........      ...... ..|+.+++||..+|+ +|.+|
T Consensus       248 lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99985322211100      111222 578999999999999 99987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.9e-26  Score=200.66  Aligned_cols=242  Identities=20%  Similarity=0.327  Sum_probs=200.0

Q ss_pred             eecccCcceEEEEee---cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEEEe
Q 022956           24 LLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+|+|+||.|+++..   ...|.-||+|+.+..........  ....|-.++...+ ||.++.+...+..+  ...+++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~l   76 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLIL   76 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccc--cchhHhh
Confidence            379999999998742   33477899999887665332222  5556777888886 89999998877544  5788999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA  179 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~  179 (289)
                      ++..|+.|...+.+.....+.........++-++.++|+.+  ++|+|+|++||+++.+ |.+++.|||++...-.....
T Consensus        77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhc
Confidence            99999999999999888999999999999999999999999  9999999999999999 99999999999876554443


Q ss_pred             ccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  259 (289)
                         ||+..|+|||+.. ....++|.||+|+++++|+||..||..    +....+....   ...+...+..+++++..++
T Consensus       154 ---cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~---~~~p~~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE---LEMPRELSAEARSLFRQLF  222 (612)
T ss_pred             ---ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc---cCCchhhhHHHHHHHHHHH
Confidence               8999999999887 668889999999999999999999987    3333333222   2245556788999999999


Q ss_pred             c-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          260 A-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       260 ~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      . +|.+|.     ...++++|+||..++|+
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            8 999995     45899999999999998

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.7e-24  Score=171.61  Aligned_cols=241  Identities=17%  Similarity=0.283  Sum_probs=191.5

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.-+|.+.-.|..|+++++  |..++.|++.....  .....+.|.+|.-.|+-..||||+++++.+-..  ..+.++.
T Consensus       193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~is  266 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIIS  266 (448)
T ss_pred             hhhhhhccCCCccccccccc--Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEee
Confidence            35577899999999999987  66888899887665  455567799999999999999999999988444  4688899


Q ss_pred             ccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956          100 EVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      .|++-+||.+.+...-  -.+..++.+++..++.|++|||+..+-+--..|+...|++|++ .+.+|..-+....+... 
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kfsfqe~-  344 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKFSFQEV-  344 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecccceeeeecc-
Confidence            9999999999997643  3567899999999999999999998755667899999999988 56665533222212111 


Q ss_pred             ccccCCCCCCCCCCcccccC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                         ...-.|.|++||.+.+.    .-.++|+|||++++||+.|...||.+..+.+--..+-..+..... +...+..+..
T Consensus       345 ---gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i-ppgis~hm~k  420 (448)
T KOG0195|consen  345 ---GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI-PPGISRHMNK  420 (448)
T ss_pred             ---ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC-CCCccHHHHH
Confidence               23457899999977643    345799999999999999999999998887776666666655443 4557889999


Q ss_pred             HHHHHHc-CCCCCCCHHHHh
Q 022956          254 FIEKCIA-QPRARPSASELL  272 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il  272 (289)
                      |+.-|++ ||.+||.++.|+
T Consensus       421 lm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  421 LMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHhcCCCCcCCCcceeh
Confidence            9999998 999999998775

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=2e-23  Score=165.65  Aligned_cols=145  Identities=19%  Similarity=0.191  Sum_probs=113.0

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHH----------------------HHHHHHHHHHHHHhCCCCc
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV----------------------LVNRLHSEVQLLRTLKNKY   79 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~~~~   79 (289)
                      ...||+|++|.||+|.+. +|+.||+|+++.........                      .......|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 89999999998653211110                      1123456999999998877


Q ss_pred             eEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCCCceEEeCC
Q 022956           80 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        80 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~l-h~~~~~~~h~dl~~~nili~~~  158 (289)
                      +........ .   ..++||||++|+++.........++...+..++.|++.+|.++ |+.|  ++|+||||+||+++. 
T Consensus        81 v~~p~~~~~-~---~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~~-  153 (190)
T cd05147          81 IPCPEPILL-K---SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCCcEEEe-c---CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEEC-
Confidence            643332221 1   1379999999987766544456799999999999999999999 7999  999999999999984 


Q ss_pred             CCcEEEeccCCccccCC
Q 022956          159 IGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~~~  175 (289)
                       +.++|+|||++.....
T Consensus       154 -~~v~LiDFG~a~~~~~  169 (190)
T cd05147         154 -GKLYIIDVSQSVEHDH  169 (190)
T ss_pred             -CcEEEEEccccccCCC
Confidence             6899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=2.6e-23  Score=167.18  Aligned_cols=177  Identities=15%  Similarity=0.119  Sum_probs=133.4

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHH------HHHHHHHHHhCCCCceEEeeeeE
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR------LHSEVQLLRTLKNKYIIVCYSVW   87 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~------~~~e~~~l~~l~~~~i~~~~~~~   87 (289)
                      ..++| +..+.||.|+||.||++..  ++..+|+|++..... ..+.....      +.+|+..+.++.|+++..+...+
T Consensus        29 l~~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         29 LSYNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             hhCce-EEEEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            45665 8899999999999999744  477899999975433 23444344      68999999999999999888776


Q ss_pred             EeCC------CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc
Q 022956           88 LDDQ------HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ  161 (289)
Q Consensus        88 ~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~  161 (289)
                      ....      ....+++|||++|.+|.++..    +++    ....+++.++..+|+.|  ++|+|++|+||+++++ | 
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~-g-  172 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN-G-  172 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC-C-
Confidence            5432      235789999999999988742    333    24568999999999999  9999999999999988 7 


Q ss_pred             EEEeccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHh
Q 022956          162 VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVT  216 (289)
Q Consensus       162 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~t  216 (289)
                      ++|+|||.............      +    .+...+..++|+|+||+++.....
T Consensus       173 i~liDfg~~~~~~e~~a~d~------~----vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKDR------I----DLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEEECCCcccccchhhHHH------H----HHHhHhcccccccceeEeehHHHH
Confidence            99999998765432211100      0    122335678999999999877653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.7e-22  Score=159.64  Aligned_cols=145  Identities=21%  Similarity=0.229  Sum_probs=113.1

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCC--------------------C--HHHHHHHHHHHHHHHhCCCCc
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE--------------------D--PVLVNRLHSEVQLLRTLKNKY   79 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--------------------~--~~~~~~~~~e~~~l~~l~~~~   79 (289)
                      .+.||+|++|.||+|.+. +|+.||+|+++......                    +  ......+..|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            578999999999999987 89999999998653110                    0  011234568999999999988


Q ss_pred             eEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCC
Q 022956           80 IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        80 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~  158 (289)
                      +......... .   .++||||++|+++.........++...+..++.|++.++.++|+ .|  ++|+||+|+||+++ +
T Consensus        81 i~~p~~~~~~-~---~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~  153 (190)
T cd05145          81 VPVPEPILLK-K---NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCceEEEec-C---CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C
Confidence            7544333222 1   37999999987554432234568889999999999999999999 99  99999999999999 5


Q ss_pred             CCcEEEeccCCccccCC
Q 022956          159 IGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~~~  175 (289)
                       +.++|+|||++.....
T Consensus       154 -~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 -GKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCEEEEEcccceecCC
Confidence             7999999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=2.7e-22  Score=185.12  Aligned_cols=222  Identities=25%  Similarity=0.413  Sum_probs=169.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      +.-+ ...+.|.-|+||.||.+.|+.+.+.+|+|+-+..-      ..+.      ++.....|.+|             
T Consensus        82 e~df-~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn------ilt~a~npfvv-------------  135 (1205)
T KOG0606|consen   82 ESDF-NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN------ILTFAGNPFVV-------------  135 (1205)
T ss_pred             cccc-ceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc------cccccCCccee-------------
Confidence            3444 34789999999999999999999999995443210      0110      11222222222             


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                                |.=...+...++++...        +.+++|||+.|  ++|+|++|+|.+|+.- |.+|++|||+.....
T Consensus       136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~m-GhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ----------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeec-ccccccchhhhhhhh
Confidence                      23444445555566544        78899999999  9999999999999999 999999999986532


Q ss_pred             Ccc----------------ccccCCCCCCCCCCcc-cccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC
Q 022956          175 RSH----------------AAHSIIGTPEYMAPEL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       175 ~~~----------------~~~~~~~~~~~~aPE~-~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  237 (289)
                      ...                .....+++|.|.|||+ +..+|..+.|.|+||+|+|+.+-|..||.+...++-+-+.+...
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            111                1123489999999995 55669999999999999999999999999877776666666666


Q ss_pred             CCCCCCCCCCChHHHHHHHHHHc-CCCCC---CCHHHHhcCcccccCCCC
Q 022956          238 VKPQALNKVKDPEVKAFIEKCIA-QPRAR---PSASELLKDPFFSELNDD  283 (289)
Q Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~-dp~~R---ps~~~il~h~~~~~~~~~  283 (289)
                      ..+..-....++++++++..+|+ +|..|   +.+-++..|+||..+||.
T Consensus       275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            66655567778999999999998 99999   578899999999999997

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=2.6e-21  Score=152.57  Aligned_cols=185  Identities=12%  Similarity=0.048  Sum_probs=139.3

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCCCeeEEEe
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      +...|+.|+||+|+.+..  .+.+++.+.+.....-........+.+|+++|++|.| ++++.+++.      +..+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence            578899999999998854  6888988888766543223334468999999999965 778888774      2368999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDL-NCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl-~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      +|+.|.+|......       ....++.|++.+|.++|+.|  ++|+|| +|.||+++.+ +.++|+|||++........
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC-CCEEEEECCCceecCCcch
Confidence            99999998764322       12457789999999999999  999999 7999999987 8999999999986543321


Q ss_pred             c----c----------cCCCCCCCCCCccc--ccCCC-CcchHHHHHHHHHHHHhCCCCCCC
Q 022956          179 A----H----------SIIGTPEYMAPELY--EEDYT-EMVDIYSFGLCLLEMVTMEIPYSE  223 (289)
Q Consensus       179 ~----~----------~~~~~~~~~aPE~~--~~~~~-~~~Di~slG~il~~l~tg~~p~~~  223 (289)
                      .    .          -...++.++.|+..  -...+ ++.+.++.|+-+|.++|+..++-+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            1    0          01245667777632  22344 567888999999999999887653

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=7.3e-20  Score=146.68  Aligned_cols=137  Identities=18%  Similarity=0.128  Sum_probs=106.7

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-----CCCceEEeeeeEEeCCC-Ce-
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-----KNKYIIVCYSVWLDDQH-NT-   94 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~-~~-   94 (289)
                      .+.||+|++|.||.  +..++.. +||++.....    ...+.+.+|+++++.+     .||||+++++++.++.+ .. 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            46799999999995  7777666 6998876432    2246789999999999     57999999999876542 33 


Q ss_pred             eEEEecc--ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhcCCCCceecCCCCCceEEeCC---CCcEEEeccC
Q 022956           95 LNFITEV--CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL-EYLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGDLG  168 (289)
Q Consensus        95 ~~lv~e~--~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l-~~lh~~~~~~~h~dl~~~nili~~~---~~~~~l~d~g  168 (289)
                      +.+|+||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+++  ++|+||||+||+++.+   ...++|+|++
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            3378999  5578999999774 46655  35677888777 9999999  9999999999999743   1479999954


Q ss_pred             Cc
Q 022956          169 FA  170 (289)
Q Consensus       169 ~~  170 (289)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.7e-20  Score=154.52  Aligned_cols=189  Identities=22%  Similarity=0.300  Sum_probs=140.5

Q ss_pred             CCCceEEeeeeEEe-------------------------CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHH
Q 022956           76 KNKYIIVCYSVWLD-------------------------DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL  130 (289)
Q Consensus        76 ~~~~i~~~~~~~~~-------------------------~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~  130 (289)
                      +||||+.+...|.+                         .++.++|+||..++. +|..++.... .+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence            59999998876643                         124689999999977 9999998643 67788899999999


Q ss_pred             HHHHHHhcCCCCceecCCCCCceEEeCC---CCcEEEeccCCccccCCccc-----c-c-cCCCCCCCCCCcccccCC--
Q 022956          131 EGLEYLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGDLGFAAIVGRSHA-----A-H-SIIGTPEYMAPELYEEDY--  198 (289)
Q Consensus       131 ~~l~~lh~~~~~~~h~dl~~~nili~~~---~~~~~l~d~g~~~~~~~~~~-----~-~-~~~~~~~~~aPE~~~~~~--  198 (289)
                      +|+.|||++|  +.|+|+|.+||++.-+   -..++++|||.+.....-.-     + . ...|.-.-+|||+....+  
T Consensus       352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            9999999999  9999999999999322   24799999998754432111     1 1 123566789999765332  


Q ss_pred             -----CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHH
Q 022956          199 -----TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSAS  269 (289)
Q Consensus       199 -----~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~  269 (289)
                           -.++|.|+.|.+.||+++...||-......-.... .+......++..+++.+++|+..+|+ ||++|++..
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                 23799999999999999999999752211111111 11223345677789999999999999 999998763

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.3e-20  Score=176.59  Aligned_cols=199  Identities=20%  Similarity=0.210  Sum_probs=153.8

Q ss_pred             CceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC---CCceEEee
Q 022956            8 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK---NKYIIVCY   84 (289)
Q Consensus         8 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~   84 (289)
                      +......++.-+-|.+.||+|+||+||.|.+.. |+.||+|+-+....= +..+.      .+++.+|+   -+.|..+.
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-EfYI~------~q~~~RLk~~~~~~~~~~~  760 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-EFYIC------LQVMERLKPQMLPSIMHIS  760 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-eeeeh------HHHHHhhchhhhcchHHHH
Confidence            334444444444589999999999999998875 999999998765321 11122      23333333   23444444


Q ss_pred             eeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe------CC
Q 022956           85 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN------GN  158 (289)
Q Consensus        85 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~------~~  158 (289)
                      ..+...  +.-++|++|.+.|+|.+++...+.+++..+..+..|++..+.+||..+  |+||||||+|+++.      .+
T Consensus       761 ~a~~~~--~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  761 SAHVFQ--NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             HHHccC--CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCc
Confidence            444444  346779999999999999998899999999999999999999999999  99999999999993      23


Q ss_pred             CCcEEEeccCCcccc---CCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCC
Q 022956          159 IGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME  218 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~  218 (289)
                      .--++|+|||.+...   .....+...+.+-.|-++|...|. ++...|.|+|+.+++.|+.|+
T Consensus       837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            356999999998654   344456667888899999977766 999999999999999999984

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=4.9e-20  Score=151.11  Aligned_cols=151  Identities=19%  Similarity=0.188  Sum_probs=116.5

Q ss_pred             CcccceeeeecccCcceEEEEe-ecCCCcEEEEEEeeecccCC------------------C--HHHHHHHHHHHHHHHh
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAF-DQEEGIEVAWNQVRLSHFSE------------------D--PVLVNRLHSEVQLLRT   74 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~~aiK~~~~~~~~~------------------~--~~~~~~~~~e~~~l~~   74 (289)
                      ++.|++.+.||+|++|.||+|. +..+|+.||+|+++......                  +  ......+..|+..+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3445788999999999999998 77789999999998653210                  0  0122346789999999


Q ss_pred             CCCCc--eEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCc
Q 022956           75 LKNKY--IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN  152 (289)
Q Consensus        75 l~~~~--i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~n  152 (289)
                      +.+.+  ++..+..   .   ..++||||++|.+|.........+....+..++.|++.++.+||+.|. ++|+||+|+|
T Consensus       107 L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~-iiH~Dikp~N  179 (237)
T smart00090      107 LYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE-LVHGDLSEYN  179 (237)
T ss_pred             HHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC-EEeCCCChhh
Confidence            97533  3333332   2   247999999998887765444556777788999999999999999874 8999999999


Q ss_pred             eEEeCCCCcEEEeccCCccccCC
Q 022956          153 IFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       153 ili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |+++ + +.++|+|||.+.....
T Consensus       180 Ili~-~-~~i~LiDFg~a~~~~~  200 (237)
T smart00090      180 ILVH-D-GKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEEE-C-CCEEEEEChhhhccCC
Confidence            9999 5 7999999998875443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=1.5e-18  Score=140.49  Aligned_cols=138  Identities=19%  Similarity=0.268  Sum_probs=111.9

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +.||+|++|.||++.+  +|..+++|+.........    .....++.+|+..+..+.|+++......+...  ...+++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv   77 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV   77 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence            5799999999999976  678899998764332211    11234688899999999998887665555444  357889


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      |||++|.+|.+++.....    ....++.+++.+|.++|+.+  ++|+|++|.||+++ + +.++++|||.+..
T Consensus        78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~  143 (211)
T PRK14879         78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-G-GKIYLIDFGLAEF  143 (211)
T ss_pred             EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence            999999999999876432    88899999999999999999  99999999999999 5 7899999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2e-20  Score=171.26  Aligned_cols=257  Identities=20%  Similarity=0.300  Sum_probs=204.5

Q ss_pred             CCcccceeeeecccCcceEEEEeecCC-CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH   92 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   92 (289)
                      ...| ++.+.||+|+++.+-.+....+ ...+|.|.+....  ......+.+..|..+.+.+. |+|++..++....  .
T Consensus        19 ~~~~-~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~   93 (601)
T KOG0590|consen   19 NSQY-KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--P   93 (601)
T ss_pred             cccc-cccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCC--C
Confidence            5555 6789999999999998876444 3446666666554  34555677777888888887 9999999988744  3


Q ss_pred             CeeEEEeccccCCcHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCceEEeCCCC-cEEEeccC
Q 022956           93 NTLNFITEVCTSGNLRTYR-KKHR-HVSIKALKKWSKQVLEGLEYLH-THEPCIIHRDLNCSNIFINGNIG-QVKIGDLG  168 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~-~~~~-~l~~~~~~~~~~ql~~~l~~lh-~~~~~~~h~dl~~~nili~~~~~-~~~l~d~g  168 (289)
                      ...++..++..|+++.+.+ ..+. ..+...+...+.|+..++.|+| ..+  +.|+|++|+|.+++.. + .+++.|||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df~  170 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADFG  170 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCch
Confidence            6788899999999999988 5544 6778889999999999999999 889  9999999999999988 7 99999999


Q ss_pred             CccccCC-cc---ccccCCC-CCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CC
Q 022956          169 FAAIVGR-SH---AAHSIIG-TPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VK  239 (289)
Q Consensus       169 ~~~~~~~-~~---~~~~~~~-~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~  239 (289)
                      ++..+.. .+   .....+| ++.|.|||...+.  ..+..|+||.|+++.-+++|..||.........+......  ..
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF  250 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence            9987755 22   2334577 9999999977763  7888999999999999999999998765444333222222  11


Q ss_pred             CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          240 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       240 ~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ....+...+....+++.+++. +|.+|.+.+++-.+||+..
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            234455567888999999997 9999999999999999988

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=1.9e-19  Score=155.93  Aligned_cols=175  Identities=29%  Similarity=0.518  Sum_probs=136.1

Q ss_pred             CeeEEEeccccCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      .+++|.|++|.-.+|.+|+...   ...+....+.++.|++.++.|   ++  .+|+|++|.||++..+ ..++|.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d-~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDD-DQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccc-hhhhhhhhhh
Confidence            3689999999999999999743   456778899999999999999   78  9999999999999888 6999999999


Q ss_pred             ccccCCcc-------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC
Q 022956          170 AAIVGRSH-------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ  241 (289)
Q Consensus       170 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  241 (289)
                      .+......       ......++..|++||.+.+. ++.++|||+||+++++++.   +|.....-......+..+.-++
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~  479 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPP  479 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCCh
Confidence            98765444       23346789999999987765 9999999999999999997   3433222233333444433332


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      .... ..+.-.+|+.+|+. .|.+||++.+.-.|.|.
T Consensus       480 ~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  480 EFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             HHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2111 24566789999998 99999988887777775

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=4.5e-18  Score=136.41  Aligned_cols=134  Identities=17%  Similarity=0.236  Sum_probs=106.0

Q ss_pred             eecccCcceEEEEeecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           24 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      .||+|++|.||++..  +|..+++|..........    .....++.+|+++++.+.++++..........  ...+++|
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~   76 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVM   76 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEE
Confidence            489999999999974  578999999765432221    12246688999999999988755444333333  3468899


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ||++|++|.+++.....       .++.+++.+|.+||+.|  ++|+|++|.||+++ + +.++++|||.+..
T Consensus        77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~-~~~~liDfg~a~~  138 (199)
T TIGR03724        77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-D-DKLYLIDFGLGKY  138 (199)
T ss_pred             EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence            99999999998765321       88999999999999999  99999999999999 5 7999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.5e-18  Score=152.61  Aligned_cols=198  Identities=24%  Similarity=0.395  Sum_probs=152.8

Q ss_pred             HHhCCCCceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 022956           72 LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC  150 (289)
Q Consensus        72 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~  150 (289)
                      |+.+.|.|+.++++...+.  ...+.|.+||.-|+|.+.+.. .-.++......+++.++.||.|+|..-. .+|+.++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecc
Confidence            3568899999999999877  578889999999999999987 4568888889999999999999998863 39999999


Q ss_pred             CceEEeCCCCcEEEeccCCccccCCc---cccccCCCCCCCCCCcccccC--------CCCcchHHHHHHHHHHHHhCCC
Q 022956          151 SNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYEED--------YTEMVDIYSFGLCLLEMVTMEI  219 (289)
Q Consensus       151 ~nili~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~--------~~~~~Di~slG~il~~l~tg~~  219 (289)
                      .|.+++.. -.+|++|||+.......   .......-..-|.|||.++..        .+.+.|+||+|++++++++...
T Consensus        78 ~nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   78 SNCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             ccceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999 79999999998776431   111112234578899977653        4667999999999999999999


Q ss_pred             CCCCCC---cHHHHHHHHhC-CC---CCCCCCC-CCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          220 PYSECD---SVAKIYKKVTG-GV---KPQALNK-VKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       220 p~~~~~---~~~~~~~~~~~-~~---~~~~~~~-~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ||+...   ........+.+ +.   .|..... -..+.+..+++.||. +|.+||+++++-.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            998522   11234444444 22   1111111 234578999999998 9999999999866

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=4.1e-18  Score=136.57  Aligned_cols=143  Identities=22%  Similarity=0.196  Sum_probs=109.1

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC--H----------------HHHHHHHHHHHHHHhCCCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--P----------------VLVNRLHSEVQLLRTLKNK   78 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~----------------~~~~~~~~e~~~l~~l~~~   78 (289)
                      ..+.+.+.||+|+||.||++.+. +|+.+|+|++........  .                ........|+..+..+.++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            33567899999999999999875 799999999875431000  0                1112367788889888777


Q ss_pred             c--eEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe
Q 022956           79 Y--IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN  156 (289)
Q Consensus        79 ~--i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~  156 (289)
                      +  ++..+.    .  ...+++|||++|++|......      .....++.+++.++.++|+.|  ++|+||+|.||+++
T Consensus        94 ~i~v~~~~~----~--~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~  159 (198)
T cd05144          94 GFPVPKPID----W--NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVD  159 (198)
T ss_pred             CCCCCceee----c--CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEc
Confidence            4  333332    1  235889999999998765431      345678899999999999999  99999999999999


Q ss_pred             CCCCcEEEeccCCccccCC
Q 022956          157 GNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       157 ~~~~~~~l~d~g~~~~~~~  175 (289)
                      .+ +.++|+|||++.....
T Consensus       160 ~~-~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DD-EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CC-CcEEEEECCccccCCC
Confidence            87 8999999999975544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.6e-17  Score=152.30  Aligned_cols=141  Identities=18%  Similarity=0.222  Sum_probs=108.8

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCC----CHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE----DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ..+...++||+|+||+||++.+.  +..+++|+........    .....+++.+|+++++.++|++++.........  
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--  408 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--  408 (535)
T ss_pred             cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence            33345789999999999999765  4455555433222111    112346788999999999999988766554443  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ...++||||++|++|.+++.        ....++.+++.+|.+||+.|  ++|+|++|+||+++ + +.++|+|||++..
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~-~-~~~~liDFGla~~  476 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR-D-DRLYLIDFGLGKY  476 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE-C-CcEEEEeCccccc
Confidence            34679999999999999886        35678999999999999999  99999999999994 4 6899999998875


Q ss_pred             c
Q 022956          173 V  173 (289)
Q Consensus       173 ~  173 (289)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            3

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=3.4e-17  Score=130.04  Aligned_cols=141  Identities=22%  Similarity=0.230  Sum_probs=99.5

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHH--------------------HHHHHHHHHHHhCCCCc--
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV--------------------NRLHSEVQLLRTLKNKY--   79 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~l~~~~--   79 (289)
                      .+.||+|+||+||+|.+. +|..||+|++............                    .....|...+.++.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999886 8999999998764321111000                    01245666666665443  


Q ss_pred             eEEeeeeEEeCCCCeeEEEeccccCCcHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeC
Q 022956           80 IIVCYSVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFING  157 (289)
Q Consensus        80 i~~~~~~~~~~~~~~~~lv~e~~~~~sL~-~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~  157 (289)
                      +++.+..   .   ..+++|||++++.+. ..+.... .. ..+..++.+++.++.++|. .+  ++|+||+|+||+++ 
T Consensus        81 ~~~~~~~---~---~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-  149 (187)
T cd05119          81 VPKPIDL---N---RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-  149 (187)
T ss_pred             CCceEec---C---CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence            3333332   1   258999999994332 1111111 11 6788999999999999999 99  99999999999999 


Q ss_pred             CCCcEEEeccCCccccCC
Q 022956          158 NIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       158 ~~~~~~l~d~g~~~~~~~  175 (289)
                      + +.++++|||.+.....
T Consensus       150 ~-~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 D-GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             C-CcEEEEECcccccccC
Confidence            5 7999999999875544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=4e-16  Score=128.25  Aligned_cols=142  Identities=14%  Similarity=0.181  Sum_probs=107.7

Q ss_pred             eeeec-ccCcceEEEEeecCCCcEEEEEEeeeccc-----CC----CHHHHHHHHHHHHHHHhCCCCce--EEeeeeEEe
Q 022956           22 SDLLG-SGAVKKVYRAFDQEEGIEVAWNQVRLSHF-----SE----DPVLVNRLHSEVQLLRTLKNKYI--IVCYSVWLD   89 (289)
Q Consensus        22 ~~~lg-~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-----~~----~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~   89 (289)
                      ...|| .|+.|+||.+...  +..+++|.+.....     .+    ......++.+|+.++..|.|+++  +..++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35688 8999999999764  78999999865321     10    12334678889999999998875  555554333


Q ss_pred             CCCC--eeEEEeccccC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           90 DQHN--TLNFITEVCTS-GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        90 ~~~~--~~~lv~e~~~~-~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      ....  ..++|+|+++| .+|.+++... .+++..    +.+++.++.+||+.|  ++|+||+|.||+++.+ +.++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEE
Confidence            2221  23589999997 6899888753 466543    568999999999999  9999999999999988 7999999


Q ss_pred             cCCcccc
Q 022956          167 LGFAAIV  173 (289)
Q Consensus       167 ~g~~~~~  173 (289)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=3.5e-18  Score=140.13  Aligned_cols=267  Identities=32%  Similarity=0.566  Sum_probs=180.8

Q ss_pred             CCceeeCCCCcccceeeeecccCc---ceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEe
Q 022956            7 EPFVEVDPSGRFGRYSDLLGSGAV---KKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC   83 (289)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~lg~g~~---g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   83 (289)
                      .-+....+-+|..+-.+..|+..-   -.||++.+...|..|++-.+......+-...-+..+.-...|-++.|.|+++.
T Consensus        53 ~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkf  132 (458)
T KOG1266|consen   53 SEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKF  132 (458)
T ss_pred             hhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHH
Confidence            334455666666655666776332   36788888888888877555443221111111223334455566779999988


Q ss_pred             eeeEEeC---CCCeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe
Q 022956           84 YSVWLDD---QHNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN  156 (289)
Q Consensus        84 ~~~~~~~---~~~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~  156 (289)
                      +.++.+.   +.....++.||++.|+|..+++.    ...+......+|..||.+||.|||+..|+++|+++..+.|++.
T Consensus       133 H~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq  212 (458)
T KOG1266|consen  133 HKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ  212 (458)
T ss_pred             HHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec
Confidence            8766432   23467889999999999999874    4568888999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeccCCccccCCcc-----ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 022956          157 GNIGQVKIGDLGFAAIVGRSH-----AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI  230 (289)
Q Consensus       157 ~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~  230 (289)
                      .+ |-+|+.--.........+     ......+-++|.+||.-.-. .+-++|||++|....+|.-+..--.+.......
T Consensus       213 ~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~  291 (458)
T KOG1266|consen  213 HN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEV  291 (458)
T ss_pred             CC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeeh
Confidence            88 777776544333322211     12234467889999854433 566899999999999998876543322221111


Q ss_pred             HHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          231 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ...+.     ..........-+.++.+|++ +|..||++++++.||.+=+
T Consensus       292 ee~ia-----~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  292 EENIA-----NVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             hhhhh-----hheeeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            11111     11122223445788999999 9999999999999997644

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=4.9e-15  Score=112.92  Aligned_cols=134  Identities=19%  Similarity=0.135  Sum_probs=106.5

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC--CceEEeeeeEEeCCCCeeEEE
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN--KYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +.+.||+|.++.||++...  +..+++|.......      ...+.+|+..++.+++  ..+++++.....  .+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEE
Confidence            3578999999999999875  47899999864321      4567788899999876  477777766533  2578999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE-PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~-~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +||+.|.++..+       +......++.+++.++..+|... .+++|+|++|.||+++.+ +.++++|||.+..
T Consensus        72 ~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~  138 (155)
T cd05120          72 MEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY  138 (155)
T ss_pred             EEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence            999998777654       55677788999999999999852 129999999999999987 8999999997763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.60  E-value=4.3e-14  Score=126.36  Aligned_cols=180  Identities=19%  Similarity=0.252  Sum_probs=135.5

Q ss_pred             eeecccCcceEE-EEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVY-RAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~-~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +...-++.+ +| .+..+.++.++.|...+....    .......+-++.|+.++||+|+..+..+..+  ..+|+|+|.
T Consensus        18 e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTEr   90 (690)
T KOG1243|consen   18 EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTER   90 (690)
T ss_pred             ccccCCCcc-cccccceeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeec
Confidence            444444444 45 467788899999999986532    3355677889999999999999999988444  589999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc-c
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH-THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-A  179 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh-~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~-~  179 (289)
                      +.  .|..++.+   ++...+...+.||+.||.||| ..+  ++|++|+-+.|+++.. |..||.+|.++........ .
T Consensus        91 V~--Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~  162 (690)
T KOG1243|consen   91 VR--PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPA  162 (690)
T ss_pred             cc--cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCccc
Confidence            86  58877776   457788889999999999997 557  9999999999999999 9999999998865544332 1


Q ss_pred             ccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCC
Q 022956          180 HSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTME  218 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~  218 (289)
                      .....--.|..|+..... ....|.|.|||++++++.|.
T Consensus       163 ~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  163 KSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCcc
Confidence            111222344455432211 13469999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=5.5e-15  Score=130.53  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=186.8

Q ss_pred             ceeeeecc--cCcceEEEEee--cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGS--GAVKKVYRAFD--QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~--g~~g~v~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   94 (289)
                      .+.+-+|.  |.+|.+|.+..  ..++..+|+|.=+....  .+....+=.+++.....+ .|++.+..+..+  ++.+.
T Consensus       117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~~  192 (524)
T KOG0601|consen  117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSGI  192 (524)
T ss_pred             ccccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCccc--ccCCc
Confidence            34567999  99999999988  88999999998544322  111122223455555555 377888766655  34467


Q ss_pred             eEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHH----HHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           95 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLE----GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~----~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      .++-+|.+. .+|..+...- ..+++..++..+.+...    ||.++|+.+  ++|.|++|.||+...+-...+++|||+
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcce
Confidence            888999996 4777777654 44888999999999988    999999999  999999999999988755899999999


Q ss_pred             ccccCCcccc------ccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          170 AAIVGRSHAA------HSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       170 ~~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      ...+......      ....+...|++||...+-+....|+|+||-++.+..++..+......  ..+..+.+...+...
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN--SSWSQLRQGYIPLEF  347 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC--CCccccccccCchhh
Confidence            9887654422      22357789999999999999999999999999999887655543210  111122222233334


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ....+.+++..+..|++ +|-.|+++..++.|+++...
T Consensus       348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            44456777788889998 99999999999999988754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=6.7e-13  Score=104.72  Aligned_cols=145  Identities=14%  Similarity=0.137  Sum_probs=103.0

Q ss_pred             eeeecccCcceEEEEeecC------CCcEEEEEEeeeccc--CC-------CH-------------HHHHHHHHHHHHHH
Q 022956           22 SDLLGSGAVKKVYRAFDQE------EGIEVAWNQVRLSHF--SE-------DP-------------VLVNRLHSEVQLLR   73 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~------~~~~~aiK~~~~~~~--~~-------~~-------------~~~~~~~~e~~~l~   73 (289)
                      ...||+|--+.||.|....      .+..+|+|+++....  ..       ++             ......++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3468999999999997543      357999999886332  10       00             11112448999999


Q ss_pred             hCCCC--ceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCC
Q 022956           74 TLKNK--YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNC  150 (289)
Q Consensus        74 ~l~~~--~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~l-h~~~~~~~h~dl~~  150 (289)
                      ++...  +++.++..      ..-++||||+.+..+....-+...++..++..+..+++.+|..| |+.|  ++||||++
T Consensus        82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            99654  44555543      12577999998754432222223466667788899999999988 8999  99999999


Q ss_pred             CceEEeCCCCcEEEeccCCccccCCc
Q 022956          151 SNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus       151 ~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      .||+++.  +.++|+|||.+.....+
T Consensus       154 ~NIL~~~--~~v~iIDF~qav~~~hp  177 (197)
T cd05146         154 YNMLWHD--GKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             HHEEEEC--CcEEEEECCCceeCCCC
Confidence            9999985  57999999988765433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.48  E-value=3.1e-14  Score=132.55  Aligned_cols=257  Identities=20%  Similarity=0.299  Sum_probs=194.2

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      .+-+-.|.++.++.+.-..+|...++|+.......... ..+....+-.++-...+|-++.....+  ......++++++
T Consensus       809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~~  885 (1205)
T KOG0606|consen  809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-DYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGHY  885 (1205)
T ss_pred             cccccCCCCcccccCCccccccccchhhhccchhhccc-cccccCCccCccccCCCCceecccCCC--CCCCCcchhhHH
Confidence            34567899999999988788877777776654322111 012222222222222334444333222  334568999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-----
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-----  176 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-----  176 (289)
                      ..++.|...+.+.+..+.+.+......++.++++||...  ..|+|++|.|.+...+ +..++++++.......-     
T Consensus       886 ~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  886 LNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             hccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc-CCcccCccccccccccccCcCC
Confidence            999999999998888888888888889999999999998  8999999999999988 89999999843322100     


Q ss_pred             ---------------------------cccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 022956          177 ---------------------------HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA  228 (289)
Q Consensus       177 ---------------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~  228 (289)
                                                 +......+++.|.+||..-+ ...+.+|.|+.|.++++.++|..||.......
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence                                       00112347899999996654 48889999999999999999999999877777


Q ss_pred             HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHH---HHhcCcccccCCCCC
Q 022956          229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSAS---ELLKDPFFSELNDDD  284 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~---~il~h~~~~~~~~~~  284 (289)
                      ....++....++.......++..++++..++. +|.+|..+.   ++-.|+||+..+|++
T Consensus      1043 ~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1043 IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            77777777777777788889999999999998 999998777   889999999999875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=6.7e-13  Score=118.30  Aligned_cols=145  Identities=19%  Similarity=0.170  Sum_probs=96.9

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCH------------------------------HHHH------HHH
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP------------------------------VLVN------RLH   66 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------------------------------~~~~------~~~   66 (289)
                      +-||+|++|.||+|+.+ +|+.||||+.+..-...-.                              +...      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            56999999999999864 8999999998653210000                              0000      134


Q ss_pred             HHHHHHHhCC----CCceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHhcCC
Q 022956           67 SEVQLLRTLK----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLE-GLEYLHTHE  140 (289)
Q Consensus        67 ~e~~~l~~l~----~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~-~l~~lh~~~  140 (289)
                      +|+..+.++.    +.+-+.+-.++.+-. ...++||||++|.+|.++.... ...+   ...++.+++. .+..+|..|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            4555444442    333333333332222 3468999999999998876532 1222   2345555555 467789999


Q ss_pred             CCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       141 ~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                        ++|+|++|.||+++.+ +.++++|||++.....
T Consensus       278 --~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 --FFHADLHPGNIFVLKD-GKIIALDFGIVGRLSE  309 (437)
T ss_pred             --ceeCCCCcccEEECCC-CcEEEEeCCCeeECCH
Confidence              9999999999999888 8999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=2.5e-12  Score=116.19  Aligned_cols=142  Identities=16%  Similarity=0.201  Sum_probs=93.1

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeeccc---------------------CC----C-----HHHHHH------HH
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF---------------------SE----D-----PVLVNR------LH   66 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~---------------------~~----~-----~~~~~~------~~   66 (289)
                      +-||+|++|.||+|..+.+|+.||||+.+..-.                     .+    +     .+..+.      +.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            569999999999999987899999999975310                     00    0     011222      33


Q ss_pred             HHHHHHHhCC----CCceEEeeeeEEeCCCCeeEEEeccccCCcHHHH--HHhcC----CCCHHHHHHHHHHHHHHHHHH
Q 022956           67 SEVQLLRTLK----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHR----HVSIKALKKWSKQVLEGLEYL  136 (289)
Q Consensus        67 ~e~~~l~~l~----~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~--~~~~~----~l~~~~~~~~~~ql~~~l~~l  136 (289)
                      +|+..+.++.    +...+.+-.++.+-. ...++||||+.|+.+.+.  +...+    .+.+..+..++.|+.      
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence            3444444442    333333333333211 346899999999999874  23222    244444444445543      


Q ss_pred             hcCCCCceecCCCCCceEEeCCCC----cEEEeccCCccccCC
Q 022956          137 HTHEPCIIHRDLNCSNIFINGNIG----QVKIGDLGFAAIVGR  175 (289)
Q Consensus       137 h~~~~~~~h~dl~~~nili~~~~~----~~~l~d~g~~~~~~~  175 (289)
                       ..|  ++|+|++|.||+++.+ |    .++++|||++...+.
T Consensus       278 -~~G--ffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -RDG--FFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -hCC--eeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence             578  9999999999999987 6    999999999876643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.43  E-value=6.4e-12  Score=107.20  Aligned_cols=240  Identities=15%  Similarity=0.225  Sum_probs=158.8

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCc----eEEeeeeEEe-CCCCe
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY----IIVCYSVWLD-DQHNT   94 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~----i~~~~~~~~~-~~~~~   94 (289)
                      ..+-||+|+-+.+|-.-   .-..-+-|++....-.    ....   -+.+|... .||-    ++........ ..+..
T Consensus        15 ~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa----~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          15 PGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPA----AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCccccCCccceeeecc---hhhchhheeecCCCch----HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            45679999999999873   2233456888765421    1111   12223222 4443    2222222222 23345


Q ss_pred             eEEEeccccCCc-HHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           95 LNFITEVCTSGN-LRTYR------KKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        95 ~~lv~e~~~~~s-L~~~~------~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      +.++|+.++|.. ...+.      +..+...+..++..++.++.+.+.||..|  ..-||++++|+|+.++ +.|.|+|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~-~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDD-SKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecC-ceEEEEcc
Confidence            888999998852 23322      22345678899999999999999999999  9999999999999998 89999998


Q ss_pred             CCccccCCccccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhC-CCCCCCC-------CcHH-HHH-
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTM-EIPYSEC-------DSVA-KIY-  231 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg-~~p~~~~-------~~~~-~~~-  231 (289)
                      +............+..+...|.+||.-.      .+-+...|-|.||+++++++.| ..||++.       ...+ .+. 
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            7666555555556677899999999543      2367789999999999999885 9999852       1111 111 


Q ss_pred             ------HHHhCC--CCC-CCCCCCCChHHHHHHHHHHcC---CCCCCCHHHHhc
Q 022956          232 ------KKVTGG--VKP-QALNKVKDPEVKAFIEKCIAQ---PRARPSASELLK  273 (289)
Q Consensus       232 ------~~~~~~--~~~-~~~~~~~~~~~~~li~~~l~d---p~~Rps~~~il~  273 (289)
                            .....+  ..+ .......++.+..|..+|+.+   +.-|||++..+.
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~a  295 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVA  295 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHH
Confidence                  010011  111 122334578999999999963   558999976543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=6.5e-13  Score=103.60  Aligned_cols=129  Identities=20%  Similarity=0.145  Sum_probs=93.2

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-EeeeeEEeCCCCeeEEEec
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~e  100 (289)
                      .+.|+.|..+.||++...  +..+++|.......     ....+.+|+.+++.+.+.+++ +++..  ..+  ..++|||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~--~~~lv~e   71 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPE--TGVLITE   71 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCC--CCeEEEE
Confidence            356899999999999764  78999999864321     122456788888888665544 33332  222  2478999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCC---CceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP---CIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~---~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      |++|.++.+.    . .   .....+.+++.++..||+.+.   .++|+|++|.||+++ + +.++++||+.+.
T Consensus        72 ~i~G~~l~~~----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~  135 (170)
T cd05151          72 FIEGSELLTE----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG  135 (170)
T ss_pred             ecCCCccccc----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence            9999877653    0 1   123456789999999999871   149999999999999 4 589999998765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=1.1e-11  Score=94.96  Aligned_cols=136  Identities=20%  Similarity=0.236  Sum_probs=101.3

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHH-----HHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV-----LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      ..+++|+-+.++.+...  |.++++|.=..... ..++     ..++..+|++++.++..-.+....-+.++..  ...|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~Y-R~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--~~~I   76 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRY-RHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--NGLI   76 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCccc-CChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCEE
Confidence            35789999999999664  55666665433322 2222     3456888999999998777665554444443  4567


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|||++|..|.+.+...       ...++..+-.-+.-||..|  ++||||+++|+++..+  .++++|||++.+..
T Consensus        77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~s~  142 (204)
T COG3642          77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEFSD  142 (204)
T ss_pred             EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCcccccc
Confidence            99999999999999875       1455666666778899999  9999999999999876  59999999998554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.34  E-value=9.5e-11  Score=102.42  Aligned_cols=214  Identities=16%  Similarity=0.217  Sum_probs=154.5

Q ss_pred             CcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC--CCCeeEEEeccccCC-
Q 022956           29 AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD--QHNTLNFITEVCTSG-  105 (289)
Q Consensus        29 ~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~~lv~e~~~~~-  105 (289)
                      .-.+.|++....||..|++|.+...+...    ...-..-++.++++.|+|+|++.+++...  .+..+++|++|+++. 
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~----~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS----TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC----cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            45688999999999999999995433211    11223367889999999999998887632  336799999999884 


Q ss_pred             cHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956          106 NLRTYRK---------------KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus       106 sL~~~~~---------------~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      +|.++.-               ++...++..++.++.|+..||.++|+.|  +...-|.+.+|+++.+ .+++|...|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~-~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGK-MRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCc-ceEEEecccce
Confidence            6665531               2345788999999999999999999999  9999999999999988 69999999988


Q ss_pred             cccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ........           +|  +.  ...+-|.-.||.+++.|.||..- +............         +....+.
T Consensus       441 Dvl~~d~~-----------~~--le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~  496 (655)
T KOG3741|consen  441 DVLQEDPT-----------EP--LE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYST  496 (655)
T ss_pred             eeecCCCC-----------cc--hh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhH
Confidence            76654420           01  00  12356889999999999998432 2221111111222         2334577


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ++++++..+.. .+++ -++.+++.+
T Consensus       497 D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  497 DLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            88888888886 6665 677777764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=4.1e-11  Score=91.53  Aligned_cols=146  Identities=19%  Similarity=0.267  Sum_probs=109.6

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccC----CCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      ...|-+|+-+.|+++.+.  |+..+||.-......    +..-...+..+|++.|.++.--.|....-++.+..+  -.+
T Consensus        12 l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~i   87 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQI   87 (229)
T ss_pred             ceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--CeE
Confidence            577889999999999765  888888875443332    123346678999999999987677655555555543  455


Q ss_pred             EeccccC-CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcE--EEeccCCccc
Q 022956           98 ITEVCTS-GNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV--KIGDLGFAAI  172 (289)
Q Consensus        98 v~e~~~~-~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~--~l~d~g~~~~  172 (289)
                      .|||++| .++.+++...  ..........++.++-+.+.-||..+  ++||||+.+||++.++.+.+  .++|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence            7999988 4778887653  22333444788999999999999999  99999999999997764444  8999998875


Q ss_pred             c
Q 022956          173 V  173 (289)
Q Consensus       173 ~  173 (289)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            4

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=7.6e-12  Score=110.84  Aligned_cols=251  Identities=20%  Similarity=0.198  Sum_probs=168.3

Q ss_pred             CCCcccceeeeecccCcceEEEEeec-CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQ-EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   91 (289)
                      ..+.+. .+.+||.|.|+.++.+... .++..|++|-....-.....+  ..-..|+.+...+ .|.+++.....+..- 
T Consensus       263 ~~~df~-~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d--i~sl~ev~l~~~l~~~~~~~g~~~~W~~~-  338 (524)
T KOG0601|consen  263 KLTDFG-LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD--IFSLGEVILEAILGSHLPSVGKNSSWSQL-  338 (524)
T ss_pred             ecCCcc-eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh--hcchhhhhHhhHhhcccccCCCCCCcccc-
Confidence            344553 5789999999999988644 678899999887654322111  2223344444444 466666655555332 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       ...++-.|||.++++.....-...+.+...+.+..|++.++.++|+..  ++|+|++|+||++..+.+..++.|++.+.
T Consensus       339 -r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  339 -RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             -ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccc
Confidence             345688999999988777655566888899999999999999999999  99999999999997754788999998886


Q ss_pred             ccCCccccccCCCCCCCCC-Cc-ccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          172 IVGRSHAAHSIIGTPEYMA-PE-LYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~a-PE-~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      .......  ......++.| .| ..... +..++|+++||..+.+.+++...-....    ....+.++..+.. +.. .
T Consensus       416 ~~~~~~~--~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~-~~~-~  487 (524)
T KOG0601|consen  416 RLAFSSG--VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNL-PGL-K  487 (524)
T ss_pred             ccceecc--cccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCC-Cch-H
Confidence            4221111  1112223442 44 33333 7889999999999999999853221111    1112222222222 222 2


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ..+..+.+.+.. ++..||.+.++..|.=|..
T Consensus       488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            667777778877 9999999999998865543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.2e-10  Score=94.62  Aligned_cols=144  Identities=17%  Similarity=0.205  Sum_probs=102.2

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc--eEEeeeeEEeCC-CCeeEEEe
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVWLDDQ-HNTLNFIT   99 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~-~~~~~lv~   99 (289)
                      +.||.|..+.+|++... +|..+++|........   .....+.+|+++++.+.+.+  +++++....... .+..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            56899999999999764 3689999998654321   12456788999999997644  345554432211 12568999


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH----------------------------------------  139 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~----------------------------------------  139 (289)
                      |+++|.++.+.+.. ..+++.+...++.+++.+|..||+.                                        
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99999888765432 3466677777777777777777742                                        


Q ss_pred             --------------CCCceecCCCCCceEEeCC-CCcEEEeccCCcc
Q 022956          140 --------------EPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAA  171 (289)
Q Consensus       140 --------------~~~~~h~dl~~~nili~~~-~~~~~l~d~g~~~  171 (289)
                                    ...++|+|+.+.||+++++ .+.+.++||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          1247999999999999983 2678999998665

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=1.3e-11  Score=111.13  Aligned_cols=153  Identities=19%  Similarity=0.335  Sum_probs=111.6

Q ss_pred             HHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc----------cccCCCCCCCCCCcccc
Q 022956          126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA----------AHSIIGTPEYMAPELYE  195 (289)
Q Consensus       126 ~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~----------~~~~~~~~~~~aPE~~~  195 (289)
                      +.+++.|+.++|..-. ++|++|.|++|.++.+ +.+|+++|+++.....+..          ......+..|.|||...
T Consensus       105 l~~v~dgl~flh~sAk-~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAK-VVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcc-eeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3444499999998732 9999999999999999 9999999998865543111          11123467999999766


Q ss_pred             cC-CCCcchHHHHHHHHHHHHhC-CCCCCCCCcH-HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHH
Q 022956          196 ED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSV-AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL  271 (289)
Q Consensus       196 ~~-~~~~~Di~slG~il~~l~tg-~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~i  271 (289)
                      +. .++++|+||||+++|.+..| +.-+...... ..-......+..........++++++=+.+++. ++.-||++..+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence            55 78899999999999999964 4444332212 222222222222333456678999999999998 99999999999


Q ss_pred             hcCcccccC
Q 022956          272 LKDPFFSEL  280 (289)
Q Consensus       272 l~h~~~~~~  280 (289)
                      +..|||.+-
T Consensus       263 ~~~~ff~D~  271 (700)
T KOG2137|consen  263 LSIPFFSDP  271 (700)
T ss_pred             hcccccCCc
Confidence            999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.18  E-value=4.8e-10  Score=88.22  Aligned_cols=130  Identities=25%  Similarity=0.272  Sum_probs=84.7

Q ss_pred             eEEEEeecCCCcEEEEEEeeecccC----------------------CCHHHHHHHHHHHHHHHhCCCCc--eEEeeeeE
Q 022956           32 KVYRAFDQEEGIEVAWNQVRLSHFS----------------------EDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVW   87 (289)
Q Consensus        32 ~v~~~~~~~~~~~~aiK~~~~~~~~----------------------~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~   87 (289)
                      .||.|.. .+|..+|+|+.+.....                      ..........+|.+.|.++...+  ++.++.+ 
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            4788875 46889999998763211                      11234556899999999998764  4555543 


Q ss_pred             EeCCCCeeEEEecccc--CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           88 LDDQHNTLNFITEVCT--SGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY-LHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~--~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~-lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                       ..    -++||||++  |..+..+....  ++......++.+++..+.. +|+.|  ++||||++.||+++++  .+++
T Consensus        79 -~~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~i  147 (188)
T PF01163_consen   79 -NR----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYI  147 (188)
T ss_dssp             -ET----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE
T ss_pred             -eC----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEE
Confidence             22    468999999  76665544432  1234556677777774444 58999  9999999999999986  8999


Q ss_pred             eccCCccccC
Q 022956          165 GDLGFAAIVG  174 (289)
Q Consensus       165 ~d~g~~~~~~  174 (289)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=1.4e-09  Score=90.68  Aligned_cols=138  Identities=17%  Similarity=0.082  Sum_probs=94.8

Q ss_pred             ceEEEEeecCCCcEEEEEEeeecccCCC-H------HHHHHHHHHHHHHHhCCCCceE--EeeeeEEeCC---CCeeEEE
Q 022956           31 KKVYRAFDQEEGIEVAWNQVRLSHFSED-P------VLVNRLHSEVQLLRTLKNKYII--VCYSVWLDDQ---HNTLNFI   98 (289)
Q Consensus        31 g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~------~~~~~~~~e~~~l~~l~~~~i~--~~~~~~~~~~---~~~~~lv   98 (289)
                      ..|.++..  .|+.|.+|......+.+- .      .-...+.+|...+.+|...+|.  .++.+.....   ...-++|
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            34556543  478899997744332100 0      0011367888888888544443  2333332111   2346789


Q ss_pred             eccccCC-cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC------CCCcEEEeccCC
Q 022956           99 TEVCTSG-NLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING------NIGQVKIGDLGF  169 (289)
Q Consensus        99 ~e~~~~~-sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~------~~~~~~l~d~g~  169 (289)
                      +|++++. +|.+++..  ....+......++.+++..+..||..|  ++|+|++++||+++.      +...+.|+||+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            9999986 89998864  345667788899999999999999999  999999999999975      226899999987


Q ss_pred             ccc
Q 022956          170 AAI  172 (289)
Q Consensus       170 ~~~  172 (289)
                      +..
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.04  E-value=2.1e-09  Score=87.36  Aligned_cols=141  Identities=22%  Similarity=0.227  Sum_probs=101.7

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC-------C---------C--HHHHHHHHHHHHHHHhCCCC-
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-------E---------D--PVLVNRLHSEVQLLRTLKNK-   78 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-------~---------~--~~~~~~~~~e~~~l~~l~~~-   78 (289)
                      ...++.+||-|--|.||.|.+. .|.++|+|.=+.....       .         +  ...+...++|.++|..|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            4467789999999999999875 7899999985543210       0         0  12345578899999999765 


Q ss_pred             -ceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC
Q 022956           79 -YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING  157 (289)
Q Consensus        79 -~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~  157 (289)
                       .+++.+++      +.-.+|||+++|..|....-     +.+..-.++..|+.-+..+-..|  ++|||+++-||+++.
T Consensus       171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~  237 (304)
T COG0478         171 VKVPKPIAW------NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCCcccc------ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEec
Confidence             66676654      35678999999977766442     23333444444444444444678  999999999999999


Q ss_pred             CCCcEEEeccCCcccc
Q 022956          158 NIGQVKIGDLGFAAIV  173 (289)
Q Consensus       158 ~~~~~~l~d~g~~~~~  173 (289)
                      + |.++++||..+...
T Consensus       238 d-g~~~vIDwPQ~v~~  252 (304)
T COG0478         238 D-GDIVVIDWPQAVPI  252 (304)
T ss_pred             C-CCEEEEeCcccccC
Confidence            9 99999999766543

>PRK09902 hypothetical protein; Provisional

Probab=98.95  E-value=1.2e-08  Score=80.91  Aligned_cols=141  Identities=13%  Similarity=0.083  Sum_probs=98.9

Q ss_pred             cccCcceEEEEeecCCCcEEEEEEeeecccCC--CHHHHHHHHHHHHHHHhCCCCce--EEeeeeEE--eCCCCeeEEEe
Q 022956           26 GSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE--DPVLVNRLHSEVQLLRTLKNKYI--IVCYSVWL--DDQHNTLNFIT   99 (289)
Q Consensus        26 g~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~--~~~~~~~~lv~   99 (289)
                      |.|+.|.|++....  |+.+-+|.-...-...  -+--...|.+|...|++|..-++  ++++..-.  ......-.||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            45888999998654  5567788764111000  01234678889888888865443  33331111  11123467899


Q ss_pred             ccccC-CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc--EEEeccCCcc
Q 022956          100 EVCTS-GNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAA  171 (289)
Q Consensus       100 e~~~~-~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~--~~l~d~g~~~  171 (289)
                      |-+.| .+|.+++.+.  .+.+..+...++.+++..+.-||+.|  +.|+|+.+.||+++.+ +.  +.++||.-+.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence            97765 4899998763  35678888999999999999999999  9999999999999866 56  9999996443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=1.2e-08  Score=82.02  Aligned_cols=109  Identities=20%  Similarity=0.190  Sum_probs=83.6

Q ss_pred             HHHHHHHHHHHHhCCCCce--EEeeeeEEeCC--CCeeEEEeccccCC-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 022956           62 VNRLHSEVQLLRTLKNKYI--IVCYSVWLDDQ--HNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQVLEGLEYL  136 (289)
Q Consensus        62 ~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~--~~~~~lv~e~~~~~-sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~l  136 (289)
                      ..+..+|...+..|...+|  +..+.+.....  ....++|+|++++. +|.+++.....++......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3457778887777754443  23333332211  13458899999885 8999998755577888899999999999999


Q ss_pred             hcCCCCceecCCCCCceEEeCCCC---cEEEeccCCcccc
Q 022956          137 HTHEPCIIHRDLNCSNIFINGNIG---QVKIGDLGFAAIV  173 (289)
Q Consensus       137 h~~~~~~~h~dl~~~nili~~~~~---~~~l~d~g~~~~~  173 (289)
                      |..|  ++|+|+++.|||++.+ +   .+.++||+-+...
T Consensus       135 H~~g--i~H~Dl~~~NILv~~~-~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAG--IYHGDLNPSNILVDPD-DGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCc--CCCCCCCcccEEEeCC-CCceeEEEEcchhceeC
Confidence            9999  9999999999999988 5   7999999876643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.73  E-value=8.5e-08  Score=91.58  Aligned_cols=211  Identities=23%  Similarity=0.347  Sum_probs=152.0

Q ss_pred             HHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC--eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 022956           60 VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN--TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH  137 (289)
Q Consensus        60 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh  137 (289)
                      ..+....-|...+....|+|++..+.+.+.....  ...+..+++..-++...++.-..++...++.+..++..++.++|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            3455667788888999999999988777654321  23446788888899999998888999999999999999999999


Q ss_pred             cCCCCceecCCCCC---ceEEeCCCCcEEEe--ccCCccccCCccccccCCCCCCCCCCcccccC---CCCcchHHHHHH
Q 022956          138 THEPCIIHRDLNCS---NIFINGNIGQVKIG--DLGFAAIVGRSHAAHSIIGTPEYMAPELYEED---YTEMVDIYSFGL  209 (289)
Q Consensus       138 ~~~~~~~h~dl~~~---nili~~~~~~~~l~--d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~  209 (289)
                      +..  ..|.-+..+   +.-++.. +.+...  ||+.+.................+.++|.....   .+..+|+|++|.
T Consensus       304 ~~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  304 SLS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             Hhc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            987  666666555   4444444 566666  88888877666655555566677778865543   344579999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          210 CLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       210 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      ....+..|..+-.....            ..............+++.+|+. ++++|+++.+++.|+|.+-......
T Consensus       381 l~~~~~~~~~i~~~~~~------------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV------------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             HHhhhhhcCcccccccc------------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            99999887543221110            0111112122267888999997 9999999999999999887655443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.73  E-value=2.5e-07  Score=75.46  Aligned_cols=135  Identities=17%  Similarity=0.204  Sum_probs=79.3

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce--EEeeeeEEeCCCCeeEEEec
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI--IVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ..||+|..+.||+.    .|..+++|......   .   ...+.+|.++++.+..-++  ++.+.+.  +..+...+||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~---~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---D---KETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC---C---HHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeee
Confidence            56899999999984    25578888886432   1   3446789999988875544  3444433  33356788999


Q ss_pred             cccCCc-HHHH--------------HHh-----c----CCCCHHHHH-HHHH----------HHHHH-HHHH--hcCCCC
Q 022956          101 VCTSGN-LRTY--------------RKK-----H----RHVSIKALK-KWSK----------QVLEG-LEYL--HTHEPC  142 (289)
Q Consensus       101 ~~~~~s-L~~~--------------~~~-----~----~~l~~~~~~-~~~~----------ql~~~-l~~l--h~~~~~  142 (289)
                      +++|.. +...              +..     +    ...+..... .+..          .+... ..+|  +...+.
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            999963 2111              100     0    001111000 0000          00111 1111  122334


Q ss_pred             ceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          143 IIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       143 ~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ++|+|+.|.||+++++ + +.++||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~-~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGK-G-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCC-C-cEEEechhcC
Confidence            8999999999999987 6 9999998665

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.70  E-value=1.9e-07  Score=75.34  Aligned_cols=144  Identities=19%  Similarity=0.187  Sum_probs=98.3

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC--------------------HHHHHHHHHHHHHHHhCCCCce-
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--------------------PVLVNRLHSEVQLLRTLKNKYI-   80 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~~~~i-   80 (289)
                      .--|++|.-+.||+|.. .++..+|+|+++.......                    ........+|...|+++...++ 
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34566788889999864 5689999999987433111                    1122346778888888865543 


Q ss_pred             -EEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCC
Q 022956           81 -IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        81 -~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~  158 (289)
                       ++.+.+.  .    -.+||||+.....---.-+.-++..+++..+..+++..+.-|-. .+  ++|+||+.-|||+. +
T Consensus       132 vP~Pi~~~--~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~  202 (268)
T COG1718         132 VPEPIAFR--N----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-D  202 (268)
T ss_pred             CCCceeec--C----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-C
Confidence             4445442  2    46799998664211111112234444788888888888888866 78  99999999999999 4


Q ss_pred             CCcEEEeccCCccccCCc
Q 022956          159 IGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~~~~  176 (289)
                       +.+.++|++.+.....+
T Consensus       203 -~~p~iID~~QaV~~~hp  219 (268)
T COG1718         203 -GEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             -CeEEEEECccccccCCC
Confidence             68999999988765533

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.61  E-value=4.1e-07  Score=72.62  Aligned_cols=66  Identities=18%  Similarity=0.305  Sum_probs=52.4

Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ..+++|||++|..|.+..+    +++    .+...+++++.-+|+.|  ++|||.+|.|++++.+  .+++.|++...
T Consensus       117 ~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~--~i~iID~~~k~  182 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN--GIRIIDTQGKR  182 (229)
T ss_pred             EEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC--cEEEEECcccc
Confidence            4678999999988877543    332    24455677789999999  9999999999999965  59999997554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.60  E-value=8e-07  Score=68.04  Aligned_cols=136  Identities=23%  Similarity=0.154  Sum_probs=97.1

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .--+..+.|+.|..|.||++.+.  |..+|+|+-+....      +..+..|+++|..+...++.+-+..+  ..   -.
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~------r~~l~kEakiLeil~g~~~~p~vy~y--g~---~~   88 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP------RRNLEKEAKILEILAGEGVTPEVYFY--GE---DF   88 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc------hhhHHHHHHHHHHhhhcCCCceEEEe--ch---hh
Confidence            33356688999999999999775  77999999875443      67889999999999888876655444  22   23


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCC-C-CceEEeCCCCcEEEeccCCccccC
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN-C-SNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~-~-~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +.|||+.|-+|.++-...   +-.++    ..++++-.-|...|  +-|+.|+ | .||++.+  +.+.|+||..|++..
T Consensus        89 i~me~i~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~--~~~~iIDFd~At~k~  157 (201)
T COG2112          89 IRMEYIDGRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLG--IEHGELSRPWKNVLVND--RDVYIIDFDSATFKK  157 (201)
T ss_pred             hhhhhhcCcchhhhhhcc---cHHHH----HHHHHHHHHHHHhc--cchhhhcCCceeEEecC--CcEEEEEccchhhcc
Confidence            459999998887766542   22333    33555555567778  9999886 3 4555554  489999999888554


Q ss_pred             Cc
Q 022956          175 RS  176 (289)
Q Consensus       175 ~~  176 (289)
                      .+
T Consensus       158 ~p  159 (201)
T COG2112         158 KP  159 (201)
T ss_pred             CC
Confidence            33

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.57  E-value=1.5e-06  Score=70.98  Aligned_cols=80  Identities=19%  Similarity=0.165  Sum_probs=55.1

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc--eEEeeeeEEeC-CCCeeEEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSVWLDD-QHNTLNFI   98 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~-~~~~~~lv   98 (289)
                      .+.|+.|..+.||++....  ..+++|.....      .....+.+|..+++.+....  ++.++...... .....+.+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence            4678999999999997653  59999997632      34567778888888885443  44555432222 22457889


Q ss_pred             eccccCCcHHH
Q 022956           99 TEVCTSGNLRT  109 (289)
Q Consensus        99 ~e~~~~~sL~~  109 (289)
                      |++++|.++..
T Consensus        74 ~~~i~g~~~~~   84 (239)
T PF01636_consen   74 MEYIPGRPLDD   84 (239)
T ss_dssp             EEEESSEEHHH
T ss_pred             EEEeccccccc
Confidence            99999988777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.55  E-value=6e-07  Score=81.14  Aligned_cols=144  Identities=17%  Similarity=0.191  Sum_probs=91.5

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccC--------------------------CC----HHHHHH------HH
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--------------------------ED----PVLVNR------LH   66 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--------------------------~~----~~~~~~------~~   66 (289)
                      +-|+.++-|-||+|+.+ +|+.||||+.+..-..                          +-    .+..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            55899999999999976 5999999997652110                          00    011222      23


Q ss_pred             HHHHHHHhCC-----CCceEEeeeeEEeCCCCeeEEEeccccCCcHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHhcC
Q 022956           67 SEVQLLRTLK-----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYR--KKHRHVSIKALKKWSKQVLEGLEYLHTH  139 (289)
Q Consensus        67 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh~~  139 (289)
                      +|...+.+++     .+.+ .+=.+|.+-+ +.-.++|||++|..+.+..  .. ...+.+.+.....++.-  ..+=..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-Eeceeehhcc-CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhc
Confidence            3333333332     2333 2223333212 2467899999999888874  33 34554444444333332  222236


Q ss_pred             CCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956          140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus       140 ~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |  ++|.|.+|.||+++.+ |.+.+.|||+....+.
T Consensus       285 g--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 G--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP  317 (517)
T ss_pred             C--ccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence            7  9999999999999999 9999999999987754

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.31  E-value=5.7e-06  Score=74.76  Aligned_cols=151  Identities=14%  Similarity=0.144  Sum_probs=92.8

Q ss_pred             Cccccee-eeecccCcceEEEEeecCCCcEEEEEEeeecccCC---------------------------CHHHHHHHHH
Q 022956           16 GRFGRYS-DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE---------------------------DPVLVNRLHS   67 (289)
Q Consensus        16 ~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~---------------------------~~~~~~~~~~   67 (289)
                      +-|..+. +-||..+.|.|++|+.+ +|+.||||+-+..-...                           -.+..+.+..
T Consensus       159 ~if~~f~~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~  237 (538)
T KOG1235|consen  159 DIFSEFDEEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQ  237 (538)
T ss_pred             HHHHhcCcchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHh
Confidence            3344444 56999999999999876 49999999965421100                           0112222333


Q ss_pred             HHHHH----------HhCCCCc------eEEeeeeEEeCCCCeeEEEeccccCCcHHHH--HHhcCCCCHHHHHHHHHHH
Q 022956           68 EVQLL----------RTLKNKY------IIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQV  129 (289)
Q Consensus        68 e~~~l----------~~l~~~~------i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~--~~~~~~l~~~~~~~~~~ql  129 (289)
                      |++++          +.+.|-+      |++++-.+   + ....++|||++|..+.|.  +.+. .++...+..-+.++
T Consensus       238 ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---s-t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~  312 (538)
T KOG1235|consen  238 ELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL---S-TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEA  312 (538)
T ss_pred             hcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc---C-cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHH
Confidence            32222          2233433      33444332   2 347899999999866554  3333 36655444444443


Q ss_pred             HHHHHHHhcCCCCceecCCCCCceEEeC---CCCcEEEeccCCccccCCc
Q 022956          130 LEGLEYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus       130 ~~~l~~lh~~~~~~~h~dl~~~nili~~---~~~~~~l~d~g~~~~~~~~  176 (289)
                      ..-+  +=..|  ++|+|-+|.||++++   +...+.+.|+|+.......
T Consensus       313 ~~~q--If~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  313 YLEQ--IFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHH--HHhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            3322  23457  999999999999984   2378999999999876543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.31  E-value=9.1e-06  Score=67.17  Aligned_cols=74  Identities=15%  Similarity=0.065  Sum_probs=46.9

Q ss_pred             ecccCc-ceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCCCeeEEEeccc
Q 022956           25 LGSGAV-KKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        25 lg~g~~-g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      |..|.. ..||++...  +..+++|......       ...+.+|+++++.+.. --+++++.....  ++..++||+++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i   74 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAV   74 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEee
Confidence            444444 789999643  4678888876432       2345668888887743 223455544322  24578899999


Q ss_pred             cCCcHHH
Q 022956          103 TSGNLRT  109 (289)
Q Consensus       103 ~~~sL~~  109 (289)
                      +|.++..
T Consensus        75 ~G~~l~~   81 (244)
T cd05150          75 PGVPAAA   81 (244)
T ss_pred             CCccHhH
Confidence            9987754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.29  E-value=8.1e-08  Score=86.49  Aligned_cols=244  Identities=19%  Similarity=0.204  Sum_probs=155.7

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc-eEEeeeeEEeCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY-IIVCYSVWLDDQ   91 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~   91 (289)
                      +....+ ...+-.+.++++++++.+...+.... .+.+...         ....-++++|.+++||| .+.-++.+  +.
T Consensus       239 Dk~kws-~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~  305 (829)
T KOG0576|consen  239 DKTKWS-EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DG  305 (829)
T ss_pred             CCccch-HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Cc
Confidence            444444 56778999999999998776554444 5655432         23344788999999999 33333333  34


Q ss_pred             CCeeEEEeccccCC-cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 HNTLNFITEVCTSG-NLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 ~~~~~lv~e~~~~~-sL~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      ..+.++.++++.++ +-...+. ....+.+-+...+.+.-..+++++|+.-  -+|+|    ||+...  +..+..+++.
T Consensus       306 E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~--~~~~~~~~~v  377 (829)
T KOG0576|consen  306 EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE--EEVKLLDFAV  377 (829)
T ss_pred             ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc--cccccccccC
Confidence            46889999999887 3222221 1123444555666777788899999875  46777    777655  4799999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcc-cccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC-CCCCC--CC
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPEL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-KPQAL--NK  245 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~-~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~  245 (289)
                      +..+..........+++.++|||. ..+.+..+.|.|++|.-..++.-|-.|-........   .+..+. .+...  ..
T Consensus       378 ~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~---~~g~~p~s~~L~~~~a  454 (829)
T KOG0576|consen  378 PPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLP---MIGNGPNSPMLTDKSA  454 (829)
T ss_pred             CcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccccC---CCCCCCCccccchhhh
Confidence            988876666667789999999995 445588899999999877777777666543110000   000000 00000  00


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ..+..-+++...|+. .|..|+.....+-|.+|.+=
T Consensus       455 w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  455 WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            001111245667777 78888888888888777653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.23  E-value=1e-05  Score=66.53  Aligned_cols=74  Identities=9%  Similarity=0.003  Sum_probs=43.9

Q ss_pred             eeecccCcc-eEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCC---ceEEeeeeEEeCCC-CeeEE
Q 022956           23 DLLGSGAVK-KVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK---YIIVCYSVWLDDQH-NTLNF   97 (289)
Q Consensus        23 ~~lg~g~~g-~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~-~~~~l   97 (289)
                      +-|+.|+.. .||++     +..+++|..+..      .....+.+|.++++.+...   .++..+......+. ...++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            457766666 58987     235777765431      1234688899999888642   23333332211111 23478


Q ss_pred             EeccccCCcH
Q 022956           98 ITEVCTSGNL  107 (289)
Q Consensus        98 v~e~~~~~sL  107 (289)
                      +|++++|.++
T Consensus        72 l~~~i~G~~l   81 (235)
T cd05155          72 VYRWLEGETA   81 (235)
T ss_pred             EEEeecCCCC
Confidence            8999999766

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.18  E-value=3.7e-05  Score=74.52  Aligned_cols=149  Identities=17%  Similarity=0.259  Sum_probs=88.0

Q ss_pred             eeeecccCcceEEEEeecCCC--cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCce--EEeeeeEEeCC-CCee
Q 022956           22 SDLLGSGAVKKVYRAFDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYI--IVCYSVWLDDQ-HNTL   95 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~~-~~~~   95 (289)
                      .+.|+.|.+..+|++.....+  ..+++|+........   ....+.+|+++++.+. |+++  ++++..+.+.+ .+..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            567899999999998764332  467788765432211   1346778999999995 6665  45554442221 1356


Q ss_pred             EEEeccccCCcHHH--------------------HHHh-c----C--CC---------CHHHHHHHHHH-----------
Q 022956           96 NFITEVCTSGNLRT--------------------YRKK-H----R--HV---------SIKALKKWSKQ-----------  128 (289)
Q Consensus        96 ~lv~e~~~~~sL~~--------------------~~~~-~----~--~l---------~~~~~~~~~~q-----------  128 (289)
                      ++|||+++|..+.+                    .+.. +    .  .+         ...++..|..+           
T Consensus       120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~  199 (822)
T PLN02876        120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP  199 (822)
T ss_pred             eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence            78999999865321                    1110 0    0  00         01233332222           


Q ss_pred             ----HHHHHHHHhcCC---------CCceecCCCCCceEEeCCCC-cEEEeccCCcccc
Q 022956          129 ----VLEGLEYLHTHE---------PCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIV  173 (289)
Q Consensus       129 ----l~~~l~~lh~~~---------~~~~h~dl~~~nili~~~~~-~~~l~d~g~~~~~  173 (289)
                          +...+.+|..+-         +.++|+|+++.||+++++.+ ..-+.||+++..-
T Consensus       200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence                223345553321         23999999999999986423 3579999987643

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.16  E-value=3.2e-05  Score=66.12  Aligned_cols=143  Identities=20%  Similarity=0.267  Sum_probs=104.8

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeeccc--------------------CCCH--HHHHHHHHHHHHHHhCCCCce
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--------------------SEDP--VLVNRLHSEVQLLRTLKNKYI   80 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~--------------------~~~~--~~~~~~~~e~~~l~~l~~~~i   80 (289)
                      .-|.+|--+.||.|.. .+|..+|||+++.+-+                    ..++  -..-....|+..|.+|....|
T Consensus       150 GCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  150 GCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             cccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3367888899999974 5789999999876321                    0111  123347788999999988876


Q ss_pred             EEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCCCceEEeCCC
Q 022956           81 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL-HTHEPCIIHRDLNCSNIFINGNI  159 (289)
Q Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~l-h~~~~~~~h~dl~~~nili~~~~  159 (289)
                      +..--+.+..    -.|||+|+.........-+...++...+..+-.+++.-+.-| +..+  ++|.||+-=|+|+..  
T Consensus       229 P~PePIlLk~----hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd--  300 (520)
T KOG2270|consen  229 PCPEPILLKN----HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD--  300 (520)
T ss_pred             CCCCceeeec----ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC--
Confidence            6444444333    578999997644444444456688888999999998888888 6668  999999999999986  


Q ss_pred             CcEEEeccCCccccC
Q 022956          160 GQVKIGDLGFAAIVG  174 (289)
Q Consensus       160 ~~~~l~d~g~~~~~~  174 (289)
                      |.++++|.+.+....
T Consensus       301 G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHD  315 (520)
T ss_pred             CEEEEEEccccccCC
Confidence            589999998776544

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.06  E-value=0.00015  Score=57.62  Aligned_cols=136  Identities=21%  Similarity=0.294  Sum_probs=90.8

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCC------------CHHHHHHHHHHHHHHHhCC------CCceEEee
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE------------DPVLVNRLHSEVQLLRTLK------NKYIIVCY   84 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~~~e~~~l~~l~------~~~i~~~~   84 (289)
                      ..||+|+.-.||.-   ..+....||+........            .....+...+|++....+.      +.+|..++
T Consensus         7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46999999999986   345677899988765000            0112455566666666665      77889999


Q ss_pred             eeEEeCCCCeeEEEeccccC------CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC
Q 022956           85 SVWLDDQHNTLNFITEVCTS------GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        85 ~~~~~~~~~~~~lv~e~~~~------~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~  158 (289)
                      |...++  ....+|+|.+..      .+|.+++.++ .++. ...+.+.++..   +|-+.+  ++.+|++|.||++..+
T Consensus        84 G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~~f~~---~l~~~~--Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVETN--LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALDEFKR---YLLDHH--IVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEecC--CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHHHHHH---HHHHcC--CeecCCCcccEEEEec
Confidence            988554  457778887544      2688888654 3665 55555555444   566777  9999999999999544


Q ss_pred             C-C--cEEEec-cCCc
Q 022956          159 I-G--QVKIGD-LGFA  170 (289)
Q Consensus       159 ~-~--~~~l~d-~g~~  170 (289)
                      . +  .++++| ||..
T Consensus       155 ~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCCceEEEEEeCCCCc
Confidence            2 2  467776 4433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.99  E-value=0.0001  Score=60.53  Aligned_cols=75  Identities=12%  Similarity=0.062  Sum_probs=46.3

Q ss_pred             eeecccCcceEEEEeecC-CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      +.|..|-...+|++.... ++..|++|+......    . .-...+|+.+++.+...++.+-+-.. ...    .+++||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~-~~d~~~E~~~~~~l~~~gl~P~v~~~-~~~----~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----L-IIDRERELRIHKLLSKHGLAPKLYAT-FQN----GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----c-eecHHHHHHHHHHHHhCCCCCeEEEE-eCC----cEEEEe
Confidence            567888888999996432 357899997753211    1 11234688888888654444332112 121    369999


Q ss_pred             ccCCcH
Q 022956          102 CTSGNL  107 (289)
Q Consensus       102 ~~~~sL  107 (289)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            999765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.98  E-value=0.00014  Score=57.60  Aligned_cols=128  Identities=19%  Similarity=0.299  Sum_probs=87.2

Q ss_pred             ceeeeecccCc-ceEEEEeecCCCcEEEEEEeeecccC----------CCH-------HHHHHHHHHHHHHHhCCC---C
Q 022956           20 RYSDLLGSGAV-KKVYRAFDQEEGIEVAWNQVRLSHFS----------EDP-------VLVNRLHSEVQLLRTLKN---K   78 (289)
Q Consensus        20 ~~~~~lg~g~~-g~v~~~~~~~~~~~~aiK~~~~~~~~----------~~~-------~~~~~~~~e~~~l~~l~~---~   78 (289)
                      ++.+.||.|.- |.||++..  +|..||+|+++.-...          ..+       ....-|..|.+...+|+.   .
T Consensus        40 ~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e  117 (207)
T PF13095_consen   40 EFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE  117 (207)
T ss_pred             eeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence            57899999999 99999976  4889999994431111          011       223457788887777754   4


Q ss_pred             ce--EEeeeeEEeCC----------------CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 022956           79 YI--IVCYSVWLDDQ----------------HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE  140 (289)
Q Consensus        79 ~i--~~~~~~~~~~~----------------~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~  140 (289)
                      ++  ++++++..-+.                .....||.||++...         .++...+    .+|.+-+..+|+.|
T Consensus       118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~----~~~~~dl~~~~k~g  184 (207)
T PF13095_consen  118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDI----PQMLRDLKILHKLG  184 (207)
T ss_pred             CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHH----HHHHHHHHHHHHCC
Confidence            45  88888774321                113466777776532         3444444    44666677799999


Q ss_pred             CCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956          141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus       141 ~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ++-+|+++.|..      .-+|+|||.+
T Consensus       185 --I~~~Dv~~~ny~------~G~lvDfs~~  206 (207)
T PF13095_consen  185 --IVPRDVKPRNYR------GGKLVDFSSS  206 (207)
T ss_pred             --eeeccCcccccc------CCEEEecccC
Confidence              999999999987      3578899854

>PRK10593 hypothetical protein; Provisional

Probab=97.96  E-value=0.00027  Score=60.23  Aligned_cols=78  Identities=10%  Similarity=0.030  Sum_probs=52.2

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCC---ceEEeeeeEEeC-CCCeeEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK---YIIVCYSVWLDD-QHNTLNF   97 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~-~~~~~~l   97 (289)
                      .+-||+|..+.||+....  +..+++|..+....      ...+..|...|+.|...   .++++++.+... ..+.-++
T Consensus        19 ~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         19 VECISEQPYAALWALYDS--QGNPMPLMARSFST------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeecCCccceeEEEEEcC--CCCEEEEEeccccc------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            456999999999998542  33577777543111      25677888988888542   456666654322 2245789


Q ss_pred             EeccccCCcH
Q 022956           98 ITEVCTSGNL  107 (289)
Q Consensus        98 v~e~~~~~sL  107 (289)
                      |||+++|.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.92  E-value=5.4e-05  Score=63.08  Aligned_cols=133  Identities=18%  Similarity=0.236  Sum_probs=74.5

Q ss_pred             ecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-EeeeeEEeCCCCeeEEEecccc
Q 022956           25 LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFITEVCT  103 (289)
Q Consensus        25 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~e~~~  103 (289)
                      +..|....+|++.  .++..+++|.......    ..--...+|..+++.+....+. +++..  ..    -++|+||++
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEecc
Confidence            5667778899885  4577888987653211    1101246688888888654443 33322  22    257899999


Q ss_pred             CCcHHHH--------------HHh-------cCCCCHH-HHHHHHHHH---------HHHHHHHhcC------CCCceec
Q 022956          104 SGNLRTY--------------RKK-------HRHVSIK-ALKKWSKQV---------LEGLEYLHTH------EPCIIHR  146 (289)
Q Consensus       104 ~~sL~~~--------------~~~-------~~~l~~~-~~~~~~~ql---------~~~l~~lh~~------~~~~~h~  146 (289)
                      |..+...              +.+       ..+++.. .+.....++         ...+..+...      ...++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            9765321              111       0111211 111211111         1112222111      1238999


Q ss_pred             CCCCCceEEeCCCCcEEEeccCCcc
Q 022956          147 DLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       147 dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      |+.|.||+++++ + +.++||+.+.
T Consensus       152 Dl~~~Nil~~~~-~-~~lIDwE~a~  174 (256)
T TIGR02721       152 DVHAYNLVVTPQ-G-LKLIDWEYAS  174 (256)
T ss_pred             CCCcCcEEEeCC-C-CEEEeccccC
Confidence            999999999987 5 8899998665

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.86  E-value=0.00065  Score=59.92  Aligned_cols=81  Identities=21%  Similarity=0.273  Sum_probs=52.2

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeeccc--CCC-HHHHHHHHHHHHHHHhCC---CCceEEeeeeEEeCCCCee
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SED-PVLVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~--~~~-~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~   95 (289)
                      .+.||.|.+..||++.+...++.++||.-.....  .+. +...++...|.+.|+.+.   ..++++++.+  ++  ...
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~--~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE--ELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC--CCC
Confidence            3679999999999998864336899998541100  011 123566777888888763   2345556654  22  346


Q ss_pred             EEEeccccCCc
Q 022956           96 NFITEVCTSGN  106 (289)
Q Consensus        96 ~lv~e~~~~~s  106 (289)
                      ++|||++++..
T Consensus       107 ~lVME~L~~~~  117 (401)
T PRK09550        107 VTVMEDLSDHK  117 (401)
T ss_pred             EEEEecCCCcc
Confidence            78999998743

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.76  E-value=5.8e-06  Score=81.57  Aligned_cols=215  Identities=16%  Similarity=0.064  Sum_probs=141.4

Q ss_pred             HHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHh
Q 022956           62 VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLH  137 (289)
Q Consensus        62 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh  137 (289)
                      .+....|...++...|+++.....-....++...+..++++.+|.+++.+.++    .++....+.....+.+....-+|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            44455566667778898887776655555566788899999999999998764    44555555555555455555544


Q ss_pred             cC---CCCceecCCCCCceEEeCCCCcEEEeccCCcccc-CCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHH
Q 022956          138 TH---EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLL  212 (289)
Q Consensus       138 ~~---~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~  212 (289)
                      +.   |--.+|.++++.|.++..+ .++++.++|+.+.. ..........+++-|+.|++...- ++.++|+|.+|+.+|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            43   2236899999999999999 68999999999833 322233344556666777765544 777799999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHhCCC----CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          213 EMVTMEIPYSECDSVAKIYKKVTGGV----KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       213 ~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ....|..+|-      ...+...++.    .-..+....|.........+|- .-..||.-..++..+.|.-...+
T Consensus      1432 ~rs~~n~~fi------~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~~d 1501 (2724)
T KOG1826|consen 1432 LRSDGNAYFI------FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGLRD 1501 (2724)
T ss_pred             HHhcccHHHH------HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccccccC
Confidence            9988887763      2222222221    2222233333444444444444 67778888888887666554433

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.76  E-value=0.00012  Score=57.87  Aligned_cols=101  Identities=21%  Similarity=0.171  Sum_probs=77.2

Q ss_pred             HHHHHHHhCCC-CceEEeeeeEEeCCCCeeEEEeccccCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhcCCC-
Q 022956           67 SEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSKQVLEGLEYLHTHEP-  141 (289)
Q Consensus        67 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~---~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~-  141 (289)
                      .|.-+++.+.+ +++++++|.+  .    -.++.|+...+++.+.   +.+--..++..+.+++.+++..+.+++..-. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            47777888876 6899999987  2    2447899987666431   2222335889999999999999999977411 


Q ss_pred             CceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956          142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      .+.-.|++++|+-++.+ +++|++|.+.+....
T Consensus        82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVED  113 (188)
T ss_pred             cEEEeecchHHeEEeCC-CcEEEEechhcchhH
Confidence            16779999999999988 899999998876553

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.67  E-value=4.2e-05  Score=64.39  Aligned_cols=141  Identities=18%  Similarity=0.218  Sum_probs=95.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC--C---CH-------------HHHHHHHHHHHHHHhCCCCce-
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--E---DP-------------VLVNRLHSEVQLLRTLKNKYI-   80 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~---~~-------------~~~~~~~~e~~~l~~l~~~~i-   80 (289)
                      -++.+||=|--+.||.+.+ +.|.++++|.=+..+..  .   +.             -.+-...+|..+++.|....+ 
T Consensus        95 svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            3578899999999999976 46888888875443221  0   00             012235667888888865443 


Q ss_pred             -EEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC
Q 022956           81 -IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI  159 (289)
Q Consensus        81 -~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~  159 (289)
                       ++.+++      +..++|||++.|..|.....-   ....   .+...++.-+--|..+|  ++|+|++-=||+++++ 
T Consensus       174 VPkpiD~------~RH~Vvmelv~g~Pl~~v~~v---~d~~---~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd-  238 (465)
T KOG2268|consen  174 VPKPIDH------NRHCVVMELVDGYPLRQVRHV---EDPP---TLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDD-  238 (465)
T ss_pred             CCCcccc------cceeeHHHhhcccceeeeeec---CChH---HHHHHHHHHHHHHHHcC--ceecccchheeEEecC-
Confidence             333432      457889999999888765432   1222   33344444555677899  9999999999999987 


Q ss_pred             CcEEEeccCCccccCCc
Q 022956          160 GQVKIGDLGFAAIVGRS  176 (289)
Q Consensus       160 ~~~~l~d~g~~~~~~~~  176 (289)
                      +.++++||..+...+.+
T Consensus       239 ~~i~vIDFPQmvS~sh~  255 (465)
T KOG2268|consen  239 DKIVVIDFPQMVSTSHP  255 (465)
T ss_pred             CCEEEeechHhhccCCC
Confidence            79999999776554433

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.63  E-value=0.00048  Score=58.62  Aligned_cols=140  Identities=14%  Similarity=0.107  Sum_probs=77.2

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc--eEEeeee----EEeCCCCee
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSV----WLDDQHNTL   95 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~----~~~~~~~~~   95 (289)
                      .+.|..|....+|++..  ++..+++|+....    .   ...+..|+.++..+.+.+  +++++..    ....-++..
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~----~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV----S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC----C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            35577787789999853  3557999987641    1   234555777777774333  3333321    111112356


Q ss_pred             EEEeccccCCcHHH-----H------HH------hc--CC-----C-CHHHH--H--------HHHHHHHHHHHHHhc--
Q 022956           96 NFITEVCTSGNLRT-----Y------RK------KH--RH-----V-SIKAL--K--------KWSKQVLEGLEYLHT--  138 (289)
Q Consensus        96 ~lv~e~~~~~sL~~-----~------~~------~~--~~-----l-~~~~~--~--------~~~~ql~~~l~~lh~--  138 (289)
                      +.|+++++|..+..     .      +.      .+  ..     . .....  .        .....+..++..+.+  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            78999999976421     0      00      00  00     0 00000  0        001112233344432  


Q ss_pred             ---CCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          139 ---HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       139 ---~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                         ....++|+|+.|.||+++.+ +.+.|.||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence               11139999999999999987 667899997654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.62  E-value=0.0002  Score=63.91  Aligned_cols=163  Identities=20%  Similarity=0.274  Sum_probs=101.0

Q ss_pred             HHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 022956           63 NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC  142 (289)
Q Consensus        63 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~  142 (289)
                      ..+.-...+++.+.|++....+.+... ...+..+|+|++. .||.+.+..+. +-.....              .++  
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~-~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~--   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRG-KHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHG--   87 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecC-ccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccc--
Confidence            456677899999999999998876544 3456888999995 49999988754 3222222              122  


Q ss_pred             ceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCC
Q 022956          143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYS  222 (289)
Q Consensus       143 ~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~  222 (289)
                      +.|-             +.++.+| .+++..                 |-    ...+++|||++|.++.++.-|..-+.
T Consensus        88 ~~~~-------------~~~~~td-~~~t~~-----------------~~----~~~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   88 VLHL-------------NIIYITD-HFLTKY-----------------PS----PIGPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             ccee-------------hhhhccc-cccccC-----------------CC----CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence            2222             2333333 111100                 00    01258999999999999999877765


Q ss_pred             CCCcHHHHHHHHhCC-CCCCC---------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          223 ECDSVAKIYKKVTGG-VKPQA---------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       223 ~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .....+.. ..+.+. ..+..         ..--.+....++..+|+. .|..||...++.+++-|++.
T Consensus       133 ~~~~s~~l-~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  133 ELTESEYL-EILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHH-HHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            43333222 222221 11111         011135566788889997 99999999999998887653

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.46  E-value=0.0018  Score=55.22  Aligned_cols=75  Identities=19%  Similarity=0.199  Sum_probs=45.6

Q ss_pred             eeecccCcceEEEEeecC------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-EeeeeEEeCCCCee
Q 022956           23 DLLGSGAVKKVYRAFDQE------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTL   95 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~   95 (289)
                      +.|..|-.-.+|++....      +++.+++|+......     ......+|.++++.+...++. +++..+  .+    
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----   72 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-----LLIDRERELVVFARLSERNLGPKLYGIF--PN----   72 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-----ceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence            446666666888886532      268899999764321     123456688888887654443 333332  22    


Q ss_pred             EEEeccccCCcHH
Q 022956           96 NFITEVCTSGNLR  108 (289)
Q Consensus        96 ~lv~e~~~~~sL~  108 (289)
                      ..|++|++|.++.
T Consensus        73 ~~v~e~i~G~~l~   85 (302)
T cd05156          73 GRIEEFIPSRTLT   85 (302)
T ss_pred             CchhheeCCCcCC
Confidence            2478999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.46  E-value=0.0018  Score=55.43  Aligned_cols=141  Identities=15%  Similarity=0.118  Sum_probs=75.3

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc--eEEeeee----EEeCCCCee
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSV----WLDDQHNTL   95 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~----~~~~~~~~~   95 (289)
                      .+.++.|....+|++..  ++..+++|+.....   ..   ..+..++.++..|...+  +++++..    ....-++..
T Consensus        27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~---~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV---KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             ccccCCccccceEEEEe--CCCcEEEEEecCCC---CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            34567777788999853  34468889875421   12   23344566666664322  2333321    111123457


Q ss_pred             EEEeccccCCcHH-----HH------HHh----cCCC--------CHH---HH-H-----------HHHHHHHHHHHHHh
Q 022956           96 NFITEVCTSGNLR-----TY------RKK----HRHV--------SIK---AL-K-----------KWSKQVLEGLEYLH  137 (289)
Q Consensus        96 ~lv~e~~~~~sL~-----~~------~~~----~~~l--------~~~---~~-~-----------~~~~ql~~~l~~lh  137 (289)
                      +++++|++|..+.     .+      +..    ...+        ...   .. .           .....+...+.++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8899999985431     11      100    0000        000   00 0           00111223444443


Q ss_pred             c-----CCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          138 T-----HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       138 ~-----~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .     ...+++|+|+++.||+++.+ +.+.+.||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence            2     11239999999999999988 667899998654

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.43  E-value=0.0054  Score=52.79  Aligned_cols=28  Identities=32%  Similarity=0.482  Sum_probs=24.3

Q ss_pred             ceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          143 IIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       143 ~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ++|+|+.+.||+++.+ ...-++||+.+.
T Consensus       189 liHgD~~~~Nil~~~~-~~~~iIDf~~~~  216 (319)
T PRK05231        189 VIHADLFRDNVLFEGD-RLSGFIDFYFAC  216 (319)
T ss_pred             cCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence            9999999999999966 456899998765

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.41  E-value=0.0024  Score=54.46  Aligned_cols=142  Identities=13%  Similarity=0.158  Sum_probs=78.7

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE--EeeeeEEeCCCCeeEEEe
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII--VCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.+..|..-.+|.....  ++.++++ ...  ............+|+.+++.+..--+.  ..++.+.+..-...+.||
T Consensus        30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             eeeccCCcccceEEEecC--CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            344434444455555443  8889888 321  111233456677888888888643332  333333222113568899


Q ss_pred             ccccCCcHHHHHHhcCCCCHHHHHHHH-HHHHHHHHHHh-----------------------------------------
Q 022956          100 EVCTSGNLRTYRKKHRHVSIKALKKWS-KQVLEGLEYLH-----------------------------------------  137 (289)
Q Consensus       100 e~~~~~sL~~~~~~~~~l~~~~~~~~~-~ql~~~l~~lh-----------------------------------------  137 (289)
                      +|++|..+.+....   .+  ...+.+ ..+...|.-||                                         
T Consensus       105 ~~veGe~~~~~~~~---~~--~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         105 EWVEGEVVWSALPP---ES--LGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             EEecceeccCcCCc---cc--chHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            99999433221110   00  001111 13333333333                                         


Q ss_pred             ---------cCCC------CceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956          138 ---------THEP------CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus       138 ---------~~~~------~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                               .+.+      .++|||+.+.|++++++ +-+-+.||+++..-.
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGD  230 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCC
Confidence                     2222      59999999999999998 569999999887543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.31  E-value=0.0037  Score=52.65  Aligned_cols=29  Identities=24%  Similarity=0.382  Sum_probs=24.2

Q ss_pred             CceecCCCCCceEEeCCCCc-EEEeccCCcc
Q 022956          142 CIIHRDLNCSNIFINGNIGQ-VKIGDLGFAA  171 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~~~-~~l~d~g~~~  171 (289)
                      .++|+|+++.||+++.+ +. .-|.||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDED-ARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCC-CCEEEEECcHhcc
Confidence            48999999999999975 44 5699998665

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.23  E-value=0.0061  Score=52.89  Aligned_cols=84  Identities=18%  Similarity=0.184  Sum_probs=50.0

Q ss_pred             eecccCcceEEEEeecCCCcEEEEEEeeecc--cCCC-HHHHHHHHHHHHHHHhCCC--Cc-eEEeeeeEEeCCCCeeEE
Q 022956           24 LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSH--FSED-PVLVNRLHSEVQLLRTLKN--KY-IIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        24 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~--~~~~-~~~~~~~~~e~~~l~~l~~--~~-i~~~~~~~~~~~~~~~~l   97 (289)
                      .||.|....||++.+...++.++||.-..--  ..++ +-..++..-|...|+....  |. +++++. + ++  ....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~--e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DT--EMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-cc--cccee
Confidence            4799999999999875444689998743211  0111 2234555667777777642  54 444443 3 22  34567


Q ss_pred             EeccccCC-cHHHHH
Q 022956           98 ITEVCTSG-NLRTYR  111 (289)
Q Consensus        98 v~e~~~~~-sL~~~~  111 (289)
                      +||+++.. .|.+.+
T Consensus        78 vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        78 VMEDLSHHKIARKGL   92 (370)
T ss_pred             hHhhCccchHHHHHH
Confidence            89998654 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.16  E-value=0.0036  Score=54.55  Aligned_cols=138  Identities=16%  Similarity=0.197  Sum_probs=77.7

Q ss_pred             eeecccCcceEEEEeecC----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-EeeeeEEeCCCCeeEE
Q 022956           23 DLLGSGAVKKVYRAFDQE----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNF   97 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~l   97 (289)
                      +.|..|-.-.+|++....    +++.|++|+.....    +..+.+ .+|..+++.+...++. ++++.+  .. .   .
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~-g---~  110 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PN-G---R  110 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CC-c---e
Confidence            456567777899986432    24689999886432    222222 6688888888765554 334333  22 2   3


Q ss_pred             EeccccCCcHHHH--------------HHh---cC------CCCHHHHHHHHHHH-----------------HHHHHH--
Q 022956           98 ITEVCTSGNLRTY--------------RKK---HR------HVSIKALKKWSKQV-----------------LEGLEY--  135 (289)
Q Consensus        98 v~e~~~~~sL~~~--------------~~~---~~------~l~~~~~~~~~~ql-----------------~~~l~~--  135 (289)
                      |++|++|.+|...              +.+   ..      ......+..+..++                 ...+..  
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            7888887665311              110   00      01112233332221                 111111  


Q ss_pred             --Hhc--CCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          136 --LHT--HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       136 --lh~--~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                        +..  ....++|+|+++.||+++.+.+.+.++||+.+.
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence              111  112389999999999998643689999998765

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.11  E-value=0.0086  Score=52.89  Aligned_cols=77  Identities=14%  Similarity=0.037  Sum_probs=48.2

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeeccc-CCC--HHHHHHHHHHHHHHHhCC---CCceEEeeeeEEeCCCCee
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SED--PVLVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~   95 (289)
                      .+.||.|..-.||++.+.  +..++||.-..... ...  +....+...|+..|+.+.   ...+++++.+.  +  ..-
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~~  110 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TMA  110 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CCC
Confidence            577999999999999763  55788988652111 000  112344445677776664   23566666553  2  335


Q ss_pred             EEEeccccC
Q 022956           96 NFITEVCTS  104 (289)
Q Consensus        96 ~lv~e~~~~  104 (289)
                      +++||++++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            778999977

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.10  E-value=0.0046  Score=54.28  Aligned_cols=86  Identities=22%  Similarity=0.308  Sum_probs=53.0

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeec-ccCCC-HHHHHHHHHHHHHHHhCCC--Cc-eEEeeeeEEeCCCCeeE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS-HFSED-PVLVNRLHSEVQLLRTLKN--KY-IIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~-~~~~~-~~~~~~~~~e~~~l~~l~~--~~-i~~~~~~~~~~~~~~~~   96 (289)
                      .+.||.|.-..||++.+...+..++||.-..- +...+ +-..++..-|...|+.+..  |. +++++. + ++  ....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~--e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DS--VMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-Cc--HHhh
Confidence            46789999999999987544678999874321 11111 3335666668788877642  54 444543 3 22  4566


Q ss_pred             EEeccccCC-cHHHHH
Q 022956           97 FITEVCTSG-NLRTYR  111 (289)
Q Consensus        97 lv~e~~~~~-sL~~~~  111 (289)
                      +|||+++.. .|.+.+
T Consensus       110 ~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        110 CVMEDLSDHTILRTAL  125 (409)
T ss_pred             HHHHhCcccHHHHHHH
Confidence            789998653 344443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.96  E-value=0.0058  Score=52.94  Aligned_cols=140  Identities=14%  Similarity=0.208  Sum_probs=76.3

Q ss_pred             eeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-EeeeeEEeCCCCeeEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNF   97 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~l   97 (289)
                      .+.|..|-.-.+|++.....   +..|++|+.....    +. .-.-.+|..+++.+...++- ++++.+  .. .   +
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~-~IdR~~E~~il~~l~~~gl~P~~l~~~--~~-G---~   87 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DY-VIDRERELQAIKYLSAAGFGAKLLGVF--GN-G---M   87 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc----Ce-EechHHHHHHHHHHHhcCCCCceeEEe--CC-c---E
Confidence            34555577777888864322   3478899876421    11 12225688888888765554 334333  22 1   4


Q ss_pred             EeccccCCcHHH-------HH-------Hh--c-C-C----C-CHHHHHHHHHHH-------------------------
Q 022956           98 ITEVCTSGNLRT-------YR-------KK--H-R-H----V-SIKALKKWSKQV-------------------------  129 (289)
Q Consensus        98 v~e~~~~~sL~~-------~~-------~~--~-~-~----l-~~~~~~~~~~ql-------------------------  129 (289)
                      |.+|++|.+|..       .+       .+  . + +    . ....+..+..++                         
T Consensus        88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  167 (330)
T PLN02421         88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE  167 (330)
T ss_pred             eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence            789988765521       01       10  0 0 0    1 112222222111                         


Q ss_pred             HHHHHHH-hcCC--CCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956          130 LEGLEYL-HTHE--PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus       130 ~~~l~~l-h~~~--~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +..+..+ ...+  ..++|+|+.+.||+++++.+.++++||+.+..
T Consensus       168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1111111 1111  13899999999999986536899999987754

>PTZ00384 choline kinase; Provisional

Probab=96.78  E-value=0.011  Score=52.20  Aligned_cols=80  Identities=14%  Similarity=0.063  Sum_probs=43.8

Q ss_pred             eeeecccCcceEEEEeecCC-CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-EeeeeEEeCCCCeeEEEe
Q 022956           22 SDLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~   99 (289)
                      .+.|..|-...+|++..... +..+.+|.+.........+..-.-.+|+++++.+...++. ++++.+  .    -+++.
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f--~----~g~l~  128 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF--G----DFTIQ  128 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec--C----CEEEE
Confidence            45566688888999865432 2233333221111111111112235588889898766665 444443  2    25789


Q ss_pred             ccccCCcH
Q 022956          100 EVCTSGNL  107 (289)
Q Consensus       100 e~~~~~sL  107 (289)
                      ||++|.+|
T Consensus       129 efIeGr~l  136 (383)
T PTZ00384        129 EWVEGNTM  136 (383)
T ss_pred             EEeccccC
Confidence            99999765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.60  E-value=0.031  Score=47.95  Aligned_cols=29  Identities=14%  Similarity=0.175  Sum_probs=25.7

Q ss_pred             CceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      +++|+|+.++||+++++ +.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDET-RGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCC-CCEEEEEhhhcc
Confidence            39999999999999988 789999997654

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.54  E-value=0.029  Score=48.57  Aligned_cols=75  Identities=16%  Similarity=0.171  Sum_probs=56.4

Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      +..+.|+++++. |+++.-.-.    -..+++..++++.+..+.-+..+ .++-|+++...||+++ + |+|.|+||-++
T Consensus       297 e~~y~yl~~kdh-gt~is~ik~----~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~-GnvtLIDfkls  368 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISIIKA----DRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-E-GNVTLIDFKLS  368 (488)
T ss_pred             CceEEEEEEecC-Cceeeeeec----ccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-c-CceEEEEeeee
Confidence            446778888886 335433211    24578889999988887776654 3489999999999999 5 89999999988


Q ss_pred             ccc
Q 022956          171 AIV  173 (289)
Q Consensus       171 ~~~  173 (289)
                      +..
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            744

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.44  E-value=0.043  Score=46.42  Aligned_cols=73  Identities=15%  Similarity=0.103  Sum_probs=43.8

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC---CCceEEeeeeEEeCCCCeeEEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK---NKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+.|+.|....+|++.  .++..+.+|+-....       ...+..|..-|+.|.   .-.+++++.+....  +.-++|
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLl   90 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLL   90 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEE
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecChhh-------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEE
Confidence            4668889999999986  678899999987322       245677888888874   23456666655433  335889


Q ss_pred             eccccCC
Q 022956           99 TEVCTSG  105 (289)
Q Consensus        99 ~e~~~~~  105 (289)
                      +||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9998876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.09  E-value=0.048  Score=43.95  Aligned_cols=103  Identities=17%  Similarity=0.176  Sum_probs=66.2

Q ss_pred             EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHH
Q 022956           44 EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK  123 (289)
Q Consensus        44 ~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~  123 (289)
                      +..+|+++..+..-   ....+..+.+++.++.  .|+++..    +.+-.+.++.|.|-...            ... .
T Consensus        87 ~L~lKKi~slp~~~---~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~------------i~~-~  144 (308)
T PF07387_consen   87 PLFLKKIRSLPCCI---NDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIK------------INF-S  144 (308)
T ss_pred             hhhhhhccCCCccc---chhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcc------------cch-h
Confidence            45566665443321   1244567788887775  5666652    34456778888874421            111 1


Q ss_pred             HHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956          124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus       124 ~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      .+...=+++|.-.|+......|||.+|+||+-|.. |.+||+|-+.
T Consensus       145 N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~~  189 (308)
T PF07387_consen  145 NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPVC  189 (308)
T ss_pred             HHHHHhHHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChhh
Confidence            11111246677789766669999999999999999 9999999764

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.90  E-value=0.095  Score=45.26  Aligned_cols=29  Identities=28%  Similarity=0.373  Sum_probs=24.3

Q ss_pred             ceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          143 IIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       143 ~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ++|+|+.|.||+++++...+.+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            89999999999999882248899997554

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.72  E-value=0.054  Score=47.65  Aligned_cols=64  Identities=20%  Similarity=0.180  Sum_probs=46.0

Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhcCCCCceecCCCCCceEEeCCCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE-YLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~-~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      ...++-+|..|.++..++.... .++....+++.-.++|+- .+--.+  ++|.|++|.||++..+.+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~t  383 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNKT  383 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecCC
Confidence            3567888888989998888643 455566666666666643 334557  999999999999976643

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.51  E-value=0.25  Score=40.13  Aligned_cols=75  Identities=13%  Similarity=0.147  Sum_probs=48.7

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc---eEEeeeeEEeCCCCeeEEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY---IIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~---i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+.+..|.--..|.+.+  ...++.+|+-.       ......+..|+.-|..|.-.+   +.+.+.+  ..++.+.|+|
T Consensus        21 r~~v~gG~inea~~v~d--g~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~--G~~~~~sylV   89 (286)
T COG3001          21 REEVSGGDINEAWRLRD--GTDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIAV--GASRDHSYLV   89 (286)
T ss_pred             ccccCCccccceeEeec--CCcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEEe--cCCCCeeEEE
Confidence            34565565556666643  24567777764       233567888888888886555   3444443  4566789999


Q ss_pred             eccccCCcH
Q 022956           99 TEVCTSGNL  107 (289)
Q Consensus        99 ~e~~~~~sL  107 (289)
                      ++|++.+.+
T Consensus        90 le~L~~~~~   98 (286)
T COG3001          90 LEYLPTGPL   98 (286)
T ss_pred             EeeccCCCC
Confidence            999988655

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.26  E-value=1.1  Score=38.79  Aligned_cols=26  Identities=27%  Similarity=0.248  Sum_probs=21.8

Q ss_pred             ceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          143 IIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       143 ~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ++|+|+.+.||+++ +  .+.++||+-+.
T Consensus       198 liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        198 RLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             ceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            89999999999995 3  47899997554

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.02  E-value=0.25  Score=41.95  Aligned_cols=30  Identities=27%  Similarity=0.370  Sum_probs=23.8

Q ss_pred             CceecCCCCCceEEeCCC-C---cEEEeccCCcc
Q 022956          142 CIIHRDLNCSNIFINGNI-G---QVKIGDLGFAA  171 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~-~---~~~l~d~g~~~  171 (289)
                      -++|||+...||++..+. |   .+++.||..+.
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeecccccc
Confidence            389999999999996652 3   69999996544

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK06148 hypothetical protein; Provisional

Probab=94.94  E-value=1.4  Score=44.28  Aligned_cols=31  Identities=29%  Similarity=0.415  Sum_probs=24.6

Q ss_pred             CceecCCCCCceEEeCCC-CcEE-EeccCCccc
Q 022956          142 CIIHRDLNCSNIFINGNI-GQVK-IGDLGFAAI  172 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~-~~~~-l~d~g~~~~  172 (289)
                      .++|+|+++.||+++.+. +.+. |+|||-+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            399999999999998772 1454 999987754

>PTZ00296 choline kinase; Provisional

Probab=94.91  E-value=0.25  Score=44.61  Aligned_cols=29  Identities=21%  Similarity=0.386  Sum_probs=24.3

Q ss_pred             CceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956          142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      .++|.|+.+.||+.+.+  .++|+||..+..
T Consensus       285 VfCHNDl~~~NiL~~~~--~l~LIDfEYAg~  313 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK--CLRLIDFEYSGY  313 (442)
T ss_pred             eEEeCCCCccceeecCC--CEEEEeeccccc
Confidence            48999999999998654  599999987753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	289
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-62
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-25
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-23
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-22
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-21
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-20
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-20
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-20
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-17
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-17
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-17
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-17
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-17
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-17
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-17
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-17
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-17
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-17
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-17
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-17
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-15
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-14
3soa_A	444	Full-Length Human Camkii Length = 444		1e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-14
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-13
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-12
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-10
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-08
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-07
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-06
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-06
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-06
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-06
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-06
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-06
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-06
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-06
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-05
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-05
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-05
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-04

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  234 bits (597), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 120/267 (44%), Positives = 163/267 (61%), Gaps = 6/267 (2%)
Query: 16  GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           GRF ++   +G G+ K VY+  D E  +EVAW +++    ++      R   E + L+ L
Sbjct: 25  GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER--QRFKEEAEXLKGL 82
Query: 76  KNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           ++  I+  Y  W         +  +TE+ TSG L+TY K+ +   IK L+ W +Q+L+GL
Sbjct: 83  QHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGL 142
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           ++LHT  P IIHRDL C NIFI G  G VKIGDLG A +  R+  A ++IGTPE+ APE 
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFXAPEX 201
Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           YEE Y E VD+Y+FG C LE  T E PYSEC + A+IY++VT GVKP + +KV  PEVK 
Sbjct: 202 YEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
Query: 254 FIEKCIAQPR-ARPSASELLKDPFFSE 279
            IE CI Q +  R S  +LL   FF E
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 135/258 (52%), Gaps = 14/258 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           R    +G G   +VYRA    +G+ VA  +V++    +     + +  E+ LL+ L +  
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPN 93
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEY 135
           +I  Y+ +++D  N LN + E+  +G+L    + ++K+ R +  + + K+  Q+   LE+
Sbjct: 94  VIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPE-L 193
           +H+    ++HRD+  +N+FI    G VK+GDLG       ++ AAHS++GTP YM+PE +
Sbjct: 152 MHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 252
           +E  Y    DI+S G  L EM  ++ P Y +  ++  + KK+     P   +     E++
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268
Query: 253 AFIEKCI-AQPRARPSAS 269
             +  CI   P  RP  +
Sbjct: 269 QLVNMCINPDPEKRPDVT 286

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 17/277 (6%)
Query: 8   PFVEVDPSG--RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
           P V VDP    R+ R    LG G   K Y   D +   EV   +V        P    ++
Sbjct: 32  PDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKSMLLKPHQKEKM 89
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 125
            +E+ + ++L N +++  +  + DD  + +  + E+C   +L    K+ + V+    + +
Sbjct: 90  STEIAIHKSLDNPHVVGFHGFFEDD--DFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIG 184
            +Q ++G++YLH +   +IHRDL   N+F+N ++  VKIGD G A  I        ++ G
Sbjct: 148 MRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKTLCG 204
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY-SECDSVAKIYKKVTGGVKPQA 242
           TP Y+APE L ++ ++  VDI+S G  L  ++  + P+ + C     I  K      P+ 
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 243 LNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFS 278
           +N    P   A I + + A P  RPS +ELL D FF+
Sbjct: 265 IN----PVASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 136/277 (49%), Gaps = 17/277 (6%)
Query: 8   PFVEVDPSG--RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
           P V VDP    R+ R    LG G   K Y   D +   EV   +V        P    ++
Sbjct: 16  PDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKSMLLKPHQKEKM 73
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 125
            +E+ + ++L N +++  +  + DD  + +  + E+C   +L    K+ + V+    + +
Sbjct: 74  STEIAIHKSLDNPHVVGFHGFFEDD--DFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 131
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIG 184
            +Q ++G++YLH +   +IHRDL   N+F+N ++  VKIGD G A  I         + G
Sbjct: 132 MRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCG 188
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY-SECDSVAKIYKKVTGGVKPQA 242
           TP Y+APE L ++ ++  VDI+S G  L  ++  + P+ + C     I  K      P+ 
Sbjct: 189 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 248
Query: 243 LNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFS 278
           +N    P   A I + + A P  RPS +ELL D FF+
Sbjct: 249 IN----PVASALIRRMLHADPTLRPSVAELLTDEFFT 281

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 136/277 (49%), Gaps = 17/277 (6%)
Query: 8   PFVEVDPSG--RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
           P V VDP    R+ R    LG G   K Y   D +   EV   +V        P    ++
Sbjct: 32  PDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKSMLLKPHQKEKM 89
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 125
            +E+ + ++L N +++  +  + DD  + +  + E+C   +L    K+ + V+    + +
Sbjct: 90  STEIAIHKSLDNPHVVGFHGFFEDD--DFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIG 184
            +Q ++G++YLH +   +IHRDL   N+F+N ++  VKIGD G A  I         + G
Sbjct: 148 MRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCG 204
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY-SECDSVAKIYKKVTGGVKPQA 242
           TP Y+APE L ++ ++  VDI+S G  L  ++  + P+ + C     I  K      P+ 
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 243 LNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFS 278
           +N    P   A I + + A P  RPS +ELL D FF+
Sbjct: 265 IN----PVASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 136/277 (49%), Gaps = 17/277 (6%)
Query: 8   PFVEVDPSG--RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
           P V VDP    R+ R    LG G   K Y   D +   EV   +V        P    ++
Sbjct: 32  PDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKSMLLKPHQKEKM 89
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 125
            +E+ + ++L N +++  +  + DD  + +  + E+C   +L    K+ + V+    + +
Sbjct: 90  STEIAIHKSLDNPHVVGFHGFFEDD--DFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIG 184
            +Q ++G++YLH +   +IHRDL   N+F+N ++  VKIGD G A  I         + G
Sbjct: 148 MRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKXLCG 204
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY-SECDSVAKIYKKVTGGVKPQA 242
           TP Y+APE L ++ ++  VDI+S G  L  ++  + P+ + C     I  K      P+ 
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 243 LNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFS 278
           +N    P   A I + + A P  RPS +ELL D FF+
Sbjct: 265 IN----PVASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 132/269 (49%), Gaps = 16/269 (5%)
Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+  + G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 17  DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 71
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  KN  I+     +L    + L  + E    G+L T       +    +    ++ L+ 
Sbjct: 72  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 128
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           LE+LH+++  +IHRD+   NI + G  G VK+ D GF A +    +  S ++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 185
Query: 192 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+   + Y   VDI+S G+  +EM+  E PY   + +  +Y   T G  P+  N  K   
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA 244
Query: 251 V-KAFIEKCIAQP-RARPSASELLKDPFF 277
           + + F+ +C+      R SA ELL+  F 
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 132/269 (49%), Gaps = 16/269 (5%)
Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+  + G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 17  DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 71
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  KN  I+     +L    + L  + E    G+L T       +    +    ++ L+ 
Sbjct: 72  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 128
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           LE+LH+++  +IHRD+   NI + G  G VK+ D GF A +    +  S ++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAP 185
Query: 192 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+   + Y   VDI+S G+  +EM+  E PY   + +  +Y   T G  P+  N  K   
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA 244
Query: 251 V-KAFIEKCI-AQPRARPSASELLKDPFF 277
           + + F+ +C+      R SA ELL+  F 
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 132/269 (49%), Gaps = 16/269 (5%)
Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+  + G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 17  DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 71
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  KN  I+     +L    + L  + E    G+L T       +    +    ++ L+ 
Sbjct: 72  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 128
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           LE+LH+++  +IHRD+   NI + G  G VK+ D GF A +    +  S ++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 192 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+   + Y   VDI+S G+  +EM+  E PY   + +  +Y   T G  P+  N  K   
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA 244
Query: 251 V-KAFIEKCI-AQPRARPSASELLKDPFF 277
           + + F+ +C+      R SA ELL+  F 
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 16/269 (5%)
Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+  + G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 18  DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 72
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  KN  I+     +L    + L  + E    G+L T       +    +    ++ L+ 
Sbjct: 73  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 129
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           LE+LH+++  +IHRD+   NI + G  G VK+ D GF A +    +  S ++GTP +MAP
Sbjct: 130 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 186
Query: 192 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+   + Y   VDI+S G+  +EM+  E PY   + +  +Y   T G  P+  N  K   
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA 245
Query: 251 V-KAFIEKCIAQP-RARPSASELLKDPFF 277
           + + F+ +C+      R SA EL++  F 
Sbjct: 246 IFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           +LG G    VY   D    + +A  ++  R S +S+       LH E+ L + LK+K I+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP------LHEEIALHKHLKHKNIV 82
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV--SIKALKKWSKQVLEGLEYLHT 138
                +   ++  +    E    G+L    R K   +  + + +  ++KQ+LEGL+YLH 
Sbjct: 83  QYLGSF--SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELYEE- 196
           ++  I+HRD+   N+ IN   G +KI D G +  + G +    +  GT +YMAPE+ ++ 
Sbjct: 141 NQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 197 --DYTEMVDIYSFGLCLLEMVTMEIPYSEC-DSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
              Y +  DI+S G  ++EM T + P+ E  +  A ++K     V P+ + +    E KA
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-IPESMSAEAKA 257
Query: 254 FIEKCI-AQPRARPSASELLKDPFF 277
           FI KC    P  R  A++LL D F 
Sbjct: 258 FILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           +LG G    VY   D    + +A  ++  R S +S+       LH E+ L + LK+K I+
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP------LHEEIALHKHLKHKNIV 68
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV--SIKALKKWSKQVLEGLEYLHT 138
                +   ++  +    E    G+L    R K   +  + + +  ++KQ+LEGL+YLH 
Sbjct: 69  QYLGSF--SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELYEE- 196
           ++  I+HRD+   N+ IN   G +KI D G +  + G +    +  GT +YMAPE+ ++ 
Sbjct: 127 NQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 184
Query: 197 --DYTEMVDIYSFGLCLLEMVTMEIPYSEC-DSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
              Y +  DI+S G  ++EM T + P+ E  +  A ++K     V P+ + +    E KA
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-IPESMSAEAKA 243
Query: 254 FIEKCI-AQPRARPSASELLKDPFF 277
           FI KC    P  R  A++LL D F 
Sbjct: 244 FILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 18/256 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G+G+   V+RA  +  G +VA   +    F  +   VN    EV +++ L++  I++  
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE--RVNEFLREVAIMKRLRHPNIVLFM 100
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK-----QVLEGLEYLHTH 139
                 Q   L+ +TE  + G+L  YR  H+  + + L +  +      V +G+ YLH  
Sbjct: 101 GA--VTQPPNLSIVTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AAHSIIGTPEYMAPE-LYEED 197
            P I+HR+L   N+ ++     VK+ D G + +   +  ++ S  GTPE+MAPE L +E 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
             E  D+YSFG+ L E+ T++ P+   +  A++   V    K   + +  +P+V A IE 
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 258 CIA-QPRARPSASELL 272
           C   +P  RPS + ++
Sbjct: 275 CWTNEPWKRPSFATIM 290

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 132/269 (49%), Gaps = 16/269 (5%)
Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+  + G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 18  DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 72
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  KN  I+     +L    + L  + E    G+L T       +    +    ++ L+ 
Sbjct: 73  RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQA 129
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAP 191
           LE+LH+++  +IHR++   NI + G  G VK+ D GF A +    +  S ++GTP +MAP
Sbjct: 130 LEFLHSNQ--VIHRNIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186
Query: 192 ELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+   + Y   VDI+S G+  +EM+  E PY   + +  +Y   T G  P+  N  K   
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA 245
Query: 251 V-KAFIEKCIAQP-RARPSASELLKDPFF 277
           + + F+ +C+      R SA EL++  F 
Sbjct: 246 IFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 20/271 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  KVY+A ++E G   A   +      E    +     E+++L T  + YI+   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATCDHPYIVKLL 82
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +  D    L  + E C  G +     +  R ++   ++   +Q+LE L +LH+    I
Sbjct: 83  GAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--I 138
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPE------LYEE 196
           IHRDL   N+ +    G +++ D G +A   ++     S IGTP +MAPE      + + 
Sbjct: 139 IHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFI 255
            Y    DI+S G+ L+EM  +E P+ E + + ++  K+     P  L   K   E + F+
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 256 EKCIAQ-PRARPSASELLKDPFFSELNDDDS 285
           +  + + P  RPSA++LL+ PF S +  + +
Sbjct: 257 KIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 20/271 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  KVY+A ++E G   A   +      E    +     E+++L T  + YI+   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATCDHPYIVKLL 74
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +  D    L  + E C  G +     +  R ++   ++   +Q+LE L +LH+    I
Sbjct: 75  GAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--I 130
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPE------LYEE 196
           IHRDL   N+ +    G +++ D G +A   ++     S IGTP +MAPE      + + 
Sbjct: 131 IHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFI 255
            Y    DI+S G+ L+EM  +E P+ E + + ++  K+     P  L   K   E + F+
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSDPPTLLTPSKWSVEFRDFL 248
Query: 256 EKCIAQ-PRARPSASELLKDPFFSELNDDDS 285
           +  + + P  RPSA++LL+ PF S +  + +
Sbjct: 249 KIALDKNPETRPSAAQLLEHPFVSSITSNKA 279

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 127/263 (48%), Gaps = 13/263 (4%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +  +LLG G+   VYRA     G+EVA   +      +   +V R+ +EV++   LK+  
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG-MVQRVQNEVKIHCQLKHPS 72
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHT 138
           I+  Y+ + D   N +  + E+C +G +  Y K   +  S    + +  Q++ G+ YLH+
Sbjct: 73  ILELYNYFEDS--NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPELYEED 197
           H   I+HRDL  SN+ +  N+  +KI D G A  +   H  H ++ GTP Y++PE+    
Sbjct: 131 HG--ILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 198 YTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
              +  D++S G C+   + +  P  + D+V     KV   +    +      E K  I 
Sbjct: 188 AHGLESDVWSLG-CMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIH 244
Query: 257 KCIAQ-PRARPSASELLKDPFFS 278
           + + + P  R S S +L  PF S
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMS 267

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 127/256 (49%), Gaps = 18/256 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G+G+   V+RA  +  G +VA   +    F  +   VN    EV +++ L++  I++  
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE--RVNEFLREVAIMKRLRHPNIVLFM 100
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK-----QVLEGLEYLHTH 139
                 Q   L+ +TE  + G+L  YR  H+  + + L +  +      V +G+ YLH  
Sbjct: 101 GA--VTQPPNLSIVTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AAHSIIGTPEYMAPE-LYEED 197
            P I+HRDL   N+ ++     VK+ D G + +       +    GTPE+MAPE L +E 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKY-TVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEP 215
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
             E  D+YSFG+ L E+ T++ P+   +  A++   V    K   + +  +P+V A IE 
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 258 CIA-QPRARPSASELL 272
           C   +P  RPS + ++
Sbjct: 275 CWTNEPWKRPSFATIM 290

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 131/261 (50%), Gaps = 25/261 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+   VY+A  +E G  VA  QV +    ++ +       E+ +++   + +++  Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII------KEISIMQQCDSPHVVKYY 90
Query: 85  SVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +   ++  L  + E C +G++    R +++ ++   +    +  L+GLEYLH      
Sbjct: 91  GSYF--KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK-- 146
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE-DYTEM 201
           IHRD+   NI +N   G  K+ D G A  +    A  + +IGTP +MAPE+ +E  Y  +
Sbjct: 147 IHRDIKAGNILLNTE-GHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCV 205
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA-----FIE 256
            DI+S G+  +EM   + PY++   +  I+   T    P    K   PE+ +     F++
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PPPTFRK---PELWSDNFTDFVK 260
Query: 257 KCIAQ-PRARPSASELLKDPF 276
           +C+ + P  R +A++LL+ PF
Sbjct: 261 QCLVKSPEQRATATQLLQHPF 281

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 132/258 (51%), Gaps = 12/258 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G   K +   D +   EV   ++        P    ++  E+ + R+L +++++  
Sbjct: 28  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +  + D+  + +  + E+C   +L    K+ + ++    + + +Q++ G +YLH +   +
Sbjct: 87  HGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 142
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           IHRDL   N+F+N ++ +VKIGD G A  V        ++ GTP Y+APE L ++ ++  
Sbjct: 143 IHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 201
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-A 260
           VD++S G C++  + +  P  E   + + Y ++       ++ K  +P   + I+K +  
Sbjct: 202 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 258
Query: 261 QPRARPSASELLKDPFFS 278
            P ARP+ +ELL D FF+
Sbjct: 259 DPTARPTINELLNDEFFT 276

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 132/258 (51%), Gaps = 12/258 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G   K +   D +   EV   ++        P    ++  E+ + R+L +++++  
Sbjct: 24  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +  + D+  + +  + E+C   +L    K+ + ++    + + +Q++ G +YLH +   +
Sbjct: 83  HGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 138
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           IHRDL   N+F+N ++ +VKIGD G A  V        ++ GTP Y+APE L ++ ++  
Sbjct: 139 IHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-A 260
           VD++S G C++  + +  P  E   + + Y ++       ++ K  +P   + I+K +  
Sbjct: 198 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 254
Query: 261 QPRARPSASELLKDPFFS 278
            P ARP+ +ELL D FF+
Sbjct: 255 DPTARPTINELLNDEFFT 272

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 132/258 (51%), Gaps = 12/258 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G   K +   D +   EV   ++        P    ++  E+ + R+L +++++  
Sbjct: 48  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +  + D+  + +  + E+C   +L    K+ + ++    + + +Q++ G +YLH +   +
Sbjct: 107 HGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 162
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII-GTPEYMAPE-LYEEDYTEM 201
           IHRDL   N+F+N ++ +VKIGD G A  V        ++ GTP Y+APE L ++ ++  
Sbjct: 163 IHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-A 260
           VD++S G C++  + +  P  E   + + Y ++       ++ K  +P   + I+K +  
Sbjct: 222 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 278
Query: 261 QPRARPSASELLKDPFFS 278
            P ARP+ +ELL D FF+
Sbjct: 279 DPTARPTINELLNDEFFT 296

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 132/258 (51%), Gaps = 12/258 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G   K +   D +   EV   ++        P    ++  E+ + R+L +++++  
Sbjct: 24  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +  + D+  + +  + E+C   +L    K+ + ++    + + +Q++ G +YLH +   +
Sbjct: 83  HGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 138
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           IHRDL   N+F+N ++ +VKIGD G A  V        ++ GTP Y+APE L ++ ++  
Sbjct: 139 IHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-A 260
           VD++S G C++  + +  P  E   + + Y ++       ++ K  +P   + I+K +  
Sbjct: 198 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 254
Query: 261 QPRARPSASELLKDPFFS 278
            P ARP+ +ELL D FF+
Sbjct: 255 DPTARPTINELLNDEFFT 272

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 132/258 (51%), Gaps = 12/258 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G   K +   D +   EV   ++        P    ++  E+ + R+L +++++  
Sbjct: 46  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +  + D+  + +  + E+C   +L    K+ + ++    + + +Q++ G +YLH +   +
Sbjct: 105 HGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 160
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII-GTPEYMAPE-LYEEDYTEM 201
           IHRDL   N+F+N ++ +VKIGD G A  V        ++ GTP Y+APE L ++ ++  
Sbjct: 161 IHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-A 260
           VD++S G C++  + +  P  E   + + Y ++       ++ K  +P   + I+K +  
Sbjct: 220 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 276
Query: 261 QPRARPSASELLKDPFFS 278
            P ARP+ +ELL D FF+
Sbjct: 277 DPTARPTINELLNDEFFT 294

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 132/258 (51%), Gaps = 12/258 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G   K +   D +   EV   ++        P    ++  E+ + R+L +++++  
Sbjct: 22  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +  + D+  + +  + E+C   +L    K+ + ++    + + +Q++ G +YLH +   +
Sbjct: 81  HGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 136
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII-GTPEYMAPE-LYEEDYTEM 201
           IHRDL   N+F+N ++ +VKIGD G A  V        ++ GTP Y+APE L ++ ++  
Sbjct: 137 IHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-A 260
           VD++S G C++  + +  P  E   + + Y ++       ++ K  +P   + I+K +  
Sbjct: 196 VDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQKMLQT 252
Query: 261 QPRARPSASELLKDPFFS 278
            P ARP+ +ELL D FF+
Sbjct: 253 DPTARPTINELLNDEFFT 270

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 129/268 (48%), Gaps = 21/268 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G+G+  +  +   + +G  + W ++     +E    +  L SEV LLR LK+  I+  Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRYY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTY----RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
              +D  + TL  + E C  G+L +      K+ +++  + + +   Q+   L+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 141 P---CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYE 195
                ++HRDL  +N+F++G    VK+GD G A I+    + A + +GTP YM+PE +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK---DPEVK 252
             Y E  DI+S G  L E+  +  P++     A   K++ G ++     ++      E+ 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 253 AFIEKCI-AQPRARPSASELLKDPFFSE 279
             I + +  +   RPS  E+L++P   E
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 129/268 (48%), Gaps = 21/268 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G+G+  +  +   + +G  + W ++     +E    +  L SEV LLR LK+  I+  Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRYY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTY----RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
              +D  + TL  + E C  G+L +      K+ +++  + + +   Q+   L+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 141 P---CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYE 195
                ++HRDL  +N+F++G    VK+GD G A I+    + A + +GTP YM+PE +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK---DPEVK 252
             Y E  DI+S G  L E+  +  P++     A   K++ G ++     ++      E+ 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 253 AFIEKCI-AQPRARPSASELLKDPFFSE 279
             I + +  +   RPS  E+L++P   E
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 120/258 (46%), Gaps = 13/258 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 89
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 90  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 146
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 147 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 204
Query: 204 IYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK---PQALNKVKDPEVKAFIEKC-I 259
           I+S GL L+EM     P         I++ +   V    P+  + V   E + F+ KC I
Sbjct: 205 IWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 264
Query: 260 AQPRARPSASELLKDPFF 277
             P  R    +L+   F 
Sbjct: 265 KNPAERADLKQLMVHAFI 282

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 31/266 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 20  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS-----IKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H S     +K L   ++Q   G++YLH  
Sbjct: 75  GYSTKPQ---LAIVTQWCEGSSLY----HHLHASETKFEMKKLIDIARQTARGMDYLHAK 127
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELYEE 196
              IIHRDL  +NIF++ +   VKIGD G A +  R   SH    + G+  +MAPE+   
Sbjct: 128 --SIIHRDLKSNNIFLHED-NTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 197 D----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
                Y+   D+Y+FG+ L E++T ++PYS  ++  +I + V  G     L+KV+     
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 244
Query: 250 EVKAFIEKCIAQPR-ARPSASELLKD 274
            +K  + +C+ + R  RPS   +L +
Sbjct: 245 RMKRLMAECLKKKRDERPSFPRILAE 270

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 126/257 (49%), Gaps = 15/257 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A ++  G +VA   + L       +L N    EV ++R  ++  ++  Y
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN----EVVIMRDYQHFNVVEMY 108
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +L  +   L  + E    G L     + R ++ + +    + VL+ L YLH     +I
Sbjct: 109 KSYLVGEE--LWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQ--GVI 163
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEED-YTEMV 202
           HRD+   +I +  + G+VK+ D GF A + +       ++GTP +MAPE+     Y   V
Sbjct: 164 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQ 261
           DI+S G+ ++EMV  E PY   DS  +  K++     P+  N  K  P ++ F+E+ + +
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 262 -PRARPSASELLKDPFF 277
            P+ R +A ELL  PF 
Sbjct: 282 DPQERATAQELLDHPFL 298

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 21/268 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G+G+  +  +   + +G  + W ++     +E    +  L SEV LLR LK+  I+  Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRYY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTY----RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
              +D  + TL  + E C  G+L +      K+ +++  + + +   Q+   L+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 141 P---CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPE-LYE 195
                ++HRDL  +N+F++G    VK+GD G A I+      A   +GTP YM+PE +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNR 190
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK---DPEVK 252
             Y E  DI+S G  L E+  +  P++     A   K++ G ++     ++      E+ 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 253 AFIEKCI-AQPRARPSASELLKDPFFSE 279
             I + +  +   RPS  E+L++P   E
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A  +  G  VA  ++ L       +L N    EV ++R  +++ ++  Y
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN----EVVIMRDYQHENVVEMY 214
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + +L    + L  + E    G L T    H  ++ + +      VL+ L  LH     +I
Sbjct: 215 NSYLVG--DELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--GVI 269
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE-DYTEMV 202
           HRD+   +I +  + G+VK+ D GF A V +       ++GTP +MAPEL     Y   V
Sbjct: 270 HRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQ 261
           DI+S G+ ++EMV  E PY   +   K  K +   + P+  N  K  P +K F+++ + +
Sbjct: 329 DIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 387
Query: 262 -PRARPSASELLKDPFFSE 279
            P  R +A+ELLK PF ++
Sbjct: 388 DPAQRATAAELLKHPFLAK 406

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A  +  G  VA  ++ L       +L N    EV ++R  +++ ++  Y
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN----EVVIMRDYQHENVVEMY 94
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + +L    + L  + E    G L T    H  ++ + +      VL+ L  LH     +I
Sbjct: 95  NSYLVG--DELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--GVI 149
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE-DYTEMV 202
           HRD+   +I +  + G+VK+ D GF A V +       ++GTP +MAPEL     Y   V
Sbjct: 150 HRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQ 261
           DI+S G+ ++EMV  E PY   +   K  K +   + P+  N  K  P +K F+++ + +
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 267
Query: 262 -PRARPSASELLKDPFFSE 279
            P  R +A+ELLK PF ++
Sbjct: 268 DPAQRATAAELLKHPFLAK 286

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A  +  G  VA  ++ L       +L N    EV ++R  +++ ++  Y
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN----EVVIMRDYQHENVVEMY 137
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + +L    + L  + E    G L T    H  ++ + +      VL+ L  LH     +I
Sbjct: 138 NSYLVG--DELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--GVI 192
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE-DYTEMV 202
           HRD+   +I +  + G+VK+ D GF A V +       ++GTP +MAPEL     Y   V
Sbjct: 193 HRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQ 261
           DI+S G+ ++EMV  E PY   +   K  K +   + P+  N  K  P +K F+++ + +
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 310
Query: 262 -PRARPSASELLKDPFFSE 279
            P  R +A+ELLK PF ++
Sbjct: 311 DPAQRATAAELLKHPFLAK 329

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 19/264 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 128 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 204 IYSFGLCLLEMVTMEIPYSECD---------SVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
           I+S GL L+EM     P    D         ++ ++   +     P+  + V   E + F
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 245
Query: 255 IEKC-IAQPRARPSASELLKDPFF 277
           + KC I  P  R    +L+   F 
Sbjct: 246 VNKCLIKNPAERADLKQLMVHAFI 269

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A  +  G  VA  ++ L       +L N    EV ++R  +++ ++  Y
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN----EVVIMRDYQHENVVEMY 92
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + +L    + L  + E    G L T    H  ++ + +      VL+ L  LH     +I
Sbjct: 93  NSYLVG--DELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--GVI 147
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE-DYTEMV 202
           HRD+   +I +  + G+VK+ D GF A V +       ++GTP +MAPEL     Y   V
Sbjct: 148 HRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQ 261
           DI+S G+ ++EMV  E PY   +   K  K +   + P+  N  K  P +K F+++ + +
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 265
Query: 262 -PRARPSASELLKDPFFSE 279
            P  R +A+ELLK PF ++
Sbjct: 266 DPAQRATAAELLKHPFLAK 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A  +  G  VA  ++ L       +L N    EV ++R  +++ ++  Y
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN----EVVIMRDYQHENVVEMY 83
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + +L    + L  + E    G L T    H  ++ + +      VL+ L  LH     +I
Sbjct: 84  NSYLVG--DELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--GVI 138
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE-DYTEMV 202
           HRD+   +I +  + G+VK+ D GF A V +       ++GTP +MAPEL     Y   V
Sbjct: 139 HRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQ 261
           DI+S G+ ++EMV  E PY   +   K  K +   + P+  N  K  P +K F+++ + +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 256
Query: 262 -PRARPSASELLKDPFFSE 279
            P  R +A+ELLK PF ++
Sbjct: 257 DPAQRATAAELLKHPFLAK 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A  +  G  VA  ++ L       +L N    EV ++R  +++ ++  Y
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN----EVVIMRDYQHENVVEMY 87
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + +L    + L  + E    G L T    H  ++ + +      VL+ L  LH     +I
Sbjct: 88  NSYLVG--DELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ--GVI 142
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE-DYTEMV 202
           HRD+   +I +  + G+VK+ D GF A V +       ++GTP +MAPEL     Y   V
Sbjct: 143 HRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIEKCIAQ 261
           DI+S G+ ++EMV  E PY   +   K  K +   + P+  N  K  P +K F+++ + +
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 260
Query: 262 -PRARPSASELLKDPFFSE 279
            P  R +A+ELLK PF ++
Sbjct: 261 DPAQRATAAELLKHPFLAK 279

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 135/281 (48%), Gaps = 26/281 (9%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
            E F + DP   F   SDL  +G G+   VY A D      VA  ++  S    +    +
Sbjct: 44  AELFFKDDPEKLF---SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRHVSIK 120
            +  EV+ L+ L++   I     +L  + +T   + E C    S  L  ++K  + V I 
Sbjct: 101 II-KEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
           A+   +   L+GL YLH+H   +IHRD+   NI ++   G VK+GD G A+I+     A+
Sbjct: 158 AV---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PAN 208
Query: 181 SIIGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
             +GTP +MAPE+     E  Y   VD++S G+  +E+   + P    ++++ +Y  +  
Sbjct: 209 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQ 267
Query: 237 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 276
              P   +       + F++ C+ + P+ RP++  LLK  F
Sbjct: 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 135/281 (48%), Gaps = 26/281 (9%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
            E F + DP   F   SDL  +G G+   VY A D      VA  ++  S    +    +
Sbjct: 5   AELFFKDDPEKLF---SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC---TSGNLRTYRKKHRHVSIK 120
            +  EV+ L+ L++   I     +L  + +T   + E C    S  L  ++K  + V I 
Sbjct: 62  II-KEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 118
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
           A+   +   L+GL YLH+H   +IHRD+   NI ++   G VK+GD G A+I+     A+
Sbjct: 119 AV---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PAN 169
Query: 181 SIIGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
             +GTP +MAPE+     E  Y   VD++S G+  +E+   + P    ++++ +Y  +  
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQ 228
Query: 237 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 276
              P   +       + F++ C+ + P+ RP++  LLK  F
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 120/263 (45%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  KVY+A ++E  +  A   +      E    +     E+ +L +  +  I+   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVEIDILASCDHPNIVKLL 100
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +     N L  + E C  G +     +  R ++   ++   KQ L+ L YLH ++  I
Sbjct: 101 DAFY--YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELY------EE 196
           IHRDL   NI    + G +K+ D G +A   R+     S IGTP +MAPE+       + 
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
            Y    D++S G+ L+EM  +E P+ E + +  + K         A         K F++
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 275
Query: 257 KCIAQP-RARPSASELLKDPFFS 278
           KC+ +   AR + S+LL+ PF +
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFVT 298

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 31/266 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 32  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS-----IKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H S     +K L   ++Q   G++YLH  
Sbjct: 87  GYSTKPQ---LAIVTQWCEGSSLY----HHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELYE- 195
              IIHRDL  +NIF++ +   VKIGD G A    R   SH    + G+  +MAPE+   
Sbjct: 140 --SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 196 ---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
                Y+   D+Y+FG+ L E++T ++PYS  ++  +I + V  G     L+KV+     
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 250 EVKAFIEKCIAQPR-ARPSASELLKD 274
            +K  + +C+ + R  RPS   +L +
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAE 282

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 129/272 (47%), Gaps = 15/272 (5%)
Query: 9   FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 68
           F  +DP   F +   + G G+  +V++  D      VA   +++    E    +  +  E
Sbjct: 20  FQSMDPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQE 75
Query: 69  VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 128
           + +L    + Y+   Y  +L D    L  I E    G+     +    +    +    ++
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLLEPGP-LDETQIATILRE 132
Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPE 187
           +L+GL+YLH+ +   IHRD+  +N+ ++ + G+VK+ D G A  +  +    ++ +GTP 
Sbjct: 133 ILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPF 189
Query: 188 YMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 246
           +MAPE+ ++  Y    DI+S G+  +E+   E P+SE   +  ++  +     P  L   
Sbjct: 190 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIPKNNPPTLEGN 247
Query: 247 KDPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
               +K F+E C+  +P  RP+A ELLK  F 
Sbjct: 248 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 117/260 (45%), Gaps = 17/260 (6%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +++G G   KVYRAF    G EVA    R     +    +  +  E +L   LK+  II 
Sbjct: 13  EIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
              V L + +  L  + E    G L       R +    L  W+ Q+  G+ YLH     
Sbjct: 71  LRGVCLKEPN--LCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 143 -IIHRDLNCSNIFI-----NGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY 194
            IIHRDL  SNI I     NG++    +KI D G A    R+    S  G   +MAPE+ 
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVI 186
Query: 195 EED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
               +++  D++S+G+ L E++T E+P+   D +A  Y      +     +   +P  K 
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAK- 245
Query: 254 FIEKCI-AQPRARPSASELL 272
            +E C    P +RPS + +L
Sbjct: 246 LMEDCWNPDPHSRPSFTNIL 265

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 119/263 (45%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  KVY+A ++E  +  A   +      E    +     E+ +L +  +  I+   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVEIDILASCDHPNIVKLL 100
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +     N L  + E C  G +     +  R ++   ++   KQ L+ L YLH ++  I
Sbjct: 101 DAFY--YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELY------EE 196
           IHRDL   NI    + G +K+ D G +A   R      S IGTP +MAPE+       + 
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
            Y    D++S G+ L+EM  +E P+ E + +  + K         A         K F++
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 275
Query: 257 KCIAQP-RARPSASELLKDPFFS 278
           KC+ +   AR + S+LL+ PF +
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFVT 298

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 31/266 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 32  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS-----IKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H S     +K L   ++Q   G++YLH  
Sbjct: 87  GYSTAPQ---LAIVTQWCEGSSLY----HHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELYE- 195
              IIHRDL  +NIF++ +   VKIGD G A    R   SH    + G+  +MAPE+   
Sbjct: 140 --SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 196 ---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
                Y+   D+Y+FG+ L E++T ++PYS  ++  +I + V  G     L+KV+     
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 250 EVKAFIEKCIAQPR-ARPSASELLKD 274
            +K  + +C+ + R  RPS   +L +
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAE 282

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 118/255 (46%), Gaps = 11/255 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 73
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 74  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 130
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +     A+  +GT  YM+PE L    Y+   D
Sbjct: 131 HRDVKPSNILVNSR-GEIKLCDFGVSGQL-IDEMANEFVGTRSYMSPERLQGTHYSVQSD 188
Query: 204 IYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC-IAQP 262
           I+S GL L+EM     P     ++ ++   +     P+  + V   E + F+ KC I  P
Sbjct: 189 IWSMGLSLVEMAVGRYPRPPM-AIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNP 247
Query: 263 RARPSASELLKDPFF 277
             R    +L+   F 
Sbjct: 248 AERADLKQLMVHAFI 262

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 134/289 (46%), Gaps = 38/289 (13%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +++GSGA   V  A+   +  +VA  ++ L         ++ L  E+Q +    +  I+ 
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEIQAMSQCHHPNIVS 77
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS-----------KQVLE 131
            Y+ ++    + L  + ++ + G++    K   H+  K   K             ++VLE
Sbjct: 78  YYTSFV--VKDELWLVMKLLSGGSVLDIIK---HIVAKGEHKSGVLDESTIATILREVLE 132
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG------RSHAAHSIIGT 185
           GLEYLH +    IHRD+   NI + G  G V+I D G +A +       R+    + +GT
Sbjct: 133 GLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 186 PEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG------- 236
           P +MAPE+ E+   Y    DI+SFG+  +E+ T   PY +   +  +   +         
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 237 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDD 284
           GV+ + + K      +  I  C+ + P  RP+A+ELL+  FF +  + +
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +++GSGA   V  A+   +  +VA  ++ L         ++ L  E+Q +    +  I+ 
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEIQAMSQCHHPNIVS 72
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS-----------KQVLE 131
            Y+ ++    + L  + ++ + G++    K   H+  K   K             ++VLE
Sbjct: 73  YYTSFV--VKDELWLVMKLLSGGSVLDIIK---HIVAKGEHKSGVLDESTIATILREVLE 127
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG------RSHAAHSIIGT 185
           GLEYLH +    IHRD+   NI + G  G V+I D G +A +       R+    + +GT
Sbjct: 128 GLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 186 PEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG------- 236
           P +MAPE+ E+   Y    DI+SFG+  +E+ T   PY +   +  +   +         
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 244
Query: 237 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
           GV+ + + K      +  I  C+ + P  RP+A+ELL+  FF +
Sbjct: 245 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 129/271 (47%), Gaps = 15/271 (5%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
           + +DP   F +   + G G+  +V++  D      VA   +++    E    +  +  E+
Sbjct: 1   MSLDPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEI 56
Query: 70  QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
            +L    + Y+   Y  +L D    L  I E    G+     +    +    +    +++
Sbjct: 57  TVLSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREI 113
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEY 188
           L+GL+YLH+ +   IHRD+  +N+ ++ + G+VK+ D G A  +  +    ++ +GTP +
Sbjct: 114 LKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFW 170
Query: 189 MAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           MAPE+ ++  Y    DI+S G+  +E+   E P+SE   +  ++  +     P  L    
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIPKNNPPTLEGNY 228
Query: 248 DPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
              +K F+E C+  +P  RP+A ELLK  F 
Sbjct: 229 SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 125/257 (48%), Gaps = 15/257 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  KV  A+    G +VA   +     ++   +  R+  E+  LR L++ +II  Y
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-MQGRIEREISYLRLLRHPHIIKLY 74
Query: 85  SVWLDDQHNTLNFITEVCTSGN-LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V           I  +  +GN L  Y  +   +S +  +++ +Q++  +EY H H+  I
Sbjct: 75  DVIKSKD----EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--I 128
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE--M 201
           +HRDL   N+ ++ ++  VKI D G + I+   +   +  G+P Y APE+          
Sbjct: 129 VHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK-CIA 260
           VD++S G+ L  M+   +P+ + +S+  ++K ++ GV    L K   P     I++  I 
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGV--YTLPKFLSPGAAGLIKRMLIV 244
Query: 261 QPRARPSASELLKDPFF 277
            P  R S  E+++D +F
Sbjct: 245 NPLNRISIHEIMQDDWF 261

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 125/257 (48%), Gaps = 15/257 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  KV  A+    G +VA   +     ++   +  R+  E+  LR L++ +II  Y
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-MQGRIEREISYLRLLRHPHIIKLY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGN-LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V           I  +  +GN L  Y  +   +S +  +++ +Q++  +EY H H+  I
Sbjct: 71  DVIKSKD----EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--I 124
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE--M 201
           +HRDL   N+ ++ ++  VKI D G + I+   +   +  G+P Y APE+          
Sbjct: 125 VHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 183
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK-CIA 260
           VD++S G+ L  M+   +P+ + +S+  ++K ++ GV    L K   P     I++  I 
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGV--YTLPKFLSPGAAGLIKRMLIV 240
Query: 261 QPRARPSASELLKDPFF 277
            P  R S  E+++D +F
Sbjct: 241 NPLNRISIHEIMQDDWF 257

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 125/257 (48%), Gaps = 15/257 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  KV  A+    G +VA   +     ++   +  R+  E+  LR L++ +II  Y
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-MQGRIEREISYLRLLRHPHIIKLY 80
Query: 85  SVWLDDQHNTLNFITEVCTSGN-LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V           I  +  +GN L  Y  +   +S +  +++ +Q++  +EY H H+  I
Sbjct: 81  DVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--I 134
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE--M 201
           +HRDL   N+ ++ ++  VKI D G + I+   +   +  G+P Y APE+          
Sbjct: 135 VHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 193
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK-CIA 260
           VD++S G+ L  M+   +P+ + +S+  ++K ++ GV    L K   P     I++  I 
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGV--YTLPKFLSPGAAGLIKRMLIV 250
Query: 261 QPRARPSASELLKDPFF 277
            P  R S  E+++D +F
Sbjct: 251 NPLNRISIHEIMQDDWF 267

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 125/257 (48%), Gaps = 15/257 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  KV  A+    G +VA   +     ++   +  R+  E+  LR L++ +II  Y
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD-MQGRIEREISYLRLLRHPHIIKLY 79
Query: 85  SVWLDDQHNTLNFITEVCTSGN-LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V           I  +  +GN L  Y  +   +S +  +++ +Q++  +EY H H+  I
Sbjct: 80  DVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--I 133
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE--M 201
           +HRDL   N+ ++ ++  VKI D G + I+   +   +  G+P Y APE+          
Sbjct: 134 VHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK-CIA 260
           VD++S G+ L  M+   +P+ + +S+  ++K ++ GV    L K   P     I++  I 
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGV--YTLPKFLSPGAAGLIKRMLIV 249
Query: 261 QPRARPSASELLKDPFF 277
            P  R S  E+++D +F
Sbjct: 250 NPLNRISIHEIMQDDWF 266

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 15/271 (5%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
           ++ DP   F +   + G G+  +V++  D      VA   +++    E    +  +  E+
Sbjct: 16  LKADPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEI 71
Query: 70  QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
            +L    + Y+   Y  +L D    L  I E    G+     +    +    +    +++
Sbjct: 72  TVLSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREI 128
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEY 188
           L+GL+YLH+ +   IHRD+  +N+ ++ + G+VK+ D G A  +  +    +  +GTP +
Sbjct: 129 LKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNXFVGTPFW 185
Query: 189 MAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           MAPE+ ++  Y    DI+S G+  +E+   E P+SE   +  ++  +     P  L    
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIPKNNPPTLEGNY 243
Query: 248 DPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
              +K F+E C+  +P  RP+A ELLK  F 
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  KVY+A ++E  +  A   +      E    +     E+ +L +  +  I+   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVEIDILASCDHPNIVKLL 100
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +     N L  + E C  G +     +  R ++   ++   KQ L+ L YLH ++  I
Sbjct: 101 DAFY--YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELY------EE 196
           IHRDL   NI    + G +K+ D G +A   R        IGTP +MAPE+       + 
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
            Y    D++S G+ L+EM  +E P+ E + +  + K         A         K F++
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 275
Query: 257 KCIAQP-RARPSASELLKDPFFS 278
           KC+ +   AR + S+LL+ PF +
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFVT 298

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 128/271 (47%), Gaps = 15/271 (5%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
           + +DP   F +   + G G+  +V++  D      VA   +++    E    +  +  E+
Sbjct: 1   MSLDPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEI 56
Query: 70  QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
            +L    + Y+   Y  +L D    L  I E    G+     +    +    +    +++
Sbjct: 57  TVLSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREI 113
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEY 188
           L+GL+YLH+ +   IHRD+  +N+ ++ + G+VK+ D G A  +  +    +  +GTP +
Sbjct: 114 LKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNXFVGTPFW 170
Query: 189 MAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           MAPE+ ++  Y    DI+S G+  +E+   E P+SE   +  ++  +     P  L    
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIPKNNPPTLEGNY 228
Query: 248 DPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
              +K F+E C+  +P  RP+A ELLK  F 
Sbjct: 229 SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 43  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 98  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHA- 149
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A +  R   SH    + G+  +MAPE+   
Sbjct: 150 -KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 267
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 268 AMKRLMAECLKKKRDERPLFPQIL 291

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN------ 77
           +G GA   VY+A D   G  VA   VR+ +  E  P+   R   EV LLR L+       
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR---EVALLRRLEAFEHPNV 68
Query: 78  -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA--LKKWSKQVLEGLE 134
            + + VC +   D +         V    +LRTY  K     + A  +K   +Q L GL+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV--DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-L 193
           +LH +  CI+HRDL   NI +    G VK+ D G A I     A   ++ T  Y APE L
Sbjct: 127 FLHAN--CIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQ 241
            +  Y   VD++S G    EM   +  +   SE D + KI+  +  G+ P+
Sbjct: 184 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI--GLPPE 232

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 137/287 (47%), Gaps = 35/287 (12%)
Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP+G F    +L+G+G   +VY+    + G   A   + ++   E+ +       E+ +L
Sbjct: 21  DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI-----KQEINML 74
Query: 73  RTLKNKYIIVCY--------SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
           +   +   I  Y           +DDQ   L  + E C +G++    K  +  ++K  ++
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQ---LWLVMEFCGAGSVTDLIKNTKGNTLK--EE 129
Query: 125 W----SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-A 179
           W     +++L GL +LH H+  +IHRD+   N+ +  N  +VK+ D G +A + R+    
Sbjct: 130 WIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRR 186
Query: 180 HSIIGTPEYMAPELYEED------YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
           ++ IGTP +MAPE+   D      Y    D++S G+  +EM     P  +   +  ++  
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-L 245
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRA-RPSASELLKDPFFSE 279
           +     P+  +K    + ++FIE C+ +  + RP+  +L+K PF  +
Sbjct: 246 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 44  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 99  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A +  R   SH    + G+  +MAPE+   
Sbjct: 152 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 268
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 269 AMKRLMAECLKKKRDERPLFPQIL 292

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 132
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 133 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 189
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 190 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 247
Query: 204 IYSFGLCLLEMVTMEIPYSECDS 226
           I+S GL L+EM     P    D+
Sbjct: 248 IWSMGLSLVEMAVGRYPIPPPDA 270

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 15/277 (5%)
Query: 12  VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           VDP   F +  D +G G+  +VY+  D      VA   +++    E    +  +  E+ +
Sbjct: 15  VDPEELFTKL-DRIGKGSFGEVYKGIDNHTKEVVA---IKIIDLEEAEDEIEDIQQEITV 70
Query: 72  LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLE 131
           L    + YI   +  +L  +   L  I E    G+     K    +    +    +++L+
Sbjct: 71  LSQCDSPYITRYFGSYL--KSTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILK 127
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMA 190
           GL+YLH+     IHRD+  +N+ ++   G VK+ D G A  +  +    +  +GTP +MA
Sbjct: 128 GLDYLHSERK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 184
Query: 191 PELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
           PE+ ++  Y    DI+S G+  +E+   E P S+   +  ++  +     P  L      
Sbjct: 185 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--LIPKNSPPTLEGQHSK 242
Query: 250 EVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDS 285
             K F+E C+ + PR RP+A ELLK  F +      S
Sbjct: 243 PFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 279

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN------ 77
           +G GA   VY+A D   G  VA   VR+ +  E  P+   R   EV LLR L+       
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR---EVALLRRLEAFEHPNV 68
Query: 78  -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA--LKKWSKQVLEGLE 134
            + + VC +   D +         V    +LRTY  K     + A  +K   +Q L GL+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV--DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-L 193
           +LH +  CI+HRDL   NI +    G VK+ D G A I     A   ++ T  Y APE L
Sbjct: 127 FLHAN--CIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQ 241
            +  Y   VD++S G    EM   +  +   SE D + KI+  +  G+ P+
Sbjct: 184 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI--GLPPE 232

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 18  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 73  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A +  R   SH    + G+  +MAPE+   
Sbjct: 126 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 242
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 243 AMKRLMAECLKKKRDERPLFPQIL 266

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 21  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 76  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A +  R   SH    + G+  +MAPE+   
Sbjct: 129 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 245
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 246 AMKRLMAECLKKKRDERPLFPQIL 269

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/231 (32%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN------ 77
           +G GA   VY+A D   G  VA   VR+ +  E  P+   R   EV LLR L+       
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR---EVALLRRLEAFEHPNV 68
Query: 78  -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA--LKKWSKQVLEGLE 134
            + + VC +   D +         V    +LRTY  K     + A  +K   +Q L GL+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV--DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 126
Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-L 193
           +LH +  CI+HRDL   NI +    G VK+ D G A I     A   ++ T  Y APE L
Sbjct: 127 FLHAN--CIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQ 241
            +  Y   VD++S G    EM   +  +   SE D + KI+  +  G+ P+
Sbjct: 184 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI--GLPPE 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 21  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 76  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A +  R   SH    + G+  +MAPE+   
Sbjct: 129 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 245
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 246 AMKRLMAECLKKKRDERPLFPQIL 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 16  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 71  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A +  R   SH    + G+  +MAPE+   
Sbjct: 124 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 16  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 71  GYSTAPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A +  R   SH    + G+  +MAPE+   
Sbjct: 124 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 131/271 (48%), Gaps = 32/271 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSGA   V+   ++  G+E     ++  +     V + ++ +E+++L++L +  II  +
Sbjct: 30  LGSGAFGDVHLVEERSSGLE---RVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 85  SVWLDDQHNTLNFITEVCTSGNLR----TYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
            V+ +D HN +  + E C  G L     + + + + +S   + +  KQ++  L Y H+  
Sbjct: 87  EVF-EDYHN-MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 141 PCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDY 198
             ++H+DL   NI          +KI D G A +      + +  GT  YMAPE+++ D 
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV 202
Query: 199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT----------GGVKPQALNKVKD 248
           T   DI+S G+ +  ++T  +P++   S+ ++ +K T            + PQA++ +K 
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGT-SLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261
Query: 249 PEVKAFIEKCIAQPRARPSASELLKDPFFSE 279
              K         P  RPSA+++L   +F +
Sbjct: 262 MLTK--------DPERRPSAAQVLHHEWFKQ 284

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 128 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 204 IYSFGLCLLEMVTMEIPYSECDS 226
           I+S GL L+EM     P    D+
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRTL 75
           S  LGSGA  +V  AF+++   +VA   +    F+       DP L   + +E+++L+ L
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL--NVETEIEILKKL 197
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            +  II   + +  + +     + E+   G L      ++ +     K +  Q+L  ++Y
Sbjct: 198 NHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           LH  E  IIHRDL   N+ ++       +KI D G + I+G +    ++ GTP Y+APE+
Sbjct: 255 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 194 Y----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
                   Y   VD +S G+ L   ++   P+SE  +   +  ++T G     P+   +V
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372
Query: 247 KDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
            +  +    +  +  P+AR +  E L+ P+   L D+D
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPW---LQDED 407

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 98  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 154
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 155 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 212
Query: 204 IYSFGLCLLEMVTMEIPYSECDS 226
           I+S GL L+EM     P    D+
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDA 235

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 128 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 204 IYSFGLCLLEMVTMEIPYSECDS 226
           I+S GL L+EM     P    D+
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 126/260 (48%), Gaps = 14/260 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+  K       E+G +    ++ +S  S      +R   EV +L  +K+  I+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR--REVAVLANMKHPNIVQYR 89
Query: 85  SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
             +  +++ +L  + + C  G+L  R   +K        +  W  Q+   L+  H H+  
Sbjct: 90  ESF--EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--HVHDRK 145
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYE-EDYTE 200
           I+HRD+   NIF+  + G V++GD G A ++  +   A + IGTP Y++PE+ E + Y  
Sbjct: 146 ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
             DI++ G  L E+ T++  +        + K ++G   P +L+   D  +++ + +   
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYD--LRSLVSQLFK 262
Query: 261 Q-PRARPSASELLKDPFFSE 279
           + PR RPS + +L+  F ++
Sbjct: 263 RNPRDRPSVNSILEKGFIAK 282

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRTL 75
           S  LGSGA  +V  AF+++   +VA   +    F+       DP L   + +E+++L+ L
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKL 78
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            +  II   + +  + +     + E+   G L      ++ +     K +  Q+L  ++Y
Sbjct: 79  NHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           LH  E  IIHRDL   N+ ++       +KI D G + I+G +    ++ GTP Y+APE+
Sbjct: 136 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 193
Query: 194 Y----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
                   Y   VD +S G+ L   ++   P+SE  +   +  ++T G     P+   +V
Sbjct: 194 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 253
Query: 247 KDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
            +  +    +  +  P+AR +  E L+ P+   L D+D
Sbjct: 254 SEKALDLVKKLLVVDPKARFTTEEALRHPW---LQDED 288

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRTL 75
           S  LGSGA  +V  AF+++   +VA   +    F+       DP L   + +E+++L+ L
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL--NVETEIEILKKL 211
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            +  II   + +  + +     + E+   G L      ++ +     K +  Q+L  ++Y
Sbjct: 212 NHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           LH  E  IIHRDL   N+ ++       +KI D G + I+G +    ++ GTP Y+APE+
Sbjct: 269 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 326
Query: 194 Y----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
                   Y   VD +S G+ L   ++   P+SE  +   +  ++T G     P+   +V
Sbjct: 327 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 386
Query: 247 KDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
            +  +    +  +  P+AR +  E L+ P+   L D+D
Sbjct: 387 SEKALDLVKKLLVVDPKARFTTEEALRHPW---LQDED 421

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRTL 75
           S  LGSGA  +V  AF+++   +VA   +    F+       DP L   + +E+++L+ L
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKL 71
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            +  II   + +  + +     + E+   G L      ++ +     K +  Q+L  ++Y
Sbjct: 72  NHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           LH  E  IIHRDL   N+ ++       +KI D G + I+G +    ++ GTP Y+APE+
Sbjct: 129 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 186
Query: 194 Y----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
                   Y   VD +S G+ L   ++   P+SE  +   +  ++T G     P+   +V
Sbjct: 187 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 246
Query: 247 KDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
            +  +    +  +  P+AR +  E L+ P+   L D+D
Sbjct: 247 SEKALDLVKKLLVVDPKARFTTEEALRHPW---LQDED 281

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 128 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 204 IYSFGLCLLEMVTMEIPYSECDS 226
           I+S GL L+EM     P    D+
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 9/203 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+  Y
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMAR---KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL      I+
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 128 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 204 IYSFGLCLLEMVTMEIPYSECDS 226
           I+S GL L+EM     P    D+
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRTL 75
           S  LGSGA  +V  AF+++   +VA   +    F+       DP L   + +E+++L+ L
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKL 72
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            +  II   + +  + +     + E+   G L      ++ +     K +  Q+L  ++Y
Sbjct: 73  NHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           LH  E  IIHRDL   N+ ++       +KI D G + I+G +    ++ GTP Y+APE+
Sbjct: 130 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 194 Y----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
                   Y   VD +S G+ L   ++   P+SE  +   +  ++T G     P+   +V
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 247 KDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
            +  +    +  +  P+AR +  E L+ P+   L D+D
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPW---LQDED 282

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRTL 75
           S  LGSGA  +V  AF+++   +VA   +    F+       DP L   + +E+++L+ L
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKL 72
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            +  II   + +  + +     + E+   G L      ++ +     K +  Q+L  ++Y
Sbjct: 73  NHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           LH  E  IIHRDL   N+ ++       +KI D G + I+G +    ++ GTP Y+APE+
Sbjct: 130 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 194 Y----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
                   Y   VD +S G+ L   ++   P+SE  +   +  ++T G     P+   +V
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 247 KDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
            +  +    +  +  P+AR +  E L+ P+   L D+D
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPW---LQDED 282

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQLLRTL 75
           S  LGSGA  +V  AF+++   +VA   +    F+       DP L   + +E+++L+ L
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKL 72
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            +  II   + +  + +     + E+   G L      ++ +     K +  Q+L  ++Y
Sbjct: 73  NHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           LH  E  IIHRDL   N+ ++       +KI D G + I+G +    ++ GTP Y+APE+
Sbjct: 130 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 194 Y----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
                   Y   VD +S G+ L   ++   P+SE  +   +  ++T G     P+   +V
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 247 KDPEVKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
            +  +    +  +  P+AR +  E L+ P+   L D+D
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPW---LQDED 282

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 133/286 (46%), Gaps = 53/286 (18%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LG GA  +V +A +  +    A  ++R  H  E    ++ + SEV LL +L ++Y++  
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEK---LSTILSEVMLLASLNHQYVVRY 67
Query: 84  YSVWLDDQH-----------NTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWS--KQV 129
           Y+ WL+ ++           +TL    E C +G L  Y   H  +++ +  + W   +Q+
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--YDLIHSENLNQQRDEYWRLFRQI 125
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---------------G 174
           LE L Y+H+    IIHRDL   NIFI+ +   VKIGD G A  V               G
Sbjct: 126 LEALSYIHSQ--GIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 175 RSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK 232
            S    S IGT  Y+A E+ +    Y E +D+YS G+   EM+    P+S       I K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 233 KVTGGVKPQALNKVKDPEVKAFIEKCIAQ------PRARPSASELL 272
           K+   V  +      D ++K  +EK I +      P  RP A  LL
Sbjct: 240 KLR-SVSIEFPPDFDDNKMK--VEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 12/211 (5%)
Query: 18  FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           F R S+L G+G    V +   +  G+ +A    +L H    P + N++  E+Q+L    +
Sbjct: 18  FERISEL-GAGNGGVVTKVQHRPSGLIMAR---KLIHLEIKPAIRNQIIRELQVLHECNS 73
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
            YI+  Y  +  D    ++   E    G+L    K+ + +  + L K S  VL GL YL 
Sbjct: 74  PYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 138 -THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYE 195
             H+  I+HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YMAPE L  
Sbjct: 132 EKHQ--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPERLQG 187
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
             Y+   DI+S GL L+E+     P    D+
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYPIPPPDA 218

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 130/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 44  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 99  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A    R   SH    + G+  +MAPE+   
Sbjct: 152 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 268
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 269 AMKRLMAECLKKKRDERPLFPQIL 292

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 130/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 36  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 91  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A    R   SH    + G+  +MAPE+   
Sbjct: 144 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 260
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 261 AMKRLMAECLKKKRDERPLFPQIL 284

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 130/264 (49%), Gaps = 31/264 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   VY+   +  G +VA   + ++  +  P  +    +EV +LR  ++  I++  
Sbjct: 16  IGSGSFGTVYKG--KWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-----SIKALKKWSKQVLEGLEYLHTH 139
                 Q   L  +T+ C   +L      H H+      +  L   ++Q  +G++YLH  
Sbjct: 71  GYSTKPQ---LAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPELY-- 194
              IIHRDL  +NIF++ ++  VKIGD G A    R   SH    + G+  +MAPE+   
Sbjct: 124 --SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---P 249
             +  Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+     
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 250 EVKAFIEKCIAQPR-ARPSASELL 272
            +K  + +C+ + R  RP   ++L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 105/234 (44%), Gaps = 27/234 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKN--- 77
           +G GA   VY+A D   G  VA   VR+ +        P+   R   EV LLR L+    
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR---EVALLRRLEAFEH 73
Query: 78  ----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA--LKKWSKQVLE 131
               + + VC +   D +         V    +LRTY  K     + A  +K   +Q L 
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHV--DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           GL++LH +  CI+HRDL   NI +    G VK+ D G A I     A   ++ T  Y AP
Sbjct: 132 GLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQ 241
           E L +  Y   VD++S G    EM   +  +   SE D + KI+  +  G+ P+
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI--GLPPE 240

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 17/258 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V  A ++  G +VA  ++ L       +L N    EV ++R   +  ++  Y
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN----EVVIMRDYHHDNVVDMY 108
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           S +L    + L  + E    G L T    H  ++ + +      VL  L YLH     +I
Sbjct: 109 SSYLVG--DELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQ--GVI 163
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEE-DYTEMV 202
           HRD+   +I +  + G++K+ D GF A V +       ++GTP +MAPE+     Y   V
Sbjct: 164 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA--LNKVKDPEVKAFIE-KCI 259
           DI+S G+ ++EM+  E PY   +   +  +++   + P+   L+KV    ++ F++   +
Sbjct: 223 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDSLPPRVKDLHKVSS-VLRGFLDLMLV 280
Query: 260 AQPRARPSASELLKDPFF 277
            +P  R +A ELL  PF 
Sbjct: 281 REPSQRATAQELLGHPFL 298

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 35/286 (12%)
Query: 4   RDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRA-FDQEEGIEVAWNQVRLSHFSEDPVLV 62
           RD   + E++ S      S  +GSG+   VY+  +  +  +++      L      P   
Sbjct: 25  RDSSYYWEIEASEVM--LSTRIGSGSFGTVYKGKWHGDVAVKI------LKVVDPTPEQF 76
Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
               +EV +LR  ++  I++       D    L  +T+ C   +L     KH HV     
Sbjct: 77  QAFRNEVAVLRKTRHVNILLFMGYMTKD---NLAIVTQWCEGSSLY----KHLHVQETKF 129
Query: 123 KKW-----SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 177
           + +     ++Q  +G++YLH     IIHRD+  +NIF++  +  VKIGD G A +  R  
Sbjct: 130 QMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWS 186
Query: 178 AAHSI---IGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI 230
            +  +    G+  +MAPE+        ++   D+YS+G+ L E++T E+PYS  ++  +I
Sbjct: 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI 246
Query: 231 YKKVTGGVKPQALNKVKD---PEVKAFIEKCIAQPR-ARPSASELL 272
              V  G     L+K+       +K  +  C+ + +  RP   ++L
Sbjct: 247 IFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 134/295 (45%), Gaps = 22/295 (7%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           G      D     G Y  L  +G G   KV  A     G EVA   +  +  +   +   
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--Q 58
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           +L  EV++++ L +  I+  + V   +   TL  + E  + G +  Y   H  +  K  +
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
              +Q++  ++Y   H+  I+HRDL   N+ ++ ++  +KI D GF+      +   +  
Sbjct: 117 AKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFC 173
Query: 184 GTPEYMAPELYEEDYTE--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           G+P Y APEL++    +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G    
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232
Query: 242 ALNKVKDPE--VKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS-----EPSP 289
                 D E  +K F+   I  P  R +  +++KD + +  ++DD      EP P
Sbjct: 233 PFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 284

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 120/261 (45%), Gaps = 28/261 (10%)
Query: 10  VEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH- 66
           + +D   R  RY   D LG G    VY+A D+     VA  +++L H SE    +NR   
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF-----ITEVCTSGNLRTYRKKHRHVSIKA 121
            E++LL+ L +  II     +    + +L F       EV    N       H       
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH------- 113
Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-- 179
           +K +    L+GLEYLH H   I+HRDL  +N+ ++ N G +K+ D G A   G  + A  
Sbjct: 114 IKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYX 170
Query: 180 HSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKK 233
           H ++ T  Y APEL      Y   VD+++ G C+L  + + +P+    S+ D + +I++ 
Sbjct: 171 HQVV-TRWYRAPELLFGARMYGVGVDMWAVG-CILAELLLRVPFLPGDSDLDQLTRIFET 228
Query: 234 VTGGVKPQALNKVKDPEVKAF 254
           +    + Q  +    P+   F
Sbjct: 229 LGTPTEEQWPDMCSLPDYVTF 249

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 134/295 (45%), Gaps = 22/295 (7%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           G      D     G Y  L  +G G   KV  A     G EVA   +  +  +   +   
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL--Q 58
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           +L  EV++++ L +  I+  + V   +   TL  + E  + G +  Y   H  +  K  +
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
              +Q++  ++Y   H+  I+HRDL   N+ ++ ++  +KI D GF+      +   +  
Sbjct: 117 AKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFC 173
Query: 184 GTPEYMAPELYEEDYTE--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           G+P Y APEL++    +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G    
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232
Query: 242 ALNKVKDPE--VKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS-----EPSP 289
                 D E  +K F+   I  P  R +  +++KD + +  ++DD      EP P
Sbjct: 233 PFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 284

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 127/293 (43%), Gaps = 44/293 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    VY+  ++  G+ VA  +V+L      P    R   E+ L++ LK++ I+  Y
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKHENIVRLY 69
Query: 85  SVWLDDQHNTLNF---ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
            V   +   TL F     ++    + RT     R + +  +K +  Q+L+GL +   HE 
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF--CHEN 127
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELY--EEDY 198
            I+HRDL   N+ IN   GQ+K+GD G A   G   +   S + T  Y AP++      Y
Sbjct: 128 KILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 199 TEMVDIYSFGLCLLEMVT--------------------MEIPY-SECDSVAKI--YKKVT 235
           +  +DI+S G  L EM+T                    M  P  S   SV K+  Y    
Sbjct: 187 STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNI 246
Query: 236 GGVKPQALNKVKDPEVKAFIEKCIA---------QPRARPSASELLKDPFFSE 279
               P+ L +V  P  K  ++  +           P  R SA + L  P+F+E
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 118/258 (45%), Gaps = 13/258 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R   +  G+E A   +     S       +L  E ++ R L++  I+  +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRLH 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++  + L F  ++ T G L          S        +Q+LE + Y H++   I+
Sbjct: 72  DSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IV 127
Query: 145 HRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEM 201
           HR+L   N+ +        VK+ D G A  V  S A H   GTP Y++PE+ ++D Y++ 
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPEVKAFIEKCI 259
           VDI++ G+ L  ++    P+ + D   ++Y ++  G    P        PE K+ I+  +
Sbjct: 188 VDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246
Query: 260 A-QPRARPSASELLKDPF 276
              P+ R +A + LK P+
Sbjct: 247 TVNPKKRITADQALKVPW 264

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           R    +G G   KV  A     G EVA   +  +    +P  + +L  EV++++ L +  
Sbjct: 18  RLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL--NPTSLQKLFREVRIMKILNHPN 75
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
           I+  + V   +   TL  + E  + G +  Y   H  +  K  +   +Q++  ++Y   H
Sbjct: 76  IVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQY--CH 131
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYT 199
           +  I+HRDL   N+ ++G++  +KI D GF+      +   +  G+P Y APEL++    
Sbjct: 132 QKYIVHRDLKAENLLLDGDM-NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 200 E--MVDIYSFGLCLLEMVTMEIPY 221
           +   VD++S G+ L  +V+  +P+
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 131/285 (45%), Gaps = 17/285 (5%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           G      D     G Y  L  +G G   KV  A     G EVA   +  +  +   +   
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--Q 58
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           +L  EV++++ L +  I+  + V   +   TL  + E  + G +  Y   H  +  K  +
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
              +Q++  ++Y   H+  I+HRDL   N+ ++ ++  +KI D GF+      +   +  
Sbjct: 117 AKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFC 173
Query: 184 GTPEYMAPELYEEDYTE--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           G+P Y APEL++    +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G    
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232
Query: 242 ALNKVKDPE--VKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
                 D E  +K F+   I  P  R +  +++KD + +  ++DD
Sbjct: 233 PFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWMNVGHEDD 274

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 127/273 (46%), Gaps = 24/273 (8%)
Query: 17  RFGRY--SDLLGSGAVKKVYRAFDQEEGIEVA---WNQVRLSHFSEDPVLVNRLHSEVQL 71
           + G Y   D LG G   KV     +  G +VA    N+ ++        +V ++  E+Q 
Sbjct: 14  KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD----VVGKIRREIQN 69
Query: 72  LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLE 131
           L+  ++ +II  Y V      + +  + E  + G L  Y  K+  +  K  ++  +Q+L 
Sbjct: 70  LKLFRHPHIIKLYQVI--STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           G++Y H H   ++HRDL   N+ ++ ++   KI D G + ++          G+P Y AP
Sbjct: 128 GVDYCHRH--MVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRXSCGSPNYAAP 184
Query: 192 ELYEEDYTE--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVK 247
           E+          VDI+S G+ L  ++   +P+ + D V  ++KK+  G+   PQ LN   
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLN--- 240
Query: 248 DPEVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
            P V + ++  +   P  R +  ++ +  +F +
Sbjct: 241 -PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 13/259 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R   +  G+E A   +     S       +L  E ++ R L++  I+  +
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRLH 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++  + L F  ++ T G L          S        +Q+LE + Y H++   I+
Sbjct: 71  DSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IV 126
Query: 145 HRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEM 201
           HR+L   N+ +        VK+ D G A  V  S A H   GTP Y++PE+ ++D Y++ 
Sbjct: 127 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 186
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPEVKAFIEKCI 259
           VDI++ G+ L  ++    P+ + D   ++Y ++  G    P        PE K+ I+  +
Sbjct: 187 VDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 245
Query: 260 A-QPRARPSASELLKDPFF 277
              P+ R +A + LK P+ 
Sbjct: 246 TVNPKKRITADQALKVPWI 264

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 125/264 (47%), Gaps = 17/264 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL-LRTLKNKYIIVC 83
           LG GA   V +      G  +A  ++R +  S++     RL  ++ + +RT+   + +  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ---KRLLMDLDISMRTVDCPFTVTF 115
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRK---KHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           Y      +   +    E+  +   + Y++   K + +    L K +  +++ LE+LH+ +
Sbjct: 116 YGALF--REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-K 172
Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-----LYE 195
             +IHRD+  SN+ IN  +GQVK+ D G +  +  S A     G   YMAPE     L +
Sbjct: 173 LSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
           + Y+   DI+S G+ ++E+  +  PY    +  +  K+V     PQ        E   F 
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 256 EKCIAQ-PRARPSASELLKDPFFS 278
            +C+ +  + RP+  EL++ PFF+
Sbjct: 292 SQCLKKNSKERPTYPELMQHPFFT 315

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 13/259 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R   +  G+E A   +     S       +L  E ++ R L++  I+  +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRLH 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++  + L F  ++ T G L          S        +Q+LE + Y H++   I+
Sbjct: 72  DSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IV 127
Query: 145 HRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEM 201
           HR+L   N+ +        VK+ D G A  V  S A H   GTP Y++PE+ ++D Y++ 
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPEVKAFIEKCI 259
           VDI++ G+ L  ++    P+ + D   ++Y ++  G    P        PE K+ I+  +
Sbjct: 188 VDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246
Query: 260 A-QPRARPSASELLKDPFF 277
              P+ R +A + LK P+ 
Sbjct: 247 TVNPKKRITADQALKVPWI 265

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D LG G +  VY A D    I+VA   + +    ++  L  R   EV     L ++ I+ 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-KRFEREVHNSSQLSHQNIVS 75
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
              V  D++ +    + E      L  Y + H  +S+     ++ Q+L+G++  H H+  
Sbjct: 76  MIDV--DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK--HAHDMR 131
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPELYEEDYT- 199
           I+HRD+   NI I+ N   +KI D G A  +  +    +  ++GT +Y +PE  + + T 
Sbjct: 132 IVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----------PQALNKV 246
           E  DIYS G+ L EM+  E P++   +V+   K +   V           PQ+L+ V
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 22/295 (7%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           G      D     G Y  L  +G G   KV  A     G EVA   +  +  +   +   
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--Q 58
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           +L  EV++++ L +  I+  + V   +   TL  + E  + G +  Y   H  +  K  +
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
              +Q++  ++Y   H+  I+HRDL   N+ ++ ++  +KI D GF+      +   +  
Sbjct: 117 AKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDAFC 173
Query: 184 GTPEYMAPELYEEDYTE--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           G P Y APEL++    +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G    
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232
Query: 242 ALNKVKDPE--VKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS-----EPSP 289
                 D E  +K F+   I  P  R +  +++KD + +  ++DD      EP P
Sbjct: 233 PFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 284

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 17/281 (6%)
Query: 6   GEPFVEVDPSGRFGRYSDL---LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV 62
           G  F+ ++ S +F    D+   LG GA   V R   +  G+E A   +     S      
Sbjct: 16  GSEFM-MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-- 72
Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
            +L  E ++ R L++  I+  +    ++  + L F  ++ T G L          S    
Sbjct: 73  QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADA 130
Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAH 180
               +Q+LE + Y H++   I+HR+L   N+ +        VK+ D G A  V  S A H
Sbjct: 131 SHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV- 238
              GTP Y++PE+ ++D Y++ VDI++ G+ L  ++    P+ + D   ++Y ++  G  
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAY 247
Query: 239 -KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
             P        PE K+ I+  +   P+ R +A + LK P+ 
Sbjct: 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 135/278 (48%), Gaps = 39/278 (14%)
Query: 17  RFG---RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR 73
           RFG   +  +L+GSG   +V++A  + +G      +V+ ++         +   EV+ L 
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALA 59
Query: 74  TLKNKYIIVCYSVW----LDDQHNTLN---------FI-TEVCTSGNLRTYRKKHRHVSI 119
            L +  I+     W     D + ++ N         FI  E C  G L  + +K R   +
Sbjct: 60  KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 120 KALKKWS--KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 177
             +      +Q+ +G++Y+H+ +  +I+RDL  SNIF+  +  QVKIGD G    +    
Sbjct: 120 DKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDG 176
Query: 178 AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
                 GT  YM+PE +  +DY + VD+Y+ GL L E++ +      CD+  +  K  T 
Sbjct: 177 KRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------CDTAFETSKFFT- 229
Query: 237 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 273
            ++   ++ + D + K  ++K ++ +P  RP+ SE+L+
Sbjct: 230 DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 22/295 (7%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           G      D     G Y  L  +G G   KV  A     G EVA   +  +  +   +   
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL--Q 58
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           +L  EV++++ L +  I+  + V   +   TL  + E  + G +  Y   H  +  K  +
Sbjct: 59  KLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
              +Q++  ++Y   H+  I+HRDL   N+ ++ ++  +KI D GF+      +      
Sbjct: 117 AKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDEFC 173
Query: 184 GTPEYMAPELYEEDYTE--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           G+P Y APEL++    +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G    
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232
Query: 242 ALNKVKDPE--VKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS-----EPSP 289
                 D E  +K F+   I  P  R +  +++KD + +  ++DD      EP P
Sbjct: 233 PFYMSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 284

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 53/286 (18%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LG GA  +V +A +  +    A  ++R  H  E    ++ + SEV LL +L ++Y++  
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEK---LSTILSEVMLLASLNHQYVVRY 67
Query: 84  YSVWLDDQH-----------NTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWS--KQV 129
           Y+ WL+ ++           +TL    E C +  L  Y   H  +++ +  + W   +Q+
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL--YDLIHSENLNQQRDEYWRLFRQI 125
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---------------G 174
           LE L Y+H+    IIHRDL   NIFI+ +   VKIGD G A  V               G
Sbjct: 126 LEALSYIHSQ--GIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 175 RSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK 232
            S    S IGT  Y+A E+ +    Y E +D+YS G+   EM+    P+S       I K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 233 KVTGGVKPQALNKVKDPEVKAFIEKCIAQ------PRARPSASELL 272
           K+   V  +      D ++K  +EK I +      P  RP A  LL
Sbjct: 240 KLR-SVSIEFPPDFDDNKMK--VEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 7/153 (4%)
Query: 125 WSKQVLEGLEYLHTHEP-CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
           W  Q  +G+ YLH+ +P  +IHRDL   N+ +      +KI D G A  + ++H  ++  
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-QTHMTNNK- 165
Query: 184 GTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA-KIYKKVTGGVKPQ 241
           G+  +MAPE++E  +Y+E  D++S+G+ L E++T   P+ E    A +I   V  G +P 
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 225
Query: 242 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
            +  +  P +++ + +C ++ P  RPS  E++K
Sbjct: 226 LIKNLPKP-IESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 87/153 (56%), Gaps = 7/153 (4%)
Query: 125 WSKQVLEGLEYLHTHEP-CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
           W  Q  +G+ YLH+ +P  +IHRDL   N+ +      +KI D G A  + ++H  ++  
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-QTHMTNNK- 164
Query: 184 GTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA-KIYKKVTGGVKPQ 241
           G+  +MAPE++E  +Y+E  D++S+G+ L E++T   P+ E    A +I   V  G +P 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 242 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
            +  +  P +++ + +C ++ P  RPS  E++K
Sbjct: 225 LIKNLPKP-IESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 125/268 (46%), Gaps = 15/268 (5%)
Query: 12  VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
            DP   F +  + +G G+  +V++  D      VA   +++    E    +  +  E+ +
Sbjct: 19  ADPEELFTKL-ERIGKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITV 74
Query: 72  LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLE 131
           L    + Y+   Y  +L  + + L  I E    G+     +       + +    K++L+
Sbjct: 75  LSQCDSSYVTKYYGSYL--KGSKLWIIMEYLGGGSALDLLRAGPFDEFQ-IATMLKEILK 131
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMA 190
           GL+YLH+ +   IHRD+  +N+ ++   G VK+ D G A  +  +    ++ +GTP +MA
Sbjct: 132 GLDYLHSEKK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 188
Query: 191 PELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
           PE+ ++  Y    DI+S G+  +E+   E P S+   +  ++  +     P  L      
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--LIPKNNPPTLVGDFTK 246
Query: 250 EVKAFIEKCIAQ-PRARPSASELLKDPF 276
             K FI+ C+ + P  RP+A ELLK  F
Sbjct: 247 SFKEFIDACLNKDPSFRPTAKELLKHKF 274

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 95/178 (53%), Gaps = 14/178 (7%)
Query: 100 EVCTSGNLRTYRKKHRHVSIKALKKWS--KQVLEGLEYLHTHEPCIIHRDLNCSNIFING 157
           E C  G L  + +K R   +  +      +Q+ +G++Y+H+ +  +IHRDL  SNIF+  
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LIHRDLKPSNIFLV- 170
Query: 158 NIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           +  QVKIGD G    +          GT  YM+PE +  +DY + VD+Y+ GL L E++ 
Sbjct: 171 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 230
Query: 217 MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK 273
           +      CD+  +  K  T  ++   ++ + D + K  ++K ++ +P  RP+ SE+L+
Sbjct: 231 V------CDTAFETSKFFT-DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 281

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 41/291 (14%)
Query: 25  LGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII- 81
           +G GA  KV++A D + G   VA  +VR+    E  P+   R  + ++ L T ++  ++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 82  ---VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYL 136
              VC +V   D+   L  + E     +L TY  K     V  + +K    Q+L GL++L
Sbjct: 79  LFDVC-TVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYE 195
           H+H   ++HRDL   NI +  + GQ+K+ D G A I     A  S++ T  Y APE L +
Sbjct: 137 HSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTG-----------GVKPQ 241
             Y   VD++S G    EM   +  +   S+ D + KI   V G            +  Q
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPGEEDWPRDVALPRQ 252
Query: 242 ALNKVKDPEVKAFIE-----------KCIA-QPRARPSASELLKDPFFSEL 280
           A +      ++ F+            KC+   P  R SA   L  P+F +L
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 41/291 (14%)
Query: 25  LGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII- 81
           +G GA  KV++A D + G   VA  +VR+    E  P+   R  + ++ L T ++  ++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 82  ---VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYL 136
              VC +V   D+   L  + E     +L TY  K     V  + +K    Q+L GL++L
Sbjct: 79  LFDVC-TVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYE 195
           H+H   ++HRDL   NI +  + GQ+K+ D G A I     A  S++ T  Y APE L +
Sbjct: 137 HSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTG-----------GVKPQ 241
             Y   VD++S G    EM   +  +   S+ D + KI   V G            +  Q
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPGEEDWPRDVALPRQ 252
Query: 242 ALNKVKDPEVKAFIE-----------KCIA-QPRARPSASELLKDPFFSEL 280
           A +      ++ F+            KC+   P  R SA   L  P+F +L
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 130/279 (46%), Gaps = 20/279 (7%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           R    +G G   KV  A     G EVA   +  +  +   +   +L  EV++++ L +  
Sbjct: 10  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--QKLFREVRIMKVLNHPN 67
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
           I+  + V   +   TL  + E  + G +  Y   H  +  K  +   +Q++  ++Y   H
Sbjct: 68  IVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY--CH 123
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYT 199
           +  I+HRDL   N+ ++ ++  +KI D GF+      +   +  G+P Y APEL++    
Sbjct: 124 QKFIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 200 E--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE--VKAFI 255
           +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G          D E  +K F+
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFL 241
Query: 256 EKCIAQPRARPSASELLKDPFFSELNDDDS-----EPSP 289
              I  P  R +  +++KD + +  ++DD      EP P
Sbjct: 242 ---ILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLP 277

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 124/264 (46%), Gaps = 17/264 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL-LRTLKNKYIIVC 83
           LG GA   V +      G  +A  ++R +  S++     RL  ++ + +RT+   + +  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ---KRLLMDLDISMRTVDCPFTVTF 71
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRK---KHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           Y      +   +    E+  +   + Y++   K + +    L K +  +++ LE+LH+ +
Sbjct: 72  YGALF--REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-K 128
Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-----LYE 195
             +IHRD+  SN+ IN  +GQVK+ D G +  +    A     G   YMAPE     L +
Sbjct: 129 LSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
           + Y+   DI+S G+ ++E+  +  PY    +  +  K+V     PQ        E   F 
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 256 EKCIAQ-PRARPSASELLKDPFFS 278
            +C+ +  + RP+  EL++ PFF+
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFT 271

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 13/239 (5%)
Query: 13  DPSGRFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 70
           D   + G Y   D LG G   KV     Q  G +VA   +         V V ++  E+Q
Sbjct: 5   DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDV-VGKIKREIQ 63
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
            L+  ++ +II  Y V           + E  + G L  Y  KH  V     ++  +Q+L
Sbjct: 64  NLKLFRHPHIIKLYQVI--STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
             ++Y H H   ++HRDL   N+ ++ ++   KI D G + ++       +  G+P Y A
Sbjct: 122 SAVDYCHRH--MVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAA 178
Query: 191 PELYEEDYTEM--VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNK 245
           PE+          VDI+S G+ L  ++   +P+ + + V  ++KK+ GGV   P+ LN+
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNR 236

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 92/174 (52%), Gaps = 9/174 (5%)
Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V   + E  +L  + + +II  +  + D Q   +  I +    G L +  +K +      
Sbjct: 50  VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPV 107
Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
            K ++ +V   LEYLH+ +  II+RDL   NI ++ N G +KI D GFA  V      + 
Sbjct: 108 AKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYV--PDVTYX 162
Query: 182 IIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           + GTP+Y+APE+   + Y + +D +SFG+ + EM+    P+ + +++ K Y+K+
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKI 215

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R      G E A   +     S       +L  E ++ R LK+  I+  +
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDH--QKLEREARICRLLKHPNIVRLH 87
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++ H+ L F  ++ T G L        + S        +Q+LE +  LH H+  ++
Sbjct: 88  DSISEEGHHYLIF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV--LHCHQMGVV 143
Query: 145 HRDLNCSNIFINGNI--GQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPELYEED-YTE 200
           HRDL   N+ +   +    VK+ D G A  V G   A     GTP Y++PE+  +D Y +
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 203
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPEVKAFIEKC 258
            VD+++ G+ L  ++    P+ + D   ++Y+++  G    P        PE K  I K 
Sbjct: 204 PVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 262
Query: 259 IA-QPRARPSASELLKDPFFS 278
           +   P  R +A+E LK P+ S
Sbjct: 263 LTINPSKRITAAEALKHPWIS 283

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 127/269 (47%), Gaps = 15/269 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           R    +G G   KV  A     G EVA   +  +    +P  + +L  EV++++ L +  
Sbjct: 15  RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPN 72
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
           I+  + V   +   TL  I E  + G +  Y   H  +  K  +   +Q++  ++Y   H
Sbjct: 73  IVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY--CH 128
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYT 199
           +  I+HRDL   N+ ++ ++  +KI D GF+          +  G+P Y APEL++    
Sbjct: 129 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 200 E--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE--VKAFI 255
           +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G          D E  +K F+
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 246
Query: 256 EKCIAQPRARPSASELLKDPFFSELNDDD 284
              +  P  R +  +++KD + +  +++D
Sbjct: 247 ---VLNPIKRGTLEQIMKDRWINAGHEED 272

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 13/239 (5%)
Query: 13  DPSGRFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 70
           D   + G Y   D LG G   KV     Q  G +VA   +         V V ++  E+Q
Sbjct: 5   DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDV-VGKIKREIQ 63
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
            L+  ++ +II  Y V           + E  + G L  Y  KH  V     ++  +Q+L
Sbjct: 64  NLKLFRHPHIIKLYQVI--STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
             ++Y H H   ++HRDL   N+ ++ ++   KI D G + ++          G+P Y A
Sbjct: 122 SAVDYCHRH--MVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRDSCGSPNYAA 178
Query: 191 PELYEEDYTEM--VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNK 245
           PE+          VDI+S G+ L  ++   +P+ + + V  ++KK+ GGV   P+ LN+
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNR 236

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 140/308 (45%), Gaps = 52/308 (16%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEYMA 190
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A      H A  + G   T  Y A
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA-----RHTADEMTGYVATRWYRA 197
Query: 191 PELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKV 246
           PE+      Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 247 KDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSE 279
                + +I+     P+                            R +A++ L   +F++
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 280 LNDDDSEP 287
            +D D EP
Sbjct: 318 YHDPDDEP 325

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 140/308 (45%), Gaps = 52/308 (16%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEYMA 190
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A      H A  + G   T  Y A
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA-----RHTADEMTGYVATRWYRA 197
Query: 191 PELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKV 246
           PE+      Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 247 KDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSE 279
                + +I+     P+                            R +A++ L   +F++
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 280 LNDDDSEP 287
            +D D EP
Sbjct: 318 YHDPDDEP 325

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 140/308 (45%), Gaps = 52/308 (16%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEYMA 190
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A      H A  + G   T  Y A
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA-----RHTADEMTGYVATRWYRA 197
Query: 191 PELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKV 246
           PE+      Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 247 KDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSE 279
                + +I+     P+                            R +A++ L   +F++
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 280 LNDDDSEP 287
            +D D EP
Sbjct: 318 YHDPDDEP 325

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 134/303 (44%), Gaps = 42/303 (13%)
Query: 21  YSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y DL  +GSGA   V  A D   G +VA  ++     SE  +   R + E++LL+ ++++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHE 84
Query: 79  YIIVCYSVWLDDQ--HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
            +I    V+  D+   +  +F   +   G       KH  +    ++    Q+L+GL Y+
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 144
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE--LY 194
           H     IIHRDL   N+ +N +  ++KI D G A           +  T  Y APE  L 
Sbjct: 145 HA--AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEMXGXVV--TRWYRAPEVILN 199
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVK 252
              YT+ VDI+S G  + EM+T +  +   D + ++ +  KVTG    + + +++  E K
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 253 AFIEKCI-------------AQPRA--------------RPSASELLKDPFFSELNDDDS 285
            +++                A P A              R +A E L  P+F  L+D + 
Sbjct: 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319
Query: 286 EPS 288
           EP 
Sbjct: 320 EPQ 322

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNED-XELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII- 81
           +G GA  KV++A D + G   VA  +VR+    E  P+   R  + ++ L T ++  ++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 82  ---VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYL 136
              VC +V   D+   L  + E     +L TY  K     V  + +K    Q+L GL++L
Sbjct: 79  LFDVC-TVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYE 195
           H+H   ++HRDL   NI +  + GQ+K+ D G A I     A  S++ T  Y APE L +
Sbjct: 137 HSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI 230
             Y   VD++S G    EM   +  +   S+ D + KI
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 129/278 (46%), Gaps = 17/278 (6%)
Query: 13  DPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 70
           D     G Y  L  +G G   KV  A     G EVA   +  +    +P  + +L  EV+
Sbjct: 9   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVR 66
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
           +++ L +  I+  + V   +   TL  I E  + G +  Y   H  +  K  +   +Q++
Sbjct: 67  IMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
             ++Y   H+  I+HRDL   N+ ++ ++  +KI D GF+          +  G P Y A
Sbjct: 125 SAVQY--CHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 191 PELYEEDYTE--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
           PEL++    +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G          D
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRIPFYMSTD 240
Query: 249 PE--VKAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
            E  +K F+   +  P  R +  +++KD + +  +++D
Sbjct: 241 CENLLKRFL---VLNPIKRGTLEQIMKDRWINAGHEED 275

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 123/262 (46%), Gaps = 16/262 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG   +V++   ++ G  +A  Q+R S   E+   +  L     +L++    YI+ C+
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI--LMDLDVVLKSHDCPYIVQCF 90
Query: 85  SVWLDDQHNTLNFIT-EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             ++    NT  FI  E+  +   +  ++    +  + L K +  +++ L YL      +
Sbjct: 91  GTFIT---NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-V 146
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE------D 197
           IHRD+  SNI ++   GQ+K+ D G +  +    A     G   YMAPE  +       D
Sbjct: 147 IHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           Y    D++S G+ L+E+ T + PY  C +  ++  KV     P     +    + ++F++
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265
Query: 257 KCIAQP-RARPSASELLKDPFF 277
            C+ +  R RP  ++LL+  F 
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFI 287

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNED-SELKILDFGLARHTDDEMTGY--VATRWYRAPEI 195
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 283 DDSEP 287
            D EP
Sbjct: 316 PDDEP 320

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNED-SELKILDFGLARHTDDEMTGY--VATRWYRAPEI 199
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 283 DDSEP 287
            D EP
Sbjct: 320 PDDEP 324

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 193 -LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
            L    Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 127/273 (46%), Gaps = 19/273 (6%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KY 79
           Y  LLG G   KV    ++  G   A   +R     E  +  + +   V   R L+N ++
Sbjct: 12  YLKLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             +    +    H+ L F+ E    G L  +  + R  + +  + +  +++  LEYLH+ 
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 127
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYEE-D 197
           +  +++RD+   N+ ++ + G +KI D G     +       +  GTPEY+APE+ E+ D
Sbjct: 128 D--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y   VD +  G+ + EM+   +P+   D   ++++ +   ++     +   PE K+ +  
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL--MEEIRFPRTLSPEAKSLLAG 241
Query: 258 CIAQ-PRAR----PS-ASELLKDPFFSELNDDD 284
            + + P+ R    PS A E+++  FF  +N  D
Sbjct: 242 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 274

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 123/259 (47%), Gaps = 17/259 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  KV  A   +   +VA   +      +  + + R+  E+  L+ L++ +II  Y
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM-RVEREISYLKLLRHPHIIKLY 75
Query: 85  SVWLDDQHNTLNFITEVC--TSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V       T   I  V     G L  Y  + + ++    +++ +Q++  +EY H H+  
Sbjct: 76  DVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE-- 200
           I+HRDL   N+ ++ N+  VKI D G + I+   +   +  G+P Y APE+         
Sbjct: 129 IVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI- 259
            VD++S G+ L  M+   +P+ + + +  ++KKV   V    +     P  ++ I + I 
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCV--YVMPDFLSPGAQSLIRRMIV 244
Query: 260 AQPRARPSASELLKDPFFS 278
           A P  R +  E+ +DP+F+
Sbjct: 245 ADPMQRITIQEIRRDPWFN 263

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 127/273 (46%), Gaps = 19/273 (6%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KY 79
           Y  LLG G   KV    ++  G   A   +R     E  +  + +   V   R L+N ++
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             +    +    H+ L F+ E    G L  +  + R  + +  + +  +++  LEYLH+ 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELYEE-D 197
           +  +++RD+   N+ ++ + G +KI D G     +       +  GTPEY+APE+ E+ D
Sbjct: 125 D--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y   VD +  G+ + EM+   +P+   D   ++++ +   ++     +   PE K+ +  
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL--MEEIRFPRTLSPEAKSLLAG 238
Query: 258 CIAQ-PRAR----PS-ASELLKDPFFSELNDDD 284
            + + P+ R    PS A E+++  FF  +N  D
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 91
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 149
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 204
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 283 DDSEP 287
            D EP
Sbjct: 325 PDDEP 329

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNED-XELKILDFGLARHTDDEMTGY--VATRWYRAPEI 198
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 283 DDSEP 287
            D EP
Sbjct: 319 PDDEP 323

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 127/273 (46%), Gaps = 19/273 (6%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KY 79
           Y  LLG G   KV    ++  G   A   +R     E  +  + +   V   R L+N ++
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             +    +    H+ L F+ E    G L  +  + R  + +  + +  +++  LEYLH+ 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYEE-D 197
           +  +++RD+   N+ ++ + G +KI D G     +       +  GTPEY+APE+ E+ D
Sbjct: 125 D--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y   VD +  G+ + EM+   +P+   D   ++++ +   ++     +   PE K+ +  
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL--MEEIRFPRTLSPEAKSLLAG 238
Query: 258 CIAQ-PRAR----PS-ASELLKDPFFSELNDDD 284
            + + P+ R    PS A E+++  FF  +N  D
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 195
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 283 DDSEP 287
            D EP
Sbjct: 316 PDDEP 320

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 213
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 274 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 283 DDSEP 287
            D EP
Sbjct: 334 PDDEP 338

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 157
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 212
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 273 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 283 DDSEP 287
            D EP
Sbjct: 333 PDDEP 337

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 103
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 161
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 216
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 283 DDSEP 287
            D EP
Sbjct: 337 PDDEP 341

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 205
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 283 DDSEP 287
            D EP
Sbjct: 326 PDDEP 330

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 205
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 283 DDSEP 287
            D EP
Sbjct: 326 PDDEP 330

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 135
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 190
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 251 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 283 DDSEP 287
            D EP
Sbjct: 311 PDDEP 315

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 91
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 149
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 204
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 283 DDSEP 287
            D EP
Sbjct: 325 PDDEP 329

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNED-XELKILDFGLARHTDDEMTGY--VATRWYRAPEI 198
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 283 DDSEP 287
            D EP
Sbjct: 319 PDDEP 323

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 199
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 283 DDSEP 287
            D EP
Sbjct: 320 PDDEP 324

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 78
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 136
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 191
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 251
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 252 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 311
Query: 283 DDSEP 287
            D EP
Sbjct: 312 PDDEP 316

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 199
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 283 DDSEP 287
            D EP
Sbjct: 320 PDDEP 324

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 135
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 190
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 251 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 283 DDSEP 287
            D EP
Sbjct: 311 PDDEP 315

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 122/269 (45%), Gaps = 18/269 (6%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR-LHSEVQLLRTLKNKYII 81
           +++G GA   V R  ++E G + A   V ++ F+  P L    L  E  +   LK+ +I+
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNL---RTYRKKHRHVSIKALKK-WSKQVLEGLEYLH 137
                +  D    L  + E     +L      R     V  +A+   + +Q+LE L Y H
Sbjct: 90  ELLETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 138 THEPCIIHRDLNCSNIFING--NIGQVKIGDLGFAAIVGRSH-AAHSIIGTPEYMAPELY 194
            +   IIHRD+   N+ +    N   VK+GD G A  +G S   A   +GTP +MAPE+ 
Sbjct: 148 DNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 195 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKVKDPE 250
           + E Y + VD++  G+ L  +++  +P+    +  ++++ +  G   + P+  + + +  
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 251 VKAFIEKCIAQPRARPSASELLKDPFFSE 279
                   +  P  R +  E L  P+  E
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 195
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 283 DDSEP 287
            D EP
Sbjct: 316 PDDEP 320

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 195
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 283 DDSEP 287
            D EP
Sbjct: 316 PDDEP 320

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 140/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY  L  +GSGA   V  ++D + G+++A    +LS   +  +   R + E++LL+ +K+
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 109
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 167
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 168 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 222
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDP 249
                 Y   VDI+S G  + E++T    +   D + ++ +  ++TG      ++++   
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSH 282
Query: 250 EVKAFIEKCIAQPR---------------------------ARPSASELLKDPFFSELND 282
           E + +I      P+                            R +ASE L  P+FS+ +D
Sbjct: 283 EARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHD 342
Query: 283 DDSEP 287
            D EP
Sbjct: 343 PDDEP 347

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 189
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 283 DDSEP 287
            D EP
Sbjct: 310 PDDEP 314

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSKPFQSIIHAKRTYRELRLLKHMKH 92
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 205
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 283 DDSEP 287
            D EP
Sbjct: 326 PDDEP 330

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 200
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 283 DDSEP 287
            D EP
Sbjct: 321 PDDEP 325

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 198
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 283 DDSEP 287
            D EP
Sbjct: 319 PDDEP 323

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 79
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 137
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 192
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 252
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 253 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 312
Query: 283 DDSEP 287
            D EP
Sbjct: 313 PDDEP 317

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 103
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 161
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMXGY--VATRWYRAPEI 216
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 283 DDSEP 287
            D EP
Sbjct: 337 PDDEP 341

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 198
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 283 DDSEP 287
            D EP
Sbjct: 319 PDDEP 323

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 126/273 (46%), Gaps = 19/273 (6%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KY 79
           Y  LLG G   KV    ++  G   A   +R     E  +  + +   V   R L+N ++
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             +    +    H+ L F+ E    G L  +  + R  + +  + +  +++  LEYLH+ 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYEE-D 197
           +  +++RD+   N+ ++ + G +KI D G     +          GTPEY+APE+ E+ D
Sbjct: 125 D--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y   VD +  G+ + EM+   +P+   D   ++++ +   ++     +   PE K+ +  
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL--MEEIRFPRTLSPEAKSLLAG 238
Query: 258 CIAQ-PRAR----PS-ASELLKDPFFSELNDDD 284
            + + P+ R    PS A E+++  FF  +N  D
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKSQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G           +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNED-SELKILDFGLCRHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 126/273 (46%), Gaps = 19/273 (6%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KY 79
           Y  LLG G   KV    ++  G   A   +R     E  +  + +   V   R L+N ++
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             +    +    H+ L F+ E    G L  +  + R  + +  + +  +++  LEYLH+ 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYEE-D 197
           +  +++RD+   N+ ++ + G +KI D G     +          GTPEY+APE+ E+ D
Sbjct: 125 D--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y   VD +  G+ + EM+   +P+   D   ++++ +   ++     +   PE K+ +  
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL--MEEIRFPRTLSPEAKSLLAG 238
Query: 258 CIAQ-PRAR----PS-ASELLKDPFFSELNDDD 284
            + + P+ R    PS A E+++  FF  +N  D
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 126/273 (46%), Gaps = 19/273 (6%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KY 79
           Y  LLG G   KV    ++  G   A   +R     E  +  + +   V   R L+N ++
Sbjct: 14  YLKLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             +    +    H+ L F+ E    G L  +  + R  + +  + +  +++  LEYLH+ 
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 129
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYEE-D 197
           +  +++RD+   N+ ++ + G +KI D G     +          GTPEY+APE+ E+ D
Sbjct: 130 D--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y   VD +  G+ + EM+   +P+   D   ++++ +   ++     +   PE K+ +  
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL--MEEIRFPRTLSPEAKSLLAG 243
Query: 258 CIAQ-PRAR----PS-ASELLKDPFFSELNDDD 284
            + + P+ R    PS A E+++  FF  +N  D
Sbjct: 244 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 117/261 (44%), Gaps = 14/261 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R      G E A   +     S       +L  E ++ R LK+  I+  +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH--QKLEREARICRLLKHPNIVRLH 76
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++ H+ L F  ++ T G L        + S        +Q+LE +  LH H+  ++
Sbjct: 77  DSISEEGHHYLIF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV--LHCHQMGVV 132
Query: 145 HRDLNCSNIFINGNI--GQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPELYEED-YTE 200
           HR+L   N+ +   +    VK+ D G A  V G   A     GTP Y++PE+  +D Y +
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPEVKAFIEKC 258
            VD+++ G+ L  ++    P+ + D   ++Y+++  G    P        PE K  I K 
Sbjct: 193 PVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 251
Query: 259 IA-QPRARPSASELLKDPFFS 278
           +   P  R +A+E LK P+ S
Sbjct: 252 LTINPSKRITAAEALKHPWIS 272

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 126/273 (46%), Gaps = 19/273 (6%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KY 79
           Y  LLG G   KV    ++  G   A   +R     E  +  + +   V   R L+N ++
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             +    +    H+ L F+ E    G L  +  + R  + +  + +  +++  LEYLH+ 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI-VGRSHAAHSIIGTPEYMAPELYEE-D 197
           +  +++RD+   N+ ++ + G +KI D G     +          GTPEY+APE+ E+ D
Sbjct: 125 D--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y   VD +  G+ + EM+   +P+   D   ++++ +   ++     +   PE K+ +  
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL--MEEIRFPRTLSPEAKSLLAG 238
Query: 258 CIAQ-PRAR----PS-ASELLKDPFFSELNDDD 284
            + + P+ R    PS A E+++  FF  +N  D
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDYGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A       A    + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMAG--FVATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 139/308 (45%), Gaps = 52/308 (16%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEYMA 190
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A      H    + G   T  Y A
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA-----RHTDDEMTGXVATRWYRA 190
Query: 191 PELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKV 246
           PE+      Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 247 KDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSE 279
                + +I+     P+                            R +A++ L   +F++
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 280 LNDDDSEP 287
            +D D EP
Sbjct: 311 YHDPDDEP 318

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDAGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 123/283 (43%), Gaps = 47/283 (16%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LG GA  +V +A +  +    A  ++R +      +L     SEV LL +L ++Y++  
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-----SEVXLLASLNHQYVVRY 67
Query: 84  YSVWLDDQH-----------NTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWS--KQV 129
           Y+ WL+ ++           +TL    E C +  L  Y   H  +++ +  + W   +Q+
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL--YDLIHSENLNQQRDEYWRLFRQI 125
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---------------G 174
           LE L Y+H+    IIHR+L   NIFI+ +   VKIGD G A  V               G
Sbjct: 126 LEALSYIHSQ--GIIHRNLKPXNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 175 RSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK 232
            S    S IGT  Y+A E+ +    Y E +D YS G+   E +    P+S       I K
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILK 239
Query: 233 KVTGGVK--PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELL 272
           K+       P   +  K    K  I   I   P  RP A  LL
Sbjct: 240 KLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A       A    + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMAG--FVATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDRGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A       A    + T  Y APE+
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMAG--FVATRWYRAPEI 189
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 283 DDSEP 287
            D EP
Sbjct: 310 PDDEP 314

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 129/295 (43%), Gaps = 22/295 (7%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           G      D     G Y  L  +G G   KV  A     G EVA   +  +  +   +   
Sbjct: 1   GNSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--Q 58
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           +L  EV++ + L +  I+  + V   +   TL  + E  + G +  Y   H     K  +
Sbjct: 59  KLFREVRIXKVLNHPNIVKLFEVI--ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEAR 116
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
              +Q++  ++Y   H+  I+HRDL   N+ ++ +   +KI D GF+      +   +  
Sbjct: 117 AKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADX-NIKIADFGFSNEFTFGNKLDAFC 173
Query: 184 GTPEYMAPELYEEDYTE--MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           G P Y APEL++    +   VD++S G+ L  +V+  +P+ +  ++ ++ ++V  G    
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232
Query: 242 ALNKVKDPE--VKAFIEKCIAQPRARPSASELLKDPFFSELNDDDS-----EPSP 289
                 D E  +K F+   I  P  R +  ++ KD + +  ++DD      EP P
Sbjct: 233 PFYXSTDCENLLKKFL---ILNPSKRGTLEQIXKDRWXNVGHEDDELKPYVEPLP 284

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI  LGF             + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKI--LGFGLARHTDDEMTGYVATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEG---------IEVAWNQVRLSH-FSEDPVLVNRLHSEVQ 70
           Y  LLG G   KV    ++  G          EV   +  ++H  +E+ VL N  H    
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP--- 208
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
            L  LK  +            H+ L F+ E    G L  +  + R  S    + +  +++
Sbjct: 209 FLTALKYSF----------QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYM 189
             L+YLH+ E  +++RDL   N+ ++ + G +KI D G      +  A   +  GTPEY+
Sbjct: 259 SALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316
Query: 190 APELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
           APE+ E+ DY   VD +  G+ + EM+   +P+   D   K+++ +   ++     +   
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL--MEEIRFPRTLG 373
Query: 249 PEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFS 278
           PE K+ +   + + P+ R       A E+++  FF+
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEG---------IEVAWNQVRLSH-FSEDPVLVNRLHSEVQ 70
           Y  LLG G   KV    ++  G          EV   +  ++H  +E+ VL N  H    
Sbjct: 155 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP--- 211
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
            L  LK  +            H+ L F+ E    G L  +  + R  S    + +  +++
Sbjct: 212 FLTALKYSF----------QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 261
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYM 189
             L+YLH+ E  +++RDL   N+ ++ + G +KI D G      +  A   +  GTPEY+
Sbjct: 262 SALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYL 319
Query: 190 APELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
           APE+ E+ DY   VD +  G+ + EM+   +P+   D   K+++ +   ++     +   
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL--MEEIRFPRTLG 376
Query: 249 PEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFS 278
           PE K+ +   + + P+ R       A E+++  FF+
Sbjct: 377 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 412

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDGGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 213
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 283 DDSEP 287
            D EP
Sbjct: 334 PDDEP 338

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 189
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 283 DDSEP 287
            D EP
Sbjct: 310 PDDEP 314

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 157
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 212
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 273 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 283 DDSEP 287
            D EP
Sbjct: 333 PDDEP 337

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEG---------IEVAWNQVRLSH-FSEDPVLVNRLHSEVQ 70
           Y  LLG G   KV    ++  G          EV   +  ++H  +E+ VL N  H    
Sbjct: 14  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP--- 70
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
            L  LK  +            H+ L F+ E    G L  +  + R  S    + +  +++
Sbjct: 71  FLTALKYSF----------QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 120
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYM 189
             L+YLH+ E  +++RDL   N+ ++ + G +KI D G      +  A      GTPEY+
Sbjct: 121 SALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFCGTPEYL 178
Query: 190 APELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
           APE+ E+ DY   VD +  G+ + EM+   +P+   D   K+++ +   ++     +   
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL--MEEIRFPRTLG 235
Query: 249 PEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFS 278
           PE K+ +   + + P+ R       A E+++  FF+
Sbjct: 236 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 271

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 90
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 148
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 149 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 203
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 204 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 263
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 264 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 323
Query: 283 DDSEP 287
            D EP
Sbjct: 324 PDDEP 328

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEG---------IEVAWNQVRLSH-FSEDPVLVNRLHSEVQ 70
           Y  LLG G   KV    ++  G          EV   +  ++H  +E+ VL N  H    
Sbjct: 13  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP--- 69
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
            L  LK  +            H+ L F+ E    G L  +  + R  S    + +  +++
Sbjct: 70  FLTALKYSF----------QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 119
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYM 189
             L+YLH+ E  +++RDL   N+ ++ + G +KI D G      +  A      GTPEY+
Sbjct: 120 SALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFCGTPEYL 177
Query: 190 APELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
           APE+ E+ DY   VD +  G+ + EM+   +P+   D   K+++ +   ++     +   
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL--MEEIRFPRTLG 234
Query: 249 PEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFS 278
           PE K+ +   + + P+ R       A E+++  FF+
Sbjct: 235 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 270

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 39/282 (13%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS---EVQLLRTLKN 77
           Y   +G G    V++    ++   VA   + L     +  ++ +      EV ++  L +
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ------VLE 131
             I+  Y +     HN    + E    G+L      HR +      KWS +      +  
Sbjct: 83  PNIVKLYGL----MHNPPRMVMEFVPCGDLY-----HRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFI-----NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP 186
           G+EY+    P I+HRDL   NIF+     N  +   K+ D G +      H+   ++G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC-AKVADFGLSQ--QSVHSVSGLLGNF 190
Query: 187 EYMAPELY---EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           ++MAPE     EE YTE  D YSF + L  ++T E P+ E  S  KI  K    ++ + L
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SYGKI--KFINMIREEGL 247
Query: 244 NKVK----DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
                    P ++  IE C +  P+ RP  S ++K+   SEL
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE--LSEL 287

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEG---------IEVAWNQVRLSH-FSEDPVLVNRLHSEVQ 70
           Y  LLG G   KV    ++  G          EV   +  ++H  +E+ VL N  H    
Sbjct: 12  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP--- 68
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
            L  LK  +            H+ L F+ E    G L  +  + R  S    + +  +++
Sbjct: 69  FLTALKYSF----------QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 118
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYM 189
             L+YLH+ E  +++RDL   N+ ++ + G +KI D G      +  A      GTPEY+
Sbjct: 119 SALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXFCGTPEYL 176
Query: 190 APELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
           APE+ E+ DY   VD +  G+ + EM+   +P+   D   K+++ +   ++     +   
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL--MEEIRFPRTLG 233
Query: 249 PEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFS 278
           PE K+ +   + + P+ R       A E+++  FF+
Sbjct: 234 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 269

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 137/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y APE+
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEI 199
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 260 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 283 DDSEP 287
            D EP
Sbjct: 320 PDDEP 324

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 128/300 (42%), Gaps = 65/300 (21%)
Query: 29  AVKKVYRAFDQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTL----KNKYIIVC 83
           A+KK+  AFD     +    +++ L HF  D ++  +      +LR      + K + V 
Sbjct: 84  AIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK-----DILRPTVPYGEFKSVYVV 138
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +   D H  ++                  + ++++ ++ +  Q+L GL+Y+H+ +  +
Sbjct: 139 LDLMESDLHQIIH----------------SSQPLTLEHVRYFLYQLLRGLKYMHSAQ--V 180
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-----IIGTPEYMAPELYEE-- 196
           IHRDL  SN+ +N N  ++KIGD G A  +  S A H       + T  Y APEL     
Sbjct: 181 IHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 239
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDPEVKAF 254
           +YT+ +D++S G    EM+     +   + V   ++   V G   P  +  V    V+A+
Sbjct: 240 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 299
Query: 255 IEKCIA---------------------------QPRARPSASELLKDPFFSELNDDDSEP 287
           I+                               +P AR SA+  L+ PF ++ +D D EP
Sbjct: 300 IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP 359

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 130/267 (48%), Gaps = 29/267 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSGA   V  A D+  G +VA    +LS   +  +   R + E+ LL+ ++++ +I   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V+     +  NF         ++T  +K      S + ++    Q+L+GL+Y+H+    
Sbjct: 108 DVF-TPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS--AG 164
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEYMAPE--LYEED 197
           ++HRDL   N+ +N +  ++KI D G A      HA   + G   T  Y APE  L    
Sbjct: 165 VVHRDLKPGNLAVNEDC-ELKILDFGLA-----RHADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFI 255
           Y + VDI+S G  + EM+T +  +   D + ++ +  KVTG    + + K+ D   K++I
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278
Query: 256 E-------KCIAQ--PRARPSASELLK 273
           +       K   Q  PRA P A++LL+
Sbjct: 279 QSLPQTPRKDFTQLFPRASPQAADLLE 305

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 135/308 (43%), Gaps = 52/308 (16%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTS---GNLRTYRKKHRHVSIKALKKWSKQVL 130
           + +I    V+      ++ N +  +T +  +     ++  +    HV          Q+L
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIY-----QIL 131
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
            GL+Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A         +  + T  Y A
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRA 186
Query: 191 PELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKV 246
           PE+      Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 247 KDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSE 279
                + +I+     P+                            R +A++ L   +F++
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 280 LNDDDSEP 287
            +D D EP
Sbjct: 307 YHDPDDEP 314

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A            + T  Y APE+
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMXGXVATRWYRAPEI 213
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 283 DDSEP 287
            D EP
Sbjct: 334 PDDEP 338

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 128/300 (42%), Gaps = 65/300 (21%)
Query: 29  AVKKVYRAFDQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTL----KNKYIIVC 83
           A+KK+  AFD     +    +++ L HF  D ++  +      +LR      + K + V 
Sbjct: 83  AIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK-----DILRPTVPYGEFKSVYVV 137
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +   D H  ++                  + ++++ ++ +  Q+L GL+Y+H+ +  +
Sbjct: 138 LDLMESDLHQIIH----------------SSQPLTLEHVRYFLYQLLRGLKYMHSAQ--V 179
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-----IIGTPEYMAPELYEE-- 196
           IHRDL  SN+ +N N  ++KIGD G A  +  S A H       + T  Y APEL     
Sbjct: 180 IHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH 238
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDPEVKAF 254
           +YT+ +D++S G    EM+     +   + V   ++   V G   P  +  V    V+A+
Sbjct: 239 EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 298
Query: 255 IEKCIA---------------------------QPRARPSASELLKDPFFSELNDDDSEP 287
           I+                               +P AR SA+  L+ PF ++ +D D EP
Sbjct: 299 IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP 358

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS 126
            E+ +LRTL +++II       D    +L  + E    G+LR Y  +H  + +  L  ++
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 140
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP 186
           +Q+ EG+ YLH      IHRDL   N+ ++ N   VKIGD G A  V   H  + +    
Sbjct: 141 QQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDG 197
Query: 187 E----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
           +    + APE L E  +    D++SFG+ L E++T       CDS
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT------HCDS 236

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 6   GEPFVEVDPSG---RFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSED 58
           G  F + DP+    R  ++   LG G    V    Y       G  VA    +L H +E+
Sbjct: 27  GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEE 84
Query: 59  PVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 114
            +       E+++L++L++    KY  VCYS         L  I E    G+LR Y +KH
Sbjct: 85  HL--RDFEREIEILKSLQHDNIVKYKGVCYSAG----RRNLKLIMEYLPYGSLRDYLQKH 138
Query: 115 R-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 173
           +  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIGD G   ++
Sbjct: 139 KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVL 195
Query: 174 GRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 196 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 8/163 (4%)
Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           L K +  +++ LE+LH+ +  +IHRD+  SN+ IN  +GQVK  D G +  +    A   
Sbjct: 138 LGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDI 195
Query: 182 IIG-----TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
             G      PE + PEL ++ Y+   DI+S G+  +E+  +  PY    +  +  K+V  
Sbjct: 196 DAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE 255
Query: 237 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFS 278
              PQ        E   F  +C+ +  + RP+  EL + PFF+
Sbjct: 256 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFFT 298

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 39/282 (13%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS---EVQLLRTLKN 77
           Y   +G G    V++    ++   VA   + L     +  ++ +      EV ++  L +
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ------VLE 131
             I+  Y +     HN    + E    G+L      HR +      KWS +      +  
Sbjct: 83  PNIVKLYGL----MHNPPRMVMEFVPCGDLY-----HRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFI-----NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP 186
           G+EY+    P I+HRDL   NIF+     N  +   K+ D G +      H+   ++G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC-AKVADFGTSQ--QSVHSVSGLLGNF 190
Query: 187 EYMAPELY---EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           ++MAPE     EE YTE  D YSF + L  ++T E P+ E  S  KI  K    ++ + L
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SYGKI--KFINMIREEGL 247
Query: 244 NKVK----DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
                    P ++  IE C +  P+ RP  S ++K+   SEL
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE--LSEL 287

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 130/267 (48%), Gaps = 29/267 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSGA   V  A D+  G +VA    +LS   +  +   R + E+ LL+ ++++ +I   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V+     +  NF         ++T  +K      S + ++    Q+L+GL+Y+H+    
Sbjct: 90  DVF-TPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS--AG 146
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG---TPEYMAPE--LYEED 197
           ++HRDL   N+ +N +  ++KI D G A      HA   + G   T  Y APE  L    
Sbjct: 147 VVHRDLKPGNLAVNEDC-ELKILDFGLA-----RHADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFI 255
           Y + VDI+S G  + EM+T +  +   D + ++ +  KVTG    + + K+ D   K++I
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260
Query: 256 E-------KCIAQ--PRARPSASELLK 273
           +       K   Q  PRA P A++LL+
Sbjct: 261 QSLPQTPRKDFTQLFPRASPQAADLLE 287

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSED 58
           DRD   F E     R  ++   LG G    V    Y       G  VA    +L H +E+
Sbjct: 5   DRDPTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEE 57
Query: 59  PVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 114
            +       E+++L++L++    KY  VCYS         L  I E    G+LR Y +KH
Sbjct: 58  HL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGSLRDYLQKH 111
Query: 115 R-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 173
           +  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIGD G   ++
Sbjct: 112 KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVL 168
Query: 174 GRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 169 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEG-IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           + ++LG G   +  +   +E G + V    +R    ++   L      EV+++R L++  
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL-----KEVKVMRCLEHPN 68
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS------KQVLEGL 133
           ++    V   D+   LNFITE    G LR   K     S+ +   WS      K +  G+
Sbjct: 69  VLKFIGVLYKDKR--LNFITEYIKGGTLRGIIK-----SMDSQYPWSQRVSFAKDIASGM 121
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-------------- 179
            YLH+    IIHRDLN  N  +  N   V + D G A ++                    
Sbjct: 122 AYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 180 -HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMV 215
            ++++G P +MAPE+     Y E VD++SFG+ L E++
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSED 58
           DRD   F E     R  ++   LG G    V    Y       G  VA    +L H +E+
Sbjct: 4   DRDPTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEE 56
Query: 59  PVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 114
            +       E+++L++L++    KY  VCYS         L  I E    G+LR Y +KH
Sbjct: 57  HL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGSLRDYLQKH 110
Query: 115 R-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 173
           +  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIGD G   ++
Sbjct: 111 KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVL 167
Query: 174 GRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 168 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSED 58
           DRD   F E     R  ++   LG G    V    Y       G  VA    +L H +E+
Sbjct: 7   DRDPTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEE 59
Query: 59  PVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 114
            +       E+++L++L++    KY  VCYS         L  I E    G+LR Y +KH
Sbjct: 60  HL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGSLRDYLQKH 113
Query: 115 R-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 173
           +  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIGD G   ++
Sbjct: 114 KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVL 170
Query: 174 GRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 171 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSED 58
           DRD   F E     R  ++   LG G    V    Y       G  VA    +L H +E+
Sbjct: 6   DRDPTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEE 58
Query: 59  PVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 114
            +       E+++L++L++    KY  VCYS         L  I E    G+LR Y +KH
Sbjct: 59  HL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGSLRDYLQKH 112
Query: 115 R-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 173
           +  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIGD G   ++
Sbjct: 113 KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVL 169
Query: 174 GRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 170 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSED 58
           DRD   F E     R  ++   LG G    V    Y       G  VA    +L H +E+
Sbjct: 8   DRDPTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEE 60
Query: 59  PVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 114
            +       E+++L++L++    KY  VCYS         L  I E    G+LR Y +KH
Sbjct: 61  HL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGSLRDYLQKH 114
Query: 115 R-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV 173
           +  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIGD G   ++
Sbjct: 115 KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVL 171
Query: 174 GRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 172 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 30/230 (13%)
Query: 1   MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFS 56
             DRD   F E     R  ++   LG G    V    Y       G  VA    +L H +
Sbjct: 2   FEDRDPTQFEE-----RHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHST 54
Query: 57  EDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK 112
           E+ +       E+++L++L++    KY  VCYS         L  I E    G+LR Y +
Sbjct: 55  EEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEFLPYGSLREYLQ 108
Query: 113 KHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 171
           KH+  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIGD G   
Sbjct: 109 KHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTK 165
Query: 172 IVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           ++ +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 166 VLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 7   EPFVEVDPS---GRFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSEDP 59
           +P  EVDP+    RF +    LG G   KV    Y       G +VA   ++        
Sbjct: 8   KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH- 66
Query: 60  VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VS 118
             +  L  E+++LR L ++ I+    +  +D  N +  I E   SG+L+ Y  K+++ ++
Sbjct: 67  --IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 178
           +K   K++ Q+ +G++YL + +   +HRDL   N+ +     QVKIGD G    +     
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKE 181
Query: 179 AHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
             ++    +    + APE L +  +    D++SFG+ L E++T    Y + DS
Sbjct: 182 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT----YCDSDS 230

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 15/165 (9%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS 126
            E+ +LRTL +++II       D    +L  + E    G+LR Y  +H  + +  L  ++
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 123
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP 186
           +Q+ EG+ YLH+     IHR+L   N+ ++ N   VKIGD G A  V   H  + +    
Sbjct: 124 QQICEGMAYLHSQH--YIHRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 187 E----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
           +    + APE L E  +    D++SFG+ L E++T       CDS
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT------HCDS 219

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 119/271 (43%), Gaps = 20/271 (7%)
Query: 15  SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
           S R+ R   L GSGA  +V    D+  G E A   ++ S  +        L  EV +L+ 
Sbjct: 20  SDRYQRVKKL-GSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSN-SGALLDEVAVLKQ 77
Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR---TYRKKHRHVSIKALKKWSKQVLE 131
           L +  I+  Y  + D ++  L  + EV   G L      R+K   V    +    KQVL 
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYL--VMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLS 132
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 189
           G  YLH H   I+HRDL   N+ +        +KI D G +A           +GT  Y+
Sbjct: 133 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 190 APELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
           APE+  + Y E  D++S G+ L  ++    P+    +  +I K+V  G     P    +V
Sbjct: 191 APEVLRKKYDEKCDVWSCGVILYILLCGYPPFG-GQTDQEILKRVEKGKFSFDPPDWTQV 249
Query: 247 KDPEVKAFIEKCIA-QPRARPSASELLKDPF 276
            D E K  ++  +  +P  R SA E L  P+
Sbjct: 250 SD-EAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS 126
            E+ +LRTL +++II       D    +L  + E    G+LR Y  +H  + +  L  ++
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 123
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP 186
           +Q+ EG+ YLH      IHR+L   N+ ++ N   VKIGD G A  V   H  + +    
Sbjct: 124 QQICEGMAYLHAQH--YIHRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 187 E----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
           +    + APE L E  +    D++SFG+ L E++T       CDS
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT------HCDS 219

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 39/282 (13%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS---EVQLLRTLKN 77
           Y   +G G    V++    ++   VA   + L     +  ++ +      EV ++  L +
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ------VLE 131
             I+  Y +     HN    + E    G+L      HR +      KWS +      +  
Sbjct: 83  PNIVKLYGL----MHNPPRMVMEFVPCGDLY-----HRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFI-----NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP 186
           G+EY+    P I+HRDL   NIF+     N  +   K+ D  F+      H+   ++G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC-AKVAD--FSLSQQSVHSVSGLLGNF 190
Query: 187 EYMAPELY---EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           ++MAPE     EE YTE  D YSF + L  ++T E P+ E  S  KI  K    ++ + L
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SYGKI--KFINMIREEGL 247
Query: 244 NKVK----DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
                    P ++  IE C +  P+ RP  S ++K+   SEL
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE--LSEL 287

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-----SEDPVLVNRLH----SEVQLLRTL 75
           LGSGA  +V    ++    E A   ++ S F     S+D   + + H    +E+ LL++L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL-RTYRKKHRHVSIKALKKWSKQVLEGLE 134
            +  II  + V+ D ++  L  +TE    G L      +H+     A     KQ+L G+ 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYL--VTEFYEGGELFEQIINRHKFDECDAAN-IMKQILSGIC 160
Query: 135 YLHTHEPCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 192
           YLH H   I+HRD+   NI +    ++  +KI D G ++   + +     +GT  Y+APE
Sbjct: 161 YLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPE 218
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           + ++ Y E  D++S G+ +  ++    P+   +    I KKV  G
Sbjct: 219 VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDIIKKVEKG 262

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 119/271 (43%), Gaps = 20/271 (7%)
Query: 15  SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
           S R+ R   L GSGA  +V    D+  G E A   ++ S  +        L  EV +L+ 
Sbjct: 3   SDRYQRVKKL-GSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSN-SGALLDEVAVLKQ 60
Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR---TYRKKHRHVSIKALKKWSKQVLE 131
           L +  I+  Y  + D ++  L  + EV   G L      R+K   V    +    KQVL 
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYL--VMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLS 115
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 189
           G  YLH H   I+HRDL   N+ +        +KI D G +A           +GT  Y+
Sbjct: 116 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 173
Query: 190 APELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKV 246
           APE+  + Y E  D++S G+ L  ++    P+    +  +I K+V  G     P    +V
Sbjct: 174 APEVLRKKYDEKCDVWSCGVILYILLCGYPPFG-GQTDQEILKRVEKGKFSFDPPDWTQV 232
Query: 247 KDPEVKAFIEKCIA-QPRARPSASELLKDPF 276
            D E K  ++  +  +P  R SA E L  P+
Sbjct: 233 SD-EAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGN 106
           +L H +E+ +       E+++L++L++    KY  VCYS         L  I E    G+
Sbjct: 44  KLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGS 97
Query: 107 LRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           LR Y +KH+  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIG
Sbjct: 98  LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIG 154
Query: 166 DLGFAAIVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           D G   ++ +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 155 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGN 106
           +L H +E+ +       E+++L++L++    KY  VCYS         L  I E    G+
Sbjct: 45  KLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGS 98
Query: 107 LRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           LR Y +KH+  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIG
Sbjct: 99  LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIG 155
Query: 166 DLGFAAIVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           D G   ++ +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 156 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGN 106
           +L H +E+ +       E+++L++L++    KY  VCYS         L  I E    G+
Sbjct: 46  KLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGS 99
Query: 107 LRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           LR Y +KH+  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIG
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIG 156
Query: 166 DLGFAAIVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           D G   ++ +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 157 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGN 106
           +L H +E+ +       E+++L++L++    KY  VCYS         L  I E    G+
Sbjct: 46  KLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGS 99
Query: 107 LRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           LR Y +KH+  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIG
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIG 156
Query: 166 DLGFAAIVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           D G   ++ +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 157 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 59  PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS 118
           P L +    E+++LRTL +++I+       D    ++  + E    G+LR Y  +H  V 
Sbjct: 52  PQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVG 110
Query: 119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 178
           +  L  +++Q+ EG+ YLH      IHR L   N+ ++ N   VKIGD G A  V   H 
Sbjct: 111 LAQLLLFAQQICEGMAYLHAQH--YIHRALAARNVLLD-NDRLVKIGDFGLAKAVPEGHE 167
Query: 179 AHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
            + +    +    + APE L E  +    D++SFG+ L E++T       CDS    + K
Sbjct: 168 YYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTY------CDSNQSPHTK 221
Query: 234 VT 235
            T
Sbjct: 222 FT 223

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 70
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+T+        + +  +K +  Q+L+GL + H+H  
Sbjct: 71  LDVI--HTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 126
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 127 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 182
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 298

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 120/266 (45%), Gaps = 22/266 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSGA  +V    D+   +E A   +R +  S      ++L  EV +L+ L +  I+  Y
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN--SKLLEEVAVLKLLDHPNIMKLY 102
Query: 85  SVWLDDQHNTLNFITEVCTSGNLR---TYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
             + D ++  L  + E    G L     +R K   V    +    KQVL G+ YLH H  
Sbjct: 103 DFFEDKRNYYL--VMECYKGGELFDEIIHRMKFNEVDAAVI---IKQVLSGVTYLHKHN- 156
Query: 142 CIIHRDLNCSNIFINGN--IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYT 199
            I+HRDL   N+ +        +KI D G +A+          +GT  Y+APE+  + Y 
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD 215
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV----KPQALNKVKDPEVKAFI 255
           E  D++S G+ L  ++    P+    +  +I +KV  G      P+  N  +    K  I
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNVSEGA--KDLI 272
Query: 256 EKCIA-QPRARPSASELLKDPFFSEL 280
           ++ +    + R SA + L+ P+  E+
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 110/229 (48%), Gaps = 24/229 (10%)
Query: 17  RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
           R+ R + L G G   +VY+A D      VA  ++RL H  E+  +      EV LL+ L+
Sbjct: 35  RYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQ 91
Query: 77  NKYIIVCYSVWLDDQHN-TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
           ++ II   SV     HN  L+ I E     +L+ Y  K+  VS++ +K +  Q++ G+ +
Sbjct: 92  HRNIIELKSV---IHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 136 LHTHEPCIIHRDLNCSNIFIN----GNIGQVKIGDLGFAAIVG--RSHAAHSIIGTPEYM 189
            H+   C +HRDL   N+ ++         +KIGD G A   G       H II T  Y 
Sbjct: 148 CHSRR-C-LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYR 204
Query: 190 APE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYK 232
            PE  L    Y+  VDI+S      EM+ M+ P     SE D + KI++
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFE 252

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 130/272 (47%), Gaps = 18/272 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G+E A   +  R S  S   V    +  EV +LR + +  +I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+ + G L  +  +   +S +    + KQ+L+G+ YLHT +  
Sbjct: 80  LHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N  I  +K+ D G A  +       +I GTPE++APE+  YE  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             E  D++S G+    +++   P+   ++ +++A I   V+     +  ++  +   K F
Sbjct: 196 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFDEEFFSQTSEL-AKDF 252
Query: 255 IEK-CIAQPRARPSASELLKDPFFSELNDDDS 285
           I K  + + R R +  E L+ P+ + +++  +
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 59  PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS 118
           P L +    E+++LRTL +++I+       D    ++  + E    G+LR Y  +H  V 
Sbjct: 51  PQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVG 109
Query: 119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 178
           +  L  +++Q+ EG+ YLH      IHR L   N+ ++ N   VKIGD G A  V   H 
Sbjct: 110 LAQLLLFAQQICEGMAYLHAQH--YIHRALAARNVLLD-NDRLVKIGDFGLAKAVPEGHE 166
Query: 179 AHSIIGTPE----YMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
            + +    +    + APE  +E  +    D++SFG+ L E++T       CDS    + K
Sbjct: 167 YYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTY------CDSNQSPHTK 220
Query: 234 VT 235
            T
Sbjct: 221 FT 222

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGN 106
           +L H +E+ +       E+++L++L++    KY  VCYS         L  I E    G+
Sbjct: 64  KLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGS 117
Query: 107 LRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           LR Y +KH+  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIG
Sbjct: 118 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIG 174
Query: 166 DLGFAAIVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           D G   ++ +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 175 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGN 106
           +L H +E+ +       E+++L++L++    KY  VCYS         L  I E    G+
Sbjct: 46  KLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGS 99
Query: 107 LRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           LR Y +KH+  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIG
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIG 156
Query: 166 DLGFAAIVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           D G   ++ +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGN 106
           +L H +E+ +       E+++L++L++    KY  VCYS         L  I E    G+
Sbjct: 64  KLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGS 117
Query: 107 LRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           LR Y +KH+  +    L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIG
Sbjct: 118 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIG 174
Query: 166 DLGFAAIVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           D G   ++ +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 175 DFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 130/272 (47%), Gaps = 18/272 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G+E A   +  R S  S   V    +  EV +LR + +  +I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+ + G L  +  +   +S +    + KQ+L+G+ YLHT +  
Sbjct: 80  LHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N  I  +K+ D G A  +       +I GTPE++APE+  YE  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             E  D++S G+    +++   P+   ++ +++A I   V+     +  ++  +   K F
Sbjct: 196 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFDEEFFSQTSEL-AKDF 252
Query: 255 IEK-CIAQPRARPSASELLKDPFFSELNDDDS 285
           I K  + + R R +  E L+ P+ + +++  +
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 136/305 (44%), Gaps = 46/305 (15%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G  VA    +LS   +  +   R + E++LL+ +K+
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + +I    V+      ++ N +  +T +    +L    K  + ++   ++    Q+L GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +Y+H+ +  IIHRDL  SN+ +N +  ++KI D   A         +  + T  Y APE+
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFYLARHTDDEMTGY--VATRWYRAPEI 193
Query: 194 YEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP 249
                 Y + VDI+S G  + E++T    +   D +   K+  ++ G    + L K+   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 250 EVKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELND 282
             + +I+     P+                            R +A++ L   +F++ +D
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 283 DDSEP 287
            D EP
Sbjct: 314 PDDEP 318

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 14/262 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R   +    E A   +     S       +L  E ++ R LK+  I+  +
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDH--QKLEREARICRLLKHPNIVRLH 96
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++  + L F  ++ T G L        + S         Q+LE + ++H H+  I+
Sbjct: 97  DSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD--IV 152
Query: 145 HRDLNCSNIFINGNI--GQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPELYEED-YTE 200
           HRDL   N+ +        VK+ D G A  + G   A     GTP Y++PE+  +D Y +
Sbjct: 153 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGK 212
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPEVKAFIEKC 258
            VDI++ G+ L  ++    P+ + D   K+Y+++  G    P        PE K  I + 
Sbjct: 213 PVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQM 271
Query: 259 IA-QPRARPSASELLKDPFFSE 279
           +   P  R +A + LK P+  +
Sbjct: 272 LTINPAKRITADQALKHPWVCQ 293

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V R   Q+ G +VA  Q R       P    R   E+Q+++ L +  ++   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 85  SVWLDDQHNTLN----FITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLH 137
            V    Q    N       E C  G+LR Y  +  +   +    ++     +   L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 138 THEPCIIHRDLNCSNIFINGNIGQV--KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE 195
            +   IIHRDL   NI +     ++  KI DLG+A  + +       +GT +Y+APEL E
Sbjct: 139 ENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE 196
Query: 196 E-DYTEMVDIYSFGLCLLEMVTMEIPY 221
           +  YT  VD +SFG    E +T   P+
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 18/265 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G+E A   +  R S  S   V    +  EV +LR + +  II 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+ + G L  +  +   +S +    + KQ+L+G+ YLHT +  
Sbjct: 80  LHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N  I  +K+ D G A  +       +I GTPE++APE+  YE  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             E  D++S G+    +++   P+   ++ +++A I   V+     +  ++  +   K F
Sbjct: 196 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFDEEFFSQTSEL-AKDF 252
Query: 255 IEK-CIAQPRARPSASELLKDPFFS 278
           I K  + + R R +  E L+ P+ +
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 94  TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 153
            L F+ E    G+L  + +      +     ++ +++ GL++LH+    I++RDL   NI
Sbjct: 93  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNI 150
Query: 154 FINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLC 210
            ++ + G +KI D G     ++G +   +   GTP+Y+APE L  + Y   VD +SFG+ 
Sbjct: 151 LLDKD-GHIKIADFGMCKENMLGDA-KTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 208
Query: 211 LLEMVTMEIPYSECDSVAKIYK-KVTGGVKPQALNK-VKDPEVKAFIEKCIAQPRARPSA 268
           L EM+  + P+   D     +  ++     P+ L K  KD  VK F+     +P  R   
Sbjct: 209 LYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR----EPEKRLGV 264
Query: 269 -SELLKDPFFSELNDDDSE 286
             ++ + P F E+N ++ E
Sbjct: 265 RGDIRQHPLFREINWEELE 283

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G+E A   +  R S  S   V    +  EV +LR + +  +I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+ + G L  +  +   +S +    + KQ+L+G+ YLHT +  
Sbjct: 80  LHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N  I  +K+ D G A  +       +I GTPE++APE+  YE  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             E  D++S G+    +++   P+   ++ +++A I   V+     +  +   +   K F
Sbjct: 196 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFDEEFFSHTSEL-AKDF 252
Query: 255 IEK-CIAQPRARPSASELLKDPFFSELNDDDS 285
           I K  + + R R +  E L+ P+ + +++  +
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 70
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E   S +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 71  LDVI--HTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 126
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 127 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 182
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 298

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V R   Q+ G +VA  Q R       P    R   E+Q+++ L +  ++   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 85  SVWLDDQHNTLN----FITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLH 137
            V    Q    N       E C  G+LR Y  +  +   +    ++     +   L YLH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 138 THEPCIIHRDLNCSNIFINGNIGQV--KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE 195
            +   IIHRDL   NI +     ++  KI DLG+A  + +       +GT +Y+APEL E
Sbjct: 140 ENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE 197
Query: 196 E-DYTEMVDIYSFGLCLLEMVTMEIPY 221
           +  YT  VD +SFG    E +T   P+
Sbjct: 198 QKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 8/149 (5%)
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 192
           L   H H   ++H D+  +NIF+ G  G+ K+GD G    +G + A     G P YMAPE
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFL-GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 193 LYEEDYTEMVDIYSFGLCLLEMV-TMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 251
           L +  Y    D++S GL +LE+   ME+P+       + ++++  G  P         E+
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNMELPHG-----GEGWQQLRQGYLPPEFTAGLSSEL 281
Query: 252 KAFIEKCI-AQPRARPSASELLKDPFFSE 279
           ++ +   +   P+ R +A  LL  P   +
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 68
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E   S +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 69  LDVI--HTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 124
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 125 -VLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 180
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 296

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 94  TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 153
            L F+ E    G+L  + +      +     ++ +++ GL++LH+    I++RDL   NI
Sbjct: 92  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNI 149
Query: 154 FINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLC 210
            ++ + G +KI D G     ++G +   +   GTP+Y+APE L  + Y   VD +SFG+ 
Sbjct: 150 LLDKD-GHIKIADFGMCKENMLGDA-KTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 207
Query: 211 LLEMVTMEIPYSECDSVAKIYK-KVTGGVKPQALNK-VKDPEVKAFIEKCIAQPRARPSA 268
           L EM+  + P+   D     +  ++     P+ L K  KD  VK F+     +P  R   
Sbjct: 208 LYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR----EPEKRLGV 263
Query: 269 -SELLKDPFFSELNDDDSE 286
             ++ + P F E+N ++ E
Sbjct: 264 RGDIRQHPLFREINWEELE 282

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 13/229 (5%)
Query: 18  FGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
            G+Y   DLLG G+  KV    D E     A   ++       P     +  E+QLLR L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLE 134
           ++K +I    V  +++   +  + E C  G          +   +     +  Q+++GLE
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAP 191
           YLH+    I+H+D+   N+ +    G +KI  LG A  +          +  G+P +  P
Sbjct: 124 YLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 192 ELYE--EDYTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           E+    + ++   VDI+S G+ L  + T   P+ E D++ K+++ +  G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKG 228

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 70
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E   S +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 71  LDVI--HTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 126
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 127 -VLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 182
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 298

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 69
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E   S +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 70  LDVI--HTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 125
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 126 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 181
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 297

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 66
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+T+        + +  +K +  Q+L+GL + H+H  
Sbjct: 67  LDVI--HTENKLYLVFE-HVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 123 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 178
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 294

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 113/262 (43%), Gaps = 14/262 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R      G E A   +     S       +L  E ++ R LK+  I+  +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH--QKLEREARICRLLKHPNIVRLH 69
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++  + L F  ++ T G L        + S        +Q+LE +   H H   I+
Sbjct: 70  DSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILESVN--HCHLNGIV 125
Query: 145 HRDLNCSNIFI--NGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPELYEED-YTE 200
           HRDL   N+ +        VK+ D G A  + G   A     GTP Y++PE+  +D Y +
Sbjct: 126 HRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGK 185
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPEVKAFIEKC 258
            VD+++ G+ L  ++    P+ + D   ++Y+++  G    P        PE K  I K 
Sbjct: 186 PVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 244
Query: 259 IA-QPRARPSASELLKDPFFSE 279
           +   P  R +ASE LK P+  +
Sbjct: 245 LTINPAKRITASEALKHPWICQ 266

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    V++A ++E    VA  +VRL    +D  + +    E+ LL+ LK+K I+  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            V   D+  TL F  E C     + +   +  +  + +K +  Q+L+GL + H+    ++
Sbjct: 68  DVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VL 123
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELY--EEDYT 199
           HRDL   N+ IN N G++K+ D G A   G   R ++A  +  T  Y  P++    + Y+
Sbjct: 124 HRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 180
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQALNKVKDPEVKAF- 254
             +D++S G    E+     P        D + +I++ +    + Q  +  K P+ K + 
Sbjct: 181 TSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 255 -------------------------IEKCIAQPRARPSASELLKDPFFSEL 280
                                    + KC   P  R SA E L+ P+FS+ 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKC--NPVQRISAEEALQHPYFSDF 289

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 15/266 (5%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           Y D+ G GA   V R      G E A   +     S       +L  E ++ R LK+  I
Sbjct: 9   YEDI-GKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDH--QKLEREARICRLLKHSNI 65
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +  +    ++  + L F  ++ T G L        + S        +Q+LE +  LH H+
Sbjct: 66  VRLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV--LHCHQ 121
Query: 141 PCIIHRDLNCSNIFINGNI--GQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEE 196
             ++HRDL   N+ +        VK+ D G A  + G   A     GTP Y++PE L +E
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE 181
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPEVKAF 254
            Y + VDI++ G+ L  ++    P+ + D   K+Y+++  G    P        PE K  
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKAGAYDFPSPEWDTVTPEAKNL 240
Query: 255 IEKCIA-QPRARPSASELLKDPFFSE 279
           I + +   P  R +A E LK P+  +
Sbjct: 241 INQMLTINPAKRITAHEALKHPWVCQ 266

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G+E A   +  R S  S   V    +  EV +LR + +  +I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+ + G L  +  +   +S +    + KQ+L+G+ YLHT +  
Sbjct: 80  LHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N  I  +K+ D G A  +       +I GTPE++APE+  YE  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             E  D++S G+    +++   P+   ++ +++A I   V+     +  +   +   K F
Sbjct: 196 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFDEEFFSHTSEL-AKDF 252
Query: 255 IEK-CIAQPRARPSASELLKDPFFSELNDDDS 285
           I K  + + R R +  E L+ P+ + +++  +
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 74
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 75  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 130
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEE 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE  L  +
Sbjct: 131 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGXK 186
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 246
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 302

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 90/176 (51%), Gaps = 19/176 (10%)
Query: 51  RLSHFSEDPVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGN 106
           +L H +E+ +       E+++L++L++    KY  VCYS         L  I E    G+
Sbjct: 47  KLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGS 100
Query: 107 LRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG 165
           LR Y +KH+  +    L +++ Q+ +G+EYL T     IHR+L   NI +  N  +VKIG
Sbjct: 101 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRNLATRNILVE-NENRVKIG 157
Query: 166 DLGFAAIVGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           D G   ++ +    + +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 158 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 113/262 (43%), Gaps = 14/262 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R      G E A   +     S       +L  E ++ R LK+  I+  +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH--QKLEREARICRLLKHPNIVRLH 69
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++  + L F  ++ T G L        + S        +Q+LE +   H H   I+
Sbjct: 70  DSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILESVN--HCHLNGIV 125
Query: 145 HRDLNCSNIFI--NGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPELYEED-YTE 200
           HRDL   N+ +        VK+ D G A  + G   A     GTP Y++PE+  +D Y +
Sbjct: 126 HRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGK 185
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQALNKVKDPEVKAFIEKC 258
            VD+++ G+ L  ++    P+ + D   ++Y+++  G    P        PE K  I K 
Sbjct: 186 PVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 244
Query: 259 IA-QPRARPSASELLKDPFFSE 279
           +   P  R +ASE LK P+  +
Sbjct: 245 LTINPAKRITASEALKHPWICQ 266

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G+E A   +  R S  S   V    +  EV +LR + +  +I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+ + G L  +  +   +S +    + KQ+L+G+ YLHT +  
Sbjct: 80  LHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N  I  +K+ D G A  +       +I GTPE++APE+  YE  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             E  D++S G+    +++   P+   ++ +++A I   V+     +  +   +   K F
Sbjct: 196 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFDEEFFSHTSEL-AKDF 252
Query: 255 IEK-CIAQPRARPSASELLKDPFFSELNDDDS 285
           I K  + + R R +  E L+ P+ + +++  +
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE--LYEE 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE  L  +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGXK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 122/268 (45%), Gaps = 16/268 (5%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV-RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +LG G+  +V +  D+    E A   + + S  ++D   + R   EV+LL+ L +  I+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + +  D   ++   + E+ T G L     K +  S     +  KQV  G+ Y+H H   
Sbjct: 86  LFEILEDS--SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 143 IIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 200
           I+HRDL   NI +        +KI D G +    ++      IGT  Y+APE+    Y E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 201 MVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
             D++S G+ L  +++   P+   +E D + ++         PQ   +    + K  I K
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--RTISDDAKDLIRK 259
Query: 258 CIA-QPRARPSASELLKDPFFSELNDDD 284
            +   P  R +A++ L+ P+  + + ++
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSEE 287

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 132/299 (44%), Gaps = 46/299 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSGA   V  A+D     +VA    +LS   +  +   R + E++LL+ LK++ +I   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 85  SVW-----LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V+     ++D      ++       +L    K  + +S + ++    Q+L GL+Y+H+ 
Sbjct: 94  DVFTPATSIEDFSEV--YLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHS- 149
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--D 197
              IIHRDL  SN+ +N +  +++I D G A         +  + T  Y APE+      
Sbjct: 150 -AGIIHRDLKPSNVAVNED-SELRILDFGLARQADEEMTGY--VATRWYRAPEIMLNWMH 205
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFI 255
           Y + VDI+S G  + E++  +  +   D + ++ +  +V G   P+ L K+     + +I
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265
Query: 256 EKCIAQPR---------------------------ARPSASELLKDPFFSELNDDDSEP 287
           +     P+                            R SA+E L   +FS+ +D + EP
Sbjct: 266 QSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 16/273 (5%)
Query: 14  PSGRFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           PS    RY   ++LG G + +V+ A D  +  +VA   +R +  + DP    R   E Q 
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQN 65
Query: 72  LRTLKNKYIIVCYSVW-LDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQV 129
              L +  I+  Y     +     L +I      G  LR        ++ K   +     
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS----HAAHSIIGT 185
            + L +  +H+  IIHRD+  +NI I+     VK+ D G A  +  S        ++IGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANILISAT-NAVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 186 PEYMAPELYEEDYTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT-GGVKPQAL 243
            +Y++PE    D  +   D+YS G  L E++T E P++    V+  Y+ V    + P A 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242
Query: 244 NKVKDPEVKAFIEKCIAQ-PRAR-PSASELLKD 274
           ++    ++ A + K +A+ P  R  +A+E+  D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 16/273 (5%)
Query: 14  PSGRFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           PS    RY   ++LG G + +V+ A D  +  +VA   +R +  + DP    R   E Q 
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQN 65
Query: 72  LRTLKNKYIIVCYSVW-LDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQV 129
              L +  I+  Y     +     L +I      G  LR        ++ K   +     
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA----HSIIGT 185
            + L +  +H+  IIHRD+  +NI I+     VK+ D G A  +  S  +     ++IGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 186 PEYMAPELYEEDYTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT-GGVKPQAL 243
            +Y++PE    D  +   D+YS G  L E++T E P++    V+  Y+ V    + P A 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242
Query: 244 NKVKDPEVKAFIEKCIAQ-PRAR-PSASELLKD 274
           ++    ++ A + K +A+ P  R  +A+E+  D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 105/229 (45%), Gaps = 32/229 (13%)
Query: 3   DRDGEPFVEVDPSGRFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSED 58
           DRD   F E     R  ++   LG G    V    Y       G  VA    +L H +E+
Sbjct: 4   DRDPTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEE 56
Query: 59  PVLVNRLHSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH 114
            +       E+++L++L++    KY  VCYS         L  I E    G+LR Y + H
Sbjct: 57  HL--RDFEREIEILKSLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGSLRDYLQAH 110
Query: 115 --RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 172
             R   IK L +++ Q+ +G+EYL T     IHRDL   NI +  N  +VKIGD G   +
Sbjct: 111 AERIDHIKLL-QYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKV 166
Query: 173 VGRSHAAHSIIGTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           + +      +    E    + APE L E  ++   D++SFG+ L E+ T
Sbjct: 167 LPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 120/269 (44%), Gaps = 18/269 (6%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR-LHSEVQLLRTLKNKYII 81
           +++G G    V R  ++E G + A   V ++ F+  P L    L  E  +   LK+ +I+
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNL---RTYRKKHRHVSIKALKK-WSKQVLEGLEYLH 137
                +  D    L  + E     +L      R     V  +A+   + +Q+LE L Y H
Sbjct: 92  ELLETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 149
Query: 138 THEPCIIHRDL--NCSNIFINGNIGQVKIGDLGFAAIVGRSH-AAHSIIGTPEYMAPELY 194
            +   IIHRD+  +C  +    N   VK+G  G A  +G S   A   +GTP +MAPE+ 
Sbjct: 150 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 195 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKVKDPE 250
           + E Y + VD++  G+ L  +++  +P+    +  ++++ +  G   + P+  + + +  
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIKGKYKMNPRQWSHISESA 265
Query: 251 VKAFIEKCIAQPRARPSASELLKDPFFSE 279
                   +  P  R +  E L  P+  E
Sbjct: 266 KDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 120/269 (44%), Gaps = 18/269 (6%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR-LHSEVQLLRTLKNKYII 81
           +++G G    V R  ++E G + A   V ++ F+  P L    L  E  +   LK+ +I+
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNL---RTYRKKHRHVSIKALKK-WSKQVLEGLEYLH 137
                +  D    L  + E     +L      R     V  +A+   + +Q+LE L Y H
Sbjct: 90  ELLETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 138 THEPCIIHRDL--NCSNIFINGNIGQVKIGDLGFAAIVGRSH-AAHSIIGTPEYMAPELY 194
            +   IIHRD+  +C  +    N   VK+G  G A  +G S   A   +GTP +MAPE+ 
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 195 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG---VKPQALNKVKDPE 250
           + E Y + VD++  G+ L  +++  +P+    +  ++++ +  G   + P+  + + +  
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 251 VKAFIEKCIAQPRARPSASELLKDPFFSE 279
                   +  P  R +  E L  P+  E
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 74
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 75  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 130
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 131 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 186
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 246
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 302

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV-RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +LG G+  +V +  D+    E A   + + S  ++D   + R   EV+LL+ L +  I+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + +  D   ++   + E+ T G L     K +  S     +  KQV  G+ Y+H H   
Sbjct: 86  LFEILEDS--SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 143 IIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 200
           I+HRDL   NI +        +KI D G +    ++      IGT  Y+APE+    Y E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 201 MVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
             D++S G+ L  +++   P+   +E D + ++         PQ   +    + K  I K
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--RTISDDAKDLIRK 259
Query: 258 CIA-QPRARPSASELLKDPFFSELNDD 283
            +   P  R +A++ L+ P+  + + +
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSE 286

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 66
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 67  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 123 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 178
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 294

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 66
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 67  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 123 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 178
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 294

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 71
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 72  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 127
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 128 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 183
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 299

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 16/260 (6%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV-RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +LG G+  +V +  D+    E A   + + S  ++D   + R   EV+LL+ L +  I+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMK 85
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + +  D   ++   + E+ T G L     K +  S     +  KQV  G+ Y+H H   
Sbjct: 86  LFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 143 IIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 200
           I+HRDL   NI +        +KI D G +    ++      IGT  Y+APE+    Y E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 201 MVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
             D++S G+ L  +++   P+   +E D + ++         PQ   +    + K  I K
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--RTISDDAKDLIRK 259
Query: 258 CIA-QPRARPSASELLKDPF 276
            +   P  R +A++ L+ P+
Sbjct: 260 MLTFHPSLRITATQCLEHPW 279

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 70
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 71  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 126
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 127 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 182
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 298

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 68
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 69  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 124
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 125 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 180
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 296

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 66
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 67  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 123 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 178
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 294

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 132/299 (44%), Gaps = 46/299 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSGA   V  A+D     +VA    +LS   +  +   R + E++LL+ LK++ +I   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 85  SVW-----LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V+     ++D      ++       +L     K + +S + ++    Q+L GL+Y+H+ 
Sbjct: 94  DVFTPATSIEDFSEV--YLVTTLMGADLNNI-VKCQALSDEHVQFLVYQLLRGLKYIHS- 149
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--D 197
              IIHRDL  SN+ +N +  +++I D G A         +  + T  Y APE+      
Sbjct: 150 -AGIIHRDLKPSNVAVNED-SELRILDFGLARQADEEMTGY--VATRWYRAPEIMLNWMH 205
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFI 255
           Y + VDI+S G  + E++  +  +   D + ++ +  +V G   P+ L K+     + +I
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265
Query: 256 EKCIAQPR---------------------------ARPSASELLKDPFFSELNDDDSEP 287
           +     P+                            R SA+E L   +FS+ +D + EP
Sbjct: 266 QSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 71
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 72  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 127
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 128 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 183
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 299

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 68
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 69  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 124
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 125 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 180
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 296

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 68
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 69  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 124
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 125 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 180
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 296

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 87/164 (53%), Gaps = 9/164 (5%)
Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V  +  E+Q+++ L++ +++  +  + D++   +  + ++   G+LR + +++ H   + 
Sbjct: 59  VRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMFMVVDLLLGGDLRYHLQQNVHFKEET 116
Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           +K +  +++  L+YL      IIHRD+   NI ++ + G V I D   AA++ R     +
Sbjct: 117 VKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRETQITT 173
Query: 182 IIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPY 221
           + GT  YMAPE++       Y+  VD +S G+   E++    PY
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 70
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 71  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 126
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 127 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 182
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 298

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 69
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 70  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 125
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 126 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 181
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 297

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 69
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 70  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 125
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 126 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 181
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 297

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 66
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 67  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 123 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT-HEVV-TLWYRAPEILLGCK 178
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 294

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 66
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 67  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 123 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 178
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 294

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 68
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 69  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 124
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 125 -VLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 180
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 296

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 69
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 70  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 125
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 126 -VLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 181
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 297

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 111/233 (47%), Gaps = 31/233 (13%)
Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALK 123
           L  E+++LR L ++ I+    +  +D  N +  I E   SG+L+ Y  K+++ +++K   
Sbjct: 58  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 117
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
           K++ Q+ +G++YL + +   +HRDL   N+ +     QVKIGD G    +       ++ 
Sbjct: 118 KYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVK 174
Query: 184 GTPE----YMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKIYKKVTGG 237
              +    + APE L +  +    D++SFG+ L E++T    Y + DS    ++ K+ G 
Sbjct: 175 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGP 230
Query: 238 VKPQA-----LNKVKD-----------PEVKAFIEKCIA-QPRARPSASELLK 273
              Q      +N +K+            EV   + KC   QP  R S   L++
Sbjct: 231 THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 295

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            IVC S       + L+FI ++   G+L  +  +H   S   ++ ++ +++ GLE  H H
Sbjct: 252 FIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 308
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-- 197
              +++RDL  +NI ++ + G V+I DLG A    +    H+ +GT  YMAPE+ ++   
Sbjct: 309 NRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVA 366
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y    D +S G  L +++    P+ +  +  K             L     PE+++ +E 
Sbjct: 367 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 426
Query: 258 CIAQPRAR------PSASELLKDPFFSELN 281
            + +   R        A E+ + PFF  L+
Sbjct: 427 LLQRDVNRRLGCLGRGAQEVKESPFFRSLD 456

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 16/273 (5%)
Query: 14  PSGRFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           PS    RY   ++LG G + +V+ A D     +VA   +R +  + DP    R   E Q 
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQN 65
Query: 72  LRTLKNKYIIVCYSVW-LDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQV 129
              L +  I+  Y+    +     L +I      G  LR        ++ K   +     
Sbjct: 66  AAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA----HSIIGT 185
            + L +  +H+  IIHRD+  +NI I+     VK+ D G A  +  S  +     ++IGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 186 PEYMAPELYEEDYTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT-GGVKPQAL 243
            +Y++PE    D  +   D+YS G  L E++T E P++    V+  Y+ V    + P A 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242
Query: 244 NKVKDPEVKAFIEKCIAQ-PRAR-PSASELLKD 274
           ++    ++ A + K +A+ P  R  +A+E+  D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            IVC S       + L+FI ++   G+L  +  +H   S   ++ ++ +++ GLE  H H
Sbjct: 253 FIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-- 197
              +++RDL  +NI ++ + G V+I DLG A    +    H+ +GT  YMAPE+ ++   
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVA 367
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y    D +S G  L +++    P+ +  +  K             L     PE+++ +E 
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
Query: 258 CIAQPRAR------PSASELLKDPFFSELN 281
            + +   R        A E+ + PFF  L+
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            IVC S       + L+FI ++   G+L  +  +H   S   ++ ++ +++ GLE  H H
Sbjct: 253 FIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-- 197
              +++RDL  +NI ++ + G V+I DLG A    +    H+ +GT  YMAPE+ ++   
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVA 367
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y    D +S G  L +++    P+ +  +  K             L     PE+++ +E 
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
Query: 258 CIAQPRAR------PSASELLKDPFFSELN 281
            + +   R        A E+ + PFF  L+
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            IVC S       + L+FI ++   G+L  +  +H   S   ++ ++ +++ GLE  H H
Sbjct: 253 FIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-- 197
              +++RDL  +NI ++ + G V+I DLG A    +    H+ +GT  YMAPE+ ++   
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVA 367
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           Y    D +S G  L +++    P+ +  +  K             L     PE+++ +E 
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
Query: 258 CIAQPRAR------PSASELLKDPFFSELN 281
            + +   R        A E+ + PFF  L+
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 17  RFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           R  +Y   LG G    V    Y       G  VA  Q++ S     P        E+Q+L
Sbjct: 11  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQIL 66
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLE 131
           + L + +I+    V       +L  + E   SG LR + ++HR  +    L  +S Q+ +
Sbjct: 67  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 126
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE---- 187
           G+EYL +     +HRDL   NI +      VKI D G A ++      + ++  P     
Sbjct: 127 GMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFGLAKLLPLD-KDYYVVREPGQSPI 182
Query: 188 -YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            + APE L +  ++   D++SFG+ L E+ T
Sbjct: 183 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 70
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 71  LDVI--HTENKLYLVFE-HVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 126
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 127 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 182
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF     D ++P P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ----DVTKPVP 298

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 17  RFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           R  +Y   LG G    V    Y       G  VA  Q++ S     P        E+Q+L
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQIL 65
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLE 131
           + L + +I+    V       +L  + E   SG LR + ++HR  +    L  +S Q+ +
Sbjct: 66  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 125
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE---- 187
           G+EYL +     +HRDL   NI +      VKI D G A ++      + ++  P     
Sbjct: 126 GMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFGLAKLLPLD-KDYYVVREPGQSPI 181
Query: 188 -YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            + APE L +  ++   D++SFG+ L E+ T
Sbjct: 182 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 132/299 (44%), Gaps = 46/299 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSGA   V  A+D     +VA    +LS   +  +   R + E++LL+ LK++ +I   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 85  SVW-----LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V+     ++D      ++       +L     K + +S + ++    Q+L GL+Y+H+ 
Sbjct: 86  DVFTPATSIEDFSEV--YLVTTLMGADLNNI-VKCQALSDEHVQFLVYQLLRGLKYIHS- 141
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--D 197
              IIHRDL  SN+ +N +  +++I D G A         +  + T  Y APE+      
Sbjct: 142 -AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADEEMTGY--VATRWYRAPEIMLNWMH 197
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFI 255
           Y + VDI+S G  + E++  +  +   D + ++ +  +V G   P+ L K+     + +I
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 257
Query: 256 EKCIAQPR---------------------------ARPSASELLKDPFFSELNDDDSEP 287
           +     P+                            R SA+E L   +FS+ +D + EP
Sbjct: 258 QSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 316

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 17  RFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           R  +Y   LG G    V    Y       G  VA  Q++ S     P        E+Q+L
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQIL 78
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLE 131
           + L + +I+    V       +L  + E   SG LR + ++HR  +    L  +S Q+ +
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE---- 187
           G+EYL +     +HRDL   NI +      VKI D G A ++      + ++  P     
Sbjct: 139 GMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFGLAKLLPLD-KDYYVVREPGQSPI 194
Query: 188 -YMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            + APE L +  ++   D++SFG+ L E+ T
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A ++  G  VA  ++RL   +E  P    R   E+ LL+ L +  I+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKL 67
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEP 141
             V      N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H  
Sbjct: 68  LDVI--HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYE--E 196
            ++HRDL   N+ IN   G +K+ D G A   G   R++  H ++ T  Y APE+    +
Sbjct: 124 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYX-HEVV-TLWYRAPEILLGCK 179
Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKK-------VTGGV------KP 240
            Y+  VDI+S G    EMVT    +   SE D + +I++        V  GV      KP
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 241 -------QALNKVKDP---EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
                  Q  +KV  P   + ++ + + +   P  R SA   L  PFF +
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 16/273 (5%)
Query: 14  PSGRFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           PS    RY   ++LG G + +V+ A D     +VA   +R +  + DP    R   E Q 
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQN 65
Query: 72  LRTLKNKYIIVCYSVW-LDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQV 129
              L +  I+  Y     +     L +I      G  LR        ++ K   +     
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA----HSIIGT 185
            + L +  +H+  IIHRD+  +NI I+     VK+ D G A  +  S  +     ++IGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 186 PEYMAPELYEEDYTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT-GGVKPQAL 243
            +Y++PE    D  +   D+YS G  L E++T E P++    V+  Y+ V    + P A 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242
Query: 244 NKVKDPEVKAFIEKCIAQ-PRAR-PSASELLKD 274
           ++    ++ A + K +A+ P  R  +A+E+  D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 119/271 (43%), Gaps = 23/271 (8%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS----EVQLLRTLKNK 78
           D++G G    V R   +  G E A   + ++     P  +  +      E  +LR +   
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 79  YIIVCYSVWLDDQHNTLNF---ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
             I+     L D + + +F   + ++   G L  Y  +   +S K  +   + +LE + +
Sbjct: 160 PHIIT----LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE 195
           LH +   I+HRDL   NI ++ N+ Q+++ D GF+  +        + GTP Y+APE+ +
Sbjct: 216 LHANN--IVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 196 -------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVK 247
                    Y + VD+++ G+ L  ++    P+     +  +   + G  +  +     +
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 248 DPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
              VK  I + +   P AR +A + L+ PFF
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    V++A ++E    VA  +VRL    +D  + +    E+ LL+ LK+K I+  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            V   D+  TL F  E C     + +   +  +  + +K +  Q+L+GL + H+    ++
Sbjct: 68  DVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VL 123
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELY--EEDYT 199
           HRDL   N+ IN N G++K+ + G A   G   R ++A  +  T  Y  P++    + Y+
Sbjct: 124 HRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 180
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQALNKVKDPEVKAF- 254
             +D++S G    E+     P        D + +I++ +    + Q  +  K P+ K + 
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 255 -------------------------IEKCIAQPRARPSASELLKDPFFSEL 280
                                    + KC   P  R SA E L+ P+FS+ 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKC--NPVQRISAEEALQHPYFSDF 289

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 75
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ EG+ YL  
Sbjct: 76  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLED 132
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 133 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 189
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 190 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 228

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 23  DLLGSGAVKK-VYRA-FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           D+LG GA    VYR  FD  +   VA  ++    FS      +R   EVQLLR       
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRD---VAVKRILPECFS----FADR---EVQLLRESDEHPN 79
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGLEYLHT 138
           ++ Y  +  ++     +I     +  L+ Y  +K   H+ ++ +    +Q   GL +LH+
Sbjct: 80  VIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHLHS 136
Query: 139 HEPCIIHRDLNCSNIFIN--GNIGQVK--IGDLGFAA--IVGRSHAAH--SIIGTPEYMA 190
               I+HRDL   NI I+     G++K  I D G      VGR   +    + GT  ++A
Sbjct: 137 LN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 191 PELYEEDYTE----MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 246
           PE+  ED  E     VDI+S G C+   V  E  +    S+ +    + G      L+  
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 247 KDPEVKA--FIEKCIAQ-PRARPSASELLKDPFFSEL 280
           K  +V A   IEK IA  P+ RPSA  +LK PFF  L
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 20/275 (7%)
Query: 14  PSGRFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           PS    RY   ++LG G + +V+ A D  +  +VA   +R +  + DP    R   E Q 
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQN 65
Query: 72  LRTLKNKYIIVCYSVW-LDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQV 129
              L +  I+  Y     +     L +I      G  LR        ++ K   +     
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA----HSIIGT 185
            + L +  +H+  IIHRD+  +NI I+     VK+ D G A  +  S  +     ++IGT
Sbjct: 126 CQALNF--SHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 186 PEYMAPELYEEDYTEM-VDIYSFGLCLLEMVTMEIPYS--ECDSVAKIYKKVT-GGVKPQ 241
            +Y++PE    D  +   D+YS G  L E++T E P++    DSVA  Y+ V    + P 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVA--YQHVREDPIPPS 240
Query: 242 ALNKVKDPEVKAFIEKCIAQ-PRAR-PSASELLKD 274
           A ++    ++ A + K +A+ P  R  +A+E+  D
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 80/148 (54%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G++ ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIKVADFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 80/148 (54%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G++ ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIKVADFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 16/273 (5%)
Query: 14  PSGRFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           PS    RY   ++LG G + +V+ A D     +VA   +R +  + DP    R   E Q 
Sbjct: 24  PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQN 82
Query: 72  LRTLKNKYIIVCYSVW-LDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQV 129
              L +  I+  Y     +     L +I      G  LR        ++ K   +     
Sbjct: 83  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 142
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA----HSIIGT 185
            + L +  +H+  IIHRD+  +NI I+     VK+ D G A  +  S  +     ++IGT
Sbjct: 143 CQALNF--SHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 186 PEYMAPELYEEDYTEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT-GGVKPQAL 243
            +Y++PE    D  +   D+YS G  L E++T E P++    V+  Y+ V    + P A 
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 259
Query: 244 NKVKDPEVKAFIEKCIAQ-PRAR-PSASELLKD 274
           ++    ++ A + K +A+ P  R  +A+E+  D
Sbjct: 260 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 292

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 69/144 (47%), Gaps = 10/144 (6%)
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-----ED 197
           IIHRD+  SNI ++ + G +K+ D G +  +  S A     G   YMAPE  +     + 
Sbjct: 147 IIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK---DPEVKAF 254
           Y    D++S G+ L E+ T   PY + +SV     +V  G  PQ  N  +    P    F
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINF 265
Query: 255 IEKCIAQPRA-RPSASELLKDPFF 277
           +  C+ +  + RP   ELLK PF 
Sbjct: 266 VNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 123/266 (46%), Gaps = 19/266 (7%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           +++LG G   +V++  +   G+++A   ++     +   + N    E+ ++  L +  +I
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN----EISVMNQLDHANLI 149
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             Y  +  +  N +  + E    G L  R   + +    +  +  + KQ+ EG+   H H
Sbjct: 150 QLYDAF--ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-FMKQICEGIR--HMH 204
Query: 140 EPCIIHRDLNCSNIF-INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDY 198
           +  I+H DL   NI  +N +  Q+KI D G A             GTPE++APE+   D+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF 264
Query: 199 TEM-VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GVKPQALNKVKDPEVKAF 254
                D++S G+    +++   P+   D+ A+    +      ++ +    + + E K F
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILACRWDLEDEEFQDISE-EAKEF 322
Query: 255 IEKCIAQPRA-RPSASELLKDPFFSE 279
           I K + + ++ R SASE LK P+ S+
Sbjct: 323 ISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLLIDQQ-GYIKVADFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 7/147 (4%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 134 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 191
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLC 210
           N+ I+   G +++ D GFA  V    A  ++ GTPEY+APE +  + Y + VD ++ G+ 
Sbjct: 192 NLLIDQQ-GYIQVTDFGFAKRV--KGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVL 248
Query: 211 LLEMVTMEIPYSECDSVAKIYKKVTGG 237
           + EM     P+   D   +IY+K+  G
Sbjct: 249 IYEMAAGYPPFF-ADQPIQIYEKIVSG 274

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 81
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 82  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 139 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
              YT   D++S+G+ + E++T        IP SE  S+ +      G   PQ    +  
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQP--PICT 248
Query: 249 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDD 283
            +V   + KC +    +RP   EL+ +  FS++  D
Sbjct: 249 IDVYMIMRKCWMIDADSRPKFRELIIE--FSKMARD 282

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 78
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  VCRLLGICLT---STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 136 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIKVADFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 88
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 89  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 145
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 146 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
              YT   D++S+G+ + E++T        IP SE  S+ +      G   PQ    +  
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQP--PICT 255
Query: 249 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDD 283
            +V   + KC +    +RP   EL+ +  FS++  D
Sbjct: 256 IDVYMIMRKCWMIDADSRPKFRELIIE--FSKMARD 289

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 78
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 136 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
              YT   D++S+G+ + E++T        IP SE  S+ +      G   PQ    +  
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQP--PICT 245
Query: 249 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDD 283
            +V   + KC +    +RP   EL+ +  FS++  D
Sbjct: 246 IDVYMIMRKCWMIDADSRPKFRELIIE--FSKMARD 279

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLVGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G+ + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 17  RFGRYSDLLGSGAVKKV----YRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           R  +Y   LG G    V    Y       G  VA  Q++ S     P        E+Q+L
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQIL 62
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLE 131
           + L + +I+    V        L  + E   SG LR + ++HR  +    L  +S Q+ +
Sbjct: 63  KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 122
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI--------VGRSHAAHSII 183
           G+EYL +     +HRDL   NI +      VKI D G A +        V R      I 
Sbjct: 123 GMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDXXVVREPGQSPIF 179
Query: 184 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
               + APE L +  ++   D++SFG+ L E+ T
Sbjct: 180 ----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 81
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 82  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 139 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 81
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 82  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 139 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 80
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 81  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 138 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 103
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 104 VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 160
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 161 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 256

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 78
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 136 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 85
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 86  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 143 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 84
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 85  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 141
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 142 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLMIDQQ-GYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLMIDQQ-GYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLMIDQQ-GYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLMIDQQ-GYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 18/273 (6%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY  L  +GSGA   V  AFD   GI VA    +LS   ++     R + E+ LL+ + +
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 80
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +    +  H  +  L     Q+L G+
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL---LYQMLCGI 137
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A     +      + T  Y APE 
Sbjct: 138 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEV 194
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDPEV 251
           +    Y E VDI+S G  + E+V   + +   D + +  K +     P A       P V
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 252 KAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
           + ++E   A P    +  EL  D  F   ++ D
Sbjct: 255 RNYVENRPAYPGI--AFEELFPDWIFPSESERD 285

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLAGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 129/290 (44%), Gaps = 31/290 (10%)
Query: 10  VEVDPSGRFG----RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
           + V+ S R G     +  +LG G+  KV  A  +E G   A   ++     +D   V   
Sbjct: 12  IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD-VECT 70
Query: 66  HSEVQLLRTLKN----KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
            +E ++L   +N      +  C+        + L F+ E    G+L  + +K R      
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQT-----PDRLFFVMEFVNGGDLMFHIQKSRRFDEAR 125
Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAH 180
            + ++ +++  L +LH  +  II+RDL   N+ ++   G  K+ D G     +       
Sbjct: 126 ARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTA 182
Query: 181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG-- 237
           +  GTP+Y+APE+ +E  Y   VD ++ G+ L EM+    P+ E ++   +++ +     
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEV 241
Query: 238 VKPQALNKVKDPEVKAFIEKCIAQPRARPSA------SELLKDPFFSELN 281
           V P  L++     +K+F+ K    P  R  +        +L+ PFF E++
Sbjct: 242 VYPTWLHEDATGILKSFMTK---NPTMRLGSLTQGGEHAILRHPFFKEID 288

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 129/280 (46%), Gaps = 27/280 (9%)
Query: 24  LLGSGAVKKVY---RAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           +LG+GA  KV+   +    + G   A   ++ +   +         +E Q+L  ++    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +V        +   L+ I +    G L T+  +    +   ++ +  +++  LE  H H+
Sbjct: 121 LVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE--HLHK 177
Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAA--IVGRSHAAHSIIGTPEYMAPELY---E 195
             II+RD+   NI ++ N G V + D G +   +   +  A+   GT EYMAP++    +
Sbjct: 178 LGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 236
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYS---ECDSVAKIYKKVTGGVK--PQALNKVKDPE 250
             + + VD +S G+ + E++T   P++   E +S A+I +++       PQ ++ +    
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL---- 292
Query: 251 VKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELNDDD 284
            K  I++ + + P+ R       A E+ +  FF ++N DD
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 332

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLXGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 72
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 73  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 130 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
              YT   D++S+G+ + E++T        IP SE  S+ +      G   PQ    +  
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQP--PICT 239
Query: 249 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDD 283
            +V   + KC +    +RP   EL+ +  FS++  D
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIE--FSKMARD 273

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 119/288 (41%), Gaps = 44/288 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G    V+ A ++ +    A  ++RL +     +   ++  EV+ L  L++  I+  +
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYF 69
Query: 85  SVWLDDQHNT----------LNFITEVCTSGNLR-------TYRKKHRHVSIKALKKWSK 127
           + WL+               L    ++C   NL+       T  ++ R V +        
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL---- 125
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----- 182
           Q+ E +E+LH+    ++HRDL  SNIF   +   VK+GD G    + +     ++     
Sbjct: 126 QIAEAVEFLHSK--GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 183 --------IGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
                   +GT  YM+PE ++   Y+  VDI+S GL L E++    P+S      +    
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTD 239
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSELN 281
           V     P    +    E     +     P  RP A  ++++  F +L+
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 30/235 (12%)
Query: 68  EVQLLR--TLKNKYIIVCYS-----VWLDDQHNTLNF---ITEVCTSGNLRTYRKKHRHV 117
           EVQ LR  TLK   I+   S     + L D + T  F   + ++   G L  Y  +   +
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 118 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 177
           S K  +K  + +LE +  LH     I+HRDL   NI ++ ++  +K+ D GF+  +    
Sbjct: 122 SEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGE 178
Query: 178 AAHSIIGTPEYMAPELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI 230
              S+ GTP Y+APE+ E         Y + VD++S G+ +  ++    P+     +  +
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 231 YKKVTGGVK---PQ---ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSE 279
              ++G  +   P+     + VKD  V  F+   + QP+ R +A E L  PFF +
Sbjct: 239 RMIMSGNYQFGSPEWDDYSDTVKDL-VSRFL---VVQPQKRYTAEEALAHPFFQQ 289

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 99  NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 156
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+    ++ GTPEY+APE +  + Y + VD ++ G+
Sbjct: 157 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---TLCGTPEYLAPEIILSKGYNKAVDWWALGV 212
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 213 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 239

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 80
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 81  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 138 RR--LVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
              YT   D++S+G+ + E++T        IP SE  S+ +      G   PQ    +  
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQP--PICT 247
Query: 249 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDD 283
            +V   + KC +    +RP   EL+ +  FS++  D
Sbjct: 248 IDVYMIMRKCWMIDADSRPKFRELIIE--FSKMARD 281

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLVGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G+ + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+    ++ GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---TLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADEPIQIYEKIVSG 253

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRNYVE 261

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 26/222 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC- 83
           LG+G+  +V     +E G          +HF+   +   ++    Q+  TL  K I+   
Sbjct: 49  LGTGSFGRVMLVKHKETG----------NHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 84  ---YSVWLD---DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
              + V L+     ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYE 195
           + +  +I+RDL   N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  
Sbjct: 159 SLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILS 212
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           + Y + VD ++ G+ + EM     P+   D   +IY+K+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELR---EATSPKANKEILDEAYVMASVDNPH 112
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 113 VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 169
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 170 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 265

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 100 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 157
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 158 NLLIDEQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 213
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 214 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 240

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 132
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 249 VRNYVE 254

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 26/222 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC- 83
           LG+G+  +V     +E G          +HF+   +   ++    Q+  TL  K I+   
Sbjct: 49  LGTGSFGRVMLVKHKETG----------NHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 84  ---YSVWLD---DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
              + V L+     ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYE 195
           + +  +I+RDL   N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  
Sbjct: 159 SLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILS 212
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           + Y + VD ++ G+ + EM     P+   D   +IY+K+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 26/222 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC- 83
           LG+G+  +V     +E G          +HF+   +   ++    Q+  TL  K I+   
Sbjct: 49  LGTGSFGRVMLVKHKETG----------NHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 84  ---YSVWLD---DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
              + V L+     ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYE 195
           + +  +I+RDL   N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  
Sbjct: 159 SLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILS 212
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           + Y + VD ++ G+ + EM     P+   D   +IY+K+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLIIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIIISKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 85
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 86  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 143 RR--LVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRNYVE 261

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     ED   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEED--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198
Query: 165 GDLGFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 106 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 163
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 164 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 219
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 220 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 246

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLMIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 78
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 136 RR--LVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 79
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 80  VCRLLGICLT---STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 137 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 232

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 78  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 133
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 194 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 252
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 253 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 134 NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 191
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 192 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 247
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 248 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 274

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLVGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 78  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 133
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 194 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 252
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 253 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 82
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 83  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 140 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    +    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     +D   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 142 XSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198
Query: 165 GDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +                ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 116/243 (47%), Gaps = 21/243 (8%)
Query: 16  GRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR 73
           G   +Y  L  +G G    VY+A D +  I VA  ++RL   +ED  + +    E+ LL+
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLD--AEDEGIPSTAIREISLLK 74
Query: 74  TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
            L +  I+    V   ++  TL F  E       +   +    +    +K +  Q+L G+
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVF--EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMA 190
            + H H   I+HRDL   N+ IN + G +K+ D G A   G   RS+  H ++ T  Y A
Sbjct: 133 AHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSY-THEVV-TLWYRA 187
Query: 191 PELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNK 245
           P++    + Y+  VDI+S G    EM+T +  +   ++ D + KI+  + G   P+   +
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF-SILGTPNPREWPQ 246
Query: 246 VKD 248
           V++
Sbjct: 247 VQE 249

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 116/244 (47%), Gaps = 21/244 (8%)
Query: 15  SGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
            G   +Y  L  +G G    VY+A D +  I VA  ++RL   +ED  + +    E+ LL
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLD--AEDEGIPSTAIREISLL 73
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           + L +  I+    V   ++  TL F  E       +   +    +    +K +  Q+L G
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVF--EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYM 189
           + + H H   I+HRDL   N+ IN + G +K+ D G A   G   RS+  H ++ T  Y 
Sbjct: 132 VAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSY-THEVV-TLWYR 186
Query: 190 APELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALN 244
           AP++    + Y+  VDI+S G    EM+T +  +   ++ D + KI+  + G   P+   
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF-SILGTPNPREWP 245
Query: 245 KVKD 248
           +V++
Sbjct: 246 QVQE 249

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     +D   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIITLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198
Query: 165 GDLGFAAIVGR-SHAAHSIIGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNI-FINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI  ++ N+ +  +KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 80
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 81  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 138 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + +M     P+   D   +IY+K+  G
Sbjct: 227 LIYQMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLMIDQQ-GYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH------------VSIKALKKWSKQVLEGLEYLHTHEPC 142
           L  I E C  GNL TY +  R+            ++++ L  +S QV +G+E+L + +  
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK-- 164
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LYEEDY 198
            IHRDL   NI ++     VKI D G A  + +   +        P ++MAPE +++  Y
Sbjct: 165 XIHRDLAARNILLSEK-NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 223
Query: 199 TEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           T   D++SFG+ L E+ ++   PY       +  +++  G + +A +       +  ++ 
Sbjct: 224 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDC 283
Query: 258 CIAQPRARPSASELLK 273
              +P  RP+ SEL++
Sbjct: 284 WHGEPSQRPTFSELVE 299

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     +D   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198
Query: 165 GDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +                ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLMIDQQ-GYIKVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 117/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 73
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +  +    +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 131
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 132 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 190
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 240
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 241 WCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 81
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 82  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 139 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 79
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 80  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 137 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 78
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 136 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           L+G G+   VY A+D+     VA  +V  +   ED +   R+  E+ +L  LK+ YII  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 84  YSVWLDD---QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           Y + + D   + + L  + E+  S +L+   K    ++ + +K     +L G  ++H  E
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIH--E 147
Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI------------------ 182
             IIHRDL  +N  +N +   VK+ D G A  +      + +                  
Sbjct: 148 SGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 183 -----IGTPEYMAPEL--YEEDYTEMVDIYSFGLCLLEMVTM 217
                + T  Y APEL   +E+YT+ +DI+S G    E++ M
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNI-FINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI  ++ N+ +  +KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 123/264 (46%), Gaps = 27/264 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARP 266
           +  VKDP+ +  I+  +  P  +P
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 30/235 (12%)
Query: 68  EVQLLR--TLKNKYIIVCYS-----VWLDDQHNTLNF---ITEVCTSGNLRTYRKKHRHV 117
           EVQ LR  TLK   I+   S     + L D + T  F   + ++   G L  Y  +   +
Sbjct: 49  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 108
Query: 118 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 177
           S K  +K  + +LE +  LH     I+HRDL   NI ++ ++  +K+ D GF+  +    
Sbjct: 109 SEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGE 165
Query: 178 AAHSIIGTPEYMAPELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI 230
               + GTP Y+APE+ E         Y + VD++S G+ +  ++    P+     +  +
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 225
Query: 231 YKKVTGGVK---PQ---ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSE 279
              ++G  +   P+     + VKD  V  F+   + QP+ R +A E L  PFF +
Sbjct: 226 RMIMSGNYQFGSPEWDDYSDTVKDL-VSRFL---VVQPQKRYTAEEALAHPFFQQ 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 123/264 (46%), Gaps = 27/264 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARP 266
           +  VKDP+ +  I+  +  P  +P
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 30/235 (12%)
Query: 68  EVQLLR--TLKNKYIIVCYS-----VWLDDQHNTLNF---ITEVCTSGNLRTYRKKHRHV 117
           EVQ LR  TLK   I+   S     + L D + T  F   + ++   G L  Y  +   +
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 118 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 177
           S K  +K  + +LE +  LH     I+HRDL   NI ++ ++  +K+ D GF+  +    
Sbjct: 122 SEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGE 178
Query: 178 AAHSIIGTPEYMAPELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI 230
               + GTP Y+APE+ E         Y + VD++S G+ +  ++    P+     +  +
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 231 YKKVTGGVK---PQ---ALNKVKDPEVKAFIEKCIAQPRARPSASELLKDPFFSE 279
              ++G  +   P+     + VKD  V  F+   + QP+ R +A E L  PFF +
Sbjct: 239 RMIMSGNYQFGSPEWDDYSDTVKDL-VSRFL---VVQPQKRYTAEEALAHPFFQQ 289

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY DL  LG G    V+ A D +    VA  ++ L+    DP  V     E++++R L +
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDH 67
Query: 78  KYIIVCYSVW------LDDQHNTLN-----FITEVCTSGNLRTYRKKHRHVSIKALKKWS 126
             I+  + +       L D   +L      +I +     +L    ++   +   A + + 
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA-RLFM 126
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG--RSHAAHSIIG 184
            Q+L GL+Y+H+    ++HRDL  +N+FIN     +KIGD G A I+    SH  H   G
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 185 --TPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVT 216
             T  Y +P L     +YT+ +D+++ G    EM+T
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNI-FINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI  ++ N+ +  +KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNI-FINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI  ++ N+ +  +KI D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 11/254 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LG G+  +V    D+  G E A   +      +       L  EVQLL+ L +  I+  
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKL 91
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           Y  + D  +  L  + EV T G L       +  S     +  +QVL G+ Y+H ++  I
Sbjct: 92  YEFFEDKGYFYL--VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 147
Query: 144 IHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEM 201
           +HRDL   N+ +        ++I D G +     S      IGT  Y+APE+    Y E 
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEK 207
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEKCI 259
            D++S G+ L  +++   P++  +    I KKV  G     L + K      K  I K +
Sbjct: 208 CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFELPQWKKVSESAKDLIRKML 266
Query: 260 AQ-PRARPSASELL 272
              P  R SA + L
Sbjct: 267 TYVPSMRISARDAL 280

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 177
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 178 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 293
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 294 VRNYVE 299

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRNYVE 261

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 104/219 (47%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 93
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 94  FVKLYFTFQDDEK--LYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+S +GT +Y++PEL  E
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +  ++  D+++ G C++  +   +P     +   I++K+
Sbjct: 209 KSASKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRNYVE 261

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 11/254 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LG G+  +V    D+  G E A   +      +       L  EVQLL+ L +  I+  
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKL 114
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           Y  + D  +  L  + EV T G L       +  S     +  +QVL G+ Y+H ++  I
Sbjct: 115 YEFFEDKGYFYL--VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 170
Query: 144 IHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEM 201
           +HRDL   N+ +        ++I D G +     S      IGT  Y+APE+    Y E 
Sbjct: 171 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEK 230
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEKCI 259
            D++S G+ L  +++   P++  +    I KKV  G     L + K      K  I K +
Sbjct: 231 CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFELPQWKKVSESAKDLIRKML 289
Query: 260 AQ-PRARPSASELL 272
              P  R SA + L
Sbjct: 290 TYVPSMRISARDAL 303

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 140
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 141 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 256
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 257 VRNYVE 262

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 140
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 141 KHLHS--AGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 256
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 257 VRNYVE 262

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 133
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 134 KHLHS--AGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 249
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 250 VRNYVE 255

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 94
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 95  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+S +GT +Y++PEL  E
Sbjct: 153 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 210 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 247

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 11/254 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LG G+  +V    D+  G E A   +      +       L  EVQLL+ L +  I+  
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKL 115
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           Y  + D  +  L  + EV T G L       +  S     +  +QVL G+ Y+H ++  I
Sbjct: 116 YEFFEDKGYFYL--VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 171
Query: 144 IHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEM 201
           +HRDL   N+ +        ++I D G +     S      IGT  Y+APE+    Y E 
Sbjct: 172 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEK 231
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEKCI 259
            D++S G+ L  +++   P++  +    I KKV  G     L + K      K  I K +
Sbjct: 232 CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFELPQWKKVSESAKDLIRKML 290
Query: 260 AQ-PRARPSASELL 272
              P  R SA + L
Sbjct: 291 TYVPSMRISARDAL 304

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 130/298 (43%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     +D   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198
Query: 165 GDLGFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +  ++  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 11/254 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LG G+  +V    D+  G E A   +      +       L  EVQLL+ L +  I+  
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKL 97
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           Y  + D  +  L  + EV T G L       +  S     +  +QVL G+ Y+H ++  I
Sbjct: 98  YEFFEDKGYFYL--VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 153
Query: 144 IHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEM 201
           +HRDL   N+ +        ++I D G +     S      IGT  Y+APE+    Y E 
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEK 213
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEKCI 259
            D++S G+ L  +++   P++  +    I KKV  G     L + K      K  I K +
Sbjct: 214 CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFELPQWKKVSESAKDLIRKML 272
Query: 260 AQ-PRARPSASELL 272
              P  R SA + L
Sbjct: 273 TYVPSMRISARDAL 286

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRNYVE 261

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 108 NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 165
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 166 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 221
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 222 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 248

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 6   GEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           G+PF +V P     RY+ L  +G GA   V  A+D      VA  ++  S F E      
Sbjct: 36  GQPF-DVGP-----RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKI--SPF-EHQTYCQ 86
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR---TYRK-KHRHVSI 119
           R   E+Q+L   +++ +I    +    + +TL  + +V    +L     Y+  K + +S 
Sbjct: 87  RTLREIQILLRFRHENVIGIRDIL---RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSN 143
Query: 120 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 179
             +  +  Q+L GL+Y+H+    ++HRDL  SN+ IN     +KI D G A I    H  
Sbjct: 144 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLINTTC-DLKICDFGLARIADPEHDH 200
Query: 180 HSI----IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVT 216
                  + T  Y APE  L  + YT+ +DI+S G  L EM++
Sbjct: 201 TGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +L SGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 85
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 86  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 143 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +K+ D G A  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLMIDQQ-GYIKVTDFGLAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 177
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 178 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 293
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 294 VRNYVE 299

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 133
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 134 KHLHS--AGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 249
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 250 VRNYVE 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 81
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 138
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 139 KHLHS--AGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 195
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 196 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 254
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 255 VRNYVE 260

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 132
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 249 VRNYVE 254

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 134 NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 191
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 192 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 247
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 248 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 274

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 22/163 (13%)
Query: 132 GLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTPEY 188
           GL YLH H +P IIHRD+  +NI ++     V +GD G A ++     H   ++ GT  +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQAL 243
           +APE L     +E  D++ +G+ LLE++T +  +       D    +   V G +K + L
Sbjct: 210 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 269
Query: 244 NKV---------KDPEVKAFIEKCI----AQPRARPSASELLK 273
             +         KD EV+  I+  +    + P  RP  SE+++
Sbjct: 270 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 312

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 34/276 (12%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 80
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 81  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 138 RR--LVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSVAKIYKKVTGGVKPQALNKVKD 248
              YT   D++S+G+ + E++T        IP SE  S+ +      G   PQ    +  
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----KGERLPQP--PICT 247
Query: 249 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDD 283
            +V   + KC +    +RP   EL+ +  FS++  D
Sbjct: 248 IDVYMIMRKCWMIDADSRPKFRELIIE--FSKMARD 281

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +L SGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 78
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  VCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 136 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 74
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 135 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 192
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 252
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 253 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 283

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 123/290 (42%), Gaps = 39/290 (13%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   V++  +++ G  VA  +   S   +DPV+      E+++L+ LK+  ++   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            V+   +   L+ + E C    L    +  R V    +K  + Q L+ + + H H    I
Sbjct: 69  EVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CI 124
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPELYEED--YTEM 201
           HRD+   NI I  +   +K+ D GFA ++ G S      + T  Y +PEL   D  Y   
Sbjct: 125 HRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIY--KKVTGGVKPQALN-----------KVKD 248
           VD+++ G    E+++    +     V ++Y  +K  G + P+              K+ D
Sbjct: 184 VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243
Query: 249 PE---------------VKAFIEKCI-AQPRARPSASELLKDPFFSELND 282
           PE                   ++ C+   P  R +  +LL  P+F  + +
Sbjct: 244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 73
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 134 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L  I +    G+L T   K    + + +K +  ++   L++LH+    II+RDL   NI 
Sbjct: 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENIL 158
Query: 155 INGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G +   +     A+S  GT EYMAPE+     +T+  D +SFG+ + 
Sbjct: 159 LDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMF 217
Query: 213 EMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSA 268
           EM+T  +P+   D   ++  I K   G   PQ L+    PE ++ +     + P  R  A
Sbjct: 218 EMLTGTLPFQGKDRKETMTMILKAKLG--MPQFLS----PEAQSLLRMLFKRNPANRLGA 271
Query: 269 S-----ELLKDPFFSELN 281
                 E+ +  FFS ++
Sbjct: 272 GPDGVEEIKRHSFFSTID 289

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 22/229 (9%)
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALK 123
           R   E  +L  + + +I+  +  +       L  I +    G+L T   K    + + +K
Sbjct: 72  RTKMERDILVEVNHPFIVKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSI 182
            +  ++   L++LH+    II+RDL   NI ++   G +K+ D G +   +     A+S 
Sbjct: 130 FYLAELALALDHLHS--LGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSF 186
Query: 183 IGTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGV 238
            GT EYMAPE+     +T+  D +SFG+ + EM+T  +P+   D   ++  I K   G  
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-- 244
Query: 239 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSAS-----ELLKDPFFSELN 281
            PQ L+    PE ++ +     + P  R  A      E+ +  FFS ++
Sbjct: 245 MPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 15/263 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+GA   V+R  ++  G   A   V   H S+   +      E+Q +  L++  ++  +
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV----RKEIQTMSVLRHPTLVNLH 114
Query: 85  SVWLDDQHNTLNFITEVCTSGNL-RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             + DD  N +  I E  + G L      +H  +S     ++ +QV +GL   H HE   
Sbjct: 115 DAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL--CHMHENNY 170
Query: 144 IHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEM 201
           +H DL   NI F      ++K+ D G  A +    +     GT E+ APE+ E +     
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 230
Query: 202 VDIYSFGLCLLEMVTMEIPYS--ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK-C 258
            D++S G+    +++   P+     D   +  K     +   A + + + + K FI K  
Sbjct: 231 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRKLL 289
Query: 259 IAQPRARPSASELLKDPFFSELN 281
           +A P  R +  + L+ P+ +  N
Sbjct: 290 LADPNTRMTIHQALEHPWLTPGN 312

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+AP  +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPAIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRNYVE 261

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 77
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 138 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 195
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 255
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 256 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 286

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L  I +    G+L T   K    + + +K +  ++   L++LH+    II+RDL   NI 
Sbjct: 102 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENIL 159
Query: 155 INGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G +   +     A+S  GT EYMAPE+     +T+  D +SFG+ + 
Sbjct: 160 LDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMF 218
Query: 213 EMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSA 268
           EM+T  +P+   D   ++  I K   G   PQ L+    PE ++ +     + P  R  A
Sbjct: 219 EMLTGTLPFQGKDRKETMTMILKAKLG--MPQFLS----PEAQSLLRMLFKRNPANRLGA 272
Query: 269 S-----ELLKDPFFSELN 281
                 E+ +  FFS ++
Sbjct: 273 GPDGVEEIKRHSFFSTID 290

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 73
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 134 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 85
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 146 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 263
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 264 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 294

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 92
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 153 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 210
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 270
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 271 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 301

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 86
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 147 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 204
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 264
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 265 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 295

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 85
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 146 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 263
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 264 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 294

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR--LHSEVQLLRTLKNKYIIV 82
           LGSG    V +   +  G E A   ++    S     V+R  +  EV +LR +++  II 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + ++  +    +  I E+ + G L  +  +   ++     ++ KQ+L+G+ YLH+    
Sbjct: 73  LHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR-- 128
Query: 143 IIHRDLNCSNI-FINGNIG--QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI  ++ N+   ++K+ D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 188
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY 221
             E  D++S G+    +++   P+
Sbjct: 189 GLE-ADMWSIGVITYILLSGASPF 211

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 73
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 134 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 106 NSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 163
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 164 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 219
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 220 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 246

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 15/263 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+GA   V+R  ++  G   A   V   H S+   +      E+Q +  L++  ++  +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV----RKEIQTMSVLRHPTLVNLH 220
Query: 85  SVWLDDQHNTLNFITEVCTSGNL-RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             + DD  N +  I E  + G L      +H  +S     ++ +QV +GL   H HE   
Sbjct: 221 DAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL--CHMHENNY 276
Query: 144 IHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEM 201
           +H DL   NI F      ++K+ D G  A +    +     GT E+ APE+ E +     
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 202 VDIYSFGLCLLEMVTMEIPYS--ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK-C 258
            D++S G+    +++   P+     D   +  K     +   A + + + + K FI K  
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRKLL 395
Query: 259 IAQPRARPSASELLKDPFFSELN 281
           +A P  R +  + L+ P+ +  N
Sbjct: 396 LADPNTRMTIHQALEHPWLTPGN 418

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 74
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 132
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 133 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 191
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 241
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 80
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 81  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 138 RR--LVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 81
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 142 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 199
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 259
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 260 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 290

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 69
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 127
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 128 NXGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSXECQHLIR 236
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR--LHSEVQLLRTLKNKYIIV 82
           LGSG    V +   +  G E A   ++    S     V+R  +  EV +LR +++  II 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + ++  +    +  I E+ + G L  +  +   ++     ++ KQ+L+G+ YLH+    
Sbjct: 80  LHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR-- 135
Query: 143 IIHRDLNCSNI-FINGNIG--QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI  ++ N+   ++K+ D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 195
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY 221
             E  D++S G+    +++   P+
Sbjct: 196 GLE-ADMWSIGVITYILLSGASPF 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 108
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 166
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 225
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 275
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 276 WCLALRPSDRPTFEEIQNHPWMQDV 300

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     +D   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIIHLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198
Query: 165 GDLGFAAIVGR-SHAAHSIIGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++         + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 114 NSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 171
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 172 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 227
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 228 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 254

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 73
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 131
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 132 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 190
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 240
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 241 WCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 74
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 132
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 133 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 191
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 241
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 74
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 132
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 133 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 191
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 241
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 242 WCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 96
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 154
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 155 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 213
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 214 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSXECQHLIR 263
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 264 WCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 65/129 (50%), Gaps = 5/129 (3%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++ R +  +  + +S ++   L YL  HE  II+RDL   N+ 
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--HERGIIYRDLKLDNVL 185
Query: 155 INGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G      R      +  GTP Y+APE L  EDY   VD ++ G+ + 
Sbjct: 186 LDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244
Query: 213 EMVTMEIPY 221
           EM+    P+
Sbjct: 245 EMMAGRSPF 253

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 89
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 147
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 148 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 206
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 256
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 257 WCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 88
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 146
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 147 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 205
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 255
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 256 WCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 88
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 146
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 147 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 205
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSXECQHLIR 255
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 256 WCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 116
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 174
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 175 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 233
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 283
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 284 WCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 89
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 147
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 148 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 206
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSXECQHLIR 256
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 257 WCLALRPXDRPTFEEIQNHPWMQDV 281

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 89
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 147
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 148 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 206
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSXECQHLIR 256
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 257 WCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 69
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 127
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+ E D      +++ GG   Q   + +   E +  I 
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPF-EHD------EEIIGG---QVFFRQRVSSECQHLIR 236
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 111
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 172 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 229
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 289
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 290 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 320

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 69
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 127
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 236
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 72
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 130
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 131 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 189
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 190 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 239
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 240 WCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 107
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 168 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 225
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 316

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 109
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 170 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 227
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 287
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 288 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 318

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFING--NIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           KQ+LEG+ YLH +   I+H DL   NI ++    +G +KI D G +  +G +     I+G
Sbjct: 138 KQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 185 TPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPY 221
           TPEY+APE+   D  T   D+++ G+    ++T   P+
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 101
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 162 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 219
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 279
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 280 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 310

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 82
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 83  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 140 RR--LVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 235

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 93
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 94  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I+ K+
Sbjct: 209 KSAXKSSDLWALG-CIIYQLVAGLPPFRAGNEGLIFAKI 246

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 78
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 139 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 196
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 256
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 257 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 287

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 152
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 213 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 270
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 330
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 331 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 361

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 65/129 (50%), Gaps = 5/129 (3%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++ R +  +  + +S ++   L YL  HE  II+RDL   N+ 
Sbjct: 81  LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--HERGIIYRDLKLDNVL 138
Query: 155 INGNIGQVKIGDLGFAAIVGRSHAAHSII-GTPEYMAPELYE-EDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G      R     S   GTP Y+APE+   EDY   VD ++ G+ + 
Sbjct: 139 LDSE-GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 197
Query: 213 EMVTMEIPY 221
           EM+    P+
Sbjct: 198 EMMAGRSPF 206

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 101
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 159
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 160 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 218
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSSECQHLIR 268
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 107
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 168 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 225
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 316

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 5/129 (3%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++ R +  +  + +S ++   L YL  HE  II+RDL   N+ 
Sbjct: 85  LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--HERGIIYRDLKLDNVL 142
Query: 155 INGNIGQVKIGDLGFAAIVGRSHAAHSII-GTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G      R     S   GTP Y+APE L  EDY   VD ++ G+ + 
Sbjct: 143 LDSE-GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201
Query: 213 EMVTMEIPY 221
           EM+    P+
Sbjct: 202 EMMAGRSPF 210

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +D    NR   E+Q++R L + 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHC 73
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 134 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 103/219 (47%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 91
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 92  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A++ +GT +Y++PEL  E
Sbjct: 150 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 207 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 90
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 91  FVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+S +GT +Y++PEL  E
Sbjct: 149 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 206 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 101
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 159
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 160 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 218
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+ E D      +++ GG   Q   + +   E +  I 
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPF-EHD------EEIIGG---QVFFRQRVSSECQHLIR 268
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 102
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 160
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 161 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 219
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+ E D      +++ GG   Q   + +   E +  I 
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPF-EHD------EEIIGG---QVFFRQRVSSECQHLIR 269
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 270 WCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 102
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 160
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 161 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 219
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+ E D      +++ GG   Q   + +   E +  I 
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPF-EHD------EEIIGG---QVFFRQRVSSECQHLIR 269
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 270 WCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 87
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 144
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 145 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 201
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VD++S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 202 ILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 260
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 261 VRTYVE 266

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D G A  V GR+     + GTPEY+APE +  + Y + VD ++ G+
Sbjct: 171 NLMIDQQ-GYIQVTDFGLAKRVKGRTW---XLCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 121
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 122 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 179
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 180 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 238
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 239 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSXECQHLIR 288
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 289 WCLALRPSDRPTFEEIQNHPWMQDV 313

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 96  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +          
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDXXKKTT 210
Query: 184 GTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
                 ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 269
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 270 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 305

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 107/230 (46%), Gaps = 25/230 (10%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK-- 124
           +E Q+L  + +++++     +  +  + L  +  +   G+L+ +            +   
Sbjct: 233 NEKQILEKVNSRFVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           ++ ++  GLE LH     I++RDL   NI ++ + G ++I DLG A  V         +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 185 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSE------CDSVAKIYKKVTGG 237
           T  YMAPE+ + E YT   D ++ G  L EM+  + P+ +       + V ++ K+V   
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--- 404
Query: 238 VKPQALNKVKDPEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELN 281
             P+  ++   P+ ++   + + + P  R      SA E+ + P F +LN
Sbjct: 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 24/200 (12%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  ITE C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 98  LMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR--SHAAHSIIGTP-EYMAPE-LY 194
            +   IHRDL   NI ++     VKI D G A  + +   +        P ++MAPE ++
Sbjct: 158 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 214
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           +  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       + 
Sbjct: 215 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 274
Query: 254 FIEKCIAQPRARPSASELLK 273
            ++    +P  RP+ SEL++
Sbjct: 275 MLDCWHGEPSQRPTFSELVE 294

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 37/225 (16%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           L+G G+   VY A+D+     VA  +V  +   ED +   R+  E+ +L  LK+ YII  
Sbjct: 35  LIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL 92
Query: 84  YSVWLDD---QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           + + + +   + + L  + E+  S +L+   K    ++ + +K     +L G +++H  E
Sbjct: 93  HDLIIPEDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH--E 149
Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI------------------ 182
             IIHRDL  +N  +N +   VKI D G A  +      H +                  
Sbjct: 150 SGIIHRDLKPANCLLNQDCS-VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKN 208
Query: 183 --------IGTPEYMAPEL--YEEDYTEMVDIYSFGLCLLEMVTM 217
                   + T  Y APEL   +E+YT  +DI+S G    E++ M
Sbjct: 209 LKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNM 253

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 116
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 174
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 175 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 233
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+   + +          ++ Q   + +   E +  I 
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFRQRVSXECQHLIR 283
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 284 WCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 141
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 142 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEV 198
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 257
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 258 VRTYVE 263

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 101
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 159
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 160 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 218
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+ E D      +++ GG   Q   + +   E +  I 
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPF-EHD------EEIIGG---QVFFRQRVSSECQHLIR 268
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 65/129 (50%), Gaps = 5/129 (3%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++ R +  +  + +S ++   L YL  HE  II+RDL   N+ 
Sbjct: 96  LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--HERGIIYRDLKLDNVL 153
Query: 155 INGNIGQVKIGDLGFAAIVGRSHAAHSII-GTPEYMAPELYE-EDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G      R     S   GTP Y+APE+   EDY   VD ++ G+ + 
Sbjct: 154 LDSE-GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 212
Query: 213 EMVTMEIPY 221
           EM+    P+
Sbjct: 213 EMMAGRSPF 221

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 102
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 160
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 161 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 219
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+ E D      +++ GG   Q   + +   E +  I 
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPF-EHD------EEIIGG---QVFFRQRVSXECQHLIR 269
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 270 WCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 93
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 94  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I+ K+
Sbjct: 209 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEGLIFAKI 246

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH------------VSIKALKKWSKQVLEGLEYLHTHEPC 142
           L  I E C  GNL TY +  R+            ++++ L  +S QV +G+E+L + +  
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK-- 164
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LYEEDY 198
            IHRDL   NI ++     VKI D G A  + +   +        P ++MAPE +++  Y
Sbjct: 165 XIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 223
Query: 199 TEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           T   D++SFG+ L E+ ++   PY       +  +++  G + +A +       +  ++ 
Sbjct: 224 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 283
Query: 258 CIAQPRARPSASELLK 273
              +P  RP+ SEL++
Sbjct: 284 WHGEPSQRPTFSELVE 299

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     +D   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   ++I
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMRI 198
Query: 165 GDLGFAAIVGR-SHAAHSIIGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 107/230 (46%), Gaps = 25/230 (10%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK-- 124
           +E Q+L  + +++++     +  +  + L  +  +   G+L+ +            +   
Sbjct: 233 NEKQILEKVNSRFVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           ++ ++  GLE LH     I++RDL   NI ++ + G ++I DLG A  V         +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 185 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSE------CDSVAKIYKKVTGG 237
           T  YMAPE+ + E YT   D ++ G  L EM+  + P+ +       + V ++ K+V   
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--- 404
Query: 238 VKPQALNKVKDPEVKAFIEKCIAQ-PRAR-----PSASELLKDPFFSELN 281
             P+  ++   P+ ++   + + + P  R      SA E+ + P F +LN
Sbjct: 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 24/200 (12%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  ITE C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 98  LMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR--SHAAHSIIGTP-EYMAPE-LY 194
            +   IHRDL   NI ++     VKI D G A  + +   +        P ++MAPE ++
Sbjct: 158 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 214
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           +  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       + 
Sbjct: 215 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 274
Query: 254 FIEKCIAQPRARPSASELLK 273
            ++    +P  RP+ SEL++
Sbjct: 275 MLDCWHGEPSQRPTFSELVE 294

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 96
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 97  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 155 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 212 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 249

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 101
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 159
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 160 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 218
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+ E D      +++ GG   Q   + +   E +  I 
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPF-EHD------EEIIGG---QVFFRQRVSXECQHLIR 268
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 269 WCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV---RLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LLGSG    VY      + + VA   V   R+S + E P    R+  EV LL+ + + + 
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVLLKKVSSGFS 102
Query: 81  IVCYSV-WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            V   + W +   + +  +       +L  +  +   +  +  + +  QVLE +   H H
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 160
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
              ++HRD+   NI I+ N G++K+ D G  A++ +        GT  Y  PE   Y   
Sbjct: 161 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRY 219
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           +     ++S G+ L +MV  +IP+ E D      +++ GG   Q   + +   E +  I 
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPF-EHD------EEIIGG---QVFFRQRVSXECQHLIR 269
Query: 257 KCIA-QPRARPSASELLKDPFFSEL 280
            C+A +P  RP+  E+   P+  ++
Sbjct: 270 WCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++ L  + E    G + ++ ++    S    + ++ Q++   EYLH+ +  +I+RDL   
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 152 NIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ I+   G +++ D GFA  V GR+     + GTPE +APE +  + Y + VD ++ G+
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTW---XLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 210 CLLEMVTMEIPYSECDSVAKIYKKVTGG 237
            + EM     P+   D   +IY+K+  G
Sbjct: 227 LIYEMAAGYPPFF-ADQPIQIYEKIVSG 253

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 71
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 72  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 130 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 187 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 224

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG G   +V  A     D++   E + VA   ++     +D   
Sbjct: 14  DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 70
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 71  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 128
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 129 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLTARNVLVTEN-NVMKI 185
Query: 165 GDLGFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 186 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 245
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 246 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 299

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 133
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 134 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VD++S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 249
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 250 VRTYVE 255

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 93
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 94  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 209 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 94
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 95  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 153 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 210 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 247

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           + +++ E+ +L+ L +  ++    V  D   + L  + E+   G +       + +S   
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQ 138
Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
            + + + +++G+EYLH  +  IIHRD+  SN+ + G  G +KI D G +     S A  S
Sbjct: 139 ARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADFGVSNEFKGSDALLS 195
Query: 182 -IIGTPEYMAPELYEEDYT----EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
             +GTP +MAPE   E       + +D+++ G+ L   V  + P+ + + +  ++ K   
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSK--- 251
Query: 237 GVKPQALNKVKDPEVKAFIEKCIAQ-----PRARPSASELLKDPFFS 278
            +K QAL     P++   ++  I +     P +R    E+   P+ +
Sbjct: 252 -IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 140
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 141 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 256
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 257 VRTYVE 262

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 70
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 71  FVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 129 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY 221
           +   +  D+++ G  + ++V    P+
Sbjct: 186 KSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH--------------VSIKALKKWSKQVLEGLEYLHTHE 140
           L  I E C  GNL TY +  R+              ++++ L  +S QV +G+E+L + +
Sbjct: 109 LMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK 168
Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LYEE 196
              IHRDL   NI ++     VKI D G A  + +            P ++MAPE +++ 
Sbjct: 169 --XIHRDLAARNILLSEK-NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDR 225
Query: 197 DYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
            YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       +  +
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 285
Query: 256 EKCIAQPRARPSASELLK 273
           +    +P  RP+ SEL++
Sbjct: 286 DCWHGEPSQRPTFSELVE 303

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 93
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 94  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 209 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 98
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 99  FVKLYFCFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 157 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 214 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 251

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 117/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VD++S G  + EMV  +I +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 109/262 (41%), Gaps = 42/262 (16%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           LLG GA   V  A  +  G  VA  ++      + P+   R   E+++L+  K++ II  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITI 74
Query: 84  YSVWLDDQHNTLN--FITEVCTSGNLRTYRKKHRHVSIKAL-----KKWSKQVLEGLEYL 136
           +++   D     N  +I +     +L      HR +S + L     + +  Q L  ++ L
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-----------IIGT 185
           H     +IHRDL  SN+ IN N   +K+ D G A I+  S A +S            + T
Sbjct: 129 HGSN--VIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 186 PEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
             Y APE  L    Y+  +D++S G  L E+      +   D   ++         P + 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 244 NKVKDPEVKAFIEKCIAQPRAR 265
           N +          +CI  PRAR
Sbjct: 246 NDL----------RCIESPRAR 257

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 91
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 92  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 150 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 207 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 91
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 92  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 150 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 207 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 93
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 94  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 209 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  ITE C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 98  LMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR--SHAAHSIIGTP-EYMAPE-LY 194
            +   IHRDL   NI ++     VKI D G A  + +            P ++MAPE ++
Sbjct: 158 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF 214
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           +  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       + 
Sbjct: 215 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 274
Query: 254 FIEKCIAQPRARPSASELLK 273
            ++    +P  RP+ SEL++
Sbjct: 275 MLDCWHGEPSQRPTFSELVE 294

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSII 183
           ++ Q++ GLE+LH     II+RDL   N+ ++ + G V+I DLG A  +           
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYA 350
Query: 184 GTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPY 221
           GTP +MAPEL   E+Y   VD ++ G+ L EM+    P+
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 16/245 (6%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG-GVKPQALNKVKDPEV 251
           +    Y E VDI+S G  + EMV  +I +   D + +  K +   G    A  K   P V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTV 256
Query: 252 KAFIE 256
           + ++E
Sbjct: 257 RNYVE 261

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG G   +V  A     D++   E + VA   ++     +D   
Sbjct: 73  DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 129
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 244
Query: 165 GDLGFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 305 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 358

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +L SGA   VY+     EG    I VA  ++R    +  P     +  E  ++ ++ N +
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPH 85
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L    +T+  I ++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 86  VCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G     ++MA E + 
Sbjct: 143 RR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 195 EEDYTEMVDIYSFGLCLLEMVTM------EIPYSECDSV 227
              YT   D++S+G+ + E++T        IP SE  S+
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 69
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 70  FVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 128 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 185 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 222

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 12/194 (6%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L  I +    G+L T   K    + + +K +  ++  GL++LH+    II+RDL   NI 
Sbjct: 105 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS--LGIIYRDLKPENIL 162
Query: 155 INGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELY-EEDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G +   +     A+S  GT EYMAPE+   + ++   D +S+G+ + 
Sbjct: 163 LDEE-GHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMF 221
Query: 213 EMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRAR--PS 267
           EM+T  +P+   D   ++  I K   G   PQ L+      ++A  ++  A         
Sbjct: 222 EMLTGSLPFQGKDRKETMTLILKAKLG--MPQFLSTEAQSLLRALFKRNPANRLGSGPDG 279
Query: 268 ASELLKDPFFSELN 281
           A E+ +  F+S ++
Sbjct: 280 AEEIKRHVFYSTID 293

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 68
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 69  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 127 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY 221
           +   +  D+++ G  + ++V    P+
Sbjct: 184 KSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 107/254 (42%), Gaps = 11/254 (4%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LG G+  +V    D+  G E A   +      +       L  EVQLL+ L +  I   
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIXKL 91
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           Y  + D  +  L  + EV T G L       +  S     +  +QVL G+ Y H ++  I
Sbjct: 92  YEFFEDKGYFYL--VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK--I 147
Query: 144 IHRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEM 201
           +HRDL   N+ +        ++I D G +     S      IGT  Y+APE+    Y E 
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDEK 207
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEKCI 259
            D++S G+ L  +++   P++  +    I KKV  G     L + K      K  I K +
Sbjct: 208 CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFELPQWKKVSESAKDLIRKXL 266
Query: 260 AQ-PRARPSASELL 272
              P  R SA + L
Sbjct: 267 TYVPSXRISARDAL 280

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSII 183
           ++ Q++ GLE+LH     II+RDL   N+ ++ + G V+I DLG A  +           
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYA 350
Query: 184 GTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPY 221
           GTP +MAPEL   E+Y   VD ++ G+ L EM+    P+
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSII 183
           ++ Q++ GLE+LH     II+RDL   N+ ++ + G V+I DLG A  +           
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYA 350
Query: 184 GTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPY 221
           GTP +MAPEL   E+Y   VD ++ G+ L EM+    P+
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 126/268 (47%), Gaps = 27/268 (10%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+  +    +  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 143 IIHRDLNCSNI-FINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI  ++ N+ +  +KI D G A  +   +   +I GTP ++APE+  YE  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPL 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKI----------YKKVTGGVKPQALN 244
             E  D++S G+    +++   P+   ++ +++A +          Y   T  +    + 
Sbjct: 195 GLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 245 K--VKDPEVKAFIEKCIAQPRARPSASE 270
           +  VKDP+ +  I+  +  P  +P  ++
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +     NR   E+Q++R L + 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNR---ELQIMRKLDHC 73
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 134 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               + K P++KA     + +PR  P A  L
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSII 183
           ++ Q++ GLE+LH     II+RDL   N+ ++ + G V+I DLG A  +           
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYA 350
Query: 184 GTPEYMAPELY-EEDYTEMVDIYSFGLCLLEMVTMEIPY 221
           GTP +MAPEL   E+Y   VD ++ G+ L EM+    P+
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG G   +V  A     D++   E + VA   ++     +D   
Sbjct: 19  DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 75
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 76  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 133
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 134 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 190
Query: 165 GDLGFAAIVGR-SHAAHSIIGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 191 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 250
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 251 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 304

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 132 GLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTPEY 188
           GL YLH H +P IIHRD+  +NI ++     V +GD G A ++     H   ++ G   +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVKPQAL 243
           +APE L     +E  D++ +G+ LLE++T +  +       D    +   V G +K + L
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 244 NKV---------KDPEVKAFIEKCI----AQPRARPSASELLK 273
             +         KD EV+  I+  +    + P  RP  SE+++
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 29/282 (10%)
Query: 10  VEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR--L 65
           VEV     +  Y  L  LGSGA   V+R       +E A  +V ++ F   P  +++  +
Sbjct: 42  VEVKQGSVYDYYDILEELGSGAFGVVHRC------VEKATGRVFVAKFINTPYPLDKYTV 95
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALK 123
            +E+ ++  L +  +I  +  + D     L  I E  + G L  R   + ++ +S   + 
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVL--ILEFLSGGELFDRIAAEDYK-MSEAEVI 152
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSI 182
            + +Q  EGL+++H H   I+H D+   NI         VKI D G A  +         
Sbjct: 153 NYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 210
Query: 183 IGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI--YKKVTG 236
             T E+ APE+ + +    YT+M  I   G  LL  ++   P++  D +  +   K+   
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRCDW 267
Query: 237 GVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
                A + V  PE K FI+  +  +PR R +  + L+ P+ 
Sbjct: 268 EFDEDAFSSV-SPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG G   +V  A     D++   E + VA   ++     +D   
Sbjct: 16  DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 72
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I E  + GNLR Y +  R     
Sbjct: 73  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGME 130
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 131 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 187
Query: 165 GDLGFAAIVGR-SHAAHSIIG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 188 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 247
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 248 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 301

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 109/262 (41%), Gaps = 42/262 (16%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           LLG GA   V  A  +  G  VA  ++      + P+   R   E+++L+  K++ II  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITI 74
Query: 84  YSVWLDDQHNTLN--FITEVCTSGNLRTYRKKHRHVSIKAL-----KKWSKQVLEGLEYL 136
           +++   D     N  +I +     +L      HR +S + L     + +  Q L  ++ L
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-----------IIGT 185
           H     +IHRDL  SN+ IN N   +K+ D G A I+  S A +S            + T
Sbjct: 129 HGSN--VIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 186 PEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
             Y APE  L    Y+  +D++S G  L E+      +   D   ++         P + 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 244 NKVKDPEVKAFIEKCIAQPRAR 265
           N +          +CI  PRAR
Sbjct: 246 NDL----------RCIESPRAR 257

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 75
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 76  FVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 134 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 191 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 228

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR--LHSEVQLLRTLKNKYIIV 82
           LGSG    V +   +  G E A   ++          V+R  +  EV +LR +++  II 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + ++  +    +  I E+ + G L  +  +   ++     ++ KQ+L+G+ YLH+    
Sbjct: 94  LHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR-- 149
Query: 143 IIHRDLNCSNI-FINGNIG--QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL--YEED 197
           I H DL   NI  ++ N+   ++K+ D G A  +   +   +I GTPE++APE+  YE  
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 209
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPY 221
             E  D++S G+    +++   P+
Sbjct: 210 GLE-ADMWSIGVITYILLSGASPF 232

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 96  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSI 182
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +    +   + 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTT 210
Query: 183 IG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            G    ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 269
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 270 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 305

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TGGVKPQALNKVKDPE 250
           +    Y E VDI+S G  + EM+   + +   D + +  K +   G   P+ + K++ P 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PT 255
Query: 251 VKAFIE 256
           V+ ++E
Sbjct: 256 VRTYVE 261

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 81  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSI 182
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +    +   + 
Sbjct: 139 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTT 195
Query: 183 IGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            G    ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 254
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 255 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 290

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     +D   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I    + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVAYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198
Query: 165 GDLGFAAIVGR-SHAAHSIIGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 109/262 (41%), Gaps = 42/262 (16%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           LLG GA   V  A  +  G  VA  ++      + P+   R   E+++L+  K++ II  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITI 74
Query: 84  YSVWLDDQHNTLN--FITEVCTSGNLRTYRKKHRHVSIKAL-----KKWSKQVLEGLEYL 136
           +++   D     N  +I +     +L      HR +S + L     + +  Q L  ++ L
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-----------IIGT 185
           H     +IHRDL  SN+ IN N   +K+ D G A I+  S A +S            + T
Sbjct: 129 HGSN--VIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 186 PEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
             Y APE  L    Y+  +D++S G  L E+      +   D   ++         P + 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 244 NKVKDPEVKAFIEKCIAQPRAR 265
           N +          +CI  PRAR
Sbjct: 246 NDL----------RCIESPRAR 257

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 49/299 (16%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           ++G+G+   V++A    E  EVA  +V      +D    NR   E+Q++R +K+  ++  
Sbjct: 47  VIGNGSFGVVFQA-KLVESDEVAIKKVL-----QDKRFKNR---ELQIMRIVKHPNVVDL 97
Query: 84  YSVWLDDQHNT----LNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLEGLEYL 136
            + +  +        LN + E       R    Y K  + + +  +K +  Q+L  L Y+
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY-- 194
           H+   C  HRD+   N+ ++   G +K+ D G A I+       S I +  Y APEL   
Sbjct: 158 HSIGIC--HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFG 215
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGG-------------- 237
             +YT  +DI+S G  + E++  +  +   S  D + +I  KV G               
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII-KVLGTPSREQIKTMNPNYM 274
Query: 238 ------VKPQALNKVKDPEVKAFIEKCIAQ-----PRARPSASELLKDPFFSELNDDDS 285
                 ++P   +KV  P         I++     P AR +A E L  PFF EL   ++
Sbjct: 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 85  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSI 182
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +    +   + 
Sbjct: 143 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTT 199
Query: 183 IGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            G    ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 258
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 259 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 294

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 89  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSI 182
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +    +   + 
Sbjct: 147 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTT 203
Query: 183 IGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            G    ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 262
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 263 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 298

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 137 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSI 182
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +    +   + 
Sbjct: 195 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTT 251
Query: 183 IG--TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            G    ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 310
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 311 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 346

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 96  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSI 182
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +    +   + 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTT 210
Query: 183 IGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            G    ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 269
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 270 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 305

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +  R                 +S K L 
Sbjct: 88  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSI 182
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +    +   + 
Sbjct: 146 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTT 202
Query: 183 IGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            G    ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 261
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 262 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 297

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 90
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 91  FVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 149 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 206 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLAFRH 82
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 143 HSAN--VLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 100
Query: 78  KYIIVCYSVWLD---DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
           + II    +      +Q   +  +T +  +   +    K +H+S   +  +  Q+L GL+
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRGLK 158
Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMA 190
           Y+H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y A
Sbjct: 159 YIHSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 191 PE--LYEEDYTEMVDIYSFGLCLLEMVT 216
           PE  L  + YT+ +DI+S G  L EM++
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  I E C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LY 194
            +   IHRDL   NI ++     VKI D G A  + +   +        P ++MAPE ++
Sbjct: 167 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 223
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           +  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       + 
Sbjct: 224 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 283
Query: 254 FIEKCIAQPRARPSASELLK 273
            ++    +P  RP+ SEL++
Sbjct: 284 MLDCWHGEPSQRPTFSELVE 303

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 127/284 (44%), Gaps = 29/284 (10%)
Query: 9   FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 68
           F++V   G FG+   LL     ++V+ A      ++V   +  L    E  ++  R    
Sbjct: 42  FLKVIGKGSFGKV--LLARHKAEEVFYA------VKVLQKKAILKKKEEKHIMSER---- 89
Query: 69  VQLLRTLKNKYII-VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
             LL+ +K+ +++ + +S    D+   L F+ +    G L  + ++ R       + ++ 
Sbjct: 90  NVLLKNVKHPFLVGLHFSFQTADK---LYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTP 186
           ++   L YLH+    I++RDL   NI ++   G + + D G     +  +    +  GTP
Sbjct: 147 EIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTP 203
Query: 187 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 245
           EY+APE L+++ Y   VD +  G  L EM+    P+   ++ A++Y  +    KP  L  
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILN--KPLQLKP 260
Query: 246 VKDPEVKAFIEKCIAQPR-----ARPSASELLKDPFFSELNDDD 284
                 +  +E  + + R     A+    E+    FFS +N DD
Sbjct: 261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  I E C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 109 LMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 168
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LY 194
            +   IHRDL   NI ++     VKI D G A  + +   +        P ++MAPE ++
Sbjct: 169 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 225
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           +  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       + 
Sbjct: 226 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 285
Query: 254 FIEKCIAQPRARPSASELLK 273
            ++    +P  RP+ SEL++
Sbjct: 286 MLDCWHGEPSQRPTFSELVE 305

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRA----FDQE---EGIEVAWNQVRLSHFSEDPVL 61
           DP   F R        LG GA  +V  A     D++   E + VA   ++     +D   
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--- 83
Query: 62  VNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----- 115
           ++ L SE+++++ + K+K II        D    L  I    + GNLR Y +  R     
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVGYASKGNLREYLRARRPPGME 141
Query: 116 -----------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                       ++ K L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKI 198
Query: 165 GDLGFAAIVGR-SHAAHSIIGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM--- 217
            D G A  +    +   +  G    ++MAPE L++  YT   D++SFG+ + E+ T+   
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
             P    + + K+ K+     KP         E+   +  C  A P  RP+  +L++D
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 26/170 (15%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----- 182
           Q+ E +E+LH+    ++HRDL  SNIF   +   VK+GD G    + +     ++     
Sbjct: 172 QIAEAVEFLHSK--GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 183 --------IGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
                   +GT  YM+PE ++  +Y+  VDI+S GL L E++     YS    + ++ + 
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-----YSFSTQMERV-RI 282
Query: 234 VTG--GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
           +T    +K   L   K P+    ++  ++  P  RP A++++++  F  L
Sbjct: 283 ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH---------------VSIKALKKWSKQVLEGLEYLHTH 139
           L  I E C  GNL TY +  R+               ++++ L  +S QV +G+E+L + 
Sbjct: 108 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 167
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LYE 195
           +   IHRDL   NI ++     VKI D G A  + +            P ++MAPE +++
Sbjct: 168 K--CIHRDLAARNILLSEK-NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD 224
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       +  
Sbjct: 225 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 284
Query: 255 IEKCIAQPRARPSASELLK 273
           ++    +P  RP+ SEL++
Sbjct: 285 LDCWHGEPSQRPTFSELVE 303

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  I E C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 203
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LY 194
            +   IHRDL   NI ++     VKI D G A  + +   +        P ++MAPE ++
Sbjct: 204 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 260
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           +  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       + 
Sbjct: 261 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 320
Query: 254 FIEKCIAQPRARPSASELLK 273
            ++    +P  RP+ SEL++
Sbjct: 321 MLDCWHGEPSQRPTFSELVE 340

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +     NR   E+Q++R L + 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNR---ELQIMRKLDHC 73
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +   +   R    Y +  + + +  +K +  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 134 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               +   P++KA     + +PR  P A  L
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+      A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPF 91
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYLH  
Sbjct: 92  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELY-E 195
              IIHRDL   NI +N ++  ++I D G A ++    +   A+  +GT +Y++PEL  E
Sbjct: 150 --GIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           +   +  D+++ G C++  +   +P     +   I++K+
Sbjct: 207 KSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSH-----FSEDPVLVNRLHSEVQLL 72
           +YS +  LGSGA   V+ A D+E+  EV    ++        + EDP L  ++  E+ +L
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL-GKVTLEIAIL 83
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQVLE 131
             +++  II    ++  +       + E   SG +L  +  +H  +         +Q++ 
Sbjct: 84  SRVEHANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            + YL   +  IIHRD+   NI I  +   +K+ D G AA + R    ++  GT EY AP
Sbjct: 142 AVGYLRLKD--IIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 192 ELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
           E+   +      ++++S G+ L  +V  E P+ E +      + V   + P  L      
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYL---VSK 249
Query: 250 EVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
           E+ + +   +   P  R +  +L+ DP+ ++
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 24/200 (12%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  I E C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LY 194
            +   IHRDL   NI ++     VKI D G A  + +            P ++MAPE ++
Sbjct: 167 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF 223
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           +  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       + 
Sbjct: 224 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 283
Query: 254 FIEKCIAQPRARPSASELLK 273
            ++    +P  RP+ SEL++
Sbjct: 284 MLDCWHGEPSQRPTFSELVE 303

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLAFRH 82
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 143 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 98  ITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD 147
           ITE C  G+L  + ++           R + ++ L  +S QV +G+ +L +     IHRD
Sbjct: 120 ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRD 177
Query: 148 LNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP----EYMAPE-LYEEDYTEM 201
           +   N+ + NG++   KIGD G A  +  + + + + G      ++MAPE +++  YT  
Sbjct: 178 VAARNVLLTNGHVA--KIGDFGLARDI-MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 234
Query: 202 VDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
            D++S+G+ L E+ ++ + PY      +K YK V  G +  A        + + ++ C A
Sbjct: 235 SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ-MAQPAFAPKNIYSIMQACWA 293
Query: 261 -QPRARPSASELLKDPFFSELNDDD 284
            +P  RP+  ++    F  E   +D
Sbjct: 294 LEPTHRPTFQQICS--FLQEQAQED 316

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 1   MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV 60
           M D D   FV+   SG FG  + L+     K++      E G  +  N  R         
Sbjct: 16  MHDSDRYDFVKDIGSGNFG-VARLMRDKLTKELVAVKYIERGAAIDENVQR--------- 65
Query: 61  LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 120
                  E+   R+L++  I+    V L   H  L  I E  + G L          S  
Sbjct: 66  -------EIINHRSLRHPNIVRFKEVILTPTH--LAIIMEYASGGELYERICNAGRFSED 116
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGRSHAA 179
             + + +Q+L G+ Y H+ + C  HRDL   N  ++G+   ++KI D G++         
Sbjct: 117 EARFFFQQLLSGVSYCHSMQIC--HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 180 HSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG- 236
            S +GTP Y+APE  L +E   ++ D++S G+ L  M+    P+ + +   + Y+K    
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PRDYRKTIQR 233
Query: 237 --GVKPQALNKVK-DPEVKAFIEKC-IAQPRARPSASELLKDPFF 277
              VK    + ++  PE    I +  +A P  R S  E+    +F
Sbjct: 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 118/273 (43%), Gaps = 18/273 (6%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY  L  +GSGA   V  AFD   GI VA    +LS   ++     R + E+ LL+ + +
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 82
Query: 78  KYIIVCYSVWLD----DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +    +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL---LYQMLCGI 139
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A     +      + T  Y APE 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 196
Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA-LNKVKDPEV 251
           +    Y   VDI+S G  + E+V   + +   D + +  K +     P A       P V
Sbjct: 197 ILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 252 KAFIEKCIAQPRARPSASELLKDPFFSELNDDD 284
           + ++E     P  +    EL  D  F   ++ D
Sbjct: 257 RNYVENRPKYPGIK--FEELFPDWIFPSESERD 287

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 98  ITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD 147
           ITE C  G+L  + ++           R + ++ L  +S QV +G+ +L +     IHRD
Sbjct: 128 ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRD 185
Query: 148 LNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP----EYMAPE-LYEEDYTEM 201
           +   N+ + NG++   KIGD G A  +  + + + + G      ++MAPE +++  YT  
Sbjct: 186 VAARNVLLTNGHVA--KIGDFGLARDI-MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 242
Query: 202 VDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
            D++S+G+ L E+ ++ + PY      +K YK V  G +  A        + + ++ C A
Sbjct: 243 SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ-MAQPAFAPKNIYSIMQACWA 301
Query: 261 -QPRARPSASELLKDPFFSELNDDD 284
            +P  RP+  ++    F  E   +D
Sbjct: 302 LEPTHRPTFQQICS--FLQEQAQED 324

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 24/200 (12%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  I E C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 98  LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTP-EYMAPE-LY 194
            +   IHRDL   NI ++     VKI D G A  + +            P ++MAPE ++
Sbjct: 158 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIF 214
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
           +  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +       + 
Sbjct: 215 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 274
Query: 254 FIEKCIAQPRARPSASELLK 273
            ++    +P  RP+ SEL++
Sbjct: 275 MLDCWHGEPSQRPTFSELVE 294

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 80
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 141 HSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 122/264 (46%), Gaps = 18/264 (6%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + +G G+  +V  A  +   I  A  ++   +F ED   V+R   E++++++L +  II 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVED---VDRFKQEIEIMKSLDHPNIIR 70
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA-LKKWSKQVLEGLEYLHTHEP 141
            Y  + D+    +  + E+CT G L   R  H+ V  ++   +  K VL  + Y H    
Sbjct: 71  LYETFEDN--TDIYLVMELCTGGELFE-RVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 126
Query: 142 CIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYT 199
            + HRDL   N     +     +K+ D G AA         + +GTP Y++P++ E  Y 
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYG 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYS---ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
              D +S G+ +  ++    P+S   + + + KI +      +   LN    P+ ++ I 
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLN--VSPQAESLIR 243
Query: 257 KCIAQ-PRARPSASELLKDPFFSE 279
           + + + P+ R ++ + L+  +F +
Sbjct: 244 RLLTKSPKQRITSLQALEHEWFEK 267

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 80
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 141 HSAN--VLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 32/204 (15%)
Query: 95  LNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHT 138
           L  I E C  GNL TY +  R+                ++++ L  +S QV +G+E+L +
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-------IVGRSHAAHSIIGTPEYMAP 191
            +   IHRDL   NI ++     VKI D G A         V +  A   +    ++MAP
Sbjct: 167 RK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDXVRKGDARLPL----KWMAP 219
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
           E +++  YT   D++SFG+ L E+ ++   PY       +  +++  G + +A +     
Sbjct: 220 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 279
Query: 250 EVKAFIEKCIAQPRARPSASELLK 273
             +  ++    +P  RP+ SEL++
Sbjct: 280 MYQTMLDCWHGEPSQRPTFSELVE 303

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 88
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 89  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 148
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 149 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 80
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 141 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 84
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 145 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 85
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 146 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 16/181 (8%)
Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--------RKKHRH 116
             +E+Q++  +KN+Y + C  +  +  ++ +  I E   + ++  +        +     
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 176
           + I+ +K   K VL    Y+H +E  I HRD+  SNI ++ N G+VK+ D G +  +   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDK 205
Query: 177 HAAHSIIGTPEYMAPELY--EEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
               S  GT E+M PE +  E  Y    VDI+S G+CL  M    +P+S   S+ +++  
Sbjct: 206 KIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264
Query: 234 V 234
           +
Sbjct: 265 I 265

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 82
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 143 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 118/262 (45%), Gaps = 14/262 (5%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + +G G+  +V  A  +   I  A  ++   +F ED   V+R   E++++++L +  II 
Sbjct: 32  NTIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVED---VDRFKQEIEIMKSLDHPNIIR 87
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA-LKKWSKQVLEGLEYLHTHEP 141
            Y  + D+    +  + E+CT G L   R  H+ V  ++   +  K VL  + Y H    
Sbjct: 88  LYETFEDN--TDIYLVMELCTGGELFE-RVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 143
Query: 142 CIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYT 199
            + HRDL   N     +     +K+ D G AA         + +GTP Y++P++ E  Y 
Sbjct: 144 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYG 202
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKC 258
              D +S G+ +  ++    P+S       + K   G    P+       P+ ++ I + 
Sbjct: 203 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRL 262
Query: 259 IAQ-PRARPSASELLKDPFFSE 279
           + + P+ R ++ + L+  +F +
Sbjct: 263 LTKSPKQRITSLQALEHEWFEK 284

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 21  YSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           Y+D  ++G+G+   VY+A   + G  VA  +V      +     NR   E+Q++R L + 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNR---ELQIMRKLDHC 73
Query: 79  YII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVLE 131
            I+      YS         LN + +       R    Y +  + + +  +K +  Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            L Y+H+   C  HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y AP
Sbjct: 134 SLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQA---- 242
           EL     DYT  +D++S G  L E++  +  +   S  D + +I K +    + Q     
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 243 --LNKVKDPEVKAFIEKCIAQPRARPSASEL 271
               +   P++KA     + +PR  P A  L
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 78
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 139 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 100
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 161 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 84
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 145 HSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKI--SPF-EHQTYCQRTLREIKILLRFRH 84
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 145 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYXQRTLREIKILLRFRH 84
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 145 HSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 80
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 141 HSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 80
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 141 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 85
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 146 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 86
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 87  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 146
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 147 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 77
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 78  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 137
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 138 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 84
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 145 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 78
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 139 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA   +++ + +  P        E  ++ ++ + +
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHPH 78
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           ++    V L     T+  +T++   G L  Y  +H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  LVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE- 134
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
            E  ++HRDL   N+ +      VKI D G A ++      ++  G     ++MA E ++
Sbjct: 135 -ERRLVHRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 195 EEDYTEMVDIYSFGLCLLEMVT 216
              +T   D++S+G+ + E++T
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMT 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 98  ITEVCTSGNLRTY-RKKHR-------------HVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           ITE C  G+L  + R+K R              +S + L  +S QV +G+ +L +     
Sbjct: 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN--C 185
Query: 144 IHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP----EYMAPE-LYEED 197
           IHRD+   N+ + NG++   KIGD G A  +  + + + + G      ++MAPE +++  
Sbjct: 186 IHRDVAARNVLLTNGHVA--KIGDFGLARDI-MNDSNYIVKGNARLPVKWMAPESIFDCV 242
Query: 198 YTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
           YT   D++S+G+ L E+ ++ + PY      +K YK V  G +  A        + + ++
Sbjct: 243 YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ-MAQPAFAPKNIYSIMQ 301
Query: 257 KCIA-QPRARPSASELLKDPFFSELNDDD 284
            C A +P  RP+  ++    F  E   +D
Sbjct: 302 ACWALEPTHRPTFQQICS--FLQEQAQED 328

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    VY+A     G   A  ++RL    ED  + +    E+ +L+ LK+  I+  Y
Sbjct: 10  IGEGTYGVVYKA-QNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 85  SVWLDDQHNTLNF---------ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            V    +   L F         + +VC  G           +     K +  Q+L G+ Y
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----------LESVTAKSFLLQLLNGIAY 115
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG--RSHAAHSIIGTPEYMAPEL 193
            H     ++HRDL   N+ IN   G++KI D G A   G       H I+ T  Y AP++
Sbjct: 116 CHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDV 171
Query: 194 Y--EEDYTEMVDIYSFGLCLLEMV--TMEIP-YSECDSVAKIYK 232
               + Y+  +DI+S G    EMV  T   P  SE D + +I++
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPE-LY 194
           H H+  II+RDL   NI +N + G VK+ D G     +      H+  GT EYMAPE L 
Sbjct: 136 HLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVK 252
              +   VD +S G  + +M+T   P++  +    I K  K    + P    + +D   K
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKK 254
Query: 253 AFIEKCIAQPRARPS-ASELLKDPFFSELN 281
                  ++  A P  A E+   PFF  +N
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 24  LLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           +LGSGA   VY+     EG    I VA   +++ + +  P        E  ++ ++ + +
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHPH 101
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           ++    V L     T+  +T++   G L  Y  +H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 102 LVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE- 157
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPE-LY 194
            E  ++HRDL   N+ +  +   VKI D G A ++      ++  G     ++MA E ++
Sbjct: 158 -ERRLVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 195 EEDYTEMVDIYSFGLCLLEMVT 216
              +T   D++S+G+ + E++T
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMT 237

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
           LLR  ++  II    V+ D ++  +  +TE+   G L     + +  S +        + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKY--VYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP- 186
           + +EYLH     ++HRDL  SNI     +GN   ++I D GFA    +  A + ++ TP 
Sbjct: 127 KTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAK---QLRAENGLLMTPC 181
Query: 187 ---EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSEC--DSVAKIYKKVTGG--- 237
               ++APE+ E + Y    DI+S G+ L  M+T   P++    D+  +I  ++  G   
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241
Query: 238 VKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
           +     N V D   K  + K +   P  R +A+ +L+ P+ 
Sbjct: 242 LSGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
           LLR  ++  II    V+ D +H  +  +TE+   G L     + +  S +        + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKH--VYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG 131
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           + +EYLH+    ++HRDL  SNI     +GN   ++I D GFA    +  A + ++ TP 
Sbjct: 132 KTVEYLHSQ--GVVHRDLKPSNILYVDESGNPECLRICDFGFAK---QLRAENGLLMTPC 186
Query: 188 Y----MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE--CDSVAKIYKKVTGG--- 237
           Y    +APE L  + Y E  DI+S G+ L  M+    P++    D+  +I  ++  G   
Sbjct: 187 YTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFT 246
Query: 238 VKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           +     N V +   K  + K +   P  R +A ++L+ P+ ++
Sbjct: 247 LSGGNWNTVSE-TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
           LLR  ++  II    V+ D +H  +  +TE+   G L     + +  S +        + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKH--VYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG 131
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           + +EYLH+    ++HRDL  SNI     +GN   ++I D GFA    +  A + ++ TP 
Sbjct: 132 KTVEYLHSQ--GVVHRDLKPSNILYVDESGNPECLRICDFGFAK---QLRAENGLLMTPC 186
Query: 188 Y----MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE--CDSVAKIYKKVTGG--- 237
           Y    +APE L  + Y E  DI+S G+ L  M+    P++    D+  +I  ++  G   
Sbjct: 187 YTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFT 246
Query: 238 VKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           +     N V +   K  + K +   P  R +A ++L+ P+ ++
Sbjct: 247 LSGGNWNTVSE-TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 98  ITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEP 141
           ITE C  G+L  + ++ R                 +S + L  +S QV +G+ +L +   
Sbjct: 128 ITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKN- 186
Query: 142 CIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP----EYMAPE-LYE 195
             IHRD+   N+ + NG++   KIGD G A  +  + + + + G      ++MAPE +++
Sbjct: 187 -CIHRDVAARNVLLTNGHVA--KIGDFGLARDI-MNDSNYIVKGNARLPVKWMAPESIFD 242
Query: 196 EDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             YT   D++S+G+ L E+ ++ + PY      +K YK V  G +  A        + + 
Sbjct: 243 CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ-MAQPAFAPKNIYSI 301
Query: 255 IEKCIA-QPRARPSASELLKDPFFSELNDDD 284
           ++ C A +P  RP+  ++    F  E   +D
Sbjct: 302 MQACWALEPTHRPTFQQICS--FLQEQAQED 330

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D LG G    VY+   +     VA  ++RL H    P    R   EV LL+ LK+  I+ 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 64
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEP 141
            + +   ++  TL F        +L+ Y     ++ ++  +K +  Q+L GL Y H  + 
Sbjct: 65  LHDIIHTEKSLTLVF---EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPE--LYEE 196
            ++HRDL   N+ IN   G++K+ D G A   +I  +++    +  T  Y  P+  L   
Sbjct: 121 -VLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGST 176
Query: 197 DYTEMVDIYSFGLCLLEMVT 216
           DY+  +D++  G    EM T
Sbjct: 177 DYSTQIDMWGVGCIFYEMAT 196

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA  ++  S F E      R   E+++L   ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-EHQTYCQRTLREIKILLRFRH 84
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYL 136
           + II    +        +  +  V        Y+  K +H+S   +  +  Q+L GL+Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYI 144
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI----IGTPEYMAPE 192
           H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y APE
Sbjct: 145 HSAN--VLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 193 --LYEEDYTEMVDIYSFGLCLLEMVT 216
             L  + YT+ +DI+S G  L EM++
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLD--DQHNTLNF------ITEVCTSGNLRTYRKKHRHVSI 119
           E+ LLR LK+  +I    V+L   D+   L F      +  +          KK   +  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 120 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN---IGQVKIGDLGFAAIVGRS 176
             +K    Q+L+G+ YLH +   ++HRDL  +NI + G     G+VKI D+GFA +    
Sbjct: 128 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 177 HAAHS----IIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSEC 224
               +    ++ T  Y APEL      YT+ +DI++ G    E++T E P   C
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 238

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 16/169 (9%)
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
           I+  + V+ D  H  L  + E+   G L    KK +H S        ++++  +   H H
Sbjct: 68  IVKLHEVFHDQLHTFL--VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS--HMH 123
Query: 140 EPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVG-RSHAAHSIIGTPEYMAPELYE 195
           +  ++HRDL   N+     N N+ ++KI D GFA +    +    +   T  Y APEL  
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNL-EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 196 ED-YTEMVDIYSFGLCLLEMVTMEIPYSE------CDSVAKIYKKVTGG 237
           ++ Y E  D++S G+ L  M++ ++P+        C S  +I KK+  G
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 98  ITEVCTSGNLRTY-RKKHR-------------HVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           ITE C  G+L  + R+K R               S + L  +S QV +G+ +L +     
Sbjct: 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--C 185
Query: 144 IHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP----EYMAPE-LYEED 197
           IHRD+   N+ + NG++   KIGD G A  +  + + + + G      ++MAPE +++  
Sbjct: 186 IHRDVAARNVLLTNGHVA--KIGDFGLARDI-MNDSNYIVKGNARLPVKWMAPESIFDCV 242
Query: 198 YTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
           YT   D++S+G+ L E+ ++ + PY      +K YK V  G +  A        + + ++
Sbjct: 243 YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ-MAQPAFAPKNIYSIMQ 301
Query: 257 KCIA-QPRARPSASELLKDPFFSELNDDD 284
            C A +P  RP+  ++    F  E   +D
Sbjct: 302 ACWALEPTHRPTFQQICS--FLQEQAQED 328

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  ++ + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 83  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 140
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 141 NVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 199
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 200 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 257
Query: 267 SASEL 271
             +EL
Sbjct: 258 RFTEL 262

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  ++ + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 80  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 137
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 138 NVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 196
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 197 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 254
Query: 267 SASEL 271
             +EL
Sbjct: 255 RFTEL 259

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 104/218 (47%), Gaps = 13/218 (5%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           + + LG+GA  +V  A ++  G   A   +            + + +E+ +LR +K++ I
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE---SSIENEIAVLRKIKHENI 82
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +    ++  +  N L  + ++ + G L     +    + K      +QVL+ + YLH   
Sbjct: 83  VALEDIY--ESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRM- 139
Query: 141 PCIIHRDLNCSNI--FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 197
             I+HRDL   N+  +      ++ I D G + + G+     +  GTP Y+APE L ++ 
Sbjct: 140 -GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKP 198
Query: 198 YTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKV 234
           Y++ VD +S G+    ++    P Y E DS  K+++++
Sbjct: 199 YSKAVDCWSIGVIAYILLCGYPPFYDENDS--KLFEQI 234

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  +  + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 83  NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 140
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 141 NVLVSSN-DCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFG 199
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 200 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 257
Query: 267 SASEL 271
             +EL
Sbjct: 258 RFTEL 262

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 39/287 (13%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           L+G G+   V +  +++ G  VA  +   S   +D ++      E++LL+ L+++ ++  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             V    +   L F  E      L         +  + ++K+  Q++ G+ + H+H   I
Sbjct: 90  LEVCKKKKRWYLVF--EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--I 145
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPELYEED--YTE 200
           IHRD+   NI ++ + G VK+ D GFA  +          + T  Y APEL   D  Y +
Sbjct: 146 IHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKP---QALNK------VKDP 249
            VD+++ G  + EM   E  +     + ++Y  +   G + P   +  NK      V+ P
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264
Query: 250 EVKA-----------------FIEKCI-AQPRARPSASELLKDPFFS 278
           E+K                    +KC+   P  RP  +ELL   FF 
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    VY+A     G   A  ++RL    ED  + +    E+ +L+ LK+  I+  Y
Sbjct: 10  IGEGTYGVVYKA-QNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 85  SVWLDDQHNTLNF---------ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            V    +   L F         + +VC  G           +     K +  Q+L G+ Y
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----------LESVTAKSFLLQLLNGIAY 115
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG--RSHAAHSIIGTPEYMAPEL 193
            H     ++HRDL   N+ IN   G++KI D G A   G       H ++ T  Y AP++
Sbjct: 116 CHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDV 171
Query: 194 Y--EEDYTEMVDIYSFGLCLLEMV--TMEIP-YSECDSVAKIYK 232
               + Y+  +DI+S G    EMV  T   P  SE D + +I++
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  ++ + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 83  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 140
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 141 NVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 199
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 200 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 257
Query: 267 SASEL 271
             +EL
Sbjct: 258 RFTEL 262

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  ++ + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 111 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 168
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 169 NVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 227
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 228 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 285
Query: 267 SASEL 271
             +EL
Sbjct: 286 RFTEL 290

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 124/277 (44%), Gaps = 34/277 (12%)
Query: 25  LGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKY 79
           LG GA  +V  A     D+++   V    V++         ++ L SE+++++ + K+K 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           II        D    L  I E  + GNLR Y +                    +S K L 
Sbjct: 96  IINLLGACTQD--GPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSI 182
             + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G A  +    +   + 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTT 210
Query: 183 IGT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            G    ++MAPE L++  YT   D++SFG+ L E+ T+   PY     V +++K +  G 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGH 269
Query: 239 KPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKD 274
           +    +   + E+   +  C  A P  RP+  +L++D
Sbjct: 270 RMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVED 305

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  ++ + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 86  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 143
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 144 NVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 202
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 203 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 260
Query: 267 SASEL 271
             +EL
Sbjct: 261 RFTEL 265

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  ++ + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 88  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 145
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 146 NVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 204
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 205 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 262
Query: 267 SASEL 271
             +EL
Sbjct: 263 RFTEL 267

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +           +V +       + V     E  L++TL++  ++  Y
Sbjct: 21  LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
           +V    +   +  ITE    G+L  + K      V +  L  +S Q+ EG+ Y+      
Sbjct: 75  AV--VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 130
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPELYEED-YT 199
            IHRDL  +N+ ++ ++   KI D G A ++    + A      P ++ APE      +T
Sbjct: 131 YIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L E+VT  +IPY
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPY 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  ++ + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 85  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 142
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 143 NVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 201
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 202 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 259
Query: 267 SASEL 271
             +EL
Sbjct: 260 RFTEL 264

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPE-LY 194
           H H+  II+RDL   NI +N + G VK+ D G     +      H   GT EYMAPE L 
Sbjct: 136 HLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKVKDPEVK 252
              +   VD +S G  + +M+T   P++  +    I K  K    + P    + +D   K
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKK 254
Query: 253 AFIEKCIAQPRARPS-ASELLKDPFFSELN 281
                  ++  A P  A E+   PFF  +N
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 36/225 (16%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    VY+A     G   A  ++RL    ED  + +    E+ +L+ LK+  I+  Y
Sbjct: 10  IGEGTYGVVYKA-QNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 85  SVWLDDQHNTLNF---------ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            V    +   L F         + +VC  G           +     K +  Q+L G+ Y
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----------LESVTAKSFLLQLLNGIAY 115
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE 192
            H     ++HRDL   N+ IN   G++KI D G A   G   R +  H ++ T  Y AP+
Sbjct: 116 CHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKY-THEVV-TLWYRAPD 170
Query: 193 LY--EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK 232
           +    + Y+  +DI+S G    EMV     +   SE D + +I++
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFR 215

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 33/231 (14%)
Query: 6   GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVR--LSHFSEDPVLVN 63
           G PF+      R     + +G G   +V+R   Q E + V     R   S F E      
Sbjct: 26  GLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE-----T 80
Query: 64  RLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT--LNFITEVCTSGNLRTYRKKHRHVSIKA 121
            L++ V L    +++ I+   +  +  +H++  L  IT     G+L  Y +     ++  
Sbjct: 81  ELYNTVML----RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC 136
Query: 122 LKKWSKQVLEGLEYLHTH------EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 175
           L+     +  GL +LH        +P I HRDL   NI +  N GQ  I DLG A +  +
Sbjct: 137 LRI-VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQ 194
Query: 176 SHAAHSI-----IGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEM 214
           S     +     +GT  YMAPE+ +E       D  + VDI++FGL L E+
Sbjct: 195 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEIXINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEIXINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEIXINKMLNHENVVKFY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 72  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 244
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 115/257 (44%), Gaps = 23/257 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG    V+  +   +  +VA   ++    SED  +      E +++  L +  ++  Y
Sbjct: 35  IGSGQFGLVHLGYWLNKD-KVAIKTIKEGSMSEDDFI-----EEAEVMMKLSHPKLVQLY 88
Query: 85  SVWLDDQHNTL--NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V L+     L   F+   C S  LRT R      + + L      V EG+ YL   E C
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLE--EAC 143
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPELYE-EDY 198
           +IHRDL   N  +  N   +K+ D G    V       S  GT    ++ +PE++    Y
Sbjct: 144 VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRY 201
Query: 199 TEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           +   D++SFG+ + E+ +  +IPY E  S +++ + ++ G +     ++    V   +  
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNH 259
Query: 258 CIAQ-PRARPSASELLK 273
           C  + P  RP+ S LL+
Sbjct: 260 CWKERPEDRPAFSRLLR 276

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 52/104 (50%), Gaps = 19/104 (18%)
Query: 129 VLEGLEYLHTH------EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           +  GL +LH        +P I HRDL   NI +  N GQ  I DLG A +  +S     +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDV 172
Query: 183 -----IGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEM 214
                +GT  YMAPE+ +E       D  + VDI++FGL L E+
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 21  LGAGQAGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 74
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 75  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHRDL  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 130 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDAEXTAREGAKFPI----KWTAPEAINY 184
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 29  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 82
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 83  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 137
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHRDL  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 138 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEXTAREGAKFPI----KWTAPEAINY 192
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPY 219

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 12  VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           +DPS     +   +GSG    V+  +   +  +VA   +R    SE+  +      E ++
Sbjct: 5   IDPSEL--TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFI-----EEAEV 56
Query: 72  LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVL 130
           +  L +  ++  Y V L  +   +  +TE    G L  Y +  R + + + L      V 
Sbjct: 57  MMKLSHPKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---E 187
           EG+ YL   E C+IHRDL   N  +  N   +K+ D G    V       S  GT    +
Sbjct: 115 EGMAYLE--EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSS-TGTKFPVK 170
Query: 188 YMAPELYE-EDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNK 245
           + +PE++    Y+   D++SFG+ + E+ +  +IPY E  S +++ + ++ G +     +
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYK-PR 228
Query: 246 VKDPEVKAFIEKCIAQ-PRARPSASELLK 273
           +    V   +  C  + P  RP+ S LL+
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLR 257

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 52/104 (50%), Gaps = 19/104 (18%)
Query: 129 VLEGLEYLHTH------EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           +  GL +LH        +P I HRDL   NI +  N GQ  I DLG A +  +S     +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDV 172
Query: 183 -----IGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEM 214
                +GT  YMAPE+ +E       D  + VDI++FGL L E+
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 30  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 83
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 84  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 138
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHRDL  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 139 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEXTAREGAKFPI----KWTAPEAINY 193
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPY 220

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 31  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 84
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 85  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 139
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            IHRDL  +NI ++  +   KI D G A ++    + A      P ++ APE +    +T
Sbjct: 140 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L E+VT   IPY
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPY 221

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  +V+R  D++ G + A  +VRL  F  +         E+     L +  I+  Y
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE---------ELMACAGLTSPRIVPLY 151
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               +     +N   E+   G+L    K+   +       +  Q LEGLEYLH+    I+
Sbjct: 152 GAVREGP--WVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR--IL 207
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII------GTPEYMAPE-LYEED 197
           H D+   N+ ++ +     + D G A  +       S++      GT  +MAPE +    
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSE 223
               VD++S    +L M+    P+++
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHPWTQ 293

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 27  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 80
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 81  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 135
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHRDL  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 136 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEXTAREGAKFPI----KWTAPEAINY 190
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPY 217

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 21/220 (9%)
Query: 12  VDPSGRFGRYS----DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 67
           +DP+    R S      LG+G   +V+  +           +V +       + V     
Sbjct: 3   MDPAWEIPRESIKLVKKLGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLE 56
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKW 125
           E  L++TL++  ++  Y+V   ++   +  ITE    G+L  + K      V +  L  +
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEE--PIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDF 114
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIG 184
           S Q+ EG+ Y+       IHRDL  +N+ ++ ++   KI D G A ++    + A     
Sbjct: 115 SAQIAEGMAYIERKN--YIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAK 171
Query: 185 TP-EYMAPELYEED-YTEMVDIYSFGLCLLEMVTM-EIPY 221
            P ++ APE      +T   +++SFG+ L E+VT  +IPY
Sbjct: 172 FPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 21  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 74
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 75  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHRDL  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 130 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEXTAREGAKFPI----KWTAPEAINY 184
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 27  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 80
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 81  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 135
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            IHRDL  +NI ++  +   KI D G A ++    + A      P ++ APE +    +T
Sbjct: 136 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L E+VT   IPY
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPY 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  +  + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 520
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++ N   VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 521 NVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 579
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 580 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 637
Query: 267 SASEL 271
             +EL
Sbjct: 638 RFTEL 642

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 72  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 244
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 72  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 244
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 26  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 79
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 80  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 134
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            IHRDL  +NI ++  +   KI D G A ++    + A      P ++ APE +    +T
Sbjct: 135 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L E+VT   IPY
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIPY 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 95/198 (47%), Gaps = 8/198 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G    VY A +++    +A   +  S   ++ V  ++L  E+++   L++  I+  Y
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMY 81
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + + D +   +  + E    G L    +KH     +    + +++ + L Y   HE  +I
Sbjct: 82  NYFHDRK--RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY--CHERKVI 137
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVD 203
           HRD+   N+ + G  G++KI D G+ ++   S     + GT +Y+ PE+ E + + E VD
Sbjct: 138 HRDIKPENLLM-GYKGELKIADFGW-SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVD 195
Query: 204 IYSFGLCLLEMVTMEIPY 221
           ++  G+   E +    P+
Sbjct: 196 LWCAGVLCYEFLVGMPPF 213

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 72  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 244
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 72  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 244
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 72  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 244
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 25/270 (9%)
Query: 12  VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           +DPS     +   +GSG    V+  +   +  +VA   +R    SE+  +      E ++
Sbjct: 4   IDPSEL--TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFI-----EEAEV 55
Query: 72  LRTLKNKYIIVCYSVWLDDQHNTL--NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
           +  L +  ++  Y V L+     L   F+   C S  LRT R      + + L      V
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDV 112
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--- 186
            EG+ YL   E C+IHRDL   N  +  N   +K+ D G    V       S  GT    
Sbjct: 113 CEGMAYLE--EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSS-TGTKFPV 168
Query: 187 EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALN 244
           ++ +PE++    Y+   D++SFG+ + E+ +  +IPY E  S +++ + ++ G +     
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYK-P 226
Query: 245 KVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
           ++    V   +  C  + P  RP+ S LL+
Sbjct: 227 RLASTHVYQIMNHCWKERPEDRPAFSRLLR 256

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 23  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 76
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 77  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 131
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHRDL  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 132 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEXTAREGAKFPI----KWTAPEAINY 186
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPY 213

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 25/270 (9%)
Query: 12  VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           +DPS     +   +GSG    V+  +   +  +VA   +R    SE+  +      E ++
Sbjct: 2   IDPSEL--TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFI-----EEAEV 53
Query: 72  LRTLKNKYIIVCYSVWLDDQHNTL--NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQV 129
           +  L +  ++  Y V L+     L   F+   C S  LRT R      + + L      V
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDV 110
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--- 186
            EG+ YL   E C+IHRDL   N  +  N   +K+ D G    V       S  GT    
Sbjct: 111 CEGMAYLE--EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSS-TGTKFPV 166
Query: 187 EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALN 244
           ++ +PE++    Y+   D++SFG+ + E+ +  +IPY E  S +++ + ++ G +     
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYK-P 224
Query: 245 KVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
           ++    V   +  C  + P  RP+ S LL+
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R+L++  I+    V L   H  L  + E  + G L          S    + + +Q++ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           + Y H  + C  HRDL   N  ++G+   ++KI D G++          S +GTP Y+AP
Sbjct: 128 VSYCHAMQVC--HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 185
Query: 192 E-LYEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD- 248
           E L +++Y  ++ D++S G+ L  M+    P+ + +      K +   +  Q    + D 
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY--AIPDY 243
Query: 249 ----PEVKAFIEKC-IAQPRARPSASELLKDPFF 277
               PE +  I +  +A P  R S  E+    +F
Sbjct: 244 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 21  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 74
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 75  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            IHRDL  +NI ++  +   KI D G A ++    + A      P ++ APE +    +T
Sbjct: 130 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L E+VT   IPY
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 95/198 (47%), Gaps = 8/198 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G    VY A +++    +A   +  S   ++ V  ++L  E+++   L++  I+  Y
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMY 80
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
           + + D +   +  + E    G L    +KH     +    + +++ + L Y   HE  +I
Sbjct: 81  NYFHDRK--RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY--CHERKVI 136
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVD 203
           HRD+   N+ + G  G++KI D G+ ++   S     + GT +Y+ PE+ E + + E VD
Sbjct: 137 HRDIKPENLLM-GYKGELKIADFGW-SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 204 IYSFGLCLLEMVTMEIPY 221
           ++  G+   E +    P+
Sbjct: 195 LWCAGVLCYEFLVGMPPF 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 21  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 74
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 75  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHRDL  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 130 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEXTAREGAKFPI----KWTAPEAINY 184
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R+L++  I+    V L   H  L  + E  + G L          S    + + +Q++ G
Sbjct: 69  RSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 126
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           + Y H  + C  HRDL   N  ++G+   ++KI D G++          S +GTP Y+AP
Sbjct: 127 VSYCHAMQVC--HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 184
Query: 192 E-LYEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD- 248
           E L +++Y  ++ D++S G+ L  M+    P+ + +      K +   +  Q    + D 
Sbjct: 185 EVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY--AIPDY 242
Query: 249 ----PEVKAFIEKC-IAQPRARPSASELLKDPFF 277
               PE +  I +  +A P  R S  E+    +F
Sbjct: 243 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 71
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 72  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 127
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 244
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 22  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 75
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 76  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 130
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHRDL  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 131 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEXTAREGAKFPI----KWTAPEAINY 185
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 115/257 (44%), Gaps = 23/257 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG    V+  +   +  +VA   +R    SE+  +      E +++  L +  ++  Y
Sbjct: 18  IGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFI-----EEAEVMMKLSHPKLVQLY 71
Query: 85  SVWLDDQHNTL--NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V L+     L   F+   C S  LRT R      + + L      V EG+ YL   E C
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLE--EAC 126
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPELYE-EDY 198
           +IHRDL   N  +  N   +K+ D G    V       S  GT    ++ +PE++    Y
Sbjct: 127 VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRY 184
Query: 199 TEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           +   D++SFG+ + E+ +  +IPY E  S +++ + ++ G +     ++    V   +  
Sbjct: 185 SSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYK-PRLASTHVYQIMNH 242
Query: 258 CIAQ-PRARPSASELLK 273
           C  + P  RP+ S LL+
Sbjct: 243 CWRERPEDRPAFSRLLR 259

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 16  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 69
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 70  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 124
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            IHRDL  +NI ++  +   KI D G A ++    + A      P ++ APE +    +T
Sbjct: 125 YIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L E+VT   IPY
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIPY 206

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 109/227 (48%), Gaps = 27/227 (11%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           + ++LGSGA  +V+    +  G   A   ++ S    D  L N    E+ +L+ +K++ I
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN----EIAVLKKIKHENI 68
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNL-------RTYRKKHRHVSIKALKKWSKQVLEGL 133
           +    ++    H  L  + ++ + G L         Y +K   + I+       QVL  +
Sbjct: 69  VTLEDIYESTTHYYL--VMQLVSGGELFDRILERGVYTEKDASLVIQ-------QVLSAV 119
Query: 134 EYLHTHEPCIIHRDLNCSNI--FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           +YLH  E  I+HRDL   N+         ++ I D G + +  ++    +  GTP Y+AP
Sbjct: 120 KYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMSTACGTPGYVAP 176
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           E L ++ Y++ VD +S G+    ++    P+ E ++ +K+++K+  G
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEG 222

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 71  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 126
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 127 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 243
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 244 ILVENPSARITIPDIKKDRWYNK 266

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
           LLR  ++  II    V+ D ++  +  +TE+   G L     + +  S +        + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKY--VYVVTELXKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP- 186
           + +EYLH     ++HRDL  SNI     +GN   ++I D GFA    +  A + ++ TP 
Sbjct: 127 KTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAK---QLRAENGLLXTPC 181
Query: 187 ---EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSEC--DSVAKIYKKVTGG--- 237
               ++APE+ E + Y    DI+S G+ L   +T   P++    D+  +I  ++  G   
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFS 241
Query: 238 VKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
           +     N V D   K  + K +   P  R +A+ +L+ P+ 
Sbjct: 242 LSGGYWNSVSD-TAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R+L++  I+    V L   H  L  + E  + G L          S    + + +Q++ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           + Y H  +  + HRDL   N  ++G+   ++KI D G++          S +GTP Y+AP
Sbjct: 128 VSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAP 185
Query: 192 E-LYEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD- 248
           E L +++Y  ++ D++S G+ L  M+    P+ + +      K +   +  Q    + D 
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY--AIPDY 243
Query: 249 ----PEVKAFIEKC-IAQPRARPSASELLKDPFF 277
               PE +  I +  +A P  R S  E+    +F
Sbjct: 244 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 49/301 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLH 66
           DP   F R        LG G   KV +A          +  V +    E+  P  +  L 
Sbjct: 15  DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--------- 117
           SE  +L+ + + ++I  Y      Q   L  I E    G+LR + ++ R V         
Sbjct: 75  SEFNVLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 118 ---------------SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 162
                          ++  L  ++ Q+ +G++YL   E  ++HRDL   NI +     ++
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMSLVHRDLAARNILV-AEGRKM 189
Query: 163 KIGDLGFA-------AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEM 214
           KI D G +       + V RS     +    ++MA E L++  YT   D++SFG+ L E+
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 215 VTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT+   PY       +++  +  G + +  +   +   +  ++    +P  RP  +++ K
Sbjct: 246 VTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 274 D 274
           D
Sbjct: 305 D 305

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 18/263 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA  +V  A ++     VA   V +    + P     +  E+ + + L ++ ++  Y
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVKFY 69
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 + N      E C+ G L    +    +     +++  Q++ G+ YLH     I 
Sbjct: 70  G--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GIT 125
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYT 199
           HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL +  E + 
Sbjct: 126 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEK 257
           E VD++S G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHK 242
Query: 258 CIAQ-PRARPSASELLKDPFFSE 279
            + + P AR +  ++ KD ++++
Sbjct: 243 ILVENPSARITIPDIKKDRWYNK 265

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 110/249 (44%), Gaps = 27/249 (10%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           SD+LG GA   V+R   ++ G   A        F   PV V     E ++L+ L +K I+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQM--REFEVLKKLNHKNIV 70
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS---KQVLEGLEYLHT 138
             +++  +        I E C  G+L T  ++  +       ++    + V+ G+   H 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN--HL 128
Query: 139 HEPCIIHRDLNCSNIF-INGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE 195
            E  I+HR++   NI  + G  GQ   K+ D G A  +       S+ GT EY+ P++YE
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 196 ---------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK----IYKKVTGGVKPQ- 241
                    + Y   VD++S G+      T  +P+   +   +    +YK +TG  KP  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--KPSG 246
Query: 242 ALNKVKDPE 250
           A++ V+  E
Sbjct: 247 AISGVQKAE 255

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 437 GIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 491
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 492 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 544
Query: 194 YEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
               ++   D++SFG+ + E  +  + PY
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYI 80
           S+LLG GA  KV  A   + G E A   +            +R+  EV+ L   + NK I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSR----SRVFREVETLYQCQGNKNI 73
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +     + DD    L F  E    G++  + +K +H + +   +  + V   L++LHT  
Sbjct: 74  LELIEFFEDDTRFYLVF--EKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 141 PCIIHRDLNCSNIFING--NIGQVKIGDLGFAAIVGRSHAAHSII--------GTPEYMA 190
             I HRDL   NI       +  VKI D    + +  +++   I         G+ EYMA
Sbjct: 132 --IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 191 PELYE------EDYTEMVDIYSFGLCLLEMVTMEIPY 221
           PE+ E        Y +  D++S G+ L  M++   P+
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 438 GIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 492
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 493 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 545
Query: 194 YEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
               ++   D++SFG+ + E  +  + PY
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 13/188 (6%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   VYR   +++G +  +    L    +  ++     +E+ +L  L +  II   
Sbjct: 61  LGRGATSIVYRC--KQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLSHPNIIKLK 114
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            ++  +    ++ + E+ T G L     +  + S +      KQ+LE + YLH  E  I+
Sbjct: 115 EIF--ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH--ENGIV 170
Query: 145 HRDLNCSNIFINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEM 201
           HRDL   N+          +KI D G + IV       ++ GTP Y APE+     Y   
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 202 VDIYSFGL 209
           VD++S G+
Sbjct: 231 VDMWSVGI 238

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 20  RYSDLLGSGAVKKVYRA-FDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
           R  + LG G+   V R  +D   G  + VA   ++    S+ P  ++    EV  + +L 
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLD 79
Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEY 135
           ++ +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ Y
Sbjct: 80  HRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMA 190
           L +     IHRDL   N+ +      VKIGD G    + ++   H ++         + A
Sbjct: 137 LESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQND-DHXVMQEHRKVPFAWCA 192
Query: 191 PE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           PE L    ++   D + FG+ L EM T
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 81/166 (48%), Gaps = 17/166 (10%)
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI-GQVKIGDLGFA-AIVGRSHAAHS 181
           K++  +  G+ +LHT EP I    LN  ++ I+ ++  ++ + D+ F+    GR +A   
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA--- 171
Query: 182 IIGTPEYMAPELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
               P ++APE      E+      D++SF + L E+VT E+P+++  ++    K    G
Sbjct: 172 ----PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227
Query: 238 VKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELND 282
           ++P     +  P V   ++ C+ + P  RP    ++  P   ++ D
Sbjct: 228 LRPTIPPGI-SPHVSKLMKICMNEDPAKRPKFDMIV--PILEKMQD 270

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 20/139 (14%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------EPCIIHRDL 148
           L  IT+   +G+L  Y K    +  K++ K +   + GL +LHT       +P I HRDL
Sbjct: 110 LYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 149 NCSNIFINGNIGQVKIGDLGFAA-IVGRSHAA----HSIIGTPEYMAPELYEEDYTE--- 200
              NI +  N G   I DLG A   +  ++      ++ +GT  YM PE+ +E       
Sbjct: 169 KSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 201 ----MVDIYSFGLCLLEMV 215
               M D+YSFGL L E+ 
Sbjct: 228 QSYIMADMYSFGLILWEVA 246

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI---VGRSHAAH 180
           K ++    G+ +LH +    IHRD+  +NI ++      KI D G A       ++    
Sbjct: 137 KIAQGAANGINFLHENHH--IHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMXS 193
Query: 181 SIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVT 216
            I+GT  YMAPE    + T   DIYSFG+ LLE++T
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI---VGRSHAAH 180
           K ++    G+ +LH +    IHRD+  +NI ++      KI D G A       ++    
Sbjct: 137 KIAQGAANGINFLHENHH--IHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMXX 193
Query: 181 SIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVT 216
            I+GT  YMAPE    + T   DIYSFG+ LLE++T
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  +V+R  D++ G + A  +VRL  F  +         E+     L +  I+  Y
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVPLY 130
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 +   +N   E+   G+L    K+   +       +  Q LEGLEYLHT    I+
Sbjct: 131 GA--VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 186
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII------GTPEYMAPELYEEDY 198
           H D+   N+ ++ +  +  + D G A  +       S++      GT  +MAPE+     
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 199 TEM-VDIYSFGLCLLEMVTMEIPYSE 223
            +  VDI+S    +L M+    P+++
Sbjct: 247 CDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 20  RYSDLLGSGAVKKVYRA-FDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
           R  + LG G+   V R  +D   G  + VA   ++    S+ P  ++    EV  + +L 
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLD 79
Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEY 135
           ++ +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ Y
Sbjct: 80  HRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTP-EYMAP 191
           L +     IHRDL   N+ +      VKIGD G    + ++   +        P  + AP
Sbjct: 137 LESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVT 216
           E L    ++   D + FG+ L EM T
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 20  RYSDLLGSGAVKKVYRA-FDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
           R  + LG G+   V R  +D   G  + VA   ++    S+ P  ++    EV  + +L 
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLD 69
Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEY 135
           ++ +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ Y
Sbjct: 70  HRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMA 190
           L +     IHRDL   N+ +      VKIGD G    + ++   H ++         + A
Sbjct: 127 LESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQND-DHXVMQEHRKVPFAWCA 182
Query: 191 PE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           PE L    ++   D + FG+ L EM T
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 49/301 (16%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLH 66
           DP   F R        LG G   KV +A          +  V +    E+  P  +  L 
Sbjct: 15  DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--------- 117
           SE  +L+ + + ++I  Y      Q   L  I E    G+LR + ++ R V         
Sbjct: 75  SEFNVLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 118 ---------------SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 162
                          ++  L  ++ Q+ +G++YL   E  ++HRDL   NI +     ++
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILV-AEGRKM 189
Query: 163 KIGDLGFA-------AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEM 214
           KI D G +       + V RS     +    ++MA E L++  YT   D++SFG+ L E+
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 215 VTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT+   PY       +++  +  G + +  +   +   +  ++    +P  RP  +++ K
Sbjct: 246 VTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 274 D 274
           D
Sbjct: 305 D 305

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 85/174 (48%), Gaps = 14/174 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E  ++    + +++  +  + DD++  L  + E    G+L      +  V  K  K ++ 
Sbjct: 125 ERDIMAFANSPWVVQLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTA 181
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGT 185
           +V+  L+ +H+    +IHRD+   N+ ++ + G +K+ D G    +  +   H  + +GT
Sbjct: 182 EVVLALDAIHSM--GLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVHCDTAVGT 238
Query: 186 PEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           P+Y++PE+ +       Y    D +S G+ L EM+  + P+   DS+   Y K+
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKI 291

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 90  DQHNTLNFITEVCTSGNLRTYRKKHRHVS-IKALKKWSKQVLE-------GLEYLHTHEP 141
           D+ N +  I +   +GNL    K+H + S +  +    +Q LE       GL YLHT   
Sbjct: 105 DERNEMILIYKYMENGNL----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-- 158
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPELY-EED 197
            IIHRD+   NI ++ N    KI D G +     +G++H    + GT  Y+ PE + +  
Sbjct: 159 AIIHRDVKSINILLDENFVP-KITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGR 217
Query: 198 YTEMVDIYSFGLCLLEM------VTMEIPYSECDSVAKIYKKVTGG-----VKPQALNKV 246
            TE  D+YSFG+ L E+      +   +P    +      +    G     V P   +K+
Sbjct: 218 LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277
Query: 247 KDPEVKAFIE---KCIA-QPRARPSASELL 272
           +   ++ F +   KC+A     RPS  ++L
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 20  RYSDLLGSGAVKKVYRA-FDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
           R  + LG G+   V R  +D   G  + VA   ++    S+ P  ++    EV  + +L 
Sbjct: 15  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLD 73
Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEY 135
           ++ +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ Y
Sbjct: 74  HRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 130
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTP-EYMAP 191
           L +     IHRDL   N+ +      VKIGD G    + ++   +        P  + AP
Sbjct: 131 LESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVT 216
           E L    ++   D + FG+ L EM T
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 41/297 (13%)
Query: 13  DPSGRFGR----YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLH 66
           DP   F R        LG G   KV +A          +  V +    E+  P  +  L 
Sbjct: 15  DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--------- 117
           SE  +L+ + + ++I  Y      Q   L  I E    G+LR + ++ R V         
Sbjct: 75  SEFNVLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 118 ---------------SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV 162
                          ++  L  ++ Q+ +G++YL   E  ++HRDL   NI +     ++
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILV-AEGRKM 189
Query: 163 KIGDLGFAAIVGR--SHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM- 217
           KI D G +  V    S+   S    P ++MA E L++  YT   D++SFG+ L E+VT+ 
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 218 EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLKD 274
             PY       +++  +  G + +  +   +   +  ++    +P  RP  +++ KD
Sbjct: 250 GNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  +  + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 83  NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 140
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++     VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 141 NVLVSAT-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 199
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 200 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 257
Query: 267 SASEL 271
             +EL
Sbjct: 258 RFTEL 262

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 20  RYSDLLGSGAVKKVYRA-FDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
           R  + LG G+   V R  +D   G  + VA   ++    S+ P  ++    EV  + +L 
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLD 69
Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEY 135
           ++ +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ Y
Sbjct: 70  HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTP-EYMAP 191
           L +     IHRDL   N+ +      VKIGD G    + ++   +        P  + AP
Sbjct: 127 LESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVT 216
           E L    ++   D + FG+ L EM T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 109/249 (43%), Gaps = 27/249 (10%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           SD+LG GA   V+R   ++ G   A        F   PV V     E ++L+ L +K I+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQM--REFEVLKKLNHKNIV 70
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS---KQVLEGLEYLHT 138
             +++  +        I E C  G+L T  ++  +       ++    + V+ G+   H 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN--HL 128
Query: 139 HEPCIIHRDLNCSNIF-INGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE 195
            E  I+HR++   NI  + G  GQ   K+ D G A  +        + GT EY+ P++YE
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYE 188
Query: 196 ---------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK----IYKKVTGGVKPQ- 241
                    + Y   VD++S G+      T  +P+   +   +    +YK +TG  KP  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--KPSG 246
Query: 242 ALNKVKDPE 250
           A++ V+  E
Sbjct: 247 AISGVQKAE 255

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 17/235 (7%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           + G G    V    ++  G+ VA  +V      +DP   NR    +Q L  L +  I+  
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 84  YSVWL-----DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA---LKKWSKQVLEGLEY 135
            S +      D +   LN + E       R  R  +R         +K +  Q++  +  
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY- 194
           LH     + HRD+   N+ +N   G +K+ D G A  +  S    + I +  Y APEL  
Sbjct: 145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF 204
Query: 195 -EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNKV 246
             + YT  VDI+S G    EM+  E  +   +S  ++++  +V G    + L K+
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 95  GI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 149
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 150 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 202
Query: 194 YEEDYTEMVDIYSFGLCLLEMVT 216
               ++   D++SFG+ + E  +
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 95  GI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 149
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 150 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 202
Query: 194 YEEDYTEMVDIYSFGLCLLEMVT 216
               ++   D++SFG+ + E  +
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 93  GI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 147
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 148 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 200
Query: 194 YEEDYTEMVDIYSFGLCLLEMVT 216
               ++   D++SFG+ + E  +
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN 152
           N      E C+ G L    +    +     +++  Q++ G+ YLH     I HRD+   N
Sbjct: 78  NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPEN 135
Query: 153 IFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSF 207
           + ++     +KI D G A +     R    + + GT  Y+APEL +  E + E VD++S 
Sbjct: 136 LLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 208 GLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK--DPEVKAFIEKCIAQ-PRA 264
           G+ L  M+  E+P+ +     + Y       K   LN  K  D    A + K + + P A
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHKILVENPSA 252
Query: 265 RPSASELLKDPFFSE 279
           R +  ++ KD ++++
Sbjct: 253 RITIPDIKKDRWYNK 267

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 79  GI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 133
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 134 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENXYKAQTHGKWPV----KWYAPECI 186
Query: 194 YEEDYTEMVDIYSFGLCLLE 213
               ++   D++SFG+ + E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWE 206

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 21/212 (9%)
Query: 87  WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHR 146
           W + Q   +  +     + +L  Y  +   +     + +  QV+  ++  H H   ++HR
Sbjct: 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ--HCHSRGVVHR 163
Query: 147 DLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM-VDI 204
           D+   NI I+   G  K+ D G  A++          GT  Y  PE +    Y  +   +
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATV 222
Query: 205 YSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPR 263
           +S G+ L +MV  +IP+     + +        V          P+  A I +C+A +P 
Sbjct: 223 WSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS---------PDCCALIRRCLAPKPS 273
Query: 264 ARPSASELLKDPFFS------ELNDDDSEPSP 289
           +RPS  E+L DP+         LN     P+P
Sbjct: 274 SRPSLEEILLDPWMQTPAEDVPLNPSKGGPAP 305

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 20  RYSDLLGSGAVKKVYRA-FDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
           R  + LG G+   V R  +D   G  + VA   ++    S+ P  ++    EV  + +L 
Sbjct: 15  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLD 73
Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEY 135
           ++ +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ Y
Sbjct: 74  HRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 130
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTP-EYMAP 191
           L +     IHRDL   N+ +      VKIGD G    + ++   +        P  + AP
Sbjct: 131 LESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVT 216
           E L    ++   D + FG+ L EM T
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 132/302 (43%), Gaps = 50/302 (16%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRL------SHFSEDPVLVNRLHSEVQLLR 73
           ++   LG+GA  KV  A     G E A  +V +      +H  E   L+    SE++++ 
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM----SELKIMS 89
Query: 74  TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH------------------- 114
            L     IV   +        +  ITE C  G+L  + ++                    
Sbjct: 90  HLGQHENIVNL-LGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLD 148
Query: 115 ----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGF 169
               R + ++ L  +S QV +G+ +L +     IHRD+   N+ + NG++   KIGD G 
Sbjct: 149 KEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVA--KIGDFGL 204
Query: 170 AAIVGRSHAAHSIIGTP----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSE 223
           A  +  + + + + G      ++MAPE +++  YT   D++S+G+ L E+ ++ + PY  
Sbjct: 205 ARDI-MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 263
Query: 224 CDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND 282
               +K YK V  G +  A        + + ++ C A +P  RP+  ++    F  E   
Sbjct: 264 ILVNSKFYKLVKDGYQ-MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQ 320
Query: 283 DD 284
           +D
Sbjct: 321 ED 322

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 20  RYSDLLGSGAVKKVYRA-FDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
           R  + LG G+   V R  +D   G  + VA   ++    S+ P  ++    EV  + +L 
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLD 69
Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEY 135
           ++ +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ Y
Sbjct: 70  HRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTP-EYMAP 191
           L +     IHRDL   N+ +      VKIGD G    + ++   +        P  + AP
Sbjct: 127 LESKR--FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVT 216
           E L    ++   D + FG+ L EM T
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  +V+R  D++ G + A  +VRL  F  +         E+     L +  I+  Y
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE---------ELMACAGLTSPRIVPLY 132
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               +     +N   E+   G+L    K+   +       +  Q LEGLEYLH+    I+
Sbjct: 133 GAVREGP--WVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR--IL 188
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII------GTPEYMAPE-LYEED 197
           H D+   N+ ++ +     + D G A  +        ++      GT  +MAPE +    
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSE 223
               VD++S    +L M+    P+++
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHPWTQ 274

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 11/185 (5%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N +  I E+CT G LR++ +  +  + + +L  ++ Q+   L YL +     +HRD+   
Sbjct: 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAAR 520
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP--EYMAPE-LYEEDYTEMVDIYSFG 208
           N+ ++     VK+GD G +  +  S    +  G    ++MAPE +    +T   D++ FG
Sbjct: 521 NVLVSAT-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 579
Query: 209 LCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARP 266
           +C+ E++   + P+    +   I +   G   P   N    P + + + KC A  P  RP
Sbjct: 580 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRP 637
Query: 267 SASEL 271
             +EL
Sbjct: 638 RFTEL 642

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 79  GI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 133
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 134 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 186
Query: 194 YEEDYTEMVDIYSFGLCLLEMVT 216
               ++   D++SFG+ + E  +
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 9/212 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G    VY A +++    +A  +V      E   + ++L  EV++   L++  I+  Y
Sbjct: 20  LGKGKFGNVYLARERQSKFILAL-KVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             + D     +  I E    G +    +K      +    +  ++   L Y H+    +I
Sbjct: 79  GYFHDA--TRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VI 134
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVD 203
           HRD+   N+ +  N G++KI D G+ ++   S    ++ GT +Y+ PE+ E   + E VD
Sbjct: 135 HRDIKPENLLLGSN-GELKIADFGW-SVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVD 192
Query: 204 IYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 235
           ++S G+   E +    P+ E  +  + Y++++
Sbjct: 193 LWSLGVLCYEFLVGMPPF-EAHTYQETYRRIS 223

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI---VGRSHAAH 180
           K ++    G+ +LH +    IHRD+  +NI ++      KI D G A       +     
Sbjct: 131 KIAQGAANGINFLHENHH--IHRDIKSANILLDEAF-TAKISDFGLARASEKFAQXVMXX 187
Query: 181 SIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVT 216
            I+GT  YMAPE    + T   DIYSFG+ LLE++T
Sbjct: 188 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 223

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 9/212 (4%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G    VY A +++    +A  +V      E   + ++L  EV++   L++  I+  Y
Sbjct: 20  LGKGKFGNVYLARERQSKFILAL-KVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             + D     +  I E    G +    +K      +    +  ++   L Y H+    +I
Sbjct: 79  GYFHDA--TRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VI 134
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVD 203
           HRD+   N+ +  N G++KI D G++     S    ++ GT +Y+ PE+ E   + E VD
Sbjct: 135 HRDIKPENLLLGSN-GELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMIEGRMHDEKVD 192
Query: 204 IYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 235
           ++S G+   E +    P+ E  +  + Y++++
Sbjct: 193 LWSLGVLCYEFLVGMPPF-EAHTYQETYRRIS 223

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT--------HEPCIIHR 146
           L  IT     G+L  + K +  VS   L   ++ +  GL YLH         H+P I HR
Sbjct: 97  LWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155
Query: 147 DLNCSNIFINGNIGQVKIGDLGFAAI--VGRSHA-AHSIIGTPEYMAPEL------YEED 197
           D+   N+ +  N+    I D G A     G+S    H  +GT  YMAPE+      ++ D
Sbjct: 156 DIKSKNVLLKNNLTAC-IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD 214
Query: 198 YTEMVDIYSFGLCLLEMVT 216
               +D+Y+ GL L E+ +
Sbjct: 215 AFLRIDMYAMGLVLWELAS 233

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 85  GI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 139
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 140 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 192
Query: 194 YEEDYTEMVDIYSFGLCLLE 213
               ++   D++SFG+ + E
Sbjct: 193 NYYKFSSKSDVWSFGVLMWE 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 17  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 70
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHEPC 142
           +V        +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++   E  
Sbjct: 71  AV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 125
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAAHSIIGTPEYMAPE-LYE 195
            IHR+L  +NI ++  +   KI D G A ++       R  A   I    ++ APE +  
Sbjct: 126 YIHRNLRAANILVSDTLS-CKIADFGLARLIEDNEYTAREGAKFPI----KWTAPEAINY 180
Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             +T   D++SFG+ L E+VT   IPY
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPY 207

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 83/189 (43%), Gaps = 33/189 (17%)
Query: 39  QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 98
           Q++ +E    + R+    + P  + +LHS  Q +                    + L F+
Sbjct: 59  QDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTV--------------------DRLYFV 98
Query: 99  TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 158
            E    G+L  + ++           ++ ++  GL +LH     II+RDL   N+ ++  
Sbjct: 99  MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR--GIIYRDLKLDNVMLDSE 156
Query: 159 IGQVKIGDLGFAAIVGRSHAAHSII-----GTPEYMAPELYE-EDYTEMVDIYSFGLCLL 212
            G +KI D G      + H    +      GTP+Y+APE+   + Y + VD +++G+ L 
Sbjct: 157 -GHIKIADFGMC----KEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLY 211
Query: 213 EMVTMEIPY 221
           EM+  + P+
Sbjct: 212 EMLAGQPPF 220

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK--KHRHVSIKALKKW 125
           E Q+++ LK+  ++  Y+V        +  +TE    G+L  + K  + R + +  L   
Sbjct: 54  EAQIMKKLKHDKLVQLYAV---VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM 110
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAA 179
           + QV  G+ Y+       IHRDL  +NI + GN    KI D G A ++       R  A 
Sbjct: 111 AAQVAAGMAYIERMN--YIHRDLRSANILV-GNGLICKIADFGLARLIEDNEXTARQGAK 167
Query: 180 HSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             I    ++ APE  LY   +T   D++SFG+ L E+VT   +PY
Sbjct: 168 FPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPY 207

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
            +L+G G   +VY    +  G EVA   + +   +ED +       EV   R  +++ ++
Sbjct: 38  GELIGKGRFGQVYHG--RWHG-EVAIRLIDIERDNEDQL--KAFKREVMAYRQTRHENVV 92
Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHE 140
           +     +   H  L  IT +C    L +  +  + V  +   ++ ++++++G+ YLH   
Sbjct: 93  LFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK- 149
Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS------IIGTPEYMAPELY 194
             I+H+DL   N+F +   G+V I D G  +I G   A           G   ++APE+ 
Sbjct: 150 -GILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 195 -------EED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 244
                  EED   +++  D+++ G    E+   E P+    + A I++  T G+KP    
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT-GMKPNLSQ 265
Query: 245 KVKDPEVKAFIEKCIA-QPRARPSASELL 272
                E+   +  C A +   RP+ ++L+
Sbjct: 266 IGMGKEISDILLFCWAFEQEERPTFTKLM 294

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+ A   +        +V +       + V    +E  +++TL++  ++  +
Sbjct: 23  LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 76
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
           +V   +    +  ITE    G+L  + K        +  L  +S Q+ EG+ ++      
Sbjct: 77  AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 131
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPELYE-EDYT 199
            IHRDL  +NI ++ ++   KI D G A ++    + A      P ++ APE      +T
Sbjct: 132 YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L+E+VT   IPY
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPY 213

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 73  GI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 127
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 128 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 180
Query: 194 YEEDYTEMVDIYSFGLCLLEMVT 216
               ++   D++SFG+ + E  +
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/276 (21%), Positives = 125/276 (45%), Gaps = 25/276 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII-- 81
           +G G   +V++A  ++ G +VA  +V + +  E  P+   R   E+++L+ LK++ ++  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 82
Query: 82  --VCYSVW--LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
             +C +     +    ++  + + C               ++  +K+  + +L GL Y+H
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-----SIIGTPEYMAPE 192
            ++  I+HRD+  +N+ I  + G +K+ D G A     +  +      + + T  Y  PE
Sbjct: 143 RNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 193 LY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKVK 247
           L   E DY   +D++  G  + EM T   P  + ++      +  ++ G + P+    V 
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 248 DPEVKAFIEKCIAQPR-ARPSASELLKDPFFSELND 282
           + E+   +E    Q R  +      ++DP+  +L D
Sbjct: 259 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 294

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 80/185 (43%), Gaps = 25/185 (13%)
Query: 39  QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 98
           Q++ +E    + R+      P  + +LHS  Q +                    + L F+
Sbjct: 60  QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--------------------DRLYFV 99
Query: 99  TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 158
            E    G+L  + ++           ++ ++  GL +L +    II+RDL   N+ ++  
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSE 157
Query: 159 IGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT 216
            G +KI D G     +          GTP+Y+APE+   + Y + VD ++FG+ L EM+ 
Sbjct: 158 -GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
Query: 217 MEIPY 221
            + P+
Sbjct: 217 GQAPF 221

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V + + Q + +        L + + DP L + L +E  +++ L N YI+   
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL   E   +
Sbjct: 75  GI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 129
Query: 145 HRDLNCSNIFINGNIGQ--VKIGDLGFAAIV--------GRSHAAHSIIGTPEYMAPE-L 193
           HRDL   N+ +   + Q   KI D G +  +         ++H    +    ++ APE +
Sbjct: 130 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPV----KWYAPECI 182
Query: 194 YEEDYTEMVDIYSFGLCLLE 213
               ++   D++SFG+ + E
Sbjct: 183 NYYKFSSKSDVWSFGVLMWE 202

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+ A   +        +V +       + V    +E  +++TL++  ++  +
Sbjct: 196 LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS--IKALKKWSKQVLEGLEYLHTHEPC 142
           +V   +    +  ITE    G+L  + K        +  L  +S Q+ EG+ ++      
Sbjct: 250 AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPELYE-EDYT 199
            IHRDL  +NI ++ ++   KI D G A ++    + A      P ++ APE      +T
Sbjct: 305 YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L+E+VT   IPY
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPY 386

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 124/287 (43%), Gaps = 46/287 (16%)
Query: 21  YSDLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNR--LHSEVQLLRTL 75
           +  +LGSGA  KV  A      + G+ +   QV +    E      R  L SE++++  L
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSI---QVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH------------------- 116
            +   IV   +        +  I E C  G+L  Y +  R                    
Sbjct: 106 GSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 117 ----VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAA 171
               ++ + L  ++ QV +G+E+L   + C+ HRDL   N+ + +G +  VKI D G A 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLE-FKSCV-HRDLAARNVLVTHGKV--VKICDFGLAR 220
Query: 172 IVGRSHAAHSIIGTP----EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECD 225
            +  S + + + G      ++MAPE L+E  YT   D++S+G+ L E+ ++ + PY    
Sbjct: 221 DI-MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
             A  YK +  G K        + E+   ++ C A   R RPS   L
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATE-EIYIIMQSCWAFDSRKRPSFPNL 325

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/276 (21%), Positives = 125/276 (45%), Gaps = 25/276 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII-- 81
           +G G   +V++A  ++ G +VA  +V + +  E  P+   R   E+++L+ LK++ ++  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 81
Query: 82  --VCYSVW--LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
             +C +     +    ++  + + C               ++  +K+  + +L GL Y+H
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-----SIIGTPEYMAPE 192
            ++  I+HRD+  +N+ I  + G +K+ D G A     +  +      + + T  Y  PE
Sbjct: 142 RNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 198
Query: 193 LY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKVK 247
           L   E DY   +D++  G  + EM T   P  + ++      +  ++ G + P+    V 
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 248 DPEVKAFIEKCIAQPR-ARPSASELLKDPFFSELND 282
           + E+   +E    Q R  +      ++DP+  +L D
Sbjct: 258 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 293

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 64/142 (45%), Gaps = 26/142 (18%)
Query: 97  FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-------HEPCIIHRDLN 149
            + E   +G+L  Y   H    + + +  +  V  GL YLHT       ++P I HRDLN
Sbjct: 89  LVMEYYPNGSLXKYLSLHTSDWVSSCR-LAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147
Query: 150 CSNIFINGNIGQVKIGDLGFAA-IVG--------RSHAAHSIIGTPEYMAPELYE----- 195
             N+ +  N G   I D G +  + G          +AA S +GT  YMAPE+ E     
Sbjct: 148 SRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL 206
Query: 196 ---EDYTEMVDIYSFGLCLLEM 214
              E   + VD+Y+ GL   E+
Sbjct: 207 RDXESALKQVDMYALGLIYWEI 228

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/276 (21%), Positives = 125/276 (45%), Gaps = 25/276 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII-- 81
           +G G   +V++A  ++ G +VA  +V + +  E  P+   R   E+++L+ LK++ ++  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 82
Query: 82  --VCYSVW--LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
             +C +     +    ++  + + C               ++  +K+  + +L GL Y+H
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-----SIIGTPEYMAPE 192
            ++  I+HRD+  +N+ I  + G +K+ D G A     +  +      + + T  Y  PE
Sbjct: 143 RNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 193 LY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKVK 247
           L   E DY   +D++  G  + EM T   P  + ++      +  ++ G + P+    V 
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 248 DPEVKAFIEKCIAQPR-ARPSASELLKDPFFSELND 282
           + E+   +E    Q R  +      ++DP+  +L D
Sbjct: 259 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 294

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+  +V+R  D++ G + A  +VRL  F  +         E+     L +  I+  Y
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVPLY 132
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 +   +N   E+   G+L    K+   +       +  Q LEGLEYLHT    I+
Sbjct: 133 GA--VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 188
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII------GTPEYMAPELYEEDY 198
           H D+   N+ ++ +  +  + D G A  +       S++      GT  +MAPE+     
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 248
Query: 199 TEM-VDIYSFGLCLLEMVTMEIPYSE 223
            +  VDI+S    +L M+    P+++
Sbjct: 249 CDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 80/185 (43%), Gaps = 25/185 (13%)
Query: 39  QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI 98
           Q++ +E    + R+      P  + +LHS  Q +                    + L F+
Sbjct: 381 QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--------------------DRLYFV 420
Query: 99  TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 158
            E    G+L  + ++           ++ ++  GL +L +    II+RDL   N+ ++  
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE 478
Query: 159 IGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT 216
            G +KI D G     +          GTP+Y+APE+   + Y + VD ++FG+ L EM+ 
Sbjct: 479 -GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537
Query: 217 MEIPY 221
            + P+
Sbjct: 538 GQAPF 542

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+  +V+R  D++ G + A  +VRL  F  +         E+     L +  I+  Y
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVPLY 116
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
                 +   +N   E+   G+L    K+   +       +  Q LEGLEYLHT    I+
Sbjct: 117 GA--VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 172
Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII------GTPEYMAPELYEEDY 198
           H D+   N+ ++ +  +  + D G A  +       S++      GT  +MAPE+     
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 199 TEM-VDIYSFGLCLLEMVTMEIPYSE 223
            +  VDI+S    +L M+    P+++
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/276 (21%), Positives = 125/276 (45%), Gaps = 25/276 (9%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII-- 81
           +G G   +V++A  ++ G +VA  +V + +  E  P+   R   E+++L+ LK++ ++  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 82
Query: 82  --VCYSVW--LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
             +C +     +    ++  + + C               ++  +K+  + +L GL Y+H
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-----SIIGTPEYMAPE 192
            ++  I+HRD+  +N+ I  + G +K+ D G A     +  +      + + T  Y  PE
Sbjct: 143 RNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPE 199
Query: 193 LY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS---VAKIYKKVTGGVKPQALNKVK 247
           L   E DY   +D++  G  + EM T   P  + ++      +  ++ G + P+    V 
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 248 DPEVKAFIEKCIAQPR-ARPSASELLKDPFFSELND 282
           + E+   +E    Q R  +      ++DP+  +L D
Sbjct: 259 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 294

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 13/218 (5%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           + D+LG+GA  +V  A D+     VA   +              + +E+ +L  +K+  I
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE---GSMENEIAVLHKIKHPNI 78
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +    ++    H  L  I ++ + G L     +    + +   +   QVL+ ++YLH  +
Sbjct: 79  VALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--D 134
Query: 141 PCIIHRDLNCSNIFING--NIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 197
             I+HRDL   N+         ++ I D G + +        +  GTP Y+APE L ++ 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKV 234
           Y++ VD +S G+    ++    P Y E D  AK+++++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQI 230

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 15/214 (7%)
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R+L++  I+    V L   H  L  + E  + G L          S    + + +Q++ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           + Y H  + C  HRDL   N  ++G+   ++KI   G++          S +GTP Y+AP
Sbjct: 128 VSYCHAMQVC--HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAP 185
Query: 192 E-LYEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD- 248
           E L +++Y  ++ D++S G+ L  M+    P+ + +      K +   +  Q    + D 
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY--AIPDY 243
Query: 249 ----PEVKAFIEKC-IAQPRARPSASELLKDPFF 277
               PE +  I +  +A P  R S  E+    +F
Sbjct: 244 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           QVLE +   H H   ++HRD+   NI I+ N G++K+ D G  A++ +        GT  
Sbjct: 165 QVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRV 221
Query: 188 YMAPEL--YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 245
           Y  PE   Y   +     ++S G+ L +MV  +IP+   + +          ++ Q   +
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQVFFR 271
Query: 246 VK-DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
            +   E +  I  C+A +P  RP+  E+   P+  ++
Sbjct: 272 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 13/218 (5%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           + D+LG+GA  +V  A D+     VA   +              + +E+ +L  +K+  I
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE---GSMENEIAVLHKIKHPNI 78
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +    ++    H  L  I ++ + G L     +    + +   +   QVL+ ++YLH  +
Sbjct: 79  VALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--D 134
Query: 141 PCIIHRDLNCSNIFING--NIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 197
             I+HRDL   N+         ++ I D G + +        +  GTP Y+APE L ++ 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKV 234
           Y++ VD +S G+    ++    P Y E D  AK+++++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQI 230

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           L+G+G+   V  A+D+ E   VA  ++ L  F ED +   R+  E+ +L  L + +++  
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVF-EDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 84  YSVWLD---DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
             + +    ++ + L  + E+  S   + +R    +++   +K     +L G++Y+H+  
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHS-- 174
Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS------------IIGTPE- 187
             I+HRDL  +N  +N +   VK+ D G A  V      +S            ++  P  
Sbjct: 175 AGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 188 ---------------YMAPEL--YEEDYTEMVDIYSFGLCLLEMVTM 217
                          Y APEL   +E+YTE +D++S G    E++ M
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE  + G+L  + K    +++ +  L  
Sbjct: 53  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 109
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 110 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 166
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 167 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 221
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 222 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 13/218 (5%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           + D+LG+GA  +V  A D+     VA   +              + +E+ +L  +K+  I
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE---GSMENEIAVLHKIKHPNI 78
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +    ++    H  L  I ++ + G L     +    + +   +   QVL+ ++YLH  +
Sbjct: 79  VALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--D 134
Query: 141 PCIIHRDLNCSNIFING--NIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 197
             I+HRDL   N+         ++ I D G + +        +  GTP Y+APE L ++ 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKV 234
           Y++ VD +S G+    ++    P Y E D  AK+++++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQI 230

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE  + G+L  + K    +++ +  L  
Sbjct: 51  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 107
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 108 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 164
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 165 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 219
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 220 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 13/218 (5%)
Query: 21  YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           + D+LG+GA  +V  A D+     VA   +              + +E+ +L  +K+  I
Sbjct: 22  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE---GSMENEIAVLHKIKHPNI 78
Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +    ++    H  L  I ++ + G L     +    + +   +   QVL+ ++YLH  +
Sbjct: 79  VALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--D 134
Query: 141 PCIIHRDLNCSNIFING--NIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEED 197
             I+HRDL   N+         ++ I D G + +        +  GTP Y+APE L ++ 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 198 YTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKV 234
           Y++ VD +S G+    ++    P Y E D  AK+++++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQI 230

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE  + G+L  + K    +++ +  L  
Sbjct: 62  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 175
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 176 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 82/165 (49%), Gaps = 22/165 (13%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 125
           E Q+++ L+++ ++  Y+V  ++    +  +TE  + G+L  + K    +++ +  L   
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHAA 179
           + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A 
Sbjct: 369 AAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAK 425
Query: 180 HSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY
Sbjct: 426 FPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 465

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI---VGRSHAAH 180
           K ++    G+ +LH  E   IHRD+  +NI ++      KI D G A       +     
Sbjct: 128 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQXVXXS 184
Query: 181 SIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVT 216
            I+GT  Y APE    + T   DIYSFG+ LLE++T
Sbjct: 185 RIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIIT 220

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 90  DQHNTLNFITEVCTSGNLRTYRKKHRHVS-IKALKKWSKQVLE-------GLEYLHTHEP 141
           D+ N +  I +   +GNL    K+H + S +  +    +Q LE       GL YLHT   
Sbjct: 105 DERNEMILIYKYMENGNL----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-- 158
Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEYMAPELY-EED 197
            IIHRD+   NI ++ N    KI D G +     + ++H    + GT  Y+ PE + +  
Sbjct: 159 AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGR 217
Query: 198 YTEMVDIYSFGLCLLEM------VTMEIPYSECDSVAKIYKKVTGG-----VKPQALNKV 246
            TE  D+YSFG+ L E+      +   +P    +      +    G     V P   +K+
Sbjct: 218 LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277
Query: 247 KDPEVKAFIE---KCIA-QPRARPSASELL 272
           +   ++ F +   KC+A     RPS  ++L
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE  + G+L  + K    +++ +  L  
Sbjct: 62  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLAAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 175
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 176 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+ A   +        +V +       + V    +E  +++TL++  ++  +
Sbjct: 190 LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 243
Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVS--IKALKKWSKQVLEGLEYLHTHEPC 142
           +V   +    +  ITE    G+L  + K        +  L  +S Q+ EG+ ++      
Sbjct: 244 AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 298
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEM 201
            IHRDL  +NI ++ ++   KI D G A    R  A   I    ++ APE      +T  
Sbjct: 299 YIHRDLRAANILVSASL-VCKIADFGLA----RVGAKFPI----KWTAPEAINFGSFTIK 349
Query: 202 VDIYSFGLCLLEMVTM-EIPY 221
            D++SFG+ L+E+VT   IPY
Sbjct: 350 SDVWSFGILLMEIVTYGRIPY 370

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE  + G+L  + K    +++ +  L  
Sbjct: 52  QEAQVMKKLRHEKLVQLYAV---VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 108
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 109 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEXTARQGA 165
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY
Sbjct: 166 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 206

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 29/260 (11%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG    V+  +   +  +VA   +R    SE+  +      E +++  L +  ++  Y
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFI-----EEAEVMMKLSHPKLVQLY 68
Query: 85  SVWLDDQHNTL--NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V L+     L   F+   C S  LRT R      + + L      V EG+ YL   E  
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLE--EAS 123
Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAPELYE-EDY 198
           +IHRDL   N  +  N   +K+ D G    V       S  GT    ++ +PE++    Y
Sbjct: 124 VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRY 181
Query: 199 TEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAF 254
           +   D++SFG+ + E+ +  +IPY E  S +++ + ++ G    KP    ++    V   
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYKP----RLASTHVYQI 236
Query: 255 IEKCIAQ-PRARPSASELLK 273
           +  C  + P  RP+ S LL+
Sbjct: 237 MNHCWKERPEDRPAFSRLLR 256

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE    G+L  + K    +++ +  L  
Sbjct: 59  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            S Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 116 MSAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEWTARQGA 172
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY
Sbjct: 173 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 103/236 (43%), Gaps = 23/236 (9%)
Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKK 124
              E  +L    +K+I   +  + DD  N L  + +    G+L T   K      + + +
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR 178
Query: 125 -WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-- 181
            +  +++  ++ +H      +HRD+   NI ++ N G +++ D G    +       S  
Sbjct: 179 FYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSV 235
Query: 182 IIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 235
            +GTP+Y++PE+ +        Y    D +S G+C+ EM+  E P+   +S+ + Y K+ 
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 294
Query: 236 GGVK----PQALNKVKDPEVKAFIEKCIAQPRARPSAS---ELLKDPFFSELNDDD 284
              +    P  +  V +   K  I + I     R   +   +  K PFFS ++ D+
Sbjct: 295 NHKERFQFPTQVTDVSE-NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R+L++  I+    V L   H  L  + E  + G L          S    + + +Q++ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGRSHAAHS----IIGTPE 187
           + Y H  + C  HRDL   N  ++G+   ++KI   G++    +S   HS     +GTP 
Sbjct: 128 VSYCHAMQVC--HRDLKLENTLLDGSPAPRLKICAFGYS----KSSVLHSQPKDTVGTPA 181
Query: 188 YMAPE-LYEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 245
           Y+APE L +++Y  ++ D++S G+ L  M+    P+ + +      K +   +  Q    
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY--A 239
Query: 246 VKD-----PEVKAFIEKC-IAQPRARPSASELLKDPFF 277
           + D     PE +  I +  +A P  R S  E+    +F
Sbjct: 240 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE    G+L  + K    +++ +  L  
Sbjct: 59  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            S Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 116 MSAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 172
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY
Sbjct: 173 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           R   +LGSGA   VY+     +G    I VA   +++   +  P     +  E  ++  +
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGV 76
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLE 134
            + Y+     + L    +T+  +T++   G L  + +++R  +  + L  W  Q+ +G+ 
Sbjct: 77  GSPYVSRLLGICL---TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP---EYMAP 191
           YL      ++HRDL   N+ +  +   VKI D G A ++      +   G     ++MA 
Sbjct: 134 YLEDVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK---VK 247
           E +    +T   D++S+G+ + E++T           AK Y  +     P  L K   + 
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFG---------AKPYDGIPAREIPDLLEKGERLP 241
Query: 248 DP-----EVKAFIEKCI-----AQPRARPSASE---LLKDP--FFSELNDDDSEPSP 289
            P     +V   + KC       +PR R   SE   + +DP  F    N+D    SP
Sbjct: 242 QPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASP 298

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSI---KALKKWSKQVLE 131
           ++ +++  +S W +D H  +    E C  G+L     + +R +S      LK    QV  
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFIN------------------GNIGQVKIGDLGFAAIV 173
           GL Y+H+    ++H D+  SNIFI+                   N    KIGDLG    V
Sbjct: 123 GLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH---V 177
Query: 174 GRSHAAHSIIGTPEYMAPELYEEDYTEM--VDIYSFGLCLLEMVTMEIPYSECDSVAKIY 231
            R  +     G   ++A E+ +E+YT +   DI++  L ++     E      D   +I 
Sbjct: 178 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWHEIR 237
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           +     + PQ L++     +K  I      P  RPSA  L+K
Sbjct: 238 QGRLPRI-PQVLSQEFTELLKVMIH---PDPERRPSAMALVK 275

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ ++++ ++  Y+V        +  +TE  + G+L  + K    +++ +  L  
Sbjct: 62  QEAQVMKKIRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 175
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 176 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 73/136 (53%), Gaps = 9/136 (6%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++L  +T+    G+L  + ++HR  +  + L  W  Q+ +G+ YL  H   ++HR+L   
Sbjct: 105 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAAR 162
Query: 152 NIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSF 207
           N+ +  +  QV++ D G A ++        +S   TP ++MA E ++   YT   D++S+
Sbjct: 163 NVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 221
Query: 208 GLCLLEMVTMEI-PYS 222
           G+ + E++T    PY+
Sbjct: 222 GVTVWELMTFGAEPYA 237

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 20/140 (14%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT---------HEPCIIH 145
           L  IT     G+L  Y K +  ++   L   ++ +  GL YLH          H+P I H
Sbjct: 88  LWLITAFHDKGSLTDYLKGNI-ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAH 146
Query: 146 RDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHA-AHSIIGTPEYMAPEL------YEE 196
           RD    N+ +  ++  V + D G A     G+     H  +GT  YMAPE+      ++ 
Sbjct: 147 RDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQR 205
Query: 197 DYTEMVDIYSFGLCLLEMVT 216
           D    +D+Y+ GL L E+V+
Sbjct: 206 DAFLRIDMYAMGLVLWELVS 225

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 176
           ++++ L  +S QV +G+E+L + +   IHRDL   NI ++     VKI D G A  + + 
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKD 251
Query: 177 --HAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIY 231
             +        P ++MAPE +++  YT   D++SFG+ L E+ ++   PY       +  
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           +++  G + +A +       +  ++    +P  RP+ SEL++
Sbjct: 312 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 353

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 107/228 (46%), Gaps = 35/228 (15%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 125
           E Q+++ L+++ ++  Y+V  ++    +  +TE  + G+L  + K    +++ +  L   
Sbjct: 230 EAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 286
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIG 184
           + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G   ++    + A     
Sbjct: 287 AAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLGRLIEDNEYTARQGAK 343
Query: 185 TP-EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAKIYKKV 234
            P ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V + Y+  
Sbjct: 344 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 402
Query: 235 TGGVKPQALNKV------KDPE-------VKAFIEKCI--AQPRARPS 267
                P++L+ +      KDPE       ++AF+E      +P+ +P 
Sbjct: 403 CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE  + G+L  + K    +++ +  L  
Sbjct: 55  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 111
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 112 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 168
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY
Sbjct: 169 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYR-KKHRHVSIKALK 123
           +  E Q++  L N YI+    V    Q   L  + E+   G L  +   K   + +  + 
Sbjct: 57  MMREAQIMHQLDNPYIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 113
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAH 180
           +   QV  G++YL   E   +HRDL   N+ +  N    KI D G +  +G     + A 
Sbjct: 114 ELLHQVSMGMKYLE--EKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTAR 170
Query: 181 SIIGTP-EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
           S    P ++ APE      ++   D++S+G+ + E ++                    G 
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY-------------------GQ 211
Query: 239 KPQALNKVKDPEVKAFIE---KCIAQPRARPSASELLKDPFFSELND 282
           KP    K+K PEV AFIE   +    P   P    L+ D +  +  D
Sbjct: 212 KP--YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWED 256

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 22/274 (8%)
Query: 14  PSGRFGRYSD-LLGSGAVKKVYRAFDQEEGIEVAWNQVR-----LSHFSEDPVLVNRLHS 67
           P  R   +SD ++G G    VY      E I+ A N+++     LS  +E    V     
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHG----EYIDQAQNRIQCAIKSLSRITEMQQ-VEAFLR 71
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E  L+R L +  ++    + L  +      +  +C    L+  R   R+ ++K L  +  
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAA-----HS 181
           QV  G+EYL   E   +HRDL   N  ++ +   VK+ D G A  I+ R + +     H+
Sbjct: 132 QVARGMEYLA--EQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHA 188
Query: 182 IIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIYKKVTGGVKP 240
            +         L    +T   D++SFG+ L E++T    PY   D     +    G   P
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP 248
Query: 241 QALNKVKDPEVKAFIEKCIAQPRARPSASELLKD 274
           Q      D   +   +   A P  RP+   L+ +
Sbjct: 249 QP-EYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 73/136 (53%), Gaps = 9/136 (6%)
Query: 93  NTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           ++L  +T+    G+L  + ++HR  +  + L  W  Q+ +G+ YL  H   ++HR+L   
Sbjct: 87  SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAAR 144
Query: 152 NIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSF 207
           N+ +  +  QV++ D G A ++        +S   TP ++MA E ++   YT   D++S+
Sbjct: 145 NVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203
Query: 208 GLCLLEMVTMEI-PYS 222
           G+ + E++T    PY+
Sbjct: 204 GVTVWELMTFGAEPYA 219

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 86/163 (52%), Gaps = 10/163 (6%)
Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 176
           ++++ L  +S QV  G+E+L + +   IHRDL   NI ++ N   VKI D G A  + ++
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKN 252
Query: 177 --HAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIY 231
             +        P ++MAPE ++++ Y+   D++S+G+ L E+ ++   PY          
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFC 312
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
            ++  G++ +A  +   PE+   +  C  + P+ RP  +EL++
Sbjct: 313 SRLREGMRMRA-PEYSTPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 176
           ++++ L  +S QV +G+E+L + +   IHRDL   NI ++     VKI D G A  + + 
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKD 253
Query: 177 --HAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIY 231
             +        P ++MAPE +++  YT   D++SFG+ L E+ ++   PY       +  
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 313
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           +++  G + +A +       +  ++    +P  RP+ SEL++
Sbjct: 314 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 355

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 176
           ++++ L  +S QV +G+E+L + +   IHRDL   NI ++     VKI D G A  + + 
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKD 244
Query: 177 --HAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIY 231
             +        P ++MAPE +++  YT   D++SFG+ L E+ ++   PY       +  
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           +++  G + +A +       +  ++    +P  RP+ SEL++
Sbjct: 305 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 346

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  +TE  + G L  + K    +++ +  L  
Sbjct: 62  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 175
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 176 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 83/162 (51%), Gaps = 8/162 (4%)
Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS 176
           ++++ L  +S QV +G+E+L + +   IHRDL   NI ++     VKI D G A  + + 
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKD 246
Query: 177 --HAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI-PYSECDSVAKIY 231
             +        P ++MAPE +++  YT   D++SFG+ L E+ ++   PY       +  
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           +++  G + +A +       +  ++    +P  RP+ SEL++
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPELYE- 195
           H+   +HRD+   N+ ++ N G +++ D G    +       S   +GTP+Y++PE+ + 
Sbjct: 192 HQLHYVHRDIKPDNVLLDVN-GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 196 -ED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----PQALNKV 246
            ED    Y    D +S G+C+ EM+  E P+   +S+ + Y K+    +    P  +  V
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHVTDV 309
Query: 247 KDPEVKAFIEKCIAQPRARPSAS---ELLKDPFFSELN 281
            + E K  I++ I     R   +   +  K  FF  LN
Sbjct: 310 SE-EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLN 346

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS--IIGTPEYMAPELYE- 195
           H+   +HRD+   N+ ++ N G +++ D G    +       S   +GTP+Y++PE+ + 
Sbjct: 208 HQLHYVHRDIKPDNVLLDVN-GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 266
Query: 196 -ED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----PQALNKV 246
            ED    Y    D +S G+C+ EM+  E P+   +S+ + Y K+    +    P  +  V
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHVTDV 325
Query: 247 KDPEVKAFIEKCIAQPRARPSAS---ELLKDPFFSELN 281
            + E K  I++ I     R   +   +  K  FF  LN
Sbjct: 326 SE-EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLN 362

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 108/227 (47%), Gaps = 35/227 (15%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 125
           E Q+++ L+++ ++  Y+V  ++    +  +TE  + G+L  + K    +++ +  L   
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIG 184
           + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++    + A     
Sbjct: 286 AAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAK 342
Query: 185 TP-EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAKIYKKV 234
            P ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V + Y+  
Sbjct: 343 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 401
Query: 235 TGGVKPQALNKV------KDPE-------VKAFIEKCI--AQPRARP 266
                P++L+ +      K+PE       ++AF+E      +P+ +P
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQP 448

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 125
           E Q+++ L+++ ++  Y+V  ++    +  +TE  + G+L  + K    +++ +  L   
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIG 184
           + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++    + A     
Sbjct: 286 AAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAK 342
Query: 185 TP-EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
            P ++ APE  LY   +T   D++SFG+ L E+ T   +PY
Sbjct: 343 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  + E  + G+L  + K    +++ +  L  
Sbjct: 62  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEXTARQGA 175
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 176 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  + E  + G+L  + K    +++ +  L  
Sbjct: 62  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 175
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 176 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 110/265 (41%), Gaps = 42/265 (15%)
Query: 28  GAVKK-VYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV 86
           G+V++ VYR   +++ I+VA   ++      D      +  E Q++  L N YI+    V
Sbjct: 350 GSVRQGVYRM--RKKQIDVAIKVLKQGTEKAD---TEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 87  WLDDQHNTLNFITEVCTSGNLRTYR-KKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIH 145
               Q   L  + E+   G L  +   K   + +  + +   QV  G++YL   E   +H
Sbjct: 405 C---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EKNFVH 459
Query: 146 RDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTP-EYMAPELYE-EDYTE 200
           R+L   N+ +  N    KI D G +  +G     + A S    P ++ APE      ++ 
Sbjct: 460 RNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE---K 257
             D++S+G+ + E ++                    G KP    K+K PEV AFIE   +
Sbjct: 519 RSDVWSYGVTMWEALSY-------------------GQKP--YKKMKGPEVMAFIEQGKR 557
Query: 258 CIAQPRARPSASELLKDPFFSELND 282
               P   P    L+ D +  +  D
Sbjct: 558 MECPPECPPELYALMSDCWIYKWED 582

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 67/169 (39%), Gaps = 34/169 (20%)
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRT--YRKKHRHVSIKALKKWSKQVLE---------- 131
           Y+  L    N L FI    TS N  T  +   H H          +Q LE          
Sbjct: 54  YNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVS 113
Query: 132 ---GLEYLHTH------EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
              GL +LH        +P I HRD    N+ +  N+ Q  I DLG A +  +      I
Sbjct: 114 AACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDI 172
Query: 183 -----IGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEI 219
                +GT  YMAPE+ +E       +  +  DI++FGL L E+    I
Sbjct: 173 GNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTI 221

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  + E  + G+L  + K    +++ +  L  
Sbjct: 62  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 175
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 176 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 91  QHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN 149
           ++  +  ITE   +G L  + R+K    S+  L    + +  G++YL       +HRDL 
Sbjct: 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLA 174
Query: 150 CSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDI 204
             NI +N N+   K+ D G + ++     A ++  G      + APE +    +T   D+
Sbjct: 175 ARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 205 YSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKCIAQP 262
           +SFG+ + E++T  E PY E  S  ++ K +  G + P  ++      +   + +C  Q 
Sbjct: 234 WSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFRLPTPMD--CPSAIYQLMMQCWQQE 290
Query: 263 RAR 265
           RAR
Sbjct: 291 RAR 293

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSI---KALKKWSKQVLE 131
           ++ +++  +S W +D H  +    E C  G+L     + +R +S      LK    QV  
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFIN------------------GNIGQVKIGDLGFAAIV 173
           GL Y+H+    ++H D+  SNIFI+                   N    KIGDLG    V
Sbjct: 125 GLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH---V 179
Query: 174 GRSHAAHSIIGTPEYMAPELYEEDYTEM--VDIYSFGLCLLEMVTMEIPYSECDSVAKIY 231
            R  +     G   ++A E+ +E+YT +   DI++  L ++     E      D   +I 
Sbjct: 180 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 239
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           +     + PQ L++     +K  I      P  RPSA  L+K
Sbjct: 240 QGRLPRI-PQVLSQEFTELLKVMIH---PDPERRPSAMALVK 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/174 (22%), Positives = 83/174 (47%), Gaps = 14/174 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E  ++    + +++  +  + DD++  L  + E    G+L      +  V  K  + ++ 
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTA 175
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGT 185
           +V+  L+ +H+     IHRD+   N+ ++ + G +K+ D G    + +       + +GT
Sbjct: 176 EVVLALDAIHSM--GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 186 PEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           P+Y++PE+ +       Y    D +S G+ L EM+  + P+   DS+   Y K+
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKI 285

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 93  NTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           N L  + E    G+L T   K    +  +  + +  +++  ++    H    +HRD+   
Sbjct: 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID--SVHRLGYVHRDIKPD 191
Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSII--GTPEYMAPELYEEDYTEM-------- 201
           NI ++   G +++ D G    +       S++  GTP+Y++PE+ +              
Sbjct: 192 NILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---PEVKAFIEKC 258
            D ++ G+   EM   + P+   DS A+ Y K+    +  +L  V +    E + FI++ 
Sbjct: 251 CDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRL 309
Query: 259 IAQPR---ARPSASELLKDPFFSELNDD---DSEP 287
           +  P     R  A +    PFF  L+ D   DS P
Sbjct: 310 LCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVP 344

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSI---KALKKWSKQVLE 131
           ++ +++  +S W +D H  +    E C  G+L     + +R +S      LK    QV  
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFIN------------------GNIGQVKIGDLGFAAIV 173
           GL Y+H+    ++H D+  SNIFI+                   N    KIGDLG    V
Sbjct: 127 GLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH---V 181
Query: 174 GRSHAAHSIIGTPEYMAPELYEEDYTEM--VDIYSFGLCLLEMVTMEIPYSECDSVAKIY 231
            R  +     G   ++A E+ +E+YT +   DI++  L ++     E      D   +I 
Sbjct: 182 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 241
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           +     + PQ L++     +K  I      P  RPSA  L+K
Sbjct: 242 QGRLPRI-PQVLSQEFTELLKVMIH---PDPERRPSAMALVK 279

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLR-TYRKKHRHVSI---KALKKWSKQVLE 131
           ++ +++  +S W +D H  +    E C  G+L     + +R +S      LK    QV  
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFIN------------------GNIGQVKIGDLGFAAIV 173
           GL Y+H+    ++H D+  SNIFI+                   N    KIGDLG    V
Sbjct: 125 GLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH---V 179
Query: 174 GRSHAAHSIIGTPEYMAPELYEEDYTEM--VDIYSFGLCLLEMVTMEIPYSECDSVAKIY 231
            R  +     G   ++A E+ +E+YT +   DI++  L ++     E      D   +I 
Sbjct: 180 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 239
Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           +     + PQ L++     +K  I      P  RPSA  L+K
Sbjct: 240 QGRLPRI-PQVLSQEFTELLKVMIH---PDPERRPSAMALVK 277

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/174 (22%), Positives = 83/174 (47%), Gaps = 14/174 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E  ++    + +++  +  + DD++  L  + E    G+L      +  V  K  + ++ 
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTA 180
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGT 185
           +V+  L+ +H+     IHRD+   N+ ++ + G +K+ D G    + +       + +GT
Sbjct: 181 EVVLALDAIHSM--GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 186 PEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           P+Y++PE+ +       Y    D +S G+ L EM+  + P+   DS+   Y K+
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKI 290

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/174 (22%), Positives = 83/174 (47%), Gaps = 14/174 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E  ++    + +++  +  + DD++  L  + E    G+L      +  V  K  + ++ 
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTA 180
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGT 185
           +V+  L+ +H+     IHRD+   N+ ++ + G +K+ D G    + +       + +GT
Sbjct: 181 EVVLALDAIHSM--GFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 186 PEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
           P+Y++PE+ +       Y    D +S G+ L EM+  + P+   DS+   Y K+
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKI 290

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 41  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 96
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 97  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 155
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 156 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 212
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 213 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 272
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 273 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 21  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 76
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 77  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 135
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 136 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 192
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 193 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 252
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 253 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 18  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 73
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 132
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 133 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 189
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 23  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 78
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 138 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 194
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 255 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNR--LHSEVQLLRTLKN 77
           LG GA  KV+ A        ++ + VA   ++      DP L  R     E +LL  L++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK------DPTLAARKDFQREAELLTNLQH 76
Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKA 121
           ++I+  Y V  D   + L  + E    G+L  + + H                  + +  
Sbjct: 77  EHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---- 177
           +   + Q+  G+ YL +     +HRDL   N  +  N+  VKIGD G +  V  +     
Sbjct: 135 MLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRV 191
Query: 178 AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
             H+++    +M PE +    +T   D++SFG+ L E+ T
Sbjct: 192 GGHTMLPI-RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 20  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 75
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 135 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 191
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 42  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 97
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 98  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 156
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 157 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 213
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 214 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 273
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 274 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 15  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 70
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 71  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 129
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 130 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 186
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 187 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 246
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 247 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 22  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 77
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 78  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 136
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 137 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 193
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 253
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 254 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 122/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 23  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 78
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +     ++ H+ 
Sbjct: 138 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 194
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 255 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/260 (22%), Positives = 111/260 (42%), Gaps = 26/260 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV-------RLSHFSEDPVLVNRLHSEVQLLRTLK 76
            + SG+   V    D E GI VA  +V       R  +   D  L  R+  E++LL    
Sbjct: 29  FISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 77  NKYIIVCYSVWL---DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           +  I+    +++   +   + L  +TE+  +   +    +   +S + ++ +   +L GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA----AIVGRSHAAHSIIGTPEYM 189
             LH  E  ++HRDL+  NI +  N   + I D   A    A   ++H     +    Y 
Sbjct: 148 HVLH--EAGVVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTH----YVTHRWYR 200
Query: 190 APELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNK 245
           APEL  +   +T++VD++S G  + EM   +  +       ++ K  +V G  K + +  
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 246 VKDPEVKAFIEKCIAQPRAR 265
              P  + ++   ++   AR
Sbjct: 261 FSSPSARDYLRNSLSNVPAR 280

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/260 (22%), Positives = 111/260 (42%), Gaps = 26/260 (10%)
Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQV-------RLSHFSEDPVLVNRLHSEVQLLRTLK 76
            + SG+   V    D E GI VA  +V       R  +   D  L  R+  E++LL    
Sbjct: 29  FISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 77  NKYIIVCYSVWL---DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           +  I+    +++   +   + L  +TE+  +   +    +   +S + ++ +   +L GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA----AIVGRSHAAHSIIGTPEYM 189
             LH  E  ++HRDL+  NI +  N   + I D   A    A   ++H     +    Y 
Sbjct: 148 HVLH--EAGVVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTH----YVTHRWYR 200
Query: 190 APELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQALNK 245
           APEL  +   +T++VD++S G  + EM   +  +       ++ K  +V G  K + +  
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 246 VKDPEVKAFIEKCIAQPRAR 265
              P  + ++   ++   AR
Sbjct: 261 FSSPSARDYLRNSLSNVPAR 280

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 41/220 (18%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKK 124
            E Q+++ L+++ ++  Y+V        +  + E  + G L  + K    +++ +  L  
Sbjct: 62  QEAQVMKKLRHEKLVQLYAV---VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV------GRSHA 178
            + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++       R  A
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGA 175
Query: 179 AHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAK 229
              I    ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V +
Sbjct: 176 KFPI----KWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230
Query: 230 IYKKVTGGVKPQALNKV------KDPE-------VKAFIE 256
            Y+       P++L+ +      KDPE       ++AF+E
Sbjct: 231 GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 121/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 22  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 77
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 78  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 136
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G++YL + +   +HRDL   N  ++     VK+ D G A  +      + H+ 
Sbjct: 137 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEXXSVHNK 193
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 253
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 254 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 24/141 (17%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------EPCIIHRDL 148
           L  +++    G+L  Y  ++  V+++ + K +     GL +LH        +P I HRDL
Sbjct: 115 LWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173
Query: 149 NCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-------IGTPEYMAPELYEEDYT-- 199
              NI +  N G   I DLG A  V    A  +I       +GT  YMAPE+ ++     
Sbjct: 174 KSKNILVKKN-GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 200 -----EMVDIYSFGLCLLEMV 215
                +  DIY+ GL   E+ 
Sbjct: 231 HFESFKRADIYAMGLVFWEIA 251

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 24/141 (17%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------EPCIIHRDL 148
           L  +++    G+L  Y  ++  V+++ + K +     GL +LH        +P I HRDL
Sbjct: 102 LWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 160
Query: 149 NCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-------IGTPEYMAPELYEEDYT-- 199
              NI +  N G   I DLG A  V    A  +I       +GT  YMAPE+ ++     
Sbjct: 161 KSKNILVKKN-GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 217
Query: 200 -----EMVDIYSFGLCLLEMV 215
                +  DIY+ GL   E+ 
Sbjct: 218 HFESFKRADIYAMGLVFWEIA 238

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G A ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/250 (21%), Positives = 103/250 (41%), Gaps = 44/250 (17%)
Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           VN  H  V ++   +NKY+ V      D  H  L            +++ +  R + +  
Sbjct: 96  VNNHHKSV-IVNPSQNKYLNVIMEYVPDTLHKVL------------KSFIRSGRSIPMNL 142
Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
           +  +  Q+   + ++H+   C  HRD+   N+ +N     +K+ D G A  +  S  + +
Sbjct: 143 ISIYIYQLFRAVGFIHSLGIC--HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200
Query: 182 IIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYS---ECDSVAKIYKKVTG 236
            I +  Y APEL     +YT  +D++S G    E++  +  +S     D + +I + +  
Sbjct: 201 XICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT 260
Query: 237 GVKPQAL------NKVKDPEVKA-----------------FIEKCIA-QPRARPSASELL 272
             K Q +       +V+ P +KA                  +E+ +  +P  R +  E +
Sbjct: 261 PTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320
Query: 273 KDPFFSELND 282
             PFF  L +
Sbjct: 321 AHPFFDHLRN 330

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 24/141 (17%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------EPCIIHRDL 148
           L  +++    G+L  Y  ++  V+++ + K +     GL +LH        +P I HRDL
Sbjct: 82  LWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 140
Query: 149 NCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-------IGTPEYMAPELYEEDYT-- 199
              NI +  N G   I DLG A  V    A  +I       +GT  YMAPE+ ++     
Sbjct: 141 KSKNILVKKN-GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 197
Query: 200 -----EMVDIYSFGLCLLEMV 215
                +  DIY+ GL   E+ 
Sbjct: 198 HFESFKRADIYAMGLVFWEIA 218

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 24/141 (17%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------EPCIIHRDL 148
           L  +++    G+L  Y  ++  V+++ + K +     GL +LH        +P I HRDL
Sbjct: 77  LWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 135
Query: 149 NCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-------IGTPEYMAPELYEEDYT-- 199
              NI +  N G   I DLG A  V    A  +I       +GT  YMAPE+ ++     
Sbjct: 136 KSKNILVKKN-GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 192
Query: 200 -----EMVDIYSFGLCLLEMV 215
                +  DIY+ GL   E+ 
Sbjct: 193 HFESFKRADIYAMGLVFWEIA 213

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV----------SIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 93  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 151 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 263
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 264 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 24/141 (17%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------EPCIIHRDL 148
           L  +++    G+L  Y  ++  V+++ + K +     GL +LH        +P I HRDL
Sbjct: 76  LWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 134
Query: 149 NCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-------IGTPEYMAPELYEEDYT-- 199
              NI +  N G   I DLG A  V    A  +I       +GT  YMAPE+ ++     
Sbjct: 135 KSKNILVKKN-GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 191
Query: 200 -----EMVDIYSFGLCLLEMV 215
                +  DIY+ GL   E+ 
Sbjct: 192 HFESFKRADIYAMGLVFWEIA 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++ D++G G   +V +A  +++G+ +     R+  ++      +    E+++L  L +  
Sbjct: 18  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHP 76
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
            I+   +   +    L    E    GNL  + +K R                 +S + L 
Sbjct: 77  NIINL-LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
            ++  V  G++YL   +   IHRDL   NI +  N    KI D G +   G+       +
Sbjct: 136 HFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSR--GQEVYVKKTM 190
Query: 184 GT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK 239
           G     +MA E L    YT   D++S+G+ L E+V++   PY    + A++Y+K+  G +
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYR 249
Query: 240 -PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELL 272
             + LN   D EV   + +C  + P  RPS +++L
Sbjct: 250 LEKPLN--CDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 107/227 (47%), Gaps = 35/227 (15%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKW 125
           E Q+++ L+++ ++  Y+V  ++    +  + E  + G+L  + K    +++ +  L   
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEE---PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIG 184
           + Q+  G+ Y+       +HRDL  +NI +  N+   K+ D G A ++    + A     
Sbjct: 286 AAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAK 342
Query: 185 TP-EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSE------CDSVAKIYKKV 234
            P ++ APE  LY   +T   D++SFG+ L E+ T   +PY         D V + Y+  
Sbjct: 343 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 401
Query: 235 TGGVKPQALNKV------KDPE-------VKAFIEKCI--AQPRARP 266
                P++L+ +      K+PE       ++AF+E      +P+ +P
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQP 448

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 87  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 145 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 257
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 258 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 300

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 24/141 (17%)
Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH------EPCIIHRDL 148
           L  +++    G+L  Y  ++  V+++ + K +     GL +LH        +P I HRDL
Sbjct: 79  LWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 137
Query: 149 NCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI-------IGTPEYMAPELYEEDYT-- 199
              NI +  N G   I DLG A  V    A  +I       +GT  YMAPE+ ++     
Sbjct: 138 KSKNILVKKN-GTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 194
Query: 200 -----EMVDIYSFGLCLLEMV 215
                +  DIY+ GL   E+ 
Sbjct: 195 HFESFKRADIYAMGLVFWEIA 215

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++  L ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 84  EALIISKLNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 142 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 258
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 259 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++  L ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 98  EALIISKLNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 156 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 272
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 273 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 78  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 136 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 193 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 248
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 249 NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 291

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++ D++G G   +V +A  +++G+ +     R+  ++      +    E+++L  L +  
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHP 86
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
            I+   +   +    L    E    GNL  + +K R                 +S + L 
Sbjct: 87  NIINL-LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
            ++  V  G++YL   +   IHRDL   NI +  N    KI D G +   G+       +
Sbjct: 146 HFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSR--GQEVYVKKTM 200
Query: 184 GT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK 239
           G     +MA E L    YT   D++S+G+ L E+V++   PY    + A++Y+K+  G +
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYR 259
Query: 240 -PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELL 272
             + LN   D EV   + +C  + P  RPS +++L
Sbjct: 260 LEKPLN--CDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV----------SIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 83  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 141 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 197
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 253
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 254 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 296

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/276 (22%), Positives = 114/276 (41%), Gaps = 55/276 (19%)
Query: 58  DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--------------NTLN-FI---- 98
           +P  V R+ +EV+L++ L +  I   Y V+ D+Q+              + LN FI    
Sbjct: 68  NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 99  ---------TEVC---------TSGNLRTYRKKHRHVSI-KALKKWSKQVLEGLEYLHTH 139
                    T++C          +G++  +R+    V   K +    +Q+   L YLH  
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187
Query: 140 EPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIV-----GRSHAAHSIIGTPEYMAPEL 193
             C  HRD+   N   + N   ++K+ D G +        G  +   +  GTP ++APE+
Sbjct: 188 GIC--HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 194 Y---EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVK 247
                E Y    D +S G+ L  ++   +P+   ++ D+++++  K      P     V 
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY--NVL 303
Query: 248 DPEVKAFIEKCIAQP-RARPSASELLKDPFFSELND 282
            P  +  +   + +    R  A   L+ P+ S+ +D
Sbjct: 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGFVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGAVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 94  IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 151
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 152 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 210
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 211 LWEVMSYGERPYWE 224

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 94  IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 151
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 152 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 210
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 211 LWEVMSYGERPYWE 224

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 93  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 151 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 263
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 264 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 111 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 168
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 169 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 227
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 228 LWEVMSYGERPYWE 241

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 80  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 138 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 250
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 251 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 293

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 120/274 (43%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY      +  + I  A   + R++   E    V++ 
Sbjct: 24  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 79
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 80  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 138
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA--AIVGRSHAAHSI 182
           +  QV +G+++L + +   +HRDL   N  ++     VK+ D G A   +     + H+ 
Sbjct: 139 FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMLDKEFDSVHNK 195
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 255
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 256 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 84  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 142 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 254
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 255 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 297

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 121 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 178
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 179 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 237
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 238 LWEVMSYGERPYWE 251

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 87  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 145 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 201
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 257
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 258 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 300

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 84  EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 142 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASY 199
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 258
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 259 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 75  EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 132
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 133 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 190
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 191 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 249
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 250 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 83  EALIISKFNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 141 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 257
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 258 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 68/134 (50%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L ++ +KH    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILI 180
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G   ++     AA++  G      + +PE +    +T   D++S+G+ 
Sbjct: 181 NSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 211 LLEMVTM-EIPYSE 223
           L E+++  E PY E
Sbjct: 240 LWEVMSYGERPYWE 253

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 15/142 (10%)
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYM 189
           G  +LHT EP I    LN  ++ I+ +   ++   D+ F+    GR +A       P ++
Sbjct: 123 GXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYA-------PAWV 175
Query: 190 APELY----EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 245
           APE      E+      D +SF + L E+VT E+P+++  +     K    G++P     
Sbjct: 176 APEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPG 235
Query: 246 VKDPEVKAFIEKCIAQ-PRARP 266
           +  P V    + C  + P  RP
Sbjct: 236 I-SPHVSKLXKICXNEDPAKRP 256

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 98  EALIISKFNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 156 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 272
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 273 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 86  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 144 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 256
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 257 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 299

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV-SIKALKK 124
           +E  ++  L++  ++    V ++++   L  +TE    G+L  Y R + R V     L K
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           +S  V E +EYL  +    +HRDL   N+ ++ +    K+ D G       +     +  
Sbjct: 122 FSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL-- 176
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             ++ APE L E+ ++   D++SFG+ L E+ +   +PY
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 83  EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 141 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 257
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 258 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 84  EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 142 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 258
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 259 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 86  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 144 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 256
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 257 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 299

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 97  FITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            +TE   +G+L T+ KK+    ++  L    + +  G++YL   +   +HRDL   NI I
Sbjct: 100 IVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLS--DMGYVHRDLAARNILI 157
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + APE +    +T   D++S+G+ 
Sbjct: 158 NSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIV 216
Query: 211 LLEMVTM-EIPYSE 223
           + E+V+  E PY E
Sbjct: 217 MWEVVSYGERPYWE 230

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/286 (20%), Positives = 112/286 (39%), Gaps = 62/286 (21%)
Query: 61  LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 120
           +V  L  E+ + +   +  I+   + ++ D  N L  +T     G+ +     H    + 
Sbjct: 69  MVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLICTHFMDGMN 126
Query: 121 --ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL-GFAAIVGRSH 177
             A+    + VL+ L+Y+H      +HR +  S+I I+ + G+V +  L    +++    
Sbjct: 127 ELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQ 183
Query: 178 AAHSIIGTPEY-------MAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSV 227
               +   P+Y       ++PE+ +++   Y    DIYS G+   E+    +P+ +  + 
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 228 AKIYKKVTGGV----------------------------------KPQALN--------- 244
             + +K+ G V                                   P+  N         
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 245 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
           +   P    F+E+C+ + P ARPSAS LL   FF ++    SE  P
Sbjct: 304 RTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 349

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/286 (20%), Positives = 112/286 (39%), Gaps = 62/286 (21%)
Query: 61  LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 120
           +V  L  E+ + +   +  I+   + ++ D  N L  +T     G+ +     H    + 
Sbjct: 53  MVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLICTHFMDGMN 110
Query: 121 --ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL-GFAAIVGRSH 177
             A+    + VL+ L+Y+H      +HR +  S+I I+ + G+V +  L    +++    
Sbjct: 111 ELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQ 167
Query: 178 AAHSIIGTPEY-------MAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSV 227
               +   P+Y       ++PE+ +++   Y    DIYS G+   E+    +P+ +  + 
Sbjct: 168 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 227
Query: 228 AKIYKKVTGGV----------------------------------KPQALN--------- 244
             + +K+ G V                                   P+  N         
Sbjct: 228 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 287
Query: 245 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
           +   P    F+E+C+ + P ARPSAS LL   FF ++    SE  P
Sbjct: 288 RTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 333

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 121/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 23  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 78
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G+++L + +   +HRDL   N  ++     VK+ D G A  +      + H+ 
Sbjct: 138 FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNK 194
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 255 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 98  EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 156 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 272
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 273 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 80  LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 138 MAYLNANK--FVHRDLAARNCXVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 250
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 251 NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 293

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 121/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 28  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 83
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 84  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 142
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G+++L + +   +HRDL   N  ++     VK+ D G A  +      + H+ 
Sbjct: 143 FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNK 199
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 200 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 259
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 260 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 293

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 120/274 (43%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY      +  + I  A   + R++   E    V++ 
Sbjct: 82  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 137
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G+++L + +   +HRDL   N  ++     VK+ D G A  +      + H+ 
Sbjct: 197 FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNK 253
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 347

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 100 EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 157
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 158 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 215
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 216 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 274
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 275 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 314

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV-SIKALKK 124
           +E  ++  L++  ++    V ++++   L  +TE    G+L  Y R + R V     L K
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           +S  V E +EYL  +    +HRDL   N+ ++ +    K+ D G       +     +  
Sbjct: 107 FSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL-- 161
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             ++ APE L E+ ++   D++SFG+ L E+ +   +PY
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIV 82
           LG G+   VY    +    +    +V +   +E   +  R+   +E  +++     +++ 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQVLEG 132
              V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++ +G
Sbjct: 115 LLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYM 189
           + YL+ ++   +HRDL   N  +  +   VKIGD G    +  +         +    +M
Sbjct: 173 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 229
Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +PE L +  +T   D++SFG+ L E+ T+ E PY    +   +   + GG+    L+K  
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----LDKPD 285
Query: 248 D-PEVKAFIEKCIAQ--PRARPSASELLK------DPFFSELN 281
           + P++   + +   Q  P+ RPS  E++       +P F E++
Sbjct: 286 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 328

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 101 EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 158
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 159 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 216
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 217 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 275
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 276 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 315

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 121/274 (44%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRA--FDQE-EGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY     D + + I  A   + R++   E    V++ 
Sbjct: 21  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 76
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 77  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 135
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G+++L + +   +HRDL   N  ++     VK+ D G A  +      + H+ 
Sbjct: 136 FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNK 192
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 193 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 252
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 253 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 90  EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 147
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 148 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 205
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 206 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 264
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 265 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 304

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 124 EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 182 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 298
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 120/274 (43%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY      +  + I  A   + R++   E    V++ 
Sbjct: 24  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 79
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 80  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 138
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G+++L + +   +HRDL   N  ++     VK+ D G A  +      + H+ 
Sbjct: 139 FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNK 195
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 196 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 255
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 256 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 120/274 (43%), Gaps = 19/274 (6%)
Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQV-RLSHFSEDPVLVNRL 65
           V + PS     +++++G G    VY      +  + I  A   + R++   E    V++ 
Sbjct: 23  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQF 78
Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKK 124
            +E  +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSI 182
           +  QV +G+++L + +   +HRDL   N  ++     VK+ D G A  +      + H+ 
Sbjct: 138 FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNK 194
Query: 183 IGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            G     ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G 
Sbjct: 195 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 254
Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
           +        DP  +  ++    +   RPS SEL+
Sbjct: 255 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-------HVSIK 120
           E  ++    ++ I+ C  V L  Q      + E+   G+L+++ ++ R        +++ 
Sbjct: 110 EALIISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 167
Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRS-- 176
            L   ++ +  G +YL  +    IHRD+   N  +   G     KIGD G A  + R+  
Sbjct: 168 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 225
Query: 177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKK 233
                  +   ++M PE + E  +T   D +SFG+ L E+ ++  +PY    S  ++ + 
Sbjct: 226 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 284
Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQPRARPSASELLK 273
           VT G +         P  +   +    QP  RP+ + +L+
Sbjct: 285 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHV-SIKALKK 124
           +E  ++  L++  ++    V ++++   L  +TE    G+L  Y R + R V     L K
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           +S  V E +EYL  +    +HRDL   N+ ++ +    K+ D G       +     +  
Sbjct: 294 FSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL-- 348
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
             ++ APE L E+ ++   D++SFG+ L E+ +   +PY
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL------KNK 78
           LG G    V+ A D      VA   VR      D V       E++LL+ +      K  
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 79  YIIVCYSVWLDDQHNT-------LNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVL 130
            +   + + L D  N        +  + EV     L   +K +HR + +  +K+ SKQ+L
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 131 EGLEYLHTHEPC-IIHRDLNCSNIFIN-----GNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
            GL+Y+H    C IIH D+   N+ +       N+ Q+KI DLG A      H  +S I 
Sbjct: 142 LGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD-EHYTNS-IQ 197
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           T EY +PE L    +    DI+S    + E++T
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL------KNK 78
           LG G    V+ A D      VA   VR      D V       E++LL+ +      K  
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 79  YIIVCYSVWLDDQHNT-------LNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVL 130
            +   + + L D  N        +  + EV     L   +K +HR + +  +K+ SKQ+L
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 131 EGLEYLHTHEPC-IIHRDLNCSNIFIN-----GNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
            GL+Y+H    C IIH D+   N+ +       N+ Q+KI DLG A      H  +S I 
Sbjct: 142 LGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD-EHYTNS-IQ 197
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           T EY +PE L    +    DI+S    + E++T
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++ D++G G   +V +A  +++G+ +     R+  ++      +    E+++L  L +  
Sbjct: 25  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHP 83
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
            I+   +   +    L    E    GNL  + +K R                 +S + L 
Sbjct: 84  NIINL-LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
            ++  V  G++YL   +   IHR+L   NI +  N    KI D G +   G+       +
Sbjct: 143 HFAADVARGMDYLSQKQ--FIHRNLAARNILVGENY-VAKIADFGLSR--GQEVYVKKTM 197
Query: 184 GT--PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK 239
           G     +MA E L    YT   D++S+G+ L E+V++   PY    + A++Y+K+  G +
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYR 256
Query: 240 -PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELL 272
             + LN   D EV   + +C  + P  RPS +++L
Sbjct: 257 LEKPLN--CDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 24/170 (14%)
Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH---------- 114
            H E +LL  L++++I+  Y V ++   + L  + E    G+L  + + H          
Sbjct: 62  FHREAELLTNLQHEHIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 119
Query: 115 ---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA 171
                ++   +   ++Q+  G+ YL +     +HRDL   N  +  N+  VKIGD G + 
Sbjct: 120 NPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL-LVKIGDFGMSR 176
Query: 172 IVGRSH----AAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            V  +       H+++    +M PE +    +T   D++S G+ L E+ T
Sbjct: 177 DVYSTDYYRVGGHTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 3   DRDGEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV 60
           D D   +V+V       RY  L  +G G+  +V +A+D +    VA   VR      +  
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKR 135
Query: 61  LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN---------FITEVCTSGNLRTY- 110
              +   E+++L  L+ +           D+ NT+N         F   +C +  L +  
Sbjct: 136 FHRQAAEEIRILEHLRKQ-----------DKDNTMNVIHMLENFTFRNHICMTFELLSMN 184
Query: 111 ------RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                 + K +  S+  ++K++  +L+ L+ LH +   IIH DL   NI +    G+  I
Sbjct: 185 LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGI 241
Query: 165 GDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
             + F +        ++ I +  Y APE +    Y   +D++S G  L E++T
Sbjct: 242 KVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 3   DRDGEPFVEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV 60
           D D   +V+V       RY  L  +G G+  +V +A+D +    VA   VR      +  
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKR 135
Query: 61  LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN---------FITEVCTSGNLRTY- 110
              +   E+++L  L+ +           D+ NT+N         F   +C +  L +  
Sbjct: 136 FHRQAAEEIRILEHLRKQ-----------DKDNTMNVIHMLENFTFRNHICMTFELLSMN 184
Query: 111 ------RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
                 + K +  S+  ++K++  +L+ L+ LH +   IIH DL   NI +    G+  I
Sbjct: 185 LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGI 241
Query: 165 GDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
             + F +        ++ I +  Y APE +    Y   +D++S G  L E++T
Sbjct: 242 KVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 33/231 (14%)
Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           R   +L  G    VY A D   G E A  ++  +   ++  ++     EV  ++ L    
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ----EVCFMKKLSGHP 86
Query: 80  IIV--CYSVWL-----DDQHNTLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQV 129
            IV  C +  +     D        +TE+C  G L  + KK      +S   + K   Q 
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-----------RSHA 178
              ++++H  +P IIHRDL   N+ ++ N G +K+ D G A  +            R+  
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 179 AHSII--GTPEYMAPE---LYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSE 223
              I    TP Y  PE   LY      E  DI++ G  L  +   + P+ +
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 154 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 211
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 212 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNA 271
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 272 YLNKYRIELDPQLEALVGRHSRKP 295

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 111 RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 170
           R K + + +     +  ++L  L YLH+    +++ DL   NI +     Q+K+ DLG  
Sbjct: 173 RSKGQKLPVAEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE--QLKLIDLG-- 226
Query: 171 AIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIP 220
             V R ++   + GTP + APE+     T   DIY+ G  L  + T+++P
Sbjct: 227 -AVSRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAAL-TLDLP 274

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 133 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKP 274

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 133 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKP 274

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 97  FITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            ITE   +G+L  + RK     ++  L    + +  G++YL       +HRDL   NI +
Sbjct: 107 IITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA--VHRDLAARNILV 164
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + APE +    +T   D++S+G+ 
Sbjct: 165 NSNL-VCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 223
Query: 211 LLEMVTM-EIPY 221
           + E+++  E PY
Sbjct: 224 MWEVMSYGERPY 235

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 134 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 251
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 252 YLNKYRIELDPQLEALVGRHSRKP 275

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 133 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKP 274

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 135 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 192
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 193 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 252
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 253 YLNKYRIELDPQLEALVGRHSRKP 276

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 133 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKP 274

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 133 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKP 274

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 133 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKP 274

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           ++L+ L+Y H+    I+HRD+   N+ I+  + ++++ D G A         +  + +  
Sbjct: 134 ELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 188 YMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTGGVKPQ 241
           +  PEL    +DY   +D++S G     M+  + P+       D + KI K +       
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 251
Query: 242 ALNKVK---DPEVKAFIEKCIAQP 262
            LNK +   DP+++A + +   +P
Sbjct: 252 YLNKYRIELDPQLEALVGRHSRKP 275

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 97  FITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            ITE   +G+L  + RK     ++  L    + +  G++YL   +   +HRDL   NI +
Sbjct: 92  IITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS--DMSYVHRDLAARNILV 149
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + APE +    +T   D++S+G+ 
Sbjct: 150 NSNL-VCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 208
Query: 211 LLEMVTM-EIPY 221
           + E+++  E PY
Sbjct: 209 MWEVMSYGERPY 220

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 97  FITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            ITE   +G+L  + RK     ++  L    + +  G++YL   +   +HRDL   NI +
Sbjct: 86  IITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS--DMSYVHRDLAARNILV 143
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     AA++  G      + APE +    +T   D++S+G+ 
Sbjct: 144 NSNL-VCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 202
Query: 211 LLEMVTM-EIPY 221
           + E+++  E PY
Sbjct: 203 MWEVMSYGERPY 214

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 116 HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-- 173
           ++ ++ L ++   +  G+EYL +     IHRDL   N  +  ++  V + D G +  +  
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLSRKIYS 189
Query: 174 GRSHAAHSIIGTP-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 230
           G  +        P +++A E L +  YT   D+++FG+ + E++T  + PY+  ++ A+I
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEI 248
Query: 231 YKKVTGGVKPQALNKVKDP-----EVKAFIEKCI-AQPRARPS 267
           Y  + GG      N++K P     EV   + +C  A P+ RPS
Sbjct: 249 YNYLIGG------NRLKQPPECMEEVYDLMYQCWSADPKQRPS 285

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 97  FITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI 155
            + E   +G L  + +KH    ++  L    + +  G+ YL   +   +HRDL   NI +
Sbjct: 121 IVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA--DMGYVHRDLAARNILV 178
Query: 156 NGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP---EYMAPELYE-EDYTEMVDIYSFGLC 210
           N N+   K+ D G + ++     A ++  G      + APE  +   +T   D++S+G+ 
Sbjct: 179 NSNL-VCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIV 237
Query: 211 LLEMVTM-EIPY 221
           + E+++  E PY
Sbjct: 238 MWEVMSYGERPY 249

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
           +  QV E L++LH+H   I H D+   NI +       +KI + G A  +        + 
Sbjct: 107 YVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
Query: 184 GTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
             PEY APE+++ D  +   D++S G  +  +++   P+   ++  +I + +        
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFD 223
Query: 243 LNKVKDPEVKA--FIEKCIAQPR-ARPSASELLKDPFFSE 279
               K+  ++A  F+++ + + R +R +ASE L+ P+  +
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 123 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 180
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 181 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 235
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 236 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 282

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 128 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 185
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 186 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 240
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 241 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 287

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 130 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 187
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 188 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 242
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 243 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 289

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 129 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 186
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 187 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 241
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 242 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 288

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 122 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 179
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 180 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 234
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 235 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 281

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 124 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 181
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 182 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 236
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 237 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 283

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 124 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 181
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 182 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 236
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 237 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 283

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 174 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 231
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 232 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 286
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 287 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 333

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 168 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 280
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIG 184
           K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++  +   
Sbjct: 138 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 195
Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA- 242
           TP Y+APE L  E Y +  D++S G+ +  ++    P+     +A     ++ G+K +  
Sbjct: 196 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 250
Query: 243 LNKVKDP---------EVKAFIEKCI-AQPRARPSASELLKDPFFSE 279
           + + + P         EVK  I   +  +P  R + +E +  P+  +
Sbjct: 251 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 297

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG------------QVKIGDLGFAAIVG 174
           +Q+  G+ +LH+ +  IIHRDL   NI ++ +              ++ I D G    + 
Sbjct: 140 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 175 RSHAA-----HSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECD 225
                     ++  GT  + APEL EE      T  +DI+S G C+   +  +  +   D
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMG-CVFYYILSKGKHPFGD 256
Query: 226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-----PRARPSASELLKDPFF 277
             ++    + G      +  + D  + A     I+Q     P  RP+A ++L+ P F
Sbjct: 257 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG------------QVKIGDLGFAAIVG 174
           +Q+  G+ +LH+ +  IIHRDL   NI ++ +              ++ I D G    + 
Sbjct: 140 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 175 RSHAA-----HSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECD 225
                     ++  GT  + APEL EE      T  +DI+S G C+   +  +  +   D
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMG-CVFYYILSKGKHPFGD 256
Query: 226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-----PRARPSASELLKDPFF 277
             ++    + G      +  + D  + A     I+Q     P  RP+A ++L+ P F
Sbjct: 257 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 45/277 (16%)
Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG GA  KV+ A       +++ + VA   ++ +  S           E +LL  L++++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTMLQHQH 81
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---------------VSIKALKK 124
           I+  + V  + +   L  + E    G+L  + + H                 + +  L  
Sbjct: 82  IVRFFGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHS 181
            + QV  G+ YL       +HRDL   N  +   +  VKIGD G +  +  +        
Sbjct: 140 VASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGR 196
Query: 182 IIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            +    +M PE  LY +  TE  D++SFG+ L E+ T  + P+ +  +   I   +T G 
Sbjct: 197 TMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-DCITQGR 254
Query: 239 ---KPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
              +P+A      PEV A +  C   +P+ R S  ++
Sbjct: 255 ELERPRAC----PPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/200 (20%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVC 83
           LG G   +V+ A +     +V    ++       PV  N++  E+++L  L+    II  
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILK-------PVKKNKIKREIKILENLRGGPNIITL 97
Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             +  D    T   + E   + +   +++ ++ ++   ++ +  ++L+ L+Y H+    I
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD---FKQLYQTLTDYDIRFYMYEILKALDYCHSM--GI 152
Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY--EEDYTEM 201
           +HRD+   N+ I+    ++++ D G A         +  + +  +  PEL    + Y   
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 212
Query: 202 VDIYSFGLCLLEMVTMEIPY 221
           +D++S G  L  M+  + P+
Sbjct: 213 LDMWSLGCMLASMIFRKEPF 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 45/277 (16%)
Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG GA  KV+ A       +++ + VA   ++ +  S           E +LL  L++++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTMLQHQH 104
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---------------VSIKALKK 124
           I+  + V  + +   L  + E    G+L  + + H                 + +  L  
Sbjct: 105 IVRFFGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHS 181
            + QV  G+ YL       +HRDL   N  +   +  VKIGD G +  +  +        
Sbjct: 163 VASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 182 IIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            +    +M PE  LY +  TE  D++SFG+ L E+ T  + P+ +  +   I   +T G 
Sbjct: 220 TMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-DCITQGR 277
Query: 239 ---KPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
              +P+A      PEV A +  C   +P+ R S  ++
Sbjct: 278 ELERPRAC----PPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 33/181 (18%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG------------QVKIGDLGFAAIVG 174
           +Q+  G+ +LH+ +  IIHRDL   NI ++ +              ++ I D G    + 
Sbjct: 122 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 175 RSHAA-----HSIIGTPEYMAPELYEED--------YTEMVDIYSFGLCLLEMVTMEIPY 221
              ++     ++  GT  + APEL EE          T  +DI+S G C+   +  +  +
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKH 238
Query: 222 SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-----PRARPSASELLKDPF 276
              D  ++    + G      +  + D  + A     I+Q     P  RP+A ++L+ P 
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 277 F 277
           F
Sbjct: 299 F 299

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 24  LLGSGAVKKVYRA-FDQEEG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           +LG G    V      QE+G  ++VA   ++L + S+  +      SE   ++   +  +
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI--EEFLSEAACMKDFSHPNV 98
Query: 81  IVCYSVWLDDQHNTL---NFITEVCTSGNLRTYRKKHR------HVSIKALKKWSKQVLE 131
           I    V ++     +     I      G+L TY    R      H+ ++ L K+   +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP-EY 188
           G+EYL       +HRDL   N  +  ++  V + D G +  +  G  +    I   P ++
Sbjct: 159 GMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
           +A E L +  YT   D+++FG+ + E+ T
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 45/277 (16%)
Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG GA  KV+ A       +++ + VA   ++ +  S           E +LL  L++++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTMLQHQH 75
Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---------------VSIKALKK 124
           I+  + V  + +   L  + E    G+L  + + H                 + +  L  
Sbjct: 76  IVRFFGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HAAHS 181
            + QV  G+ YL       +HRDL   N  +   +  VKIGD G +  +  +        
Sbjct: 134 VASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGR 190
Query: 182 IIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
            +    +M PE  LY +  TE  D++SFG+ L E+ T  + P+ +  +   I   +T G 
Sbjct: 191 TMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-DCITQGR 248
Query: 239 ---KPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
              +P+A      PEV A +  C   +P+ R S  ++
Sbjct: 249 ELERPRAC----PPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 12/133 (9%)
Query: 98  ITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 156
           ITE   +G+L ++ R+     ++  L    + +  G++YL       +HRDL   NI +N
Sbjct: 112 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN 169
Query: 157 GNIGQVKIGDLGFAAIV---GRSHAAHSIIGTP---EYMAPELYE-EDYTEMVDIYSFGL 209
            N+   K+ D G +  +          S +G      + APE  +   +T   D++S+G+
Sbjct: 170 SNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGI 228
Query: 210 CLLEMVTM-EIPY 221
            + E+++  E PY
Sbjct: 229 VMWEVMSYGERPY 241

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 59/141 (41%), Gaps = 18/141 (12%)
Query: 97  FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN 156
            + E    G++ ++  K RH +        + V   L++LH     I HRDL   NI   
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCE 145
Query: 157 --GNIGQVKIGDLGFAAIVGRSHAAHSI--------IGTPEYMAPELYE------EDYTE 200
               +  VKI D G  + +  +     I         G+ EYMAPE+ E        Y +
Sbjct: 146 HPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK 205
Query: 201 MVDIYSFGLCLLEMVTMEIPY 221
             D++S G+ L  +++   P+
Sbjct: 206 RCDLWSLGVILYILLSGYPPF 226

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 74/181 (40%), Gaps = 33/181 (18%)
Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG------------QVKIGDLGFAAIVG 174
           +Q+  G+ +LH+ +  IIHRDL   NI ++ +              ++ I D G    + 
Sbjct: 122 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 175 RSHAA-----HSIIGTPEYMAPELYEED--------YTEMVDIYSFGLCLLEMVTMEIPY 221
                     ++  GT  + APEL EE          T  +DI+S G C+   +  +  +
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKH 238
Query: 222 SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-----PRARPSASELLKDPF 276
              D  ++    + G      +  + D  + A     I+Q     P  RP+A ++L+ P 
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 277 F 277
           F
Sbjct: 299 F 299

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	289
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-136
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-60
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-60
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-59
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-58
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-58
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-56
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-55
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-53
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-51
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-51
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-48
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-48
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-48
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-47
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-46
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-46
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-45
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-44
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-43
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-42
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-42
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-42
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-42
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-41
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-41
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-41
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-40
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-39
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-39
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-38
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-38
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-38
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-38
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-37
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-37
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-37
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-35
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-35
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-34
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-33
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-33
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-30
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-29
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-29
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-28
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-28
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-28
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-28
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-27
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-26
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-25
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-25
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-22
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-21
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-21
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-21
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-19
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-19
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-18
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-17
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-14
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-05

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  386 bits (994), Expect = e-136
 Identities = 123/281 (43%), Positives = 171/281 (60%), Gaps = 6/281 (2%)

Query: 2   SDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVL 61
            +      V +   GRF ++   +G G+ K VY+  D E  +EVAW +++    ++    
Sbjct: 11  IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER- 69

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLRTYRKKHRHVSI 119
             R   E ++L+ L++  I+  Y  W         +  +TE+ TSG L+TY K+ + + I
Sbjct: 70  -QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 128

Query: 120 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 179
           K L+ W +Q+L+GL++LHT  P IIHRDL C NIFI G  G VKIGDLG A +   S  A
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-A 187

Query: 180 HSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 239
            ++IGTPE+MAPE+YEE Y E VD+Y+FG+C+LEM T E PYSEC + A+IY++VT GVK
Sbjct: 188 KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 240 PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
           P + +KV  PEVK  IE CI Q    R S  +LL   FF E
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  193 bits (493), Expect = 5e-60
 Identities = 61/262 (23%), Positives = 121/262 (46%), Gaps = 14/262 (5%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             +G G+  K       E+G +    ++ +S  S           EV +L  +K+  I+ 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER--EESRREVAVLANMKHPNIVQ 87

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI--KALKKWSKQVLEGLEYLHTHE 140
               + ++   +L  + + C  G+L       + V      +  W  Q+   L+++H  +
Sbjct: 88  YRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYEED-Y 198
             I+HRD+   NIF+  + G V++GD G A ++  +   A + IGTP Y++PE+ E   Y
Sbjct: 146 --ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202

Query: 199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKC 258
               DI++ G  L E+ T++  + E  S+  +  K+  G     ++     ++++ + + 
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260

Query: 259 IA-QPRARPSASELLKDPFFSE 279
               PR RPS + +L+  F ++
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAK 282

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  191 bits (487), Expect = 6e-60
 Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 15/266 (5%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            +G+G+  +  +   + +G  + W ++     +E       L SEV LLR LK+  I+  
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELKHPNIVRY 70

Query: 84  YSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLH-- 137
           Y   +D  + TL  + E C  G+L        K+ +++  + + +   Q+   L+  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 138 -THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYE 195
                 ++HRDL  +N+F++G    VK+GD G A I+    + A + +GTP YM+PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN 189

Query: 196 ED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF 254
              Y E  DI+S G  L E+  +  P+    S  ++  K+  G K + +      E+   
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEI 247

Query: 255 IEKCIA-QPRARPSASELLKDPFFSE 279
           I + +  +   RPS  E+L++P   E
Sbjct: 248 ITRMLNLKDYHRPSVEEILENPLILE 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  190 bits (486), Expect = 2e-59
 Identities = 58/276 (21%), Positives = 109/276 (39%), Gaps = 21/276 (7%)

Query: 13  DPSGRFGRYSD------LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 66
           DPS     +         LG G+  +V++   +E+G   A  +              R  
Sbjct: 47  DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR--ARKL 104

Query: 67  SEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKK 124
           +EV     + ++   +     W +     L   TE+C   +L+ + +     +    +  
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTELC-GPSLQQHCEAWGASLPEAQVWG 161

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           + +  L  L +LH+    ++H D+  +NIF+    G+ K+GD G    +G + A     G
Sbjct: 162 YLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEG 218

Query: 185 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN 244
            P YMAPEL +  Y    D++S GL +LE+          +   ++ +          L 
Sbjct: 219 DPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL- 277

Query: 245 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
                E+++ +   +   P+ R +A  LL  P   +
Sbjct: 278 ---SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  186 bits (475), Expect = 3e-58
 Identities = 65/284 (22%), Positives = 122/284 (42%), Gaps = 36/284 (12%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           L+GSG   +V++A  + +G      +V+ ++         +   EV+ L  L +  I+  
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHY 69

Query: 84  YSVWLDDQH--------------NTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSK 127
              W    +                L    E C  G L  +  +++   +      +  +
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           Q+ +G++Y+H+ +  +I+RDL  SNIF+     QVKIGD G    +          GT  
Sbjct: 130 QITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLR 186

Query: 188 YMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV 246
           YM+PE      Y + VD+Y+ GL L E++ +     E    +K +  +  G+        
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIF--- 240

Query: 247 KDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
            D + K  ++K +++ P  RP+ SE+L+     + + + +E   
Sbjct: 241 -DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  187 bits (477), Expect = 4e-58
 Identities = 73/279 (26%), Positives = 130/279 (46%), Gaps = 16/279 (5%)

Query: 8   PFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
                        +     +G G   +VYRA    +G+ VA  +V++     D       
Sbjct: 21  ALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARADC 79

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKA 121
             E+ LL+ L +  +I  Y+ +++D  N LN + E+  +G+L    + ++K+ R +  + 
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AH 180
           + K+  Q+   LE++H+    ++HRD+  +N+FI    G VK+GDLG           AH
Sbjct: 138 VWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAH 194

Query: 181 SIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPY-SECDSVAKIYKKVTGGV 238
           S++GTP YM+PE   E+ Y    DI+S G  L EM  ++ P+  +  ++  + KK+    
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254

Query: 239 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 276
            P   +     E++  +  CI   P  RP  + +     
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  181 bits (462), Expect = 4e-56
 Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 44/303 (14%)

Query: 19  GRYSD------LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           GRY         LG G    V+ A ++ +    A  ++RL +         ++  EV+ L
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA---REKVMREVKAL 57

Query: 73  RTLKNKYIIVCYSVWLDD----------QHNTLNFITEVCTSGNLRTY---RKKHRHVSI 119
             L++  I+  ++ WL+               L    ++C   NL+ +   R        
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 120 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 179
                   Q+ E +E+LH+    ++HRDL  SNIF   +   VK+GD G    + +    
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEE 174

Query: 180 H-------------SIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD 225
                           +GT  YM+PE      Y+  VDI+S GL L E++    P+S   
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231

Query: 226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD 284
              +    V    K   L   K P     ++  ++  P  RP A  ++++  F +L+   
Sbjct: 232 ERVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290

Query: 285 SEP 287
              
Sbjct: 291 KTV 293

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  179 bits (456), Expect = 4e-55
 Identities = 78/263 (29%), Positives = 120/263 (45%), Gaps = 18/263 (6%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
            +LG G    VY   D    + +A  ++       D      LH E+ L + LK+K I+ 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPE----RDSRYSQPLHEEIALHKHLKHKNIVQ 83

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRT-YRKKHRHVSIK--ALKKWSKQVLEGLEYLHTH 139
               + ++    +    E    G+L    R K   +      +  ++KQ+LEGL+YLH +
Sbjct: 84  YLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGRSHAAHSIIGTPEYMAPE---LYE 195
              I+HRD+   N+ IN   G +KI D G +  + G +    +  GT +YMAPE      
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDS-VAKIYKKVTGGVKPQALNKVKDPEVKAF 254
             Y +  DI+S G  ++EM T + P+ E     A ++K     V P+    +   E KAF
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM-SAEAKAF 258

Query: 255 IEKC-IAQPRARPSASELLKDPF 276
           I KC    P  R  A++LL D F
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEF 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  178 bits (453), Expect = 1e-54
 Identities = 82/294 (27%), Positives = 125/294 (42%), Gaps = 43/294 (14%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
            +LG GA  +V +A +  +    A  ++R +           + SEV LL +L ++Y++ 
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-----TILSEVMLLASLNHQYVVR 66

Query: 83  CYSVWLDDQH-----------NTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVL 130
            Y+ WL+ ++           +TL    E C +G L      ++ +       +  +Q+L
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---------------GR 175
           E L Y+H+    IIHRDL   NIFI+ +   VKIGD G A  V               G 
Sbjct: 127 EALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 176 SHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK 233
           S    S IGT  Y+A E+ +    Y E +D+YS G+   EM+    P+S       I KK
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240

Query: 234 VTGGVK--PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDD 284
           +       P   +  K    K  I   I   P  RP A  LL   +    + D+
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  173 bits (440), Expect = 7e-53
 Identities = 62/272 (22%), Positives = 112/272 (41%), Gaps = 26/272 (9%)

Query: 21  YSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL---HSEVQLL 72
            +++     +G G    V++    ++   VA   + L     +  ++ +      EV ++
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLE 131
             L +  I+  Y +  +        + E    G+L      K   +      +    +  
Sbjct: 78  SNLNHPNIVKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQ----VKIGDLGFAAIVGRSHAAHSIIGTPE 187
           G+EY+    P I+HRDL   NIF+           K+ D G +      H+   ++G  +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQ 191

Query: 188 YMAPELY---EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTGGVKPQA 242
           +MAPE     EE YTE  D YSF + L  ++T E P+ E     +  I      G++P  
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT- 250

Query: 243 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
           + +   P ++  IE C +  P+ RP  S ++K
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  174 bits (444), Expect = 7e-53
 Identities = 60/262 (22%), Positives = 104/262 (39%), Gaps = 21/262 (8%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             +G G+  +V+R  D++ G + A  +VRL  F  +         E+     L +  I+ 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVP 114

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            Y    +     +N   E+   G+L    K+   +       +  Q LEGLEYLHT    
Sbjct: 115 LYGAVREG--PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR--R 170

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA------HSIIGTPEYMAPELYEE 196
           I+H D+   N+ ++ +  +  + D G A  +              I GT  +MAPE+   
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 197 D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
                 VDI+S    +L M+    P+++        K  +     + +     P     I
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290

Query: 256 EKCIAQ-PRARPSASELLKDPF 276
           ++ + + P  R SA EL +   
Sbjct: 291 QEGLRKEPVHRASAMELRRKVG 312

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  173 bits (441), Expect = 9e-53
 Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 19/264 (7%)

Query: 21  YSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           + DL     +G+G+   V+RA     G +VA   +    F  +   VN    EV +++ L
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAE--RVNEFLREVAIMKRL 91

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSKQVLEG 132
           ++  I++         +  L+ +TE  + G+L            +  +     +  V +G
Sbjct: 92  RHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAP 191
           + YLH   P I+HR+L   N+ ++     VK+ D G + +   +  ++ S  GTPE+MAP
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208

Query: 192 ELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E+   E   E  D+YSFG+ L E+ T++ P+   +    +        + + + +  +P+
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE-IPRNLNPQ 267

Query: 251 VKAFIEKCIAQ-PRARPSASELLK 273
           V A IE C    P  RPS + ++ 
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMD 291

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  168 bits (428), Expect = 3e-51
 Identities = 48/265 (18%), Positives = 100/265 (37%), Gaps = 22/265 (8%)

Query: 21  YSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           +  L     L      ++++   Q  G ++    +++  +S         + E   LR  
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTR--KSRDFNEECPRLRIF 64

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGL 133
            +  ++                IT     G+L        +  V      K++  +  G+
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
            +LHT EP I    LN  ++ I+ +    +I           S  +   +  P ++APE 
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVK----FSFQSPGRMYAPAWVAPEA 179

Query: 194 YE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
            +    +      D++SF + L E+VT E+P+++  ++    K    G++P     +  P
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI-SP 238

Query: 250 EVKAFIEKCIAQ-PRARPSASELLK 273
            V   ++ C+ + P  RP    ++ 
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVP 263

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  167 bits (426), Expect = 9e-51
 Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 40/280 (14%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYII 81
           + +GSG    V++   + +G   A  + +                EV     L ++ +++
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE--QNALREVYAHAVLGQHSHVV 74

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
             +S W +D H  +    E C  G+L        +   +     LK    QV  GL Y+H
Sbjct: 75  RYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 138 THEPCIIHRDLNCSNIFINGN------------------IGQVKIGDLGFAAIVGRSHAA 179
           +    ++H D+  SNIFI+                        KIGDLG    V R  + 
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG---HVTRISSP 187

Query: 180 HSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
               G   ++A E+ +E+  +    DI++  L ++     E      D   +I +     
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG---- 243

Query: 238 VKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPF 276
            +   + +V   E    ++  I   P  RPSA  L+K   
Sbjct: 244 -RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  163 bits (415), Expect = 1e-48
 Identities = 62/286 (21%), Positives = 122/286 (42%), Gaps = 30/286 (10%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYI 80
             +GSG   KV++  + E+    A   V L         ++   +E+  L  L+  +  I
Sbjct: 15  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQHSDKI 71

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           I  Y   + DQ+  +  + E C + +L ++ KK + +     K + K +LE +  +H H 
Sbjct: 72  IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPEL---- 193
             I+H DL  +N  I    G +K+ D G A  +     S    S +GT  YM PE     
Sbjct: 129 --IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 194 --------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSEC-DSVAKIYKKVTGGVKPQALN 244
                    +   +   D++S G  L  M   + P+ +  + ++K++  +    + +  +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244

Query: 245 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
              + +++  ++ C+ + P+ R S  ELL  P+        ++ + 
Sbjct: 245 IP-EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  164 bits (417), Expect = 2e-48
 Identities = 62/286 (21%), Positives = 123/286 (43%), Gaps = 30/286 (10%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYI 80
             +GSG   KV++  + E+    A   V L     D   ++   +E+  L  L+  +  I
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           I  Y   + DQ+  +  + E C + +L ++ KK + +     K + K +LE +  +H H 
Sbjct: 119 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYEED 197
             I+H DL  +N  I    G +K+ D G A  +     S    S +G   YM PE  ++ 
Sbjct: 176 --IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 198 ------------YTEMVDIYSFGLCLLEMVTMEIPYSEC-DSVAKIYKKVTGGVKPQALN 244
                        +   D++S G  L  M   + P+ +  + ++K++  +    + +   
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FP 290

Query: 245 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
            + + +++  ++ C+ + P+ R S  ELL  P+        ++ + 
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  162 bits (411), Expect = 3e-48
 Identities = 62/286 (21%), Positives = 122/286 (42%), Gaps = 30/286 (10%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYI 80
             +GSG   KV++  + E+    A   V L         ++   +E+  L  L+  +  I
Sbjct: 34  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQHSDKI 90

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           I  Y   + DQ+  +  + E C + +L ++ KK + +     K + K +LE +  +H H 
Sbjct: 91  IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPELYEED 197
             I+H DL  +N  I    G +K+ D G A  +     S    S +GT  YM PE  ++ 
Sbjct: 148 --IVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 198 ------------YTEMVDIYSFGLCLLEMVTMEIPYSEC-DSVAKIYKKVTGGVKPQALN 244
                        +   D++S G  L  M   + P+ +  + ++K++  +    + +   
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FP 262

Query: 245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
            + + +++  ++ C+   P+ R S  ELL  P+        ++ + 
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  160 bits (408), Expect = 9e-48
 Identities = 61/269 (22%), Positives = 122/269 (45%), Gaps = 16/269 (5%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVC 83
           +GSG   +V++   ++ G  +A  Q+R S    +     R+  ++  +L++    YI+ C
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIVQC 89

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +  ++ +    +    E+  +   +  ++    +  + L K +  +++ L YL   +  +
Sbjct: 90  FGTFITN--TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EKHGV 146

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE------LYEED 197
           IHRD+  SNI ++   GQ+K+ D G +  +    A     G   YMAPE        + D
Sbjct: 147 IHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DPEVKAFIE 256
           Y    D++S G+ L+E+ T + PY  C +  ++  KV     P     +    + ++F++
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265

Query: 257 KC-IAQPRARPSASELLKDPFFSELNDDD 284
            C     R RP  ++LL+  F       +
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  158 bits (402), Expect = 2e-47
 Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 21/276 (7%)

Query: 9   FVEVDPSG-RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 67
            +E+D +         ++G G   KVYRAF    G EVA    R     +    +  +  
Sbjct: 1   LLEIDFAELTLEE---IIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQ 55

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E +L   LK+  II    V L + +  L  + E    G L       + +    L  W+ 
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAV 112

Query: 128 QVLEGLEYLHTHEPC-IIHRDLNCSNIFINGNIGQ-------VKIGDLGFAAIVGRSHAA 179
           Q+  G+ YLH      IIHRDL  SNI I   +         +KI D G A    R+   
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TK 171

Query: 180 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV 238
            S  G   +MAPE+     +++  D++S+G+ L E++T E+P+   D +A  Y      +
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231

Query: 239 KPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK 273
                +          +E C    P +RPS + +L 
Sbjct: 232 ALPIPSTC-PEPFAKLMEDCWNPDPHSRPSFTNILD 266

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  158 bits (402), Expect = 5e-47
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 31/267 (11%)

Query: 21  YSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           Y ++     +G GA   V +A  +    +VA  Q+      +          E++ L  +
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKA------FIVELRQLSRV 58

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKALKKWSKQVLEG 132
            +  I+  Y   L    N +  + E    G+L       +   + +      W  Q  +G
Sbjct: 59  NHPNIVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 133 LEYLHTHEPC-IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTPEYM 189
           + YLH+ +P  +IHRDL   N+ +      +KI D G A         H  +  G+  +M
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWM 170

Query: 190 APELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA-KIYKKVTGGVKPQALNKVK 247
           APE++E  +Y+E  D++S+G+ L E++T   P+ E    A +I   V  G +P  +  + 
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL- 229

Query: 248 DPEVKAFIEKCIAQ-PRARPSASELLK 273
              +++ + +C ++ P  RPS  E++K
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVK 256

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  156 bits (397), Expect = 4e-46
 Identities = 54/273 (19%), Positives = 111/273 (40%), Gaps = 38/273 (13%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWN-QV---RLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           +L+G G   +VY            W+ +V    +    ++   +     EV   R  +++
Sbjct: 39  ELIGKGRFGQVYHGR---------WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLH 137
            +++     +   H  L  IT +C    L +  R     + +   ++ ++++++G+ YLH
Sbjct: 90  NVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH------SIIGTPEYMAP 191
                I+H+DL   N+F +     V I D G  +I G   A           G   ++AP
Sbjct: 148 AKG--ILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 192 EL----------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           E+           +  +++  D+++ G    E+   E P+    + A I+ ++  G+KP 
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-QMGTGMKPN 262

Query: 242 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
                   E+   +  C A     RP+ ++L+ 
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  155 bits (393), Expect = 9e-46
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 29/264 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           +GSG+   VY+      G    +VA   + ++  +     +    +EV +LR  ++  I+
Sbjct: 32  IGSGSFGTVYK------GKWHGDVAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRHVNIL 83

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           +        Q   L  +T+ C   +L  +         +K L   ++Q   G++YLH   
Sbjct: 84  LFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAPEL--YE 195
             IIHRDL  +NIF++ +   VKIGD G A    R   SH    + G+  +MAPE+   +
Sbjct: 141 --IIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 196 ED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK---DPE 250
           +   Y+   D+Y+FG+ L E++T ++PYS  ++  +I + V  G     L+KV+      
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257

Query: 251 VKAFIEKCIAQ-PRARPSASELLK 273
           +K  + +C+ +    RPS   +L 
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILA 281

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  153 bits (389), Expect = 3e-45
 Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 17/270 (6%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVC 83
           LG GA   V +      G  +A  ++R +    +     RL  ++   +RT+   + +  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYR---KKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           Y     +    +    E+  +   + Y+    K + +    L K +  +++ LE+LH  +
Sbjct: 72  YGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH-SK 128

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-----LYE 195
             +IHRD+  SN+ IN   GQVK+ D G +  +    A     G   YMAPE     L +
Sbjct: 129 LSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
           + Y+   DI+S G+ ++E+  +  PY    +  +  K+V     PQ        E   F 
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247

Query: 256 EKC-IAQPRARPSASELLKDPFFSELNDDD 284
            +C     + RP+  EL++ PFF+      
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  152 bits (387), Expect = 1e-44
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 21/274 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVC 83
           +G GA   V +   +  G  +A  ++R +    D     +L  ++  ++R+    YI+  
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQLLMDLDVVMRSSDCPYIVQF 86

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTH 139
           Y     +         E+ ++   + Y+         +  + L K +   ++ L +L   
Sbjct: 87  YGALFRE--GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-E 143

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-----LY 194
              IIHRD+  SNI ++ + G +K+ D G +  +  S A     G   YMAPE       
Sbjct: 144 NLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD---PEV 251
            + Y    D++S G+ L E+ T   PY + +SV     +V  G  PQ  N  +    P  
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262

Query: 252 KAFIEKC-IAQPRARPSASELLKDPFFSELNDDD 284
             F+  C       RP   ELLK PF     +  
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  149 bits (377), Expect = 2e-43
 Identities = 72/292 (24%), Positives = 130/292 (44%), Gaps = 23/292 (7%)

Query: 1   MSDRDGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV 60
            S   G   ++ DP   F +  + +G G+  +V++  D      VA   + L    ++  
Sbjct: 7   QSGLPGMQNLKADPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-- 63

Query: 61  LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH----RH 116
            +  +  E+ +L    + Y+   Y  +L D    L  I E    G+     +        
Sbjct: 64  -IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLLEPGPLDETQ 120

Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA-IVGR 175
           ++        +++L+GL+YLH+ +   IHRD+  +N+ ++ + G+VK+ D G A  +   
Sbjct: 121 IATI-----LREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDT 172

Query: 176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
               ++ +GTP +MAPE+ ++  Y    DI+S G+  +E+   E P+SE   +  ++   
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 232

Query: 235 TGGVKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 285
                P  L       +K F+E C   +P  RP+A ELLK  F        S
Sbjct: 233 KN--NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  149 bits (378), Expect = 3e-43
 Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 27/233 (11%)

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY---RKKHRHVSIKAL 122
             +++ +     K  +          +  L    ++C   NL+ +   R           
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVY--LYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA--- 179
                Q+ E +E+LH+    ++HRDL  SNIF   +   VK+GD G    + +       
Sbjct: 167 LHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTV 223

Query: 180 ----------HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA 228
                        +GT  YM+PE    + Y+  VDI+S GL L E++     +S      
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERV 280

Query: 229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSEL 280
           +I   V     P    + K P+    ++  ++  P  RP A++++++  F  L
Sbjct: 281 RIITDVRNLKFPLLFTQ-KYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  148 bits (376), Expect = 1e-42
 Identities = 71/303 (23%), Positives = 119/303 (39%), Gaps = 51/303 (16%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V++   +  G+ +A   + L      P + N++  E+Q+L    + YI+  Y
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 97

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             +  D    ++   E    G+L    KK   +  + L K S  V++GL YL   +  I+
Sbjct: 98  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIM 154

Query: 145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVD 203
           HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+   D
Sbjct: 155 HRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 212

Query: 204 IYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD--------------- 248
           I+S GL L+EM     P    D+               A    +                
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272

Query: 249 --------------------------PEVKAFIEKCIAQ-PRARPSASELLKDPFFSELN 281
                                      E + F+ KC+ + P  R    +L+   F    +
Sbjct: 273 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332

Query: 282 DDD 284
            ++
Sbjct: 333 AEE 335

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  145 bits (367), Expect = 6e-42
 Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 20/272 (7%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+ + +G GA   VY A D   G EVA  Q+ L    +  +++N    E+ ++
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN----EILVM 71

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVL 130
           R  KN  I+     +L    + L  + E    G+L     +       I A+    ++ L
Sbjct: 72  RENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECL 126

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYM 189
           + LE+LH+++  +IHRD+   NI +  + G VK+ D GF A +    +   +++GTP +M
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 190 APEL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK- 247
           APE+   + Y   VDI+S G+  +EM+  E PY   + +  +Y   T G  P+  N  K 
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKL 242

Query: 248 DPEVKAFIEKCIAQ-PRARPSASELLKDPFFS 278
               + F+ +C+      R SA ELL+  F  
Sbjct: 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  144 bits (365), Expect = 1e-41
 Identities = 69/279 (24%), Positives = 123/279 (44%), Gaps = 32/279 (11%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +++GSGA   V  A+   +  +VA  ++ L         ++ L  E+Q +    +  I+ 
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEIQAMSQCHHPNIVS 77

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS--------KQVLEGLE 134
            Y+ ++      L  + ++ + G++    K                      ++VLEGLE
Sbjct: 78  YYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA------IVGRSHAAHSIIGTPEY 188
           YLH +    IHRD+   NI +  + G V+I D G +A       + R+    + +GTP +
Sbjct: 136 YLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 189 MAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQAL 243
           MAPE+ E+   Y    DI+SFG+  +E+ T   PY +      +    +     ++    
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 244 NKVKD----PEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
           +K          +  I  C+ + P  RP+A+ELL+  FF
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  143 bits (363), Expect = 4e-41
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 16/270 (5%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP      Y   +G G+   V  A ++  G +VA   + L       +L N    EV ++
Sbjct: 42  DPRLLLDSY-VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN----EVVIM 96

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  ++  ++  Y  +L      L  + E    G L T       ++ + +    + VL+ 
Sbjct: 97  RDYQHFNVVEMYKSYLVG--EELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQA 153

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAP 191
           L YLH     +IHRD+   +I +  + G+VK+ D GF A + +      S++GTP +MAP
Sbjct: 154 LAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210

Query: 192 EL-YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-DP 249
           E+     Y   VDI+S G+ ++EMV  E PY     V  + +       P+  N  K  P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSP 269

Query: 250 EVKAFIEKCIA-QPRARPSASELLKDPFFS 278
            ++ F+E+ +   P+ R +A ELL  PF  
Sbjct: 270 VLRDFLERMLVRDPQERATAQELLDHPFLL 299

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  142 bits (361), Expect = 6e-41
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 29/286 (10%)

Query: 7   EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 66
               ++DP+  +      LG GA  KVY+A ++E G   A   +      E    +    
Sbjct: 10  HVRRDLDPNEVWEIV-GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--- 65

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV----SIKAL 122
            E+++L T  + YI+     +  D    L  + E C  G +     +         I+ +
Sbjct: 66  -EIEILATCDHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 122

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHS 181
               +Q+LE L +LH+    IIHRDL   N+ +    G +++ D G +A   ++     S
Sbjct: 123 ---CRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDS 176

Query: 182 IIGTPEYMAPE------LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 235
            IGTP +MAPE      + +  Y    DI+S G+ L+EM  +E P+ E + +  + K   
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236

Query: 236 GGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLKDPFFS 278
               P  L        E + F++      P  RPSA++LL+ PF S
Sbjct: 237 SD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  141 bits (358), Expect = 2e-40
 Identities = 72/271 (26%), Positives = 130/271 (47%), Gaps = 20/271 (7%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
            P   F    + LG G+   VY+A  +E G  VA  QV +    ++      +  E+ ++
Sbjct: 26  QPEEVFDVL-EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIM 78

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRT-YRKKHRHVSIKALKKWSKQVLE 131
           +   + +++  Y  +  +    L  + E C +G++    R +++ ++   +    +  L+
Sbjct: 79  QQCDSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMA 190
           GLEYLH      IHRD+   NI +N   G  K+ D G A  +  + A  +++IGTP +MA
Sbjct: 137 GLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 191 PE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD- 248
           PE + E  Y  + DI+S G+  +EM   + PY++   +  I+   T    P    K +  
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PPTFRKPELW 251

Query: 249 -PEVKAFIEKC-IAQPRARPSASELLKDPFF 277
                 F+++C +  P  R +A++LL+ PF 
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  142 bits (359), Expect = 3e-40
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 19/285 (6%)

Query: 1   MSDRD-GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP 59
           + D D  E F + DP   F      +G G+   VY A D      VA  ++  S    + 
Sbjct: 38  LKDPDVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 96

Query: 60  VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI 119
                +  EV+ L+ L++   I     +L +  +T   + E C            + +  
Sbjct: 97  K-WQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQE 153

Query: 120 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA 179
             +   +   L+GL YLH+H   +IHRD+   NI ++   G VK+GD G A+I+     A
Sbjct: 154 VEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---A 207

Query: 180 HSIIGTPEYMAPE----LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 235
           +S +GTP +MAPE    + E  Y   VD++S G+  +E+   + P    ++++ +Y    
Sbjct: 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267

Query: 236 GGVKPQALNKVK-DPEVKAFIEKC-IAQPRARPSASELLKDPFFS 278
                 AL         + F++ C    P+ RP++  LLK  F  
Sbjct: 268 NE--SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  138 bits (350), Expect = 4e-39
 Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 57/295 (19%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVA----WNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
             +G G   +V+    +  G +VA    +     S F E         +E+     ++++
Sbjct: 43  KQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEASWFRE---------TEIYQTVLMRHE 91

Query: 79  YIIVCYSVWLDDQHNTLNF--ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
            I+   +  +    +      IT+   +G+L  Y K    +  K++ K +   + GL +L
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHL 150

Query: 137 HT------HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-----AAHSIIGT 185
           HT       +P I HRDL   NI +  N G   I DLG A              ++ +GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

Query: 186 PEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVT----------MEIPYSECDSVA 228
             YM PE+ +E           M D+YSFGL L E+             ++PY +     
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269

Query: 229 KIYKKVTGGV---------KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
             Y+ +   V           +  +     ++   + +C A  P +R +A  + K
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  138 bits (350), Expect = 1e-38
 Identities = 58/327 (17%), Positives = 112/327 (34%), Gaps = 73/327 (22%)

Query: 13  DPSGRFGRYSDLLGSGAVK--KVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 70
              G +     ++G G      V  A  +  G  V   ++ L   S +  +V  L  E+ 
Sbjct: 22  PEGGCYELL-TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE--MVTFLQGELH 78

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-----VSIKALKKW 125
           + +   +  I+   + ++ D    L  +T     G+ +     H       ++I  +   
Sbjct: 79  VSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI--- 133

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA------- 178
            + VL+ L+Y+H      +HR +  S+I I+ + G+V +  L     +            
Sbjct: 134 LQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 179 -AHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSE----------- 223
                +    +++PE+ +++   Y    DIYS G+   E+    +P+ +           
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250

Query: 224 --------------------------------CDSVAKIYKKVTGGVKPQALNKVKDPEV 251
                                                   +   G       ++   P  
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

Query: 252 KAFIEKCIAQ-PRARPSASELLKDPFF 277
             F+E+C+ + P ARPSAS LL   FF
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFF 337

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  137 bits (346), Expect = 1e-38
 Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 36/296 (12%)

Query: 20  RYSDL-----LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
           R SDL     LG G   +  +   +E G  +      L  F E+         EV+++R 
Sbjct: 8   RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMV--MKELIRFDEE--TQRTFLKEVKVMRC 63

Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGL 133
           L++  ++    V   D+   LNFITE    G LR   +             ++K +  G+
Sbjct: 64  LEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA-------------- 179
            YLH+    IIHRDLN  N  +  N   V + D G A ++                    
Sbjct: 122 AYLHSM--NIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 180 -HSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY-KKVTG 236
            ++++G P +MAPE +    Y E VD++SFG+ L E++       +       +   V G
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238

Query: 237 GVKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DPFFSELNDDDSEPSP 289
            +          P       +C    P  RPS  +L    +     L         
Sbjct: 239 FLDRYCPPNC-PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  137 bits (346), Expect = 1e-38
 Identities = 67/291 (23%), Positives = 133/291 (45%), Gaps = 31/291 (10%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP+G F    +L+G+G   +VY+    + G   A   + ++   E+ +       E+ +L
Sbjct: 21  DPAGIFELV-ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-----EINML 74

Query: 73  RTLKN-KYIIVCYSVWLDDQHNTLN----FITEVCTSGNLRTYRKKHRHVSIKALKKW-- 125
           +   + + I   Y  ++      ++     + E C +G++    K  +  ++K  ++W  
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIA 132

Query: 126 --SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSI 182
              +++L GL +LH H+  +IHRD+   N+ +  N  +VK+ D G +A + R+    ++ 
Sbjct: 133 YICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTF 189

Query: 183 IGTPEYMAPE------LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG 236
           IGTP +MAPE        +  Y    D++S G+  +EM     P  +   +  ++     
Sbjct: 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249

Query: 237 GVKPQALNKVK-DPEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 285
                 L   K   + ++FIE C +     RP+  +L+K PF  +  ++  
Sbjct: 250 P--APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQ 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  136 bits (345), Expect = 2e-38
 Identities = 58/291 (19%), Positives = 107/291 (36%), Gaps = 49/291 (16%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + +G G   +V+R   +  G EVA                    +E+     L+++ I+ 
Sbjct: 48  ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILG 100

Query: 83  CYSVWLDDQHNTLNF--ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-- 138
             +    D         +++    G+L  Y  ++  V+++ + K +     GL +LH   
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEI 159

Query: 139 ----HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-----AAHSIIGTPEYM 189
                +P I HRDL   NI +  N G   I DLG A     +      A +  +GT  YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 190 APELYEE-------DYTEMVDIYSFGLCLLEMVT----------MEIPYSECDSVAKIYK 232
           APE+ ++       +  +  DIY+ GL   E+             ++PY +        +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 233 KVTGGV---------KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
           ++   V           +  +      +   + +C      AR +A  + K
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  135 bits (341), Expect = 4e-38
 Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 57/295 (19%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVA----WNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK 78
           + +G G   +V+R     +G  VA     ++   S F E         +E+     L+++
Sbjct: 14  ECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRE---------TELYNTVMLRHE 62

Query: 79  YIIVCYSVWLDDQHNTLNF--ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
            I+   +  +  +H++     IT     G+L  Y +    +   +  +    +  GL +L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHL 121

Query: 137 HT------HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-----AAHSIIGT 185
           H        +P I HRDL   NI +  N GQ  I DLG A +  +S        +  +GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

Query: 186 PEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVT----------MEIPYSECDSVA 228
             YMAPE+ +E       D  + VDI++FGL L E+             + P+ +     
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240

Query: 229 KIYKKVTGGV---------KPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK 273
             ++ +   V           +  +      +   +++C    P AR +A  + K
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  137 bits (345), Expect = 7e-38
 Identities = 56/330 (16%), Positives = 103/330 (31%), Gaps = 57/330 (17%)

Query: 4   RDGEPFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPV- 60
                 VE +   R        +LG         A DQE G       V + +F+E P  
Sbjct: 63  TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVPYFTERPPS 119

Query: 61  -LVNRLHSEVQLLRTLK------------------------NKYIIVCYSVWLDDQHNTL 95
             + ++  EV  LR L+                         K  ++   +   D     
Sbjct: 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179

Query: 96  NFITEVCTSGN-------LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDL 148
            F        N       L ++   H+ +   A  + + QV+  L  LH +   ++H  L
Sbjct: 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYL 237

Query: 149 NCSNIFINGNIGQVKIGDLGFAAIVGRSH--AAHSIIGTPEYMAPELYEED------YTE 200
              +I ++   G V +         G S           PE  A  +           T 
Sbjct: 238 RPVDIVLDQR-GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
             D ++ GL +  +   ++P ++ D+     + +    K           V+A +E  + 
Sbjct: 297 AFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLR 349

Query: 261 -QPRARPSASELLKDPFFSELNDDDSEPSP 289
                R    + ++ P + +L  + S   P
Sbjct: 350 YPKEDRLLPLQAMETPEYEQLRTELSAALP 379

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  134 bits (339), Expect = 9e-38
 Identities = 75/292 (25%), Positives = 136/292 (46%), Gaps = 25/292 (8%)

Query: 8   PFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAW---NQVRLSHFSEDPVLV 62
           P V VDP     RY     LG G   K +   D +     A     +  L      P   
Sbjct: 5   PEVLVDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL----LKPHQR 59

Query: 63  NRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL 122
            ++  E+ + R+L +++++  +  + D+    +  + E+C   +L    K+ + ++    
Sbjct: 60  EKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEA 117

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHS 181
           + + +Q++ G +YLH +   +IHRDL   N+F+N +  +VKIGD G A  V         
Sbjct: 118 RYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKV 174

Query: 182 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--V 238
           + GTP Y+APE L ++ ++  VD++S G  +  ++  + P+ E   + + Y ++      
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEYS 233

Query: 239 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
            P+ +N    P   + I+K +   P ARP+ +ELL D FF+        P  
Sbjct: 234 IPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 281

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  140 bits (353), Expect = 1e-37
 Identities = 71/307 (23%), Positives = 116/307 (37%), Gaps = 39/307 (12%)

Query: 14  PSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           P+   G +   + LG+G    V R   Q+ G +VA  Q R     ++     R   E+Q+
Sbjct: 9   PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN---RERWCLEIQI 65

Query: 72  LRTLKNKYIIVCYSVWLDDQHNTLN----FITEVCTSGNLRTYRKKHRHVSI---KALKK 124
           ++ L +  ++    V    Q    N       E C  G+LR Y  +  +        ++ 
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSI 182
               +   L YLH +   IIHRDL   NI +         KI DLG+A  + +       
Sbjct: 126 LLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183

Query: 183 IGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           +GT +Y+APEL E + YT  VD +SFG    E +T   P+       + + KV       
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243

Query: 242 AL------------NKVKDPE-----VKAFIEKCIAQ-----PRARPSASELLKDPFFSE 279
            +            + +  P      +   +E+ +        R R +  +      F  
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303

Query: 280 LNDDDSE 286
           L+   S 
Sbjct: 304 LDSILSL 310

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (338), Expect = 2e-37
 Identities = 49/276 (17%), Positives = 79/276 (28%), Gaps = 30/276 (10%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G    V       +G   A  ++      +          E  + R   +  I+  
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD----REEAQREADMHRLFNHPNILRL 91

Query: 84  YSVWLDDQ--HNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
            +  L ++   +    +      G L       + K   ++   +      +  GLE +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII----------GTPE 187
                  HRDL  +NI +    GQ  + DLG                          T  
Sbjct: 152 --AKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 188 YMAPELYE----EDYTEMVDIYSFGLCLL-EMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           Y APEL+         E  D++S G C+L  M+  E PY                     
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267

Query: 243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
            +      +   +   +   P  RP    LL     
Sbjct: 268 QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  134 bits (339), Expect = 2e-37
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 29/294 (9%)

Query: 8   PFVEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA-----WNQVRLSHFSEDPV 60
           P V VDP     RY     LG G   K +   D +     A      + +   H      
Sbjct: 31  PEVLVDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH------ 83

Query: 61  LVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIK 120
              ++  E+ + R+L +++++  +  + D+    +  + E+C   +L    K+ + ++  
Sbjct: 84  QREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEP 141

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAA 179
             + + +Q++ G +YLH +   +IHRDL   N+F+N +  +VKIGD G A  V       
Sbjct: 142 EARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERK 198

Query: 180 HSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG- 237
             + GTP Y+APE L ++ ++  VD++S G  +  ++  + P+ E   + + Y ++    
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNE 257

Query: 238 -VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
              P+ +N    P   + I+K +   P ARP+ +ELL D FF+        P  
Sbjct: 258 YSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 307

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  134 bits (339), Expect = 4e-37
 Identities = 52/334 (15%), Positives = 100/334 (29%), Gaps = 63/334 (18%)

Query: 4   RDGEPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVA-------------- 46
             G+PF      G   R      +LG         A DQE G                  
Sbjct: 57  NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 116

Query: 47  ----------WNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN 96
                        +R     +   +  R      L++  + K +I       D    +  
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176

Query: 97  FITEVCTS------GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC 150
           F+     S        L ++   H+ +   A  + + QV+  L  LH +   ++H  L  
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRP 234

Query: 151 SNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL------------YEEDY 198
            +I ++   G V +         G          +  +  PEL                 
Sbjct: 235 VDIVLDQR-GGVFLTGFEHLVRDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLM 290

Query: 199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIE 256
           T   D ++ GL +  +   ++P ++ D+     + +            K+    V+A +E
Sbjct: 291 TFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWI--------FRSCKNIPQPVRALLE 341

Query: 257 KCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
             +      R    + ++ P + +L  + S   P
Sbjct: 342 GFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  133 bits (335), Expect = 1e-36
 Identities = 46/328 (14%), Positives = 86/328 (26%), Gaps = 47/328 (14%)

Query: 4   RDGEPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVA-------------- 46
                        +  R     + L  G    V+   D E   + A              
Sbjct: 46  PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105

Query: 47  WNQVR---------LSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF 97
             ++          L    E+     RL      +                D        
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 98  ITEVCTS------GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           +    +         L           I AL   + Q++     L +    ++H      
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPD 223

Query: 152 NIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY---EEDYTEMVDIYSFG 208
           N+FI  + G++ +GD+     VG      +      Y   E        +T  ++ +  G
Sbjct: 224 NLFIMPD-GRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 209 LCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD------PEVKAFIEKCIA-Q 261
           L +  +  + +P+       K   K      P   +            VK  I + +   
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340

Query: 262 PRARPSASELLKDPFFSELNDDDSEPSP 289
            R R    E ++ P F +L ++ S    
Sbjct: 341 RRRRLLPLEAMETPEFLQLQNEISSSLS 368

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  130 bits (328), Expect = 5e-36
 Identities = 56/272 (20%), Positives = 101/272 (37%), Gaps = 25/272 (9%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D+LG GA   V+R   ++ G   A        F      V+    E ++L+ L +K I+ 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVK 71

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI---KALKKWSKQVLEGLEYLHTH 139
            +++  +        I E C  G+L T  ++  +             + V+ G+ +L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 140 EPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE- 195
              I+HR++   NI            K+ D G A  +       S+ GT EY+ P++YE 
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189

Query: 196 --------EDYTEMVDIYSFGLCLLEMVTMEIP---YSECDSVAKIYKKVTGGVKPQALN 244
                   + Y   VD++S G+      T  +P   +       ++  K+  G    A++
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 245 KVKDPEVKA--FIEKCIAQPRARPSASELLKD 274
            V+  E     +                LL  
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (323), Expect = 2e-35
 Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 17/266 (6%)

Query: 19  GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY   D LG G +  VY A D    I+VA   +      E    + R   EV     L 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLS 69

Query: 77  NKYIIVCYSVWLDDQHNTLNFIT-EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
           ++ I+    V   D+ +   ++  E      L  Y + H  +S+     ++ Q+L+G+++
Sbjct: 70  HQNIVSMIDV---DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--AAHSIIGTPEYMAPEL 193
            H     I+HRD+   NI I+ N   +KI D G A  +  +     + ++GT +Y +PE 
Sbjct: 127 AHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183

Query: 194 YE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPE 250
            + E   E  DIYS G+ L EM+  E P++   +V+   K +   V      + K     
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243

Query: 251 VKAFIEKCIA-QPRARP-SASELLKD 274
           +   I +        R  +  E+  D
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMKDD 269

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  129 bits (325), Expect = 5e-35
 Identities = 56/272 (20%), Positives = 100/272 (36%), Gaps = 25/272 (9%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D+LG GA   V+R   ++ G   A        F      V+    E ++L+ L +K I+ 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVK 71

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSI---KALKKWSKQVLEGLEYLHTH 139
            +++  +        I E C  G+L T  ++  +             + V+ G+ +L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 140 EPCIIHRDLNCSNIFINGNI---GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE 196
              I+HR++   NI            K+ D G A  +       S+ GT EY+ P++YE 
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189

Query: 197 D---------YTEMVDIYSFGLCLLEMVTMEIP---YSECDSVAKIYKKVTGGVKPQALN 244
                     Y   VD++S G+      T  +P   +       ++  K+  G    A++
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249

Query: 245 KVKDPEVKA--FIEKCIAQPRARPSASELLKD 274
            V+  E     +                LL  
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (326), Expect = 8e-35
 Identities = 71/272 (26%), Positives = 107/272 (39%), Gaps = 31/272 (11%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYII 81
           D+LG GA   +       +  +VA  ++    FS           EVQLLR       +I
Sbjct: 30  DVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSF-------ADREVQLLRESDEHPNVI 81

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
             +    D Q        E+C    L+ Y  +K   H+ ++      +Q   GL +LH+ 
Sbjct: 82  RYFCTEKDRQF--QYIAIELCA-ATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLHSL 137

Query: 140 EPCIIHRDLNCSNIFI----NGNIGQVKIGDLGFAAIVGRSHAA----HSIIGTPEYMAP 191
              I+HRDL   NI I         +  I D G    +     +      + GT  ++AP
Sbjct: 138 N--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 192 ELYEED----YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKV 246
           E+  ED     T  VDI+S G     +++    P+ +              +      K 
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 247 KDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
           +D   +  IEK IA  P+ RPSA  +LK PFF
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  126 bits (318), Expect = 2e-34
 Identities = 67/298 (22%), Positives = 109/298 (36%), Gaps = 57/298 (19%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVA----WNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           +  ++   G    V++A    E   VA      Q + S  +E          EV  L  +
Sbjct: 27  QLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQNE---------YEVYSLPGM 75

Query: 76  KNKYII--VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K++ I+  +            L  IT     G+L  + K +  VS   L   ++ +  GL
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGL 134

Query: 134 EYLHT--------HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA---HSI 182
            YLH         H+P I HRD+   N+ +  N     I D G A       +A   H  
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 183 IGTPEYMAPEL------YEEDYTEMVDIYSFGLCLLEMVTMEIPYS-------------- 222
           +GT  YMAPE+      ++ D    +D+Y+ GL L E+ +                    
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253

Query: 223 -ECDSVAKIYKKV-TGGVKPQALNKV-KDPEVKAF---IEKCIAQ-PRARPSASELLK 273
            +  S+  + + V     +P   +   K   +      IE+C      AR SA  + +
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  128 bits (323), Expect = 5e-34
 Identities = 69/273 (25%), Positives = 108/273 (39%), Gaps = 13/273 (4%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
            +LG G+  +V    D+  G E A   +              L  EVQLL+ L +  I+ 
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMK 90

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            Y  + D  +     + EV T G L       +  S     +  +QVL G+ Y+H +   
Sbjct: 91  LYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--K 146

Query: 143 IIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 200
           I+HRDL   N+ +        ++I D G +     S      IGT  Y+APE+    Y E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEK 257
             D++S G+ L  +++   P++   +   I KKV  G    +     KV     K  I K
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKV-SESAKDLIRK 264

Query: 258 CIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
            +   P  R SA + L   +      +      
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  124 bits (313), Expect = 9e-34
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 20/270 (7%)

Query: 19  GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRL--SHFSEDPVLVNRLHSEVQLLRT 74
            RY   ++LG G + +V+ A D  +  +VA   V++  +  + DP    R   E Q    
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAA 68

Query: 75  LKNKYIIVCYSV-WLDDQHNTLNFIT-EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           L +  I+  Y     +     L +I  E      LR        ++ K   +      + 
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAA----HSIIGTPEY 188
           L + H +   IIHRD+  +NI I+     VK+ D G A  +  S  +     ++IGT +Y
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 189 MAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKV 246
           ++PE    +      D+YS G  L E++T E P++    V+  Y+ V      P A ++ 
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245

Query: 247 KDPEVKAFIEKCIA-QPRARP-SASELLKD 274
              ++ A + K +A  P  R  +A+E+  D
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (312), Expect = 1e-33
 Identities = 56/269 (20%), Positives = 103/269 (38%), Gaps = 21/269 (7%)

Query: 17  RFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRL--SHFSEDPVLVNRLHSEVQLL 72
           +FG Y    L+G G +  VY A D      VA   ++L     S DPV   R+  E +  
Sbjct: 32  QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTA 88

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFIT-EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLE 131
             L+  +++  +      + +   ++   +    +L    ++   ++        +Q+  
Sbjct: 89  GRLQEPHVVPIHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH--AAHSIIGTPEYM 189
            L+  H       HRD+   NI ++ +     + D G A+           + +GT  YM
Sbjct: 146 ALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202

Query: 190 APELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-KPQALNKVK 247
           APE +     T   DIY+    L E +T   PY   D ++ +   +   + +P  +    
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGI 261

Query: 248 DPEVKAFIEKCIA-QPRAR-PSASELLKD 274
                A I + +A  P  R  +  +L   
Sbjct: 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAA 290

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  127 bits (320), Expect = 1e-33
 Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 14/273 (5%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             LGSGA  +V    D+   +E A   +R +  S      ++L  EV +L+ L +  I+ 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN--SKLLEEVAVLKLLDHPNIMK 100

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            Y  + D ++     + E    G L          +        KQVL G+ YLH H   
Sbjct: 101 LYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH--N 156

Query: 143 IIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 200
           I+HRDL   N+ +        +KI D G +A+          +GT  Y+APE+  + Y E
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDE 216

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEK 257
             D++S G+ L  ++    P+    +  +I +KV  G           V     K  I++
Sbjct: 217 KCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLIKQ 274

Query: 258 CIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
            +    + R SA + L+ P+  E+         
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  122 bits (308), Expect = 2e-33
 Identities = 56/263 (21%), Positives = 112/263 (42%), Gaps = 22/263 (8%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G    VY A +++    +A   +  +   +  V  ++L  EV++   L++  I+  
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILRL 74

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           Y  + D     +  I E    G +    +K      +    +  ++   L Y H+    +
Sbjct: 75  YGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--V 130

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMV 202
           IHRD+   N+ +    G++KI D G++     S     + GT +Y+ PE+ E   + E V
Sbjct: 131 IHRDIKPENLLLGSA-GELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188

Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK-----DPEVKAFIEK 257
           D++S G+   E +  + P+ E ++  + YK+++         +           +  I +
Sbjct: 189 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV-------EFTFPDFVTEGARDLISR 240

Query: 258 CI-AQPRARPSASELLKDPFFSE 279
            +   P  RP   E+L+ P+ + 
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITA 263

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 2e-33
 Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 29/278 (10%)

Query: 13  DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA-----WNQVRLSHFSEDPVLVNRL 65
               +   +   +LLG G+   VYRA     G+EVA        +  +       +V R+
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG------MVQRV 58

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKK 124
            +EV++   LK+  I+  Y+ + D  +  +  + E+C +G +  Y + + +  S    + 
Sbjct: 59  QNEVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARH 116

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSII 183
           +  Q++ G+ YLH+H   I+HRDL  SN+ +  N   +KI D G A  +       +++ 
Sbjct: 117 FMHQIITGMLYLHSH--GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC 173

Query: 184 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKP 240
           GTP Y++PE      +    D++S G     ++    P+ + D+V     KV       P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMP 232

Query: 241 QALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
             L+     E K  I + +   P  R S S +L  PF 
Sbjct: 233 SFLS----IEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  125 bits (315), Expect = 6e-33
 Identities = 63/280 (22%), Positives = 112/280 (40%), Gaps = 21/280 (7%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVA---------WNQVRLSHFSEDPVLVNRLHSEVQLLR 73
             LGSGA  +V    ++    E A                           +++E+ LL+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 74  TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           +L +  II  + V+ D ++     +TE    G L                   KQ+L G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159

Query: 134 EYLHTHEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
            YLH H   I+HRD+   NI   N  ++  +KI D G ++   + +     +GT  Y+AP
Sbjct: 160 CYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217

Query: 192 ELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKD 248
           E+ ++ Y E  D++S G+ +  ++    P+    +   I KKV  G           +  
Sbjct: 218 EVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNI-S 275

Query: 249 PEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
            E K  I+  +      R +A E L   +  +  ++ ++ 
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  122 bits (308), Expect = 6e-32
 Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 14/273 (5%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
            +LG G+  +V +  D+    E A   +  +         + +  EV+LL+ L +  I+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT--STILREVELLKKLDHPNIMK 85

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + +  D        + E+ T G L     K +  S     +  KQV  G+ Y+H H   
Sbjct: 86  LFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--N 141

Query: 143 IIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTE 200
           I+HRDL   NI +        +KI D G +    ++      IGT  Y+APE+    Y E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEK 257
             D++S G+ L  +++   P+    +   I K+V  G           +   + K  I K
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTI-SDDAKDLIRK 259

Query: 258 CIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
            +   P  R +A++ L+ P+  + + +    S 
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  118 bits (297), Expect = 2e-31
 Identities = 59/294 (20%), Positives = 101/294 (34%), Gaps = 39/294 (13%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIV 82
           +L  G    VY A D   G E A  ++     S +      +  EV  ++ L     I+ 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90

Query: 83  CYSVWLDDQHNTLN-----FITEVCTSGNLRTYRKKHRHV---SIKALKKWSKQVLEGLE 134
             S     +  +        +      G L  + KK       S   + K   Q    ++
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI------------ 182
           ++H  +P IIHRDL   N+ ++   G +K+ D G A  +                     
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 183 -IGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
              TP Y  PE+ +        E  DI++ G  L  +   + P+ E  +  +I   V G 
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-EDGAKLRI---VNGK 265

Query: 238 VK-PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
              P   +  +     + I   +   P  R S +E++          + +  SP
Sbjct: 266 YSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP 317

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  116 bits (294), Expect = 3e-31
 Identities = 56/270 (20%), Positives = 116/270 (42%), Gaps = 16/270 (5%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            LG G    VY A +++    +A   +  S   ++ V  ++L  E+++   L++  I+  
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRM 79

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           Y+ + D +   +  + E    G L    +KH     +    + +++ + L Y H  +  +
Sbjct: 80  YNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--V 135

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMV 202
           IHRD+   N+ +    G++KI D G++     S    ++ GT +Y+ PE+ E + + E V
Sbjct: 136 IHRDIKPENLLMGYK-GELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMIEGKTHDEKV 193

Query: 203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPEVKAFIEKCI- 259
           D++  G+   E +    P+ +  S  + ++++       P  L        K  I K + 
Sbjct: 194 DLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFL----SDGSKDLISKLLR 248

Query: 260 AQPRARPSASELLKDPFFSELNDDDSEPSP 289
             P  R     +++ P+    +     P  
Sbjct: 249 YHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  116 bits (292), Expect = 2e-30
 Identities = 57/307 (18%), Positives = 109/307 (35%), Gaps = 49/307 (15%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVA-------------WNQVRLSHFSEDPVLVNRLHSEVQL 71
           L  G   K+     +++    A                   +         +   +E+Q+
Sbjct: 39  LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 72  LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWS----- 126
           +  +KN+Y + C  +  +     +  I E   + ++  + +    +              
Sbjct: 97  ITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 127 ---KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
              K VL    Y+H  +  I HRD+  SNI ++ N G+VK+ D G +  +          
Sbjct: 155 CIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKN-GRVKLSDFGESEYM-VDKKIKGSR 211

Query: 184 GTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--- 237
           GT E+M PE +          VDI+S G+CL  M    +P+S   S+ +++  +      
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271

Query: 238 --------------VKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSELND 282
                          K    N     E   F++  +   P  R ++ + LK  + ++ N 
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331

Query: 283 DDSEPSP 289
           +D     
Sbjct: 332 EDLREFS 338

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  114 bits (288), Expect = 2e-30
 Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 50/294 (17%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    V++A ++E    VA  +VRL    E  P    R   E+ LL+ LK+K I+  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRL 66

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPC 142
           + V   D    L  + E C   +L+ Y          + +K +  Q+L+GL + H+    
Sbjct: 67  HDVLHSD--KKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--N 121

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY--E 195
           ++HRDL   N+ IN N G++K+ + G A    R+        + E     Y  P++    
Sbjct: 122 VLHRDLKPQNLLINRN-GELKLANFGLA----RAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI--------------------Y 231
           + Y+  +D++S G    E+     P        D + +I                    Y
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 232 KKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 281
           K         +L  V    +   +  ++  +   P  R SA E L+ P+FS+  
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  115 bits (291), Expect = 7e-30
 Identities = 65/269 (24%), Positives = 124/269 (46%), Gaps = 20/269 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNKYI 80
           LGSGA  +V  AF+++   +VA   +    F+     +      + +E+++L+ L +  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           I   + +  + +     + E+   G L      ++ +     K +  Q+L  ++YLH + 
Sbjct: 203 IKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 259

Query: 141 PCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE----LY 194
             IIHRDL   N+ +        +KI D G + I+G +    ++ GTP Y+APE    + 
Sbjct: 260 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 317

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEV 251
              Y   VD +S G+ L   ++   P+SE  +   +  ++T G     P+   +V   + 
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV-SEKA 376

Query: 252 KAFIEKCIAQ-PRARPSASELLKDPFFSE 279
              ++K +   P+AR +  E L+ P+  +
Sbjct: 377 LDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  113 bits (284), Expect = 1e-29
 Identities = 62/312 (19%), Positives = 119/312 (38%), Gaps = 57/312 (18%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLK 76
           +Y  +  +G G+   V++  +++ G  VA  +   S        +  R   E+++L+ LK
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLK 60

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEY 135
           +  ++    V+       L+ + E C    +     +  R V    +K  + Q L+ + +
Sbjct: 61  HPNLVNLLEVFRRK--RRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMA 190
            H H    IHRD+   NI I  +   +K+ D GFA    R     S     E     Y +
Sbjct: 118 CHKHN--CIHRDVKPENILITKH-SVIKLCDFGFA----RLLTGPSDYYDDEVATRWYRS 170

Query: 191 PELY--EEDYTEMVDIYSFGLCLL-EMVTMEIPY----SECDSVAKIYK-------KVTG 236
           PEL   +  Y   VD+++ G C+  E+++   P     S+ D +  I K       +   
Sbjct: 171 PELLVGDTQYGPPVDVWAIG-CVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228

Query: 237 GV------------KPQALNKVK------DPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                          P+ +  ++             ++ C+   P  R +  +LL  P+F
Sbjct: 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

Query: 278 SELNDDDSEPSP 289
             + + +     
Sbjct: 289 ENIREIEDLAKE 300

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  113 bits (284), Expect = 2e-29
 Identities = 79/297 (26%), Positives = 123/297 (41%), Gaps = 54/297 (18%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           LG G   +VY+A D      VA  ++RL H  E  P    R   EV LL+ L+++ II  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---EVSLLKELQHRNIIEL 98

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            SV   +  + L+ I E   + +L+ Y  K+  VS++ +K +  Q++ G+ + H+     
Sbjct: 99  KSVIHHN--HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR--RC 153

Query: 144 IHRDLNCSNIFIN----GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY 194
           +HRDL   N+ ++         +KIGD G A    R+        T E     Y  PE+ 
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLA----RAFGIPIRQFTHEIITLWYRPPEIL 209

Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI------------------ 230
                Y+  VDI+S      EM+    P     SE D + KI                  
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKT-PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268

Query: 231 --YKKVTGGVKPQALNKVK----DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
             +K+     + + L +V     D E    +   +   P  R SA   L+ P+FS  
Sbjct: 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 4e-29
 Identities = 62/267 (23%), Positives = 128/267 (47%), Gaps = 24/267 (8%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSGA   V+   ++  G+E     +           + ++ +E+++L++L +  II  +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP---MEQIEAEIEVLKSLDHPNIIKIF 86

Query: 85  SVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
            V+ D  +  +  + E C  G L     + + + + +S   + +  KQ++  L Y H+  
Sbjct: 87  EVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144

Query: 141 PCIIHRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDY 198
             ++H+DL   NI F + +    +KI D G A +      + +  GT  YMAPE+++ D 
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV 202

Query: 199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP-----EVKA 253
           T   DI+S G+ +  ++T  +P++   S+ ++ +K T        N   +      +   
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKE----PNYAVECRPLTPQAVD 257

Query: 254 FIEKCIAQ-PRARPSASELLKDPFFSE 279
            +++ + + P  RPSA+++L   +F +
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  113 bits (284), Expect = 5e-29
 Identities = 79/309 (25%), Positives = 130/309 (42%), Gaps = 55/309 (17%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            Y++   +G+G+   V++A   E   EVA  +V       D    NR   E+Q++R +K+
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQ-----DKRFKNR---ELQIMRIVKH 91

Query: 78  KYII----VCYSVWLDDQHNTLNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQV 129
             ++      YS         LN + E      +    R Y K  + + +  +K +  Q+
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 189
           L  L Y+H+    I HRD+   N+ ++   G +K+ D G A I+       S I +  Y 
Sbjct: 151 LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 190 APELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG------- 236
           APEL     +YT  +DI+S G  + E++  + P     S  D + +I  KV G       
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEII-KVLGTPSREQI 266

Query: 237 -------------GVKPQALNKV----KDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 278
                         ++P   +KV      P+    I + +   P AR +A E L  PFF 
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326

Query: 279 ELNDDDSEP 287
           EL   ++  
Sbjct: 327 ELRTGEARM 335

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  111 bits (280), Expect = 6e-29
 Identities = 65/287 (22%), Positives = 130/287 (45%), Gaps = 25/287 (8%)

Query: 13  DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA---WNQVRLSHFSEDPVLVNRLHS 67
           D     G Y     +G G   KV  A     G EVA    ++ +L     +P  + +L  
Sbjct: 9   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-----NPTSLQKLFR 63

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           EV++++ L +  I+  + V   +   TL  I E  + G +  Y   H  +  K  +   +
Sbjct: 64  EVRIMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           Q++  ++Y H     I+HRDL   N+ ++ +   +KI D GF+          +  G P 
Sbjct: 122 QIVSAVQYCHQK--RIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPP 178

Query: 188 YMAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQAL 243
           Y APEL++ + Y    VD++S G+ L  +V+  +P+    ++ ++ ++V  G    P  +
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFYM 237

Query: 244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
           +     + +  +++ +   P  R +  +++KD + +  +++D     
Sbjct: 238 S----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPF 280

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  111 bits (279), Expect = 6e-29
 Identities = 68/288 (23%), Positives = 125/288 (43%), Gaps = 22/288 (7%)

Query: 15  SGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           +   G+Y   DLLG G+  KV    D E     A   ++       P     +  E+QLL
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGN--LRTYRKKHRHVSIKALKKWSKQVL 130
           R L++K +I    V  +++   +  + E C  G   +     + R    +A   +  Q++
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-CQLI 119

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI---VGRSHAAHSIIGTPE 187
           +GLEYLH+    I+H+D+   N+ +    G +KI  LG A             +  G+P 
Sbjct: 120 DGLEYLHSQ--GIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 188 YMAPELY--EEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQA 242
           +  PE+    + ++   VDI+S G+ L  + T   P+ E D++ K+++ +  G    P  
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGD 235

Query: 243 LNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSELNDDDSEPSP 289
                 P +   ++  +  +P  R S  ++ +  +F + +     P P
Sbjct: 236 C----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVP 279

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  114 bits (286), Expect = 1e-28
 Identities = 52/264 (19%), Positives = 97/264 (36%), Gaps = 29/264 (10%)

Query: 19  GRY--SDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           G+Y     +  G +  +Y A D+   G  V    ++    S D        +E Q L  +
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAEV 136

Query: 76  KNKYIIVCYSV--WLDDQHNTLNFIT-EVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
            +  I+  ++     D   + + +I  E     +L+  +   + + +     +  ++L  
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPA 194

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 192
           L YLH+    +++ DL   NI +     Q+K+ DLG  + +        + GTP + APE
Sbjct: 195 LSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSFGY---LYGTPGFQAPE 247

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 252
           +     T   DIY+ G  L  +       +    V         G+              
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPTRNG-RYVD--------GLPEDDPVLKTYDSYG 298

Query: 253 AFIEKCIA-QPRARP-SASELLKD 274
             + + I   PR R  +A E+   
Sbjct: 299 RLLRRAIDPDPRQRFTTAEEMSAQ 322

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  109 bits (275), Expect = 2e-28
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 26/272 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G+  +V +  D+    E A   +  +         + +  EV+LL+ L +  I+  +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT--STILREVELLKKLDHPNIMKLF 87

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
            +  D        + E+ T G L     K +  S     +  KQV  G+ Y+H H   I+
Sbjct: 88  EILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IV 143

Query: 145 HRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMV 202
           HRDL   NI +        +KI D G +    ++      IGT  Y+APE+    Y E  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKC 203

Query: 203 DIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKA 253
           D++S G      V + I      P+    +   I K+V  G           + D + K 
Sbjct: 204 DVWSAG------VILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD-DAKD 255

Query: 254 FIEKCIAQ-PRARPSASELLKDPFFSELNDDD 284
            I K +   P  R +A++ L+ P+  + + ++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  110 bits (276), Expect = 2e-28
 Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 28/281 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNR--LHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G+E A   ++          V+R  +  EV +LR + +  +I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+ +     L  I E+ + G L  +  +   +S +    + KQ+L+G+ YLHT +  
Sbjct: 80  LHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135

Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 198
           I H DL   NI +   N  I  +K+ D G A  +       +I GTPE++APE +  E  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195

Query: 199 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 249
               D++S G      L          P+   D+  +    +T        +  +   + 
Sbjct: 196 GLEADMWSIGVITYILLSGAS------PFLG-DTKQETLANITSVSYDFDEEFFSHTSE- 247

Query: 250 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 289
             K FI K  + + R R +  E L+ P+ + +++  +    
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  110 bits (276), Expect = 2e-28
 Identities = 53/224 (23%), Positives = 85/224 (37%), Gaps = 50/224 (22%)

Query: 98  ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-------HEPCIIHRDLNC 150
           + E   +G+L  Y   H      +  + +  V  GL YLHT       ++P I HRDLN 
Sbjct: 90  VMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148

Query: 151 SNIFINGNIGQVKIGDLGFAAIVGRS---------HAAHSIIGTPEYMAPELYE------ 195
            N+ +  + G   I D G +  +  +         +AA S +GT  YMAPE+ E      
Sbjct: 149 RNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207

Query: 196 --EDYTEMVDIYSFGLCLLEMVT-------------MEIPYSEC----DSVAKIYKKV-T 235
             E   + VD+Y+ GL   E+                ++ +        +   +   V  
Sbjct: 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR 267

Query: 236 GGVKPQ-----ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
              +P+       N +    +K  IE C  Q   AR +A    +
Sbjct: 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (273), Expect = 2e-28
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 28/267 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+  +V  A  +   I  A  ++      +    V+R   E++++++L +  II  Y
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIRLY 72

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
             + D+    +  + E+CT G L       R        +  K VL  + Y H     + 
Sbjct: 73  ETFEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VA 128

Query: 145 HRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMV 202
           HRDL   N  F+  +    +K+ D G AA         + +GTP Y++P++ E  Y    
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPEC 188

Query: 203 DIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKA 253
           D +S G      V M +      P+S   + +++  K+  G      +    V   + ++
Sbjct: 189 DEWSAG------VMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSP-QAES 240

Query: 254 FIEKCIAQ-PRARPSASELLKDPFFSE 279
            I + + + P+ R ++ + L+  +F +
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEK 267

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  111 bits (280), Expect = 2e-28
 Identities = 83/337 (24%), Positives = 133/337 (39%), Gaps = 63/337 (18%)

Query: 2   SDRDGEPFVEVDPSGRFG-------RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRL 52
            D+DG     V  +   G        Y+D   +G+G+   VY+A   + G  VA  +V  
Sbjct: 30  RDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 89

Query: 53  SHFSEDPVLVNRLHSEVQLLRTLKNKYII----VCYSVWLDDQHNTLNFITEVCTSGNL- 107
                D    NR   E+Q++R L +  I+      YS         LN + +      + 
Sbjct: 90  -----DKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY 140

Query: 108 ---RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI 164
              R Y +  + + +  +K +  Q+   L Y+H+    I HRD+   N+ ++ +   +K+
Sbjct: 141 RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKL 198

Query: 165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLL-EMVTMEIPY 221
            D G A  + R     S I +  Y APEL     DYT  +D++S G C+L E++  + P 
Sbjct: 199 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQ-PI 256

Query: 222 ----SECDSVAKIYKKVTG--------------------GVKPQALNKV----KDPEVKA 253
               S  D + +I  KV G                     +K     KV      PE  A
Sbjct: 257 FPGDSGVDQLVEII-KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 315

Query: 254 FIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
              + +   P AR +  E     FF EL D + +   
Sbjct: 316 LCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN 352

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  109 bits (275), Expect = 3e-28
 Identities = 66/284 (23%), Positives = 125/284 (44%), Gaps = 32/284 (11%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNKYI 80
           LGSGA  +V  AF+++   +VA   +    F+     +      + +E+++L+ L +  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
           I   + +  + +     + E+   G L      ++ +     K +  Q+L  ++YLH + 
Sbjct: 78  IKIKNFFDAEDYY---IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134

Query: 141 PCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE----LY 194
             IIHRDL   N+ +        +KI D G + I+G +    ++ GTP Y+APE    + 
Sbjct: 135 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG 192

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNK 245
              Y   VD +S G      V + I      P+SE  +   +  ++T G     P+   +
Sbjct: 193 TAGYNRAVDCWSLG------VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246

Query: 246 VKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPS 288
           V + +    ++K +   P+AR +  E L+ P+  + +       
Sbjct: 247 VSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  109 bits (274), Expect = 3e-28
 Identities = 54/291 (18%), Positives = 121/291 (41%), Gaps = 35/291 (12%)

Query: 17  RFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA----------------------WNQVRL 52
           +  +Y+  D +G G+   V  A+++ +    A                        +   
Sbjct: 11  QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 53  SHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRK 112
               +    + +++ E+ +L+ L +  ++    V  D   + L  + E+   G +     
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130

Query: 113 KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI 172
               +S    + + + +++G+EYLH  +  IIHRD+  SN+ +  + G +KI D G +  
Sbjct: 131 LKP-LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNE 186

Query: 173 VGRSHA-AHSIIGTPEYMAPEL---YEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSV 227
              S A   + +GTP +MAPE      + ++ + +D+++ G+ L   V  + P+ + + +
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERI 245

Query: 228 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
             ++ K+               ++K  I + +   P +R    E+   P+ 
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  108 bits (273), Expect = 8e-28
 Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 28/281 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--EDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G+E A   ++          V    +  EV +LR + +  II 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+ +     L  I E+ + G L  +  +   +S +    + KQ+L+G+ YLHT +  
Sbjct: 80  LHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-- 135

Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 198
           I H DL   NI +   N  I  +K+ D G A  +       +I GTPE++APE +  E  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195

Query: 199 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 249
               D++S G      L          P+   D+  +    +T        +  ++  + 
Sbjct: 196 GLEADMWSIGVITYILLSGAS------PFLG-DTKQETLANITAVSYDFDEEFFSQTSE- 247

Query: 250 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 289
             K FI K  + + R R +  E L+ P+ + ++   +    
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRR 288

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  108 bits (272), Expect = 1e-27
 Identities = 72/304 (23%), Positives = 126/304 (41%), Gaps = 57/304 (18%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLK 76
           +Y +L  +G G+   V +  +++ G  VA  +   S   +    +  R   E++LL+ L+
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLLKQLR 82

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEY 135
           ++ ++    V           + E      +    +   + +  + ++K+  Q++ G+ +
Sbjct: 83  HENLVNLLEVCKKK--KRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMA 190
            H+H   IIHRD+   NI ++ + G VK+ D GFA    R+ AA   +   E     Y A
Sbjct: 140 CHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFA----RTLAAPGEVYDDEVATRWYRA 192

Query: 191 PELY--EEDYTEMVDIYSFGLCLL-EMVTMEIPY----SECDSVAKIYKKV--------T 235
           PEL   +  Y + VD+++ G CL+ EM   E P     S+ D +  I   +         
Sbjct: 193 PELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQE 250

Query: 236 GGVKPQALNKVKDPEVKA-----------------FIEKCIA-QPRARPSASELLKDPFF 277
              K      V+ PE+K                    +KC+   P  RP  +ELL   FF
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

Query: 278 SELN 281
               
Sbjct: 311 QMDG 314

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  108 bits (271), Expect = 1e-27
 Identities = 61/339 (17%), Positives = 116/339 (34%), Gaps = 65/339 (19%)

Query: 2   SDRDGEPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE- 57
           S      + +        +       +G G+   V  A + +     A   +  +   + 
Sbjct: 8   SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67

Query: 58  DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHR 115
           +P  V R+ +EV+L++ L +  I   Y V+ D+Q+  +  + E+C  G+L  +       
Sbjct: 68  NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDD 125

Query: 116 HVSIKALKKWS--------------------------------------KQVLEGLEYLH 137
                A+                                          +Q+   L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 138 THEPCIIHRDLNCSNI-FINGNIGQVKIGDLGFAAIV-----GRSHAAHSIIGTPEYMAP 191
                I HRD+   N  F      ++K+ D G +        G  +   +  GTP ++AP
Sbjct: 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Query: 192 EL---YEEDYTEMVDIYSFGLCLLEMVTMEIP-YSECDSVAKIYKKVTGGV---KPQALN 244
           E+     E Y    D +S G+ L  ++   +P     D+      +V       +    N
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCFENPNYN 301

Query: 245 KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELND 282
            +  P  +  +   + +    R  A   L+ P+ S+ +D
Sbjct: 302 VL-SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  107 bits (269), Expect = 1e-27
 Identities = 70/294 (23%), Positives = 107/294 (36%), Gaps = 52/294 (17%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A +       A  ++RL    E  P    R   E+ +L+ LK+  I+  
Sbjct: 10  IGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKL 65

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPC 142
           Y V        L  + E     +L+               K +  Q+L G+ Y H     
Sbjct: 66  YDVIHTK--KRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--R 120

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY--E 195
           ++HRDL   N+ IN   G++KI D G A    R+        T E     Y AP++    
Sbjct: 121 VLHRDLKPQNLLINRE-GELKIADFGLA----RAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI--------------------Y 231
           + Y+  +DI+S G    EMV    P     SE D + +I                    Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 232 KKVTGGVKPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 281
                  +P          D      + K +   P  R +A + L+  +F E N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  107 bits (269), Expect = 2e-27
 Identities = 71/296 (23%), Positives = 121/296 (40%), Gaps = 55/296 (18%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVC 83
           +G G    VY+A D +  I VA  ++RL    E  P    R   E+ LL+ L +  I+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIVSL 84

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPC 142
             V   +    L  + E     +L+    +++       +K +  Q+L G+ + H H   
Sbjct: 85  IDVIHSE--RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH--R 139

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY--E 195
           I+HRDL   N+ IN + G +K+ D G A    R+        T E     Y AP++    
Sbjct: 140 ILHRDLKPQNLLIN-SDGALKLADFGLA----RAFGIPVRSYTHEVVTLWYRAPDVLMGS 194

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GV----- 238
           + Y+  VDI+S G    EM+T + P     ++ D + KI+  + G         V     
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIF-SILGTPNPREWPQVQELPL 252

Query: 239 ---------KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 281
                    + +  + +      E    +   +   P  R SA + +  P+F +L+
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  109 bits (273), Expect = 2e-27
 Identities = 58/292 (19%), Positives = 105/292 (35%), Gaps = 50/292 (17%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYII 81
            +LG G+   V       +G  VA  ++ +               E++LL    +   +I
Sbjct: 21  KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD-------IALMEIKLLTESDDHPNVI 72

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNL-------RTYRKKHRHVSIKALKKWSKQVLEGLE 134
             Y     D+   L    E+C   NL           +  +           +Q+  G+ 
Sbjct: 73  RYYCSETTDRF--LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 135 YLHTHEPCIIHRDLNCSNIFIN------------GNIGQVKIGDLGFAAIVGRSHAA--- 179
           +LH+    IIHRDL   NI ++                ++ I D G    +    ++   
Sbjct: 130 HLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 180 --HSIIGTPEYMAPELYEED--------YTEMVDIYSFGLCLLEMVTMEIP--YSECDSV 227
             ++  GT  + APEL EE          T  +DI+S G     +++        +    
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 228 AKIYKKVTGGVKPQALN-KVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
           + I + +    + + L+ +    E    I + I   P  RP+A ++L+ P F
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (270), Expect = 4e-27
 Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 31/279 (11%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSGA   V+R  ++  G       +   +   D   V     E+ ++  L +  +I  +
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKN---EISIMNQLHHPKLINLH 114

Query: 85  SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
             + D     L  I E  + G L  R   + ++  S   +  + +Q  EGL+++H H   
Sbjct: 115 DAFEDKYEMVL--ILEFLSGGELFDRIAAEDYKM-SEAEVINYMRQACEGLKHMHEHS-- 169

Query: 143 IIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTE 200
           I+H D+   NI         VKI D G A  +           T E+ APE +  E    
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229

Query: 201 MVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEV 251
             D+++ G      L  L       P++  +   +  + V          A + V   E 
Sbjct: 230 YTDMWAIGVLGYVLLSGLS------PFAG-EDDLETLQNVKRCDWEFDEDAFSSVSP-EA 281

Query: 252 KAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 289
           K FI+     +PR R +  + L+ P+    + + +   P
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  105 bits (265), Expect = 4e-27
 Identities = 65/268 (24%), Positives = 114/268 (42%), Gaps = 27/268 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R   +  G+E A   +     S       +L  E ++ R L++  I+  +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRLH 71

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++       + ++ T G L          S        +Q+LE + Y H++   I+
Sbjct: 72  DSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IV 127

Query: 145 HRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           HR+L   N+   +      VK+ D G A  V  S A H   GTP Y++PE L ++ Y++ 
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

Query: 202 VDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVK 252
           VDI++ G      V + I      P+ + +   ++Y ++  G         + V   E K
Sbjct: 188 VDIWACG------VILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAK 239

Query: 253 AFIEKCIAQ-PRARPSASELLKDPFFSE 279
           + I+  +   P+ R +A + LK P+   
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICN 267

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  106 bits (267), Expect = 6e-27
 Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 27/276 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R   +  G+E A   +     S       +L  E ++ R L++  I+  +
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNIVRLH 94

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++       + ++ T G L          S        +Q+LE + Y H++   I+
Sbjct: 95  DSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IV 150

Query: 145 HRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           HR+L   N+   +   G  VK+ D G A  V  S A H   GTP Y++PE L ++ Y++ 
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210

Query: 202 VDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVK 252
           VDI++ G      V + I      P+ + +   ++Y ++  G         + V   E K
Sbjct: 211 VDIWACG------VILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAK 262

Query: 253 AFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
           + I+  +   P+ R +A + LK P+        S  
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  105 bits (264), Expect = 1e-26
 Identities = 79/306 (25%), Positives = 122/306 (39%), Gaps = 56/306 (18%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN----RLHSEVQLLRTLKN--- 77
           +G GA   VY+A D   G  VA   VR+ +       +     R   EV LLR L+    
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR---EVALLRRLEAFEH 73

Query: 78  KYII----VCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLE 131
             ++    VC +   D +   +  + E     +LRTY  +     +  + +K   +Q L 
Sbjct: 74  PNVVRLMDVCATSRTDRE-IKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLR 131

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP 191
           GL++LH +  CI+HRDL   NI +    G VK+ D G A I     A   ++ T  Y AP
Sbjct: 132 GLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188

Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GV 238
           E L +  Y   VD++S G    EM   + P     SE D + KI+  + G          
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFD-LIGLPPEDDWPRD 246

Query: 239 -----------KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 283
                       P+ +  V    +      + + +   P  R SA   L+  +  +    
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD--- 303

Query: 284 DSEPSP 289
             E +P
Sbjct: 304 --EGNP 307

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  107 bits (269), Expect = 2e-26
 Identities = 58/270 (21%), Positives = 114/270 (42%), Gaps = 19/270 (7%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+GA   V+R  ++  G   A   V   H   D   V +   E+Q +  L++  ++  +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRK---EIQTMSVLRHPTLVNLH 220

Query: 85  SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
             + DD    +  I E  + G L  +   + +  +S     ++ +QV +GL ++H +   
Sbjct: 221 DAFEDDNEMVM--IYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN-- 275

Query: 143 IIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTE 200
            +H DL   NI F      ++K+ D G  A +    +     GT E+ APE    +    
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFIEK 257
             D++S G+    +++   P+   ++  +  + V          A + + + + K FI K
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRK 393

Query: 258 CIAQ-PRARPSASELLKDPFFSELNDDDSE 286
            +   P  R +  + L+ P+ +  N    +
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTPGNAPGRD 423

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (264), Expect = 2e-26
 Identities = 62/287 (21%), Positives = 113/287 (39%), Gaps = 38/287 (13%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF-SEDPVLVNRLHSEVQLLRTLKNKYII 81
           +++G G    V R  ++E G + A   V ++ F S   +    L  E  +   LK+ +I+
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHV--SIKALKKWSKQVLEGLEYLH 137
                +  D    L  + E     +L     ++       S      + +Q+LE L Y H
Sbjct: 90  ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 138 THEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAA-HSIIGTPEYMAPE-L 193
            +   IIHRD+    +   +  N   VK+G  G A  +G S       +GTP +MAPE +
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 194 YEEDYTEMVDIYSFGL---CLLEMVTMEIPYSEC------DSVAKIYKKVTGGV---KPQ 241
             E Y + VD++  G+    LL                   +  ++++ +  G     P+
Sbjct: 206 KREPYGKPVDVWGCGVILFILL-----------SGCLPFYGTKERLFEGIIKGKYKMNPR 254

Query: 242 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
             + + +   K  + + +   P  R +  E L  P+  E +    + 
Sbjct: 255 QWSHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (264), Expect = 2e-26
 Identities = 63/281 (22%), Positives = 114/281 (40%), Gaps = 33/281 (11%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           ++LG G   +V++  +   G+++A   ++     +       + +E+ ++  L +  +I 
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD----KEEVKNEISVMNQLDHANLIQ 150

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
            Y  +       L  + E    G L  R   + +    +     + KQ+ EG+ ++H   
Sbjct: 151 LYDAFESKNDIVL--VMEYVDGGELFDRIIDESYNLTELDT-ILFMKQICEGIRHMHQMY 207

Query: 141 PCIIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 198
             I+H DL   NI  +N +  Q+KI D G A             GTPE++APE +  +  
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265

Query: 199 TEMVDIYSFG------LCLLEMVTMEIP-YSECDSVAKIYKKVTGGV---KPQALNKVKD 248
           +   D++S G      L  L       P   + D  A+    +       + +    + +
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLS------PFLGDND--AETLNNILACRWDLEDEEFQDISE 317

Query: 249 PEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPS 288
            E K FI K  I +   R SASE LK P+ S+        +
Sbjct: 318 -EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSA 357

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (259), Expect = 3e-26
 Identities = 63/286 (22%), Positives = 103/286 (36%), Gaps = 36/286 (12%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVA-----WNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-K 78
           LG G    V R   +    E A               E   L      EV +LR +    
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            II     +  +       + ++   G L  Y  +   +S K  +K  + +LE +  LH 
Sbjct: 85  NIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE------ 192
               I+HRDL   NI ++ +   +K+ D GF+  +        + GTP Y+APE      
Sbjct: 143 LN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 199

Query: 193 -LYEEDYTEMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQA 242
                 Y + VD++S G      V M        P+        + + +  G        
Sbjct: 200 NDNHPGYGKEVDMWSTG------VIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPE 252

Query: 243 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
            +   D  VK  + + +   P+ R +A E L  PFF +   ++   
Sbjct: 253 WDDYSD-TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  103 bits (258), Expect = 4e-26
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 18/272 (6%)

Query: 13  DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 70
           D   + G Y   D LG G   KV     Q  G +VA   +          +V ++  E+Q
Sbjct: 5   DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQ 63

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
            L+  ++ +II  Y V           + E  + G L  Y  KH  V     ++  +Q+L
Sbjct: 64  NLKLFRHPHIIKLYQVI--STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
             ++Y H H   ++HRDL   N+ ++ +    KI D G + ++       +  G+P Y A
Sbjct: 122 SAVDYCHRH--MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 178

Query: 191 PELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKV 246
           PE+     Y    VDI+S G+ L  ++   +P+ + + V  ++KK+ GGV   P+ LN  
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN-- 235

Query: 247 KDPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
               V   +   +   P  R +  ++ +  +F
Sbjct: 236 --RSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (258), Expect = 4e-26
 Identities = 59/280 (21%), Positives = 115/280 (41%), Gaps = 28/280 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +   +  G E A   ++      S   V    +  EV +LR +++  II 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + ++ +     L  I E+ + G L  +  +   ++     ++ KQ+L+G+ YLH+    
Sbjct: 73  LHDIFENKTDVVL--ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR-- 128

Query: 143 IIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 198
           I H DL   NI +   N    ++K+ D G A  +   +   +I GTPE++APE +  E  
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 188

Query: 199 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 249
               D++S G      L          P+   ++  +    ++        +  +   + 
Sbjct: 189 GLEADMWSIGVITYILLSGAS------PFLG-ETKQETLTNISAVNYDFDEEYFSNTSE- 240

Query: 250 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPS 288
             K FI +  +  P+ R + ++ L+  +   +   +    
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  103 bits (260), Expect = 6e-26
 Identities = 67/320 (20%), Positives = 114/320 (35%), Gaps = 67/320 (20%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           R+      G G    V    ++  G+ VA  +V      +DP   NR    +Q L  L +
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-----QDPRFRNRELQIMQDLAVLHH 78

Query: 78  KYII----VCYSVWLDDQHNT-LNFITEVCTS---GNLRTYRKKHRHVSIKALKKWSKQV 129
             I+      Y++   D+ +  LN + E          R Y ++        +K +  Q+
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 189
           +  +  LH     + HRD+   N+ +N   G +K+ D G A  +  S    + I +  Y 
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198

Query: 190 APELY--EEDYTEMVDIYSFGLCLL-EMVT--------------MEI------------- 219
           APEL    + YT  VDI+S G C+  EM+                EI             
Sbjct: 199 APELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257

Query: 220 -----------PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPS 267
                        S+    + ++   +     +A +          +   +   P  R  
Sbjct: 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYD---------LLSALLQYLPEERMK 308

Query: 268 ASELLKDPFFSELNDDDSEP 287
             E L  P+F EL+D  ++ 
Sbjct: 309 PYEALCHPYFDELHDPATKL 328

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  103 bits (258), Expect = 9e-26
 Identities = 38/280 (13%), Positives = 83/280 (29%), Gaps = 32/280 (11%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-EDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LLG GA  +VY A   +        +  L      +P         ++ L+       + 
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKAL-----KKWSKQVLEGLEYLH 137
            YS  L         + E+ + G L      +++   K +       ++ ++L  +E +H
Sbjct: 132 FYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189

Query: 138 THEPCIIHRDLNCSNIFINGNI----------GQVKIGDLGFAA---IVGRSHAAHSIIG 184
             E  IIH D+   N  +                + + DLG +    +  +     +   
Sbjct: 190 DCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247

Query: 185 TPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           T  +   E L  + +   +D +     +  M+       + +      + +   +     
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP---- 303

Query: 244 NKVKDPEVKAFIEKCI-AQPRARPSASELLKDPFFSELND 282
                     F    +         + +LL+         
Sbjct: 304 ---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 1e-25
 Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 28/277 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQV--RLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V +  ++  G++ A   +  R +  S   V    +  EV +L+ +++  +I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            + V+ +     L  I E+   G L  +  +   ++ +   ++ KQ+L G+ YLH+ +  
Sbjct: 79  LHEVYENKTDVIL--ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134

Query: 143 IIHRDLNCSNI-FINGNI--GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 198
           I H DL   NI  ++ N+   ++KI D G A  +   +   +I GTPE++APE +  E  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194

Query: 199 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 249
               D++S G      L          P+   D+  +    V+      + +  +     
Sbjct: 195 GLEADMWSIGVITYILLSGAS------PFLG-DTKQETLANVSAVNYEFEDEYFSNTSA- 246

Query: 250 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 285
             K FI +  +  P+ R +  + L+ P+    +   +
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (257), Expect = 1e-25
 Identities = 86/295 (29%), Positives = 126/295 (42%), Gaps = 49/295 (16%)

Query: 25  LGSGAVKKVYRAFDQEEGIE-VAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKN---KY 79
           +G GA  KV++A D + G   VA  +VR+    E  P+   R   EV +LR L+      
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---EVAVLRHLETFEHPN 75

Query: 80  II----VCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGL 133
           ++    VC     D +   L  + E     +L TY  +     V  + +K    Q+L GL
Sbjct: 76  VVRLFDVCTVSRTDRETK-LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+H   ++HRDL   NI +  + GQ+K+ D G A I     A  S++ T  Y APE 
Sbjct: 134 DFLHSH--RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GV-- 238
           L +  Y   VD++S G    EM   + P     S+ D + KI   V G            
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKIL-DVIGLPGEEDWPRDVA 248

Query: 239 ---------KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
                      Q + K     D   K  + KC+   P  R SA   L  P+F +L
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  102 bits (257), Expect = 1e-25
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 57/297 (19%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIV 82
           LG G    VY+   +     VA  ++RL H  E+  P    R   EV LL+ LK+  I+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIR---EVSLLKDLKHANIVT 64

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
            + +   +   +L  + E     +L+ Y       +++  +K +  Q+L GL Y H    
Sbjct: 65  LHDIIHTE--KSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY-- 194
            ++HRDL   N+ IN   G++K+ D G A    R+ +  +     E     Y  P++   
Sbjct: 120 KVLHRDLKPQNLLIN-ERGELKLADFGLA----RAKSIPTKTYDNEVVTLWYRPPDILLG 174

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKIYKKVTG--------GV---- 238
             DY+  +D++  G    EM T   P     +  + +  I+ ++ G        G+    
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIF-RILGTPTEETWPGILSNE 232

Query: 239 ----------KPQALNKVK---DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN 281
                     + +AL       D +    + K +  + R R SA + +K PFF  L 
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  102 bits (257), Expect = 1e-25
 Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 57/297 (19%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN----RLHSEVQLLRTLKNKYI 80
           LG G    VY+A D+     VA  +++L H SE    +N    R   E++LL+ L +  I
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHPNI 74

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-SIKALKKWSKQVLEGLEYLHTH 139
           I     +     + ++ + +   + +L    K +  V +   +K +    L+GLEYLH H
Sbjct: 75  IGLLDAFGHK--SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAPELY 194
              I+HRDL  +N+ ++ N G +K+ D G A    +S  + +   T +     Y APEL 
Sbjct: 132 --WILHRDLKPNNLLLDEN-GVLKLADFGLA----KSFGSPNRAYTHQVVTRWYRAPELL 184

Query: 195 --EEDYTEMVDIYSFGLCLL-EMVTMEIPY----SECDSVAKIYKKVTG--------GV- 238
                Y   VD+++ G C+L E++    P+    S+ D + +I+ +  G         + 
Sbjct: 185 FGARMYGVGVDMWAVG-CILAELLLRV-PFLPGDSDLDQLTRIF-ETLGTPTEEQWPDMC 241

Query: 239 -----------KPQALNKV---KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
                          L+ +      ++   I+      P AR +A++ LK  +FS  
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  102 bits (256), Expect = 1e-25
 Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 64/313 (20%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIV 82
           LG+G    VY+  ++  G+ VA  +V+L    E+  P    R   E+ L++ LK++ I+ 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIR---EISLMKELKHENIVR 67

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTY------RKKHRHVSIKALKKWSKQVLEGLEYL 136
            Y V   +  N L  + E   + +L+ Y          R + +  +K +  Q+L+GL + 
Sbjct: 68  LYDVIHTE--NKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAP 191
           H +   I+HRDL   N+ IN   GQ+K+GD G A    R+        + E     Y AP
Sbjct: 125 HEN--KILHRDLKPQNLLINKR-GQLKLGDFGLA----RAFGIPVNTFSSEVVTLWYRAP 177

Query: 192 ELY--EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI--------------- 230
           ++      Y+  +DI+S G  L EM+T + P     ++ + +  I               
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236

Query: 231 -----YKKVTGGVKPQALNKV--------KDPEVKAFIEKCIA-QPRARPSASELLKDPF 276
                Y        P+ L +V         D  +  F+   +   P  R SA + L  P+
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

Query: 277 FSELNDDDSEPSP 289
           F+E     S    
Sbjct: 297 FAEYYHHASMGGS 309

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  102 bits (257), Expect = 2e-25
 Identities = 67/313 (21%), Positives = 128/313 (40%), Gaps = 64/313 (20%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYII-- 81
           +G G   +V++A  ++ G +VA  +V + +  E  P+   R   E+++L+ LK++ ++  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 81

Query: 82  --VCYS--VWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYL 136
             +C +     +    ++  + + C   +L           ++  +K+  + +L GL Y+
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-----YMAP 191
           H +   I+HRD+  +N+ I    G +K+ D G A     +  +     T       Y  P
Sbjct: 141 HRN--KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 197

Query: 192 ELY--EEDYTEMVDIYSFGLCLL-EMVTMEIPY----SECDSVAKIYKKVTG-------- 236
           EL   E DY   +D++  G C++ EM T   P     +E   +A I  ++ G        
Sbjct: 198 ELLLGERDYGPPIDLWGAG-CIMAEMWTRS-PIMQGNTEQHQLALIS-QLCGSITPEVWP 254

Query: 237 GV--------------KPQAL-----NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF 276
            V              + + +       V+DP     I+K +   P  R  + + L   F
Sbjct: 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

Query: 277 FSELNDDDSEPSP 289
           F        +P P
Sbjct: 315 FWS------DPMP 321

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (254), Expect = 3e-25
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 30/277 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVC 83
           LG G    V +   +  G E A   ++     +D      +  E+ +L   K    +I  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEILHEIAVLELAKSCPRVINL 94

Query: 84  YSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
           + V+ +     L  I E    G +      +    VS   + +  KQ+LEG+ YLH +  
Sbjct: 95  HEVYENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN- 151

Query: 142 CIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 198
            I+H DL   NI +     +G +KI D G +  +G +     I+GTPEY+APE L  +  
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI 210

Query: 199 TEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDP 249
           T   D+++ G      L          P+   +   + Y  ++        +  + V   
Sbjct: 211 TTATDMWNIGIIAYMLLTHTS------PFVG-EDNQETYLNISQVNVDYSEETFSSVSQ- 262

Query: 250 EVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 285
               FI+   +  P  RP+A   L   +  + + ++ 
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (253), Expect = 4e-25
 Identities = 51/275 (18%), Positives = 109/275 (39%), Gaps = 32/275 (11%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G    V+R  +           V++    +  V       E+ +L   +++ I+  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK-----KEISILNIARHRNILHLH 67

Query: 85  SVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
             +   +   +  I E  +  ++  R        ++ + +  +  QV E L++LH+H   
Sbjct: 68  ESFESMEELVM--IFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHN-- 122

Query: 143 IIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTE 200
           I H D+   NI +       +KI + G A  +        +   PEY APE    +  + 
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 201 MVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEV 251
             D++S G      L  +       P+   ++  +I + +         +A  ++   E 
Sbjct: 183 ATDMWSLGTLVYVLLSGIN------PFLA-ETNQQIIENIMNAEYTFDEEAFKEISI-EA 234

Query: 252 KAFIEKC-IAQPRARPSASELLKDPFFSELNDDDS 285
             F+++  + + ++R +ASE L+ P+  +  +  S
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  101 bits (253), Expect = 4e-25
 Identities = 66/287 (22%), Positives = 107/287 (37%), Gaps = 47/287 (16%)

Query: 20  RYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           +Y   LG G    V            G  VA  Q++       P        E+Q+L+ L
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREIQILKAL 81

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLE 134
            + +I+    V       +L  + E   SG LR + ++HR  +    L  +S Q+ +G+E
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------ 188
           YL +     +HRDL   NI +      VKI D G A ++              Y      
Sbjct: 142 YLGSR--RCVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKD--------YYVVREPG 190

Query: 189 ------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK- 239
                  APE L +  ++   D++SFG+ L E+ T  +   S      ++          
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250

Query: 240 PQALNKVKD-----------PEVKAFIEKC-IAQPRARPSASELLKD 274
            + L  +++            EV   ++ C    P+ RPS S L   
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =   99 bits (250), Expect = 5e-25
 Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 16/267 (5%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
             +     LG GA  +V  A ++     VA   V +    + P  + +   E+ + + L 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
           ++ ++  Y    +          E C+ G L    +    +     +++  Q++ G+ YL
Sbjct: 64  HENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPE- 192
           H     I HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APE 
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 193 LYEEDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 251
           L   ++  E VD++S G+ L  M+  E+P+ +     + Y             K  D   
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238

Query: 252 KAFIEKC-IAQPRARPSASELLKDPFF 277
            A + K  +  P AR +  ++ KD ++
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWY 265

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  100 bits (251), Expect = 5e-25
 Identities = 65/298 (21%), Positives = 113/298 (37%), Gaps = 38/298 (12%)

Query: 13  DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA---WNQVRLSHFSEDPVLVNRLHS 67
           D       Y    LLG G    V+      + ++VA     + R+  +S     V     
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSV-TCPL 83

Query: 68  EVQLLRTLKNK----YIIVCYSVWLDDQHNTLNFITE-VCTSGNLRTYRKKHRHVSIKAL 122
           EV LL  +        +I     +   +      + E    + +L  Y  +   +     
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEG--FMLVLERPLPAQDLFDYITEKGPLGEGPS 141

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
           + +  QV+  +++ H+    ++HRD+   NI I+   G  K+ D G  A++         
Sbjct: 142 RCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDF 198

Query: 183 IGTPEYMAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-- 238
            GT  Y  PE      Y      ++S G+ L +MV  +IP+          +++      
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-------DQEILEAELH 251

Query: 239 KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF------SELNDDDSEPSP 289
            P  ++    P+  A I +C+A  P +RPS  E+L DP+         LN     P+P
Sbjct: 252 FPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAP 305

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (251), Expect = 7e-25
 Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 37/298 (12%)

Query: 13  DPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVA---WNQVRLSHFSEDPVLVNRLHS 67
           +      +Y    LLGSG    VY      + + VA     + R+S + E P    R+  
Sbjct: 37  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG-TRVPM 95

Query: 68  EVQLLRTLKNK--YIIVCYSVWLDDQHNTLNFITEVCT-SGNLRTYRKKHRHVSIKALKK 124
           EV LL+ + +    +I     +          I E      +L  +  +   +  +  + 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARS 153

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           +  QVLE + + H     ++HRD+   NI I+ N G++K+ D G  A++  +       G
Sbjct: 154 FFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DG 210

Query: 185 TPEYMAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQ 241
           T  Y  PE      Y      ++S G+ L +MV  +IP+   +   +I +   G V   Q
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHDEEIIR---GQVFFRQ 264

Query: 242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF---------SELNDDDSEPSP 289
            ++     E +  I  C+A +P  RP+  E+   P+          +E++     P P
Sbjct: 265 RVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  101 bits (253), Expect = 7e-25
 Identities = 61/342 (17%), Positives = 116/342 (33%), Gaps = 84/342 (24%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           +YS    LG+G+   V   FD E G   A  +V      +DP   NR   E+ +++ L +
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNR---ELDIMKVLDH 59

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGN------------------------------- 106
             II     +                                                  
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 107 --------LRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN 158
                   L+++ +  R + +  +  +  Q+   + ++H+    I HRD+   N+ +N  
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSK 177

Query: 159 IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVT 216
              +K+ D G A  +  S  + + I +  Y APEL     +YT  +D++S G    E++ 
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 217 MEIPY----SECDSVAKIYKKVTG--------------------GVKPQALNKV----KD 248
            + P     +  D + +I  ++ G                     +K +   K+      
Sbjct: 238 GK-PLFSGETSIDQLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295

Query: 249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
                 +E+ +  +P  R +  E +  PFF  L +       
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVK 337

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  100 bits (252), Expect = 1e-24
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 17/197 (8%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           +  + ++   G+LR + +++ H   + +K +  +++  L+YL      IIHRD+   NI 
Sbjct: 90  MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNIL 147

Query: 155 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLC 210
           ++ + G V I D   AA++ R     ++ GT  YMAPE++       Y+  VD +S G+ 
Sbjct: 148 LDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206

Query: 211 LLEMVTMEIPY--SECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCI-AQPRAR 265
             E++    PY      S  +I     T  V  P A       E+ + ++K +   P  R
Sbjct: 207 AYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW----SQEMVSLLKKLLEPNPDQR 262

Query: 266 PSASELLKD-PFFSELN 281
            S    +++ P+ +++N
Sbjct: 263 FSQLSDVQNFPYMNDIN 279

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (251), Expect = 1e-24
 Identities = 61/275 (22%), Positives = 109/275 (39%), Gaps = 30/275 (10%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             LG GA   VYR   +      A   ++ +      V    + +E+ +L  L +  II 
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPNIIK 112

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
              ++       ++ + E+ T G L     +  + S +      KQ+LE + YLH +   
Sbjct: 113 LKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG-- 168

Query: 143 IIHRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYT 199
           I+HRDL   N+ +        +KI D G + IV       ++ GTP Y APE L    Y 
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228

Query: 200 EMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPE 250
             VD++S G      +   I      P+ +      +++++            ++V    
Sbjct: 229 PEVDMWSVG------IITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL-N 281

Query: 251 VKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDD 284
            K  + K I   P+ R +  + L+ P+ +    + 
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.8 bits (249), Expect = 1e-24
 Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 28/275 (10%)

Query: 17  RFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVR----LSHFSEDPVLVNRLHSEVQ 70
              +YS    LGSGA   V+ A D+E+  EV    ++    L     +   + ++  E+ 
Sbjct: 22  YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA 81

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGN-LRTYRKKHRHVSIKALKKWSKQV 129
           +L  +++  II    ++ +        + E   SG  L  +  +H  +         +Q+
Sbjct: 82  ILSRVEHANIIKVLDIFENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYM 189
           +  + YL      IIHRD+   NI I  +   +K+ D G AA + R    ++  GT EY 
Sbjct: 140 VSAVGYLRLK--DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196

Query: 190 APELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNK 245
           APE+     Y    ++++S G+ L  +V  E P+ E        ++        P  ++ 
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE-------LEETVEAAIHPPYLVS- 248

Query: 246 VKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
               E+ + +   +   P  R +  +L+ DP+ ++
Sbjct: 249 ---KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.4 bits (248), Expect = 3e-24
 Identities = 65/279 (23%), Positives = 112/279 (40%), Gaps = 24/279 (8%)

Query: 11  EVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 68
           ++       RY     +GSG         D+     VA     + +      +   +  E
Sbjct: 12  DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVA-----VKYIERGAAIDENVQRE 66

Query: 69  VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 128
           +   R+L++  I+    V L   H  L  I E  + G L          S    + + +Q
Sbjct: 67  IINHRSLRHPNIVRFKEVILTPTH--LAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           +L G+ Y H+    I HRDL   N  ++G+   ++KI D G++          S +GTP 
Sbjct: 125 LLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182

Query: 188 YMAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK------ 239
           Y+APE+   ++Y  ++ D++S G+ L  M+    P+ E     + Y+K    +       
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSI 241

Query: 240 PQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKDPFF 277
           P  +     PE    I +  +A P  R S  E+    +F
Sbjct: 242 PDDIR--ISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 99.7 bits (249), Expect = 5e-24
 Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 28/277 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG GA   V R      G E A   +     S       +L  E ++ R LK+  I+  +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH--QKLEREARICRLLKHPNIVRLH 76

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCII 144
               ++ H     I ++ T G L        + S        +Q+LE + + H     ++
Sbjct: 77  DSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VV 132

Query: 145 HRDLNCSNI-FINGNIG-QVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDYTE 200
           HR+L   N+   +   G  VK+ D G A  V G   A     GTP Y++PE L ++ Y +
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192

Query: 201 MVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDPEV 251
            VD+++ G      V + I      P+ + +   ++Y+++  G         + V   E 
Sbjct: 193 PVDLWACG------VILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTP-EA 244

Query: 252 KAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
           K  I K +   P  R +A+E LK P+ S  +   S  
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM 281

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.1 bits (245), Expect = 6e-24
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 19/268 (7%)

Query: 17  RFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
             G Y   + LG G+  KV  A   +   +VA   +      +   +  R+  E+  L+ 
Sbjct: 7   HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKL 65

Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
           L++ +II  Y V        +  + E    G L  Y  + + ++    +++ +Q++  +E
Sbjct: 66  LRHPHIIKLYDVI--TTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY 194
           Y H H   I+HRDL   N+ ++ N   VKI D G + I+   +   +  G+P Y APE+ 
Sbjct: 123 YCHRH--KIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179

Query: 195 E-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALNKVKDPE 250
             + Y    VD++S G+ L  M+   +P+ + + +  ++KKV   V   P  L+    P 
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLS----PG 234

Query: 251 VKAFIEKCI-AQPRARPSASELLKDPFF 277
            ++ I + I A P  R +  E+ +DP+F
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWF 262

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 97.8 bits (244), Expect = 8e-24
 Identities = 59/280 (21%), Positives = 116/280 (41%), Gaps = 18/280 (6%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
             +     LG GA  +V  A ++     VA   V +    + P  + +   E+ + + L 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
           ++ ++  Y    +          E C+ G L    +    +     +++  Q++ G+ YL
Sbjct: 64  HENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPEL 193
           H     I HRD+   N+ ++     +KI D G A +     R    + + GT  Y+APEL
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 194 YE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY-KKVTGGVKPQALNKVKDPE 250
            +  ++  E VD++S G+ L  M+  E+P+ +     + Y              K+ D  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSA 237

Query: 251 VKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 289
             A + K  +  P AR +  ++ KD ++++     ++   
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 98.7 bits (246), Expect = 8e-24
 Identities = 68/334 (20%), Positives = 119/334 (35%), Gaps = 79/334 (23%)

Query: 25  LGSGAVKKVYRAFDQEE--GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +G G    VY+A  ++     + A  Q+  +  S           E+ LLR LK+  +I 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC------REIALLRELKHPNVIS 82

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA---------LKKWSKQVLEGL 133
              V+L      +  + +     +L    K HR               +K    Q+L+G+
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 134 EYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGDLGFAAIVG-----RSHAAHSIIGT 185
            YLH +   ++HRDL  +NI + G     G+VKI D+GFA +        +     ++ T
Sbjct: 142 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198

Query: 186 PEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTME------------IPYSECDSVAKI- 230
             Y APEL      YT+ +DI++ G    E++T E                  D + +I 
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258

Query: 231 -------------------YKKVTGGVKPQALNKVK------------DPEVKAFIEKCI 259
                              +  +    +                    D +    ++K +
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318

Query: 260 A-QPRARPSASELLKDPFFSEL---NDDDSEPSP 289
              P  R ++ + ++DP+F E      D      
Sbjct: 319 TMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQ 352

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 99.1 bits (247), Expect = 9e-24
 Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 18/274 (6%)

Query: 11  EVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSE 68
           + D   + G Y   D LG G   KV     +  G +VA   +          +V ++  E
Sbjct: 8   KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-RSLDVVGKIRRE 66

Query: 69  VQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQ 128
           +Q L+  ++ +II  Y V      + +  + E  + G L  Y  K+  +  K  ++  +Q
Sbjct: 67  IQNLKLFRHPHIIKLYQVI--STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ 124

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 188
           +L G++Y H H   ++HRDL   N+ ++ +    KI D G + ++       +  G+P Y
Sbjct: 125 ILSGVDYCHRH--MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNY 181

Query: 189 MAPELYE-EDYT-EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV--KPQALN 244
            APE+     Y    VDI+S G+ L  ++   +P+ + D V  ++KK+  G+   PQ LN
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLN 240

Query: 245 KVKDPEVKAFIEKCI-AQPRARPSASELLKDPFF 277
               P V + ++  +   P  R +  ++ +  +F
Sbjct: 241 ----PSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 1e-23
 Identities = 59/248 (23%), Positives = 101/248 (40%), Gaps = 23/248 (9%)

Query: 20  RYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           ++   LG G    V            G  VA  +++ S        +     E+++L++L
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSL 99

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLE 134
           ++  I+    V        L  I E    G+LR Y +KH+  +    L +++ Q+ +G+E
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY----MA 190
           YL T     IHRDL   NI +     +VKIGD G   ++ +    + +    E      A
Sbjct: 160 YLGTK--RYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216

Query: 191 PE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
           PE L E  ++   D++SFG+ L E+ T    Y E             G   Q   ++   
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG--QMIVF 270

Query: 250 EVKAFIEK 257
            +   ++ 
Sbjct: 271 HLIELLKN 278

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.4 bits (243), Expect = 1e-23
 Identities = 59/287 (20%), Positives = 107/287 (37%), Gaps = 40/287 (13%)

Query: 22  SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYI 80
             +LG G   KV   F +  G + A   +       D     +   EV          +I
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLL------YDSPKARQ---EVDHHWQASGGPHI 84

Query: 81  IVCYSVWLDDQHNTLNF--ITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
           +    V+ +  H       I E    G L  R   +  +  + +   +  + +   +++L
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144

Query: 137 HTHEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-L 193
           H+H   I HRD+   N+ + +      +K+ D GFA      +A  +   TP Y+APE L
Sbjct: 145 HSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVL 201

Query: 194 YEEDYTEMVDIYSFGLCLLEMVTMEI------P-YSECDS--VAKIYKKVTGGV---KPQ 241
             E Y +  D++S G      V M I      P YS         + +++  G       
Sbjct: 202 GPEKYDKSCDMWSLG------VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255

Query: 242 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
             ++V + + K  I   +   P  R + ++ +  P+ ++       P
Sbjct: 256 EWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.5 bits (241), Expect = 2e-23
 Identities = 54/233 (23%), Positives = 101/233 (43%), Gaps = 23/233 (9%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V  +  E  ++  L + + +  Y  + DD+   L F      +G L  Y +K        
Sbjct: 74  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETC 131

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHA 178
            + ++ +++  LEYLH     IIHRDL   NI +N +   ++I D G A ++    +   
Sbjct: 132 TRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQAR 188

Query: 179 AHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTG 236
           A+S +GT +Y++PE L E+   +  D+++ G  + ++V    P+    +   I++K +  
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL 247

Query: 237 GVK-PQALNKVKDPEVKAFIEKCI-AQPRARP------SASELLKDPFFSELN 281
               P+       P+ +  +EK +      R           L   PFF  + 
Sbjct: 248 EYDFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 296

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 96.2 bits (240), Expect = 2e-23
 Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 23/248 (9%)

Query: 20  RYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           ++   LG G    V            G  VA  +++ S        +     E+++L++L
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSL 68

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLE 134
           ++  I+    V        L  I E    G+LR Y +KH+  +    L +++ Q+ +G+E
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY----MA 190
           YL T     IHRDL   NI +     +VKIGD G   ++ +      +    E      A
Sbjct: 129 YLGTKR--YIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 191 PE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP 249
           PE L E  ++   D++SFG+ L E+ T    Y E             G   Q   ++   
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG--QMIVF 239

Query: 250 EVKAFIEK 257
            +   ++ 
Sbjct: 240 HLIELLKN 247

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 96.6 bits (241), Expect = 2e-23
 Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 27/285 (9%)

Query: 18  FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
                  LG G+     +   ++     A   +          +      E+  L+  + 
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEG 64

Query: 78  -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
              I+  + V+ D  H     + E+   G L    KK +H S        ++++  + ++
Sbjct: 65  HPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 137 HTHEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE- 192
           H     ++HRDL   N+ F +  +  ++KI D GFA +    +    +   T  Y APE 
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180

Query: 193 LYEEDYTEMVDIYSFG------LCLLEMVTMEIPYSECDSVAKIYKKVTGGV---KPQAL 243
           L +  Y E  D++S G      L              C S  +I KK+  G    + +A 
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240

Query: 244 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
             V   E K  I+  +   P  R   S L  + +  + +   S P
Sbjct: 241 KNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 96.3 bits (240), Expect = 3e-23
 Identities = 67/287 (23%), Positives = 111/287 (38%), Gaps = 48/287 (16%)

Query: 20  RYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           +    LG G   KV        +   G  VA   ++     +     +    E+ +LRTL
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR---SGWKQEIDILRTL 90

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
            +++II       D    +L  + E    G+LR Y  +H  + +  L  +++Q+ EG+ Y
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------- 188
           LH      IHRDL   N+ ++ +   VKIGD G A  V   H         EY       
Sbjct: 150 LHAQH--YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGH---------EYYRVREDG 197

Query: 189 ------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK- 239
                  APE L E  +    D++SFG+ L E++T  +   S      ++     G +  
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257

Query: 240 PQALNKVKD-----------PEVKAFIEKC-IAQPRARPSASELLKD 274
            +    ++             EV   ++ C   +   RP+   L+  
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 96.7 bits (241), Expect = 3e-23
 Identities = 59/275 (21%), Positives = 106/275 (38%), Gaps = 35/275 (12%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV----NRLHSEVQLLRTLKN-KY 79
           +G G    V R   +  G E A   + ++     P  +         E  +LR +    +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
           II     +       +  + ++   G L  Y  +   +S K  +   + +LE + +LH +
Sbjct: 162 IITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE------- 192
              I+HRDL   NI ++ N  Q+++ D GF+  +        + GTP Y+APE       
Sbjct: 220 N--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD 276

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQAL 243
                Y + VD+++ G      V +        P+        + + +  G         
Sbjct: 277 ETHPGYGKEVDLWACG------VILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEW 329

Query: 244 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
           +      VK  I + +   P AR +A + L+ PFF
Sbjct: 330 DDRSS-TVKDLISRLLQVDPEARLTAEQALQHPFF 363

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 95.5 bits (238), Expect = 4e-23
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 33/295 (11%)

Query: 7   EPFVEVDP---SGRFGRYSDLLGSGAVKKVYRA----FDQEEGIEVAWNQVRLSHFSEDP 59
           +P  EVDP     RF +    LG G   KV            G +VA   ++        
Sbjct: 8   KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 67

Query: 60  VLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VS 118
                L  E+++LR L ++ I+    +  +D  N +  I E   SG+L+ Y  K+++ ++
Sbjct: 68  ---ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124

Query: 119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA 178
           +K   K++ Q+ +G++YL + +   +HRDL   N+ +     QVKIGD G    +     
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKE 181

Query: 179 AHSIIGTPEY----MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYK 232
            +++    +      APE L +  +    D++SFG+ L E++T  +   S      K+  
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

Query: 233 KVTGGVK-PQALNKVKD-----------PEVKAFIEKC-IAQPRARPSASELLKD 274
              G +   + +N +K+            EV   + KC   QP  R S   L++ 
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 96.2 bits (240), Expect = 4e-23
 Identities = 49/225 (21%), Positives = 104/225 (46%), Gaps = 21/225 (9%)

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 125
            +E ++L+ +   +++     + D+ +  L  + E    G + ++ ++    S    + +
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFY 146

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 185
           + Q++   EYLH+ +  +I+RDL   N+ I+   G +++ D GFA  V       ++ GT
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK--GRTWTLCGT 201

Query: 186 PEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQA 242
           PE +APE +  + Y + VD ++ G+ + EM     P+   D   +IY+K V+G V+ P  
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSH 260

Query: 243 LNKVKDPEVKAFIEK-CIAQPRAR-----PSASELLKDPFFSELN 281
                  ++K  +          R        +++    +F+  +
Sbjct: 261 F----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 94.9 bits (237), Expect = 5e-23
 Identities = 62/271 (22%), Positives = 122/271 (45%), Gaps = 34/271 (12%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           +LGSGA  +V+    +  G   A   ++ S    D    + L +E+ +L+ +K++ I+  
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLKKIKHENIVTL 71

Query: 84  YSVWLDDQHNTLNFITEVCTSGNL--RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
             ++    H     + ++ + G L  R   +     + K      +QVL  ++YLH +  
Sbjct: 72  EDIYESTTH--YYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENG- 126

Query: 142 CIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDY 198
            I+HRDL   N+ ++      ++ I D G + +   +    +  GTP Y+APE L ++ Y
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQKPY 184

Query: 199 TEMVDIYSFGLCLLEMVTMEI------PYSECDSVAKIYKKVTGGV---KPQALNKVKDP 249
           ++ VD +S G      V   I      P+ E ++ +K+++K+  G    +    + + + 
Sbjct: 185 SKAVDCWSIG------VITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISE- 236

Query: 250 EVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
             K FI   + + P  R +  + L  P+   
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 96.3 bits (240), Expect = 6e-23
 Identities = 64/305 (20%), Positives = 116/305 (38%), Gaps = 42/305 (13%)

Query: 7   EPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           +  +++  +     Y   S +LG G   KV + F++    + A   +      +D     
Sbjct: 49  KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKAR 102

Query: 64  RLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNF--ITEVCTSGNL--RTYRKKHRHVS 118
           R   EV+L        +I+    V+ +          + E    G L  R   +  +  +
Sbjct: 103 R---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 159

Query: 119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRS 176
            +   +  K + E ++YLH+    I HRD+   N+ + +      +K+ D GFA      
Sbjct: 160 EREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217

Query: 177 HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEI------P-YSECDSV- 227
           ++  +   TP Y+APE L  E Y +  D++S G      V M I      P YS      
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG------VIMYILLCGYPPFYSNHGLAI 271

Query: 228 -AKIYKKVTGGV---KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELND 282
              +  ++  G         ++V + EVK  I   +   P  R + +E +  P+  +   
Sbjct: 272 SPGMKTRIRMGQYEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330

Query: 283 DDSEP 287
               P
Sbjct: 331 VPQTP 335

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.6 bits (233), Expect = 2e-22
 Identities = 59/297 (19%), Positives = 108/297 (36%), Gaps = 50/297 (16%)

Query: 25  LGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           LG G    V  A    +    ++VA   ++    +     +     E   ++   + ++ 
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHPHVA 88

Query: 82  VCYSVWLDDQHNTLNF----ITEVCTSGNLRTYRKKHRH------VSIKALKKWSKQVLE 131
               V L  +          I      G+L  +    R       + ++ L ++   +  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY--- 188
           G+EYL +     IHRDL   N  +  +   V + D G +           I     Y   
Sbjct: 149 GMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADFGLS---------RKIYSGDYYRQG 196

Query: 189 ---------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
                    +A E L +  YT   D+++FG+ + E++T  + PY+     A+IY  + GG
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLIGG 255

Query: 238 VKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK--DPFFSELNDDDSEPSP 289
                L +  +   EV   + +C  A P+ RPS + L    +     L+   +   P
Sbjct: 256 ---NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 92.7 bits (231), Expect = 5e-22
 Identities = 52/305 (17%), Positives = 117/305 (38%), Gaps = 53/305 (17%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            Y  +  LG G   +V+ A +     +V    ++       PV   ++  E+++L  L+ 
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 89

Query: 78  -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
              II    +  D    T   + E   + + +   +    ++   ++ +  ++L+ L+Y 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 146

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE--LY 194
           H+    I+HRD+   N+ I+    ++++ D G A         +  + +  +  PE  + 
Sbjct: 147 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPY----SECDSVAKI-------------------- 230
            + Y   +D++S G  L  M+  + P+       D + +I                    
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264

Query: 231 ---YKKVTGGVKPQALNKV--------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFS 278
              +  + G    +   +           PE   F++K +    ++R +A E ++ P+F 
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324

Query: 279 ELNDD 283
            +  D
Sbjct: 325 TVVKD 329

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 93.6 bits (233), Expect = 7e-22
 Identities = 47/232 (20%), Positives = 94/232 (40%), Gaps = 19/232 (8%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
                 E  ++    + +++  +  + DD++  L  + E    G+L      +  V  K 
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD-VPEKW 169

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--A 179
            + ++ +V+  L+ +H+     IHRD+   N+ ++ + G +K+ D G    + +      
Sbjct: 170 ARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRC 226

Query: 180 HSIIGTPEYMAPEL-----YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV 234
            + +GTP+Y++PE+      +  Y    D +S G+ L EM+  + P+   DS+   Y K+
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKI 285

Query: 235 TGGVKPQALNKVKD--PEVKAFIEKCIAQPRAR---PSASELLKDPFFSELN 281
                        D   E K  I   +     R       E+ +  FF    
Sbjct: 286 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 92.3 bits (230), Expect = 8e-22
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 22/224 (9%)

Query: 25  LGSGAVKKVYRAF----DQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LGSGA   VY+       ++  I VA   ++ L   +        L  E  ++ ++ N +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEIL-DEAYVMASVDNPH 78

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L      +  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  VCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT--P-EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G   P ++MA E + 
Sbjct: 136 R--RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 195 EEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
              YT   D++S+G+ + E++T    PY      ++I   +  G
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKG 235

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.4 bits (230), Expect = 8e-22
 Identities = 61/281 (21%), Positives = 111/281 (39%), Gaps = 37/281 (13%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVC 83
           +G G+     R   +   +E A     +    +          E++ LLR  ++  II  
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFA-----VKIIDKSKRDPTE---EIEILLRYGQHPNIITL 81

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             V+ D ++  +  +TE+   G L     + +  S +        + + +EYLH     +
Sbjct: 82  KDVYDDGKY--VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--V 137

Query: 144 IHRDLNCSNI-FIN--GNIGQVKIGDLGFAAIV-GRSHAAHSIIGTPEYMAPE-LYEEDY 198
           +HRDL  SNI +++  GN   ++I D GFA  +   +    +   T  ++APE L  + Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197

Query: 199 TEMVDIYSFGLCLLEMVTMEI------PY--SECDSVAKIYKKVTGGV---KPQALNKVK 247
               DI+S G      V +        P+     D+  +I  ++  G         N V 
Sbjct: 198 DAACDIWSLG------VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251

Query: 248 DPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
           D   K  + K +   P  R +A+ +L+ P+    +      
Sbjct: 252 D-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 91.2 bits (227), Expect = 1e-21
 Identities = 56/302 (18%), Positives = 109/302 (36%), Gaps = 44/302 (14%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYII 81
           D+LG GA  +V    +     E A   +            +R+  EV++L   +  + ++
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI----RSRVFREVEMLYQCQGHRNVL 74

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
                + ++       + E    G++ ++  K RH +        + V   L++LH    
Sbjct: 75  ELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG- 131

Query: 142 CIIHRDLNCSNI-FIN-GNIGQVKIGDLGFAAIVGRSHAAHSI--------IGTPEYMAP 191
            I HRDL   NI   +   +  VKI D    + +  +     I         G+ EYMAP
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 192 E------LYEEDYTEMVDIYSFG------LC--------LLEMVTMEIPYSECDSVAKIY 231
           E           Y +  D++S G      L                +   +       ++
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250

Query: 232 KKVTGGV---KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEP 287
           + +  G      +    +     K  I K + +  + R SA+++L+ P+      +++ P
Sbjct: 251 ESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309

Query: 288 SP 289
           +P
Sbjct: 310 TP 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 77/325 (23%), Positives = 127/325 (39%), Gaps = 74/325 (22%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY DL  LG G    V+ A D +    VA  ++       DP  V     E++++R L +
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VL-TDPQSVKHALREIKIIRRLDH 67

Query: 78  KYII------------VCYSVWLDDQHNTLNFITE--------VCTSGNLRTYRKKHRHV 117
             I+            +   V    + N++  + E        V   G L        H 
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-----LEEHA 122

Query: 118 SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH 177
                + +  Q+L GL+Y+H+    ++HRDL  +N+FIN     +KIGD G A I+   H
Sbjct: 123 -----RLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD-PH 174

Query: 178 AAHSIIGTPE-----YMAPE--LYEEDYTEMVDIYSFGLCLLEMVT-------------- 216
            +H    +       Y +P   L   +YT+ +D+++ G    EM+T              
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234

Query: 217 ---MEI---PYSE----CDSVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QP 262
              +E     + E      SV  +Y +       + L ++      E   F+E+ +   P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294

Query: 263 RARPSASELLKDPFFSELNDDDSEP 287
             R +A E L  P+ S  +    EP
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEP 319

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 91.6 bits (228), Expect = 2e-21
 Identities = 64/317 (20%), Positives = 121/317 (38%), Gaps = 64/317 (20%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY++L  +G GA   V  A+D    + VA    ++S F E      R   E+++L   ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPF-EHQTYCQRTLREIKILLRFRH 84

Query: 78  KYIIVCYSVWLDDQHNTLN---FITE--------VCTSGNLRTYRKKHRHVSIKALKKWS 126
           + II    +        +     + +        +  + +L      + H+       + 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL-----SNDHI-----CYFL 134

Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI---- 182
            Q+L GL+Y+H+    ++HRDL  SN+ +N     +KI D G A +    H         
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEY 191

Query: 183 IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGV 238
           + T  Y APE  L  + YT+ +DI+S G  L EM++    +     + ++     + G  
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

Query: 239 KPQALNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASEL 271
             + LN + + + + ++     + +                            R    + 
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311

Query: 272 LKDPFFSELNDDDSEPS 288
           L  P+  +  D   EP 
Sbjct: 312 LAHPYLEQYYDPSDEPI 328

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 20/199 (10%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L+FI ++   G+L  +  +H   S   ++ ++ +++ GLE++H     +++RDL  +NI 
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANIL 324

Query: 155 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLL 212
           ++ + G V+I DLG A    +    H+ +GT  YMAPE       Y    D +S G  L 
Sbjct: 325 LDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382

Query: 213 EMVTMEIPY--SECDSVAKIYKKV-TGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR-- 265
           +++    P+   +     +I +   T  V+ P +      PE+++ +E  +      R  
Sbjct: 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLG 438

Query: 266 ---PSASELLKDPFFSELN 281
                A E+ + PFF  L+
Sbjct: 439 CLGRGAQEVKESPFFRSLD 457

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 60/261 (22%), Positives = 103/261 (39%), Gaps = 27/261 (10%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G   +V+    + +   VA    R +   +      +   E ++L+   +  I+   
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK---AKFLQEARILKQYSHPNIVRLI 178

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V    Q   +  + E+   G+  T+ R +   + +K L +       G+EYL +   C 
Sbjct: 179 GVCTQKQPIYI--VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CC 234

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEY----MAPE-LYEED 197
           IHRDL   N  +      +KI D G +       +AA    G  +      APE L    
Sbjct: 235 IHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYAASG--GLRQVPVKWTAPEALNYGR 291

Query: 198 YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKA 253
           Y+   D++SFG+ L E  ++   PY    S  +  + V  G     P+         V  
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRLPCPELCP----DAVFR 346

Query: 254 FIEKC-IAQPRARPSASELLK 273
            +E+C   +P  RPS S + +
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 90.7 bits (226), Expect = 3e-21
 Identities = 61/229 (26%), Positives = 111/229 (48%), Gaps = 21/229 (9%)

Query: 62  VNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           V   + E  +L  + + +II  +  + D Q   +  I +    G L +  +K +      
Sbjct: 50  VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPV 107

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS 181
            K ++ +V   LEYLH+ +  II+RDL   NI ++ N G +KI D GFA  V      ++
Sbjct: 108 AKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV--TYT 162

Query: 182 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK 239
           + GTP+Y+APE +  + Y + +D +SFG+ + EM+    P+    +  K Y+K +   ++
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELR 221

Query: 240 -PQALNKVKDPEVKAFIEK-CIAQPRAR----PSASELLKD-PFFSELN 281
            P       + +VK  + +        R     + +E +K+ P+F E+ 
Sbjct: 222 FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 90.8 bits (226), Expect = 4e-21
 Identities = 76/314 (24%), Positives = 131/314 (41%), Gaps = 60/314 (19%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            Y DL  +GSGA   V  A D   G +VA    +L    +  +   R + E++LL+ +++
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 78  KYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK-----Q 128
           + +I    V+      D       +     + +L       + +  + L +        Q
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DL------GKLMKHEKLGEDRIQFLVYQ 136

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTP 186
           +L+GL Y+H     IIHRDL   N+ +N +  ++KI D G A    R   +     + T 
Sbjct: 137 MLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLA----RQADSEMTGYVVTR 189

Query: 187 EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQA 242
            Y APE  L    YT+ VDI+S G  + EM+T +  +   D + ++ +  KVTG    + 
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 243 LNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDP 275
           + +++  E K +++      +                            R +A E L  P
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309

Query: 276 FFSELNDDDSEPSP 289
           +F  L+D + EP  
Sbjct: 310 YFESLHDTEDEPQV 323

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 90.4 bits (225), Expect = 5e-21
 Identities = 76/334 (22%), Positives = 135/334 (40%), Gaps = 61/334 (18%)

Query: 1   MSDRDGEPFVEVDPSG-RF---GRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSH 54
           +S    + F + D +   +     Y     +GSGA   V  A D+  G +VA    +LS 
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSR 59

Query: 55  FSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTY 110
             +  +   R + E+ LL+ ++++ +I    V+              +     + +L+  
Sbjct: 60  PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKI 118

Query: 111 RKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL 167
                    +     +    Q+L+GL+Y+H+    ++HRDL   N+ +N +  ++KI D 
Sbjct: 119 MGLKFSEEKI-----QYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDF 170

Query: 168 GFAAIVGRSHAAHSI--IGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSE 223
           G A    R   A     + T  Y APE  L    Y + VDI+S G  + EM+T +  +  
Sbjct: 171 GLA----RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226

Query: 224 CDSVAKIYK--KVTGGVKPQALNKVKDPEVKAFIEKCIAQPRA----------------- 264
            D + ++ +  KVTG    + + K+ D   K++I+     PR                  
Sbjct: 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286

Query: 265 ----------RPSASELLKDPFFSELNDDDSEPS 288
                     R +A++ L  PFF    D + E  
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFEPFRDPEEETE 320

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 88.9 bits (221), Expect = 6e-21
 Identities = 60/291 (20%), Positives = 111/291 (38%), Gaps = 50/291 (17%)

Query: 25  LGSGAVKKVYRA-------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           LG G   K+++        + Q    EV    +  +H +              ++  L +
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS----ESFFEAASMMSKLSH 71

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYL 136
           K++++ Y V +    N L  + E    G+L TY KK+++ ++I    + +KQ+   + +L
Sbjct: 72  KHLVLNYGVCVCGDENIL--VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 137 HTHEPCIIHRDLNCSNIFIN-------GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY- 188
             +   +IH ++   NI +        GN   +K+ D G +  V             +  
Sbjct: 130 EEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----------DIL 177

Query: 189 ------MAPE--LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVK 239
                 + PE     ++     D +SFG  L E+ +  + P S  DS  +  +       
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDR-- 234

Query: 240 PQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKDPFFSELNDDDSEPSP 289
              L   K  E+   I  C   +P  RPS   +++D   + L   D  P  
Sbjct: 235 -HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPDLVPRG 282

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 90.1 bits (224), Expect = 7e-21
 Identities = 60/314 (19%), Positives = 117/314 (37%), Gaps = 48/314 (15%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVA-------WNQVRLSHFSEDPVLVNRLHSEVQ 70
            Y+    + SG+   V    D E GI VA        +  R  +   D  L  R+  E++
Sbjct: 23  PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           LL    +  I+    +++  +   ++    +TE+  +   +    +   +S + ++ +  
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
            +L GL  LH     ++HRDL+  NI +  N   + I D   A            +    
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRW 198

Query: 188 YMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQAL 243
           Y APE  +  + +T++VD++S G  + EM   +  +       ++ K  +V G  K + +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258

Query: 244 NKVKDPEVKAFIEKCIAQ----------------------------PRARPSASELLKDP 275
                P  + ++   ++                             P+ R S  + L+ P
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318

Query: 276 FFSELNDDDSEPSP 289
           +F  L D       
Sbjct: 319 YFESLFDPLDLTEG 332

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 90.0 bits (224), Expect = 7e-21
 Identities = 78/322 (24%), Positives = 127/322 (39%), Gaps = 66/322 (20%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            +     LG GA   V  A  +  G  VA  ++    F + P+   R   E+++L+  K+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--F-DKPLFALRTLREIKILKHFKH 68

Query: 78  KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSK-----QV 129
           + II  +++   D     N    I E+  + +L      HR +S + L          Q 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DL------HRVISTQMLSDDHIQYFIYQT 121

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE-- 187
           L  ++ LH     +IHRDL  SN+ IN N   +K+ D G A I+  S A +S     +  
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 188 ---------YMAPE--LYEEDYTEMVDIYSFGLCLLEMVT-----------------MEI 219
                    Y APE  L    Y+  +D++S G  L E+                     I
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238

Query: 220 ---PYSECD------SVAKIYKKVTGGVKPQALNKV---KDPEVKAFIEKCIA-QPRARP 266
              P+S+ D        A+ Y K         L K+    +P+    +++ +   P  R 
Sbjct: 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298

Query: 267 SASELLKDPFFSELNDDDSEPS 288
           +A E L+ P+    +D + EP 
Sbjct: 299 TAKEALEHPYLQTYHDPNDEPE 320

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 63/273 (23%), Positives = 117/273 (42%), Gaps = 25/273 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G   +VY    ++  + VA   ++      +  L      E  +++ +K+  ++   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-----KEAAVMKEIKHPNLVQLL 282

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V   +       ITE  T GNL  Y ++     VS   L   + Q+   +EYL      
Sbjct: 283 GVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--N 338

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            IHR+L   N  +  N   VK+ D G +  + G ++ AH+    P ++ APE L    ++
Sbjct: 339 FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 200 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIE 256
              D+++FG+ L E+ T    PY     ++++Y+ +    +   + + +    +V   + 
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYR---MERPEGCPEKVYELMR 453

Query: 257 KC-IAQPRARPSASELLK--DPFFSELNDDDSE 286
            C    P  RPS +E+ +  +  F E +  D  
Sbjct: 454 ACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 39/169 (23%), Positives = 75/169 (44%), Gaps = 20/169 (11%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--AHSIIGT 185
           +++  ++ +H      +HRD+   NI ++ N G +++ D G    +       +   +GT
Sbjct: 183 EMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGT 239

Query: 186 PEYMAPEL------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK 239
           P+Y++PE+       +  Y    D +S G+C+ EM+  E P+   +S+ + Y K+    +
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKE 298

Query: 240 ----PQALNKVKDPEVKAFIEKCIAQPRAR---PSASELLKDPFFSELN 281
               P  +  V     K  I + I     R       +  K PFFS ++
Sbjct: 299 RFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 89.3 bits (222), Expect = 1e-20
 Identities = 77/314 (24%), Positives = 138/314 (43%), Gaps = 60/314 (19%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA  ++    F +  +   R + E++LL+ +K+
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-F-QSIIHAKRTYRELRLLKHMKH 87

Query: 78  KYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK-----Q 128
           + +I    V+      ++ N +  +T +  + +L      +  V  + L          Q
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DL------NNIVKCQKLTDDHVQFLIYQ 140

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH--SIIGTP 186
           +L GL+Y+H+ +  IIHRDL  SN+ +N +  ++KI D G A    R  A      + T 
Sbjct: 141 ILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA----RHTADEMTGYVATR 193

Query: 187 EYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK--KVTGGVKPQA 242
            Y APE  L    Y + VDI+S G  + E++T    +   D + ++    ++ G    + 
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253

Query: 243 LNKVKDPEVKAFIEKCIAQPRA---------------------------RPSASELLKDP 275
           L K+     + +I+     P+                            R +A++ L   
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

Query: 276 FFSELNDDDSEPSP 289
           +F++ +D D EP  
Sbjct: 314 YFAQYHDPDDEPVA 327

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.7 bits (218), Expect = 2e-20
 Identities = 60/289 (20%), Positives = 105/289 (36%), Gaps = 49/289 (16%)

Query: 25  LGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           LG G    V       +    ++VA   ++L + S+    +    SE   ++   +  +I
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVI 99

Query: 82  VCYSVWLDDQHNTLNF---ITEVCTSGNLRTYRKKHR------HVSIKALKKWSKQVLEG 132
               V ++     +     I      G+L TY    R      H+ ++ L K+   +  G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY---- 188
           +EYL       +HRDL   N  +  +   V + D G +    +      I     Y    
Sbjct: 160 MEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGLS----KK-----IYSGDYYRQGR 207

Query: 189 --------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV 238
                   +A E L +  YT   D+++FG+ + E+ T    PY       ++Y  +  G 
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYLLHG- 265

Query: 239 KPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK--DPFFSELND 282
               L + +D   E+   +  C    P  RP+ S L    +     L D
Sbjct: 266 --HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.2 bits (221), Expect = 3e-20
 Identities = 57/275 (20%), Positives = 112/275 (40%), Gaps = 27/275 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G   +V+          VA   ++    S +  L      E Q+++ L+++ ++  Y
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL-----QEAQVMKKLRHEKLVQLY 328

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
           +V  ++    +  +TE  + G+L  + K     ++ +  L   + Q+  G+ Y+      
Sbjct: 329 AVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--N 383

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            +HRDL  +NI +  N    K+ D G A  I    + A      P ++ APE      +T
Sbjct: 384 YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 200 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIE 256
              D++SFG+ L E+ T   +PY       ++  +V  G +   +    +    +   + 
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYR---MPCPPECPESLHDLMC 498

Query: 257 KC-IAQPRARPSASELLK--DPFFSELNDDDSEPS 288
           +C   +P  RP+   L    + +F+          
Sbjct: 499 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.3 bits (217), Expect = 4e-20
 Identities = 68/304 (22%), Positives = 121/304 (39%), Gaps = 61/304 (20%)

Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG G+   VY          E    VA   V  +    +        +E  +++     +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASVMKEFNCHH 89

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------VSIKALKKWSKQV 129
           ++    V    Q   +  I E+ T G+L++Y +  R            S+  + + + ++
Sbjct: 90  VVRLLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY- 188
            +G+ YL+ ++   +HRDL   N  +  +   VKIGD G      R       I   +Y 
Sbjct: 148 ADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMT----RD------IYETDYY 194

Query: 189 ------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV 234
                       M+PE L +  +T   D++SFG+ L E+ T+ E PY    S  ++ + V
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFV 253

Query: 235 TGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK------DPFFSELNDDDS 285
             G     L+K  +    +   +  C    P+ RPS  E++       +P F E++   S
Sbjct: 254 MEG---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310

Query: 286 EPSP 289
           E + 
Sbjct: 311 EENK 314

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 89.1 bits (221), Expect = 4e-20
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 17/199 (8%)

Query: 95  LNFITEVCTSGNLRT--YRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN 152
           L  +  +   G+L+   Y              ++ ++  GLE LH     I++RDL   N
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPEN 316

Query: 153 IFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCL 211
           I ++ + G ++I DLG A  V         +GT  YMAPE +  E YT   D ++ G  L
Sbjct: 317 ILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375

Query: 212 LEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRAR-- 265
            EM+  + P+    +     ++ + V     P+  ++   P+ ++   + +   P  R  
Sbjct: 376 YEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARSLCSQLLCKDPAERLG 433

Query: 266 ---PSASELLKDPFFSELN 281
               SA E+ + P F +LN
Sbjct: 434 CRGGSAREVKEHPLFKKLN 452

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 88.7 bits (220), Expect = 4e-20
 Identities = 57/275 (20%), Positives = 112/275 (40%), Gaps = 27/275 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G   +V+          VA   ++    S +  L      E Q+++ L+++ ++  Y
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL-----QEAQVMKKLRHEKLVQLY 245

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
           +V  ++    +  +TE  + G+L  + K     ++ +  L   + Q+  G+ Y+      
Sbjct: 246 AVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--N 300

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            +HRDL  +NI +  N    K+ D G A  I    + A      P ++ APE      +T
Sbjct: 301 YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 200 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIE 256
              D++SFG+ L E+ T   +PY       ++  +V  G +   +    +    +   + 
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYR---MPCPPECPESLHDLMC 415

Query: 257 KC-IAQPRARPSASELLK--DPFFSELNDDDSEPS 288
           +C   +P  RP+   L    + +F+          
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.6 bits (215), Expect = 7e-20
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 22/224 (9%)

Query: 25  LGSGAVKKVYRAF----DQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LGSGA   VY+       ++  I VA   ++ L   +        L  E  ++ ++ N +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEIL-DEAYVMASVDNPH 78

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +     + L      +  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL  
Sbjct: 79  VCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT--P-EYMAPE-LY 194
               ++HRDL   N+ +      VKI D G A ++G     +   G   P ++MA E + 
Sbjct: 136 R--RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 195 EEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
              YT   D++S+G+ + E++T    PY      ++I   +  G
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKG 235

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 87.5 bits (217), Expect = 8e-20
 Identities = 36/170 (21%), Positives = 73/170 (42%), Gaps = 20/170 (11%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--AHSIIGT 185
           +++  ++ +H      +HRD+   NI ++   G +++ D G    +       +   +GT
Sbjct: 170 EIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLKLRADGTVRSLVAVGT 226

Query: 186 PEYMAPEL--------YEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG 237
           P+Y++PE+            Y    D ++ G+   EM   + P+   DS A+ Y K+   
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHY 285

Query: 238 ---VKPQALNKVKDPEVKAFIEKCIAQPRAR---PSASELLKDPFFSELN 281
              +    +++    E + FI++ +  P  R     A +    PFF  L+
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLD 335

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 85.6 bits (212), Expect = 1e-19
 Identities = 40/272 (14%), Positives = 77/272 (28%), Gaps = 43/272 (15%)

Query: 10  VEVDPSGRF--GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
           V++ P  R   GRY      G     + ++A D     +VA   V          ++   
Sbjct: 20  VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD-PQGVLPDDVLQET 78

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI-TEVCTSGNLRTYRKKHRHVSIKALKK 124
            S    L  +    +     V           +  E    G+L+         S     +
Sbjct: 79  LSRTLRLSRIDKPGVARVLDV---VHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIR 133

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
             + +    +  H     +     + S + ++ + G V +                    
Sbjct: 134 AMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAY------------------ 172

Query: 185 TPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGG-VKP 240
            P  M             DI   G  L  ++    P  E      +A   +   G  ++P
Sbjct: 173 -PATMPDA------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225

Query: 241 QALNKVKDPEVKAFIEKCIAQPRARPSASELL 272
             +++    ++ A   + +       SAS LL
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 75/337 (22%), Positives = 113/337 (33%), Gaps = 92/337 (27%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAW----NQVRLSHFSEDPVLVNRLHSEVQLL 72
            RY     LG G    V+ A D      VA          +  +ED         E++LL
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---------EIKLL 69

Query: 73  RTLK----------NKYIIVCYSVWLDD-QHNTLN-----FITEVCTSGNLRTYRKKHRH 116
           + +               I+     LD   H   N      + EV    NL    KK+ H
Sbjct: 70  QRVNDADNTKEDSMGANHILKL---LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH 125

Query: 117 V--SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI-----NGNIGQVKIGDLGF 169
               +  +K+ SKQ+L GL+Y+H     IIH D+   N+ +       N+ Q+KI DLG 
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184

Query: 170 AAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT---------MEI 219
           A      +   + I T EY +PE L    +    DI+S    + E++T            
Sbjct: 185 ACWYDEHY--TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242

Query: 220 PYSECDSVAKI------------------------------YKKVTGGVKPQALN---KV 246
              + D +A+I                                K+        L    K 
Sbjct: 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302

Query: 247 KDPEVKAF---IEKCIA-QPRARPSASELLKDPFFSE 279
              E K     +   +   PR R  A  L+  P+  +
Sbjct: 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 70/307 (22%), Positives = 118/307 (38%), Gaps = 65/307 (21%)

Query: 20  RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
            +   LG+GA  KV  A        +  + VA   ++ S    +      L SE+++L  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER---EALMSELKVLSY 82

Query: 75  LKN-KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------------------ 115
           L N   I+             +  ITE C  G+L  + ++ R                  
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 116 HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 175
            + ++ L  +S QV +G+ +L +     IHRDL   NI +       KI D G       
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGL------ 191

Query: 176 SHAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              A  I     Y            MAPE ++   YT   D++S+G+ L E+ ++   PY
Sbjct: 192 ---ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

Query: 222 SECDSVAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DP 275
                 +K YK +  G   + P+        E+   ++ C  A P  RP+  ++++  + 
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 276 FFSELND 282
             SE  +
Sbjct: 305 QISESTN 311

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.5 bits (212), Expect = 2e-19
 Identities = 46/223 (20%), Positives = 95/223 (42%), Gaps = 20/223 (8%)

Query: 25  LGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI 80
           LGSG    V++       +   I V    +      +       +   +  + +L + +I
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF---QAVTDHMLAIGSLDHAHI 77

Query: 81  IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTH 139
           +    +        L  +T+    G+L  + ++HR  +  + L  W  Q+ +G+ YL  H
Sbjct: 78  VRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT--P-EYMAPE-LYE 195
              ++HR+L   N+ +     QV++ D G A ++              P ++MA E ++ 
Sbjct: 135 --GMVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191

Query: 196 EDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
             YT   D++S+G+ + E++T    PY+    +A++   +  G
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKG 233

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 59/288 (20%)

Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-K 78
           LG+GA  KV  A       ++  ++VA   ++ +  +++      L SE++++  L   +
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE---KEALMSELKIMSHLGQHE 110

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--------------HVSIKALKK 124
            I+             +  ITE C  G+L  + ++                  S + L  
Sbjct: 111 NIVNLLGACTHGGPVLV--ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG 184
           +S QV +G+ +L +     IHRD+   N+ +       KIGD G          A  I+ 
Sbjct: 169 FSSQVAQGMAFLASKN--CIHRDVAARNVLLTNG-HVAKIGDFGL---------ARDIMN 216

Query: 185 TPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKI 230
              Y            MAPE +++  YT   D++S+G+ L E+ ++   PY      +K 
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276

Query: 231 YKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKD 274
           YK V  G    +P          + + ++ C   +P  RP+  ++   
Sbjct: 277 YKLVKDGYQMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSF 320

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.9 bits (213), Expect = 2e-19
 Identities = 75/320 (23%), Positives = 123/320 (38%), Gaps = 61/320 (19%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 78  KYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTYRKK---HRHVSIKALKKWSKQVL 130
           K II   +V+      ++   +  + E+  + NL    +    H  +S         Q+L
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY-----QML 137

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
            G+++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y A
Sbjct: 138 CGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 191 PE-LYEEDYTEMVDIYSFGLCLLEMVT-----------------MEI---PYSE----CD 225
           PE +    Y E VDI+S G  + EM+                  +E    P  E      
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254

Query: 226 SVAKIYKKVTGGVKPQALNKV---------------KDPEVKAFIEKCIA-QPRARPSAS 269
              + Y +        +  K+               K  + +  + K +      R S  
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 270 ELLKDPFFSELNDDDSEPSP 289
           E L+ P+ +   D     +P
Sbjct: 315 EALQHPYINVWYDPSEAEAP 334

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 84.6 bits (210), Expect = 4e-19
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 22/162 (13%)

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA---AIVGRSHAAHSIIGTPEY 188
           GL YLH     IIHRD+   NI ++ N    KI D G +     + ++H +  + GT  Y
Sbjct: 151 GLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGY 207

Query: 189 MAPELYEEDY-TEMVDIYSFGLCLLEMVT------MEIPYSECDSV--AKIYKK---VTG 236
           + PE + +   TE  D+YSFG+ L E++         +P    +    A        +  
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267

Query: 237 GVKPQALNKVKDPEVKAFIE---KCIA-QPRARPSASELLKD 274
            V P   +K++   ++ F +   KC+A     RPS  ++L  
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 83.9 bits (208), Expect = 5e-19
 Identities = 51/243 (20%), Positives = 107/243 (44%), Gaps = 27/243 (11%)

Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLH 66
           V + PS     +++++G G    VY      +  + I  A   +       +   V++  
Sbjct: 18  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFL 74

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKW 125
           +E  +++   +  ++    + L  + + L  +      G+LR + R +  + ++K L  +
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA---------AIVGRS 176
             QV +G++YL + +   +HRDL   N  ++     VK+ D G A         ++  ++
Sbjct: 134 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKT 190

Query: 177 HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV 234
            A   +    ++MA E L  + +T   D++SFG+ L E++T    PY +  +   I   +
Sbjct: 191 GAKLPV----KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYL 245

Query: 235 TGG 237
             G
Sbjct: 246 LQG 248

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 85.2 bits (211), Expect = 7e-19
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 24/204 (11%)

Query: 95  LNFITEVCTSGNL----RTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC 150
           L  +  +   G++        + +          ++ Q++ GLE+LH     II+RDL  
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKP 317

Query: 151 SNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFG 208
            N+ ++ + G V+I DLG A  +           GTP +MAPE L  E+Y   VD ++ G
Sbjct: 318 ENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG 376

Query: 209 LCLLEMVTMEIPY---SECDSVAKIYKKV-TGGVK-PQALNKVKDPEVKAFIEKCIA-QP 262
           + L EM+    P+    E     ++ ++V    V  P        P  K F E  +   P
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF----SPASKDFCEALLQKDP 432

Query: 263 RAR-----PSASELLKDPFFSELN 281
             R      S   L   P F +++
Sbjct: 433 EKRLGFRDGSCDGLRTHPLFRDIS 456

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 83.4 bits (207), Expect = 7e-19
 Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 27/274 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG G   +VY    ++  + VA   ++      +  L      E  +++ +K+  ++   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-----KEAAVMKEIKHPNLVQLL 75

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V   +    +  ITE  T GNL  Y ++     VS   L   + Q+   +EYL      
Sbjct: 76  GVCTREPPFYI--ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--N 131

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            IHRDL   N  +  N   VK+ D G + ++ G ++ AH+    P ++ APE L    ++
Sbjct: 132 FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 200 EMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV---KPQALNKVKDPEVKAFI 255
              D+++FG+ L E+ T    PY     ++++Y+ +       +P+        +V   +
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERPEGCP----EKVYELM 245

Query: 256 EKC-IAQPRARPSASELLK--DPFFSELNDDDSE 286
             C    P  RPS +E+ +  +  F E +  D  
Sbjct: 246 RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.9 bits (210), Expect = 7e-19
 Identities = 74/318 (23%), Positives = 124/318 (38%), Gaps = 57/318 (17%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  A+D      VA    +LS   ++     R + E+ L++ + +
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 78  KYIIVCYSVWL----DDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           K II   +V+      ++   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 177

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE- 192
           ++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE 
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVT-----------------MEI---------------- 219
           +    Y E VDI+S G  + EMV                  +E                 
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294

Query: 220 -------PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASEL 271
                  P     +  K++            NK+K  + +  + K +   P  R S  + 
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353

Query: 272 LKDPFFSELNDDDSEPSP 289
           L+ P+ +   D     +P
Sbjct: 354 LQHPYINVWYDPAEVEAP 371

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 83.4 bits (207), Expect = 9e-19
 Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 6/88 (6%)

Query: 132 GLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEY 188
           G+ +LH  E   IHRD+  +NI ++      KI D G A       ++     I+GT  Y
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201

Query: 189 MAPELYEEDYTEMVDIYSFGLCLLEMVT 216
           MAPE    + T   DIYSFG+ LLE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 83.4 bits (207), Expect = 9e-19
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 15/95 (15%)

Query: 131 EGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPE 187
            GL YLH H +P IIHRD+  +NI ++    +  +GD G A ++    +H   ++ GT  
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200

Query: 188 YMAPELYEEDY------TEMVDIYSFGLCLLEMVT 216
           ++APE     Y      +E  D++ +G+ LLE++T
Sbjct: 201 HIAPE-----YLSTGKSSEKTDVFGYGVMLLELIT 230

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 71/309 (22%), Positives = 112/309 (36%), Gaps = 70/309 (22%)

Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNK 78
           LGSGA  KV  A           I+VA   ++    S +      L SE++++  L  ++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE---REALMSELKMMTQLGSHE 109

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH---------------------- 116
            I+             L  I E C  G+L  Y +  R                       
Sbjct: 110 NIVNLLGACTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 117 -VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 175
            ++ + L  ++ QV +G+E+L       +HRDL   N+ +      VKI D G       
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGL------ 218

Query: 176 SHAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              A  I+    Y            MAPE L+E  YT   D++S+G+ L E+ ++   PY
Sbjct: 219 ---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

Query: 222 SECDSVAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DP 275
                 A  YK +  G    +P         E+   ++ C     R RPS   L      
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331

Query: 276 FFSELNDDD 284
             ++  +  
Sbjct: 332 QLADAEEAM 340

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 27/226 (11%)

Query: 25  LGSGAVKKVYRAF--DQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           LGSG    V + +   ++    VA   V+ L + + DP L + L +E  +++ L N YI+
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 82  ----VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
               +C       +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL 
Sbjct: 82  RMIGIC-------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGT--P-EYMAPE- 192
                 +HRDL   N+ +       KI D G + A+    +   +      P ++ APE 
Sbjct: 135 ES--NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191

Query: 193 LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
           +    ++   D++SFG+ + E  +  + PY      +++   +  G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEKG 236

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 83.1 bits (206), Expect = 1e-18
 Identities = 51/239 (21%), Positives = 85/239 (35%), Gaps = 39/239 (16%)

Query: 20  RYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
               ++G G    VY        +  I+ A   +      +          E  L+R L 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV---EAFLREGLLMRGLN 80

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEY 135
           +  ++    + L  +      +      G+L  + R   R+ ++K L  +  QV  G+EY
Sbjct: 81  HPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------- 188
           L   +   +HRDL   N  ++ +   VK+ D G A    R       I   EY       
Sbjct: 140 LAEQK--FVHRDLAARNCMLDES-FTVKVADFGLA----R------DILDREYYSVQQHR 186

Query: 189 --------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
                    A E L    +T   D++SFG+ L E++T    PY        +   +  G
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQG 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 62/301 (20%), Positives = 122/301 (40%), Gaps = 47/301 (15%)

Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLH 66
           V + PS     +++++G G    VY      +  + I  A   +       +   V++  
Sbjct: 82  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE---VSQFL 138

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKW 125
           +E  +++   +  ++    + L  + + L  +      G+LR + R +  + ++K L  +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 185
             QV +G+++L + +   +HRDL   N  ++     VK+ D G A    R       +  
Sbjct: 198 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLA----RD------MYD 244

Query: 186 PEY---------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVA 228
            E+               MA E L  + +T   D++SFG+ L E++T    PY +  +  
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTF 303

Query: 229 KIYKKVTGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK--DPFFSELNDD 283
            I   +  G   + L + +     +   + KC   +   RPS SEL+      FS    +
Sbjct: 304 DITVYLLQG---RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360

Query: 284 D 284
            
Sbjct: 361 H 361

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.2 bits (206), Expect = 2e-18
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 66/304 (21%)

Query: 25  LGSGAVKKVYRA-------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-K 76
           LG G   +V  A          +E + VA   ++     +D   ++ L SE+++++ + K
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD---LSDLVSEMEMMKMIGK 145

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIK 120
           +K II        D    +  I E  + GNLR Y +  R                 ++ K
Sbjct: 146 HKNIINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
            L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI D G A          
Sbjct: 204 DLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLA---------R 251

Query: 181 SIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 226
            I     Y            MAPE L++  YT   D++SFG+ + E+ T+   PY     
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-P 310

Query: 227 VAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DPFFSEL 280
           V +++K +  G    KP         E+   +  C  A P  RP+  +L++  D   +  
Sbjct: 311 VEELFKLLKEGHRMDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366

Query: 281 NDDD 284
            +++
Sbjct: 367 TNEE 370

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 65/365 (17%), Positives = 126/365 (34%), Gaps = 103/365 (28%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY     +G+G+   V  A+D+ E   VA  ++    F ED +   R+  E+ +L  L +
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-F-EDLIDCKRILREIAILNRLNH 111

Query: 78  KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
            +++    + +       +    + E+  S + +   +   +++   +K     +L G++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE------- 187
           Y+H+    I+HRDL  +N  +N +   VK+ D G A  V      +S +           
Sbjct: 171 YVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 188 ---------------------YMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEI----- 219
                                Y APE  L +E+YTE +D++S G    E++ M       
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287

Query: 220 -----------------------------PYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
                                             D +  I+  + G    + +  ++  +
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF-NILGTPSEEDIEALEKED 346

Query: 251 VKAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELNDD 283
            K +I     +                              R + +E L  PFF E+   
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406

Query: 284 DSEPS 288
           + E +
Sbjct: 407 EVETN 411

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 82.8 bits (205), Expect = 3e-18
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY    L+G G+  +V +A+D+ E   VA   ++          +N+   EV+LL  + 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLLELMN 108

Query: 77  -----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQV 129
                 KY IV          N L  + E+  S NL    +      VS+   +K+++Q+
Sbjct: 109 KHDTEMKYYIVHLKRHFMF-RNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQM 166

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 188
              L +L T E  IIH DL   NI   N     +KI D G +  +G+    +  I +  Y
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQYIQSRFY 224

Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            +PE L    Y   +D++S G  L+EM T
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 14/193 (7%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + +      +     ++ +++ GL++LH+    I++RDL   NI 
Sbjct: 93  LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNIL 150

Query: 155 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++ + G +KI D G     +      ++  GTP+Y+APE L  + Y   VD +SFG+ L 
Sbjct: 151 LDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209

Query: 213 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR-PSA 268
           EM+  + P+       +++          P+ L    + E K  + K    +P  R    
Sbjct: 210 EMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL----EKEAKDLLVKLFVREPEKRLGVR 264

Query: 269 SELLKDPFFSELN 281
            ++ + P F E+N
Sbjct: 265 GDIRQHPLFREIN 277

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 81.5 bits (202), Expect = 4e-18
 Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 62/302 (20%)

Query: 25  LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNK 78
           LG GA  +V  A             VA   ++      +      L SE+++L  +  + 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGHHL 91

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------VSIKAL 122
            ++             +  I E C  GNL TY +  R+                ++++ L
Sbjct: 92  NVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 123 KKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSI 182
             +S QV +G+E+L + +   IHRDL   NI ++     VKI D G          A  I
Sbjct: 151 ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGL---------ARDI 198

Query: 183 IGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVA 228
              P+Y            MAPE +++  YT   D++SFG+ L E+ ++   PY       
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258

Query: 229 KIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DPFFSELND 282
           +  +++  G     P        PE+   +  C   +P  RP+ SEL++           
Sbjct: 259 EFCRRLKEGTRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

Query: 283 DD 284
            D
Sbjct: 315 QD 316

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 81.6 bits (202), Expect = 5e-18
 Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 66/304 (21%)

Query: 25  LGSGAVKKVYRA-------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-K 76
           LG GA  +V  A          +E + VA   ++     +D   ++ L SE+++++ + K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD---LSDLVSEMEMMKMIGK 99

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------VSIK 120
           +K II        D    +  I E  + GNLR Y +  R                 ++ K
Sbjct: 100 HKNIINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
            L   + Q+  G+EYL + +   IHRDL   N+ +  N   +KI D G A          
Sbjct: 158 DLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLA---------R 205

Query: 181 SIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 226
            I     Y            MAPE L++  YT   D++SFG+ + E+ T+   PY     
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-P 264

Query: 227 VAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLK--DPFFSEL 280
           V +++K +  G    KP         E+   +  C  A P  RP+  +L++  D   +  
Sbjct: 265 VEELFKLLKEGHRMDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

Query: 281 NDDD 284
            +++
Sbjct: 321 TNEE 324

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 81.9 bits (203), Expect = 6e-18
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 17/163 (10%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP 186
           ++   L YLH+    I++RDL   NI ++   G + + D G     +  +    +  GTP
Sbjct: 147 EIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTP 203

Query: 187 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQAL 243
           EY+APE L+++ Y   VD +  G  L EM+    P+    + A++Y   +   ++    +
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNI 262

Query: 244 NKVKDPEVKAFIEKCIA-QPRAR----PSASELLKDPFFSELN 281
                   +  +E  +      R        E+    FFS +N
Sbjct: 263 ----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.8 bits (200), Expect = 6e-18
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 23  DLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           + LG G+   V R        + + VA   ++    S+   + + +  EV  + +L ++ 
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHRN 82

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ YL +
Sbjct: 83  LIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGT--P-EYMAPE-L 193
                IHRDL   N+ +      VKIGD G   A+               P  + APE L
Sbjct: 140 K--RFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 194 YEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
               ++   D + FG+ L EM T  + P+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.0 bits (201), Expect = 8e-18
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 18/164 (10%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP 186
           ++   L +LH     II+RDL   NI +N   G VK+ D G     +      H+  GT 
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTI 185

Query: 187 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQAL 243
           EYMAPE L    +   VD +S G  + +M+T   P+   ++  K   K +   +  P  L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYL 244

Query: 244 NKVKDPEVKAFIEKCIA-QPRAR-----PSASELLKDPFFSELN 281
                 E +  ++K +     +R       A E+   PFF  +N
Sbjct: 245 ----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.7 bits (200), Expect = 9e-18
 Identities = 48/197 (24%), Positives = 95/197 (48%), Gaps = 18/197 (9%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G L  +  + R  + +  + +  +++  LEYLH+ +  +++RD+   N+ 
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLM 137

Query: 155 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++ + G +KI D G     +       +  GTPEY+APE L + DY   VD +  G+ + 
Sbjct: 138 LDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196

Query: 213 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR---- 265
           EM+   +P+       ++++  +   ++ P+ L     PE K+ +   +   P+ R    
Sbjct: 197 EMMCGRLPF-YNQDHERLFELILMEEIRFPRTL----SPEAKSLLAGLLKKDPKQRLGGG 251

Query: 266 -PSASELLKDPFFSELN 281
              A E+++  FF  +N
Sbjct: 252 PSDAKEVMEHRFFLSIN 268

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 92  HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS 151
           H+ L F+ E    G L  +  + R  S    + +  +++  L+YLH+ +  +++RDL   
Sbjct: 220 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLE 278

Query: 152 NIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGL 209
           N+ ++ + G +KI D G     +       +  GTPEY+APE L + DY   VD +  G+
Sbjct: 279 NLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337

Query: 210 CLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR- 265
            + EM+   +P+   D   K+++  +   ++ P+ L     PE K+ +   +   P+ R 
Sbjct: 338 VMYEMMCGRLPFYNQD-HEKLFELILMEEIRFPRTL----GPEAKSLLSGLLKKDPKQRL 392

Query: 266 ---PS-ASELLKDPFFSELN 281
                 A E+++  FF+ + 
Sbjct: 393 GGGSEDAKEIMQHRFFAGIV 412

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 80.4 bits (199), Expect = 1e-17
 Identities = 63/297 (21%), Positives = 116/297 (39%), Gaps = 69/297 (23%)

Query: 25  LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG G   KV +A       +     VA   ++ +    +   +  L SE  +L+ + + +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE---LRDLLSEFNVLKQVNHPH 87

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------------- 116
           +I  Y     D    L  I E    G+LR + ++ R                        
Sbjct: 88  VIKLYGACSQDGPLLL--IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 117 -VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 175
            +++  L  ++ Q+ +G++YL   +  ++HRDL   NI +     ++KI D G       
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEG-RKMKISDFGL------ 196

Query: 176 SHAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              +  +     Y            MA E L++  YT   D++SFG+ L E+VT+   PY
Sbjct: 197 ---SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

Query: 222 SECDSVAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKD 274
                  +++  +  G    +P         E+   + +C   +P  RP  +++ KD
Sbjct: 254 PGI-PPERLFNLLKTGHRMERPDNC----SEEMYRLMLQCWKQEPDKRPVFADISKD 305

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.9 bits (198), Expect = 2e-17
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 18/164 (10%)

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP 186
           ++   L++LH+    II+RDL   NI ++   G +K+ D G +   +     A+S  GT 
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTV 190

Query: 187 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK-VTGGVK-PQAL 243
           EYMAPE +    +T+  D +SFG+ + EM+T  +P+   D   +     +   +  PQ L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMILKAKLGMPQFL 249

Query: 244 NKVKDPEVKAFIEKCIA-QPRAR-----PSASELLKDPFFSELN 281
                PE ++ +       P  R         E+ +  FFS ++
Sbjct: 250 ----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 23/203 (11%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L+ I +    G L T+  +    +   ++ +  +++  LE+LH     II+RD+   NI 
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENIL 191

Query: 155 INGNIGQVKIGDLGFA--AIVGRSHAAHSIIGTPEYMAPELYEED---YTEMVDIYSFGL 209
           ++ N G V + D G +   +   +  A+   GT EYMAP++       + + VD +S G+
Sbjct: 192 LDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250

Query: 210 CLLEMVTMEIPYSECD---SVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPR 263
            + E++T   P++      S A+I ++ +      PQ +        K  I++ +   P+
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM----SALAKDLIQRLLMKDPK 306

Query: 264 AR-----PSASELLKDPFFSELN 281
            R       A E+ +  FF ++N
Sbjct: 307 KRLGCGPRDADEIKEHLFFQKIN 329

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 60/281 (21%), Positives = 109/281 (38%), Gaps = 51/281 (18%)

Query: 25  LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG GA  +VY        +    ++VA   +      +D         E  ++    ++ 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 135

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-------VSIKALKKWSKQVLEG 132
           I+ C  V L      +  + E+   G+L+++ ++ R        +++  L   ++ +  G
Sbjct: 136 IVRCIGVSLQSLPRFI--LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEY-- 188
            +YL  +    IHRD+   N  +         KIGD G A           I     Y  
Sbjct: 194 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRAGYYRK 242

Query: 189 ----------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTG 236
                     M PE   E  +T   D +SFG+ L E+ ++  +PY    S  ++ + VT 
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVTS 301

Query: 237 GVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLKD 274
           G     ++  K+    V   + +C   QP  RP+ + +L+ 
Sbjct: 302 G---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 37/228 (16%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LGSG    V     + +  +VA   ++    SED         E Q +  L +  ++  Y
Sbjct: 16  LGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFF-----QEAQTMMKLSHPKLVKFY 69

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V   +    +  +TE  ++G L  Y R   + +    L +    V EG+ +L +H    
Sbjct: 70  GVCSKEYPIYI--VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH--QF 125

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------MAP 191
           IHRDL   N  ++ +   VK+ D G    V             +Y             AP
Sbjct: 126 IHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDD----------QYVSSVGTKFPVKWSAP 174

Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
           E  +   Y+   D+++FG+ + E+ ++ ++PY    + +++  KV+ G
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQG 221

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 79.7 bits (197), Expect = 2e-17
 Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 53/282 (18%)

Query: 25  LGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG GA  +VY        +    ++VA   +      +D         E  ++    ++ 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 94

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-------VSIKALKKWSKQVLEG 132
           I+ C  V L      +  + E+   G+L+++ ++ R        +++  L   ++ +  G
Sbjct: 95  IVRCIGVSLQSLPRFI--LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKIGDLGFAAIVGRSHAAHSIIGTPEY-- 188
            +YL  +    IHRD+   N  +         KIGD G A    R       I    Y  
Sbjct: 153 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RD------IYRASYYR 200

Query: 189 -----------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVT 235
                      M PE   E  +T   D +SFG+ L E+ ++  +PY    S  ++ + VT
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVT 259

Query: 236 GGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLKD 274
            G     ++  K+    V   + +C   QP  RP+ + +L+ 
Sbjct: 260 SG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 49/224 (21%), Positives = 99/224 (44%), Gaps = 20/224 (8%)

Query: 23  DLLGSGAVKKVYRAFDQEEG---IEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTLKNK 78
             +G G    V++          + VA   ++   + + D V    L  E   +R   + 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFL-QEALTMRQFDHP 451

Query: 79  YIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLH 137
           +I+    V  ++    +  I E+CT G LR++ +  +  + + +L  ++ Q+   L YL 
Sbjct: 452 HIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIG-TP-EYMAPE-LY 194
           +     +HRD+   N+ ++ N   VK+GD G +  +  S    +  G  P ++MAPE + 
Sbjct: 509 SK--RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

Query: 195 EEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
              +T   D++ FG+C+ E++     P+        +  ++  G
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENG 608

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 18/197 (9%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++           ++ ++  GL +L +    II+RDL   N+ 
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM 474

Query: 155 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G +KI D G     +       +  GTP+Y+APE +  + Y + VD ++FG+ L 
Sbjct: 475 LDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533

Query: 213 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR---- 265
           EM+  + P+ E +   ++++  +   V  P+++      E  A  +  +   P  R    
Sbjct: 534 EMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM----SKEAVAICKGLMTKHPGKRLGCG 588

Query: 266 -PSASELLKDPFFSELN 281
                ++ +  FF  ++
Sbjct: 589 PEGERDIKEHAFFRYID 605

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 66/364 (18%), Positives = 116/364 (31%), Gaps = 109/364 (29%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            Y     +G G+   VY A+D+     VA    +++   ED +   R+  E+ +L  LK+
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKS 84

Query: 78  KYIIVCYSVWLDDQHNTLN---FITEVCTSGNLRTYRKKHRHVSIKALKKWSK------- 127
            YII  Y + + D     +    + E+  S +L            K     ++       
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL--------KKLFKTPIFLTEEHIKTIL 135

Query: 128 -QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP 186
             +L G  ++H     IIHRDL  +N  +N +   VK+ D G A  +      + +    
Sbjct: 136 YNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 187 E-----------------------YMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPY 221
           E                       Y APE  L +E+YT+ +DI+S G    E++ M   +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252

Query: 222 SECDSVAKI-----------------------YK-------KVTGGVKPQALNKVKDPEV 251
               +                            +        + G      L  +  PEV
Sbjct: 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV 312

Query: 252 KAFIEKCIAQPRA---------------------------RPSASELLKDPFFSELNDDD 284
             +I+    +                              R +  + L  P+  ++    
Sbjct: 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

Query: 285 SEPS 288
            E  
Sbjct: 373 LENF 376

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 78.4 bits (194), Expect = 4e-17
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 37/228 (16%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG    V+  +   +  +VA   +R    SE+  +      E +++  L +  ++  Y
Sbjct: 16  IGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFI-----EEAEVMMKLSHPKLVQLY 69

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V L+     L  +TE    G L  Y +  R   + + L      V EG+ YL     C+
Sbjct: 70  GVCLEQAPICL--VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--CV 125

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------MAP 191
           IHRDL   N  +  N   +K+ D G    V             +Y             +P
Sbjct: 126 IHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDD----------QYTSSTGTKFPVKWASP 174

Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
           E      Y+   D++SFG+ + E+ +  +IPY    S +++ + ++ G
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTG 221

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.4 bits (194), Expect = 4e-17
 Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 41/243 (16%)

Query: 11  EVDPSG-RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
           E+DP    F +    LG+G    V     + +  +VA   ++    SED  +      E 
Sbjct: 20  EIDPKDLTFLK---ELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFI-----EEA 70

Query: 70  QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQ 128
           +++  L ++ ++  Y V    +   +  ITE   +G L  Y ++ RH    + L +  K 
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFI--ITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 188
           V E +EYL +     +HRDL   N  +N   G VK+ D G +  V             EY
Sbjct: 129 VCEAMEYLESK--QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDD----------EY 175

Query: 189 ------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKV 234
                         PE L    ++   DI++FG+ + E+ ++ ++PY    + ++  + +
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHI 234

Query: 235 TGG 237
             G
Sbjct: 235 AQG 237

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 18/197 (9%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++           ++ ++  GL +L +    II+RDL   N+ 
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM 153

Query: 155 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G +KI D G     +       +  GTP+Y+APE +  + Y + VD ++FG+ L 
Sbjct: 154 LDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212

Query: 213 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR---- 265
           EM+  + P+ E +   ++++  +   V  P+++      E  A  +  +   P  R    
Sbjct: 213 EMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM----SKEAVAICKGLMTKHPGKRLGCG 267

Query: 266 -PSASELLKDPFFSELN 281
                ++ +  FF  ++
Sbjct: 268 PEGERDIKEHAFFRYID 284

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.4 bits (194), Expect = 4e-17
 Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 60/287 (20%)

Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG GA  KV+ A        ++ + VA   ++    +           E +LL  L++++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA----RKDFQREAELLTNLQHEH 78

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           I+  Y V  D     L  + E    G+L  + + H                  + +  + 
Sbjct: 79  IVKFYGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
             + Q+  G+ YL +     +HRDL   N  +  N+  VKIGD G +           + 
Sbjct: 137 HIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGMS---------RDVY 184

Query: 184 GTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 229
            T  Y            M PE +    +T   D++SFG+ L E+ T  + P+ +  S  +
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTE 243

Query: 230 IYKKVTGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK 273
           + + +T G   + L + +    EV   +  C   +P+ R +  E+ K
Sbjct: 244 VIECITQG---RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 78.4 bits (194), Expect = 4e-17
 Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 43/234 (18%)

Query: 25  LGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII- 81
           LG G    V +     +++ I+VA   ++      D      +  E Q++  L N YI+ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 74

Query: 82  ---VCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLH 137
              VC       Q   L  + E+   G L  +   K   + +  + +   QV  G++YL 
Sbjct: 75  LIGVC-------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY--------- 188
                 +HRDL   N+ +       KI D G +  +G             Y         
Sbjct: 128 EK--NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADD--------SYYTARSAGKWP 176

Query: 189 ---MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
               APE +    ++   D++S+G+ + E ++  + PY +     ++   +  G
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQG 229

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY    ++G G+  +V +A+D +    VA   VR      +     +   E+++L  L+
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLR 151

Query: 77  -----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQV 129
                N   ++          N +    E+  S NL    KK++    S+  ++K++  +
Sbjct: 152 KQDKDNTMNVIHMLENFT-FRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNI-FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY 188
           L+ L+ LH +   IIH DL   NI         +K+ D G +    +    ++ I +  Y
Sbjct: 210 LQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTYIQSRFY 265

Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVT 216
            APE +    Y   +D++S G  L E++T
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLT 294

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 78.4 bits (194), Expect = 8e-17
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 19/198 (9%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + +K R       + ++ +++  L +LH     II+RDL   N+ 
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVL 156

Query: 155 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G  K+ D G     +       +  GTP+Y+APE L E  Y   VD ++ G+ L 
Sbjct: 157 LDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215

Query: 213 EMVTMEIPYSECDSVAKIYKK-VTGGVK-PQALNKVKDPEVKAFIEKCIA-QPRAR---- 265
           EM+    P+ E ++   +++  +   V  P  L      +    ++  +   P  R    
Sbjct: 216 EMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL----HEDATGILKSFMTKNPTMRLGSL 270

Query: 266 -PSASELLKD-PFFSELN 281
                  +   PFF E++
Sbjct: 271 TQGGEHAILRHPFFKEID 288

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 78.1 bits (193), Expect = 9e-17
 Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 65/303 (21%)

Query: 11  EVDPSG-RFGRYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNR 64
            +             LG GA  KV+ A       +++ + VA   ++ +  S        
Sbjct: 37  HIKRRDIVLKW---ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQD 89

Query: 65  LHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--------- 115
              E +LL  L++++I+  + V  + +   +  + E    G+L  + + H          
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLM--VFEYMRHGDLNRFLRSHGPDAKLLAGG 147

Query: 116 ------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF 169
                  + +  L   + QV  G+ YL       +HRDL   N  +   +  VKIGD G 
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGM 204

Query: 170 AAIVGRSHAAHSIIGTPEY-------------MAPE-LYEEDYTEMVDIYSFGLCLLEMV 215
           +    R       I + +Y             M PE +    +T   D++SFG+ L E+ 
Sbjct: 205 S----RD------IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

Query: 216 TM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASEL 271
           T  + P+ +  S  +    +T G   + L + +   PEV A +  C   +P+ R S  ++
Sbjct: 255 TYGKQPWYQL-SNTEAIDCITQG---RELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310

Query: 272 LKD 274
              
Sbjct: 311 HAR 313

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 18/203 (8%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+ A   +   +VA   ++    S +  L     +E  +++TL++  ++  +
Sbjct: 196 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVEAFL-----AEANVMKTLQHDKLVKLH 249

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
           +V   +    +  ITE    G+L  + K        +  L  +S Q+ EG+ ++      
Sbjct: 250 AVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--N 304

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTP-EYMAPE-LYEEDYT 199
            IHRDL  +NI ++ +    KI D G A  I    + A      P ++ APE +    +T
Sbjct: 305 YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363

Query: 200 EMVDIYSFGLCLLEMVTM-EIPY 221
              D++SFG+ L+E+VT   IPY
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPY 386

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 43/214 (20%), Positives = 83/214 (38%), Gaps = 34/214 (15%)

Query: 25  LGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LG G    V +     +++ I+VA   +++     +      +  E Q++  L N YI+ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEP 141
              V   +    L  + E+   G L  +    R  + +  + +   QV  G++YL     
Sbjct: 401 LIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 455

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------M 189
             +HR+L   N+ +       KI D G +  +G             Y             
Sbjct: 456 NFVHRNLAARNVLLVNR-HYAKISDFGLSKALGA--------DDSYYTARSAGKWPLKWY 506

Query: 190 APE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
           APE +    ++   D++S+G+ + E ++  + PY
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 77.2 bits (191), Expect = 1e-16
 Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 21/218 (9%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G    V        G +VA   ++    ++         +E  ++  L++  ++   
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQLL 80

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
            V ++++   L  +TE    G+L  Y +      +    L K+S  V E +EYL  +   
Sbjct: 81  GVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--N 137

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP-EYMAPE-LYEEDYTE 200
            +HRDL   N+ ++ +    K+ D G       +     +   P ++ APE L E+ ++ 
Sbjct: 138 FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKFST 193

Query: 201 MVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
             D++SFG+ L E+ +   +PY     +  +  +V  G
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG 230

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 47/220 (21%), Positives = 94/220 (42%), Gaps = 21/220 (9%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             +G G    V     +  G +VA   ++    ++         +E  ++  L++  ++ 
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQ 250

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHE 140
              V ++++   L  +TE    G+L  Y +      +    L K+S  V E +EYL  + 
Sbjct: 251 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 308

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTP-EYMAPE-LYEEDY 198
              +HRDL   N+ ++ +    K+ D G       +     +   P ++ APE L E+ +
Sbjct: 309 -NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREKKF 363

Query: 199 TEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
           +   D++SFG+ L E+ +   +PY     +  +  +V  G
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG 402

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 75/314 (23%), Positives = 117/314 (37%), Gaps = 71/314 (22%)

Query: 25  LGSGAVKKVYRA-------FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           LG GA  +V  A              +VA   ++     +D   ++ L SE+++++ +  
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD---LSDLISEMEMMKMIGK 133

Query: 78  -KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIK 120
            K II        D    +  I E  + GNLR Y +  R                 +S K
Sbjct: 134 HKNIINLLGACTQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
            L   + QV  G+EYL + +   IHRDL   N+ +  +   +KI D G          A 
Sbjct: 192 DLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGL---------AR 239

Query: 181 SIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 226
            I     Y            MAPE L++  YT   D++SFG+ L E+ T+   PY     
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-P 298

Query: 227 VAKIYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASEL-------LKDP 275
           V +++K +  G    KP         E+   +  C  A P  RP+  +L       +   
Sbjct: 299 VEELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354

Query: 276 FFSELNDDDSEPSP 289
              E+         
Sbjct: 355 SNQEMGYYHHHHHH 368

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 23/238 (9%)

Query: 11  EVDPSG-RFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLH 66
           E++ S     +    +GSG   +V     +  G   + VA   ++  +            
Sbjct: 45  EIEASRIHIEKI---IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ---RRDFL 98

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKW 125
           SE  ++    +  II    V    +      +TE   +G+L T+ + H    +I  L   
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIG 184
            + V  G+ YL       +HRDL   N+ ++ N    K+ D G +  +     AA++  G
Sbjct: 157 LRGVGAGMRYLSDL--GYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTG 213

Query: 185 T--P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
              P  + APE +    ++   D++SFG+ + E++   E PY    +   +   V  G
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVISSVEEG 270

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 57/301 (18%), Positives = 100/301 (33%), Gaps = 67/301 (22%)

Query: 20  RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
            Y   +G GA  +V++A        E    VA   ++    ++          E  L+  
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALMAE 106

Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR------------------- 115
             N  I+    V    +   L  + E    G+L  + +                      
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 116 -----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 170
                 +S       ++QV  G+ YL   +   +HRDL   N  +  N+  VKI D G +
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS 221

Query: 171 AIVGRSHAAHSIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM 217
                     +I     Y            M PE ++   YT   D++++G+ L E+ + 
Sbjct: 222 ---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272

Query: 218 -EIPYSECDSVAKIYKKVTGGVKPQALNKVKD--PEVKAFIEKC-IAQPRARPSASELLK 273
              PY    +  ++   V  G     L   ++   E+   +  C    P  RPS   + +
Sbjct: 273 GLQPYYGM-AHEEVIYYVRDG---NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328

Query: 274 D 274
            
Sbjct: 329 I 329

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.5 bits (189), Expect = 4e-16
 Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++ R +  +  + +S ++   L YLH     II+RDL   N+ 
Sbjct: 85  LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL 142

Query: 155 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G     +       +  GTP Y+APE L  EDY   VD ++ G+ + 
Sbjct: 143 LDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201

Query: 213 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALN-KVKDP-----EVKAFIEKCIA-QPRAR 265
           EM+    P+    S     +     +    L  +++ P     +  + ++  +   P+ R
Sbjct: 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

Query: 266 ------PSASELLKDPFFSELN 281
                    +++   PFF  ++
Sbjct: 262 LGCHPQTGFADIQGHPFFRNVD 283

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 39/141 (27%), Positives = 66/141 (46%), Gaps = 5/141 (3%)

Query: 95  LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF 154
           L F+ E    G+L  + ++ R +  +  + +S ++   L YLH     II+RDL   N+ 
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVL 185

Query: 155 INGNIGQVKIGDLGFA-AIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLL 212
           ++   G +K+ D G     +       +  GTP Y+APE L  EDY   VD ++ G+ + 
Sbjct: 186 LDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244

Query: 213 EMVTMEIPYSECDSVAKIYKK 233
           EM+    P+    S     + 
Sbjct: 245 EMMAGRSPFDIVGSSDNPDQN 265

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 75.3 bits (186), Expect = 4e-16
 Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 39/229 (17%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G   +V+  +      +VA   ++    S D  L     +E  L++ L+++ ++  Y
Sbjct: 21  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFL-----AEANLMKQLQHQRLVRLY 74

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPC 142
           +V   +    +  ITE   +G+L  + K      ++I  L   + Q+ EG+ ++      
Sbjct: 75  AVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------MA 190
            IHRDL  +NI ++      KI D G A ++  +          EY             A
Sbjct: 130 YIHRDLRAANILVSDT-LSCKIADFGLARLIEDN----------EYTAREGAKFPIKWTA 178

Query: 191 PE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
           PE +    +T   D++SFG+ L E+VT   IPY    +  ++ + +  G
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERG 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 75.3 bits (186), Expect = 5e-16
 Identities = 48/231 (20%), Positives = 95/231 (41%), Gaps = 38/231 (16%)

Query: 25  LGSGAVKKVYRA---FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           +G G    V++      +   + VA    +    + D V    L  E   +R   + +I+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFL-QEALTMRQFDHPHIV 79

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHE 140
               V  ++    +  I E+CT G LR++ +  ++ + + +L  ++ Q+   L YL +  
Sbjct: 80  KLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------ 188
              +HRD+   N+ ++ N   VK+GD G +  +  S           Y            
Sbjct: 136 -RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDS----------TYYKASKGKLPIKW 183

Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
           MAPE +    +T   D++ FG+C+ E++     P+        +  ++  G
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENG 233

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 49/222 (22%), Positives = 96/222 (43%), Gaps = 22/222 (9%)

Query: 11  EVDPSG-RFGRYSDLLGSGAVKKVYRA---FDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 66
           E+D +     +   ++G+G   +V         ++ I VA   +++ +  +         
Sbjct: 41  ELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFL 94

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKW 125
            E  ++    +  II    V    +   +  +TE   +G+L ++ +KH    ++  L   
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSIIG 184
            + +  G++YL       +HRDL   NI IN N    K+ D G    +     AA++  G
Sbjct: 153 LRGIASGMKYLSDM--GYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRG 209

Query: 185 T--P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
              P  + +PE +    +T   D++S+G+ L E+++  E PY
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.6 bits (184), Expect = 9e-16
 Identities = 48/248 (19%), Positives = 83/248 (33%), Gaps = 53/248 (21%)

Query: 25  LGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           LG     KVY+         E+   VA   ++                E  L   L++  
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL---REEFRHEAMLRARLQHPN 73

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALK 123
           ++    V   DQ  ++  I   C+ G+L  +                      +      
Sbjct: 74  VVCLLGVVTKDQPLSM--IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
               Q+  G+EYL +H   ++H+DL   N+ +   +  VKI DLG             + 
Sbjct: 132 HLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLF---------REVY 179

Query: 184 GTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 229
               Y            MAPE +    ++   DI+S+G+ L E+ +    PY    S   
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQD 238

Query: 230 IYKKVTGG 237
           + + +   
Sbjct: 239 VVEMIRNR 246

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 67/352 (19%), Positives = 123/352 (34%), Gaps = 101/352 (28%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           +Y  +  LG GA   V+++ D+  G  VA    ++    ++     R   E+ +L  L  
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 78  -KYIIVCYSVWLDDQHNTLNFITE--------VCTSGNLRTYRKKHRHVSIKALKKWSKQ 128
            + I+   +V   D    +  + +        V  +  L     +  H      +    Q
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL-----EPVHK-----QYVVYQ 117

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE- 187
           +++ ++YLH+    ++HRD+  SNI +N     VK+ D G +          + I     
Sbjct: 118 LIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 188 ---------------------YMAPE--LYEEDYTEMVDIYSFGLCLLEMVT-------- 216
                                Y APE  L    YT+ +D++S G  L E++         
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234

Query: 217 ---------------------------------------MEIPYSECDSVAKIYKKVTGG 237
                                                  +EI  S    +   +K +   
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294

Query: 238 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPS 288
           + P+A     + E    ++K +   P  R SA++ LK PF S  ++ + EP+
Sbjct: 295 INPKAD---CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPN 343

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 23/223 (10%)

Query: 11  EVDPSG-RFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
           E+ PS     +    +G+G   +VY+        ++ + VA   ++  +  +  V     
Sbjct: 40  EIHPSCVTRQKV---IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV---DF 93

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKK 124
             E  ++    +  II    V    +   +  ITE   +G L  + ++     S+  L  
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA-AIVGRSHAAHSII 183
             + +  G++YL       +HRDL   NI +N N    K+ D G +  +     A ++  
Sbjct: 152 MLRGIAAGMKYLANM--NYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTS 208

Query: 184 GT--P-EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPY 221
           G   P  + APE +    +T   D++SFG+ + E++T  E PY
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.0 bits (180), Expect = 3e-15
 Identities = 44/231 (19%), Positives = 95/231 (41%), Gaps = 38/231 (16%)

Query: 25  LGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII 81
           LG G   +VY       + E I VA    +     ++     +  SE  +++ L + +I+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHPHIV 76

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHE 140
               +  ++       I E+   G L  Y +++++ + +  L  +S Q+ + + YL +  
Sbjct: 77  KLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI- 132

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEY------------ 188
              +HRD+   NI +      VK+GD G +  +             +Y            
Sbjct: 133 -NCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDE----------DYYKASVTRLPIKW 180

Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGG 237
           M+PE +    +T   D++ F +C+ E+++  + P+   ++   +   +  G
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.8 bits (181), Expect = 4e-15
 Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 16/169 (9%)

Query: 115 RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG 174
             ++++ L  +S QV +G+E+L + +   IHRDL   NI ++     VKI D G A  + 
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIY 244

Query: 175 RSHAAHSIIGTP---EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAK 229
           +              ++MAPE +++  YT   D++SFG+ L E+ ++   PY       +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

Query: 230 IYKKVTGG---VKPQALNKVKDPEVKAFIEKC-IAQPRARPSASELLKD 274
             +++  G     P        PE+   +  C   +P  RP+ SEL++ 
Sbjct: 305 FCRRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEH 349

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.6 bits (176), Expect = 1e-14
 Identities = 59/304 (19%), Positives = 108/304 (35%), Gaps = 61/304 (20%)

Query: 7   EPFVEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN 63
           +  +++  +     Y   S +LG G   KV + F++    + A   +      +D     
Sbjct: 5   KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKAR 58

Query: 64  RLHSEVQLL-RTLKNKYIIVCYSVWLDDQHNTLNF--ITEVCTSGNL--RTYRKKHRHVS 118
           R   EV+L  R  +  +I+    V+ +          + E    G L  R   +  +  +
Sbjct: 59  R---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 115

Query: 119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI-FINGNIG-QVKIGDLGFAAIVGRS 176
            +   +  K + E ++YLH+    I HRD+   N+ + +      +K+ D GFA      
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA------ 167

Query: 177 HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEI------P-YSECDSV-- 227
                          E   E Y +  D++S G      V M I      P YS       
Sbjct: 168 --------------KETTGEKYDKSCDMWSLG------VIMYILLCGYPPFYSNHGLAIS 207

Query: 228 AKIYKKVTGGV---KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDD 283
             +  ++  G         ++V + EVK  I   +   P  R + +E +  P+  +    
Sbjct: 208 PGMKTRIRMGQYEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266

Query: 284 DSEP 287
              P
Sbjct: 267 PQTP 270

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 70.4 bits (173), Expect = 4e-14
 Identities = 57/251 (22%), Positives = 97/251 (38%), Gaps = 54/251 (21%)

Query: 20  RYSDLLGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-K 76
           ++ D++G G   +V +A        ++ A  +++     +D         E+++L  L  
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGH 84

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIK 120
           +  II          +  L    E    GNL  + +K R                 +S +
Sbjct: 85  HPNIINLLGACEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 121 ALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH 180
            L  ++  V  G++YL   +   IHRDL   NI +  N    KI D G +    R     
Sbjct: 143 QLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLS----RG---- 191

Query: 181 SIIGTPEY------------MAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDS 226
                  Y            MA E L    YT   D++S+G+ L E+V++   PY    +
Sbjct: 192 ----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-T 246

Query: 227 VAKIYKKVTGG 237
            A++Y+K+  G
Sbjct: 247 CAELYEKLPQG 257

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 70.0 bits (172), Expect = 7e-14
 Identities = 62/346 (17%), Positives = 115/346 (33%), Gaps = 90/346 (26%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIE-VAW----NQVRLSHFSEDPVLVNRLHSEVQL 71
            RY     LG G   KV    D   G   VA     N  +    +           E+ +
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---------EINV 69

Query: 72  LRTLK-----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKK 124
           L+ +K     NK++ V  S W +  H  +    E+    N   + K++      +  ++ 
Sbjct: 70  LKKIKEKDKENKFLCVLMSDWFNF-HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH 127

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ------------------VKIGD 166
            + Q+   L +LH ++  + H DL   NI    +  +                  +++ D
Sbjct: 128 MAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 167 LGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT--------- 216
            G A      H   +I+ T  Y  PE + E  + +  D++S G  L E            
Sbjct: 186 FGSATFDHEHH--TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243

Query: 217 --------MEI-----------------------PYSECDSVAKIYKKVTGGVKPQAL-N 244
                    +I                        + E  S  +  K+    +K   L +
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303

Query: 245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
            ++  ++   + + +   P  R + +E L  PFF+ L  ++     
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT 349

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 67.3 bits (165), Expect = 6e-13
 Identities = 65/340 (19%), Positives = 115/340 (33%), Gaps = 96/340 (28%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIE-VAW----NQVRLSHFSEDPVLVNRLHSEVQL 71
            RY   D LG GA  KV    D + G   VA     N  R    +           E+Q+
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---------EIQV 64

Query: 72  LRTLK-----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKK 124
           L  L      + +  V    W +  H  +  + E+    +   + K++  +   +  ++K
Sbjct: 65  LEHLNTTDPNSTFRCVQMLEWFEH-HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK 122

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG------------------QVKIGD 166
            + Q+ + + +LH+++  + H DL   NI    +                     +K+ D
Sbjct: 123 MAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 167 LGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT--------- 216
            G A      H   +++ T  Y APE +    +++  D++S G  L+E            
Sbjct: 181 FGSATYDDEHH--STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

Query: 217 --------MEI-----------------------PYSECDSVAKIYKKVTGGVKP--QAL 243
                     I                        + E  S  +   +     KP  + +
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC---KPLKEFM 295

Query: 244 --NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL 280
               V+   +   I+K +   P  R +  E LK PFF  L
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 63/338 (18%), Positives = 108/338 (31%), Gaps = 92/338 (27%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVR-LSHFSEDPVLVNRLHSEVQLLRTL 75
             +     +G G   +V      +     A   VR +  ++    +      E  +L+ +
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI------EADILKKI 88

Query: 76  K----NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQV 129
           +    N   IV Y       ++ +  I E     +L     ++ +    I+ +K +  ++
Sbjct: 89  QNDDINNNNIVKYHGKFM-YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI 146

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ------------------------VKIG 165
           L+ L YL      + H DL   NI ++    +                        +K+ 
Sbjct: 147 LKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 166 DLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVT-------- 216
           D G A      H   SII T +Y APE +    +    D++SFG  L E+ T        
Sbjct: 205 DFGCATFKSDYH--GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 217 --------ME-----IPYS-----------------------ECDSVAKIYKKVTGGVKP 240
                   ME     IP +                         ++ +    K      P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFF 277
                +K      F+   +   P  RPS +ELLK  F 
Sbjct: 323 LY-KIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 80/400 (20%), Positives = 133/400 (33%), Gaps = 137/400 (34%)

Query: 2   SDRDGEPFVEVDPSGRF---------GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWN-Q 49
            D + E   +    G           GRY     LG G    V+ ++D +    VA    
Sbjct: 11  DDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV 70

Query: 50  VRLSHFSEDPVLVNRLHSEVQLLRTLKN--------KYIIVCYSVWLDD-QHNTLN---- 96
               H++E          E++LL++++N        + ++      LDD + + +N    
Sbjct: 71  KSAEHYTET------ALDEIRLLKSVRNSDPNDPNREMVVQL----LDDFKISGVNGTHI 120

Query: 97  -FITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI 153
             + EV    +L  +  K  ++ + +  +KK  +QVL+GL+YLHT +  IIH D+   NI
Sbjct: 121 CMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENI 178

Query: 154 FI------------------------------------------------NGNIGQVKIG 165
            +                                                N    +VKI 
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238

Query: 166 DLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIP---- 220
           DLG A  V +       I T +Y + E L    Y    DI+S      E+ T +      
Sbjct: 239 DLGNACWVHKHFT--EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296

Query: 221 -----YSECDSVAKIYK--------------------------KVTGGVKPQALNKV--- 246
                  + D +A I +                          K    +KP  L +V   
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356

Query: 247 ----KDPEVKA---FIEKCIA-QPRARPSASELLKDPFFS 278
                  E      F+   +   P  R +A+E L+ P+ +
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 36/196 (18%), Positives = 70/196 (35%), Gaps = 42/196 (21%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
            +GSG    +Y AF   +  + A + V++     +      L SE++  + +  K  I  
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVAKKDCI-- 96

Query: 84  YSVWLDDQHNTLNFITEVCTSG-------------------NLRTYRKKHRHVSIKALKK 124
              W++ +      I     SG                   +L+    ++       + +
Sbjct: 97  -KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ 155

Query: 125 WSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDLGFA----------AIV 173
              ++L+ LEY+H +E   +H D+  +N+ +   N  QV + D G +             
Sbjct: 156 LGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213

Query: 174 GRSHAAHSIIGTPEYM 189
                 H   GT E+ 
Sbjct: 214 ENPRKGH--NGTIEFT 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 38/176 (21%), Positives = 66/176 (37%), Gaps = 21/176 (11%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+   +Y   D   G EVA     +   ++ P L    H E ++ + ++    I   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQL----HIESKIYKMMQGGVGIP-- 68

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           ++         N +       +L        R  S+K +   + Q++  +EY+H+     
Sbjct: 69  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NF 126

Query: 144 IHRDLNCSNIFI--NGNIGQVKIGDLGFAA--IVGRSH------AAHSIIGTPEYM 189
           IHRD+   N  +        V I D G A      R+H         ++ GT  Y 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 36/176 (20%), Positives = 66/176 (37%), Gaps = 21/176 (11%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +GSG+  ++Y   + +   EVA     +   ++ P L      E ++ R L+    I   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQL----LYESKIYRILQGGTGI-PN 67

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
             W        N +       +L        R +S+K +   + Q++  +E++H+     
Sbjct: 68  VRWFG-VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SF 124

Query: 144 IHRDLNCSNIFI--NGNIGQVKIGDLGFAA--IVGRSH------AAHSIIGTPEYM 189
           +HRD+   N  +       QV I D G A       +H         ++ GT  Y 
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 49.8 bits (119), Expect = 4e-07
 Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 15/91 (16%)

Query: 110 YRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDLG 168
           Y    +  S K + + S ++L+ LEY+H HE   +H D+  SN+ +N  N  QV + D G
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYG 199

Query: 169 FA----------AIVGRSHAAHSIIGTPEYM 189
            A          A        H   GT E+ 
Sbjct: 200 LAYRYCPEGVHKAYAADPKRCH--DGTIEFT 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 20/90 (22%), Positives = 42/90 (46%), Gaps = 12/90 (13%)

Query: 110 YRKKHRHV-SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN-GNIGQVKIGDL 167
                +HV S +++ + + ++L+ LE+LH +E   +H ++   NIF++  +  QV +   
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGY 205

Query: 168 GFAA--------IVGRSHAAHSIIGTPEYM 189
           GFA         +     +     G  E++
Sbjct: 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 36/187 (19%), Positives = 67/187 (35%), Gaps = 27/187 (14%)

Query: 19  GRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
             +     +G G   ++    +      VA   ++L           +LH E +  + L 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRA---PQLHLEYRFYKQLG 62

Query: 77  N-KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLE 134
           +   I   Y      ++N +  + E+    +L        R  S+K +   + Q++  +E
Sbjct: 63  SGDGIPQVYYFGPCGKYNAM--VLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRME 119

Query: 135 YLHTHEPCIIHRDLNCSNIFI----NGNIGQVKIGDLGFAA--IVGRSHA------AHSI 182
           Y+H+    +I+RD+   N  I    N     + I D   A   I   +          S+
Sbjct: 120 YVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177

Query: 183 IGTPEYM 189
            GT  YM
Sbjct: 178 TGTARYM 184

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 32/178 (17%), Positives = 63/178 (35%), Gaps = 23/178 (12%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           +G G+   ++   +     +VA         S+ P    +L  E +  + L     I   
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAP----QLRDEYRTYKLLAGCTGIP-- 69

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCI 143
           +V+   Q    N +       +L        R  S+K +   +KQ+L  ++ +H     +
Sbjct: 70  NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SL 127

Query: 144 IHRDLNCSNIFI----NGNIGQVKIGDLGFAA--IVGRSHA------AHSIIGTPEYM 189
           ++RD+   N  I    + N   + + D G         +          ++ GT  YM
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.9 bits (100), Expect = 5e-05
 Identities = 50/330 (15%), Positives = 88/330 (26%), Gaps = 67/330 (20%)

Query: 8   PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF----SEDPVLVN 63
           PF    P+ +  R   + G G   +V++     +   VA   + +               
Sbjct: 12  PFSHCLPTEKLQRCEKI-GEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 64  RLHSEVQLLRTLKNKYIIVCYS-----------------------VWLDDQH-------- 92
            +  E+ + + L      VC                          W             
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 93  ------NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHR 146
                 + L  + E    G     + + +  S+   K    Q+   L           HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGID-LEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHR 186

Query: 147 DLNCSNIFIN----------GNIGQVKIGDLGF-AAIVGRSHAAHSIIGTPEYM----AP 191
           DL+  N+ +            N     I   G   +I+  + +     G   +       
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246

Query: 192 ELYEEDYTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           +L+  D     DIY            E  PYS    +  +  K+   +  +   K   P 
Sbjct: 247 DLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK--TKCNTPA 304

Query: 251 VKAFIEKCIAQPRARP---SASELLKDPFF 277
           +K    K     R      SA++LL     
Sbjct: 305 MKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	289
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.92
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.72
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.27
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.21
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.09
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.0
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.79
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.63
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.59
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.26
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.24
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.11
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.98
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.96
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.95
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.9
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.67
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.89
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.7
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.06
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.39
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.61
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.02

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-65  Score=430.92  Aligned_cols=268  Identities=46%  Similarity=0.844  Sum_probs=238.6

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      .+.....+||+++.++||+|+||+||+|.++.++..||+|++.....  .....+.+.+|++++++++|||||++++++.
T Consensus        18 ~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   95 (290)
T 3fpq_A           18 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             EEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            34556788999999999999999999999999999999999986654  4556788999999999999999999999886


Q ss_pred             eC--CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           89 DD--QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        89 ~~--~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      ..  ....+|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||++|++++||||||+|||++...+.+||+|
T Consensus        96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             eccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEe
Confidence            42  3357899999999999999999988999999999999999999999999877999999999999985338999999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ||+|...... .....+||+.|+|||++.+.++.++|||||||++|+|+||+.||.+..........+..+..+...+..
T Consensus       176 FGla~~~~~~-~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  254 (290)
T 3fpq_A          176 LGLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             TTGGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             CcCCEeCCCC-ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence            9999765433 345678999999999988889999999999999999999999998878888888888887777666777


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      .++++++||.+||+ ||++|||++|+|+||||++
T Consensus       255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            88999999999998 9999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-63  Score=420.44  Aligned_cols=257  Identities=24%  Similarity=0.396  Sum_probs=223.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||+||+|.++.+|+.||+|++...... +....+.+.+|++++++++||||+++++++.+.  +.+|+|
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yiv  110 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFG  110 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence            47899999999999999999999999999999865431 122356789999999999999999999998554  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc--
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~--  176 (289)
                      |||++||+|.+++.+.+.+++..+..++.|++.||.|||++|  ++||||||+|||++.+ +.+||+|||++......  
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCC
Confidence            999999999999999889999999999999999999999999  9999999999999998 89999999999876432  


Q ss_pred             -cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          177 -HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       177 -~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                       ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+.......+.....   ..+...++++++|
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dl  264 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY---DFPEKFFPKARDL  264 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---CCCTTCCHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCcccCHHHHHH
Confidence             234567899999999987755 89999999999999999999999988655555555544432   2345679999999


Q ss_pred             HHHHHc-CCCCCCCHHH------HhcCcccccCCCCC
Q 022956          255 IEKCIA-QPRARPSASE------LLKDPFFSELNDDD  284 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~------il~h~~~~~~~~~~  284 (289)
                      |.+||+ ||++|||++|      |++||||++++|+.
T Consensus       265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence            999998 9999999988      58999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-62  Score=420.71  Aligned_cols=254  Identities=23%  Similarity=0.470  Sum_probs=216.4

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +| ++.++||+|+||+||+|.++.+|+.||||++.....  .....+.+.+|++++++|+||||+++++++.+.  +.+|
T Consensus        25 ~Y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~y   99 (350)
T 4b9d_A           25 KY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLY   99 (350)
T ss_dssp             CE-EEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred             ce-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEE
Confidence            44 688999999999999999999999999999987654  455678899999999999999999999998654  6899


Q ss_pred             EEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           97 FITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|||||+||+|.+++...  ..+++.++..++.|++.||.|||++|  ++||||||+|||++.+ |.+||+|||++....
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT-CCEEECSTTEESCCC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CCEEEcccccceeec
Confidence            999999999999999753  45799999999999999999999999  9999999999999998 899999999998775


Q ss_pred             Ccc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ... .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........++....++  .+...+++++
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~~s~~~~  254 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP--VSLHYSYDLR  254 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CCTTSCHHHH
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--CCccCCHHHH
Confidence            432 23456799999999987765 9999999999999999999999999866666666665554432  3456789999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +||.+||+ ||++|||++|+|+||||++-
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            99999998 99999999999999999763

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.3e-62  Score=417.62  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=220.6

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      +|++.++||+|+||+||+|.++.+|+.||||++.......    .+.+.+|++++++++||||+++++++.+.  +.+|+
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~i  148 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWV  148 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS----GGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence            3477899999999999999999999999999998654322    35678899999999999999999998665  67999


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-  176 (289)
                      |||||+||+|.+++.+ .++++.++..++.|++.||.|||++|  ++||||||+|||++.+ |.+||+|||++...... 
T Consensus       149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSS
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC-CCEEEecCcCceecCCCC
Confidence            9999999999999986 56999999999999999999999999  9999999999999998 99999999999877543 


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+..............++++++||
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  304 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  304 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            345567899999999987654 9999999999999999999999998865555544444443333334456789999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          256 EKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .+||+ ||++|||++|+|+||||++...
T Consensus       305 ~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          305 DRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            99998 9999999999999999997643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.4e-62  Score=405.44  Aligned_cols=253  Identities=26%  Similarity=0.502  Sum_probs=203.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++...... .......+.+|++++++++||||+++++++.++  +.+
T Consensus        13 g~Y-~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~   88 (275)
T 3hyh_A           13 GNY-QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEI   88 (275)
T ss_dssp             -CC-EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred             eCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence            566 7899999999999999999999999999999865432 234467799999999999999999999998554  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |+||||+ +|+|.+++.+.+++++.++..++.|++.||.|||++|  ++||||||+||+++.+ +.+||+|||++.....
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH-LNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-CCEEECCSSCC-----
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC-CCEEEeecCCCeecCC
Confidence            9999999 5699999998889999999999999999999999999  9999999999999998 8999999999988766


Q ss_pred             ccccccCCCCCCCCCCcccccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .......+||+.|+|||++.+. + ++++|||||||++|+|++|+.||.+.... ...+.+..+..  ..+...++.+++
T Consensus       165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~~~~~--~~p~~~s~~~~~  241 (275)
T 3hyh_A          165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNISNGVY--TLPKFLSPGAAG  241 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC--CCCTTSCHHHHH
T ss_pred             CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCC--CCCCCCCHHHHH
Confidence            6666678899999999987765 4 57999999999999999999999875444 44444444332  234567999999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      |+.+||+ ||++|||++|+++||||+.
T Consensus       242 li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          242 LIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHHcCccccc
Confidence            9999998 9999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.1e-61  Score=420.20  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=221.5

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      +|++.++||+|+||+||+|.++.+|+.||||++.......    .+.+.+|+++++.++||||+++++++.+.  +.+|+
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~i  225 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWV  225 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS----GGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH----HHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEE
Confidence            3478999999999999999999999999999998654322    45678899999999999999999999665  68999


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc-
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~-  176 (289)
                      |||||+||+|.+++.. ..+++.++..++.|++.||.|||++|  ++||||||+|||++.+ |.+||+|||++...... 
T Consensus       226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT-CCEEECCCTTCEECCSSC
T ss_pred             EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEecCccceECCCCC
Confidence            9999999999999976 45999999999999999999999999  9999999999999998 99999999999877543 


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+..............++.+++||
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence            345567899999999987655 9999999999999999999999998866555555444443333344556799999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          256 EKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .+||+ ||++|||++|+|+||||++...
T Consensus       382 ~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          382 DRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            99998 9999999999999999997643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-61  Score=409.76  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=212.7

Q ss_pred             cceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      |++.+.||+|+||+||+|.+.   .+++.||+|+++.......  ...++.+|++++++++||||+++++++.++  +.+
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~  101 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL  101 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE--ECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence            478999999999999999874   4688999999976543211  123577899999999999999999998665  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |+||||++||+|.+++.+.+.+++.++..++.|++.||.|||++|  ++||||||+|||++.+ |.+||+|||++.....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-SCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC-CCEEecccccceeccC
Confidence            999999999999999999889999999999999999999999999  9999999999999998 8999999999986543


Q ss_pred             -ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 -SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 -~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                       .......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+.......+.....   ..+...++++++
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~  255 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL---GMPQFLSPEAQS  255 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC---CCCCcCCHHHHH
Confidence             3344567899999999987655 99999999999999999999999988665555555544432   235567999999


Q ss_pred             HHHHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          254 FIEKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       254 li~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      ||.+||+ ||++|||     ++|+++||||++++|+
T Consensus       256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            9999998 9999998     5899999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.2e-60  Score=405.41  Aligned_cols=254  Identities=26%  Similarity=0.343  Sum_probs=216.4

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      ++++.++||+|+||+||+|.++.+|+.||||+++.....         .+|+.+++.++|||||++++++.+.  +.+|+
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~---------~~E~~il~~l~HpnIV~l~~~~~~~--~~~~i  127 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR---------VEELVACAGLSSPRIVPLYGAVREG--PWVNI  127 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---------THHHHTTTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH---------HHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence            456789999999999999999999999999999864331         3589999999999999999998654  68999


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC-cEEEeccCCccccCCc
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG-QVKIGDLGFAAIVGRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~-~~~l~d~g~~~~~~~~  176 (289)
                      ||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|  ++||||||+|||++.+ | .+||+|||++......
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTT-SCCEEECCCTTCEEC---
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCC-CCEEEEeeCCCCeEccCC
Confidence            9999999999999998889999999999999999999999999  9999999999999988 6 6999999999876432


Q ss_pred             cc------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          177 HA------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       177 ~~------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ..      ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+.....+....+...++
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  284 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP  284 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence            21      2335799999999977655 9999999999999999999999998765544455555554444455667899


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHH-------------hcCcccccCCCCCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASEL-------------LKDPFFSELNDDDS  285 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~i-------------l~h~~~~~~~~~~~  285 (289)
                      .+++||.+||+ ||++|||+.|+             |+|||+.+...+.+
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence            99999999998 99999999997             67999988765543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-59  Score=396.43  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=200.4

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC------
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH------   92 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------   92 (289)
                      |++.+.||+|+||+||+|.++.+|+.||||+++...   .+...+.+.+|++++++++||||+++++++...+.      
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            468899999999999999999999999999998653   45567789999999999999999999998865432      


Q ss_pred             ----CeeEEEeccccCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           93 ----NTLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        93 ----~~~~lv~e~~~~~sL~~~~~~~~~---l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                          .++|+|||||+|++|.+++.....   .+...+..++.|++.||.|||++|  ++||||||+|||++.+ +.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~-~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC-CcEEEc
Confidence                257999999999999999987654   445678899999999999999999  9999999999999998 899999


Q ss_pred             ccCCccccCCccc-------------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 022956          166 DLGFAAIVGRSHA-------------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY  231 (289)
Q Consensus       166 d~g~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~  231 (289)
                      |||++........             ....+||+.|+|||++.+. ++.++|||||||++|+|++   ||.+..+.....
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            9999987643221             2235799999999987755 9999999999999999996   886533333333


Q ss_pred             HHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          232 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      ..+.....+.. ....++.+.+|+.+||+ ||++|||+.|+|+||||++++++..
T Consensus       238 ~~~~~~~~p~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~~  291 (299)
T 4g31_A          238 TDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK  291 (299)
T ss_dssp             HHHHTTCCCHH-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-----
T ss_pred             HHHhcCCCCCC-CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence            33333332222 12235678899999998 9999999999999999999988653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-58  Score=401.61  Aligned_cols=266  Identities=24%  Similarity=0.386  Sum_probs=220.3

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC---
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD---   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   90 (289)
                      .+++| ++.++||+|+||+||+|.++.+|+.||||+++....  .....+.+.+|+++|+.++||||+++++++...   
T Consensus        52 i~~~Y-~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           52 VGDEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCSSE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred             CCCCe-EEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc--chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence            34566 789999999999999999999999999999975432  455567889999999999999999999987532   


Q ss_pred             -CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 -QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 -~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                       +.+.+|+||||++| +|.+++.+.+++++..+..++.|++.||.|||++|  ++||||||+|||++.+ +.+||+|||+
T Consensus       129 ~~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~-~~~Ki~DFGl  204 (398)
T 4b99_A          129 GEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN-CELKIGDFGM  204 (398)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTT
T ss_pred             ccCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCC-CCEEEeecce
Confidence             33678999999975 89999998899999999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCc-----cccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-
Q 022956          170 AAIVGRS-----HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-  241 (289)
Q Consensus       170 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-  241 (289)
                      +......     ......+||+.|+|||++.+  .++.++||||+||++|+|++|..||.+....+....+......+. 
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9866332     22345789999999997654  378999999999999999999999988666555544332211110 


Q ss_pred             -C--------------------------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          242 -A--------------------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       242 -~--------------------------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                       .                          .....++++.+||.+||+ ||++|||++|+|+||||++......+
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~  357 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDE  357 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccc
Confidence             0                          112357899999999999 99999999999999999988654433

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-56  Score=375.17  Aligned_cols=243  Identities=27%  Similarity=0.463  Sum_probs=204.0

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||+||+|.+.   ..||||+++....  .....+.|.+|++++++++||||+++++++..   +.+++||
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVm  110 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP--TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVT  110 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEE
Confidence            57899999999999999865   3599999976543  56667889999999999999999999997632   4589999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc--
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--  176 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~--  176 (289)
                      ||++||+|.+++.. ..++++.++..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||++......  
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT-EEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC-CcEEEeeccCceecccCCc
Confidence            99999999999975 467999999999999999999999999  9999999999999999 89999999999866432  


Q ss_pred             -cccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC---CCCCCCC
Q 022956          177 -HAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ---ALNKVKD  248 (289)
Q Consensus       177 -~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  248 (289)
                       ......+||+.|+|||++.    +.++.++|||||||++|||+||+.||.+..........+..+....   ..+..++
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  267 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP  267 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence             2234568999999999764    2388899999999999999999999998777777777666654332   3345578


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +.+.+|+.+||+ ||++|||+.||++
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            999999999998 9999999998865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.1e-57  Score=380.84  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=209.9

Q ss_pred             cceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +.+.++||+|+||+||+|.+.     .++..||||+++..    .....+.|.+|++++++++|||||++++++.+.  +
T Consensus        15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~   88 (299)
T 4asz_A           15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D   88 (299)
T ss_dssp             EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred             eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--C
Confidence            367899999999999999864     46889999999743    455678899999999999999999999998543  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      .+++||||+++|+|.+++.+.             ..+++.++..++.|++.||.|||+++  ++||||||+|||++.+ +
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~-~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-L  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-G
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC-C
Confidence            799999999999999999753             36999999999999999999999999  9999999999999998 8


Q ss_pred             cEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHh
Q 022956          161 QVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVT  235 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~  235 (289)
                      .+||+|||++........   .....+|+.|+|||.+. +.++.++|||||||++|||+| |+.||.+....+...... 
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence            999999999986643322   22345899999999776 459999999999999999999 899999866555444444 


Q ss_pred             CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          236 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      .+..+. .+...++++.+|+.+||+ ||++|||+++|+.  |++++....+
T Consensus       245 ~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~~~~~~~p  292 (299)
T 4asz_A          245 QGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQNLAKASP  292 (299)
T ss_dssp             HTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHSC
T ss_pred             cCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHHHhcCC
Confidence            433322 345678999999999998 9999999999965  8887654433

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9e-56  Score=384.01  Aligned_cols=254  Identities=19%  Similarity=0.327  Sum_probs=203.8

Q ss_pred             CCCcccceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD   89 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   89 (289)
                      ..++| ++.++||+|+||+||+|.++   .+++.||+|.+....   .   ..++.+|+++++.+ +||||+++++++.+
T Consensus        19 l~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           19 LSNVF-KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---H---PIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGTC-EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             ccCcE-EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---C---HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            34566 78999999999999999875   468899999986432   1   35678899999988 69999999998865


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      .  +.+|+||||++|++|.+++.   .+++.++..++.|++.||.|||++|  ++||||||+|||++.+.+.+||+|||+
T Consensus        92 ~--~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           92 N--DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             T--TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             C--CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            4  68999999999999999984   4999999999999999999999999  999999999999998768999999999


Q ss_pred             ccccCCcc-----------------------------ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCC
Q 022956          170 AAIVGRSH-----------------------------AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTME  218 (289)
Q Consensus       170 ~~~~~~~~-----------------------------~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~  218 (289)
                      |.......                             .....+||+.|+|||++.+  .++.++||||+||++|+|++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            97543221                             1223579999999997654  3889999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHhC----------------------------------------------------CCCCCCCCCC
Q 022956          219 IPYSECDSVAKIYKKVTG----------------------------------------------------GVKPQALNKV  246 (289)
Q Consensus       219 ~p~~~~~~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~  246 (289)
                      .||....+.......+..                                                    ..........
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            999654433222221110                                                    0000112334


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .++++.+||.+||+ ||++|||++|+|+||||+++.
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            68899999999999 999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-55  Score=377.98  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=203.7

Q ss_pred             cceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..+.++||+|+||+||+|.+.     .++..||||+++..    .....+.|.+|++++++++|||||++++++.+.  +
T Consensus        43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~  116 (329)
T 4aoj_A           43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--R  116 (329)
T ss_dssp             EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred             eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence            356799999999999999754     46889999999743    456678899999999999999999999998543  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKH---------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~---------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~  158 (289)
                      .+++||||+++|+|.+++.+.               .++++.++..++.|++.||.|||+++  ++||||||+|||++.+
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC
Confidence            799999999999999998753               35899999999999999999999999  9999999999999999


Q ss_pred             CCcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 022956          159 IGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK  233 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  233 (289)
                       +.+||+|||++.......   ......+|+.|+|||.+.+. ++.++|||||||++|||+| |+.||.+....+.....
T Consensus       195 -~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          195 -LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             -TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             -CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             899999999998654322   23345789999999977654 9999999999999999999 89999886655544444


Q ss_pred             HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                       ..+..+. .+..+++.+.+|+.+||+ ||++|||++||++  +++.+.+.
T Consensus       274 -~~g~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~l~~~  320 (329)
T 4aoj_A          274 -TQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA--RLQALAQA  320 (329)
T ss_dssp             -HHTCCCC-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH--HHHHHHHS
T ss_pred             -HcCCCCC-CcccccHHHHHHHHHHcCcChhHCcCHHHHHH--HHHHHhhC
Confidence             4433332 345679999999999998 9999999999998  56655443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.7e-56  Score=407.26  Aligned_cols=258  Identities=23%  Similarity=0.410  Sum_probs=219.0

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeeccc--CCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .| ++.++||+|+||+||+|.++.+|+.||+|++.....  ............++++++.++||||+++++++.+.  +.
T Consensus       190 df-~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~~  266 (689)
T 3v5w_A          190 DF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DK  266 (689)
T ss_dssp             GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SE
T ss_pred             He-EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--CE
Confidence            44 789999999999999999999999999999986543  12333444455667888889999999999998554  68


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++|  ++||||||+|||++.+ |.+||+|||+|....
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~-G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC-CCEEecccceeeecC
Confidence            9999999999999999999899999999999999999999999999  9999999999999999 999999999998765


Q ss_pred             CccccccCCCCCCCCCCcccc-c-CCCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          175 RSHAAHSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      .. .....+||+.|+|||++. + .++.++|+|||||++|+|++|..||.+..  ........+....  ...+...+++
T Consensus       344 ~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S~~  420 (689)
T 3v5w_A          344 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPE  420 (689)
T ss_dssp             SC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSCHH
T ss_pred             CC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCCHH
Confidence            44 345678999999999874 4 48999999999999999999999997532  2333333333322  2345667999


Q ss_pred             HHHHHHHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          251 VKAFIEKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      +++||.+||+ ||.+|++     ++||++||||++++|+
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            9999999998 9999998     7999999999999885

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-55  Score=373.34  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=204.6

Q ss_pred             ceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      ++.++||+|+||+||+|...     .+++.||||+++...   .....+.|.+|+.++++++|||||++++++...  +.
T Consensus        29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~~  103 (308)
T 4gt4_A           29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--QP  103 (308)
T ss_dssp             EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred             eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--CE
Confidence            67899999999999999853     467899999997543   233467899999999999999999999998543  57


Q ss_pred             eEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC
Q 022956           95 LNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~  158 (289)
                      +++||||+++|+|.+++...                ..+++.++..++.|++.||.|||+++  ++||||||+|||++.+
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK  181 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCC
Confidence            89999999999999999642                35899999999999999999999999  9999999999999998


Q ss_pred             CCcEEEeccCCccccCCc---cccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 022956          159 IGQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK  233 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  233 (289)
                       +.+||+|||++......   .......+|+.|+|||.+. +.++.++|||||||++|||+| |..||.+....+ ....
T Consensus       182 -~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-~~~~  259 (308)
T 4gt4_A          182 -LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VVEM  259 (308)
T ss_dssp             -GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-HHHH
T ss_pred             -CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-HHHH
Confidence             89999999999765432   2234467899999999765 459999999999999999999 899998866544 4444


Q ss_pred             HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      +..+..+. .+..+++.+.+|+.+||+ ||++|||+.||+++
T Consensus       260 i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            54443333 345678999999999998 99999999999983

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.3e-55  Score=399.35  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=225.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||+|.++.+|+.||+|++...    .....+.+.+|+++|+.++||||+++++++.+.  +.+
T Consensus       157 ~~Y-~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~  229 (573)
T 3uto_A          157 DHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEM  229 (573)
T ss_dssp             GTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEE
T ss_pred             ccc-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEE
Confidence            455 7899999999999999999999999999999754    344567789999999999999999999998554  689


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-CCcEEEeccCCcccc
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIV  173 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-~~~~~l~d~g~~~~~  173 (289)
                      |+||||++||+|.+++.. ...+++.++..++.||+.||.|||++|  ++||||||+|||++.+ .+.+||+|||++...
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999999999864 467999999999999999999999999  9999999999999753 378999999999988


Q ss_pred             CCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChHH
Q 022956          174 GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEV  251 (289)
Q Consensus       174 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  251 (289)
                      .........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+...... +.......++.+
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            766666677899999999977655 899999999999999999999999986665555554444322 233345578999


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      ++||.+||+ ||++|||++|+|+||||+...+...
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence            999999998 9999999999999999998776543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-54  Score=372.71  Aligned_cols=248  Identities=26%  Similarity=0.378  Sum_probs=209.0

Q ss_pred             cceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQH   92 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~   92 (289)
                      +++.++||+|+||+||+|.+..+     ++.||+|.++...   .....+.+.+|++++++++| ||||++++++..+ +
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-~  141 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G  141 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-C
Confidence            37889999999999999987654     4679999987543   34556789999999999976 8999999987554 3


Q ss_pred             CeeEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN  156 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~  156 (289)
                      +.+++|||||++|+|.+++.+.                ..+++..+..++.|++.||.|||+++  ++||||||+|||++
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~  219 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS  219 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeC
Confidence            5789999999999999999753                34899999999999999999999999  99999999999999


Q ss_pred             CCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 022956          157 GNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIY  231 (289)
Q Consensus       157 ~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~  231 (289)
                      .+ +.+||+|||++.......   .....++|+.|+|||.+.+ .++.++|||||||++|||+| |..||.+........
T Consensus       220 ~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~  298 (353)
T 4ase_A          220 EK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  298 (353)
T ss_dssp             GG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             CC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            98 899999999998664332   2334568999999997664 59999999999999999998 899998876556666


Q ss_pred             HHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          232 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..+..+..+. .+...++++.+|+..||+ ||++|||+.+|++|
T Consensus       299 ~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          299 RRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            6666654443 345678999999999998 99999999999997

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-52  Score=361.53  Aligned_cols=257  Identities=23%  Similarity=0.454  Sum_probs=224.4

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.+.||+|+||.||+|.+..+|+.||+|++.....  +....+.+.+|+++++.++||||+++++++...  +.
T Consensus        14 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~   88 (328)
T 3fe3_A           14 IGNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KT   88 (328)
T ss_dssp             ETTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred             cCCE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CE
Confidence            3455 789999999999999999999999999999987654  556677899999999999999999999988544  67


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++||||+++++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFT  165 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTCCGGGS
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC-CCEEEeeccCceecC
Confidence            9999999999999999988888999999999999999999999999  9999999999999998 899999999998776


Q ss_pred             CccccccCCCCCCCCCCcccccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED-Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ........++++.|+|||.+.+. + ++++|||||||++|+|++|..||.+................   .+...++.+.
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~  242 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---IPFYMSTDCE  242 (328)
T ss_dssp             SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHH
T ss_pred             CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHH
Confidence            66666677899999999977655 4 47899999999999999999999886555444444443322   3445789999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +|+.+||+ ||.+|||++|+++||||+....
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            99999999 9999999999999999987654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.3e-52  Score=350.82  Aligned_cols=269  Identities=45%  Similarity=0.838  Sum_probs=236.5

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      .......++++++.+.||+|+||+||+|.+..++..||+|++.....  .....+.+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (290)
T 1t4h_A           18 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence            34556788888999999999999999999999999999999986654  4566788999999999999999999999875


Q ss_pred             eC--CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           89 DD--QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        89 ~~--~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      ..  .+..+++||||+++++|.+++.....+++..+..++.|++.||.|||+.+++++|+||+|+||+++.+.+.++|+|
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             cccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEee
Confidence            42  3467899999999999999999888899999999999999999999999867999999999999984338999999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ||++...... ......+++.|+|||.+.+.+++++||||||+++++|++|..||............+..+..+......
T Consensus       176 fg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (290)
T 1t4h_A          176 LGLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             TTGGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             CCCccccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence            9999755433 233456899999999988889999999999999999999999999888888888888887777777777


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .++.+.+++.+||+ ||++|||++++++||||++.
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            88999999999999 99999999999999999863

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.3e-52  Score=362.64  Aligned_cols=265  Identities=23%  Similarity=0.365  Sum_probs=224.3

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ....++| ++.+.||+|+||+||+|.++.+|..||+|+++.......  ....+.+.+|+.+++.++||||+++++++.+
T Consensus         8 ~~~~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            8 QKVEDFY-DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             SCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CChhhce-EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            3455565 789999999999999999999999999999987654221  1235678899999999999999999998854


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC----cEEEe
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG----QVKIG  165 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~----~~~l~  165 (289)
                      .  ..+++||||++|++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +    .++|+
T Consensus        87 ~--~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~~~~vkl~  161 (361)
T 2yab_A           87 R--TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDK-NIPIPHIKLI  161 (361)
T ss_dssp             S--SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCT-TSSSCCEEEC
T ss_pred             C--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCC-CCCccCEEEE
Confidence            3  689999999999999999998888999999999999999999999999  9999999999999877 4    79999


Q ss_pred             ccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCC
Q 022956          166 DLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QAL  243 (289)
Q Consensus       166 d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~  243 (289)
                      |||++............+|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+................. ...
T Consensus       162 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  241 (361)
T 2yab_A          162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF  241 (361)
T ss_dssp             CCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             ecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence            9999988766555566789999999997765 48999999999999999999999998865554444443332221 122


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ....++.+++||.+||. ||++|||++|+++||||+..++
T Consensus       242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            34568899999999998 9999999999999999997654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.2e-51  Score=348.81  Aligned_cols=258  Identities=28%  Similarity=0.499  Sum_probs=223.0

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ++.++| ++.++||+|+||+||+|.+..+|+.||+|++.......    .+.+.+|+.+++.++||||+++++.+...  
T Consensus        17 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   89 (297)
T 3fxz_A           17 DPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVG--   89 (297)
T ss_dssp             CGGGTB-CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred             Chhhce-eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH----HHHHHHHHHHHhcCCCCCCCeEeEEEEEC--
Confidence            455565 78999999999999999999999999999998654322    45678899999999999999999988665  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +.+++||||++|++|.+++... .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~  165 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQ  165 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred             CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC-CCEEEeeCCCcee
Confidence            5799999999999999999875 5999999999999999999999999  9999999999999998 8999999999977


Q ss_pred             cCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          173 VGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      ..... ......+++.|+|||.+.+. +++++||||||+++|+|++|..||.+....................+...++.
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (297)
T 3fxz_A          166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI  245 (297)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHH
T ss_pred             cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHH
Confidence            65432 33456789999999977654 89999999999999999999999988776666666555555444455667899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +++|+.+||+ ||++|||++++++||||+...
T Consensus       246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            9999999999 999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-51  Score=354.01  Aligned_cols=258  Identities=23%  Similarity=0.432  Sum_probs=220.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|+++..... .......+.+|+++++.++||||+++++.+...  +.+
T Consensus         5 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~   80 (337)
T 1o6l_A            5 NDF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEE
T ss_pred             HHe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEE
Confidence            344 6899999999999999999999999999999754321 111246688899999999999999999988554  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-  174 (289)
                      ++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++.... 
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC-CCEEEeeccchhhccc
Confidence            999999999999999998888999999999999999999999999  9999999999999998 899999999997643 


Q ss_pred             CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ........+|++.|+|||.+.+. ++.++|+||||+++|+|++|..||.+...............   ..+...++.+++
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~  234 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKS  234 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHH
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHH
Confidence            33344566799999999987654 89999999999999999999999987655544444444332   234567899999


Q ss_pred             HHHHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          254 FIEKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       254 li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      ||.+||+ ||++||     +++++++||||++++|+
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999998 999999     99999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-51  Score=345.79  Aligned_cols=265  Identities=23%  Similarity=0.402  Sum_probs=217.8

Q ss_pred             CCceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeee
Q 022956            7 EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV   86 (289)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   86 (289)
                      .+..+....++| ++.++||+|+||+||+|.++.++..+|+|++........   .+.+.+|++++++++||||++++++
T Consensus        13 ~~~~~g~i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~   88 (285)
T 3is5_A           13 NLYFQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP---MEQIEAEIEVLKSLDHPNIIKIFEV   88 (285)
T ss_dssp             CCEESSCHHHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC---HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCCCCCChhhhe-eecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh---HHHHHHHHHHHHhCCCchHHhHHHh
Confidence            344555566676 789999999999999999999999999999987653222   5678899999999999999999998


Q ss_pred             EEeCCCCeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CC
Q 022956           87 WLDDQHNTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IG  160 (289)
Q Consensus        87 ~~~~~~~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~  160 (289)
                      +...  ...++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+  .+
T Consensus        89 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~  164 (285)
T 3is5_A           89 FEDY--HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHS  164 (285)
T ss_dssp             EECS--SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTC
T ss_pred             eecC--CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCC
Confidence            8543  679999999999999998854    367999999999999999999999999  9999999999999432  27


Q ss_pred             cEEEeccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC
Q 022956          161 QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP  240 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  240 (289)
                      .++|+|||++.............+++.|+|||.+.+.++.++||||||+++++|++|..||.+.................
T Consensus       165 ~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  244 (285)
T 3is5_A          165 PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY  244 (285)
T ss_dssp             CEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             CEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence            89999999998776555555667899999999888889999999999999999999999998866555555444444443


Q ss_pred             CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      .......++.+.+|+.+||+ ||++|||++|+|+||||++
T Consensus       245 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            33344468999999999999 9999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=358.23  Aligned_cols=258  Identities=22%  Similarity=0.383  Sum_probs=216.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   94 (289)
                      ++| ++.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|..+++.+ +||||+++++++.+.  +.
T Consensus        23 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~   98 (353)
T 3txo_A           23 DNF-EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR   98 (353)
T ss_dssp             CCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             hhe-EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence            344 7899999999999999999999999999999854321 122356678899999988 799999999988554  67


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-g~ikL~DFG~a~~~~  175 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC-CCEEEccccceeecc
Confidence            9999999999999999998889999999999999999999999999  9999999999999998 899999999998643


Q ss_pred             -CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 -RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 -~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                       ........+|++.|+|||++.+. ++.++|+|||||++|+|++|..||.+................   .+...++.+.
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~  252 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---YPTWLHEDAT  252 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHH
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCHHHH
Confidence             33344556899999999977655 999999999999999999999999886655555555544332   3455789999


Q ss_pred             HHHHHHHc-CCCCCCCH------HHHhcCcccccCCCC
Q 022956          253 AFIEKCIA-QPRARPSA------SELLKDPFFSELNDD  283 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~------~~il~h~~~~~~~~~  283 (289)
                      +|+.+||+ ||.+||++      +++++||||++++|+
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            99999998 99999998      899999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.3e-51  Score=360.76  Aligned_cols=257  Identities=19%  Similarity=0.379  Sum_probs=216.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      |++.++||+|+||+||+|.++.+++.||+|+++..... .....+.+.+|..++.++ +||||+++++++.+.  +.+++
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~~l  130 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFF  130 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CEEEE
Confidence            37899999999999999999999999999999875442 233355678899998877 899999999988554  68999


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc-CCc
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-GRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~-~~~  176 (289)
                      ||||++|++|..++...+.+++..+..++.|++.||.|||++|  ++||||||+||+++.+ +.+||+|||++... ...
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC-CCEEEeecceeeecccCC
Confidence            9999999999999998889999999999999999999999999  9999999999999999 89999999999863 334


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC--------CcHHHHHHHHhCCCCCCCCCCCC
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC--------DSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      ......+||+.|+|||++.+. ++.++|+|||||++|+|++|..||...        .......+.+....  ...+...
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~  285 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSL  285 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTTS
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCcC
Confidence            445667899999999977654 899999999999999999999999632        12233344444332  2244567


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCH------HHHhcCcccccCCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSA------SELLKDPFFSELNDD  283 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~------~~il~h~~~~~~~~~  283 (289)
                      ++.+++||.+||+ ||++||++      +||++||||++++|+
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence            8999999999998 99999985      899999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-51  Score=352.81  Aligned_cols=266  Identities=20%  Similarity=0.348  Sum_probs=223.1

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhCCCCceEEeeeeE
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVW   87 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   87 (289)
                      ......++| ++.+.||+|+||.||+|.++.+|..||+|++........  ....+.+.+|+++++.++||||+++++++
T Consensus         5 ~~~~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A            5 RQENVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             BCSCHHHHE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCcccce-EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            333444555 789999999999999999999999999999987654221  11356788999999999999999999988


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC----cEE
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG----QVK  163 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~----~~~  163 (289)
                      ...  ..+++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +    .++
T Consensus        84 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~-~~~~~~~k  158 (326)
T 2y0a_A           84 ENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDR-NVPKPRIK  158 (326)
T ss_dssp             ECS--SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCS-SSSSCCEE
T ss_pred             EeC--CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecC-CCCCCCEE
Confidence            543  679999999999999999998888999999999999999999999999  9999999999999877 5    799


Q ss_pred             EeccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-C
Q 022956          164 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-Q  241 (289)
Q Consensus       164 l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~  241 (289)
                      |+|||++.............+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+................. .
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  238 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence            999999988765555556779999999997764 48999999999999999999999998765554444443332221 1


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ......++.+.+|+.+||+ ||++|||++++|+||||+..+
T Consensus       239 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            1224568899999999998 999999999999999998764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.7e-50  Score=339.68  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=226.7

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||+||+|.++.+|..||+|++.....  .....+.+.+|++++++++||||+++++++...  +
T Consensus         4 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   78 (284)
T 3kk8_A            4 FSDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--S   78 (284)
T ss_dssp             TTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred             hhhhh-hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--C
Confidence            45666 789999999999999999999999999999987654  455677899999999999999999999988543  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC--CcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~--~~~~l~d~g~~~  171 (289)
                      ..++|+||+++++|.+.+.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+.  +.++|+|||++.
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            78999999999999999998888999999999999999999999999  99999999999997651  349999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCCh
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  249 (289)
                      ............+++.|+|||.+.+. ++.++||||||+++++|++|..||.+................ +.......++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T 3kk8_A          157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP  236 (284)
T ss_dssp             ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence            77766555667899999999977655 899999999999999999999999886655555544444332 2222345689


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      .+.+|+.+||+ ||++|||++|+++||||++.....+
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence            99999999999 9999999999999999998765443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-50  Score=353.34  Aligned_cols=256  Identities=25%  Similarity=0.400  Sum_probs=220.4

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||.||+|.++.+|..||+|++.....  .....+.+.+|+.+++.++||||+++++++.+.  +..++|
T Consensus        31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv  106 (362)
T 2bdw_A           31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLV  106 (362)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence            4789999999999999999999999999999986544  455567899999999999999999999988544  679999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+.|++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+  .+.+||+|||++......
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            999999999999998888999999999999999999999999  9999999999999765  146999999999877665


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAF  254 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  254 (289)
                      .......+++.|+|||.+.+. ++.++|||||||++|+|++|..||.+................ +.......++.+++|
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  264 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL  264 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred             cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            555567899999999987654 899999999999999999999999876655544444444322 222234568999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          255 IEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +.+||+ ||++||++.++|+||||++.
T Consensus       265 i~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          265 IDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            999998 99999999999999999764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-50  Score=347.02  Aligned_cols=256  Identities=25%  Similarity=0.435  Sum_probs=220.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +.| ++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|..+++.++||||+++++.+.+.  ..+
T Consensus         6 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~   81 (318)
T 1fot_A            6 QDF-QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQI   81 (318)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEE
T ss_pred             HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEE
Confidence            344 6899999999999999999999999999999754321 111246678899999999999999999988544  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||++|++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ |.+||+|||++.....
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC-CCEEEeecCcceecCC
Confidence            999999999999999998888999999999999999999999999  9999999999999998 8999999999986643


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .  ....++++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+..........+.....   .+...++.+++|
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~l  233 (318)
T 1fot_A          159 V--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---FPPFFNEDVKDL  233 (318)
T ss_dssp             C--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHH
T ss_pred             c--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHHHH
Confidence            2  3456799999999977654 899999999999999999999999886665555555554322   345578999999


Q ss_pred             HHHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          255 IEKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       255 i~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      +.+||+ ||++||     +++++++||||++++|+
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence            999998 999999     99999999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-50  Score=349.43  Aligned_cols=259  Identities=20%  Similarity=0.386  Sum_probs=219.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   94 (289)
                      +.| ++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+.+|..+++++ +||||+++++++.+.  +.
T Consensus         9 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   84 (345)
T 3a8x_A            9 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR   84 (345)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC-SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc-chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence            344 6899999999999999999999999999999865442 455677888999999888 899999999988554  68


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCGGGCBCSC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEEecccccccc
Confidence            9999999999999999998888999999999999999999999999  9999999999999998 899999999997643


Q ss_pred             -CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC--------CcHHHHHHHHhCCCCCCCCC
Q 022956          175 -RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC--------DSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       175 -~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~  244 (289)
                       ........++++.|+|||.+.+. ++.++|+|||||++|+|++|..||...        .......+.+....  ...+
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p  239 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP  239 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCC
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCC
Confidence             33344566899999999977654 899999999999999999999999642        12233333343332  2244


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCH------HHHhcCcccccCCCC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSA------SELLKDPFFSELNDD  283 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~------~~il~h~~~~~~~~~  283 (289)
                      ...++.+++||.+||+ ||++||++      +++++||||++++|+
T Consensus       240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence            5678999999999998 99999995      899999999998864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=359.38  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=219.1

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.++||+|+||+||+|.++.+|+.+|+|++.....  .....+.+.+|+++++.++||||+++++++.+.  +.
T Consensus        10 ~~~Y-~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~   84 (444)
T 3soa_A           10 TEEY-QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEE--GH   84 (444)
T ss_dssp             HHHE-EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SE
T ss_pred             cCCe-EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CE
Confidence            3455 789999999999999999999999999999987543  344567799999999999999999999988544  68


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCCccc
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAAI  172 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~~~~  172 (289)
                      +++||||+.|++|.+.+.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+  .+.+||+|||++..
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999999999999889999999999999999999999999  9999999999999842  27899999999977


Q ss_pred             cCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCCh
Q 022956          173 VGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDP  249 (289)
Q Consensus       173 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  249 (289)
                      ..... ......|++.|+|||.+.+. +++++|||||||++|+|++|..||.+................ +.......++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            65433 23456799999999987764 899999999999999999999999886655555544444332 2223345789


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+++|+.+||+ ||++|||+.|+|+||||++.
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999998 99999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.2e-50  Score=341.70  Aligned_cols=258  Identities=24%  Similarity=0.398  Sum_probs=209.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.++.+|+.||+|++.....  .......+.+|++++++++||||+++++++...  +.+
T Consensus         2 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   76 (292)
T 3o0g_A            2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL   76 (292)
T ss_dssp             CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred             CCc-eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEE
Confidence            355 689999999999999999999999999999986653  344467788999999999999999999998654  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||++++.+..+....+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++.....
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecCC
Confidence            999999988444444445678999999999999999999999999  9999999999999998 8999999999987653


Q ss_pred             c-cccccCCCCCCCCCCccccc-C-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC---CCCC---------
Q 022956          176 S-HAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GVKP---------  240 (289)
Q Consensus       176 ~-~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~---------  240 (289)
                      . .......+++.|+|||.+.+ . ++.++||||||+++++|++|..||............+..   ....         
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            3 23344578999999997654 3 799999999999999999988885444444433333321   1100         


Q ss_pred             ---------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          241 ---------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       241 ---------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                                     .......++.+++|+.+||+ ||++|||++|+|+||||+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                           01122357899999999999 999999999999999999753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-51  Score=349.52  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=192.3

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC--Ce
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--NT   94 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~   94 (289)
                      |.+.+.++||+|+||+||+|.+  +|+.||||+++...     ......+.|+..+.+++||||+++++++..+..  ..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            4457889999999999999987  58999999986432     212234456777778999999999999876533  36


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCceecCCCCCceEEeCCCCcEEEec
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH--------EPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--------~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      +++||||+++|+|.+++... .++++.+..++.|++.||.|||++        +  ++||||||+|||++.+ +.+||+|
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~--IiHRDlKp~NILl~~~-~~~Ki~D  151 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCCIAD  151 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC--EECSCCCGGGEEECTT-SCEEECC
T ss_pred             EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--EeeccCCcccEEECCC-CCEEEEe
Confidence            89999999999999999864 599999999999999999999987        6  9999999999999999 8999999


Q ss_pred             cCCccccCCccc-----cccCCCCCCCCCCcccccC-------CCCcchHHHHHHHHHHHHhCCCCCCCC----------
Q 022956          167 LGFAAIVGRSHA-----AHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTMEIPYSEC----------  224 (289)
Q Consensus       167 ~g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~il~~l~tg~~p~~~~----------  224 (289)
                      ||++........     ....+||+.|+|||.+.+.       ++.++|||||||++|||+||..||...          
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            999987643322     2345799999999977543       567899999999999999997665321          


Q ss_pred             ----CcHHHHHHHHhC-CCCCCCCCCC----CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          225 ----DSVAKIYKKVTG-GVKPQALNKV----KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       225 ----~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                          .........+.. ...+......    .+..+.+|+.+||+ ||++|||+.+|++  -++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~--~L~~l  295 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK--TLSQL  295 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH--HHHHH
Confidence                122334443333 2222221111    12468899999998 9999999999998  45544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-50  Score=346.65  Aligned_cols=265  Identities=25%  Similarity=0.387  Sum_probs=212.2

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      -...+..++| ++.++||+|+||+||+|.+. +|+.||+|++.....  .......+.+|++++++++||||+++++++.
T Consensus        14 ~~~q~l~~~y-~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   89 (311)
T 3niz_A           14 LYFQGLMEKY-QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIH   89 (311)
T ss_dssp             -CEECSSCEE-EEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             eeecchHhhh-HhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence            3455677887 68999999999999999985 589999999976533  3334577889999999999999999999884


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      .  .+.+++||||+++ +|.+.+... ..+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.+||+||
T Consensus        90 ~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Df  163 (311)
T 3niz_A           90 S--ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADF  163 (311)
T ss_dssp             C--SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCC
T ss_pred             c--CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC-CCEEEccC
Confidence            4  3679999999987 788877654 56999999999999999999999999  9999999999999998 89999999


Q ss_pred             CCccccCCc-cccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--CCCCCCC
Q 022956          168 GFAAIVGRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQA  242 (289)
Q Consensus       168 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~~  242 (289)
                      |++...... .......+++.|+|||.+.+  .++.++|||||||++++|++|..||.+............  ....+..
T Consensus       164 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  243 (311)
T 3niz_A          164 GLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE  243 (311)
T ss_dssp             TTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred             cCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence            999876533 22334578999999997654  489999999999999999999999987554443333222  1111111


Q ss_pred             -------------------------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          243 -------------------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       243 -------------------------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                               .....++++.+|+.+||+ ||++|||++|+|+||||++++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence                                     112356789999999999 99999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-50  Score=357.16  Aligned_cols=269  Identities=23%  Similarity=0.412  Sum_probs=217.4

Q ss_pred             eeeCCCCcccceeeeeccc--CcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeE
Q 022956           10 VEVDPSGRFGRYSDLLGSG--AVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW   87 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g--~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   87 (289)
                      ......++| ++.++||+|  +||+||+|.++.+|+.||+|++.....  .....+.+.+|+++++.++||||+++++++
T Consensus        19 ~~~~~~~~y-~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           19 SFLPEGGCY-ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             CCCCCGGGE-EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCCCcE-EEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            334455666 789999999  999999999999999999999987643  456678899999999999999999999998


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                      ...  +.+++||||+++++|.+++...  ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+
T Consensus        96 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~  170 (389)
T 3gni_B           96 IAD--NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLS  170 (389)
T ss_dssp             EET--TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEEC
T ss_pred             EEC--CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEc
Confidence            655  5799999999999999999875  67999999999999999999999999  9999999999999988 899999


Q ss_pred             ccCCccccCCc--------cccccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 022956          166 DLGFAAIVGRS--------HAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV  234 (289)
Q Consensus       166 d~g~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~  234 (289)
                      |||.+......        .......+++.|+|||.+.+   .++.++|||||||++|+|++|..||.+..........+
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  250 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL  250 (389)
T ss_dssp             CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred             ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            99988654221        11223467889999997765   48999999999999999999999998755444433322


Q ss_pred             hCCCC-------------------------------------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHH
Q 022956          235 TGGVK-------------------------------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASE  270 (289)
Q Consensus       235 ~~~~~-------------------------------------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~  270 (289)
                      .....                                           ........++.+.+||.+||+ ||++|||++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            21110                                           011234467889999999999 9999999999


Q ss_pred             HhcCcccccCCCCCCC
Q 022956          271 LLKDPFFSELNDDDSE  286 (289)
Q Consensus       271 il~h~~~~~~~~~~~~  286 (289)
                      +|+||||+++.+...+
T Consensus       331 ll~hp~f~~~~~~~~~  346 (389)
T 3gni_B          331 LLNHSFFKQIKRRASE  346 (389)
T ss_dssp             HTTSGGGGGC---CCS
T ss_pred             HhcCHHHHHHhhcchh
Confidence            9999999998775543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-51  Score=357.80  Aligned_cols=259  Identities=23%  Similarity=0.415  Sum_probs=221.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+.+|+++++.++||||+++++++.+.  ..+
T Consensus        15 ~~y-~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~   90 (384)
T 4fr4_A           15 DHF-EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--EDM   90 (384)
T ss_dssp             GGE-EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred             HHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence            344 7899999999999999999999999999999764321 112256788999999999999999999988554  579


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||+.|++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.....
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAMLPR  167 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC-CCEEEeccceeeeccC
Confidence            999999999999999999888999999999999999999999999  9999999999999998 8999999999988776


Q ss_pred             ccccccCCCCCCCCCCccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          176 SHAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSEC--DSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .......+|++.|+|||.+.+    .++.++|+|||||++|+|++|..||...  .........+....  ...+...++
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s~  245 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQ  245 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCCH
Confidence            666677889999999997752    3889999999999999999999999742  33344444433322  223455789


Q ss_pred             HHHHHHHHHHc-CCCCCCC-HHHHhcCcccccCCCC
Q 022956          250 EVKAFIEKCIA-QPRARPS-ASELLKDPFFSELNDD  283 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps-~~~il~h~~~~~~~~~  283 (289)
                      .+.+||.+||+ ||++||+ +++++.||||++++|+
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence            99999999998 9999998 9999999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.5e-51  Score=352.00  Aligned_cols=258  Identities=22%  Similarity=0.378  Sum_probs=218.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   94 (289)
                      +.| ++.+.||+|+||+||+|.++.+|+.||+|+++...... ......+..|..++..+ +||||+++++++.+.  +.
T Consensus        17 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~   92 (345)
T 1xjd_A           17 EDF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--EN   92 (345)
T ss_dssp             TTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred             HHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CE
Confidence            444 78999999999999999999999999999998643211 11245677788888876 999999999988554  67


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC-CCEEEeEChhhhhcc
Confidence            9999999999999999998888999999999999999999999999  9999999999999998 899999999997643


Q ss_pred             -CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 -RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 -~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                       ........+|++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+...............   ..+...++.++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~  246 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---FYPRWLEKEAK  246 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC---CCCcccCHHHH
Confidence             23344567899999999977654 89999999999999999999999987655544444444332   23455789999


Q ss_pred             HHHHHHHc-CCCCCCCHH-HHhcCcccccCCCC
Q 022956          253 AFIEKCIA-QPRARPSAS-ELLKDPFFSELNDD  283 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~-~il~h~~~~~~~~~  283 (289)
                      +||.+||+ ||++||++. ++++||||++++|+
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence            99999998 999999998 99999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.6e-51  Score=349.48  Aligned_cols=260  Identities=22%  Similarity=0.345  Sum_probs=216.2

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ...++| ++.++||+|+||+||+|.++.+++.||+|++.....   ....+.+.+|+.+++.++||||+++++++...  
T Consensus         4 ~~~~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--   77 (323)
T 3tki_A            4 PFVEDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--   77 (323)
T ss_dssp             TTTTCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             cHhhhc-eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence            345676 789999999999999999999999999999976542   22346688899999999999999999988543  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  154 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATV  154 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred             CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC-CCEEEEEeeccce
Confidence            688999999999999999998888999999999999999999999999  9999999999999998 8999999999976


Q ss_pred             cCCc---cccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          173 VGRS---HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       173 ~~~~---~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      ....   .......+++.|+|||.+.+.  .+.++||||||+++|+|++|..||..........................
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI  234 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccC
Confidence            5322   223356789999999977654  47789999999999999999999987655434444444333333333457


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ++.+.+|+.+||+ ||++|||++|+++||||++..
T Consensus       235 ~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            8999999999998 999999999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-51  Score=348.74  Aligned_cols=259  Identities=19%  Similarity=0.267  Sum_probs=220.3

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.+.||+|+||+||+|.++.+|+.+|+|.+...     ......+.+|+++++.++||||+++++++.+.  +
T Consensus         3 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~   74 (321)
T 1tki_A            3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESM--E   74 (321)
T ss_dssp             CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--T
T ss_pred             hhhce-EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--C
Confidence            34566 6899999999999999999999999999999743     23356788999999999999999999988654  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-CCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-~~~~~l~d~g~~~  171 (289)
                      .+++||||++|++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ .+.++|+|||++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            799999999999999999865 47999999999999999999999999  9999999999999872 2899999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCCh
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  249 (289)
                      ............+++.|+|||.+.+. +++++||||||+++|+|++|..||.+.................. ......++
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T 1tki_A          153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence            87655555556789999999987765 78999999999999999999999988665555555544433221 12235688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .+.+|+.+||. ||++|||+.|+|+||||++...
T Consensus       233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            99999999998 9999999999999999987543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.5e-50  Score=345.90  Aligned_cols=258  Identities=23%  Similarity=0.328  Sum_probs=207.8

Q ss_pred             cccceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..|++.++||+|+||.||+|.+.   .+|+.||+|+++.............+.+|+.+++.++||||+++++++...  +
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~   94 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG--G   94 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--C
Confidence            33478999999999999999875   689999999998654433344456788899999999999999999988554  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKES  171 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-SCEEECCCSCC---
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC-CcEEEEeCCccccc
Confidence            79999999999999999998888999999999999999999999999  9999999999999988 89999999999764


Q ss_pred             CC-ccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          174 GR-SHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       174 ~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      .. .......++++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+...............   ..+...++.+
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~  248 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL---NLPPYLTQEA  248 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---CCCTTSCHHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHH
Confidence            32 223445678999999997654 489999999999999999999999988665555544444332   2345578999


Q ss_pred             HHHHHHHHc-CCCCCC-----CHHHHhcCcccccCCC
Q 022956          252 KAFIEKCIA-QPRARP-----SASELLKDPFFSELND  282 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~  282 (289)
                      ++|+.+||+ ||.+||     +++++++||||++++|
T Consensus       249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence            999999998 999999     8999999999998865

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-50  Score=342.36  Aligned_cols=258  Identities=21%  Similarity=0.379  Sum_probs=209.9

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC----------------------HHHHHHHHHHHHHHH
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----------------------PVLVNRLHSEVQLLR   73 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~----------------------~~~~~~~~~e~~~l~   73 (289)
                      ++| ++.+.||+|+||.||+|.+..+|+.||+|++........                      ....+.+.+|+++++
T Consensus        13 ~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           13 NQY-TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             TTE-EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             cce-EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            455 789999999999999999999999999999986543211                      122456889999999


Q ss_pred             hCCCCceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 022956           74 TLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI  153 (289)
Q Consensus        74 ~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~ni  153 (289)
                      +++||||+++++++.......+++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|  ++|+||+|+||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Ni  168 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNL  168 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHE
Confidence            9999999999999876556789999999999999886543 57999999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEeccCCccccCCcc-ccccCCCCCCCCCCcccccC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 022956          154 FINGNIGQVKIGDLGFAAIVGRSH-AAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA  228 (289)
Q Consensus       154 li~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~  228 (289)
                      +++.+ +.+||+|||++....... ......+++.|+|||.+.+.    .+.++||||||+++|+|++|..||.......
T Consensus       169 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          169 LVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99998 899999999998765432 23445789999999987654    3678999999999999999999998755444


Q ss_pred             HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ........... .......++.+.+|+.+||+ ||++|||++|+++||||++
T Consensus       248 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          248 LHSKIKSQALE-FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHCCCC-CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHhcccCC-CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            33333333222 22234578999999999998 9999999999999999964

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-50  Score=350.79  Aligned_cols=258  Identities=22%  Similarity=0.322  Sum_probs=219.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   94 (289)
                      +.| ++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..++..+ +||+|+++++.+...  +.
T Consensus        20 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   95 (353)
T 2i0e_A           20 TDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR   95 (353)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SE
T ss_pred             HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CE
Confidence            455 68999999999999999999999999999998643211 12245678899999888 799999999988544  68


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|+||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC-CcEEEEeCCcccccc
Confidence            9999999999999999998888999999999999999999999999  9999999999999998 899999999998643


Q ss_pred             -CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 -RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 -~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                       ........+|++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+................   .+...++.+.
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~  249 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---YPKSMSKEAV  249 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHH
T ss_pred             cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---CCCCCCHHHH
Confidence             33345567899999999977644 899999999999999999999999876655554454444322   3456789999


Q ss_pred             HHHHHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          253 AFIEKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      +||.+||+ ||++||+     ++++++||||++++|+
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence            99999998 9999994     6999999999998874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-50  Score=353.73  Aligned_cols=264  Identities=22%  Similarity=0.339  Sum_probs=209.4

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   93 (289)
                      .++| ++.++||+|+||+||+|.++.+|+.||+|++....  ........+.+|+.+++.+. ||||+++++++...+..
T Consensus         8 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            8 LRKY-ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HTTE-EEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cCce-EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            3455 78999999999999999999999999999986442  24566778889999999997 99999999998776666


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+|+||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.+||+|||++...
T Consensus        85 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           85 DVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSF  159 (388)
T ss_dssp             CEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEES
T ss_pred             EEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC-CCEEecCCcccccc
Confidence            89999999986 89999886 46999999999999999999999999  9999999999999998 89999999999765


Q ss_pred             CCc----------------------cccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 022956          174 GRS----------------------HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK  229 (289)
Q Consensus       174 ~~~----------------------~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~  229 (289)
                      ...                      ......++|+.|+|||.+.+  .++.++|||||||++++|++|..||.+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            321                      11233578999999997654  489999999999999999999999988766655


Q ss_pred             HHHHHhCCCCCC--------------------------------------------CCCCCCChHHHHHHHHHHc-CCCC
Q 022956          230 IYKKVTGGVKPQ--------------------------------------------ALNKVKDPEVKAFIEKCIA-QPRA  264 (289)
Q Consensus       230 ~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~li~~~l~-dp~~  264 (289)
                      ....+.....+.                                            ......++.+.+|+.+||+ ||++
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            544432111110                                            0112468899999999999 9999


Q ss_pred             CCCHHHHhcCcccccCCCCCCC
Q 022956          265 RPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       265 Rps~~~il~h~~~~~~~~~~~~  286 (289)
                      |||++|+|+||||+.+.....+
T Consensus       320 R~t~~e~l~Hp~~~~~~~~~~~  341 (388)
T 3oz6_A          320 RISANDALKHPFVSIFHNPNEE  341 (388)
T ss_dssp             SCCHHHHTTSTTTTTTCCGGGC
T ss_pred             CCCHHHHhCCHHHHHhcCCccC
Confidence            9999999999999887654443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-50  Score=338.95  Aligned_cols=262  Identities=21%  Similarity=0.357  Sum_probs=224.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||+||+|.++.++..+|+|++.......    .+.+.+|++++++++||||+++++++...  .
T Consensus         7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~   79 (277)
T 3f3z_A            7 INQYY-TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIRLYETFEDN--T   79 (277)
T ss_dssp             HHHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred             hhhhE-EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch----HHHHHHHHHHHHhCCCCCEeeEEEEEecC--C
Confidence            34454 78999999999999999999999999999998654322    56788999999999999999999988543  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE---eCCCCcEEEeccCCc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFA  170 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili---~~~~~~~~l~d~g~~  170 (289)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||++   +.+ +.++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~  156 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPD-SPLKLIDFGLA  156 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTT-CCEEECCCTTC
T ss_pred             eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCC-CcEEEEecccc
Confidence            79999999999999999998888999999999999999999999999  9999999999999   556 89999999999


Q ss_pred             cccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCCh
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDP  249 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  249 (289)
                      .............+++.|+|||.+.+.+++++||||||+++++|++|..||.................... ......++
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP  236 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred             eeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence            88766666666789999999998888899999999999999999999999988666655555554433221 11224688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      .+.+|+.+||+ ||++||++.++|+||||++.....+
T Consensus       237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~  273 (277)
T 3f3z_A          237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP  273 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCSG
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhccccccc
Confidence            99999999998 9999999999999999988655443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.2e-50  Score=348.94  Aligned_cols=256  Identities=21%  Similarity=0.353  Sum_probs=219.8

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+.+|+++++.++||||+++++.+.+.  ..+
T Consensus        41 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~  116 (350)
T 1rdq_E           41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNL  116 (350)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             HHC-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEE
Confidence            455 6899999999999999999999999999999764321 112256788899999999999999999988554  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC-CCEEEcccccceeccC
Confidence            999999999999999998888999999999999999999999999  9999999999999998 8999999999987654


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .  ....+|++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+...............   ..+...++.+.+|
T Consensus       194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~l  268 (350)
T 1rdq_E          194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---RFPSHFSSDLKDL  268 (350)
T ss_dssp             C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTCCHHHHHH
T ss_pred             C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCHHHHHH
Confidence            3  3456789999999976654 89999999999999999999999987655554444444432   2345678999999


Q ss_pred             HHHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          255 IEKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       255 i~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      |.+||+ ||.+||+     +++|++||||++++|.
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence            999998 9999998     9999999999998763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.1e-50  Score=347.72  Aligned_cols=257  Identities=23%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||+||++.++.+|+.||+|++......     .+.+.+|+.+++.++||||+++++++...  .
T Consensus        18 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~   89 (361)
T 3uc3_A           18 DSDRY-DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTP--T   89 (361)
T ss_dssp             CTTTE-EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred             CCCcE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeC--C
Confidence            45666 7899999999999999999999999999999764321     25577899999999999999999998654  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC-CcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI-GQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~-~~~~l~d~g~~~~  172 (289)
                      .+++||||+++++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+. +.+||+|||++..
T Consensus        90 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            79999999999999999988888999999999999999999999999  99999999999998661 3499999999986


Q ss_pred             cCCccccccCCCCCCCCCCcccccC-CCCc-chHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhCCCCCCCCCCCC
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEED-YTEM-VDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      ...........+++.|+|||.+.+. ++.+ +|||||||++|+|++|..||.+..   ......+.+.............
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI  247 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence            5544445556799999999976544 5444 899999999999999999998643   2333344444433322233356


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ++.+.+||.+||+ ||++|||++++++||||.+.
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            8999999999998 99999999999999999654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.2e-49  Score=353.19  Aligned_cols=274  Identities=25%  Similarity=0.382  Sum_probs=215.5

Q ss_pred             CCceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeee
Q 022956            7 EPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV   86 (289)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   86 (289)
                      .........++| ++.+.||+|+||+||+|.++.+|+.||+|++....  ......+++.+|+++++.++||||++++++
T Consensus        17 Q~~~~~~i~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~   93 (432)
T 3n9x_A           17 QGIKNVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDL   93 (432)
T ss_dssp             TCGGGCCCCTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCCcceecCCE-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            334445667777 68999999999999999999999999999997542  255667889999999999999999999998


Q ss_pred             EEeCCC---CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956           87 WLDDQH---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus        87 ~~~~~~---~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                      +.....   ..+|+|||++++ +|.+++.....+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.+|
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~-~~~k  169 (432)
T 3n9x_A           94 IIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVK  169 (432)
T ss_dssp             CCCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEE
T ss_pred             EecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCC-CCEE
Confidence            865422   568999999976 99999998888999999999999999999999999  9999999999999998 8999


Q ss_pred             EeccCCccccCCcc-----------------------ccccCCCCCCCCCCccc-c-cCCCCcchHHHHHHHHHHHHhCC
Q 022956          164 IGDLGFAAIVGRSH-----------------------AAHSIIGTPEYMAPELY-E-EDYTEMVDIYSFGLCLLEMVTME  218 (289)
Q Consensus       164 l~d~g~~~~~~~~~-----------------------~~~~~~~~~~~~aPE~~-~-~~~~~~~Di~slG~il~~l~tg~  218 (289)
                      |+|||++.......                       .....++++.|+|||.+ . ..++.++|||||||++++|++|.
T Consensus       170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~  249 (432)
T 3n9x_A          170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML  249 (432)
T ss_dssp             ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred             EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence            99999998764322                       12456789999999964 3 34999999999999999999854


Q ss_pred             CCC-----------CCCCc-----------------HHHH-----------------------HHHHhCCCCCCC-----
Q 022956          219 IPY-----------SECDS-----------------VAKI-----------------------YKKVTGGVKPQA-----  242 (289)
Q Consensus       219 ~p~-----------~~~~~-----------------~~~~-----------------------~~~~~~~~~~~~-----  242 (289)
                      .||           .+...                 ....                       ...+........     
T Consensus       250 ~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (432)
T 3n9x_A          250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ  329 (432)
T ss_dssp             TTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred             cccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH
Confidence            443           32210                 1111                       111111100000     


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                      .....++.+.+||.+||+ ||++|||++|+|+||||+++.+...++
T Consensus       330 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          330 KYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             HSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC-
T ss_pred             HCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCc
Confidence            013468899999999999 999999999999999999998776554

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.2e-50  Score=347.45  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=209.6

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ...++| ++.++||+|+||+||+|.+..+|+.||+|+++....  .......+.+|++++++++||||+++++++...  
T Consensus        31 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--  105 (329)
T 3gbz_A           31 TSIDRY-RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--  105 (329)
T ss_dssp             -CGGGE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET--
T ss_pred             cchhhE-EEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC--
Confidence            344566 689999999999999999999999999999976543  334456778899999999999999999988654  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC----CCcEEEeccC
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN----IGQVKIGDLG  168 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~----~~~~~l~d~g  168 (289)
                      ..+++||||+++ +|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+    .+.++|+|||
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            679999999986 99999999888999999999999999999999999  9999999999999533    2569999999


Q ss_pred             CccccCCc-cccccCCCCCCCCCCccccc-C-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--CCC
Q 022956          169 FAAIVGRS-HAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QAL  243 (289)
Q Consensus       169 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~  243 (289)
                      ++...... .......+++.|+|||.+.+ . ++.++|||||||++++|++|..||.+................+  ...
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            99876533 22334567999999997754 3 7999999999999999999999998876666555544321111  000


Q ss_pred             -------------------------CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          244 -------------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       244 -------------------------~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                               ....++.+.+|+.+||+ ||++|||++|+|+||||++.+|+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence                                     01157889999999999 99999999999999999999886

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-50  Score=345.88  Aligned_cols=267  Identities=22%  Similarity=0.373  Sum_probs=223.4

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhCCCCceEEeeeeE
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVW   87 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   87 (289)
                      ......++| ++.+.||+|+||.||+|.++.+|+.||+|++........  ....+.+.+|++++++++||||+++++++
T Consensus         6 ~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (321)
T 2a2a_A            6 KQQKVEDFY-DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY   84 (321)
T ss_dssp             BCSCHHHHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cchhhhccE-EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            333444555 789999999999999999999999999999987654221  11356788999999999999999999988


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC----cEE
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG----QVK  163 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~----~~~  163 (289)
                      ...  ..+++||||+++++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +    .++
T Consensus        85 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~-~~~~~~~k  159 (321)
T 2a2a_A           85 ENR--TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDK-NIPIPHIK  159 (321)
T ss_dssp             ECS--SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCT-TSSSCCEE
T ss_pred             ecC--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecC-CCCcCCEE
Confidence            544  679999999999999999998888999999999999999999999999  9999999999999887 5    799


Q ss_pred             EeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CC
Q 022956          164 IGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQ  241 (289)
Q Consensus       164 l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~  241 (289)
                      |+|||++.............+++.|+|||.+.+. ++.++||||||+++++|++|..||.+................ +.
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            9999999877665555566789999999977654 899999999999999999999999876554444443332221 11


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ......++.+.+|+.+||. ||++|||++++++||||+..++
T Consensus       240 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            1224568899999999998 9999999999999999987653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-51  Score=353.94  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=214.1

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+++++.++||||+++++++...  +.
T Consensus         8 i~~Y-~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~   83 (336)
T 3h4j_B            8 IGPY-IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TD   83 (336)
T ss_dssp             ETTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred             cCCE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CE
Confidence            4566 6899999999999999999999999999999754321 111235688999999999999999999988554  57


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +++||||+ +++|.+++...+.+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.+||+|||++....
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMT  159 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT-CCEEECCSSCTBTTT
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC-CCEEEEEeccceecc
Confidence            99999999 5699999988888999999999999999999999999  9999999999999998 899999999998877


Q ss_pred             CccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ........++++.|+|||.+.+.  .++++||||||+++|+|++|..||.+...... ...+..  .....+...++.+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i~~--~~~~~p~~~s~~~~  236 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-FKKVNS--CVYVMPDFLSPGAQ  236 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-BCCCCS--SCCCCCTTSCHHHH
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-HHHHHc--CCCCCcccCCHHHH
Confidence            66666677899999999988765  37899999999999999999999986332211 111111  11223455789999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +|+.+||+ ||.+|||++|+++||||+.-
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            99999998 99999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-50  Score=350.44  Aligned_cols=261  Identities=21%  Similarity=0.313  Sum_probs=220.2

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++ |++.+.||+|+||+||+|.++.+|+.+|+|++...    .......+.+|+++++.++||||+++++++...  ..
T Consensus        50 ~~~-y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~  122 (387)
T 1kob_A           50 YDY-YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YE  122 (387)
T ss_dssp             GGT-EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SE
T ss_pred             ccc-eEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CE
Confidence            344 47899999999999999999999999999999754    233456789999999999999999999988544  68


Q ss_pred             eEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-CCcEEEeccCCccc
Q 022956           95 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAI  172 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-~~~~~l~d~g~~~~  172 (289)
                      +++||||+.|++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ .+.+||+|||++..
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999999999999999764 47999999999999999999999999  9999999999999753 36899999999987


Q ss_pred             cCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  250 (289)
                      ...........+++.|+|||.+.+. ++.++|||||||++|+|++|..||.+................ +.......++.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  280 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  280 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence            7655445556789999999977654 889999999999999999999999886655554444443322 22233457899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +++||.+||+ ||++|||++++|+||||++.....
T Consensus       281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  315 (387)
T 1kob_A          281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL  315 (387)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhhCccccCCcccc
Confidence            9999999998 999999999999999999765443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9e-50  Score=340.48  Aligned_cols=264  Identities=25%  Similarity=0.362  Sum_probs=208.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-HHHHHHHHHHHHHHHhC---CCCceEEeeeeEEeC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLDD   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~   90 (289)
                      .++| ++.++||+|+||+||+|.+..+|+.||+|++........ ......+.+|+.+++.+   +||||+++++++...
T Consensus         8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            8 TSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             --CC-EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             ccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4555 789999999999999999999999999999986543211 11123444566655555   599999999988764


Q ss_pred             CCC---eeEEEeccccCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           91 QHN---TLNFITEVCTSGNLRTYRKKHRH--VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        91 ~~~---~~~lv~e~~~~~sL~~~~~~~~~--l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                      ...   .+++++|++.+ +|.+++.....  +++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT-SCEEEC
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEEe
Confidence            322   58999999976 99999987644  999999999999999999999999  9999999999999998 899999


Q ss_pred             ccCCccccCCccccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CCCCC
Q 022956          166 DLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQA  242 (289)
Q Consensus       166 d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~  242 (289)
                      |||++.............+++.|+|||.+. ..++.++|||||||++|+|++|..||.+..............  .....
T Consensus       163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             eCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            999998776665566678899999999765 448999999999999999999999998866655554443321  11111


Q ss_pred             ----------------------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          243 ----------------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       243 ----------------------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                            .....++.+.+|+.+||+ ||++|||++|+|+||||++...+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~  306 (308)
T 3g33_A          243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN  306 (308)
T ss_dssp             SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC------
T ss_pred             ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCC
Confidence                                  112357899999999999 99999999999999999986544

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6e-50  Score=347.37  Aligned_cols=255  Identities=22%  Similarity=0.329  Sum_probs=202.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||+||+|.++.+++.||+|+++...      ..+.+.+|++++++++||||+++++++...  ..+++|
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  126 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEISLV  126 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEEEE
Confidence            478999999999999999999999999999998532      245678899999999999999999988554  679999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC---CCCcEEEeccCCccccCC
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~---~~~~~~l~d~g~~~~~~~  175 (289)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.   + +.+||+|||++.....
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~-~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPD-APLKIADFGLSKIVEH  203 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTT-CCEEECCCC-------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCC-CCEEEccCccccccCc
Confidence            999999999999998888999999999999999999999999  999999999999975   5 8999999999987765


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--CCCCCCCChHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QALNKVKDPEVK  252 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  252 (289)
                      ........+++.|+|||.+.+. +++++|||||||++|+|++|..||............+......  .......++.+.
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  283 (349)
T 2w4o_A          204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK  283 (349)
T ss_dssp             ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence            5445556789999999977654 8999999999999999999999998766665555555443221  222345688999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +|+.+||+ ||++|||++++|+||||.+...+.
T Consensus       284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  316 (349)
T 2w4o_A          284 DLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF  316 (349)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCccch
Confidence            99999998 999999999999999999876543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=339.80  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=211.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.+..+|+.||+|++.....  .....+.+.+|++++++++||||+++++++...  +..
T Consensus         3 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~   77 (311)
T 4agu_A            3 EKY-EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED--DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRL   77 (311)
T ss_dssp             CCE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred             ccc-eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeE
Confidence            455 689999999999999999999999999999876532  455677889999999999999999999998654  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC-
T ss_pred             EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC-CCEEEeeCCCchhccC
Confidence            999999999999999988888999999999999999999999999  9999999999999988 8999999999987653


Q ss_pred             cc-ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--C-------------
Q 022956          176 SH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--G-------------  237 (289)
Q Consensus       176 ~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~-------------  237 (289)
                      .. ......+++.|+|||.+.+  .+++++||||||+++++|++|..||.+.............  .             
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            32 2344578899999997754  4799999999999999999999999886655544332211  0             


Q ss_pred             ----CCCCC---------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          238 ----VKPQA---------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       238 ----~~~~~---------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                          .....         .....++.+.+|+.+||+ ||++|||++|+++||||+++.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence                00000         012457889999999999 999999999999999999986543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.6e-50  Score=348.46  Aligned_cols=256  Identities=21%  Similarity=0.341  Sum_probs=211.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHH-HHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL-LRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      |++.+.||+|+||.||+|.++.+++.||+|++....... ......+.+|..+ ++.++||||+++++.+.+.  +.+|+
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~~~l  116 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYF  116 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECS--SEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CEEEE
Confidence            478999999999999999999999999999998765432 2234455566665 5778999999999988554  68999


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Cc
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~  176 (289)
                      ||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ |.+||+|||++.... ..
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEeeCccccccccCC
Confidence            9999999999999998888999999999999999999999999  9999999999999998 899999999997643 33


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      ......+|++.|+|||++.+. ++.++|+|||||++|+|++|..||.+..........+....   ..+...++.+++||
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li  270 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---QLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC---CCCSSSCHHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---CCCCCCCHHHHHHH
Confidence            345567899999999977654 89999999999999999999999987655555555544422   23455789999999


Q ss_pred             HHHHc-CCCCCCCH----HHHhcCcccccCCCC
Q 022956          256 EKCIA-QPRARPSA----SELLKDPFFSELNDD  283 (289)
Q Consensus       256 ~~~l~-dp~~Rps~----~~il~h~~~~~~~~~  283 (289)
                      .+||+ ||.+||++    +++++||||++++|+
T Consensus       271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             HHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            99998 99999986    699999999998874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8e-50  Score=361.19  Aligned_cols=264  Identities=24%  Similarity=0.389  Sum_probs=222.4

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||+||+|.++.+|+.||+|++........  ....+.+|++++++++||||+++++++...  .
T Consensus        20 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~   94 (486)
T 3mwu_A           20 FAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK--DTSTILREVELLKKLDHPNIMKLFEILEDS--S   94 (486)
T ss_dssp             HHHHE-EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred             hhcce-EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch--HHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--C
Confidence            44555 789999999999999999999999999999976443211  246788999999999999999999988543  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~~~  171 (289)
                      .+++|+||+.+++|.+.+.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+  .+.+||+|||++.
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            89999999999999999988888999999999999999999999999  9999999999999542  2579999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCChH
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPE  250 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  250 (289)
                      ............+++.|+|||.+.+.+++++|||||||++|+|++|..||.+................. .......++.
T Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            776665566678999999999998889999999999999999999999998866655555544443322 1223456899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +++||.+||+ ||++|||+.++|+||||++.....
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            9999999999 999999999999999999876543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.8e-49  Score=340.05  Aligned_cols=261  Identities=28%  Similarity=0.456  Sum_probs=201.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.++||+|+||+||+|.++.+|+.||+|+++.....   ...+.+.+|++++++++||||+++++++..  .+.
T Consensus         4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   77 (317)
T 2pmi_A            4 SSQF-KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPSTAIREISLMKELKHENIVRLYDVIHT--ENK   77 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTE
T ss_pred             ccce-eEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCe
Confidence            3455 6899999999999999999999999999999865422   223567789999999999999999998854  368


Q ss_pred             eEEEeccccCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           95 LNFITEVCTSGNLRTYRKKH------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      +++||||+++ +|.+++...      ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||
T Consensus        78 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg  153 (317)
T 2pmi_A           78 LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKR-GQLKLGDFG  153 (317)
T ss_dssp             EEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCS
T ss_pred             EEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCC-CCEEECcCc
Confidence            9999999986 999998753      35899999999999999999999999  9999999999999998 899999999


Q ss_pred             CccccCCc-cccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--CCCC---
Q 022956          169 FAAIVGRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKP---  240 (289)
Q Consensus       169 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~---  240 (289)
                      ++...... .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||.+.............  ....   
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW  233 (317)
T ss_dssp             SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred             cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence            99876533 23345578999999997754  3899999999999999999999999886655544433221  1000   


Q ss_pred             --------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          241 --------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       241 --------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                                .......++.+.+|+.+||+ ||++|||++|+|+||||++..+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence                                      00122467899999999999 9999999999999999999866543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.5e-50  Score=359.15  Aligned_cols=256  Identities=23%  Similarity=0.414  Sum_probs=209.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||.||+|.++.+|+.||+|++...... .......+.+|+.+++.++||||+++++++...  +.+++|
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv  226 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFV  226 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEET--TEEEEE
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEEEEE
Confidence            47899999999999999999999999999999864321 233456678899999999999999999988654  579999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-Cc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-RS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-~~  176 (289)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+ +|  ++|+||||+||+++.+ +.+||+|||++.... ..
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC-CCEEEccCCCceeccCCC
Confidence            9999999999999988899999999999999999999998 89  9999999999999998 899999999997643 23


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      ......+|++.|+|||.+.+. ++.++|||||||++|+|++|..||.+................   .+...++.+.+||
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~li  380 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR---FPRTLGPEAKSLL  380 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTSCHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---CCccCCHHHHHHH
Confidence            334556899999999977644 999999999999999999999999886655554444444322   3455789999999


Q ss_pred             HHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          256 EKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       256 ~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      .+||+ ||.+||     +++|+++||||++++|.
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence            99998 999999     99999999999998764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-49  Score=339.46  Aligned_cols=269  Identities=22%  Similarity=0.317  Sum_probs=206.3

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD   90 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   90 (289)
                      ....++|....++||+|+||+||+|.++.+++.||+|++.....    .....+.+|++++.++ +||||+++++++...
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            34566774325889999999999999999999999999976532    2256788899999885 799999999998654


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc---EEEecc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ---VKIGDL  167 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~---~~l~d~  167 (289)
                        +.+++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.   +||+||
T Consensus        84 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~~~kl~Df  158 (316)
T 2ac3_A           84 --DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHP-NQVSPVKICDF  158 (316)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCS-SSSCSEEECCT
T ss_pred             --CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccC-CCcCceEEEEc
Confidence              689999999999999999998888999999999999999999999999  9999999999999876 44   999999


Q ss_pred             CCccccCCcc--------ccccCCCCCCCCCCccccc------CCCCcchHHHHHHHHHHHHhCCCCCCCCCc-------
Q 022956          168 GFAAIVGRSH--------AAHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECDS-------  226 (289)
Q Consensus       168 g~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~~~-------  226 (289)
                      |++.......        ......+++.|+|||.+.+      .++.++|||||||++|+|++|..||.+...       
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            9987653211        1223458999999997653      378999999999999999999999976432       


Q ss_pred             -------HHHHHHHHhCCCCCC--CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCCCC
Q 022956          227 -------VAKIYKKVTGGVKPQ--ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEPSP  289 (289)
Q Consensus       227 -------~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~~~  289 (289)
                             .......+.......  ......++.+++|+.+||+ ||++|||++|+++||||++.......+.|
T Consensus       239 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~  311 (316)
T 2ac3_A          239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTP  311 (316)
T ss_dssp             --CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----------
T ss_pred             cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCc
Confidence                   122333333322111  1113468899999999998 99999999999999999998877766654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-48  Score=331.51  Aligned_cols=264  Identities=25%  Similarity=0.426  Sum_probs=224.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++ |++.+.||+|+||.||++.++.+++.+|+|++..... ......+.+.+|+.+++.++||||+++++++...  +
T Consensus        13 ~~~~-y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~   88 (294)
T 2rku_A           13 SRRR-YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--D   88 (294)
T ss_dssp             TTEE-EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred             cccc-eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--C
Confidence            4444 4789999999999999999999999999999976543 2455677899999999999999999999988543  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ..++|+||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~  165 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKV  165 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC-CCEEEEeccCceec
Confidence            79999999999999999998888999999999999999999999999  9999999999999988 89999999999876


Q ss_pred             CCc-cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          174 GRS-HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       174 ~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ... .......+++.|+|||.+.+. ++.++|+||||+++++|++|..||.................   ..+...++.+
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  242 (294)
T 2rku_A          166 EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINPVA  242 (294)
T ss_dssp             CSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHH
T ss_pred             ccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---CCccccCHHH
Confidence            432 233445689999999977654 88899999999999999999999987655444443333222   2345578999


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                      .+++.+||+ ||++|||++++++||||++...+...+
T Consensus       243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~  279 (294)
T 2rku_A          243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP  279 (294)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCC
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCC
Confidence            999999998 999999999999999999876655443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.9e-50  Score=360.62  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=207.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC----
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ----   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   91 (289)
                      ++| ++.++||+|+||+||+|.+..+|+.||+|++.....  .....+++.+|+++++.++||||+++++++....    
T Consensus        62 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           62 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             TTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc--ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            455 689999999999999999999999999999986532  4566778999999999999999999999885432    


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ...+++||||+++ +|.+.+..  .+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.+||+|||++.
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~-~~~kl~DFG~a~  212 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR  212 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCCC-
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCC-CCEEEEEEEeee
Confidence            2468999999987 56666643  4999999999999999999999999  9999999999999998 899999999998


Q ss_pred             ccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--C-------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--Q-------  241 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~-------  241 (289)
                      ............+++.|+|||++.+ .++.++|||||||++++|++|+.||.+.+..+.....+.....+  .       
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            7766555566789999999997665 48999999999999999999999999876655554443321110  0       


Q ss_pred             -----------C--------CCCC-----------CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          242 -----------A--------LNKV-----------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       242 -----------~--------~~~~-----------~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                 .        .+..           .++.+.+||.+||+ ||++|||++|+|+||||+.+..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                       0        0000           04568999999999 9999999999999999997643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-49  Score=344.81  Aligned_cols=264  Identities=25%  Similarity=0.399  Sum_probs=211.0

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      +..++| ++.+.||+|+||.||+|.++.+|+.||+|++....  ......+++.+|+++++.++||||+++++++.....
T Consensus        22 ~~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           22 EVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             CCBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eecceE-EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            345566 78999999999999999999999999999996543  255667889999999999999999999998855421


Q ss_pred             ----CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           93 ----NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        93 ----~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                          ..+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.+||+|||
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg  173 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFG  173 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCC-CCEEEEeee
Confidence                3569999999 6799999987 56999999999999999999999999  9999999999999998 899999999


Q ss_pred             CccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-------
Q 022956          169 FAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-------  239 (289)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------  239 (289)
                      ++......  .....+++.|+|||.+.+  .++.++|||||||++++|++|+.||.+................       
T Consensus       174 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          174 LARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             TCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99876533  334578999999997654  4899999999999999999999999886665554433321100       


Q ss_pred             ---------------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          240 ---------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       240 ---------------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                                           ........++.+.+|+.+||. ||++|||++++|+||||+++.....+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~  320 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE  320 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccC
Confidence                                 011223468899999999999 99999999999999999998665443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-49  Score=360.31  Aligned_cols=256  Identities=26%  Similarity=0.374  Sum_probs=216.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||+||+|.++.++..||+|++.......  .....+.+|+.+++.++||||+++++++...  ..+++|
T Consensus        39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv  114 (494)
T 3lij_A           39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYYLV  114 (494)
T ss_dssp             EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence            478999999999999999999999999999998654321  1246788899999999999999999988544  679999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++++|.+.+.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+  .+.+||+|||++......
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999999988888999999999999999999999999  9999999999999764  246999999999887766


Q ss_pred             cccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCChHHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPEVKAFI  255 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li  255 (289)
                      .......+++.|+|||.+.+.+++++|||||||++|+|++|..||.+................. .......++.+++|+
T Consensus       193 ~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  272 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI  272 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHH
T ss_pred             ccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHH
Confidence            6666678999999999888889999999999999999999999998866655555444443322 222345789999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          256 EKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+||+ ||.+|||++++|+||||++.
T Consensus       273 ~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          273 KQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHCCCChhhCccHHHHhcCcccccC
Confidence            99999 99999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-50  Score=355.16  Aligned_cols=262  Identities=20%  Similarity=0.321  Sum_probs=216.4

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      -|++.++||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|..++..++||+|+++++.+.+.  +.+|+
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~l  138 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--NYLYL  138 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEE
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEE
Confidence            347899999999999999999999999999999753211 111234478899999999999999999988554  68999


Q ss_pred             EeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           98 ITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      ||||++|++|.+++.+. ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++......
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~-g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC-CCEEEeechhheeccCC
Confidence            99999999999999874 47999999999999999999999999  9999999999999998 89999999999876543


Q ss_pred             cc--cccCCCCCCCCCCcccc--------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CCCCCCC
Q 022956          177 HA--AHSIIGTPEYMAPELYE--------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQALN  244 (289)
Q Consensus       177 ~~--~~~~~~~~~~~aPE~~~--------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~  244 (289)
                      ..  ....+||+.|+|||++.        +.++.++|+|||||++|+|++|..||.+.........++...  .......
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            32  33467999999999765        348999999999999999999999998766555444443321  1222223


Q ss_pred             CCCChHHHHHHHHHHcCCCCC---CCHHHHhcCcccccCCCCCC
Q 022956          245 KVKDPEVKAFIEKCIAQPRAR---PSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~dp~~R---ps~~~il~h~~~~~~~~~~~  285 (289)
                      ...++.+++||.+||.+|.+|   |+++++++||||++++|+.-
T Consensus       296 ~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             -CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             cCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            567999999999999988887   69999999999999998753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.9e-50  Score=358.01  Aligned_cols=255  Identities=23%  Similarity=0.411  Sum_probs=219.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||+|.++.+|+.||+|++...... .......+.+|+++++.++||||+++++++...  +.+
T Consensus        16 ~~Y-~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~   91 (476)
T 2y94_A           16 GHY-ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDI   91 (476)
T ss_dssp             TTE-EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             cCE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence            455 6899999999999999999999999999999764321 112356788999999999999999999988554  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++.....
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECCT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC-CCeEEEeccchhhccc
Confidence            999999999999999998888999999999999999999999999  9999999999999998 8999999999988766


Q ss_pred             ccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .......++++.|+|||.+.+.  .++++|||||||++|+|++|..||.+........... .+..  ..+...++.+.+
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~~--~~p~~~s~~~~~  245 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC-DGIF--YTPQYLNPSVIS  245 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH-TTCC--CCCTTCCHHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-cCCc--CCCccCCHHHHH
Confidence            5555667899999999987765  4679999999999999999999998765554444443 3322  234557899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      |+.+||+ ||++|||++++++||||++.
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            9999998 99999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.7e-50  Score=352.09  Aligned_cols=259  Identities=19%  Similarity=0.291  Sum_probs=214.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||+||+|.++.+++.||+|++....... ......+.+|..+++.++||||+++++++.+.  ..+++|
T Consensus        71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lV  147 (410)
T 3v8s_A           71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMV  147 (410)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred             cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEE
Confidence            478999999999999999999999999999997532110 00123477899999999999999999988554  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      |||++|++|.+++.. ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....... 
T Consensus       148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSE
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC-CCEEEeccceeEeeccCCc
Confidence            999999999999976 45999999999999999999999999  9999999999999998 899999999998765443 


Q ss_pred             -ccccCCCCCCCCCCcccccC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC-CCCCCCCCCChH
Q 022956          178 -AAHSIIGTPEYMAPELYEED-----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-KPQALNKVKDPE  250 (289)
Q Consensus       178 -~~~~~~~~~~~~aPE~~~~~-----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  250 (289)
                       .....+|++.|+|||++.+.     ++.++|+|||||++|+|++|..||.+.........++.... .........++.
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence             23456899999999976532     67899999999999999999999987655544444433211 111122357899


Q ss_pred             HHHHHHHHHc-CCCC--CCCHHHHhcCcccccCCCCC
Q 022956          251 VKAFIEKCIA-QPRA--RPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       251 ~~~li~~~l~-dp~~--Rps~~~il~h~~~~~~~~~~  284 (289)
                      +++||.+||+ +|.+  ||+++||++||||++++|+.
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence            9999999998 8888  99999999999999998863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.4e-49  Score=353.65  Aligned_cols=260  Identities=20%  Similarity=0.332  Sum_probs=216.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||+||+|.++.+++.||+|++....... ......+.+|..++..++||||+++++.+.+.  +.+++|
T Consensus        76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~lV  152 (437)
T 4aw2_A           76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD--NNLYLV  152 (437)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CEEEEE
Confidence            478999999999999999999999999999997532210 11123378899999999999999999988554  679999


Q ss_pred             eccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      |||++|++|.+++.+ ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++.......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTTS
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC-CCEEEcchhhhhhcccCC
Confidence            999999999999987 578999999999999999999999999  9999999999999998 899999999997664432


Q ss_pred             c--cccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CCCCCCCCCC
Q 022956          178 A--AHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQALNKVK  247 (289)
Q Consensus       178 ~--~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~  247 (289)
                      .  ....+||+.|+|||++.      +.++.++|+|||||++|+|++|..||.+.........++...  ..........
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence            2  33467999999999764      348999999999999999999999998866555544443321  1212222347


Q ss_pred             ChHHHHHHHHHHc-CCCC--CCCHHHHhcCcccccCCCCC
Q 022956          248 DPEVKAFIEKCIA-QPRA--RPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~--Rps~~~il~h~~~~~~~~~~  284 (289)
                      ++.+++||.+||. +|++  ||+++|+++||||++++|+.
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence            8999999999997 7777  99999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.4e-50  Score=347.97  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=211.4

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      |++.+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+.+++.++||||+++++++...  +.+++
T Consensus        26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l  103 (351)
T 3c0i_A           26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GMLYM  103 (351)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred             eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEE
Confidence            4789999999999999999999999999999976432111 11256788999999999999999999988654  67999


Q ss_pred             EeccccCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCCcc
Q 022956           98 ITEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGFAA  171 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~~~  171 (289)
                      ||||++|++|.+.+...    ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+  .+.+||+|||++.
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            99999999998887642    35899999999999999999999999  9999999999999865  1349999999998


Q ss_pred             ccCCccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCC
Q 022956          172 IVGRSHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKD  248 (289)
Q Consensus       172 ~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  248 (289)
                      ....... .....+++.|+|||.+.+. ++.++|||||||++|+|++|..||.+. ............... .......+
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s  260 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHIS  260 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCC
Confidence            7654432 3456799999999977654 899999999999999999999999863 233333333332221 11124568


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +.+++|+.+||+ ||++|||+.++|+||||++.+
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            999999999998 999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7e-49  Score=337.00  Aligned_cols=254  Identities=27%  Similarity=0.445  Sum_probs=215.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +...++||+|+||.||+|.++.+|+.||||++.....    ...+.+.+|+.+++.++||||+++++.+...  +..++|
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  120 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVL  120 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEE
Confidence            3557899999999999999999999999999975432    2246688899999999999999999988665  579999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      |||+++++|.+++.. ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcc
Confidence            999999999999876 46999999999999999999999999  9999999999999988 899999999997765432 


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      ......+++.|+|||.+.+. ++.++||||||+++++|++|..||..........................++.+.+++.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence            33456789999999977654 89999999999999999999999987665555444444433333334456889999999


Q ss_pred             HHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          257 KCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +||+ ||++|||++++++||||.+...
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~~~~  303 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQTGL  303 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred             HHccCChhhCcCHHHHhcChhhccCCC
Confidence            9998 9999999999999999987643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-49  Score=359.46  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=221.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC---------HHHHHHHHHHHHHHHhCCCCceEEee
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED---------PVLVNRLHSEVQLLRTLKNKYIIVCY   84 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~   84 (289)
                      ..++| ++.++||+|+||+||+|.++.++..||+|++........         +...+.+.+|+.++++++||||++++
T Consensus        34 i~~~Y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           34 IGESY-FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             GGGTE-EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cccce-EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            34555 789999999999999999999999999999986543211         12356789999999999999999999


Q ss_pred             eeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC--CcE
Q 022956           85 SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQV  162 (289)
Q Consensus        85 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~--~~~  162 (289)
                      +++.+.  ..+++||||++|++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+.  ..+
T Consensus       113 ~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          113 DVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccE
Confidence            998543  689999999999999999988888999999999999999999999999  99999999999998762  269


Q ss_pred             EEeccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-
Q 022956          163 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-  241 (289)
Q Consensus       163 ~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-  241 (289)
                      ||+|||++.............+++.|+|||.+.+.+++++|||||||++|+|++|..||.+.................. 
T Consensus       189 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             EECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             EEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            9999999988776666667789999999998888899999999999999999999999998665555444444332211 


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ......++.+++|+.+||+ ||.+|||++|+|+||||++....
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            1124568999999999999 99999999999999999987544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-49  Score=336.57  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=206.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.+ .+|+.||+|++.....  .....+.+.+|+++++.++||||+++++++...  +.+
T Consensus         2 ~~y-~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   75 (288)
T 1ob3_A            2 EKY-HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL   75 (288)
T ss_dssp             CSE-EEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred             ccc-hhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeE
Confidence            355 6899999999999999998 6899999999976543  222246678899999999999999999988554  579


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++ +|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++....
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFG  151 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHC
T ss_pred             EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEeECccccccC
Confidence            999999987 999988764 67999999999999999999999999  9999999999999998 899999999997664


Q ss_pred             Ccc-ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--CCCC---------
Q 022956          175 RSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKP---------  240 (289)
Q Consensus       175 ~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~---------  240 (289)
                      ... ......+++.|+|||.+.+  .++.++||||||+++++|++|..||.+.............  ....         
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence            322 2334568999999997754  3899999999999999999999999886655554443321  1100         


Q ss_pred             ---------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          241 ---------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       241 ---------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                                     .......++.+.+|+.+||+ ||++|||++|+++||||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                           01123468899999999999 99999999999999999874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-49  Score=340.05  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=214.5

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC--CceEEeeeeEEe
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN--KYIIVCYSVWLD   89 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~   89 (289)
                      +...++.|++.+.||+|+||+||++.+. ++..||+|++.....  .....+.+.+|+.+++.++|  +||+++++++..
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            3445666689999999999999999884 689999999986543  55667889999999999987  999999998855


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      .  ..+++|||+ .+++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.  +.+||+|||+
T Consensus        81 ~--~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~~--~~~kl~DFG~  153 (343)
T 3dbq_A           81 D--QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGI  153 (343)
T ss_dssp             S--SEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSS
T ss_pred             C--CEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEEC--CcEEEeeccc
Confidence            4  689999995 56799999999889999999999999999999999999  999999999999974  6899999999


Q ss_pred             ccccCCccc---cccCCCCCCCCCCcccc------------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 022956          170 AAIVGRSHA---AHSIIGTPEYMAPELYE------------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV  234 (289)
Q Consensus       170 ~~~~~~~~~---~~~~~~~~~~~aPE~~~------------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~  234 (289)
                      +........   .....+++.|+|||.+.            ..++.++||||||+++|+|++|..||............+
T Consensus       154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  233 (343)
T 3dbq_A          154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  233 (343)
T ss_dssp             SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence            987643322   23457899999999764            347889999999999999999999998765554444444


Q ss_pred             hCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          235 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .........+...++.+.+|+.+||+ ||++|||+.++|+||||+....
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            44444445566678899999999999 9999999999999999986543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=336.48  Aligned_cols=249  Identities=23%  Similarity=0.367  Sum_probs=202.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH-HhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL-RTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      |++.++||+|+||+||+|.++.+|+.||+|++.....  ..........|+..+ +..+||||+++++++...  +.+++
T Consensus        59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l  134 (311)
T 3p1a_A           59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL  134 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred             eeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence            4788999999999999999999999999999865432  333334444455444 444999999999988554  68999


Q ss_pred             EeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           98 ITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      ||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.+||+|||++......
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG-GCEEECCCTTCEECC--
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEccceeeeecccC
Confidence            99999 5588888765 456999999999999999999999999  9999999999999988 89999999999877666


Q ss_pred             cccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE  256 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  256 (289)
                      .......+++.|+|||.+.+.++.++||||||+++++|++|..|+...    .....+.....+.......++.+.+++.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred             CCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCcccccCCCHHHHHHHH
Confidence            555666799999999988888999999999999999999997666542    2233444444444445567899999999


Q ss_pred             HHHc-CCCCCCCHHHHhcCccccc
Q 022956          257 KCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       257 ~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +||+ ||++|||++++|+||||++
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHcCCChhhCcCHHHHHhCccccC
Confidence            9999 9999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-48  Score=336.03  Aligned_cols=262  Identities=25%  Similarity=0.415  Sum_probs=223.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      .+.|++.+.||+|+||.||++.+..+++.+|+|++..... ......+.+.+|+.+++.++||||+++++++...  +.+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  116 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFV  116 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeE
Confidence            3344789999999999999999999999999999986543 2455677899999999999999999999988544  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||+.+++|.+++.....+++.++..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC-CCEEEeeccCceeccc
Confidence            999999999999999998888999999999999999999999999  9999999999999998 8999999999987643


Q ss_pred             c-cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 S-HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      . .......+++.|+|||.+.+. ++.++||||||+++|+|++|..||.................   ..+...++.+.+
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  270 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---SIPKHINPVAAS  270 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---CCCTTSCHHHHH
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC---CCCccCCHHHHH
Confidence            2 233445789999999977654 88899999999999999999999987655544444433322   234457899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                      |+.+||+ ||++||+++++++||||.+.......
T Consensus       271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~  304 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  304 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccCCCccccC
Confidence            9999998 99999999999999999987655443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.2e-50  Score=361.00  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=223.9

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.++++++||||+++++++...  +.+
T Consensus        26 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~  101 (484)
T 3nyv_A           26 DRY-KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYF  101 (484)
T ss_dssp             HHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             Cce-EEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence            444 78999999999999999999999999999997654321 22357788999999999999999999988543  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe---CCCCcEEEeccCCccc
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN---GNIGQVKIGDLGFAAI  172 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~---~~~~~~~l~d~g~~~~  172 (289)
                      ++|+||+.+++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++   .+ +.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~-~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKD-ANIRIIDFGLSTH  178 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTT-CCEEECCTTHHHH
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCC-CcEEEEeeeeeEE
Confidence            999999999999999998889999999999999999999999999  99999999999994   44 7999999999987


Q ss_pred             cCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCChHH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEV  251 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  251 (289)
                      ...........+++.|+|||.+.+.+++++|||||||++|+|++|..||.+.................. ......++.+
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            766655556679999999999888899999999999999999999999998666555555544433221 2234568999


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ++||.+||+ ||++|||++++|+||||+....
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            999999999 9999999999999999998754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-49  Score=355.14  Aligned_cols=265  Identities=23%  Similarity=0.381  Sum_probs=200.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..++| ++.++||+|+||+||+|.++.+|+.||+|++....  ......+++.+|+++++.++||||+++++++....  
T Consensus        51 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           51 IPDRY-EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             SCTTE-EECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             cCCCe-EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence            34566 78999999999999999999999999999996542  25566788999999999999999999999885432  


Q ss_pred             -CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 -~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       ...+|+|||++.+ +|.+++.....+++..+..++.|++.||.|||+.|  ++|+||||+|||++.+ +.+||+|||++
T Consensus       128 ~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~-~~~kl~DFGla  203 (458)
T 3rp9_A          128 KFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLA  203 (458)
T ss_dssp             TCCCEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred             cCceEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCC-CCEeecccccc
Confidence             2578999999854 99999998888999999999999999999999999  9999999999999999 89999999999


Q ss_pred             cccCCcc----------------------------ccccCCCCCCCCCCccc-c-cCCCCcchHHHHHHHHHHHHh----
Q 022956          171 AIVGRSH----------------------------AAHSIIGTPEYMAPELY-E-EDYTEMVDIYSFGLCLLEMVT----  216 (289)
Q Consensus       171 ~~~~~~~----------------------------~~~~~~~~~~~~aPE~~-~-~~~~~~~Di~slG~il~~l~t----  216 (289)
                      .......                            .....++|+.|+|||++ . ..++.++|||||||++|+|++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            8764221                            12334679999999964 3 349999999999999999998    


Q ss_pred             -------CCCCCCCCCc--------------------HHHHHHH--HhCCC--------------------C------CC
Q 022956          217 -------MEIPYSECDS--------------------VAKIYKK--VTGGV--------------------K------PQ  241 (289)
Q Consensus       217 -------g~~p~~~~~~--------------------~~~~~~~--~~~~~--------------------~------~~  241 (289)
                             |..+|.+...                    ......+  +.+..                    .      ..
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   6666654321                    0111000  00000                    0      01


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      ......++.+.+||.+||+ ||++|||++|+|+||||+++.+...
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~  408 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV  408 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence            1123358899999999999 9999999999999999999976543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-49  Score=342.33  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=216.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   92 (289)
                      ..++|....+.||+|+||+||+|.++.+|+.||+|++.....  .......+.+|+.+++.+. ||||+++++++...  
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--  101 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--  101 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--
Confidence            445664333899999999999999999999999999986543  2233567888999999995 59999999988543  


Q ss_pred             CeeEEEeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC---CCCcEEEecc
Q 022956           93 NTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING---NIGQVKIGDL  167 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~---~~~~~~l~d~  167 (289)
                      ..+++||||+.+++|.+++..  ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.   + +.++|+||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~-~~~kL~Df  178 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPL-GDIKIVDF  178 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTB-CCEEECCG
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCC-CcEEEeeC
Confidence            679999999999999999864  367999999999999999999999999  999999999999987   4 79999999


Q ss_pred             CCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC-CCCCCCC
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-KPQALNK  245 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  245 (289)
                      |++.............+++.|+|||.+.+. +++++||||||+++++|++|..||................. .+.....
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  258 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS  258 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred             ccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence            999887665555567799999999977644 89999999999999999999999988666655554444332 2233344


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      ..++.+.+|+.+||+ ||++|||++++|+||||+++++..
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence            578999999999999 999999999999999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.8e-49  Score=342.11  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=211.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   93 (289)
                      .++| ++.+.||+|+||.||+|.++.+|+.||+|++.....        ...+|++++.++ +||||+++++++.+.  .
T Consensus        21 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~   89 (342)
T 2qr7_A           21 TDGY-EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDG--K   89 (342)
T ss_dssp             HHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECS--S
T ss_pred             cccE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcC--C
Confidence            3445 689999999999999999999999999999976432        123477777777 799999999988543  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC---cEEEeccCCc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG---QVKIGDLGFA  170 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~---~~~l~d~g~~  170 (289)
                      .+++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||++..+.+   .+||+|||++
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            89999999999999999998888999999999999999999999999  999999999999854423   5999999999


Q ss_pred             cccCCc-cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHhCCCCC--CCCC
Q 022956          171 AIVGRS-HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC--DSVAKIYKKVTGGVKP--QALN  244 (289)
Q Consensus       171 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~--~~~~~~~~~~~~~~~~--~~~~  244 (289)
                      ...... ......++++.|+|||.+.+. ++.++|+|||||++|+|++|..||.+.  .........+..+...  ...+
T Consensus       168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred             ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence            876433 234456789999999987655 888999999999999999999999753  3444444444443222  2233


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ...++.+++|+.+||. ||++||++.++++||||.+++.
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence            5678999999999998 9999999999999999987654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.8e-48  Score=329.51  Aligned_cols=266  Identities=23%  Similarity=0.366  Sum_probs=222.1

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCC-----CHHHHHHHHHHHHHHHhCC-CCceEEeeee
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-----DPVLVNRLHSEVQLLRTLK-NKYIIVCYSV   86 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~   86 (289)
                      ...++| ++.+.||+|+||.||+|.++.+|+.||+|++.......     .....+.+.+|+++++++. ||||++++++
T Consensus        14 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           14 GFYENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             -CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             chhhcc-ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            455666 68999999999999999999999999999998654211     1234567889999999995 9999999998


Q ss_pred             EEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           87 WLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        87 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      +..  ....++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|
T Consensus        93 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~d  167 (298)
T 1phk_A           93 YET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTD  167 (298)
T ss_dssp             EEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECC
T ss_pred             ecc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC-CcEEEec
Confidence            844  3689999999999999999998888999999999999999999999999  9999999999999998 8999999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCcccc-------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK  239 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  239 (289)
                      ||++.............+++.|+|||.+.       ..++.++||||||+++++|++|..||..................
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence            99998776555555667899999999763       33788999999999999999999999876655544444444332


Q ss_pred             CC-CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          240 PQ-ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       240 ~~-~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      .. ......++.+.+++.+||+ ||++|||++++++||||++..+..
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence            21 1123468899999999998 999999999999999999887654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5e-49  Score=344.34  Aligned_cols=255  Identities=23%  Similarity=0.322  Sum_probs=212.1

Q ss_pred             cccce--eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           17 RFGRY--SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        17 ~~~~~--~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++++  .+.||+|+||.||+|.++.+|..||+|+++..    .....+.+.+|++++++++||||+++++++...  +.
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~  160 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK--ND  160 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CE
Confidence            34455  46899999999999999999999999999864    334567899999999999999999999988554  67


Q ss_pred             eEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe--CCCCcEEEeccCCcc
Q 022956           95 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAA  171 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~--~~~~~~~l~d~g~~~  171 (289)
                      +++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++  .+ +.+||+|||++.
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~kl~DFG~a~  237 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDA-KQIKIIDFGLAR  237 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTT-TEEEECCCSSCE
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCC-CcEEEEeCCCce
Confidence            99999999999999988653 56999999999999999999999999  99999999999994  44 789999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCCh
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  249 (289)
                      ............+++.|+|||.+.+. ++.++|||||||++|+|++|..||.+................. .......++
T Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  317 (373)
T 2x4f_A          238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE  317 (373)
T ss_dssp             ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred             ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence            87665555566799999999977654 8889999999999999999999998876666555555543322 222345689


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+++||.+||+ ||.+||+++++|+||||++.
T Consensus       318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          318 EAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            99999999999 99999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.3e-49  Score=343.41  Aligned_cols=258  Identities=28%  Similarity=0.485  Sum_probs=216.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.+..+|..||+|++....   .....+.+.+|+++++.++||||+++++++...  +.+
T Consensus        33 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  106 (360)
T 3eqc_A           33 DDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI  106 (360)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEE
T ss_pred             ccc-eeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEE
Confidence            444 78999999999999999999999999999998642   456678899999999999999999999988654  579


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+. |  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHH
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC-CCEEEEECCCCcccc
Confidence            99999999999999999888899999999999999999999996 9  9999999999999998 899999999997553


Q ss_pred             CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH------------------------
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK------------------------  229 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~------------------------  229 (289)
                      .. ......+++.|+|||.+.+. ++.++||||||+++++|++|..||........                        
T Consensus       184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          184 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             HH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             cc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence            32 23345789999999977654 89999999999999999999999986443221                        


Q ss_pred             -----------------HHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          230 -----------------IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       230 -----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                       ....+.....+.......++.+.+|+.+||+ ||++|||++++|+||||++..+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence                             1122222233333344568899999999999 99999999999999999987654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.2e-49  Score=344.43  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=211.0

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC----
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   90 (289)
                      .++| ++.++||+|+||+||+|.+..+|+.||+|++......        ..+|+++++.++||||+++++++...    
T Consensus         6 ~~~y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            6 SKKY-SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             CTTE-EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cceE-EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            3455 7899999999999999999999999999999754321        23599999999999999999988542    


Q ss_pred             --------------------------------CCCeeEEEeccccCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 022956           91 --------------------------------QHNTLNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLE  134 (289)
Q Consensus        91 --------------------------------~~~~~~lv~e~~~~~sL~~~~~----~~~~l~~~~~~~~~~ql~~~l~  134 (289)
                                                      .+.++++||||+++ +|.+.+.    .+..+++..+..++.|++.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                            23468999999986 7766654    4578999999999999999999


Q ss_pred             HHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHH
Q 022956          135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLL  212 (289)
Q Consensus       135 ~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~  212 (289)
                      |||+.|  ++|+||||+||+++.+.+.+||+|||++.............+++.|+|||.+.+  .++.++|||||||+++
T Consensus       156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            999999  999999999999985448999999999987766656666778999999997654  3899999999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHhCCCCC--------------------------CCCCCCCChHHHHHHHHHHc-CCCCC
Q 022956          213 EMVTMEIPYSECDSVAKIYKKVTGGVKP--------------------------QALNKVKDPEVKAFIEKCIA-QPRAR  265 (289)
Q Consensus       213 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~-dp~~R  265 (289)
                      +|++|..||.+....+.....+.....+                          ...+...++.+.+|+.+||+ ||++|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            9999999999877666655544311110                          01233468889999999999 99999


Q ss_pred             CCHHHHhcCcccccCCC
Q 022956          266 PSASELLKDPFFSELND  282 (289)
Q Consensus       266 ps~~~il~h~~~~~~~~  282 (289)
                      ||+.|+|+||||+++..
T Consensus       314 ~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          314 INPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CCHHHHHTSGGGHHHHH
T ss_pred             CCHHHHhcCHHHHHHHh
Confidence            99999999999998643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-48  Score=335.62  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=194.7

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEEEecc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      ++||+|+||+||+|.++.+|+.||+|++....       ...+.+|+.+++.+. ||||+++++++.+.  ...++||||
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e~   87 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-------EANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMEL   87 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-------HHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECC
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhh-------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEEc
Confidence            78999999999999999999999999997431       356778999999997 99999999998544  679999999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC---cEEEeccCCccccCCcc-
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG---QVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~---~~~l~d~g~~~~~~~~~-  177 (289)
                      +++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +   .++|+|||++....... 
T Consensus        88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDE-NDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC-----CEEEECCCTTCEECCC---
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecC-CCcccEEEeccccceecCCCCC
Confidence            999999999999889999999999999999999999999  9999999999999865 4   89999999998654332 


Q ss_pred             ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHhCCCCCCC--CCCCCC
Q 022956          178 AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS------VAKIYKKVTGGVKPQA--LNKVKD  248 (289)
Q Consensus       178 ~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~  248 (289)
                      .....++++.|+|||.+.+. +++++||||||+++|+|++|..||.....      .......+..+.....  .....+
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            23445689999999987654 89999999999999999999999976332      2344444444332111  113468


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                      +.+++|+.+||+ ||++|||++++++||||++.......+
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~  284 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP  284 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSC
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCC
Confidence            899999999998 999999999999999999876655443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.5e-49  Score=329.37  Aligned_cols=258  Identities=22%  Similarity=0.355  Sum_probs=216.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||+|.++.+|+.||+|++.....   ....+.+.+|+.+++.++||||+++++++...  +..
T Consensus         7 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   80 (276)
T 2yex_A            7 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ   80 (276)
T ss_dssp             HHE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred             cce-EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEE
Confidence            345 689999999999999999999999999999986543   23457788999999999999999999988554  678


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY  157 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC-CCEEEeeCCCccccCC
Confidence            999999999999999988888999999999999999999999999  9999999999999988 8999999999976532


Q ss_pred             c---cccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          176 S---HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       176 ~---~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      .   .......+++.|+|||.+.+.  .+.++|+||||+++++|++|..||..........................++.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA  237 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHH
Confidence            2   223345689999999987654  46789999999999999999999987654433333333333222233456899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +.+|+.+||+ ||++|||++++++||||++...
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          238 PLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            9999999998 9999999999999999987643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-48  Score=341.15  Aligned_cols=267  Identities=24%  Similarity=0.401  Sum_probs=218.0

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .+.+++| ++.++||+|+||.||+|.+..++..||+|++...   ......+.+.+|++++++++||||+++++++....
T Consensus        23 ~~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           23 FDVGPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             CCCTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             ccccccE-EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            3456677 7899999999999999999999999999999743   24556678999999999999999999999885432


Q ss_pred             ---CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           92 ---HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        92 ---~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                         ...+++|+|++.+ +|.+++.. ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||
T Consensus        99 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg  173 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFG  173 (364)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred             ccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCC-CCEEEEeCc
Confidence               2468999999986 99999876 45999999999999999999999999  9999999999999998 899999999


Q ss_pred             CccccCCccc----cccCCCCCCCCCCcccc-cC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--
Q 022956          169 FAAIVGRSHA----AHSIIGTPEYMAPELYE-ED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--  240 (289)
Q Consensus       169 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~-~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--  240 (289)
                      ++........    .....+++.|+|||.+. +. ++.++|||||||++++|++|..||.+................+  
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9987654322    23457899999999654 33 8999999999999999999999998765444433332110000  


Q ss_pred             --------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          241 --------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       241 --------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                                .......++.+.+|+.+||+ ||++|||++|+|+||||++...+..++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~  327 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP  327 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc
Confidence                                      01123457899999999999 999999999999999999986554443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-48  Score=343.66  Aligned_cols=258  Identities=23%  Similarity=0.409  Sum_probs=212.5

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC--CCceEEeeeeEEeCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYIIVCYSVWLDDQH   92 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~   92 (289)
                      .++.|++.+.||+|+||+||++.+.. +..||+|++.....  .....+.+.+|+.+++.+.  ||||+++++++...  
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--  128 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--  128 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--
Confidence            34546889999999999999999864 89999999986543  4566788999999999996  49999999987654  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +.+++||| +.+++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||||+||+++ + +.+||+|||++..
T Consensus       129 ~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~-~~~kl~DFG~a~~  203 (390)
T 2zmd_A          129 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIANQ  203 (390)
T ss_dssp             SEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-S-SCEEECCCSSSCC
T ss_pred             CEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-C-CeEEEEecCcccc
Confidence            57999999 557799999998889999999999999999999999999  99999999999995 3 6899999999987


Q ss_pred             cCCcc---ccccCCCCCCCCCCccccc------------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC
Q 022956          173 VGRSH---AAHSIIGTPEYMAPELYEE------------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       173 ~~~~~---~~~~~~~~~~~~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  237 (289)
                      .....   .....++++.|+|||.+.+            .+++++|||||||++|+|++|..||............+...
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  283 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  283 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence            64332   2335679999999997653            48889999999999999999999998765444444444443


Q ss_pred             CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          238 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ......+...++.+.+|+.+||+ ||++||++.|+|+||||+....
T Consensus       284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            33334455568899999999998 9999999999999999986543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.7e-49  Score=332.41  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=200.9

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .|++.++||+|+||+||+|.+..+|+.||+|+++....  .....+.+.++...++.++||||+++++++...  +..++
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~~l   83 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDVWI   83 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSEEE
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCEEE
Confidence            34789999999999999999999999999999975432  233344566666678889999999999988654  57899


Q ss_pred             EeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           98 ITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ||||+++ +|.+++..    ...+++..+..++.|++.||.|||++ |  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL-GQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTT-CCEEBCCC-----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecCCccc
Confidence            9999986 88777653    56899999999999999999999998 9  9999999999999998 8999999999987


Q ss_pred             cCCccccccCCCCCCCCCCccc----c-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          173 VGRSHAAHSIIGTPEYMAPELY----E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~----~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      ...........+++.|+|||.+    . ..++.++||||||+++++|++|..||..................+.......
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence            7665555556789999999975    2 3388899999999999999999999987554444444444443444445567


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ++.+.+++.+||+ ||++|||++++++||||+....
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence            8999999999999 9999999999999999987543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.7e-49  Score=331.42  Aligned_cols=259  Identities=21%  Similarity=0.378  Sum_probs=215.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++...... .......+.+|+.+++.++||||+++++++.+.  ...
T Consensus         9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   84 (279)
T 3fdn_A            9 EDF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV   84 (279)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             ccE-EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence            455 7899999999999999999999999999999754321 122246688999999999999999999988544  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPS  161 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT-SCEEECSCCEESCC--
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC-CCEEEEeccccccCCc
Confidence            999999999999999998888999999999999999999999999  9999999999999998 8999999998865543


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      . ......+++.|+|||.+.+. ++.++||||||+++++|++|..||.................   ..+...++.+.+|
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l  237 (279)
T 3fdn_A          162 S-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---TFPDFVTEGARDL  237 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---CCCTTSCHHHHHH
T ss_pred             c-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC---CCCCcCCHHHHHH
Confidence            3 23345689999999977655 88899999999999999999999987555444443333222   2345578999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          255 IEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      +.+||+ ||++|||++++++||||++.....+
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~  269 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPS  269 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCC
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCccCcc
Confidence            999998 9999999999999999998755443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-48  Score=339.76  Aligned_cols=257  Identities=23%  Similarity=0.424  Sum_probs=217.3

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   91 (289)
                      +| ++.+.||+|+||.||+|.++.+|+.||||++........    ....+.+.+|+.+++++ +||||+++++++... 
T Consensus        95 ~y-~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  172 (365)
T 2y7j_A           95 KY-DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS-  172 (365)
T ss_dssp             HE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred             hc-ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence            44 678999999999999999999999999999986542212    23456788999999999 799999999987543 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       ...++||||++|++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus       173 -~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~-~~ikl~DfG~~~  248 (365)
T 2y7j_A          173 -SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSC  248 (365)
T ss_dssp             -SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred             -CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEecCccc
Confidence             689999999999999999998888999999999999999999999999  9999999999999998 899999999998


Q ss_pred             ccCCccccccCCCCCCCCCCccccc-------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CC
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-AL  243 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~  243 (289)
                      ............+++.|+|||.+.+       .++.++||||||+++|+|++|..||.................... ..
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            8766555566789999999997642       378899999999999999999999987655554444443332221 11


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ....++.+.+|+.+||+ ||++|||++++|+||||++
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            23467889999999998 9999999999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-49  Score=352.58  Aligned_cols=260  Identities=25%  Similarity=0.412  Sum_probs=207.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCC----CHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE----DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      ++| ++.++||+|+||+||+|.++.+++.||+|++.......    .......+.+|++++++++||||+++++++..  
T Consensus       135 ~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  211 (419)
T 3i6u_A          135 DEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--  211 (419)
T ss_dssp             TTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred             ccE-EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence            445 68999999999999999999999999999998754321    12223458899999999999999999998632  


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccCC
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLGF  169 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g~  169 (289)
                       ..+++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+  ...+||+|||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccc
Confidence             358899999999999999988888999999999999999999999999  9999999999999754  14599999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC--CC
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--AL  243 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~  243 (289)
                      +............++++.|+|||.+.    ..++.++||||||+++|+|++|..||............+..+....  ..
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            98877665556678999999999764    3478899999999999999999999987554444444444433221  12


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ....++.+.+|+.+||+ ||++||+++|+|+||||++.+
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            23468899999999999 999999999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.3e-49  Score=359.08  Aligned_cols=259  Identities=22%  Similarity=0.352  Sum_probs=219.5

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      ..+++.+.||+|+||.||+|.++.+|+.||+|++....... ......+.+|+++++.++||||+++++.+.+.  +.++
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~  260 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALC  260 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEEE
Confidence            33578999999999999999999999999999997643211 11245678899999999999999999988544  6899


Q ss_pred             EEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           97 FITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +||||++|++|.+++...+  .+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~-g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCC-CCeEEEecccceecc
Confidence            9999999999999998754  4999999999999999999999999  9999999999999998 899999999998776


Q ss_pred             CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          175 RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      ........+|++.|+|||++.+. ++.++|+|||||++|+|++|..||....   ........+....  ...+...++.
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--~~~p~~~s~~  415 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EEYSERFSPQ  415 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--CCCCTTSCHH
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--ccCCccCCHH
Confidence            55555567899999999977654 8999999999999999999999998643   2344444444332  2344667999


Q ss_pred             HHHHHHHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          251 VKAFIEKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      +++||.+||+ ||.+||     +++|+++||||++++|+
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            9999999998 999999     89999999999998763

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-48  Score=339.63  Aligned_cols=265  Identities=21%  Similarity=0.374  Sum_probs=213.5

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC-
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ-   91 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   91 (289)
                      +..++| ++.++||+|+||+||+|.++.+|+.||+|++......  ......+.+|+++++.++||||+++++++.... 
T Consensus        14 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           14 DEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             CBGGGE-EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             ccccce-eEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            345666 6899999999999999999999999999999765432  222456778999999999999999999886643 


Q ss_pred             -----CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           92 -----HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        92 -----~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                           .+.+++||||+++ +|.+.+.. ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~-~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEEC
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CCEEEc
Confidence                 3578999999987 77777665 467999999999999999999999999  9999999999999998 899999


Q ss_pred             ccCCccccCC-----ccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH--hC
Q 022956          166 DLGFAAIVGR-----SHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV--TG  236 (289)
Q Consensus       166 d~g~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~--~~  236 (289)
                      |||++.....     ........+++.|+|||.+.+  .+++++|||||||++++|++|..||.+...........  ..
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999976642     222334567999999997654  37999999999999999999999998865554443322  22


Q ss_pred             CCCCCCCCCC---------------------------CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          237 GVKPQALNKV---------------------------KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       237 ~~~~~~~~~~---------------------------~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      ...+...+..                           .++.+.+|+.+||+ ||++|||++|+|+||||.+...+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            2222221111                           26779999999999 999999999999999998765544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-49  Score=340.84  Aligned_cols=267  Identities=21%  Similarity=0.372  Sum_probs=217.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCC-CHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ..++| ++.+.||+|+||+||+|.++.++..||+|++....... .....+.+.+|++++++++||||+++++++.+.  
T Consensus        24 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--  100 (345)
T 3hko_A           24 LQKKY-HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE--  100 (345)
T ss_dssp             HHHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             hhhhe-eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC--
Confidence            44555 78999999999999999999999999999997653211 234467899999999999999999999988543  


Q ss_pred             CeeEEEeccccCCcHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 022956           93 NTLNFITEVCTSGNLRTYRKK----------------------------------------HRHVSIKALKKWSKQVLEG  132 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~----------------------------------------~~~l~~~~~~~~~~ql~~~  132 (289)
                      +..++||||++|++|.+++..                                        ...+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            689999999999999999852                                        1123677889999999999


Q ss_pred             HHHHhcCCCCceecCCCCCceEEeCCCC--cEEEeccCCccccCCcc-----ccccCCCCCCCCCCcccc---cCCCCcc
Q 022956          133 LEYLHTHEPCIIHRDLNCSNIFINGNIG--QVKIGDLGFAAIVGRSH-----AAHSIIGTPEYMAPELYE---EDYTEMV  202 (289)
Q Consensus       133 l~~lh~~~~~~~h~dl~~~nili~~~~~--~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~aPE~~~---~~~~~~~  202 (289)
                      |.|||+.|  ++|+||+|+||+++.+ +  .++|+|||++.......     ......+++.|+|||.+.   ..+++++
T Consensus       181 l~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG--ICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT--EECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC--ccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999999  9999999999999866 4  89999999998653321     133456899999999765   3488999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          203 DIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       203 Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ||||||+++|+|++|..||.+.................. ......++.+.+|+.+||+ ||++||++.++|+||||++.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999998777766666665543322 1222368899999999999 99999999999999999998


Q ss_pred             CCCCCC
Q 022956          281 NDDDSE  286 (289)
Q Consensus       281 ~~~~~~  286 (289)
                      .+....
T Consensus       338 ~~~~~~  343 (345)
T 3hko_A          338 SDKIYK  343 (345)
T ss_dssp             SSCSSC
T ss_pred             hHhhEe
Confidence            776543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-49  Score=338.04  Aligned_cols=266  Identities=25%  Similarity=0.364  Sum_probs=219.4

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC-
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH-   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-   92 (289)
                      ..++| ++.++||+|+||.||+|.+..+++.||+|+++.... .+......+.+|++++++++||||+++++++..... 
T Consensus        10 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A           10 LSDRY-ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             ETTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ecCcE-EEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            45666 789999999999999999999999999999976433 356667889999999999999999999998865432 


Q ss_pred             -CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           93 -NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        93 -~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       ...++||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++.
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~  164 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT-SCEEECCCSCC-
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC-CCEEEeeccCcc
Confidence             245999999999999999998888999999999999999999999999  9999999999999998 899999999997


Q ss_pred             ccCCcc----ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCC
Q 022956          172 IVGRSH----AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNK  245 (289)
Q Consensus       172 ~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  245 (289)
                      ......    ......+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+........+.......+. ....
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            664332    22335689999999977654 89999999999999999999999998777666666665543332 2234


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      ..++.+.+++.+||+ ||++||++.+++.|+|++......
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence            578999999999998 999999999999999998765443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.6e-49  Score=339.60  Aligned_cols=253  Identities=26%  Similarity=0.462  Sum_probs=205.0

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC----
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH----   92 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   92 (289)
                      +| ++.+.||+|+||.||+|.++.+|+.||+|+++...   .+...+.+.+|++++++++||||+++++++.....    
T Consensus         7 ~y-~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            7 DF-EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HE-EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             cC-ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            44 68999999999999999999999999999998653   34456789999999999999999999998865432    


Q ss_pred             ---------------------------------------------------CeeEEEeccccCCcHHHHHHhcC---CCC
Q 022956           93 ---------------------------------------------------NTLNFITEVCTSGNLRTYRKKHR---HVS  118 (289)
Q Consensus        93 ---------------------------------------------------~~~~lv~e~~~~~sL~~~~~~~~---~l~  118 (289)
                                                                         .++++||||+++++|.+++....   ..+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                               24899999999999999998753   356


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-------------ccccCCCC
Q 022956          119 IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-------------AAHSIIGT  185 (289)
Q Consensus       119 ~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-------------~~~~~~~~  185 (289)
                      +..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++.......             ......++
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            6679999999999999999999  9999999999999988 899999999998765432             22345689


Q ss_pred             CCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCC
Q 022956          186 PEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPR  263 (289)
Q Consensus       186 ~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~  263 (289)
                      +.|+|||.+.+. +++++||||||+++++|++|..|+..   .............+. .....++.+.+|+.+||+ ||+
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGG
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCC
Confidence            999999977654 89999999999999999998766432   222333333332221 122346788999999999 999


Q ss_pred             CCCCHHHHhcCcccccC
Q 022956          264 ARPSASELLKDPFFSEL  280 (289)
Q Consensus       264 ~Rps~~~il~h~~~~~~  280 (289)
                      +|||++|+++||||+++
T Consensus       316 ~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          316 ERPEATDIIENAIFENL  332 (332)
T ss_dssp             GSCCHHHHHHSTTCCCC
T ss_pred             cCCCHHHHhhchhhhcC
Confidence            99999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.5e-49  Score=331.45  Aligned_cols=261  Identities=21%  Similarity=0.366  Sum_probs=215.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      |++.+.||+|+||+||+|.++.+|+.||+|+++.......  ....+.+.+|++++++++||||+++++++...  ...+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~   84 (283)
T 3bhy_A            7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TDVV   84 (283)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred             hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--CeEE
Confidence            4789999999999999999999999999999987654322  12357788999999999999999999988554  6799


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC----cEEEeccCCccc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG----QVKIGDLGFAAI  172 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~----~~~l~d~g~~~~  172 (289)
                      +||||+++++|.+++.....+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +    .++|+|||++..
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDK-NVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCS-SSSSCCEEECCCTTCEE
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecC-CCCCCceEEEeccccee
Confidence            99999999999999998888999999999999999999999999  9999999999999876 4    899999999987


Q ss_pred             cCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCChH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  250 (289)
                      ...........+++.|+|||.+.+. ++.++|+||||+++++|++|..||................... .......++.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            7655555556789999999977644 8999999999999999999999998765544443333222211 1122456889


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      +.+++.+||+ ||++||++.++++||||+++.+..
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            9999999998 999999999999999999886554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.9e-49  Score=331.40  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=220.8

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.++||+|+||+||+|.++.+++.||+|++......  ....+.+.+|++++++++||||+++++++...  +.
T Consensus        21 ~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   95 (287)
T 2wei_A           21 AERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDS--SS   95 (287)
T ss_dssp             HHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred             hhcc-eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--Ce
Confidence            3455 7899999999999999999999999999999765432  22356788999999999999999999988543  67


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC--CcEEEeccCCccc
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGFAAI  172 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~--~~~~l~d~g~~~~  172 (289)
                      +++|+|++.+++|.+++.....+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+.  +.++|+|||++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999999999999988888999999999999999999999999  99999999999997641  4799999999987


Q ss_pred             cCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-CCCCCCChHH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-ALNKVKDPEV  251 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  251 (289)
                      ...........+++.|+|||.+.+.++.++|+||||+++++|++|..||.+.................. ......++.+
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             BCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             ecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            655544444567889999998888899999999999999999999999988665544444443332221 1224568899


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      .+++.+||+ ||++|||++++++||||++..++
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             HHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence            999999999 99999999999999999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.7e-48  Score=329.88  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=213.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++.....    ...+.+.+|+++++.++||||+++++++...  ..+
T Consensus         9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   81 (304)
T 2jam_A            9 KTF-IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYEST--THY   81 (304)
T ss_dssp             HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred             ccc-eeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccC--CEE
Confidence            444 789999999999999999999999999999985432    2245688899999999999999999987544  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE---eCCCCcEEEeccCCccc
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili---~~~~~~~~l~d~g~~~~  172 (289)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|  ++|+||+|+||++   +.+ +.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~  158 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEEN-SKIMITDFGLSKM  158 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCC
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCC-CCEEEccCCccee
Confidence            999999999999999988888999999999999999999999999  9999999999999   555 8999999999876


Q ss_pred             cCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  250 (289)
                      .... ......+++.|+|||.+.+. +++++||||||+++++|++|..||.................. +.......++.
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (304)
T 2jam_A          159 EQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES  237 (304)
T ss_dssp             CCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred             cCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence            5433 22334689999999987655 889999999999999999999999876554444443333322 22233457899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +.+++.+||+ ||++||+++++++||||++...
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          238 AKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence            9999999998 9999999999999999987644

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-48  Score=336.73  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=212.8

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.+.||+|+||.||+|.+..+|+.||+|++.....  .....+.+.+|+++++.++||||+++++++...  +
T Consensus        23 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~   97 (331)
T 4aaa_A           23 SMEKY-ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--K   97 (331)
T ss_dssp             CGGGE-EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--T
T ss_pred             hhhhh-eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC--chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--C
Confidence            34555 678999999999999999999999999999976532  456667788999999999999999999988654  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+++||||+++++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCTTC---
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC-CcEEEEeCCCceee
Confidence            79999999999999998887788999999999999999999999999  9999999999999998 89999999999766


Q ss_pred             CCc-cccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC------------
Q 022956          174 GRS-HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV------------  238 (289)
Q Consensus       174 ~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------  238 (289)
                      ... .......+++.|+|||.+.+  .+++++||||||+++|+|++|..||.+...............            
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            443 22344568999999997765  478999999999999999999999988766555444332100            


Q ss_pred             -------CCCC---------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          239 -------KPQA---------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       239 -------~~~~---------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                             ....         .....++.+.+|+.+||+ ||++|||++|+|+||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence                   0000         012357899999999999 999999999999999998753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.2e-49  Score=333.75  Aligned_cols=262  Identities=28%  Similarity=0.500  Sum_probs=217.2

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .++.++| ++.+.||+|+||.||+|.++.+|..+|+|++....    ....+.+.+|+++++.++||||+++++++... 
T Consensus        15 ~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   88 (302)
T 2j7t_A           15 LDPNEVW-EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHD-   88 (302)
T ss_dssp             SCGGGTE-EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             cCCccce-eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-
Confidence            4566666 78999999999999999999999999999997543    22356788899999999999999999988654 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       +.+++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        89 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  164 (302)
T 2j7t_A           89 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVS  164 (302)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-SCEEECCCHHH
T ss_pred             -CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC-CCEEEEECCCC
Confidence             578999999999999999875 567999999999999999999999999  9999999999999988 89999999987


Q ss_pred             cccCC-ccccccCCCCCCCCCCccc------ccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          171 AIVGR-SHAAHSIIGTPEYMAPELY------EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       171 ~~~~~-~~~~~~~~~~~~~~aPE~~------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      ..... ........+++.|+|||.+      ...++.++||||||+++++|++|..||......................
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T 2j7t_A          165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT  244 (302)
T ss_dssp             HHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred             ccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC
Confidence            54321 1122345688999999976      2348889999999999999999999999877666665555554444444


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      +...+..+.+++..||+ ||++|||++++++||||++..+.
T Consensus       245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            55668899999999998 99999999999999999988654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=331.63  Aligned_cols=265  Identities=23%  Similarity=0.417  Sum_probs=216.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.+.||+|+||.||+|.+..++..+|+|++..............+.+|+++++.++||||+++++++...+...
T Consensus         4 ~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKY-LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCB-CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             ccce-eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3566 689999999999999999999999999999986543222334677999999999999999999999987666678


Q ss_pred             eEEEeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           95 LNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +++||||+.++ |.+++..  ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC-CcEEeeccccccc
Confidence            99999999885 7777765  457999999999999999999999999  9999999999999988 8999999999986


Q ss_pred             cCCc---cccccCCCCCCCCCCcccccC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          173 VGRS---HAAHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       173 ~~~~---~~~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ....   .......+++.|+|||.+.+.   .+.++||||||+++++|++|..||.+...... ...+.....  ..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i~~~~~--~~~~~  235 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-FENIGKGSY--AIPGD  235 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCC--CCCSS
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHHHhcCCC--CCCCc
Confidence            6422   223345689999999977643   47789999999999999999999987554443 333333322  23445


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                      .++.+.+++.+||+ ||++|||++++++||||++.....+.+
T Consensus       236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~  277 (305)
T 2wtk_C          236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP  277 (305)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCC
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCC
Confidence            78999999999998 999999999999999999886655444

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.1e-48  Score=328.28  Aligned_cols=260  Identities=20%  Similarity=0.356  Sum_probs=219.1

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||+|.+..++..||+|++...... .......+.+|+++++.++||||+++++++...  +.+
T Consensus        14 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   89 (284)
T 2vgo_A           14 DDF-DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRI   89 (284)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred             hhc-eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEE
Confidence            455 7899999999999999999999999999999754321 112246788999999999999999999988554  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKIADFGWSVHAPS  166 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECSS
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC-CCEEEecccccccCcc
Confidence            999999999999999998888999999999999999999999999  9999999999999988 8999999999876544


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      . ......+++.|+|||.+.+. +++++|+||||+++++|++|..||.................   ..+...++.++++
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l  242 (284)
T 2vgo_A          167 L-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---KFPPFLSDGSKDL  242 (284)
T ss_dssp             S-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---CCCTTSCHHHHHH
T ss_pred             c-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---CCCCcCCHHHHHH
Confidence            3 23345689999999977654 88999999999999999999999987655544444333222   2345578999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          255 IEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                      +.+||+ ||++||+++++++||||++.......
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p  275 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP  275 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCC
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhhccccCC
Confidence            999998 99999999999999999987654433

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-48  Score=328.68  Aligned_cols=255  Identities=24%  Similarity=0.433  Sum_probs=207.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+.+|+..++.++||||+++++++...  +.+
T Consensus        11 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   86 (276)
T 2h6d_A           11 GHY-VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDF   86 (276)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred             ccE-EEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeE
Confidence            455 7899999999999999999999999999999754321 112356788999999999999999999988554  679


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC-CCEEEeecccccccCC
Confidence            999999999999999998888999999999999999999999999  9999999999999988 8999999999987765


Q ss_pred             ccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ........+++.|+|||.+.+.  .++++|+||||+++++|++|..||....... ..+.+.....  ..+...++.+.+
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~~~~~~~~l~~  240 (276)
T 2h6d_A          164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGGVF--YIPEYLNRSVAT  240 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC--CCCTTSCHHHHH
T ss_pred             CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcCcc--cCchhcCHHHHH
Confidence            5444556789999999987765  3578999999999999999999998755443 3333333322  234556899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ++.+||+ ||++|||++++++||||++.
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhccC
Confidence            9999999 99999999999999999865

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8e-49  Score=342.35  Aligned_cols=264  Identities=26%  Similarity=0.422  Sum_probs=199.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC---
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD---   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   90 (289)
                      ..++| ++.+.||+|+||.||+|.++.+|+.||+|++....  ......+.+.+|+++++.++||||+++++++...   
T Consensus        27 ~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           27 VPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL  103 (367)
T ss_dssp             EETTE-EEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             CCCce-EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence            34666 68999999999999999999999999999997543  2455677889999999999999999999988543   


Q ss_pred             -CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 -QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 -~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                       ....+++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.+||+|||+
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kL~DFG~  178 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGL  178 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECC---
T ss_pred             ccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCC-CCEEEeeccc
Confidence             125689999999 5699998876 56999999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------  240 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------  240 (289)
                      +......  .....+++.|+|||.+.+  .++.++|||||||++++|++|..||.+................+       
T Consensus       179 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          179 ARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9865433  334578999999997654  48999999999999999999999998866555443332210000       


Q ss_pred             ---------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          241 ---------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       241 ---------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                           .......++.+.+||.+||+ ||++|||++++|+||||++......++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~  325 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  325 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC
Confidence                                 00112357889999999999 999999999999999999886655443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-48  Score=334.12  Aligned_cols=256  Identities=18%  Similarity=0.341  Sum_probs=211.4

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   93 (289)
                      .++| ++.++||+|+||+||+|.+..+++.||+|+++...       .+.+.+|++++++++ ||||+++++++......
T Consensus        35 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           35 QDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCce-EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            4555 78999999999999999999999999999997432       467889999999997 99999999998776567


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ..++||||+.+++|.+++..   +++..+..++.|++.||.|||++|  ++|+||+|+||+++.+...++|+|||++...
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            89999999999999998864   899999999999999999999999  9999999999999977348999999999877


Q ss_pred             CCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-------------hCCC
Q 022956          174 GRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-------------TGGV  238 (289)
Q Consensus       174 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------------~~~~  238 (289)
                      ..........+++.|+|||.+.+  .++.++|||||||++++|++|..||............+             ....
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            66555566778999999997654  48999999999999999999999996433322211111             0000


Q ss_pred             ----------------------CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          239 ----------------------KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       239 ----------------------~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                                            .........++.+.+||.+||+ ||++|||++|+|+||||+++.++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence                                  0001122268899999999999 99999999999999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.6e-48  Score=329.65  Aligned_cols=258  Identities=26%  Similarity=0.519  Sum_probs=213.3

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      .+.++| ++.+.||+|+||+||+|.++.+|+.||+|.+.....      .+.+.+|+++++.++||||+++++.+...  
T Consensus        26 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   96 (314)
T 3com_A           26 QPEEVF-DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYFKN--   96 (314)
T ss_dssp             ----CE-EEEEECC----CEEEEEEETTTCCEEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEEET--
T ss_pred             cchhhh-hhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEEeC--
Confidence            345555 689999999999999999999999999999975431      35678899999999999999999988664  


Q ss_pred             CeeEEEeccccCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           93 NTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      +.+++|+||+++++|.+++. ....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~  173 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAG  173 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC-CCEEEeecccch
Confidence            57899999999999999997 4567999999999999999999999999  9999999999999998 899999999997


Q ss_pred             ccCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          172 IVGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ...... ......+++.|+|||.+.+. ++.++||||||+++++|++|..||......................+...++
T Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
T 3com_A          174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSD  253 (314)
T ss_dssp             ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCH
Confidence            664432 23445689999999977654 8999999999999999999999998866655554444443333333445688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .+.+|+.+||+ ||.+|||++++++||||++..+
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            99999999998 9999999999999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.2e-49  Score=343.38  Aligned_cols=259  Identities=25%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC---
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ---   91 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   91 (289)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|++.....  .....+.+.+|+.+++.++||||+++++++....   
T Consensus        24 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           24 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             ETTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             hhhe-eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC--ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            3565 689999999999999999999999999999986432  4566778899999999999999999999885432   


Q ss_pred             -CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 -HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 -~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       ...+++||||+++ +|.+.+.  ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a  174 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA  174 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCC-
T ss_pred             cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEEEeecc
Confidence             2378999999986 7888886  35899999999999999999999999  9999999999999998 89999999999


Q ss_pred             cccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC--------
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--------  241 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  241 (289)
                      .............+++.|+|||.+.+. ++.++|||||||++++|++|..||.+..........+.....+.        
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            877655445556789999999976654 89999999999999999999999998766655554443321110        


Q ss_pred             ------------C-------------CCC------CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          242 ------------A-------------LNK------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       242 ------------~-------------~~~------~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                  .             .+.      ..++.+++|+.+||+ ||++|||++|+|+||||+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                        0             000      014678999999999 9999999999999999997644

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.2e-48  Score=328.91  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=215.5

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.+.||+|+||.||+|.+..++..||+|++..... ......+.+.+|+.++++++||||+++++++..  ++
T Consensus         9 ~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~   84 (294)
T 4eqm_A            9 INERY-KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DD   84 (294)
T ss_dssp             EETTE-EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SS
T ss_pred             hhccE-EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CC
Confidence            44565 789999999999999999999999999999976543 356667889999999999999999999998744  36


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+++||||++|++|.+++...+++++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCSSSTTC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEEeCCCcccc
Confidence            89999999999999999998888999999999999999999999999  9999999999999998 89999999999876


Q ss_pred             CCcc--ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--CCCCCCCC
Q 022956          174 GRSH--AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QALNKVKD  248 (289)
Q Consensus       174 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  248 (289)
                      ....  ......+++.|+|||.+.+. +++++||||||+++|+|++|..||.+..........+....+.  .......+
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP  241 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence            5432  23345689999999977655 8899999999999999999999999877666666666554332  12345578


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +.+.+++.+||+ ||.+||+..+.+.+.|.+-+.
T Consensus       242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          242 QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            999999999998 999999666666666554443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-48  Score=342.19  Aligned_cols=258  Identities=21%  Similarity=0.330  Sum_probs=201.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH-HhCCCCceEEeeeeEEe--C
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL-RTLKNKYIIVCYSVWLD--D   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~--~   90 (289)
                      ..+.|+.+.++||+|+||+||++.++.+|+.||+|++...         ..+.+|+.++ +..+||||+++++++..  .
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            3455644447899999999999999999999999999632         3456677776 45589999999998754  2


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEec
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGD  166 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d  166 (289)
                      +...+++||||++|++|.+++...  ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+  .+.+||+|
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEe
Confidence            346789999999999999999874  35999999999999999999999999  9999999999999872  27899999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHhCCC-CC
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA----KIYKKVTGGV-KP  240 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~-~~  240 (289)
                      ||++............++++.|+|||.+.+. ++.++|||||||++|+|++|..||.+.....    .......... .+
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            9999877655555567789999999987654 8999999999999999999999997543211    1122222221 22


Q ss_pred             CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .......++.+.+||.+||+ ||++|||++++++||||.+...
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence            22234578999999999998 9999999999999999987543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.7e-48  Score=334.26  Aligned_cols=255  Identities=26%  Similarity=0.456  Sum_probs=216.8

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|++++++++||||+++++++...  +.
T Consensus        53 ~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~  128 (348)
T 1u5q_A           53 EKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HT  128 (348)
T ss_dssp             HHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred             hhhe-eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--Ce
Confidence            3444 678999999999999999999999999999976533 2344567899999999999999999999988665  57


Q ss_pred             eEEEeccccCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .++||||+.| +|.+++. ....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++...
T Consensus       129 ~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          129 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIM  204 (348)
T ss_dssp             EEEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSS
T ss_pred             EEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEeeccCceec
Confidence            9999999986 7877775 4567999999999999999999999999  9999999999999998 89999999999766


Q ss_pred             CCccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          174 GRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       174 ~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ...   ....+++.|+|||.+.    +.++.++||||||+++++|++|..||.+.............. .+.......++
T Consensus       205 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  280 (348)
T 1u5q_A          205 APA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWSE  280 (348)
T ss_dssp             SSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCCTTSCH
T ss_pred             CCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCCCCCCH
Confidence            432   3457899999999763    448999999999999999999999998876666655555544 33334556789


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+++|+.+||+ ||++|||++++++||||.+..
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            99999999998 999999999999999997654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=339.42  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=212.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++........    ......+.+|++++++++||||+++++++... 
T Consensus        24 ~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-  101 (335)
T 3dls_A           24 QKY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-  101 (335)
T ss_dssp             HHE-EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred             cce-EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-
Confidence            455 789999999999999999999999999999987543211    11234577799999999999999999988544 


Q ss_pred             CCeeEEEeccccCC-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 HNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 ~~~~~lv~e~~~~~-sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       +.+++|||++.++ +|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++
T Consensus       102 -~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~a  177 (335)
T 3dls_A          102 -GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSA  177 (335)
T ss_dssp             -SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTC
T ss_pred             -CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC-CcEEEeecccc
Confidence             6899999998766 99999999889999999999999999999999999  9999999999999998 89999999999


Q ss_pred             cccCCccccccCCCCCCCCCCcccccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEED-Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      .............+++.|+|||.+.+. + ++++||||||+++|+|++|..||......         .......+...+
T Consensus       178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~~~~~~  248 (335)
T 3dls_A          178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEAAIHPPYLVS  248 (335)
T ss_dssp             EECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTTCCCCSSCCC
T ss_pred             eECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------HhhccCCCcccC
Confidence            887666555667799999999977654 3 78899999999999999999999763221         111222344578


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +.+.+|+.+||+ ||++|||++++++||||++.
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            999999999999 99999999999999999764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2e-48  Score=363.57  Aligned_cols=257  Identities=22%  Similarity=0.329  Sum_probs=218.6

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCee
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   95 (289)
                      .| ++.++||+|+||+||+|.++.+++.||+|+++...... ....+.+..|..++..+ +||+|+.+++.+.+  .+.+
T Consensus       342 ~f-~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~  417 (674)
T 3pfq_A          342 DF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL  417 (674)
T ss_dssp             TE-EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEE
T ss_pred             ce-EEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEE
Confidence            44 67899999999999999999999999999998543211 12245677888999887 68999999988744  3689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC-
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~-  174 (289)
                      |+||||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+|||++.+ +.+||+|||++.... 
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS-SCEEECCCTTCEECCC
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC-CcEEEeecceeecccc
Confidence            999999999999999998888999999999999999999999999  9999999999999999 899999999998643 


Q ss_pred             CccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          175 RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ........+||+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.........+.....   ..+...++++.+
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~  571 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYPKSMSKEAVA  571 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---CCCTTSCHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---CCCccCCHHHHH
Confidence            3334556789999999997764 489999999999999999999999988655554444444332   244567999999


Q ss_pred             HHHHHHc-CCCCCCCH-----HHHhcCcccccCCCC
Q 022956          254 FIEKCIA-QPRARPSA-----SELLKDPFFSELNDD  283 (289)
Q Consensus       254 li~~~l~-dp~~Rps~-----~~il~h~~~~~~~~~  283 (289)
                      ||.+||+ ||++||++     ++|++||||++++|+
T Consensus       572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             HHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence            9999998 99999998     999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-49  Score=337.62  Aligned_cols=260  Identities=24%  Similarity=0.376  Sum_probs=205.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.++.+++.||+|++.....   ......+.+|+++++.++||||+++++++...  +.+
T Consensus         2 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   75 (324)
T 3mtl_A            2 ETY-IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSL   75 (324)
T ss_dssp             CSE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCE
T ss_pred             Cce-EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEE
Confidence            355 689999999999999999999999999999975432   11122455799999999999999999988554  678


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER-GELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT-CCEEECSSSEEECC-
T ss_pred             EEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC-CCEEEccCccccccc
Confidence            999999986 888888764 56999999999999999999999999  9999999999999998 899999999997654


Q ss_pred             Ccc-ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--CCCCCCCC------
Q 022956          175 RSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT--GGVKPQAL------  243 (289)
Q Consensus       175 ~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~------  243 (289)
                      ... ......+++.|+|||.+.+  .++.++||||||+++++|++|..||.+............  +......+      
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            332 2334567999999997654  379999999999999999999999988665554433322  11111111      


Q ss_pred             -------------------CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          244 -------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       244 -------------------~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                         ....++.+.+|+.+||+ ||++|||++|+|+||||.++.....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence                               12357889999999999 9999999999999999999876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=333.21  Aligned_cols=256  Identities=22%  Similarity=0.370  Sum_probs=210.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||+||+|.+..+|+.||+|++........   .+.+.+|++++++++||||+++++++......
T Consensus         7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            7 SNHLW-LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             SSEEE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC---HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCE-EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch---HHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            34454 789999999999999999999999999999986543222   56678899999999999999999988776666


Q ss_pred             eeEEEeccccCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE----eCCCCcEEEec
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI----NGNIGQVKIGD  166 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~---l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili----~~~~~~~~l~d  166 (289)
                      .+++||||+++++|.+++.....   +++..+..++.|++.||.|||+.|  ++|+||||+||++    +.+ +.+||+|
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~D  159 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTD  159 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSC-EEEEECC
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCC-ceEEEcc
Confidence            88999999999999999986433   999999999999999999999999  9999999999998    555 6899999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCcccc---------cCCCCcchHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHH
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYE---------EDYTEMVDIYSFGLCLLEMVTMEIPYSECD----SVAKIYKK  233 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~Di~slG~il~~l~tg~~p~~~~~----~~~~~~~~  233 (289)
                      ||++.............+++.|+|||.+.         ..++.++|||||||++|+|++|..||....    ........
T Consensus       160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            99998877666666677999999999764         448899999999999999999999996432    23333333


Q ss_pred             HhCCCCC----------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcc
Q 022956          234 VTGGVKP----------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPF  276 (289)
Q Consensus       234 ~~~~~~~----------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~  276 (289)
                      +......                      .......++.+.+++.+||+ ||++|||++|+|+||-
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            3332211                      01112234578899999999 9999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.1e-48  Score=341.50  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=208.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC----CCCe
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----QHNT   94 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~   94 (289)
                      |++.+.||+|+||.||+|.++.+|+.||||++.....        ...+|+++++.++||||+++++++...    ...+
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            4788999999999999999999999999999975421        233589999999999999999887542    2235


Q ss_pred             eEEEeccccCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           95 LNFITEVCTSGNLRTYRK----KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                      +++||||+++ +|.+.+.    ....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+.+.+||+|||++
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            7789999987 6665554    3567999999999999999999999999  9999999999999976467899999999


Q ss_pred             cccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC----------
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV----------  238 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----------  238 (289)
                      .............+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+....+...+.+....          
T Consensus       205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            87755555556678999999997653  489999999999999999999999998766555544433100          


Q ss_pred             ----CCC------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          239 ----KPQ------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       239 ----~~~------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                          ...            ......++.+.+||.+||+ ||++||++.|+++||||+++.+..
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence                000            0123457899999999999 999999999999999999886543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.4e-48  Score=351.32  Aligned_cols=259  Identities=22%  Similarity=0.365  Sum_probs=216.6

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      ..|++.+.||+|+||.||+|.++.+|+.||+|++....... ......+.+|++++++++||||+++++.+...  ..+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~  261 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLC  261 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEEE
Confidence            33478899999999999999999999999999997643211 12245688899999999999999999987544  6799


Q ss_pred             EEeccccCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           97 FITEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +||||++|++|.+++...    ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ |.+||+|||++..
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~-g~vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCC-CCEEEeecceeee
Confidence            999999999999999763    46999999999999999999999999  9999999999999998 8999999999987


Q ss_pred             cCCccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhCCCCCCCCCCCC
Q 022956          173 VGRSHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       173 ~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      ...... ....+|++.|+|||++.+. ++.++|+|||||++|+|++|..||.+..   ........+....  ...+...
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~~~  416 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKF  416 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCTTS
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCCccc
Confidence            654332 3445899999999977654 8999999999999999999999998642   2334444443322  2234567


Q ss_pred             ChHHHHHHHHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      ++.+++||.+||+ ||++||+     +++|++||||++++|+
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            8999999999998 9999995     5899999999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-48  Score=334.75  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=209.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      .++| ++.+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+++++.++||||+++++++..  ..
T Consensus         9 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~   85 (346)
T 1ua2_A            9 AKRY-EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KS   85 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TT
T ss_pred             hccc-EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CC
Confidence            4455 689999999999999999999999999999986543221 2223568889999999999999999998844  36


Q ss_pred             eeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..++|+||+++ +|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++..
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC-CCEEEEeccccee
Confidence            78999999987 888888764 46899999999999999999999999  9999999999999998 8999999999987


Q ss_pred             cCCcc-ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC--CCCCCC----
Q 022956          173 VGRSH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG--VKPQAL----  243 (289)
Q Consensus       173 ~~~~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~----  243 (289)
                      ..... ......+++.|+|||.+.+  .++.++|||||||++|+|++|..||.+..............  .....+    
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            64432 3345678999999997754  37889999999999999999999998876665555444321  111100    


Q ss_pred             -------------------CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          244 -------------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       244 -------------------~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                                         ....++.+.+||.+||+ ||++|||++|+|+||||++..++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence                               13346899999999999 999999999999999999876554

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=329.70  Aligned_cols=260  Identities=25%  Similarity=0.511  Sum_probs=213.3

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDD   90 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   90 (289)
                      .+..++| ++.+.||+|+||.||+|.+..+|+.||+|++.....  .   .+.+.+|+.+++++ +||||+++++++...
T Consensus        20 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           20 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--E---EEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--T---THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cCCCCcE-EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--c---HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3566676 789999999999999999999999999999975432  1   35678899999998 799999999998764


Q ss_pred             C----CCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           91 Q----HNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        91 ~----~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                      .    ...+++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~-~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC-CCEEE
Confidence            2    46899999999999999999864  57999999999999999999999999  9999999999999988 89999


Q ss_pred             eccCCccccCCcc-ccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC
Q 022956          165 GDLGFAAIVGRSH-AAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       165 ~d~g~~~~~~~~~-~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  237 (289)
                      +|||++....... ......+++.|+|||.+.      ..++.++||||||+++|+|++|..||............. ..
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~  249 (326)
T 2x7f_A          171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RN  249 (326)
T ss_dssp             CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HS
T ss_pred             eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-cC
Confidence            9999997664332 233456899999999764      348899999999999999999999998766555444433 33


Q ss_pred             CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          238 VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ..+.......++.+.+|+.+||. ||++||+++++++||||++..
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            34444456678999999999998 999999999999999998764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-48  Score=335.13  Aligned_cols=260  Identities=25%  Similarity=0.423  Sum_probs=209.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC----CCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      ++| ++.+.||+|+||.||+|.++.+++.||+|++......    ........+.+|+++++.++||||+++++++... 
T Consensus        10 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A           10 DEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             hce-eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence            444 7899999999999999999999999999999764321    1122345688999999999999999999987433 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC--CcEEEeccCC
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI--GQVKIGDLGF  169 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~--~~~~l~d~g~  169 (289)
                        .+++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+.  ..++|+|||+
T Consensus        88 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           88 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             --SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             --ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence              38999999999999999988888999999999999999999999999  99999999999998761  2499999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--CCC
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--QAL  243 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~  243 (289)
                      +.............+++.|+|||.+.    ..++.++||||||+++|+|++|..||............+..+...  ...
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            98776544444456899999999753    348899999999999999999999997654332333333322211  112


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ....++.+.+|+.+||+ ||++||+++++++||||++.+
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            23468899999999998 999999999999999998653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=327.46  Aligned_cols=259  Identities=28%  Similarity=0.485  Sum_probs=193.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+.+|++++++++||||+++++++...  +
T Consensus         9 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   84 (278)
T 3cok_A            9 KIEDF-KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--N   84 (278)
T ss_dssp             SGGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--S
T ss_pred             ccccc-eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--C
Confidence            33455 7899999999999999999999999999999754321 112246788999999999999999999988543  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..++|+||+++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~  161 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEEeecceee
Confidence            899999999999999999875 67999999999999999999999999  9999999999999988 8999999999987


Q ss_pred             cCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          173 VGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      ..... ......+++.|+|||.+.+. +++++|+||||+++++|++|..||..............   .....+...++.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~  238 (278)
T 3cok_A          162 LKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---ADYEMPSFLSIE  238 (278)
T ss_dssp             CC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---SCCCCCTTSCHH
T ss_pred             ccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---cccCCccccCHH
Confidence            65332 23345688999999977654 88899999999999999999999986443322221111   112234557889


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +.+++.+||+ ||++|||++++++||||.+...
T Consensus       239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            9999999998 9999999999999999987643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.2e-47  Score=324.89  Aligned_cols=259  Identities=26%  Similarity=0.497  Sum_probs=219.9

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ..++..+| ++.++||+|+||.||+|.+..+++.||+|++......   ...+.+.+|+.+++.++||||+++++.+...
T Consensus        17 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   92 (303)
T 3a7i_A           17 KADPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   92 (303)
T ss_dssp             EECGGGTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCChHHHH-HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            44666666 6799999999999999999999999999999865432   2367788999999999999999999988664


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ..+++||||+++++|.+++.. ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        93 --~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~  166 (303)
T 3a7i_A           93 --TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVA  166 (303)
T ss_dssp             --TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTC
T ss_pred             --CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC-CCEEEeecccc
Confidence              579999999999999999876 56999999999999999999999999  9999999999999988 89999999999


Q ss_pred             cccCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          171 AIVGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       171 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ....... ......+++.|+|||.+.+. ++.++||||||+++++|++|..||................ . .......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~  244 (303)
T 3a7i_A          167 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-P-PTLEGNYS  244 (303)
T ss_dssp             EECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C-CCCCSSCC
T ss_pred             eecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-C-CCCccccC
Confidence            7765432 23445689999999977654 8899999999999999999999998766555444433332 2 23455678


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +.+.+|+.+||+ ||++|||++++++||||.+..
T Consensus       245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            999999999998 999999999999999997654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.7e-48  Score=325.11  Aligned_cols=261  Identities=26%  Similarity=0.449  Sum_probs=217.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||++.++.+|+.||+|++.....  .....+.+.+|++++++++||||+++++.+....+..+
T Consensus         6 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            6 EDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             hhe-eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            455 789999999999999999999999999999987654  45667889999999999999999999998877666789


Q ss_pred             EEEeccccCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---CCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           96 NFITEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHE---PCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.+   .+++|+||+|+||+++.+ +.++|+|||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg  161 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFG  161 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCc
Confidence            9999999999999999753    34999999999999999999999977   249999999999999988 899999999


Q ss_pred             CccccCCccc-cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          169 FAAIVGRSHA-AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       169 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ++........ .....+++.|+|||.+.+. ++.++||||||+++++|++|..||................ .+ ..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~-~~~~~  239 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FR-RIPYR  239 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CC-CCCTT
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cc-cCCcc
Confidence            9976643322 2234688999999977654 8899999999999999999999998765544333333332 22 33455


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .++.+.+++.+||+ ||++||+++++++|+|+.+-+.
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            78999999999998 9999999999999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.5e-48  Score=330.59  Aligned_cols=267  Identities=25%  Similarity=0.379  Sum_probs=209.4

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe---
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD---   89 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   89 (289)
                      ...++| ++.+.||+|+||+||+|.++.+|+.||+|++...    +....+.+.+|++++++++||||+++++++..   
T Consensus         8 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            8 DLGSRY-MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             EETTTE-EEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             ccCCce-eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            345676 6899999999999999999999999999999754    45567789999999999999999999987632   


Q ss_pred             ---------CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           90 ---------DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        90 ---------~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                               .....+++||||+++ +|.+++.+ +++++..+..++.|++.||.|||++|  ++|+||+|+||+++.+.+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTT
T ss_pred             ccccccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCC
Confidence                     233678999999985 99999876 56999999999999999999999999  999999999999985547


Q ss_pred             cEEEeccCCccccCCc----cccccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 022956          161 QVKIGDLGFAAIVGRS----HAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV  234 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~  234 (289)
                      .+||+|||++......    .......+++.|+|||.+.  ..++.++||||||+++++|++|..||.+...........
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999876432    1223345688999999664  348899999999999999999999998866555444333


Q ss_pred             hCCCCC---------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          235 TGGVKP---------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       235 ~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                      ......                           .......++.+.+|+.+||+ ||++|||++++++||||+...++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~  318 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE  318 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence            221110                           01123468899999999999 99999999999999999999998877


Q ss_pred             CC
Q 022956          287 PS  288 (289)
Q Consensus       287 ~~  288 (289)
                      |+
T Consensus       319 ~~  320 (320)
T 2i6l_A          319 PI  320 (320)
T ss_dssp             --
T ss_pred             CC
Confidence            63

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-47  Score=327.15  Aligned_cols=248  Identities=27%  Similarity=0.452  Sum_probs=201.8

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .|++.++||+|+||+||+|.+  +|..||+|++.....  .....+.+.+|++++++++||||+++++++...  ..+++
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l  111 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP--PNLSI  111 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--TCCEE
T ss_pred             HceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CceEE
Confidence            347899999999999999976  588999999976543  455677899999999999999999999988443  56899


Q ss_pred             EeccccCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           98 ITEVCTSGNLRTYRKKHRH---VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~---l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ||||+++++|.+++.....   +++..+..++.|++.||.|||++|++++|+||||+||+++.+ +.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCcccc
Confidence            9999999999999987543   999999999999999999999998779999999999999998 899999999997654


Q ss_pred             Ccc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ... ......+++.|+|||.+.+. +++++||||||+++|+|++|..||................ .....+...++.+.
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  269 (309)
T 3p86_A          191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-KRLEIPRNLNPQVA  269 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-CCCCCCTTSCHHHH
T ss_pred             ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCccCCHHHH
Confidence            332 23445789999999977655 8999999999999999999999998866555444443333 33344566789999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +|+.+||+ ||++|||++++++
T Consensus       270 ~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          270 AIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHH
Confidence            99999998 9999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-47  Score=333.10  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=206.0

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-----CCceEEeeeeEEe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-----NKYIIVCYSVWLD   89 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~   89 (289)
                      .++| ++.++||+|+||+||+|.+..+++.||+|+++.     .......+..|+.+++.+.     ||||+++++.+..
T Consensus        34 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           34 NNAF-LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             TTTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             cCEE-EEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            3455 789999999999999999999999999999973     3444667788999999997     9999999998866


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC----------
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING----------  157 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~----------  157 (289)
                      .  +.+++|||++ +++|.+++....  .+++..+..++.|++.||.|||++|  ++|+||||+||+++.          
T Consensus       108 ~--~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          108 Y--DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             T--TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             C--CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccch
Confidence            5  5799999999 789999998754  5999999999999999999999999  999999999999974          


Q ss_pred             --------------CCCcEEEeccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCC
Q 022956          158 --------------NIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYS  222 (289)
Q Consensus       158 --------------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~  222 (289)
                                    ..+.+||+|||++......  .....+++.|+|||.+.+ .++.++|||||||++|+|++|..||.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                          1379999999999865443  234578999999997665 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHhCCCCCC-------------------------------------------CCCCCCChHHHHHHHHHH
Q 022956          223 ECDSVAKIYKKVTGGVKPQ-------------------------------------------ALNKVKDPEVKAFIEKCI  259 (289)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l  259 (289)
                      ...................                                           ......++.+.+|+.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            7655444332222111100                                           000112367889999999


Q ss_pred             c-CCCCCCCHHHHhcCcccc
Q 022956          260 A-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       260 ~-dp~~Rps~~~il~h~~~~  278 (289)
                      + ||++|||++|+|+||||+
T Consensus       341 ~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          341 QIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CSSGGGSCCHHHHTTSGGGC
T ss_pred             cCChhhCCCHHHHhcCcccC
Confidence            9 999999999999999996

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.1e-47  Score=329.90  Aligned_cols=264  Identities=25%  Similarity=0.410  Sum_probs=214.1

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC--
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD--   90 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   90 (289)
                      ...++| ++.+.||+|+||+||+|.+..+|+.||+|++...   ........+.+|++++++++||||+++++++...  
T Consensus         8 ~i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            8 NISSDF-QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CSCTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccce-EEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            456666 7899999999999999999999999999999643   2455667788999999999999999999876542  


Q ss_pred             -CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 -QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 -~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                       .....++|+|++.+ +|.+++.. ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        84 ~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~  158 (353)
T 2b9h_A           84 ENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGL  158 (353)
T ss_dssp             TTCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTT
T ss_pred             CccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCC-CcEEEEeccc
Confidence             23578999999986 89999886 56999999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccc-----------cccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-
Q 022956          170 AAIVGRSHA-----------AHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT-  235 (289)
Q Consensus       170 ~~~~~~~~~-----------~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-  235 (289)
                      +........           .....+++.|+|||.+.  ..++.++|||||||++++|++|..||.+............ 
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            987643211           12346789999999654  3488999999999999999999999987654443332221 


Q ss_pred             -CCCC-C--------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          236 -GGVK-P--------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       236 -~~~~-~--------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                       +... .                          .......++.+.+|+.+||+ ||++|||++++++||||+...+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  317 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND  317 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence             1100 0                          00113468899999999999 9999999999999999999876554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.2e-47  Score=332.96  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=209.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC--
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN--   93 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--   93 (289)
                      ++| ++.+.||+|+||+||+|.++.+|+.||+|++.....  .+.....+.+|+.+++.++||||+++++++......  
T Consensus        42 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           42 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             ccE-EEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc--chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            455 689999999999999999999999999999976432  456678899999999999999999999988554321  


Q ss_pred             --eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           94 --TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        94 --~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                        .+++||||+.+ +|.+.+.  ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus       119 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kL~Dfg~a~  192 (371)
T 4exu_A          119 FYDFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLAR  192 (371)
T ss_dssp             CCCCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECSTTCC-
T ss_pred             ceeEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCC-CCEEEEecCccc
Confidence              24899999985 8888774  34999999999999999999999999  9999999999999998 899999999998


Q ss_pred             ccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC---------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---------  240 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------  240 (289)
                      .....  .....+++.|+|||.+.+  .++.++||||||+++++|++|..||.+..........+.....+         
T Consensus       193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          193 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             ccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            65433  234568999999997654  48999999999999999999999998866555544433211110         


Q ss_pred             -------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          241 -------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       241 -------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                                         .......++.+.+|+.+||+ ||++|||++|+|+||||+.+..+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  334 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  334 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence                               00123458899999999999 999999999999999999875543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.6e-47  Score=321.57  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=206.0

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   93 (289)
                      .++| ++.+.||+|+||+||+|.++.+++.||+|++.....  .......+.+|+..+..+ +||||+++++++...  +
T Consensus        10 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~   84 (289)
T 1x8b_A           10 TTEF-HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--D   84 (289)
T ss_dssp             HHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--T
T ss_pred             cchh-hhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--C
Confidence            3455 689999999999999999999999999999986543  333456788899999999 999999999988654  5


Q ss_pred             eeEEEeccccCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-----------
Q 022956           94 TLNFITEVCTSGNLRTYRKKH----RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-----------  158 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-----------  158 (289)
                      .+++||||+++++|.+++...    ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+           
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccc
Confidence            899999999999999999864    67999999999999999999999999  9999999999999843           


Q ss_pred             -------CCcEEEeccCCccccCCccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 022956          159 -------IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK  229 (289)
Q Consensus       159 -------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~  229 (289)
                             ...++|+|||.+.......   ...+++.|+|||.+.+.  +++++||||||+++++|++|..++.....   
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             cccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                   2479999999998765432   34589999999977654  55799999999999999999877654322   


Q ss_pred             HHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          230 IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                       ...+..+.. ...+...++.+.+++.+||+ ||++|||++++++||||++..
T Consensus       237 -~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          237 -WHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             -HHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             -HHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence             222333322 23445678999999999998 999999999999999998753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.8e-47  Score=335.77  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=206.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC----CCe
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ----HNT   94 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   94 (289)
                      |++.++||+|+||+||+|.+..++. +|+|++......        ..+|+++++.++||||+++++++....    ..+
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            4789999999999999999987766 888888643321        235899999999999999999886532    234


Q ss_pred             eEEEeccccCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           95 LNFITEVCTSGNLRTYR---KKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      +++||||++++.+....   .....+++..+..++.|++.||.|||++|  ++|+||||+||+++...+.+||+|||++.
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            78999999885433332   23567999999999999999999999999  99999999999999433899999999998


Q ss_pred             ccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC---------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP---------  240 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------  240 (289)
                      ............+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+..........+.....+         
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            7765555556778999999997654  38999999999999999999999999876665555444311000         


Q ss_pred             -----------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          241 -----------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       241 -----------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                                       .......++.+.+|+.+||+ ||.+|||+.++++||||+++.+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence                             01223467899999999999 999999999999999999987654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.6e-47  Score=325.98  Aligned_cols=265  Identities=29%  Similarity=0.421  Sum_probs=213.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeec-CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC---CCCceEEeeeeEEe
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQ-EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL---KNKYIIVCYSVWLD   89 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~   89 (289)
                      ..++| ++.+.||+|+||+||+|.+. .+|+.||+|+++.......  ....+.+|+.+++.+   +||||+++++++..
T Consensus         9 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            9 ADQQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             GGGTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             chhce-eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            34555 78999999999999999985 6789999999986543211  112344566655555   89999999998752


Q ss_pred             ---CCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           90 ---DQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        90 ---~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                         .....+++|+||+.+ +|.+++...  ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~-~~~kl  161 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKL  161 (326)
T ss_dssp             EECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEE
T ss_pred             cccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC-CCEEE
Confidence               234678999999985 999999864  34999999999999999999999999  9999999999999998 89999


Q ss_pred             eccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC----
Q 022956          165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK----  239 (289)
Q Consensus       165 ~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----  239 (289)
                      +|||++.............+++.|+|||.+.+ .++.++||||||+++++|++|..||.+..........+.....    
T Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            99999987765555556678999999997654 4899999999999999999999999886665554444321100    


Q ss_pred             --------------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          240 --------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       240 --------------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                          ........++.+++|+.+||+ ||++||+++++++||||+++.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence                                011224468899999999998 9999999999999999999876543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.2e-47  Score=332.75  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=205.5

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC-------CCHHHHHHHHHHHHHHHhCCCCceEEeeee
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-------EDPVLVNRLHSEVQLLRTLKNKYIIVCYSV   86 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   86 (289)
                      ..++| ++.++||+|+||+||+|.+.. |..||+|++......       .+....+.+.+|++++++++||||++++++
T Consensus        20 ~~~~y-~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           20 MQSPY-TVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             TTCSC-EEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             hccce-EEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            44566 789999999999999998864 999999999764332       234456889999999999999999999998


Q ss_pred             EEeC---CCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcE
Q 022956           87 WLDD---QHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV  162 (289)
Q Consensus        87 ~~~~---~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~  162 (289)
                      +...   ....+++||||+.| +|.+.+... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~  173 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDI  173 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCE
T ss_pred             EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC-CCE
Confidence            8653   33578999999986 787777653 47999999999999999999999999  9999999999999988 899


Q ss_pred             EEeccCCccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC
Q 022956          163 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP  240 (289)
Q Consensus       163 ~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  240 (289)
                      +|+|||++.............+++.|+|||.+.+  .++.++|||||||++++|++|..||.+................+
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999999986655555556678999999997654  48999999999999999999999998866554444333211100


Q ss_pred             -----------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          241 -----------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       241 -----------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                                                   .......++.+.+|+.+||+ ||++|||++++++||||+++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                                         01122347889999999999 9999999999999999998743

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.5e-47  Score=331.15  Aligned_cols=261  Identities=25%  Similarity=0.302  Sum_probs=200.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC----
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ----   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   91 (289)
                      ++| ++.++||+|+||+||+|.++.+|+.||+|++......     .....++++.++.++||||+++++++....    
T Consensus        23 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           23 DRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             TTE-EEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             cce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            455 6899999999999999999999999999998654322     234556788888999999999999886532    


Q ss_pred             -CCeeEEEeccccCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHh--cCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           92 -HNTLNFITEVCTSGNLRTYR----KKHRHVSIKALKKWSKQVLEGLEYLH--THEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        92 -~~~~~lv~e~~~~~sL~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lh--~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                       ..++++||||+++ +|...+    .....+++..+..++.|++.||.|||  +.|  ++|+||||+||+++...+.+||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence             2348899999988 554433    34567899999999999999999999  888  9999999999999973389999


Q ss_pred             eccCCccccCCccccccCCCCCCCCCCccccc-C-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--
Q 022956          165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--  240 (289)
Q Consensus       165 ~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--  240 (289)
                      +|||++.............+++.|+|||.+.+ . ++.++||||||+++|+|++|..||.+................+  
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            99999988776655566778999999997643 3 7999999999999999999999998866555544443211100  


Q ss_pred             ---------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          241 ---------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       241 ---------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                                 .......++.+.+|+.+||+ ||++|||+.|+|+||||++...+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence                                       00111246789999999999 9999999999999999999876554

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-48  Score=335.94  Aligned_cols=259  Identities=23%  Similarity=0.383  Sum_probs=211.6

Q ss_pred             CcccceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   91 (289)
                      ++| ++.++||+|+||+||+|.+.   .+|+.||+|+++...........+.+.+|+++++.+ +||||+++++.+... 
T Consensus        54 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  131 (355)
T 1vzo_A           54 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  131 (355)
T ss_dssp             GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             cce-EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence            344 78999999999999999884   589999999987643221222234566789999999 699999999988554 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       ..+++||||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++.
T Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~DfG~a~  207 (355)
T 1vzo_A          132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSK  207 (355)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred             -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CcEEEeeCCCCe
Confidence             579999999999999999998888999999999999999999999999  9999999999999998 899999999997


Q ss_pred             ccCCc--cccccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHhCCCCCCCC
Q 022956          172 IVGRS--HAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSEC---DSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       172 ~~~~~--~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~  243 (289)
                      .....  .......+++.|+|||.+.+   .++.++|||||||++|+|++|..||...   .........+.....  ..
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~  285 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PY  285 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CC
Confidence            65432  22334578999999997764   2788999999999999999999999742   233333333333222  23


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCC-----CHHHHhcCcccccCCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARP-----SASELLKDPFFSELND  282 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~  282 (289)
                      +...++.+.+||.+||. ||++||     +++++++||||++++|
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence            45568899999999998 999999     9999999999998764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=338.87  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=193.5

Q ss_pred             CcccceeeeecccCcceEEEEeec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ++|...+++||+|+||+||+|.++  .+++.||+|++.....      ...+.+|+.+++.++||||+++++++......
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            444323578999999999999965  5789999999975432      24577899999999999999999999877678


Q ss_pred             eeEEEeccccCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE----eCCCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKH---------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI----NGNIG  160 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili----~~~~~  160 (289)
                      .+++||||+.+ +|.+++...         ..+++..+..++.|++.||.|||++|  ++|+||||+||++    +.+ +
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~  169 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPER-G  169 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTT-T
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCC-C
Confidence            89999999976 888877532         24999999999999999999999999  9999999999999    445 8


Q ss_pred             cEEEeccCCccccCCc----cccccCCCCCCCCCCccccc-C-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH-------
Q 022956          161 QVKIGDLGFAAIVGRS----HAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV-------  227 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~-------  227 (289)
                      .+||+|||++......    .......+++.|+|||.+.+ . ++.++|||||||++|+|++|..||.+....       
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            9999999999876533    22334578999999997664 3 899999999999999999999999754321       


Q ss_pred             --HHHHHHH--hCCCCCCCC---------------------------------CCCCChHHHHHHHHHHc-CCCCCCCHH
Q 022956          228 --AKIYKKV--TGGVKPQAL---------------------------------NKVKDPEVKAFIEKCIA-QPRARPSAS  269 (289)
Q Consensus       228 --~~~~~~~--~~~~~~~~~---------------------------------~~~~~~~~~~li~~~l~-dp~~Rps~~  269 (289)
                        ......+  .+......+                                 ....++.+.+||.+||+ ||.+|||++
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence              2221111  111111100                                 11126788999999999 999999999


Q ss_pred             HHhcCcccccCCCCCC
Q 022956          270 ELLKDPFFSELNDDDS  285 (289)
Q Consensus       270 ~il~h~~~~~~~~~~~  285 (289)
                      |+|+||||.+...+..
T Consensus       330 e~L~hp~f~~~~~~~~  345 (405)
T 3rgf_A          330 QAMQDPYFLEDPLPTS  345 (405)
T ss_dssp             HHHTSGGGTSSSCCCS
T ss_pred             HHhcChhhccCCCCcc
Confidence            9999999998765543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.4e-47  Score=329.33  Aligned_cols=260  Identities=23%  Similarity=0.369  Sum_probs=210.1

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC--
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--   92 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   92 (289)
                      .++| ++.+.||+|+||+||+|.++.+|+.||+|++.....  .+...+.+.+|+.+++.++||||+++++++.....  
T Consensus        23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           23 PKTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             ETTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CceE-EEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            4555 689999999999999999999999999999976432  45667789999999999999999999998855432  


Q ss_pred             --CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           93 --NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        93 --~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ..+++||||+.+ +|.+++..  .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~  173 (353)
T 3coi_A          100 NFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLA  173 (353)
T ss_dssp             GCCCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-CCEEECSTTCT
T ss_pred             cceeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCC-CcEEEeecccc
Confidence              235999999985 88887753  4999999999999999999999999  9999999999999998 89999999999


Q ss_pred             cccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC-----------
Q 022956          171 AIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG-----------  237 (289)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----------  237 (289)
                      ......  .....+++.|+|||.+.+  .++.++||||||+++++|++|..||.+..............           
T Consensus       174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            865433  234567899999997654  48899999999999999999999998765544433322210           


Q ss_pred             -----------------CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          238 -----------------VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       238 -----------------~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                       ..........++.+.+|+.+||+ ||++|||++++++||||+......+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~  317 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  317 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccc
Confidence                             00111223468899999999999 9999999999999999998765443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.7e-47  Score=322.42  Aligned_cols=263  Identities=23%  Similarity=0.396  Sum_probs=210.2

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC--CCceEEeeeeEEeC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--NKYIIVCYSVWLDD   90 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   90 (289)
                      ...++.|++.+.||+|+||.||++.+. +++.||+|++.....  .....+.+.+|++++++++  |+||+++++++...
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            344454588999999999999999885 589999999986543  4566788999999999997  49999999987554


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ..+++||| +.+++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.  +.++|+|||++
T Consensus       101 --~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~--~~~kL~Dfg~~  173 (313)
T 3cek_A          101 --QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIA  173 (313)
T ss_dssp             --SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSSS
T ss_pred             --CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC--CeEEEeecccc
Confidence              57999999 556799999998889999999999999999999999999  999999999999974  68999999999


Q ss_pred             cccCCccc---cccCCCCCCCCCCccccc------------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Q 022956          171 AIVGRSHA---AHSIIGTPEYMAPELYEE------------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT  235 (289)
Q Consensus       171 ~~~~~~~~---~~~~~~~~~~~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~  235 (289)
                      ........   .....+++.|+|||.+.+            .++.++||||||+++++|++|..||..............
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            86643322   234568999999997653            478899999999999999999999987654444444444


Q ss_pred             CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          236 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      ........+...++.+.+++.+||+ ||++||+++++++||||+....+..
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  304 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  304 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence            4333334455568899999999998 9999999999999999998765544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.4e-48  Score=327.82  Aligned_cols=262  Identities=26%  Similarity=0.477  Sum_probs=192.5

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      .....|++.+.||+|+||+||+|.+..+++.||+|++.....   ....+.+.+|+.++++++||||+++++++...  +
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--D   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESS--S
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--C
Confidence            333344789999999999999999999999999999875432   23356788899999999999999999988654  5


Q ss_pred             eeEEEeccccCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           94 TLNFITEVCTSGNLRTYRKK--------HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~--------~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                      ..++||||+++++|.+++..        ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC-CCEEEE
Confidence            68999999999999999874        456999999999999999999999999  9999999999999998 899999


Q ss_pred             ccCCccccCCcc------ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC
Q 022956          166 DLGFAAIVGRSH------AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       166 d~g~~~~~~~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  237 (289)
                      |||++.......      ......+++.|+|||.+.+  .++.++||||||+++++|++|..||................
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            999987654321      1233468999999997754  48999999999999999999999998766555554444433


Q ss_pred             CCC-------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          238 VKP-------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       238 ~~~-------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      ...       .......++.+.+++.+||+ ||.+||+++++++||||++....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            221       11224467899999999999 99999999999999999987543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.9e-47  Score=319.70  Aligned_cols=252  Identities=29%  Similarity=0.470  Sum_probs=204.7

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEeccc
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVC  102 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  102 (289)
                      ..||+|+||+||+|.+..++..||+|.+....    ....+.+.+|+.+++.++||||+++++++...  +..++|+||+
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~  101 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQV  101 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECC
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEeC
Confidence            48999999999999999999999999997542    33457788999999999999999999988554  5799999999


Q ss_pred             cCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-c
Q 022956          103 TSGNLRTYRKKH---RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-A  178 (289)
Q Consensus       103 ~~~sL~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-~  178 (289)
                      ++++|.+++...   ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++...+.++|+|||++....... .
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            999999999864   24678999999999999999999999  99999999999999833899999999998765432 2


Q ss_pred             cccCCCCCCCCCCcccccC---CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED---YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                      .....+++.|+|||.+.+.   ++.++||||||+++++|++|..||......................+...++.+.+++
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI  259 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence            3345689999999977542   7889999999999999999999997654433322222111122234556789999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          256 EKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .+||+ ||++||+++++++||||+....
T Consensus       260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          260 LKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHccCChhhCCCHHHHhcChhhhhccc
Confidence            99998 9999999999999999987643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-46  Score=334.88  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=205.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC------CCCceEEeeeeEE
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL------KNKYIIVCYSVWL   88 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~   88 (289)
                      ..+| ++.++||+|+||+||+|.+..+++.||+|+++.     .......+.+|+++++.+      +|+||+.+++.+.
T Consensus        96 ~~ry-~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           96 AYRY-EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             TTTE-EEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cCcE-EEEEEcccCccEEEEEEEECCCCcEEEEEEECC-----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            3455 789999999999999999999999999999974     344456677788888777      5679999999886


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc--EEE
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--VKI  164 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~--~~l  164 (289)
                      ..  ..+++|||++.+ +|.+++....  .+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.  +||
T Consensus       170 ~~--~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vkL  243 (429)
T 3kvw_A          170 FR--NHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIKV  243 (429)
T ss_dssp             ET--TEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEEE
T ss_pred             cC--CeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceEE
Confidence            54  679999999975 9999988653  5999999999999999999999999  9999999999999988 66  999


Q ss_pred             eccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC--
Q 022956          165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--  241 (289)
Q Consensus       165 ~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--  241 (289)
                      +|||++......  .....+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+..........+.....+.  
T Consensus       244 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          244 IDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             CCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            999999765433  334578999999997665 499999999999999999999999988665555443332100000  


Q ss_pred             ------------------------------------------------------CCCCCCChHHHHHHHHHHc-CCCCCC
Q 022956          242 ------------------------------------------------------ALNKVKDPEVKAFIEKCIA-QPRARP  266 (289)
Q Consensus       242 ------------------------------------------------------~~~~~~~~~~~~li~~~l~-dp~~Rp  266 (289)
                                                                            ......++.+.+||.+||+ ||++||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence                                                                  0112347889999999999 999999


Q ss_pred             CHHHHhcCcccccCC
Q 022956          267 SASELLKDPFFSELN  281 (289)
Q Consensus       267 s~~~il~h~~~~~~~  281 (289)
                      |++|+|+||||++..
T Consensus       402 ta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          402 TPGQALRHPWLRRRL  416 (429)
T ss_dssp             CHHHHHTSTTTC---
T ss_pred             CHHHHhCChhhccCC
Confidence            999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.2e-48  Score=329.38  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=206.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.+..+++.||+|++...    +....+.+.+|++++++++||||+++++++...  +..
T Consensus        10 ~~~-~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~   82 (310)
T 3s95_A           10 SDL-IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRL   82 (310)
T ss_dssp             GGE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred             hHe-eccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Cee
Confidence            444 6899999999999999999999999999998542    566678899999999999999999999998655  679


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++++|.+++.. ...+++.++..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT-SCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC-CCEEEeecccceecc
Confidence            999999999999999987 567999999999999999999999999  9999999999999998 899999999998664


Q ss_pred             Ccccc---------------ccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHH
Q 022956          175 RSHAA---------------HSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVA-----KIYKK  233 (289)
Q Consensus       175 ~~~~~---------------~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~-----~~~~~  233 (289)
                      .....               ....|++.|+|||.+.+. +++++||||||+++|+|++|..||.......     .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  239 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF  239 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence            32221               145689999999977655 8999999999999999999999987532110     00111


Q ss_pred             HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ...     ..+...++.+.+++.+||+ ||++|||++++++  +++.+
T Consensus       240 ~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          240 LDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             HHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            111     1234567899999999999 9999999999998  76655

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.8e-47  Score=326.23  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=190.7

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH-HHHhCCCCceEEeeeeEEeCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ-LLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      +.....|++.+.||+|+||.||+|.++.+|+.||+|++....   .......+..|+. +++.++||||+++++++... 
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-   93 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-   93 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-
Confidence            333334478999999999999999999999999999997543   2333444555555 77888999999999988654 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEe
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                       +..++||||+.+ +|.+++..     ...+++..+..++.|++.||.|||+. |  ++|+||+|+||+++.+ +.+||+
T Consensus        94 -~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~-~~~kl~  168 (327)
T 3aln_A           94 -GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS-GNIKLC  168 (327)
T ss_dssp             -SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETT-TEEEEC
T ss_pred             -CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCC-CCEEEc
Confidence             578999999987 88888763     56799999999999999999999998 9  9999999999999998 899999


Q ss_pred             ccCCccccCCccccccCCCCCCCCCCcccc-----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC
Q 022956          166 DLGFAAIVGRSHAAHSIIGTPEYMAPELYE-----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP  240 (289)
Q Consensus       166 d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  240 (289)
                      |||++.............+++.|+|||.+.     ..++.++||||||+++++|++|..||............+..+..+
T Consensus       169 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (327)
T 3aln_A          169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP  248 (327)
T ss_dssp             CCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred             cCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence            999998775554444457899999999762     348899999999999999999999998654332222222222111


Q ss_pred             C---CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          241 Q---ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       241 ~---~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      .   ......++.+.+|+.+||+ ||++||+++++++||||.+..+..
T Consensus       249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  296 (327)
T 3aln_A          249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA  296 (327)
T ss_dssp             CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred             CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhH
Confidence            1   1123468899999999998 999999999999999998765443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.8e-49  Score=343.25  Aligned_cols=250  Identities=20%  Similarity=0.218  Sum_probs=196.5

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHH---HHHHhCCCCceEEee-------ee
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV---QLLRTLKNKYIIVCY-------SV   86 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~---~~l~~l~~~~i~~~~-------~~   86 (289)
                      +.|++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+   +.+++++||||++++       ++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4457899999999999999999999999999999865432 334567888999   555666899999887       44


Q ss_pred             EEeCCC----------C-----eeEEEeccccCCcHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHhcCCCCce
Q 022956           87 WLDDQH----------N-----TLNFITEVCTSGNLRTYRKKHRHVSI-------KALKKWSKQVLEGLEYLHTHEPCII  144 (289)
Q Consensus        87 ~~~~~~----------~-----~~~lv~e~~~~~sL~~~~~~~~~l~~-------~~~~~~~~ql~~~l~~lh~~~~~~~  144 (289)
                      +...+.          +     ..+++|||+ +++|.+++...+.+++       ..+..++.|++.||.|||++|  ++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            332210          1     378999999 5699999987555555       788899999999999999999  99


Q ss_pred             ecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCccccc------------CCCCcchHHHHHHHHH
Q 022956          145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE------------DYTEMVDIYSFGLCLL  212 (289)
Q Consensus       145 h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~------------~~~~~~Di~slG~il~  212 (289)
                      |+||||+||+++.+ +.+||+|||++.....  ......+ +.|+|||.+.+            .++.++|||||||++|
T Consensus       229 HrDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          229 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CSCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            99999999999988 8999999999986543  2334566 99999997653            4899999999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          213 EMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       213 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +|++|..||.+....... ..+.      ......++.+.+|+.+||+ ||++||++.++++||||+++.
T Consensus       305 elltg~~Pf~~~~~~~~~-~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          305 WIWCADLPITKDAALGGS-EWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHSSCCC------CCS-GGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHHCCCCCcccccccch-hhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            999999999753322111 1111      1124568999999999999 999999999999999998764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.5e-47  Score=328.98  Aligned_cols=258  Identities=24%  Similarity=0.424  Sum_probs=214.6

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCH-------------HHHHHHHHHHHHHHhCCCCceEE
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP-------------VLVNRLHSEVQLLRTLKNKYIIV   82 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~   82 (289)
                      ++| ++.+.||+|+||.||+|.+  +|+.||+|++.........             ...+.+.+|++++++++||||++
T Consensus        31 ~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           31 NDY-RIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             TTE-EEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             Cce-EEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            455 6899999999999999998  8999999999865432111             11277889999999999999999


Q ss_pred             eeeeEEeCCCCeeEEEeccccCCcHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCce
Q 022956           83 CYSVWLDDQHNTLNFITEVCTSGNLRTY------RKK--HRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNI  153 (289)
Q Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~------~~~--~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~ni  153 (289)
                      +++++...  +.+++||||+++++|.++      +..  ...+++..+..++.|++.||.|||+ +|  ++|+||+|+||
T Consensus       108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni  183 (348)
T 2pml_X          108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI  183 (348)
T ss_dssp             CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred             EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence            99988554  689999999999999998      665  5779999999999999999999999 99  99999999999


Q ss_pred             EEeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCcccccC--CCC-cchHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 022956          154 FINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YTE-MVDIYSFGLCLLEMVTMEIPYSECDSVAKI  230 (289)
Q Consensus       154 li~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~-~~Di~slG~il~~l~tg~~p~~~~~~~~~~  230 (289)
                      +++.+ +.++|+|||.+...... ......+++.|+|||.+.+.  ++. ++||||||+++++|++|..||.........
T Consensus       184 l~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          184 LMDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             EECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EEcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99998 89999999999876443 34456789999999987654  444 899999999999999999999887664555


Q ss_pred             HHHHhCCCCCCCC-----------------CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          231 YKKVTGGVKPQAL-----------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       231 ~~~~~~~~~~~~~-----------------~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ...+.........                 ....++.+.+|+.+||+ ||.+|||++++++||||++..+
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~  331 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI  331 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence            5555544222111                 14578999999999999 9999999999999999998754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-46  Score=318.29  Aligned_cols=254  Identities=32%  Similarity=0.513  Sum_probs=205.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC-----
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD-----   90 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   90 (289)
                      ++| ++.+.||+|+||.||+|.+..+|+.||+|++...     ....+.+.+|+++++.++|||++++++.+...     
T Consensus         6 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            6 SDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccc-hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            345 6899999999999999999999999999999642     44567889999999999999999999987653     


Q ss_pred             ------CCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956           91 ------QHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus        91 ------~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                            ....+++||||+++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~-~~~k  156 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVK  156 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC-CCEE
Confidence                  236789999999999999999854 46888999999999999999999999  9999999999999988 8999


Q ss_pred             EeccCCccccCCc---------------cccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 022956          164 IGDLGFAAIVGRS---------------HAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDS  226 (289)
Q Consensus       164 l~d~g~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~  226 (289)
                      |+|||++......               .......+++.|+|||.+.+  .++.++||||||+++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999999765422               12234468899999997764  48999999999999999998   6654333


Q ss_pred             HHHHHHHHhCCC--CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          227 VAKIYKKVTGGV--KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       227 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .......+....  .+.......++.+++++.+||+ ||++|||++++++||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            344444444322  2233445567889999999998 999999999999999998654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=319.25  Aligned_cols=257  Identities=24%  Similarity=0.427  Sum_probs=194.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||.||+|.++.+|+.||+|++.....  .....+.+.++..+++.++||||+++++++...  +.+
T Consensus        25 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~   99 (318)
T 2dyl_A           25 NDL-ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDV   99 (318)
T ss_dssp             GGE-EEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             ccc-cccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcE
Confidence            344 568999999999999999999999999999986532  233345566666778899999999999988654  579


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ++||||+ ++.+..+... ...+++..+..++.|++.||.|||+. |  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GQIKLCDFGISGRL  175 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT-SCEEECCCTTC---
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC-CCEEEEECCCchhc
Confidence            9999999 5466666554 56799999999999999999999995 9  9999999999999988 89999999999776


Q ss_pred             CCccccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-hCCCCCCCCCCC
Q 022956          174 GRSHAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV-TGGVKPQALNKV  246 (289)
Q Consensus       174 ~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (289)
                      ..........+++.|+|||.+.      ..+++++||||||+++++|++|..||............+ ............
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG  255 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence            5554445567899999999763      348889999999999999999999998754444444333 333322222345


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .++.+.+++.+||+ ||.+||+++++++||||++..
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            68999999999998 999999999999999998753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.2e-47  Score=324.53  Aligned_cols=261  Identities=20%  Similarity=0.317  Sum_probs=192.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .++| ++.+.||+|+||+||+|.+..++.   .||+|+++....  .....+.+.+|++++++++||||+++++++....
T Consensus        22 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           22 EQQF-TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             ---C-EEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             hhHe-EEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            4444 789999999999999999887765   899999976543  3344678999999999999999999999886543


Q ss_pred             CC----eeEEEeccccCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc
Q 022956           92 HN----TLNFITEVCTSGNLRTYRKKHR------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ  161 (289)
Q Consensus        92 ~~----~~~lv~e~~~~~sL~~~~~~~~------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~  161 (289)
                      ..    ..++|+||+.+++|.+++....      .+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~-~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC-CC
Confidence            21    2389999999999999986532      5999999999999999999999999  9999999999999998 89


Q ss_pred             EEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhC
Q 022956          162 VKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG  236 (289)
Q Consensus       162 ~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  236 (289)
                      ++|+|||++........   .....+++.|+|||.+.+. ++.++||||||+++|+|++ |..||.+.............
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            99999999976643322   2233457789999977654 8999999999999999999 99999876655554444443


Q ss_pred             CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCC-------HHHHhcCcccccCCCC
Q 022956          237 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPS-------ASELLKDPFFSELNDD  283 (289)
Q Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps-------~~~il~h~~~~~~~~~  283 (289)
                      .. . ..+...++.+.+|+.+||+ ||++|||       +++++.|||+....++
T Consensus       256 ~~-~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          256 NR-L-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             CC-C-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             CC-C-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            32 2 2344568999999999998 9999999       7888899999886554

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=323.18  Aligned_cols=253  Identities=21%  Similarity=0.292  Sum_probs=207.5

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ...|++.+.||+|+||+||+|.+..++.   .||+|+++...   .....+.+.+|+++++.++||||+++++++..  +
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--G  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--G
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--C
Confidence            3344789999999999999999886655   49999997532   45567789999999999999999999998844  3


Q ss_pred             CeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      +.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~  199 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSR  199 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCSSCE
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC-CCEEECCCCccc
Confidence            6789999999999999999754 57999999999999999999999999  9999999999999998 899999999998


Q ss_pred             ccCCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          172 IVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       172 ~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      .......    .....+++.|+|||.+.+. ++.++||||||+++|+|++ |..||.+......... +..+.... .+.
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~-~~~  277 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEGYRLP-APM  277 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTTCCCC-CCT
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCCCC-CCC
Confidence            7654321    2223456789999977644 8999999999999999999 9999987655544444 44432222 344


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ..++.+.+|+..||. ||++|||++++++  .++.+
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~--~L~~l  311 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS--VLDAL  311 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            578999999999998 9999999999998  66555

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-46  Score=324.94  Aligned_cols=261  Identities=19%  Similarity=0.292  Sum_probs=185.1

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe--C
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD--D   90 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   90 (289)
                      ...++|..+.+.||+|+||+||+|.++.+|+.||+|++...     ....   .+....++.++|||++++++++..  .
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKAR---QEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHH---HHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            45566643356799999999999999999999999999642     2222   223344677899999999998864  2


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEec
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGD  166 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d  166 (289)
                      ++..+++||||++|++|.+++...  ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+  .+.++|+|
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEec
Confidence            235689999999999999999875  36999999999999999999999999  9999999999999764  25699999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhC--CCCC
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKI---YKKVTG--GVKP  240 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~---~~~~~~--~~~~  240 (289)
                      ||++...... ......+++.|+|||.+.+. +++++||||||+++|+|++|..||.........   ...+..  ...+
T Consensus       175 fg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          175 FGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             CTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             cccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            9999766533 23345679999999987654 888999999999999999999999764322211   111111  1112


Q ss_pred             CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      .......++.+.+|+.+||+ ||++|||++++++||||++.....
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence            22234568999999999998 999999999999999998764433

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-45  Score=311.75  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=206.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHH---HHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLV---NRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      .++| ++.+.||+|+||+||+|.+..+++.||+|++............   +.+.+|++++++++||||+++++++.+. 
T Consensus        18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   95 (287)
T 4f0f_A           18 DNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-   95 (287)
T ss_dssp             STTE-EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred             hccc-eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence            4455 7899999999999999999999999999999876544333332   6789999999999999999999987332 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc-----EEEe
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ-----VKIG  165 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~-----~~l~  165 (289)
                         .++||||+++++|.+.+.. ...+++..+..++.|++.||.|||++|++++|+||+|+||+++.+ +.     ++|+
T Consensus        96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~  171 (287)
T 4f0f_A           96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKVA  171 (287)
T ss_dssp             ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEEC
T ss_pred             ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEeC
Confidence               3689999999999888865 457999999999999999999999998779999999999999876 55     9999


Q ss_pred             ccCCccccCCccccccCCCCCCCCCCcccc---cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhCCCCCC
Q 022956          166 DLGFAAIVGRSHAAHSIIGTPEYMAPELYE---EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA-KIYKKVTGGVKPQ  241 (289)
Q Consensus       166 d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~  241 (289)
                      |||++......  .....+++.|+|||.+.   ..+++++||||||+++|+|++|..||....... .....+.......
T Consensus       172 Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  249 (287)
T 4f0f_A          172 DFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP  249 (287)
T ss_dssp             CCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred             CCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence            99999755432  33456899999999873   237889999999999999999999998654322 2233333333333


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..+...++.+.+++.+||+ ||++|||++++++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            4556678999999999999 9999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-47  Score=335.69  Aligned_cols=259  Identities=15%  Similarity=0.170  Sum_probs=191.1

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC--CCCceEEee-------eeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL--KNKYIIVCY-------SVW   87 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~   87 (289)
                      +-|++.++||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+++++.+  +|||+++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3357899999999999999999999999999999875432 244566778885544444  699988755       333


Q ss_pred             EeCCC---------------CeeEEEeccccCCcHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHhcCCCCcee
Q 022956           88 LDDQH---------------NTLNFITEVCTSGNLRTYRKKH-RHVSIKAL------KKWSKQVLEGLEYLHTHEPCIIH  145 (289)
Q Consensus        88 ~~~~~---------------~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~------~~~~~ql~~~l~~lh~~~~~~~h  145 (289)
                      .....               ..+++||||++ ++|.+++... ..++...+      ..++.|++.||.|||++|  ++|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH  217 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH  217 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence            22221               34899999998 6999999863 34555555      677899999999999999  999


Q ss_pred             cCCCCCceEEeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCC
Q 022956          146 RDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYS  222 (289)
Q Consensus       146 ~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~  222 (289)
                      +||||+||+++.+ +.+||+|||++........  ...+++.|+|||.+.+   .++.++|||||||++|+|++|..||.
T Consensus       218 rDikp~NIll~~~-~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          218 GHFTPDNLFIMPD-GRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             TTCSGGGEEECTT-SCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CcCCHHHEEECCC-CCEEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999999998 8999999999987654321  3446699999997764   48999999999999999999999998


Q ss_pred             CCCcHHHH-HHH---Hh--CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          223 ECDSVAKI-YKK---VT--GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       223 ~~~~~~~~-~~~---~~--~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      +....... ...   ..  ............++.+.+|+.+||+ ||++|||++++|+||||+++.+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            64221100 000   00  0000111123568999999999998 9999999999999999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.9e-46  Score=321.40  Aligned_cols=255  Identities=23%  Similarity=0.354  Sum_probs=205.1

Q ss_pred             CCcccceeeeecccCcceEEEEee-cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc------eEEeeeeE
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFD-QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY------IIVCYSVW   87 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~   87 (289)
                      .++| ++.++||+|+||+||+|.+ +.+|+.||+|+++.     .....+.+.+|+++++.++|++      ++++++++
T Consensus        13 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           13 SARY-EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             TTTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             cCce-EEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            4565 7899999999999999998 56789999999964     3445677888999999887654      88888887


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-------
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-------  158 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-------  158 (289)
                      ...  +.+++||||+ +++|.+++....  ++++..+..++.|++.||.|||++|  ++|+||+|+||+++.+       
T Consensus        87 ~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           87 EHH--GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred             ccC--CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence            554  6899999999 779999998764  6899999999999999999999999  9999999999999862       


Q ss_pred             -----------CCcEEEeccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 022956          159 -----------IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDS  226 (289)
Q Consensus       159 -----------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~  226 (289)
                                 .+.++|+|||++......  .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.....
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             CccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       268999999999865433  234578999999997765 489999999999999999999999987654


Q ss_pred             HHHHHHH--HhCCCCC---------------------------------------CCCCCCCChHHHHHHHHHHc-CCCC
Q 022956          227 VAKIYKK--VTGGVKP---------------------------------------QALNKVKDPEVKAFIEKCIA-QPRA  264 (289)
Q Consensus       227 ~~~~~~~--~~~~~~~---------------------------------------~~~~~~~~~~~~~li~~~l~-dp~~  264 (289)
                      .......  +....+.                                       .......++.+.+|+.+||+ ||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            4332221  1111100                                       00011224678899999999 9999


Q ss_pred             CCCHHHHhcCcccccCCC
Q 022956          265 RPSASELLKDPFFSELND  282 (289)
Q Consensus       265 Rps~~~il~h~~~~~~~~  282 (289)
                      |||++|+++||||+.+..
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-46  Score=317.91  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=204.1

Q ss_pred             CCCCcccceeeeecccCcceEEEEe----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      ....+.|++.++||+|+||+||+|.    +..+++.||+|++...    .....+.+.+|++++++++||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3445556899999999999999998    6778999999999743    4566778999999999999999999999886


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      ..+...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+||
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Df  158 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDF  158 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC-CeEEEccC
Confidence            65556789999999999999999875 45999999999999999999999999  9999999999999998 89999999


Q ss_pred             CCccccCCccc----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------------
Q 022956          168 GFAAIVGRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---------------  227 (289)
Q Consensus       168 g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------------  227 (289)
                      |++........    .....++..|+|||.+.+ .+++++||||||+++++|++|..|+......               
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            99987643322    223345667999997664 4899999999999999999999988642111               


Q ss_pred             HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          228 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ......+...... ..+...++.+.+++..||+ ||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 FHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccCcC-CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0122223333222 2345678999999999998 9999999999987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-45  Score=323.05  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=204.4

Q ss_pred             ccceeeeecccCcceEEEEeec-------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQ-------EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD   89 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   89 (289)
                      .|++.+.||+|+||+||+|.+.       .++..||+|+++...   .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3478999999999999999864       346679999997542   455677899999999999 89999999998744


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI  153 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~----------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~ni  153 (289)
                        .+.+++||||+++++|.+++....                .+++..+..++.|++.||.|||++|  ++|+||||+||
T Consensus       159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI  234 (370)
T 2psq_A          159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV  234 (370)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred             --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhE
Confidence              367899999999999999998643                4789999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 022956          154 FINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVA  228 (289)
Q Consensus       154 li~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  228 (289)
                      +++.+ +.+||+|||++.......   ......+++.|+|||.+.+. ++.++|||||||++|+|++ |..||.+.....
T Consensus       235 ll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          235 LVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99998 899999999998664322   22334567889999976544 8999999999999999999 999998755443


Q ss_pred             HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                       ....+..+..+ ..+...++.+.+++.+||+ ||++||++.++++
T Consensus       314 -~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          314 -LFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             -HHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -HHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             33444444332 2345578999999999998 9999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.8e-46  Score=325.78  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CC-----ceEEeeeeEEe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NK-----YIIVCYSVWLD   89 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~   89 (289)
                      ++| ++.++||+|+||+||+|.++.+++.||+|+++.     .......+..|+.+++.++ |+     +++.+.+.+..
T Consensus        54 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           54 DRY-EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeE-EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            455 689999999999999999999999999999973     3444667788888888885 44     48888888765


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhc--CCCCceecCCCCCceEEeC-CCCcEEE
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHT--HEPCIIHRDLNCSNIFING-NIGQVKI  164 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~~~~~h~dl~~~nili~~-~~~~~~l  164 (289)
                      .  +.+++||||+.+ +|.+++...  ..+++..+..++.|++.||.|||+  .|  ++|+||||+||+++. +.+.+||
T Consensus       128 ~--~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          128 R--NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             T--TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEEE
T ss_pred             C--CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEEE
Confidence            4  689999999976 999999865  469999999999999999999995  57  999999999999953 2278999


Q ss_pred             eccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC-C
Q 022956          165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ-A  242 (289)
Q Consensus       165 ~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~  242 (289)
                      +|||++......  .....+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+................+. .
T Consensus       203 ~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          203 VDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             EeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999999876533  334678999999997765 489999999999999999999999998665555444332111000 0


Q ss_pred             -------------------------------C--CC---------------------------CCChHHHHHHHHHHc-C
Q 022956          243 -------------------------------L--NK---------------------------VKDPEVKAFIEKCIA-Q  261 (289)
Q Consensus       243 -------------------------------~--~~---------------------------~~~~~~~~li~~~l~-d  261 (289)
                                                     .  +.                           ..++.+.+||.+||+ |
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                                           0  00                           001378999999999 9


Q ss_pred             CCCCCCHHHHhcCcccccCCC
Q 022956          262 PRARPSASELLKDPFFSELND  282 (289)
Q Consensus       262 p~~Rps~~~il~h~~~~~~~~  282 (289)
                      |++|||++|+|+||||++..+
T Consensus       361 P~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          361 PKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             TTTSCCHHHHTTSGGGCC---
T ss_pred             hhhCCCHHHHhcCcccccCCC
Confidence            999999999999999998654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-45  Score=314.85  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=203.4

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||.||+|.++.+++.||+|++..... ..+...+.+.+|+++++.++||||+++++++...  +
T Consensus        32 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~  107 (309)
T 2h34_A           32 QFGPY-RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--G  107 (309)
T ss_dssp             --CCE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--T
T ss_pred             EeccE-EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--C
Confidence            44565 789999999999999999999999999999975433 3456678899999999999999999999988654  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSCCC----
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC-CCEEEecCccCccc
Confidence            79999999999999999998888999999999999999999999999  9999999999999988 89999999999766


Q ss_pred             CCcc--ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC-CCCCCCCCCCh
Q 022956          174 GRSH--AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV-KPQALNKVKDP  249 (289)
Q Consensus       174 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  249 (289)
                      ....  ......+++.|+|||.+.+. ++.++||||||+++|+|++|..||...... .....+.... .+.......++
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCT
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCH
Confidence            4432  22345688999999977654 889999999999999999999999874433 4444444433 23344556789


Q ss_pred             HHHHHHHHHHc-CCCCCC-CHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARP-SASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rp-s~~~il~  273 (289)
                      .+.+++.+||+ ||++|| +++++++
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99999999998 999999 7888776

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-46  Score=320.83  Aligned_cols=257  Identities=22%  Similarity=0.307  Sum_probs=210.7

Q ss_pred             cccceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      ..|++.+.||+|+||.||+|.+.     .++..||+|+++...   .....+.+.+|+++++.++||||+++++++..  
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--  121 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAV--  121 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence            33478999999999999999987     456899999997542   45567789999999999999999999998844  


Q ss_pred             CCeeEEEeccccCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKH------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD  147 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~------------------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~d  147 (289)
                      .+.+++||||+++++|.+++...                        ..+++.++..++.|++.||.|||++|  ++|+|
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~D  199 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD  199 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence            46789999999999999999763                        56899999999999999999999999  99999


Q ss_pred             CCCCceEEeCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCC
Q 022956          148 LNCSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYS  222 (289)
Q Consensus       148 l~~~nili~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~  222 (289)
                      |+|+||+++.+ +.++|+|||++.......   ......+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.
T Consensus       200 lkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          200 LATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            99999999988 899999999997654322   2233457889999997664 48999999999999999999 999998


Q ss_pred             CCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          223 ECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      +........ .+..+... ..+...++.+.+++.+||+ ||++||++.++++  .|+++....+
T Consensus       279 ~~~~~~~~~-~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~--~L~~~~~~~~  338 (343)
T 1luf_A          279 GMAHEEVIY-YVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRMCERAE  338 (343)
T ss_dssp             TSCHHHHHH-HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTTC---
T ss_pred             CCChHHHHH-HHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH--HHHHHHhhhh
Confidence            765544443 34443322 2345678999999999998 9999999999998  7777655443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-46  Score=331.32  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=200.8

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC--------CCceEEeeee
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK--------NKYIIVCYSV   86 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~   86 (289)
                      .++| ++.++||+|+||+||+|.+..+++.||+|++..     .....+.+.+|+++++.++        |+||+++++.
T Consensus        36 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           36 NGRY-HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             CCeE-EEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            3555 789999999999999999999999999999963     3455677889999999986        7789999998


Q ss_pred             EEeC--CCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCCCC-
Q 022956           87 WLDD--QHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGNIG-  160 (289)
Q Consensus        87 ~~~~--~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~~~-  160 (289)
                      +...  .+..+++||||+.+ +|.+.+...  ..+++..+..++.|++.||.|||++ |  ++|+||||+||+++.+ + 
T Consensus       110 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~-~~  185 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN-EQ  185 (397)
T ss_dssp             EEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCC-HH
T ss_pred             eeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEecc-ch
Confidence            7632  34689999999955 666666543  5699999999999999999999998 9  9999999999999876 4 


Q ss_pred             ------------------------------------------------cEEEeccCCccccCCccccccCCCCCCCCCCc
Q 022956          161 ------------------------------------------------QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE  192 (289)
Q Consensus       161 ------------------------------------------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE  192 (289)
                                                                      .++|+|||++......  .....+++.|+|||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE  263 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHH
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCCh
Confidence                                                            7999999999876543  33456899999999


Q ss_pred             ccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHH--HhCCCCC-------------------C---
Q 022956          193 LYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS------VAKIYKK--VTGGVKP-------------------Q---  241 (289)
Q Consensus       193 ~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~------~~~~~~~--~~~~~~~-------------------~---  241 (289)
                      .+.+. ++.++|||||||++|+|++|..||.....      .......  +.+..+.                   .   
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            77654 89999999999999999999999975331      1111111  1111100                   0   


Q ss_pred             ---------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          242 ---------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       242 ---------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                                     ......++.+.+||.+||+ ||++|||++|+|+||||++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                           0011123568899999999 9999999999999999974

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-45  Score=313.54  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=208.0

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEe----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeee
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYS   85 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   85 (289)
                      .......+++++.++||+|+||.||+|.    +..+++.||+|++.....   ....+.+.+|+++++.++||||+++++
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKG   90 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            3334566777899999999999999998    677899999999975532   223567889999999999999999999


Q ss_pred             eEEeCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           86 VWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                      ++.......+++||||+++++|.+++.. ...+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl  167 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKI  167 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEE
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC-CCEEE
Confidence            9877666779999999999999999954 467999999999999999999999999  9999999999999998 89999


Q ss_pred             eccCCccccCCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCC--------------CC
Q 022956          165 GDLGFAAIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSE--------------CD  225 (289)
Q Consensus       165 ~d~g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~--------------~~  225 (289)
                      +|||++........    .....++..|+|||.+.+. ++.++||||||+++++|++|..|+..              ..
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (302)
T 4e5w_A          168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM  247 (302)
T ss_dssp             CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred             CcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence            99999987654332    2334577789999977654 88899999999999999999887642              12


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ........+...... ..+...++.+.+|+.+||+ ||.+|||++++++
T Consensus       248 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRL-PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            233334444444332 2345578999999999999 9999999999997

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=325.54  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             ccceeeeecccCcceEEEEe-----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           18 FGRYSDLLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      .+++.++||+|+||+||+|.     +..++..||+|+++...   .......+.+|+.++++++||||+++++++...  
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  146 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--  146 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence            34789999999999999998     45678899999996432   345566788999999999999999999988543  


Q ss_pred             CeeEEEeccccCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEE
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH-------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVK  163 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~  163 (289)
                      ...++||||+++++|.+++...       ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+  ...+|
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEE
Confidence            5689999999999999999864       35899999999999999999999999  9999999999999854  13599


Q ss_pred             EeccCCccccCC---ccccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCC
Q 022956          164 IGDLGFAAIVGR---SHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       164 l~d~g~~~~~~~---~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      |+|||++.....   ........+++.|+|||.+. +.++.++|||||||++|+|++ |..||....... ....+..+.
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-~~~~i~~~~  303 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTSGG  303 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCC
Confidence            999999975422   22233456788999999765 458999999999999999998 999998755444 444444443


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      .. ..+...++.+.+|+.+||+ ||++|||+++|+++.++-
T Consensus       304 ~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          304 RM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22 2345568899999999998 999999999999986554

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-46  Score=322.42  Aligned_cols=263  Identities=25%  Similarity=0.372  Sum_probs=213.5

Q ss_pred             CceeeCCCCcccceeeeecccCcceEEEEe----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEe
Q 022956            8 PFVEVDPSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC   83 (289)
Q Consensus         8 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   83 (289)
                      |.-..-..++|+++.++||+|+||+||++.    +..+|+.||+|+++...   .....+.+.+|++++++++||||+++
T Consensus        22 pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~   98 (318)
T 3lxp_A           22 PGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKY   98 (318)
T ss_dssp             --CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhE
Confidence            344445678888999999999999997664    55689999999997542   45667889999999999999999999


Q ss_pred             eeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEE
Q 022956           84 YSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVK  163 (289)
Q Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~  163 (289)
                      ++++...+...+++||||+++++|.+++... .+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~-~~~k  174 (318)
T 3lxp_A           99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND-RLVK  174 (318)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEE
T ss_pred             EEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC-CCEE
Confidence            9999876667899999999999999999875 4999999999999999999999999  9999999999999998 8999


Q ss_pred             EeccCCccccCCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH-----------
Q 022956          164 IGDLGFAAIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV-----------  227 (289)
Q Consensus       164 l~d~g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~-----------  227 (289)
                      |+|||++........    .....+++.|+|||.+.+. +++++||||||+++++|++|..||......           
T Consensus       175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  254 (318)
T 3lxp_A          175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ  254 (318)
T ss_dssp             ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred             ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence            999999987654322    2334567789999977654 888999999999999999999999753211           


Q ss_pred             ---HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          228 ---AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       228 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                         ......+..... ...+...++.+.+|+..||+ ||++|||++++++  +++.+
T Consensus       255 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l  308 (318)
T 3lxp_A          255 MTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTV  308 (318)
T ss_dssp             HHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             hhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHH
Confidence               122233333332 23345678999999999999 9999999999997  66654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-45  Score=312.02  Aligned_cols=249  Identities=22%  Similarity=0.342  Sum_probs=204.4

Q ss_pred             CCCcccceee-eecccCcceEEEE--eecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           14 PSGRFGRYSD-LLGSGAVKKVYRA--FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        14 ~~~~~~~~~~-~lg~g~~g~v~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ..++| ++.+ .||+|+||+||+|  .+..+++.||+|+++....  .....+.+.+|+++++.++||||+++++++ . 
T Consensus        14 ~~~~y-~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~-   88 (291)
T 1xbb_A           14 DRKLL-TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGIC-E-   88 (291)
T ss_dssp             CGGGE-EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-
T ss_pred             cchhh-hhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C-
Confidence            34455 6676 9999999999999  4566789999999976532  345577899999999999999999999987 2 


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                       .+..++|+||+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        89 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~  164 (291)
T 1xbb_A           89 -AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLS  164 (291)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTC
T ss_pred             -CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC-CcEEEccCCcc
Confidence             2468899999999999999998888999999999999999999999999  9999999999999998 89999999999


Q ss_pred             cccCCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCC
Q 022956          171 AIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       171 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (289)
                      ........    .....+++.|+|||.+.+. +++++||||||+++++|++ |..||.+.... .....+..+..+ ..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~  242 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGERM-GCP  242 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCC-CCC
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCC-CCC
Confidence            87644322    1223456789999977654 8889999999999999999 99999875544 344444444332 234


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ...++.+.+++.+||+ ||++||++.++++
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            5678999999999998 9999999999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-45  Score=308.02  Aligned_cols=250  Identities=18%  Similarity=0.323  Sum_probs=212.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.++||+|+||+||+|.+.  |..+|+|++.....  .....+.+.+|+.++++++||||+++++++........++|
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             hHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            478999999999999999885  88999999987543  45566789999999999999999999999876655788999


Q ss_pred             eccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++|++++|+||+|+||+++.+ +.++++|||+...... 
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQS-  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTTSC-
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeeecc-
Confidence            99999999999998765  4899999999999999999999988779999999999999988 8999999887764332 


Q ss_pred             cccccCCCCCCCCCCcccccC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                         ....+++.|+|||.+.+.    ++.++||||||+++|+|++|..||.+................+ ..+...++.+.
T Consensus       166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  241 (271)
T 3kmu_A          166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVS  241 (271)
T ss_dssp             ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-CCCTTCCHHHH
T ss_pred             ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence               234678999999977643    3337999999999999999999999877666666665555443 34556799999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +++.+||+ ||++|||++++++  .++++
T Consensus       242 ~li~~~l~~~p~~Rps~~~il~--~L~~l  268 (271)
T 3kmu_A          242 KLMKICMNEDPAKRPKFDMIVP--ILEKM  268 (271)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHH--HHHHh
Confidence            99999998 9999999999998  55544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.9e-46  Score=325.23  Aligned_cols=251  Identities=27%  Similarity=0.405  Sum_probs=208.4

Q ss_pred             CCcccceeeeecccCcceEEEEe-----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEE
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWL   88 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   88 (289)
                      .++| ++.++||+|+||.||+|.     +..+++.||+|+++...   .....+.+.+|+++++++ +||||+++++++.
T Consensus        21 ~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           21 RDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             GGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccce-eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            3454 789999999999999998     56678999999997542   445567899999999999 7899999999875


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhcCC----------------------------------------------------
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKHRH----------------------------------------------------  116 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~----------------------------------------------------  116 (289)
                      .. +..+++||||+++++|.+++.....                                                    
T Consensus        97 ~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           97 KP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             ST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             cC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            53 3568999999999999999986533                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc---cc
Q 022956          117 --------------VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---AA  179 (289)
Q Consensus       117 --------------l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~---~~  179 (289)
                                    +++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.......   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhc
Confidence                          899999999999999999999999  9999999999999988 899999999998654322   22


Q ss_pred             ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          180 HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+..........+...... ..+...++.+.+++..
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~  331 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLD  331 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence            33457889999997654 48999999999999999998 999998766555555555444332 2345578999999999


Q ss_pred             HHc-CCCCCCCHHHHhcC
Q 022956          258 CIA-QPRARPSASELLKD  274 (289)
Q Consensus       258 ~l~-dp~~Rps~~~il~h  274 (289)
                      ||+ ||.+|||++++++|
T Consensus       332 ~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          332 CWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCChhhCCCHHHHHHH
Confidence            998 99999999999984

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-45  Score=309.31  Aligned_cols=251  Identities=29%  Similarity=0.466  Sum_probs=195.9

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.+.  |..+|+|+++...........+.+.+|+++++.++||||+++++++...  +..
T Consensus         7 ~~~-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~   81 (271)
T 3dtc_A            7 AEL-TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNL   81 (271)
T ss_dssp             TSE-EEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----C
T ss_pred             hhe-eeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cce
Confidence            444 78999999999999999875  8899999998765433344467889999999999999999999988543  578


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCceEEeCC-------CCcEEEecc
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP-CIIHRDLNCSNIFINGN-------IGQVKIGDL  167 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~-~~~h~dl~~~nili~~~-------~~~~~l~d~  167 (289)
                      ++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|. +++|+||+|+||+++.+       .+.++|+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999999864 579999999999999999999999983 27799999999999861       378999999


Q ss_pred             CCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      |++........ ....+++.|+|||.+.+. +++++||||||+++++|++|..||.+.............. .....+..
T Consensus       161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  238 (271)
T 3dtc_A          161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-LALPIPST  238 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC-CCCCCCTT
T ss_pred             Ccccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC-CCCCCCcc
Confidence            99986654332 245689999999977654 8999999999999999999999998866655555544443 33334566


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .++.+.+++.+||+ ||++|||+++++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            78999999999998 99999999999983

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-45  Score=314.75  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=207.4

Q ss_pred             CCcccceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ..+.|++.+.||+|+||.||+|.+.     .++..||+|+++...   .....+.+.+|+++++.++||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3455578999999999999999873     456899999997432   45667889999999999999999999998744


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRH------------------------VSIKALKKWSKQVLEGLEYLHTHEPCIIH  145 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~------------------------l~~~~~~~~~~ql~~~l~~lh~~~~~~~h  145 (289)
                        .+.+++||||+++++|.+++.....                        +++..+..++.|++.||.|||++|  ++|
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH  173 (314)
T 2ivs_A           98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH  173 (314)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence              3678999999999999999986543                        899999999999999999999999  999


Q ss_pred             cCCCCCceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCC
Q 022956          146 RDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIP  220 (289)
Q Consensus       146 ~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p  220 (289)
                      +||+|+||+++.+ +.++|+|||++........   .....+++.|+|||.+.+. +++++||||||+++++|++ |..|
T Consensus       174 ~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          174 RDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999988 8999999999986643322   2234567889999976654 8999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          221 YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      |.+..... ....+...... ..+...++.+.+++.+||+ ||++||++++++++
T Consensus       253 ~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          253 YPGIPPER-LFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             STTCCGGG-HHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHH-HHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            98755443 33444443322 2345678999999999998 99999999999983

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.5e-46  Score=321.00  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=209.8

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhCC--CCceEEeeeeEEe
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLK--NKYIIVCYSVWLD   89 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~   89 (289)
                      ..++| ++.+.||+|+||+||+|.++.+|+.||+|++........  ......+.+|+.++++++  |+|++++++++..
T Consensus        41 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           41 LESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CTTTE-EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             ccCce-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            44555 789999999999999999999999999999987543210  011245667899999996  5999999998855


Q ss_pred             CCCCeeEEEeccccC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           90 DQHNTLNFITEVCTS-GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~-~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      .  +.+++|+|++.+ ++|.+++.....+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+.+.+||+|||
T Consensus       120 ~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 P--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             S--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             C--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            4  678999999976 799999998888999999999999999999999999  99999999999999444899999999


Q ss_pred             CccccCCccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          169 FAAIVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ++...... ......+++.|+|||.+.+.  .++++||||||+++|+|++|..||....   .   .....   ......
T Consensus       196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~---~~~~~---~~~~~~  265 (320)
T 3a99_A          196 SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---E---IIRGQ---VFFRQR  265 (320)
T ss_dssp             TCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H---HHHCC---CCCSSC
T ss_pred             cccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---h---hhccc---cccccc
Confidence            99876543 23345689999999977644  4678999999999999999999997521   1   11221   223455


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      .++.+.+|+.+||+ ||++|||++++++||||++...
T Consensus       266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            78999999999998 9999999999999999998754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.1e-46  Score=325.83  Aligned_cols=261  Identities=26%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-----------CCceEEe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-----------NKYIIVC   83 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~   83 (289)
                      .++| ++.+.||+|+||+||+|.+..+|+.||+|++..     .....+.+.+|+++++++.           |+||+++
T Consensus        18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeE-EEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            3555 789999999999999999999999999999974     3444567888999998886           7899999


Q ss_pred             eeeEEeCC--CCeeEEEeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceEEeCC
Q 022956           84 YSVWLDDQ--HNTLNFITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTH-EPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        84 ~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~-~~~~~h~dl~~~nili~~~  158 (289)
                      ++++....  ...+++++|++ +++|.+++..  ...+++..+..++.|++.||.|||++ |  ++|+||||+||+++.+
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence            99886532  23789999999 7799999986  34599999999999999999999998 9  9999999999999532


Q ss_pred             -----CCcEEEeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc------
Q 022956          159 -----IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS------  226 (289)
Q Consensus       159 -----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~------  226 (289)
                           .+.++|+|||++......  .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||.....      
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence                 247999999999876543  2345689999999977654 89999999999999999999999975331      


Q ss_pred             HHHHHHHHh--CCCCC-------------------------------------CCCCCCCChHHHHHHHHHHc-CCCCCC
Q 022956          227 VAKIYKKVT--GGVKP-------------------------------------QALNKVKDPEVKAFIEKCIA-QPRARP  266 (289)
Q Consensus       227 ~~~~~~~~~--~~~~~-------------------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rp  266 (289)
                      .....+.+.  +..+.                                     ...+...++.+.+||.+||+ ||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            111111111  00000                                     00112235678899999999 999999


Q ss_pred             CHHHHhcCcccccCCCCCCC
Q 022956          267 SASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       267 s~~~il~h~~~~~~~~~~~~  286 (289)
                      |++|+|+||||++.......
T Consensus       327 t~~ell~hp~f~~~~~~~~~  346 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTLGMEEI  346 (373)
T ss_dssp             CHHHHHTCGGGTTCTTCTTC
T ss_pred             CHHHHhhChhhhcccCcccc
Confidence            99999999999987554443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-45  Score=317.40  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=210.6

Q ss_pred             CCcccceeeeecccCcceEEEEe----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ..+.|++.++||+|+||.||+|.    +..++..||+|++...    .....+.+.+|++++++++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            33445889999999999999998    5778999999999753    455567899999999999999999999988876


Q ss_pred             CCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      ....+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~  173 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFGL  173 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCGGG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC-CCEEEccccc
Confidence            66789999999999999999986 456999999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc--------------HHHH
Q 022956          170 AAIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS--------------VAKI  230 (289)
Q Consensus       170 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~--------------~~~~  230 (289)
                      +........    .....+++.|+|||.+.+. +++++||||||+++++|++|..||.....              ....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            987643322    2334577889999977655 78899999999999999999999864222              1233


Q ss_pred             HHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          231 YKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ...+..+.... .+...++.+.+|+.+||+ ||++|||+++++++
T Consensus       254 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          254 LELLEEGQRLP-APPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcccCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33444443322 345678999999999999 99999999999873

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.2e-45  Score=306.19  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=207.0

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .-|++.+.||+|+||+||++.++ ++..||+|+++....  .   .+.+.+|++++++++||||+++++++.  .....+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~   79 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM--S---EDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPIY   79 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB--C---HHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEE
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC--c---HHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCceE
Confidence            33478999999999999999776 577899999976543  2   356888999999999999999999884  346789


Q ss_pred             EEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           97 FITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +||||+++++|.+++... ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT-CCEEECCTTCEEECCT
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC-CCEEEccCccceecch
Confidence            999999999999999864 45999999999999999999999999  9999999999999998 8999999999986644


Q ss_pred             ccc--cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          176 SHA--AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       176 ~~~--~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ...  .....+++.|+|||.+.+. +++++||||||+++++|++ |..||................ . ...+...++.+
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~l  234 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-R-LYRPHLASDTI  234 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-C-CCCCTTSCHHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-C-CCCCCcChHHH
Confidence            322  2233456789999977654 8999999999999999999 999998766555544443332 2 22345568999


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+++..||+ ||++|||++++++  .++.+.
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~--~L~~l~  263 (268)
T 3sxs_A          235 YQIMYSCWHELPEKRPTFQQLLS--SIEPLR  263 (268)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHH--HHGGGC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH--HHHHhh
Confidence            999999998 9999999999999  455543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.3e-45  Score=318.63  Aligned_cols=254  Identities=20%  Similarity=0.339  Sum_probs=201.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCC-cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc------eEEeeeeE
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEG-IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY------IIVCYSVW   87 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~   87 (289)
                      .++| ++.+.||+|+||+||+|.+..++ ..||+|+++.     .....+.+.+|+.+++.++|++      ++.+.+.+
T Consensus        18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           18 QERY-EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             TTTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             cccE-EEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            4555 78999999999999999998777 7899999963     3445677888999999997765      77777776


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE----------
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI----------  155 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili----------  155 (289)
                      ...  +.+++||||+. ++|.+++...  ..+++..+..++.|++.||.|||++|  ++|+||||+||++          
T Consensus        92 ~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           92 NFH--GHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EET--TEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeC--CeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence            444  58999999995 4777776654  46999999999999999999999999  9999999999999          


Q ss_pred             ---------eCCCCcEEEeccCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 022956          156 ---------NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECD  225 (289)
Q Consensus       156 ---------~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~  225 (289)
                               +.+ +.++|+|||++......  .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||....
T Consensus       167 ~~~~~~~~~~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          167 EHKSCEEKSVKN-TSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CC-CCCEEEESC-CCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccCC-CcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                     455 79999999999865433  234578999999997654 48999999999999999999999998765


Q ss_pred             cHHHHHHHH--hCCCCCC---------------------------------------CCCCCCChHHHHHHHHHHc-CCC
Q 022956          226 SVAKIYKKV--TGGVKPQ---------------------------------------ALNKVKDPEVKAFIEKCIA-QPR  263 (289)
Q Consensus       226 ~~~~~~~~~--~~~~~~~---------------------------------------~~~~~~~~~~~~li~~~l~-dp~  263 (289)
                      .........  ....+..                                       ......++.+.+|+.+||+ ||+
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            443332211  1111000                                       0011113478899999999 999


Q ss_pred             CCCCHHHHhcCcccccCCC
Q 022956          264 ARPSASELLKDPFFSELND  282 (289)
Q Consensus       264 ~Rps~~~il~h~~~~~~~~  282 (289)
                      +|||++|+|+||||+++++
T Consensus       324 ~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             TSCCHHHHTTSGGGGGCCH
T ss_pred             hCcCHHHHhcChhhcCCCh
Confidence            9999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-45  Score=306.63  Aligned_cols=243  Identities=22%  Similarity=0.402  Sum_probs=203.3

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||+||++.+. ++..||+|++.....  .   .+.+.+|++++++++||||+++++++.+  ....++|
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   83 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--S---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLV   83 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB--C---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEE
T ss_pred             ceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc--C---HHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEEE
Confidence            478999999999999999986 577899999985433  2   3568889999999999999999998844  3578999


Q ss_pred             eccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      |||+++++|.+++.. ...+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC-CCEEeccccccccccccc
Confidence            999999999999975 456899999999999999999999999  9999999999999988 899999999998664332


Q ss_pred             --ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 --AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 --~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                        ......+++.|+|||.+. ..+++++|+||||+++++|++ |..||........ ...+...... ..+...++.+.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~  238 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-VEDISTGFRL-YKPRLASTHVYQ  238 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTTCCC-CCCTTSCHHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-HHHHhcCccC-CCCCcCCHHHHH
Confidence              223345677899999776 448999999999999999999 9999987555444 4444443222 234556899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcC
Q 022956          254 FIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ++..||+ ||++||+++++++|
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHH
Confidence            9999998 99999999999984

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=320.24  Aligned_cols=247  Identities=28%  Similarity=0.396  Sum_probs=206.6

Q ss_pred             ccceeeeecccCcceEEEEeecCC-------CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEE-------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD   89 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   89 (289)
                      .+++.++||+|+||+||+|.+..+       +..||+|+++...   .......+.+|+++++++ +||||+++++++..
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            347899999999999999987543       4679999997542   456678899999999999 99999999998844


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI  153 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~----------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~ni  153 (289)
                        .+.+++||||+++++|.+++....                .+++..+..++.|++.||.|||+.|  ++|+||||+||
T Consensus       147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI  222 (382)
T 3tt0_A          147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV  222 (382)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred             --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceE
Confidence              367899999999999999998643                4899999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 022956          154 FINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVA  228 (289)
Q Consensus       154 li~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  228 (289)
                      +++.+ +.+||+|||++.......   ......+++.|+|||.+.+. +++++||||||+++++|++ |..||.+... .
T Consensus       223 ll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-~  300 (382)
T 3tt0_A          223 LVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-E  300 (382)
T ss_dssp             EECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-H
T ss_pred             EEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-H
Confidence            99998 899999999998665432   23334567889999976654 8999999999999999999 9999987544 4


Q ss_pred             HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .....+..+.... .+...++.+.+|+.+||+ ||++|||+++++++
T Consensus       301 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          301 ELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4455555543332 345578999999999998 99999999999984

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.2e-46  Score=325.03  Aligned_cols=246  Identities=22%  Similarity=0.346  Sum_probs=205.4

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .+++.++||+|+||.||+|.++.+++.||+|+++...   .....+.+.+|++++++++||||+++++++..  .+.+++
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l  189 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYI  189 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEE
Confidence            3478899999999999999999999999999987432   45556778999999999999999999998844  357899


Q ss_pred             EeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           98 ITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++......
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK-NVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC-CcEEECcCCCceecCCC
Confidence            99999999999999764 46999999999999999999999999  9999999999999988 89999999999765432


Q ss_pred             ccc---ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          177 HAA---HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       177 ~~~---~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ...   ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+..... ....+..+.... .+...++.+
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~l  344 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEKGGRLP-CPELCPDAV  344 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-HHHHHHTTCCCC-CCTTCCHHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCC-CCCCCCHHH
Confidence            111   11234668999997764 48899999999999999998 999998765444 344444443322 345578999


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhc
Q 022956          252 KAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+|+.+||+ ||++|||++++++
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            999999998 9999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-45  Score=309.82  Aligned_cols=253  Identities=28%  Similarity=0.499  Sum_probs=200.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +.++| ++.++||+|+||+||++.+.   ..+|+|+++....  .....+.+.+|++++++++||||++++++.   ...
T Consensus        22 ~~~~y-~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---~~~   92 (289)
T 3og7_A           22 PDGQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYS---TAP   92 (289)
T ss_dssp             CTTSC-EEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE---CSS
T ss_pred             Cccce-eeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEEEEEeec---cCC
Confidence            34454 78999999999999999764   3599999976543  566678899999999999999999999854   234


Q ss_pred             eeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~  169 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLATE  169 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-TEEEECCCC----
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-CCEEEccceeccc
Confidence            68999999999999999964 457999999999999999999999999  9999999999999998 8999999999976


Q ss_pred             cCC---ccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC---C
Q 022956          173 VGR---SHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ---A  242 (289)
Q Consensus       173 ~~~---~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~  242 (289)
                      ...   ........+++.|+|||.+.    ..++.++||||||+++++|++|..||.+..........+.......   .
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            543   22233456899999999764    3378899999999999999999999998777776666665543322   2


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .....++.+.+|+.+||+ ||++|||++++++  .++++
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~l  286 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA--EIEEL  286 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHH
Confidence            344568999999999998 9999999999998  55444

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.5e-45  Score=308.32  Aligned_cols=248  Identities=21%  Similarity=0.352  Sum_probs=203.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ...+.|++.+.||+|+||+||++.+. ++..||+|+++....  .   .+.+.+|+++++.++||||+++++++..  .+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~   92 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCTK--QR   92 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB--C---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC--C---HHHHHHHHHHHhcCCCCCEeeEEEEEec--CC
Confidence            33444578999999999999999876 678899999986543  2   3568889999999999999999998844  46


Q ss_pred             eeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      .+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~  169 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRY  169 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-SCEEECSTTGGGG
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCC-CCEEEcccccccc
Confidence            78999999999999999986 567999999999999999999999999  9999999999999988 8999999999986


Q ss_pred             cCCccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          173 VGRSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       173 ~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ......  .....+++.|+|||.+.+ .+++++||||||+++|+|++ |..||........... +..... ...+...+
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~-~~~~~~~~  247 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLR-LYRPHLAS  247 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCC-CCCCTTCC
T ss_pred             ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-HhcccC-CCCCCcCC
Confidence            643322  223346778999997764 48999999999999999998 9999987665544444 444322 22345568


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      +.+.+++..||+ ||++|||++++++|
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999998 99999999999984

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-46  Score=326.75  Aligned_cols=252  Identities=22%  Similarity=0.367  Sum_probs=207.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +..|++.++||+|+||+||+|.++.+|+.||+|++........   .+.+.+|++++++++||||+++++++........
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC---HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch---HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            3445899999999999999999999999999999986543222   4667789999999999999999998877665688


Q ss_pred             EEEeccccCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE----eCCCCcEEEeccC
Q 022956           96 NFITEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI----NGNIGQVKIGDLG  168 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili----~~~~~~~~l~d~g  168 (289)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+.|  ++|+||||+||++    +.+ +.+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSC-EEEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCc-eeEEEecCC
Confidence            99999999999999998643   3999999999999999999999999  9999999999998    555 679999999


Q ss_pred             CccccCCccccccCCCCCCCCCCccccc---------CCCCcchHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHh
Q 022956          169 FAAIVGRSHAAHSIIGTPEYMAPELYEE---------DYTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVT  235 (289)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~  235 (289)
                      ++.............+++.|+|||.+.+         .++.++|||||||++|+|++|..||...    .........+.
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            9988766655666779999999997653         3778999999999999999999999642    23344444444


Q ss_pred             CCCCCC----------------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          236 GGVKPQ----------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       236 ~~~~~~----------------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ......                      ......++.+.+++..||+ ||++||+++++++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            332210                      1112234578899999998 9999999999866

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.2e-44  Score=309.04  Aligned_cols=258  Identities=29%  Similarity=0.532  Sum_probs=203.0

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.+.||+|+||.||+|.+..+|+.||+|++..... ........+.+|++++++++||||+++++.+...  +
T Consensus        30 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~  105 (310)
T 2wqm_A           30 TLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--N  105 (310)
T ss_dssp             SGGGE-EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred             cccce-EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--C
Confidence            34555 789999999999999999999999999999976433 2456678899999999999999999999988664  5


Q ss_pred             eeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           94 TLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~-~~~kl~Dfg~  182 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGL  182 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCC--
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCC-CCEEEEeccc
Confidence            79999999999999999864    466999999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhCCCCCCCCCCC
Q 022956          170 AAIVGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       170 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      +....... ......+++.|+|||.+.+. ++.++||||||+++++|++|..||.+.. ........+.....+......
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH  262 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTT
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccc
Confidence            87664332 23345688999999976644 8899999999999999999999997532 333444445554444444456


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .++.+.+++.+||+ ||++|||++++++  .++++
T Consensus       263 ~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l  295 (310)
T 2wqm_A          263 YSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRM  295 (310)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence            78999999999998 9999999999998  55554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=315.83  Aligned_cols=261  Identities=19%  Similarity=0.227  Sum_probs=206.8

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC--CC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD--QH   92 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   92 (289)
                      .+..|++.+.||+|+||.||++.++.+|+.||+|++...    .....+.+.+|+++++.++||||+++++++...  ..
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            334447899999999999999999999999999999753    455677899999999999999999999988643  23


Q ss_pred             CeeEEEeccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           93 NTLNFITEVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      ...++|+||+.+++|.+++..    ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~dfg  179 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDE-GQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCS
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC-CCEEEEecC
Confidence            578999999999999999875    467999999999999999999999999  9999999999999988 899999999


Q ss_pred             CccccCCccc----------cccCCCCCCCCCCcccccC----CCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHH
Q 022956          169 FAAIVGRSHA----------AHSIIGTPEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKIYKK  233 (289)
Q Consensus       169 ~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~-~~~~~~  233 (289)
                      ++........          .....+++.|+|||.+.+.    +++++||||||+++|+|++|..||...... ......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            9876532211          1123468999999977543    688999999999999999999999531100 011112


Q ss_pred             HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                      +..... .......++.+.+++.+||+ ||.+||+++++++  .+..+....+
T Consensus       260 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~L~~~~~~~~  309 (317)
T 2buj_A          260 VQNQLS-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS--QLEALQPPAP  309 (317)
T ss_dssp             HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHTCCCCC
T ss_pred             hhccCC-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHH--HhhhcCCCCC
Confidence            222211 12234568899999999999 9999999999999  5666654433

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-46  Score=316.75  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=201.5

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCH--HHHHHHHHHHHHHHhC----CCCceEEeeeeE
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP--VLVNRLHSEVQLLRTL----KNKYIIVCYSVW   87 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~~e~~~l~~l----~~~~i~~~~~~~   87 (289)
                      ..++| ++.+.||+|+||.||+|.++.+|+.||+|++.........  .....+.+|+.+++++    +|+||+++++++
T Consensus        29 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           29 FEAEY-RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             ----C-EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhce-EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34555 7899999999999999999999999999999765432211  2234466788888888    899999999988


Q ss_pred             EeCCCCeeEEEecc-ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           88 LDDQHNTLNFITEV-CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        88 ~~~~~~~~~lv~e~-~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      ...  +..++|+|+ +.+++|.+++.....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+.+.++|+|
T Consensus       108 ~~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          108 ETQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             -------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred             ecC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence            554  568889998 788899999998888999999999999999999999999  999999999999994338999999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCcccccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCC
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYEED-Y-TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (289)
                      ||++...... ......+++.|+|||.+.+. + +.++||||||+++++|++|..||....   .   .....   ...+
T Consensus       184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~---~~~~~---~~~~  253 (312)
T 2iwi_A          184 FGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---E---ILEAE---LHFP  253 (312)
T ss_dssp             CSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H---HHHTC---CCCC
T ss_pred             cchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---H---Hhhhc---cCCc
Confidence            9999876543 23445689999999976544 3 458999999999999999999997521   1   11211   2234


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      ...++.+.+++.+||+ ||++|||++++++||||++...+.
T Consensus       254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~  294 (312)
T 2iwi_A          254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV  294 (312)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence            5578999999999998 999999999999999999876543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4e-45  Score=313.49  Aligned_cols=258  Identities=22%  Similarity=0.348  Sum_probs=211.1

Q ss_pred             cccceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      ..|++.+.||+|+||.||+|.++     .++..||+|.+....   .......+.+|+++++.++||||+++++++..  
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   99 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--   99 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--
Confidence            33478999999999999999876     467889999997432   34556678999999999999999999998744  


Q ss_pred             CCeeEEEeccccCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ  161 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~  161 (289)
                      .+..++||||+++++|.+++...          ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~-~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-CC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC-Ce
Confidence            36789999999999999998752          35799999999999999999999999  9999999999999988 89


Q ss_pred             EEEeccCCccccCCcc---ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhC
Q 022956          162 VKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG  236 (289)
Q Consensus       162 ~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  236 (289)
                      ++|+|||++.......   ......+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+.............
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            9999999997654332   1223346788999997764 48999999999999999999 89999876555444443333


Q ss_pred             CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC------cccccCCCCC
Q 022956          237 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD------PFFSELNDDD  284 (289)
Q Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h------~~~~~~~~~~  284 (289)
                      ...  ..+...++.+.+++.+||+ ||++|||+.+++++      ++|+.+.+..
T Consensus       257 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~  309 (322)
T 1p4o_A          257 GLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY  309 (322)
T ss_dssp             CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTT
T ss_pred             CcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccccc
Confidence            322  2345578999999999998 99999999999996      7777654443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.6e-45  Score=313.21  Aligned_cols=249  Identities=26%  Similarity=0.403  Sum_probs=208.5

Q ss_pred             CCcccceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEE
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWL   88 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   88 (289)
                      .++| ++.+.||+|+||+||+|.+     ..++..||+|+++...   .....+.+.+|+++++++ +||||+++++++.
T Consensus        22 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           22 RNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhhh-hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            3455 7899999999999999984     5678899999997542   345567899999999999 9999999999884


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKHR------------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC  150 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~~------------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~  150 (289)
                      ..  +..++||||+++++|.+++....                  .+++..+..++.|++.||.|||++|  ++|+||+|
T Consensus        98 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp  173 (313)
T 1t46_A           98 IG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA  173 (313)
T ss_dssp             SS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             cC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence            43  57899999999999999998643                  4899999999999999999999999  99999999


Q ss_pred             CceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 022956          151 SNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECD  225 (289)
Q Consensus       151 ~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~  225 (289)
                      +||+++.+ +.++|+|||++........   .....+++.|+|||.+.+ .++.++||||||+++++|++ |..||.+..
T Consensus       174 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          174 RNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999998 8999999999987654332   223446778999997654 48999999999999999999 999998766


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ........+....... .+...++.+.+++.+||+ ||.+|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          253 VDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             SSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5555555555443332 344578999999999998 9999999999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.4e-45  Score=307.56  Aligned_cols=246  Identities=27%  Similarity=0.488  Sum_probs=207.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe------
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD------   89 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   89 (289)
                      ++| ++.+.||+|+||.||+|.+..+|+.||+|++....        +.+.+|+++++.++||||+++++++..      
T Consensus        11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B           11 MDF-KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHE-EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             ccc-ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            444 68999999999999999999999999999997542        345679999999999999999987743      


Q ss_pred             --------CCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC
Q 022956           90 --------DQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI  159 (289)
Q Consensus        90 --------~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~  159 (289)
                              .....+++||||+++++|.+++...  ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ 
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-  158 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-  158 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC-
Confidence                    1235689999999999999999754  67999999999999999999999999  9999999999999988 


Q ss_pred             CcEEEeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC
Q 022956          160 GQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       160 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      +.++|+|||++.............+++.|+|||.+.+. ++.++||||||+++++|++|..|+..   .......+....
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~  235 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGI  235 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccc
Confidence            89999999999877665555566789999999977654 89999999999999999999988753   222333333322


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                          .+...++.+.+++.+||. ||++|||+.+++++.+.-.-
T Consensus       236 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          236 ----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence                345568899999999998 99999999999998665443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.5e-45  Score=307.46  Aligned_cols=249  Identities=22%  Similarity=0.387  Sum_probs=195.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .....|++.+.||+|+||+||+|.+..+   +..||+|++...   ......+.+.+|+.++++++||||+++++++.  
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--   86 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--
Confidence            3334457899999999999999998654   456999988643   24566778999999999999999999999862  


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                       .+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~  162 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGL  162 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC---
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC-CCEEECcccc
Confidence             246889999999999999998654 6999999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          170 AAIVGRSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       170 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      +........  .....+++.|+|||.+.+ .+++++||||||+++|+|++ |..||.+.......... ...... ..+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-~~~~~~-~~~~  240 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERL-PMPP  240 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCC-CCCT
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-HcCCCC-CCCC
Confidence            987644322  223345678999997764 48899999999999999997 99999876554444333 333222 2345


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..++.+.+++.+||+ ||++|||+.++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          241 NCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            678999999999998 9999999999988

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=317.64  Aligned_cols=251  Identities=27%  Similarity=0.393  Sum_probs=205.9

Q ss_pred             cceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   92 (289)
                      |++.+.||+|+||+||+|.+     ..++..||+|++....   .....+.+.+|+.+++++ +||||+++++++..  .
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~  121 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL--S  121 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--C
Confidence            47889999999999999986     3467789999997542   233457789999999999 89999999998854  3


Q ss_pred             CeeEEEeccccCCcHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHR-----------------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLN  149 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~-----------------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~  149 (289)
                      +.+++||||+++++|.+++....                       .+++..+..++.|++.||.|||++|  ++|+||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dik  199 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLA  199 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCS
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence            67899999999999999998643                       3799999999999999999999999  9999999


Q ss_pred             CCceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 022956          150 CSNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSEC  224 (289)
Q Consensus       150 ~~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~  224 (289)
                      |+||+++.+ +.++|+|||++........   .....+++.|+|||.+. +.+++++||||||+++++|++ |..||.+.
T Consensus       200 p~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          200 ARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999998 8999999999976643322   22344678899999765 448999999999999999998 99999887


Q ss_pred             CcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          225 DSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .........+....... .+...++.+.+|+..||. ||.+|||+.++++  .++.+
T Consensus       279 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~~  332 (344)
T 1rjb_A          279 PVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS--FLGCQ  332 (344)
T ss_dssp             CCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             CcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH--HHHHH
Confidence            66566666665554332 344568999999999998 9999999999999  44444

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.9e-45  Score=314.21  Aligned_cols=245  Identities=18%  Similarity=0.238  Sum_probs=199.4

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   93 (289)
                      +++| ++.+.||+|+||+||+|.++.+|+.||+|++.....      .+.+.+|+++++.+ +||||+.+++++...  +
T Consensus         8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~   78 (330)
T 2izr_A            8 GPNF-RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCG--K   78 (330)
T ss_dssp             TTTE-EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEET--T
T ss_pred             cCCe-EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecC--C
Confidence            3555 789999999999999999999999999999975432      23577899999999 999999999988654  6


Q ss_pred             eeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc-----EEEecc
Q 022956           94 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ-----VKIGDL  167 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~-----~~l~d~  167 (289)
                      ..++||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.     ++|+||
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~-~~~~~~~~kl~DF  154 (330)
T 2izr_A           79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP-GNKTQQVIHIIDF  154 (330)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-GGTCTTSEEECCC
T ss_pred             ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-CCCCCceEEEEEc
Confidence            789999999 8899999986 467999999999999999999999999  9999999999999887 66     999999


Q ss_pred             CCccccCCccc--------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhC
Q 022956          168 GFAAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTG  236 (289)
Q Consensus       168 g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~  236 (289)
                      |++........        .....|++.|+|||.+.+. +++++||||||+++|+|++|..||.+..  ........+..
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            99987643322        2356789999999977655 8999999999999999999999998642  22222222211


Q ss_pred             C---CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          237 G---VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       237 ~---~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .   ..........+ .+.+++..||+ ||.+||++++|++
T Consensus       235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1   11111122233 99999999998 9999999999887

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.1e-45  Score=315.46  Aligned_cols=246  Identities=25%  Similarity=0.279  Sum_probs=196.8

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--CCe
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--HNT   94 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~   94 (289)
                      ..|++.++||+|+||+||+|.+.  ++.||+|++...     .........|+.++++++||||+++++++....  ...
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            33478999999999999999875  899999999653     223445666899999999999999999987643  345


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC----------CCCceecCCCCCceEEeCCCCcEEE
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH----------EPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~----------~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                      +++||||+++++|.+++... .+++..+..++.|++.||.|||+.          |  ++|+||||+||+++.+ +.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~-~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN-LTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT-CCEEE
T ss_pred             EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC-CeEEE
Confidence            79999999999999999874 499999999999999999999999          8  9999999999999988 89999


Q ss_pred             eccCCccccCCccc---cccCCCCCCCCCCccccc------CCCCcchHHHHHHHHHHHHhCCCCCCCCC----------
Q 022956          165 GDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE------DYTEMVDIYSFGLCLLEMVTMEIPYSECD----------  225 (289)
Q Consensus       165 ~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~~----------  225 (289)
                      +|||++........   .....+++.|+|||.+.+      .++.++|||||||++|+|++|..||.+..          
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999976643322   333578999999997764      35668899999999999999999996522          


Q ss_pred             -----cHHHHHHHHhCCCCCCCCCC-----CCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          226 -----SVAKIYKKVTGGVKPQALNK-----VKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       226 -----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                           ....................     ..++.+.+|+.+||+ ||++|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                 22333333333222221111     113459999999998 9999999999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.7e-45  Score=314.50  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=203.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEE--EEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEV--AWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   92 (289)
                      ++| ++.+.||+|+||.||+|.++.+|..+  |+|.++...   .....+.+.+|+++++++ +||||+++++++...  
T Consensus        25 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--   98 (327)
T 1fvr_A           25 NDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--   98 (327)
T ss_dssp             GGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred             HHc-cceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--
Confidence            444 78999999999999999999888866  899887432   233456788999999999 899999999988554  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN  156 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~----------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~  156 (289)
                      +.+++||||+++++|.+++...+                .+++..+..++.|++.||.|||++|  ++|+||+|+||+++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG  176 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc
Confidence            67999999999999999998654                6999999999999999999999999  99999999999999


Q ss_pred             CCCCcEEEeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 022956          157 GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKV  234 (289)
Q Consensus       157 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~  234 (289)
                      .+ +.++|+|||++.............+++.|+|||.+.+. +++++||||||+++++|++ |..||.+..... ....+
T Consensus       177 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~~~~  254 (327)
T 1fvr_A          177 EN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKL  254 (327)
T ss_dssp             GG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHG
T ss_pred             CC-CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-HHHHh
Confidence            88 89999999999765444344445568899999977655 8899999999999999998 999998755443 44444


Q ss_pred             hCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          235 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..+... ..+...++.+.+|+.+||+ ||++|||+++++++
T Consensus       255 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          255 PQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            443322 2344568999999999998 99999999999984

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=318.95  Aligned_cols=264  Identities=16%  Similarity=0.185  Sum_probs=200.2

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecC---CCcEEEEEEeeecccCCCH--H-----HHHHHHHHHHHHHhCCCCceE
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDP--V-----LVNRLHSEVQLLRTLKNKYII   81 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~~--~-----~~~~~~~e~~~l~~l~~~~i~   81 (289)
                      .+..+..|++.+.||+|+||+||+|.+..   ++..+|+|++.........  .     ....+.+|+..++.++||||+
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            34444445789999999999999999987   7899999999864321000  0     112366788899999999999


Q ss_pred             EeeeeEEeC--CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC
Q 022956           82 VCYSVWLDD--QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI  159 (289)
Q Consensus        82 ~~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~  159 (289)
                      ++++++...  ....+++||||+ +++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-  187 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK-  187 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS-
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC-
Confidence            999988762  246899999999 8899999988778999999999999999999999999  9999999999999877 


Q ss_pred             C--cEEEeccCCccccCCccc--------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCC-CcH
Q 022956          160 G--QVKIGDLGFAAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSEC-DSV  227 (289)
Q Consensus       160 ~--~~~l~d~g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~-~~~  227 (289)
                      +  .+||+|||++........        .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||... ...
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            5  999999999976643211        1345789999999987665 899999999999999999999999542 222


Q ss_pred             HHHHH---HHhCCCCCC----CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          228 AKIYK---KVTGGVKPQ----ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       228 ~~~~~---~~~~~~~~~----~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .....   ......+..    ......++.+.+++..||+ ||++||++++|++  .|++..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~  327 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK--ILNPHG  327 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHCTTC
T ss_pred             HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH--HHhccC
Confidence            22111   111111110    0112568899999999998 9999999999998  666554

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-44  Score=311.69  Aligned_cols=248  Identities=27%  Similarity=0.410  Sum_probs=204.1

Q ss_pred             cccceeeeecccCcceEEEEeec-------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQ-------EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWL   88 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   88 (289)
                      ..|++.+.||+|+||+||+|.+.       .++..||+|+++...   .....+.+.+|+++++++ +||||+++++++.
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            33478999999999999999875       457889999997542   455677899999999999 8999999999874


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCc
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSN  152 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~~----------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~n  152 (289)
                      .  .+.+++||||+++++|.+++....                .+++..+..++.|++.||.|||+.|  ++|+||+|+|
T Consensus       112 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~N  187 (334)
T 2pvf_A          112 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARN  187 (334)
T ss_dssp             S--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred             c--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccce
Confidence            4  367899999999999999998653                3899999999999999999999999  9999999999


Q ss_pred             eEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcH
Q 022956          153 IFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSV  227 (289)
Q Consensus       153 ili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~  227 (289)
                      |+++.+ +.+||+|||++........   .....+++.|+|||.+.+. ++.++||||||+++|+|++ |..||.+....
T Consensus       188 Ill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          188 VLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             EEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            999988 8999999999987654322   2234567889999976544 8999999999999999999 99999875544


Q ss_pred             HHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          228 AKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      . ....+..+... ..+...++.+.+++.+||+ ||.+||++++++++
T Consensus       267 ~-~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          267 E-LFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             H-HHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H-HHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3 34444433322 2345578999999999998 99999999999984

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7e-45  Score=310.84  Aligned_cols=254  Identities=20%  Similarity=0.306  Sum_probs=198.5

Q ss_pred             CCCcccceeeeecccCcceEEEEeecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .....|++.+.||+|+||+||+|.+..   ++..||+|+++....  .....+.+.+|+.++++++||||+++++++...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            444556889999999999999998765   566899999986543  455677899999999999999999999988664


Q ss_pred             CCC---eeEEEeccccCCcHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc
Q 022956           91 QHN---TLNFITEVCTSGNLRTYRK------KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ  161 (289)
Q Consensus        91 ~~~---~~~lv~e~~~~~sL~~~~~------~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~  161 (289)
                      ...   ..++|+||+++++|.+++.      ....+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT-SC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-Cc
Confidence            332   4699999999999999984      2356999999999999999999999999  9999999999999998 89


Q ss_pred             EEEeccCCccccCCcc---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhC
Q 022956          162 VKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG  236 (289)
Q Consensus       162 ~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  236 (289)
                      ++|+|||++.......   ......+++.|+|||.+.+. +++++||||||+++++|++ |..||............. .
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-H  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-T
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-c
Confidence            9999999997664332   12234567889999977654 8999999999999999999 889998765544444333 3


Q ss_pred             CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          237 GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      +..+ ..+...++.+.+++.+||. ||++|||+++++++
T Consensus       265 ~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          265 GHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3222 2344568999999999998 99999999999983

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.5e-45  Score=318.38  Aligned_cols=246  Identities=20%  Similarity=0.326  Sum_probs=193.7

Q ss_pred             ccceeeeecccCcceEEEEeec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQ---EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .+++.+.||+|+||.||+|.++   .++..||+|+++...   .+...+.+.+|++++++++||||+++++++..  .+.
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~  120 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKP  120 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCc
Confidence            3468999999999999999876   567889999997542   45567789999999999999999999998844  367


Q ss_pred             eEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      +++||||+++++|.+++... ..+++.++..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC-CCEEECcCcccccc
Confidence            89999999999999999865 46999999999999999999999999  9999999999999998 89999999999876


Q ss_pred             CCccc----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          174 GRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       174 ~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      .....    .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||........ ...+..+.... .+...
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~-~~~i~~~~~~~-~~~~~  275 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-IKAVDEGYRLP-PPMDC  275 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH-HHHHHTTEECC-CCTTC
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCC-CCccc
Confidence            43321    112234678999997664 48999999999999999998 9999987654443 34444432222 23456


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ++.+.+++..||+ ||++||+++++++
T Consensus       276 ~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          276 PAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             BHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8899999999998 9999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.3e-45  Score=314.22  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=198.7

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEE----EEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeee
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEV----AWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSV   86 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   86 (289)
                      ..-..++| ++.++||+|+||+||+|.+..++..+    |+|.+....   .....+.+.+|+.++++++||||++++++
T Consensus        10 ~~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   85 (327)
T 3poz_A           10 RILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             EECCGGGE-EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred             hhcCHHHc-ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            33445565 78999999999999999998887765    666665332   23345778999999999999999999998


Q ss_pred             EEeCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           87 WLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        87 ~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                      +...   ..+++++++.+++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+
T Consensus        86 ~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~  159 (327)
T 3poz_A           86 CLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKIT  159 (327)
T ss_dssp             EESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEEC
T ss_pred             EecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC-CCEEEc
Confidence            8653   37789999999999999986 467999999999999999999999999  9999999999999998 899999


Q ss_pred             ccCCccccCCcccc---ccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCC
Q 022956          166 DLGFAAIVGRSHAA---HSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP  240 (289)
Q Consensus       166 d~g~~~~~~~~~~~---~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~  240 (289)
                      |||++.........   ....+++.|+|||.+.+ .+++++||||||+++|+|++ |..||.+..... ....+......
T Consensus       160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~  238 (327)
T 3poz_A          160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL  238 (327)
T ss_dssp             CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTCCC
T ss_pred             cCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-HHHHHHcCCCC
Confidence            99999876443322   23345779999997654 48999999999999999999 999998754433 33444443322


Q ss_pred             CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      . .+...+..+.+++.+||+ ||++||++.+++++
T Consensus       239 ~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 P-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             C-CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             C-CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            2 344568899999999998 99999999999974

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=305.79  Aligned_cols=248  Identities=20%  Similarity=0.346  Sum_probs=204.8

Q ss_pred             CcccceeeeecccCcceEEEEeec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ++|+.+.+.||+|+||.||+|.+.  .++..||+|+++...   .....+.+.+|++++++++||||+++++++ ..  +
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~--~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA--E   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES--S
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC--C
Confidence            455444459999999999999753  468889999997642   456678899999999999999999999987 22  4


Q ss_pred             eeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           94 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      .+++|||++++++|.+++.. ...+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~  159 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKA  159 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC-CCEEECcccceee
Confidence            58999999999999999975 356999999999999999999999999  9999999999999988 8999999999987


Q ss_pred             cCCccc----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCC
Q 022956          173 VGRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKV  246 (289)
Q Consensus       173 ~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (289)
                      ......    .....+++.|+|||.+.+ .+++++||||||+++++|++ |..||......... ..+..+..+ ..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~i~~~~~~-~~~~~  237 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRM-ECPPE  237 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHHHTTCCC-CCCTT
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHhcCCcC-CCCCC
Confidence            643322    222345788999997764 48999999999999999998 99999876655444 344443322 23456


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .++.+.+++..||+ ||++||++.+++++
T Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          238 CPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999998 99999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-44  Score=306.35  Aligned_cols=246  Identities=15%  Similarity=0.195  Sum_probs=200.4

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   93 (289)
                      .++| ++.+.||+|+||.||+|.+..+|+.||+|++.....      .+.+.+|+..++.+ +|++++.+++++...  .
T Consensus         9 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~   79 (298)
T 1csn_A            9 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L   79 (298)
T ss_dssp             TTTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred             ccce-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCC--c
Confidence            4455 789999999999999999999999999999875432      23467799999999 789999999887443  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc-----EEEecc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ-----VKIGDL  167 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~-----~~l~d~  167 (289)
                      ..++|+||+ +++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.     ++|+||
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Df  155 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRP-NSKNANMIYVVDF  155 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCS-SSTTTTCEEECCC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccC-CCCCCCeEEEEEC
Confidence            789999999 88999999864 46999999999999999999999999  9999999999999866 44     999999


Q ss_pred             CCccccCCccc--------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhC
Q 022956          168 GFAAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD--SVAKIYKKVTG  236 (289)
Q Consensus       168 g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~  236 (289)
                      |++........        .....+++.|+|||.+.+. +++++||||||+++++|++|..||.+..  ........+..
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            99987654322        3445689999999977654 8999999999999999999999998632  22222222211


Q ss_pred             C---CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          237 G---VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       237 ~---~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .   ..........++.+.+++..||+ ||++||++++|++
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1   11122233568999999999998 9999999999988

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.9e-46  Score=341.52  Aligned_cols=265  Identities=26%  Similarity=0.408  Sum_probs=208.0

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ......++| ++.++||+|+||+||+|.+..+|..||+|++....   .....+.+.+|++++++++||||+++++++..
T Consensus         8 ~pg~~~grY-~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~   83 (676)
T 3qa8_A            8 LPTQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDG   83 (676)
T ss_dssp             ----------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred             CCCCCCCCe-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence            334455777 78999999999999999999999999999987532   45667789999999999999999999987633


Q ss_pred             ----CCCCeeEEEeccccCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC--
Q 022956           90 ----DQHNTLNFITEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG--  160 (289)
Q Consensus        90 ----~~~~~~~lv~e~~~~~sL~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~--  160 (289)
                          ..++..++||||++|++|.+++....   .+++..+..++.|++.||.|||+.|  ++|+||+|+||+++.+ +  
T Consensus        84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~-g~~  160 (676)
T 3qa8_A           84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPG-PQR  160 (676)
T ss_dssp             TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECC-SSS
T ss_pred             cccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecC-CCc
Confidence                22467899999999999999998743   6899999999999999999999999  9999999999999876 4  


Q ss_pred             -cEEEeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH----
Q 022956          161 -QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKV----  234 (289)
Q Consensus       161 -~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~----  234 (289)
                       .++|+|||++.............+++.|+|||.+.+. ++.++||||||+++|+|++|..||............+    
T Consensus       161 ~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~  240 (676)
T 3qa8_A          161 LIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS  240 (676)
T ss_dssp             CEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---
T ss_pred             eeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhccc
Confidence             3999999999887666555667899999999987644 8999999999999999999999997643222110000    


Q ss_pred             ----------hCC-------CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          235 ----------TGG-------VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       235 ----------~~~-------~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                                .+.       ..+.......++.+.+++..||. ||++|||+++++.||||+.++
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence                      000       00111222246789999999999 999999999999999998764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-44  Score=304.21  Aligned_cols=251  Identities=21%  Similarity=0.340  Sum_probs=202.1

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQE---EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      +.....|++.+.||+|+||+||+|.+..   ++..||+|.+....   .....+.+.+|+++++.++||||+++++++..
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            3344445789999999999999998653   34569999987542   45557889999999999999999999998632


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                         +..++|+||+++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||
T Consensus        85 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg  158 (281)
T 3cc6_A           85 ---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP-ECVKLGDFG  158 (281)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET-TEEEECCCC
T ss_pred             ---CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC-CcEEeCccC
Confidence               3468999999999999999764 46999999999999999999999999  9999999999999998 899999999


Q ss_pred             CccccCCccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCC
Q 022956          169 FAAIVGRSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALN  244 (289)
Q Consensus       169 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (289)
                      ++........  .....+++.|+|||.+.+ .+++++||||||+++++|++ |..||..................  ..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--~~~  236 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--PKP  236 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--CCC
T ss_pred             CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--CCC
Confidence            9986644322  233456778999997764 48999999999999999998 99999865544433333333222  234


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ...++.+.+++.+||. ||++||++.+++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            4578999999999998 99999999999983

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.1e-45  Score=312.43  Aligned_cols=250  Identities=27%  Similarity=0.406  Sum_probs=207.6

Q ss_pred             CcccceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD   89 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   89 (289)
                      ++| ++.+.||+|+||+||+|.+     ..+++.||+|+++...   .....+.+.+|+++++++ +||||+++++.+..
T Consensus        27 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           27 DRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhe-eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            444 7899999999999999984     4578999999997542   355567899999999999 68999999998755


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRH----------------VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI  153 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~----------------l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~ni  153 (289)
                      . +..+++|+||+++++|.+++.....                +++..+..++.|++.||.|||++|  ++|+||+|+||
T Consensus       103 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Ni  179 (316)
T 2xir_A          103 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI  179 (316)
T ss_dssp             T-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             C-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceE
Confidence            4 3568999999999999999987543                899999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 022956          154 FINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVA  228 (289)
Q Consensus       154 li~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~  228 (289)
                      +++.+ +.++|+|||++........   .....+++.|+|||.+.+ .++.++||||||+++++|++ |..||.+.....
T Consensus       180 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          180 LLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99988 8999999999976643322   223456789999997654 48999999999999999998 999998766555


Q ss_pred             HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .....+..+... ..+...++.+.+++..||+ ||.+|||++++++|
T Consensus       259 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555555444332 2344578999999999998 99999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=305.46  Aligned_cols=263  Identities=20%  Similarity=0.303  Sum_probs=208.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +++.++||+|+||+||+|.+..++.   .+|+|.+...   ......+.+.+|+++++.++||||+++++++...+ ...
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   98 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLP   98 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCC
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCc
Confidence            3567999999999999998765544   7999998643   24556788999999999999999999999886543 445


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++++||+.+++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEeCcCCCccccc
Confidence            889999999999999986 467899999999999999999999999  9999999999999988 899999999997654


Q ss_pred             Ccc-----ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          175 RSH-----AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       175 ~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ...     ......+++.|+|||.+.+. +++++||||||+++++|++|..|+............+...... ..+...+
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  254 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCP  254 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCC
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccch
Confidence            321     22334567899999977654 8999999999999999999655544434444444444444332 2345568


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcC--cccccCCCCCCCCCC
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKD--PFFSELNDDDSEPSP  289 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h--~~~~~~~~~~~~~~~  289 (289)
                      +.+.+++.+||+ ||.+|||++++++.  ..++++......+.|
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~~~lp  298 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP  298 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCBCCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccchhhCC
Confidence            999999999998 99999999999983  344444555554444

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.3e-45  Score=307.57  Aligned_cols=245  Identities=22%  Similarity=0.370  Sum_probs=200.0

Q ss_pred             ccceeeeecccCcceEEEEeecCCC-------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEG-------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .|++.+.||+|+||+||+|.+..++       ..||+|++....    ....+.+.+|++++++++||||+++++++...
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            3478999999999999999998877       479999996542    33357789999999999999999999988543


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCc--------
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQ--------  161 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~-l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~--------  161 (289)
                        +..++||||+++++|.+++..... +++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.        
T Consensus        85 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~~~~~  159 (289)
T 4fvq_A           85 --DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE-EDRKTGNPPF  159 (289)
T ss_dssp             --TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-CBGGGTBCCE
T ss_pred             --CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-Ccccccccce
Confidence              568899999999999999987654 999999999999999999999999  9999999999999887 55        


Q ss_pred             EEEeccCCccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhCCC
Q 022956          162 VKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       162 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~  238 (289)
                      ++|+|||++.......   ...+++.|+|||.+.+  .+++++||||||+++|+|++| ..||.. ..............
T Consensus       160 ~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-~~~~~~~~~~~~~~  235 (289)
T 4fvq_A          160 IKLSDPGISITVLPKD---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-LDSQRKLQFYEDRH  235 (289)
T ss_dssp             EEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTC
T ss_pred             eeeccCcccccccCcc---ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-cchHHHHHHhhccC
Confidence            9999999987554322   2346788999997764  389999999999999999995 455544 43434333333322


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                         ..+...++.+.+|+.+||+ ||++|||++++++  .|+++
T Consensus       236 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~l  273 (289)
T 4fvq_A          236 ---QLPAPKAAELANLINNCMDYEPDHRPSFRAIIR--DLNSL  273 (289)
T ss_dssp             ---CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH--HHHTC
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHh
Confidence               2334457889999999998 9999999999999  45444

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.5e-45  Score=306.31  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=207.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      .....+++.+.||+|+||+||+|.++.++..||+|++...     ....+.+.+|++++++++||||+++++++..  ..
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~   82 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EP   82 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence            3444457899999999999999999999999999999743     2235778899999999999999999998744  36


Q ss_pred             eeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .+++||||+++++|.+++...  ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~  159 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSR  159 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG-GCEEECCCCGGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC-CCEEEccCccce
Confidence            789999999999999999863  45899999999999999999999999  9999999999999988 899999999998


Q ss_pred             ccCCccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          172 IVGRSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       172 ~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      .......  .....+++.|+|||.+.+ .+++++||||||+++++|++ |..||....... ....+...... ..+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~  237 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRM-ERPEGC  237 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHTTCCC-CCCTTC
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhccCCC-CCCCCC
Confidence            7654332  223345778999997764 48999999999999999999 999998754433 33444444332 234557


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ++.+.+|+..||+ ||++|||++++++
T Consensus       238 ~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          238 PEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            8999999999999 9999999999988

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-44  Score=305.57  Aligned_cols=248  Identities=20%  Similarity=0.303  Sum_probs=194.6

Q ss_pred             CCCCceeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH-HhCCCCceEEe
Q 022956            5 DGEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL-RTLKNKYIIVC   83 (289)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~   83 (289)
                      .+..+......++|+.+.+.||+|+||.||+|.++.+|+.||+|++...         ..+.+|+.++ +.++||||+++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~   76 (299)
T 3m2w_A            6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRI   76 (299)
T ss_dssp             CCCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCE
T ss_pred             ccccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhH
Confidence            3444445567778865458899999999999999999999999999632         3456677777 66699999999


Q ss_pred             eeeEEe--CCCCeeEEEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-
Q 022956           84 YSVWLD--DQHNTLNFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-  158 (289)
Q Consensus        84 ~~~~~~--~~~~~~~lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-  158 (289)
                      ++++..  .....+++||||+++++|.+++....  .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ 
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~  154 (299)
T 3m2w_A           77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKR  154 (299)
T ss_dssp             EEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSS
T ss_pred             HhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCC
Confidence            998854  33467899999999999999998753  6999999999999999999999999  9999999999999872 


Q ss_pred             -CCcEEEeccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC
Q 022956          159 -IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG  237 (289)
Q Consensus       159 -~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  237 (289)
                       .+.++|+|||++.....                    ..++.++|||||||++|+|++|..||.+......... ....
T Consensus       155 ~~~~~kl~Dfg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~~~  213 (299)
T 3m2w_A          155 PNAILKLTDFGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTR  213 (299)
T ss_dssp             TTCCEEECCCTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-SCCS
T ss_pred             CCCcEEEecccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-HHHH
Confidence             27899999998864432                    2357789999999999999999999976432221100 0010


Q ss_pred             CCCC--CCC----CCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          238 VKPQ--ALN----KVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       238 ~~~~--~~~----~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      ....  ..+    ...++.+.+|+.+||+ ||++|||++++++||||++.....
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~  267 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  267 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence            0000  011    3468899999999998 999999999999999998875443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.3e-44  Score=322.40  Aligned_cols=239  Identities=22%  Similarity=0.378  Sum_probs=199.7

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||.||++.+.  |..||||+++...      ..+.+.+|++++++++||||+++++++.... ..+++|
T Consensus       195 ~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~iv  265 (450)
T 1k9a_A          195 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV  265 (450)
T ss_dssp             EEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCEEEE
T ss_pred             eEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-CceEEE
Confidence            478899999999999999875  7899999997542      2467889999999999999999999876543 468999


Q ss_pred             eccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++++|.+++...+  .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++......
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-SCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC-CCEEEeeCCCccccccc
Confidence            99999999999998754  3799999999999999999999999  9999999999999988 89999999999855433


Q ss_pred             cccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .  ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||......... ..+..+.... .+...++.+.+|
T Consensus       343 ~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-~~i~~~~~~~-~p~~~~~~l~~l  418 (450)
T 1k9a_A          343 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMD-APDGCPPAVYDV  418 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-HHHHTTCCCC-CCTTCCHHHHHH
T ss_pred             c--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCC-CCCcCCHHHHHH
Confidence            2  22356789999997754 48999999999999999998 99999875544433 3444443332 345678999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhc
Q 022956          255 IEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~  273 (289)
                      +..||+ ||++|||+.++++
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            999998 9999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-44  Score=307.91  Aligned_cols=250  Identities=20%  Similarity=0.328  Sum_probs=198.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ....+++.+.||+|+||+||+|.++.++    ..||+|+++...   .......+.+|+++++.++||||+++++++.. 
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-  117 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-  117 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-
Confidence            3344477899999999999999877553    459999997532   45556789999999999999999999998743 


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                       .+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus       118 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~  193 (333)
T 1mqb_A          118 -YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGL  193 (333)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC
T ss_pred             -CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC-CcEEECCCCc
Confidence             46799999999999999999764 67999999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccc----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          170 AAIVGRSHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       170 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      +........    .....+++.|+|||.+.+ .++.++||||||+++++|++ |..||........ ...+..+.... .
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~-~  271 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAINDGFRLP-T  271 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTTCCCC-C
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH-HHHHHCCCcCC-C
Confidence            987643321    122345678999997764 48899999999999999999 9999987555444 34444432222 2


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      +...++.+.+++.+||+ ||++||++.+++++
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            34568899999999998 99999999999883

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=310.56  Aligned_cols=251  Identities=22%  Similarity=0.320  Sum_probs=188.5

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEe--
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLD--   89 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--   89 (289)
                      +..+..|++.++||+|+||.||+|.++.+|+.||+|++...    .....+.+.+|+.+++++. ||||+++++++..  
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            33444458999999999999999999999999999998654    4555678899999999996 9999999988752  


Q ss_pred             ----CCCCeeEEEeccccCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcE
Q 022956           90 ----DQHNTLNFITEVCTSGNLRTYRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV  162 (289)
Q Consensus        90 ----~~~~~~~lv~e~~~~~sL~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~  162 (289)
                          .....+++++||+.| +|.+++..   ...+++..+..++.|++.||.|||+.|++++|+||+|+||+++.+ +.+
T Consensus       100 ~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~  177 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTI  177 (337)
T ss_dssp             TTSTTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCE
T ss_pred             cccccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCE
Confidence                334568999999975 89888764   467999999999999999999999988779999999999999998 899


Q ss_pred             EEeccCCccccCCcccc-------------ccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 022956          163 KIGDLGFAAIVGRSHAA-------------HSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECD  225 (289)
Q Consensus       163 ~l~d~g~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~  225 (289)
                      +|+|||++.........             ....+++.|+|||.+.    ..+++++||||||+++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999876543221             1345889999999762    337889999999999999999999997643


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ....    .... .........++.+.+|+.+||+ ||++||++++++++
T Consensus       258 ~~~~----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          258 KLRI----VNGK-YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHh----hcCc-ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3221    1111 1222344557889999999999 99999999999996

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-44  Score=305.80  Aligned_cols=249  Identities=20%  Similarity=0.283  Sum_probs=200.9

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      ....++| ++.+.||+|+||.||+|.+..+|+.||+|++.....      .+.+.+|+.+++.++|++++..+..+... 
T Consensus         5 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-   76 (296)
T 3uzp_A            5 LRVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-   76 (296)
T ss_dssp             CEETTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred             ceeccEE-EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCC-
Confidence            3456776 789999999999999999999999999999876543      23577899999999998877776655443 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe---CCCCcEEEecc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN---GNIGQVKIGDL  167 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~---~~~~~~~l~d~  167 (289)
                      +...++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++   .+ +.++|+||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~-~~~kl~Df  152 (296)
T 3uzp_A           77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG-NLVYIIDF  152 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGT-TCEEECCC
T ss_pred             CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCC-CeEEEeeC
Confidence            46889999999 8899999984 567999999999999999999999999  99999999999995   55 89999999


Q ss_pred             CCccccCCccc--------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc------HHHHHH
Q 022956          168 GFAAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS------VAKIYK  232 (289)
Q Consensus       168 g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~------~~~~~~  232 (289)
                      |++........        .....+++.|+|||.+.+. +++++||||||+++|+|++|..||.....      ......
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            99987654322        2345789999999977654 89999999999999999999999976321      111111


Q ss_pred             HHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          233 KVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .... .+........++.+.+++..||+ ||++|||++++++
T Consensus       233 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          233 KKMS-TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHH-SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cccC-CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1111 11111234468999999999998 9999999999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.1e-45  Score=312.58  Aligned_cols=249  Identities=21%  Similarity=0.341  Sum_probs=200.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcE----EEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIE----VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ..++| ++.++||+|+||+||+|.+..++..    +|+|.+.....   ......+.+|+.++++++||||+++++++. 
T Consensus        11 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           11 KETEL-RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             CTTTE-EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CHhHc-eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            34555 7899999999999999999888876    66666643322   122345677999999999999999999773 


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                        +...++|+||+.+++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||
T Consensus        86 --~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg  160 (325)
T 3kex_A           86 --GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADFG  160 (325)
T ss_dssp             --BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSS-SCEEECSCS
T ss_pred             --CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCC-CeEEECCCC
Confidence              24688999999999999999864 57999999999999999999999999  9999999999999988 899999999


Q ss_pred             CccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          169 FAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       169 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      ++........   .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+...... ...+..... ...
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~-~~~  238 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-PDLLEKGER-LAQ  238 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-HHHHHTTCB-CCC
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-HHHHHcCCC-CCC
Confidence            9987644322   23345677999999776 448999999999999999999 9999987544433 333343322 223


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      +...++.+.+++.+||. ||.+||++.+++++
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44467889999999998 99999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.5e-44  Score=306.06  Aligned_cols=250  Identities=21%  Similarity=0.288  Sum_probs=196.4

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      .....++| ++.+.||+|+||+||+|.+..+++.||+|++.....      .+.+.+|+++++.++|++++..+..+...
T Consensus         4 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            4 ELRVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             -------C-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             ccccCCce-EEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            34566777 789999999999999999999999999999765432      23577899999999998888777666543


Q ss_pred             CCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE---eCCCCcEEEec
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGD  166 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili---~~~~~~~~l~d  166 (289)
                       ....++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||+|+||++   +.+ +.+||+|
T Consensus        77 -~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~-~~~kL~D  151 (296)
T 4hgt_A           77 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG-NLVYIID  151 (296)
T ss_dssp             -TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGT-TCEEECC
T ss_pred             -CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCC-CeEEEec
Confidence             36889999999 8899999985 467999999999999999999999999  9999999999999   566 8999999


Q ss_pred             cCCccccCCccc--------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH------HHHH
Q 022956          167 LGFAAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV------AKIY  231 (289)
Q Consensus       167 ~g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~------~~~~  231 (289)
                      ||++........        .....+++.|+|||.+.+. +++++||||||+++|+|++|..||.+....      ....
T Consensus       152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            999987644322        2345789999999977654 889999999999999999999999763211      1111


Q ss_pred             HHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          232 KKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..... .+........++.+.+++..||+ ||++|||++++++
T Consensus       232 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          232 EKKMS-TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHH-SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccccc-chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11111 11111224468899999999999 9999999999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-44  Score=311.17  Aligned_cols=256  Identities=21%  Similarity=0.334  Sum_probs=203.2

Q ss_pred             CCCcccceeeeecccCcceEEEEe-----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAF-----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      ...+.|++.+.||+|+||.||+|.     +..++..||+|++....   .......+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            333444789999999999999998     55678899999996432   4555677899999999999999999999885


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--C
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKH-------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--I  159 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~  159 (289)
                      ..  ...++||||+++++|.+++...       ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+  .
T Consensus       104 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          104 QS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             SS--SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTT
T ss_pred             CC--CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCc
Confidence            43  5689999999999999999865       34899999999999999999999999  9999999999999843  1


Q ss_pred             CcEEEeccCCccccCCc---cccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 022956          160 GQVKIGDLGFAAIVGRS---HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKV  234 (289)
Q Consensus       160 ~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~  234 (289)
                      ..++|+|||++......   .......+++.|+|||.+. +.+++++||||||+++|+|++ |..||...... .....+
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~  258 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFV  258 (327)
T ss_dssp             CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHH
T ss_pred             ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HHHHHH
Confidence            46999999998754322   1223345788999999765 448999999999999999998 99999875544 344444


Q ss_pred             hCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          235 TGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      ..+... ......++.+.+++.+||+ ||.+||++++++++.|+-
T Consensus       259 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            444332 2345578999999999999 999999999999987754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=309.55  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=204.5

Q ss_pred             CCCcccceeeeecccCcceEEEEe----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ...+.+++.++||+|+||.||++.    +..+|+.||+|++...    .....+.+.+|++++++++||||+++++++..
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            344556889999999999999998    5678999999999753    44556789999999999999999999998866


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      .+...+++|+||+++++|.+++... ..+++..+..++.|++.||.+||+.|  ++|+||+|+||+++.+ +.++|+|||
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kL~Dfg  190 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFG  190 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCT
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC-CcEEEecCc
Confidence            5556789999999999999999875 46999999999999999999999999  9999999999999988 899999999


Q ss_pred             CccccCCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------------H
Q 022956          169 FAAIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV---------------A  228 (289)
Q Consensus       169 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~---------------~  228 (289)
                      ++........    .....++..|+|||.+.+. ++.++||||||+++++|++|..||......               .
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            9987654322    2233466789999977654 888999999999999999999888642110               1


Q ss_pred             HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ...+.+...... ..+...++.+.+++.+||+ ||++|||+.++++
T Consensus       271 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          271 HLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            122333333222 2345578999999999998 9999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=310.31  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=198.7

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEE----EEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeee
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEV----AWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYS   85 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   85 (289)
                      ..+-..++| ++.++||+|+||+||+|.+..+++.+    |+|.+....   .....+.+.+|+.+++.++||||+++++
T Consensus         9 ~~~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~   84 (327)
T 3lzb_A            9 LRILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLG   84 (327)
T ss_dssp             CEECCTTTE-EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred             hcccCHhHc-eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence            333445666 78999999999999999998888766    555554332   2233577889999999999999999999


Q ss_pred             eEEeCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEE
Q 022956           86 VWLDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                      ++...   ..+++++++.+++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|
T Consensus        85 ~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kL  158 (327)
T 3lzb_A           85 ICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKI  158 (327)
T ss_dssp             EEESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEE
T ss_pred             EEecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC-CCEEE
Confidence            88654   37889999999999999976 467999999999999999999999999  9999999999999998 89999


Q ss_pred             eccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC
Q 022956          165 GDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK  239 (289)
Q Consensus       165 ~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  239 (289)
                      +|||++........   .....+++.|+|||.+.+. +++++||||||+++|+|++ |..||.+..... ....+.....
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~~~~~  237 (327)
T 3lzb_A          159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGER  237 (327)
T ss_dssp             CCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTCC
T ss_pred             ccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcCCC
Confidence            99999987643322   2233457789999976644 8999999999999999999 999998755443 3334444332


Q ss_pred             CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          240 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       240 ~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .. .+...++.+.+++.+||+ ||++||+++++++
T Consensus       238 ~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          238 LP-QPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            22 344578899999999999 9999999999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=304.91  Aligned_cols=237  Identities=27%  Similarity=0.471  Sum_probs=190.8

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.+.||+|+||+||++.+.  ++.||+|.+..      +...+.+.+|++++++++||||+++++++.    +..++|
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~lv   77 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACL----NPVCLV   77 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT----TTTEEE
T ss_pred             eeeeeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc----CCcEEE
Confidence            478999999999999999875  78999999863      233577899999999999999999998763    247899


Q ss_pred             eccccCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhc---CCCCceecCCCCCceEEeCCCCc-EEEeccCCcc
Q 022956           99 TEVCTSGNLRTYRKKHR---HVSIKALKKWSKQVLEGLEYLHT---HEPCIIHRDLNCSNIFINGNIGQ-VKIGDLGFAA  171 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~---~~~~~~h~dl~~~nili~~~~~~-~~l~d~g~~~  171 (289)
                      |||+++++|.+++....   .++...+..++.|++.||.|||+   +|  ++|+||+|+||+++.+ +. +||+|||++.
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~-~~~~kl~Dfg~~~  154 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAG-GTVLKICDFGTAC  154 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETT-TTEEEECCCCC--
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCC-CCEEEEccccccc
Confidence            99999999999998754   47899999999999999999999   78  9999999999999988 55 8999999997


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECD-SVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .....  .....+++.|+|||.+.+. ++.++||||||+++++|++|..||.... ..............+. .....++
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  231 (307)
T 2eva_A          155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP-LIKNLPK  231 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC-CBTTCCH
T ss_pred             ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC-cccccCH
Confidence            65432  2234589999999977654 8999999999999999999999998543 2223333333333332 3345689


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.+++.+||+ ||++|||++++++
T Consensus       232 ~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          232 PIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999998 9999999999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.2e-44  Score=314.23  Aligned_cols=256  Identities=17%  Similarity=0.170  Sum_probs=195.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCC-----CcEEEEEEeeecccCCC--HHH-----HHHHHHHHHHHHhCCCCceE
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEE-----GIEVAWNQVRLSHFSED--PVL-----VNRLHSEVQLLRTLKNKYII   81 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~aiK~~~~~~~~~~--~~~-----~~~~~~e~~~l~~l~~~~i~   81 (289)
                      ....-|++.++||+|+||+||+|.+..+     ++.||+|++........  ...     ...+.+++..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3333457899999999999999988765     58899999875421000  000     11233455667788899999


Q ss_pred             EeeeeEEeCC--CCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEe--
Q 022956           82 VCYSVWLDDQ--HNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--  156 (289)
Q Consensus        82 ~~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~--  156 (289)
                      ++++++....  ..+.++||||+ |++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||||+||+++  
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence            9999886643  25689999999 88999999875 67999999999999999999999999  99999999999998  


Q ss_pred             CCCCcEEEeccCCccccCCccc--------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 022956          157 GNIGQVKIGDLGFAAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV  227 (289)
Q Consensus       157 ~~~~~~~l~d~g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~  227 (289)
                      .+ +.+||+|||++........        .....+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+....
T Consensus       189 ~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          189 NP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             CT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            66 8999999999976643221        1334589999999977655 899999999999999999999999853222


Q ss_pred             HHHHHHHhCC----C----CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          228 AKIYKKVTGG----V----KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       228 ~~~~~~~~~~----~----~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ..........    .    .........++.+.+++..||. ||++||++++|++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2211111100    0    0001124568999999999998 9999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.2e-44  Score=304.60  Aligned_cols=254  Identities=21%  Similarity=0.350  Sum_probs=203.6

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeE
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVW   87 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   87 (289)
                      .+++....|++.++||+|+||+||+|.+..++   ..+|+|.+...   ......+.+.+|+.++++++||||+++++++
T Consensus        19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (298)
T 3f66_A           19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC   95 (298)
T ss_dssp             BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            34555666688999999999999999865443   45888888643   2456678899999999999999999999986


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      ...+ +..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|
T Consensus        96 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~D  171 (298)
T 3f66_A           96 LRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVAD  171 (298)
T ss_dssp             CCSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECS
T ss_pred             EcCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC-CCEEECc
Confidence            5543 578899999999999999976 456899999999999999999999999  9999999999999988 8999999


Q ss_pred             cCCccccCCccc-----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCC
Q 022956          167 LGFAAIVGRSHA-----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVK  239 (289)
Q Consensus       167 ~g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  239 (289)
                      ||++........     .....+++.|+|||.+.+ .+++++||||||+++++|++ |..||............. ....
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~  250 (298)
T 3f66_A          172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRR  250 (298)
T ss_dssp             CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCC
T ss_pred             ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCC
Confidence            999986643321     223456788999997764 48999999999999999999 566776644444333333 3322


Q ss_pred             CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          240 PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       240 ~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                       ...+...++.+.+++.+||+ ||++|||++++++
T Consensus       251 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             22345568999999999998 9999999999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-44  Score=310.40  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=207.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCc-----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCC
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGI-----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   92 (289)
                      |++.+.||+|+||+||+|.+..++.     .||+|.+....   .....+.+.+|+++++.+ +||||+++++++..  .
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~  122 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGACTH--G  122 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--C
Confidence            4789999999999999999877664     79999997543   455577899999999999 89999999998844  3


Q ss_pred             CeeEEEeccccCCcHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC
Q 022956           93 NTLNFITEVCTSGNLRTYRKKH--------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN  158 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~--------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~  158 (289)
                      +.+++||||+++++|.+++...              ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCC
Confidence            5789999999999999998752              35799999999999999999999999  9999999999999988


Q ss_pred             CCcEEEeccCCccccCCccc---cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 022956          159 IGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKK  233 (289)
Q Consensus       159 ~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~  233 (289)
                       +.++|+|||++........   .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+..........
T Consensus       201 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          201 -HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             -GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             -CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence             8999999999976543222   223445778999997654 48999999999999999998 99999876655555555


Q ss_pred             HhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          234 VTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +...... ..+...++.+.+++..||+ ||.+|||+.++++  ++++
T Consensus       280 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~L~~  323 (333)
T 2i1m_A          280 VKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQE  323 (333)
T ss_dssp             HHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH--HHHH
Confidence            5444332 2344568999999999998 9999999999998  4443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.2e-44  Score=298.44  Aligned_cols=243  Identities=22%  Similarity=0.397  Sum_probs=203.1

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .|++.+.||+|+||.||++.+. ++..||+|++.....  .   .+.+.+|++++++++||||+++++++...  +..++
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l   80 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICL   80 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB--C---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEE
T ss_pred             heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC--C---HHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeEE
Confidence            3478999999999999999986 678899999986543  2   35688899999999999999999988543  57899


Q ss_pred             EeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           98 ITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      ||||+++++|.+++... ..+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC-CCEEEcccccccccccc
Confidence            99999999999999864 56899999999999999999999999  9999999999999988 89999999999766432


Q ss_pred             c--ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 H--AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~--~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      .  ......+++.|+|||.+.+ .+++++|+||||+++++|++ |..||........ ...+..+... ..+...++.+.
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~i~~~~~~-~~~~~~~~~l~  235 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-VEDISTGFRL-YKPRLASTHVY  235 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTTCCC-CCCTTSCHHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-HHHHhcCCcC-CCCccCcHHHH
Confidence            2  1223456778999997764 48899999999999999999 8999987554444 4444444322 23445689999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc
Q 022956          253 AFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +++.+||+ ||++||+++++++
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          236 QIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHH
Confidence            99999998 9999999999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.2e-44  Score=324.87  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=208.3

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||.||+|.++.++..||+|+++....     ..+.+.+|++++++++||||+++++++...  ..+++|
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv  294 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII  294 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEEE
Confidence            4678999999999999999999999999999975432     156788999999999999999999988443  578999


Q ss_pred             eccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++......
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEECCTTCEECCTTC
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCC-CcEEEeecccceeccCC
Confidence            9999999999999863  45899999999999999999999999  9999999999999988 89999999999876432


Q ss_pred             c--ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 H--AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~--~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      .  ......+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+.... ...+.+....... .+...++.+.
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~l~  449 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRME-RPEGCPEKVY  449 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCC-CCTTCCHHHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCC-CCCCCCHHHH
Confidence            2  1223345678999997764 48999999999999999999 99999875544 3344444443332 3456789999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      +|+.+||+ ||++|||+.+|++  .|+.+-
T Consensus       450 ~li~~cl~~dP~~RPs~~el~~--~L~~~~  477 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFAEIHQ--AFETMF  477 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHTSC
T ss_pred             HHHHHHcCcChhHCcCHHHHHH--HHHHHH
Confidence            99999998 9999999999998  666553

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.2e-45  Score=313.42  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=198.7

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.+.||+|+||+||+|.+. +|..||+|++....    ....+.+.+|+++++.++||||+++++++..  .+
T Consensus        37 ~~~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~  108 (321)
T 2qkw_B           37 ATNNF-DHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RN  108 (321)
T ss_dssp             CCCCC-SCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TT
T ss_pred             HHhcc-CccceeecCCCeeEEEEEEC-CCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CC
Confidence            44555 78999999999999999864 78999999886542    2346778999999999999999999998744  36


Q ss_pred             eeEEEeccccCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKHR----HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      ..++||||+++++|.+++....    .+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDEN-FVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTT-CCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCC-CCEEEeeccc
Confidence            7899999999999999987543    5899999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCcc---ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-----HH-HHHHHhCCCC
Q 022956          170 AAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV-----AK-IYKKVTGGVK  239 (289)
Q Consensus       170 ~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-----~~-~~~~~~~~~~  239 (289)
                      +.......   ......+++.|+|||.+. +.++.++||||||+++|+|++|+.||......     .. ..........
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            97654322   223345789999999765 45899999999999999999999999753221     11 1111111111


Q ss_pred             CC--------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          240 PQ--------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       240 ~~--------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..        ......+..+.+++.+||+ ||++|||+.+++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11        1111224578899999998 99999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=324.69  Aligned_cols=251  Identities=27%  Similarity=0.354  Sum_probs=191.3

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   94 (289)
                      +..+++.++||+|+||+|+. ....+|+.||||++.....       ..+.+|+++++.+ +||||+++++.+.+.  ..
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~   92 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDR--QF   92 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEET--TE
T ss_pred             cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecC--CE
Confidence            33346789999999999764 3456799999999964332       2345699999999 799999999887554  67


Q ss_pred             eEEEeccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC----CCcEEEeccCC
Q 022956           95 LNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN----IGQVKIGDLGF  169 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~----~~~~~l~d~g~  169 (289)
                      +++|||++.| +|.+++.... .+++..+..++.|++.||.|||++|  ++|+||||+||+++.+    ...++|+|||+
T Consensus        93 ~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           93 QYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            8999999976 9999998653 4556677899999999999999999  9999999999999532    13688999999


Q ss_pred             ccccCCcc----ccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCC
Q 022956          170 AAIVGRSH----AAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKP  240 (289)
Q Consensus       170 ~~~~~~~~----~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~  240 (289)
                      +.......    ......+++.|+|||.+.    ..++.++|||||||++++|++ |..||........  .........
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~~~~~~~  247 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLGACSL  247 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHHTTCCCC
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHHhccCCc
Confidence            98765332    233457899999999775    337789999999999999999 9999976443322  222222221


Q ss_pred             CC--CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          241 QA--LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       241 ~~--~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ..  .....+..+++|+.+||+ ||++|||++++++||||.++.
T Consensus       248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            11  122234568999999999 999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-44  Score=305.63  Aligned_cols=246  Identities=26%  Similarity=0.379  Sum_probs=193.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh--CCCCceEEeeeeEEeC-
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT--LKNKYIIVCYSVWLDD-   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~-   90 (289)
                      ..++| ++.++||+|+||+||++.+  +|+.||+|++....       ...+.+|.+++..  ++||||+++++.+... 
T Consensus         6 ~~~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            6 VARDI-TLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CGGGC-EEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccCcE-EEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            44555 7899999999999999987  58999999986431       2444556666666  7999999999886543 


Q ss_pred             -CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCceecCCCCCceEEeCCCCc
Q 022956           91 -QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH--------THEPCIIHRDLNCSNIFINGNIGQ  161 (289)
Q Consensus        91 -~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh--------~~~~~~~h~dl~~~nili~~~~~~  161 (289)
                       ....+++||||+++++|.+++.. ..+++..+..++.|++.||.|||        +.+  ++|+||||+||+++.+ +.
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~-~~  151 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN-GQ  151 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT-SC
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC-CC
Confidence             33568999999999999999965 56999999999999999999999        889  9999999999999988 89


Q ss_pred             EEEeccCCccccCCccc-----cccCCCCCCCCCCcccccC-------CCCcchHHHHHHHHHHHHhC----------CC
Q 022956          162 VKIGDLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTM----------EI  219 (289)
Q Consensus       162 ~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~il~~l~tg----------~~  219 (289)
                      +||+|||++........     .....+++.|+|||.+.+.       +++++||||||+++|+|++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            99999999976543322     2234789999999977653       34689999999999999999          88


Q ss_pred             CCCCC----CcHHHHHHHHhCCCCCCCCC-----CCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          220 PYSEC----DSVAKIYKKVTGGVKPQALN-----KVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       220 p~~~~----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ||...    ...................+     ...++.+.+|+..||+ ||++|||++++++
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            88542    22233333332222211111     1234679999999998 9999999999997

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3e-44  Score=306.04  Aligned_cols=247  Identities=21%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ...++||+|+||+||+|.+  ++..||+|++........+...+.+.+|++++++++||||+++++++...  +..++||
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~  109 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVY  109 (307)
T ss_dssp             TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred             ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEE
Confidence            3468999999999999976  58899999997654434455678899999999999999999999988443  5789999


Q ss_pred             ccccCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956          100 EVCTSGNLRTYRKK---HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus       100 e~~~~~sL~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEA-FTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCC-CcEEEeecccccccccc
Confidence            99999999999874   356999999999999999999999999  9999999999999988 89999999999766432


Q ss_pred             cc---cccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhCCCC---------CC
Q 022956          177 HA---AHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV---AKIYKKVTGGVK---------PQ  241 (289)
Q Consensus       177 ~~---~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~---------~~  241 (289)
                      ..   .....+++.|+|||.+.+.++.++||||||+++|+|++|..||......   ......+.....         ..
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence            22   2345689999999988888899999999999999999999999764322   122222222111         01


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      ......++.+.+++.+||+ ||++|||++++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1122234678999999998 9999999999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.2e-44  Score=318.83  Aligned_cols=248  Identities=23%  Similarity=0.388  Sum_probs=205.4

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .+++.++||+|+||+||+|.++ ++..||||+++....     ..+.+.+|++++++++||||+++++++.   ...+++
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~l  259 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYI  259 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEE
T ss_pred             HeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEE
Confidence            3478899999999999999885 578899999975432     2567889999999999999999998873   356899


Q ss_pred             EeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           98 ITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ||||+.+++|.+++...  ..+++..+..++.|++.||.|||+++  ++|+||+|+||+++.+ +.+||+|||++.....
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIED  336 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-CCEEECSTTGGGGBCC
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC-CcEEEeeCCCceEcCC
Confidence            99999999999999753  36899999999999999999999999  9999999999999998 8999999999987643


Q ss_pred             cc--ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          176 SH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       176 ~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ..  ......+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+........... .+.... .+...++.+
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~-~~~~~~~~l  414 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMP-RPENCPEEL  414 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCC-CCTTSCHHH
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC-CCCCCCHHH
Confidence            22  122334577899999776 458999999999999999999 999998866555444443 333222 244578999


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+|+.+||+ ||++|||+++|++  .++++.
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~--~L~~~~  443 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQS--VLDDFY  443 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH--HHHTSS
T ss_pred             HHHHHHHccCChhHCcCHHHHHH--HHHHHH
Confidence            999999998 9999999999988  555553

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.9e-44  Score=316.83  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=191.7

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEE
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWL   88 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   88 (289)
                      .+....+.| .+.++||+|+||+||.+ ...+|+.||||++....       .+.+.+|+++++++ +||||+++++.+.
T Consensus         9 ~~~~l~~~~-~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~   79 (434)
T 2rio_A            9 FEQSLKNLV-VSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSET   79 (434)
T ss_dssp             CSCSCSSCE-EEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             hhhhhhhee-eccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence            334445554 67899999999999865 45679999999997432       34567899999876 8999999998874


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC---
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKHRHVS-------IKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN---  158 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~-------~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~---  158 (289)
                      .  .+.+++||||+.| +|.+++.......       +..+..++.|++.||.|||++|  ++|+||||+||+++.+   
T Consensus        80 ~--~~~~~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~  154 (434)
T 2rio_A           80 T--DRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRF  154 (434)
T ss_dssp             C--SSEEEEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHH
T ss_pred             c--CCeEEEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccc
Confidence            4  3689999999975 9999998754332       2345789999999999999999  9999999999999753   


Q ss_pred             ---------CCcEEEeccCCccccCCccc-----cccCCCCCCCCCCccccc--------CCCCcchHHHHHHHHHHHHh
Q 022956          159 ---------IGQVKIGDLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVT  216 (289)
Q Consensus       159 ---------~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~--------~~~~~~Di~slG~il~~l~t  216 (289)
                               .+.++|+|||++........     .....+++.|+|||.+.+        .++.++|||||||++|+|++
T Consensus       155 ~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt  234 (434)
T 2rio_A          155 TADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS  234 (434)
T ss_dssp             HSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence                     24899999999987654322     223578999999997643        48899999999999999999


Q ss_pred             -CCCCCCCCCcHHHHHHHHhCCCCCCCCCC----CCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          217 -MEIPYSECDSVAKIYKKVTGGVKPQALNK----VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       217 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                       |..||.......  ...+...........    ..++.+.+|+.+||+ ||++|||+.++++||||..
T Consensus       235 ~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          235 KGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence             999997654333  223333322222211    124689999999998 9999999999999999964

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.7e-44  Score=303.06  Aligned_cols=258  Identities=25%  Similarity=0.402  Sum_probs=199.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeecC-CC--cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQE-EG--IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ..++| ++.++||+|+||+||+|.+.. ++  ..||+|+++..... .....+.+.+|++++++++||||+++++++...
T Consensus        16 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           16 GEKDL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             CGGGE-EEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             chhHe-eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            34454 789999999999999998643 33  36899999765432 345577899999999999999999999988543


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                         ..++|+||+.+++|.+++... ..+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        94 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~  167 (291)
T 1u46_A           94 ---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGL  167 (291)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTT
T ss_pred             ---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC-CCEEEccccc
Confidence               378999999999999999764 67999999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCC
Q 022956          170 AAIVGRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       170 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  243 (289)
                      +........    .....+++.|+|||.+.+. ++.++||||||+++++|++ |..||.+........ .+.........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~  246 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-KIDKEGERLPR  246 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTSCCCCCC
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH-HHHccCCCCCC
Confidence            987654322    2234567789999977654 7889999999999999999 999998765554444 44333333334


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ....++.+.+++.+||+ ||++|||+.++++  +++++..
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~~  284 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQP  284 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC-
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHhCc
Confidence            45678999999999998 9999999999998  6666543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.6e-44  Score=301.42  Aligned_cols=245  Identities=22%  Similarity=0.368  Sum_probs=195.7

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .-|++.+.||+|+||+||++.+.  |..||+|+++...      ..+.+.+|++++++++|||++++++++.... +.++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~   91 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY   91 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred             hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-CceE
Confidence            33478999999999999999774  8899999997432      2567889999999999999999999875543 4689


Q ss_pred             EEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           97 FITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +|+||+++++|.+++....  .+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC-CcEEEeecccccccc
Confidence            9999999999999998654  3899999999999999999999999  9999999999999988 899999999987654


Q ss_pred             CccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          175 RSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ...  ....+++.|+|||.+.+ .+++++||||||+++++|++ |..||....... ....+..+.. ...+...++.+.
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~l~  244 (278)
T 1byg_A          169 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGYK-MDAPDGCPPAVY  244 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHHTTTCC-CCCCTTCCHHHH
T ss_pred             ccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhcCCC-CCCcccCCHHHH
Confidence            332  23356789999997764 48999999999999999998 999998754433 3344444332 233456789999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +++.+||+ ||++||++.++++  .+++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~--~L~~  270 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLRE--QLEH  270 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHH--HHHH
Confidence            99999998 9999999999987  4443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.5e-44  Score=309.13  Aligned_cols=257  Identities=21%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||+||+|.+. +|..||+|++........   ...+.+|+++++.++||||+++++++...  +
T Consensus        28 ~~~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~  100 (326)
T 3uim_A           28 ASDNF-SNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG---ELQFQTEVEMISMAVHRNLLRLRGFCMTP--T  100 (326)
T ss_dssp             TTTSS-CSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C---CCHHHHHHHGGGTCCCTTBCCCCEEECCS--S
T ss_pred             Hhhcc-ccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH---HHHHHHHHHHHHhccCCCccceEEEEecC--C
Confidence            34555 68999999999999999854 689999999976543211   23578899999999999999999988544  5


Q ss_pred             eeEEEeccccCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CCCceecCCCCCceEEeCCCCcEEEec
Q 022956           94 TLNFITEVCTSGNLRTYRKKHR----HVSIKALKKWSKQVLEGLEYLHTH---EPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~---~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                      ..++||||+.+++|.+++....    .+++..+..++.|++.||.|||++   |  ++|+||+|+||+++.+ +.++|+|
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~-~~~kl~D  177 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEE-FEAVVGD  177 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTT-CCEEECC
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCC-CCEEecc
Confidence            6889999999999999998643    499999999999999999999999   8  9999999999999998 8999999


Q ss_pred             cCCccccCCcc--ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhCCCC
Q 022956          167 LGFAAIVGRSH--AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSEC----DSVAKIYKKVTGGVK  239 (289)
Q Consensus       167 ~g~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~----~~~~~~~~~~~~~~~  239 (289)
                      ||++.......  ......+++.|+|||.+.+ .+++++||||||+++++|++|..||...    .........+.....
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            99998764332  2334568999999997754 4899999999999999999999999521    100111111111111


Q ss_pred             CCC------------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          240 PQA------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       240 ~~~------------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ...            .....++.+.+++..||+ ||++|||++++++|..-..+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            110            011113678999999998 99999999999997543333

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.8e-43  Score=297.20  Aligned_cols=243  Identities=23%  Similarity=0.409  Sum_probs=202.1

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.+.||+|+||+||+|.+. ++..||+|++.....  .   .+.+.+|+++++.++||||+++++++.   .+..
T Consensus        13 ~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~   82 (279)
T 1qpc_A           13 ETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--S---PDAFLAEANLMKQLQHQRLVRLYAVVT---QEPI   82 (279)
T ss_dssp             GGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSC
T ss_pred             Hhh-hheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--c---HHHHHHHHHHHHhCCCcCcceEEEEEc---CCCc
Confidence            444 78999999999999999875 567899999975432  2   467889999999999999999998863   2458


Q ss_pred             EEEeccccCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           96 NFITEVCTSGNLRTYRKKHR--HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.+||++|  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCC-CCEEECCCcccccc
Confidence            89999999999999997543  6999999999999999999999999  9999999999999988 89999999999876


Q ss_pred             CCccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          174 GRSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       174 ~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      .....  .....+++.|+|||.+.+ .++.++||||||+++++|++ |..||.+...... ...+...... ..+...++
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~  237 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-IQNLERGYRM-VRPDNCPE  237 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCC-CCCTTCCH
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-HHHHhcccCC-CCcccccH
Confidence            54322  223456778999997764 48899999999999999999 9999987555443 3444443322 23456789


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.+++..||+ ||++|||++++++
T Consensus       238 ~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          238 ELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            99999999998 9999999999988

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=309.76  Aligned_cols=247  Identities=18%  Similarity=0.281  Sum_probs=197.4

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCC--------CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEE--
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEE--------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV--   82 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~--------~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~--   82 (289)
                      +..+..|++.+.||+|+||+||+|.++.+        ++.||+|++...         +.+.+|++++++++|||+++  
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~  108 (352)
T 2jii_A           38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKW  108 (352)
T ss_dssp             CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHH
T ss_pred             cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhh
Confidence            44444458999999999999999999874        889999999743         35678999999999999887  


Q ss_pred             -------------eeeeEEeCCCCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 022956           83 -------------CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRD  147 (289)
Q Consensus        83 -------------~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~d  147 (289)
                                   +++++.. ++..+++||||+ +++|.+++...  ..+++..+..++.|++.||.|||++|  ++|+|
T Consensus       109 ~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~D  184 (352)
T 2jii_A          109 KKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGN  184 (352)
T ss_dssp             HHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSC
T ss_pred             hhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCC
Confidence                         4555444 347899999999 88999999875  78999999999999999999999999  99999


Q ss_pred             CCCCceEEeCCCC--cEEEeccCCccccCCccc--------cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh
Q 022956          148 LNCSNIFINGNIG--QVKIGDLGFAAIVGRSHA--------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT  216 (289)
Q Consensus       148 l~~~nili~~~~~--~~~l~d~g~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t  216 (289)
                      |+|+||+++.+ +  .++|+|||++........        .....+++.|+|||.+.+ .++.++||||||+++|+|++
T Consensus       185 ikp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  263 (352)
T 2jii_A          185 VTAENIFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY  263 (352)
T ss_dssp             CCGGGEEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence            99999999988 6  899999999976643221        133478999999997765 48999999999999999999


Q ss_pred             CCCCCCCCC-cHHHHHHHH---hCCCCCCC----CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          217 MEIPYSECD-SVAKIYKKV---TGGVKPQA----LNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       217 g~~p~~~~~-~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      |..||.... .........   ........    .....++.+.+|+.+||+ ||++||+++++++
T Consensus       264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          264 GFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             SCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            999998653 333332222   12111111    112458999999999998 9999999999988

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-43  Score=316.85  Aligned_cols=246  Identities=22%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||.||+|.++. +..||+|+++....  .   .+.+.+|++++++++||||+++++++..   +.+++|
T Consensus       186 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv  256 (452)
T 1fmk_A          186 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV  256 (452)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred             ceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--C---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEE
Confidence            4789999999999999999864 46799999975432  2   4578899999999999999999988733   468999


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++++|.+++..  +..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++......
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCC-CCEEECCCccceecCCC
Confidence            999999999999974  356999999999999999999999999  9999999999999988 89999999999866432


Q ss_pred             c--ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          177 H--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       177 ~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      .  ......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+...... ...+..+.... .+...++.+.
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-~~~i~~~~~~~-~~~~~~~~l~  411 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGYRMP-CPPECPESLH  411 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCC-CCTTSCHHHH
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCCCC-CCCCCCHHHH
Confidence            2  122334677899999765 458999999999999999999 9999987655444 44444443322 2445789999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          253 AFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +|+.+||+ ||++|||++++++  +++++
T Consensus       412 ~li~~cl~~dP~~Rpt~~~l~~--~L~~~  438 (452)
T 1fmk_A          412 DLMCQCWRKEPEERPTFEYLQA--FLEDY  438 (452)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            99999998 9999999999998  55544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-44  Score=311.12  Aligned_cols=253  Identities=21%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ......+++.++||+|+||+||+|.+..+   +..+|+|.++..   ......+.+.+|+.++++++||||+++++++..
T Consensus        85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  161 (373)
T 3c1x_A           85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR  161 (373)
T ss_dssp             CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred             ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            34444457889999999999999987543   346889988643   244567889999999999999999999998654


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      .+ +..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||
T Consensus       162 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DFG  237 (373)
T 3c1x_A          162 SE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFG  237 (373)
T ss_dssp             CS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC-
T ss_pred             CC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC-CCEEEeecc
Confidence            43 5678999999999999999864 46899999999999999999999999  9999999999999988 899999999


Q ss_pred             CccccCCccc-----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCC
Q 022956          169 FAAIVGRSHA-----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQ  241 (289)
Q Consensus       169 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  241 (289)
                      ++........     .....+++.|+|||.+.+ .+++++||||||+++|+|++ |..||............ ..+... 
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-~~~~~~-  315 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRL-  315 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-HTTCCC-
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-HcCCCC-
Confidence            9976533221     223446778999997764 48999999999999999999 77888765444333333 333222 


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..+...++.+.+++.+||+ ||++|||+++++++
T Consensus       316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2345578999999999998 99999999999984

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-43  Score=328.66  Aligned_cols=241  Identities=22%  Similarity=0.357  Sum_probs=200.0

Q ss_pred             eeecccCcceEEEEe--ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           23 DLLGSGAVKKVYRAF--DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      ++||+|+||+||+|.  .+.+++.||||+++....  .....+.+.+|++++++++||||+++++++..   ..+++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEE
Confidence            579999999999994  456678999999976533  34446789999999999999999999998732   35889999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc--
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA--  178 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~--  178 (289)
                      |+++++|.+++.....+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++........  
T Consensus       450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-----
T ss_pred             ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC-CCEEEEEcCCccccccCcccc
Confidence            9999999999998888999999999999999999999999  9999999999999998 8999999999986643321  


Q ss_pred             --cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          179 --AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                        .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+..... ....+..+... ..+...++.+.+|
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~~i~~~~~~-~~p~~~~~~l~~l  604 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERM-GCPAGCPREMYDL  604 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCC-CCCCCCCHHHHHH
Confidence              222345678999997765 48999999999999999998 999998755544 44445544333 2345578999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhc
Q 022956          255 IEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~  273 (289)
                      +..||+ ||++||++++|++
T Consensus       605 i~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHH
Confidence            999998 9999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=306.38  Aligned_cols=246  Identities=16%  Similarity=0.181  Sum_probs=192.5

Q ss_pred             ceeeCCCCcccceeeeecccCcceEEEE-----eecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC---CCce
Q 022956            9 FVEVDPSGRFGRYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK---NKYI   80 (289)
Q Consensus         9 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i   80 (289)
                      .......+..|++.++||+|+||+||+|     .+..+++.||+|++....       ...+..|.++++.++   |+|+
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~i  129 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMF  129 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGB
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhh
Confidence            3444455666688999999999999999     467789999999997432       345667777777776   8999


Q ss_pred             EEeeeeEEeCCCCeeEEEeccccCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE
Q 022956           81 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKK-----HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI  155 (289)
Q Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili  155 (289)
                      +.+++.+...  +..++||||+++++|.+++..     ...+++..+..++.|++.||.|||++|  ++|+||||+||++
T Consensus       130 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll  205 (365)
T 3e7e_A          130 MKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFIL  205 (365)
T ss_dssp             CCEEEEEECS--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE
T ss_pred             hhhheeeecC--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEe
Confidence            9999988654  568999999999999999974     467999999999999999999999999  9999999999999


Q ss_pred             eC-----------CCCcEEEeccCCccccC---CccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCC
Q 022956          156 NG-----------NIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIP  220 (289)
Q Consensus       156 ~~-----------~~~~~~l~d~g~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p  220 (289)
                      +.           + +.+||+|||++....   ........+|++.|+|||.+.+. ++.++|||||||++|+|++|+.|
T Consensus       206 ~~~~~~~~~~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  284 (365)
T 3e7e_A          206 GNGFLEQDDEDDLS-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM  284 (365)
T ss_dssp             CGGGTCC------C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred             cccccCcccccccc-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence            87           6 899999999996543   23334556799999999977655 89999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          221 YSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      |........       ...........++.+.+++..||+ +|.+|++..+.+.
T Consensus       285 f~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          285 KVKNEGGEC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             CEEEETTEE-------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             cccCCCCce-------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            964321100       001111122346789999999999 9999865444444

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=304.78  Aligned_cols=252  Identities=22%  Similarity=0.410  Sum_probs=201.0

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      -|++.+.||+|+||+||+|.+..   .+|+|+++....  .....+.+.+|+.++++++||||+++++++...  ..+++
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~i  106 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--PHLAI  106 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS--SCEEE
T ss_pred             HeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CceEE
Confidence            34789999999999999998753   599999976543  222235577799999999999999999988654  56899


Q ss_pred             EeccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-
Q 022956           98 ITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-  175 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-  175 (289)
                      |+||+++++|.+++...+ .+++..+..++.|++.||.|||++|  ++|+||+|+||+++ + +.++|+|||++..... 
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-N-GKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-C-CCEEEeecCCccccccc
Confidence            999999999999998754 7999999999999999999999999  99999999999998 4 6999999999865432 


Q ss_pred             -----ccccccCCCCCCCCCCccccc----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC
Q 022956          176 -----SHAAHSIIGTPEYMAPELYEE----------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP  240 (289)
Q Consensus       176 -----~~~~~~~~~~~~~~aPE~~~~----------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  240 (289)
                           ........+++.|+|||.+.+          .++.++||||||+++|+|++|..||....... ....+..+..+
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~  261 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-IIWQMGTGMKP  261 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-HHHHHHTTCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhccCCCC
Confidence                 112233457889999997653          36889999999999999999999998755444 44444454444


Q ss_pred             CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          241 QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       241 ~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      .......++.+.+++.+||. ||++|||++++++  .++++...
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~  303 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKR  303 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC---
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHh
Confidence            44445678899999999998 9999999999999  77666543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.3e-43  Score=317.21  Aligned_cols=248  Identities=19%  Similarity=0.291  Sum_probs=197.0

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.++||+|+||.||+|.+..+++.||||++......      ..+.+|+++++.+.|++.+..+..+.. ...
T Consensus         5 i~~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~   76 (483)
T 3sv0_A            5 VGNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGV-EGD   76 (483)
T ss_dssp             ETTTE-ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETT
T ss_pred             cCCcE-EEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCC
Confidence            45666 7899999999999999999999999999998765432      346779999999988655555544433 336


Q ss_pred             eeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEE---eCCCCcEEEeccCC
Q 022956           94 TLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGF  169 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili---~~~~~~~~l~d~g~  169 (289)
                      ..++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++|  ++|+||||+|||+   +.+ +.+||+|||+
T Consensus        77 ~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~-~~vkL~DFGl  152 (483)
T 3sv0_A           77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRA-NQVYIIDFGL  152 (483)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGT-TCEEECCCTT
T ss_pred             EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCC-CeEEEEeCCc
Confidence            889999999 8899999985 567999999999999999999999999  9999999999999   456 8999999999


Q ss_pred             ccccCCccc--------cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhC-C
Q 022956          170 AAIVGRSHA--------AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKVTG-G  237 (289)
Q Consensus       170 ~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~-~  237 (289)
                      +........        .....+++.|+|||.+.+. ++.++|||||||++|+|++|..||.+...  ....+..+.. .
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (483)
T 3sv0_A          153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (483)
T ss_dssp             CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred             ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence            987654322        2256789999999977654 89999999999999999999999986432  1111111111 1


Q ss_pred             --CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          238 --VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       238 --~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                        ..........++++.+|+..||+ ||++||++++|++
T Consensus       233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              01111223468899999999998 9999999998876

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-43  Score=300.47  Aligned_cols=245  Identities=25%  Similarity=0.375  Sum_probs=189.3

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh--CCCCceEEeeeeEEeCCC--
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT--LKNKYIIVCYSVWLDDQH--   92 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~~--   92 (289)
                      ..|++.++||+|+||.||+|.+.  |+.||+|++....       ......|.+++..  ++||||+++++.+.....  
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            33478999999999999999875  8999999996432       1233344555544  489999999998876533  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCceecCCCCCceEEeCCCCcEEE
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH--------EPCIIHRDLNCSNIFINGNIGQVKI  164 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~--------~~~~~h~dl~~~nili~~~~~~~~l  164 (289)
                      ..+++||||+++++|.+++... .+++..+..++.|++.||.|||+.        |  ++|+||||+||+++.+ +.+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~~kl  183 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKN-GTCCI  183 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTT-SCEEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCC-CCEEE
Confidence            5789999999999999999764 699999999999999999999998        8  9999999999999988 89999


Q ss_pred             eccCCccccCCccc-----cccCCCCCCCCCCcccccC-CCCc------chHHHHHHHHHHHHhC----------CCCCC
Q 022956          165 GDLGFAAIVGRSHA-----AHSIIGTPEYMAPELYEED-YTEM------VDIYSFGLCLLEMVTM----------EIPYS  222 (289)
Q Consensus       165 ~d~g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-~~~~------~Di~slG~il~~l~tg----------~~p~~  222 (289)
                      +|||++........     .....+++.|+|||.+.+. ....      +|||||||++|+|++|          ..||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999976543322     2245789999999987654 4443      8999999999999999          77775


Q ss_pred             CC----CcHHHHHHHHhCCCCCCCCC-----CCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          223 EC----DSVAKIYKKVTGGVKPQALN-----KVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       223 ~~----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..    .........+.........+     ...++.+.+|+.+||+ ||++|||+++++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            42    12233333332222211111     1235679999999998 99999999999983

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9e-43  Score=318.14  Aligned_cols=247  Identities=22%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .+++.++||+|+||.||++.+.. +..||||+++....  .   .+.+.+|++++++++|+||+++++++..   +.+++
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~l  338 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI  338 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred             hhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--C---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceE
Confidence            34789999999999999999864 46799999976432  2   4578899999999999999999988733   46899


Q ss_pred             EeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           98 ITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ||||+.+++|.+++..  +..+++..+..++.|++.||.|||+++  ++|+||+|+|||++.+ +.+||+|||++.....
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIED  415 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCTTSTTTCCC
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCC-CcEEEcccccceecCC
Confidence            9999999999999974  356999999999999999999999999  9999999999999988 8999999999986643


Q ss_pred             cc--ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          176 SH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       176 ~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      ..  ......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+ ....+..+.... .+...++.+
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-~~~~i~~~~~~~-~~~~~~~~l  493 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMP-CPPECPESL  493 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-HHHHHHTTCCCC-CCTTCCHHH
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCC-CCCCCCHHH
Confidence            21  122334577899999665 458999999999999999999 999998765544 444444443322 344578999


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+||.+||+ ||++|||+++|++  +++++
T Consensus       494 ~~li~~cl~~dP~~RPt~~~l~~--~L~~~  521 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFEYLQA--FLEDY  521 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH--HHHHH
Confidence            999999998 9999999999998  55544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=320.35  Aligned_cols=240  Identities=20%  Similarity=0.359  Sum_probs=196.4

Q ss_pred             eeecccCcceEEEEeec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           23 DLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      .+||+|+||.||+|.++  .++..||||+++....   ....+.+.+|++++++++||||+++++++..   +.+++|||
T Consensus       342 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E  415 (613)
T 2ozo_A          342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVME  415 (613)
T ss_dssp             EEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS---STTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEE
T ss_pred             cEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEE
Confidence            38999999999999765  4567799999976532   2336778999999999999999999998743   35899999


Q ss_pred             cccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc-
Q 022956          101 VCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-  178 (289)
Q Consensus       101 ~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~-  178 (289)
                      |+.+++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++........ 
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR-HYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCSTTTTCC-----
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC-CcEEEeeccCcccccCCCce
Confidence            9999999999975 456999999999999999999999999  9999999999999988 8999999999987643222 


Q ss_pred             ---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          179 ---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       179 ---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                         .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.. ..+..+.... .+...++.+.+
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-~~i~~~~~~~-~p~~~~~~l~~  570 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRME-CPPECPPELYA  570 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-HHHHTTCCCC-CCTTCCHHHHH
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCC-CCCcCCHHHHH
Confidence               11223467899999776 459999999999999999998 99999886665544 4444443322 34557899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhc
Q 022956          254 FIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~  273 (289)
                      |+..||+ ||++||++++|++
T Consensus       571 li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            9999998 9999999999976

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=299.82  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=185.9

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHH--HHHHHHHhCCCCceEEeeeeEEe---C
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH--SEVQLLRTLKNKYIIVCYSVWLD---D   90 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~--~e~~~l~~l~~~~i~~~~~~~~~---~   90 (289)
                      ++| ++.++||+|+||+||+|.+  +++.||+|++....       ...+.  .++..+..++||||+++++.+..   .
T Consensus        13 ~~y-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A           13 DNL-KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             TSE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             HHh-heeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            455 7899999999999999976  68999999997532       12233  34444556899999999875432   3


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC---------CCCceecCCCCCceEEeCCCCc
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH---------EPCIIHRDLNCSNIFINGNIGQ  161 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---------~~~~~h~dl~~~nili~~~~~~  161 (289)
                      ....+++||||+++++|.+++.... .++..+..++.|++.||.|||+.         |  ++|+||||+||+++.+ +.
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~  158 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND-GT  158 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT-SC
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC-Cc
Confidence            3346789999999999999998754 58999999999999999999999         8  9999999999999988 89


Q ss_pred             EEEeccCCccccCCcc---------ccccCCCCCCCCCCccccc--------CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 022956          162 VKIGDLGFAAIVGRSH---------AAHSIIGTPEYMAPELYEE--------DYTEMVDIYSFGLCLLEMVTMEIPYSEC  224 (289)
Q Consensus       162 ~~l~d~g~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~--------~~~~~~Di~slG~il~~l~tg~~p~~~~  224 (289)
                      +||+|||++.......         ......+++.|+|||.+.+        .+++++|||||||++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            9999999997664321         1224568999999997764        2567899999999999999997766421


Q ss_pred             C-----------------cHHHHHHHHhCCCCCCCCCCC------CChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          225 D-----------------SVAKIYKKVTGGVKPQALNKV------KDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       225 ~-----------------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .                 ..................+..      .++.+.+|+.+||+ ||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            1                 112222222222222222222      23479999999999 9999999999966

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.1e-44  Score=315.48  Aligned_cols=251  Identities=22%  Similarity=0.241  Sum_probs=189.7

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-Cce---------E---
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYI---------I---   81 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i---------~---   81 (289)
                      ..+.+++.+.||+|+||+||+|.+..+|+.||||++...... .....+.+.+|+.+++.+.| ++.         +   
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            334456789999999999999999999999999998744321 23336778899999999987 211         1   


Q ss_pred             ---Ee------eeeEEeCC---CCeeEEEeccccCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 022956           82 ---VC------YSVWLDDQ---HNTLNFITEVCTSGNLRTYRKK-------HRHVSIKALKKWSKQVLEGLEYLHTHEPC  142 (289)
Q Consensus        82 ---~~------~~~~~~~~---~~~~~lv~e~~~~~sL~~~~~~-------~~~l~~~~~~~~~~ql~~~l~~lh~~~~~  142 (289)
                         .+      ...+....   ...++++|+.+. ++|.+++..       ...+++..+..++.|++.||.|||++|  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence               11      01111111   124677777764 599988851       345778899999999999999999999  


Q ss_pred             ceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCccc----------ccC-CCCcchHHHHHHHH
Q 022956          143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY----------EED-YTEMVDIYSFGLCL  211 (289)
Q Consensus       143 ~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~-~~~~~Di~slG~il  211 (289)
                      ++|+||||+||+++.+ +.+||+|||++......  ....++ +.|+|||.+          .+. ++.++|||||||++
T Consensus       232 iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             EECSCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999 89999999998866544  334566 999999976          322 78899999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          212 LEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       212 ~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      |+|++|+.||.......... .+..      .....++.+.+|+.+||+ ||++||++.++++||||+++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~-~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSE-WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSG-GGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHCCCCCCCcchhhhHH-HHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            99999999998643222111 1111      123468999999999998 99999999999999999876

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-42  Score=299.50  Aligned_cols=244  Identities=25%  Similarity=0.361  Sum_probs=195.5

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh--CCCCceEEeeeeEEeCCC--C
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT--LKNKYIIVCYSVWLDDQH--N   93 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~~--~   93 (289)
                      .|++.+.||+|+||+||++.+  +|+.||+|++....       ...+.+|.+++..  ++||||+++++++.....  .
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            347899999999999999987  48999999996431       3556778888887  789999999998866532  2


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH--------THEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh--------~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                      .+++||||+++++|.+++.+. .+++..+..++.|++.||.|||        +.|  ++|+||+|+||+++.+ +.++|+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~-~~~kL~  189 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCCIA  189 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTT-SCEEEC
T ss_pred             eeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCC-CCEEEE
Confidence            789999999999999999864 5999999999999999999999        888  9999999999999998 899999


Q ss_pred             ccCCccccCCcc-----ccccCCCCCCCCCCcccccC-------CCCcchHHHHHHHHHHHHhC----------CCCCCC
Q 022956          166 DLGFAAIVGRSH-----AAHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTM----------EIPYSE  223 (289)
Q Consensus       166 d~g~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~il~~l~tg----------~~p~~~  223 (289)
                      |||++.......     ......+++.|+|||.+.+.       +++++||||||+++|+|++|          ..||..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~  269 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  269 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence            999997664433     23445789999999977654       23689999999999999999          788865


Q ss_pred             CC----cHHHHHHHHhCCCCCCCCC-----CCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          224 CD----SVAKIYKKVTGGVKPQALN-----KVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       224 ~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..    ........+.........+     ...++.+.+|+.+||+ ||++|||+++++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            32    2334444443322211111     1223578999999998 99999999999983

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-41  Score=315.53  Aligned_cols=244  Identities=23%  Similarity=0.388  Sum_probs=200.4

Q ss_pred             cceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +++.+.||+|+||+||+|.+..+   +..+|+|.++...   .....+.+.+|+.++++++||||+++++++.   .+.+
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~  465 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV  465 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSC
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---cCce
Confidence            46789999999999999988654   4568999886432   4566778999999999999999999999872   2458


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~-~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC-CCEEEEecCCCeecC
Confidence            9999999999999999864 36899999999999999999999999  9999999999999988 899999999998764


Q ss_pred             Cccc--cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          175 RSHA--AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       175 ~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      ....  .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+................  ..+...++.
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~  620 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPT  620 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC--CCCTTCCHH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCccccHH
Confidence            4322  222345678999997664 48999999999999999997 99999886655544444443322  234567899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          251 VKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      +.+++.+||. ||++|||+.++++
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999998 9999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.8e-42  Score=296.22  Aligned_cols=248  Identities=17%  Similarity=0.196  Sum_probs=190.9

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC----CCHHHHHHHHHHHHHHHhCC---------CCceE
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS----EDPVLVNRLHSEVQLLRTLK---------NKYII   81 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~---------~~~i~   81 (289)
                      .++| ++.++||+|+||+||+|.+  +|+.||+|++......    ......+.+.+|+.+++.++         |||++
T Consensus        19 ~~~y-~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           19 TEKL-QRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             HHHH-HTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccc-hheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3455 6899999999999999987  6899999999876432    12223467788888888886         77777


Q ss_pred             EeeeeEEeC----------------------------CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 022956           82 VCYSVWLDD----------------------------QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL  133 (289)
Q Consensus        82 ~~~~~~~~~----------------------------~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l  133 (289)
                      .+.+++...                            ....+++||||++++++.+.+.+ ..+++..+..++.|++.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            776654321                            14689999999999976666644 5689999999999999999


Q ss_pred             HHHh-cCCCCceecCCCCCceEEeCCCC--------------------cEEEeccCCccccCCccccccCCCCCCCCCCc
Q 022956          134 EYLH-THEPCIIHRDLNCSNIFINGNIG--------------------QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE  192 (289)
Q Consensus       134 ~~lh-~~~~~~~h~dl~~~nili~~~~~--------------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE  192 (289)
                      .||| ++|  ++|+||||+|||++.+ +                    .+||+|||++......    ...|++.|+|||
T Consensus       175 ~~lH~~~~--ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE  247 (336)
T 2vuw_A          175 AVAEASLR--FEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHC--CBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred             HHHHHhCC--EeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence            9999 999  9999999999999987 5                    8999999999876533    346899999999


Q ss_pred             ccccCCCCcchHHHHHHH-HHHHHhCCCCCCCCCcHHHHHHHHh-CCCCCCC----CCCCCChHHHHHHHHHHc-CCCCC
Q 022956          193 LYEEDYTEMVDIYSFGLC-LLEMVTMEIPYSECDSVAKIYKKVT-GGVKPQA----LNKVKDPEVKAFIEKCIA-QPRAR  265 (289)
Q Consensus       193 ~~~~~~~~~~Di~slG~i-l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~li~~~l~-dp~~R  265 (289)
                      .+.+..+.++||||||++ .+++++|..||.+..........+. .......    .....++.+++||.+||+ |    
T Consensus       248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             hhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            988777889999998777 6678889999854211122222222 1111111    112346789999999998 6    


Q ss_pred             CCHHHHh-cCcccc
Q 022956          266 PSASELL-KDPFFS  278 (289)
Q Consensus       266 ps~~~il-~h~~~~  278 (289)
                       |++|+| +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.3e-41  Score=285.60  Aligned_cols=229  Identities=16%  Similarity=0.156  Sum_probs=185.8

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+..+++++||||+++++++...  +.
T Consensus        30 ~~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~  105 (286)
T 3uqc_A           30 NGRY-RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AG  105 (286)
T ss_dssp             TTTE-EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred             cCcE-EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--Cc
Confidence            3566 789999999999999999999999999999976543 3466678899999999999999999999988654  67


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      .|+||||++|++|.+++..+  ....++..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|++++      
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~-g~~kl~~~~------  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPA------  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT-SCEEECSCC------
T ss_pred             EEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC-CCEEEEecc------
Confidence            99999999999999999653  466688999999999999999999  9999999999999998 899998543      


Q ss_pred             CccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHhCCC-CCCCCCCCCChH
Q 022956          175 RSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY---KKVTGGV-KPQALNKVKDPE  250 (289)
Q Consensus       175 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~  250 (289)
                                   |++|      ++.++|||||||++|+|++|..||.+........   ..+.... .+.......++.
T Consensus       175 -------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          175 -------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             -------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             -------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                         2222      5889999999999999999999998644321110   0001110 111223456889


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +.+++.+||+ ||++| |++++++  .+.+.
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~--~L~~~  263 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLN--LMQQA  263 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHH--HHHHH
T ss_pred             HHHHHHHHcccCCccC-CHHHHHH--HHHHH
Confidence            9999999998 99999 9999998  55554

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6e-42  Score=321.20  Aligned_cols=242  Identities=19%  Similarity=0.281  Sum_probs=198.1

Q ss_pred             CcccceeeeecccCcceEEEEeecC-CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC--
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQE-EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--   92 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   92 (289)
                      ++| ++.+.||+|+||+||++.+.. +|+.||+|++...   ........+.+|++++++++||||+++++++.....  
T Consensus        80 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             Cce-EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            565 789999999999999999876 7899999998643   245667788999999999999999999998865432  


Q ss_pred             -CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           93 -NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        93 -~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       ...|+||||++|++|.+++..  .+++.++..++.|++.||.|||++|  ++|+||||+||+++.+  .+||+|||++.
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC--cEEEEecccch
Confidence             126999999999999998765  6999999999999999999999999  9999999999999875  89999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHH
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV  251 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
                      .....   ....+++.|+|||.+.+.++.++||||||+++++|++|..||.+...         ............++.+
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l  297 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSY  297 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHH
T ss_pred             hcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHH
Confidence            76543   34568999999998887788999999999999999999888864210         0001000111125789


Q ss_pred             HHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          252 KAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       252 ~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      .++|.+||+ ||++||+..+.+.|+|+..
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            999999998 9999999999999988764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=7.6e-35  Score=266.79  Aligned_cols=189  Identities=12%  Similarity=0.024  Sum_probs=135.4

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCC------CHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCe
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE------DPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   94 (289)
                      ....+.|+.|....+.....|+.+++|++.......      .+...+++.+|+++|+++ .|+||+++++++.+  ++.
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~  316 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQS  316 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCE
Confidence            344677888877777777889999999998653211      234566799999999999 68999999998844  468


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      +||||||++|++|.+++...+++++.   +++.||+.||.|+|++|  ++||||||+|||++.+ |.+||+|||++....
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~  390 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDAR-QHARLIDFGSIVTTP  390 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTT-SCEEECCCTTEESCC
T ss_pred             EEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCC-CCEEEeecccCeeCC
Confidence            99999999999999999998888875   47899999999999999  9999999999999998 999999999998765


Q ss_pred             Cc-cccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCC
Q 022956          175 RS-HAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTME  218 (289)
Q Consensus       175 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~  218 (289)
                      .. ......+||+.|+|||++.+.+..++|+|++|++++.+.++.
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC-----------------CCCCTTH
T ss_pred             CCCccccCceechhhccHHHhCCCCCCcccccccccchhhhcccc
Confidence            43 234456799999999999888888999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.1e-27  Score=218.19  Aligned_cols=184  Identities=19%  Similarity=0.239  Sum_probs=142.4

Q ss_pred             eeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           21 YSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED----PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        21 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      -.++||+|+||+||++.  ..+..+++|..........    ....+++.+|++++++++||||+.+..+....  +..+
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~  415 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DNKR  415 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TTTE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--CccE
Confidence            35789999999999994  4588999998765433211    12355689999999999999999554444434  3569


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||||++|++|.+++..        +..++.|++.+|.|||++|  ++|+||||+||+++.   .+||+|||++......
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCCc
Confidence            99999999999999886        5789999999999999999  999999999999987   8999999999887653


Q ss_pred             cc--------cccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCC
Q 022956          177 HA--------AHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPY  221 (289)
Q Consensus       177 ~~--------~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~  221 (289)
                      ..        .....+|+.|+|||.+..   .|+...|+|+...-..+-+.++-+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            22        124578999999998774   3777889999988888877776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=7.1e-25  Score=184.04  Aligned_cols=149  Identities=18%  Similarity=0.211  Sum_probs=116.2

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-----H---------HHHHHHHHHHHHHHhCCCCceEE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-----P---------VLVNRLHSEVQLLRTLKNKYIIV   82 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-----~---------~~~~~~~~e~~~l~~l~~~~i~~   82 (289)
                      .++.+.+.||+|+||.||+|.+ .+|+.||+|+++.......     .         .....+.+|+.++++++  | ++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            3445679999999999999999 8899999999975332100     0         24567899999999999  4 55


Q ss_pred             eeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcE
Q 022956           83 CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQV  162 (289)
Q Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~  162 (289)
                      +.+.+..   +..++||||++|++|.+ +..      .....++.|++.||.+||+.|  ++|+||||+||+++ + +.+
T Consensus       166 v~~~~~~---~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~-~~v  231 (282)
T 1zar_A          166 VPKVYAW---EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGI  231 (282)
T ss_dssp             SCCEEEE---ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEE
T ss_pred             cCeEEec---cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-C-CcE
Confidence            5554422   34699999999999988 421      235579999999999999999  99999999999999 6 899


Q ss_pred             EEeccCCccccCCccccccCCCCCCCCCCcccc
Q 022956          163 KIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE  195 (289)
Q Consensus       163 ~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~  195 (289)
                      +|+|||++...            ..+.|||.+.
T Consensus       232 kl~DFG~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          232 WIIDFPQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             EECCCTTCEET------------TSTTHHHHHH
T ss_pred             EEEECCCCeEC------------CCCCHHHHHH
Confidence            99999998733            2456777664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=2.5e-21  Score=160.48  Aligned_cols=145  Identities=17%  Similarity=0.154  Sum_probs=110.0

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcE--EEEEEeeecccC--C------------------CHHHHHHHHHHHHHHHh
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIE--VAWNQVRLSHFS--E------------------DPVLVNRLHSEVQLLRT   74 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~--~aiK~~~~~~~~--~------------------~~~~~~~~~~e~~~l~~   74 (289)
                      ..+.+.+.||+|+||.||+|.+..+|..  ||||+++.....  .                  .......+.+|+.+++.
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3457889999999999999998778999  999998654211  0                  01223468899999999


Q ss_pred             CCCCceEEeeeeEEeCCCCeeEEEeccccC-C----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-cCCCCceecCC
Q 022956           75 LKNKYIIVCYSVWLDDQHNTLNFITEVCTS-G----NLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH-THEPCIIHRDL  148 (289)
Q Consensus        75 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh-~~~~~~~h~dl  148 (289)
                      +.|+++.....+..    ...++||||+.+ +    +|.++...   .++..+..++.|++.+|.+|| +.|  ++|+||
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl  197 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADL  197 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence            98876522221111    236899999943 3    67776543   235577899999999999999 999  999999


Q ss_pred             CCCceEEeCCCCcEEEeccCCcccc
Q 022956          149 NCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus       149 ~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      +|.||+++.   .++|+|||++...
T Consensus       198 kp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS---SEEECCCTTCEET
T ss_pred             CHHHEEEcC---cEEEEECcccccC
Confidence            999999987   7999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=4.4e-18  Score=146.99  Aligned_cols=143  Identities=15%  Similarity=0.137  Sum_probs=103.3

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC--C-----------CH-----HHHHHHHHHHHHHHhCCCCce
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--E-----------DP-----VLVNRLHSEVQLLRTLKNKYI   80 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~-----------~~-----~~~~~~~~e~~~l~~l~~~~i   80 (289)
                      |++.+.||+|++|.||+|.+. +|+.||||+++.....  .           ..     ...-...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            478999999999999999874 7999999998643211  0           00     011123567788888865554


Q ss_pred             EEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           81 IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      ....-+....    .++||||++|.+|..+..      .+....++.|++.+|.+||+.|  ++|+||||.|||++.+ +
T Consensus       176 ~vp~p~~~~~----~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~d-g  242 (397)
T 4gyi_A          176 PVPEPIAQSR----HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREE-K  242 (397)
T ss_dssp             SCCCEEEEET----TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEE-E
T ss_pred             CCCeeeeccC----ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCC-C
Confidence            3222221122    378999999988865432      2245678899999999999999  9999999999999876 4


Q ss_pred             ----------cEEEeccCCccccCC
Q 022956          161 ----------QVKIGDLGFAAIVGR  175 (289)
Q Consensus       161 ----------~~~l~d~g~~~~~~~  175 (289)
                                .+.++||+.+.....
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             CcccccccccceEEEEeCCcccCCC
Confidence                      389999998765543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=4.7e-12  Score=104.64  Aligned_cols=138  Identities=14%  Similarity=0.084  Sum_probs=102.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      ++...++.|+.+.||++...  +..+++|+........    ...+.+|+.+++.+. +..+++++.....  .+..++|
T Consensus        17 ~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv   88 (263)
T 3tm0_A           17 RCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL   88 (263)
T ss_dssp             EEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred             eeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC----HHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEE
Confidence            57888899999999999643  7899999987532111    235777899998885 4556677766543  3578999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE--------------------------------------  140 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--------------------------------------  140 (289)
                      ||+++|.+|.+...     +......++.++..++..||+..                                      
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999887531     22234577888999999999810                                      


Q ss_pred             -------------------CCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          141 -------------------PCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       141 -------------------~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                                         ..++|+|+++.||+++++ +.+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcc
Confidence                               238999999999999876 556799997654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.18  E-value=1.2e-10  Score=98.42  Aligned_cols=187  Identities=16%  Similarity=0.142  Sum_probs=119.9

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCce--EEeeeeEEeCCC-CeeEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYI--IVCYSVWLDDQH-NTLNF   97 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~~~-~~~~l   97 (289)
                      .+.++.|....||++.     ..+++|+...      ......+.+|..+++.+. +..+  +.++........ ...++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            3558999999999983     5688998642      234567889999998884 3333  233322211111 13478


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE-------------------------------------  140 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~-------------------------------------  140 (289)
                      ||++++|.+|.+...  ..++..+...++.+++..+..||+..                                     
T Consensus        94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            899999988875433  23677788888888888888888511                                     


Q ss_pred             -------------------CCceecCCCCCceEEeCC-CCcEEEeccCCccccCCccccccCCCCCCCCCCcccc-----
Q 022956          141 -------------------PCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-----  195 (289)
Q Consensus       141 -------------------~~~~h~dl~~~nili~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~-----  195 (289)
                                         +.++|+|+++.||+++.+ .+.+.++||+.+.................-..|+...     
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                               137999999999999983 2578899999886542211100000000001222111     


Q ss_pred             -cCC---------CCcchHHHHHHHHHHHHhCCCCC
Q 022956          196 -EDY---------TEMVDIYSFGLCLLEMVTMEIPY  221 (289)
Q Consensus       196 -~~~---------~~~~Di~slG~il~~l~tg~~p~  221 (289)
                       +..         ....+.|+++.+++.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             011         11258899999999999998766

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.15  E-value=9.3e-11  Score=96.43  Aligned_cols=133  Identities=14%  Similarity=0.101  Sum_probs=90.8

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce--EEeeeeEEeCCCCeeEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI--IVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~~~~~~l   97 (289)
                      .+....+.|..+.||++.. .+|..+++|+.....       ...+.+|+.+++.+.+.++  ++++.....  ++..++
T Consensus        23 ~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~   92 (264)
T 1nd4_A           23 DWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWL   92 (264)
T ss_dssp             EEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEE
T ss_pred             ceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEE
Confidence            3333334666799999954 467889999976431       2346678888888865444  446655433  356889


Q ss_pred             EeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 022956           98 ITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE-------------------------------------  140 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~-------------------------------------  140 (289)
                      |||+++|.+|.  ..   ..+   ...++.+++..+..||+..                                     
T Consensus        93 v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999998884  11   122   2255666777777777643                                     


Q ss_pred             -------------------CCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          141 -------------------PCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       141 -------------------~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                                         ..++|+|++|.||+++.+ +.+.|+||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~  213 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG  213 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcc
Confidence                               129999999999999876 566799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=2e-10  Score=99.32  Aligned_cols=144  Identities=13%  Similarity=0.167  Sum_probs=101.6

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEee--ecccCCCHHHHHHHHHHHHHHHhCCCC--ceEEeeeeEEeCCC-CeeE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVR--LSHFSEDPVLVNRLHSEVQLLRTLKNK--YIIVCYSVWLDDQH-NTLN   96 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~-~~~~   96 (289)
                      .+.|+.|.++.||++...  +..+++|+..  ....   ......+.+|+.+++.+...  .+++++....+.+. +..+
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            577999999999999754  5688888876  3221   11134677899999999753  35566655433211 3478


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH-------------------------------------  139 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-------------------------------------  139 (289)
                      +|||+++|.++.+.  .-..++..+...++.+++.+|..||+.                                     
T Consensus       118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            89999999877541  123477888899999999999999972                                     


Q ss_pred             -------------------CCCceecCCCCCceEEeCCCCc-EEEeccCCccc
Q 022956          140 -------------------EPCIIHRDLNCSNIFINGNIGQ-VKIGDLGFAAI  172 (289)
Q Consensus       140 -------------------~~~~~h~dl~~~nili~~~~~~-~~l~d~g~~~~  172 (289)
                                         ...++|+|+++.||+++++.+. +.++||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               1249999999999999876323 68999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=2.5e-07  Score=78.02  Aligned_cols=138  Identities=20%  Similarity=0.106  Sum_probs=90.5

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCC---ceEEeeeeEEeCCCCeeEEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK---YIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+.++.|....||++     |..+++|+-.      .......+.+|..+++.+.+.   .++..+.... ...+..++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v   91 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVG   91 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEE
Confidence            355788888899998     5778899853      334467889999999999753   2344444332 233556799


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH---------------------------------------  139 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---------------------------------------  139 (289)
                      |++++|.++.+..-  ..++..+...+..++...|..||+.                                       
T Consensus        92 ~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           92 YRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             EECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             EeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            99999988866321  1134444444444444444444432                                       


Q ss_pred             -------------------CCCceecCCCCCceEEeC---CCCcEEEeccCCcccc
Q 022956          140 -------------------EPCIIHRDLNCSNIFING---NIGQVKIGDLGFAAIV  173 (289)
Q Consensus       140 -------------------~~~~~h~dl~~~nili~~---~~~~~~l~d~g~~~~~  173 (289)
                                         .+.++|+|+++.||++++   +...+.|+||+.+..-
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               123699999999999987   3134589999977643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.72  E-value=3.5e-07  Score=75.44  Aligned_cols=134  Identities=13%  Similarity=0.111  Sum_probs=92.0

Q ss_pred             eecccCcc-eEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCCCeeEEEecc
Q 022956           24 LLGSGAVK-KVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFITEV  101 (289)
Q Consensus        24 ~lg~g~~g-~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e~  101 (289)
                      .+..|..+ .||+......+..+++|+-...       ....+.+|...|+.+.. -.+++++.+..+.  +..++||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~  101 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTA  101 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEEC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEe
Confidence            34455554 6999988777888999987632       24567889999988853 2244555554333  568899999


Q ss_pred             ccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 022956          102 CTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHE-----------------------------------------  140 (289)
Q Consensus       102 ~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~-----------------------------------------  140 (289)
                      ++|.++.+.....    ......+..++...|..||+..                                         
T Consensus       102 l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          102 IPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             eCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            9998887765432    1223345556666666666311                                         


Q ss_pred             ---------------CCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          141 ---------------PCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       141 ---------------~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                                     +.++|+|+.+.||+++++ +.+-|+||+.+.
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~  222 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECcccc
Confidence                           137999999999999987 667799998665

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=1.6e-06  Score=75.73  Aligned_cols=80  Identities=16%  Similarity=0.160  Sum_probs=47.7

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeeccc--C-CCHHHHHHHHHHHHHHHhCCC--Cce-EEeeeeEEeCCCCee
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--S-EDPVLVNRLHSEVQLLRTLKN--KYI-IVCYSVWLDDQHNTL   95 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~--~-~~~~~~~~~~~e~~~l~~l~~--~~i-~~~~~~~~~~~~~~~   95 (289)
                      .+.||.|..+.||++.+..++..+++|.......  . +......++..|.++++.+..  +.. +.++..  +.  ...
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~--~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC--Ccc
Confidence            5679999999999997766678999998653210  0 000113455668888877742  333 344432  23  235


Q ss_pred             EEEeccccCC
Q 022956           96 NFITEVCTSG  105 (289)
Q Consensus        96 ~lv~e~~~~~  105 (289)
                      ++|||+++|.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7899999874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.27  E-value=2e-05  Score=61.99  Aligned_cols=133  Identities=16%  Similarity=0.162  Sum_probs=91.5

Q ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccccccCC
Q 022956          106 NLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLH-THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII  183 (289)
Q Consensus       106 sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh-~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~~~~~~  183 (289)
                      ||.+.++. +.++++++++.+..|.+.+|.-+- ...  -...=+.|..|++..+ |.|.+.+-. +.           .
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~d-G~V~f~~~~-s~-----------~   98 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRD-GAVTLAPAA-DD-----------A   98 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETT-SCEEECCC----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecC-Cceeccccc-cc-----------c
Confidence            89999985 578999999999999999987762 122  1233456799999999 888877421 10           1


Q ss_pred             CCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHcC--
Q 022956          184 GTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ--  261 (289)
Q Consensus       184 ~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~d--  261 (289)
                      ....+.|||......+.+.-|||||.++|..+--.+|-                    .-....++.+.+||..|.++  
T Consensus        99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e--------------------~eE~eLS~~LE~LL~~Mt~~~~  158 (229)
T 2yle_A           99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE--------------------NEERELSPPLEQLIDHMANTVE  158 (229)
T ss_dssp             --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT--------------------TEEECCCHHHHHHHHHHTTCCC
T ss_pred             cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc--------------------ccchhhCHHHHHHHHHHHhccc
Confidence            12356688876555677889999999999998744332                    22344688999999999752  


Q ss_pred             ------------------------CCCCCCHHHHhc
Q 022956          262 ------------------------PRARPSASELLK  273 (289)
Q Consensus       262 ------------------------p~~Rps~~~il~  273 (289)
                                              +..|+++++|++
T Consensus       159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             --------------------CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccccccccccccccccccCcCCHHHHHH
Confidence                                    246888988886

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.09  E-value=4.8e-06  Score=71.50  Aligned_cols=83  Identities=7%  Similarity=-0.008  Sum_probs=49.4

Q ss_pred             eeee-cccCcceEEEEeec--C----CCcEEEEEEeeecc---cCCCHHHHHHHHHHHHHHHhCCC---CceEEeeeeEE
Q 022956           22 SDLL-GSGAVKKVYRAFDQ--E----EGIEVAWNQVRLSH---FSEDPVLVNRLHSEVQLLRTLKN---KYIIVCYSVWL   88 (289)
Q Consensus        22 ~~~l-g~g~~g~v~~~~~~--~----~~~~~aiK~~~~~~---~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~   88 (289)
                      .+.| +.|....+|++...  .    ++..+++|......   ...    ...+.+|+.+++.+..   -.+++++....
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~  100 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----TYRLDHQFEVIRLVGELTDVPVPRVRWIET  100 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence            4667 88888999998643  1    26789999875432   101    1345567777776643   23445554432


Q ss_pred             eCC-CCeeEEEeccccCCcHH
Q 022956           89 DDQ-HNTLNFITEVCTSGNLR  108 (289)
Q Consensus        89 ~~~-~~~~~lv~e~~~~~sL~  108 (289)
                      +.+ ....++|||+++|.++.
T Consensus       101 ~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          101 TGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSTTTSSCEEEEECCCCBCCC
T ss_pred             CCCccCCceEEEEecCCCChh
Confidence            221 02457899999986543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.00  E-value=6.6e-05  Score=63.72  Aligned_cols=29  Identities=24%  Similarity=0.366  Sum_probs=25.6

Q ss_pred             CceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      .++|+|+++.||+++.+ +.+.++||+.+.
T Consensus       223 ~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~  251 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGEN-EQIWVIDLDTVS  251 (346)
T ss_dssp             CEECSSCSTTSEEECGG-GCEEECCCTTCE
T ss_pred             ceecCCCCcccEEEeCC-CcEEEEehhhcc
Confidence            39999999999999877 689999998664

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.83  E-value=0.00016  Score=60.90  Aligned_cols=75  Identities=16%  Similarity=0.124  Sum_probs=54.1

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC---CceEEeeeeEEeCCCCeeEEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN---KYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+.|+.|....+|++..  ++..+++|+....       ....+..|...|+.|..   ..+++++.....  .+..++|
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lv  109 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLL  109 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEE
Confidence            46789999999999964  4778999987632       14567788888888742   345566655432  3568999


Q ss_pred             eccccCCcH
Q 022956           99 TEVCTSGNL  107 (289)
Q Consensus        99 ~e~~~~~sL  107 (289)
                      ||+++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999999754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.79  E-value=0.00029  Score=61.81  Aligned_cols=29  Identities=21%  Similarity=0.414  Sum_probs=25.8

Q ss_pred             ceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956          143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus       143 ~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ++|||+++.||+++.+ + +.++||+.+..-
T Consensus       234 liHGDl~~~Nil~~~~-~-~~lID~e~a~~G  262 (420)
T 2pyw_A          234 LIHGDLHTGSVMVTQD-S-TQVIDPEFSFYG  262 (420)
T ss_dssp             EECSCCSGGGEEECSS-C-EEECCCTTCEEE
T ss_pred             EEecCCCCCcEEEeCC-C-CEEEeCcccccC
Confidence            9999999999999987 5 999999887643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.63  E-value=0.00043  Score=57.41  Aligned_cols=74  Identities=14%  Similarity=-0.018  Sum_probs=49.9

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCC-c--eEEeeeeEEeCCCCeeEEE
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNK-Y--IIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~--i~~~~~~~~~~~~~~~~lv   98 (289)
                      .+.+|.|..+.||++.. .+|+.|++|+....... .   ...+..|+..|+.|... .  +++++..  +.    -++|
T Consensus        20 v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~----~~lv   88 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA-L---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD----RTLA   88 (288)
T ss_dssp             EEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC-C---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET----TEEE
T ss_pred             EEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc-h---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC----ceEE
Confidence            57799999999999975 57899999986543221 1   23567799998888532 2  2333332  22    3668


Q ss_pred             eccccCCc
Q 022956           99 TEVCTSGN  106 (289)
Q Consensus        99 ~e~~~~~s  106 (289)
                      ||++.+..
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            89988764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.59  E-value=0.00022  Score=59.55  Aligned_cols=71  Identities=14%  Similarity=-0.010  Sum_probs=41.7

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce-EEeeeeEEeCCCCeeEEEec
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~~lv~e  100 (289)
                      .+.|+.|....+|++      ..+++|+......    . .....+|+.+++.+...++ ++++..  +.+  .-+++++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~--~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----E-YINRANEAVAAREAAKAGVSPEVLHV--DPA--TGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTT--TCCEEEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc----c-eeCHHHHHHHHHHHHHcCCCCceEEE--ECC--CCEEEEe
Confidence            567888999999998      5688998864311    0 1112346666666643333 334432  222  2356899


Q ss_pred             cc-cCCcH
Q 022956          101 VC-TSGNL  107 (289)
Q Consensus       101 ~~-~~~sL  107 (289)
                      |+ +|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.26  E-value=0.00097  Score=56.41  Aligned_cols=32  Identities=22%  Similarity=0.365  Sum_probs=26.4

Q ss_pred             CceecCCCCCceEEeCC---CCcEEEeccCCcccc
Q 022956          142 CIIHRDLNCSNIFINGN---IGQVKIGDLGFAAIV  173 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~---~~~~~l~d~g~~~~~  173 (289)
                      .++|||+.+.||+++.+   .+.+.++||+.+..-
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            39999999999999873   147999999987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.24  E-value=0.00046  Score=58.09  Aligned_cols=142  Identities=18%  Similarity=0.152  Sum_probs=72.5

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce--EEeeeeE----EeCCCCee
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI--IVCYSVW----LDDQHNTL   95 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~----~~~~~~~~   95 (289)
                      .+.|+.|....+|++...  +..+++|.......      ...+..|+.+++.|...++  +.++...    ...-.+..
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCCCC------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            355778888899998643  34788998864211      1234456666666643222  2222110    00011356


Q ss_pred             EEEeccccCCcHH-----HH------H----HhcC----C----CCH---HHHHH------------HHHHHHHHHHHHh
Q 022956           96 NFITEVCTSGNLR-----TY------R----KKHR----H----VSI---KALKK------------WSKQVLEGLEYLH  137 (289)
Q Consensus        96 ~lv~e~~~~~sL~-----~~------~----~~~~----~----l~~---~~~~~------------~~~ql~~~l~~lh  137 (289)
                      ++++++++|..+.     .+      +    ....    +    ...   .....            +...+...+..+.
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            8899999986431     11      1    0000    0    110   00000            0001233344443


Q ss_pred             cC-----CCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956          138 TH-----EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus       138 ~~-----~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..     ...++|+|+++.||+++.+ +.+.++||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence            21     1139999999999999977 5568999987653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.11  E-value=0.0017  Score=56.02  Aligned_cols=140  Identities=16%  Similarity=0.236  Sum_probs=78.9

Q ss_pred             eeeecccCcceEEEEeecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce-EEeeeeEEeCCCC
Q 022956           22 SDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQHN   93 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~   93 (289)
                      .+.|..|-...+|++....       ++..+++|+....  ...   ...+.+|..+++.|...++ +++++.+  ++  
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQG---VDSLVLESVMFAILAERSLGPQLYGVF--PE--  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cch---HHHHHHHHHHHHHHHhcCCCCeEEEEc--CC--
Confidence            3567778788899987642       3578999986321  111   3445578888888754444 3444432  32  


Q ss_pred             eeEEEeccccCCcHHH--------------HHHh--------cCCCC--HHHHHHHHHHHHH------------------
Q 022956           94 TLNFITEVCTSGNLRT--------------YRKK--------HRHVS--IKALKKWSKQVLE------------------  131 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~--------------~~~~--------~~~l~--~~~~~~~~~ql~~------------------  131 (289)
                        .+|+||++|.+|..              .+.+        .+...  ..++..+..++-.                  
T Consensus       126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  203 (379)
T 3feg_A          126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK  203 (379)
T ss_dssp             --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred             --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence              27899999865421              1111        11112  3455555544422                  


Q ss_pred             -HHHH----HhcC--CCCceecCCCCCceEEeCC---CCcEEEeccCCccc
Q 022956          132 -GLEY----LHTH--EPCIIHRDLNCSNIFINGN---IGQVKIGDLGFAAI  172 (289)
Q Consensus       132 -~l~~----lh~~--~~~~~h~dl~~~nili~~~---~~~~~l~d~g~~~~  172 (289)
                       .+..    |...  ...++|+|+.+.||+++.+   .+.+.++||..+..
T Consensus       204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence             1222    2222  1249999999999999875   25899999988764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.98  E-value=0.0091  Score=50.14  Aligned_cols=77  Identities=14%  Similarity=0.100  Sum_probs=44.6

Q ss_pred             eeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCc--eEEeeee---EEeCCCCeeEE
Q 022956           23 DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY--IIVCYSV---WLDDQHNTLNF   97 (289)
Q Consensus        23 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~---~~~~~~~~~~l   97 (289)
                      +.|+ |....||++.. .+|+.+++|.......  .   ...+..|..+++.+....  ++.++..   ......+..++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence            3466 77788998854 3567899999863322  2   234555777777664322  2333322   00011245678


Q ss_pred             EeccccCCc
Q 022956           98 ITEVCTSGN  106 (289)
Q Consensus        98 v~e~~~~~s  106 (289)
                      ++++++|.+
T Consensus       105 l~~~i~G~~  113 (328)
T 1zyl_A          105 VFPSVGGRQ  113 (328)
T ss_dssp             EEECCCCEE
T ss_pred             EEEecCCCC
Confidence            999998854

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.96  E-value=0.011  Score=52.45  Aligned_cols=75  Identities=16%  Similarity=0.175  Sum_probs=46.3

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-EeeeeEEeCCCCeeEEEec
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv~e  100 (289)
                      .+.|+.|....+|++....++..+++|+..... . .  .. ...+|..+++.|...++. ++++.+  .  +  ..|++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~--~--G~v~e  181 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-E--II-NREREKKISCILYNKNIAKKIYVFF--T--N--GRIEE  181 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-S--CS-CHHHHHHHHHHHTTSSSBCCEEEEE--T--T--EEEEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-h--hc-CHHHHHHHHHHHHhcCCCCCEEEEe--C--C--eEEEE
Confidence            466888888999999765445789999875321 0 1  01 124688888888765554 444443  3  2  24899


Q ss_pred             cccCCcH
Q 022956          101 VCTSGNL  107 (289)
Q Consensus       101 ~~~~~sL  107 (289)
                      |++|.+|
T Consensus       182 ~I~G~~l  188 (458)
T 2qg7_A          182 FMDGYAL  188 (458)
T ss_dssp             CCCSEEC
T ss_pred             eeCCccC
Confidence            9988544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.95  E-value=0.0032  Score=55.37  Aligned_cols=74  Identities=16%  Similarity=0.145  Sum_probs=46.7

Q ss_pred             eeeecccCcceEEEEeecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce-EEeeeeEEeCCCC
Q 022956           22 SDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQHN   93 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~   93 (289)
                      .+.|+.|....+|++....       ++..+++|+....   ..   ...+.+|..+++.|...++ +++++.+  .+  
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG--  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--
Confidence            4568888888999997542       2578999998431   11   1334468888887754444 3444433  32  


Q ss_pred             eeEEEeccccCCcH
Q 022956           94 TLNFITEVCTSGNL  107 (289)
Q Consensus        94 ~~~lv~e~~~~~sL  107 (289)
                        .+|++|++|.+|
T Consensus       148 --g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 --GRLEEYIPSRPL  159 (429)
T ss_dssp             --EEEECCCCEEEC
T ss_pred             --CEEEEEeCCccc
Confidence              268999987443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.90  E-value=0.012  Score=49.85  Aligned_cols=31  Identities=16%  Similarity=0.360  Sum_probs=26.8

Q ss_pred             CceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956          142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus       207 ~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNE-ESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGG-GCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCC-CeEEEEECCCCeeC
Confidence            49999999999999877 68999999877543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.67  E-value=0.0027  Score=54.53  Aligned_cols=74  Identities=14%  Similarity=0.035  Sum_probs=41.0

Q ss_pred             eeeecccCcceEEEEeecC--------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce-EEeeeeEEeCCC
Q 022956           22 SDLLGSGAVKKVYRAFDQE--------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQH   92 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~   92 (289)
                      .+.|+.|..-.+|++....        .+..+++|+......    . ......|..+++.+...++ +++++..  .  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----E-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----c-eecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence            4567888888999997543        126888888754211    0 1123457777777754343 3444332  2  


Q ss_pred             CeeEEEeccccCCc
Q 022956           93 NTLNFITEVCTSGN  106 (289)
Q Consensus        93 ~~~~lv~e~~~~~s  106 (289)
                        -++|++|++|.+
T Consensus       109 --~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 --GGRIEEWLYGDP  120 (369)
T ss_dssp             --TEEEEECCCSEE
T ss_pred             --CcEEEEEecCCc
Confidence              256899998854

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.70  E-value=0.09  Score=45.96  Aligned_cols=75  Identities=15%  Similarity=0.059  Sum_probs=45.0

Q ss_pred             eeeecccCcceEEEEeecCC-------CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce-EEeeeeEEeCCCC
Q 022956           22 SDLLGSGAVKKVYRAFDQEE-------GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI-IVCYSVWLDDQHN   93 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~   93 (289)
                      .+.|..|-.-.+|++.....       +..+++|+.....    +. .-...+|..+++.+...++ +++++.+  .   
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~---  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GK-FYDSKVELDVFRYLSNINIAPNIIADF--P---  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T---
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C---
Confidence            46677788888999876421       5789999875321    11 1123457777777754333 3334322  2   


Q ss_pred             eeEEEeccccCCcH
Q 022956           94 TLNFITEVCTSGNL  107 (289)
Q Consensus        94 ~~~lv~e~~~~~sL  107 (289)
                       -+.|++|++|.+|
T Consensus       145 -~~~I~efI~G~~l  157 (424)
T 3mes_A          145 -EGRIEEFIDGEPL  157 (424)
T ss_dssp             -TEEEEECCCSEEC
T ss_pred             -CCEEEEEeCCccC
Confidence             2568999999653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.06  E-value=0.9  Score=35.60  Aligned_cols=114  Identities=9%  Similarity=0.025  Sum_probs=73.9

Q ss_pred             CCCceEEeeeeEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhcCCCCceecCCCCCceE
Q 022956           76 KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE-YLHTHEPCIIHRDLNCSNIF  154 (289)
Q Consensus        76 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~-~lh~~~~~~~h~dl~~~nil  154 (289)
                      .||++ ..- +-  ...+.+.+.++.-++..=+..+..   ++....+.++.+++.... +++  .  -+|.-++|+|++
T Consensus        48 ~~~~f-~~~-I~--~~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI-VRD-ID--VSEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS-EEE-EE--ECSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCC-CeE-EE--EeCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            57888 332 22  233567776666544433333433   788999999999988766 433  3  579999999999


Q ss_pred             EeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCC
Q 022956          155 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPY  221 (289)
Q Consensus       155 i~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~  221 (289)
                      ++.+ +.+++.-.|+....                +|..+    ++..=.-.+=|++..++.++..|
T Consensus       117 f~~~-~~p~i~hRGi~~~l----------------pP~e~----~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          117 FNRA-LEPFFLHVGVKESL----------------PPDEW----DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             ECTT-CCEEESCCEETTTB----------------SSCSC----CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EeCC-CcEEEEEcCCcccC----------------CCCCC----CHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999 89999988754422                22211    11112236777888888887665

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.39  E-value=0.8  Score=35.79  Aligned_cols=115  Identities=10%  Similarity=0.098  Sum_probs=75.1

Q ss_pred             CCCceEEeeeeEEeCCCCeeEEEeccccCC-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceE
Q 022956           76 KNKYIIVCYSVWLDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIF  154 (289)
Q Consensus        76 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nil  154 (289)
                      .+|++++.- +..  ..+.+.+.++.-+.. ++.. +.+   ++....+.++.+++....++++    -+|.-++|+|++
T Consensus        43 ~~~~Fl~~~-I~e--~eD~v~~~y~~~~~~~~f~~-ik~---~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDAE-LTE--LRDSFQIHYDINDNHTPFDN-IKS---FTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCEE-EEE--CSSEEEEEECCCTTSEEGGG-GGG---SCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEE
T ss_pred             cCCcccceE-EEE--cccEEEEEEEcCcccCCHHH-HHh---cCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEE
Confidence            578888663 322  224676666655432 3333 333   7889999999999987754433    379999999999


Q ss_pred             EeCCCCcEEEeccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCC
Q 022956          155 INGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYS  222 (289)
Q Consensus       155 i~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~  222 (289)
                      ++.+ +.+++.-.|+....                +|.    ..+...=.-.+=|++..+++++..|.
T Consensus       112 f~~~-~~p~i~~RGik~~l----------------~P~----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRD-GLPIAKTRGLQNVV----------------DPL----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTT-SCEEESCCEETTTB----------------SCC----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCC-CCEEEEEccCccCC----------------CCC----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999 89999887754322                221    01222223367788888888877763

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.61  E-value=0.042  Score=48.71  Aligned_cols=64  Identities=8%  Similarity=-0.038  Sum_probs=18.0

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEE------EEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAW------NQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~ai------K~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      .+.++||   ||.||++.......+||+      |..+....  ..+....+.++..+.+.++|||+++.+.+..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~--~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV--SEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccc--cccccccccccccccccccccccCCCcceEE
Confidence            3556777   999999988766678888      66553322  2334556778888888899999988876553

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.02  E-value=0.46  Score=41.03  Aligned_cols=31  Identities=16%  Similarity=0.266  Sum_probs=25.2

Q ss_pred             ceecCCCCCceEEeC-----CCCcEEEeccCCcccc
Q 022956          143 IIHRDLNCSNIFING-----NIGQVKIGDLGFAAIV  173 (289)
Q Consensus       143 ~~h~dl~~~nili~~-----~~~~~~l~d~g~~~~~  173 (289)
                      ++|+|+.+.||++.+     ..+.+.++||.++..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            679999999999943     2267999999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	289
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-53
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-53
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-53
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-52
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-50
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-49
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-47
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-44
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-43
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-43
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-42
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-41
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-39
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-36
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-34
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-13

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (599), Expect = 1e-77
 Identities = 122/271 (45%), Positives = 170/271 (62%), Gaps = 6/271 (2%)

Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
           V +   GRF ++   +G G+ K VY+  D E  +EVAW +++    ++      R   E 
Sbjct: 2   VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEA 59

Query: 70  QLLRTLKNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           ++L+ L++  I+  Y  W         +  +TE+ TSG L+TY K+ + + IK L+ W +
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPE 187
           Q+L+GL++LHT  P IIHRDL C NIFI G  G VKIGDLG A +  R+  A ++IGTPE
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPE 178

Query: 188 YMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           +MAPE+YEE Y E VD+Y+FG+C+LEM T E PYSEC + A+IY++VT GVKP + +KV 
Sbjct: 179 FMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238

Query: 248 DPEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
            PEVK  IE CI Q    R S  +LL   FF
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (476), Expect = 2e-58
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 16/277 (5%)

Query: 6   GEPFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRL 65
            E F + DP   F      +G G+   VY A D      VA  ++  S   +       +
Sbjct: 5   AELFFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDI 62

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKW 125
             EV+ L+ L++   I     +L +       + E C            + +    +   
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGT 185
           +   L+GL YLH+H   +IHRD+   NI ++   G VK+GD G A+I+  +   +S +GT
Sbjct: 121 THGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA---NSFVGT 174

Query: 186 PEYMAPELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ 241
           P +MAPE+        Y   VD++S G+  +E+   + P    ++++ +Y        P 
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPA 233

Query: 242 ALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFF 277
             +       + F++ C+ + P+ RP++  LLK  F 
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 7e-58
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 15/264 (5%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             +G+G+  +  +   + +G  + W ++     +E       L SEV LLR LK+  I+ 
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELKHPNIVR 67

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTY----RKKHRHVSIKALKKWSKQVLEGLEYLHT 138
            Y   +D  + TL  + E C  G+L +      K+ +++  + + +   Q+   L+  H 
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 139 HEPC---IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAPELY 194
                  ++HRDL  +N+F++G    VK+GD G A I+   +  A + +GTP YM+PE  
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186

Query: 195 E-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA 253
               Y E  DI+S G  L E+  +  P+    S  ++  K+  G K + +      E+  
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 244

Query: 254 FIEKCIAQ-PRARPSASELLKDPF 276
            I + +      RPS  E+L++P 
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPL 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-57
 Identities = 74/268 (27%), Positives = 123/268 (45%), Gaps = 14/268 (5%)

Query: 13  DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL 72
           DP  ++ R+ + +G GA   VY A D   G EVA  Q+ L    +       + +E+ ++
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVM 71

Query: 73  RTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           R  KN  I+     +L      L  + E    G+L     +        +    ++ L+ 
Sbjct: 72  RENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQA 128

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-SHAAHSIIGTPEYMAP 191
           LE+LH++   +IHRD+   NI +  + G VK+ D GF A +        +++GTP +MAP
Sbjct: 129 LEFLHSN--QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 192 E-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE 250
           E +  + Y   VDI+S G+  +EM+  E PY   + +  +Y   T G       +     
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Query: 251 VKAFIEKCIAQ-PRARPSASELLKDPFF 277
            + F+ +C+      R SA ELL+  F 
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-56
 Identities = 56/259 (21%), Positives = 112/259 (43%), Gaps = 12/259 (4%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             LG G    VY A +++    +A   +  +   E   + ++L  EV++   L++  I+ 
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILR 70

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            Y  + D     +  I E    G +    +K      +    +  ++   L Y H+    
Sbjct: 71  LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--R 126

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEM 201
           +IHRD+   N+ +    G++KI D G++     S    ++ GT +Y+ PE+ E   + E 
Sbjct: 127 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEK 184

Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ 261
           VD++S G+   E +  + P+ E ++  + YK+++                +  I + +  
Sbjct: 185 VDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKH 241

Query: 262 -PRARPSASELLKDPFFSE 279
            P  RP   E+L+ P+ + 
Sbjct: 242 NPSQRPMLREVLEHPWITA 260

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-55
 Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 19/278 (6%)

Query: 11  EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 70
           +++P   +      LG GA  KVY+A ++E  +  A   +      E    +     E+ 
Sbjct: 7   DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVEID 61

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQV 129
           +L +  +  I+     +  + +  L  + E C  G +     +  R ++   ++   KQ 
Sbjct: 62  ILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119

Query: 130 LEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEY 188
           L+ L YLH +   IIHRDL   NI    + G +K+ D G +A   R+     S IGTP +
Sbjct: 120 LDALNYLHDN--KIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 189 MAPELY------EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           MAPE+       +  Y    D++S G+ L+EM  +E P+ E + +  + K         A
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236

Query: 243 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
                    K F++KC+ +   AR + S+LL+ PF + 
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-55
 Identities = 73/307 (23%), Positives = 127/307 (41%), Gaps = 51/307 (16%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             LG+G    V++   +  G+ +A    +L H    P + N++  E+Q+L    + YI+ 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            Y  +  D    ++   E    G+L    KK   +  + L K S  V++GL YL   +  
Sbjct: 69  FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           I+HRD+  SNI +N   G++K+ D G +  +  S  A+S +GT  YM+PE L    Y+  
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQ 183

Query: 202 VDIYSFGLCLLEMVTMEIPYSECDS----------------------------------- 226
            DI+S GL L+EM     P    D+                                   
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 227 ------VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
                 + ++   +     P+  + V   E + F+ KC+ + P  R    +L+   F   
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

Query: 280 LNDDDSE 286
            + ++ +
Sbjct: 304 SDAEEVD 310

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-53
 Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 20/278 (7%)

Query: 8   PFVEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 67
           PFVE      +      LG GA  +V  A ++     VA   V +    + P     +  
Sbjct: 2   PFVE-----DW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKK 52

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSK 127
           E+ + + L ++ ++  Y    +          E C+ G L    +    +     +++  
Sbjct: 53  EICINKMLNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 110

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIG 184
           Q++ G+ YLH     I HRD+   N+ ++     +KI D G A +     R    + + G
Sbjct: 111 QLMAGVVYLHGI--GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCG 167

Query: 185 TPEYMAPELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
           T  Y+APEL    E + E VD++S G+ L  M+  E+P+ +     + Y           
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227

Query: 243 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
             K  D    A + K + + P AR +  ++ KD ++++
Sbjct: 228 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  175 bits (445), Expect = 2e-53
 Identities = 59/287 (20%), Positives = 115/287 (40%), Gaps = 15/287 (5%)

Query: 10  VEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 67
           VEV     +  Y   + LGSGA   V+R  ++  G       +   +  +       + +
Sbjct: 20  VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK----YTVKN 75

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWS 126
           E+ ++  L +  +I  +  + D     +  I E  + G L      +   +S   +  + 
Sbjct: 76  EISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133

Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAAIVGRSHAAHSIIGT 185
           +Q  EGL+++H H   I+H D+   NI         VKI D G A  +           T
Sbjct: 134 RQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191

Query: 186 PEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQAL 243
            E+ APE+ + E      D+++ G+    +++   P++  D +  +        +  +  
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251

Query: 244 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
                PE K FI+  + + PR R +  + L+ P+    + + +   P
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 298

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  175 bits (444), Expect = 3e-53
 Identities = 59/286 (20%), Positives = 114/286 (39%), Gaps = 15/286 (5%)

Query: 10  VEVDPSGRFGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 67
           VE+        Y   + LG+GA   V+R  ++  G   A   V   H S+       +  
Sbjct: 17  VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETVRK 72

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWS 126
           E+Q +  L++  ++  +  + DD    +  I E  + G L      +H  +S     ++ 
Sbjct: 73  EIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130

Query: 127 KQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI-GQVKIGDLGFAAIVGRSHAAHSIIGT 185
           +QV +GL ++H +    +H DL   NI        ++K+ D G  A +    +     GT
Sbjct: 131 RQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188

Query: 186 PEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQAL 243
            E+ APE+ E +      D++S G+    +++   P+   +    +    +       + 
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248

Query: 244 NKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPS 288
                 + K FI K +   P  R +  + L+ P+ +  N    +  
Sbjct: 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 294

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-53
 Identities = 70/270 (25%), Positives = 126/270 (46%), Gaps = 25/270 (9%)

Query: 18  FGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
            G+ +    +GSG+   VY+     +   VA   + ++  +     +    +EV +LR  
Sbjct: 7   DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKT 61

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLE 134
           ++  I++        Q   L  +T+ C   +L  +         +  L   ++Q  +G++
Sbjct: 62  RHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR---SHAAHSIIGTPEYMAP 191
           YLH     IIHRDL  +NIF++ +   VKIGD G A +  R   SH    + G+  +MAP
Sbjct: 119 YLHAK--SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 192 ELYEED----YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
           E+        Y+   D+Y+FG+ L E++T ++PYS  ++  +I   V  G     L+KV+
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 248 D---PEVKAFIEKCIAQ-PRARPSASELLK 273
                 +K  + +C+ +    RP   ++L 
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (437), Expect = 9e-53
 Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 12/272 (4%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           D+LG+GA  +V  A D+     VA   +              + +E+ +L  +K+  I+ 
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE---GSMENEIAVLHKIKHPNIVA 71

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
              ++    H  L  I ++ + G L     +    + +   +   QVL+ ++YLH  +  
Sbjct: 72  LDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--DLG 127

Query: 143 IIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAP-ELYEEDYT 199
           I+HRDL   N+         ++ I D G + +        +  GTP Y+AP  L ++ Y+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEVKAFIEKC 258
           + VD +S G+    ++    P+ + +      + +    +             K FI   
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247

Query: 259 IAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
           + + P  R +  + L+ P+ +     D     
Sbjct: 248 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ 279

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  169 bits (428), Expect = 9e-52
 Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 20/278 (7%)

Query: 18  FGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-----EDPVLVNRLHSEVQ 70
           +  Y   ++LG G    V R   +    E A   + ++        E   L      EV 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVL 130
           +LR +     I+      +        + ++   G L  Y  +   +S K  +K  + +L
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
           E +  LH     I+HRDL   NI ++ +   +K+ D GF+  +        + GTP Y+A
Sbjct: 121 EVICALHKL--NIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177

Query: 191 PELYE-------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQAL 243
           PE+ E         Y + VD++S G+ +  ++    P+     +  +   ++G  +  + 
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237

Query: 244 NKVK-DPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 279
                   VK  + + +  QP+ R +A E L  PFF +
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 6e-50
 Identities = 54/269 (20%), Positives = 112/269 (41%), Gaps = 16/269 (5%)

Query: 18  FGRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
           + +Y   + LG G    V+R  +           V++     D VLV +   E+ +L   
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKK---EISILNIA 58

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLE 134
           +++ I+  +  +   +   L  I E  +  ++          ++ + +  +  QV E L+
Sbjct: 59  RHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 135 YLHTHEPCIIHRDLNCSNIFI-NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
           +LH+H   I H D+   NI         +KI + G A  +        +   PEY APE+
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 194 YEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPEV 251
           ++ D  +   D++S G  +  +++   P+    +   I   +       +   K    E 
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 252 KAFIEKCIAQ-PRARPSASELLKDPFFSE 279
             F+++ + +  ++R +ASE L+ P+  +
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-49
 Identities = 57/280 (20%), Positives = 115/280 (41%), Gaps = 14/280 (5%)

Query: 20  RYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHF--SEDPVLVNRLHSEVQLLRTL 75
            Y   + LGSG    V +  ++  G++ A   ++      S   V    +  EV +L+ +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
           ++  +I  + V+ +     +  I E+   G L  +  +   ++ +   ++ KQ+L G+  
Sbjct: 71  QHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY- 127

Query: 136 LHTHEPCIIHRDLNCSNIFI---NGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 192
            + H   I H DL   NI +   N    ++KI D G A  +   +   +I GTPE++APE
Sbjct: 128 -YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 193 LYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPE 250
           +   E      D++S G+    +++   P+        +        +            
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246

Query: 251 VKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
            K FI + + + P+ R +  + L+ P+    +   +  S 
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSA 286

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-49
 Identities = 63/276 (22%), Positives = 120/276 (43%), Gaps = 20/276 (7%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++  +LG G+   V  A +     E A   +   H  ++   V  +  E  ++  L + +
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMSRLDHPF 69

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +  Y  + DD+   L F      +G L  Y +K         + ++ +++  LEYL  H
Sbjct: 70  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL--H 125

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV---GRSHAAHSIIGTPEYMAPE-LYE 195
              IIHRDL   NI +N +   ++I D G A ++    +   A+S +GT +Y++PE L E
Sbjct: 126 GKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
           +   +  D+++ G  + ++V    P+    +   I++K+    +     K   P+ +  +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL-EYDFPEKF-FPKARDLV 241

Query: 256 EKCIAQ-PRARPSASE------LLKDPFFSELNDDD 284
           EK +      R    E      L   PFF  +  ++
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-47
 Identities = 60/270 (22%), Positives = 111/270 (41%), Gaps = 20/270 (7%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVN--RLHSEVQLLRT 74
            +Y    LLGSG    VY      + + VA   V     S+   L N  R+  EV LL+ 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 75  LKNKYI-IVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGL 133
           + + +  ++    W +   + +  +       +L  +  +   +  +  + +  QVLE +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 134 EYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPEL 193
            + H     ++HRD+   NI I+ N G++K+ D G  A++  +       GT  Y  PE 
Sbjct: 124 RHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEW 180

Query: 194 Y--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEV 251
                 +     ++S G+ L +MV  +IP+   + + +        V           E 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSEC 231

Query: 252 KAFIEKCIAQ-PRARPSASELLKDPFFSEL 280
           +  I  C+A  P  RP+  E+   P+  ++
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 6e-46
 Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 35/296 (11%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE-DPVLVNRLHSEVQLLRTLKNKYII 81
           D LG G    VY+A D+     VA  +++L H SE    +      E++LL+ L +  II
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
                +    +  ++ + +   +      +     ++   +K +    L+GLEYL  H+ 
Sbjct: 64  GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL--HQH 119

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELYEED--Y 198
            I+HRDL  +N+ ++ N G +K+ D G A   G  + A++  + T  Y APEL      Y
Sbjct: 120 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 199 TEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK----------------------K 233
              VD+++ G  L E++         S+ D + +I++                      K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPS 288
              G+    +      ++   I+      P AR +A++ LK  +FS          
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 9e-46
 Identities = 55/270 (20%), Positives = 109/270 (40%), Gaps = 20/270 (7%)

Query: 25  LGSGAVKKVYRAFDQEE--GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LGSG    V + + Q +     VA   ++    + DP L + L +E  +++ L N YI+ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
              +    +  +   + E+   G L  Y +++RHV  K + +   QV  G++YL      
Sbjct: 73  MIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--N 127

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH----AAHSIIGTPEYMAPE-LYEED 197
            +HRDL   N+ +       KI D G +  +        A        ++ APE +    
Sbjct: 128 FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           ++   D++SFG+ + E  +           +++   +  G +          E+   +  
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNL 245

Query: 258 CIAQ-PRARPSASEL---LKDPFFSELNDD 283
           C       RP  + +   L++ ++  +N+ 
Sbjct: 246 CWTYDVENRPGFAAVELRLRNYYYDVVNEG 275

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-45
 Identities = 57/266 (21%), Positives = 117/266 (43%), Gaps = 12/266 (4%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
            +LG G+  KV+ A  ++     A   ++      D  +   +  +  L    ++ ++  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            +  +   ++  L F+ E    G+L  + +      +     ++ +++ GL++LH+    
Sbjct: 68  MFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--G 123

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH-SIIGTPEYMAPE-LYEEDYTE 200
           I++RDL   NI ++ + G +KI D G         A   +  GTP+Y+APE L  + Y  
Sbjct: 124 IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
            VD +SFG+ L EM+  + P+       +++  +          +  + E K  + K   
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFV 239

Query: 261 Q-PRARPSA-SELLKDPFFSELNDDD 284
           + P  R     ++ + P F E+N ++
Sbjct: 240 REPEKRLGVRGDIRQHPLFREINWEE 265

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 4e-45
 Identities = 57/297 (19%), Positives = 113/297 (38%), Gaps = 28/297 (9%)

Query: 10  VEVDPSGRFGRY---SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLH 66
           +++  +     Y   S +LG G   KV + F++    + A   ++            +  
Sbjct: 2   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---------KAR 52

Query: 67  SEVQ-LLRTLKNKYIIVCYSVWLD--DQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKA 121
            EV+   R  +  +I+    V+ +       L  + E    G L +    +  +  + + 
Sbjct: 53  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFIN--GNIGQVKIGDLGFAAIVGRSHAA 179
             +  K + E ++YLH+    I HRD+   N+          +K+ D GFA      ++ 
Sbjct: 113 ASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170

Query: 180 HSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVA---KIYKKVT 235
            +   TP Y+APE+   E Y +  D++S G+ +  ++    P+     +A    +  ++ 
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230

Query: 236 GGVK--PQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDDSEPSP 289
            G    P         EVK  I   +   P  R + +E +  P+  +       P  
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 287

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (383), Expect = 5e-45
 Identities = 67/268 (25%), Positives = 114/268 (42%), Gaps = 16/268 (5%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY   ++LG G + +V+ A D     +VA   +R    + DP    R   E Q    L 
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALN 65

Query: 77  NKYIIVCYSVWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
           +  I+  Y     +         + E      LR        ++ K   +      + L 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA----AHSIIGTPEYMA 190
           + H +   IIHRD+  +NI I+     VK+ D G A  +  S        ++IGT +Y++
Sbjct: 126 FSHQN--GIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 191 PELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG-VKPQALNKVKD 248
           PE    +      D+YS G  L E++T E P++    V+  Y+ V    + P A ++   
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242

Query: 249 PEVKAFIEKCIAQ-PRARP-SASELLKD 274
            ++ A + K +A+ P  R  +A+E+  D
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (383), Expect = 1e-44
 Identities = 64/269 (23%), Positives = 119/269 (44%), Gaps = 18/269 (6%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             LG+G+  +V+    +  G   A   ++          V   + E  +L  + + +II 
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            +  + D Q   +  I +    G L +  +K +       K ++ +V   LEYLH     
Sbjct: 69  MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--SKD 124

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           II+RDL   NI ++ N G +KI D GFA  V      +++ GTP+Y+APE +  + Y + 
Sbjct: 125 IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPYNKS 181

Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ 261
           +D +SFG+ + EM+    P+ +  +  K Y+K+             + +VK  + + I +
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238

Query: 262 ------PRARPSASELLKDPFFSELNDDD 284
                    +    ++   P+F E+  + 
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-44
 Identities = 58/270 (21%), Positives = 114/270 (42%), Gaps = 17/270 (6%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
            LLG G   KV    ++  G   A   +R          V    +E ++L+  ++ ++  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
               +       L F+ E    G L  +  + R  + +  + +  +++  LE  + H   
Sbjct: 70  LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE--YLHSRD 125

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA-AHSIIGTPEYMAPELYE-EDYTE 200
           +++RD+   N+ ++ + G +KI D G         A   +  GTPEY+APE+ E  DY  
Sbjct: 126 VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
            VD +  G+ + EM+   +P+       ++++ +          +   PE K+ +   + 
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLK 241

Query: 261 Q-PRARPS-----ASELLKDPFFSELNDDD 284
           + P+ R       A E+++  FF  +N  D
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-44
 Identities = 60/267 (22%), Positives = 111/267 (41%), Gaps = 19/267 (7%)

Query: 12  VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQL 71
           +DPS     +   +GSG    V+  +      +VA   +R    SE+         E ++
Sbjct: 2   IDPS-EL-TFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE-----DFIEEAEV 53

Query: 72  LRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVL 130
           +  L +  ++  Y V L+     +  + E    G L  Y R +    + + L      V 
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPEY 188
           EG+ YL   E C+IHRDL   N  +  N   +K+ D G    V   +  ++       ++
Sbjct: 112 EGMAYLE--EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 168

Query: 189 MAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK 247
            +PE      Y+   D++SFG+ + E+ +      E  S +++ + ++ G +     ++ 
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLA 227

Query: 248 DPEVKAFIEKCIAQ-PRARPSASELLK 273
              V   +  C  + P  RP+ S LL+
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLR 254

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-44
 Identities = 53/255 (20%), Positives = 102/255 (40%), Gaps = 19/255 (7%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             +G G    V        G +VA   ++    ++         +E  ++  L++  ++ 
Sbjct: 13  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ------AFLAEASVMTQLRHSNLVQ 64

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQVLEGLEYLHTHE 140
              V ++++   L  +TE    G+L  Y   +    +    L K+S  V E +EYL    
Sbjct: 65  LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--G 121

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYT 199
              +HRDL   N+ ++ +    K+ D G       +    +     ++ APE L E+ ++
Sbjct: 122 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFS 178

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 259
              D++SFG+ L E+ +          +  +  +V  G K  A +    P V   ++ C 
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCW 237

Query: 260 AQ-PRARPSASELLK 273
                 RPS  +L +
Sbjct: 238 HLDAAMRPSFLQLRE 252

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  149 bits (378), Expect = 2e-43
 Identities = 59/271 (21%), Positives = 114/271 (42%), Gaps = 16/271 (5%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--EDPVLVNRLHSEVQLLRTLKNKYII 81
           ++G G   +VY     + G   A   +        +   L       + L+ T    +I+
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
                +       L+FI ++   G+L  +  +H   S   ++ ++ +++ GLE++H    
Sbjct: 71  CMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR-- 126

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YT 199
            +++RDL  +NI ++   G V+I DLG A    +    H+ +GT  YMAPE+ ++   Y 
Sbjct: 127 FVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYD 184

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCI 259
              D +S G  L +++    P+ +  +  K             L     PE+++ +E  +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 260 AQ-PRARPS-----ASELLKDPFFSELNDDD 284
            +    R       A E+ + PFF  L+   
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-43
 Identities = 66/307 (21%), Positives = 117/307 (38%), Gaps = 48/307 (15%)

Query: 20  RYSD--LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            Y+D  ++G+G+   VY+A   + G  VA  +V               + E+Q++R L +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDH 72

Query: 78  KYII----VCYSVWLDDQHNTLNFITEVCTSGNLRT---YRKKHRHVSIKALKKWSKQVL 130
             I+      YS         LN + +       R    Y +  + + +  +K +  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 131 EGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMA 190
             L Y+H+    I HRD+   N+ ++ +   +K+ D G A  + R     S I +  Y A
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 191 PELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------- 240
           PEL     DYT  +D++S G  L E++  +  +     V ++ + +     P        
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 241 ------------------QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELN 281
                             +       PE  A   + +   P AR +  E     FF EL 
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

Query: 282 DDDSEPS 288
           D + +  
Sbjct: 311 DPNVKLP 317

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-43
 Identities = 57/264 (21%), Positives = 113/264 (42%), Gaps = 21/264 (7%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + LG+G   +V+  +      +VA   ++    S D        +E  L++ L+++ ++ 
Sbjct: 19  ERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 72

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV--SIKALKKWSKQVLEGLEYLHTHE 140
            Y+V   +    +  ITE   +G+L  + K    +  +I  L   + Q+ EG+ ++    
Sbjct: 73  LYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128

Query: 141 PCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPEYMAP-ELYEED 197
              IHRDL  +NI ++ +    KI D G A ++      A        ++ AP  +    
Sbjct: 129 -NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           +T   D++SFG+ L E+VT         +  ++ + +  G +    +     E+   +  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRL 245

Query: 258 CIAQ-PRARPSASELLK--DPFFS 278
           C  + P  RP+   L    + FF+
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFFT 269

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 6e-43
 Identities = 53/278 (19%), Positives = 108/278 (38%), Gaps = 23/278 (8%)

Query: 11  EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 70
           E+       R    LG G   +V+          VA   ++    S +         E Q
Sbjct: 13  EIPRE-SL-RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPE-----AFLQEAQ 64

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQ 128
           +++ L+++ ++  Y+V        +  +TE  + G+L  +   +  +++ +  L   + Q
Sbjct: 65  VMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP 186
           +  G+ Y+       +HRDL  +NI +  N    K+ D G A ++      A        
Sbjct: 122 IASGMAYVERM--NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPI 178

Query: 187 EYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 245
           ++ APE      +T   D++SFG+ L E+ T            ++  +V  G +     +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238

Query: 246 VKDPEVKAFIEKCIAQ-PRARPSASELLK--DPFFSEL 280
                +   + +C  + P  RP+   L    + +F+  
Sbjct: 239 C-PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 8e-43
 Identities = 59/258 (22%), Positives = 113/258 (43%), Gaps = 14/258 (5%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQ-VRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           +LGSGA   VY+     EG +V     ++    +  P     +  E  ++ ++ N ++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEP 141
              + L     T+  IT++   G L  Y ++H+ ++  + L  W  Q+ +G+ YL     
Sbjct: 76  LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 130

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG---RSHAAHSIIGTPEYMAPE-LYEED 197
            ++HRDL   N+ +      VKI D G A ++G   + + A       ++MA E +    
Sbjct: 131 RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 198 YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK 257
           YT   D++S+G+ + E++T      +    ++I   +  G +          +V   + K
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMVK 248

Query: 258 CIAQ-PRARPSASELLKD 274
           C      +RP   EL+ +
Sbjct: 249 CWMIDADSRPKFRELIIE 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 1e-42
 Identities = 51/274 (18%), Positives = 106/274 (38%), Gaps = 22/274 (8%)

Query: 25  LGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           LG G    V +   +   + I+VA   ++      D      +  E Q++  L N YI+ 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD---TEEMMREAQIMHQLDNPYIVR 73

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
              V    Q   L  + E+   G L  +   K   + +  + +   QV  G++YL     
Sbjct: 74  LIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 128

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH----SIIGTPEYMAPE-LYEE 196
             +HRDL   N+ +       KI D G +  +G   + +    +     ++ APE +   
Sbjct: 129 NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 197 DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIE 256
            ++   D++S+G+ + E ++      +     ++   +  G + +   +   PE+ A + 
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMS 246

Query: 257 KCIAQ-PRARPSASEL---LKDPFFSELNDDDSE 286
            C       RP    +   ++  ++S  +  +  
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-42
 Identities = 64/315 (20%), Positives = 118/315 (37%), Gaps = 50/315 (15%)

Query: 10  VEVDPSGRFGRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHS 67
           VE        +Y  L  +G G   +V++A  ++ G +VA  +V + +  E          
Sbjct: 1   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG--FPITALR 58

Query: 68  EVQLLRTLKNKYIIVCYSVWLDDQH------NTLNFITEVCTSGNLRTYRKKHRHVSIKA 121
           E+++L+ LK++ ++    +             ++  + + C               ++  
Sbjct: 59  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 118

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH- 180
           +K+  + +L GL Y+H     I+HRD+  +N+ I  + G +K+ D G A     +  +  
Sbjct: 119 IKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQP 175

Query: 181 ----SIIGTPEYMAPE--LYEEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIY 231
               + + T  Y  PE  L E DY   +D++  G  + EM T        +E   +A I 
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235

Query: 232 --------------------------KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRA 264
                                     K     VK +    V+DP     I+K +   P  
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295

Query: 265 RPSASELLKDPFFSE 279
           R  + + L   FF  
Sbjct: 296 RIDSDDALNHDFFWS 310

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 8e-42
 Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 13/272 (4%)

Query: 10  VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEV 69
           V + PS     +++++G G    VY     +   +     V+  +   D   V++  +E 
Sbjct: 20  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79

Query: 70  QLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQ 128
            +++   +  ++    + L  + + L  +      G+LR + +   H  ++K L  +  Q
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG-----RSHAAHSII 183
           V +G++         +HRDL   N  ++     VK+ D G A  +        H      
Sbjct: 139 VAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAK 195

Query: 184 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
              ++MA E L  + +T   D++SFG+ L E++T   P     +   I   +  G +   
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255

Query: 243 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
                   +   + KC       RPS SEL+ 
Sbjct: 256 PEYC-PDPLYEVMLKCWHPKAEMRPSFSELVS 286

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (362), Expect = 1e-41
 Identities = 40/259 (15%), Positives = 92/259 (35%), Gaps = 15/259 (5%)

Query: 24  LLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVC 83
           ++G+G   +V     +  G    +  ++               SE  ++    +  +I  
Sbjct: 33  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92

Query: 84  YSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
             V        +  ITE   +G+L ++ R+     ++  L    + +  G++YL      
Sbjct: 93  EGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--N 148

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS------IIGTPEYMAPELYE- 195
            +HRDL   NI +N N    K+ D G +  +    +  +            + APE  + 
Sbjct: 149 YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
             +T   D++S+G+ + E+++         +   +   +    +           +   +
Sbjct: 208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLM 266

Query: 256 EKCIAQ-PRARPSASELLK 273
             C  +    RP   +++ 
Sbjct: 267 LDCWQKDRNHRPKFGQIVN 285

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-41
 Identities = 64/291 (21%), Positives = 113/291 (38%), Gaps = 38/291 (13%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + +G G    VY+A ++  G  VA  ++RL   +E   + +    E+ LL+ L +  I+ 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG--VPSTAIREISLLKELNHPNIVK 65

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEP 141
              V   +    L  + E       +         + +  +K +  Q+L+GL + H+H  
Sbjct: 66  LLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-- 121

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEED--Y 198
            ++HRDL   N+ IN   G +K+ D G A   G         + T  Y APE+      Y
Sbjct: 122 RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 199 TEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK----------- 247
           +  VDI+S G    EMVT    +     + ++++       P  +               
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 248 ---------------DPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELND 282
                          D + ++ + + +   P  R SA   L  PFF ++  
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-41
 Identities = 55/255 (21%), Positives = 106/255 (41%), Gaps = 17/255 (6%)

Query: 25  LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCY 84
           LG+G    V     +    +VA   ++    SED         E +++  L ++ ++  Y
Sbjct: 12  LGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLY 65

Query: 85  SVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH-VSIKALKKWSKQVLEGLEYLHTHEPCI 143
            V    +   +  ITE   +G L  Y ++ RH    + L +  K V E +EYL +     
Sbjct: 66  GVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QF 121

Query: 144 IHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTPEYMAPELYE-EDYTE 200
           +HRDL   N  +N   G VK+ D G +  V      ++        +  PE+     ++ 
Sbjct: 122 LHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 201 MVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA 260
             DI++FG+ + E+ ++     E  + ++  + +  G++      +   +V   +  C  
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYSCWH 239

Query: 261 Q-PRARPSASELLKD 274
           +    RP+   LL +
Sbjct: 240 EKADERPTFKILLSN 254

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-41
 Identities = 63/279 (22%), Positives = 123/279 (44%), Gaps = 23/279 (8%)

Query: 23  DLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
            +LG+GA  KV+        + G   A   ++ +   +         +E Q+L  ++   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH 139
            +V        +   L+ I +    G L T+  +    +   ++ +  +++  LE+LH  
Sbjct: 90  FLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148

Query: 140 EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG--RSHAAHSIIGTPEYMAPELY--- 194
              II+RD+   NI ++ N G V + D G +       +  A+   GT EYMAP++    
Sbjct: 149 --GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYKKVTGGVKPQALNKVKDPEV 251
           +  + + VD +S G+ + E++T   P+    E +S A+I +++     P    +      
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALA 263

Query: 252 KAFIEKCIAQ-PRARPS-----ASELLKDPFFSELNDDD 284
           K  I++ + + P+ R       A E+ +  FF ++N DD
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (357), Expect = 4e-41
 Identities = 61/282 (21%), Positives = 114/282 (40%), Gaps = 21/282 (7%)

Query: 11  EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQ 70
           E++ +         LG G   +VY    ++  + VA   ++     ED + V     E  
Sbjct: 13  EMERT-DI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 65

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTY--RKKHRHVSIKALKKWSKQ 128
           +++ +K+  ++    V   +       ITE  T GNL  Y      + VS   L   + Q
Sbjct: 66  VMKEIKHPNLVQLLGVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 129 VLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--GRSHAAHSIIGTP 186
           +   +EYL   +   IHRDL   N  +  N   VK+ D G + ++      A        
Sbjct: 124 ISSAMEYLE--KKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 187 EYMAP-ELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK 245
           ++ AP  L    ++   D+++FG+ L E+ T  +       ++++Y+ +    + +    
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240

Query: 246 VKDPEVKAFIEKCIAQ-PRARPSASELLK--DPFFSELNDDD 284
               +V   +  C    P  RPS +E+ +  +  F E +  D
Sbjct: 241 C-PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 6e-41
 Identities = 54/288 (18%), Positives = 101/288 (35%), Gaps = 31/288 (10%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY     +GSG+   +Y   D   G EVA     +           +LH E ++ + ++
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP------QLHIESKIYKMMQ 60

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
               I     W   + +    + E+        +    R  S+K +   + Q++  +EY+
Sbjct: 61  GGVGIPTI-RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 137 HTHEPCIIHRDLNCSNIFI--NGNIGQVKIGDLGFAAIVGRS--------HAAHSIIGTP 186
           H+     IHRD+   N  +        V I D G A     +            ++ GT 
Sbjct: 120 HSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 187 EYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-----P 240
            Y +   +   + +   D+ S G  L+      +P+    +  K  K      K      
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 241 QALNKVKDPEVKAFIEKCIA-QPRARPSAS---ELLKDPFFSELNDDD 284
           + L K    E   ++  C + +   +P  S   +L ++ F  +    D
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 8e-41
 Identities = 65/296 (21%), Positives = 123/296 (41%), Gaps = 40/296 (13%)

Query: 20  RYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           +Y   + +G G    V++A ++E    VA  +VRL    E   + +    E+ LL+ LK+
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKH 60

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLH 137
           K I+  + V   D+  TL  + E C     + +   +  +  + +K +  Q+L+GL + H
Sbjct: 61  KNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 138 THEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHS-IIGTPEYMAPELY-- 194
           +    ++HRDL   N+ IN N G++K+ + G A   G     +S  + T  Y  P++   
Sbjct: 119 SR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 195 EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV---------------- 238
            + Y+  +D++S G    E+     P    + V    K++   +                
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 239 -----------KPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELND 282
                          +    +   +  ++  +   P  R SA E L+ P+FS+   
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-40
 Identities = 61/272 (22%), Positives = 114/272 (41%), Gaps = 24/272 (8%)

Query: 20  RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           ++ D++G G   +V +A  +++G+ +     R+  ++           E+++L  L +  
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHP 71

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV----------------SIKALK 123
            I+   +   +    L    E    GNL  + +K R +                S + L 
Sbjct: 72  NIINL-LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 124 KWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSII 183
            ++  V  G++YL   +   IHRDL   NI +  N    KI D G +             
Sbjct: 131 HFAADVARGMDYLS--QKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGR 187

Query: 184 GTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA 242
               +MA E L    YT   D++S+G+ L E+V++        + A++Y+K+  G + + 
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247

Query: 243 LNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
                D EV   + +C  + P  RPS +++L 
Sbjct: 248 PLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-40
 Identities = 53/260 (20%), Positives = 109/260 (41%), Gaps = 18/260 (6%)

Query: 23  DLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
             +G G    V++      +   + VA   ++         +  +   E   +R   + +
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTY-RKKHRHVSIKALKKWSKQVLEGLEYLHT 138
           I+    V  ++    +  I E+CT G LR++ + +   + + +L  ++ Q+   L YL  
Sbjct: 70  IVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-- 124

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--HAAHSIIGTPEYMAPE-LYE 195
                +HRD+   N+ ++ N   VK+GD G +  +  S  + A       ++MAPE +  
Sbjct: 125 ESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI 255
             +T   D++ FG+C+ E++   +   +      +  ++  G +         P + + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLM 242

Query: 256 EKCIAQ-PRARPSASELLKD 274
            KC A  P  RP  +EL   
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-40
 Identities = 64/310 (20%), Positives = 115/310 (37%), Gaps = 46/310 (14%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY+    +G GA   V  A+D    + VA  ++      E      R   E+++L   +
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFR 64

Query: 77  NKYIIVCYSVWLDDQHNTLN--FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
           ++ II    +        +   ++       +L    K  +H+S   +  +  Q+L GL+
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLK 123

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH----SIIGTPEYMA 190
           Y+H+    ++HRDL  SN+ +N     +KI D G A +    H         + T  Y A
Sbjct: 124 YIHSA--NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 191 PELY--EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-------- 240
           PE+    + YT+ +DI+S G  L EM++    +     + ++   +     P        
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 241 --------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE 279
                                 L    D +    ++K +   P  R    + L  P+  +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

Query: 280 LNDDDSEPSP 289
             D   EP  
Sbjct: 301 YYDPSDEPIA 310

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-40
 Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 35/290 (12%)

Query: 23  DLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYI 80
             +G GA  KV++A D +  G  VA  +VR+    E  P+   R  + ++ L T ++  +
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 81  IVCYSVWLD---DQHNTLNFITEVCTSGNLR-TYRKKHRHVSIKALKKWSKQVLEGLEYL 136
           +  + V      D+   L  + E           +     V  + +K    Q+L GL++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 137 HTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYE 195
           H+H   ++HRDL   NI +  + GQ+K+ D G A I     A  S++ T  Y APE L +
Sbjct: 133 HSH--RVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189

Query: 196 EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD------- 248
             Y   VD++S G    EM   +  +     V ++ K +     P   +  +D       
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249

Query: 249 -----------------PEVKAFIEKCIAQ-PRARPSASELLKDPFFSEL 280
                               K  + KC+   P  R SA   L  P+F +L
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-40
 Identities = 52/274 (18%), Positives = 106/274 (38%), Gaps = 22/274 (8%)

Query: 11  EVDPSGRFGRYSDLLGSGAVKKVYRAF----DQEEGIEVAWNQVRLSHFSEDPVLVNRLH 66
           E+ PS    R   ++G+G   +VY+        ++ + VA   ++  +  +         
Sbjct: 3   EIHPS-CVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ---RVDFL 57

Query: 67  SEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSG-NLRTYRKKHRHVSIKALKKW 125
            E  ++    +  II    V    +   +  ITE   +G   +  R+K    S+  L   
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGM 115

Query: 126 SKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG----RSHAAHS 181
            + +  G++Y        +HRDL   NI +N N    K+ D G + ++      ++    
Sbjct: 116 LRGIAAGMKY--LANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 182 IIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP 240
                 + APE +    +T   D++SFG+ + E++T         S  ++ K +  G + 
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232

Query: 241 QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
                     +   + +C  Q    RP  ++++ 
Sbjct: 233 PTPMDC-PSAIYQLMMQCWQQERARRPKFADIVS 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-39
 Identities = 62/262 (23%), Positives = 108/262 (41%), Gaps = 19/262 (7%)

Query: 23  DLLGSGAVKKVYRAF---DQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKY 79
           + LG G+   V R        + + VA   ++    S  P  ++    EV  + +L ++ 
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRN 72

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHT 138
           +I  Y V L      +  +TE+   G+L    +KH+ H  +  L +++ QV EG+ YL  
Sbjct: 73  LIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE- 128

Query: 139 HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAH----SIIGTPEYMAPE-L 193
                IHRDL   N+ +      VKIGD G    + ++   +           + APE L
Sbjct: 129 -SKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 194 YEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK 252
               ++   D + FG+ L EM T  + P+   +    ++K    G +          ++ 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC-PQDIY 245

Query: 253 AFIEKCIAQ-PRARPSASELLK 273
             + +C A  P  RP+   L  
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRD 267

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  138 bits (348), Expect = 2e-39
 Identities = 49/300 (16%), Positives = 110/300 (36%), Gaps = 51/300 (17%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYII 81
             LG G   +V+ A +     +V    ++       PV   ++  E+++L  L+    II
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNII 93

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
               +  D    T   + E   + + +     ++ ++   ++ +  ++L+ L+Y H+   
Sbjct: 94  TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM-- 148

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED--YT 199
            I+HRD+   N+ I+    ++++ D G A         +  + +  +  PEL  +   Y 
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 200 EMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT------------------------ 235
             +D++S G  L  M+  + P+           ++                         
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 236 -----------GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD 283
                                +  PE   F++K +    ++R +A E ++ P+F  +  D
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-39
 Identities = 69/283 (24%), Positives = 108/283 (38%), Gaps = 38/283 (13%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSE--DPVLVNRLHSEVQLLRTLKN-KY 79
            +LGSGA  KV  A            QV +    E  D      L SE++++  L + + 
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 80  IIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------------- 116
           I+             +  I E C  G+L  Y +  R                        
Sbjct: 103 IVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 117 VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV--- 173
           ++ + L  ++ QV +G+E+L       +HRDL   N+ +      VKI D G A  +   
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSD 217

Query: 174 GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIY 231
                  +     ++MAPE L+E  YT   D++S+G+ L E+ ++   PY      A  Y
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277

Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
           K +  G K          E+   ++ C A   R RPS   L  
Sbjct: 278 KLIQNGFKMDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLTS 319

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-38
 Identities = 73/305 (23%), Positives = 123/305 (40%), Gaps = 42/305 (13%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
            Y DL  +GSGA   V  A D   G +VA  ++     SE      R + E++LL+ +++
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMRH 76

Query: 78  KYIIVCYSVWLDDQH--NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEY 135
           + +I    V+  D+   +  +F   +   G       KH  +    ++    Q+L+GL Y
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136

Query: 136 LHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY- 194
           +H       HRDL   N+ +N +  ++KI D G A            + T  Y APE+  
Sbjct: 137 IHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQADSEM--TGYVVTRWYRAPEVIL 191

Query: 195 -EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP------------- 240
               YT+ VDI+S G  + EM+T +  +   D + ++ + +     P             
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 241 ---------------QALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDDD 284
                           ++     P     +EK +      R +A E L  P+F  L+D +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311

Query: 285 SEPSP 289
            EP  
Sbjct: 312 DEPQV 316

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (340), Expect = 4e-38
 Identities = 53/269 (19%), Positives = 116/269 (43%), Gaps = 18/269 (6%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
             LG+G+  +V     +E G   A   +           +    +E ++L+ +   +++ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
               + D+ +  L  + E    G + ++ ++    S    + ++ Q++   EYLH+    
Sbjct: 106 LEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL--D 161

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE-LYEEDYTEM 201
           +I+RDL   N+ I+   G +++ D GFA  V       ++ GTPE +APE +  + Y + 
Sbjct: 162 LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKA 218

Query: 202 VDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ 261
           VD ++ G+ + EM     P+   D   +IY+K+  G K +  +     ++K  +   +  
Sbjct: 219 VDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSG-KVRFPSHF-SSDLKDLLRNLLQV 275

Query: 262 ------PRARPSASELLKDPFFSELNDDD 284
                    +   +++    +F+  +   
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  133 bits (334), Expect = 9e-38
 Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 38/287 (13%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + +G G    VY+A +   G   A  ++RL    ED  + +    E+ +L+ LK+  I+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64

Query: 83  CYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPC 142
            Y V    +   L  + E       +        +     K +  Q+L G+ Y H  +  
Sbjct: 65  LYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DRR 120

Query: 143 IIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS-HAAHSIIGTPEYMAPELYEED--YT 199
           ++HRDL   N+ IN   G++KI D G A   G         I T  Y AP++      Y+
Sbjct: 121 VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 200 EMVDIYSFGLCLLEMVTMEIPY---SECDSVAKIYK-----------------------K 233
             +DI+S G    EMV     +   SE D + +I++                        
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 234 VTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSE 279
           V   +  ++  K  D      + K +   P  R +A + L+  +F E
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 2e-37
 Identities = 52/288 (18%), Positives = 98/288 (34%), Gaps = 43/288 (14%)

Query: 20  RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
            Y   +G GA  +V++A        E    VA   ++    ++   +      E  L+  
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD---MQADFQREAALMAE 72

Query: 75  LKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH------------------ 116
             N  I+    V    +   +  + E    G+L  + +                      
Sbjct: 73  FDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 117 ------VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA 170
                 +S       ++QV  G+ YL       +HRDL   N  +  N   VKI D G +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGEN-MVVKIADFGLS 187

Query: 171 AIV---GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDS 226
             +       A  +      +M PE ++   YT   D++++G+ L E+ +  +      +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 227 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
             ++   V  G            E+   +  C ++ P  RPS   + +
Sbjct: 248 HEEVIYYVRDGNILACPENC-PLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-36
 Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 36/280 (12%)

Query: 23  DLLGSGAVKKVYRAFD-------QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL 75
             LG GA  +V  A              +VA   ++     +D   ++ L SE+++++ +
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD---LSDLISEMEMMKMI 75

Query: 76  KNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHR----------------HVSI 119
                I+            L  I E  + GNLR Y +  R                 +S 
Sbjct: 76  GKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134

Query: 120 KALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS--- 176
           K L   + QV  G+EYL       IHRDL   N+ +  +   +KI D G A  +      
Sbjct: 135 KDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYY 191

Query: 177 HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT 235
               +     ++MAPE L++  YT   D++SFG+ L E+ T+         V +++K + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 236 GGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLKD 274
            G +    +     E+   +  C    P  RP+  +L++D
Sbjct: 252 EGHRMDKPSNC-TNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-36
 Identities = 70/306 (22%), Positives = 124/306 (40%), Gaps = 44/306 (14%)

Query: 20  RYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
           RY +L  +GSGA   V  AFD + G+ VA  ++      +  +   R + E++LL+ +K+
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKH 76

Query: 78  KYIIVCYSVWLDDQH---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLE 134
           + +I    V+   +        ++       +L    K  +       +    Q+L GL+
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLK 135

Query: 135 YLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELY 194
           Y+H+    IIHRDL  SN+ +N    ++KI D G A            + T  Y APE+ 
Sbjct: 136 YIHSA--DIIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 190

Query: 195 --EEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA---------- 242
                Y + VDI+S G  + E++T    +   D + ++   +     P A          
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 243 ------------------LNKVKDPEVKAFIEKCIAQ-PRARPSASELLKDPFFSELNDD 283
                             +    +P     +EK +      R +A++ L   +F++ +D 
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 284 DSEPSP 289
           D EP  
Sbjct: 311 DDEPVA 316

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-36
 Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 37/302 (12%)

Query: 11  EVDPSGRFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRL 65
           EV    +    S  LG G+   VY    +     E    VA   V  +    +       
Sbjct: 16  EVARE-KI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE---RIEF 70

Query: 66  HSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHV-------- 117
            +E  +++     +++    V    Q      I E+ T G+L++Y +  R          
Sbjct: 71  LNEASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128

Query: 118 --SIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR 175
             S+  + + + ++ +G+ YL+ +    +HRDL   N  +  +   VKIGD G    +  
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYE 185

Query: 176 S---HAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIY 231
           +         +    +M+PE L +  +T   D++SFG+ L E+ T+     +  S  ++ 
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245

Query: 232 KKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK------DPFFSELNDDD 284
           + V  G      +      +   +  C    P+ RPS  E++       +P F E++   
Sbjct: 246 RFVMEGGLLDKPDNC-PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 304

Query: 285 SE 286
           SE
Sbjct: 305 SE 306

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 4e-36
 Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 34/278 (12%)

Query: 23  DLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN 77
             LG GA  +V  A             VA   ++      +      L SE+++L  + +
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRALMSELKILIHIGH 75

Query: 78  KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------VSIKA 121
              +V            L  I E C  GNL TY +  R+                ++++ 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 122 LKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS---HA 178
           L  +S QV +G+E+L +     IHRDL   NI ++     VKI D G A  + +      
Sbjct: 136 LICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVR 192

Query: 179 AHSIIGTPEYMA-PELYEEDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTG 236
                   ++MA   +++  YT   D++SFG+ L E+ +    PY       +  +++  
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252

Query: 237 GVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
           G + +A +    PE+   +  C    P  RP+ SEL++
Sbjct: 253 GTRMRAPDYT-TPEMYQTMLDCWHGEPSQRPTFSELVE 289

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 7e-36
 Identities = 62/303 (20%), Positives = 111/303 (36%), Gaps = 51/303 (16%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIV 82
           + +G G   +V+R   +  G EVA                    +E+     L+++ I+ 
Sbjct: 9   ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILG 61

Query: 83  CYSVWLDDQHN--TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-- 138
             +    D      L  +++    G+L  Y  ++  V+++ + K +     GL +LH   
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEI 120

Query: 139 ----HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-----SHAAHSIIGTPEYM 189
                +P I HRDL   NI +  N G   I DLG A            A +  +GT  YM
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 190 APELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVT------- 235
           APE+ ++       +  +  DIY+ GL   E+          +     Y  +        
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 236 --------GGVKPQALNKVKDPE----VKAFIEKCIAQ-PRARPSASELLKDPFFSELND 282
                     ++P   N+ +  E    +   + +C      AR +A  + K    S+L+ 
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLSQ 297

Query: 283 DDS 285
            + 
Sbjct: 298 QEG 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  127 bits (320), Expect = 1e-35
 Identities = 37/292 (12%), Positives = 86/292 (29%), Gaps = 32/292 (10%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
             Y     +G G+   ++   +     +VA         +       +L  E +  + L 
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP------QLRDEYRTYKLLA 58

Query: 77  NKYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYL 136
               I     +   +      + ++             R  S+K +   +KQ+L  ++ +
Sbjct: 59  GCTGIPNV-YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 137 HTHEPCIIHRDLNCSNIFINGNI----GQVKIGDLGFAAIVG--------RSHAAHSIIG 184
           H     +++RD+   N  I          + + D G                    ++ G
Sbjct: 118 HEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 185 TPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT--MEIPYSECDSVAKIYKKVTGG---V 238
           T  YM+   +   + +   D+ + G   +  +   +     +  +  + Y+++       
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235

Query: 239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK--DPFFSELNDDDSEP 287
             + L      E   ++         A P    L          LN  + E 
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-34
 Identities = 63/284 (22%), Positives = 112/284 (39%), Gaps = 39/284 (13%)

Query: 20  RYSDLLGSGAVKKVYRA-----FDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT 74
            +   LG+GA  KV  A        +  + VA   ++ S    +      L SE+++L  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE---REALMSELKVLSY 82

Query: 75  LKN-KYIIVCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRH----------------- 116
           L N   I+                ITE C  G+L  + ++ R                  
Sbjct: 83  LGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 117 -VSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV-- 173
            + ++ L  +S QV +G+ +L +     IHRDL   NI +       KI D G A  +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHG-RITKICDFGLARDIKN 197

Query: 174 -GRSHAAHSIIGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV-AKI 230
                   +     ++MAPE ++   YT   D++S+G+ L E+ ++         V +K 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 231 YKKVTGGVKPQALNKVKDPEVKAFIEKCIAQ-PRARPSASELLK 273
           YK +  G +  +       E+   ++ C    P  RP+  ++++
Sbjct: 258 YKMIKEGFRMLSPEHA-PAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (313), Expect = 4e-34
 Identities = 72/318 (22%), Positives = 124/318 (38%), Gaps = 55/318 (17%)

Query: 19  GRYSDL--LGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK 76
            RY +L  +GSGA   V  A+D      VA  ++      ++     R + E+ L++ + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVN 74

Query: 77  NKYIIVCYSVWLDDQH----NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEG 132
           +K II   +V+   +       +  + E+  +   +  + +  H   + +     Q+L G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH---ERMSYLLYQMLCG 131

Query: 133 LEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPE 192
           +++LH+    IIHRDL  SNI +  +   +KI D G A   G S      + T  Y APE
Sbjct: 132 IKHLHSA--GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188

Query: 193 -LYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP----------- 240
            +    Y E VDI+S G  + EMV  +I +   D + +  K +     P           
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

Query: 241 ----------------------------QALNKVKDPEVKAFIEKCIAQ-PRARPSASEL 271
                                          NK+K  + +  + K +   P  R S  + 
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

Query: 272 LKDPFFSELNDDDSEPSP 289
           L+ P+ +   D     +P
Sbjct: 309 LQHPYINVWYDPAEVEAP 326

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (265), Expect = 3e-27
 Identities = 66/334 (19%), Positives = 117/334 (35%), Gaps = 66/334 (19%)

Query: 19  GRYS--DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS------EDPVLVNRLHSEVQ 70
            RY     LG G    V+ A D      VA   VR           E  +L     ++  
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72

Query: 71  LLRTLKNKYIIVCYSVWLDDQHNTLNFITEVCTSGN---LRTYRKKHRHVSIKALKKWSK 127
              ++   +I+     +     N ++ +      G        + +HR + +  +K+ SK
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 128 QVLEGLEYLHTHEPCIIHRDLNCSNIFIN-----GNIGQVKIGDLGFAAIVGRSHAAHSI 182
           Q+L GL+Y+H     IIH D+   N+ +       N+ Q+KI DLG A      +   + 
Sbjct: 133 QLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNS 189

Query: 183 IGTPEYMAPE-LYEEDYTEMVDIYSFGLCLLEMVTMEIPYS---------ECDSVAKIYK 232
           I T EY +PE L    +    DI+S    + E++T +  +          + D +A+I +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 233 KV------------------------------------TGGVKPQALNKVKDPEVKAFIE 256
            +                                        +    +K +  E+  F+ 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 257 KCIA-QPRARPSASELLKDPFFSELNDDDSEPSP 289
             +   PR R  A  L+  P+  +    +    P
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 343

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 63.6 bits (154), Expect = 7e-13
 Identities = 30/192 (15%), Positives = 62/192 (32%), Gaps = 7/192 (3%)

Query: 23  DLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR-TLKNKYII 81
            L+G G    V+  +  E+  E      ++ H S   V   R + ++      +++    
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 82  VCYSVWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEP 141
                 L        +  E           K+   V ++   +    +LE +   +    
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR-- 122

Query: 142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEM 201
            I+H DL+  N+ ++     + I D   +  VG       +      +    +   Y   
Sbjct: 123 GIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEEGWREILERDVRNII-TYFSRTYRTE 179

Query: 202 VDIYSFGLCLLE 213
            DI S    +L+
Sbjct: 180 KDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	289
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.23
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.18
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.46
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.77
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.4

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-63  Score=414.39  Aligned_cols=265  Identities=45%  Similarity=0.848  Sum_probs=236.6

Q ss_pred             eeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           11 EVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        11 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ....++||+++.++||+|+||+||+|.++.++..||+|++.....  .....+.+.+|++++++++||||+++++++...
T Consensus         3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   80 (270)
T d1t4ha_           3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   80 (270)
T ss_dssp             EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence            346788999999999999999999999999999999999987654  455677899999999999999999999988652


Q ss_pred             --CCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           91 --QHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        91 --~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                        ....+++||||+++++|.+++.+...+++..+..++.|++.||.|||+++++++||||||+|||++...+.+||+|||
T Consensus        81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          81 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             cccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence              345789999999999999999988899999999999999999999999987799999999999997543899999999


Q ss_pred             CccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          169 FAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ++...... .....+||+.|+|||.+.+.+++++|||||||++|+|++|+.||.+..........+..+..+...+...+
T Consensus       161 la~~~~~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (270)
T d1t4ha_         161 LATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  239 (270)
T ss_dssp             GGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             cceeccCC-ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence            99765433 33456899999999999888999999999999999999999999987888888888888777766777789


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      +++++|+.+||+ ||++|||++|+|+||||+
T Consensus       240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999998 999999999999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=401.28  Aligned_cols=257  Identities=28%  Similarity=0.498  Sum_probs=225.3

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ++.++| ++.++||+|+||+||+|.++.+|+.||+|++.......    .+.+.+|++++++++||||+++++++.+.  
T Consensus        17 dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~--   89 (293)
T d1yhwa1          17 DPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVG--   89 (293)
T ss_dssp             CTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred             Cccccc-EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH----HHHHHHHHHHHHhCCCCCEeeEeEEEEEC--
Confidence            466676 67999999999999999999999999999998654322    46788999999999999999999998665  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      +.+|+||||++|++|.+++.+ ..+++.++..++.|++.||.|||++|  ++||||||+|||++.+ +.+||+|||++..
T Consensus        90 ~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~vkl~DFG~a~~  165 (293)
T d1yhwa1          90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQ  165 (293)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred             CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC-CcEeeccchhhee
Confidence            579999999999999998876 46999999999999999999999999  9999999999999988 8999999999987


Q ss_pred             cCCc-cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          173 VGRS-HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      .... ......+||+.|+|||.+.+. +++++|||||||++|+|++|..||.+....................+...++.
T Consensus       166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  245 (293)
T d1yhwa1         166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI  245 (293)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHH
T ss_pred             eccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHH
Confidence            6543 344566799999999977655 89999999999999999999999998777777766666655555555667999


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      +++||.+||+ ||++|||++|+|+||||+..
T Consensus       246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999998 99999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-61  Score=401.33  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=216.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +.| ++.++||+|+||+||+|.++.+|+.||+|++.....   ....+.+.+|++++++++||||+++++++.+.  +.+
T Consensus         5 ~dy-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~   78 (271)
T d1nvra_           5 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ   78 (271)
T ss_dssp             TEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred             cce-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--cee
Confidence            455 789999999999999999999999999999986542   23346788999999999999999999998665  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |+||||++|++|.+++.....+++..+..++.|++.||.|||++|  ++||||||+||+++.+ +.+||+|||++.....
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY  155 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC-CCEEEccchhheeecc
Confidence            999999999999999988888999999999999999999999999  9999999999999988 8999999999987643


Q ss_pred             c---cccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          176 S---HAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       176 ~---~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      .   ......+||+.|+|||.+.+.  ++.++|||||||++|+|++|+.||..........................+++
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA  235 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHH
Confidence            2   223456799999999987654  45789999999999999999999987655544444444444444444557899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +.+|+.+||+ ||++|||++|+|+||||++
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            9999999998 9999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=394.30  Aligned_cols=252  Identities=22%  Similarity=0.411  Sum_probs=217.9

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .| ++.+.||+|+||+||+|.++.+|+.||+|++...... +....+.+.+|+++++.++||||+++++++.+.  +.++
T Consensus         7 dy-~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~   82 (263)
T d2j4za1           7 DF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVY   82 (263)
T ss_dssp             GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred             He-EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEE
Confidence            45 6899999999999999999999999999999754331 122356788999999999999999999998654  6799


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      +||||+++++|.+++.+.+.+++..+..++.|++.||.|||++|  ++||||||+||+++.+ +.+||+|||++......
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCC
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC-CCEeecccceeeecCCC
Confidence            99999999999999998889999999999999999999999999  9999999999999998 89999999999876543


Q ss_pred             cccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFI  255 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  255 (289)
                       ......||+.|+|||++.+. +++++|||||||++|+|++|+.||.+..... ....+.+...  ..+...++++++|+
T Consensus       160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~--~~p~~~s~~~~~li  235 (263)
T d2j4za1         160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEF--TFPDFVTEGARDLI  235 (263)
T ss_dssp             -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCC--CCCTTSCHHHHHHH
T ss_pred             -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC--CCCccCCHHHHHHH
Confidence             23456799999999987765 8999999999999999999999998755444 4444444332  24456799999999


Q ss_pred             HHHHc-CCCCCCCHHHHhcCccccc
Q 022956          256 EKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       256 ~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      .+||+ ||++|||++|+|+||||++
T Consensus       236 ~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         236 SRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHcCcCcCC
Confidence            99999 9999999999999999974

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-60  Score=399.14  Aligned_cols=260  Identities=28%  Similarity=0.475  Sum_probs=224.8

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ..+++.+.| ++.++||+|+||+||+|.++.+|..||+|+++...    ....+.+.+|++++++++||||+++++++.+
T Consensus         6 r~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   80 (288)
T d2jfla1           6 RDLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYY   80 (288)
T ss_dssp             ESSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCCCcccCe-EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            346677776 78999999999999999999999999999997643    2335678899999999999999999999866


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      +  +.+++||||++|++|.+++.+ .+.+++.++..++.|++.||.|||++|  ++||||||+||+++.+ +.+||+|||
T Consensus        81 ~--~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFG  155 (288)
T d2jfla1          81 E--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFG  155 (288)
T ss_dssp             T--TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCT
T ss_pred             C--CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC-CCEEEEech
Confidence            5  679999999999999999765 567999999999999999999999999  9999999999999998 899999999


Q ss_pred             CccccCCc-cccccCCCCCCCCCCcccc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC
Q 022956          169 FAAIVGRS-HAAHSIIGTPEYMAPELYE------EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ  241 (289)
Q Consensus       169 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  241 (289)
                      ++...... .......||+.|+|||++.      ..++.++|||||||++|+|++|+.||.+...............+..
T Consensus       156 ~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~  235 (288)
T d2jfla1         156 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL  235 (288)
T ss_dssp             TCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC
T ss_pred             hhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99765432 2234567999999999763      3378999999999999999999999998777776666666655544


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      ..+...++++++||.+||+ ||++|||++|+|+||||+.
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            4556679999999999998 9999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-60  Score=396.44  Aligned_cols=256  Identities=24%  Similarity=0.399  Sum_probs=217.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||+||+|.++.+|+.||||++...... .+...+.+.+|++++++++||||+++++++.+.  +.+|+|
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~iv   86 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFG   86 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEEE
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEEE
Confidence            47899999999999999999999999999999864321 122356789999999999999999999988554  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-  177 (289)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||++|  ++||||||+||+++.+ +.+||+|||++....... 
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC-ceEEecccccceecccCCc
Confidence            999999999999999899999999999999999999999999  9999999999999998 899999999998765332 


Q ss_pred             --ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          178 --AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       178 --~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                        .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+...............   ..+...++.+++|
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~l  240 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---DFPEKFFPKARDL  240 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---CCCTTCCHHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC---CCCccCCHHHHHH
Confidence              23456799999999987655 89999999999999999999999987655544444443322   2345679999999


Q ss_pred             HHHHHc-CCCCCCCHHH------HhcCcccccCCCC
Q 022956          255 IEKCIA-QPRARPSASE------LLKDPFFSELNDD  283 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~------il~h~~~~~~~~~  283 (289)
                      |.+||+ ||++|||++|      +++||||++++|+
T Consensus       241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence            999998 9999999988      5889999999876

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=396.61  Aligned_cols=270  Identities=20%  Similarity=0.343  Sum_probs=226.0

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhCCCCceEEeeeeE
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED--PVLVNRLHSEVQLLRTLKNKYIIVCYSVW   87 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   87 (289)
                      ...+..++| ++.+.||+|+||+||+|.++.+|+.||+|+++.......  ....+.+.+|++++++++||||+++++++
T Consensus         4 ~~~~i~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_           4 RQENVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             BCSCGGGTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCCcccCE-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            344555665 789999999999999999999999999999987654322  22467889999999999999999999998


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCC---CcEEE
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNI---GQVKI  164 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~---~~~~l  164 (289)
                      .+.  +.+|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+.   ..+|+
T Consensus        83 ~~~--~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          83 ENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             ECS--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEC--CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEe
Confidence            554  689999999999999999998889999999999999999999999999  99999999999997661   25999


Q ss_pred             eccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CC
Q 022956          165 GDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QA  242 (289)
Q Consensus       165 ~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~  242 (289)
                      +|||++.............+++.|+|||.+.+. ++.++|||||||++|+|++|+.||.+................. ..
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE  238 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            999999888766666677899999999987755 8999999999999999999999998865555544444433222 22


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                      .....++.+++||.+||+ ||++|||++|+|+||||+..++..
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence            234568899999999999 999999999999999999876654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-59  Score=395.17  Aligned_cols=260  Identities=20%  Similarity=0.339  Sum_probs=204.2

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ..++| ++.+.||+|+||+||+|.++.+|+.||+|++......   .....+.+|++++++++||||+++++++.+.  +
T Consensus         7 i~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~   80 (307)
T d1a06a_           7 IRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESG--G   80 (307)
T ss_dssp             GGGTE-EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred             Cccce-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence            34455 7899999999999999999999999999999865432   2245688999999999999999999988544  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC--CCCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING--NIGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~--~~~~~~l~d~g~~~  171 (289)
                      .+|+||||++|++|.+++...+.+++.++..++.|++.||.|||++|  ++|+||||+||++..  +.+.+||+|||++.
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeE
Confidence            89999999999999999998889999999999999999999999999  999999999999953  23799999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCCh
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  249 (289)
                      ...........+||+.|+|||.+.+. +++++|||||||++|+|++|..||.+................. .......++
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  238 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD  238 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence            77666556667899999999987655 8999999999999999999999998866555544444443322 223445789


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      .+++|+.+||+ ||++|||++|+++||||++..
T Consensus       239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            99999999998 999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-59  Score=396.09  Aligned_cols=260  Identities=26%  Similarity=0.443  Sum_probs=224.9

Q ss_pred             eeeCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           10 VEVDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        10 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      ...++..+| +..++||+|+||+||+|.++.+|+.||||++...... .....+.+.+|++++++++||||+++++++.+
T Consensus         9 ~~~dp~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_           9 FKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             CCSCHHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cccCcHHhc-EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            344566666 5789999999999999999999999999999865432 34556789999999999999999999999866


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                      .  +.+|+||||+.+++|..++...+++++.++..++.|++.||.|||++|  ++||||||+|||++.+ +.+||+|||+
T Consensus        87 ~--~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~~Kl~DFG~  161 (309)
T d1u5ra_          87 E--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGS  161 (309)
T ss_dssp             T--TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTT
T ss_pred             C--CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC-CCEEEeeccc
Confidence            5  679999999999999888888889999999999999999999999999  9999999999999998 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYE----EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      +......   ....||+.|+|||++.    +.++.++|||||||++|+|++|..||.+...............+ .....
T Consensus       162 a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~  237 (309)
T d1u5ra_         162 ASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-ALQSG  237 (309)
T ss_dssp             CBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCT
T ss_pred             ccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-CCCCC
Confidence            9866443   3467999999999764    34889999999999999999999999887766666665555433 33455


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ..++.+++||.+||+ ||++|||++|+|+||||.+-
T Consensus       238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            678999999999999 99999999999999999763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-59  Score=388.73  Aligned_cols=253  Identities=26%  Similarity=0.466  Sum_probs=205.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.+.||+|+||+||+|.++.+|+.||+|++.....  .+...+.+.+|++++++++||||+++++++.+..++.+|+||
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            689999999999999999999999999999987654  455677899999999999999999999998876667899999


Q ss_pred             ccccCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhcCCC---CceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956          100 EVCTSGNLRTYRKK----HRHVSIKALKKWSKQVLEGLEYLHTHEP---CIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus       100 e~~~~~sL~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~~---~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ||++|++|.+++.+    ...+++..+..++.|++.||.|||++|.   +++||||||+||+++.+ +.+||+|||++..
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a~~  163 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARI  163 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHHHH
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccceee
Confidence            99999999999864    4679999999999999999999998642   39999999999999998 8999999999987


Q ss_pred             cCCcc-ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChH
Q 022956          173 VGRSH-AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
                      ..... ......||+.|+|||.+.+. +++++|||||||++|+|+||+.||.+....+.. ..+..+..+ ..+...+++
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~-~~i~~~~~~-~~~~~~s~~  241 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFR-RIPYRYSDE  241 (269)
T ss_dssp             C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHTCCC-CCCTTSCHH
T ss_pred             cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH-HHHHcCCCC-CCCcccCHH
Confidence            65432 34456789999999987654 899999999999999999999999875554444 344333222 345567899


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCccc
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFF  277 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~  277 (289)
                      +++|+.+||+ ||++|||++|+|+|||+
T Consensus       242 l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999998 99999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-59  Score=399.33  Aligned_cols=260  Identities=28%  Similarity=0.493  Sum_probs=216.9

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.++||+|+||+||+|.++.+|+.||+|+++...   .+.....+.+|++++++++||||+++++++.+.  +.
T Consensus         5 ~d~y-~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~   78 (322)
T d1s9ja_           5 DDDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GE   78 (322)
T ss_dssp             GGGE-EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SE
T ss_pred             ccCC-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence            3455 67899999999999999999999999999997643   344467889999999999999999999998654  57


Q ss_pred             eEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      +++||||++|++|.+++.+.+.+++..+..++.|++.||.|||+ +|  ++||||||+|||++.+ +.+||+|||+|...
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~  155 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHH
T ss_pred             EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC-CCEEEeeCCCcccc
Confidence            99999999999999999988899999999999999999999997 59  9999999999999998 89999999999866


Q ss_pred             CCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-----------------------
Q 022956          174 GRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAK-----------------------  229 (289)
Q Consensus       174 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~-----------------------  229 (289)
                      ... .....+||+.|+|||.+.+. +++++|||||||++|+|++|+.||.+......                       
T Consensus       156 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         156 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             CCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            433 23456899999999977654 99999999999999999999999976432211                       


Q ss_pred             ------------------HHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          230 ------------------IYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       230 ------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                                        ....+....++.......++++.+|+.+||+ ||++|||++|+|+||||++.++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~  308 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  308 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccc
Confidence                              1112222222333334457899999999999 999999999999999999876544

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-58  Score=397.86  Aligned_cols=263  Identities=21%  Similarity=0.324  Sum_probs=225.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .++| ++.++||+|+||+||+|.++.+|+.||+|++...    .......+.+|++++++++||||+++++++.+.  +.
T Consensus        28 ~d~Y-~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~  100 (352)
T d1koba_          28 YDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YE  100 (352)
T ss_dssp             GGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SE
T ss_pred             ccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence            3444 7899999999999999999999999999999754    233456788999999999999999999988544  68


Q ss_pred             eEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC-CCCcEEEeccCCccc
Q 022956           95 LNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING-NIGQVKIGDLGFAAI  172 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~-~~~~~~l~d~g~~~~  172 (289)
                      +|+||||++|++|.+++... .++++.++..++.|++.||.|||++|  ++||||||+|||++. +.+.+||+|||++..
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeeccccee
Confidence            99999999999999887654 47999999999999999999999999  999999999999973 238999999999998


Q ss_pred             cCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-CCCCCCCCChH
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-PQALNKVKDPE  250 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  250 (289)
                      ...........+++.|+|||++.+. ++.++|||||||++|+|++|..||.+................ +.......+++
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  258 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  258 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             cCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            8766666667899999999987655 899999999999999999999999987666665555554433 33344567999


Q ss_pred             HHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          251 VKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       251 ~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                      +++||.+||+ ||++|||++|+|+||||++...+...
T Consensus       259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~~  295 (352)
T d1koba_         259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS  295 (352)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchhcc
Confidence            9999999999 99999999999999999876544433

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-58  Score=396.27  Aligned_cols=261  Identities=21%  Similarity=0.302  Sum_probs=224.4

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      .-++| ++.+.||+|+||+||+|.++.+|+.||+|++...    .....+.+.+|++++++++||||+++++++.+.  +
T Consensus        24 il~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~   96 (350)
T d1koaa2          24 VLDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--N   96 (350)
T ss_dssp             GGGTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--T
T ss_pred             CccCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence            34566 7899999999999999999999999999999754    344567889999999999999999999998654  6


Q ss_pred             eeEEEeccccCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-CCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-~~~~~l~d~g~~~  171 (289)
                      .+|+||||++|++|.+++. ..+.+++..+..++.||+.||.|||++|  ++||||||+||+++.+ .+.+||+|||++.
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            8999999999999999985 4567999999999999999999999999  9999999999999642 3789999999999


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCCh
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  249 (289)
                      ............||+.|+|||++.+. ++.++|||||||++|+|++|..||.+................. .......++
T Consensus       175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  254 (350)
T d1koaa2         175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE  254 (350)
T ss_dssp             ECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred             ecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            88776666677899999999987755 8899999999999999999999998766655555555443322 223345789


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      .+++||.+||+ ||++|||++|+|+||||+...+.
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            99999999999 99999999999999999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=390.27  Aligned_cols=256  Identities=23%  Similarity=0.434  Sum_probs=221.3

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .| ++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|++++++++||||+++++++.+.  +.+|
T Consensus         6 dy-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~   81 (337)
T d1o6la_           6 DF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC   81 (337)
T ss_dssp             GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred             hc-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccc
Confidence            34 68999999999999999999999999999998643211 12356788999999999999999999998554  6899


Q ss_pred             EEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC-
Q 022956           97 FITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR-  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~-  175 (289)
                      +||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|  ++||||||+||+++.+ |.+||+|||++..... 
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCT
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC-CCEEEeecccccccccC
Confidence            99999999999999999899999999999999999999999999  9999999999999999 9999999999987644 


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .......+||+.|+|||++.+. +++++|+|||||++|+|++|..||.+...............   ..+...++++++|
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dl  235 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSL  235 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHH
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC---CCCccCCHHHHHH
Confidence            3345567899999999987655 99999999999999999999999988665544444443332   2455679999999


Q ss_pred             HHHHHc-CCCCCCC-----HHHHhcCcccccCCC
Q 022956          255 IEKCIA-QPRARPS-----ASELLKDPFFSELND  282 (289)
Q Consensus       255 i~~~l~-dp~~Rps-----~~~il~h~~~~~~~~  282 (289)
                      |.+||+ ||.+|++     ++|+++||||++++|
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence            999998 9999994     899999999998765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.6e-57  Score=377.52  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=224.8

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-----HHHHHHHHHHHHHHHhCC-CCceEEeeeeEEe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-----PVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLD   89 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   89 (289)
                      .+| ++.+.||+|+||+||+|+++.+|+.||||+++.......     +...+.+.+|+.++++++ ||||+++++++.+
T Consensus         3 ~~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           3 ENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             ccC-EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            466 789999999999999999999999999999987654322     234557889999999997 9999999999854


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ++.+|+||||++|++|.+++...+++++.++..++.||+.||.|||++|  ++|+||||+||+++.+ +.+||+|||+
T Consensus        82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~  156 (277)
T d1phka_          82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGF  156 (277)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred             --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC-CCeEEccchh
Confidence              4689999999999999999998889999999999999999999999999  9999999999999988 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc-------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-C
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE-------DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-Q  241 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~  241 (289)
                      +.............||+.|+|||.+.+       .+++++||||+||++|+|++|+.||.+............+.... .
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            998876666666789999999997642       26789999999999999999999999877666665566554332 2


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ......|+++++|+.+||+ ||++|||++|+|+||||++.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            2333578999999999999 99999999999999999863

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-57  Score=387.14  Aligned_cols=254  Identities=24%  Similarity=0.420  Sum_probs=221.1

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      |++.+.||+|+||+||+|.++.+|+.||||+++..... .....+.+.+|+.++++++||||+++++++.+.  +.+|+|
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv   82 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMI   82 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEE
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--CeeeeE
Confidence            37899999999999999999999999999999754321 122356788999999999999999999998654  689999


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      |||+.|++|..++.....+++..+..++.|++.||.|||++|  ++||||||+||+++.+ |.+||+|||++......  
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSSC--
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC-CCEEEecCccceEeccc--
Confidence            999999999999999999999999999999999999999999  9999999999999998 89999999999877544  


Q ss_pred             cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHH
Q 022956          179 AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEK  257 (289)
Q Consensus       179 ~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  257 (289)
                      ....+||+.|+|||++.+. +++++|||||||++|+|++|+.||.+...............   ..+...++.+++++.+
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~  234 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---RFPPFFNEDVKDLLSR  234 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC---CCCCCCCHHHHHHHHH
Confidence            3356799999999987765 89999999999999999999999988665555555554432   2345678999999999


Q ss_pred             HHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          258 CIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       258 ~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      ||. ||.+|+     |++++++||||++++|+
T Consensus       235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence            998 999996     99999999999998654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-57  Score=391.49  Aligned_cols=259  Identities=23%  Similarity=0.406  Sum_probs=216.4

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC--CCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS--EDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      +.| ++.+.||+|+||+||+|.++.+|+.||+|++......  .......+..+++++++.++||||+++++++.+.  +
T Consensus         4 ddy-~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~   80 (364)
T d1omwa3           4 NDF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D   80 (364)
T ss_dssp             TTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred             HhC-eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--C
Confidence            345 7899999999999999999999999999999754321  1233333445567888888999999999988554  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      .+|+||||++|++|.+++.+...+++..+..++.|++.||.|||++|  ++||||||+|||++.+ |.+||+|||++...
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~-g~iKl~DFGla~~~  157 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDF  157 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-SCEEECCCTTCEEC
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCC-CcEEEeeeceeeec
Confidence            79999999999999999998889999999999999999999999999  9999999999999998 89999999999876


Q ss_pred             CCccccccCCCCCCCCCCcccc-cC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhCCCCCCCCCCCCCh
Q 022956          174 GRSHAAHSIIGTPEYMAPELYE-ED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSV--AKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       174 ~~~~~~~~~~~~~~~~aPE~~~-~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ... .....+||+.|+|||.+. +. +++++|||||||++|+|+||+.||.+....  ......  ........+...++
T Consensus       158 ~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~s~  234 (364)
T d1omwa3         158 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSP  234 (364)
T ss_dssp             SSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH--SSSCCCCCCSSSCH
T ss_pred             CCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cccCCCCCCCCCCH
Confidence            544 344567999999999765 43 899999999999999999999999764322  222222  22233344566799


Q ss_pred             HHHHHHHHHHc-CCCCCCC-----HHHHhcCcccccCCCC
Q 022956          250 EVKAFIEKCIA-QPRARPS-----ASELLKDPFFSELNDD  283 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps-----~~~il~h~~~~~~~~~  283 (289)
                      .+++||.+||+ ||++|||     ++|+++||||++++|.
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence            99999999998 9999999     7999999999998753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-57  Score=387.88  Aligned_cols=256  Identities=21%  Similarity=0.357  Sum_probs=221.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.++.+|+.||||++...... .....+.+.+|+++++.++||||+++++++...  ..+
T Consensus        41 d~y-~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~  116 (350)
T d1rdqe_          41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNL  116 (350)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             cCe-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeecccccccc--ccc
Confidence            466 6899999999999999999999999999999754321 122356788999999999999999999988554  678


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ++|+||+.|++|..++.+.+.+++..+..++.||+.||.|||++|  ++||||||+|||++.+ |.+||+|||++.....
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC-CCEEeeeceeeeeccc
Confidence            999999999999999998889999999999999999999999999  9999999999999998 8999999999987754


Q ss_pred             ccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          176 SHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       176 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .  .....||+.|+|||++.+. +++++|||||||++|+|++|..||.+................   .+...++.+.+|
T Consensus       194 ~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~l  268 (350)
T d1rdqe_         194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---FPSHFSSDLKDL  268 (350)
T ss_dssp             C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---CCTTCCHHHHHH
T ss_pred             c--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC---CCccCCHHHHHH
Confidence            3  3346799999999977655 899999999999999999999999886655555555444322   345678999999


Q ss_pred             HHHHHc-CCCCCC-----CHHHHhcCcccccCCCC
Q 022956          255 IEKCIA-QPRARP-----SASELLKDPFFSELNDD  283 (289)
Q Consensus       255 i~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~~  283 (289)
                      |.+||+ ||.+|+     |++++++||||++.+|.
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence            999998 999994     99999999999998763

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-57  Score=382.78  Aligned_cols=256  Identities=23%  Similarity=0.388  Sum_probs=215.1

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH-HhCCCCceEEeeeeEEeCCCCee
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLL-RTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      .| ++.++||+|+||+||+|.++.+|+.||||+++......... .+.+..|..++ +.++||||+++++++.+.  +.+
T Consensus         3 dy-~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~-~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~   78 (320)
T d1xjda_           3 DF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD-VECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENL   78 (320)
T ss_dssp             TE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTC-HHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEE
T ss_pred             Ce-EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHH-HHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Cce
Confidence            34 68999999999999999999999999999998643221222 34455555555 578999999999998554  689


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      |+||||++||+|.+++.....+++.++..++.|++.||.|||++|  ++|+||||+|||++.+ +.+||+|||++.....
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENML  155 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCC-Cceeccccchhhhccc
Confidence            999999999999999999889999999999999999999999999  9999999999999988 8999999999986653


Q ss_pred             c-cccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          176 S-HAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       176 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      . .......||+.|+|||++.+ .+++++|||||||++|+|++|+.||.+...............   ..+...++++++
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~d  232 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---FYPRWLEKEAKD  232 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHH
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCccCCHHHHH
Confidence            3 33444679999999997765 499999999999999999999999987655544444443322   234567999999


Q ss_pred             HHHHHHc-CCCCCCCHH-HHhcCcccccCCC
Q 022956          254 FIEKCIA-QPRARPSAS-ELLKDPFFSELND  282 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~-~il~h~~~~~~~~  282 (289)
                      ||.+||+ ||++||++. ++++||||++++|
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence            9999998 999999996 8999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=380.41  Aligned_cols=257  Identities=19%  Similarity=0.274  Sum_probs=219.7

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      .-+|| ++.+.||+|+||+||+|.++.+|+.||+|+++...     .....+.+|+++|++++||||+++++++.+.  +
T Consensus         3 ~~~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~   74 (321)
T d1tkia_           3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--E   74 (321)
T ss_dssp             CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--T
T ss_pred             Cccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence            34676 68999999999999999999999999999997542     2245688999999999999999999998654  6


Q ss_pred             eeEEEeccccCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC-CCcEEEeccCCcc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHR-HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN-IGQVKIGDLGFAA  171 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~-~~~~~l~d~g~~~  171 (289)
                      .+|+||||++|++|.+++...+ .+++.++..++.|++.||.|||++|  ++||||||+||+++.+ ...++|+|||++.
T Consensus        75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence            7999999999999999998654 7999999999999999999999999  9999999999999754 2589999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCCCCh
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKVKDP  249 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  249 (289)
                      ............+++.|+|||...+. +++++|||||||++|+|++|..||.+................. .......++
T Consensus       153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T d1tkia_         153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence            87666556667789999999977655 8999999999999999999999998866665555555443322 122234688


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+++||.+||. ||++|||++|+++||||++-
T Consensus       233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999998 99999999999999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-56  Score=376.99  Aligned_cols=258  Identities=25%  Similarity=0.356  Sum_probs=209.8

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeecccCCC-HHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEec
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSED-PVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  100 (289)
                      .++||+|+||+||+|.++.+|+.||||+++....... ....+.+.+|++++++++||||+++++++...  +.+++|||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivmE   80 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVFD   80 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehhh
Confidence            5789999999999999999999999999987654322 22345788999999999999999999998554  67999999


Q ss_pred             cccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc-cc
Q 022956          101 VCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH-AA  179 (289)
Q Consensus       101 ~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~-~~  179 (289)
                      |+.++++..+...+..+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++....... ..
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence            9999888888777788999999999999999999999999  9999999999999988 899999999998765443 33


Q ss_pred             ccCCCCCCCCCCcccc-c-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--CCCCCC-------------
Q 022956          180 HSIIGTPEYMAPELYE-E-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--GVKPQA-------------  242 (289)
Q Consensus       180 ~~~~~~~~~~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~-------------  242 (289)
                      ...++|+.|+|||.+. + .++.++|||||||++|+|++|..||.+....+........  ......             
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            4567899999999764 3 3789999999999999999999999887666555443321  110000             


Q ss_pred             ----------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCC
Q 022956          243 ----------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDD  284 (289)
Q Consensus       243 ----------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~  284 (289)
                                .....++.+.+|+.+||+ ||++|||++|+|+||||++...+.
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~  290 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  290 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence                      012357899999999999 999999999999999999876544

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=377.47  Aligned_cols=256  Identities=21%  Similarity=0.312  Sum_probs=207.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH-hCCCCceEEeeeeEEe--CC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLR-TLKNKYIIVCYSVWLD--DQ   91 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~--~~   91 (289)
                      .+.|..+.+.||+|+||+||+|.++.+|+.||||+++..         ..+.+|++++. ..+||||+++++++.+  ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            456743346799999999999999999999999999632         45667888865 4589999999998864  33


Q ss_pred             CCeeEEEeccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEecc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDL  167 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~  167 (289)
                      +..+|+|||||+||+|.+++.+.  ..+++.++..++.|++.||.|||++|  ++||||||+||+++.+  .+.+||+||
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccccc
Confidence            46799999999999999999864  46999999999999999999999999  9999999999999753  267999999


Q ss_pred             CCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-----CC
Q 022956          168 GFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-----PQ  241 (289)
Q Consensus       168 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~  241 (289)
                      |++............+|++.|+|||++.+. +++++|||||||++|+|+||+.||.+................     +.
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            999888776666777899999999988765 899999999999999999999999764432222211111111     11


Q ss_pred             CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          242 ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       242 ~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                      ......++++++||.+||+ ||++|||++|+++||||.+-.
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            1112358899999999998 999999999999999997643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=371.44  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=211.1

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCH--HHHHHHHHHHHHHHhCC--CCceEEeeeeEEeC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDP--VLVNRLHSEVQLLRTLK--NKYIIVCYSVWLDD   90 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~   90 (289)
                      .++| ++.++||+|+||+||+|.++.+|+.||||++......+..  ....++.+|+.++++++  ||||+++++++.+.
T Consensus         3 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           3 ESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             TTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCeE-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            5676 7899999999999999999999999999999865432211  11234667999999986  89999999988554


Q ss_pred             CCCeeEEEeccccC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           91 QHNTLNFITEVCTS-GNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        91 ~~~~~~lv~e~~~~-~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        +.+++|||++.+ +++.+++.+...+++.++..++.|++.||.|||++|  ++||||||+||+++.+.+.+||+|||+
T Consensus        82 --~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          82 --DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             --SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             --CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence              679999999976 588899988889999999999999999999999999  999999999999997657999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      +...... ......||+.|+|||.+.+.  ++.++|||||||++|+|++|+.||....      +.....   ...+...
T Consensus       158 a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~---~~~~~~~  227 (273)
T d1xwsa_         158 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ---VFFRQRV  227 (273)
T ss_dssp             CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC---CCCSSCC
T ss_pred             ceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc---cCCCCCC
Confidence            9866443 33456799999999977644  4667999999999999999999997521      122222   2344567


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                      ++++++||.+||+ ||++|||++|+++||||+++..
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence            9999999999998 9999999999999999998643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=366.27  Aligned_cols=261  Identities=25%  Similarity=0.397  Sum_probs=209.9

Q ss_pred             cccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           17 RFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        17 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      +| ++.++||+|+||+||+|.++.+|+.||+|+++....  .+...+.+.+|++++++++||||+++++.+.+.  +.+|
T Consensus         3 ~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~   77 (298)
T d1gz8a_           3 NF-QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLY   77 (298)
T ss_dssp             TE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred             CC-EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--ccee
Confidence            55 679999999999999999999999999999976543  233356788999999999999999999998654  6799


Q ss_pred             EEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           97 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +||||+.++++...... ...+++..+..++.|++.||.|||++|  ++||||||+||+++.+ +.+||+|||.+.....
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGV  154 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTHHHHHCC
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc-CcceeccCCcceeccC
Confidence            99999987444433333 467999999999999999999999999  9999999999999988 8999999999987654


Q ss_pred             c-cccccCCCCCCCCCCccccc-C-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC--CCC--------
Q 022956          176 S-HAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK--PQA--------  242 (289)
Q Consensus       176 ~-~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~--------  242 (289)
                      . .......+++.|+|||.+.. . .+.++|||||||++|+|++|+.||.+................  ...        
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            3 33445678999999996543 3 688999999999999999999999887666555444321110  000        


Q ss_pred             ----------------CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          243 ----------------LNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       243 ----------------~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                      .....++.+.+|+.+||+ ||++|||++|+|+||||+++..+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p  294 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP  294 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence                            011346789999999999 9999999999999999998866533

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=367.85  Aligned_cols=265  Identities=27%  Similarity=0.397  Sum_probs=212.2

Q ss_pred             CCcccceeeeecccCcceEEEEeecCC-CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh---CCCCceEEeeeeEEe-
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEE-GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRT---LKNKYIIVCYSVWLD-   89 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~---l~~~~i~~~~~~~~~-   89 (289)
                      +++| ++.++||+|+||+||+|.+..+ ++.||||+++.....+.  ....+.+|+.+++.   ++||||+++++++.. 
T Consensus         6 ~~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           6 DQQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCCE-EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            4566 7899999999999999999766 67799999987543221  12234455555554   489999999998854 


Q ss_pred             --CCCCeeEEEeccccCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEec
Q 022956           90 --DQHNTLNFITEVCTSGNLRTYRK-KHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGD  166 (289)
Q Consensus        90 --~~~~~~~lv~e~~~~~sL~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d  166 (289)
                        .....+++++|++.++++..... ....+++..+..++.|++.||.|||++|  ++||||||+|||++.+ +.+||+|
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~-~~~kl~d  159 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLAD  159 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECS
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC-CCeeecc
Confidence              23357899999999877655544 3467999999999999999999999999  9999999999999998 8999999


Q ss_pred             cCCccccCCccccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC------
Q 022956          167 LGFAAIVGRSHAAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK------  239 (289)
Q Consensus       167 ~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------  239 (289)
                      ||++.............||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+....+.....+.....      
T Consensus       160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            999987776666677889999999997654 4999999999999999999999999887665554443321100      


Q ss_pred             ------------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCC
Q 022956          240 ------------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDS  285 (289)
Q Consensus       240 ------------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~  285 (289)
                                        ........++.+++||.+||+ ||++|||++|+|+||||++++.-.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ke  304 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  304 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhCC
Confidence                              011233457899999999999 9999999999999999999976543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=361.19  Aligned_cols=253  Identities=21%  Similarity=0.354  Sum_probs=206.0

Q ss_pred             ccccee-eeecccCcceEEEEeec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCC
Q 022956           17 RFGRYS-DLLGSGAVKKVYRAFDQ--EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        17 ~~~~~~-~~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   93 (289)
                      ++..+. ++||+|+||+||+|.+.  .+++.||||+++....  ++...+.+.+|++++++++||||+++++++..   +
T Consensus         6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~   80 (277)
T d1xbba_           6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA---E   80 (277)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---S
T ss_pred             hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---C
Confidence            333444 47999999999999754  4568899999975432  45557789999999999999999999998733   3


Q ss_pred             eeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           94 TLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      ..++||||+++++|.+++.+..++++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+|++|||++...
T Consensus        81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~~~kl~DFGla~~~  157 (277)
T d1xbba_          81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKAL  157 (277)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred             CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc-Ccccccchhhhhhc
Confidence            47899999999999999999899999999999999999999999999  9999999999999998 89999999999866


Q ss_pred             CCccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          174 GRSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       174 ~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      .....    .....+++.|+|||.+.+. ++.++||||||+++|||+| |+.||.+.... .....+..+..+. .+...
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~~i~~~~~~~-~p~~~  235 (277)
T d1xbba_         158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGERMG-CPAGC  235 (277)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCC-CCTTC
T ss_pred             cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHHHHHcCCCCC-CCccc
Confidence            43322    2234688999999976544 8999999999999999998 89999885544 4555555554433 34567


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHh---cCccccc
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELL---KDPFFSE  279 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il---~h~~~~~  279 (289)
                      ++++.+|+.+||+ ||++|||+++|+   +|+|++-
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            8999999999998 999999999984   5666543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=360.96  Aligned_cols=247  Identities=27%  Similarity=0.461  Sum_probs=205.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++| ++.++||+|+||+||+|.++   ..||||+++....  +....+.+.+|++++++++||||++++++..   ...+
T Consensus         8 ~~~-~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~   78 (276)
T d1uwha_           8 GQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQL   78 (276)
T ss_dssp             TCC-CCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSC
T ss_pred             ccE-EEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe---ccEE
Confidence            444 68999999999999999754   3599999976544  3445788999999999999999999998752   2458


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||++....
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-SSEEECCCCCSCC--
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC-CCEEEccccceeecc
Confidence            9999999999999999754 56999999999999999999999999  9999999999999999 899999999997764


Q ss_pred             Cc---cccccCCCCCCCCCCccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC---CCC
Q 022956          175 RS---HAAHSIIGTPEYMAPELYEE----DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ---ALN  244 (289)
Q Consensus       175 ~~---~~~~~~~~~~~~~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~  244 (289)
                      ..   .......+|+.|+|||.+.+    .++.++|||||||++|+|+||+.||.+..........+..+....   ..+
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence            32   22344578999999997642    378899999999999999999999998777776666666554332   345


Q ss_pred             CCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          245 KVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       245 ~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ...++.+++|+.+||+ ||++|||++||+++
T Consensus       236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5678999999999998 99999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.8e-54  Score=360.15  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=214.9

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC--
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--   92 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   92 (289)
                      .++| ++.+.||+|+||+||+|.++.+|+.||+|+++.... .+......+.+|+++++.++||||+++++++.....  
T Consensus         6 ~drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             ccee-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            5676 789999999999999999999999999999976543 356667889999999999999999999998876432  


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..+|+||||++|++|.+++...+++++.++..++.|++.||.|||++|  ++|+||||+||+++.+ +.++++|||.+..
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~-~~~~l~d~~~~~~  160 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT-SCEEECCCTTCEE
T ss_pred             ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc-ccceeehhhhhhh
Confidence            458999999999999999998889999999999999999999999999  9999999999999999 8999999999876


Q ss_pred             cCCcc----ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC-CCCCCC
Q 022956          173 VGRSH----AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP-QALNKV  246 (289)
Q Consensus       173 ~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  246 (289)
                      .....    .....+||+.|+|||++.+. +++++|||||||++|+|+||+.||.+........+.+.....+ ......
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  240 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence            54322    23445789999999987755 8999999999999999999999999877777777777665443 334556


Q ss_pred             CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccc
Q 022956          247 KDPEVKAFIEKCIA-QPRARPSASELLKDPFFS  278 (289)
Q Consensus       247 ~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~  278 (289)
                      .|+++.+||.+||+ ||++||+..+.+.|+|.+
T Consensus       241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            78999999999998 999999554455566654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-54  Score=360.16  Aligned_cols=252  Identities=22%  Similarity=0.353  Sum_probs=214.0

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||+||+|.++.+|+.||||+++....     ..+.+.+|++++++++||||+++++++.+  ++.+++|
T Consensus        19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv   91 (287)
T d1opja_          19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII   91 (287)
T ss_dssp             EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred             eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----hHHHHHHHHHHHHhCCCCCEecCCccEee--CCeeEEE
Confidence            4789999999999999999999999999999875432     24678899999999999999999998854  3678999


Q ss_pred             eccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||++|  ++||||||+|||++.+ +.+||+|||++......
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC-CcEEEccccceeecCCC
Confidence            9999999999998753  57899999999999999999999999  9999999999999998 89999999999876543


Q ss_pred             cc--cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          177 HA--AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       177 ~~--~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      ..  .....+++.|+|||.+. +.+++++|||||||++|+|++|..||....+.....+.+..+..+. .+...++.+.+
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~  247 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEKVYE  247 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC-CCccchHHHHH
Confidence            22  22335788999999765 4599999999999999999998777766666777777777665443 34567899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          254 FIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                      |+.+||+ ||++|||+++|++  +|+.+...
T Consensus       248 li~~cl~~dP~~Rps~~ei~~--~L~~~~~~  276 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQ--AFETMFQE  276 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH--HHHHTTSS
T ss_pred             HHHHHcCCCHhHCcCHHHHHH--HHHHHHHh
Confidence            9999998 9999999999987  77666443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=367.24  Aligned_cols=263  Identities=25%  Similarity=0.395  Sum_probs=208.7

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ...+| ++.++||+|+||+||+|.++.+|+.||||+++....  ++...+.+.+|++++++++|||++++++++...+  
T Consensus        16 ~~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cCCcE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            45676 689999999999999999999999999999975432  5566788999999999999999999999886543  


Q ss_pred             --CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCC
Q 022956           92 --HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGF  169 (289)
Q Consensus        92 --~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~  169 (289)
                        ...+|+||||+ +.+|..+... .++++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+|++|||+
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~-~~~kl~Dfg~  167 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGL  167 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTT
T ss_pred             cccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccc-cccccccccc
Confidence              23579999999 5578777654 56999999999999999999999999  9999999999999999 8999999999


Q ss_pred             ccccCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCC----------
Q 022956          170 AAIVGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGG----------  237 (289)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------  237 (289)
                      +......  .....+++.|+|||.+.+  .++.++|||||||++|+|++|..||.+..............          
T Consensus       168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         168 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            9876543  334678999999997643  37899999999999999999999998765554433222110          


Q ss_pred             ------------------CCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          238 ------------------VKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       238 ------------------~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                                        ..........++.+.+||.+||. ||++|||++|+|+||||+++.....+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~  313 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE  313 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccc
Confidence                              01111234468899999999999 99999999999999999998655443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-53  Score=365.87  Aligned_cols=257  Identities=18%  Similarity=0.338  Sum_probs=213.5

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-CCceEEeeeeEEeCCC
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-NKYIIVCYSVWLDDQH   92 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   92 (289)
                      ..++| ++.++||+|+||+||+|.++.+|+.||+|+++...       .+++.+|++++++++ ||||+++++++.....
T Consensus        33 ~~d~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          33 NQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             CGGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CCcCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            34555 78999999999999999999999999999997432       467888999999995 9999999999876666


Q ss_pred             CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccc
Q 022956           93 NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAI  172 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~  172 (289)
                      ..+++||||+.+++|..+.   +.+++..+..++.|++.||.|||++|  ++|+||||+|||++.+.+.++|+|||++..
T Consensus       105 ~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             CceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeeccccccee
Confidence            7899999999999987653   46999999999999999999999999  999999999999997645799999999988


Q ss_pred             cCCccccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--------------
Q 022956          173 VGRSHAAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--------------  236 (289)
Q Consensus       173 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------------  236 (289)
                      ...........+|+.|+|||.+.+  .++.++|||||||++++|++|..||............+..              
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            776666667789999999997554  3789999999999999999999999765543322111100              


Q ss_pred             -CC--------------------CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCC
Q 022956          237 -GV--------------------KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDD  283 (289)
Q Consensus       237 -~~--------------------~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~  283 (289)
                       ..                    .........++++.+||++||+ ||++|||++|+|+||||+.+.|+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence             00                    0011123357889999999999 99999999999999999998774

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.5e-54  Score=361.43  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=208.5

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +|| ++.++||+|+||+||+|.++ +|+.||||++.....  .+...+.+.+|++++++++||||+++++.+...  +..
T Consensus         2 ~~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~   75 (286)
T d1ob3a_           2 EKY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL   75 (286)
T ss_dssp             CSE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred             CCc-eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--Cce
Confidence            466 68999999999999999985 889999999976543  233356788999999999999999999988655  578


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +++++++.++.+..+....+.+++..+..++.|++.||+|||+.|  ++|+||||+||+++.+ +.+|++|||.+.....
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGI  152 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC
T ss_pred             eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC-CCEEecccccceeccc
Confidence            999999999877887777888999999999999999999999999  9999999999999998 8999999999987654


Q ss_pred             cc-ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCC-------------
Q 022956          176 SH-AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVK-------------  239 (289)
Q Consensus       176 ~~-~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------------  239 (289)
                      .. ......+++.|+|||.+.+  .+++++|||||||++++|++|+.||.+....+...+.......             
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence            32 2344568899999997653  3789999999999999999999999876655544433221000             


Q ss_pred             -------------CCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          240 -------------PQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       240 -------------~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                                   ........++.+.+|+.+||+ ||++|||++|+|+||||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                         011123457899999999999 9999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-53  Score=357.60  Aligned_cols=247  Identities=18%  Similarity=0.314  Sum_probs=195.0

Q ss_pred             ccceeeeecccCcceEEEEeecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCe
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGI---EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNT   94 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   94 (289)
                      .+++.++||+|+||+||+|.++.+|.   .||||.+....   .....+.+.+|++++++++||||+++++++...  +.
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~  101 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TP  101 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CE
Confidence            45789999999999999999887765   47777775432   456677899999999999999999999988443  67


Q ss_pred             eEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcccc
Q 022956           95 LNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIV  173 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~  173 (289)
                      +++||||+++++|.+++.. .+.+++.++..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||++...
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC-CcEEECCcccceEc
Confidence            9999999999999998876 457999999999999999999999999  9999999999999998 89999999999876


Q ss_pred             CCccc------cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          174 GRSHA------AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       174 ~~~~~------~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      .....      .....+++.|+|||.+.+ .+++++|||||||++|||+| |..||.+..... ....+..+..+. .+.
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-~~~~i~~~~~~~-~~~  256 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-VINAIEQDYRLP-PPM  256 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCC-CCT
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCC-CCc
Confidence            43322      122356889999997664 48999999999999999998 899998765544 444444443332 344


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..++.+.+|+.+||+ ||++|||+.||+++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            578999999999998 99999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-53  Score=362.81  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=208.2

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC----CCCe
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----QHNT   94 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~   94 (289)
                      |+..++||+|+||+||+|+++.+|+.||||++.....        ...+|++++++++||||+++++++...    ...+
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            4678999999999999999999999999999976432        123689999999999999999988542    3356


Q ss_pred             eEEEeccccCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           95 LNFITEVCTSGNLRTYR---KKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        95 ~~lv~e~~~~~sL~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      +++||||++++.+..+.   .....+++.++..++.|++.||.|||++|  ++||||||+|||++.+...+||+|||++.
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence            89999999876433332   34567999999999999999999999999  99999999999999874589999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC--C----------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYE--EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG--G----------  237 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~----------  237 (289)
                      ............+++.|+|||.+.  ..++.++|||||||++|+|++|+.||......+.....+..  .          
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            877666666778999999999654  34899999999999999999999999876655554443321  0          


Q ss_pred             ------CCC--------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCC
Q 022956          238 ------VKP--------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELND  282 (289)
Q Consensus       238 ------~~~--------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~  282 (289)
                            ..+        .......++.+.+|+.+||+ ||++|||++|+|+||||+++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                  000        11223468899999999999 9999999999999999998744

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-53  Score=362.00  Aligned_cols=266  Identities=23%  Similarity=0.380  Sum_probs=211.0

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      -+.++|| ++.++||+|+||+||+|.++.+|+.||||++....   .....+.+.+|+.++++++|||++++++++....
T Consensus         4 ~~i~~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           4 FDVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CCCCTTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cCcCCCe-EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            3567787 78999999999999999999999999999997532   4556778899999999999999999999885532


Q ss_pred             C---CeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           92 H---NTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        92 ~---~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      .   ..++++ +++.+++|.+++... .+++..+..++.|++.||.|||++|  ++||||||+|||++.+ +.+||+|||
T Consensus        80 ~~~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~-~~~kl~DfG  154 (345)
T d1pmea_          80 IEQMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFG  154 (345)
T ss_dssp             TTTCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred             ccccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCC-CCEEEcccC
Confidence            1   234555 556688999999764 6999999999999999999999999  9999999999999988 899999999


Q ss_pred             CccccCCccc----cccCCCCCCCCCCccccc-C-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCC--
Q 022956          169 FAAIVGRSHA----AHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKP--  240 (289)
Q Consensus       169 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--  240 (289)
                      ++........    ....++++.|+|||.+.. . ++.++||||+||++++|++|..||.+................+  
T Consensus       155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~  234 (345)
T d1pmea_         155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  234 (345)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence            9986643322    344568999999997643 3 7889999999999999999999998765444333322110000  


Q ss_pred             --------------------------CCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCC
Q 022956          241 --------------------------QALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSE  286 (289)
Q Consensus       241 --------------------------~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~  286 (289)
                                                .......++.+.+|+.+||+ ||++|||++|+|+||||+.......+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~  307 (345)
T d1pmea_         235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE  307 (345)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred             hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC
Confidence                                      01122457789999999999 99999999999999999977554433

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=353.94  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=215.1

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +|| ++.++||+|+||+||+|+++.+|+.||||+++....  .+.....+.+|+.+++.++||||+++++.+...  ...
T Consensus         2 ~ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~   76 (292)
T d1unla_           2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL   76 (292)
T ss_dssp             CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred             CCC-EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cce
Confidence            355 789999999999999999999999999999976643  445577899999999999999999999988554  578


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +++++++.+++|..++...+.+++..+..++.|++.||+|||++|  ++|+||||+||+++.+ +.+||+|||.+.....
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred             eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC-CceeeeecchhhcccC
Confidence            999999999999999998899999999999999999999999999  9999999999999998 8999999999987765


Q ss_pred             ccc-cccCCCCCCCCCCcccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhC---CC-----------
Q 022956          176 SHA-AHSIIGTPEYMAPELYEED--YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTG---GV-----------  238 (289)
Q Consensus       176 ~~~-~~~~~~~~~~~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~-----------  238 (289)
                      ... .....+++.|.|||.+.+.  +++++|||||||++++|++|+.||....+.......+..   ..           
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            433 3334567788899966533  689999999999999999999997655544443333211   10           


Q ss_pred             -------------CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          239 -------------KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       239 -------------~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                                   .........++.+.+|+.+||+ ||++|||++|+|+||||++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                         1111223457889999999999 999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=354.35  Aligned_cols=249  Identities=22%  Similarity=0.378  Sum_probs=207.5

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEE
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNF   97 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   97 (289)
                      .+++.++||+|+||+||+|.++ ++..||||+++....  .   .+.+.+|++++++++||||+++++++.+   +.+++
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i   84 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--S---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI   84 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred             HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--C---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEE
Confidence            3478999999999999999975 678899999975432  2   4578999999999999999999997632   45789


Q ss_pred             EeccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           98 ITEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        98 v~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      ||||+++|+|.+++..  ..++++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++.....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc-cceeeccccceEEccC
Confidence            9999999999997754  346999999999999999999999999  9999999999999998 8999999999987754


Q ss_pred             cc--ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHH
Q 022956          176 SH--AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVK  252 (289)
Q Consensus       176 ~~--~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
                      ..  ......+++.|+|||.+.+ .++.++|||||||++|+|+||..|+............+..+..+. .+...++.+.
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~  240 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEELY  240 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHHH
Confidence            32  2334568899999997764 489999999999999999996555544455555666666654433 3456789999


Q ss_pred             HHHHHHHc-CCCCCCCHHHHhc--Cccccc
Q 022956          253 AFIEKCIA-QPRARPSASELLK--DPFFSE  279 (289)
Q Consensus       253 ~li~~~l~-dp~~Rps~~~il~--h~~~~~  279 (289)
                      +|+.+||+ ||++|||+++|++  |+||+.
T Consensus       241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            99999998 9999999999998  788864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=353.28  Aligned_cols=250  Identities=20%  Similarity=0.374  Sum_probs=207.0

Q ss_pred             ceee-eecccCcceEEEEeecC--CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeE
Q 022956           20 RYSD-LLGSGAVKKVYRAFDQE--EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        20 ~~~~-~lg~g~~g~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      .+.+ +||+|+||+||+|.++.  ++..||||+++...   .....+.+.+|++++++++||||+++++++..   +.++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~   84 (285)
T d1u59a_          11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM   84 (285)
T ss_dssp             EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred             EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEE
Confidence            3556 59999999999997654  45679999997542   45667889999999999999999999998743   3589


Q ss_pred             EEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCC
Q 022956           97 FITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGR  175 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~  175 (289)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++.....
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEECTT
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC-Cceeeccchhhhcccc
Confidence            99999999999999765 467999999999999999999999999  9999999999999998 8999999999987654


Q ss_pred             ccc----cccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          176 SHA----AHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       176 ~~~----~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ...    .....+++.|+|||.+.. .+++++|||||||++|||+| |..||.+....+ ....+..+..+. .+...++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-~~~~i~~~~~~~-~p~~~~~  239 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRME-CPPECPP  239 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHHHHHTTCCCC-CCTTCCH
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCC-CCCcCCH
Confidence            322    223467889999997764 48999999999999999998 899998866544 445555554433 3456789


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHH---hcCcccccC
Q 022956          250 EVKAFIEKCIA-QPRARPSASEL---LKDPFFSEL  280 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~i---l~h~~~~~~  280 (289)
                      ++.+|+..||+ ||++|||+.+|   |+|+|+.-.
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            99999999998 99999999888   567777533

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-53  Score=349.50  Aligned_cols=243  Identities=22%  Similarity=0.409  Sum_probs=194.5

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||+||+|.++ ++..||||+++....  .   .+.+.+|++++++++||||+++++++...  +.+++|
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv   78 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV   78 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC--c---HHHHHHHHHHHHhcCCCCcccccceeccC--CceEEE
Confidence            368999999999999999876 577899999875432  2   35688999999999999999999998544  578999


Q ss_pred             eccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCcc
Q 022956           99 TEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH  177 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~  177 (289)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++.......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC-CCeEecccchheeccCCC
Confidence            9999999999998754 56899999999999999999999999  9999999999999998 899999999998765432


Q ss_pred             c--cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          178 A--AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       178 ~--~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .  .....+++.|+|||.+.+. ++.++||||||+++|||+|+ ..||.. .........+..+..+. .+...++.+.+
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~l~~  233 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRLY-KPRLASTHVYQ  233 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCHHHHHHHHHHTCCCC-CCTTSCHHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-CCHHHHHHHHHhcCCCC-CccccCHHHHH
Confidence            2  2345688999999977654 99999999999999999995 555544 55555555555554332 34567899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhcC
Q 022956          254 FIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~h  274 (289)
                      |+..||+ ||++|||++||++|
T Consensus       234 li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         234 IMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHH
Confidence            9999998 99999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-53  Score=358.80  Aligned_cols=261  Identities=21%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             CCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC--
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ--   91 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   91 (289)
                      ..+|| ++.++||+|+||+||+|.++.+|+.||||++.....  .+.....+.+|++++++++|||++.+++.+....  
T Consensus         8 ~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           8 EVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             BGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccCCE-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            45787 689999999999999999999999999999876543  2333566788999999999999999998875421  


Q ss_pred             ----CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           92 ----HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        92 ----~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                          ...++++||++.++.+.........+++..+..++.|++.||.|||++|  ++||||||+||+++.+ +.+|++||
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~-~~~kl~df  161 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF  161 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCC
T ss_pred             ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC-CcEEeeec
Confidence                3468999999998777766666778999999999999999999999999  9999999999999999 89999999


Q ss_pred             CCccccCCcc-----ccccCCCCCCCCCCccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--HhCCC
Q 022956          168 GFAAIVGRSH-----AAHSIIGTPEYMAPELYEE--DYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKK--VTGGV  238 (289)
Q Consensus       168 g~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~--~~~~~  238 (289)
                      |++.......     .....++|+.|+|||.+.+  .+++++|||||||++++|++|+.||.+..........  .....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9997664322     2334578999999997643  4889999999999999999999999876555443322  22222


Q ss_pred             CCCCCCC---------------------------CCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          239 KPQALNK---------------------------VKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       239 ~~~~~~~---------------------------~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      .+.....                           ..++.+.+||.+||+ ||++|||++|+|.||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            2211111                           125678899999999 99999999999999999853

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=360.08  Aligned_cols=246  Identities=26%  Similarity=0.378  Sum_probs=204.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCc-----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCC
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGI-----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHN   93 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   93 (289)
                      ++.++||+|+||+||+|.+..+++     .||+|.+....   .......+.+|+.++.++ +||||+++++++.+.  +
T Consensus        40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~  114 (325)
T d1rjba_          40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS--G  114 (325)
T ss_dssp             EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred             EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--C
Confidence            688999999999999999876543     68999886543   233456788999999988 899999999988544  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-----------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNC  150 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-----------------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~  150 (289)
                      .+++||||+++|+|.+++.+.                       ..+++..+..++.|++.||.|||+++  ++||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp  192 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAA  192 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCch
Confidence            799999999999999999753                       24899999999999999999999999  99999999


Q ss_pred             CceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 022956          151 SNIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECD  225 (289)
Q Consensus       151 ~nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~  225 (289)
                      +||+++.+ +.+||+|||++........   .....+|+.|+|||.+. +.+++++|||||||++|+|+| |..||.+..
T Consensus       193 ~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         193 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99999999 8999999999976644322   22445789999999765 559999999999999999998 899998876


Q ss_pred             cHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          226 SVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ......+.+..+..+. .+...++.+++|+.+||+ ||++|||++||++|
T Consensus       272 ~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCC-CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6666677776665443 345678999999999998 99999999999985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=342.84  Aligned_cols=242  Identities=21%  Similarity=0.381  Sum_probs=206.3

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEEe
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFIT   99 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   99 (289)
                      ++.++||+|+||+||+|+++ ++..||||+++....  .   .+.+.+|++++++++||||+++++++.++  +.+++||
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~   78 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIIT   78 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--C---HHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEE
T ss_pred             EEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--C---HHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEE
Confidence            68999999999999999985 788999999986543  2   35688999999999999999999988543  6799999


Q ss_pred             ccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCccc
Q 022956          100 EVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSHA  178 (289)
Q Consensus       100 e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~~  178 (289)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||++|  ++|+||+|+||+++.+ +.+||+|||++........
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCC-CcEEECcchhheeccCCCc
Confidence            99999999998654 467999999999999999999999999  9999999999999988 8999999999976543322


Q ss_pred             --cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          179 --AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       179 --~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                        .....+++.|+|||.+. +.++.++||||||+++|||+| |+.||...... +....+..+..+ ..+...++.+.+|
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~-~~p~~~~~~l~~l  233 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLRL-YRPHLASEKVYTI  233 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-HHHHHHHhCCCC-CCcccccHHHHHH
Confidence              23356889999999766 448999999999999999998 89999886654 445555555433 3456778999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcC
Q 022956          255 IEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h  274 (289)
                      +.+||+ ||++|||+++|++|
T Consensus       234 i~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         234 MYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999998 99999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=346.68  Aligned_cols=250  Identities=21%  Similarity=0.342  Sum_probs=204.6

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.+.||+|+||+||+|.++.+ ..||||+++....  .   .+.+.+|+.++++++||||+++++++.+   +.+++|
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv   89 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV   89 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred             EEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--C---HHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEE
Confidence            47899999999999999998754 6799999975432  2   3678899999999999999999998732   347899


Q ss_pred             eccccCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKK--HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++|+|..++..  ...+++.++..++.|++.||.|||++|  ++|+||||+||+++.+ +.+||+|||++......
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC-CcEEEcccchhhhccCC
Confidence            999999999988754  457999999999999999999999999  9999999999999988 89999999999866433


Q ss_pred             c--ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHH
Q 022956          177 H--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKA  253 (289)
Q Consensus       177 ~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
                      .  ......+++.|+|||.+. +.+++++||||||+++|+|++|..|+............+..+.... .+...++++++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~  245 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHD  245 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHHHH
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHHHH
Confidence            2  223356889999999765 4599999999999999999997666655566666666666654443 45567899999


Q ss_pred             HHHHHHc-CCCCCCCHHHHhc--CcccccCC
Q 022956          254 FIEKCIA-QPRARPSASELLK--DPFFSELN  281 (289)
Q Consensus       254 li~~~l~-dp~~Rps~~~il~--h~~~~~~~  281 (289)
                      |+.+||+ ||++||++++|++  ++||+...
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            9999998 9999999999998  78887764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=359.12  Aligned_cols=264  Identities=25%  Similarity=0.391  Sum_probs=210.5

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC---C
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD---Q   91 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~   91 (289)
                      .+|| ++.++||+|+||+||+|.++.+|+.||||+++....  +....+.+.+|++++++++|||++++++++...   +
T Consensus        17 ~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            3566 789999999999999999999999999999976432  455567889999999999999999999987532   1


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ....+++++++.|++|.+++.. +++++..+..++.|++.||.|||++|  ++||||||+||+++.+ +.++++|||++.
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~-~~~kl~dfg~a~  169 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLAR  169 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCC----
T ss_pred             cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccc-ccccccccchhc
Confidence            2234455667778899999865 56999999999999999999999999  9999999999999999 899999999997


Q ss_pred             ccCCccccccCCCCCCCCCCccccc-C-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCC--------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEE-D-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQ--------  241 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  241 (289)
                      .....  .....+++.|+|||...+ . ++.++|||||||++|+|++|..||.+.+..............+.        
T Consensus       170 ~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            65433  334568899999996543 3 68899999999999999999999987655444433322211100        


Q ss_pred             --------------------CCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCCCCCCCC
Q 022956          242 --------------------ALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELNDDDSEP  287 (289)
Q Consensus       242 --------------------~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~~~~~~~  287 (289)
                                          ......++.+.+||.+||+ ||.+|||++|+|+||||++......++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~  314 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  314 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence                                0112468899999999999 999999999999999999987655554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=361.20  Aligned_cols=257  Identities=26%  Similarity=0.361  Sum_probs=199.0

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC----C
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD----Q   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~   91 (289)
                      ++| ++.++||+|+||+||+|.++.+|+.||||++.....  +.....++.+|+.++++++||||+++++++...    .
T Consensus        17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCe-EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            565 789999999999999999999999999999986543  456677899999999999999999999988643    3


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      ...+|+||||+.++++ +.+  ...+++..+..++.|++.||.|||+.|  ++|+||||+||+++.+ +.++++|||++.
T Consensus        94 ~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~-~~~kl~df~~~~  167 (355)
T d2b1pa1          94 FQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR  167 (355)
T ss_dssp             CCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC--
T ss_pred             CceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccc-cceeeechhhhh
Confidence            3689999999987544 443  345899999999999999999999999  9999999999999998 899999999998


Q ss_pred             ccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCC------------
Q 022956          172 IVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGV------------  238 (289)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------  238 (289)
                      ............+|+.|+|||.+.+. +++++||||+||++++|++|+.||.+.+........+....            
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            87776666677899999999976654 89999999999999999999999987654444333221110            


Q ss_pred             ----------CCCCC-----------------CCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccCC
Q 022956          239 ----------KPQAL-----------------NKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSELN  281 (289)
Q Consensus       239 ----------~~~~~-----------------~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~~  281 (289)
                                .....                 ....++.+.+|+.+||. ||++|||++|+|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                      00000                 00124578899999999 999999999999999999754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=359.15  Aligned_cols=259  Identities=23%  Similarity=0.386  Sum_probs=212.8

Q ss_pred             CcccceeeeecccCcceEEEEee---cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFD---QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~   91 (289)
                      ++| ++.++||+|+||+||+|.+   +.+|+.||+|+++.....++....+.+.+|++++++++| |||+++++.+.+. 
T Consensus        24 ~~y-~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          24 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hce-EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            344 7899999999999999986   457899999999765543333345678889999999977 8999999887554 


Q ss_pred             CCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                       ..+++++||+.+++|.+++...+.+++..+..++.|++.||.|||++|  ++|+||||+||+++.+ +.++|+|||++.
T Consensus       102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DFG~a~  177 (322)
T d1vzoa_         102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSK  177 (322)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred             -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC-CCEEEeeccchh
Confidence             679999999999999999999889999999999999999999999999  9999999999999998 899999999997


Q ss_pred             ccCCcc--ccccCCCCCCCCCCccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhCCCCCCCC
Q 022956          172 IVGRSH--AAHSIIGTPEYMAPELYEE---DYTEMVDIYSFGLCLLEMVTMEIPYSECD---SVAKIYKKVTGGVKPQAL  243 (289)
Q Consensus       172 ~~~~~~--~~~~~~~~~~~~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~  243 (289)
                      ......  ......+++.|++||.+.+   .++.++|||||||++|+|++|..||....   ..............  ..
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~  255 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PY  255 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CC
Confidence            664322  2345678999999996643   27889999999999999999999997542   23333333333222  23


Q ss_pred             CCCCChHHHHHHHHHHc-CCCCCC-----CHHHHhcCcccccCCC
Q 022956          244 NKVKDPEVKAFIEKCIA-QPRARP-----SASELLKDPFFSELND  282 (289)
Q Consensus       244 ~~~~~~~~~~li~~~l~-dp~~Rp-----s~~~il~h~~~~~~~~  282 (289)
                      +...++.+.+|+.+||. ||++||     +++|+++||||++++|
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence            44579999999999999 999999     5899999999998763

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=342.98  Aligned_cols=245  Identities=19%  Similarity=0.312  Sum_probs=199.1

Q ss_pred             ceeeeecccCcceEEEEeecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEG----IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      ++.++||+|+||+||+|.++.++    ..||||++....   .+.....+.+|++++++++||||+++++++...  +.+
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~~   84 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPM   84 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--Cce
Confidence            57899999999999999887654    469999986543   445566789999999999999999999988544  578


Q ss_pred             EEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++|+||+.++++.+.+... ..+++.++..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||++....
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC-CeEEEcccchhhccc
Confidence            9999999999999987654 67999999999999999999999999  9999999999999998 899999999998764


Q ss_pred             Ccc----ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCCh
Q 022956          175 RSH----AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQALNKVKDP  249 (289)
Q Consensus       175 ~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
                      ...    ......+++.|+|||.+.+. ++.++||||||+++|||+++..|+............+..+..+.. +...++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC-chhhHH
Confidence            322    12234578899999976654 999999999999999999976666555566666667766655443 345789


Q ss_pred             HHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          250 EVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       250 ~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .+.+|+.+||+ ||++|||+.+|++
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999998 9999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-51  Score=339.46  Aligned_cols=247  Identities=23%  Similarity=0.419  Sum_probs=194.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH   92 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   92 (289)
                      ++| ++.+.||+|+||.||+|.+..++   ..||+|.++..   ......+.+.+|++++++++||||+++++++.   .
T Consensus         7 ~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~   79 (273)
T d1mp8a_           7 ERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---E   79 (273)
T ss_dssp             GGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---S
T ss_pred             HHe-EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---c
Confidence            344 78999999999999999886553   45888887543   24566788999999999999999999999873   2


Q ss_pred             CeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956           93 NTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus        93 ~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      +.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++.
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~-~~~Kl~DfG~a~  156 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSR  156 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC-----
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC-CcEEEccchhhe
Confidence            468999999999999998765 457999999999999999999999999  9999999999999998 899999999998


Q ss_pred             ccCCcc--ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCC
Q 022956          172 IVGRSH--AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVK  247 (289)
Q Consensus       172 ~~~~~~--~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
                      ......  ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+......... +..+..+. .+...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-i~~~~~~~-~~~~~  234 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGERLP-MPPNC  234 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCC-CCTTC
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCC-CCCCC
Confidence            764332  233446788999999776 458999999999999999998 8999987655544444 44443332 35567


Q ss_pred             ChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          248 DPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       248 ~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ++.+.+||.+||+ ||++|||++||++|
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8999999999998 99999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-51  Score=345.44  Aligned_cols=247  Identities=26%  Similarity=0.431  Sum_probs=198.2

Q ss_pred             CcccceeeeecccCcceEEEEeecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEGI----EVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      +.| ++.++||+|+||+||+|.+..+|+    .||+|.++...   .....+.+.+|++++++++||||+++++++.+. 
T Consensus         9 ~dy-~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           9 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             HHC-EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            345 789999999999999999988876    57778776432   233367789999999999999999999988543 


Q ss_pred             CCeeEEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCc
Q 022956           92 HNTLNFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFA  170 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~  170 (289)
                        ..+++++++.+++|.+.+.. ...+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++
T Consensus        84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl~DFGla  158 (317)
T d1xkka_          84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLA  158 (317)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCCSHH
T ss_pred             --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC-CCeEeeccccc
Confidence              46778899999999888765 467999999999999999999999999  9999999999999999 89999999999


Q ss_pred             cccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCC
Q 022956          171 AIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNK  245 (289)
Q Consensus       171 ~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (289)
                      ........   .....+++.|+|||.+. +.++.++|||||||++|+|+| |..||.+..... ....+..+..+. .+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~~i~~~~~~~-~p~  236 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP-QPP  236 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHHHHHHTCCCC-CCT
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcCCCCC-CCc
Confidence            87654322   22345789999999765 448999999999999999998 789998754443 344444443332 345


Q ss_pred             CCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          246 VKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       246 ~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      ..++.+.+|+.+||+ ||++|||+.||++|
T Consensus       237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         237 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            578999999999998 99999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=342.91  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=197.0

Q ss_pred             CcccceeeeecccCcceEEEEeecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD   89 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   89 (289)
                      ++| ++.++||+|+||.||+|.+..     +++.||+|+++...   .....+.+.+|...+.++ +|+||+..++.+..
T Consensus        13 ~~y-~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          13 DRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHE-EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            344 789999999999999998654     45789999987543   344456677788877776 67899988887654


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNI  153 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~ni  153 (289)
                      + +..+++||||+++++|.+++...                ..+++.++..++.|++.||.|||+++  ++||||||+||
T Consensus        89 ~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NI  165 (299)
T d1ywna1          89 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI  165 (299)
T ss_dssp             T-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred             C-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccce
Confidence            3 35789999999999999999653                24889999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhC-CCCCCCCCcHH
Q 022956          154 FINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVA  228 (289)
Q Consensus       154 li~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~  228 (289)
                      +++.+ +.+||+|||++.......   ......||+.|+|||.+.+. ++.++|||||||++|+|+|| ..||.+.....
T Consensus       166 Ll~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         166 LLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99988 899999999997654322   23345689999999976654 89999999999999999996 56887766666


Q ss_pred             HHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          229 KIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .....+..+..+. .+...++.+.+|+.+||+ ||++|||++||++|
T Consensus       245 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6666666554443 355678999999999998 99999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=336.80  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=197.2

Q ss_pred             cceeeeecccCcceEEEEeecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCee
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEE---GIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTL   95 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   95 (289)
                      +++.+.||+|+||.||+|.+..+   +..||||+++..... .+...+.+.+|++++++++||||+++++++.+   ..+
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~~   85 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PPM   85 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cch
Confidence            47899999999999999976433   346899998765543 34556789999999999999999999998843   357


Q ss_pred             EEEeccccCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccC
Q 022956           96 NFITEVCTSGNLRTYRKK-HRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVG  174 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~  174 (289)
                      ++|+||++++++.+.+.. ...+++..+..++.|++.||.|||++|  ++||||||+||+++.+ +.+||+|||++....
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc-cceeeccchhhhhcc
Confidence            899999999999987765 457999999999999999999999999  9999999999999998 899999999998764


Q ss_pred             Cccc----cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCC
Q 022956          175 RSHA----AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKD  248 (289)
Q Consensus       175 ~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
                      ....    .....++..|+|||.+.+. ++.++||||||+++|||+| |..||.+.............+..+ ..+...+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~  241 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-PRPEDCP  241 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-CCCTTCC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-CCccccc
Confidence            4322    2233567899999977655 8889999999999999998 899998866666555555554433 3345678


Q ss_pred             hHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          249 PEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       249 ~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +.+++|+.+||+ ||++|||+++|++  +|++
T Consensus       242 ~~l~~li~~cl~~dp~~RPt~~ei~~--~L~~  271 (273)
T d1u46a_         242 QDIYNVMVQCWAHKPEDRPTFVALRD--FLLE  271 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHH--HHHh
Confidence            999999999998 9999999999976  6654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-50  Score=339.58  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=207.6

Q ss_pred             CCCcccceeeeecccCcceEEEEeec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEE
Q 022956           14 PSGRFGRYSDLLGSGAVKKVYRAFDQ-----EEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWL   88 (289)
Q Consensus        14 ~~~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   88 (289)
                      +-++| ++.+.||+|+||+||+|.++     .+++.||||+++...   .....+.+.+|++++++++|||++++++++.
T Consensus        11 p~~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHc-EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34555 68999999999999999865     356889999987432   4556778999999999999999999999885


Q ss_pred             eCCCCeeEEEeccccCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCce
Q 022956           89 DDQHNTLNFITEVCTSGNLRTYRKKH------------------------RHVSIKALKKWSKQVLEGLEYLHTHEPCII  144 (289)
Q Consensus        89 ~~~~~~~~lv~e~~~~~sL~~~~~~~------------------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~  144 (289)
                      ..  +..++++|++++++|.+++...                        ..+++..+..++.|++.||.|||+++  ++
T Consensus        87 ~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv  162 (301)
T d1lufa_          87 VG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV  162 (301)
T ss_dssp             SS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             cC--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence            43  6789999999999999998642                        24889999999999999999999999  99


Q ss_pred             ecCCCCCceEEeCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCccccc-CCCCcchHHHHHHHHHHHHhCC-C
Q 022956          145 HRDLNCSNIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYEE-DYTEMVDIYSFGLCLLEMVTME-I  219 (289)
Q Consensus       145 h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~Di~slG~il~~l~tg~-~  219 (289)
                      ||||||+||+++.+ +.+||+|||++.......   ......+++.|+|||.+.+ .+++++|||||||++|||++|. .
T Consensus       163 HrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         163 HRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             eeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            99999999999998 899999999997654332   2334567899999997665 4999999999999999999985 5


Q ss_pred             CCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          220 PYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       220 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                      ||.+.... +....+..+..+ ..+...++.+.+|+..||+ ||++|||+.||++  +++++
T Consensus       242 p~~~~~~~-e~~~~v~~~~~~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~i  299 (301)
T d1lufa_         242 PYYGMAHE-EVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM  299 (301)
T ss_dssp             TTTTSCHH-HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             CCCCCCHH-HHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHh
Confidence            67765444 444445554433 2355678999999999999 9999999999977  66543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=335.35  Aligned_cols=243  Identities=22%  Similarity=0.383  Sum_probs=195.9

Q ss_pred             cceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCCCeeEEE
Q 022956           19 GRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        19 ~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +++.++||+|+||.||+|.++  |..||||+++...      ..+.+.+|++++++++||||+++++++.++. +.+++|
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv   79 (262)
T d1byga_           9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV   79 (262)
T ss_dssp             EEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred             eEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEE
Confidence            368899999999999999885  7899999997432      2467889999999999999999999876543 458999


Q ss_pred             eccccCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccCCccccCCc
Q 022956           99 TEVCTSGNLRTYRKKH--RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLGFAAIVGRS  176 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~~~~~~  176 (289)
                      |||+++++|.+++.+.  ..+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++++|||++......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASST  156 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC-------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC-CCEeecccccceecCCC
Confidence            9999999999999754  35899999999999999999999999  9999999999999999 89999999999865443


Q ss_pred             cccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhCCCCCCCCCCCCChHHHHH
Q 022956          177 HAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDSVAKIYKKVTGGVKPQALNKVKDPEVKAF  254 (289)
Q Consensus       177 ~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (289)
                      .  ....+++.|+|||.+. +.+++++||||||+++|||+| |..||.... .......+..+..+.. +...++++++|
T Consensus       157 ~--~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-~~~~~~~i~~~~~~~~-~~~~~~~~~~l  232 (262)
T d1byga_         157 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDA-PDGCPPAVYEV  232 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGGHHHHHTTTCCCCC-CTTCCHHHHHH
T ss_pred             C--ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCCCC-CccCCHHHHHH
Confidence            2  2345788999999765 559999999999999999998 688887644 4444555555544443 45578999999


Q ss_pred             HHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          255 IEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       255 i~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      +.+||. ||.+|||+.++++  .+++
T Consensus       233 i~~cl~~dP~~Rps~~~l~~--~L~~  256 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLRE--QLEH  256 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHHcccCHhHCcCHHHHHH--HHHH
Confidence            999998 9999999999998  4443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=340.59  Aligned_cols=245  Identities=25%  Similarity=0.400  Sum_probs=201.2

Q ss_pred             ceeeeecccCcceEEEEeecCCCcE--EEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEeCCCCeeE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIE--VAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLDDQHNTLN   96 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~   96 (289)
                      ++.++||+|+||+||+|.++.+|..  ||||.++...   .....+.+.+|+++++++ +||||+++++++...  +.++
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~   87 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY   87 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--CeeE
Confidence            6789999999999999999988875  5666665332   233456789999999998 799999999998654  6799


Q ss_pred             EEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           97 FITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        97 lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                      +||||+++|+|.+++...                ..+++.++..++.|++.||.|||+++  ++||||||+|||++.+ +
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~-~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-Y  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-G
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC-C
Confidence            999999999999998643                56899999999999999999999999  9999999999999998 8


Q ss_pred             cEEEeccCCccccCCccccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHhCCC
Q 022956          161 QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTME-IPYSECDSVAKIYKKVTGGV  238 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~-~p~~~~~~~~~~~~~~~~~~  238 (289)
                      .+||+|||++.............++..|+|||.+.+. ++.++||||||+++|+|++|. .||.+ .+.......+..+.
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~~~~  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhcC
Confidence            9999999999877665555566789999999977644 899999999999999999965 56765 44455555555544


Q ss_pred             CCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          239 KPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       239 ~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .+. .+...++.+++||.+||+ ||++|||+++|+++
T Consensus       244 ~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         244 RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            333 345578999999999998 99999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-50  Score=338.07  Aligned_cols=254  Identities=21%  Similarity=0.321  Sum_probs=204.9

Q ss_pred             CCCCcccceeeeecccCcceEEEEeecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEe
Q 022956           13 DPSGRFGRYSDLLGSGAVKKVYRAFDQEEG---IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLD   89 (289)
Q Consensus        13 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   89 (289)
                      +......++.++||+|+||+||+|.+..++   ..||||.++..   .+....+++.+|++++++++||||+++++++..
T Consensus        23 ~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   99 (311)
T d1r0pa_          23 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   99 (311)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             ChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe
Confidence            333444456789999999999999876543   36899998643   256667889999999999999999999998765


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEeccC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIGDLG  168 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~d~g  168 (289)
                      .+ ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+  ++||||||+|||++.+ +.+||+|||
T Consensus       100 ~~-~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~-~~~kL~DFG  175 (311)
T d1r0pa_         100 SE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFG  175 (311)
T ss_dssp             TT-TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSSG
T ss_pred             cC-CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC-CCEEEeccc
Confidence            43 5789999999999999998854 45778899999999999999999999  9999999999999998 899999999


Q ss_pred             CccccCCccc-----cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhCCCCCCC
Q 022956          169 FAAIVGRSHA-----AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYKKVTGGVKPQA  242 (289)
Q Consensus       169 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  242 (289)
                      ++........     .....+++.|+|||.+. +.++.++||||||+++|||+||..||............+..+..+. 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-  254 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-  254 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-
T ss_pred             chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            9987643221     22346789999999765 4599999999999999999998878766555555555555554443 


Q ss_pred             CCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcC
Q 022956          243 LNKVKDPEVKAFIEKCIA-QPRARPSASELLKD  274 (289)
Q Consensus       243 ~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h  274 (289)
                      .+...++.+.+|+..||+ ||++||++.||++|
T Consensus       255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            345678999999999998 99999999999997

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=334.78  Aligned_cols=257  Identities=22%  Similarity=0.360  Sum_probs=210.4

Q ss_pred             CcccceeeeecccCcceEEEEeecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeC
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQE-----EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDD   90 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   90 (289)
                      ++| ++.++||+|+||+||+|.++.     ++..||||+++...   .......+.+|++++++++||||+++++++...
T Consensus        20 ~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          20 EKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             GGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             HHe-EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            444 689999999999999998753     46789999987432   455567799999999999999999999988443


Q ss_pred             CCCeeEEEeccccCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCC
Q 022956           91 QHNTLNFITEVCTSGNLRTYRKKH----------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIG  160 (289)
Q Consensus        91 ~~~~~~lv~e~~~~~sL~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~  160 (289)
                        ...++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++  ++||||||+|||++.+ +
T Consensus        96 --~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~-~  170 (308)
T d1p4oa_          96 --QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-F  170 (308)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-C
T ss_pred             --CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC-c
Confidence              5789999999999999987642          34688999999999999999999999  9999999999999998 8


Q ss_pred             cEEEeccCCccccCCccc---cccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHh
Q 022956          161 QVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTM-EIPYSECDSVAKIYKKVT  235 (289)
Q Consensus       161 ~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~~~~~  235 (289)
                      ++||+|||++........   .....+++.|+|||.+.+. ++.++||||||+++|+|+|| ..||.+...... ...+.
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~-~~~i~  249 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVM  249 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-HHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH-HHHHH
Confidence            999999999986643322   3334678999999976644 88899999999999999997 577877555444 44444


Q ss_pred             CCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc------CcccccCCCC
Q 022956          236 GGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK------DPFFSELNDD  283 (289)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~------h~~~~~~~~~  283 (289)
                      .+..+. .+...++.+.+|+.+||+ ||++|||+++|++      +|+|+++..-
T Consensus       250 ~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~~  303 (308)
T d1p4oa_         250 EGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY  303 (308)
T ss_dssp             TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred             hCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCCC
Confidence            443322 345578999999999998 9999999999998      7888776443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=332.99  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=201.7

Q ss_pred             CcccceeeeecccCcceEEEEeecCCC-------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeE
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFDQEEG-------IEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVW   87 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   87 (289)
                      ++| .+.+.||+|+||.||+|.+..++       ..||||+++...   .......+.+|...+.++ +||||+++++++
T Consensus        13 ~~~-~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          13 DRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGE-EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHe-EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            455 68899999999999999876554       479999997543   445567788898888888 799999999998


Q ss_pred             EeCCCCeeEEEeccccCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 022956           88 LDDQHNTLNFITEVCTSGNLRTYRKKH----------------RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS  151 (289)
Q Consensus        88 ~~~~~~~~~lv~e~~~~~sL~~~~~~~----------------~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~  151 (289)
                      .++  ..+++||||+++|+|.+++...                ..+++.++..++.|++.||+|||+++  ++||||||+
T Consensus        89 ~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~  164 (299)
T d1fgka_          89 TQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR  164 (299)
T ss_dssp             CSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             ccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccc
Confidence            543  6799999999999999999754                35899999999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccCCccccCCcc---ccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 022956          152 NIFINGNIGQVKIGDLGFAAIVGRSH---AAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDS  226 (289)
Q Consensus       152 nili~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~  226 (289)
                      |||++.+ +.+||+|||++.......   ......+++.|+|||.+. +.+++++||||||+++|+|++ |..||.+.. 
T Consensus       165 NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-  242 (299)
T d1fgka_         165 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-  242 (299)
T ss_dssp             GEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             ceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-
Confidence            9999999 899999999998764432   234456889999999765 459999999999999999998 788887644 


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          227 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                      .......+..+..+. .+...++.+.+|+.+||+ ||++|||+.||++
T Consensus       243 ~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         243 VEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            445556666654443 355678999999999998 9999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=331.76  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=208.6

Q ss_pred             CcccceeeeecccCcceEEEEee-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhC-CCCceEEeeeeEEe
Q 022956           16 GRFGRYSDLLGSGAVKKVYRAFD-----QEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTL-KNKYIIVCYSVWLD   89 (289)
Q Consensus        16 ~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   89 (289)
                      ++| ++.++||+|+||.||+|.+     ..+++.||||+++...   .......+.+|+.+++++ +||||+++++++.+
T Consensus        23 ~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          23 NRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHe-EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            344 6789999999999999975     3567899999997543   455567899999999999 69999999999844


Q ss_pred             CCCCeeEEEeccccCCcHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 022956           90 DQHNTLNFITEVCTSGNLRTYRKKHR------------------HVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCS  151 (289)
Q Consensus        90 ~~~~~~~lv~e~~~~~sL~~~~~~~~------------------~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~  151 (289)
                      .  ..+++||||+++++|.+++....                  .+++..+..++.|++.||.|||+++  ++||||||+
T Consensus        99 ~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~  174 (311)
T d1t46a_          99 G--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR  174 (311)
T ss_dssp             S--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             C--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence            3  57899999999999999987532                  5899999999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccCCccccCCccc---cccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 022956          152 NIFINGNIGQVKIGDLGFAAIVGRSHA---AHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVT-MEIPYSECDS  226 (289)
Q Consensus       152 nili~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~  226 (289)
                      ||+++.+ +.++++|||.+........   .....+++.|+|||.+. +.++.++||||||+++|+|+| |..||.+...
T Consensus       175 NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         175 NILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999998 8999999999987654322   23456799999999766 458999999999999999999 5666666555


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhcCccccc
Q 022956          227 VAKIYKKVTGGVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLKDPFFSE  279 (289)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~  279 (289)
                      .....+.+..+..+. .+...++.+.+||.+||+ ||++|||+++|++  .+++
T Consensus       254 ~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~--~L~~  304 (311)
T d1t46a_         254 DSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEK  304 (311)
T ss_dssp             SHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHHHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence            555666666555443 345578999999999998 9999999999997  5543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-49  Score=333.19  Aligned_cols=256  Identities=20%  Similarity=0.269  Sum_probs=197.7

Q ss_pred             eCCCCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCC
Q 022956           12 VDPSGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQ   91 (289)
Q Consensus        12 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   91 (289)
                      +..++|| ++.++||+|+||+||+|.++.+|+.||||++......      +.+..|+++++.++|++++..+..+... 
T Consensus         3 ~~vg~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-   74 (299)
T d1ckia_           3 LRVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-   74 (299)
T ss_dssp             CEETTTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-
T ss_pred             CeECCEE-EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEec-
Confidence            3456787 7899999999999999999999999999998764331      3467799999999988776666555443 


Q ss_pred             CCeeEEEeccccCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCC--CCcEEEeccC
Q 022956           92 HNTLNFITEVCTSGNLRTYR-KKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGN--IGQVKIGDLG  168 (289)
Q Consensus        92 ~~~~~lv~e~~~~~sL~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~--~~~~~l~d~g  168 (289)
                      +...++||||+.+ +|.+.+ ...+.+++..+..++.|++.||+|||++|  ++||||||+||+++..  ...++++|||
T Consensus        75 ~~~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          75 GDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             TTEEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             CCEEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccC
Confidence            3678999999966 555555 45678999999999999999999999999  9999999999998542  2579999999


Q ss_pred             CccccCCcc--------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHhC
Q 022956          169 FAAIVGRSH--------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDSVAKIYK---KVTG  236 (289)
Q Consensus       169 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~  236 (289)
                      ++.......        ......||+.|+|||.+.+. +++++|||||||++|+|++|..||...........   ....
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            998764332        22345789999999977655 89999999999999999999999986443322211   1110


Q ss_pred             --CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHH---HhcCcccc
Q 022956          237 --GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASE---LLKDPFFS  278 (289)
Q Consensus       237 --~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~---il~h~~~~  278 (289)
                        ..+........|+++.+++..||+ ||++||++++   +|+|+|.+
T Consensus       232 ~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence              112222344578999999999998 9999999874   56777654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=321.39  Aligned_cols=250  Identities=25%  Similarity=0.305  Sum_probs=190.9

Q ss_pred             ccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceEEeeeeEEeCCC--Cee
Q 022956           18 FGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYIIVCYSVWLDDQH--NTL   95 (289)
Q Consensus        18 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~   95 (289)
                      -+.+.+.||+|+||+||+|++  +|+.||||+++...     ......+.|+..+..++||||+++++++..+..  ..+
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            346889999999999999986  58999999986432     212223445666677899999999999876543  368


Q ss_pred             EEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhc--------CCCCceecCCCCCceEEeCCCCcEEEecc
Q 022956           96 NFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHT--------HEPCIIHRDLNCSNIFINGNIGQVKIGDL  167 (289)
Q Consensus        96 ~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~--------~~~~~~h~dl~~~nili~~~~~~~~l~d~  167 (289)
                      ++||||+++++|.+++.+. .+++..+..++.|++.||.|+|+        +|  ++|+||||+||+++.+ +.+||+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~-~~~Kl~DF  152 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTT-SCEEECCC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCC-CCeEEEec
Confidence            9999999999999999874 59999999999999999999997        47  9999999999999998 89999999


Q ss_pred             CCccccCCcc-----ccccCCCCCCCCCCcccccC-------CCCcchHHHHHHHHHHHHhCCCCCCC------------
Q 022956          168 GFAAIVGRSH-----AAHSIIGTPEYMAPELYEED-------YTEMVDIYSFGLCLLEMVTMEIPYSE------------  223 (289)
Q Consensus       168 g~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-------~~~~~Di~slG~il~~l~tg~~p~~~------------  223 (289)
                      |++.......     ......||+.|+|||.+.+.       ++.++|||||||++|+|+||..||..            
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            9998764432     23346789999999977643       46689999999999999999877642            


Q ss_pred             --CCcHHHHHHHHhCCCC-CCCCCCC----CChHHHHHHHHHHc-CCCCCCCHHHHhcCcccccC
Q 022956          224 --CDSVAKIYKKVTGGVK-PQALNKV----KDPEVKAFIEKCIA-QPRARPSASELLKDPFFSEL  280 (289)
Q Consensus       224 --~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~li~~~l~-dp~~Rps~~~il~h~~~~~~  280 (289)
                        ................ +......    ....+.+|+.+||+ ||++|||+.||++  .++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~--~L~~i  295 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK--TLSQL  295 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH--HHHHH
T ss_pred             cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH--HHHHH
Confidence              1122333333333222 2111111    12358899999998 9999999999988  44443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-46  Score=315.53  Aligned_cols=247  Identities=15%  Similarity=0.204  Sum_probs=196.3

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCCC
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHN   93 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~   93 (289)
                      +++| ++.++||+|+||+||+|.++.+|+.||+|++.....      ...+.+|++.++.+.| +|++.+++++...  .
T Consensus         4 g~~Y-~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~   74 (293)
T d1csna_           4 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L   74 (293)
T ss_dssp             TTTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred             CCce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC--C
Confidence            4666 799999999999999999999999999999865432      2346678889999976 8888888776443  6


Q ss_pred             eeEEEeccccCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeC----CCCcEEEeccC
Q 022956           94 TLNFITEVCTSGNLRTYRKKH-RHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFING----NIGQVKIGDLG  168 (289)
Q Consensus        94 ~~~lv~e~~~~~sL~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~----~~~~~~l~d~g  168 (289)
                      ..++|||++ +++|.+++... ..++...+..++.|++.||.|||++|  ++||||||+||+++.    ..+.++|+|||
T Consensus        75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence            789999999 56999988764 57999999999999999999999999  999999999999964    23689999999


Q ss_pred             CccccCCcc--------ccccCCCCCCCCCCcccccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHH-hC
Q 022956          169 FAAIVGRSH--------AAHSIIGTPEYMAPELYEED-YTEMVDIYSFGLCLLEMVTMEIPYSECDS--VAKIYKKV-TG  236 (289)
Q Consensus       169 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~--~~~~~~~~-~~  236 (289)
                      ++.......        ......||+.|+|||.+.+. +++++||||||+++|+|++|..||.+...  .......+ ..
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~  231 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  231 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence            998764321        23345799999999977655 99999999999999999999999975322  22211111 11


Q ss_pred             --CCCCCCCCCCCChHHHHHHHHHHc-CCCCCCCHHHHhc
Q 022956          237 --GVKPQALNKVKDPEVKAFIEKCIA-QPRARPSASELLK  273 (289)
Q Consensus       237 --~~~~~~~~~~~~~~~~~li~~~l~-dp~~Rps~~~il~  273 (289)
                        ...........|+++.+++..|++ +|++||+++.+.+
T Consensus       232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence              112222334568899999999998 9999999887765

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.9e-46  Score=320.39  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=197.6

Q ss_pred             CCcccceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCC-----------CCceEEe
Q 022956           15 SGRFGRYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLK-----------NKYIIVC   83 (289)
Q Consensus        15 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~   83 (289)
                      ++|| ++.++||+|+||+||+|+++.+|+.||||+++..     ....+.+.+|+++++.+.           |+||+++
T Consensus        12 ~~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          12 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCcE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            4566 7999999999999999999999999999999743     334566778888888775           4778888


Q ss_pred             eeeEEeCCCCeeEEEeccccCCcHHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCceEEeCCC
Q 022956           84 YSVWLDDQHNTLNFITEVCTSGNLRTY-R--KKHRHVSIKALKKWSKQVLEGLEYLHT-HEPCIIHRDLNCSNIFINGNI  159 (289)
Q Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~sL~~~-~--~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~~~~~h~dl~~~nili~~~~  159 (289)
                      ++++........++++.++........ .  .....+++..+..++.|++.||.|||+ .|  ++|+||||+||+++.+ 
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~-  162 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV-  162 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE-
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeecc-
Confidence            888765544566666666655433222 2  234678999999999999999999997 88  9999999999999765 


Q ss_pred             C------cEEEeccCCccccCCccccccCCCCCCCCCCcccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-----
Q 022956          160 G------QVKIGDLGFAAIVGRSHAAHSIIGTPEYMAPELYE-EDYTEMVDIYSFGLCLLEMVTMEIPYSECDSV-----  227 (289)
Q Consensus       160 ~------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~-----  227 (289)
                      +      .++++|||.+......  .....+++.|+|||.+. ..+++++|+|||||++++|++|+.||......     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcccccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence            3      4999999999765443  34567899999999665 44899999999999999999999999743211     


Q ss_pred             -HHHHHH--HhCCC-------------------CCCC------------------CCCCCChHHHHHHHHHHc-CCCCCC
Q 022956          228 -AKIYKK--VTGGV-------------------KPQA------------------LNKVKDPEVKAFIEKCIA-QPRARP  266 (289)
Q Consensus       228 -~~~~~~--~~~~~-------------------~~~~------------------~~~~~~~~~~~li~~~l~-dp~~Rp  266 (289)
                       ......  +.+..                   ....                  .....++.+.+||.+||+ ||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             111111  00000                   0000                  011124678999999999 999999


Q ss_pred             CHHHHhcCcccccCCCCCCCCCC
Q 022956          267 SASELLKDPFFSELNDDDSEPSP  289 (289)
Q Consensus       267 s~~~il~h~~~~~~~~~~~~~~~  289 (289)
                      |++|+|+||||++.....+...|
T Consensus       321 ta~e~L~Hp~f~~~~~~~~~~~p  343 (362)
T d1q8ya_         321 DAGGLVNHPWLKDTLGMEEIRVP  343 (362)
T ss_dssp             CHHHHHTCGGGTTCTTCTTCCCT
T ss_pred             CHHHHhcCcccCCCCCcccCCCC
Confidence            99999999999988666555544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.6e-25  Score=175.46  Aligned_cols=172  Identities=17%  Similarity=0.196  Sum_probs=122.4

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccC-----C---------CHHHHHHHHHHHHHHHhCCCCceEEeee
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFS-----E---------DPVLVNRLHSEVQLLRTLKNKYIIVCYS   85 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-----~---------~~~~~~~~~~e~~~l~~l~~~~i~~~~~   85 (289)
                      -+.++||+|+||+||+|.+. +|+.||||+++.....     .         ..........|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            36899999999999999874 7899999987643211     0         0112344667889999999999887775


Q ss_pred             eEEeCCCCeeEEEeccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceEEeCCCCcEEEe
Q 022956           86 VWLDDQHNTLNFITEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTHEPCIIHRDLNCSNIFINGNIGQVKIG  165 (289)
Q Consensus        86 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~~~~~h~dl~~~nili~~~~~~~~l~  165 (289)
                      ..  .    .+++||++++..+.+       ++...+..++.|++.++.+||++|  ++|+||||+||+++++  .++|+
T Consensus        82 ~~--~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~--~~~li  144 (191)
T d1zara2          82 WE--G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE--GIWII  144 (191)
T ss_dssp             EE--T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT--EEEEC
T ss_pred             ec--C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC--CEEEE
Confidence            42  2    368999999865433       555667889999999999999999  9999999999999965  59999


Q ss_pred             ccCCccccCCccccccCCCCCCCCCCcccccCCCCcchHHHHHHH
Q 022956          166 DLGFAAIVGRSHAAHSIIGTPEYMAPELYEEDYTEMVDIYSFGLC  210 (289)
Q Consensus       166 d~g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Di~slG~i  210 (289)
                      |||.+.....+....-....... ..+.+.+.++..+|+||+.--
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~~-~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVRN-IITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHHH-HHHHHHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHHH-HHHHHcCCCCCcccHHHHHHH
Confidence            99999766433221100000000 012233557889999996543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=7.5e-07  Score=71.09  Aligned_cols=138  Identities=16%  Similarity=0.097  Sum_probs=84.6

Q ss_pred             ceeeeecccCcceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCC-CceEEeeeeEEeCCCCeeEEE
Q 022956           20 RYSDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKN-KYIIVCYSVWLDDQHNTLNFI   98 (289)
Q Consensus        20 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv   98 (289)
                      +..+..+.++.+.||++.  .++..+++|.........    ...+.+|...++.+.. --+++++....  .++..++|
T Consensus        17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~~~lv   88 (263)
T d1j7la_          17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSNLL   88 (263)
T ss_dssp             EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEE
T ss_pred             EEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEe--cCCceEEE
Confidence            344544445557899984  457788899886543322    2345668888777742 22344554432  23577899


Q ss_pred             eccccCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 022956           99 TEVCTSGNLRTYRKKHRHVSIKALKKWSKQVLEGLEYLHTH---------------------------------------  139 (289)
Q Consensus        99 ~e~~~~~sL~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---------------------------------------  139 (289)
                      |++++|.++.+.....     .....++.++...+..||+.                                       
T Consensus        89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            9999998876543221     11222334444444445421                                       


Q ss_pred             ------------------CCCceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          140 ------------------EPCIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       140 ------------------~~~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                                        ...++|+|+.|.||+++++ +.+-|+||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~  212 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG  212 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhcc
Confidence                              1137899999999999976 556799997655

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.23  E-value=2.2e-06  Score=67.96  Aligned_cols=74  Identities=14%  Similarity=0.043  Sum_probs=46.0

Q ss_pred             eecccC-cceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCce--EEeeeeEEeCCCCeeEEEec
Q 022956           24 LLGSGA-VKKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYI--IVCYSVWLDDQHNTLNFITE  100 (289)
Q Consensus        24 ~lg~g~-~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~~~~~~lv~e  100 (289)
                      -+..|. .+.||++.. .++..+++|.......       ..+..|...++.+....+  ++++...  ...+..++||+
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-------~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~   86 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLG   86 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEE
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-------hHHHHHHHHHHHHHhcCCCCCceeeec--ccccceEEEEE
Confidence            344444 367899865 4567788898654332       235567777776654333  4445443  23356789999


Q ss_pred             cccCCcH
Q 022956          101 VCTSGNL  107 (289)
Q Consensus       101 ~~~~~sL  107 (289)
                      +++|.++
T Consensus        87 ~i~G~~~   93 (255)
T d1nd4a_          87 EVPGQDL   93 (255)
T ss_dssp             CCSSEET
T ss_pred             eeecccc
Confidence            9998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.18  E-value=4.6e-06  Score=70.61  Aligned_cols=81  Identities=17%  Similarity=0.220  Sum_probs=47.1

Q ss_pred             eeeecccCcceEEEEeecCCCcEEEEEEeeec-cc-CCC-HHHHHHHHHHHHHHHhCC-C-Cc-eEEeeeeEEeCCCCee
Q 022956           22 SDLLGSGAVKKVYRAFDQEEGIEVAWNQVRLS-HF-SED-PVLVNRLHSEVQLLRTLK-N-KY-IIVCYSVWLDDQHNTL   95 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~-~~-~~~-~~~~~~~~~e~~~l~~l~-~-~~-i~~~~~~~~~~~~~~~   95 (289)
                      .+.||.|..-.||++.+..+++.+++|.-... +. .+. +....+...|+..++.+. + |. +++++.+  +.  ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~--~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC--CCC
Confidence            45689999999999988777889999965421 00 000 111344556777777663 2 33 4444432  33  235


Q ss_pred             EEEeccccCCc
Q 022956           96 NFITEVCTSGN  106 (289)
Q Consensus        96 ~lv~e~~~~~s  106 (289)
                      ++|||++++..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            67999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.46  E-value=0.00023  Score=58.27  Aligned_cols=70  Identities=14%  Similarity=0.107  Sum_probs=42.1

Q ss_pred             ceEEEEeecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-----EeeeeEEeCCCCeeEEEeccccCC
Q 022956           31 KKVYRAFDQEEGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-----VCYSVWLDDQHNTLNFITEVCTSG  105 (289)
Q Consensus        31 g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-----~~~~~~~~~~~~~~~lv~e~~~~~  105 (289)
                      -.||++.. ++|..|++|+.+....  .   .+.+..|+..+..|...++.     ..-+..........+.++++++|.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~--s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCC--C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            37999965 5789999999875433  2   34466677777777533332     111111111234677789998874


Q ss_pred             c
Q 022956          106 N  106 (289)
Q Consensus       106 s  106 (289)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.77  E-value=0.0024  Score=53.33  Aligned_cols=74  Identities=15%  Similarity=0.129  Sum_probs=46.5

Q ss_pred             eeeecccCcceEEEEeecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhCCCCceE-EeeeeEEeCCCC
Q 022956           22 SDLLGSGAVKKVYRAFDQE-------EGIEVAWNQVRLSHFSEDPVLVNRLHSEVQLLRTLKNKYII-VCYSVWLDDQHN   93 (289)
Q Consensus        22 ~~~lg~g~~g~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~   93 (289)
                      .+.|+.|-.=.+|++....       .++.|.+++.....   ..   ....+|..+++.+...++. ++++++  ++  
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~~---idr~~E~~i~~~ls~~gl~Pkll~~~--~~--  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TE---SHLVAESVIFTLLSERHLGPKLYGIF--SG--  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CH---HHHHHHHHHHHHHHHTTSSSCEEEEE--TT--
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc---hh---hHHHHHHHHHHHHHhCCCCCeEEEEc--CC--
Confidence            4668777778899987543       24567777775221   22   2345688888888654554 455443  32  


Q ss_pred             eeEEEeccccCCcH
Q 022956           94 TLNFITEVCTSGNL  107 (289)
Q Consensus        94 ~~~lv~e~~~~~sL  107 (289)
                        .+|++|++|.++
T Consensus       117 --g~I~efi~g~~l  128 (395)
T d1nw1a_         117 --GRLEEYIPSRPL  128 (395)
T ss_dssp             --EEEECCCCEEEC
T ss_pred             --ceEEEEeccccC
Confidence              458999988644

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.40  E-value=0.004  Score=50.14  Aligned_cols=29  Identities=34%  Similarity=0.476  Sum_probs=25.4

Q ss_pred             CceecCCCCCceEEeCCCCcEEEeccCCcc
Q 022956          142 CIIHRDLNCSNIFINGNIGQVKIGDLGFAA  171 (289)
Q Consensus       142 ~~~h~dl~~~nili~~~~~~~~l~d~g~~~  171 (289)
                      +++|+|+.++||+++.+ ...-+.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGD-ELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccc-cceeEecccccc
Confidence            39999999999999988 567899998765